data_2l3t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l3t _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.9 mtp85 . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 120.863 0.363 . . . . 1.0 110.558 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.46 -27.47 41.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.565 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 13.3 pt -67.78 -40.77 84.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.435 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -107.2 14.01 26.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.432 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -46.97 145.97 2.99 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.422 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -49.98 -36.22 43.51 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.671 1.581 . . . . 1.0 112.226 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.61 ' CD2' ' CZ ' ' A' ' 30' ' ' PHE . 80.2 m-85 -82.7 -1.56 51.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.385 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.531 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 42.2 t80 -72.32 129.61 38.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.34 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 54.0 m-85 -148.69 115.92 3.85 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 120.9 -0.32 . . . . 1.0 110.43 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.477 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 73.1 Cg_endo -74.76 109.88 3.0 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.754 1.636 . . . . 1.0 112.703 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 76.5 m-85 -155.33 159.4 39.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.525 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -77.16 172.16 13.68 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.422 ' O ' ' OE2' ' A' ' 19' ' ' GLU . . . -61.67 -46.84 93.42 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.446 -0.883 . . . . 1.0 111.108 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.613 ' HE ' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -66.06 -41.52 90.69 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 121.038 -0.265 . . . . 1.0 111.164 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -66.09 -35.66 81.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.279 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.84 -44.98 96.25 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.308 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.544 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -65.78 -41.97 91.37 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.034 179.135 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.46 -41.64 97.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.212 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -63.07 -39.47 94.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.54 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.2 mp -79.57 -13.26 59.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.723 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -63.57 -42.95 98.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.731 -0.388 . . . . 1.0 110.47 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.0 t -76.65 -20.33 56.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.79 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -84.17 177.55 8.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.456 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -89.2 176.33 7.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.863 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -76.32 147.57 38.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.974 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.46 19.67 37.49 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -99.73 140.79 33.42 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.61 ' CZ ' ' CD2' ' A' ' 9' ' ' TYR . 7.1 p90 -134.68 168.56 18.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.338 0.589 . . . . 1.0 111.11 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -147.32 158.25 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.251 -0.886 . . . . 1.0 111.498 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -116.87 129.17 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -138.74 157.85 45.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.418 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -115.63 135.51 53.99 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.859 -0.423 . . . . 1.0 109.859 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.1 t -95.27 126.74 40.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.764 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 96.5 p -59.59 -37.68 79.18 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.598 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.3 -24.37 62.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.874 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -75.37 -63.24 2.54 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.689 -0.964 . . . . 1.0 110.689 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 t0 73.66 -40.19 0.46 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.694 0.283 . . . . 1.0 110.803 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 38' ' ' GLY . 92.3 m-20 -118.91 11.08 12.45 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.748 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -138.7 150.73 46.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.929 0.395 . . . . 1.0 110.205 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.04 154.19 33.51 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.064 -0.516 . . . . 1.0 109.727 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.7 t -124.39 130.01 73.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 1.0 110.079 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.7 mt -112.97 139.21 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.7 m -118.68 140.04 50.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.928 -0.578 . . . . 1.0 109.455 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -144.01 159.58 42.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.515 -0.766 . . . . 1.0 111.001 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.582 ' NZ ' ' O ' ' A' ' 50' ' ' LYS . 36.2 tttp -107.28 138.54 43.28 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.89 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.596 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 3.2 mp -95.85 -74.23 0.56 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.371 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 50' ' ' LYS . 66.9 t0 -159.66 140.08 12.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.336 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.582 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 2.9 ttmm 43.81 -152.92 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.083 0.468 . . . . 1.0 111.183 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.74 63.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.836 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 50' ' ' LYS . 17.2 tp -145.68 120.75 10.09 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.977 0.418 . . . . 1.0 110.278 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -134.18 149.16 51.0 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.36 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -137.97 153.49 49.44 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.76 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.479 ' ND1' ' N ' ' A' ' 55' ' ' HIS . 1.9 p-80 -126.61 142.37 51.56 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.153 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.5 mt -126.06 131.7 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -94.27 120.53 34.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.028 0.442 . . . . 1.0 110.726 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.1 mm -90.47 128.0 42.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.083 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 60' ' ' GLU . 3.4 tm0? -113.71 128.9 56.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.042 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.52 ' O ' ' NE2' ' A' ' 59' ' ' GLN . 1.9 pp20? -101.17 148.6 24.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.276 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 1.9 tt -142.66 173.1 11.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.475 -0.329 . . . . 1.0 110.919 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 2.0 tm-20 82.07 25.2 0.19 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.383 0.611 . . . . 1.0 110.05 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.643 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -80.49 117.1 20.92 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.794 0.807 . . . . 1.0 110.122 178.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -89.66 -33.43 16.64 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.834 -0.541 . . . . 1.0 110.539 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.05 165.4 18.0 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.073 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.5 -29.7 60.93 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.162 1.908 . . . . 1.0 112.242 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.9 mt -90.02 -1.35 57.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.535 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.25 134.45 34.87 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.278 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.4 mt -89.86 147.09 23.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.375 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.2 104.86 1.5 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -75.64 -13.43 60.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.772 0.32 . . . . 1.0 110.781 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.8 t -123.54 124.41 69.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.771 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.6 mt -117.07 133.32 56.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.52 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mp -102.41 124.61 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.825 0.345 . . . . 1.0 110.076 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -143.03 133.17 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.551 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.498 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 46.7 t0 53.44 46.49 26.13 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.985 -0.286 . . . . 1.0 111.046 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 76' ' ' ASP . 4.1 p30 56.75 18.68 3.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.977 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -125.12 147.26 49.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 1.0 110.135 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.86 127.92 44.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.224 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -120.46 139.91 52.16 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.18 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -84.51 -36.99 21.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.73 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -119.52 144.2 47.16 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.202 0.525 . . . . 1.0 111.989 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.7 tp -64.77 -39.38 93.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.764 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -60.19 -42.75 95.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 1.0 111.562 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -60.68 -37.87 83.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.58 0.229 . . . . 1.0 110.67 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.58 -47.41 92.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.901 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.75 -45.22 99.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.525 -0.47 . . . . 1.0 111.658 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.28 -43.29 74.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 112.626 0.602 . . . . 1.0 112.626 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -74.73 -15.81 60.76 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.721 -0.392 . . . . 1.0 111.862 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -94.8 -49.44 5.59 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.651 -0.419 . . . . 1.0 111.953 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.15 -40.35 78.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.228 0.455 . . . . 1.0 112.228 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -63.38 -49.2 74.74 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.797 -0.761 . . . . 1.0 111.556 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -72.67 -41.7 65.11 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.694 -0.403 . . . . 1.0 111.673 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -66.3 -41.48 89.69 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.334 -0.546 . . . . 1.0 111.389 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.99 -46.7 90.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.251 -0.58 . . . . 1.0 111.355 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -66.34 -44.27 83.78 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.495 -0.482 . . . . 1.0 111.744 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.4 tp -66.94 -43.86 82.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.42 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 tt -64.64 -43.23 94.34 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.302 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -68.11 -35.76 78.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.859 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -70.69 -41.86 71.45 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 120.776 -0.37 . . . . 1.0 111.777 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.598 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 5.2 ttt -67.81 -54.56 18.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.538 -0.465 . . . . 1.0 111.462 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.404 ' C ' ' H ' ' A' ' 104' ' ' SER . 16.8 m -58.45 -41.32 84.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.992 0.425 . . . . 1.0 110.301 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.9 m -72.37 8.09 1.51 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.863 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 101' ' ' MET . 60.2 p -85.6 140.18 30.81 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.823 0.344 . . . . 1.0 110.495 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.63 -22.15 66.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.674 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.55 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 24.8 mtmm -89.22 39.97 0.96 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.983 -0.553 . . . . 1.0 109.778 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -132.14 109.43 9.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.329 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -126.4 129.02 47.95 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.181 -0.463 . . . . 1.0 109.8 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.4 t -93.66 74.99 4.35 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.749 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.45 143.52 15.91 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.027 -0.829 . . . . 1.0 111.027 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 81.1 p -75.12 172.04 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.051 -0.351 . . . . 1.0 110.051 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -57.51 -41.2 80.36 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.419 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -68.48 -45.01 73.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.88 0.372 . . . . 1.0 110.754 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.13 -20.51 64.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.865 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.4 t -70.71 -45.52 73.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.808 0.337 . . . . 1.0 110.428 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.5 t -64.45 -45.33 96.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.148 0.499 . . . . 1.0 110.235 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -66.07 -34.3 77.76 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.942 0.401 . . . . 1.0 111.019 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -69.5 -49.2 56.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.999 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.0 tp -69.67 -39.59 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.42 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -65.37 -43.19 91.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.72 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.82 -48.24 77.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.311 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.501 ' CD2' ' OD1' ' A' ' 126' ' ' ASN . 47.1 t80 -62.91 -43.26 99.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.93 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 88.1 p -61.02 -35.38 76.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.226 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -62.36 -42.61 99.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.06 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.9 t -66.67 -30.4 49.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 1.0 109.849 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.501 ' OD1' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -128.21 74.26 79.49 Favored Pre-proline 0 N--CA 1.471 0.59 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.531 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -71.88 -24.53 20.97 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.801 2.334 . . . . 1.0 112.609 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -102.3 14.59 31.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.018 -0.537 . . . . 1.0 112.002 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -137.54 144.93 42.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.117 0.484 . . . . 1.0 110.313 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.1 p -80.89 163.09 23.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.014 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 p -152.21 147.26 15.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -143.39 142.09 31.12 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.895 0.378 . . . . 1.0 111.196 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -152.43 168.46 25.41 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.432 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.55 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.7 OUTLIER -138.1 157.53 46.14 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 179.187 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.8 p -151.61 168.38 25.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.292 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 51.5 tp -80.65 136.86 36.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.821 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 23.8 t-20 -95.12 138.48 32.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.333 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -91.31 -31.66 16.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.714 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.41 -24.55 64.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.235 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 4.5 m120 -141.67 81.0 15.41 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.268 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -58.82 134.55 61.13 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.12 1.88 . . . . 1.0 112.445 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.89 -28.62 14.04 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 110.999 -0.84 . . . . 1.0 110.999 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 10.4 m0 -95.54 147.21 23.8 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.856 0.36 . . . . 1.0 110.284 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.598 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 70.9 m-85 -111.61 149.81 30.97 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.035 -0.53 . . . . 1.0 109.812 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.538 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 14.4 m-85 -120.08 136.13 54.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.22 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 16.5 mt -107.96 124.78 50.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.424 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.58 146.76 46.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.885 -1.154 . . . . 1.0 107.885 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -162.05 152.44 17.12 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.592 -0.522 . . . . 1.0 109.592 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.535 ' NZ ' ' O ' ' A' ' 154' ' ' SER . 37.5 tttp -136.41 129.5 31.29 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.472 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.416 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 4.8 mp -72.49 -46.22 56.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.266 0.469 . . . . 1.0 112.266 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 150' ' ' ILE . 85.2 m-20 -156.95 170.15 23.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.573 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.08 71.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.947 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -89.01 6.68 38.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.433 . . . . 1.0 110.454 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.535 ' O ' ' NZ ' ' A' ' 149' ' ' LYS . 18.0 t -97.31 154.6 17.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.476 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -84.39 145.95 27.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.104 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.5 tp -70.63 126.28 29.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.958 0.409 . . . . 1.0 109.991 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -113.85 132.64 55.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.944 -0.571 . . . . 1.0 109.927 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 97.2 m -129.86 131.28 46.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.818 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.03 163.93 15.87 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.03 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.538 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 58.8 m-20 -111.9 148.85 32.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.695 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.65 137.58 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -100.17 132.36 45.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.98 0.419 . . . . 1.0 110.623 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.9 tp -92.62 131.26 37.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.662 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.0 p -130.38 171.18 13.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.482 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -84.63 15.66 3.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.759 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 2.1 m -122.66 -3.13 8.79 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.96 0.41 . . . . 1.0 110.685 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 141.01 -136.04 7.3 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -117.47 129.08 55.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.641 0.258 . . . . 1.0 110.35 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -106.38 119.84 40.33 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.0 tt -116.68 117.48 29.93 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.403 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.7 t 35.46 56.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.338 0.495 . . . . 1.0 112.338 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.5 m120 69.57 28.15 4.64 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.247 0.832 . . . . 1.0 113.247 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -134.31 121.01 20.63 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -90.83 127.66 36.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.226 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -115.16 91.59 28.17 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.32 -20.04 14.16 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.553 2.168 . . . . 1.0 113.291 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 72.1 m -133.1 138.49 46.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.044 0.45 . . . . 1.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.38 -34.4 60.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.777 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.16 -43.47 96.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -65.17 -34.62 78.83 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.8 tp -64.56 -41.36 96.36 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.389 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 77.8 m -61.29 -47.37 86.27 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 120.559 -0.456 . . . . 1.0 110.616 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 186' ' ' LYS . 62.8 t-20 -69.03 -48.4 63.02 Favored 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 119.647 -0.821 . . . . 1.0 108.915 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.51 -45.48 0.5 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.914 -1.274 . . . . 1.0 109.914 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -68.86 -47.76 65.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.061 -0.57 . . . . 1.0 109.64 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' A' ' 183' ' ' ASN . 47.0 tttp -56.77 -41.29 77.36 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.014 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 18.1 m -63.81 -44.56 92.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.429 ' O ' ' OG ' ' A' ' 191' ' ' SER . 15.4 mt -62.92 -43.28 99.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.006 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.7 tp -59.82 -43.36 94.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.34 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.39 -43.21 99.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.425 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 188' ' ' LEU . 18.2 p -65.49 -37.66 87.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.066 0.46 . . . . 1.0 110.803 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 24.4 mt -64.0 -41.01 97.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.692 -0.686 . . . . 1.0 111.818 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.72 -25.33 68.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.464 -0.334 . . . . 1.0 111.817 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 120.656 0.265 . . . . 1.0 110.987 -179.495 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 83.6 mtm-85 . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 120.896 0.379 . . . . 1.0 110.368 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.5 p -64.52 -30.98 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.55 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.6 pt -72.4 -20.96 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.658 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -96.34 7.35 46.68 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.428 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.63 141.23 64.58 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.321 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.76 -21.12 58.7 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.75 1.633 . . . . 1.0 112.181 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.88 3.22 49.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.214 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -83.68 132.4 34.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.569 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -152.41 118.14 3.03 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 120.931 -0.308 . . . . 1.0 110.247 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.49 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 72.5 Cg_endo -74.91 112.04 3.47 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.732 1.621 . . . . 1.0 112.659 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.49 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 70.2 m-85 -159.8 158.21 30.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.399 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -80.09 176.4 9.78 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.45 -50.33 67.74 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.373 -0.917 . . . . 1.0 110.988 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -66.01 -41.36 91.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.764 0.316 . . . . 1.0 110.956 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.412 ' OE1' ' N ' ' A' ' 17' ' ' GLN . 7.4 mp0 -62.8 -37.04 85.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.09 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.87 -44.52 95.9 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.508 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -60.82 -48.18 82.99 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.669 -0.412 . . . . 1.0 109.925 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -61.7 -40.22 94.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.201 -0.454 . . . . 1.0 109.899 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -61.96 -39.31 91.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.243 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.9 mp -82.15 -13.83 56.59 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.846 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.6 ttp85 -65.11 -41.16 95.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.852 0.358 . . . . 1.0 110.336 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.3 m -78.17 -19.86 53.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.875 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -85.12 -179.84 7.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.823 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -81.78 165.49 20.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.813 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -75.75 145.77 40.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.778 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 17.92 49.46 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.982 -0.847 . . . . 1.0 110.982 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -85.16 147.56 26.55 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -129.65 153.38 48.16 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.308 0.575 . . . . 1.0 111.098 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -144.55 153.91 14.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.187 -0.915 . . . . 1.0 111.211 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 32' ' ' ILE . 14.1 mm -115.49 131.19 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -133.74 151.69 51.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.997 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -109.93 130.66 55.5 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.17 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.8 t -82.72 162.82 21.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.579 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.9 p -111.7 -10.97 14.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.717 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -80.79 -30.18 35.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.165 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.656 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . -115.74 -12.14 9.68 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.01 -64.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.978 0.458 . . . . 1.0 110.405 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.656 ' N ' ' O ' ' A' ' 38' ' ' GLY . 24.8 t0 -78.45 12.47 1.96 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.441 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -117.19 142.4 47.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.83 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.25 148.33 44.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.344 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.9 t -123.49 130.2 74.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.781 -0.452 . . . . 1.0 109.781 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.3 mt -110.62 136.88 45.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 94.0 m -118.39 140.98 49.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.536 -0.756 . . . . 1.0 109.344 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -147.94 151.37 35.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.968 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -96.51 140.62 30.87 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.746 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.494 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 9.5 mp -99.57 -68.74 0.79 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.342 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -137.32 -153.19 0.47 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.226 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -68.64 136.46 53.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.667 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 42.08 43.54 2.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.848 -0.615 . . . . 1.0 111.111 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.5 tp -140.44 122.71 15.88 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.942 0.401 . . . . 1.0 109.952 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.432 ' O ' ' OE1' ' A' ' 54' ' ' GLN . 47.8 m-85 -133.22 150.1 51.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.583 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.432 ' OE1' ' O ' ' A' ' 53' ' ' PHE . 16.0 mm100 -138.57 150.22 46.09 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.667 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -125.05 138.9 54.19 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.213 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.7 mt -123.84 129.78 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 41.2 p-10 -95.5 121.03 36.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.934 0.397 . . . . 1.0 111.243 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.3 mm -98.42 122.48 50.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.032 -0.531 . . . . 1.0 109.99 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -117.4 132.28 56.6 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.813 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -98.96 153.64 18.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.342 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.8 tp -145.14 -179.07 6.39 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.567 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 20.5 tt0 70.66 42.89 0.79 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.991 -0.55 . . . . 1.0 109.705 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -83.75 102.22 12.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.78 -0.645 . . . . 1.0 109.844 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.435 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 80.6 mm-40 -68.45 -28.42 67.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.67 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 64' ' ' GLU . 2.6 m-80 -158.01 163.79 23.44 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.226 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.58 -32.04 52.1 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.12 1.88 . . . . 1.0 112.371 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.61 -5.28 57.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.826 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.73 134.28 51.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.327 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.7 mt -83.7 156.19 22.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.379 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.91 86.84 0.05 OUTLIER Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.455 -1.058 . . . . 1.0 110.455 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.27 -39.49 86.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.969 0.414 . . . . 1.0 111.067 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 51.0 t -117.13 123.92 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.768 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.3 mt -116.14 129.3 56.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.243 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.409 HG23 HD12 ' A' ' 74' ' ' ILE . 84.4 mt -101.29 125.67 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -140.91 130.24 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.313 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.426 ' OD1' ' OD1' ' A' ' 165' ' ' ASN . 15.5 t70 53.28 46.4 26.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.231 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.8 m120 57.63 16.03 3.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.895 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -120.63 136.29 54.87 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.948 0.404 . . . . 1.0 110.045 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -89.84 127.59 36.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.738 -0.665 . . . . 1.0 111.102 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -118.27 142.86 47.05 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.199 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -83.45 -37.52 23.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.817 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 50.7 t0 -129.66 153.69 47.87 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.242 0.544 . . . . 1.0 111.819 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.429 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 54.0 tp -63.98 -38.78 92.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.791 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.69 -45.47 89.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.562 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -61.18 -37.31 82.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.687 0.28 . . . . 1.0 110.641 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -58.87 -47.63 88.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.659 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.8 mm -62.99 -44.82 99.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.476 -0.489 . . . . 1.0 111.678 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.85 -43.52 96.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 112.372 0.508 . . . . 1.0 112.372 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -72.96 -21.29 60.89 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.577 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.55 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 2.2 t80 -89.35 -51.29 5.64 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.176 -0.61 . . . . 1.0 111.485 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.69 -42.69 99.77 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.629 -0.429 . . . . 1.0 111.832 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -63.54 -50.79 68.15 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.691 -0.803 . . . . 1.0 111.446 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -68.94 -42.66 76.41 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.715 -0.394 . . . . 1.0 111.54 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -65.31 -44.32 88.24 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.162 -0.615 . . . . 1.0 111.318 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.3 t -66.53 -44.22 90.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.406 -0.518 . . . . 1.0 111.205 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -67.25 -45.18 77.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.482 -0.327 . . . . 1.0 111.353 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.21 -44.59 91.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.583 -0.281 . . . . 1.0 111.649 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.2 tp -63.56 -40.55 97.28 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.021 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.4 ' O ' ' CB ' ' A' ' 103' ' ' SER . 92.7 m-20 -67.21 -42.42 84.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.77 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -64.38 -43.18 95.27 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 121.983 -0.448 . . . . 1.0 111.545 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.5 ttm -67.63 -56.23 10.21 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.42 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 104' ' ' SER . 20.2 m -59.54 -44.17 93.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.032 0.444 . . . . 1.0 110.815 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 7.6 t -72.99 11.73 0.64 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.68 -0.691 . . . . 1.0 111.298 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 102' ' ' THR . 8.3 t -92.89 135.48 34.11 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.87 0.367 . . . . 1.0 110.248 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.58 -21.14 66.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.942 0.401 . . . . 1.0 111.17 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.537 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 52.9 mttp -89.87 41.09 1.03 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.919 -0.582 . . . . 1.0 109.903 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -133.34 115.25 14.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.2 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -134.43 120.87 20.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.786 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.0 m -90.25 82.44 6.0 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.914 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.76 150.99 17.12 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.848 -0.901 . . . . 1.0 110.848 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.475 ' HG1' ' H ' ' A' ' 114' ' ' ASP . 9.0 p -79.41 173.96 12.05 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.033 -0.358 . . . . 1.0 110.033 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.652 ' HZ3' ' CD2' ' A' ' 138' ' ' HIS . 16.0 mtmm -59.39 -37.6 78.4 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.821 -0.352 . . . . 1.0 110.684 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -68.27 -43.25 78.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.052 0.453 . . . . 1.0 110.562 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.475 ' H ' ' HG1' ' A' ' 111' ' ' THR . 31.4 m-20 -70.63 -19.19 62.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.73 -0.668 . . . . 1.0 111.067 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.2 t -70.74 -45.34 74.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.704 -0.398 . . . . 1.0 110.13 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.99 -45.43 90.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-O 121.333 0.587 . . . . 1.0 110.251 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -65.84 -37.88 87.38 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.931 0.396 . . . . 1.0 111.326 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -69.43 -47.82 62.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.913 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.8 tp -69.64 -39.89 78.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.397 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.472 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 61.1 mm-40 -64.56 -42.76 95.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.728 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.13 -48.16 77.16 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.298 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CD1' ' OD1' ' A' ' 126' ' ' ASN . 30.0 t80 -62.34 -43.76 98.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.137 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.1 t -59.58 -40.4 87.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.096 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -58.48 -42.59 87.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 1.0 109.939 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.0 t -64.03 -37.98 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.445 ' OD1' ' CD1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -124.62 76.83 63.91 Favored Pre-proline 0 N--CA 1.473 0.704 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.351 179.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.487 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 7.1 Cg_exo -71.17 -27.29 20.2 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.634 2.223 . . . . 1.0 112.621 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -100.51 11.33 39.69 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.885 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -131.46 146.22 52.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.188 0.518 . . . . 1.0 110.433 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.8 m -80.83 163.52 23.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.537 -0.756 . . . . 1.0 109.913 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 p -151.24 145.65 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -145.89 142.24 28.59 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.912 0.387 . . . . 1.0 111.112 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -152.47 167.8 27.6 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.347 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -132.2 156.31 46.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 179.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.5 p -152.93 169.64 22.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.447 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 137' ' ' ASN . 54.0 tp -77.04 136.33 38.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.546 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.536 ' OD1' ' ND2' ' A' ' 140' ' ' ASN . 11.0 t-20 -44.08 170.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.403 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.652 ' CD2' ' HZ3' ' A' ' 112' ' ' LYS . 57.1 t-80 -77.26 -56.45 4.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.038 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 139' ' ' ASP . 66.5 t0 -139.6 45.25 1.93 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.981 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.536 ' ND2' ' OD1' ' A' ' 137' ' ' ASN . 1.3 m-80 -136.87 102.47 9.29 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 109.905 -0.405 . . . . 1.0 109.905 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -75.19 120.59 6.07 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.944 1.762 . . . . 1.0 112.608 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.16 20.68 22.57 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.886 -0.886 . . . . 1.0 110.886 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -134.44 139.86 45.83 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.873 0.368 . . . . 1.0 110.281 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -132.5 160.04 37.65 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.841 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 145' ' ' TYR . 8.1 p90 -142.11 146.94 35.95 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.2 mt -106.36 126.57 52.41 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.136 0.493 . . . . 1.0 110.366 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -116.86 144.83 44.05 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.928 -1.138 . . . . 1.0 107.928 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 148' ' ' PHE . 13.3 p90 -162.8 154.19 17.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.549 -0.538 . . . . 1.0 109.549 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.472 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 69.2 tttt -135.13 131.13 36.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.468 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.486 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 38.6 mm -72.41 -45.61 59.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.994 0.368 . . . . 1.0 111.994 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 27.8 m120 -161.61 173.06 15.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.577 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.52 -34.44 75.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.071 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.75 -12.96 55.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.588 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.4 t -79.82 158.71 26.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.32 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -89.77 150.58 22.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 1.0 109.98 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.6 tp -71.07 124.75 25.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.872 0.368 . . . . 1.0 110.211 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -110.91 129.3 55.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.667 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 91.1 m -131.24 131.43 43.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.114 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.75 166.15 13.13 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -107.97 142.45 38.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.114 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.5 t -122.3 138.29 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -106.01 135.15 47.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.034 0.445 . . . . 1.0 110.742 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.6 131.69 45.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.688 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.2 p -134.83 178.01 7.34 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.349 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.55 ' ND2' ' CE1' ' A' ' 90' ' ' TYR . 5.3 m120 -86.78 14.59 6.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.717 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 17.9 p -119.01 -1.12 11.01 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.483 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.74 -131.35 5.84 Favored Glycine 0 N--CA 1.465 0.59 0 N-CA-C 110.25 -1.14 . . . . 1.0 110.25 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -121.8 127.28 50.42 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -102.29 123.83 46.79 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.4 tt -117.96 111.79 19.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.519 -0.549 . . . . 1.0 109.519 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.5 t 35.94 59.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.175 0.435 . . . . 1.0 112.175 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.8 m120 69.4 27.52 4.97 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.98 0.733 . . . . 1.0 112.98 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -134.13 120.59 20.32 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -95.91 126.68 41.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.238 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -108.9 99.29 34.21 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 109.573 -0.528 . . . . 1.0 109.573 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.15 -21.57 9.51 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.382 2.055 . . . . 1.0 113.444 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 38.5 m -132.92 139.07 47.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.041 0.448 . . . . 1.0 111.253 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.96 -35.61 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.617 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.516 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 95.4 mt -63.32 -43.36 98.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 1.0 110.054 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.639 ' N ' ' NE2' ' A' ' 180' ' ' GLN . 0.6 OUTLIER -63.11 -31.46 72.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.224 -0.658 . . . . 1.0 109.224 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.78 -41.9 97.86 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.327 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . 0.63 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 3.0 p -58.96 -47.98 83.15 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.617 -0.433 . . . . 1.0 110.629 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.63 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 48.3 t30 -69.52 -48.91 58.95 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.44 -44.78 0.45 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.756 -1.338 . . . . 1.0 109.756 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -68.83 -47.44 66.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.052 -0.574 . . . . 1.0 109.76 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.574 ' N ' ' O ' ' A' ' 183' ' ' ASN . 88.8 tttt -57.03 -42.27 80.14 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.362 -0.836 . . . . 1.0 110.116 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 96.7 m -61.71 -44.33 97.14 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 53.1 mt -61.73 -41.57 97.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.773 -0.648 . . . . 1.0 109.928 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 59.2 tp -58.95 -44.15 91.4 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.388 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 16.5 tptp -62.01 -43.98 97.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.474 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.0 t -63.33 -38.45 91.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.363 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.4 mt -63.76 -42.08 97.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.829 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.41 -30.09 66.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.56 -0.291 . . . . 1.0 111.67 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.843 -179.123 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.435 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 41.1 mmm-85 . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 120.839 0.352 . . . . 1.0 110.503 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.83 -27.93 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.653 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.2 pt -76.49 -18.76 14.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.536 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 3' ' ' ARG . 56.1 p30 -99.35 7.44 45.55 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.485 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -84.99 138.49 37.12 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 110.091 -0.337 . . . . 1.0 110.091 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.59 -13.32 32.48 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.889 1.726 . . . . 1.0 112.342 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.418 ' CD1' ' CZ ' ' A' ' 30' ' ' PHE . 40.4 m-85 -99.35 10.68 40.95 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.572 -0.286 . . . . 1.0 111.069 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.532 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 91.0 t80 -85.98 123.36 31.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.316 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 49.5 m-85 -146.5 108.92 4.15 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 110.092 -0.336 . . . . 1.0 110.092 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.508 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 45.3 Cg_exo -58.88 109.57 0.54 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 121.697 1.598 . . . . 1.0 112.48 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 23.4 m-85 -159.48 155.69 26.95 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.626 -0.716 . . . . 1.0 110.555 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 18.8 t-20 -84.03 164.04 19.54 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.295 -0.631 . . . . 1.0 109.295 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . -61.14 -40.81 99.06 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.569 -0.824 . . . . 1.0 111.095 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -66.73 -43.97 82.81 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.911 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -69.46 -36.0 76.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.392 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -39.49 90.09 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.304 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -60.43 -44.07 96.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.081 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -61.57 -42.45 98.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.281 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -63.05 -42.16 99.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.59 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mp -77.67 -13.59 59.86 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.295 -0.411 . . . . 1.0 111.081 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -58.49 -42.83 88.46 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.385 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p -79.48 -18.4 52.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -82.54 177.91 8.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.499 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 56.4 mp0 -90.01 173.23 8.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.77 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 ptt-85 -81.19 145.01 31.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.727 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.94 -1.39 55.2 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -82.1 147.82 28.88 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.418 ' CZ ' ' CD1' ' A' ' 9' ' ' TYR . 13.7 p90 -133.47 163.17 29.97 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.353 0.597 . . . . 1.0 110.961 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.88 157.95 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.21 -0.904 . . . . 1.0 111.298 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.8 mt -117.53 127.47 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.109 -0.496 . . . . 1.0 109.715 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -146.46 153.29 40.26 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.394 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -104.93 139.6 39.41 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.735 -0.468 . . . . 1.0 109.735 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -67.69 149.58 49.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.796 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 t -63.77 -20.5 65.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.966 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -125.01 10.18 8.17 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.574 -0.285 . . . . 1.0 110.684 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.57 -56.93 8.76 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t0 67.54 -51.33 0.5 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.734 0.302 . . . . 1.0 110.874 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -122.05 4.92 9.84 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.008 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -120.16 149.96 41.4 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.042 0.449 . . . . 1.0 110.517 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.423 ' CD1' ' OE2' ' A' ' 60' ' ' GLU . 5.2 mp -121.45 147.5 45.66 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.096 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -126.5 132.13 70.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.0 mt -113.74 139.83 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 108.837 -0.801 . . . . 1.0 108.837 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.2 m -120.4 142.39 49.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.035 -0.53 . . . . 1.0 109.692 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -147.68 151.6 36.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.977 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -99.66 140.33 34.01 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.87 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 9.0 mp -105.77 -82.08 0.53 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.605 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -93.81 -178.67 4.75 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.801 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -57.48 -40.48 78.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.667 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -127.51 53.45 1.75 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.092 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tp -151.42 128.22 10.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.898 0.38 . . . . 1.0 110.195 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -132.31 148.72 52.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.535 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.476 ' NE2' ' O ' ' A' ' 141' ' ' PRO . 94.2 mt-30 -137.79 152.61 49.32 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.972 -0.558 . . . . 1.0 109.628 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -129.31 144.9 51.41 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.201 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 56' ' ' ILE . 96.6 mt -126.27 130.82 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.842 -0.429 . . . . 1.0 109.842 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 43.7 p-10 -99.84 124.81 45.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.899 0.38 . . . . 1.0 110.633 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 58' ' ' ILE . 90.1 mt -102.21 133.05 46.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.48 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -119.96 134.84 55.12 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.853 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.423 ' OE2' ' CD1' ' A' ' 42' ' ' LEU . 3.6 mt-10 -100.09 143.91 29.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.145 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.4 mt -141.22 174.8 10.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.413 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 74.05 35.36 0.78 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.957 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -95.12 103.14 14.99 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.021 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.3 -31.84 72.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.837 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -147.67 155.84 45.01 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.265 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.98 -31.96 46.06 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.199 1.933 . . . . 1.0 112.079 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tp -79.69 -10.82 59.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.881 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.73 136.23 45.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.494 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 71' ' ' LYS . 64.7 mt -81.44 154.23 26.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.312 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.6 86.01 0.01 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.427 -1.069 . . . . 1.0 110.427 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 69' ' ' LEU . 68.3 mttm -61.35 -35.65 78.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.997 0.427 . . . . 1.0 110.823 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.4 t -127.62 124.16 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.798 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.0 mt -114.77 126.44 54.84 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.8 mt -102.18 123.1 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.84 0.353 . . . . 1.0 110.24 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.2 t -143.45 132.72 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.138 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 54.49 43.66 29.99 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.954 -0.299 . . . . 1.0 111.05 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.6 m120 57.98 19.96 6.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.708 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -128.32 139.12 52.57 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.873 0.368 . . . . 1.0 110.33 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -89.15 133.18 34.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.041 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -124.52 138.23 54.35 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.131 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -81.92 -37.32 26.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 1.0 111.62 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -123.22 149.91 44.09 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.124 0.487 . . . . 1.0 111.887 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.2 tp -65.74 -40.76 92.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.825 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -59.44 -43.54 93.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.905 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -56.93 -38.62 73.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.566 0.222 . . . . 1.0 110.633 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.22 -44.65 99.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.619 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.01 -46.16 97.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.52 -0.472 . . . . 1.0 111.647 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.98 -41.42 59.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 112.677 0.621 . . . . 1.0 112.677 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -78.5 -13.35 59.88 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.948 -0.301 . . . . 1.0 111.401 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -94.39 -49.3 5.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.113 0.412 . . . . 1.0 112.113 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 mp -71.68 -38.08 70.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.965 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -62.07 -48.26 81.0 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.968 -0.693 . . . . 1.0 111.215 -177.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.04 -42.35 69.61 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.848 -0.341 . . . . 1.0 111.683 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -66.05 -42.33 89.64 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.503 -0.479 . . . . 1.0 111.169 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 68.6 t -63.63 -47.86 89.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.347 -0.541 . . . . 1.0 111.214 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -69.93 -42.54 73.14 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.578 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.7 tp -68.63 -41.93 78.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.428 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.2 tp -62.92 -43.41 98.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.031 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.4 ' O ' ' OG ' ' A' ' 103' ' ' SER . 85.3 m-20 -66.14 -39.98 90.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.788 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -70.06 -41.61 73.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.398 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.402 ' HB2' ' HH ' ' A' ' 168' ' ' TYR . 1.6 tpt -64.22 -56.36 15.23 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.456 -0.498 . . . . 1.0 111.369 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.423 ' C ' ' H ' ' A' ' 104' ' ' SER . 14.0 m -60.69 -39.46 88.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.043 0.449 . . . . 1.0 110.51 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 99' ' ' ASN . 91.8 p -73.16 11.26 0.76 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.767 -0.651 . . . . 1.0 111.117 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 102' ' ' THR . 13.8 t -90.5 138.02 31.89 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.259 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.67 -20.1 63.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.194 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.582 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 64.3 mttp -87.99 39.12 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.691 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -129.17 110.14 11.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.372 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.56 122.94 37.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.206 -0.452 . . . . 1.0 109.884 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.6 m -95.0 72.83 3.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.118 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.58 151.28 16.93 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.953 -0.859 . . . . 1.0 110.953 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.35 175.84 6.55 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.032 -0.359 . . . . 1.0 110.032 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt -56.11 -37.79 69.89 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.95 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -68.47 -42.73 78.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.097 0.475 . . . . 1.0 110.729 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -70.28 -23.0 62.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.112 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.3 t -69.39 -45.74 78.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.158 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.1 t -65.92 -45.75 90.31 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 CA-C-O 121.158 0.504 . . . . 1.0 110.548 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.99 -33.06 74.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.794 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -68.61 -50.01 54.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.618 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.0 tp -70.03 -39.22 77.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.851 0.358 . . . . 1.0 110.253 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -64.97 -40.12 94.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.455 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -59.9 -47.53 85.4 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.686 -0.405 . . . . 1.0 110.286 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -60.98 -40.62 94.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.076 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 7.4 t -62.18 -41.72 98.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.548 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -59.49 -43.52 93.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.297 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.38 -41.96 92.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.71 76.29 77.26 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.488 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.537 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 10.2 Cg_exo -68.03 -21.14 43.57 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.857 2.372 . . . . 1.0 112.641 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -102.45 13.76 33.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.838 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -128.05 152.8 47.52 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.107 0.479 . . . . 1.0 110.379 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.1 p -81.39 161.16 23.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.637 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.1 p -154.89 146.12 13.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 20.7 p90 -151.4 142.06 22.73 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.834 0.35 . . . . 1.0 111.026 178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -152.62 168.14 26.58 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.393 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 5.1 p90 -136.46 157.19 47.38 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.257 -0.645 . . . . 1.0 109.257 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.2 p -149.27 168.58 22.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.815 0.34 . . . . 1.0 110.184 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 46.7 tp -79.26 144.46 34.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.355 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 0.0 OUTLIER -67.56 -172.82 0.27 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.026 -0.534 . . . . 1.0 109.999 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.516 ' N ' ' ND1' ' A' ' 138' ' ' HIS . 0.2 OUTLIER -110.31 -56.59 2.32 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.941 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.441 ' OD1' ' ND2' ' A' ' 140' ' ' ASN . 41.8 p-10 -114.09 19.88 16.1 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.082 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.529 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 7.5 m-80 -125.06 68.36 56.33 Favored Pre-proline 0 N--CA 1.466 0.344 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.236 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.476 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 26.1 Cg_endo -63.13 127.71 20.93 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.989 1.793 . . . . 1.0 112.46 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.36 11.56 41.46 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 110.761 -0.936 . . . . 1.0 110.761 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.524 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 57.7 m95 -132.95 156.54 47.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.818 0.342 . . . . 1.0 110.092 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -129.67 148.65 51.58 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.479 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 18.3 m-85 -116.84 136.13 53.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.063 0.459 . . . . 1.0 110.193 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.2 mt -109.77 124.61 51.57 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.302 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -121.48 147.52 45.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.053 -1.092 . . . . 1.0 108.053 178.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -160.18 150.74 18.64 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.608 -0.515 . . . . 1.0 109.608 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -136.23 128.34 29.73 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.851 -0.34 . . . . 1.0 110.521 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.5 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 34.3 mm -69.99 -45.79 75.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.421 -0.354 . . . . 1.0 111.716 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 31.1 m120 -158.94 173.68 16.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.559 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.11 -34.6 76.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.79 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -86.86 9.2 19.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.041 0.448 . . . . 1.0 110.46 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 13.1 t -98.59 165.92 11.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.431 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -96.79 145.58 25.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.929 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.04 121.45 22.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.063 0.459 . . . . 1.0 109.931 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -111.67 128.09 55.96 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.91 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.9 m -123.76 127.61 48.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.778 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.53 171.67 7.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.024 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.479 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 93.6 m-20 -109.51 149.17 30.01 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.836 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 45.8 t -126.35 136.92 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -104.88 125.8 51.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.021 0.439 . . . . 1.0 110.715 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 46.2 tp -88.6 129.8 35.41 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.399 -0.593 . . . . 1.0 109.399 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.3 p -128.34 171.83 11.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.408 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.689 HD21 ' H ' ' A' ' 165' ' ' ASN . 0.1 OUTLIER -83.98 16.09 3.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.512 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 67.0 p -122.71 -2.94 8.78 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.555 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 139.93 -128.69 3.99 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.453 -1.059 . . . . 1.0 110.453 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.402 ' HH ' ' HB2' ' A' ' 101' ' ' MET . 46.2 m-85 -123.81 127.35 47.96 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.729 0.299 . . . . 1.0 110.445 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -103.58 123.99 47.97 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 171' ' ' VAL . 0.5 OUTLIER -115.14 112.46 22.57 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.208 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 170' ' ' LEU . 5.2 t 34.74 64.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 7.7 m120 65.0 27.39 12.64 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.012 0.745 . . . . 1.0 113.012 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -132.42 121.58 23.65 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.176 -0.675 . . . . 1.0 109.176 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -94.61 123.44 38.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.822 0.344 . . . . 1.0 111.427 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -103.47 134.96 19.47 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.01 -23.21 22.02 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.037 1.825 . . . . 1.0 113.377 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 70.8 m -156.45 161.28 40.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.952 0.406 . . . . 1.0 111.035 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.12 -42.01 91.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.853 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 48.1 mm -60.29 -47.4 92.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.722 -0.391 . . . . 1.0 110.299 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -62.02 -35.92 80.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.8 tt -62.96 -40.1 96.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.271 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 72.8 m -60.77 -47.76 84.84 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.579 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.639 ' O ' ' N ' ' A' ' 186' ' ' LYS . 56.8 t-20 -66.82 -47.37 72.25 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.58 -45.5 0.51 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.954 -1.259 . . . . 1.0 109.954 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.49 ' O ' ' HG ' ' A' ' 188' ' ' LEU . 0.3 OUTLIER -69.84 -41.82 74.4 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-O 121.913 0.863 . . . . 1.0 109.762 178.25 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.639 ' N ' ' O ' ' A' ' 183' ' ' ASN . 87.9 tttt -60.84 -34.24 74.28 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.87 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.1 m -64.09 -51.59 63.3 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.899 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 185' ' ' PHE . 0.9 OUTLIER -65.57 -35.67 81.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.123 179.001 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.419 ' N ' ' HG ' ' A' ' 188' ' ' LEU . 37.1 tp -57.27 -46.47 83.06 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.172 -0.467 . . . . 1.0 109.97 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.51 -39.82 94.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.136 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.7 t -59.9 -36.43 76.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.498 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.5 mt -67.85 -41.6 82.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.785 -0.643 . . . . 1.0 112.208 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.1 -36.98 83.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.771 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . 0.495 ' O ' ' ND1' ' A' ' 194' ' ' HIS . 2.4 t-80 . . . . . 0 C--N 1.324 -0.514 0 CA-C-O 120.843 0.354 . . . . 1.0 110.85 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.6 ttp-105 . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 120.85 0.357 . . . . 1.0 110.351 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.2 p -66.38 -32.6 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.669 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 pt -67.26 -24.07 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.672 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -93.59 0.76 56.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.397 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -64.27 130.75 94.77 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.221 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -47.64 -32.36 16.15 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.705 1.603 . . . . 1.0 112.516 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -85.32 9.66 14.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.372 -0.377 . . . . 1.0 111.181 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.505 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 80.6 t80 -89.95 129.83 36.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.467 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 61.7 m-85 -149.24 127.6 5.92 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 110.2 -0.296 . . . . 1.0 110.2 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 73.7 Cg_endo -73.24 109.9 2.94 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.901 1.734 . . . . 1.0 112.724 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 71.4 m-85 -160.89 151.78 18.56 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.489 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -76.26 -170.05 1.34 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.95 -44.53 8.17 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.546 -1.021 . . . . 1.0 110.546 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -67.02 -43.77 81.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.664 0.268 . . . . 1.0 111.025 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -65.2 -33.89 77.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.057 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.15 -39.47 90.2 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.741 -0.383 . . . . 1.0 110.326 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.25 -42.08 96.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.043 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.37 -44.39 96.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.439 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -63.32 -42.23 98.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.35 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.9 mp -73.29 -12.79 60.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.805 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -58.97 -40.73 85.63 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.357 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.6 t -75.82 -18.71 59.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.766 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.482 ' N ' ' CD ' ' A' ' 25' ' ' LYS . 3.1 mptp? -83.5 179.89 7.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.438 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.407 ' OE1' ' O ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -104.37 -176.01 2.96 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.367 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.407 ' O ' ' OE1' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -75.08 143.26 43.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.458 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.47 7.54 57.98 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.844 -0.902 . . . . 1.0 110.844 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -87.0 140.58 29.41 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -135.85 162.13 33.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.253 0.549 . . . . 1.0 110.92 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.2 m -147.44 158.65 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.155 -0.93 . . . . 1.0 111.612 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.0 mt -117.69 127.21 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -146.98 155.29 42.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.463 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.79 137.27 45.14 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.479 ' HG ' ' H ' ' A' ' 37' ' ' ARG . 30.9 t -74.75 144.85 43.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.974 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.0 p -64.83 -30.21 71.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.723 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.479 ' H ' ' HG ' ' A' ' 35' ' ' SER . 10.7 mpt_? -102.35 0.79 34.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.707 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.99 -56.47 5.29 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.428 -1.069 . . . . 1.0 110.428 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 72.64 -54.6 0.69 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.561 0.22 . . . . 1.0 111.024 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.515 ' OD1' ' CD2' ' A' ' 41' ' ' HIS . 55.2 p-10 -119.52 2.41 11.22 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.756 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.515 ' CD2' ' OD1' ' A' ' 40' ' ' ASP . 38.3 m170 -117.9 150.47 39.15 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.869 0.366 . . . . 1.0 110.566 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.03 151.76 38.52 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 116.004 -0.544 . . . . 1.0 109.912 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.1 t -126.05 132.95 70.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.26 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.2 mt -111.86 137.88 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.0 m -117.48 136.82 52.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.841 -0.618 . . . . 1.0 109.846 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.409 ' CH2' ' CD2' ' A' ' 48' ' ' LEU . 1.3 p-90 -146.22 147.2 31.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.496 -0.774 . . . . 1.0 110.921 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.554 ' HZ1' ' C ' ' A' ' 49' ' ' ASP . 64.7 tttm -93.84 140.66 29.41 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.075 -0.512 . . . . 1.0 111.255 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.409 ' CD2' ' CH2' ' A' ' 46' ' ' TRP . 82.0 mt -97.27 -66.25 0.91 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.486 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.554 ' C ' ' HZ1' ' A' ' 47' ' ' LYS . 4.6 p30 -144.56 -166.64 2.44 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.607 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -59.18 131.63 51.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.972 0.415 . . . . 1.0 110.682 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 49.87 52.79 13.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.907 -0.588 . . . . 1.0 111.156 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.8 tp -158.89 119.12 3.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.338 . . . . 1.0 110.421 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.5 149.46 52.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.592 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -137.05 151.9 49.45 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.136 -0.484 . . . . 1.0 109.751 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -125.8 140.62 52.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.203 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 56' ' ' ILE . 95.7 mt -120.85 123.7 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -94.95 122.23 37.38 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.58 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.0 mt -102.53 129.68 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.336 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -119.82 134.37 55.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.099 -0.501 . . . . 1.0 109.891 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -102.62 148.78 25.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.109 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.1 mt -141.97 174.72 10.33 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.328 -0.397 . . . . 1.0 110.461 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 67.81 41.62 2.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.016 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.633 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -111.85 134.55 53.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.242 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.25 -20.3 30.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.538 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.63 153.41 22.85 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.153 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.83 -20.91 68.53 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.267 1.978 . . . . 1.0 111.884 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.5 tp -85.49 -12.37 51.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.144 0.497 . . . . 1.0 110.639 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.35 151.57 30.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.527 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.8 mt -75.86 147.24 39.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.284 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.79 98.91 0.37 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.551 -1.02 . . . . 1.0 110.551 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -62.55 -38.27 89.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.92 0.39 . . . . 1.0 110.544 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.53 123.65 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.624 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.4 mt -116.47 130.57 56.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.869 -0.605 . . . . 1.0 109.401 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mp -107.49 124.65 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.81 0.338 . . . . 1.0 110.362 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -139.2 132.11 37.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.288 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 76' ' ' ASP . 39.3 t0 51.92 42.03 29.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.654 0.264 . . . . 1.0 111.035 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.1 t30 61.19 22.92 13.19 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.297 -0.411 . . . . 1.0 111.042 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -127.0 133.36 50.57 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.114 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -86.31 128.24 34.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.735 -0.666 . . . . 1.0 111.089 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -121.49 138.56 54.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.151 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -84.99 -34.55 22.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.542 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -126.31 149.45 49.14 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.062 0.458 . . . . 1.0 112.058 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.0 tp -65.38 -39.7 92.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.945 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -60.2 -40.81 91.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 1.0 111.741 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -61.0 -38.45 86.1 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.769 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.83 -45.84 97.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.726 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.9 mm -65.44 -43.45 94.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.506 -0.478 . . . . 1.0 111.47 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.73 -43.07 70.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 112.642 0.608 . . . . 1.0 112.642 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.03 -13.13 59.55 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.722 -0.391 . . . . 1.0 111.61 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -95.3 -49.01 5.65 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.772 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 tp -70.06 -41.41 74.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.312 -0.404 . . . . 1.0 112.018 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -63.96 -49.14 73.71 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.918 -0.713 . . . . 1.0 111.456 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -70.53 -42.05 71.73 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.62 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.549 ' HZ1' ' ND2' ' A' ' 165' ' ' ASN . 25.6 mmtm -65.88 -41.88 90.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.347 -0.541 . . . . 1.0 111.266 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.5 t -64.76 -46.43 92.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.39 -0.524 . . . . 1.0 111.181 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -65.94 -44.57 84.66 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.593 -0.443 . . . . 1.0 111.259 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.7 tp -65.57 -41.82 92.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.497 -0.32 . . . . 1.0 111.511 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.25 -42.3 99.17 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.299 -0.561 . . . . 1.0 110.045 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 103' ' ' SER . 91.1 m-20 -66.31 -40.41 89.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.262 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -69.37 -40.8 77.23 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.673 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.477 ' O ' ' OG ' ' A' ' 104' ' ' SER . 1.4 tpt -66.5 -56.11 12.41 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.104 -0.638 . . . . 1.0 111.301 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.423 ' C ' ' H ' ' A' ' 104' ' ' SER . 65.1 m -60.44 -39.11 86.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.047 0.451 . . . . 1.0 110.852 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 99' ' ' ASN . 99.2 p -71.91 10.42 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.638 -0.71 . . . . 1.0 111.124 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 101' ' ' MET . 83.1 p -93.94 133.7 37.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.711 0.291 . . . . 1.0 110.468 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 37.9 mp0 -57.46 -21.07 34.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.138 0.494 . . . . 1.0 110.594 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.555 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 49.2 mttp -87.61 39.7 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.771 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -128.45 113.22 15.25 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.604 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -125.61 110.47 13.86 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.197 -0.456 . . . . 1.0 109.804 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.7 m -85.03 77.05 10.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.981 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -116.63 157.96 14.74 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 72.3 p -78.53 168.05 20.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.843 -0.429 . . . . 1.0 109.843 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -56.68 -36.85 70.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.74 0.305 . . . . 1.0 110.329 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -67.39 -45.22 76.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.913 0.387 . . . . 1.0 110.539 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -70.52 -17.2 62.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.786 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.7 t -72.2 -44.01 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.293 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.5 t -63.45 -46.94 93.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.211 0.529 . . . . 1.0 110.304 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -66.17 -35.71 81.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.901 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -67.69 -49.12 64.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.757 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.9 tp -69.87 -39.65 77.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.856 -0.337 . . . . 1.0 110.424 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.5 -40.24 95.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.706 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.6 -47.51 78.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.514 -0.474 . . . . 1.0 110.255 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.451 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 32.1 t80 -60.61 -43.14 97.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.061 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.1 p -65.88 -33.24 75.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.486 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -60.71 -42.28 96.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.931 -0.577 . . . . 1.0 109.915 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.49 -41.5 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.451 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -125.87 74.58 70.98 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.213 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 151' ' ' ASN . 46.1 Cg_endo -73.17 -17.89 24.17 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.354 2.036 . . . . 1.0 112.557 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 48.0 p30 -90.85 -10.31 43.16 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.157 0.429 . . . . 1.0 112.157 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -118.63 147.03 44.18 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.925 0.393 . . . . 1.0 110.404 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.9 m -80.94 160.9 24.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.782 -0.645 . . . . 1.0 109.693 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.89 146.89 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 133' ' ' TYR . 26.3 p90 -139.32 143.92 38.06 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.85 0.357 . . . . 1.0 111.56 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 18.4 m-85 -151.85 166.23 32.07 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.491 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 4.1 p90 -135.01 152.3 51.6 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.8 m -150.94 172.41 15.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.442 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.21 142.36 39.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.616 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 10.7 t-20 -98.98 111.84 24.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.837 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -66.67 -43.23 85.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.676 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.15 -27.53 65.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.373 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.474 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 31.6 m120 -125.14 73.96 66.74 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.267 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.76 126.11 17.48 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.911 1.741 . . . . 1.0 112.463 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.06 -7.68 48.62 Favored Glycine 0 N--CA 1.467 0.741 0 N-CA-C 111.065 -0.814 . . . . 1.0 111.065 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -116.81 141.18 48.55 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.713 0.292 . . . . 1.0 110.418 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -102.09 142.77 32.83 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.542 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 11.1 m-85 -119.15 131.05 55.84 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.235 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.98 121.49 42.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.357 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -117.34 144.46 44.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.192 -1.04 . . . . 1.0 108.192 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -160.57 153.69 21.62 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.403 -0.591 . . . . 1.0 109.403 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -137.36 131.31 31.94 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.692 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 150' ' ' ILE . 35.9 mm -70.98 -47.2 63.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.695 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 127' ' ' PRO . 12.2 p30 -161.92 177.19 10.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.076 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.59 -34.37 78.1 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.09 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -84.88 9.5 14.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.668 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.3 t -105.28 163.61 12.47 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.182 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -92.21 156.63 17.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.936 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 50.5 tp -75.79 127.29 32.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.942 0.401 . . . . 1.0 110.26 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -112.26 133.17 54.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.081 -0.509 . . . . 1.0 109.751 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 85.5 m -131.39 131.79 43.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.036 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -121.91 164.73 17.07 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.806 -0.442 . . . . 1.0 109.806 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.542 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 24.2 m-20 -115.57 147.58 40.57 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.992 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 39.1 t -128.91 138.92 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -97.61 126.68 43.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.993 0.425 . . . . 1.0 110.704 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.4 tp -90.23 128.84 36.49 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 35.6 p -129.66 175.11 9.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.394 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.549 ' ND2' ' HZ1' ' A' ' 94' ' ' LYS . 12.8 m120 -83.96 15.87 3.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.71 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 5.6 p -121.85 -1.83 9.36 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.739 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.88 -134.02 7.1 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.337 -1.105 . . . . 1.0 110.337 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -117.79 128.6 55.03 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.142 -0.318 . . . . 1.0 110.142 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -107.86 121.55 44.98 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 171' ' ' VAL . 6.7 tt -111.71 115.84 29.76 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 109.009 -0.738 . . . . 1.0 109.009 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.568 ' C ' HD21 ' A' ' 172' ' ' ASN . 99.3 t 33.19 62.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.349 0.5 . . . . 1.0 112.349 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.695 ' N ' HD21 ' A' ' 172' ' ' ASN . 0.5 OUTLIER 67.32 27.45 8.23 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.635 0.976 . . . . 1.0 113.635 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -131.79 120.1 22.19 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.338 -0.615 . . . . 1.0 109.338 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -91.73 129.42 37.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.883 0.373 . . . . 1.0 111.253 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -109.08 99.22 34.6 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.62 -24.4 12.73 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.636 2.224 . . . . 1.0 113.603 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.436 ' OG ' ' OE1' ' A' ' 180' ' ' GLN . 6.9 p -138.05 142.87 40.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.917 0.389 . . . . 1.0 111.272 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.61 -33.92 59.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.683 -0.69 . . . . 1.0 110.583 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.37 -44.08 98.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 122.038 -0.414 . . . . 1.0 110.363 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.521 ' OE1' ' N ' ' A' ' 180' ' ' GLN . 3.2 mp0 -65.89 -29.34 69.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 52.4 tp -64.0 -40.72 97.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.255 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 74.1 m -62.56 -47.79 82.31 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.364 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 186' ' ' LYS . 43.6 t30 -68.01 -47.41 68.55 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 119.503 -0.879 . . . . 1.0 108.88 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.4 -45.31 0.67 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 109.919 -1.272 . . . . 1.0 109.919 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -68.79 -46.99 67.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.376 0.608 . . . . 1.0 109.502 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 183' ' ' ASN . 1.4 tmtp? -56.81 -42.72 80.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.243 -0.89 . . . . 1.0 110.05 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 23.8 m -61.25 -44.0 97.96 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 39.8 mt -62.21 -42.11 98.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.115 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 44.7 tp -58.48 -42.8 88.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.336 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.48 -44.94 92.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.371 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 17.4 m -62.7 -39.34 93.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.895 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.17 -41.13 99.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.609 -0.723 . . . . 1.0 111.735 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.68 -26.68 67.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.793 0.294 . . . . 1.0 111.793 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 . . . . . 0 C--N 1.326 -0.426 0 CA-C-O 120.818 0.342 . . . . 1.0 110.884 -179.619 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.537 ' O ' ' ND2' ' A' ' 6' ' ' ASN . 80.0 mtp85 . . . . . 0 CA--C 1.521 -0.162 0 CA-C-O 120.868 0.366 . . . . 1.0 110.599 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.0 p -97.06 -17.4 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.564 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.6 pt -85.51 -25.95 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.658 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.613 HD21 ' N ' ' A' ' 7' ' ' HIS . 0.0 OUTLIER -89.57 -0.01 57.22 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.613 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.613 ' N ' HD21 ' A' ' 6' ' ' ASN . 0.1 OUTLIER -69.63 146.87 96.31 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.092 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.98 -20.67 50.67 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.913 1.742 . . . . 1.0 112.353 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.439 ' CE1' ' CZ ' ' A' ' 30' ' ' PHE . 74.7 m-85 -88.97 3.3 52.01 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.326 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -88.16 135.45 33.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.322 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.573 ' O ' ' NH1' ' A' ' 33' ' ' ARG . 74.6 m-85 -151.27 119.64 3.42 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 110.013 -0.365 . . . . 1.0 110.013 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.521 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 73.7 Cg_endo -72.82 109.62 2.84 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.671 1.58 . . . . 1.0 113.129 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.551 ' O ' ' NE ' ' A' ' 33' ' ' ARG . 56.4 m-85 -160.41 159.25 30.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.623 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -78.69 173.47 12.42 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.14 -49.06 82.27 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.27 -0.967 . . . . 1.0 110.858 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -67.95 -40.15 83.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 1.0 110.823 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -66.61 -32.63 74.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 1.0 111.146 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.35 92.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.933 -0.307 . . . . 1.0 110.221 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.479 ' OE2' ' CD1' ' A' ' 53' ' ' PHE . 84.1 tt0 -63.31 -42.74 99.04 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.699 -0.4 . . . . 1.0 109.996 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -60.78 -40.36 92.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.091 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -62.19 -42.49 99.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.826 0.346 . . . . 1.0 110.474 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.16 -13.6 60.19 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.874 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.9 ttm-85 -61.33 -40.15 93.18 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.844 -0.342 . . . . 1.0 110.256 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.4 p -77.58 -19.08 56.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.751 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -84.67 -179.77 7.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.912 0.387 . . . . 1.0 110.566 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -103.15 -177.47 3.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.784 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -75.45 145.0 41.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.772 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.17 11.01 59.08 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -97.09 140.75 31.13 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CZ ' ' CE1' ' A' ' 9' ' ' TYR . 35.1 p90 -135.08 168.57 18.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.444 0.64 . . . . 1.0 111.116 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.8 m -148.54 161.32 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.012 -0.994 . . . . 1.0 111.762 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -116.09 131.19 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.573 ' NH1' ' O ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -137.74 164.13 29.64 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.839 -179.214 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -120.51 126.89 51.51 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 t -62.56 134.16 55.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.128 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.5 t -72.17 -20.77 61.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.885 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -117.8 37.59 3.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.819 0.343 . . . . 1.0 110.767 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.623 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -175.1 58.71 0.11 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.939 -0.865 . . . . 1.0 110.939 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -57.57 3.41 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.652 0.263 . . . . 1.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.623 ' H ' ' C ' ' A' ' 38' ' ' GLY . 97.9 m-20 -102.94 -1.74 28.92 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.595 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.429 ' ND1' ' O ' ' A' ' 40' ' ' ASP . 60.6 m-70 -143.59 157.72 44.21 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.375 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 mp -119.74 152.75 36.7 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.15 -0.477 . . . . 1.0 109.988 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.3 t -124.2 130.9 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 110.06 -0.348 . . . . 1.0 110.06 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.4 mt -111.58 138.1 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 96.2 m -116.93 136.13 53.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.537 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.471 ' CZ2' ' NZ ' ' A' ' 94' ' ' LYS . 4.4 p-90 -145.36 160.91 40.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.658 -0.701 . . . . 1.0 110.846 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -107.65 140.9 39.98 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.022 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 mp -98.0 -72.35 0.65 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.652 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -158.29 157.34 32.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.259 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt 41.81 -141.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.798 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -89.71 64.3 6.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.848 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.9 tp -140.57 128.89 22.46 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.877 0.37 . . . . 1.0 110.323 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.479 ' CD1' ' OE2' ' A' ' 19' ' ' GLU . 51.6 m-85 -131.4 150.36 52.18 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.379 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -136.66 153.75 50.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.831 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.421 ' ND1' ' N ' ' A' ' 55' ' ' HIS . 10.8 p-80 -127.67 143.08 51.18 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.066 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 78.2 mt -123.4 129.23 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.228 -0.442 . . . . 1.0 109.966 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -97.23 122.45 40.27 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.03 0.443 . . . . 1.0 110.513 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.9 mt -99.32 129.95 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.4 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -113.56 132.35 55.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.0 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -101.03 156.58 17.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.188 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.7 tp -126.19 172.2 10.25 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.493 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.432 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 73.9 mm-40 60.02 39.0 20.44 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.99 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -81.47 78.88 8.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.082 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.64 -36.15 80.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.869 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -142.81 152.56 59.47 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.044 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.68 -25.56 68.58 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.295 1.997 . . . . 1.0 112.142 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.7 mt -97.84 -4.41 36.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.606 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.13 144.05 52.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.581 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.5 mt -78.5 146.31 34.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.366 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.27 101.16 1.22 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.539 -1.025 . . . . 1.0 110.539 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -63.58 -38.33 90.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.04 0.448 . . . . 1.0 111.029 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.17 125.52 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.593 -0.73 . . . . 1.0 111.004 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.6 mt -115.18 129.76 56.74 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 71.5 mt -102.13 126.24 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.884 0.373 . . . . 1.0 110.189 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.9 t -143.9 133.11 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.386 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t0 53.1 45.36 28.88 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.11 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 57.63 25.57 11.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.311 -0.404 . . . . 1.0 111.051 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -130.15 156.81 43.94 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.322 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -108.06 125.98 52.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.022 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -123.89 139.47 53.93 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.134 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -85.05 -38.84 18.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.77 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -110.08 138.22 46.76 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.201 0.524 . . . . 1.0 111.844 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.39 -41.35 96.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.874 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 38.0 p-10 -59.63 -45.97 90.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.982 -177.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.535 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 33.2 tt0 -57.93 -37.86 74.86 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 120.68 0.276 . . . . 1.0 110.778 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.81 -46.44 93.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.451 -0.5 . . . . 1.0 110.714 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.7 mm -64.4 -44.08 97.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.2 -0.6 . . . . 1.0 111.626 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.16 -43.63 74.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 113.067 0.765 . . . . 1.0 113.067 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -78.17 -13.27 59.93 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.641 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.457 ' CE2' ' NZ ' ' A' ' 94' ' ' LYS . 50.0 t80 -94.75 -50.72 5.03 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.95 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.38 -38.21 71.54 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.173 0.434 . . . . 1.0 112.173 -177.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -59.31 -47.25 86.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.027 -0.669 . . . . 1.0 111.527 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -64.43 -45.1 89.01 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.537 -0.465 . . . . 1.0 111.905 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.471 ' NZ ' ' CZ2' ' A' ' 46' ' ' TRP . 45.9 mtmt -66.67 -42.68 86.17 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.237 -0.585 . . . . 1.0 111.407 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.462 ' O ' ' ND2' ' A' ' 99' ' ' ASN . 54.3 t -60.06 -45.66 95.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.398 -0.521 . . . . 1.0 111.367 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -66.59 -44.21 82.8 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.562 -0.455 . . . . 1.0 111.965 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.3 tp -67.07 -38.94 86.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.637 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.99 -42.16 90.14 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.353 -0.539 . . . . 1.0 110.626 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 95' ' ' VAL . 76.3 m-20 -68.65 -37.27 79.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.205 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -70.98 -41.22 71.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.831 -0.348 . . . . 1.0 111.564 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.576 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 15.9 ttm -70.03 -53.28 18.26 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.53 -0.468 . . . . 1.0 111.594 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.464 ' C ' ' H ' ' A' ' 104' ' ' SER . 11.5 m -57.04 -38.83 73.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.056 0.455 . . . . 1.0 110.3 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.7 m -70.36 10.96 0.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.958 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 102' ' ' THR . 74.4 p -95.61 132.17 41.05 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.893 0.378 . . . . 1.0 110.385 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -60.38 -17.4 43.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.945 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.529 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 67.8 mttm -94.73 41.1 1.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.999 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -134.91 118.63 17.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.035 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -140.1 129.6 24.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.12 -0.491 . . . . 1.0 109.717 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.6 m -100.43 93.48 5.66 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.735 0.303 . . . . 1.0 110.953 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -120.17 162.94 14.06 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.5 p -78.73 163.41 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.925 -0.398 . . . . 1.0 109.925 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -63.35 -37.08 85.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.386 . . . . 1.0 110.54 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -68.08 -45.65 73.19 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.904 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -71.12 -17.26 62.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.59 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.81 -45.4 73.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.88 -46.47 96.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.192 0.52 . . . . 1.0 110.036 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -66.05 -38.59 88.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.925 0.393 . . . . 1.0 110.663 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -65.77 -48.39 71.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.796 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.4 tp -69.19 -39.69 79.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.418 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -59.72 -43.72 94.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.353 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.02 -47.44 83.04 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.446 -0.501 . . . . 1.0 110.019 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -60.05 -44.91 94.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.972 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.1 p -62.47 -33.9 75.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.414 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -61.82 -42.44 99.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.96 -0.563 . . . . 1.0 110.243 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.32 -41.56 89.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.711 -0.396 . . . . 1.0 109.985 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.8 75.07 56.3 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 121.202 0.525 . . . . 1.0 110.128 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.526 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 42.0 Cg_endo -73.21 -14.87 25.72 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.402 2.068 . . . . 1.0 112.568 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -100.31 -13.19 18.93 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.797 0.295 . . . . 1.0 111.797 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -106.45 150.78 25.73 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.152 0.501 . . . . 1.0 110.429 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 m -80.66 162.06 24.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.629 -0.714 . . . . 1.0 109.659 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.3 p -152.74 144.96 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.538 -0.542 . . . . 1.0 109.538 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 25.3 p90 -151.3 144.19 24.5 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.848 -0.341 . . . . 1.0 111.124 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -151.45 169.75 21.26 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.344 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.529 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -137.9 153.69 49.51 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.082 -0.71 . . . . 1.0 109.082 179.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 98.9 p -151.21 169.66 21.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.9 0.381 . . . . 1.0 110.32 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.7 tp -79.49 141.54 36.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.524 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.509 ' ND2' ' CE1' ' A' ' 145' ' ' TYR . 6.6 t-20 -75.06 168.44 19.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.199 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -126.98 -30.11 2.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.356 -0.383 . . . . 1.0 110.66 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -90.53 -20.42 22.67 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.4 -0.364 . . . . 1.0 111.143 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 25.5 t-20 -138.64 76.33 35.84 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.396 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.06 130.76 41.39 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.062 1.841 . . . . 1.0 112.217 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 117.09 -26.34 8.34 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -107.28 147.92 29.63 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.576 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 75.2 m-85 -109.7 155.78 21.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.864 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.539 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 32.6 m-85 -125.77 137.46 53.8 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.048 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.9 mt -108.03 127.23 53.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.51 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -118.6 144.3 46.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -162.5 153.49 17.46 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.374 -0.53 . . . . 1.0 109.707 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -133.99 129.23 35.88 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.26 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.8 mp -76.48 -47.25 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.424 0.527 . . . . 1.0 112.424 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 152' ' ' ALA . 17.0 t-20 -154.01 166.06 34.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.554 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.532 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -60.78 -27.57 68.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -85.53 -14.3 46.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.984 0.421 . . . . 1.0 110.318 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.42 ' HG ' ' H ' ' A' ' 155' ' ' LYS . 12.8 t -81.18 160.76 24.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.335 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.42 ' H ' ' HG ' ' A' ' 154' ' ' SER . 33.8 mtmm -92.29 163.46 13.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.138 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 57.2 tp -79.67 118.71 21.74 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.011 -0.366 . . . . 1.0 110.011 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.39 132.72 52.09 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.968 -0.56 . . . . 1.0 109.986 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 96.4 m -124.38 126.29 45.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.532 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -111.48 155.7 22.82 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.241 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.539 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 82.5 m-20 -104.9 144.16 32.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.591 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.2 t -123.89 136.16 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 109.535 -0.543 . . . . 1.0 109.535 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -95.57 135.26 37.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.627 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 28.7 tp -99.38 130.14 45.63 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 166' ' ' THR . 71.5 p -128.57 159.9 34.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.244 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -76.91 17.46 0.43 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.633 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.451 ' H ' ' C ' ' A' ' 164' ' ' THR . 60.5 p -123.11 -2.29 8.65 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.669 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 143.12 -132.88 5.22 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.353 -1.099 . . . . 1.0 110.353 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.436 ' HH ' ' HB2' ' A' ' 101' ' ' MET . 59.0 m-85 -123.49 134.37 53.9 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 110.167 -0.309 . . . . 1.0 110.167 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.525 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 7.5 m-85 -111.62 122.87 48.96 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 tt -117.84 121.78 41.66 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.492 -0.559 . . . . 1.0 109.492 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.567 ' C ' HD21 ' A' ' 172' ' ' ASN . 4.2 t 37.88 51.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.153 0.427 . . . . 1.0 112.153 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.635 ' N ' HD21 ' A' ' 172' ' ' ASN . 0.6 OUTLIER 68.43 27.52 6.34 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.413 0.894 . . . . 1.0 113.413 179.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -135.65 123.09 21.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.525 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 19.5 t-20 -92.0 129.5 37.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.566 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -103.71 133.39 20.3 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.86 -20.7 22.12 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.053 1.836 . . . . 1.0 113.594 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.45 ' OG ' ' OE1' ' A' ' 180' ' ' GLN . 14.3 p -153.95 158.37 40.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.961 0.41 . . . . 1.0 111.095 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.31 -36.22 76.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.012 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.6 mm -60.54 -48.49 88.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.811 0.339 . . . . 1.0 110.243 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.45 ' OE1' ' OG ' ' A' ' 177' ' ' SER . 9.0 mp0 -65.96 -33.33 75.57 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.18 -41.9 97.62 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 110.025 -0.361 . . . . 1.0 110.025 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 81.6 m -62.3 -46.23 89.69 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 120.57 -0.452 . . . . 1.0 110.116 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 186' ' ' LYS . 65.9 m-20 -65.07 -49.02 71.68 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.89 -46.07 0.86 Allowed Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.841 -1.304 . . . . 1.0 109.841 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -67.77 -47.17 69.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 183' ' ' ASN . 64.7 tttm -56.72 -40.46 75.72 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.764 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 25.7 m -61.16 -45.11 96.0 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.428 ' O ' ' OG ' ' A' ' 191' ' ' SER . 88.6 mt -63.55 -40.86 98.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.859 -0.609 . . . . 1.0 110.1 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.0 tp -57.81 -41.23 81.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.406 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -64.03 -45.13 90.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.112 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 188' ' ' LEU . 56.7 p -62.95 -39.4 94.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.973 0.416 . . . . 1.0 110.637 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 61.2 mt -63.81 -43.5 96.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.606 -0.724 . . . . 1.0 111.965 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -71.15 -30.1 66.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.845 0.313 . . . . 1.0 111.845 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.991 -179.117 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.866 0.365 . . . . 1.0 110.583 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.805 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 7.2 p -60.41 -47.63 91.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.566 0 CA-C-O 121.756 0.789 . . . . 1.0 110.089 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.9 pt -59.94 12.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 O-C-N 121.255 -0.903 . . . . 1.0 111.011 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.671 ' H ' ' C ' ' A' ' 4' ' ' VAL . 54.9 t-20 -161.53 32.7 0.13 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.288 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.805 ' ND1' ' O ' ' A' ' 4' ' ' VAL . 3.8 p-80 -75.74 154.35 85.27 Favored Pre-proline 0 N--CA 1.468 0.426 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.02 -28.43 19.01 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.097 1.865 . . . . 1.0 112.7 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -79.94 -9.05 59.64 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.282 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -73.56 134.87 43.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.248 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -150.5 117.17 3.42 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 120.983 -0.287 . . . . 1.0 110.264 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.83 111.59 3.36 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.742 1.628 . . . . 1.0 112.829 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -156.68 155.63 32.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.275 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -78.8 -172.44 3.02 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.49 -48.36 18.5 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.543 -1.023 . . . . 1.0 110.543 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -64.41 -44.14 92.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.76 0.314 . . . . 1.0 110.734 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.17 -35.19 79.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.985 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.07 97.63 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.656 -0.417 . . . . 1.0 110.395 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.57 -43.97 83.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.008 -0.367 . . . . 1.0 110.008 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.06 -43.94 97.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.288 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.517 ' OH ' ' NZ ' ' A' ' 25' ' ' LYS . 94.1 t80 -61.63 -45.39 94.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.875 0.369 . . . . 1.0 110.288 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.4 -14.37 61.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.153 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -67.34 -41.84 84.52 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.621 -0.431 . . . . 1.0 110.799 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.6 m -76.37 -23.88 54.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.188 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.517 ' NZ ' ' OH ' ' A' ' 21' ' ' TYR . 32.7 mttp -81.9 176.78 9.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.151 0.5 . . . . 1.0 110.661 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -84.03 161.63 20.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.769 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.609 ' NH2' ' HZ2' ' A' ' 50' ' ' LYS . 2.5 mtt180 -76.07 146.31 39.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.033 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.5 12.67 47.21 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -106.54 148.05 28.7 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -127.81 172.49 10.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.473 0.654 . . . . 1.0 111.413 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.57 153.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 114.975 -1.011 . . . . 1.0 111.477 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.434 ' HB ' ' HE2' ' A' ' 7' ' ' HIS . 97.5 mt -116.84 118.48 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.93 151.01 30.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.198 -179.128 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 34' ' ' GLN . 3.0 pp0? -98.32 148.1 24.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.422 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 t -69.05 161.38 29.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.82 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.9 p -65.56 -21.83 66.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.833 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -129.53 25.18 5.42 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.413 -0.358 . . . . 1.0 111.167 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . -75.59 -62.32 2.72 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.618 -0.993 . . . . 1.0 110.618 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.3 t0 64.75 -50.62 0.32 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.728 0.299 . . . . 1.0 111.334 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.448 ' O ' ' OE1' ' A' ' 60' ' ' GLU . 99.5 m-20 -120.66 20.65 11.71 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.977 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -147.86 147.73 30.1 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 mp -119.14 151.13 38.85 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.711 -0.478 . . . . 1.0 109.711 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 33' ' ' ARG . 76.4 t -126.96 135.06 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.331 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.8 mt -111.64 137.47 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.076 -0.712 . . . . 1.0 109.076 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.1 m -117.49 135.56 53.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.928 -0.578 . . . . 1.0 109.523 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -151.99 155.58 38.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.794 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -95.44 141.13 29.35 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.35 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 mp -94.82 -35.09 12.23 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.131 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.549 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 36.2 t0 -162.89 -138.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.191 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.609 ' HZ2' ' NH2' ' A' ' 27' ' ' ARG . 70.5 mmtt -53.76 -104.05 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.055 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.476 ' O ' ' CE2' ' A' ' 53' ' ' PHE . 32.3 t70 -85.65 20.91 1.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.232 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.583 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 2.7 mm? -88.35 131.49 34.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.874 0.369 . . . . 1.0 110.612 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.476 ' CE2' ' O ' ' A' ' 51' ' ' ASP . 25.4 m-85 -136.46 143.82 44.06 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.332 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -146.54 152.67 39.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.024 -0.534 . . . . 1.0 109.677 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -126.88 139.79 52.82 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.207 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 56' ' ' ILE . 42.1 mm -115.29 117.61 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -90.53 119.39 30.75 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.904 0.383 . . . . 1.0 110.773 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.5 mt -100.19 131.29 47.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.269 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -118.06 126.52 52.44 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 40' ' ' ASP . 9.6 mp0 -99.68 147.69 25.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.126 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.8 tt -141.55 170.85 14.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.46 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.431 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 61.8 tt0 72.51 52.24 0.17 Allowed 'General case' 0 C--N 1.334 -0.099 0 O-C-N 123.625 0.578 . . . . 1.0 109.769 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -117.29 84.81 2.22 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.652 -0.703 . . . . 1.0 109.841 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -65.94 -36.76 84.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.056 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -107.66 118.5 53.02 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.051 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -50.11 -30.18 24.4 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.081 1.854 . . . . 1.0 112.105 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 tp -79.51 -11.79 59.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.043 0.449 . . . . 1.0 110.828 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.15 140.57 35.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.188 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.1 mt -81.49 151.15 27.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.498 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.38 122.79 30.97 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.499 -1.041 . . . . 1.0 110.499 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -72.01 -13.01 61.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.87 0.367 . . . . 1.0 110.797 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.1 t -118.12 120.44 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.604 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.2 mt -114.37 126.8 55.41 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.141 -0.688 . . . . 1.0 109.141 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.3 mm -100.18 121.33 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.07 0.462 . . . . 1.0 110.48 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.2 t -138.17 131.28 40.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.283 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 51.8 t0 53.26 47.83 23.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.039 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER 55.52 21.45 4.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.077 179.277 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -128.0 144.23 51.1 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.281 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -88.57 135.01 33.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.957 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -123.74 138.2 54.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.293 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -81.71 -37.97 26.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.692 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -132.7 157.57 44.55 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.225 0.536 . . . . 1.0 111.781 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.2 tp -65.17 -39.27 92.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.501 -0.772 . . . . 1.0 111.215 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.49 -40.91 88.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.734 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -62.2 -38.38 88.89 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 121.004 -0.279 . . . . 1.0 110.757 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 89.0 mt -62.23 -45.8 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.048 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.5 mt -61.39 -47.27 94.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.483 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.09 -42.38 67.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 112.569 0.581 . . . . 1.0 112.569 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.22 -18.39 60.14 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.748 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -91.89 -50.06 5.92 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.533 -0.467 . . . . 1.0 111.413 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.0 mp -67.0 -42.21 85.39 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 112.296 0.48 . . . . 1.0 112.296 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -63.34 -49.83 72.37 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.739 -0.784 . . . . 1.0 111.64 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -68.69 -43.51 75.92 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.516 -0.474 . . . . 1.0 111.546 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -65.92 -43.88 86.78 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.048 -0.661 . . . . 1.0 111.313 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.65 -45.45 92.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.237 -0.585 . . . . 1.0 111.203 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -68.24 -46.08 71.45 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.715 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.82 -41.61 87.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.467 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.96 -42.17 94.83 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.314 -0.554 . . . . 1.0 110.134 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.406 ' O ' ' OG ' ' A' ' 103' ' ' SER . 4.8 m120 -67.74 -38.61 83.73 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.035 -0.529 . . . . 1.0 111.196 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -70.59 -42.46 71.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.877 -0.329 . . . . 1.0 111.78 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.601 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 4.1 ttt -67.24 -55.03 15.71 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.465 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 104' ' ' SER . 19.1 m -59.04 -41.95 89.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.983 0.42 . . . . 1.0 110.669 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 99' ' ' ASN . 87.6 p -72.45 8.78 1.25 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.991 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 102' ' ' THR . 8.6 t -88.53 138.49 31.38 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.722 0.296 . . . . 1.0 110.234 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -61.88 -18.24 59.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.869 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.555 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 59.8 mttp -89.34 39.05 0.93 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.023 -0.535 . . . . 1.0 109.694 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -130.99 111.75 12.32 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.357 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -131.34 114.63 15.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.057 -0.519 . . . . 1.0 109.828 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.7 m -88.76 78.97 7.55 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.046 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -105.46 152.87 17.24 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 62.1 p -72.56 171.51 12.27 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -57.51 -40.72 79.36 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.575 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -68.08 -42.59 80.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.019 0.438 . . . . 1.0 110.505 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -70.18 -21.86 63.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.117 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.4 t -69.43 -44.33 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.085 -0.339 . . . . 1.0 110.085 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.7 t -65.44 -45.46 92.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.099 0.476 . . . . 1.0 110.342 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -65.91 -34.12 77.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.984 0.421 . . . . 1.0 110.842 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -67.44 -50.23 60.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.628 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.4 tp -70.18 -39.08 76.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.046 0.451 . . . . 1.0 110.312 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.434 ' O ' ' OG ' ' A' ' 123' ' ' SER . 93.0 mt-10 -64.0 -42.43 97.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.624 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -61.3 -46.85 88.6 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.264 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.537 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 34.4 t80 -61.65 -43.08 99.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.107 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.437 ' HG ' ' N ' ' A' ' 124' ' ' ARG . 80.2 p -61.89 -36.64 81.89 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.424 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.437 ' N ' ' HG ' ' A' ' 123' ' ' SER . 84.7 mtt-85 -62.3 -39.04 91.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.313 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.38 -43.06 84.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.455 -0.498 . . . . 1.0 109.834 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.537 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -128.44 73.88 80.16 Favored Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.227 179.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.69 -16.54 26.66 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.475 2.117 . . . . 1.0 112.443 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -89.76 -5.55 56.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.678 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -127.07 149.93 49.7 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.004 0.431 . . . . 1.0 110.432 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.9 p -80.18 162.63 24.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.561 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 p -151.5 145.41 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -140.06 145.48 37.75 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.852 0.358 . . . . 1.0 111.25 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -151.37 171.3 17.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.221 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -137.25 156.91 47.72 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.268 -0.641 . . . . 1.0 109.268 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 29.3 p -155.07 168.7 26.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.371 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.0 tp -79.76 138.49 37.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.51 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.724 HD21 ' H ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -97.5 141.47 30.52 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.238 179.31 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -95.01 -16.98 22.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.583 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 18.0 p30 -69.93 -27.01 64.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.274 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 139' ' ' ASP . 22.7 m120 -159.2 92.26 1.89 Allowed Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 109.954 -0.387 . . . . 1.0 109.954 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.01 142.7 94.04 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.013 1.808 . . . . 1.0 112.404 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.53 -25.38 27.0 Favored Glycine 0 N--CA 1.464 0.542 0 N-CA-C 110.779 -0.928 . . . . 1.0 110.779 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.521 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 7.6 m0 -99.47 144.87 28.08 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 120.897 0.38 . . . . 1.0 110.09 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.601 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 70.9 m-85 -109.7 146.47 34.81 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.792 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.523 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 12.0 m-85 -119.28 132.01 55.84 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.036 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.5 mt -106.78 128.56 54.34 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.442 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.582 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -126.36 148.17 49.63 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 178.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -158.44 155.34 28.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.28 -0.568 . . . . 1.0 109.57 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.524 ' NZ ' ' O ' ' A' ' 154' ' ' SER . 4.1 tttm -134.15 130.41 37.28 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.851 0.357 . . . . 1.0 110.552 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.543 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 23.5 mm -75.76 -48.65 28.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.816 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 150' ' ' ILE . 29.2 m120 -155.51 169.11 25.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.629 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.11 -28.38 66.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.787 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.68 4.78 51.92 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.06 0.457 . . . . 1.0 110.417 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.524 ' O ' ' NZ ' ' A' ' 149' ' ' LYS . 12.4 t -90.89 165.85 13.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.316 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -99.09 148.97 23.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.47 . . . . 1.0 109.789 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 44.5 tp -72.28 118.44 15.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.901 0.381 . . . . 1.0 110.285 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -109.07 131.39 55.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.077 -0.51 . . . . 1.0 109.644 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 92.5 m -128.76 130.6 47.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.926 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -116.77 168.33 10.3 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.107 -0.497 . . . . 1.0 109.914 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.523 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 83.9 m-20 -111.7 148.34 33.64 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.648 -0.706 . . . . 1.0 110.84 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 74.5 t -128.36 138.18 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -103.59 128.84 50.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.196 0.522 . . . . 1.0 110.877 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.2 tp -89.16 129.23 35.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.545 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 80.8 p -129.17 174.62 9.41 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.38 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -86.43 14.13 7.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.693 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.455 ' O ' ' CG2' ' A' ' 166' ' ' THR . 26.9 m -121.91 -2.58 9.23 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.446 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 138.1 -141.66 12.36 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.112 -1.195 . . . . 1.0 110.112 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -109.58 126.51 53.68 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.452 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 4.6 m-85 -104.76 116.48 32.09 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.9 tt -113.08 115.42 28.3 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.547 ' C ' HD21 ' A' ' 172' ' ' ASN . 4.4 t 37.89 62.3 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 112.084 0.402 . . . . 1.0 112.084 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.631 ' N ' HD21 ' A' ' 172' ' ' ASN . 0.6 OUTLIER 63.43 27.9 15.32 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.165 0.802 . . . . 1.0 113.165 178.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 62.8 m-85 -133.87 122.49 23.27 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.452 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 7.1 t-20 -100.05 120.56 40.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.688 0.28 . . . . 1.0 111.529 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -98.66 136.96 20.58 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.44 -23.11 24.05 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.185 1.923 . . . . 1.0 113.396 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 5.1 t -154.17 158.45 40.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.104 0.478 . . . . 1.0 110.923 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.9 p -59.74 -34.42 55.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.816 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.0 -44.83 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.368 . . . . 1.0 110.246 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -69.08 -31.25 69.86 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 43.8 tp -62.67 -42.18 99.48 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.102 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 75.0 m -63.21 -45.9 89.51 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 120.634 -0.426 . . . . 1.0 110.209 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 186' ' ' LYS . 38.8 m-80 -63.28 -46.47 86.65 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 108.512 -0.921 . . . . 1.0 108.512 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.54 -46.55 0.8 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.818 -1.313 . . . . 1.0 109.818 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.89 -43.9 74.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.11 -0.545 . . . . 1.0 109.935 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.0 tttm -56.92 -43.8 81.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.401 -0.818 . . . . 1.0 110.016 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 13.7 m -61.64 -45.48 93.87 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.83 -43.55 98.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.061 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.9 tp -57.85 -45.4 86.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.855 0.359 . . . . 1.0 110.493 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.406 ' CE ' ' NZ ' ' A' ' 186' ' ' LYS . 46.9 mttm -61.96 -45.02 95.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.397 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.4 m -62.1 -41.78 98.56 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.985 0.421 . . . . 1.0 110.608 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 69.5 mt -63.98 -42.96 97.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.49 -0.777 . . . . 1.0 111.831 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -67.11 -30.71 70.8 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.885 0.328 . . . . 1.0 111.885 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . 0.431 ' O ' ' ND1' ' A' ' 194' ' ' HIS . 13.0 t-80 . . . . . 0 C--N 1.326 -0.419 0 C-N-CA 120.874 -0.33 . . . . 1.0 110.696 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.429 ' O ' ' CE1' ' A' ' 7' ' ' HIS . 18.7 mmm180 . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 120.963 0.411 . . . . 1.0 110.353 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.27 -30.62 49.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.425 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.437 HD11 HG22 ' A' ' 5' ' ' ILE . 38.1 pt -69.72 -19.22 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.427 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -91.28 3.28 55.26 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.697 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.429 ' CE1' ' O ' ' A' ' 3' ' ' ARG . 0.6 OUTLIER -88.91 143.67 31.81 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.072 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.7 -15.14 40.63 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.262 1.975 . . . . 1.0 112.132 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.529 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 54.2 m-85 -92.02 8.05 39.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.12 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.497 ' OH ' ' NE2' ' A' ' 34' ' ' GLN . 85.6 t80 -104.18 125.72 50.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 1.0 110.291 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -157.73 117.69 1.94 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 109.43 -0.581 . . . . 1.0 109.43 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.9 129.5 34.85 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 121.227 1.285 . . . . 1.0 112.626 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -157.99 149.13 21.14 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.091 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 16' ' ' ARG . 13.8 t-20 -77.91 164.44 25.13 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.22 -49.79 74.75 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.462 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 23.3 mmt85 -65.7 -39.52 91.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.696 0.284 . . . . 1.0 110.797 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.5 ' N ' ' CD ' ' A' ' 17' ' ' GLN . 1.1 mp0 -66.07 -35.4 80.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.069 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.02 92.35 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.268 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -60.81 -45.15 95.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.933 -0.395 . . . . 1.0 109.933 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.04 -42.63 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.104 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.488 ' CZ ' ' NZ ' ' A' ' 25' ' ' LYS . 66.4 t80 -62.87 -42.27 99.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.403 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.27 -15.31 60.98 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.843 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -61.87 -42.57 99.22 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.393 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.1 p -77.48 -21.04 53.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.784 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' NZ ' ' CZ ' ' A' ' 21' ' ' TYR . 44.4 mmtm -79.64 176.05 10.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.51 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -100.43 171.58 7.66 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.667 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -61.73 143.58 55.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.822 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.35 10.3 59.55 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.057 -0.817 . . . . 1.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -86.88 137.43 32.4 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -135.52 161.83 34.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.266 0.555 . . . . 1.0 110.836 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 m -147.49 157.28 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.274 -0.875 . . . . 1.0 111.316 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 84.1 mt -118.43 128.41 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.481 ' CZ ' ' OG1' ' A' ' 45' ' ' THR . 23.8 ptt180 -147.34 154.78 41.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.32 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.497 ' NE2' ' OH ' ' A' ' 10' ' ' TYR . 4.2 pt20 -104.7 144.78 31.26 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.3 t -89.32 136.0 33.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.591 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.2 t -60.62 -40.6 92.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.566 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -79.32 -11.41 59.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.577 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -81.94 -68.48 1.45 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.542 -1.023 . . . . 1.0 110.542 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 t0 74.85 -39.88 0.42 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.604 0.24 . . . . 1.0 110.942 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 38' ' ' GLY . 87.5 m-20 -113.58 -11.27 13.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.838 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -117.71 151.14 37.86 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.344 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 mp -117.39 153.83 32.37 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.1 t -127.7 134.91 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.343 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.0 mt -114.24 138.35 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 108.768 -0.827 . . . . 1.0 108.768 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.481 ' OG1' ' CZ ' ' A' ' 33' ' ' ARG . 26.4 m -117.61 138.26 52.07 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.136 0.493 . . . . 1.0 109.805 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.528 ' CZ2' ' OH ' ' A' ' 90' ' ' TYR . 5.2 p-90 -148.93 156.54 42.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.457 -0.792 . . . . 1.0 111.163 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -100.78 140.2 35.41 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.034 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.505 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 8.6 mp -96.53 -68.19 0.81 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.217 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -152.98 147.88 26.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.276 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt 46.73 -127.81 1.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.858 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 16.3 p-10 -93.61 25.99 3.26 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.696 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.69 119.65 32.3 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -123.52 148.38 46.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.3 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -142.3 153.47 43.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.83 -0.623 . . . . 1.0 109.966 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -128.39 142.44 51.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.439 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.3 mt -120.55 125.35 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.001 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -95.29 120.75 36.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.912 0.386 . . . . 1.0 110.378 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.431 HG23 HD12 ' A' ' 58' ' ' ILE . 96.2 mt -98.69 132.13 44.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.431 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -114.68 140.88 48.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 1.0 109.696 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -99.39 157.55 16.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.456 . . . . 1.0 109.862 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.478 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.9 tp -141.77 171.71 13.69 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.485 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.478 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 79.1 mm-40 59.06 28.87 18.27 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.284 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -94.26 48.76 1.25 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.049 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.19 -39.17 86.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.291 -0.868 . . . . 1.0 111.411 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 68' ' ' ALA . 8.9 p30 -113.43 114.44 47.8 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.482 -0.327 . . . . 1.0 110.332 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.06 -13.31 0.92 Allowed 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.854 1.702 . . . . 1.0 112.167 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.6 mt -80.73 -7.56 59.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.433 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.435 ' N ' ' OD1' ' A' ' 65' ' ' ASN . . . -118.66 131.89 56.17 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.974 0.416 . . . . 1.0 110.18 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 71' ' ' LYS . 54.1 mt -76.43 156.46 33.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.288 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -43.62 91.84 0.01 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.594 -1.002 . . . . 1.0 110.594 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 69' ' ' LEU . 7.0 ttpm? -63.52 -31.07 72.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.974 0.416 . . . . 1.0 110.706 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.2 t -128.92 125.21 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.945 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.9 mt -115.77 130.13 56.73 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.89 -0.596 . . . . 1.0 109.424 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.6 mt -100.4 121.67 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 120.869 0.366 . . . . 1.0 110.535 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -141.84 133.11 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.452 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' A' ' 77' ' ' ASN . 90.2 m-20 52.7 47.64 24.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.968 -0.293 . . . . 1.0 111.211 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 77' ' ' ASN . 3.6 p30 56.32 15.79 2.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.123 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -124.76 142.32 51.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.367 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -93.14 131.58 38.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.008 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.07 138.31 53.18 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.199 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -84.42 -37.05 21.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.496 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -117.46 142.14 47.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.887 0.375 . . . . 1.0 111.95 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.97 -40.69 95.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.882 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.61 -41.74 91.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.796 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -59.15 -38.87 80.74 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.637 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.43 -45.11 99.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.678 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.83 -44.67 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.59 -0.444 . . . . 1.0 111.112 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 61.8 t -68.14 -42.32 84.84 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-N 115.92 -0.582 . . . . 1.0 112.282 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -80.37 -13.16 59.39 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.322 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.528 ' OH ' ' CZ2' ' A' ' 46' ' ' TRP . 77.4 t80 -94.39 -50.21 5.34 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.661 -0.416 . . . . 1.0 111.992 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.34 -43.25 86.59 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.539 -0.464 . . . . 1.0 112.197 -177.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 2.9 pt20 -64.01 -47.17 81.31 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.943 -0.703 . . . . 1.0 111.668 -178.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 165' ' ' ASN . 53.9 t-20 -69.19 -43.34 74.38 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.544 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -65.93 -42.53 89.97 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.146 -0.621 . . . . 1.0 111.363 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.524 ' O ' ' ND2' ' A' ' 99' ' ' ASN . 56.1 t -63.64 -47.13 92.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.01 -0.676 . . . . 1.0 111.336 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -68.98 -41.28 78.09 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.567 -0.453 . . . . 1.0 111.512 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 12.3 tp -66.3 -44.37 83.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.806 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 mp -65.37 -43.16 91.67 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.306 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 95' ' ' VAL . 2.7 m-80 -67.17 -37.12 83.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.987 -0.552 . . . . 1.0 111.192 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -71.28 -42.79 68.27 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 121.033 -0.267 . . . . 1.0 111.683 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 tpt -67.63 -54.0 23.32 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.397 -0.521 . . . . 1.0 111.329 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.9 m -58.6 -42.6 88.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.046 0.451 . . . . 1.0 110.335 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.4 t -73.72 8.18 2.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.881 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.8 t -86.24 141.4 29.32 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.64 0.257 . . . . 1.0 110.498 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -65.35 -20.57 66.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.9 0.381 . . . . 1.0 110.773 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.564 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 70.0 mmtt -88.92 38.87 0.9 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.831 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -131.48 111.92 12.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.754 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -118.61 109.66 16.41 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.411 -0.589 . . . . 1.0 109.411 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.2 t -87.56 70.39 9.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.565 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.51 160.85 12.97 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 110.714 -0.954 . . . . 1.0 110.714 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.5 m -70.36 164.17 25.07 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -54.67 -36.13 64.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.743 0.306 . . . . 1.0 110.493 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -66.52 -42.23 87.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.952 0.406 . . . . 1.0 110.553 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -70.29 -21.15 62.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.993 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.75 -45.44 81.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.242 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.46 -44.7 94.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.147 0.499 . . . . 1.0 110.433 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -65.89 -33.63 76.27 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.962 0.41 . . . . 1.0 110.644 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -68.42 -50.07 55.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.535 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.6 tp -69.92 -39.55 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.415 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -64.72 -40.45 95.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.645 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -59.56 -47.56 85.06 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.365 -0.534 . . . . 1.0 110.151 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -61.48 -40.3 94.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.046 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.5 t -62.39 -42.7 99.63 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.534 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -61.6 -40.04 93.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.68 -42.37 86.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.688 -0.405 . . . . 1.0 109.938 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.65 75.23 74.97 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.174 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.09 -14.08 31.68 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.237 1.958 . . . . 1.0 112.496 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.481 ' C ' HD21 ' A' ' 128' ' ' ASN . 0.1 OUTLIER -102.79 11.14 37.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.533 -0.303 . . . . 1.0 111.532 -179.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.439 ' N ' HD21 ' A' ' 128' ' ' ASN . 52.2 mtpt -132.81 147.57 52.31 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.925 0.393 . . . . 1.0 110.497 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.8 p -81.18 162.21 23.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.747 -0.661 . . . . 1.0 109.856 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.8 p -153.59 146.21 14.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.501 ' O ' ' CD1' ' A' ' 133' ' ' TYR . 10.3 p90 -144.94 142.67 30.04 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.907 0.384 . . . . 1.0 111.312 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 26.0 m-85 -152.75 167.64 28.33 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.555 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.564 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 4.1 p90 -135.64 151.8 50.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.423 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.1 p -154.17 170.51 21.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.518 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 tt -84.79 134.36 34.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.679 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 138' ' ' HIS . 69.3 m-80 -159.51 166.78 30.14 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.918 -0.401 . . . . 1.0 109.918 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.46 ' O ' ' OD1' ' A' ' 139' ' ' ASP . 3.9 t60 76.21 -158.48 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.462 -0.336 . . . . 1.0 110.733 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 138' ' ' HIS . 92.8 m-20 -142.67 64.07 1.38 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.592 ' O ' ' N ' ' A' ' 142' ' ' GLY . 2.7 m120 -129.33 156.01 79.11 Favored Pre-proline 0 CA--C 1.53 0.176 0 N-CA-C 108.897 -0.779 . . . . 1.0 108.897 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -42.81 78.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.753 2.302 . . . . 1.0 113.046 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 140' ' ' ASN . . . 52.07 64.35 4.05 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.247 -0.741 . . . . 1.0 111.247 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -94.94 152.5 18.29 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.674 -0.491 . . . . 1.0 109.674 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -121.05 153.15 37.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.798 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -127.16 127.97 45.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.872 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.1 mt -95.47 123.02 38.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.003 0.43 . . . . 1.0 110.982 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.64 145.61 46.3 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.127 -1.064 . . . . 1.0 108.127 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -159.79 157.59 29.57 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.299 -0.56 . . . . 1.0 109.944 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.554 ' NZ ' ' O ' ' A' ' 151' ' ' ASN . 36.6 tttm -142.87 126.28 16.69 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 120.668 -0.413 . . . . 1.0 110.056 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 151' ' ' ASN . 4.7 tp -78.84 -45.64 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.802 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.554 ' O ' ' NZ ' ' A' ' 149' ' ' LYS . 29.4 m120 -144.86 157.98 43.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.842 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.03 -26.5 68.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.875 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -83.25 -16.43 46.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.177 0.513 . . . . 1.0 110.199 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.496 ' O ' ' NZ ' ' A' ' 149' ' ' LYS . 14.1 t -77.94 170.51 16.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.153 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -97.31 155.03 17.06 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.367 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.22 120.03 18.27 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.26 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -106.04 127.17 52.99 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.107 -0.497 . . . . 1.0 109.839 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 95.9 m -128.62 130.87 47.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.994 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -118.88 170.1 9.3 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.863 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 161' ' ' VAL . 2.7 t-20 -111.83 147.39 35.84 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.8 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.42 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 48.1 t -128.21 135.62 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.504 ' NZ ' ' CG2' ' A' ' 164' ' ' THR . 17.1 ttpp -101.56 130.72 47.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.869 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.2 tp -88.91 130.69 35.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.686 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.504 ' CG2' ' NZ ' ' A' ' 162' ' ' LYS . 66.2 p -129.28 171.46 12.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.582 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.533 ' O ' ' ND2' ' A' ' 93' ' ' ASN . 14.4 p30 -83.84 13.97 4.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.67 -0.696 . . . . 1.0 110.472 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 25.1 p -121.76 -2.22 9.35 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.606 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 139.4 -126.37 3.3 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.303 -1.119 . . . . 1.0 110.303 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -127.41 127.31 43.93 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.652 0.263 . . . . 1.0 110.635 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.514 ' CE1' ' OD1' ' A' ' 174' ' ' ASN . 4.3 m-85 -100.87 124.47 46.58 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.8 tt -116.83 111.16 19.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.572 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 170' ' ' LEU . 4.7 t 35.49 63.44 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.6 m120 67.29 26.28 8.6 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -132.87 121.45 22.92 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.514 ' OD1' ' CE1' ' A' ' 169' ' ' PHE . 63.7 t30 -98.24 120.65 39.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.944 0.402 . . . . 1.0 111.635 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -105.13 125.61 33.15 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.2 -20.6 18.72 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.33 2.02 . . . . 1.0 113.504 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.2 m -137.2 141.39 42.13 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.982 0.42 . . . . 1.0 111.07 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.08 -34.67 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.575 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.51 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 96.8 mt -62.08 -44.31 98.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.635 -0.426 . . . . 1.0 109.934 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -68.86 -30.26 68.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.1 tp -63.53 -43.24 97.72 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.205 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 7.7 p -62.87 -47.43 83.37 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.52 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.583 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 42.8 m-80 -65.01 -48.03 75.38 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.944 -0.761 . . . . 1.0 108.944 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.84 -44.85 1.0 Allowed Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.818 -1.313 . . . . 1.0 109.818 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -69.13 -47.05 66.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.9 tttm -56.12 -41.23 74.97 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.327 -0.851 . . . . 1.0 110.039 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 94.0 m -61.39 -45.04 96.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 51.7 mt -62.86 -41.08 99.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.001 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.43 -44.16 92.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.323 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.42 -45.09 95.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.243 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 37.0 t -64.09 -38.87 92.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.804 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.2 mt -63.17 -41.95 99.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.61 -0.723 . . . . 1.0 111.608 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -59.96 -23.53 63.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.609 0.243 . . . . 1.0 111.555 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . 0.417 ' CG ' ' O ' ' A' ' 194' ' ' HIS . 47.7 t-80 . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.785 0.326 . . . . 1.0 110.906 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 . . . . . 0 N--CA 1.464 0.231 0 CA-C-O 120.806 0.336 . . . . 1.0 110.53 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.36 -37.03 79.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.676 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.3 pt -62.34 -26.45 40.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.363 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -74.9 -13.28 60.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.477 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -79.21 115.67 54.53 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.284 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.458 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 76.6 Cg_exo -48.38 -24.9 6.64 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.869 1.712 . . . . 1.0 112.305 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -81.73 3.95 23.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.184 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 91.9 t80 -85.95 132.8 34.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.594 -0.275 . . . . 1.0 110.436 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 62.1 m-85 -150.77 123.58 4.18 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 120.995 -0.282 . . . . 1.0 110.476 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.474 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 73.7 Cg_endo -73.83 110.21 3.03 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.935 1.757 . . . . 1.0 112.631 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.474 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 74.1 m-85 -159.82 154.64 24.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.338 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -80.86 166.29 21.06 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.632 ' N ' ' NH1' ' A' ' 33' ' ' ARG . . . -57.03 -46.89 90.99 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.756 -0.938 . . . . 1.0 110.756 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -65.51 -39.01 91.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.59 0.233 . . . . 1.0 110.736 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -66.14 -37.14 84.96 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.696 -0.229 . . . . 1.0 111.205 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.22 95.54 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.659 -0.417 . . . . 1.0 110.31 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -61.43 -46.5 89.86 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.669 -0.412 . . . . 1.0 109.948 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -62.28 -43.36 98.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.315 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -63.08 -44.48 95.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.56 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.8 mp -75.02 -13.6 60.52 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.647 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -60.97 -41.92 97.31 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.39 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.9 t -74.93 -18.54 60.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.503 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -85.46 -175.66 5.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.788 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 45.4 mp0 -99.72 -179.25 4.13 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.472 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -81.41 145.56 30.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.634 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.39 8.0 53.46 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.143 -0.783 . . . . 1.0 111.143 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -95.77 139.63 31.72 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.387 -0.598 . . . . 1.0 109.387 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -131.05 167.96 18.2 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.284 0.564 . . . . 1.0 111.133 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -148.81 159.54 6.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.19 -0.913 . . . . 1.0 111.414 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.56 127.11 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.338 -0.616 . . . . 1.0 109.338 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.632 ' NH1' ' N ' ' A' ' 15' ' ' GLY . 44.4 ttp180 -134.39 153.58 51.82 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.152 -0.476 . . . . 1.0 109.752 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -105.83 131.23 53.42 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.673 -0.492 . . . . 1.0 109.673 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -77.56 124.3 27.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.867 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.8 p -63.76 -38.82 92.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.625 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -79.11 -25.09 43.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.797 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -69.99 -53.85 13.58 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.54 -1.024 . . . . 1.0 110.54 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t0 70.7 -42.45 0.53 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.725 0.298 . . . . 1.0 111.034 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 38' ' ' GLY . 98.2 m-20 -119.45 19.92 12.58 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.65 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -140.27 150.71 44.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.669 0.271 . . . . 1.0 110.475 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.03 151.36 39.11 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.844 -0.428 . . . . 1.0 109.844 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.1 t -126.19 133.81 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.587 0.232 . . . . 1.0 110.727 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.3 mt -110.55 136.31 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.9 m -117.63 139.31 51.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.006 -0.543 . . . . 1.0 109.635 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.562 ' CE2' ' OH ' ' A' ' 90' ' ' TYR . 3.7 p-90 -143.3 153.1 42.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.776 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' A' ' 49' ' ' ASP . 64.7 tttp -101.4 133.3 46.22 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.829 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.1 mp -96.07 -75.51 0.53 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.503 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.511 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 72.4 m-20 -109.99 -167.81 1.24 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.872 -0.603 . . . . 1.0 110.596 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.489 ' C ' ' HZ1' ' A' ' 47' ' ' LYS . 56.7 mtpt -60.38 -42.31 95.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.775 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -128.43 56.94 1.6 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.797 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 44.5 tp -153.59 115.48 4.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.913 0.387 . . . . 1.0 110.081 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -124.88 148.19 48.41 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.33 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -136.87 152.69 50.53 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.971 -0.558 . . . . 1.0 110.283 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -129.9 144.39 51.29 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.661 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.0 mt -125.36 131.52 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.228 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 19.3 p-10 -98.27 122.79 41.87 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.978 0.418 . . . . 1.0 110.84 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.421 HG23 HD12 ' A' ' 58' ' ' ILE . 91.2 mt -101.13 133.75 43.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.385 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 59' ' ' GLN . 1.2 pm0 -120.12 132.49 55.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -99.99 144.54 28.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.103 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.613 ' CD1' ' H ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -135.91 173.48 11.66 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.158 0.504 . . . . 1.0 109.947 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.613 ' H ' ' CD1' ' A' ' 61' ' ' LEU . 13.1 tp10 87.32 33.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.677 -1.147 . . . . 1.0 109.922 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -92.33 76.26 5.23 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.756 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.4 ' O ' ' OD1' ' A' ' 65' ' ' ASN . 12.5 pt-20 -64.99 -36.48 84.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.813 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 64' ' ' GLU . 4.9 m-20 -136.15 153.66 76.82 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.305 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.12 -33.26 53.03 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.769 1.646 . . . . 1.0 112.29 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.7 mt -84.6 -6.72 59.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.373 . . . . 1.0 110.383 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.19 127.33 35.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.273 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.0 mt -86.03 153.73 21.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.302 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.9 95.51 0.41 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.313 -1.115 . . . . 1.0 110.313 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -71.92 -15.41 62.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.927 0.394 . . . . 1.0 110.684 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.2 t -118.26 120.35 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.669 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.2 mt -113.82 126.02 54.73 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.9 mt -102.08 123.64 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.882 0.372 . . . . 1.0 110.653 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.435 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 57.8 t -142.88 134.18 23.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.976 -0.557 . . . . 1.0 110.34 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.437 ' O ' ' OD2' ' A' ' 76' ' ' ASP . 3.4 p-10 48.67 44.32 21.23 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.216 0.323 . . . . 1.0 111.263 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 59.69 23.18 11.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.038 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -129.15 138.38 51.74 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.358 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -92.23 132.16 36.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 1.0 111.11 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -126.88 138.07 53.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.263 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -82.76 -37.73 24.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.821 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -109.48 133.34 53.2 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.005 0.431 . . . . 1.0 112.028 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.4 tp -64.41 -40.73 96.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.503 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -62.06 -43.23 99.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.501 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.46 ' O ' ' OE1' ' A' ' 89' ' ' GLU . 32.8 tt0 -58.39 -38.3 77.05 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.345 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.1 mt -59.66 -45.31 94.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.753 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -62.57 -47.42 93.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.429 -0.508 . . . . 1.0 111.607 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.1 t -69.86 -23.56 25.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 112.967 0.728 . . . . 1.0 112.967 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 85' ' ' GLN . 4.5 mp0 -98.1 -9.59 25.64 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.142 -0.223 . . . . 1.0 111.054 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.562 ' OH ' ' CE2' ' A' ' 46' ' ' TRP . 12.5 t80 -89.38 -54.58 4.03 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.913 0.709 . . . . 1.0 112.913 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -71.59 -33.56 69.14 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.706 -0.679 . . . . 1.0 112.107 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.435 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 3.5 mm-40 -61.2 -48.68 80.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.07 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -67.72 -40.53 84.21 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.068 -0.653 . . . . 1.0 111.448 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -63.11 -42.6 99.59 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.438 -0.505 . . . . 1.0 111.275 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.93 -45.88 93.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.331 -0.548 . . . . 1.0 111.279 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -66.8 -45.4 78.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.383 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tp -69.04 -41.16 78.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.55 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.44 -42.25 92.61 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.472 -0.491 . . . . 1.0 110.053 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -66.38 -39.92 89.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.382 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -71.18 -42.81 68.56 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 120.781 -0.368 . . . . 1.0 111.783 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.465 ' O ' ' OG ' ' A' ' 104' ' ' SER . 4.1 tpt -63.96 -54.01 41.24 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.349 -0.54 . . . . 1.0 111.096 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.7 m -61.26 -39.36 90.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.48 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.2 t -73.16 9.77 1.15 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.911 -0.586 . . . . 1.0 111.224 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 101' ' ' MET . 87.1 p -88.03 139.22 30.73 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.681 0.277 . . . . 1.0 110.725 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.68 -22.32 66.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.996 0.427 . . . . 1.0 110.626 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.564 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 31.5 mtmm -88.2 39.63 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.804 -0.635 . . . . 1.0 109.828 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -129.84 114.02 15.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.068 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -122.75 124.66 43.86 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -93.65 68.09 3.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.826 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.13 147.51 16.84 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 29.2 p -72.42 172.08 11.09 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -55.9 -37.66 69.18 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.364 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -67.47 -45.07 77.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.841 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.73 -20.37 63.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.781 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.71 -44.82 78.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.343 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.58 -46.38 95.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.207 0.527 . . . . 1.0 110.178 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -65.77 -33.99 77.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.829 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -68.31 -50.23 54.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.795 -0.639 . . . . 1.0 111.679 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.4 tp -69.99 -39.4 77.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.682 -0.407 . . . . 1.0 110.457 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.535 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 66.8 mm-40 -63.75 -40.56 97.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.716 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -63.43 -46.85 84.39 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.11 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.537 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 9.2 t80 -61.92 -41.83 98.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.14 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.5 t -62.28 -40.53 96.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.41 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -57.74 -44.03 85.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.315 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.47 -38.89 83.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.368 -0.605 . . . . 1.0 109.368 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.537 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -124.56 76.25 63.34 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.598 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -70.5 -24.56 26.14 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.799 2.333 . . . . 1.0 112.514 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -100.94 13.54 34.81 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.867 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.33 151.0 51.84 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.846 0.355 . . . . 1.0 110.482 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 m -80.91 160.87 24.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.887 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.2 p -153.05 149.81 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 109.36 -0.607 . . . . 1.0 109.36 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -151.0 143.44 24.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.922 0.392 . . . . 1.0 111.307 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -151.37 165.13 35.03 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.374 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.564 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.6 p90 -136.08 148.55 48.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 1.0 109.481 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 75.1 m -143.92 167.77 21.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.088 0.471 . . . . 1.0 110.214 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.8 tt -83.61 131.72 34.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.252 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -104.31 133.45 49.18 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.221 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -85.81 0.81 51.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.846 0.355 . . . . 1.0 110.585 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 139' ' ' ASP . 66.4 t0 -64.13 -37.9 89.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.127 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -150.81 104.59 3.04 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.085 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -48.65 124.04 10.38 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.597 1.531 . . . . 1.0 112.78 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.99 29.5 9.02 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.839 -0.905 . . . . 1.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -134.9 142.21 46.51 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.676 0.274 . . . . 1.0 110.32 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -122.16 146.49 47.18 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.625 ' CE2' ' ND2' ' A' ' 160' ' ' ASN . 13.6 m-85 -117.89 138.68 51.96 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.188 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.3 mt -110.44 120.95 44.08 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.617 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.57 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -116.07 145.01 43.37 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.988 -1.115 . . . . 1.0 107.988 178.02 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -161.68 149.74 15.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.39 -0.524 . . . . 1.0 109.679 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.535 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 67.0 tttt -135.4 130.39 34.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 120.934 -0.306 . . . . 1.0 110.257 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.439 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 28.9 mm -71.04 -45.03 74.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 1.0 111.348 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 150' ' ' ILE . 82.7 m-20 -160.31 174.23 14.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.665 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.92 -36.11 80.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.985 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -86.4 8.61 20.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.008 0.432 . . . . 1.0 110.531 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.3 t -96.9 157.53 15.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.516 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.431 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 68.8 mttm -88.16 143.24 27.17 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.216 -0.447 . . . . 1.0 109.891 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 43.6 tp -70.28 130.14 41.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.909 0.385 . . . . 1.0 110.141 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.431 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 93.6 m-85 -119.83 135.09 55.0 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.803 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 91.3 m -129.99 132.69 46.37 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.932 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.77 169.06 11.47 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.124 -0.489 . . . . 1.0 109.961 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.625 ' ND2' ' CE2' ' A' ' 145' ' ' TYR . 5.8 m120 -117.17 150.57 38.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.885 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 78.5 t -128.26 137.96 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.804 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -100.24 125.77 46.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.984 0.421 . . . . 1.0 110.592 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.9 tp -88.39 130.68 35.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.788 -0.642 . . . . 1.0 109.372 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 37.6 p -128.82 176.67 7.65 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.93 0.395 . . . . 1.0 110.445 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -88.98 13.49 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.36 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 12.5 p -121.65 -2.5 9.37 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.814 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.35 -140.56 10.68 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.36 -1.096 . . . . 1.0 110.36 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -116.42 126.99 54.21 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.616 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 7.7 m-85 -106.43 117.8 34.99 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.0 tt -113.45 117.66 32.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.7 -0.482 . . . . 1.0 109.7 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.4 t 36.25 60.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.088 0.403 . . . . 1.0 112.088 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.7 m120 65.19 27.91 12.19 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.061 0.763 . . . . 1.0 113.061 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -133.87 120.79 20.85 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.616 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 16.4 t-20 -97.48 121.19 39.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.532 -0.304 . . . . 1.0 111.435 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -101.8 137.21 19.48 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.78 -21.4 33.46 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 122.412 2.075 . . . . 1.0 113.134 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 4.5 t -156.48 160.82 39.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.111 0.481 . . . . 1.0 111.002 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.98 -34.83 61.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.795 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 93.3 mt -61.75 -44.96 99.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.081 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -69.7 -29.81 67.32 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.65 -43.87 95.5 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 110.118 -0.327 . . . . 1.0 110.118 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 86.9 m -63.22 -46.22 87.98 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.386 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.554 ' O ' ' N ' ' A' ' 186' ' ' LYS . 88.8 m-20 -64.33 -48.18 76.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.17 -44.73 0.57 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.05 -47.52 65.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.048 -0.576 . . . . 1.0 109.781 178.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 183' ' ' ASN . 64.9 tttp -56.82 -41.7 78.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.591 -0.731 . . . . 1.0 110.227 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.5 m -61.45 -44.8 96.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.451 ' O ' ' OG ' ' A' ' 191' ' ' SER . 23.1 mt -62.94 -40.47 97.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.857 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.51 -43.94 93.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.23 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -58.7 -45.96 88.36 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.269 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 188' ' ' LEU . 80.0 p -62.1 -37.36 84.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.5 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.44 ' N ' ' HG ' ' A' ' 191' ' ' SER . 73.4 mt -67.47 -42.93 82.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.347 -0.842 . . . . 1.0 111.923 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -69.15 -34.47 75.04 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 111.871 0.323 . . . . 1.0 111.871 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 6.0 t60 . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.011 -179.321 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 120.931 0.396 . . . . 1.0 110.609 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.72 -25.94 38.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.698 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.468 ' H ' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -78.91 -17.63 13.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.39 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.497 ' N ' HD21 ' A' ' 6' ' ' ASN . 2.0 m120 -98.67 3.5 47.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.413 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -77.56 143.1 67.43 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.305 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.419 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 56.3 Cg_endo -70.65 -13.83 32.76 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.855 1.703 . . . . 1.0 112.243 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.472 ' CD1' ' CZ ' ' A' ' 30' ' ' PHE . 88.6 m-85 -94.53 3.94 54.48 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.533 -0.303 . . . . 1.0 111.128 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.545 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 88.1 t80 -87.29 127.72 35.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.488 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 68.4 m-85 -155.04 106.93 2.28 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.974 -0.38 . . . . 1.0 109.974 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.5 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 32.5 Cg_exo -59.15 110.87 0.76 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.716 1.611 . . . . 1.0 112.926 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.5 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 57.0 m-85 -159.64 150.95 19.79 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.425 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -78.51 171.97 14.34 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.11 -41.22 98.54 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.34 -0.933 . . . . 1.0 111.062 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.416 ' O ' ' CG ' ' A' ' 19' ' ' GLU . 84.9 mtt85 -66.41 -42.35 87.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.884 0.373 . . . . 1.0 110.861 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -71.84 -31.97 67.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.17 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.43 -48.51 79.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.825 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 16' ' ' ARG . 14.4 pt-20 -60.32 -39.08 85.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.023 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.403 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 9.2 m-20 -63.95 -43.61 95.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.078 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.635 ' CE2' ' NZ ' ' A' ' 25' ' ' LYS . 42.5 t80 -67.4 -41.59 84.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.446 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.24 -11.2 60.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.749 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -59.18 -44.51 92.17 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.867 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 m -78.67 -19.03 53.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.765 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.635 ' NZ ' ' CE2' ' A' ' 21' ' ' TYR . 43.8 mmtm -72.91 159.1 34.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.543 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.54 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.6 pm0 -82.34 156.74 24.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.637 . . . . 1.0 110.657 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.417 ' HG2' ' HZ1' ' A' ' 47' ' ' LYS . 81.2 mtm-85 -54.05 141.62 27.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.907 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.01 17.63 50.44 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.305 -0.718 . . . . 1.0 111.305 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -94.96 136.51 35.18 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.472 ' CZ ' ' CD1' ' A' ' 9' ' ' TYR . 26.0 p90 -133.78 167.62 20.22 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.355 0.598 . . . . 1.0 110.883 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.2 m -146.77 157.76 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 114.924 -1.034 . . . . 1.0 111.64 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.0 mm -116.32 125.84 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.262 -0.644 . . . . 1.0 109.262 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -140.12 165.16 28.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.064 -0.517 . . . . 1.0 110.461 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -118.53 135.53 54.35 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 m -65.04 146.0 55.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.801 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.5 m -60.49 -26.01 66.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.692 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -123.29 27.19 7.63 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.036 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -92.49 -77.24 1.36 Allowed Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 t0 70.81 -35.49 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.623 0.249 . . . . 1.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 38' ' ' GLY . 21.1 t70 -118.63 10.49 12.52 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.754 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.443 ' ND1' ' O ' ' A' ' 40' ' ' ASP . 25.0 m-70 -142.31 151.99 42.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.381 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mt -121.13 145.58 47.66 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.076 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.9 t -123.62 129.48 74.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.096 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.3 mt -111.51 137.66 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.5 m -121.63 141.71 50.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.437 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.709 ' HE1' ' NE2' ' A' ' 54' ' ' GLN . 3.5 p-90 -154.04 154.79 34.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.215 -0.902 . . . . 1.0 110.972 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HZ1' ' HG2' ' A' ' 27' ' ' ARG . 10.6 ptmm? -95.7 143.72 26.72 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.148 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.532 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 3.3 mp -93.02 -73.06 0.57 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.458 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -145.26 119.08 9.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.594 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt 45.0 -129.13 1.05 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.064 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -70.94 73.95 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.068 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.4 tp -167.56 121.38 0.96 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.272 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -135.15 150.37 50.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.628 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.709 ' NE2' ' HE1' ' A' ' 46' ' ' TRP . 20.3 pt20 -135.8 155.05 50.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.714 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.402 ' H ' ' CD2' ' A' ' 55' ' ' HIS . 6.8 p80 -124.04 141.27 52.19 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.067 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.4 HD13 HG22 ' A' ' 56' ' ' ILE . 96.7 mt -126.44 132.47 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.743 -0.466 . . . . 1.0 109.743 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -102.23 123.81 46.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.894 0.378 . . . . 1.0 110.534 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.405 HG21 HD12 ' A' ' 58' ' ' ILE . 86.3 mt -103.1 133.87 45.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.343 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -112.95 141.78 46.39 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.869 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.545 ' OE1' ' NZ ' ' A' ' 63' ' ' LYS . 78.8 mt-10 -99.79 148.51 24.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.813 -0.44 . . . . 1.0 109.813 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.417 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.6 tp -122.73 176.22 6.08 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.579 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.417 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 69.9 mm-40 57.66 32.34 21.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.022 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.545 ' NZ ' ' OE1' ' A' ' 60' ' ' GLU . 20.1 mmtm -78.65 74.13 5.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.881 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.7 -29.51 70.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.707 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -150.31 149.11 25.96 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.068 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.62 -25.14 66.14 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.268 1.979 . . . . 1.0 112.13 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mp -91.27 -11.09 39.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.722 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.34 140.07 50.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.371 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.2 mt -77.14 148.89 35.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.377 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.47 92.39 0.27 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -63.17 -35.2 79.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.831 0.348 . . . . 1.0 110.875 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.1 t -127.11 125.06 65.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.073 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.1 mt -115.23 129.63 56.69 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.411 HG23 HD13 ' A' ' 74' ' ' ILE . 18.5 mm -99.41 123.54 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.933 0.397 . . . . 1.0 110.298 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.3 t -139.88 130.47 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.28 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 54.24 40.7 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.954 -0.298 . . . . 1.0 111.096 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.6 t30 62.0 24.05 14.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.729 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -128.21 151.78 48.85 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.264 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -96.65 130.78 43.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.81 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -125.07 138.43 54.19 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.198 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -85.91 -38.02 18.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.731 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -121.36 145.6 47.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.173 0.511 . . . . 1.0 112.039 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.51 -38.41 89.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.615 -0.72 . . . . 1.0 110.802 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -60.72 -39.89 90.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.934 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -63.12 -38.67 92.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.649 0.261 . . . . 1.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.2 mt -60.98 -46.3 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.873 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.7 mt -62.9 -46.14 97.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.581 -0.448 . . . . 1.0 111.669 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.68 -43.7 79.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 112.495 0.554 . . . . 1.0 112.495 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -75.9 -14.12 60.26 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.799 -0.36 . . . . 1.0 111.511 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -94.14 -50.77 5.13 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.638 -0.425 . . . . 1.0 111.825 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 tp -68.85 -39.97 79.62 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.301 0.482 . . . . 1.0 112.301 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -62.94 -48.91 76.85 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 119.971 -0.691 . . . . 1.0 111.379 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -69.57 -42.41 74.54 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.691 -0.403 . . . . 1.0 111.696 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -65.92 -42.55 89.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.218 -0.593 . . . . 1.0 111.191 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.86 -45.13 92.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.495 -0.482 . . . . 1.0 111.296 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -67.1 -44.9 78.79 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.86 -0.336 . . . . 1.0 111.563 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 tp -68.58 -41.77 79.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.501 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.3 tp -63.52 -43.07 98.25 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.193 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.427 ' O ' ' OG ' ' A' ' 103' ' ' SER . 3.2 m-80 -68.63 -37.66 79.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.026 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -70.4 -43.17 70.59 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.686 -0.406 . . . . 1.0 111.562 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.2 tpt -66.28 -55.06 17.93 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.279 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 104' ' ' SER . 9.7 m -58.34 -38.42 77.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.028 0.442 . . . . 1.0 110.349 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 99' ' ' ASN . 86.7 p -72.36 10.57 0.76 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.634 -0.712 . . . . 1.0 111.049 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.441 ' H ' ' C ' ' A' ' 102' ' ' THR . 11.7 t -91.84 134.16 35.01 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.832 0.349 . . . . 1.0 110.248 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.31 -20.81 46.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 1.0 111.196 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.58 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 45.9 mtpt -87.9 40.63 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.943 -0.571 . . . . 1.0 109.761 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -130.68 109.14 10.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.135 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -134.8 124.93 25.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.732 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.2 p -92.61 82.8 4.82 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.879 0.371 . . . . 1.0 110.933 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -103.84 147.89 16.78 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.887 -0.885 . . . . 1.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.6 p -73.53 168.48 19.2 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.007 -0.368 . . . . 1.0 110.007 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -58.89 -40.57 84.85 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.743 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -70.83 -44.0 67.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.183 0.516 . . . . 1.0 110.641 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.54 -22.57 63.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.994 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.7 t -68.11 -44.76 84.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.089 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.5 t -63.91 -45.85 95.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.098 0.475 . . . . 1.0 110.263 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.38 -38.65 90.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.977 0.418 . . . . 1.0 111.034 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -64.44 -49.47 71.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.778 -0.647 . . . . 1.0 111.834 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.0 tp -70.24 -38.4 74.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.485 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.447 ' C ' ' HG ' ' A' ' 123' ' ' SER . 83.0 mt-10 -62.22 -41.28 98.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.547 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.71 -48.46 74.57 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.45 -0.5 . . . . 1.0 110.255 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.552 ' CD2' ' OD1' ' A' ' 126' ' ' ASN . 39.8 t80 -61.55 -42.42 98.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.944 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.447 ' HG ' ' C ' ' A' ' 120' ' ' GLU . 96.4 p -57.77 -39.17 76.8 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.272 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -64.42 -37.52 87.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.248 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.4 t -64.8 -40.38 88.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.554 -0.536 . . . . 1.0 109.554 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.552 ' OD1' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -126.55 75.56 74.36 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.385 179.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.567 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 6.6 Cg_exo -71.52 -25.47 21.1 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.485 2.123 . . . . 1.0 112.584 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -99.35 13.48 33.03 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.188 -0.46 . . . . 1.0 112.05 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -136.24 150.41 48.95 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.931 0.396 . . . . 1.0 110.445 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.9 p -80.12 164.32 23.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.742 -0.663 . . . . 1.0 109.79 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 p -153.09 147.41 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -149.16 142.82 25.5 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.861 0.362 . . . . 1.0 111.125 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -153.15 170.5 20.37 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.313 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -135.95 157.08 47.72 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.9 p -151.02 168.0 25.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.356 -0.383 . . . . 1.0 110.296 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.3 tp -78.38 135.01 37.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.442 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 8.4 t-20 -63.25 -176.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.201 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.469 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 8.3 p-80 -138.52 -23.41 0.97 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.707 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -107.31 -10.22 15.85 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.032 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 29.3 m120 -136.93 80.09 37.02 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.413 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.65 128.61 30.72 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.013 1.809 . . . . 1.0 112.469 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.3 -19.92 41.52 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -98.86 149.33 23.02 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 110.0 -0.371 . . . . 1.0 110.0 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -118.13 153.73 33.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.524 . . . . 1.0 109.747 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.45 ' CE1' ' ND2' ' A' ' 137' ' ' ASN . 33.1 m-85 -126.82 137.49 53.2 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.016 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.6 mt -108.07 128.93 55.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.31 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -120.36 146.41 46.19 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.837 -1.172 . . . . 1.0 107.837 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -160.38 146.56 15.37 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -130.41 126.51 37.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 120.814 -0.354 . . . . 1.0 110.285 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -72.92 -45.99 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.32 0.489 . . . . 1.0 112.32 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.567 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 15.6 t-20 -153.55 168.03 27.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.522 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.561 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -61.67 -30.68 70.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.689 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.417 ' ND2' ' C ' ' A' ' 153' ' ' ASN . 0.2 OUTLIER -85.73 -12.5 50.98 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.336 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.7 t -78.77 157.09 28.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.036 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -87.47 148.18 25.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.193 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.3 tp -73.02 122.94 22.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.987 0.422 . . . . 1.0 109.902 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -113.38 132.92 55.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.917 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.7 m -126.96 131.83 50.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.756 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -116.09 163.67 15.6 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.995 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 161' ' ' VAL . 28.5 t-20 -107.54 147.74 30.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.634 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.414 ' N ' ' OD1' ' A' ' 160' ' ' ASN . 44.8 t -127.71 134.79 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.597 -0.52 . . . . 1.0 109.597 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -100.55 128.44 46.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.953 0.406 . . . . 1.0 110.436 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.7 tp -92.84 131.07 38.2 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 70.4 p -129.53 171.25 12.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.39 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -85.16 15.47 4.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.55 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 58.3 p -123.21 -2.99 8.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.466 -0.334 . . . . 1.0 110.549 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 142.74 -138.2 8.22 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.357 -1.097 . . . . 1.0 110.357 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -118.69 128.58 54.65 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.115 -0.328 . . . . 1.0 110.115 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.491 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 4.7 m-85 -103.16 125.94 50.09 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 171' ' ' VAL . 0.8 OUTLIER -119.05 113.93 21.72 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.6 t 36.64 59.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 111.886 0.328 . . . . 1.0 111.886 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.5 m120 66.96 27.87 8.72 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.913 0.709 . . . . 1.0 112.913 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -132.62 121.7 23.59 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.491 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 28.0 t-20 -94.44 119.3 32.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.253 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -99.33 132.13 23.86 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 109.63 -0.507 . . . . 1.0 109.63 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.05 -22.53 19.36 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.985 1.79 . . . . 1.0 113.5 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.8 p -150.37 153.81 36.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.917 0.389 . . . . 1.0 110.939 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.05 -35.5 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.851 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.97 -47.71 90.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.152 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.35 -31.95 73.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.16 -42.14 99.36 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.401 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . 0.467 ' SG ' ' NZ ' ' A' ' 106' ' ' LYS . 75.9 m -62.97 -46.83 85.86 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.745 -0.382 . . . . 1.0 110.343 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 186' ' ' LYS . 35.8 m-80 -64.92 -49.43 70.43 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 108.712 -0.847 . . . . 1.0 108.712 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.18 -46.19 0.49 Allowed Glycine 0 N--CA 1.466 0.657 0 N-CA-C 109.998 -1.241 . . . . 1.0 109.998 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -45.12 71.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.249 0.547 . . . . 1.0 110.046 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 183' ' ' ASN . 17.6 tptm -57.75 -44.36 86.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.242 -0.89 . . . . 1.0 110.467 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 14.4 m -61.19 -45.57 94.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.77 -42.1 98.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.079 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.1 tp -58.34 -43.6 88.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.526 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -59.03 -42.95 91.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.342 0.592 . . . . 1.0 110.228 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.3 t -66.21 -42.68 88.4 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.19 0.519 . . . . 1.0 110.207 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.88 -46.38 85.2 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.303 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.51 -30.09 69.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.456 -0.338 . . . . 1.0 111.679 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 44.1 m80 . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.902 -178.885 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 121.152 0.501 . . . . 1.0 110.387 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.2 p -64.69 -39.08 84.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.71 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.8 pt -67.49 -29.99 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.793 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -95.73 10.35 37.24 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.362 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -66.36 133.65 94.49 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.295 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.536 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 78.4 Cg_exo -48.65 -34.14 26.2 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.834 1.69 . . . . 1.0 112.398 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CE2' ' CZ ' ' A' ' 30' ' ' PHE . 90.6 m-85 -79.66 4.15 16.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.398 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.599 ' HH ' HE21 ' A' ' 34' ' ' GLN . 55.3 t80 -87.19 128.14 35.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.454 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CZ ' ' O ' ' A' ' 8' ' ' PRO . 67.6 m-85 -150.83 115.29 3.22 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.59 112.28 3.49 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.95 1.767 . . . . 1.0 113.623 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.582 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -159.03 165.33 34.22 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.375 0.607 . . . . 1.0 111.187 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 51.4 t-20 -76.71 163.7 26.57 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.506 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . -59.68 -40.2 96.19 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.876 -0.89 . . . . 1.0 110.876 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -64.83 -45.14 87.4 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.994 -0.283 . . . . 1.0 111.033 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -70.0 -36.98 75.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.506 -0.316 . . . . 1.0 111.464 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -42.9 99.36 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.42 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.69 -42.21 82.4 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.118 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -61.82 -40.1 94.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.178 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -64.31 -40.52 96.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.659 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.42 -13.27 59.92 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.019 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -59.24 -42.54 91.34 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.644 -0.423 . . . . 1.0 110.561 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 m -77.97 -19.41 54.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.681 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -79.06 171.41 15.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.003 0.43 . . . . 1.0 110.858 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -77.01 155.52 32.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.786 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -69.08 145.84 53.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.4 2.54 60.28 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.08 -0.808 . . . . 1.0 111.08 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -79.01 154.17 29.7 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.617 ' CZ ' ' CE2' ' A' ' 9' ' ' TYR . 37.5 p90 -138.71 166.33 24.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.593 0.711 . . . . 1.0 111.054 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 m -149.8 162.41 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.721 -1.127 . . . . 1.0 112.046 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.5 mt -117.01 127.02 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.705 -0.479 . . . . 1.0 109.705 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.475 ' NE ' ' O ' ' A' ' 13' ' ' PHE . 75.2 ttt-85 -136.49 158.49 44.3 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.35 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.599 HE21 ' HH ' ' A' ' 10' ' ' TYR . 49.0 mt-30 -114.31 133.09 55.91 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.824 -0.436 . . . . 1.0 109.824 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.2 m -77.2 139.21 39.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.1 p -68.7 -38.01 79.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.96 -0.563 . . . . 1.0 110.434 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 83.0 mmt-85 -88.08 -13.95 40.13 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.771 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -75.02 -64.06 2.4 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.519 -1.033 . . . . 1.0 110.519 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 t70 69.93 -40.2 0.46 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.647 0.261 . . . . 1.0 110.944 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 38' ' ' GLY . 43.0 p-10 -117.15 11.4 14.15 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.71 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -132.24 152.73 51.19 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.933 0.397 . . . . 1.0 110.371 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.8 mp -118.75 144.99 45.92 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.827 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -126.1 130.88 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.284 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 mt -112.97 139.49 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.7 m -115.99 128.64 55.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.677 ' HE1' HE21 ' A' ' 54' ' ' GLN . 8.0 p-90 -142.38 147.73 36.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.915 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.7 mtmm -90.88 136.88 32.78 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.101 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 7.4 mp -94.33 -67.59 0.85 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.192 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.518 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 26.1 t70 -125.91 -173.31 2.81 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.319 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.518 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 88.4 tttt -65.23 134.23 53.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.644 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 56.44 31.42 18.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.052 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 tp -135.02 130.27 35.4 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.879 0.371 . . . . 1.0 110.604 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -132.29 149.81 52.29 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.551 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.677 HE21 ' HE1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -142.86 153.91 43.63 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 179.203 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.482 ' N ' ' CD ' ' A' ' 54' ' ' GLN . 19.1 p80 -123.24 140.73 52.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.207 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 14.7 tt -123.87 128.43 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.788 -0.449 . . . . 1.0 109.788 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 32.6 p-10 -103.72 126.36 50.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.975 0.417 . . . . 1.0 110.919 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.431 HD12 HG21 ' A' ' 58' ' ' ILE . 79.0 mt -106.42 129.1 60.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.104 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -104.94 140.4 38.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.253 -0.431 . . . . 1.0 109.999 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -102.82 157.26 17.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.358 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.457 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -145.16 167.91 21.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.658 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.457 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 50.4 tt0 71.47 37.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.012 -0.54 . . . . 1.0 109.899 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -87.33 115.07 24.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -98.44 -25.26 14.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.011 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -157.11 151.88 20.92 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.194 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.53 -19.0 60.68 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.22 1.947 . . . . 1.0 111.859 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.9 tp -79.3 -14.12 59.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.049 0.452 . . . . 1.0 110.691 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.59 137.95 38.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.267 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.2 mt -79.54 164.38 23.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.441 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.52 97.64 0.18 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -67.78 -36.08 79.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.997 0.427 . . . . 1.0 110.618 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.4 t -117.05 123.78 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.583 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.4 mt -116.7 135.57 53.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.428 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.7 mt -107.17 126.41 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.887 0.375 . . . . 1.0 110.142 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.1 t -143.86 132.55 19.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.32 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 t70 54.68 43.28 30.39 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.052 -0.259 . . . . 1.0 111.002 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 59.27 24.57 13.06 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.943 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -128.52 154.51 46.07 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.229 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -103.94 134.8 46.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.219 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -126.23 139.39 53.38 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.348 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -84.45 -38.04 20.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.714 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -123.09 150.72 42.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.124 0.488 . . . . 1.0 111.986 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.5 tp -66.8 -36.33 82.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.584 -0.735 . . . . 1.0 111.295 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 50.2 p-10 -58.22 -33.42 69.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.805 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.494 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 27.6 mt-30 -64.88 -39.26 93.26 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.657 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.42 ' O ' ' CB ' ' A' ' 90' ' ' TYR . 31.3 mm -62.67 -48.26 89.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.857 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.47 -43.58 98.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 120.334 -0.546 . . . . 1.0 111.734 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.2 -42.59 58.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 113.148 0.796 . . . . 1.0 113.148 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -82.8 -13.41 56.29 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.636 -0.426 . . . . 1.0 111.557 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.42 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 64.1 t80 -95.52 -48.63 5.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.524 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 tp -69.52 -40.62 76.83 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.264 0.468 . . . . 1.0 112.264 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -63.89 -48.59 76.07 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.042 -0.663 . . . . 1.0 111.762 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -68.43 -43.28 77.47 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.75 -0.38 . . . . 1.0 111.757 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -66.05 -42.13 89.89 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.163 -0.615 . . . . 1.0 111.225 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.37 -46.13 91.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.226 -0.59 . . . . 1.0 111.441 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -69.17 -44.3 72.49 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.789 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.3 tp -69.01 -40.31 78.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.152 -0.476 . . . . 1.0 111.719 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.4 tp -64.43 -43.3 94.78 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.292 -0.563 . . . . 1.0 110.08 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -67.79 -38.52 83.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.129 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.452 ' OE1' ' OH ' ' A' ' 168' ' ' TYR . 2.9 tm-20 -70.91 -42.81 69.46 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.802 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.487 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 2.6 ttt -64.98 -54.42 30.8 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.531 -0.467 . . . . 1.0 111.433 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 104' ' ' SER . 55.5 m -61.23 -30.29 70.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.126 0.489 . . . . 1.0 110.496 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.1 t -73.44 10.31 1.07 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.634 -0.712 . . . . 1.0 110.926 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 102' ' ' THR . 36.4 t -96.41 131.68 42.71 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.773 0.32 . . . . 1.0 110.284 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -57.83 -17.89 18.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.944 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.536 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 37.7 mmtm -90.8 40.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.063 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -133.17 111.28 10.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.468 . . . . 1.0 111.071 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -123.34 126.46 46.89 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -94.68 85.85 4.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.977 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.0 149.35 16.9 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.464 ' HG1' ' H ' ' A' ' 114' ' ' ASP . 28.3 p -71.98 170.86 12.9 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -59.87 -39.17 84.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.859 -0.336 . . . . 1.0 110.831 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -68.15 -42.33 80.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.905 0.383 . . . . 1.0 110.455 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.464 ' H ' ' HG1' ' A' ' 111' ' ' THR . 97.7 m-20 -70.6 -18.52 62.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.094 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.19 -44.39 55.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.767 0.318 . . . . 1.0 110.144 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.8 t -62.89 -46.75 95.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.251 0.548 . . . . 1.0 110.157 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -66.02 -36.66 83.87 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.005 0.431 . . . . 1.0 111.099 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -66.61 -49.63 65.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.599 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.5 tp -69.77 -39.4 77.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.305 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -64.82 -42.03 95.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.947 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -63.33 -48.26 78.74 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.427 -0.509 . . . . 1.0 110.052 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -59.94 -43.28 95.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.95 -0.568 . . . . 1.0 109.898 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.4 t -62.9 -39.52 94.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.295 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.8 -41.6 82.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.097 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.24 -41.6 92.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.92 78.6 65.43 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.043 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.529 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 39.1 Cg_endo -71.19 -13.68 31.2 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.449 2.099 . . . . 1.0 112.46 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -101.45 -14.5 17.51 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.651 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -105.97 148.38 27.74 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.978 0.418 . . . . 1.0 110.477 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 60.2 p -81.81 163.78 22.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.883 -0.599 . . . . 1.0 109.615 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 p -152.72 146.27 15.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.421 ' O ' ' CD2' ' A' ' 133' ' ' TYR . 33.0 p90 -149.91 141.53 23.52 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.671 -0.412 . . . . 1.0 111.083 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.421 ' CD2' ' O ' ' A' ' 132' ' ' TYR . 25.4 m-85 -152.91 165.93 33.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.309 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -130.63 154.37 47.96 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 178.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.1 p -150.44 168.14 25.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.205 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.1 tp -81.24 132.41 35.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.604 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.548 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 22.6 p30 -78.25 151.9 32.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.277 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -106.22 -30.4 9.23 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.651 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 41.4 p30 -64.97 -21.14 66.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.197 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.548 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 19.8 t-20 -163.22 106.76 1.0 Allowed Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.59 143.55 38.32 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.796 1.664 . . . . 1.0 112.411 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.82 -39.19 2.81 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.422 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 19.8 m95 -94.47 149.78 20.91 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.815 0.34 . . . . 1.0 110.199 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.487 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 77.1 m-85 -113.26 154.86 26.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.847 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -126.31 139.23 53.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.115 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.5 mt -111.1 126.66 55.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.568 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.6 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -120.98 146.85 46.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.029 -1.1 . . . . 1.0 108.029 178.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -162.44 153.89 18.07 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.25 -0.58 . . . . 1.0 109.769 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -137.73 128.41 26.85 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.801 0.334 . . . . 1.0 110.604 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 150' ' ' ILE . 2.6 mp -69.76 -45.24 77.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 1.0 111.591 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 19.6 m120 -156.47 171.79 19.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.574 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.79 -28.3 69.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.792 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -90.27 8.61 32.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.983 0.421 . . . . 1.0 110.346 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 15.9 t -102.22 150.43 23.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.442 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -80.17 157.16 26.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.014 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 62.1 tp -75.07 124.11 26.41 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.259 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -108.31 129.89 55.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.518 . . . . 1.0 109.615 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 63.9 m -128.2 130.46 48.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.872 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -120.9 159.81 24.77 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.866 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 160' ' ' ASN . 34.5 p30 -105.69 148.32 27.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.984 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.77 136.12 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -98.33 135.27 40.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.773 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 29.3 tp -102.51 128.83 48.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.905 -0.588 . . . . 1.0 109.543 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 166' ' ' THR . 33.4 p -131.04 168.37 17.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.087 0.47 . . . . 1.0 110.398 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -78.74 17.35 0.72 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.669 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 164' ' ' THR . 12.1 p -121.35 -2.38 9.54 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.704 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 137.48 -126.3 3.58 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.264 -1.135 . . . . 1.0 110.264 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.452 ' OH ' ' OE1' ' A' ' 100' ' ' GLU . 19.9 m-85 -127.28 132.84 50.24 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.671 0.272 . . . . 1.0 110.447 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -110.43 120.81 43.62 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.938 0.399 . . . . 1.0 110.143 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.0 tt -114.96 120.92 41.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.4 t 35.97 52.1 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 111.95 0.352 . . . . 1.0 111.95 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 10.2 m120 69.42 27.41 4.98 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.087 0.773 . . . . 1.0 113.087 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -135.78 120.16 17.99 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -91.27 131.24 36.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.359 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -107.54 101.25 38.65 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 109.438 -0.578 . . . . 1.0 109.438 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -48.82 -23.17 5.44 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.462 2.108 . . . . 1.0 113.376 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 40.0 m -141.66 145.74 35.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.991 0.424 . . . . 1.0 111.097 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.62 -34.97 70.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.731 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.497 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 49.2 mm -60.57 -46.98 94.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.336 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.609 ' N ' ' NE2' ' A' ' 180' ' ' GLN . 0.6 OUTLIER -61.65 -32.9 73.09 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.14 -40.3 95.87 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 1.8 p -61.49 -46.85 88.25 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.769 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.6 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 54.5 t30 -71.21 -49.72 40.55 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 119.727 -0.789 . . . . 1.0 108.954 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.31 -43.87 0.53 Allowed Glycine 0 N--CA 1.462 0.398 0 N-CA-C 109.832 -1.307 . . . . 1.0 109.832 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -69.04 -47.93 64.14 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.071 -0.565 . . . . 1.0 109.596 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 183' ' ' ASN . 49.5 tttp -57.25 -39.9 76.55 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.184 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.5 m -60.5 -44.31 96.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 62.9 mt -63.86 -39.03 93.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.152 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.45 -45.32 91.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.713 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -58.7 -45.39 89.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.104 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.1 t -64.49 -40.29 95.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.714 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.76 -42.0 97.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.47 -0.786 . . . . 1.0 111.95 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -63.11 -25.8 68.53 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 7.3 m80 . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 120.726 0.298 . . . . 1.0 110.863 -179.691 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.481 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 83.8 mtp180 . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 120.871 0.367 . . . . 1.0 110.486 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.65 -31.83 53.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.522 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.6 pt -75.39 -19.93 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.447 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -103.59 9.11 37.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.6 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 3' ' ' ARG . 0.4 OUTLIER -67.77 147.87 98.55 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 110.057 -0.349 . . . . 1.0 110.057 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.64 -14.25 38.99 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.102 1.868 . . . . 1.0 112.2 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -94.74 5.52 51.64 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.203 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 40.3 t80 -82.88 128.76 34.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.478 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 58.4 m-85 -149.38 120.92 4.17 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.513 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.521 ' O ' ' CD1' ' A' ' 13' ' ' PHE . 72.7 Cg_endo -74.72 109.64 2.95 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.748 1.632 . . . . 1.0 112.479 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' A' ' 12' ' ' PRO . 70.6 m-85 -155.72 156.8 35.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.379 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -79.4 168.05 20.01 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.449 ' CA ' HH12 ' A' ' 33' ' ' ARG . . . -59.65 -43.58 97.61 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.381 -0.914 . . . . 1.0 111.203 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -66.02 -41.22 91.26 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.055 -0.258 . . . . 1.0 110.784 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.85 -35.9 77.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.543 -0.299 . . . . 1.0 111.229 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.77 -40.9 94.25 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.45 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.11 -42.69 93.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -60.47 -42.76 96.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.275 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -60.98 -41.8 97.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.815 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.8 mp -78.9 -15.22 58.62 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.984 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -61.14 -42.13 97.99 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.806 -0.357 . . . . 1.0 110.516 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.3 t -76.75 -18.71 58.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.975 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -87.09 -178.02 6.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.055 0.455 . . . . 1.0 110.676 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.18 179.45 5.56 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.819 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.6 mtt85 -81.01 146.11 30.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.049 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.56 19.44 29.77 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.83 145.67 26.73 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -132.86 167.45 20.18 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.109 0.481 . . . . 1.0 110.95 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.2 t -147.34 158.44 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.242 -0.89 . . . . 1.0 111.443 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.0 mm -114.83 126.33 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.711 -0.848 . . . . 1.0 108.711 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.449 HH12 ' CA ' ' A' ' 15' ' ' GLY . 57.1 ttp180 -137.86 155.86 48.52 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -119.69 137.91 53.61 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.786 -0.45 . . . . 1.0 109.786 178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.6 m -72.37 151.43 42.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.773 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.8 p -69.55 -20.81 63.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.018 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.28 17.68 9.07 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.023 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.58 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -84.54 -74.95 1.23 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.532 -1.027 . . . . 1.0 110.532 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.3 t70 67.68 -35.71 0.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.635 0.255 . . . . 1.0 110.884 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.58 ' H ' ' C ' ' A' ' 38' ' ' GLY . 97.2 m-20 -118.55 12.06 13.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.466 -0.334 . . . . 1.0 110.594 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -144.06 146.55 32.9 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.322 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mp -119.12 145.48 45.92 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.09 -0.504 . . . . 1.0 109.793 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.86 129.23 74.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.146 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.19 137.71 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 108.762 -0.829 . . . . 1.0 108.762 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.8 m -115.16 134.05 55.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.877 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -148.14 151.6 35.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.384 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -99.61 145.51 27.48 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.69 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.461 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 9.5 mp -102.47 -75.52 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.56 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 36.9 t0 -117.06 -166.74 1.2 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.388 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.56 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 51.7 mtmt -69.6 139.37 53.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.947 0.403 . . . . 1.0 110.814 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 52.28 26.66 4.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.909 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.8 tp -130.89 129.01 41.71 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.787 0.327 . . . . 1.0 110.327 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.46 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 61.5 m-85 -133.87 148.99 51.33 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.502 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 53' ' ' PHE . 98.6 mm-40 -139.84 152.09 46.21 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.581 -0.526 . . . . 1.0 109.581 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -129.37 144.15 51.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.427 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 92.8 mt -125.51 131.75 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.786 -0.449 . . . . 1.0 109.786 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -98.53 121.81 40.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.906 0.384 . . . . 1.0 110.575 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.3 mt -97.98 123.58 50.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.094 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -111.31 131.69 54.96 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -103.08 152.78 20.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.242 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.471 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 1.6 tp -144.45 165.69 27.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.414 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 3.1 tm-20 81.94 63.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.201 0.524 . . . . 1.0 110.063 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.89 113.91 27.74 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.034 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.468 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 57.8 mp0 -65.85 -22.85 66.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.688 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 64' ' ' GLU . 1.1 m120 -151.6 160.03 32.37 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.133 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.34 -32.97 64.06 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.986 1.791 . . . . 1.0 112.332 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.1 mt -95.14 -8.82 35.33 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.688 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.85 144.77 45.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.593 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.7 mt -89.71 147.25 23.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.271 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.98 126.76 7.59 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.7 -0.96 . . . . 1.0 110.7 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -81.96 -9.78 59.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.064 0.459 . . . . 1.0 110.459 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.28 118.68 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.735 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.5 mt -115.01 129.23 56.67 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.551 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.2 mt -101.29 121.87 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.951 0.405 . . . . 1.0 110.228 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.88 131.92 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.121 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.7 t0 55.98 42.88 28.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.178 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 59.69 21.13 9.83 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.922 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -128.06 151.98 48.52 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.059 0.456 . . . . 1.0 110.22 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -101.37 128.38 47.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.224 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -122.94 138.67 54.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.32 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -85.25 -38.38 18.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 1.0 111.606 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -113.13 141.23 47.16 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.034 0.445 . . . . 1.0 111.993 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.2 -40.66 96.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.85 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -59.21 -41.71 89.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.746 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -60.81 -38.52 85.68 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.986 -0.285 . . . . 1.0 110.723 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.37 -47.27 94.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.743 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.1 mt -62.09 -46.41 96.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.329 -0.548 . . . . 1.0 111.684 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.0 t -71.15 -42.46 75.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.844 0.683 . . . . 1.0 112.844 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -77.38 -15.4 59.39 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.662 -0.415 . . . . 1.0 111.9 -177.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.621 ' CZ ' ' NZ ' ' A' ' 94' ' ' LYS . 34.8 t80 -94.09 -49.91 5.54 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.651 -0.42 . . . . 1.0 111.713 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.2 mp -69.75 -40.57 76.08 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 112.096 0.406 . . . . 1.0 112.096 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -62.85 -48.53 78.62 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.774 -0.77 . . . . 1.0 111.544 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -69.21 -43.41 74.18 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.522 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.621 ' NZ ' ' CZ ' ' A' ' 90' ' ' TYR . 24.0 mmtp -66.14 -43.77 86.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.213 -0.595 . . . . 1.0 111.243 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.32 -44.79 90.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.339 -0.544 . . . . 1.0 111.023 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -66.03 -47.54 74.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.248 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.0 tp -69.08 -38.93 79.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.282 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.38 -43.28 98.08 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.574 -0.45 . . . . 1.0 110.118 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -67.51 -39.75 85.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.257 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -71.09 -41.38 70.7 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.007 0.373 . . . . 1.0 112.007 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.456 ' O ' ' OG ' ' A' ' 104' ' ' SER . 3.5 ttt -68.38 -54.82 14.69 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.423 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.1 m -58.7 -42.2 88.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.076 0.465 . . . . 1.0 110.411 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.3 m -72.37 8.27 1.44 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.951 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 101' ' ' MET . 60.2 p -84.29 142.82 29.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.734 0.302 . . . . 1.0 110.512 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.63 -19.5 65.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.885 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.554 ' NZ ' ' SG ' ' A' ' 182' ' ' CYS . 98.7 mttt -93.13 39.44 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.828 -0.624 . . . . 1.0 110.161 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -134.12 118.37 17.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.122 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -126.67 133.13 51.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.0 p -99.4 74.7 1.93 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.8 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.71 146.62 18.58 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.52 171.68 10.94 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.036 -0.357 . . . . 1.0 110.036 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -56.66 -38.89 72.82 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.64 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.94 -44.19 77.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.962 0.411 . . . . 1.0 110.724 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -70.17 -20.27 63.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.056 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.2 t -70.78 -45.23 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.299 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.14 -46.67 92.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 120.494 -0.482 . . . . 1.0 110.278 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.03 -35.37 80.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.053 0.454 . . . . 1.0 110.75 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -67.49 -49.63 62.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.596 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.5 tp -70.18 -39.22 76.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.962 0.41 . . . . 1.0 110.459 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -64.24 -39.94 94.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.685 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -60.32 -48.5 81.49 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.548 -0.461 . . . . 1.0 110.31 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -62.76 -39.88 95.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.293 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.9 t -61.49 -42.39 98.72 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.578 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -59.6 -38.17 80.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.055 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.1 t -66.75 -42.28 89.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.658 -0.417 . . . . 1.0 109.974 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -126.26 76.49 72.69 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.217 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -71.29 -14.25 31.21 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 122.578 2.185 . . . . 1.0 112.441 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -103.54 10.17 37.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.655 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -132.98 148.58 52.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.861 0.362 . . . . 1.0 110.621 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 42.0 t -81.08 161.5 24.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.48 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.0 p -152.65 145.19 15.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -144.17 143.66 31.19 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.949 0.404 . . . . 1.0 111.12 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -151.35 161.98 41.75 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.372 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.481 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -132.65 154.86 49.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 179.146 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.661 ' HG ' ' N ' ' A' ' 136' ' ' LEU . 43.1 t -152.54 168.41 25.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.93 0.395 . . . . 1.0 110.105 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.661 ' N ' ' HG ' ' A' ' 135' ' ' SER . 0.8 OUTLIER -82.71 128.98 34.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.067 -0.515 . . . . 1.0 111.019 179.608 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 12.5 t-20 -87.34 135.68 33.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.902 0.382 . . . . 1.0 110.368 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -73.14 -39.64 65.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.971 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -62.44 -15.11 47.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.036 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.542 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 3.6 p30 -167.66 82.52 0.83 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.269 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.25 -37.14 58.92 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.124 1.883 . . . . 1.0 113.142 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -59.78 -34.74 83.78 Favored Glycine 0 C--N 1.312 -0.798 0 N-CA-C 110.956 -0.858 . . . . 1.0 110.956 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -99.72 144.77 28.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.88 0.372 . . . . 1.0 110.242 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -106.61 153.65 22.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.879 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.587 ' HH ' HD22 ' A' ' 160' ' ' ASN . 4.0 m-85 -112.33 134.33 53.93 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.969 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.636 ' CD1' ' HE1' ' A' ' 159' ' ' TRP . 5.3 mt -112.55 123.34 50.08 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.709 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.561 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -123.55 148.89 45.9 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.469 -0.938 . . . . 1.0 108.469 178.21 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.56 ' CE1' ' CZ3' ' A' ' 159' ' ' TRP . 8.1 p90 -163.9 160.81 22.52 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.27 -0.572 . . . . 1.0 109.649 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -140.83 129.86 23.33 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.564 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.528 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 3.6 mt -77.06 -44.94 31.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.282 -0.417 . . . . 1.0 111.592 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 150' ' ' ILE . 2.9 m-80 -154.35 165.68 35.6 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.372 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.91 -31.52 69.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.712 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -85.69 -4.34 59.14 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.043 0.449 . . . . 1.0 110.611 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 11.8 t -84.28 163.21 19.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.514 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.431 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 14.7 mptt -96.57 148.6 22.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.67 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 52.6 tp -70.23 118.81 13.53 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.36 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.438 ' O ' ' CD1' ' A' ' 148' ' ' PHE . 87.4 m-85 -113.66 119.37 37.22 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 86.0 m -130.39 135.18 47.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.848 -0.615 . . . . 1.0 111.874 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . 0.636 ' HE1' ' CD1' ' A' ' 146' ' ' LEU . 7.7 p90 -128.35 -173.94 3.09 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.462 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.587 HD22 ' HH ' ' A' ' 145' ' ' TYR . 94.4 m-20 -124.82 152.7 43.59 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.445 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.6 t -118.56 139.37 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -93.9 130.65 39.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.207 0.527 . . . . 1.0 110.948 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.8 tp -90.93 129.72 36.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.562 -0.745 . . . . 1.0 109.446 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 165' ' ' ASN . 0.1 OUTLIER -131.65 177.84 7.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.616 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.508 ' N ' ' OG1' ' A' ' 164' ' ' THR . 65.3 t30 -86.13 15.68 4.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.704 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 77.2 p -121.07 -1.7 9.78 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.575 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 132.87 -126.09 4.32 Favored Glycine 0 N--CA 1.464 0.533 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.427 ' HH ' ' HB2' ' A' ' 101' ' ' MET . 22.5 m-85 -122.13 129.27 52.18 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.545 0.212 . . . . 1.0 110.517 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.54 120.77 42.47 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.0 tt -113.32 114.98 27.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.4 t 35.47 59.46 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.253 0.464 . . . . 1.0 112.253 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.8 m120 69.16 27.34 5.26 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.17 0.804 . . . . 1.0 113.17 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -134.89 119.19 17.76 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -99.73 124.9 45.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.84 0.353 . . . . 1.0 111.736 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -102.36 131.85 22.07 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.31 -0.626 . . . . 1.0 109.31 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.36 -18.41 29.95 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.193 1.929 . . . . 1.0 113.443 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 89.7 p -152.08 156.02 39.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.084 0.468 . . . . 1.0 110.908 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.16 -36.05 72.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.716 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.05 -43.32 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 120.909 0.385 . . . . 1.0 110.123 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -61.12 -35.12 76.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.25 -39.93 94.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.211 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . 0.554 ' SG ' ' NZ ' ' A' ' 106' ' ' LYS . 13.8 t -57.04 -48.4 78.62 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.271 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 186' ' ' LYS . 65.7 t30 -66.7 -47.61 71.84 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.21 -44.02 0.76 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.376 -1.49 . . . . 1.0 109.376 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -68.96 -47.58 65.28 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.387 0.613 . . . . 1.0 109.496 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 183' ' ' ASN . 63.1 tttm -55.97 -39.11 71.31 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.251 -0.886 . . . . 1.0 109.866 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 19.0 m -63.33 -47.18 83.29 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 75.6 mt -62.9 -42.71 99.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.108 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 45.0 tp -57.35 -46.53 83.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.719 -0.392 . . . . 1.0 110.29 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -56.19 -41.83 76.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.142 0.496 . . . . 1.0 109.857 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.1 t -66.59 -42.78 86.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.832 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.66 -45.55 86.26 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.595 -0.729 . . . . 1.0 112.177 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -67.81 -35.49 78.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.785 0.326 . . . . 1.0 111.826 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.577 -178.658 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.3 mmt-85 . . . . . 0 N--CA 1.465 0.306 0 CA-C-O 120.695 0.283 . . . . 1.0 110.627 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.67 -33.43 63.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.617 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.7 pt -81.48 -30.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.547 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -95.11 3.77 54.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.342 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -65.09 140.93 98.18 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.375 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.18 -12.89 35.07 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.92 1.747 . . . . 1.0 112.038 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -102.48 7.65 40.17 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.614 0.245 . . . . 1.0 111.152 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.529 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 30.6 t80 -90.95 127.76 36.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.442 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 65.1 m-85 -151.65 108.97 2.92 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.549 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 41.7 Cg_exo -57.56 108.18 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.712 1.608 . . . . 1.0 112.734 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 66.2 m-85 -160.94 157.97 27.34 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.64 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -79.09 163.87 24.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' OE1' ' A' ' 19' ' ' GLU . . . -55.48 -45.51 83.81 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.248 -0.977 . . . . 1.0 110.853 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -65.2 -39.66 93.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.868 0.366 . . . . 1.0 110.758 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.35 -33.83 76.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.498 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.06 -38.82 87.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.436 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.552 ' OE2' ' NE2' ' A' ' 55' ' ' HIS . 4.3 mp0 -67.09 -43.51 82.36 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.566 -0.454 . . . . 1.0 110.37 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.51 -46.15 91.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.227 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -61.02 -44.82 96.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.423 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 tp -75.36 -15.98 60.43 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.064 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -60.67 -42.13 96.46 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.393 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p -75.32 -18.63 59.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.627 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -82.22 179.83 7.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.621 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -90.1 154.72 19.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.812 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -68.05 143.45 55.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.759 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.0 10.09 43.62 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.223 -0.751 . . . . 1.0 111.223 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -91.68 156.43 17.6 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -125.11 155.72 39.43 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.295 0.569 . . . . 1.0 111.004 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 t -141.4 152.76 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 115.145 -0.934 . . . . 1.0 111.184 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.95 125.8 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -142.16 158.64 43.51 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.077 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.64 HE22 ' CD2' ' A' ' 42' ' ' LEU . 95.2 mm-40 -103.15 131.17 50.36 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.437 ' C ' ' H ' ' A' ' 37' ' ' ARG . 7.2 t -48.82 -12.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.918 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.493 ' H ' ' C ' ' A' ' 34' ' ' GLN . 3.0 m 63.24 2.06 1.05 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.652 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.437 ' H ' ' C ' ' A' ' 35' ' ' SER . 34.4 ttm180 -154.47 58.88 0.7 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.629 -0.26 . . . . 1.0 110.582 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.526 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -157.62 -50.06 0.01 OUTLIER Glycine 0 N--CA 1.463 0.446 0 N-CA-C 110.384 -1.086 . . . . 1.0 110.384 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.9 t0 73.63 -28.3 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.796 0.331 . . . . 1.0 111.026 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.526 ' H ' ' C ' ' A' ' 38' ' ' GLY . 36.3 t70 -121.59 20.26 11.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.984 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -142.19 141.42 32.57 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.826 0.346 . . . . 1.0 110.541 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.64 ' CD2' HE22 ' A' ' 34' ' ' GLN . 5.3 mp -120.57 144.65 47.97 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.095 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.8 t -126.16 130.78 72.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.217 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mt -112.06 139.47 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.5 m -118.25 132.2 56.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.391 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.555 ' CZ3' ' CD2' ' A' ' 48' ' ' LEU . 2.8 p-90 -146.15 143.68 29.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.989 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -92.52 140.72 29.27 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.961 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.555 ' CD2' ' CZ3' ' A' ' 46' ' ' TRP . 8.4 mt -103.67 -75.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.331 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -115.45 -176.88 3.01 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.263 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -66.21 130.23 42.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.932 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.4 t0 61.88 30.33 18.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.033 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.0 tp -137.8 126.04 23.11 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.874 0.369 . . . . 1.0 110.412 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -134.85 149.48 50.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.55 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -138.88 153.98 48.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.853 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.552 ' NE2' ' OE2' ' A' ' 19' ' ' GLU . 44.9 m80 -124.08 141.35 52.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.243 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.7 mt -121.53 124.8 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -98.2 122.07 40.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.662 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 80.8 mt -101.15 126.0 55.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.363 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -103.71 134.58 46.8 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.978 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -104.37 146.59 28.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 1.0 109.995 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.475 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 9.8 mt -142.15 166.47 24.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.764 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 1.5 tm-20 82.32 54.73 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.856 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -106.62 93.86 4.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.878 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.11 -35.12 77.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.898 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -145.71 156.5 52.28 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.973 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.16 -19.53 68.92 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.39 2.06 . . . . 1.0 112.104 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.488 ' H ' ' CG ' ' A' ' 65' ' ' ASN . 4.8 tp -83.26 -9.88 58.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.998 0.427 . . . . 1.0 110.931 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.582 ' N ' ' ND2' ' A' ' 65' ' ' ASN . . . -113.24 143.63 44.08 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.158 0.504 . . . . 1.0 110.17 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.55 168.94 11.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.319 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.34 109.69 2.86 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.417 ' NZ ' ' OE1' ' A' ' 62' ' ' GLU . 34.2 mtmm -72.8 -11.85 60.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.02 0.438 . . . . 1.0 110.727 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.1 t -118.3 120.68 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.816 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.4 mt -115.67 130.88 57.02 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.7 mt -102.47 121.08 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -140.88 132.92 30.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.201 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.422 ' OD2' ' OD1' ' A' ' 165' ' ' ASN . 46.8 t0 53.9 42.98 31.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.774 0.321 . . . . 1.0 110.997 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 59.79 22.87 11.77 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.826 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.444 ' OE1' ' OH ' ' A' ' 80' ' ' TYR . 85.9 mt-30 -128.56 143.75 51.02 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.254 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.43 ' CB ' ' HZ2' ' A' ' 79' ' ' LYS . 8.2 mtmp? -98.12 126.98 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.872 -179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.444 ' OH ' ' OE1' ' A' ' 78' ' ' GLN . 93.8 m-85 -120.32 137.48 54.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.167 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -85.29 -38.09 19.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.777 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -112.02 141.39 45.74 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.047 0.451 . . . . 1.0 112.11 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.97 -41.06 97.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.473 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -61.56 -39.75 92.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.793 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -59.89 -39.66 86.12 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.74 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.68 -50.15 81.42 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 C-N-CA 120.352 -0.539 . . . . 1.0 111.113 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.58 -43.49 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.57 -0.452 . . . . 1.0 111.795 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.435 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 93.9 t -66.4 -22.23 29.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.112 -0.495 . . . . 1.0 112.15 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -100.18 -10.84 20.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.911 0.386 . . . . 1.0 111.011 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.84 -50.33 5.62 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.39 -0.524 . . . . 1.0 112.368 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.6 mp -64.62 -45.38 87.12 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 112.802 0.667 . . . . 1.0 112.802 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 93' ' ' ASN . 14.7 pt20 -64.8 -48.12 75.59 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.706 -0.798 . . . . 1.0 111.842 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.449 ' N ' ' HG3' ' A' ' 92' ' ' GLN . 58.1 t-20 -71.37 -43.08 67.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.649 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.704 ' HZ2' ' ND2' ' A' ' 165' ' ' ASN . 37.0 mmtm -66.56 -44.38 82.46 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.18 -0.608 . . . . 1.0 111.403 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.7 t -66.5 -44.49 90.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.211 -0.596 . . . . 1.0 111.364 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -68.22 -43.11 78.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.489 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 tp -67.05 -41.02 87.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.427 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 mt -63.69 -43.85 95.41 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.272 -0.571 . . . . 1.0 110.5 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -68.78 -38.64 80.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.146 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -70.66 -43.48 69.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.954 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.404 ' HB2' ' HH ' ' A' ' 168' ' ' TYR . 1.3 tpt -66.1 -54.34 26.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.476 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 104' ' ' SER . 9.8 m -59.67 -40.36 87.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.085 0.469 . . . . 1.0 110.438 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.0 m -72.23 10.18 0.83 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.705 -0.68 . . . . 1.0 111.249 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 102' ' ' THR . 6.8 t -92.43 136.62 33.06 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.865 0.364 . . . . 1.0 110.274 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -60.82 -20.71 62.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.068 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.593 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 67.9 mttm -89.43 39.12 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.763 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -131.61 115.59 16.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.379 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -140.2 113.28 8.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.701 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.2 t -98.12 88.07 4.11 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.076 0.465 . . . . 1.0 110.916 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.98 171.13 14.67 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.1 p -74.62 165.38 25.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -60.62 -39.75 89.36 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.805 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -67.43 -42.51 83.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.154 0.502 . . . . 1.0 110.803 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -70.73 -20.11 62.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.72 . . . . 1.0 111.045 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.0 t -70.43 -45.85 73.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.809 -0.356 . . . . 1.0 110.267 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.47 -45.03 98.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.102 0.477 . . . . 1.0 110.073 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.06 -34.4 78.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.993 0.425 . . . . 1.0 110.729 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -66.58 -49.98 64.57 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.915 -0.584 . . . . 1.0 111.85 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.9 tp -69.93 -38.91 76.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.476 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.552 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 66.5 mm-40 -63.89 -39.99 95.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.56 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -64.84 -47.27 78.55 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.601 -0.439 . . . . 1.0 110.345 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -60.25 -45.46 93.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.947 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.3 t -63.87 -38.14 89.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.319 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -58.36 -41.76 85.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.839 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.3 t -66.7 -41.95 88.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -123.6 75.83 54.97 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.505 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.91 -17.21 32.53 Favored 'Trans proline' 0 N--CA 1.488 1.157 0 C-N-CA 122.531 2.154 . . . . 1.0 112.2 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -101.64 22.37 12.88 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.577 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -143.64 151.56 40.27 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.862 0.363 . . . . 1.0 110.664 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 94.4 p -81.19 163.16 23.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.817 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 p -152.41 146.55 15.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.249 -0.648 . . . . 1.0 109.249 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -147.77 142.39 26.58 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.834 0.35 . . . . 1.0 111.208 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -152.93 171.4 18.38 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.374 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.593 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.8 p90 -141.05 158.52 43.81 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.25 -0.648 . . . . 1.0 109.25 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.8 p -151.74 168.28 25.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.824 0.345 . . . . 1.0 110.255 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.9 tp -80.27 129.41 34.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.588 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -72.07 156.86 38.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.272 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.43 ' CG ' ' N ' ' A' ' 139' ' ' ASP . 12.9 p-80 -96.18 -46.95 6.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.889 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.43 ' N ' ' CG ' ' A' ' 138' ' ' HIS . 95.0 m-20 -76.15 -7.52 54.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.21 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 139' ' ' ASP . 63.4 m-80 -160.86 70.11 2.7 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.37 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -49.55 -35.4 37.04 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.258 1.972 . . . . 1.0 112.711 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -60.55 -32.16 77.14 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.793 -0.923 . . . . 1.0 110.793 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -96.36 147.13 24.12 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.726 0.298 . . . . 1.0 110.219 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -113.2 152.32 29.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.704 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -123.18 139.94 53.54 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.972 0.415 . . . . 1.0 110.181 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.5 mt -108.79 121.37 44.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.291 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -112.85 143.23 44.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.944 -1.132 . . . . 1.0 107.944 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -161.73 151.51 16.66 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.552 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 69.4 tttt -134.76 128.89 33.73 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.391 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.544 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 3.4 mp -69.53 -46.47 75.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.303 0.483 . . . . 1.0 112.303 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 150' ' ' ILE . 20.7 m120 -159.48 173.98 15.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.515 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.84 74.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.836 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -86.81 8.15 24.01 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.385 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.416 ' HG ' ' H ' ' A' ' 155' ' ' LYS . 7.8 t -96.3 165.54 12.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.441 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.48 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 61.2 mttp -99.22 149.85 22.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 1.0 109.928 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.7 tp -69.42 122.63 19.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.038 0.447 . . . . 1.0 109.871 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 87.9 m-85 -114.31 128.64 56.45 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.855 -0.611 . . . . 1.0 109.822 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 97.8 m -123.37 128.77 50.35 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.679 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -114.2 160.78 18.62 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.036 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -107.68 146.45 32.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.9 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.82 135.98 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -97.72 133.34 42.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.049 0.452 . . . . 1.0 110.844 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 31.6 tp -95.68 130.3 42.61 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.559 ' HG1' ' H ' ' A' ' 166' ' ' THR . 27.4 p -133.47 178.28 7.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.055 0.455 . . . . 1.0 110.266 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.704 ' ND2' ' HZ2' ' A' ' 94' ' ' LYS . 25.0 m120 -86.17 17.16 3.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.663 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.559 ' H ' ' HG1' ' A' ' 164' ' ' THR . 13.4 p -121.2 -2.18 9.64 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.811 0.339 . . . . 1.0 110.626 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.02 -127.16 4.47 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.373 -1.091 . . . . 1.0 110.373 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.404 ' HH ' ' HB2' ' A' ' 101' ' ' MET . 24.9 m-85 -121.31 130.06 53.44 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 110.219 -0.289 . . . . 1.0 110.219 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -104.08 124.7 49.53 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 109.854 -0.425 . . . . 1.0 109.854 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.9 tt -119.02 115.18 23.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.535 -0.543 . . . . 1.0 109.535 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.425 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 3.5 t 40.73 57.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 111.976 0.361 . . . . 1.0 111.976 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.8 m120 65.2 27.28 12.26 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.906 0.706 . . . . 1.0 112.906 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.425 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 73.6 m-85 -134.72 121.52 20.89 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.62 131.49 37.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.45 -0.341 . . . . 1.0 111.199 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -112.34 96.12 34.14 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.79 -22.53 7.22 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.499 2.133 . . . . 1.0 113.292 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.8 p -133.66 138.24 45.78 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.846 0.355 . . . . 1.0 110.999 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.6 p -61.04 -33.08 54.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.772 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.1 mm -62.0 -45.88 97.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.937 0.399 . . . . 1.0 110.194 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -65.61 -32.36 73.89 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.87 -42.5 99.79 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.424 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 74.0 m -63.36 -46.38 86.8 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.704 -0.399 . . . . 1.0 110.378 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 186' ' ' LYS . 74.6 m-20 -66.94 -49.29 65.96 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 119.682 -0.807 . . . . 1.0 108.926 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.12 -45.13 0.59 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.706 -1.357 . . . . 1.0 109.706 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -69.26 -47.06 65.73 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.218 0.532 . . . . 1.0 109.752 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 183' ' ' ASN . 89.1 tttt -56.52 -41.41 76.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.481 -0.781 . . . . 1.0 109.922 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 86.7 m -60.79 -45.58 93.84 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.57 -41.42 98.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.813 -0.631 . . . . 1.0 110.036 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.16 -43.61 82.69 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.786 -0.366 . . . . 1.0 110.716 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -60.75 -42.96 98.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.15 0.5 . . . . 1.0 110.434 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 48.4 m -61.72 -38.59 88.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.634 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 87.3 mt -65.13 -39.19 92.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.594 -0.73 . . . . 1.0 112.233 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -64.07 -30.51 71.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.651 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.471 -0.331 . . . . 1.0 111.007 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.642 0.258 . . . . 1.0 110.53 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 p -63.5 -32.91 58.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.341 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.9 pt -79.28 -12.22 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.316 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -105.13 4.91 31.86 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.645 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.16 150.05 94.51 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.446 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 41.0 Cg_endo -66.01 -22.66 54.95 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.817 1.678 . . . . 1.0 112.261 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.537 ' CD1' ' CE2' ' A' ' 30' ' ' PHE . 25.4 m-85 -87.26 5.87 36.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.556 -0.293 . . . . 1.0 111.164 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.468 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 42.0 t80 -87.23 127.8 35.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.435 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.468 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 63.4 m-85 -149.19 108.87 3.42 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 109.935 -0.394 . . . . 1.0 109.935 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.526 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 33.3 Cg_exo -59.54 109.82 0.63 Allowed 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 121.548 1.499 . . . . 1.0 112.828 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 66.0 m-85 -159.2 150.46 20.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.405 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -77.9 164.25 25.31 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.452 -0.573 . . . . 1.0 109.452 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' OE2' ' A' ' 19' ' ' GLU . . . -59.07 -41.68 96.63 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -67.0 -42.7 84.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.743 0.306 . . . . 1.0 111.144 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -66.3 -35.95 81.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.136 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.46 88.38 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.741 -0.384 . . . . 1.0 110.33 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -59.47 -46.42 88.83 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.638 -0.425 . . . . 1.0 109.872 179.479 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.85 -44.97 94.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.168 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -61.69 -41.48 97.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.701 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.8 mp -79.69 -12.96 59.78 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.995 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.23 -42.41 99.23 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.76 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.5 m -79.48 -20.24 47.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.847 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -80.48 173.76 12.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 1.0 110.636 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.1 pm0 -85.16 170.11 13.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.492 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -80.22 145.77 32.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.88 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.67 -0.27 57.96 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -85.89 146.87 26.53 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.537 ' CE2' ' CD1' ' A' ' 9' ' ' TYR . 51.7 p90 -131.42 164.64 25.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.295 0.569 . . . . 1.0 111.108 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.415 ' CG1' ' N ' ' A' ' 32' ' ' ILE . 69.1 t -147.3 158.19 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.422 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.415 ' N ' ' CG1' ' A' ' 31' ' ' VAL . 79.1 mt -116.98 123.71 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -143.38 158.44 43.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.36 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.694 ' C ' ' H ' ' A' ' 36' ' ' SER . 27.1 mt-30 -109.65 148.25 31.67 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.927 -0.397 . . . . 1.0 109.927 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 37' ' ' ARG . 7.2 m -61.17 18.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.256 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.694 ' H ' ' C ' ' A' ' 34' ' ' GLN . 1.5 m 69.21 -42.12 0.49 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.769 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 35' ' ' SER . 79.4 mtp85 -121.51 11.39 10.62 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.915 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -71.5 -66.75 2.05 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.489 -1.045 . . . . 1.0 110.489 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 67.08 -45.82 0.47 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.217 0.532 . . . . 1.0 110.914 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 38' ' ' GLY . 52.5 t0 -93.28 -4.79 51.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.802 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -146.24 149.9 34.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.542 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.91 150.85 40.45 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.991 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.9 t -124.73 132.09 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.005 -0.368 . . . . 1.0 110.005 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.8 mt -110.85 138.18 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.5 m -119.21 138.13 53.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.777 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.441 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 3.8 p-90 -147.15 146.75 30.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.743 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -92.48 138.61 31.37 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.209 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.436 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.0 mp -103.54 -82.71 0.49 Allowed 'General case' 0 C--N 1.339 0.129 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.123 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -94.16 -175.27 3.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.557 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -58.33 -41.09 83.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.898 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -127.32 53.63 1.72 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.021 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.5 tp -150.01 131.71 14.98 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.796 0.331 . . . . 1.0 110.413 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -132.7 148.89 52.34 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.297 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -137.17 151.16 48.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.722 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -127.64 141.99 51.47 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.132 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.407 HD13 HG22 ' A' ' 56' ' ' ILE . 95.5 mt -121.56 124.2 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -92.96 121.58 34.45 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.039 0.447 . . . . 1.0 110.544 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.0 mt -99.94 129.58 50.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.453 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -116.15 125.12 51.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 1.0 109.88 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -101.58 143.49 31.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.332 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 84.6 mt -143.78 -179.39 6.43 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.463 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 75.76 50.59 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.034 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.456 ' NZ ' ' OD1' ' A' ' 40' ' ' ASP . 99.4 mttt -95.49 125.88 40.4 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.779 -0.646 . . . . 1.0 109.945 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -69.72 -21.63 63.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.692 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -157.62 165.14 19.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.061 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.54 -33.89 80.18 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.91 1.74 . . . . 1.0 112.451 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.7 mt -93.43 -4.45 51.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.575 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.33 146.88 31.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.649 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.0 mt -89.47 157.41 18.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.213 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.57 126.66 8.64 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -85.67 -11.11 54.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.089 0.471 . . . . 1.0 110.582 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.43 120.18 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.571 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.1 mt -113.77 122.3 46.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.827 -0.624 . . . . 1.0 109.43 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 70.9 mt -101.82 124.39 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.985 -0.376 . . . . 1.0 109.985 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.1 t -142.63 133.31 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.261 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 77' ' ' ASN . 97.0 m-20 51.91 48.17 23.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.978 -0.289 . . . . 1.0 111.031 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 5.4 p30 55.25 21.69 4.23 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.384 0.428 . . . . 1.0 110.981 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -127.4 139.37 52.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.196 0.522 . . . . 1.0 110.155 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -88.53 134.38 33.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.002 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -129.2 138.11 51.52 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.421 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -78.66 -37.14 42.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.772 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 16.3 t0 -136.98 160.65 38.28 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.375 0.607 . . . . 1.0 111.637 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.473 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 3.0 pp -71.93 -36.27 69.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.447 -0.797 . . . . 1.0 111.799 178.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 2.4 p30 -58.58 -41.94 86.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.93 0.715 . . . . 1.0 112.93 -176.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.455 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 6.1 pt20 -63.81 -38.33 90.68 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.632 0.253 . . . . 1.0 110.882 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 86' ' ' ILE . 82.4 mt -61.27 -46.23 97.02 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 C-N-CA 120.485 -0.486 . . . . 1.0 110.882 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -61.62 -38.87 81.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 120.966 0.412 . . . . 1.0 111.49 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.8 t -78.31 -32.73 17.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 112.799 0.666 . . . . 1.0 112.799 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -88.7 -13.8 38.82 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.739 -0.384 . . . . 1.0 111.61 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.651 ' CZ ' ' NZ ' ' A' ' 94' ' ' LYS . 11.0 t80 -96.69 -48.66 5.41 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.786 -0.365 . . . . 1.0 111.525 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 4.3 mm? -71.21 -39.78 71.54 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.023 -0.535 . . . . 1.0 112.001 -177.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -63.81 -49.05 74.41 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.791 -0.764 . . . . 1.0 111.948 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -71.24 -42.72 68.49 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.616 -0.434 . . . . 1.0 111.863 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.651 ' NZ ' ' CZ ' ' A' ' 90' ' ' TYR . 21.1 mmtp -66.34 -42.12 88.6 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.274 -0.57 . . . . 1.0 111.285 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.6 t -65.02 -45.68 93.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.253 -0.579 . . . . 1.0 111.277 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -68.06 -44.78 75.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.483 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 tp -66.7 -40.04 88.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.294 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.1 tp -64.36 -42.53 96.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.401 -0.52 . . . . 1.0 109.935 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -67.84 -38.1 82.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.143 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -71.28 -42.28 68.92 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.845 -0.342 . . . . 1.0 111.617 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.512 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 5.0 ttt -66.46 -54.63 21.89 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.641 -0.424 . . . . 1.0 111.241 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.406 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 20.4 m -57.86 -32.54 67.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.273 0.558 . . . . 1.0 110.531 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -75.03 10.63 1.39 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.342 -0.845 . . . . 1.0 111.612 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 101' ' ' MET . 93.3 p -91.44 133.93 35.06 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.895 0.379 . . . . 1.0 110.489 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -60.61 -20.48 60.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.777 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.56 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 69.2 mttm -87.71 40.28 0.93 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.714 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.416 ' HB2' ' HG ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -132.25 116.87 17.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.387 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.51 ' NZ ' ' CE1' ' A' ' 118' ' ' PHE . 50.5 mtpt -135.99 109.72 8.08 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 178.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.1 t -91.21 88.88 7.1 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.216 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.97 160.86 12.98 Favored Glycine 0 N--CA 1.466 0.641 0 N-CA-C 110.829 -0.909 . . . . 1.0 110.829 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.402 ' CG2' ' N ' ' A' ' 112' ' ' LYS . 56.7 m -71.52 165.38 23.99 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.862 -0.422 . . . . 1.0 109.862 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.402 ' N ' ' CG2' ' A' ' 111' ' ' THR . 49.3 tptt -55.04 -38.54 68.11 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.56 -0.456 . . . . 1.0 110.558 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -67.35 -45.09 77.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.403 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.9 -19.85 62.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.952 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.7 t -68.82 -44.54 81.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.89 -44.62 92.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.211 0.529 . . . . 1.0 110.075 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -64.98 -36.13 83.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.915 0.388 . . . . 1.0 110.63 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.51 ' CE1' ' NZ ' ' A' ' 108' ' ' LYS . 11.1 t80 -64.64 -51.07 64.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.754 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.6 tp -69.9 -38.91 76.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.02 0.438 . . . . 1.0 110.17 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.546 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 65.1 mm-40 -64.1 -42.74 96.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.667 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.89 -48.22 82.8 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.438 -0.505 . . . . 1.0 110.24 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -60.48 -39.34 87.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.716 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.0 t -59.62 -40.99 89.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.228 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -62.17 -38.6 89.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.972 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.3 t -64.12 -43.31 97.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -130.24 74.59 80.24 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.226 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.45 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 7.7 Cg_exo -69.81 -23.6 30.38 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.894 2.396 . . . . 1.0 112.77 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -88.78 -14.38 37.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.981 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -112.59 153.96 26.75 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.144 0.497 . . . . 1.0 110.563 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.7 t -80.65 164.83 22.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.555 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 p -151.86 148.44 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -144.42 142.96 30.68 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.976 0.417 . . . . 1.0 111.213 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -151.65 167.91 26.66 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.294 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.56 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 2.1 p90 -140.53 155.28 46.67 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.2 m -155.66 171.75 19.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.343 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 51.3 tp -80.38 134.61 36.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.651 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.692 HD21 ' H ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -95.8 140.51 30.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.797 0.332 . . . . 1.0 110.348 179.381 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.455 ' ND1' ' N ' ' A' ' 138' ' ' HIS . 2.1 m80 -89.1 -28.75 19.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.712 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.66 -31.01 69.15 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.276 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.512 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -147.53 105.75 3.76 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.74 136.73 26.02 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.76 1.64 . . . . 1.0 112.691 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.11 -25.12 26.12 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.537 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 12.5 m95 -98.13 152.28 19.5 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.908 0.385 . . . . 1.0 110.246 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.512 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 91.5 m-85 -119.57 156.25 30.68 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.465 -0.568 . . . . 1.0 109.465 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -130.53 145.09 51.79 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.034 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.2 mt -111.06 121.74 46.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.893 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 11.7 ptp -110.43 140.93 44.19 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.686 -1.227 . . . . 1.0 107.686 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -161.47 153.35 19.4 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.384 -0.527 . . . . 1.0 109.59 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.546 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 33.8 mtpt -136.67 131.87 34.19 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.764 0.316 . . . . 1.0 110.604 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 23.7 mm -72.31 -45.13 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.355 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 127' ' ' PRO . 26.4 m-80 -157.81 170.58 22.04 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.495 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.37 -26.54 65.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.764 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -87.53 -10.24 52.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.056 0.455 . . . . 1.0 110.35 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 23.8 t -80.58 155.03 27.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.533 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.75 156.93 18.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.894 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.5 tp -69.99 115.98 9.83 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.188 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -107.38 130.32 54.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.628 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.3 m -126.29 130.11 50.2 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.809 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -112.95 156.91 22.19 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.025 -0.534 . . . . 1.0 109.786 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -106.38 146.22 30.73 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.867 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.82 137.7 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -99.1 135.42 40.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.854 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.17 130.71 44.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 81.4 p -129.27 172.35 11.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.332 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -85.64 18.07 3.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.871 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.07 -2.63 8.15 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.594 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 141.63 -129.73 4.1 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -125.25 132.29 52.98 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.815 0.341 . . . . 1.0 110.175 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -106.5 123.51 48.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.14 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.9 tt -119.02 117.89 30.0 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.36 -0.608 . . . . 1.0 109.36 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.2 t 36.02 52.02 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 111.89 0.329 . . . . 1.0 111.89 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.0 m120 71.98 26.66 2.85 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.105 0.78 . . . . 1.0 113.105 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -133.24 118.77 18.99 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.341 -0.614 . . . . 1.0 109.341 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -93.31 121.14 34.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.46 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -100.56 132.47 22.31 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -71.93 -18.96 27.49 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 C-N-CA 122.12 1.88 . . . . 1.0 113.33 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 35.4 m -153.47 157.12 39.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.966 0.412 . . . . 1.0 111.013 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.58 -33.97 62.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.957 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.499 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 50.4 mm -60.05 -46.64 94.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.89 -0.324 . . . . 1.0 110.548 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -68.84 -29.95 68.38 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 48.5 tp -64.81 -42.21 95.18 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.457 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . 0.607 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 8.1 p -62.44 -47.63 83.23 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.768 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.607 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 44.6 t-20 -66.38 -46.9 75.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.974 -0.75 . . . . 1.0 108.974 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.87 -45.54 0.82 Allowed Glycine 0 C--N 1.334 0.437 0 N-CA-C 110.021 -1.232 . . . . 1.0 110.021 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -69.03 -46.83 66.94 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 183' ' ' ASN . 88.4 tttt -55.49 -40.1 71.27 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.841 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.3 m -60.95 -44.76 96.82 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.54 -40.82 98.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.826 -0.625 . . . . 1.0 109.963 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 40.9 tp -57.46 -42.25 82.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.412 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -63.12 -43.07 99.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.132 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.0 t -63.52 -39.37 94.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.394 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.83 -43.31 99.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.463 -0.79 . . . . 1.0 112.064 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -68.2 -29.37 68.21 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.815 0.302 . . . . 1.0 111.815 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 1.6 t60 . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.847 -179.332 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 . . . . . 0 N--CA 1.466 0.337 0 CA-C-O 120.83 0.347 . . . . 1.0 110.565 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.36 -34.85 71.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.573 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.7 pt -79.3 -14.02 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.347 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -89.84 -4.72 57.45 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.471 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -81.38 138.34 48.32 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.393 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.54 -16.1 46.45 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.898 1.732 . . . . 1.0 112.272 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.502 ' CD1' ' CE2' ' A' ' 30' ' ' PHE . 96.0 m-85 -93.13 8.91 38.18 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.281 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 87.6 t80 -88.45 127.42 35.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.498 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 61.2 m-85 -149.28 126.12 5.39 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.525 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 74.1 Cg_endo -73.36 107.67 2.44 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.433 1.422 . . . . 1.0 112.853 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.525 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 43.8 m-85 -162.76 152.49 15.81 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.522 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.544 ' ND2' HE22 ' A' ' 17' ' ' GLN . 52.6 p-10 -88.33 -176.23 5.28 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.62 -40.63 99.39 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.314 -0.946 . . . . 1.0 111.377 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -61.97 -48.17 81.55 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.894 -0.323 . . . . 1.0 111.189 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.544 HE22 ' ND2' ' A' ' 14' ' ' ASN . 0.9 OUTLIER -69.63 -30.93 68.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.291 -179.501 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.72 -46.04 91.35 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.651 -0.42 . . . . 1.0 110.292 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE2' ' CE1' ' A' ' 53' ' ' PHE . 81.2 tt0 -65.48 -41.07 93.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.67 -0.412 . . . . 1.0 109.996 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -62.24 -43.34 99.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.083 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -62.52 -44.89 95.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.455 -0.339 . . . . 1.0 110.536 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.37 -13.32 61.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.971 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 ttp85 -59.6 -43.21 93.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.956 0.408 . . . . 1.0 110.589 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.5 t -77.46 -19.15 56.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.829 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -86.41 -174.75 5.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.47 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 55.9 mp0 -104.54 -176.67 3.14 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.672 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -81.53 146.6 30.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.804 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.85 -1.02 59.44 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.175 -0.77 . . . . 1.0 111.175 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -85.58 148.62 25.84 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.066 -0.716 . . . . 1.0 109.066 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CE2' ' CD1' ' A' ' 9' ' ' TYR . 51.9 p90 -136.26 163.12 31.13 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.363 0.602 . . . . 1.0 110.965 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.2 m -147.68 158.89 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 114.98 -1.009 . . . . 1.0 111.645 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 79.0 mt -117.79 124.73 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -143.96 157.42 44.35 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.315 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.596 ' C ' ' H ' ' A' ' 36' ' ' SER . 35.3 mt-30 -108.76 142.54 39.16 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.867 -0.419 . . . . 1.0 109.867 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.436 ' C ' ' H ' ' A' ' 37' ' ' ARG . 28.3 m -60.46 5.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.865 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.596 ' H ' ' C ' ' A' ' 34' ' ' GLN . 0.2 OUTLIER 71.72 -47.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.451 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 35' ' ' SER . 35.4 ptt180 -100.02 0.29 40.65 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.891 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.561 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -73.4 -68.42 1.59 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.425 -1.07 . . . . 1.0 110.425 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 t70 69.23 -36.36 0.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.661 0.267 . . . . 1.0 110.799 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 38' ' ' GLY . 95.2 m-20 -106.66 1.64 25.28 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -148.04 148.66 30.92 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.469 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.7 152.84 37.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.916 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.92 132.99 70.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.275 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.07 139.24 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.1 m -118.95 139.38 51.76 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.551 ' CZ2' ' NZ ' ' A' ' 94' ' ' LYS . 5.7 p-90 -148.65 144.93 27.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.415 -0.811 . . . . 1.0 111.027 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -91.58 141.22 28.95 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.807 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.3 mp -97.85 -71.99 0.66 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.42 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 50' ' ' LYS . 62.3 t0 -162.01 146.46 12.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.144 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.543 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 1.1 ttmp? 46.54 -145.93 0.2 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.948 0.404 . . . . 1.0 111.126 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -79.79 68.95 6.02 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.81 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.8 tp -149.3 126.51 11.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.848 0.356 . . . . 1.0 110.426 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.519 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 64.0 m-85 -132.32 149.1 52.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.43 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 53' ' ' PHE . 98.0 mm-40 -135.78 152.7 51.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.031 -0.531 . . . . 1.0 109.666 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -128.07 142.68 51.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.302 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -118.88 122.54 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -92.23 120.58 32.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.053 0.454 . . . . 1.0 110.804 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.1 mm -99.34 131.68 46.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.41 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -114.4 136.57 52.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.024 -0.534 . . . . 1.0 109.833 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -100.54 152.92 19.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.119 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.429 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 3.1 tt -142.97 161.19 38.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.898 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.429 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 18.4 tt0 79.51 60.64 0.02 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.142 0.496 . . . . 1.0 109.781 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -106.55 103.31 12.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.0 -0.546 . . . . 1.0 109.725 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -70.43 -34.45 72.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.75 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 68' ' ' ALA . 15.6 p30 -161.16 157.0 21.66 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.42 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.96 -28.03 22.82 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.212 1.941 . . . . 1.0 112.193 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -83.93 -11.45 56.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.998 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 65' ' ' ASN . . . -92.7 140.15 29.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.318 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.8 mt -90.15 158.25 17.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.284 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.89 108.8 2.64 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.678 -0.969 . . . . 1.0 110.678 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -76.18 -18.29 59.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.834 0.35 . . . . 1.0 110.782 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.1 t -116.56 122.92 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.915 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.4 mt -116.3 133.92 55.48 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.6 mt -103.06 124.98 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.864 0.364 . . . . 1.0 110.076 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.7 133.7 32.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.411 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 t70 52.23 41.92 30.52 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.827 -0.349 . . . . 1.0 111.094 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 61.26 22.84 13.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.965 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.406 ' NE2' ' HH ' ' A' ' 80' ' ' TYR . 32.7 mt-30 -128.48 156.75 42.74 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.177 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -102.67 130.07 49.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.05 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.406 ' HH ' ' NE2' ' A' ' 78' ' ' GLN . 84.7 m-85 -129.24 139.37 51.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.253 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -86.55 -37.26 18.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.816 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -109.3 134.95 51.16 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.127 0.489 . . . . 1.0 112.312 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 46.9 tp -65.49 -38.1 88.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.559 -0.746 . . . . 1.0 110.722 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 4.6 p30 -58.6 -33.65 70.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 1.0 111.875 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.45 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 27.1 mt-30 -64.51 -37.98 89.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.696 0.284 . . . . 1.0 110.658 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.0 mm -59.58 -49.48 83.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.146 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 72.2 mt -62.94 -43.61 99.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.15 -0.62 . . . . 1.0 111.414 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.4 t -70.36 -41.14 78.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -80.23 -15.58 56.69 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.818 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -94.02 -49.88 5.57 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.56 -0.456 . . . . 1.0 111.799 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.6 -40.06 80.62 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.463 0.542 . . . . 1.0 112.463 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -63.38 -49.28 74.44 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.67 -0.812 . . . . 1.0 111.631 -177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -65.96 -43.11 88.88 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.851 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.551 ' NZ ' ' CZ2' ' A' ' 46' ' ' TRP . 25.6 mmtp -65.93 -42.57 89.91 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.458 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.7 t -65.58 -45.88 91.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.32 -0.552 . . . . 1.0 111.407 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -67.32 -46.56 73.14 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.598 -0.441 . . . . 1.0 111.47 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.9 tp -67.92 -40.12 83.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.627 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.39 -43.32 91.05 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.544 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -68.86 -35.63 77.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.404 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -70.61 -42.52 70.86 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.921 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 13.6 ttm -71.22 -53.04 15.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.484 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 104' ' ' SER . 9.0 m -57.11 -39.83 75.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.05 0.453 . . . . 1.0 110.222 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.7 m -71.45 9.72 0.76 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.888 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 102' ' ' THR . 8.3 t -92.74 133.23 36.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.276 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -60.82 -18.42 55.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.086 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.558 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 99.0 mttt -91.85 41.01 1.06 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.055 -0.521 . . . . 1.0 109.718 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -134.69 118.18 16.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.285 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -138.15 114.81 10.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.074 -0.512 . . . . 1.0 109.732 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.5 p -93.44 91.84 7.34 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.062 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.83 166.63 13.02 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.844 -0.903 . . . . 1.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 82.5 p -76.8 163.44 26.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -56.05 -35.55 67.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.826 0.346 . . . . 1.0 110.764 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -68.58 -43.89 75.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.145 0.498 . . . . 1.0 110.768 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -71.26 -19.26 62.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.013 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.74 -44.55 76.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 110.04 -0.355 . . . . 1.0 110.04 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.68 -45.57 91.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.063 0.459 . . . . 1.0 110.416 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.59 -36.9 85.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.845 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -65.1 -50.12 67.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.888 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.8 tp -70.35 -40.01 77.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.447 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -64.47 -45.06 89.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.589 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -60.54 -48.46 81.66 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.007 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.55 ' CD1' ' OD1' ' A' ' 126' ' ' ASN . 23.9 t80 -60.86 -42.06 97.11 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.646 -0.501 . . . . 1.0 109.646 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.5 t -59.93 -42.68 94.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.596 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -60.09 -39.95 87.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.356 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.92 -41.3 91.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.55 ' OD1' ' CD1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -118.95 76.42 14.59 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.31 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.526 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 37.4 Cg_endo -72.44 -21.16 23.05 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 122.398 2.065 . . . . 1.0 112.346 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -106.81 18.24 22.11 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.71 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -138.16 152.01 48.28 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.881 0.372 . . . . 1.0 110.654 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 t -81.74 163.19 22.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.89 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -154.19 145.43 14.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.168 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -148.49 144.34 27.3 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.784 0.326 . . . . 1.0 111.053 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -151.69 167.37 28.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.406 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.558 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -139.71 155.83 47.13 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 179.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.452 ' OG ' ' CZ ' ' A' ' 145' ' ' TYR . 15.0 p -152.07 169.4 22.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.405 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.1 tp -79.43 130.33 35.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.889 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -77.82 114.51 16.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.351 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -73.31 -36.14 66.2 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.591 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -65.91 -26.2 67.5 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.098 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -139.81 84.27 15.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.77 129.72 36.12 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.079 1.853 . . . . 1.0 112.346 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.94 -24.25 23.73 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.121 -0.791 . . . . 1.0 111.121 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -99.26 150.99 21.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.79 0.328 . . . . 1.0 110.263 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -123.76 160.84 26.41 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.954 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 145' ' ' TYR . 4.7 p90 -142.89 148.3 36.75 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.343 0.402 . . . . 1.0 109.929 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.9 mt -110.07 131.47 55.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.161 0.505 . . . . 1.0 110.497 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.45 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -118.85 145.32 45.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 177.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -161.93 154.47 19.86 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.479 -0.488 . . . . 1.0 109.705 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -139.77 127.31 21.62 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.514 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.443 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 3.3 mp -68.88 -44.62 81.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.091 0.404 . . . . 1.0 112.091 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 27.4 m120 -159.22 175.31 13.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.54 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.79 -31.94 73.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -84.31 -12.61 54.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.518 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.7 t -80.03 146.28 32.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.327 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -79.64 151.18 30.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.93 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.53 127.81 34.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.997 0.427 . . . . 1.0 110.178 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -114.63 130.84 56.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.663 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 86.4 m -126.3 129.08 48.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.838 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -116.06 154.53 29.76 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.77 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -105.19 141.67 36.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.796 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.94 132.89 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -95.41 136.17 36.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.704 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.5 tp -98.2 131.09 44.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.06 -0.518 . . . . 1.0 109.712 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.503 ' HG1' ' HG1' ' A' ' 166' ' ' THR . 46.1 p -131.17 163.84 26.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.356 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -76.98 16.3 0.56 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.542 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.503 ' HG1' ' HG1' ' A' ' 164' ' ' THR . 14.8 p -122.1 -1.26 9.31 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.791 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 138.43 -129.42 4.53 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.289 -1.124 . . . . 1.0 110.289 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -126.03 130.83 51.94 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.588 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 5.8 m-85 -107.99 123.04 48.06 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.3 tt -115.32 119.24 35.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.079 -0.51 . . . . 1.0 109.638 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.2 t 34.86 52.91 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 112.132 0.419 . . . . 1.0 112.132 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.2 m120 72.47 27.37 2.42 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.074 0.768 . . . . 1.0 113.074 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -135.54 120.66 18.84 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.588 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 15.6 t-20 -91.23 131.7 36.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.156 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -112.0 95.29 28.76 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 109.545 -0.539 . . . . 1.0 109.545 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.84 -20.34 6.71 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.296 1.998 . . . . 1.0 113.536 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 48.8 m -135.66 139.76 43.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.885 0.374 . . . . 1.0 111.094 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.0 p -62.78 -34.8 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.706 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.08 -44.16 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-O 120.904 0.383 . . . . 1.0 110.124 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.36 -33.83 76.75 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.99 -39.87 94.12 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.539 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 71.8 m -61.59 -48.03 82.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.598 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 186' ' ' LYS . 41.5 t30 -69.6 -48.84 58.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.872 -0.788 . . . . 1.0 108.872 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.56 -45.96 0.54 Allowed Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.788 -1.325 . . . . 1.0 109.788 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -68.01 -47.76 67.58 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.204 0.526 . . . . 1.0 109.657 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 183' ' ' ASN . 19.3 ttpp -56.6 -41.26 76.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.427 -0.806 . . . . 1.0 110.019 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 94.3 m -61.16 -45.63 93.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.84 -41.07 99.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.908 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 57.2 tp -58.25 -43.37 87.82 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.806 -0.357 . . . . 1.0 110.719 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -58.7 -45.74 88.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.153 0.501 . . . . 1.0 110.205 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 58.5 m -62.84 -39.6 94.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.476 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.49 -39.06 93.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.592 -0.731 . . . . 1.0 112.062 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.78 -24.58 61.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.83 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.084 -179.349 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.816 0.341 . . . . 1.0 110.83 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 p -69.12 -33.81 60.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.601 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.432 HG23 HD13 ' A' ' 5' ' ' ILE . 36.6 pt -58.19 -13.95 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.658 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -134.79 24.97 3.67 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.399 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.3 147.43 58.0 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.495 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -50.88 -34.22 44.58 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.626 1.55 . . . . 1.0 112.321 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -88.74 10.14 21.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.391 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.49 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 42.5 t80 -91.17 129.07 37.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.55 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 65.2 m-85 -149.75 132.25 8.01 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.8 113.55 3.79 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.761 1.641 . . . . 1.0 112.701 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 11' ' ' PHE . 12.0 p90 -154.18 162.0 41.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.703 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -90.23 172.76 8.56 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.682 ' N ' HH12 ' A' ' 33' ' ' ARG . . . -58.31 -51.26 59.66 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.734 -0.946 . . . . 1.0 110.734 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -65.82 -39.06 90.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.676 0.274 . . . . 1.0 110.817 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -65.59 -32.48 74.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.388 . . . . 1.0 111.289 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.86 92.93 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.282 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.69 -40.88 92.78 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.662 -0.415 . . . . 1.0 109.99 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -63.06 -45.75 90.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.296 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -60.56 -42.37 96.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.542 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.7 mp -80.54 -13.29 59.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.893 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -61.72 -41.63 97.88 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.542 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.0 p -77.22 -17.17 58.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.903 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -82.85 177.86 8.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.664 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -95.31 178.22 5.59 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.713 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.476 ' NH2' ' OD1' ' A' ' 99' ' ' ASN . 60.5 ttp180 -76.17 144.73 40.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.053 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.12 26.16 17.14 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.312 -0.715 . . . . 1.0 111.312 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -112.13 142.03 45.09 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.121 -0.696 . . . . 1.0 109.121 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -134.08 169.62 16.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.499 0.666 . . . . 1.0 111.052 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.3 m -148.41 160.21 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 114.971 -1.013 . . . . 1.0 111.812 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.0 mm -115.87 130.4 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.682 HH12 ' N ' ' A' ' 15' ' ' GLY . 69.5 ttt180 -143.36 154.22 43.51 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.107 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -115.15 138.02 51.37 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 t -82.93 126.49 32.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.861 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.6 t -62.65 -43.42 98.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.672 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.75 -23.68 59.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.012 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.554 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -123.21 55.45 0.69 Allowed Glycine 0 N--CA 1.466 0.661 0 N-CA-C 110.611 -0.996 . . . . 1.0 110.611 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -59.14 -0.55 0.13 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.84 0.352 . . . . 1.0 110.731 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.554 ' H ' ' C ' ' A' ' 38' ' ' GLY . 73.0 m-20 -96.38 -2.34 45.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.663 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -140.78 164.84 29.13 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.192 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.01 146.95 46.16 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.246 -0.434 . . . . 1.0 109.905 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.97 132.05 71.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.792 0.329 . . . . 1.0 110.271 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.6 mt -112.94 138.95 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.6 m -117.54 138.73 51.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.225 0.536 . . . . 1.0 109.647 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 3.3 p-90 -145.33 156.78 44.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.687 -0.688 . . . . 1.0 110.784 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.544 ' NZ ' ' O ' ' A' ' 49' ' ' ASP . 25.1 ttpp -104.67 136.2 44.64 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.292 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.452 ' O ' ' CD ' ' A' ' 27' ' ' ARG . 10.3 mp -97.1 -68.49 0.8 Allowed 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.048 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.544 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 98.2 m-20 -106.66 -165.19 1.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.156 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.403 ' HD3' ' H ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -78.66 -17.7 55.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.674 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 51' ' ' ASP . 68.0 t0 -139.68 48.11 1.83 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.783 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.7 tp -155.69 133.47 11.21 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.926 0.394 . . . . 1.0 110.425 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -134.1 149.77 51.12 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.59 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -139.26 154.69 48.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.825 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 30.7 p-80 -127.03 142.49 51.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.212 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.51 121.34 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 109.708 -0.478 . . . . 1.0 109.708 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -92.51 121.7 34.22 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.976 0.417 . . . . 1.0 110.615 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 58' ' ' ILE . 84.2 mt -104.04 127.6 58.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.244 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -118.58 133.4 55.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.987 0.422 . . . . 1.0 109.92 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 40' ' ' ASP . 1.4 mp0 -99.97 144.63 28.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.015 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 70' ' ' GLY . 81.4 mt -146.4 167.24 24.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.627 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 17.4 tp10 81.04 17.28 0.52 Allowed 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.47 0.481 . . . . 1.0 109.89 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -54.97 116.72 2.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.194 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -73.27 -23.72 60.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.713 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -157.71 153.95 23.88 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.115 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -58.74 -26.54 80.27 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.29 1.993 . . . . 1.0 112.134 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.6 mt -98.17 -1.87 41.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.464 -0.334 . . . . 1.0 110.607 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.93 160.26 14.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.949 0.404 . . . . 1.0 110.335 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.6 mt -72.75 160.66 31.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.387 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 71' ' ' LYS . . . -60.89 -33.35 83.12 Favored Glycine 0 C--O 1.224 -0.499 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 70' ' ' GLY . 41.1 tttm 84.73 -31.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.061 0.457 . . . . 1.0 110.654 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.44 123.88 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.563 -0.744 . . . . 1.0 110.702 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.2 mt -112.82 122.85 48.88 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.476 -0.565 . . . . 1.0 109.476 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.5 mt -101.24 123.11 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.826 0.346 . . . . 1.0 110.219 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.12 130.48 29.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.233 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 165' ' ' ASN . 42.1 t0 53.66 45.35 28.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 1.0 111.116 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.9 m120 58.1 23.23 9.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.908 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -128.12 139.28 52.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.931 0.396 . . . . 1.0 110.252 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -89.62 133.37 34.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.976 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -123.96 138.57 54.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.333 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -85.4 -36.64 20.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.566 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -127.25 150.34 49.59 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.207 0.527 . . . . 1.0 111.857 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.7 tp -63.52 -39.2 93.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.671 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -58.18 -44.27 87.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.757 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -58.9 -37.87 77.6 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 110.34 -0.245 . . . . 1.0 110.34 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.1 -45.86 97.57 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 C-N-CA 120.428 -0.509 . . . . 1.0 111.008 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.6 mt -68.1 -44.24 84.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 120.526 -0.47 . . . . 1.0 111.585 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.7 t -77.8 -36.21 22.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 113.029 0.752 . . . . 1.0 113.029 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -84.78 -12.89 52.74 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.886 -0.325 . . . . 1.0 111.743 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -98.2 -48.22 5.17 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.564 -0.455 . . . . 1.0 111.727 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.16 -40.15 78.35 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.316 0.487 . . . . 1.0 112.316 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -62.73 -48.81 77.59 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.852 -0.739 . . . . 1.0 111.478 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -66.91 -42.47 85.35 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.599 -0.44 . . . . 1.0 111.814 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -65.51 -43.65 89.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.097 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.31 -44.33 94.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.405 -0.518 . . . . 1.0 111.018 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -68.0 -47.29 68.93 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.594 -0.442 . . . . 1.0 111.621 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 tp -68.05 -39.78 82.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.248 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.07 -43.13 96.37 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.314 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.476 ' OD1' ' NH2' ' A' ' 27' ' ' ARG . 94.3 m-20 -66.94 -37.71 84.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.035 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -71.01 -42.01 70.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.755 -0.378 . . . . 1.0 111.748 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.5 ttt -66.12 -54.98 18.88 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.494 -0.482 . . . . 1.0 111.458 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.409 ' C ' ' H ' ' A' ' 104' ' ' SER . 84.0 m -59.15 -40.64 86.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.043 0.449 . . . . 1.0 110.33 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.1 t -73.1 10.19 1.01 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.056 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 102' ' ' THR . 9.0 t -91.53 138.43 31.58 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.754 0.311 . . . . 1.0 110.256 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.75 -16.92 59.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.169 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.561 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 57.4 mmtt -93.87 38.57 1.07 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.056 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -133.08 116.76 16.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.045 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.497 ' NZ ' ' CE1' ' A' ' 118' ' ' PHE . 48.6 mtpt -133.2 128.83 36.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.951 -0.568 . . . . 1.0 109.901 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.4 p -96.64 77.66 2.9 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.912 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -111.29 151.8 17.72 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.946 -0.861 . . . . 1.0 110.946 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 58.1 p -73.5 168.29 19.58 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -55.46 -36.49 66.64 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.876 -0.33 . . . . 1.0 110.813 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -68.18 -44.18 76.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.625 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.53 -20.83 63.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.878 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.1 t -70.54 -44.95 76.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.746 -0.382 . . . . 1.0 110.186 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.8 t -64.31 -46.71 92.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-O 121.057 0.456 . . . . 1.0 110.334 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -65.86 -34.84 79.06 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.957 0.408 . . . . 1.0 110.821 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.497 ' CE1' ' NZ ' ' A' ' 108' ' ' LYS . 25.0 t80 -66.73 -50.11 63.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.914 -0.584 . . . . 1.0 111.667 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.2 tp -70.31 -39.86 77.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.96 0.41 . . . . 1.0 110.35 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -65.1 -40.06 94.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.646 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -63.61 -47.85 79.73 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.504 -0.478 . . . . 1.0 110.291 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -61.89 -41.77 98.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.012 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 90.6 p -64.53 -34.89 79.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.221 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -63.56 -41.21 98.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.166 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.3 t -67.18 -42.06 87.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.766 -0.457 . . . . 1.0 109.766 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -124.83 75.62 65.51 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.351 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.3 -13.71 30.9 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.676 2.251 . . . . 1.0 112.345 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -103.79 13.7 32.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.622 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -134.88 149.84 50.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.052 0.453 . . . . 1.0 110.576 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.5 p -80.58 161.78 24.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.803 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.2 p -153.32 148.13 13.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -148.05 142.84 26.73 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.887 0.375 . . . . 1.0 111.2 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -152.1 166.48 31.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.438 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.561 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.2 p90 -140.06 157.27 45.91 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 30.9 p -150.6 168.3 24.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.799 0.333 . . . . 1.0 110.237 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.3 tp -81.7 131.25 35.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.118 -0.492 . . . . 1.0 111.015 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.464 HD22 HD21 ' A' ' 140' ' ' ASN . 58.3 t-20 -79.94 111.86 16.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.409 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.46 -45.19 69.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.899 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.84 -20.39 65.04 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.195 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.464 HD21 HD22 ' A' ' 137' ' ' ASN . 68.7 m-80 -141.79 82.65 13.62 Favored Pre-proline 0 N--CA 1.463 0.193 0 N-CA-C 110.018 -0.364 . . . . 1.0 110.018 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.51 137.75 51.92 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.815 1.677 . . . . 1.0 112.5 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.5 -17.34 53.6 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -109.58 145.42 36.4 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.891 0.377 . . . . 1.0 109.989 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -120.51 159.79 24.47 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 115.992 -0.549 . . . . 1.0 109.806 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 145' ' ' TYR . 4.3 p90 -142.63 148.01 36.73 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 123.382 0.426 . . . . 1.0 110.017 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.02 132.52 54.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.129 0.49 . . . . 1.0 110.46 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.507 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -121.65 146.89 46.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 178.109 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -160.89 155.17 23.09 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -140.26 129.06 23.18 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.69 -0.404 . . . . 1.0 110.502 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.455 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 3.5 mp -72.62 -48.71 45.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.217 0.451 . . . . 1.0 112.217 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 150' ' ' ILE . 86.5 m-20 -153.35 170.31 20.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.474 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.49 -31.08 71.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.943 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -84.7 -11.48 55.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.42 . . . . 1.0 110.525 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 29.5 t -80.1 155.45 27.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.351 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -86.86 147.96 25.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.893 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.0 tp -70.7 128.72 37.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.923 0.392 . . . . 1.0 110.223 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -117.62 129.5 55.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.628 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 71.9 m -130.71 129.55 42.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.937 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -116.07 167.24 11.16 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.828 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -109.79 144.08 38.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.958 -0.565 . . . . 1.0 111.051 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 63.6 t -122.24 134.71 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -100.27 132.12 45.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.382 . . . . 1.0 110.792 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 57.0 tp -92.21 130.81 37.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.715 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.497 ' HG1' ' HG1' ' A' ' 166' ' ' THR . 41.5 p -128.04 168.14 15.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.479 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.409 ' OD1' ' OD2' ' A' ' 76' ' ' ASP . 21.9 m120 -82.58 14.24 3.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.598 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.497 ' HG1' ' HG1' ' A' ' 164' ' ' THR . 57.2 p -122.01 -2.55 9.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.707 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 143.14 -133.34 5.43 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.228 -1.149 . . . . 1.0 110.228 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -122.87 128.42 50.31 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.61 0.243 . . . . 1.0 110.448 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -103.13 123.07 45.98 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.4 tt -119.87 115.11 23.15 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.3 t 35.42 56.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.432 0.53 . . . . 1.0 112.432 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.5 m120 71.7 27.68 2.86 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.164 0.801 . . . . 1.0 113.164 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -135.54 120.11 18.19 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -94.56 119.2 32.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.411 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -99.01 133.62 22.05 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.24 -16.36 25.04 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.127 1.885 . . . . 1.0 113.604 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.1 p -154.25 158.22 39.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.946 0.403 . . . . 1.0 110.912 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 p -63.29 -40.18 88.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.739 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.7 mp -59.87 -47.09 92.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.806 0.336 . . . . 1.0 110.42 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -62.61 -35.7 80.38 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.58 -40.61 97.4 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.136 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 96.0 m -60.04 -45.57 92.38 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.54 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 186' ' ' LYS . 32.8 t30 -69.92 -49.4 52.41 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 119.692 -0.803 . . . . 1.0 108.869 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.05 -44.38 0.51 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.815 -1.314 . . . . 1.0 109.815 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -68.72 -47.4 66.46 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.084 -0.558 . . . . 1.0 109.586 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 183' ' ' ASN . 64.1 tttp -56.9 -41.83 78.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.816 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 16.9 m -61.03 -45.5 94.54 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 24.5 mt -62.19 -40.91 97.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.813 -0.631 . . . . 1.0 109.93 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.26 -44.04 92.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.461 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -59.47 -40.57 87.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.229 0.538 . . . . 1.0 110.056 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.4 t -67.18 -39.64 86.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.252 0.548 . . . . 1.0 110.791 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 25.2 mt -63.59 -44.54 93.75 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.603 -0.726 . . . . 1.0 112.261 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.8 -27.37 68.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.422 -0.354 . . . . 1.0 111.647 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.759 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 7' ' ' HIS . 36.3 mmt180 . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 120.86 0.362 . . . . 1.0 110.556 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 p -64.26 -42.8 96.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.573 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.2 pt -75.54 -25.06 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.365 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -99.44 -0.7 40.29 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.302 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 3' ' ' ARG . 1.3 t60 -54.41 140.17 56.23 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.226 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.61 -15.86 48.89 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.919 1.746 . . . . 1.0 112.152 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -93.77 -5.43 48.3 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.627 -0.261 . . . . 1.0 111.151 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 44.0 t80 -71.12 126.66 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.532 -0.303 . . . . 1.0 110.608 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 52.2 m-85 -146.36 122.21 5.63 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 110.184 -0.302 . . . . 1.0 110.184 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.59 109.76 2.92 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.887 1.725 . . . . 1.0 112.492 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -157.14 156.06 32.06 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.631 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.463 ' ND2' ' H ' ' A' ' 15' ' ' GLY . 13.2 t-20 -77.07 173.49 11.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.463 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -61.42 -46.33 94.6 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.298 -0.954 . . . . 1.0 111.032 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -67.55 -37.79 83.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.899 0.38 . . . . 1.0 110.877 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -67.41 -33.04 74.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.418 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.585 ' CB ' ' NH1' ' A' ' 33' ' ' ARG . . . -61.23 -43.12 99.38 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.482 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -61.55 -41.75 97.82 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.694 -0.402 . . . . 1.0 109.963 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.1 -39.97 91.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.106 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -63.79 -40.6 97.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.525 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.6 -13.55 59.88 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.927 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -58.09 -43.28 86.97 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.367 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 m -78.53 -17.99 55.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.72 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -84.75 -175.89 5.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.354 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.3 pm0 -112.61 -172.86 2.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.59 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -79.15 146.38 33.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.789 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.55 23.57 25.91 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.274 -0.73 . . . . 1.0 111.274 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -112.66 145.17 40.9 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 30' ' ' PHE . 11.9 p90 -133.51 160.38 37.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.214 0.531 . . . . 1.0 110.919 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 88.1 t -146.34 155.39 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.255 -0.884 . . . . 1.0 111.459 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.87 123.39 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.004 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.585 ' NH1' ' CB ' ' A' ' 18' ' ' ALA . 18.6 ptt-85 -140.5 167.11 22.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.343 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 36' ' ' SER . 25.7 mt-30 -112.41 132.17 55.17 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.037 -0.357 . . . . 1.0 110.037 178.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.522 ' C ' ' H ' ' A' ' 37' ' ' ARG . 61.7 m -56.65 80.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.657 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 34' ' ' GLN . 0.2 OUTLIER 69.83 -42.2 0.5 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.319 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.618 ' O ' ' N ' ' A' ' 39' ' ' ASP . 82.1 mtp180 -150.4 -20.9 0.24 Allowed 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.251 -0.431 . . . . 1.0 111.218 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.614 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . 60.41 -53.76 0.02 OUTLIER Glycine 0 C--O 1.221 -0.697 0 N-CA-C 110.45 -1.06 . . . . 1.0 110.45 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.618 ' N ' ' O ' ' A' ' 37' ' ' ARG . 66.7 t0 55.34 -73.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.082 0.467 . . . . 1.0 110.004 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.614 ' N ' ' O ' ' A' ' 38' ' ' GLY . 23.5 p-10 -124.89 19.06 8.53 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.039 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.488 ' ND1' ' OE1' ' A' ' 59' ' ' GLN . 88.6 m-70 -147.61 152.25 37.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.368 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mp -133.28 147.82 51.92 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.273 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.6 t -126.19 132.96 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.242 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.2 mt -113.69 139.66 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.585 ' OG1' ' NH1' ' A' ' 33' ' ' ARG . 29.2 m -122.53 143.31 49.8 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.694 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.547 ' NE1' ' CG ' ' A' ' 54' ' ' GLN . 5.8 p-90 -152.46 151.13 30.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.47 -0.786 . . . . 1.0 111.047 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -91.13 139.15 31.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.99 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.571 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 6.4 mp -95.67 -59.18 1.92 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.287 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -151.5 -174.34 4.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.338 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -54.88 128.36 32.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.815 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 56.04 39.83 30.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.129 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.63 120.38 10.53 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.844 0.354 . . . . 1.0 110.283 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -135.23 149.03 49.79 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.631 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.547 ' CG ' ' NE1' ' A' ' 46' ' ' TRP . 0.5 OUTLIER -141.96 156.09 45.47 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.707 179.353 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.48 ' CA ' ' NE2' ' A' ' 54' ' ' GLN . 33.9 m-70 -129.39 145.34 51.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.956 -0.566 . . . . 1.0 110.63 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.434 HG13 HE22 ' A' ' 54' ' ' GLN . 41.9 mt -125.39 130.96 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 43.8 p-10 -99.61 122.59 42.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.879 0.371 . . . . 1.0 110.489 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.403 HG21 HD12 ' A' ' 58' ' ' ILE . 78.0 mt -102.32 130.67 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.489 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.488 ' OE1' ' ND1' ' A' ' 41' ' ' HIS . 55.5 mm-40 -113.94 126.66 55.4 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -102.1 155.63 18.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.492 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.444 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 2.0 tp -145.19 170.67 15.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.818 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.444 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 20.6 tp10 79.77 53.07 0.02 OUTLIER 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 109.674 -0.491 . . . . 1.0 109.674 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -91.36 90.52 7.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.875 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.499 ' OE1' ' ND2' ' A' ' 65' ' ' ASN . 3.4 tm-20 -67.13 -34.54 77.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.908 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.499 ' ND2' ' OE1' ' A' ' 64' ' ' GLU . 31.2 m120 -145.63 152.81 50.0 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.244 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.64 -33.35 48.51 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.314 2.009 . . . . 1.0 112.061 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.0 mt -86.9 -9.56 55.41 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.863 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.26 134.36 51.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.271 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.8 mt -85.36 152.55 23.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.351 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.59 96.63 0.02 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.721 -0.951 . . . . 1.0 110.721 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -68.43 -43.69 76.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.153 0.501 . . . . 1.0 110.639 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.2 t -111.05 121.83 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.602 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.2 mt -116.04 130.58 56.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.455 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 66.5 mt -108.04 128.39 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 109.869 -0.419 . . . . 1.0 109.869 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.2 t -145.94 134.01 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.36 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.533 ' OD2' ' ND2' ' A' ' 165' ' ' ASN . 32.7 t70 52.96 44.52 30.32 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.208 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 57.06 25.35 10.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.8 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -128.55 147.8 50.72 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.123 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -101.16 130.36 47.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.854 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -124.59 138.84 54.29 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.165 -0.471 . . . . 1.0 109.916 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -85.29 -38.33 18.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.639 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 57.2 t0 -117.11 144.1 45.06 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.076 0.465 . . . . 1.0 111.728 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.496 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 12.3 tp -64.89 -38.44 90.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.619 -0.719 . . . . 1.0 110.551 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.0 -45.06 87.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.96 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -58.39 -38.9 78.29 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.66 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.81 -46.38 96.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.827 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.42 HG23 HD11 ' A' ' 87' ' ' ILE . 41.1 mm -64.27 -43.49 97.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.487 -0.485 . . . . 1.0 111.362 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.05 -43.35 88.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.093 -0.503 . . . . 1.0 112.21 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -71.95 -14.77 62.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.943 0.401 . . . . 1.0 111.267 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -91.94 -50.26 5.81 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.339 -0.544 . . . . 1.0 111.777 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.97 -41.51 86.73 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.329 0.492 . . . . 1.0 112.329 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -63.58 -49.9 71.57 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.65 -0.82 . . . . 1.0 111.524 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -70.39 -43.11 70.74 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.465 -0.494 . . . . 1.0 111.961 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -65.85 -42.03 90.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.184 -0.606 . . . . 1.0 111.407 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.57 -46.08 90.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.185 -0.606 . . . . 1.0 111.395 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -69.42 -44.84 70.55 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.436 -0.506 . . . . 1.0 111.415 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.1 tp -66.02 -42.58 89.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.484 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.6 tp -65.08 -40.27 94.39 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.389 -0.524 . . . . 1.0 110.4 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.424 ' O ' ' OG ' ' A' ' 103' ' ' SER . 7.0 m120 -67.93 -38.82 83.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.839 -0.618 . . . . 1.0 111.261 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -70.4 -39.97 74.16 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 120.628 -0.429 . . . . 1.0 111.71 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.602 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 2.9 ttt -69.33 -56.27 8.0 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.438 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 104' ' ' SER . 17.0 m -58.39 -41.45 84.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.085 0.469 . . . . 1.0 110.599 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 99' ' ' ASN . 35.8 m -71.64 10.82 0.58 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.625 -0.716 . . . . 1.0 111.276 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.486 ' OG ' ' O ' ' A' ' 101' ' ' MET . 65.0 p -94.38 133.76 37.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.788 0.327 . . . . 1.0 110.436 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.3 -20.55 55.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.812 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.556 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -89.29 40.57 0.99 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.136 -0.483 . . . . 1.0 109.881 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -132.2 114.34 14.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.065 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -139.33 113.12 8.54 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 116.088 -0.505 . . . . 1.0 109.868 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 t -97.41 89.89 4.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.993 0.425 . . . . 1.0 110.876 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -112.45 168.98 12.84 Favored Glycine 0 N--CA 1.467 0.731 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.8 m -71.86 162.03 30.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -57.02 -37.88 72.35 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.591 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -69.87 -45.22 68.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.164 0.507 . . . . 1.0 110.801 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -68.1 -21.67 64.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.648 -0.706 . . . . 1.0 110.906 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -69.82 -44.38 79.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.172 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.65 -44.81 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.032 0.444 . . . . 1.0 110.279 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -65.89 -34.26 77.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.902 0.382 . . . . 1.0 110.698 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.4 -50.68 62.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.849 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.6 tt -70.88 -39.97 75.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.445 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.529 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 58.7 mm-40 -59.98 -41.81 92.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.359 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.58 -46.95 83.49 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.24 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -60.73 -45.84 92.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.066 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.3 t -61.58 -38.15 86.47 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.492 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -61.64 -40.05 93.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.034 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.67 -41.93 94.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.473 ' N ' ' ND2' ' A' ' 126' ' ' ASN . 0.0 OUTLIER -126.48 78.83 71.72 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.209 179.24 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.533 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 10.3 Cg_exo -67.9 -20.22 45.46 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.967 2.444 . . . . 1.0 112.339 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -97.19 -6.86 33.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.998 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -113.92 148.04 37.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.871 0.367 . . . . 1.0 110.637 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.6 p -80.16 164.83 23.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.592 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 p -152.71 146.09 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -144.35 142.34 30.31 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.752 0.31 . . . . 1.0 111.14 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -152.54 164.54 37.42 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.51 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.556 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.5 OUTLIER -133.72 157.05 46.82 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.1 t -152.59 167.72 27.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.889 0.376 . . . . 1.0 110.223 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 137' ' ' ASN . 1.0 OUTLIER -84.05 136.19 34.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.827 179.503 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.555 ' ND2' ' H ' ' A' ' 138' ' ' HIS . 47.4 t30 -60.19 -136.18 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.422 -0.353 . . . . 1.0 110.339 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.555 ' H ' ' ND2' ' A' ' 137' ' ' ASN . 32.2 m80 -158.01 -61.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.657 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 139' ' ' ASP . 15.7 p-10 -90.29 1.58 56.38 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.937 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.541 ' OD1' ' ND2' ' A' ' 137' ' ' ASN . 6.6 m120 -116.4 90.53 30.36 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.459 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.42 104.55 1.59 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.081 1.854 . . . . 1.0 112.216 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.48 36.55 2.82 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.409 -1.076 . . . . 1.0 110.409 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -138.21 147.88 44.21 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.525 0.202 . . . . 1.0 110.552 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.602 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 69.5 m-85 -130.86 148.58 52.64 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.719 -0.475 . . . . 1.0 109.719 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.485 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 31.2 m-85 -124.41 136.82 54.36 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.051 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 16.3 mt -107.31 123.69 48.7 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.291 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -116.76 146.35 42.88 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.977 -1.119 . . . . 1.0 107.977 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -161.86 152.03 17.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.529 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 67.2 tttt -136.34 126.73 26.68 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 120.801 -0.359 . . . . 1.0 110.567 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.539 ' CD1' ' HG ' ' A' ' 154' ' ' SER . 3.4 mp -69.59 -47.96 68.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 23.6 m120 -157.48 174.55 15.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.48 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.92 75.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.88 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -85.33 6.88 24.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.039 0.447 . . . . 1.0 110.313 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.539 ' HG ' ' CD1' ' A' ' 150' ' ' ILE . 10.6 t -98.31 152.58 19.28 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.416 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.477 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 99.4 mttt -86.2 153.54 21.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.996 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 22.0 tp -69.95 125.9 28.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.407 . . . . 1.0 110.022 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 95.2 m-85 -115.9 127.29 54.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.703 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 94.3 m -126.45 130.81 51.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.823 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -115.63 160.65 19.75 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.054 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.485 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 84.7 m-20 -108.07 145.35 34.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.834 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.8 t -127.52 135.61 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -99.92 131.85 45.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.033 0.444 . . . . 1.0 110.61 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 54.5 tp -92.03 131.04 37.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 1.0 109.868 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 166' ' ' THR . 56.0 p -133.6 166.8 21.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.344 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.533 ' ND2' ' OD2' ' A' ' 76' ' ' ASP . 19.6 p30 -78.2 16.29 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.722 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.415 ' H ' ' C ' ' A' ' 164' ' ' THR . 62.1 p -119.57 -1.23 10.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.425 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 133.93 -125.8 4.03 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.251 -1.14 . . . . 1.0 110.251 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -122.78 129.66 51.99 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.242 -0.281 . . . . 1.0 110.242 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.98 118.1 35.79 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 tt -115.43 118.05 32.1 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.2 t 37.44 54.0 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.007 0.373 . . . . 1.0 112.007 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.8 m120 69.76 27.26 4.67 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.894 0.701 . . . . 1.0 112.894 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -131.96 120.38 22.41 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -94.84 120.68 35.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.364 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -98.09 135.37 21.41 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.438 -0.578 . . . . 1.0 109.438 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.26 -19.12 29.68 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.279 1.986 . . . . 1.0 113.55 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.448 ' OG ' ' OE1' ' A' ' 180' ' ' GLN . 19.4 p -150.1 153.78 36.98 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.968 0.413 . . . . 1.0 110.85 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.42 -36.27 75.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.696 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.513 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 48.5 mm -62.6 -47.63 92.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.946 0.403 . . . . 1.0 110.357 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.448 ' OE1' ' OG ' ' A' ' 177' ' ' SER . 6.0 mp0 -61.56 -30.75 70.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.8 tp -64.25 -40.46 96.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.272 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . 0.619 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 2.6 p -60.27 -47.54 85.57 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.519 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.619 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 51.3 t30 -69.64 -49.01 57.87 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.2 -45.26 0.44 Allowed Glycine 0 N--CA 1.465 0.581 0 N-CA-C 109.876 -1.29 . . . . 1.0 109.876 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -67.67 -47.88 68.22 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.1 tttm -56.45 -40.33 74.63 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.54 -0.755 . . . . 1.0 110.1 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 97.9 m -61.04 -45.28 95.44 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.33 -39.71 95.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.872 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 59.7 tp -58.73 -44.55 90.47 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.619 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -59.8 -46.17 90.04 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.737 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.5 t -63.08 -39.9 96.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.197 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.49 -43.08 95.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.64 . . . . 1.0 111.963 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.49 -29.94 67.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.465 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 . . . . . 0 N--CA 1.465 0.31 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.886 -179.015 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.846 0.355 . . . . 1.0 110.338 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.6 -27.39 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.574 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.4 pt -75.49 -22.06 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.484 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -106.32 5.98 30.13 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.961 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -58.93 150.91 58.01 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.421 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 38.2 Cg_endo -65.23 -19.88 62.47 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.171 1.914 . . . . 1.0 112.029 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.4 3.23 54.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.608 -0.269 . . . . 1.0 110.99 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -88.97 125.75 35.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.528 -0.306 . . . . 1.0 110.477 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.421 ' CZ ' ' O ' ' A' ' 8' ' ' PRO . 71.1 m-85 -143.17 128.69 10.07 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 110.186 -0.301 . . . . 1.0 110.186 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.489 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 74.0 Cg_endo -73.3 110.01 2.96 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.758 1.638 . . . . 1.0 112.766 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.489 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 52.4 m-85 -160.98 152.29 19.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.361 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 20.9 t-20 -75.84 165.09 25.52 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.464 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . -57.11 -43.41 93.36 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.461 -0.875 . . . . 1.0 110.937 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 48.6 mmm-85 -67.44 -37.65 83.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.864 0.364 . . . . 1.0 110.596 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -73.57 -32.57 64.22 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.62 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.56 -47.45 85.49 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.417 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -65.89 -36.85 84.56 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.43 ' O ' ' CG ' ' A' ' 23' ' ' ARG . 97.4 m-20 -63.33 -42.76 98.99 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -66.25 -36.55 83.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.715 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.5 tp -82.12 -11.84 58.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.101 -0.499 . . . . 1.0 111.381 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.43 ' CG ' ' O ' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -65.15 -28.57 69.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.826 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.2 t -83.56 -19.94 34.72 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.714 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -84.93 -178.15 6.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.428 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -88.69 167.9 12.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.799 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -74.72 145.15 43.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.808 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.77 4.95 56.8 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.872 -0.891 . . . . 1.0 110.872 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -88.98 148.3 23.85 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -128.31 165.03 21.33 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.219 0.533 . . . . 1.0 111.027 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 t -145.51 155.03 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.309 -0.86 . . . . 1.0 110.894 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -117.5 122.22 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.541 ' NH1' ' OG ' ' A' ' 35' ' ' SER . 32.8 ptt85 -148.66 158.76 44.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.297 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -107.55 137.08 46.23 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.541 ' OG ' ' NH1' ' A' ' 33' ' ' ARG . 2.9 p 169.16 97.74 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.539 0.524 . . . . 1.0 111.073 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.4 p -169.16 30.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.242 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? 53.15 20.26 1.74 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.233 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.702 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -150.1 89.95 0.14 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.677 -0.969 . . . . 1.0 110.677 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -57.18 11.91 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.225 -0.488 . . . . 1.0 111.142 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.702 ' H ' ' C ' ' A' ' 38' ' ' GLY . 32.0 p-10 -107.76 -0.44 21.72 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -129.59 155.47 45.76 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.783 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.41 150.28 40.46 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.006 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.7 t -126.21 133.29 69.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.109 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.5 mt -112.53 138.44 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.749 -0.834 . . . . 1.0 108.749 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 87.6 m -116.5 135.37 53.88 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.04 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.472 ' CZ2' ' OH ' ' A' ' 90' ' ' TYR . 1.8 p-90 -146.0 151.75 38.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.934 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -98.26 138.03 36.12 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.946 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.513 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 9.2 mp -95.82 -73.25 0.6 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.046 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 23.4 t70 -103.07 -170.77 1.84 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.497 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.526 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 7.8 ttpm? -63.17 -38.66 92.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.616 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -127.21 61.25 1.37 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.873 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.8 tp -157.47 130.25 7.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.421 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.3 148.66 50.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.662 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.44 ' C ' ' ND1' ' A' ' 55' ' ' HIS . 26.7 mm100 -143.09 152.37 41.77 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.016 -0.538 . . . . 1.0 109.75 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.44 ' ND1' ' C ' ' A' ' 54' ' ' GLN . 3.7 m-70 -126.36 141.2 51.99 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.288 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.07 123.14 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.291 -0.413 . . . . 1.0 109.931 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -95.67 121.94 37.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.538 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.433 HG21 HD11 ' A' ' 58' ' ' ILE . 79.9 mt -102.47 124.02 56.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.441 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -107.56 136.16 47.8 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -103.34 151.71 22.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.034 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.0 mt -139.81 171.33 14.37 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.493 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 77.66 45.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.246 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.76 77.38 2.84 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.917 -0.583 . . . . 1.0 109.927 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -65.21 -35.84 82.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.585 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -131.09 150.38 76.4 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.01 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.32 -20.39 66.54 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.235 1.957 . . . . 1.0 112.082 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.61 -4.4 50.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.711 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.26 129.79 54.23 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.947 0.403 . . . . 1.0 110.308 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.8 mt -81.21 153.35 27.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.515 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.06 114.0 6.41 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.526 -1.03 . . . . 1.0 110.526 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.98 -10.65 59.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.876 0.37 . . . . 1.0 110.799 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.7 t -117.87 118.83 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.43 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.5 mt -114.76 128.79 56.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.388 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.4 HG22 HD13 ' A' ' 74' ' ' ILE . 96.6 mt -100.28 120.26 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.883 0.373 . . . . 1.0 110.539 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.65 133.08 31.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.393 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 55.43 43.99 27.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.11 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.3 t30 58.47 21.76 8.84 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.02 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -128.86 152.27 48.7 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.336 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -100.09 131.64 45.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 1.0 111.041 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -128.81 136.8 50.99 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.204 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -85.5 -37.44 19.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.591 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -112.29 141.2 46.3 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.971 0.415 . . . . 1.0 111.575 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.9 -40.44 95.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.726 -0.67 . . . . 1.0 111.173 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 42.9 p30 -59.89 -33.66 72.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 1.0 111.64 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.561 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 25.8 mt-30 -65.92 -39.14 90.29 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.799 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.65 -45.72 98.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.716 -0.394 . . . . 1.0 110.778 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.6 mm -65.12 -44.01 95.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.422 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.453 ' O ' ' CG ' ' A' ' 92' ' ' GLN . 98.1 t -69.36 -44.6 80.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 112.433 0.531 . . . . 1.0 112.433 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -76.95 -13.05 60.02 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.288 -0.565 . . . . 1.0 111.692 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.472 ' OH ' ' CZ2' ' A' ' 46' ' ' TRP . 63.0 t80 -93.85 -48.6 6.21 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.977 0.362 . . . . 1.0 111.977 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.89 -42.45 76.92 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.425 0.528 . . . . 1.0 112.425 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.493 ' CD ' ' N ' ' A' ' 93' ' ' ASN . 1.5 pp0? -63.84 -47.46 80.65 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.025 -0.67 . . . . 1.0 111.526 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.493 ' N ' ' CD ' ' A' ' 92' ' ' GLN . 2.7 t30 -69.27 -42.81 75.05 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.685 -0.406 . . . . 1.0 111.509 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -65.68 -42.86 90.75 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.296 -0.562 . . . . 1.0 111.018 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.7 t -66.04 -46.46 87.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.12 -0.632 . . . . 1.0 111.137 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.471 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 82.6 mtp180 -67.08 -45.54 77.01 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.272 -0.571 . . . . 1.0 111.842 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.1 tp -69.57 -41.43 75.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.534 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.47 -45.72 86.18 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.43 -0.508 . . . . 1.0 110.674 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.471 ' ND2' ' HA ' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -69.11 -35.03 76.0 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.439 -0.504 . . . . 1.0 111.161 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -71.72 -42.86 66.8 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.578 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 9.2 tpt -68.78 -52.88 25.56 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.495 -0.482 . . . . 1.0 111.117 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.433 ' C ' ' H ' ' A' ' 104' ' ' SER . 58.9 m -58.48 -40.78 83.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 1.0 110.551 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.5 t -72.61 9.77 1.01 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.877 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 102' ' ' THR . 6.0 t -92.26 136.49 33.14 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 110.178 -0.305 . . . . 1.0 110.178 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -62.71 -16.83 59.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.85 0.357 . . . . 1.0 110.836 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.473 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 99.3 mttt -91.76 39.3 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.999 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -132.95 114.84 14.48 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.989 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -130.03 115.5 17.2 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 64.5 p -97.59 81.52 2.95 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.863 0.363 . . . . 1.0 110.912 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.93 167.43 12.32 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.831 -0.908 . . . . 1.0 110.831 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 80.9 p -77.28 162.81 27.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.971 -0.381 . . . . 1.0 109.971 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -55.99 -35.68 67.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.554 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.74 -43.61 83.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.651 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -70.78 -19.76 62.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.982 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 43.2 t -70.25 -44.69 77.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.336 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.31 -44.89 94.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.293 0.568 . . . . 1.0 110.395 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -65.65 -34.89 79.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.656 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -67.35 -50.13 61.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.539 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.2 tp -69.7 -39.45 78.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.225 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -63.46 -43.57 96.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.661 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.86 -47.45 86.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.29 -0.564 . . . . 1.0 110.219 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.562 ' CE2' ' OD1' ' A' ' 126' ' ' ASN . 50.3 t80 -61.42 -40.05 92.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.015 -0.539 . . . . 1.0 109.844 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.6 t -60.35 -42.41 95.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.572 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -61.14 -40.84 95.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.404 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.35 -41.27 83.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.562 ' OD1' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -123.15 73.95 48.91 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.732 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.53 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 41.2 Cg_endo -72.01 -22.26 23.18 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.131 1.887 . . . . 1.0 112.442 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -104.07 24.45 11.39 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.74 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -140.77 151.52 44.5 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.826 0.346 . . . . 1.0 110.633 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.9 p -80.12 162.22 24.88 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.554 -0.535 . . . . 1.0 109.554 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 p -152.63 144.76 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.446 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 27.2 p90 -153.49 142.76 21.51 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.962 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -151.76 169.47 22.13 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.438 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.473 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -131.02 149.92 52.39 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.435 ' HG ' ' N ' ' A' ' 136' ' ' LEU . 26.9 t -150.55 169.98 20.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.329 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.435 ' N ' ' HG ' ' A' ' 135' ' ' SER . 43.6 tp -67.89 140.55 56.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.422 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.56 ' C ' ' H ' ' A' ' 139' ' ' ASP . 9.8 p30 -55.59 -43.64 76.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.565 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 19.2 t60 70.39 -19.71 0.21 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.707 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.56 ' H ' ' C ' ' A' ' 137' ' ' ASN . 30.3 m-20 -103.0 -24.24 13.65 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.065 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.434 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 4.7 p30 -153.56 91.75 3.25 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.11 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.504 ' HA ' HD22 ' A' ' 137' ' ' ASN . 44.8 Cg_exo -54.25 135.26 64.37 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.203 1.935 . . . . 1.0 112.665 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 117.58 -28.99 6.84 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.001 -0.84 . . . . 1.0 111.001 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -113.96 150.49 33.72 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.931 0.396 . . . . 1.0 110.538 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -115.33 156.24 25.85 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -125.36 134.94 52.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.029 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.4 mt -106.68 126.24 52.03 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.651 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -117.15 146.39 43.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 178.472 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -160.86 150.59 17.31 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.216 -0.593 . . . . 1.0 109.723 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -130.94 127.37 38.31 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.746 0.308 . . . . 1.0 110.281 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 37.6 mm -72.92 -46.08 53.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.204 -0.453 . . . . 1.0 111.803 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 152' ' ' ALA . 11.9 t-20 -157.07 169.61 24.41 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.699 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.537 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -60.51 -30.08 69.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.813 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -90.41 8.79 31.88 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.036 0.446 . . . . 1.0 110.393 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 15.6 t -97.45 159.73 14.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.716 -0.674 . . . . 1.0 110.486 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -92.37 153.2 19.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.039 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 48.5 tp -70.84 118.52 13.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -108.07 129.98 55.11 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 51.8 m -126.41 128.94 47.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.611 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -113.9 160.97 18.2 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.035 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 160' ' ' ASN . 50.9 p30 -104.75 147.99 27.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.906 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 47.4 t -128.31 137.48 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.85 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -104.0 131.53 51.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.367 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.0 tp -95.26 130.53 41.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 1.0 109.789 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 48.8 p -127.89 171.01 12.18 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.252 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -84.97 16.48 3.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.851 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m -122.91 -3.25 8.65 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.935 0.398 . . . . 1.0 110.458 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 143.41 -132.24 4.88 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.422 -1.071 . . . . 1.0 110.422 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -122.91 130.2 52.55 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -106.48 122.52 46.46 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 tt -116.28 118.08 31.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 1.0 109.856 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.466 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 4.7 t 37.48 58.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.176 0.436 . . . . 1.0 112.176 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.5 m120 65.46 27.34 11.76 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.949 0.722 . . . . 1.0 112.949 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.466 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 89.0 m-85 -133.85 120.37 20.35 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -96.49 126.2 41.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.439 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -105.08 131.72 21.52 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -73.31 -20.79 20.75 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.192 1.928 . . . . 1.0 113.31 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 67.9 m -143.86 147.44 34.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.945 0.402 . . . . 1.0 111.218 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.08 -34.51 60.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.67 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 58.8 mt -62.2 -44.95 99.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.886 0.374 . . . . 1.0 110.135 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -67.98 -31.22 70.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.059 -0.519 . . . . 1.0 109.629 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.14 -42.79 99.53 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 110.084 -0.339 . . . . 1.0 110.084 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . 0.425 ' SG ' ' NZ ' ' A' ' 106' ' ' LYS . 73.1 m -63.13 -44.98 94.06 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.26 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.559 ' O ' ' N ' ' A' ' 186' ' ' LYS . 37.3 m-80 -65.73 -48.83 70.59 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.47 -43.43 0.75 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.678 -1.369 . . . . 1.0 109.678 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.432 ' O ' ' HG ' ' A' ' 188' ' ' LEU . 2.6 t80 -69.56 -46.85 65.46 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 122.096 0.951 . . . . 1.0 109.329 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.559 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.7 tttm -59.01 -35.58 73.51 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.118 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.7 m -63.43 -50.5 69.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 1.0 111.177 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 185' ' ' PHE . 0.7 OUTLIER -66.55 -36.05 81.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.66 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 45.7 tp -58.03 -43.84 86.99 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.432 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -61.13 -40.28 93.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.956 -0.566 . . . . 1.0 109.792 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.0 t -61.59 -36.85 81.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.741 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 92.6 mt -69.95 -36.94 75.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.405 -0.816 . . . . 1.0 112.047 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.57 -31.88 69.85 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.051 0.389 . . . . 1.0 112.051 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 27.2 m170 . . . . . 0 C--N 1.325 -0.464 0 C-N-CA 120.881 -0.327 . . . . 1.0 110.725 -179.595 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.402 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 69.5 mtp180 . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 120.895 0.379 . . . . 1.0 110.375 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 p -64.8 -31.36 53.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.556 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.7 pt -73.79 -17.26 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.46 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -98.03 0.32 46.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.389 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.41 ' O ' ' N ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -62.78 123.22 78.76 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.285 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.477 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 77.5 Cg_exo -43.9 -25.72 1.13 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.848 1.699 . . . . 1.0 112.39 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.598 ' CD1' ' CZ ' ' A' ' 30' ' ' PHE . 78.5 m-85 -87.0 9.16 20.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.506 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 7' ' ' HIS . 44.2 t80 -92.68 125.48 37.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.377 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.477 ' CZ ' ' O ' ' A' ' 8' ' ' PRO . 66.1 m-85 -145.3 128.27 8.29 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 110.12 -0.326 . . . . 1.0 110.12 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.88 110.54 3.1 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.717 1.611 . . . . 1.0 112.712 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -154.52 152.48 30.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.439 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -79.31 174.03 11.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.398 -0.593 . . . . 1.0 109.398 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.44 -46.86 93.56 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.403 -0.903 . . . . 1.0 111.338 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -67.32 -35.29 79.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.539 0.209 . . . . 1.0 111.15 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -67.68 -37.22 82.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.379 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.29 94.94 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.691 -0.404 . . . . 1.0 110.425 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.47 -43.99 92.47 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.019 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.61 -42.63 99.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.432 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -63.05 -41.51 99.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.831 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.9 mp -78.63 -11.31 59.96 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.97 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -56.21 -43.52 78.61 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.519 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.0 m -79.3 -15.84 57.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.739 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -81.44 175.57 10.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.472 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -100.9 -176.38 3.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.515 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -82.3 146.2 29.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.88 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.51 14.01 45.77 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.192 -0.763 . . . . 1.0 111.192 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -100.49 144.07 29.91 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.598 ' CZ ' ' CD1' ' A' ' 9' ' ' TYR . 9.1 p90 -132.9 162.19 32.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.116 0.484 . . . . 1.0 110.832 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -147.29 157.77 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.193 -0.912 . . . . 1.0 111.533 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 80.8 mt -117.75 124.82 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 43' ' ' VAL . 1.5 ptm180 -150.27 156.03 40.8 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.321 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.404 ' C ' ' H ' ' A' ' 36' ' ' SER . 54.4 mt-30 -88.33 169.87 11.46 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 37' ' ' ARG . 16.5 p -81.09 28.13 0.38 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.405 -0.362 . . . . 1.0 110.987 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 34' ' ' GLN . 1.5 m 70.94 -41.4 0.5 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.809 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.508 ' H ' ' C ' ' A' ' 35' ' ' SER . 83.9 mtt85 -140.21 19.01 2.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.01 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -70.66 -65.18 2.57 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.618 -0.993 . . . . 1.0 110.618 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 68.03 -43.72 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.726 0.298 . . . . 1.0 110.647 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 38' ' ' GLY . 38.2 t70 -94.8 -9.63 33.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.652 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -136.98 151.33 48.87 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.898 0.38 . . . . 1.0 110.348 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.96 147.91 44.81 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.097 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 33' ' ' ARG . 62.4 t -126.47 134.24 66.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.437 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.1 mt -112.95 138.86 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.1 m -116.9 135.36 53.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.825 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 4.1 p-90 -144.4 148.02 34.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.521 -0.763 . . . . 1.0 110.787 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -95.29 137.13 34.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.972 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.489 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 9.6 mp -101.87 -82.14 0.48 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.385 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -90.01 174.74 7.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.522 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -58.52 -29.59 66.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.82 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -132.56 52.95 2.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.992 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.0 tp -152.9 136.76 16.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.905 0.384 . . . . 1.0 110.442 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.553 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 87.0 m-85 -131.63 148.22 52.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.385 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 53' ' ' PHE . 98.0 mm-40 -142.73 153.81 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.681 -0.489 . . . . 1.0 109.681 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.502 ' ND1' ' O ' ' A' ' 55' ' ' HIS . 7.7 p80 -129.45 144.65 51.34 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.287 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.3 mt -122.64 125.57 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -96.45 122.67 39.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.952 0.406 . . . . 1.0 110.359 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.429 HG21 HD13 ' A' ' 58' ' ' ILE . 75.3 mt -104.82 129.64 57.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.31 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.795 ' H ' HE21 ' A' ' 59' ' ' GLN . 0.0 OUTLIER -112.23 135.15 53.26 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.096 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -100.53 151.52 21.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.312 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.44 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.7 tp -143.5 176.18 9.38 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.513 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.44 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 64.0 tt0 67.63 44.37 1.68 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.264 0.554 . . . . 1.0 109.633 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -83.01 90.44 7.02 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.806 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.466 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 49.4 tp10 -65.66 -38.38 89.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.819 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 64' ' ' GLU . 6.6 m120 -144.16 153.67 56.74 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.259 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.82 -33.83 62.61 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.079 1.853 . . . . 1.0 112.324 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 pp -85.14 -10.92 56.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.857 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.51 133.86 48.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.367 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.2 mt -79.67 152.45 29.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.364 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.86 92.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.01 -37.11 86.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.867 0.365 . . . . 1.0 110.772 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.2 t -122.93 123.0 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.804 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.7 mt -116.13 134.22 55.17 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.423 HG23 HD11 ' A' ' 74' ' ' ILE . 18.5 mm -99.57 120.09 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.919 0.39 . . . . 1.0 110.128 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.66 131.47 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.229 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.405 ' OD2' ' ND2' ' A' ' 165' ' ' ASN . 42.6 t0 54.14 43.45 30.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.18 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 59.54 24.31 13.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.017 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -129.53 156.96 43.32 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.434 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.14 133.51 41.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.187 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -135.19 136.4 41.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.241 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -87.06 -37.66 17.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.889 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -109.33 136.71 48.34 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.21 0.529 . . . . 1.0 112.324 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.4 tp -66.08 -38.12 87.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.767 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 54.1 t0 -59.7 -36.58 76.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.894 -176.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.415 ' OE1' ' OE2' ' A' ' 89' ' ' GLU . 9.5 tt0 -59.8 -38.96 83.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.627 0.251 . . . . 1.0 110.608 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.1 mm -60.71 -47.76 91.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.708 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.431 HG22 HD11 ' A' ' 87' ' ' ILE . 96.8 mt -62.16 -42.7 96.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 120.512 -0.475 . . . . 1.0 111.786 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.428 ' O ' ' OE1' ' A' ' 92' ' ' GLN . 40.6 t -76.44 -37.57 30.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.152 0.797 . . . . 1.0 113.152 -177.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.415 ' OE2' ' OE1' ' A' ' 85' ' ' GLN . 95.8 mt-10 -84.37 -14.49 49.36 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.912 0.338 . . . . 1.0 111.912 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -95.27 -48.7 5.79 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.629 -0.428 . . . . 1.0 112.129 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.9 mp -69.76 -40.49 76.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.337 0.495 . . . . 1.0 112.337 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.515 ' OE1' ' N ' ' A' ' 92' ' ' GLN . 5.1 mp0 -64.2 -48.95 73.91 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.969 -0.692 . . . . 1.0 111.767 -177.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -69.29 -42.9 74.85 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.622 -0.431 . . . . 1.0 111.866 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -66.35 -43.62 85.52 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.359 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.4 t -61.56 -45.52 98.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.3 -0.56 . . . . 1.0 111.235 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -69.24 -42.7 75.29 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.487 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.8 tp -66.44 -42.24 87.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.616 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.7 mp -65.4 -41.11 94.02 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.504 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.48 -36.24 78.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.18 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -71.66 -42.28 67.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 120.824 -0.351 . . . . 1.0 111.784 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.3 tpt -67.46 -54.96 15.72 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.438 -0.505 . . . . 1.0 111.65 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 55.3 m -59.68 -29.42 68.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.956 0.407 . . . . 1.0 110.559 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.0 p -74.25 9.61 1.58 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.123 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.7 t -98.45 130.1 45.06 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 110.123 -0.325 . . . . 1.0 110.123 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -58.23 -17.49 19.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.127 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.533 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 98.6 mttt -88.56 40.63 0.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.671 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -135.24 113.41 11.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.104 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -133.44 120.43 20.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.052 -0.522 . . . . 1.0 109.977 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.6 p -91.75 94.68 9.48 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.053 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.2 151.8 16.89 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.431 ' OG1' ' OD1' ' A' ' 114' ' ' ASP . 19.1 p -71.34 162.76 28.92 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -58.92 -40.1 83.54 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.539 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.85 -46.16 72.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.872 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.431 ' OD1' ' OG1' ' A' ' 111' ' ' THR . 2.8 m-20 -71.34 -19.37 62.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.744 -0.662 . . . . 1.0 111.084 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.2 t -73.7 -43.92 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.172 -0.307 . . . . 1.0 110.172 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.0 -46.56 96.21 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 CA-C-O 121.118 0.485 . . . . 1.0 110.054 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -65.86 -34.32 77.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.988 0.423 . . . . 1.0 110.696 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -68.94 -49.29 59.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.731 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.1 tp -70.6 -39.59 76.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.518 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -62.52 -41.65 98.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.765 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.96 -47.63 74.01 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.582 -0.447 . . . . 1.0 110.373 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.536 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 42.4 t80 -61.39 -42.09 98.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.99 -0.55 . . . . 1.0 109.914 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.5 p -64.87 -33.56 76.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.419 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -61.81 -42.02 98.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.998 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.76 -40.91 90.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.536 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -113.77 75.27 2.69 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.056 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.531 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 41.4 Cg_endo -71.99 -19.35 26.81 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.24 1.96 . . . . 1.0 112.406 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -104.67 -14.64 15.53 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.041 0.386 . . . . 1.0 112.041 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -103.4 147.1 27.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.082 0.467 . . . . 1.0 110.52 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.9 m -80.81 162.1 24.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.515 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 p -153.03 146.36 14.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -149.73 143.05 25.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.885 0.374 . . . . 1.0 111.041 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -151.24 165.25 34.53 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.317 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.533 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -133.57 151.63 51.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.383 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.9 m -146.31 167.51 23.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.252 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.9 tp -79.82 128.81 33.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.612 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.465 ' CG ' ' CD2' ' A' ' 145' ' ' TYR . 5.5 m-20 -53.11 173.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.109 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -127.58 -38.85 1.88 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.531 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -95.44 -8.04 36.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.177 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -136.62 75.5 50.36 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.255 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.34 132.42 50.79 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.964 1.776 . . . . 1.0 112.442 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 109.43 -33.49 6.06 Favored Glycine 0 N--CA 1.466 0.645 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.432 ' O ' ' CG ' ' A' ' 137' ' ' ASN . 15.6 m0 -92.16 156.49 17.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.723 0.297 . . . . 1.0 110.22 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -119.12 149.77 41.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 1.0 109.834 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.465 ' CD2' ' CG ' ' A' ' 137' ' ' ASN . 35.8 m-85 -120.99 132.99 55.25 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.246 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 15.0 mt -107.32 123.38 48.25 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.236 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -120.64 145.32 47.53 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.979 -1.119 . . . . 1.0 107.979 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -163.48 151.58 13.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.51 -0.476 . . . . 1.0 109.719 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -128.39 130.57 47.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.761 0.315 . . . . 1.0 110.455 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -75.68 -45.92 37.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.217 0.451 . . . . 1.0 112.217 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.666 ' H ' ' HG ' ' A' ' 154' ' ' SER . 17.5 t-20 -152.15 164.08 38.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.477 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.505 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -57.14 -22.89 43.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.776 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -96.87 -4.54 40.04 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.402 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.666 ' HG ' ' H ' ' A' ' 151' ' ' ASN . 5.1 p -82.91 150.76 26.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.488 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.486 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -82.35 154.56 25.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.176 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.2 tp -69.39 113.7 6.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.971 0.415 . . . . 1.0 110.073 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 99.0 m-85 -99.92 131.23 46.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.803 -0.635 . . . . 1.0 109.636 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 58.4 m -127.62 130.94 49.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.774 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -117.1 153.26 33.07 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.111 0.481 . . . . 1.0 109.942 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -105.2 144.95 31.28 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.791 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.5 t -127.61 135.44 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.646 -0.502 . . . . 1.0 109.646 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -98.19 131.23 44.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.378 -0.373 . . . . 1.0 110.474 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.3 tp -99.71 131.35 45.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.078 -0.51 . . . . 1.0 109.698 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.1 p -132.58 174.32 10.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.461 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.405 ' ND2' ' OD2' ' A' ' 76' ' ' ASP . 3.0 p30 -85.67 17.02 3.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.699 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 44.0 p -121.79 -2.63 9.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.566 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.32 -134.48 6.52 Favored Glycine 0 N--CA 1.465 0.591 0 N-CA-C 110.329 -1.108 . . . . 1.0 110.329 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -122.23 130.15 52.91 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 110.316 -0.253 . . . . 1.0 110.316 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -105.67 119.2 38.53 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.8 tt -117.02 119.73 36.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.8 t 38.54 53.66 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.004 0.372 . . . . 1.0 112.004 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.5 m120 67.7 27.19 7.66 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.017 0.747 . . . . 1.0 113.017 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -135.47 120.68 18.94 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -93.2 126.06 38.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.493 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -102.51 139.63 20.39 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -72.71 -18.59 25.02 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.024 1.816 . . . . 1.0 113.613 -177.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.9 p -154.67 158.24 39.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.917 0.389 . . . . 1.0 110.962 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.2 p -64.77 -37.52 80.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.141 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 80.4 mt -59.7 -45.03 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.306 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.468 ' HA ' HE21 ' A' ' 180' ' ' GLN . 0.3 OUTLIER -63.59 -37.6 87.96 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.7 tt -64.86 -39.78 94.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.422 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 83.1 m -59.29 -47.87 83.75 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.432 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' A' ' 186' ' ' LYS . 61.2 t30 -69.74 -49.28 54.64 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.35 -44.96 0.63 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.699 -1.36 . . . . 1.0 109.699 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.78 -47.34 69.44 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.192 -0.669 . . . . 1.0 109.192 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 183' ' ' ASN . 63.9 tttp -56.56 -41.53 77.03 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.522 -0.763 . . . . 1.0 109.827 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 94.5 m -60.02 -46.98 87.71 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.75 -41.23 98.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 1.0 109.815 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.1 tp -60.24 -45.81 91.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.542 -0.299 . . . . 1.0 110.451 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -60.89 -44.17 97.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.291 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.4 t -64.31 -37.38 87.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.258 0.551 . . . . 1.0 110.499 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.19 -42.26 99.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.87 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -63.5 -25.69 68.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 111.878 0.325 . . . . 1.0 111.878 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.086 -179.596 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.757 0.313 . . . . 1.0 110.35 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.85 -26.22 34.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.542 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.0 pt -71.63 -26.66 26.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 1.0 110.689 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -106.95 7.9 30.21 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.575 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -46.8 136.14 7.9 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.313 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -49.05 -31.55 21.16 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.648 1.565 . . . . 1.0 112.526 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.612 ' CE2' ' CZ ' ' A' ' 30' ' ' PHE . 52.0 m-85 -88.38 3.74 48.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.728 0.299 . . . . 1.0 111.244 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.528 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 34.3 t80 -75.12 127.74 33.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.178 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 52.1 m-85 -147.49 108.92 3.86 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.606 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.495 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 31.3 Cg_exo -59.67 111.74 1.05 Allowed 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 121.71 1.607 . . . . 1.0 112.624 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.529 ' O ' ' NH1' ' A' ' 33' ' ' ARG . 56.2 m-85 -160.34 159.39 31.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.29 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 15' ' ' GLY . 11.1 t-20 -81.19 164.72 22.11 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.413 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -58.26 -48.53 82.92 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.606 -0.998 . . . . 1.0 110.606 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.7 mmp_? -67.32 -39.56 85.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.723 0.297 . . . . 1.0 111.029 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.16 -37.07 84.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.326 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.59 -44.01 97.8 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.669 -0.412 . . . . 1.0 110.414 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.514 ' OE2' ' CD1' ' A' ' 53' ' ' PHE . 42.6 tt0 -61.34 -45.73 93.22 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.045 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.1 -38.71 89.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.322 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.632 ' CE2' ' NZ ' ' A' ' 25' ' ' LYS . 57.3 t80 -67.2 -36.87 82.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.078 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.8 mp -81.65 -11.88 58.92 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.115 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -63.51 -33.57 75.86 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.248 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -81.18 -20.14 41.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.004 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.632 ' NZ ' ' CE2' ' A' ' 21' ' ' TYR . 48.7 mttp -81.89 176.4 9.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.998 0.428 . . . . 1.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -88.72 165.74 14.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.809 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.538 ' NH2' ' OD1' ' A' ' 99' ' ' ASN . 64.6 ttp85 -65.65 146.18 55.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.949 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.29 22.75 31.19 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.317 -0.713 . . . . 1.0 111.317 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -101.41 142.14 33.24 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.612 ' CZ ' ' CE2' ' A' ' 9' ' ' TYR . 17.3 p90 -133.24 167.19 20.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.489 0.661 . . . . 1.0 110.699 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 m -149.68 163.1 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.715 -1.13 . . . . 1.0 111.827 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.7 mm -115.65 126.71 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 13' ' ' PHE . 26.8 ttt85 -136.76 162.58 32.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.689 -0.687 . . . . 1.0 110.188 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.557 ' C ' ' H ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -117.11 128.58 55.27 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.6 t -52.72 -6.21 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.557 ' H ' ' C ' ' A' ' 34' ' ' GLN . 1.5 t 72.07 -49.12 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.442 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -93.39 -6.09 47.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.653 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -70.96 -53.84 10.34 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.632 -0.987 . . . . 1.0 110.632 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 t70 71.44 -36.89 0.38 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.627 0.251 . . . . 1.0 111.084 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 38' ' ' GLY . 98.4 m-20 -120.08 -7.34 9.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.744 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -120.42 146.89 45.76 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.056 0.455 . . . . 1.0 110.944 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.88 151.79 41.39 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.129 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.8 t -125.82 134.36 66.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.299 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.0 mt -110.71 137.16 44.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.4 m -117.66 134.17 55.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.661 -0.699 . . . . 1.0 109.349 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.696 ' HE1' HE21 ' A' ' 54' ' ' GLN . 2.1 p-90 -151.89 154.21 35.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.349 -0.841 . . . . 1.0 110.768 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.87 143.46 28.45 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.293 0.568 . . . . 1.0 111.793 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.2 mt -97.18 -57.76 2.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.226 -0.897 . . . . 1.0 110.35 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -119.38 -166.85 1.32 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.37 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -65.1 -39.29 92.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.793 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -128.13 53.39 1.8 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.281 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.9 tp -153.87 129.36 9.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.263 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CD1' ' OE2' ' A' ' 19' ' ' GLU . 47.8 m-85 -134.99 150.25 50.31 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.983 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.696 HE21 ' HE1' ' A' ' 46' ' ' TRP . 14.9 pt20 -141.07 157.73 44.9 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.164 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -121.77 139.95 52.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.454 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.8 mt -119.41 123.42 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.806 -0.442 . . . . 1.0 109.806 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -96.29 122.1 38.8 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.889 0.376 . . . . 1.0 110.567 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 86.2 mt -102.64 129.98 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.212 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.533 HE22 ' CD1' ' A' ' 61' ' ' LEU . 1.1 tm0? -119.1 134.62 55.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.131 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 60' ' ' GLU . 0.3 OUTLIER -100.67 157.62 16.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.583 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.533 ' CD1' HE22 ' A' ' 59' ' ' GLN . 1.4 mt -146.18 178.42 8.24 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.106 0.479 . . . . 1.0 110.345 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 58.59 39.59 24.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.385 -0.825 . . . . 1.0 110.5 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -81.19 125.88 30.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.382 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -68.84 -30.78 69.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.106 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -162.39 156.95 18.83 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.556 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.64 -33.04 57.19 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.608 1.539 . . . . 1.0 112.295 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.51 -10.35 58.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.507 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.66 135.47 44.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.342 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.8 mt -78.15 148.35 34.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.51 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.68 132.82 14.65 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -77.74 -15.51 59.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.046 0.451 . . . . 1.0 110.806 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.0 t -111.09 119.64 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.682 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.6 mt -115.59 131.91 56.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.539 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.4 mt -102.53 122.33 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.838 0.351 . . . . 1.0 110.443 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.1 t -142.36 133.82 25.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.29 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 56.32 41.24 29.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.681 0.277 . . . . 1.0 111.124 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.36 13.72 5.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.91 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -120.66 151.85 38.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.983 0.421 . . . . 1.0 109.944 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -101.1 126.07 47.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.982 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.538 ' CE1' ' OE2' ' A' ' 89' ' ' GLU . 95.9 m-85 -120.75 139.13 53.53 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.186 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -85.71 -30.42 23.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.584 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 51.4 t0 -123.86 141.65 51.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.01 0.433 . . . . 1.0 111.842 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.4 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 56.6 tp -65.46 -39.9 92.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.584 -0.735 . . . . 1.0 111.147 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.48 -40.19 90.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.727 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -59.7 -39.64 85.23 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.799 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.44 -46.12 97.17 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 CA-C-O 120.898 0.38 . . . . 1.0 110.955 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 64.8 mt -62.73 -46.07 97.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.976 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.4 t -69.87 -43.58 79.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.81 0.671 . . . . 1.0 112.81 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.538 ' OE2' ' CE1' ' A' ' 80' ' ' TYR . 9.1 pt-20 -80.68 -12.07 59.54 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.523 -0.471 . . . . 1.0 111.666 -177.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.589 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 64.4 t80 -94.19 -49.11 5.89 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.636 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.37 -42.1 72.21 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.348 -0.541 . . . . 1.0 112.118 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -63.9 -49.08 74.08 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.041 -0.664 . . . . 1.0 111.565 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -69.12 -42.77 75.61 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.618 -0.433 . . . . 1.0 111.522 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.589 ' NZ ' ' CE1' ' A' ' 90' ' ' TYR . 15.9 mmtp -65.81 -42.32 90.78 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.39 -0.524 . . . . 1.0 111.228 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.41 -46.5 89.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.527 -0.469 . . . . 1.0 111.183 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -68.09 -44.02 77.21 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.615 -0.434 . . . . 1.0 111.6 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.2 tp -67.71 -41.64 83.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.267 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.7 tp -65.35 -42.92 92.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.193 -0.603 . . . . 1.0 110.217 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.538 ' OD1' ' NH2' ' A' ' 27' ' ' ARG . 99.2 m-20 -68.04 -36.95 80.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.244 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -71.82 -42.89 66.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 111.892 0.33 . . . . 1.0 111.892 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.413 ' HB2' ' HH ' ' A' ' 168' ' ' TYR . 4.5 tpt -66.03 -53.8 33.98 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.213 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.464 ' C ' ' H ' ' A' ' 104' ' ' SER . 53.8 m -60.14 -36.12 76.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.593 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.9 t -71.07 9.49 0.71 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.879 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 102' ' ' THR . 32.0 t -91.52 134.32 34.75 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 110.001 -0.37 . . . . 1.0 110.001 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -58.59 -19.21 36.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.983 0.42 . . . . 1.0 110.823 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.557 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 60.4 mttp -90.14 39.91 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.785 -0.643 . . . . 1.0 109.798 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -132.85 120.42 21.51 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.535 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.59 124.02 15.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.142 -0.481 . . . . 1.0 109.906 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.3 m -100.17 86.66 3.27 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.734 0.302 . . . . 1.0 110.968 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.16 163.63 12.12 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.924 -0.87 . . . . 1.0 110.924 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.458 ' CB ' ' HZ2' ' A' ' 113' ' ' LYS . 61.6 p -77.65 169.52 18.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -58.6 -38.59 78.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.912 0.387 . . . . 1.0 110.561 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.458 ' HZ2' ' CB ' ' A' ' 111' ' ' THR . 25.0 pttm -69.27 -39.53 78.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.654 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -70.08 -24.46 63.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.874 -0.603 . . . . 1.0 111.154 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.65 -45.5 73.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.509 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 82.6 t -63.67 -46.66 94.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.106 0.479 . . . . 1.0 110.445 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -66.04 -37.42 85.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.085 0.469 . . . . 1.0 110.896 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -67.11 -49.24 65.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.751 -0.659 . . . . 1.0 111.763 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.1 tp -69.84 -40.0 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.55 -0.46 . . . . 1.0 110.47 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -65.44 -41.64 93.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.806 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -63.82 -48.17 77.91 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.448 -0.501 . . . . 1.0 110.297 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -60.45 -44.57 95.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.007 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 81.2 p -66.25 -28.6 68.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.038 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -63.96 -43.87 94.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.337 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.7 t -66.82 -41.76 88.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.298 -0.41 . . . . 1.0 109.938 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -122.02 75.43 39.38 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.561 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -71.3 -13.51 30.81 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.662 2.241 . . . . 1.0 112.34 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -106.2 24.87 11.76 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.642 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -141.13 151.72 44.14 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.86 0.362 . . . . 1.0 110.743 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 86.5 p -80.78 160.81 24.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.119 -0.491 . . . . 1.0 109.841 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.6 p -153.97 144.86 14.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.597 -0.52 . . . . 1.0 109.597 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 19.0 p90 -153.33 143.61 22.36 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.691 -0.404 . . . . 1.0 111.104 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -152.57 169.71 21.97 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.355 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.6 p90 -136.77 156.12 48.93 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 28.8 t -148.55 169.5 20.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.322 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.4 tp -74.59 146.46 42.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.483 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 138' ' ' HIS . 28.1 t-20 -42.74 147.96 0.27 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.539 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.43 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 92.5 m-70 -60.05 -50.24 74.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.018 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 139' ' ' ASP . 25.7 p-10 -156.7 44.09 0.39 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.536 -0.302 . . . . 1.0 110.629 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.412 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 73.3 m-20 -160.26 84.32 2.07 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.31 144.86 92.28 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.699 1.599 . . . . 1.0 112.671 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.401 ' C ' ' CD1' ' A' ' 143' ' ' TRP . . . 142.93 -39.25 1.35 Allowed Glycine 0 C--O 1.226 -0.382 0 N-CA-C 110.887 -0.885 . . . . 1.0 110.887 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.534 ' CD1' ' N ' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -134.95 153.89 51.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.812 0.339 . . . . 1.0 110.188 -179.353 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -102.36 156.97 17.24 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -113.37 134.9 54.39 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.093 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.3 mt -110.55 126.17 54.12 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.436 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.62 142.98 51.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.644 -1.243 . . . . 1.0 107.644 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -159.43 160.25 34.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.781 -0.451 . . . . 1.0 109.781 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -138.57 128.63 25.48 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.858 0.361 . . . . 1.0 110.686 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.8 mp -72.43 -44.98 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.787 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -160.83 174.0 14.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.729 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.38 -32.81 73.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.784 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -83.68 -13.15 54.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.143 0.496 . . . . 1.0 110.376 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t -80.09 157.15 26.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.473 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -90.28 157.37 17.7 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.989 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 30.8 tp -76.57 121.66 23.49 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.087 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -108.32 136.39 48.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.743 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 99.8 m -128.98 132.33 47.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.905 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -123.37 161.89 23.82 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.803 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -109.72 151.79 26.47 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.796 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 67.8 t -127.78 134.18 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -97.54 132.35 43.3 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.027 0.442 . . . . 1.0 111.061 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.4 tp -92.23 130.28 37.97 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.727 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.497 ' C ' ' H ' ' A' ' 166' ' ' THR . 65.7 p -129.58 157.35 42.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.339 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -73.45 15.21 0.26 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.645 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.497 ' H ' ' C ' ' A' ' 164' ' ' THR . 19.3 p -121.46 -2.43 9.48 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.775 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.51 -135.49 7.06 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.477 -1.049 . . . . 1.0 110.477 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.413 ' HH ' ' HB2' ' A' ' 101' ' ' MET . 36.8 m-85 -118.9 131.68 56.06 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.551 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 5.9 m-85 -109.33 118.7 37.38 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.8 tt -109.29 121.3 44.87 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.465 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 5.0 t 34.93 59.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.467 0.543 . . . . 1.0 112.467 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 63.26 27.54 15.51 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.981 0.734 . . . . 1.0 112.981 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.465 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 79.3 m-85 -132.75 121.88 23.71 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.303 -0.628 . . . . 1.0 109.303 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.551 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 8.3 t-20 -91.15 133.4 35.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.391 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -115.65 131.88 23.44 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.903 -0.589 . . . . 1.0 109.462 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.66 -21.33 19.26 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.171 1.914 . . . . 1.0 113.443 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 73.4 m -147.99 150.99 35.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.928 0.394 . . . . 1.0 111.25 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.94 -36.3 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.833 -0.622 . . . . 1.0 110.857 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.511 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 46.6 mm -60.95 -45.98 97.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 1.0 110.066 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -65.82 -32.3 73.76 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.1 tp -63.95 -42.31 97.35 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.465 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . 0.611 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 5.1 p -60.99 -47.88 84.39 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.632 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.611 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 36.3 t30 -66.71 -48.51 69.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.744 -0.783 . . . . 1.0 108.983 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.57 -45.01 0.95 Allowed Glycine 0 N--CA 1.462 0.374 0 N-CA-C 109.907 -1.277 . . . . 1.0 109.907 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -68.89 -47.48 65.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 183' ' ' ASN . 36.4 ttpt -56.66 -39.53 73.91 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.544 -0.753 . . . . 1.0 109.982 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 19.9 m -60.58 -45.94 92.09 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.459 ' O ' ' OG ' ' A' ' 191' ' ' SER . 75.8 mt -63.73 -39.42 94.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.865 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.6 tp -58.88 -43.31 90.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.903 0.383 . . . . 1.0 110.458 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -59.09 -45.71 90.17 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.527 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 188' ' ' LEU . 77.6 p -61.79 -36.89 82.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.167 0.508 . . . . 1.0 110.619 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.8 mt -69.47 -39.44 77.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.381 -0.827 . . . . 1.0 111.954 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -62.46 -29.17 70.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.892 0.33 . . . . 1.0 111.892 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 . . . . . 0 C--N 1.325 -0.492 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.907 -179.592 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 . . . . . 0 N--CA 1.464 0.258 0 CA-C-O 120.928 0.394 . . . . 1.0 110.817 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.1 p -64.46 -30.48 50.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.532 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.1 pt -71.01 -15.23 18.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.515 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -94.21 -0.1 55.38 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.44 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.73 140.67 59.08 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.217 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.13 -21.39 62.74 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.111 1.874 . . . . 1.0 112.116 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.451 ' CE1' ' CZ ' ' A' ' 30' ' ' PHE . 24.5 m-85 -92.24 10.16 30.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.202 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 79.0 t80 -84.47 128.07 34.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.423 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 64.2 m-85 -150.89 114.78 3.18 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 110.154 -0.313 . . . . 1.0 110.154 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.91 110.09 3.01 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.743 1.629 . . . . 1.0 112.919 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -155.53 153.77 30.73 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.539 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.473 ' ND2' ' H ' ' A' ' 15' ' ' GLY . 11.2 t-20 -77.68 164.45 25.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.473 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -57.84 -42.73 94.77 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.207 -0.997 . . . . 1.0 110.948 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -66.31 -42.96 87.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.745 0.307 . . . . 1.0 110.963 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -67.86 -33.82 75.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.277 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.43 -43.01 97.23 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.257 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -58.61 -42.29 87.85 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.582 -0.447 . . . . 1.0 109.992 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -62.21 -46.52 88.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.503 . . . . 1.0 110.287 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -60.18 -40.95 91.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.446 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.34 -13.59 60.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.952 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -58.49 -43.85 89.17 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.403 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.4 t -76.43 -19.44 58.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.718 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -83.28 177.05 8.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.527 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.6 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 52.2 mp0 -105.3 -176.93 3.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.738 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -74.92 144.69 43.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.828 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.51 -0.34 61.4 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.219 -0.753 . . . . 1.0 111.219 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -83.88 144.3 29.31 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CZ ' ' CE1' ' A' ' 9' ' ' TYR . 16.8 p90 -136.73 165.58 25.58 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.177 0.513 . . . . 1.0 110.971 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.3 t -146.98 156.58 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.087 -0.961 . . . . 1.0 111.67 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 91.6 mt -117.3 124.19 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -152.02 153.17 33.48 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.336 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -108.41 152.19 25.01 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.917 -0.401 . . . . 1.0 109.917 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 t -82.36 145.19 30.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.843 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 m -59.02 -39.07 80.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.664 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -95.41 6.95 47.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.792 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.547 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -86.97 -79.75 1.22 Allowed Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.572 -1.011 . . . . 1.0 110.572 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 t70 68.8 -38.89 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 1.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.547 ' H ' ' C ' ' A' ' 38' ' ' GLY . 36.5 t70 -104.11 2.44 31.99 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.828 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -143.82 153.62 42.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.946 0.403 . . . . 1.0 110.283 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.12 148.8 42.66 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.952 -0.567 . . . . 1.0 109.752 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.21 132.46 71.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.221 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.8 mt -111.7 138.36 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 108.949 -0.76 . . . . 1.0 108.949 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 87.9 m -120.73 138.7 53.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.575 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.754 ' HE1' ' NE2' ' A' ' 54' ' ' GLN . 2.9 p-90 -153.91 148.11 25.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.884 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.495 ' HZ2' ' C ' ' A' ' 49' ' ' ASP . 64.1 tttm -88.93 141.19 28.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.128 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.2 mt -98.76 -68.06 0.82 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.072 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.495 ' C ' ' HZ2' ' A' ' 47' ' ' LYS . 38.2 t0 -136.11 171.22 14.79 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.186 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -46.64 130.58 11.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.986 0.422 . . . . 1.0 110.897 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 56.37 39.82 29.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.06 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.8 tp -149.01 122.38 9.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.784 0.326 . . . . 1.0 110.443 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -135.56 149.92 49.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.568 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.754 ' NE2' ' HE1' ' A' ' 46' ' ' TRP . 6.7 pt20 -139.43 156.49 46.93 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.958 -0.564 . . . . 1.0 109.823 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -125.41 142.28 51.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.301 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 83.1 mt -120.48 122.84 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -93.98 120.83 34.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.877 0.37 . . . . 1.0 110.496 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 92.6 mt -100.84 128.96 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.422 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -112.29 141.78 45.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.171 -0.468 . . . . 1.0 109.781 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -98.73 152.79 19.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 1.0 109.988 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.495 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 2.9 tp -141.56 165.49 27.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.696 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.495 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 72.6 tt0 66.04 48.61 1.72 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.41 0.624 . . . . 1.0 109.719 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.418 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 32.5 pttt -102.44 107.81 18.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.988 -0.551 . . . . 1.0 109.945 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -67.26 -25.19 65.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.857 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -159.23 158.22 28.2 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.214 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.96 -34.39 56.22 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.213 1.942 . . . . 1.0 112.074 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.441 ' CD2' ' H ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -85.49 -10.24 56.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.688 -179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.67 145.12 55.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.299 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.7 mt -77.81 151.84 33.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.371 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.22 91.25 1.13 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.673 -0.971 . . . . 1.0 110.673 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -63.78 -32.36 73.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.037 0.446 . . . . 1.0 110.596 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.7 t -125.26 124.18 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.787 -0.642 . . . . 1.0 111.051 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.13 131.07 57.04 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.0 mt -100.22 120.93 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.899 0.381 . . . . 1.0 110.179 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -141.59 132.54 26.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.235 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 56.15 43.11 27.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.717 0.294 . . . . 1.0 111.025 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.4 t30 59.27 15.9 4.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.779 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -121.68 146.52 46.93 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.228 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -99.57 126.26 45.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.644 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -125.06 137.33 54.21 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.028 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -85.75 -38.49 18.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.831 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -105.3 135.33 46.87 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.127 0.489 . . . . 1.0 111.935 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 58.2 tp -63.81 -41.93 97.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.571 -0.74 . . . . 1.0 110.672 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -60.27 -42.44 95.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 1.0 111.92 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -60.98 -37.24 81.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.762 0.315 . . . . 1.0 110.644 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.01 -44.92 99.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.564 -0.454 . . . . 1.0 110.551 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 87' ' ' ILE . 40.4 mm -62.92 -44.78 99.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.449 -0.5 . . . . 1.0 111.35 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.492 ' O ' ' CG ' ' A' ' 92' ' ' GLN . 79.7 t -67.49 -45.67 84.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 112.723 0.638 . . . . 1.0 112.723 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.06 -19.38 61.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.739 0.304 . . . . 1.0 111.76 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -93.59 -50.73 5.27 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.353 -0.539 . . . . 1.0 111.781 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.6 -43.64 84.31 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.382 0.512 . . . . 1.0 112.382 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.492 ' CG ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -65.75 -41.9 91.58 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.098 -0.641 . . . . 1.0 111.455 -177.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.414 ' H ' ' HG3' ' A' ' 92' ' ' GLN . 8.9 t-20 -70.94 -44.12 66.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.304 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -65.9 -41.99 90.77 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.239 -0.585 . . . . 1.0 111.154 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.0 t -65.53 -44.51 94.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.363 -0.535 . . . . 1.0 111.114 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.501 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -66.56 -46.96 74.32 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.569 -0.453 . . . . 1.0 111.706 -178.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 tp -69.78 -41.13 75.54 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.717 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.1 tp -61.61 -44.63 96.63 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.344 -0.542 . . . . 1.0 110.565 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.505 ' OD1' ' C ' ' A' ' 99' ' ' ASN . 1.1 p30 -70.0 -35.97 74.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.154 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.454 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 44.2 tt0 -71.37 -43.81 66.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.564 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 5.5 ttt -66.93 -55.08 16.15 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.575 -0.45 . . . . 1.0 111.63 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 104' ' ' SER . 52.6 m -57.82 -37.99 74.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.071 0.462 . . . . 1.0 110.639 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 41.4 t -72.33 10.36 0.81 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.636 -0.711 . . . . 1.0 110.999 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 101' ' ' MET . 78.1 p -92.91 135.46 34.13 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.565 -0.288 . . . . 1.0 110.454 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.59 -16.72 40.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.567 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 24.2 mmtp -93.82 38.46 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 1.0 109.808 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -132.04 111.83 11.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.284 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -131.06 114.0 14.63 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.7 p -89.67 88.97 7.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.001 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.79 156.32 15.71 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.8 p -75.05 169.58 17.73 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -57.28 -38.32 73.75 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.841 -0.343 . . . . 1.0 110.415 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -68.49 -42.94 77.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.356 0.598 . . . . 1.0 110.933 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 51.6 t0 -68.09 -21.78 64.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.411 -0.813 . . . . 1.0 110.89 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.4 t -71.63 -43.33 71.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.767 0.317 . . . . 1.0 110.198 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.83 -47.13 92.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.09 0.471 . . . . 1.0 110.409 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -65.66 -38.24 88.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.076 0.465 . . . . 1.0 110.851 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -65.02 -49.81 68.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.821 -0.627 . . . . 1.0 111.76 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.6 tp -70.26 -39.49 76.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.866 0.365 . . . . 1.0 110.571 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.513 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 63.7 mm-40 -62.67 -42.75 99.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.553 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -61.14 -47.68 85.12 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.574 -0.45 . . . . 1.0 110.279 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -61.12 -39.7 91.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.77 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 120' ' ' GLU . 59.5 p -60.16 -38.59 83.63 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.404 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -62.46 -40.32 96.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.258 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.03 -42.69 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.657 -0.498 . . . . 1.0 109.657 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.74 75.67 79.4 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.2 178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.31 -23.43 44.73 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.75 2.3 . . . . 1.0 112.53 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -95.89 -9.75 30.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.146 -0.479 . . . . 1.0 112.028 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -107.29 149.83 27.35 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.977 0.418 . . . . 1.0 110.379 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.415 ' H ' ' HG ' ' A' ' 130' ' ' SER . 14.9 p -80.83 162.81 23.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.757 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 p -152.37 147.55 14.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.489 ' O ' ' CD1' ' A' ' 133' ' ' TYR . 28.7 p90 -149.39 142.61 25.08 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.789 0.328 . . . . 1.0 111.118 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 29.7 m-85 -151.75 169.2 22.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.306 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.567 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -133.83 152.62 51.93 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 179.19 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 72.3 m -152.11 170.16 20.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.419 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.0 tp -80.94 145.2 31.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.839 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 4.3 p30 -53.85 -171.89 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.179 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.463 ' CG ' ' O ' ' A' ' 138' ' ' HIS . 35.4 t-80 -135.31 35.2 3.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.531 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -169.63 -53.89 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.67 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.52 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 21.3 t-20 -105.16 86.69 1.67 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.099 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.61 100.76 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.077 1.851 . . . . 1.0 112.316 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.497 ' H ' HD22 ' A' ' 137' ' ' ASN . . . 169.55 -36.3 0.19 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.517 -1.033 . . . . 1.0 110.517 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.407 ' CD1' ' N ' ' A' ' 143' ' ' TRP . 21.5 m95 -98.7 144.7 27.67 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 110.04 -0.356 . . . . 1.0 110.04 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 61.7 m-85 -107.42 149.6 27.71 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.173 -0.467 . . . . 1.0 109.778 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.405 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 32.3 m-85 -120.41 137.68 54.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.394 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt -110.04 121.01 44.26 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.318 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.553 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -116.41 145.89 42.91 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 178.402 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -159.69 155.26 25.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.513 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 64.5 tttt -141.36 129.61 22.27 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.752 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.438 HG23 HD13 ' A' ' 150' ' ' ILE . 41.5 mm -71.15 -46.48 66.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.875 -0.33 . . . . 1.0 111.725 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 151' ' ' ASN . 7.6 p-10 -162.24 177.88 9.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.35 . . . . 1.0 110.589 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.29 -32.89 74.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.067 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -84.45 7.59 19.22 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.018 0.437 . . . . 1.0 110.713 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.5 t -104.99 158.4 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.08 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -88.88 162.46 16.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.91 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.6 tp -80.38 118.94 22.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.982 0.42 . . . . 1.0 110.281 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -105.27 132.86 50.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.738 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 87.0 m -130.6 130.46 44.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.847 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -116.35 161.09 19.58 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.075 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.405 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 78.0 m-20 -107.2 144.68 33.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.739 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.8 t -126.57 136.7 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -99.62 130.41 45.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.912 0.387 . . . . 1.0 110.759 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.8 tp -92.36 130.8 37.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.032 -0.531 . . . . 1.0 109.66 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.3 p -129.73 165.76 21.24 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.0 0.429 . . . . 1.0 110.35 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -79.23 15.72 1.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.628 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 20.0 p -122.27 -2.31 9.08 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.802 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.56 -131.87 5.19 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.419 -1.072 . . . . 1.0 110.419 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.403 ' HH ' ' HB2' ' A' ' 101' ' ' MET . 17.2 m-85 -122.85 130.55 53.02 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.077 -0.342 . . . . 1.0 110.077 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.629 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 5.7 m-85 -107.52 121.71 45.19 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.821 -0.437 . . . . 1.0 109.821 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.8 tt -114.38 119.1 35.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.711 -0.477 . . . . 1.0 109.711 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.5 t 36.16 57.92 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 112.166 0.432 . . . . 1.0 112.166 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 14.5 m120 65.27 27.17 12.16 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.045 0.757 . . . . 1.0 113.045 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -133.95 119.95 19.72 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 8.1 t-20 -93.67 129.03 40.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 1.0 111.226 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -107.77 101.39 40.13 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -45.91 -23.49 1.72 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.489 2.126 . . . . 1.0 113.33 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.96 146.66 37.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 1.0 111.009 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.47 -33.42 56.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.92 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.87 -44.2 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.278 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -69.7 -30.34 67.96 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.5 -0.555 . . . . 1.0 109.5 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.29 -43.08 98.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.281 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 93.5 m -63.7 -46.49 85.24 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.336 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 186' ' ' LYS . 75.9 m-20 -65.19 -48.82 72.07 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.09 -45.68 0.89 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -68.92 -45.91 69.64 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 183' ' ' ASN . 36.6 tptt -57.14 -40.88 78.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.455 -0.793 . . . . 1.0 109.902 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 16.5 m -59.71 -46.7 88.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.1 -40.32 95.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.826 -0.624 . . . . 1.0 109.881 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 59.3 tp -57.87 -45.7 85.94 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.647 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -54.83 -45.65 74.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.167 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.7 t -62.25 -40.75 97.22 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.161 0.505 . . . . 1.0 110.34 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.41 -37.02 86.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.761 -0.654 . . . . 1.0 111.974 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -58.33 -30.14 66.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.622 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 24.8 m80 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.92 -179.296 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.557 ' HG1' ' H ' ' A' ' 2' ' ' HIS . 2.7 t . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.557 ' H ' ' HG1' ' A' ' 1' ' ' THR . 51.6 t-80 58.87 5.27 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.538 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.461 ' H ' ' C ' ' A' ' 1' ' ' THR . 80.9 mtp85 -135.82 1.8 2.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.558 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.46 -27.47 41.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.565 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 13.3 pt -67.78 -40.77 84.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.435 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -107.2 14.01 26.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.432 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -46.97 145.97 2.99 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.422 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -49.98 -36.22 43.51 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.671 1.581 . . . . 1.0 112.226 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.61 ' CD2' ' CZ ' ' A' ' 30' ' ' PHE . 80.2 m-85 -82.7 -1.56 51.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.385 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.531 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 42.2 t80 -72.32 129.61 38.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.34 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 54.0 m-85 -148.69 115.92 3.85 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 120.9 -0.32 . . . . 1.0 110.43 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.477 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 73.1 Cg_endo -74.76 109.88 3.0 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.754 1.636 . . . . 1.0 112.703 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 76.5 m-85 -155.33 159.4 39.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.525 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -77.16 172.16 13.68 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.422 ' O ' ' OE2' ' A' ' 19' ' ' GLU . . . -61.67 -46.84 93.42 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.446 -0.883 . . . . 1.0 111.108 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.613 ' HE ' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -66.06 -41.52 90.69 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 121.038 -0.265 . . . . 1.0 111.164 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -66.09 -35.66 81.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.279 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.84 -44.98 96.25 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.308 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.544 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -65.78 -41.97 91.37 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.034 179.135 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.46 -41.64 97.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.212 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -63.07 -39.47 94.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.54 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.2 mp -79.57 -13.26 59.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.723 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -63.57 -42.95 98.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.731 -0.388 . . . . 1.0 110.47 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.0 t -76.65 -20.33 56.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.79 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -84.17 177.55 8.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.456 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -89.2 176.33 7.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.863 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -76.32 147.57 38.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.974 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.46 19.67 37.49 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -99.73 140.79 33.42 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.61 ' CZ ' ' CD2' ' A' ' 9' ' ' TYR . 7.1 p90 -134.68 168.56 18.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.338 0.589 . . . . 1.0 111.11 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -147.32 158.25 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.251 -0.886 . . . . 1.0 111.498 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -116.87 129.17 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -138.74 157.85 45.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.418 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -115.63 135.51 53.99 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.859 -0.423 . . . . 1.0 109.859 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.1 t -95.27 126.74 40.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.764 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 96.5 p -59.59 -37.68 79.18 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.598 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.3 -24.37 62.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.874 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -75.37 -63.24 2.54 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.689 -0.964 . . . . 1.0 110.689 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 t0 73.66 -40.19 0.46 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.694 0.283 . . . . 1.0 110.803 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 38' ' ' GLY . 92.3 m-20 -118.91 11.08 12.45 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.748 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -138.7 150.73 46.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.929 0.395 . . . . 1.0 110.205 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.04 154.19 33.51 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.064 -0.516 . . . . 1.0 109.727 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.7 t -124.39 130.01 73.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 1.0 110.079 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.7 mt -112.97 139.21 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.7 m -118.68 140.04 50.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.928 -0.578 . . . . 1.0 109.455 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -144.01 159.58 42.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.515 -0.766 . . . . 1.0 111.001 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.582 ' NZ ' ' O ' ' A' ' 50' ' ' LYS . 36.2 tttp -107.28 138.54 43.28 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.89 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.596 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 3.2 mp -95.85 -74.23 0.56 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.371 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 50' ' ' LYS . 66.9 t0 -159.66 140.08 12.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.336 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.582 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 2.9 ttmm 43.81 -152.92 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.083 0.468 . . . . 1.0 111.183 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.74 63.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.836 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 50' ' ' LYS . 17.2 tp -145.68 120.75 10.09 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.977 0.418 . . . . 1.0 110.278 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -134.18 149.16 51.0 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.36 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -137.97 153.49 49.44 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.76 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.479 ' ND1' ' N ' ' A' ' 55' ' ' HIS . 1.9 p-80 -126.61 142.37 51.56 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.153 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.5 mt -126.06 131.7 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -94.27 120.53 34.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.028 0.442 . . . . 1.0 110.726 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.1 mm -90.47 128.0 42.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.083 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 60' ' ' GLU . 3.4 tm0? -113.71 128.9 56.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.042 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.52 ' O ' ' NE2' ' A' ' 59' ' ' GLN . 1.9 pp20? -101.17 148.6 24.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.276 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 1.9 tt -142.66 173.1 11.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.475 -0.329 . . . . 1.0 110.919 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 2.0 tm-20 82.07 25.2 0.19 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.383 0.611 . . . . 1.0 110.05 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.643 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -80.49 117.1 20.92 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.794 0.807 . . . . 1.0 110.122 178.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -89.66 -33.43 16.64 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.834 -0.541 . . . . 1.0 110.539 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.05 165.4 18.0 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.073 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.5 -29.7 60.93 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.162 1.908 . . . . 1.0 112.242 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.9 mt -90.02 -1.35 57.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.535 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.25 134.45 34.87 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.278 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.4 mt -89.86 147.09 23.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.375 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.2 104.86 1.5 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -75.64 -13.43 60.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.772 0.32 . . . . 1.0 110.781 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.8 t -123.54 124.41 69.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.771 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.6 mt -117.07 133.32 56.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.52 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mp -102.41 124.61 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.825 0.345 . . . . 1.0 110.076 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -143.03 133.17 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.551 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.498 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 46.7 t0 53.44 46.49 26.13 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.985 -0.286 . . . . 1.0 111.046 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 76' ' ' ASP . 4.1 p30 56.75 18.68 3.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.977 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -125.12 147.26 49.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 1.0 110.135 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.86 127.92 44.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.224 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -120.46 139.91 52.16 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.18 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -84.51 -36.99 21.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.73 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -119.52 144.2 47.16 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.202 0.525 . . . . 1.0 111.989 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.7 tp -64.77 -39.38 93.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.764 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -60.19 -42.75 95.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 1.0 111.562 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -60.68 -37.87 83.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.58 0.229 . . . . 1.0 110.67 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.58 -47.41 92.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.901 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.75 -45.22 99.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.525 -0.47 . . . . 1.0 111.658 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.28 -43.29 74.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 112.626 0.602 . . . . 1.0 112.626 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -74.73 -15.81 60.76 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.721 -0.392 . . . . 1.0 111.862 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -94.8 -49.44 5.59 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.651 -0.419 . . . . 1.0 111.953 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.15 -40.35 78.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.228 0.455 . . . . 1.0 112.228 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -63.38 -49.2 74.74 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.797 -0.761 . . . . 1.0 111.556 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -72.67 -41.7 65.11 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.694 -0.403 . . . . 1.0 111.673 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -66.3 -41.48 89.69 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.334 -0.546 . . . . 1.0 111.389 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.99 -46.7 90.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.251 -0.58 . . . . 1.0 111.355 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -66.34 -44.27 83.78 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.495 -0.482 . . . . 1.0 111.744 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.4 tp -66.94 -43.86 82.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.42 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 tt -64.64 -43.23 94.34 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.302 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -68.11 -35.76 78.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.859 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -70.69 -41.86 71.45 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 120.776 -0.37 . . . . 1.0 111.777 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.598 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 5.2 ttt -67.81 -54.56 18.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.538 -0.465 . . . . 1.0 111.462 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.404 ' C ' ' H ' ' A' ' 104' ' ' SER . 16.8 m -58.45 -41.32 84.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.992 0.425 . . . . 1.0 110.301 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.9 m -72.37 8.09 1.51 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.863 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 101' ' ' MET . 60.2 p -85.6 140.18 30.81 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.823 0.344 . . . . 1.0 110.495 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.63 -22.15 66.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.674 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.55 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 24.8 mtmm -89.22 39.97 0.96 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.983 -0.553 . . . . 1.0 109.778 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -132.14 109.43 9.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.329 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -126.4 129.02 47.95 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.181 -0.463 . . . . 1.0 109.8 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.4 t -93.66 74.99 4.35 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.749 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.45 143.52 15.91 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.027 -0.829 . . . . 1.0 111.027 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 81.1 p -75.12 172.04 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.051 -0.351 . . . . 1.0 110.051 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -57.51 -41.2 80.36 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.419 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -68.48 -45.01 73.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.88 0.372 . . . . 1.0 110.754 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.13 -20.51 64.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.865 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.4 t -70.71 -45.52 73.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.808 0.337 . . . . 1.0 110.428 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.5 t -64.45 -45.33 96.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.148 0.499 . . . . 1.0 110.235 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -66.07 -34.3 77.76 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.942 0.401 . . . . 1.0 111.019 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -69.5 -49.2 56.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.999 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.0 tp -69.67 -39.59 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.42 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -65.37 -43.19 91.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.72 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.82 -48.24 77.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.311 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.501 ' CD2' ' OD1' ' A' ' 126' ' ' ASN . 47.1 t80 -62.91 -43.26 99.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.93 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 88.1 p -61.02 -35.38 76.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.226 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -62.36 -42.61 99.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.06 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.9 t -66.67 -30.4 49.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 1.0 109.849 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.501 ' OD1' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -128.21 74.26 79.49 Favored Pre-proline 0 N--CA 1.471 0.59 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.531 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -71.88 -24.53 20.97 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.801 2.334 . . . . 1.0 112.609 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -102.3 14.59 31.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.018 -0.537 . . . . 1.0 112.002 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -137.54 144.93 42.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.117 0.484 . . . . 1.0 110.313 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.1 p -80.89 163.09 23.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.014 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 p -152.21 147.26 15.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -143.39 142.09 31.12 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.895 0.378 . . . . 1.0 111.196 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -152.43 168.46 25.41 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.432 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.55 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.7 OUTLIER -138.1 157.53 46.14 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 179.187 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.8 p -151.61 168.38 25.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.292 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 51.5 tp -80.65 136.86 36.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.821 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 23.8 t-20 -95.12 138.48 32.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.333 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -91.31 -31.66 16.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.714 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.41 -24.55 64.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.235 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 4.5 m120 -141.67 81.0 15.41 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.268 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -58.82 134.55 61.13 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.12 1.88 . . . . 1.0 112.445 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.89 -28.62 14.04 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 110.999 -0.84 . . . . 1.0 110.999 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 10.4 m0 -95.54 147.21 23.8 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.856 0.36 . . . . 1.0 110.284 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.598 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 70.9 m-85 -111.61 149.81 30.97 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.035 -0.53 . . . . 1.0 109.812 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.538 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 14.4 m-85 -120.08 136.13 54.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.22 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 16.5 mt -107.96 124.78 50.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.424 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.58 146.76 46.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.885 -1.154 . . . . 1.0 107.885 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -162.05 152.44 17.12 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.592 -0.522 . . . . 1.0 109.592 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.535 ' NZ ' ' O ' ' A' ' 154' ' ' SER . 37.5 tttp -136.41 129.5 31.29 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.472 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.416 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 4.8 mp -72.49 -46.22 56.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.266 0.469 . . . . 1.0 112.266 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 150' ' ' ILE . 85.2 m-20 -156.95 170.15 23.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.573 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.08 71.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.947 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -89.01 6.68 38.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.433 . . . . 1.0 110.454 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.535 ' O ' ' NZ ' ' A' ' 149' ' ' LYS . 18.0 t -97.31 154.6 17.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.476 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -84.39 145.95 27.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.104 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.5 tp -70.63 126.28 29.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.958 0.409 . . . . 1.0 109.991 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -113.85 132.64 55.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.944 -0.571 . . . . 1.0 109.927 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 97.2 m -129.86 131.28 46.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.818 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.03 163.93 15.87 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.03 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.538 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 58.8 m-20 -111.9 148.85 32.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.695 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.65 137.58 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -100.17 132.36 45.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.98 0.419 . . . . 1.0 110.623 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.9 tp -92.62 131.26 37.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.662 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.0 p -130.38 171.18 13.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.482 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -84.63 15.66 3.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.759 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 2.1 m -122.66 -3.13 8.79 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.96 0.41 . . . . 1.0 110.685 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 141.01 -136.04 7.3 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -117.47 129.08 55.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.641 0.258 . . . . 1.0 110.35 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -106.38 119.84 40.33 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.0 tt -116.68 117.48 29.93 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.403 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.7 t 35.46 56.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.338 0.495 . . . . 1.0 112.338 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.5 m120 69.57 28.15 4.64 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.247 0.832 . . . . 1.0 113.247 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -134.31 121.01 20.63 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -90.83 127.66 36.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.226 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -115.16 91.59 28.17 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.32 -20.04 14.16 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.553 2.168 . . . . 1.0 113.291 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 72.1 m -133.1 138.49 46.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.044 0.45 . . . . 1.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.38 -34.4 60.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.777 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.16 -43.47 96.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -65.17 -34.62 78.83 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.8 tp -64.56 -41.36 96.36 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.389 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 77.8 m -61.29 -47.37 86.27 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 120.559 -0.456 . . . . 1.0 110.616 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 186' ' ' LYS . 62.8 t-20 -69.03 -48.4 63.02 Favored 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 119.647 -0.821 . . . . 1.0 108.915 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.51 -45.48 0.5 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.914 -1.274 . . . . 1.0 109.914 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -68.86 -47.76 65.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.061 -0.57 . . . . 1.0 109.64 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' A' ' 183' ' ' ASN . 47.0 tttp -56.77 -41.29 77.36 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.014 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 18.1 m -63.81 -44.56 92.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.429 ' O ' ' OG ' ' A' ' 191' ' ' SER . 15.4 mt -62.92 -43.28 99.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.006 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.7 tp -59.82 -43.36 94.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.34 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.39 -43.21 99.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.425 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 188' ' ' LEU . 18.2 p -65.49 -37.66 87.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.066 0.46 . . . . 1.0 110.803 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 24.4 mt -64.0 -41.01 97.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.692 -0.686 . . . . 1.0 111.818 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.72 -25.33 68.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.464 -0.334 . . . . 1.0 111.817 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -94.73 -9.58 34.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.656 0.265 . . . . 1.0 110.987 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 46.35 25.84 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.445 -0.343 . . . . 1.0 111.082 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.412 ' O ' ' N ' ' A' ' 198' ' ' HIS . 0.3 OUTLIER -88.15 -6.99 57.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.617 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 51.24 -92.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.558 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.536 ' O ' ' CG ' ' A' ' 199' ' ' HIS . 99.8 m-70 -110.94 -43.51 3.76 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.751 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 198' ' ' HIS . 60.9 m-70 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 118.123 -0.941 . . . . 1.0 110.658 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -93.25 -7.15 45.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.516 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 83.6 mtm-85 -122.79 -5.47 8.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.896 0.379 . . . . 1.0 110.368 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.5 p -64.52 -30.98 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.55 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.6 pt -72.4 -20.96 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.658 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -96.34 7.35 46.68 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.428 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.63 141.23 64.58 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.321 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.76 -21.12 58.7 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.75 1.633 . . . . 1.0 112.181 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.88 3.22 49.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.214 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -83.68 132.4 34.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.569 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -152.41 118.14 3.03 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 120.931 -0.308 . . . . 1.0 110.247 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.49 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 72.5 Cg_endo -74.91 112.04 3.47 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.732 1.621 . . . . 1.0 112.659 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.49 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 70.2 m-85 -159.8 158.21 30.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.399 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -80.09 176.4 9.78 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.45 -50.33 67.74 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.373 -0.917 . . . . 1.0 110.988 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -66.01 -41.36 91.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.764 0.316 . . . . 1.0 110.956 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.412 ' OE1' ' N ' ' A' ' 17' ' ' GLN . 7.4 mp0 -62.8 -37.04 85.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.09 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.87 -44.52 95.9 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.508 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -60.82 -48.18 82.99 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.669 -0.412 . . . . 1.0 109.925 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -61.7 -40.22 94.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.201 -0.454 . . . . 1.0 109.899 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -61.96 -39.31 91.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.243 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.9 mp -82.15 -13.83 56.59 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.846 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.6 ttp85 -65.11 -41.16 95.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.852 0.358 . . . . 1.0 110.336 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.3 m -78.17 -19.86 53.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.875 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -85.12 -179.84 7.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.823 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -81.78 165.49 20.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.813 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -75.75 145.77 40.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.778 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 17.92 49.46 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.982 -0.847 . . . . 1.0 110.982 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -85.16 147.56 26.55 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -129.65 153.38 48.16 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.308 0.575 . . . . 1.0 111.098 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -144.55 153.91 14.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.187 -0.915 . . . . 1.0 111.211 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 32' ' ' ILE . 14.1 mm -115.49 131.19 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -133.74 151.69 51.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.997 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -109.93 130.66 55.5 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.17 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.8 t -82.72 162.82 21.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.579 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.9 p -111.7 -10.97 14.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.717 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -80.79 -30.18 35.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.165 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.656 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . -115.74 -12.14 9.68 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.01 -64.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.978 0.458 . . . . 1.0 110.405 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.656 ' N ' ' O ' ' A' ' 38' ' ' GLY . 24.8 t0 -78.45 12.47 1.96 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.441 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -117.19 142.4 47.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.83 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.25 148.33 44.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.344 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.9 t -123.49 130.2 74.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.781 -0.452 . . . . 1.0 109.781 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.3 mt -110.62 136.88 45.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 94.0 m -118.39 140.98 49.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.536 -0.756 . . . . 1.0 109.344 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -147.94 151.37 35.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.968 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -96.51 140.62 30.87 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.746 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.494 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 9.5 mp -99.57 -68.74 0.79 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.342 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -137.32 -153.19 0.47 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.226 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -68.64 136.46 53.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.667 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 42.08 43.54 2.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.848 -0.615 . . . . 1.0 111.111 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.5 tp -140.44 122.71 15.88 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.942 0.401 . . . . 1.0 109.952 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.432 ' O ' ' OE1' ' A' ' 54' ' ' GLN . 47.8 m-85 -133.22 150.1 51.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.583 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.432 ' OE1' ' O ' ' A' ' 53' ' ' PHE . 16.0 mm100 -138.57 150.22 46.09 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.667 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -125.05 138.9 54.19 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.213 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.7 mt -123.84 129.78 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 41.2 p-10 -95.5 121.03 36.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.934 0.397 . . . . 1.0 111.243 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.3 mm -98.42 122.48 50.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.032 -0.531 . . . . 1.0 109.99 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -117.4 132.28 56.6 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.813 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -98.96 153.64 18.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.342 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.8 tp -145.14 -179.07 6.39 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.567 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 20.5 tt0 70.66 42.89 0.79 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.991 -0.55 . . . . 1.0 109.705 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -83.75 102.22 12.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.78 -0.645 . . . . 1.0 109.844 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.435 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 80.6 mm-40 -68.45 -28.42 67.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.67 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 64' ' ' GLU . 2.6 m-80 -158.01 163.79 23.44 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.226 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.58 -32.04 52.1 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.12 1.88 . . . . 1.0 112.371 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.61 -5.28 57.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.826 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.73 134.28 51.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.327 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.7 mt -83.7 156.19 22.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.379 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.91 86.84 0.05 OUTLIER Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.455 -1.058 . . . . 1.0 110.455 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.27 -39.49 86.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.969 0.414 . . . . 1.0 111.067 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 51.0 t -117.13 123.92 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.768 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.3 mt -116.14 129.3 56.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.243 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.409 HG23 HD12 ' A' ' 74' ' ' ILE . 84.4 mt -101.29 125.67 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -140.91 130.24 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.313 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.426 ' OD1' ' OD1' ' A' ' 165' ' ' ASN . 15.5 t70 53.28 46.4 26.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.231 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.8 m120 57.63 16.03 3.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.895 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -120.63 136.29 54.87 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.948 0.404 . . . . 1.0 110.045 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -89.84 127.59 36.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.738 -0.665 . . . . 1.0 111.102 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -118.27 142.86 47.05 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.199 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -83.45 -37.52 23.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.817 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 50.7 t0 -129.66 153.69 47.87 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.242 0.544 . . . . 1.0 111.819 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.429 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 54.0 tp -63.98 -38.78 92.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.791 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.69 -45.47 89.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.562 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -61.18 -37.31 82.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.687 0.28 . . . . 1.0 110.641 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -58.87 -47.63 88.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.659 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.8 mm -62.99 -44.82 99.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.476 -0.489 . . . . 1.0 111.678 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.85 -43.52 96.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 112.372 0.508 . . . . 1.0 112.372 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -72.96 -21.29 60.89 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.577 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.55 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 2.2 t80 -89.35 -51.29 5.64 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.176 -0.61 . . . . 1.0 111.485 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.3 mp -62.69 -42.69 99.77 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.629 -0.429 . . . . 1.0 111.832 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -63.54 -50.79 68.15 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.691 -0.803 . . . . 1.0 111.446 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -68.94 -42.66 76.41 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.715 -0.394 . . . . 1.0 111.54 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -65.31 -44.32 88.24 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.162 -0.615 . . . . 1.0 111.318 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.3 t -66.53 -44.22 90.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.406 -0.518 . . . . 1.0 111.205 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -67.25 -45.18 77.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.482 -0.327 . . . . 1.0 111.353 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.21 -44.59 91.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.583 -0.281 . . . . 1.0 111.649 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.2 tp -63.56 -40.55 97.28 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.021 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.4 ' O ' ' CB ' ' A' ' 103' ' ' SER . 92.7 m-20 -67.21 -42.42 84.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.77 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -64.38 -43.18 95.27 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 121.983 -0.448 . . . . 1.0 111.545 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.5 ttm -67.63 -56.23 10.21 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.42 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 104' ' ' SER . 20.2 m -59.54 -44.17 93.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.032 0.444 . . . . 1.0 110.815 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 7.6 t -72.99 11.73 0.64 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.68 -0.691 . . . . 1.0 111.298 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 102' ' ' THR . 8.3 t -92.89 135.48 34.11 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.87 0.367 . . . . 1.0 110.248 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.58 -21.14 66.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.942 0.401 . . . . 1.0 111.17 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.537 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 52.9 mttp -89.87 41.09 1.03 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.919 -0.582 . . . . 1.0 109.903 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -133.34 115.25 14.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.2 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -134.43 120.87 20.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.786 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.0 m -90.25 82.44 6.0 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.914 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.76 150.99 17.12 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.848 -0.901 . . . . 1.0 110.848 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.475 ' HG1' ' H ' ' A' ' 114' ' ' ASP . 9.0 p -79.41 173.96 12.05 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.033 -0.358 . . . . 1.0 110.033 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.652 ' HZ3' ' CD2' ' A' ' 138' ' ' HIS . 16.0 mtmm -59.39 -37.6 78.4 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.821 -0.352 . . . . 1.0 110.684 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -68.27 -43.25 78.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.052 0.453 . . . . 1.0 110.562 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.475 ' H ' ' HG1' ' A' ' 111' ' ' THR . 31.4 m-20 -70.63 -19.19 62.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.73 -0.668 . . . . 1.0 111.067 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.2 t -70.74 -45.34 74.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.704 -0.398 . . . . 1.0 110.13 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.99 -45.43 90.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-O 121.333 0.587 . . . . 1.0 110.251 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -65.84 -37.88 87.38 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.931 0.396 . . . . 1.0 111.326 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -69.43 -47.82 62.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.913 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.8 tp -69.64 -39.89 78.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.397 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.472 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 61.1 mm-40 -64.56 -42.76 95.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.728 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.13 -48.16 77.16 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.298 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CD1' ' OD1' ' A' ' 126' ' ' ASN . 30.0 t80 -62.34 -43.76 98.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.137 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.1 t -59.58 -40.4 87.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.096 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -58.48 -42.59 87.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 1.0 109.939 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.0 t -64.03 -37.98 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.445 ' OD1' ' CD1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -124.62 76.83 63.91 Favored Pre-proline 0 N--CA 1.473 0.704 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.351 179.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.487 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 7.1 Cg_exo -71.17 -27.29 20.2 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.634 2.223 . . . . 1.0 112.621 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -100.51 11.33 39.69 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.885 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -131.46 146.22 52.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.188 0.518 . . . . 1.0 110.433 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.8 m -80.83 163.52 23.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.537 -0.756 . . . . 1.0 109.913 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 p -151.24 145.65 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -145.89 142.24 28.59 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.912 0.387 . . . . 1.0 111.112 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -152.47 167.8 27.6 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.347 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -132.2 156.31 46.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 179.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.5 p -152.93 169.64 22.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.447 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 137' ' ' ASN . 54.0 tp -77.04 136.33 38.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.546 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.536 ' OD1' ' ND2' ' A' ' 140' ' ' ASN . 11.0 t-20 -44.08 170.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.403 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.652 ' CD2' ' HZ3' ' A' ' 112' ' ' LYS . 57.1 t-80 -77.26 -56.45 4.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.038 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 139' ' ' ASP . 66.5 t0 -139.6 45.25 1.93 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.981 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.536 ' ND2' ' OD1' ' A' ' 137' ' ' ASN . 1.3 m-80 -136.87 102.47 9.29 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 109.905 -0.405 . . . . 1.0 109.905 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -75.19 120.59 6.07 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.944 1.762 . . . . 1.0 112.608 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.16 20.68 22.57 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.886 -0.886 . . . . 1.0 110.886 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -134.44 139.86 45.83 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.873 0.368 . . . . 1.0 110.281 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -132.5 160.04 37.65 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.841 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 145' ' ' TYR . 8.1 p90 -142.11 146.94 35.95 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.2 mt -106.36 126.57 52.41 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.136 0.493 . . . . 1.0 110.366 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -116.86 144.83 44.05 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.928 -1.138 . . . . 1.0 107.928 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 148' ' ' PHE . 13.3 p90 -162.8 154.19 17.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.549 -0.538 . . . . 1.0 109.549 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.472 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 69.2 tttt -135.13 131.13 36.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.468 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.486 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 38.6 mm -72.41 -45.61 59.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.994 0.368 . . . . 1.0 111.994 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 27.8 m120 -161.61 173.06 15.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.577 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.52 -34.44 75.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.071 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.75 -12.96 55.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.588 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.4 t -79.82 158.71 26.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.32 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -89.77 150.58 22.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 1.0 109.98 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.6 tp -71.07 124.75 25.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.872 0.368 . . . . 1.0 110.211 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -110.91 129.3 55.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.667 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 91.1 m -131.24 131.43 43.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.114 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.75 166.15 13.13 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -107.97 142.45 38.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.114 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.5 t -122.3 138.29 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -106.01 135.15 47.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.034 0.445 . . . . 1.0 110.742 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.6 131.69 45.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.688 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.2 p -134.83 178.01 7.34 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.349 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.55 ' ND2' ' CE1' ' A' ' 90' ' ' TYR . 5.3 m120 -86.78 14.59 6.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.717 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 17.9 p -119.01 -1.12 11.01 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.483 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.74 -131.35 5.84 Favored Glycine 0 N--CA 1.465 0.59 0 N-CA-C 110.25 -1.14 . . . . 1.0 110.25 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -121.8 127.28 50.42 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -102.29 123.83 46.79 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.4 tt -117.96 111.79 19.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.519 -0.549 . . . . 1.0 109.519 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.5 t 35.94 59.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.175 0.435 . . . . 1.0 112.175 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.8 m120 69.4 27.52 4.97 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.98 0.733 . . . . 1.0 112.98 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -134.13 120.59 20.32 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -95.91 126.68 41.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.238 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -108.9 99.29 34.21 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 109.573 -0.528 . . . . 1.0 109.573 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.15 -21.57 9.51 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.382 2.055 . . . . 1.0 113.444 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 38.5 m -132.92 139.07 47.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.041 0.448 . . . . 1.0 111.253 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.96 -35.61 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.617 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.516 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 95.4 mt -63.32 -43.36 98.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 1.0 110.054 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.639 ' N ' ' NE2' ' A' ' 180' ' ' GLN . 0.6 OUTLIER -63.11 -31.46 72.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.224 -0.658 . . . . 1.0 109.224 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.78 -41.9 97.86 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.327 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.63 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 3.0 p -58.96 -47.98 83.15 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.617 -0.433 . . . . 1.0 110.629 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.63 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 48.3 t30 -69.52 -48.91 58.95 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.44 -44.78 0.45 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.756 -1.338 . . . . 1.0 109.756 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -68.83 -47.44 66.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.052 -0.574 . . . . 1.0 109.76 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.574 ' N ' ' O ' ' A' ' 183' ' ' ASN . 88.8 tttt -57.03 -42.27 80.14 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.362 -0.836 . . . . 1.0 110.116 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 96.7 m -61.71 -44.33 97.14 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 53.1 mt -61.73 -41.57 97.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.773 -0.648 . . . . 1.0 109.928 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 59.2 tp -58.95 -44.15 91.4 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.388 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 16.5 tptp -62.01 -43.98 97.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.474 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.0 t -63.33 -38.45 91.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.363 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.4 mt -63.76 -42.08 97.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.829 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.41 -30.09 66.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.56 -0.291 . . . . 1.0 111.67 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -81.02 -3.46 51.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.843 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 79.4 t60 55.53 56.11 6.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.321 -0.399 . . . . 1.0 111.04 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -43.2 135.76 3.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.881 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -80.07 135.34 36.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.56 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.618 ' CG ' ' H ' ' A' ' 199' ' ' HIS . 26.7 t-80 -159.09 -128.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.528 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.618 ' H ' ' CG ' ' A' ' 198' ' ' HIS . 13.1 p80 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.933 -1.032 . . . . 1.0 110.853 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 74.3 p . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.675 ' CD2' ' H ' ' A' ' 3' ' ' ARG . 2.9 p80 -149.61 -49.98 0.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.524 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.675 ' H ' ' CD2' ' A' ' 2' ' ' HIS . 41.1 mmm-85 -125.64 3.82 7.52 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.839 0.352 . . . . 1.0 110.503 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.83 -27.93 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.653 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.2 pt -76.49 -18.76 14.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.536 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 3' ' ' ARG . 56.1 p30 -99.35 7.44 45.55 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.485 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -84.99 138.49 37.12 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 110.091 -0.337 . . . . 1.0 110.091 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.59 -13.32 32.48 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.889 1.726 . . . . 1.0 112.342 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.418 ' CD1' ' CZ ' ' A' ' 30' ' ' PHE . 40.4 m-85 -99.35 10.68 40.95 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.572 -0.286 . . . . 1.0 111.069 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.532 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 91.0 t80 -85.98 123.36 31.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.316 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 49.5 m-85 -146.5 108.92 4.15 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 110.092 -0.336 . . . . 1.0 110.092 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.508 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 45.3 Cg_exo -58.88 109.57 0.54 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 121.697 1.598 . . . . 1.0 112.48 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 23.4 m-85 -159.48 155.69 26.95 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.626 -0.716 . . . . 1.0 110.555 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 18.8 t-20 -84.03 164.04 19.54 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.295 -0.631 . . . . 1.0 109.295 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . -61.14 -40.81 99.06 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.569 -0.824 . . . . 1.0 111.095 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -66.73 -43.97 82.81 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.911 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -69.46 -36.0 76.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.392 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -39.49 90.09 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.304 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -60.43 -44.07 96.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.081 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -61.57 -42.45 98.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.281 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -63.05 -42.16 99.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.59 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mp -77.67 -13.59 59.86 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.295 -0.411 . . . . 1.0 111.081 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -58.49 -42.83 88.46 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.385 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p -79.48 -18.4 52.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -82.54 177.91 8.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.499 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 56.4 mp0 -90.01 173.23 8.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.77 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 ptt-85 -81.19 145.01 31.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.727 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.94 -1.39 55.2 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -82.1 147.82 28.88 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.418 ' CZ ' ' CD1' ' A' ' 9' ' ' TYR . 13.7 p90 -133.47 163.17 29.97 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.353 0.597 . . . . 1.0 110.961 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.88 157.95 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.21 -0.904 . . . . 1.0 111.298 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.8 mt -117.53 127.47 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.109 -0.496 . . . . 1.0 109.715 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -146.46 153.29 40.26 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.394 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -104.93 139.6 39.41 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.735 -0.468 . . . . 1.0 109.735 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -67.69 149.58 49.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.796 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 t -63.77 -20.5 65.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.966 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -125.01 10.18 8.17 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.574 -0.285 . . . . 1.0 110.684 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.57 -56.93 8.76 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t0 67.54 -51.33 0.5 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.734 0.302 . . . . 1.0 110.874 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -122.05 4.92 9.84 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.008 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -120.16 149.96 41.4 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.042 0.449 . . . . 1.0 110.517 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.423 ' CD1' ' OE2' ' A' ' 60' ' ' GLU . 5.2 mp -121.45 147.5 45.66 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.096 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -126.5 132.13 70.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.0 mt -113.74 139.83 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 108.837 -0.801 . . . . 1.0 108.837 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.2 m -120.4 142.39 49.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.035 -0.53 . . . . 1.0 109.692 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -147.68 151.6 36.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.977 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -99.66 140.33 34.01 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.87 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 9.0 mp -105.77 -82.08 0.53 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.605 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -93.81 -178.67 4.75 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.801 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -57.48 -40.48 78.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.667 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -127.51 53.45 1.75 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.092 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tp -151.42 128.22 10.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.898 0.38 . . . . 1.0 110.195 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -132.31 148.72 52.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.535 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.476 ' NE2' ' O ' ' A' ' 141' ' ' PRO . 94.2 mt-30 -137.79 152.61 49.32 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.972 -0.558 . . . . 1.0 109.628 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -129.31 144.9 51.41 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.201 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 56' ' ' ILE . 96.6 mt -126.27 130.82 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.842 -0.429 . . . . 1.0 109.842 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 43.7 p-10 -99.84 124.81 45.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.899 0.38 . . . . 1.0 110.633 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 58' ' ' ILE . 90.1 mt -102.21 133.05 46.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.48 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -119.96 134.84 55.12 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.853 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.423 ' OE2' ' CD1' ' A' ' 42' ' ' LEU . 3.6 mt-10 -100.09 143.91 29.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.145 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.4 mt -141.22 174.8 10.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.413 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 74.05 35.36 0.78 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.957 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -95.12 103.14 14.99 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.021 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.3 -31.84 72.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.837 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -147.67 155.84 45.01 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.265 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.98 -31.96 46.06 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.199 1.933 . . . . 1.0 112.079 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tp -79.69 -10.82 59.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.881 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.73 136.23 45.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.494 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 71' ' ' LYS . 64.7 mt -81.44 154.23 26.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.312 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.6 86.01 0.01 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.427 -1.069 . . . . 1.0 110.427 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 69' ' ' LEU . 68.3 mttm -61.35 -35.65 78.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.997 0.427 . . . . 1.0 110.823 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.4 t -127.62 124.16 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.798 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.0 mt -114.77 126.44 54.84 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.8 mt -102.18 123.1 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.84 0.353 . . . . 1.0 110.24 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.2 t -143.45 132.72 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.138 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 54.49 43.66 29.99 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.954 -0.299 . . . . 1.0 111.05 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.6 m120 57.98 19.96 6.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.708 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -128.32 139.12 52.57 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.873 0.368 . . . . 1.0 110.33 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -89.15 133.18 34.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.041 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -124.52 138.23 54.35 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.131 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -81.92 -37.32 26.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 1.0 111.62 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -123.22 149.91 44.09 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.124 0.487 . . . . 1.0 111.887 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.2 tp -65.74 -40.76 92.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.825 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -59.44 -43.54 93.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.905 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -56.93 -38.62 73.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.566 0.222 . . . . 1.0 110.633 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.22 -44.65 99.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.619 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.01 -46.16 97.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.52 -0.472 . . . . 1.0 111.647 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.98 -41.42 59.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 112.677 0.621 . . . . 1.0 112.677 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -78.5 -13.35 59.88 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.948 -0.301 . . . . 1.0 111.401 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -94.39 -49.3 5.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.113 0.412 . . . . 1.0 112.113 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 mp -71.68 -38.08 70.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.965 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -62.07 -48.26 81.0 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.968 -0.693 . . . . 1.0 111.215 -177.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.04 -42.35 69.61 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.848 -0.341 . . . . 1.0 111.683 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -66.05 -42.33 89.64 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.503 -0.479 . . . . 1.0 111.169 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 68.6 t -63.63 -47.86 89.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.347 -0.541 . . . . 1.0 111.214 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -69.93 -42.54 73.14 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.578 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.7 tp -68.63 -41.93 78.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.428 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.2 tp -62.92 -43.41 98.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.031 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.4 ' O ' ' OG ' ' A' ' 103' ' ' SER . 85.3 m-20 -66.14 -39.98 90.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.788 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -70.06 -41.61 73.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.398 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.402 ' HB2' ' HH ' ' A' ' 168' ' ' TYR . 1.6 tpt -64.22 -56.36 15.23 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.456 -0.498 . . . . 1.0 111.369 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.423 ' C ' ' H ' ' A' ' 104' ' ' SER . 14.0 m -60.69 -39.46 88.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.043 0.449 . . . . 1.0 110.51 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 99' ' ' ASN . 91.8 p -73.16 11.26 0.76 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.767 -0.651 . . . . 1.0 111.117 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 102' ' ' THR . 13.8 t -90.5 138.02 31.89 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.259 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.67 -20.1 63.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.194 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.582 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 64.3 mttp -87.99 39.12 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.691 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -129.17 110.14 11.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.372 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.56 122.94 37.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.206 -0.452 . . . . 1.0 109.884 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.6 m -95.0 72.83 3.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.118 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.58 151.28 16.93 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.953 -0.859 . . . . 1.0 110.953 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.35 175.84 6.55 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.032 -0.359 . . . . 1.0 110.032 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt -56.11 -37.79 69.89 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.95 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -68.47 -42.73 78.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.097 0.475 . . . . 1.0 110.729 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -70.28 -23.0 62.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.112 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.3 t -69.39 -45.74 78.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.158 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.1 t -65.92 -45.75 90.31 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 CA-C-O 121.158 0.504 . . . . 1.0 110.548 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.99 -33.06 74.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.794 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -68.61 -50.01 54.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.618 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.0 tp -70.03 -39.22 77.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.851 0.358 . . . . 1.0 110.253 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -64.97 -40.12 94.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.455 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -59.9 -47.53 85.4 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.686 -0.405 . . . . 1.0 110.286 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -60.98 -40.62 94.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.076 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 7.4 t -62.18 -41.72 98.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.548 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -59.49 -43.52 93.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.297 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.38 -41.96 92.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.71 76.29 77.26 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.488 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.537 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 10.2 Cg_exo -68.03 -21.14 43.57 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.857 2.372 . . . . 1.0 112.641 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -102.45 13.76 33.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.838 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -128.05 152.8 47.52 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.107 0.479 . . . . 1.0 110.379 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.1 p -81.39 161.16 23.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.637 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.1 p -154.89 146.12 13.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 20.7 p90 -151.4 142.06 22.73 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.834 0.35 . . . . 1.0 111.026 178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -152.62 168.14 26.58 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.393 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 5.1 p90 -136.46 157.19 47.38 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.257 -0.645 . . . . 1.0 109.257 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.2 p -149.27 168.58 22.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.815 0.34 . . . . 1.0 110.184 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 46.7 tp -79.26 144.46 34.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.355 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 0.0 OUTLIER -67.56 -172.82 0.27 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.026 -0.534 . . . . 1.0 109.999 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.516 ' N ' ' ND1' ' A' ' 138' ' ' HIS . 0.2 OUTLIER -110.31 -56.59 2.32 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.941 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.441 ' OD1' ' ND2' ' A' ' 140' ' ' ASN . 41.8 p-10 -114.09 19.88 16.1 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.082 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.529 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 7.5 m-80 -125.06 68.36 56.33 Favored Pre-proline 0 N--CA 1.466 0.344 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.236 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.476 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 26.1 Cg_endo -63.13 127.71 20.93 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.989 1.793 . . . . 1.0 112.46 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.36 11.56 41.46 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 110.761 -0.936 . . . . 1.0 110.761 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.524 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 57.7 m95 -132.95 156.54 47.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.818 0.342 . . . . 1.0 110.092 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -129.67 148.65 51.58 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.479 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 18.3 m-85 -116.84 136.13 53.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.063 0.459 . . . . 1.0 110.193 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.2 mt -109.77 124.61 51.57 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.302 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -121.48 147.52 45.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.053 -1.092 . . . . 1.0 108.053 178.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -160.18 150.74 18.64 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.608 -0.515 . . . . 1.0 109.608 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -136.23 128.34 29.73 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.851 -0.34 . . . . 1.0 110.521 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.5 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 34.3 mm -69.99 -45.79 75.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.421 -0.354 . . . . 1.0 111.716 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 31.1 m120 -158.94 173.68 16.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.559 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.11 -34.6 76.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.79 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -86.86 9.2 19.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.041 0.448 . . . . 1.0 110.46 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 13.1 t -98.59 165.92 11.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.431 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -96.79 145.58 25.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.929 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.04 121.45 22.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.063 0.459 . . . . 1.0 109.931 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -111.67 128.09 55.96 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.91 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.9 m -123.76 127.61 48.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.778 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.53 171.67 7.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.024 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.479 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 93.6 m-20 -109.51 149.17 30.01 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.836 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 45.8 t -126.35 136.92 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -104.88 125.8 51.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.021 0.439 . . . . 1.0 110.715 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 46.2 tp -88.6 129.8 35.41 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.399 -0.593 . . . . 1.0 109.399 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.3 p -128.34 171.83 11.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.408 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.689 HD21 ' H ' ' A' ' 165' ' ' ASN . 0.1 OUTLIER -83.98 16.09 3.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.512 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 67.0 p -122.71 -2.94 8.78 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.555 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 139.93 -128.69 3.99 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.453 -1.059 . . . . 1.0 110.453 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.402 ' HH ' ' HB2' ' A' ' 101' ' ' MET . 46.2 m-85 -123.81 127.35 47.96 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.729 0.299 . . . . 1.0 110.445 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -103.58 123.99 47.97 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 171' ' ' VAL . 0.5 OUTLIER -115.14 112.46 22.57 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.208 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 170' ' ' LEU . 5.2 t 34.74 64.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 7.7 m120 65.0 27.39 12.64 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.012 0.745 . . . . 1.0 113.012 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -132.42 121.58 23.65 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.176 -0.675 . . . . 1.0 109.176 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -94.61 123.44 38.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.822 0.344 . . . . 1.0 111.427 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -103.47 134.96 19.47 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.01 -23.21 22.02 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.037 1.825 . . . . 1.0 113.377 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 70.8 m -156.45 161.28 40.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.952 0.406 . . . . 1.0 111.035 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.12 -42.01 91.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.853 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 48.1 mm -60.29 -47.4 92.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.722 -0.391 . . . . 1.0 110.299 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -62.02 -35.92 80.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.8 tt -62.96 -40.1 96.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.271 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 72.8 m -60.77 -47.76 84.84 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.579 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.639 ' O ' ' N ' ' A' ' 186' ' ' LYS . 56.8 t-20 -66.82 -47.37 72.25 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.58 -45.5 0.51 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.954 -1.259 . . . . 1.0 109.954 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.49 ' O ' ' HG ' ' A' ' 188' ' ' LEU . 0.3 OUTLIER -69.84 -41.82 74.4 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-O 121.913 0.863 . . . . 1.0 109.762 178.25 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.639 ' N ' ' O ' ' A' ' 183' ' ' ASN . 87.9 tttt -60.84 -34.24 74.28 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.87 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.1 m -64.09 -51.59 63.3 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.899 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 185' ' ' PHE . 0.9 OUTLIER -65.57 -35.67 81.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.123 179.001 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.419 ' N ' ' HG ' ' A' ' 188' ' ' LEU . 37.1 tp -57.27 -46.47 83.06 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.172 -0.467 . . . . 1.0 109.97 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.51 -39.82 94.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.136 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.7 t -59.9 -36.43 76.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.498 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.5 mt -67.85 -41.6 82.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.785 -0.643 . . . . 1.0 112.208 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.1 -36.98 83.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.771 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . 0.495 ' O ' ' ND1' ' A' ' 194' ' ' HIS . 2.4 t-80 -80.58 -8.5 59.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.843 0.354 . . . . 1.0 110.85 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.474 ' CG ' ' O ' ' A' ' 195' ' ' HIS . 35.1 t-80 50.09 49.56 20.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.426 . . . . 1.0 111.069 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -136.59 94.51 3.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.369 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -157.15 146.5 20.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.626 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.459 ' ND1' ' C ' ' A' ' 198' ' ' HIS . 5.8 p80 -77.35 167.18 22.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.703 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.403 ' CD2' ' N ' ' A' ' 199' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.977 -1.011 . . . . 1.0 110.681 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 50.0 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -149.32 10.71 0.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.534 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.6 ttp-105 -130.52 -26.76 2.23 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.351 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.2 p -66.38 -32.6 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.669 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 pt -67.26 -24.07 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.672 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -93.59 0.76 56.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.397 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -64.27 130.75 94.77 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.221 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -47.64 -32.36 16.15 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.705 1.603 . . . . 1.0 112.516 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -85.32 9.66 14.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.372 -0.377 . . . . 1.0 111.181 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.505 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 80.6 t80 -89.95 129.83 36.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.467 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 61.7 m-85 -149.24 127.6 5.92 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 110.2 -0.296 . . . . 1.0 110.2 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 73.7 Cg_endo -73.24 109.9 2.94 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.901 1.734 . . . . 1.0 112.724 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 71.4 m-85 -160.89 151.78 18.56 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.489 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -76.26 -170.05 1.34 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.95 -44.53 8.17 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.546 -1.021 . . . . 1.0 110.546 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -67.02 -43.77 81.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.664 0.268 . . . . 1.0 111.025 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -65.2 -33.89 77.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.057 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.15 -39.47 90.2 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.741 -0.383 . . . . 1.0 110.326 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.25 -42.08 96.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.043 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.37 -44.39 96.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.439 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -63.32 -42.23 98.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.35 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.9 mp -73.29 -12.79 60.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.805 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -58.97 -40.73 85.63 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.357 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.6 t -75.82 -18.71 59.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.766 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.482 ' N ' ' CD ' ' A' ' 25' ' ' LYS . 3.1 mptp? -83.5 179.89 7.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.438 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.407 ' OE1' ' O ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -104.37 -176.01 2.96 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.367 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.407 ' O ' ' OE1' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -75.08 143.26 43.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.458 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.47 7.54 57.98 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.844 -0.902 . . . . 1.0 110.844 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -87.0 140.58 29.41 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -135.85 162.13 33.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.253 0.549 . . . . 1.0 110.92 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.2 m -147.44 158.65 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.155 -0.93 . . . . 1.0 111.612 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.0 mt -117.69 127.21 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -146.98 155.29 42.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.463 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.79 137.27 45.14 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.479 ' HG ' ' H ' ' A' ' 37' ' ' ARG . 30.9 t -74.75 144.85 43.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.974 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.0 p -64.83 -30.21 71.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.723 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.479 ' H ' ' HG ' ' A' ' 35' ' ' SER . 10.7 mpt_? -102.35 0.79 34.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.707 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.99 -56.47 5.29 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.428 -1.069 . . . . 1.0 110.428 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 72.64 -54.6 0.69 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.561 0.22 . . . . 1.0 111.024 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.515 ' OD1' ' CD2' ' A' ' 41' ' ' HIS . 55.2 p-10 -119.52 2.41 11.22 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.756 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.515 ' CD2' ' OD1' ' A' ' 40' ' ' ASP . 38.3 m170 -117.9 150.47 39.15 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.869 0.366 . . . . 1.0 110.566 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.03 151.76 38.52 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 116.004 -0.544 . . . . 1.0 109.912 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.1 t -126.05 132.95 70.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.26 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.2 mt -111.86 137.88 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.0 m -117.48 136.82 52.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.841 -0.618 . . . . 1.0 109.846 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.409 ' CH2' ' CD2' ' A' ' 48' ' ' LEU . 1.3 p-90 -146.22 147.2 31.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.496 -0.774 . . . . 1.0 110.921 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.554 ' HZ1' ' C ' ' A' ' 49' ' ' ASP . 64.7 tttm -93.84 140.66 29.41 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.075 -0.512 . . . . 1.0 111.255 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.409 ' CD2' ' CH2' ' A' ' 46' ' ' TRP . 82.0 mt -97.27 -66.25 0.91 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.486 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.554 ' C ' ' HZ1' ' A' ' 47' ' ' LYS . 4.6 p30 -144.56 -166.64 2.44 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.607 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -59.18 131.63 51.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.972 0.415 . . . . 1.0 110.682 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 49.87 52.79 13.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.907 -0.588 . . . . 1.0 111.156 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.8 tp -158.89 119.12 3.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.338 . . . . 1.0 110.421 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.5 149.46 52.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.592 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -137.05 151.9 49.45 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.136 -0.484 . . . . 1.0 109.751 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -125.8 140.62 52.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.203 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 56' ' ' ILE . 95.7 mt -120.85 123.7 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -94.95 122.23 37.38 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.58 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.0 mt -102.53 129.68 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.336 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -119.82 134.37 55.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.099 -0.501 . . . . 1.0 109.891 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -102.62 148.78 25.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.109 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.1 mt -141.97 174.72 10.33 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.328 -0.397 . . . . 1.0 110.461 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 67.81 41.62 2.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.016 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.633 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -111.85 134.55 53.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.242 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.25 -20.3 30.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.538 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.63 153.41 22.85 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.153 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.83 -20.91 68.53 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.267 1.978 . . . . 1.0 111.884 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.5 tp -85.49 -12.37 51.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.144 0.497 . . . . 1.0 110.639 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.35 151.57 30.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.527 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.8 mt -75.86 147.24 39.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.284 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.79 98.91 0.37 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.551 -1.02 . . . . 1.0 110.551 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -62.55 -38.27 89.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.92 0.39 . . . . 1.0 110.544 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.53 123.65 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.624 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.4 mt -116.47 130.57 56.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.869 -0.605 . . . . 1.0 109.401 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mp -107.49 124.65 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.81 0.338 . . . . 1.0 110.362 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -139.2 132.11 37.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.288 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 76' ' ' ASP . 39.3 t0 51.92 42.03 29.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.654 0.264 . . . . 1.0 111.035 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.1 t30 61.19 22.92 13.19 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.297 -0.411 . . . . 1.0 111.042 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -127.0 133.36 50.57 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.114 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -86.31 128.24 34.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.735 -0.666 . . . . 1.0 111.089 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -121.49 138.56 54.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.151 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -84.99 -34.55 22.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.542 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -126.31 149.45 49.14 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.062 0.458 . . . . 1.0 112.058 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.0 tp -65.38 -39.7 92.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.945 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -60.2 -40.81 91.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 1.0 111.741 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -61.0 -38.45 86.1 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.769 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.83 -45.84 97.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.726 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.9 mm -65.44 -43.45 94.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.506 -0.478 . . . . 1.0 111.47 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.73 -43.07 70.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 112.642 0.608 . . . . 1.0 112.642 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.03 -13.13 59.55 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.722 -0.391 . . . . 1.0 111.61 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -95.3 -49.01 5.65 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.772 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 tp -70.06 -41.41 74.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.312 -0.404 . . . . 1.0 112.018 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -63.96 -49.14 73.71 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.918 -0.713 . . . . 1.0 111.456 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -70.53 -42.05 71.73 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.62 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.549 ' HZ1' ' ND2' ' A' ' 165' ' ' ASN . 25.6 mmtm -65.88 -41.88 90.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.347 -0.541 . . . . 1.0 111.266 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.5 t -64.76 -46.43 92.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.39 -0.524 . . . . 1.0 111.181 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -65.94 -44.57 84.66 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.593 -0.443 . . . . 1.0 111.259 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.7 tp -65.57 -41.82 92.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.497 -0.32 . . . . 1.0 111.511 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.25 -42.3 99.17 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.299 -0.561 . . . . 1.0 110.045 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 103' ' ' SER . 91.1 m-20 -66.31 -40.41 89.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.262 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -69.37 -40.8 77.23 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.673 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.477 ' O ' ' OG ' ' A' ' 104' ' ' SER . 1.4 tpt -66.5 -56.11 12.41 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.104 -0.638 . . . . 1.0 111.301 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.423 ' C ' ' H ' ' A' ' 104' ' ' SER . 65.1 m -60.44 -39.11 86.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.047 0.451 . . . . 1.0 110.852 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 99' ' ' ASN . 99.2 p -71.91 10.42 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.638 -0.71 . . . . 1.0 111.124 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 101' ' ' MET . 83.1 p -93.94 133.7 37.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.711 0.291 . . . . 1.0 110.468 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 37.9 mp0 -57.46 -21.07 34.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.138 0.494 . . . . 1.0 110.594 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.555 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 49.2 mttp -87.61 39.7 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.771 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -128.45 113.22 15.25 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.604 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -125.61 110.47 13.86 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.197 -0.456 . . . . 1.0 109.804 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.7 m -85.03 77.05 10.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.981 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -116.63 157.96 14.74 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 72.3 p -78.53 168.05 20.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.843 -0.429 . . . . 1.0 109.843 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -56.68 -36.85 70.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.74 0.305 . . . . 1.0 110.329 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -67.39 -45.22 76.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.913 0.387 . . . . 1.0 110.539 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -70.52 -17.2 62.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.786 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.7 t -72.2 -44.01 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.293 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.5 t -63.45 -46.94 93.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.211 0.529 . . . . 1.0 110.304 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -66.17 -35.71 81.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.901 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -67.69 -49.12 64.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.757 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.9 tp -69.87 -39.65 77.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.856 -0.337 . . . . 1.0 110.424 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.5 -40.24 95.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.706 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.6 -47.51 78.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.514 -0.474 . . . . 1.0 110.255 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.451 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 32.1 t80 -60.61 -43.14 97.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.061 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.1 p -65.88 -33.24 75.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.486 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -60.71 -42.28 96.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.931 -0.577 . . . . 1.0 109.915 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.49 -41.5 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.451 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -125.87 74.58 70.98 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.213 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 151' ' ' ASN . 46.1 Cg_endo -73.17 -17.89 24.17 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.354 2.036 . . . . 1.0 112.557 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 48.0 p30 -90.85 -10.31 43.16 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.157 0.429 . . . . 1.0 112.157 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -118.63 147.03 44.18 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.925 0.393 . . . . 1.0 110.404 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.9 m -80.94 160.9 24.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.782 -0.645 . . . . 1.0 109.693 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.89 146.89 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 133' ' ' TYR . 26.3 p90 -139.32 143.92 38.06 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.85 0.357 . . . . 1.0 111.56 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 18.4 m-85 -151.85 166.23 32.07 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.491 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 4.1 p90 -135.01 152.3 51.6 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.8 m -150.94 172.41 15.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.442 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.21 142.36 39.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.616 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 10.7 t-20 -98.98 111.84 24.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.837 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -66.67 -43.23 85.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.676 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.15 -27.53 65.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.373 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.474 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 31.6 m120 -125.14 73.96 66.74 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.267 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.76 126.11 17.48 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.911 1.741 . . . . 1.0 112.463 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.06 -7.68 48.62 Favored Glycine 0 N--CA 1.467 0.741 0 N-CA-C 111.065 -0.814 . . . . 1.0 111.065 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -116.81 141.18 48.55 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.713 0.292 . . . . 1.0 110.418 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -102.09 142.77 32.83 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.542 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 11.1 m-85 -119.15 131.05 55.84 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.235 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.98 121.49 42.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.357 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -117.34 144.46 44.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.192 -1.04 . . . . 1.0 108.192 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -160.57 153.69 21.62 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.403 -0.591 . . . . 1.0 109.403 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -137.36 131.31 31.94 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.692 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 150' ' ' ILE . 35.9 mm -70.98 -47.2 63.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.695 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 127' ' ' PRO . 12.2 p30 -161.92 177.19 10.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.076 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.59 -34.37 78.1 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.09 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -84.88 9.5 14.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.668 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.3 t -105.28 163.61 12.47 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.182 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -92.21 156.63 17.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.936 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 50.5 tp -75.79 127.29 32.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.942 0.401 . . . . 1.0 110.26 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -112.26 133.17 54.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.081 -0.509 . . . . 1.0 109.751 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 85.5 m -131.39 131.79 43.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.036 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -121.91 164.73 17.07 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.806 -0.442 . . . . 1.0 109.806 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.542 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 24.2 m-20 -115.57 147.58 40.57 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.992 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 39.1 t -128.91 138.92 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -97.61 126.68 43.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.993 0.425 . . . . 1.0 110.704 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.4 tp -90.23 128.84 36.49 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 35.6 p -129.66 175.11 9.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.394 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.549 ' ND2' ' HZ1' ' A' ' 94' ' ' LYS . 12.8 m120 -83.96 15.87 3.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.71 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 5.6 p -121.85 -1.83 9.36 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.739 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.88 -134.02 7.1 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.337 -1.105 . . . . 1.0 110.337 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -117.79 128.6 55.03 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.142 -0.318 . . . . 1.0 110.142 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -107.86 121.55 44.98 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 171' ' ' VAL . 6.7 tt -111.71 115.84 29.76 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 109.009 -0.738 . . . . 1.0 109.009 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.568 ' C ' HD21 ' A' ' 172' ' ' ASN . 99.3 t 33.19 62.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.349 0.5 . . . . 1.0 112.349 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.695 ' N ' HD21 ' A' ' 172' ' ' ASN . 0.5 OUTLIER 67.32 27.45 8.23 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.635 0.976 . . . . 1.0 113.635 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -131.79 120.1 22.19 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.338 -0.615 . . . . 1.0 109.338 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -91.73 129.42 37.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.883 0.373 . . . . 1.0 111.253 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -109.08 99.22 34.6 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.62 -24.4 12.73 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.636 2.224 . . . . 1.0 113.603 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.436 ' OG ' ' OE1' ' A' ' 180' ' ' GLN . 6.9 p -138.05 142.87 40.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.917 0.389 . . . . 1.0 111.272 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.61 -33.92 59.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.683 -0.69 . . . . 1.0 110.583 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.37 -44.08 98.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 122.038 -0.414 . . . . 1.0 110.363 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.521 ' OE1' ' N ' ' A' ' 180' ' ' GLN . 3.2 mp0 -65.89 -29.34 69.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 52.4 tp -64.0 -40.72 97.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.255 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 74.1 m -62.56 -47.79 82.31 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.364 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 186' ' ' LYS . 43.6 t30 -68.01 -47.41 68.55 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 119.503 -0.879 . . . . 1.0 108.88 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.4 -45.31 0.67 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 109.919 -1.272 . . . . 1.0 109.919 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -68.79 -46.99 67.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.376 0.608 . . . . 1.0 109.502 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 183' ' ' ASN . 1.4 tmtp? -56.81 -42.72 80.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.243 -0.89 . . . . 1.0 110.05 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 23.8 m -61.25 -44.0 97.96 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 39.8 mt -62.21 -42.11 98.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.115 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 44.7 tp -58.48 -42.8 88.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.336 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.48 -44.94 92.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.371 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 17.4 m -62.7 -39.34 93.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.895 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.17 -41.13 99.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.609 -0.723 . . . . 1.0 111.735 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.68 -26.68 67.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.793 0.294 . . . . 1.0 111.793 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -82.76 6.14 19.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.818 0.342 . . . . 1.0 110.884 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 196' ' ' HIS . 73.0 t60 59.19 43.88 16.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.089 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 195' ' ' HIS . 84.7 t60 57.31 149.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.695 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -88.85 131.7 34.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.476 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.511 ' ND1' ' N ' ' A' ' 198' ' ' HIS . 0.0 OUTLIER -127.11 2.82 6.47 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.574 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.056 -0.973 . . . . 1.0 110.692 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.546 ' C ' ' H ' ' A' ' 3' ' ' ARG . 24.3 p . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.481 ' CG ' ' O ' ' A' ' 2' ' ' HIS . 86.6 t60 50.94 8.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.486 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.546 ' H ' ' C ' ' A' ' 1' ' ' THR . 80.0 mtp85 -135.51 -23.91 1.4 Allowed 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.599 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.0 p -97.06 -17.4 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.564 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.6 pt -85.51 -25.95 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.658 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.613 HD21 ' N ' ' A' ' 7' ' ' HIS . 0.0 OUTLIER -89.57 -0.01 57.22 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.613 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.613 ' N ' HD21 ' A' ' 6' ' ' ASN . 0.1 OUTLIER -69.63 146.87 96.31 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.092 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.98 -20.67 50.67 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.913 1.742 . . . . 1.0 112.353 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.439 ' CE1' ' CZ ' ' A' ' 30' ' ' PHE . 74.7 m-85 -88.97 3.3 52.01 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.326 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -88.16 135.45 33.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.322 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.573 ' O ' ' NH1' ' A' ' 33' ' ' ARG . 74.6 m-85 -151.27 119.64 3.42 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 110.013 -0.365 . . . . 1.0 110.013 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.521 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 73.7 Cg_endo -72.82 109.62 2.84 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.671 1.58 . . . . 1.0 113.129 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.551 ' O ' ' NE ' ' A' ' 33' ' ' ARG . 56.4 m-85 -160.41 159.25 30.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.623 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -78.69 173.47 12.42 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.14 -49.06 82.27 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.27 -0.967 . . . . 1.0 110.858 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -67.95 -40.15 83.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 1.0 110.823 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -66.61 -32.63 74.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 1.0 111.146 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.35 92.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.933 -0.307 . . . . 1.0 110.221 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.479 ' OE2' ' CD1' ' A' ' 53' ' ' PHE . 84.1 tt0 -63.31 -42.74 99.04 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.699 -0.4 . . . . 1.0 109.996 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -60.78 -40.36 92.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.091 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -62.19 -42.49 99.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.826 0.346 . . . . 1.0 110.474 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.16 -13.6 60.19 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.874 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.9 ttm-85 -61.33 -40.15 93.18 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.844 -0.342 . . . . 1.0 110.256 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.4 p -77.58 -19.08 56.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.751 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -84.67 -179.77 7.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.912 0.387 . . . . 1.0 110.566 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -103.15 -177.47 3.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.784 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -75.45 145.0 41.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.772 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.17 11.01 59.08 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -97.09 140.75 31.13 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CZ ' ' CE1' ' A' ' 9' ' ' TYR . 35.1 p90 -135.08 168.57 18.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.444 0.64 . . . . 1.0 111.116 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.8 m -148.54 161.32 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.012 -0.994 . . . . 1.0 111.762 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -116.09 131.19 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.573 ' NH1' ' O ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -137.74 164.13 29.64 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.839 -179.214 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -120.51 126.89 51.51 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 t -62.56 134.16 55.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.128 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.5 t -72.17 -20.77 61.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.885 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -117.8 37.59 3.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.819 0.343 . . . . 1.0 110.767 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.623 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -175.1 58.71 0.11 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.939 -0.865 . . . . 1.0 110.939 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -57.57 3.41 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.652 0.263 . . . . 1.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.623 ' H ' ' C ' ' A' ' 38' ' ' GLY . 97.9 m-20 -102.94 -1.74 28.92 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.595 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.429 ' ND1' ' O ' ' A' ' 40' ' ' ASP . 60.6 m-70 -143.59 157.72 44.21 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.375 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 mp -119.74 152.75 36.7 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.15 -0.477 . . . . 1.0 109.988 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.3 t -124.2 130.9 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 110.06 -0.348 . . . . 1.0 110.06 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.4 mt -111.58 138.1 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 96.2 m -116.93 136.13 53.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.537 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.471 ' CZ2' ' NZ ' ' A' ' 94' ' ' LYS . 4.4 p-90 -145.36 160.91 40.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.658 -0.701 . . . . 1.0 110.846 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -107.65 140.9 39.98 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.022 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 mp -98.0 -72.35 0.65 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.652 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -158.29 157.34 32.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.259 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt 41.81 -141.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.798 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -89.71 64.3 6.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.848 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.9 tp -140.57 128.89 22.46 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.877 0.37 . . . . 1.0 110.323 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.479 ' CD1' ' OE2' ' A' ' 19' ' ' GLU . 51.6 m-85 -131.4 150.36 52.18 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.379 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -136.66 153.75 50.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.831 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.421 ' ND1' ' N ' ' A' ' 55' ' ' HIS . 10.8 p-80 -127.67 143.08 51.18 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.066 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 78.2 mt -123.4 129.23 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.228 -0.442 . . . . 1.0 109.966 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -97.23 122.45 40.27 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.03 0.443 . . . . 1.0 110.513 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.9 mt -99.32 129.95 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.4 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -113.56 132.35 55.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.0 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -101.03 156.58 17.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.188 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.7 tp -126.19 172.2 10.25 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.493 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.432 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 73.9 mm-40 60.02 39.0 20.44 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.99 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -81.47 78.88 8.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.082 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.64 -36.15 80.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.869 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -142.81 152.56 59.47 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.044 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.68 -25.56 68.58 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.295 1.997 . . . . 1.0 112.142 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.7 mt -97.84 -4.41 36.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.606 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.13 144.05 52.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.581 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.5 mt -78.5 146.31 34.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.366 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.27 101.16 1.22 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.539 -1.025 . . . . 1.0 110.539 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -63.58 -38.33 90.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.04 0.448 . . . . 1.0 111.029 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.17 125.52 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.593 -0.73 . . . . 1.0 111.004 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.6 mt -115.18 129.76 56.74 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 71.5 mt -102.13 126.24 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.884 0.373 . . . . 1.0 110.189 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.9 t -143.9 133.11 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.386 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t0 53.1 45.36 28.88 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.11 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 57.63 25.57 11.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.311 -0.404 . . . . 1.0 111.051 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -130.15 156.81 43.94 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.322 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -108.06 125.98 52.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.022 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -123.89 139.47 53.93 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.134 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -85.05 -38.84 18.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.77 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -110.08 138.22 46.76 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.201 0.524 . . . . 1.0 111.844 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.39 -41.35 96.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.874 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 38.0 p-10 -59.63 -45.97 90.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.982 -177.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.535 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 33.2 tt0 -57.93 -37.86 74.86 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 120.68 0.276 . . . . 1.0 110.778 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.81 -46.44 93.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.451 -0.5 . . . . 1.0 110.714 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.7 mm -64.4 -44.08 97.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.2 -0.6 . . . . 1.0 111.626 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.16 -43.63 74.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 113.067 0.765 . . . . 1.0 113.067 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -78.17 -13.27 59.93 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.641 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.457 ' CE2' ' NZ ' ' A' ' 94' ' ' LYS . 50.0 t80 -94.75 -50.72 5.03 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.95 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.38 -38.21 71.54 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.173 0.434 . . . . 1.0 112.173 -177.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -59.31 -47.25 86.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.027 -0.669 . . . . 1.0 111.527 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -64.43 -45.1 89.01 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.537 -0.465 . . . . 1.0 111.905 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.471 ' NZ ' ' CZ2' ' A' ' 46' ' ' TRP . 45.9 mtmt -66.67 -42.68 86.17 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.237 -0.585 . . . . 1.0 111.407 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.462 ' O ' ' ND2' ' A' ' 99' ' ' ASN . 54.3 t -60.06 -45.66 95.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.398 -0.521 . . . . 1.0 111.367 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -66.59 -44.21 82.8 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.562 -0.455 . . . . 1.0 111.965 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.3 tp -67.07 -38.94 86.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.637 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.99 -42.16 90.14 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.353 -0.539 . . . . 1.0 110.626 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 95' ' ' VAL . 76.3 m-20 -68.65 -37.27 79.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.205 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -70.98 -41.22 71.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.831 -0.348 . . . . 1.0 111.564 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.576 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 15.9 ttm -70.03 -53.28 18.26 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.53 -0.468 . . . . 1.0 111.594 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.464 ' C ' ' H ' ' A' ' 104' ' ' SER . 11.5 m -57.04 -38.83 73.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.056 0.455 . . . . 1.0 110.3 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.7 m -70.36 10.96 0.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.958 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 102' ' ' THR . 74.4 p -95.61 132.17 41.05 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.893 0.378 . . . . 1.0 110.385 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -60.38 -17.4 43.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.945 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.529 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 67.8 mttm -94.73 41.1 1.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.999 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -134.91 118.63 17.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.035 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -140.1 129.6 24.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.12 -0.491 . . . . 1.0 109.717 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.6 m -100.43 93.48 5.66 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.735 0.303 . . . . 1.0 110.953 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -120.17 162.94 14.06 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.5 p -78.73 163.41 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.925 -0.398 . . . . 1.0 109.925 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -63.35 -37.08 85.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.386 . . . . 1.0 110.54 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -68.08 -45.65 73.19 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.904 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -71.12 -17.26 62.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.59 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.81 -45.4 73.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.88 -46.47 96.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.192 0.52 . . . . 1.0 110.036 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -66.05 -38.59 88.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.925 0.393 . . . . 1.0 110.663 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -65.77 -48.39 71.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.796 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.4 tp -69.19 -39.69 79.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.418 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -59.72 -43.72 94.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.353 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.02 -47.44 83.04 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.446 -0.501 . . . . 1.0 110.019 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -60.05 -44.91 94.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.972 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.1 p -62.47 -33.9 75.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.414 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -61.82 -42.44 99.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.96 -0.563 . . . . 1.0 110.243 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.32 -41.56 89.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.711 -0.396 . . . . 1.0 109.985 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.8 75.07 56.3 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 121.202 0.525 . . . . 1.0 110.128 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.526 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 42.0 Cg_endo -73.21 -14.87 25.72 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.402 2.068 . . . . 1.0 112.568 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -100.31 -13.19 18.93 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.797 0.295 . . . . 1.0 111.797 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -106.45 150.78 25.73 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.152 0.501 . . . . 1.0 110.429 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 m -80.66 162.06 24.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.629 -0.714 . . . . 1.0 109.659 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.3 p -152.74 144.96 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.538 -0.542 . . . . 1.0 109.538 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 25.3 p90 -151.3 144.19 24.5 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.848 -0.341 . . . . 1.0 111.124 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -151.45 169.75 21.26 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.344 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.529 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -137.9 153.69 49.51 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.082 -0.71 . . . . 1.0 109.082 179.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 98.9 p -151.21 169.66 21.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.9 0.381 . . . . 1.0 110.32 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.7 tp -79.49 141.54 36.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.524 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.509 ' ND2' ' CE1' ' A' ' 145' ' ' TYR . 6.6 t-20 -75.06 168.44 19.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.199 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -126.98 -30.11 2.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.356 -0.383 . . . . 1.0 110.66 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -90.53 -20.42 22.67 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.4 -0.364 . . . . 1.0 111.143 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 25.5 t-20 -138.64 76.33 35.84 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.396 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.06 130.76 41.39 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.062 1.841 . . . . 1.0 112.217 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 117.09 -26.34 8.34 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -107.28 147.92 29.63 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.576 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 75.2 m-85 -109.7 155.78 21.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.864 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.539 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 32.6 m-85 -125.77 137.46 53.8 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.048 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.9 mt -108.03 127.23 53.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.51 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -118.6 144.3 46.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -162.5 153.49 17.46 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.374 -0.53 . . . . 1.0 109.707 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -133.99 129.23 35.88 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.26 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.8 mp -76.48 -47.25 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.424 0.527 . . . . 1.0 112.424 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 152' ' ' ALA . 17.0 t-20 -154.01 166.06 34.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.554 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.532 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -60.78 -27.57 68.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -85.53 -14.3 46.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.984 0.421 . . . . 1.0 110.318 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.42 ' HG ' ' H ' ' A' ' 155' ' ' LYS . 12.8 t -81.18 160.76 24.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.335 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.42 ' H ' ' HG ' ' A' ' 154' ' ' SER . 33.8 mtmm -92.29 163.46 13.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.138 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 57.2 tp -79.67 118.71 21.74 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.011 -0.366 . . . . 1.0 110.011 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.39 132.72 52.09 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.968 -0.56 . . . . 1.0 109.986 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 96.4 m -124.38 126.29 45.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.532 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -111.48 155.7 22.82 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.241 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.539 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 82.5 m-20 -104.9 144.16 32.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.591 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.2 t -123.89 136.16 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 109.535 -0.543 . . . . 1.0 109.535 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -95.57 135.26 37.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.627 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 28.7 tp -99.38 130.14 45.63 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 166' ' ' THR . 71.5 p -128.57 159.9 34.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.244 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -76.91 17.46 0.43 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.633 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.451 ' H ' ' C ' ' A' ' 164' ' ' THR . 60.5 p -123.11 -2.29 8.65 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.669 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 143.12 -132.88 5.22 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.353 -1.099 . . . . 1.0 110.353 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.436 ' HH ' ' HB2' ' A' ' 101' ' ' MET . 59.0 m-85 -123.49 134.37 53.9 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 110.167 -0.309 . . . . 1.0 110.167 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.525 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 7.5 m-85 -111.62 122.87 48.96 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 tt -117.84 121.78 41.66 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.492 -0.559 . . . . 1.0 109.492 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.567 ' C ' HD21 ' A' ' 172' ' ' ASN . 4.2 t 37.88 51.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.153 0.427 . . . . 1.0 112.153 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.635 ' N ' HD21 ' A' ' 172' ' ' ASN . 0.6 OUTLIER 68.43 27.52 6.34 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.413 0.894 . . . . 1.0 113.413 179.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -135.65 123.09 21.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.525 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 19.5 t-20 -92.0 129.5 37.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.566 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -103.71 133.39 20.3 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.86 -20.7 22.12 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.053 1.836 . . . . 1.0 113.594 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.45 ' OG ' ' OE1' ' A' ' 180' ' ' GLN . 14.3 p -153.95 158.37 40.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.961 0.41 . . . . 1.0 111.095 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.31 -36.22 76.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.012 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.6 mm -60.54 -48.49 88.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.811 0.339 . . . . 1.0 110.243 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.45 ' OE1' ' OG ' ' A' ' 177' ' ' SER . 9.0 mp0 -65.96 -33.33 75.57 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.18 -41.9 97.62 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 110.025 -0.361 . . . . 1.0 110.025 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 81.6 m -62.3 -46.23 89.69 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 120.57 -0.452 . . . . 1.0 110.116 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 186' ' ' LYS . 65.9 m-20 -65.07 -49.02 71.68 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.89 -46.07 0.86 Allowed Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.841 -1.304 . . . . 1.0 109.841 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -67.77 -47.17 69.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 183' ' ' ASN . 64.7 tttm -56.72 -40.46 75.72 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.764 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 25.7 m -61.16 -45.11 96.0 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.428 ' O ' ' OG ' ' A' ' 191' ' ' SER . 88.6 mt -63.55 -40.86 98.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.859 -0.609 . . . . 1.0 110.1 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.0 tp -57.81 -41.23 81.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.406 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -64.03 -45.13 90.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.112 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 188' ' ' LEU . 56.7 p -62.95 -39.4 94.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.973 0.416 . . . . 1.0 110.637 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 61.2 mt -63.81 -43.5 96.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.606 -0.724 . . . . 1.0 111.965 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -71.15 -30.1 66.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.845 0.313 . . . . 1.0 111.845 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . 0.558 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 5.6 t-160 -91.24 -2.75 57.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.991 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' A' ' 194' ' ' HIS . 55.0 p-80 43.23 51.68 5.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.177 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 57.02 160.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.791 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.435 ' ND1' ' N ' ' A' ' 197' ' ' HIS . 0.0 OUTLIER -154.41 154.3 33.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.676 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 74.5 t60 40.36 81.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.055 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 37.0 m80 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 117.949 -1.025 . . . . 1.0 110.733 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 3' ' ' ARG . 20.2 p . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.439 ' H ' ' CD2' ' A' ' 2' ' ' HIS . 8.8 p80 -70.66 10.23 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.464 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.493 ' H ' ' C ' ' A' ' 1' ' ' THR . 90.4 mtt180 -148.78 23.6 0.98 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.583 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.805 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 7.2 p -60.41 -47.63 91.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.566 0 CA-C-O 121.756 0.789 . . . . 1.0 110.089 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.9 pt -59.94 12.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 O-C-N 121.255 -0.903 . . . . 1.0 111.011 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.671 ' H ' ' C ' ' A' ' 4' ' ' VAL . 54.9 t-20 -161.53 32.7 0.13 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.288 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.805 ' ND1' ' O ' ' A' ' 4' ' ' VAL . 3.8 p-80 -75.74 154.35 85.27 Favored Pre-proline 0 N--CA 1.468 0.426 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.02 -28.43 19.01 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.097 1.865 . . . . 1.0 112.7 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -79.94 -9.05 59.64 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.282 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -73.56 134.87 43.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.248 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -150.5 117.17 3.42 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 120.983 -0.287 . . . . 1.0 110.264 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.83 111.59 3.36 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.742 1.628 . . . . 1.0 112.829 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -156.68 155.63 32.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.275 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -78.8 -172.44 3.02 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.49 -48.36 18.5 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.543 -1.023 . . . . 1.0 110.543 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -64.41 -44.14 92.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.76 0.314 . . . . 1.0 110.734 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.17 -35.19 79.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.985 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.07 97.63 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.656 -0.417 . . . . 1.0 110.395 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.57 -43.97 83.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.008 -0.367 . . . . 1.0 110.008 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.06 -43.94 97.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.288 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.517 ' OH ' ' NZ ' ' A' ' 25' ' ' LYS . 94.1 t80 -61.63 -45.39 94.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.875 0.369 . . . . 1.0 110.288 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.4 -14.37 61.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.153 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -67.34 -41.84 84.52 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.621 -0.431 . . . . 1.0 110.799 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.6 m -76.37 -23.88 54.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.188 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.517 ' NZ ' ' OH ' ' A' ' 21' ' ' TYR . 32.7 mttp -81.9 176.78 9.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.151 0.5 . . . . 1.0 110.661 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -84.03 161.63 20.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.769 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.609 ' NH2' ' HZ2' ' A' ' 50' ' ' LYS . 2.5 mtt180 -76.07 146.31 39.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.033 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.5 12.67 47.21 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -106.54 148.05 28.7 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -127.81 172.49 10.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.473 0.654 . . . . 1.0 111.413 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.57 153.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 114.975 -1.011 . . . . 1.0 111.477 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.434 ' HB ' ' HE2' ' A' ' 7' ' ' HIS . 97.5 mt -116.84 118.48 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.93 151.01 30.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.198 -179.128 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 34' ' ' GLN . 3.0 pp0? -98.32 148.1 24.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.422 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 t -69.05 161.38 29.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.82 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.9 p -65.56 -21.83 66.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.833 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -129.53 25.18 5.42 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.413 -0.358 . . . . 1.0 111.167 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . -75.59 -62.32 2.72 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.618 -0.993 . . . . 1.0 110.618 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.3 t0 64.75 -50.62 0.32 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.728 0.299 . . . . 1.0 111.334 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.448 ' O ' ' OE1' ' A' ' 60' ' ' GLU . 99.5 m-20 -120.66 20.65 11.71 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.977 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -147.86 147.73 30.1 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 mp -119.14 151.13 38.85 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.711 -0.478 . . . . 1.0 109.711 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 33' ' ' ARG . 76.4 t -126.96 135.06 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.331 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.8 mt -111.64 137.47 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.076 -0.712 . . . . 1.0 109.076 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.1 m -117.49 135.56 53.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.928 -0.578 . . . . 1.0 109.523 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -151.99 155.58 38.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.794 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -95.44 141.13 29.35 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.35 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 mp -94.82 -35.09 12.23 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.131 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.549 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 36.2 t0 -162.89 -138.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.191 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.609 ' HZ2' ' NH2' ' A' ' 27' ' ' ARG . 70.5 mmtt -53.76 -104.05 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.055 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.476 ' O ' ' CE2' ' A' ' 53' ' ' PHE . 32.3 t70 -85.65 20.91 1.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.232 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.583 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 2.7 mm? -88.35 131.49 34.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.874 0.369 . . . . 1.0 110.612 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.476 ' CE2' ' O ' ' A' ' 51' ' ' ASP . 25.4 m-85 -136.46 143.82 44.06 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.332 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -146.54 152.67 39.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.024 -0.534 . . . . 1.0 109.677 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -126.88 139.79 52.82 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.207 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 56' ' ' ILE . 42.1 mm -115.29 117.61 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -90.53 119.39 30.75 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.904 0.383 . . . . 1.0 110.773 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.5 mt -100.19 131.29 47.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.269 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -118.06 126.52 52.44 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 40' ' ' ASP . 9.6 mp0 -99.68 147.69 25.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.126 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.8 tt -141.55 170.85 14.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.46 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.431 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 61.8 tt0 72.51 52.24 0.17 Allowed 'General case' 0 C--N 1.334 -0.099 0 O-C-N 123.625 0.578 . . . . 1.0 109.769 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -117.29 84.81 2.22 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.652 -0.703 . . . . 1.0 109.841 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -65.94 -36.76 84.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.056 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -107.66 118.5 53.02 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.051 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -50.11 -30.18 24.4 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.081 1.854 . . . . 1.0 112.105 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 tp -79.51 -11.79 59.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.043 0.449 . . . . 1.0 110.828 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.15 140.57 35.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.188 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.1 mt -81.49 151.15 27.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.498 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.38 122.79 30.97 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.499 -1.041 . . . . 1.0 110.499 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -72.01 -13.01 61.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.87 0.367 . . . . 1.0 110.797 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.1 t -118.12 120.44 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.604 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.2 mt -114.37 126.8 55.41 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.141 -0.688 . . . . 1.0 109.141 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.3 mm -100.18 121.33 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.07 0.462 . . . . 1.0 110.48 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.2 t -138.17 131.28 40.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.283 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 51.8 t0 53.26 47.83 23.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.039 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER 55.52 21.45 4.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.077 179.277 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -128.0 144.23 51.1 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.281 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -88.57 135.01 33.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.957 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -123.74 138.2 54.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.293 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -81.71 -37.97 26.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.692 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -132.7 157.57 44.55 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.225 0.536 . . . . 1.0 111.781 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.2 tp -65.17 -39.27 92.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.501 -0.772 . . . . 1.0 111.215 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.49 -40.91 88.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.734 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -62.2 -38.38 88.89 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 121.004 -0.279 . . . . 1.0 110.757 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 89.0 mt -62.23 -45.8 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.048 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.5 mt -61.39 -47.27 94.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.483 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.09 -42.38 67.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 112.569 0.581 . . . . 1.0 112.569 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.22 -18.39 60.14 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.748 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -91.89 -50.06 5.92 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.533 -0.467 . . . . 1.0 111.413 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.0 mp -67.0 -42.21 85.39 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 112.296 0.48 . . . . 1.0 112.296 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -63.34 -49.83 72.37 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.739 -0.784 . . . . 1.0 111.64 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -68.69 -43.51 75.92 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.516 -0.474 . . . . 1.0 111.546 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -65.92 -43.88 86.78 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.048 -0.661 . . . . 1.0 111.313 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.65 -45.45 92.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.237 -0.585 . . . . 1.0 111.203 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -68.24 -46.08 71.45 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.715 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.82 -41.61 87.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.467 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.96 -42.17 94.83 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.314 -0.554 . . . . 1.0 110.134 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.406 ' O ' ' OG ' ' A' ' 103' ' ' SER . 4.8 m120 -67.74 -38.61 83.73 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.035 -0.529 . . . . 1.0 111.196 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -70.59 -42.46 71.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.877 -0.329 . . . . 1.0 111.78 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.601 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 4.1 ttt -67.24 -55.03 15.71 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.465 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 104' ' ' SER . 19.1 m -59.04 -41.95 89.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.983 0.42 . . . . 1.0 110.669 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 99' ' ' ASN . 87.6 p -72.45 8.78 1.25 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.991 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 102' ' ' THR . 8.6 t -88.53 138.49 31.38 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.722 0.296 . . . . 1.0 110.234 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -61.88 -18.24 59.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.869 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.555 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 59.8 mttp -89.34 39.05 0.93 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.023 -0.535 . . . . 1.0 109.694 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -130.99 111.75 12.32 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.357 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -131.34 114.63 15.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.057 -0.519 . . . . 1.0 109.828 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.7 m -88.76 78.97 7.55 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.046 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -105.46 152.87 17.24 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 62.1 p -72.56 171.51 12.27 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -57.51 -40.72 79.36 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.575 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -68.08 -42.59 80.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.019 0.438 . . . . 1.0 110.505 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -70.18 -21.86 63.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.117 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.4 t -69.43 -44.33 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.085 -0.339 . . . . 1.0 110.085 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.7 t -65.44 -45.46 92.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.099 0.476 . . . . 1.0 110.342 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -65.91 -34.12 77.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.984 0.421 . . . . 1.0 110.842 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -67.44 -50.23 60.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.628 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.4 tp -70.18 -39.08 76.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.046 0.451 . . . . 1.0 110.312 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.434 ' O ' ' OG ' ' A' ' 123' ' ' SER . 93.0 mt-10 -64.0 -42.43 97.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.624 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -61.3 -46.85 88.6 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.264 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.537 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 34.4 t80 -61.65 -43.08 99.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.107 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.437 ' HG ' ' N ' ' A' ' 124' ' ' ARG . 80.2 p -61.89 -36.64 81.89 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.424 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.437 ' N ' ' HG ' ' A' ' 123' ' ' SER . 84.7 mtt-85 -62.3 -39.04 91.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.313 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.38 -43.06 84.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.455 -0.498 . . . . 1.0 109.834 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.537 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -128.44 73.88 80.16 Favored Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.227 179.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.69 -16.54 26.66 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.475 2.117 . . . . 1.0 112.443 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -89.76 -5.55 56.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.678 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -127.07 149.93 49.7 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.004 0.431 . . . . 1.0 110.432 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.9 p -80.18 162.63 24.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.561 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 p -151.5 145.41 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -140.06 145.48 37.75 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.852 0.358 . . . . 1.0 111.25 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -151.37 171.3 17.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.221 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -137.25 156.91 47.72 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.268 -0.641 . . . . 1.0 109.268 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 29.3 p -155.07 168.7 26.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.371 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.0 tp -79.76 138.49 37.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.51 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.724 HD21 ' H ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -97.5 141.47 30.52 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.238 179.31 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -95.01 -16.98 22.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.583 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 18.0 p30 -69.93 -27.01 64.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.274 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 139' ' ' ASP . 22.7 m120 -159.2 92.26 1.89 Allowed Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 109.954 -0.387 . . . . 1.0 109.954 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.01 142.7 94.04 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.013 1.808 . . . . 1.0 112.404 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.53 -25.38 27.0 Favored Glycine 0 N--CA 1.464 0.542 0 N-CA-C 110.779 -0.928 . . . . 1.0 110.779 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.521 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 7.6 m0 -99.47 144.87 28.08 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 120.897 0.38 . . . . 1.0 110.09 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.601 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 70.9 m-85 -109.7 146.47 34.81 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.792 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.523 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 12.0 m-85 -119.28 132.01 55.84 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.036 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.5 mt -106.78 128.56 54.34 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.442 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.582 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -126.36 148.17 49.63 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 178.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -158.44 155.34 28.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.28 -0.568 . . . . 1.0 109.57 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.524 ' NZ ' ' O ' ' A' ' 154' ' ' SER . 4.1 tttm -134.15 130.41 37.28 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.851 0.357 . . . . 1.0 110.552 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.543 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 23.5 mm -75.76 -48.65 28.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.816 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 150' ' ' ILE . 29.2 m120 -155.51 169.11 25.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.629 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.11 -28.38 66.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.787 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.68 4.78 51.92 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.06 0.457 . . . . 1.0 110.417 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.524 ' O ' ' NZ ' ' A' ' 149' ' ' LYS . 12.4 t -90.89 165.85 13.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.316 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -99.09 148.97 23.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.47 . . . . 1.0 109.789 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 44.5 tp -72.28 118.44 15.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.901 0.381 . . . . 1.0 110.285 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -109.07 131.39 55.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.077 -0.51 . . . . 1.0 109.644 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 92.5 m -128.76 130.6 47.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.926 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -116.77 168.33 10.3 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.107 -0.497 . . . . 1.0 109.914 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.523 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 83.9 m-20 -111.7 148.34 33.64 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.648 -0.706 . . . . 1.0 110.84 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 74.5 t -128.36 138.18 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -103.59 128.84 50.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.196 0.522 . . . . 1.0 110.877 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.2 tp -89.16 129.23 35.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.545 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 80.8 p -129.17 174.62 9.41 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.38 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -86.43 14.13 7.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.693 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.455 ' O ' ' CG2' ' A' ' 166' ' ' THR . 26.9 m -121.91 -2.58 9.23 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.446 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 138.1 -141.66 12.36 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.112 -1.195 . . . . 1.0 110.112 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -109.58 126.51 53.68 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.452 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 4.6 m-85 -104.76 116.48 32.09 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.9 tt -113.08 115.42 28.3 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.547 ' C ' HD21 ' A' ' 172' ' ' ASN . 4.4 t 37.89 62.3 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 112.084 0.402 . . . . 1.0 112.084 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.631 ' N ' HD21 ' A' ' 172' ' ' ASN . 0.6 OUTLIER 63.43 27.9 15.32 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.165 0.802 . . . . 1.0 113.165 178.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 62.8 m-85 -133.87 122.49 23.27 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.452 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 7.1 t-20 -100.05 120.56 40.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.688 0.28 . . . . 1.0 111.529 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -98.66 136.96 20.58 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.44 -23.11 24.05 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.185 1.923 . . . . 1.0 113.396 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 5.1 t -154.17 158.45 40.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.104 0.478 . . . . 1.0 110.923 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.9 p -59.74 -34.42 55.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.816 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.0 -44.83 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.368 . . . . 1.0 110.246 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -69.08 -31.25 69.86 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 43.8 tp -62.67 -42.18 99.48 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.102 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 75.0 m -63.21 -45.9 89.51 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 120.634 -0.426 . . . . 1.0 110.209 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 186' ' ' LYS . 38.8 m-80 -63.28 -46.47 86.65 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 108.512 -0.921 . . . . 1.0 108.512 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.54 -46.55 0.8 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.818 -1.313 . . . . 1.0 109.818 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.89 -43.9 74.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.11 -0.545 . . . . 1.0 109.935 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.0 tttm -56.92 -43.8 81.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.401 -0.818 . . . . 1.0 110.016 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 13.7 m -61.64 -45.48 93.87 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.83 -43.55 98.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.061 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.9 tp -57.85 -45.4 86.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.855 0.359 . . . . 1.0 110.493 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.406 ' CE ' ' NZ ' ' A' ' 186' ' ' LYS . 46.9 mttm -61.96 -45.02 95.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.397 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.4 m -62.1 -41.78 98.56 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.985 0.421 . . . . 1.0 110.608 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 69.5 mt -63.98 -42.96 97.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.49 -0.777 . . . . 1.0 111.831 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -67.11 -30.71 70.8 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.885 0.328 . . . . 1.0 111.885 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . 0.431 ' O ' ' ND1' ' A' ' 194' ' ' HIS . 13.0 t-80 -79.98 -6.22 57.14 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.874 -0.33 . . . . 1.0 110.696 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 1.7 m80 49.29 50.85 17.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.026 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.501 ' O ' ' ND1' ' A' ' 197' ' ' HIS . 83.0 t60 -70.17 -85.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.675 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 196' ' ' HIS . 68.0 m-70 -156.76 166.8 32.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.669 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -65.86 148.45 51.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.801 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 69.0 m80 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.008 -0.996 . . . . 1.0 110.67 179.741 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -107.81 -2.02 20.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.433 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.429 ' O ' ' CE1' ' A' ' 7' ' ' HIS . 18.7 mmm180 -119.31 -28.19 5.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.963 0.411 . . . . 1.0 110.353 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.27 -30.62 49.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.425 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.437 HD11 HG22 ' A' ' 5' ' ' ILE . 38.1 pt -69.72 -19.22 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.427 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -91.28 3.28 55.26 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.697 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.429 ' CE1' ' O ' ' A' ' 3' ' ' ARG . 0.6 OUTLIER -88.91 143.67 31.81 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.072 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.7 -15.14 40.63 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.262 1.975 . . . . 1.0 112.132 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.529 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 54.2 m-85 -92.02 8.05 39.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.12 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.497 ' OH ' ' NE2' ' A' ' 34' ' ' GLN . 85.6 t80 -104.18 125.72 50.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 1.0 110.291 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -157.73 117.69 1.94 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 109.43 -0.581 . . . . 1.0 109.43 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.9 129.5 34.85 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 121.227 1.285 . . . . 1.0 112.626 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -157.99 149.13 21.14 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.091 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 16' ' ' ARG . 13.8 t-20 -77.91 164.44 25.13 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.22 -49.79 74.75 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.462 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 23.3 mmt85 -65.7 -39.52 91.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.696 0.284 . . . . 1.0 110.797 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.5 ' N ' ' CD ' ' A' ' 17' ' ' GLN . 1.1 mp0 -66.07 -35.4 80.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.069 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.02 92.35 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.268 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -60.81 -45.15 95.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.933 -0.395 . . . . 1.0 109.933 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.04 -42.63 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.104 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.488 ' CZ ' ' NZ ' ' A' ' 25' ' ' LYS . 66.4 t80 -62.87 -42.27 99.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.403 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.27 -15.31 60.98 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.843 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -61.87 -42.57 99.22 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.393 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.1 p -77.48 -21.04 53.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.784 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' NZ ' ' CZ ' ' A' ' 21' ' ' TYR . 44.4 mmtm -79.64 176.05 10.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.51 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -100.43 171.58 7.66 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.667 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -61.73 143.58 55.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.822 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.35 10.3 59.55 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.057 -0.817 . . . . 1.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -86.88 137.43 32.4 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -135.52 161.83 34.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.266 0.555 . . . . 1.0 110.836 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 m -147.49 157.28 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.274 -0.875 . . . . 1.0 111.316 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 84.1 mt -118.43 128.41 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.481 ' CZ ' ' OG1' ' A' ' 45' ' ' THR . 23.8 ptt180 -147.34 154.78 41.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.32 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.497 ' NE2' ' OH ' ' A' ' 10' ' ' TYR . 4.2 pt20 -104.7 144.78 31.26 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.3 t -89.32 136.0 33.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.591 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.2 t -60.62 -40.6 92.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.566 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -79.32 -11.41 59.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.577 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -81.94 -68.48 1.45 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.542 -1.023 . . . . 1.0 110.542 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 t0 74.85 -39.88 0.42 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.604 0.24 . . . . 1.0 110.942 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 38' ' ' GLY . 87.5 m-20 -113.58 -11.27 13.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.838 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -117.71 151.14 37.86 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.344 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 mp -117.39 153.83 32.37 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.1 t -127.7 134.91 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.343 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.0 mt -114.24 138.35 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 108.768 -0.827 . . . . 1.0 108.768 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.481 ' OG1' ' CZ ' ' A' ' 33' ' ' ARG . 26.4 m -117.61 138.26 52.07 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.136 0.493 . . . . 1.0 109.805 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.528 ' CZ2' ' OH ' ' A' ' 90' ' ' TYR . 5.2 p-90 -148.93 156.54 42.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.457 -0.792 . . . . 1.0 111.163 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -100.78 140.2 35.41 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.034 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.505 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 8.6 mp -96.53 -68.19 0.81 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.217 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -152.98 147.88 26.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.276 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt 46.73 -127.81 1.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.858 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 16.3 p-10 -93.61 25.99 3.26 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.696 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.69 119.65 32.3 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -123.52 148.38 46.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.3 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -142.3 153.47 43.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.83 -0.623 . . . . 1.0 109.966 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -128.39 142.44 51.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.439 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.3 mt -120.55 125.35 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.001 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -95.29 120.75 36.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.912 0.386 . . . . 1.0 110.378 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.431 HG23 HD12 ' A' ' 58' ' ' ILE . 96.2 mt -98.69 132.13 44.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.431 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -114.68 140.88 48.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 1.0 109.696 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -99.39 157.55 16.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.456 . . . . 1.0 109.862 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.478 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.9 tp -141.77 171.71 13.69 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.485 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.478 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 79.1 mm-40 59.06 28.87 18.27 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.284 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -94.26 48.76 1.25 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.049 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.19 -39.17 86.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.291 -0.868 . . . . 1.0 111.411 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 68' ' ' ALA . 8.9 p30 -113.43 114.44 47.8 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.482 -0.327 . . . . 1.0 110.332 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.06 -13.31 0.92 Allowed 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.854 1.702 . . . . 1.0 112.167 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.6 mt -80.73 -7.56 59.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.433 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.435 ' N ' ' OD1' ' A' ' 65' ' ' ASN . . . -118.66 131.89 56.17 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.974 0.416 . . . . 1.0 110.18 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 71' ' ' LYS . 54.1 mt -76.43 156.46 33.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.288 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -43.62 91.84 0.01 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.594 -1.002 . . . . 1.0 110.594 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 69' ' ' LEU . 7.0 ttpm? -63.52 -31.07 72.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.974 0.416 . . . . 1.0 110.706 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.2 t -128.92 125.21 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.945 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.9 mt -115.77 130.13 56.73 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.89 -0.596 . . . . 1.0 109.424 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.6 mt -100.4 121.67 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 120.869 0.366 . . . . 1.0 110.535 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -141.84 133.11 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.452 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' A' ' 77' ' ' ASN . 90.2 m-20 52.7 47.64 24.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.968 -0.293 . . . . 1.0 111.211 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 77' ' ' ASN . 3.6 p30 56.32 15.79 2.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.123 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -124.76 142.32 51.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.367 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -93.14 131.58 38.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.008 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.07 138.31 53.18 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.199 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -84.42 -37.05 21.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.496 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -117.46 142.14 47.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.887 0.375 . . . . 1.0 111.95 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.97 -40.69 95.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.882 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.61 -41.74 91.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.796 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -59.15 -38.87 80.74 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.637 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.43 -45.11 99.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.678 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.83 -44.67 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.59 -0.444 . . . . 1.0 111.112 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 61.8 t -68.14 -42.32 84.84 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-N 115.92 -0.582 . . . . 1.0 112.282 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -80.37 -13.16 59.39 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.322 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.528 ' OH ' ' CZ2' ' A' ' 46' ' ' TRP . 77.4 t80 -94.39 -50.21 5.34 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.661 -0.416 . . . . 1.0 111.992 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.34 -43.25 86.59 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.539 -0.464 . . . . 1.0 112.197 -177.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 2.9 pt20 -64.01 -47.17 81.31 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.943 -0.703 . . . . 1.0 111.668 -178.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 165' ' ' ASN . 53.9 t-20 -69.19 -43.34 74.38 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.544 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -65.93 -42.53 89.97 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.146 -0.621 . . . . 1.0 111.363 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.524 ' O ' ' ND2' ' A' ' 99' ' ' ASN . 56.1 t -63.64 -47.13 92.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.01 -0.676 . . . . 1.0 111.336 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -68.98 -41.28 78.09 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.567 -0.453 . . . . 1.0 111.512 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 12.3 tp -66.3 -44.37 83.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.806 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 mp -65.37 -43.16 91.67 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.306 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 95' ' ' VAL . 2.7 m-80 -67.17 -37.12 83.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.987 -0.552 . . . . 1.0 111.192 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -71.28 -42.79 68.27 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 121.033 -0.267 . . . . 1.0 111.683 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 tpt -67.63 -54.0 23.32 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.397 -0.521 . . . . 1.0 111.329 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.9 m -58.6 -42.6 88.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.046 0.451 . . . . 1.0 110.335 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.4 t -73.72 8.18 2.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.881 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.8 t -86.24 141.4 29.32 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.64 0.257 . . . . 1.0 110.498 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -65.35 -20.57 66.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.9 0.381 . . . . 1.0 110.773 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.564 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 70.0 mmtt -88.92 38.87 0.9 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.831 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -131.48 111.92 12.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.754 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -118.61 109.66 16.41 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.411 -0.589 . . . . 1.0 109.411 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.2 t -87.56 70.39 9.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.565 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.51 160.85 12.97 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 110.714 -0.954 . . . . 1.0 110.714 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.5 m -70.36 164.17 25.07 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -54.67 -36.13 64.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.743 0.306 . . . . 1.0 110.493 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -66.52 -42.23 87.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.952 0.406 . . . . 1.0 110.553 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -70.29 -21.15 62.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.993 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.75 -45.44 81.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.242 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.46 -44.7 94.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.147 0.499 . . . . 1.0 110.433 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -65.89 -33.63 76.27 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.962 0.41 . . . . 1.0 110.644 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -68.42 -50.07 55.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.535 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.6 tp -69.92 -39.55 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.415 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -64.72 -40.45 95.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.645 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -59.56 -47.56 85.06 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.365 -0.534 . . . . 1.0 110.151 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -61.48 -40.3 94.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.046 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.5 t -62.39 -42.7 99.63 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.534 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -61.6 -40.04 93.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.68 -42.37 86.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.688 -0.405 . . . . 1.0 109.938 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.65 75.23 74.97 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.174 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.09 -14.08 31.68 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.237 1.958 . . . . 1.0 112.496 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.481 ' C ' HD21 ' A' ' 128' ' ' ASN . 0.1 OUTLIER -102.79 11.14 37.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.533 -0.303 . . . . 1.0 111.532 -179.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.439 ' N ' HD21 ' A' ' 128' ' ' ASN . 52.2 mtpt -132.81 147.57 52.31 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.925 0.393 . . . . 1.0 110.497 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.8 p -81.18 162.21 23.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.747 -0.661 . . . . 1.0 109.856 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.8 p -153.59 146.21 14.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.501 ' O ' ' CD1' ' A' ' 133' ' ' TYR . 10.3 p90 -144.94 142.67 30.04 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.907 0.384 . . . . 1.0 111.312 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 26.0 m-85 -152.75 167.64 28.33 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.555 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.564 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 4.1 p90 -135.64 151.8 50.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.423 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.1 p -154.17 170.51 21.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.518 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 tt -84.79 134.36 34.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.679 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 138' ' ' HIS . 69.3 m-80 -159.51 166.78 30.14 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.918 -0.401 . . . . 1.0 109.918 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.46 ' O ' ' OD1' ' A' ' 139' ' ' ASP . 3.9 t60 76.21 -158.48 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.462 -0.336 . . . . 1.0 110.733 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 138' ' ' HIS . 92.8 m-20 -142.67 64.07 1.38 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.592 ' O ' ' N ' ' A' ' 142' ' ' GLY . 2.7 m120 -129.33 156.01 79.11 Favored Pre-proline 0 CA--C 1.53 0.176 0 N-CA-C 108.897 -0.779 . . . . 1.0 108.897 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -42.81 78.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.753 2.302 . . . . 1.0 113.046 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 140' ' ' ASN . . . 52.07 64.35 4.05 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.247 -0.741 . . . . 1.0 111.247 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -94.94 152.5 18.29 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.674 -0.491 . . . . 1.0 109.674 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -121.05 153.15 37.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.798 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -127.16 127.97 45.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.872 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.1 mt -95.47 123.02 38.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.003 0.43 . . . . 1.0 110.982 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.64 145.61 46.3 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.127 -1.064 . . . . 1.0 108.127 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -159.79 157.59 29.57 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.299 -0.56 . . . . 1.0 109.944 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.554 ' NZ ' ' O ' ' A' ' 151' ' ' ASN . 36.6 tttm -142.87 126.28 16.69 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 120.668 -0.413 . . . . 1.0 110.056 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 151' ' ' ASN . 4.7 tp -78.84 -45.64 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.802 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.554 ' O ' ' NZ ' ' A' ' 149' ' ' LYS . 29.4 m120 -144.86 157.98 43.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.842 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.03 -26.5 68.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.875 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -83.25 -16.43 46.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.177 0.513 . . . . 1.0 110.199 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.496 ' O ' ' NZ ' ' A' ' 149' ' ' LYS . 14.1 t -77.94 170.51 16.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.153 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -97.31 155.03 17.06 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.367 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.22 120.03 18.27 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.26 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -106.04 127.17 52.99 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.107 -0.497 . . . . 1.0 109.839 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 95.9 m -128.62 130.87 47.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.994 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -118.88 170.1 9.3 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.863 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 161' ' ' VAL . 2.7 t-20 -111.83 147.39 35.84 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.8 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.42 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 48.1 t -128.21 135.62 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.504 ' NZ ' ' CG2' ' A' ' 164' ' ' THR . 17.1 ttpp -101.56 130.72 47.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.869 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.2 tp -88.91 130.69 35.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.686 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.504 ' CG2' ' NZ ' ' A' ' 162' ' ' LYS . 66.2 p -129.28 171.46 12.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.582 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.533 ' O ' ' ND2' ' A' ' 93' ' ' ASN . 14.4 p30 -83.84 13.97 4.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.67 -0.696 . . . . 1.0 110.472 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 25.1 p -121.76 -2.22 9.35 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.606 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 139.4 -126.37 3.3 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.303 -1.119 . . . . 1.0 110.303 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -127.41 127.31 43.93 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.652 0.263 . . . . 1.0 110.635 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.514 ' CE1' ' OD1' ' A' ' 174' ' ' ASN . 4.3 m-85 -100.87 124.47 46.58 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.8 tt -116.83 111.16 19.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.572 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 170' ' ' LEU . 4.7 t 35.49 63.44 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.6 m120 67.29 26.28 8.6 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -132.87 121.45 22.92 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.514 ' OD1' ' CE1' ' A' ' 169' ' ' PHE . 63.7 t30 -98.24 120.65 39.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.944 0.402 . . . . 1.0 111.635 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -105.13 125.61 33.15 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.2 -20.6 18.72 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.33 2.02 . . . . 1.0 113.504 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.2 m -137.2 141.39 42.13 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.982 0.42 . . . . 1.0 111.07 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.08 -34.67 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.575 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.51 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 96.8 mt -62.08 -44.31 98.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.635 -0.426 . . . . 1.0 109.934 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -68.86 -30.26 68.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.1 tp -63.53 -43.24 97.72 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.205 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 7.7 p -62.87 -47.43 83.37 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.52 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.583 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 42.8 m-80 -65.01 -48.03 75.38 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.944 -0.761 . . . . 1.0 108.944 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.84 -44.85 1.0 Allowed Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.818 -1.313 . . . . 1.0 109.818 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -69.13 -47.05 66.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.9 tttm -56.12 -41.23 74.97 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.327 -0.851 . . . . 1.0 110.039 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 94.0 m -61.39 -45.04 96.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 51.7 mt -62.86 -41.08 99.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.001 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.43 -44.16 92.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.323 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.42 -45.09 95.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.243 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 37.0 t -64.09 -38.87 92.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.804 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.2 mt -63.17 -41.95 99.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.61 -0.723 . . . . 1.0 111.608 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -59.96 -23.53 63.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.609 0.243 . . . . 1.0 111.555 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . 0.417 ' CG ' ' O ' ' A' ' 194' ' ' HIS . 47.7 t-80 -81.07 9.98 5.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.785 0.326 . . . . 1.0 110.906 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.41 ' O ' ' N ' ' A' ' 197' ' ' HIS . 16.5 t60 71.67 23.58 3.7 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.969 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.425 ' CG ' ' N ' ' A' ' 197' ' ' HIS . 33.6 t-80 37.44 -96.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.372 -0.377 . . . . 1.0 111.083 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.521 ' ND1' ' N ' ' A' ' 198' ' ' HIS . 56.9 t-80 48.9 -111.3 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.687 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.521 ' N ' ' ND1' ' A' ' 197' ' ' HIS . 51.5 t-80 -81.94 136.65 35.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.738 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.001 -1.0 . . . . 1.0 110.506 179.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -107.64 -22.69 12.41 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.682 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -143.02 8.55 1.66 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.806 0.336 . . . . 1.0 110.53 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.36 -37.03 79.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.676 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.3 pt -62.34 -26.45 40.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.363 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -74.9 -13.28 60.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.477 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -79.21 115.67 54.53 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.284 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 76.6 Cg_exo -48.38 -24.9 6.64 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.869 1.712 . . . . 1.0 112.305 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -81.73 3.95 23.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.184 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 91.9 t80 -85.95 132.8 34.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.594 -0.275 . . . . 1.0 110.436 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 62.1 m-85 -150.77 123.58 4.18 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 120.995 -0.282 . . . . 1.0 110.476 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.474 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 73.7 Cg_endo -73.83 110.21 3.03 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.935 1.757 . . . . 1.0 112.631 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.474 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 74.1 m-85 -159.82 154.64 24.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.338 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -80.86 166.29 21.06 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.632 ' N ' ' NH1' ' A' ' 33' ' ' ARG . . . -57.03 -46.89 90.99 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.756 -0.938 . . . . 1.0 110.756 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -65.51 -39.01 91.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.59 0.233 . . . . 1.0 110.736 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -66.14 -37.14 84.96 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.696 -0.229 . . . . 1.0 111.205 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.22 95.54 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.659 -0.417 . . . . 1.0 110.31 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -61.43 -46.5 89.86 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.669 -0.412 . . . . 1.0 109.948 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -62.28 -43.36 98.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.315 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -63.08 -44.48 95.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.56 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.8 mp -75.02 -13.6 60.52 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.647 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -60.97 -41.92 97.31 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.39 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.9 t -74.93 -18.54 60.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.503 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -85.46 -175.66 5.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.788 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 45.4 mp0 -99.72 -179.25 4.13 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.472 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -81.41 145.56 30.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.634 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.39 8.0 53.46 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.143 -0.783 . . . . 1.0 111.143 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -95.77 139.63 31.72 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.387 -0.598 . . . . 1.0 109.387 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -131.05 167.96 18.2 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.284 0.564 . . . . 1.0 111.133 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -148.81 159.54 6.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.19 -0.913 . . . . 1.0 111.414 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.56 127.11 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.338 -0.616 . . . . 1.0 109.338 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.632 ' NH1' ' N ' ' A' ' 15' ' ' GLY . 44.4 ttp180 -134.39 153.58 51.82 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.152 -0.476 . . . . 1.0 109.752 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -105.83 131.23 53.42 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.673 -0.492 . . . . 1.0 109.673 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -77.56 124.3 27.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.867 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.8 p -63.76 -38.82 92.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.625 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -79.11 -25.09 43.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.797 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -69.99 -53.85 13.58 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.54 -1.024 . . . . 1.0 110.54 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t0 70.7 -42.45 0.53 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.725 0.298 . . . . 1.0 111.034 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 38' ' ' GLY . 98.2 m-20 -119.45 19.92 12.58 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.65 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -140.27 150.71 44.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.669 0.271 . . . . 1.0 110.475 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.03 151.36 39.11 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.844 -0.428 . . . . 1.0 109.844 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.1 t -126.19 133.81 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.587 0.232 . . . . 1.0 110.727 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.3 mt -110.55 136.31 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.9 m -117.63 139.31 51.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.006 -0.543 . . . . 1.0 109.635 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.562 ' CE2' ' OH ' ' A' ' 90' ' ' TYR . 3.7 p-90 -143.3 153.1 42.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.776 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' A' ' 49' ' ' ASP . 64.7 tttp -101.4 133.3 46.22 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.829 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.1 mp -96.07 -75.51 0.53 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.503 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.511 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 72.4 m-20 -109.99 -167.81 1.24 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.872 -0.603 . . . . 1.0 110.596 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.489 ' C ' ' HZ1' ' A' ' 47' ' ' LYS . 56.7 mtpt -60.38 -42.31 95.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.775 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -128.43 56.94 1.6 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.797 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 44.5 tp -153.59 115.48 4.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.913 0.387 . . . . 1.0 110.081 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -124.88 148.19 48.41 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.33 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -136.87 152.69 50.53 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.971 -0.558 . . . . 1.0 110.283 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -129.9 144.39 51.29 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.661 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.0 mt -125.36 131.52 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.228 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 19.3 p-10 -98.27 122.79 41.87 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.978 0.418 . . . . 1.0 110.84 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.421 HG23 HD12 ' A' ' 58' ' ' ILE . 91.2 mt -101.13 133.75 43.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.385 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 59' ' ' GLN . 1.2 pm0 -120.12 132.49 55.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -99.99 144.54 28.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.103 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.613 ' CD1' ' H ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -135.91 173.48 11.66 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.158 0.504 . . . . 1.0 109.947 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.613 ' H ' ' CD1' ' A' ' 61' ' ' LEU . 13.1 tp10 87.32 33.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.677 -1.147 . . . . 1.0 109.922 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -92.33 76.26 5.23 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.756 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.4 ' O ' ' OD1' ' A' ' 65' ' ' ASN . 12.5 pt-20 -64.99 -36.48 84.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.813 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 64' ' ' GLU . 4.9 m-20 -136.15 153.66 76.82 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.305 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.12 -33.26 53.03 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.769 1.646 . . . . 1.0 112.29 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.7 mt -84.6 -6.72 59.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.373 . . . . 1.0 110.383 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.19 127.33 35.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.273 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.0 mt -86.03 153.73 21.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.302 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.9 95.51 0.41 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.313 -1.115 . . . . 1.0 110.313 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -71.92 -15.41 62.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.927 0.394 . . . . 1.0 110.684 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.2 t -118.26 120.35 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.669 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.2 mt -113.82 126.02 54.73 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.9 mt -102.08 123.64 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.882 0.372 . . . . 1.0 110.653 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.435 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 57.8 t -142.88 134.18 23.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.976 -0.557 . . . . 1.0 110.34 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.437 ' O ' ' OD2' ' A' ' 76' ' ' ASP . 3.4 p-10 48.67 44.32 21.23 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.216 0.323 . . . . 1.0 111.263 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 59.69 23.18 11.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.038 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -129.15 138.38 51.74 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.358 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -92.23 132.16 36.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 1.0 111.11 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -126.88 138.07 53.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.263 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -82.76 -37.73 24.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.821 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -109.48 133.34 53.2 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.005 0.431 . . . . 1.0 112.028 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.4 tp -64.41 -40.73 96.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.503 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -62.06 -43.23 99.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.501 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.46 ' O ' ' OE1' ' A' ' 89' ' ' GLU . 32.8 tt0 -58.39 -38.3 77.05 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.345 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.1 mt -59.66 -45.31 94.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.753 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -62.57 -47.42 93.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.429 -0.508 . . . . 1.0 111.607 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.1 t -69.86 -23.56 25.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 112.967 0.728 . . . . 1.0 112.967 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 85' ' ' GLN . 4.5 mp0 -98.1 -9.59 25.64 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.142 -0.223 . . . . 1.0 111.054 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.562 ' OH ' ' CE2' ' A' ' 46' ' ' TRP . 12.5 t80 -89.38 -54.58 4.03 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.913 0.709 . . . . 1.0 112.913 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -71.59 -33.56 69.14 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.706 -0.679 . . . . 1.0 112.107 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.435 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 3.5 mm-40 -61.2 -48.68 80.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.07 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -67.72 -40.53 84.21 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.068 -0.653 . . . . 1.0 111.448 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -63.11 -42.6 99.59 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.438 -0.505 . . . . 1.0 111.275 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.93 -45.88 93.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.331 -0.548 . . . . 1.0 111.279 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -66.8 -45.4 78.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.383 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tp -69.04 -41.16 78.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.55 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.44 -42.25 92.61 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.472 -0.491 . . . . 1.0 110.053 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -66.38 -39.92 89.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.382 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -71.18 -42.81 68.56 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 120.781 -0.368 . . . . 1.0 111.783 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.465 ' O ' ' OG ' ' A' ' 104' ' ' SER . 4.1 tpt -63.96 -54.01 41.24 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.349 -0.54 . . . . 1.0 111.096 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.7 m -61.26 -39.36 90.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.48 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.2 t -73.16 9.77 1.15 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.911 -0.586 . . . . 1.0 111.224 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 101' ' ' MET . 87.1 p -88.03 139.22 30.73 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.681 0.277 . . . . 1.0 110.725 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.68 -22.32 66.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.996 0.427 . . . . 1.0 110.626 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.564 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 31.5 mtmm -88.2 39.63 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.804 -0.635 . . . . 1.0 109.828 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -129.84 114.02 15.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.068 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -122.75 124.66 43.86 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -93.65 68.09 3.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.826 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.13 147.51 16.84 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 29.2 p -72.42 172.08 11.09 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -55.9 -37.66 69.18 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.364 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -67.47 -45.07 77.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.841 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.73 -20.37 63.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.781 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.71 -44.82 78.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.343 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.58 -46.38 95.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.207 0.527 . . . . 1.0 110.178 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -65.77 -33.99 77.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.829 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -68.31 -50.23 54.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.795 -0.639 . . . . 1.0 111.679 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.4 tp -69.99 -39.4 77.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.682 -0.407 . . . . 1.0 110.457 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.535 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 66.8 mm-40 -63.75 -40.56 97.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.716 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -63.43 -46.85 84.39 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.11 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.537 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 9.2 t80 -61.92 -41.83 98.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.14 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.5 t -62.28 -40.53 96.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.41 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -57.74 -44.03 85.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.315 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.47 -38.89 83.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.368 -0.605 . . . . 1.0 109.368 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.537 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -124.56 76.25 63.34 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.598 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -70.5 -24.56 26.14 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.799 2.333 . . . . 1.0 112.514 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -100.94 13.54 34.81 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.867 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.33 151.0 51.84 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.846 0.355 . . . . 1.0 110.482 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 m -80.91 160.87 24.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.887 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.2 p -153.05 149.81 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 109.36 -0.607 . . . . 1.0 109.36 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -151.0 143.44 24.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.922 0.392 . . . . 1.0 111.307 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -151.37 165.13 35.03 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.374 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.564 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.6 p90 -136.08 148.55 48.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 1.0 109.481 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 75.1 m -143.92 167.77 21.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.088 0.471 . . . . 1.0 110.214 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.8 tt -83.61 131.72 34.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.252 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -104.31 133.45 49.18 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.221 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -85.81 0.81 51.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.846 0.355 . . . . 1.0 110.585 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 139' ' ' ASP . 66.4 t0 -64.13 -37.9 89.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.127 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -150.81 104.59 3.04 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.085 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -48.65 124.04 10.38 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.597 1.531 . . . . 1.0 112.78 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.99 29.5 9.02 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.839 -0.905 . . . . 1.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -134.9 142.21 46.51 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.676 0.274 . . . . 1.0 110.32 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -122.16 146.49 47.18 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.625 ' CE2' ' ND2' ' A' ' 160' ' ' ASN . 13.6 m-85 -117.89 138.68 51.96 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.188 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.3 mt -110.44 120.95 44.08 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.617 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.57 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -116.07 145.01 43.37 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.988 -1.115 . . . . 1.0 107.988 178.02 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -161.68 149.74 15.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.39 -0.524 . . . . 1.0 109.679 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.535 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 67.0 tttt -135.4 130.39 34.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 120.934 -0.306 . . . . 1.0 110.257 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.439 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 28.9 mm -71.04 -45.03 74.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 1.0 111.348 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 150' ' ' ILE . 82.7 m-20 -160.31 174.23 14.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.665 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.92 -36.11 80.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.985 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -86.4 8.61 20.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.008 0.432 . . . . 1.0 110.531 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.3 t -96.9 157.53 15.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.516 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.431 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 68.8 mttm -88.16 143.24 27.17 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.216 -0.447 . . . . 1.0 109.891 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 43.6 tp -70.28 130.14 41.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.909 0.385 . . . . 1.0 110.141 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.431 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 93.6 m-85 -119.83 135.09 55.0 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.803 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 91.3 m -129.99 132.69 46.37 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.932 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.77 169.06 11.47 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.124 -0.489 . . . . 1.0 109.961 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.625 ' ND2' ' CE2' ' A' ' 145' ' ' TYR . 5.8 m120 -117.17 150.57 38.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.885 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 78.5 t -128.26 137.96 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.804 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -100.24 125.77 46.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.984 0.421 . . . . 1.0 110.592 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.9 tp -88.39 130.68 35.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.788 -0.642 . . . . 1.0 109.372 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 37.6 p -128.82 176.67 7.65 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.93 0.395 . . . . 1.0 110.445 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -88.98 13.49 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.36 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 12.5 p -121.65 -2.5 9.37 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.814 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.35 -140.56 10.68 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.36 -1.096 . . . . 1.0 110.36 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -116.42 126.99 54.21 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.616 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 7.7 m-85 -106.43 117.8 34.99 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.0 tt -113.45 117.66 32.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.7 -0.482 . . . . 1.0 109.7 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.4 t 36.25 60.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.088 0.403 . . . . 1.0 112.088 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.7 m120 65.19 27.91 12.19 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.061 0.763 . . . . 1.0 113.061 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -133.87 120.79 20.85 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.616 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 16.4 t-20 -97.48 121.19 39.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.532 -0.304 . . . . 1.0 111.435 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -101.8 137.21 19.48 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.78 -21.4 33.46 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 122.412 2.075 . . . . 1.0 113.134 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 4.5 t -156.48 160.82 39.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.111 0.481 . . . . 1.0 111.002 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.98 -34.83 61.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.795 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 93.3 mt -61.75 -44.96 99.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.081 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -69.7 -29.81 67.32 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.65 -43.87 95.5 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 110.118 -0.327 . . . . 1.0 110.118 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 86.9 m -63.22 -46.22 87.98 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.386 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.554 ' O ' ' N ' ' A' ' 186' ' ' LYS . 88.8 m-20 -64.33 -48.18 76.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.17 -44.73 0.57 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.05 -47.52 65.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.048 -0.576 . . . . 1.0 109.781 178.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 183' ' ' ASN . 64.9 tttp -56.82 -41.7 78.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.591 -0.731 . . . . 1.0 110.227 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.5 m -61.45 -44.8 96.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.451 ' O ' ' OG ' ' A' ' 191' ' ' SER . 23.1 mt -62.94 -40.47 97.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.857 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.51 -43.94 93.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.23 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -58.7 -45.96 88.36 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.269 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 188' ' ' LEU . 80.0 p -62.1 -37.36 84.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.5 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.44 ' N ' ' HG ' ' A' ' 191' ' ' SER . 73.4 mt -67.47 -42.93 82.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.347 -0.842 . . . . 1.0 111.923 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -69.15 -34.47 75.04 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 111.871 0.323 . . . . 1.0 111.871 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . 0.544 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 6.0 t60 -82.03 1.47 35.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.011 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.544 ' CG ' ' O ' ' A' ' 194' ' ' HIS . 32.8 p80 42.67 24.29 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.965 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.411 ' N ' ' C ' ' A' ' 194' ' ' HIS . 24.0 t-80 -86.31 130.9 34.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.68 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -45.66 107.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.295 -0.412 . . . . 1.0 110.632 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -77.04 93.82 3.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.695 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 77.4 m80 . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.66 179.789 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 27.6 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -127.7 -6.71 5.68 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.527 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -129.45 -1.93 4.95 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.609 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.72 -25.94 38.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.698 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.468 ' H ' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -78.91 -17.63 13.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.39 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.497 ' N ' HD21 ' A' ' 6' ' ' ASN . 2.0 m120 -98.67 3.5 47.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.413 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -77.56 143.1 67.43 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.305 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.419 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 56.3 Cg_endo -70.65 -13.83 32.76 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.855 1.703 . . . . 1.0 112.243 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.472 ' CD1' ' CZ ' ' A' ' 30' ' ' PHE . 88.6 m-85 -94.53 3.94 54.48 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.533 -0.303 . . . . 1.0 111.128 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.545 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 88.1 t80 -87.29 127.72 35.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.488 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 68.4 m-85 -155.04 106.93 2.28 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.974 -0.38 . . . . 1.0 109.974 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.5 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 32.5 Cg_exo -59.15 110.87 0.76 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.716 1.611 . . . . 1.0 112.926 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.5 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 57.0 m-85 -159.64 150.95 19.79 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.425 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -78.51 171.97 14.34 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.11 -41.22 98.54 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.34 -0.933 . . . . 1.0 111.062 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.416 ' O ' ' CG ' ' A' ' 19' ' ' GLU . 84.9 mtt85 -66.41 -42.35 87.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.884 0.373 . . . . 1.0 110.861 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -71.84 -31.97 67.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.17 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.43 -48.51 79.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.825 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 16' ' ' ARG . 14.4 pt-20 -60.32 -39.08 85.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.023 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.403 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 9.2 m-20 -63.95 -43.61 95.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.078 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.635 ' CE2' ' NZ ' ' A' ' 25' ' ' LYS . 42.5 t80 -67.4 -41.59 84.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.446 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.24 -11.2 60.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.749 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -59.18 -44.51 92.17 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.867 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 m -78.67 -19.03 53.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.765 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.635 ' NZ ' ' CE2' ' A' ' 21' ' ' TYR . 43.8 mmtm -72.91 159.1 34.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.543 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.54 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.6 pm0 -82.34 156.74 24.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.637 . . . . 1.0 110.657 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.417 ' HG2' ' HZ1' ' A' ' 47' ' ' LYS . 81.2 mtm-85 -54.05 141.62 27.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.907 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.01 17.63 50.44 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.305 -0.718 . . . . 1.0 111.305 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -94.96 136.51 35.18 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.472 ' CZ ' ' CD1' ' A' ' 9' ' ' TYR . 26.0 p90 -133.78 167.62 20.22 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.355 0.598 . . . . 1.0 110.883 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.2 m -146.77 157.76 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 114.924 -1.034 . . . . 1.0 111.64 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.0 mm -116.32 125.84 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.262 -0.644 . . . . 1.0 109.262 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -140.12 165.16 28.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.064 -0.517 . . . . 1.0 110.461 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -118.53 135.53 54.35 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 m -65.04 146.0 55.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.801 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.5 m -60.49 -26.01 66.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.692 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -123.29 27.19 7.63 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.036 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -92.49 -77.24 1.36 Allowed Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 t0 70.81 -35.49 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.623 0.249 . . . . 1.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 38' ' ' GLY . 21.1 t70 -118.63 10.49 12.52 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.754 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.443 ' ND1' ' O ' ' A' ' 40' ' ' ASP . 25.0 m-70 -142.31 151.99 42.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.381 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mt -121.13 145.58 47.66 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.076 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.9 t -123.62 129.48 74.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.096 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.3 mt -111.51 137.66 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.5 m -121.63 141.71 50.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.437 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.709 ' HE1' ' NE2' ' A' ' 54' ' ' GLN . 3.5 p-90 -154.04 154.79 34.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.215 -0.902 . . . . 1.0 110.972 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HZ1' ' HG2' ' A' ' 27' ' ' ARG . 10.6 ptmm? -95.7 143.72 26.72 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.148 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.532 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 3.3 mp -93.02 -73.06 0.57 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.458 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -145.26 119.08 9.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.594 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt 45.0 -129.13 1.05 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.064 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -70.94 73.95 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.068 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.4 tp -167.56 121.38 0.96 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.272 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -135.15 150.37 50.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.628 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.709 ' NE2' ' HE1' ' A' ' 46' ' ' TRP . 20.3 pt20 -135.8 155.05 50.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.714 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.402 ' H ' ' CD2' ' A' ' 55' ' ' HIS . 6.8 p80 -124.04 141.27 52.19 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.067 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.4 HD13 HG22 ' A' ' 56' ' ' ILE . 96.7 mt -126.44 132.47 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.743 -0.466 . . . . 1.0 109.743 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -102.23 123.81 46.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.894 0.378 . . . . 1.0 110.534 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.405 HG21 HD12 ' A' ' 58' ' ' ILE . 86.3 mt -103.1 133.87 45.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.343 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -112.95 141.78 46.39 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.869 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.545 ' OE1' ' NZ ' ' A' ' 63' ' ' LYS . 78.8 mt-10 -99.79 148.51 24.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.813 -0.44 . . . . 1.0 109.813 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.417 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.6 tp -122.73 176.22 6.08 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.579 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 69.9 mm-40 57.66 32.34 21.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.022 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.545 ' NZ ' ' OE1' ' A' ' 60' ' ' GLU . 20.1 mmtm -78.65 74.13 5.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.881 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.7 -29.51 70.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.707 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -150.31 149.11 25.96 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.068 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.62 -25.14 66.14 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.268 1.979 . . . . 1.0 112.13 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mp -91.27 -11.09 39.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.722 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.34 140.07 50.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.371 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.2 mt -77.14 148.89 35.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.377 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.47 92.39 0.27 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -63.17 -35.2 79.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.831 0.348 . . . . 1.0 110.875 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.1 t -127.11 125.06 65.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.073 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.1 mt -115.23 129.63 56.69 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.411 HG23 HD13 ' A' ' 74' ' ' ILE . 18.5 mm -99.41 123.54 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.933 0.397 . . . . 1.0 110.298 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.3 t -139.88 130.47 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.28 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 54.24 40.7 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.954 -0.298 . . . . 1.0 111.096 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.6 t30 62.0 24.05 14.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.729 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -128.21 151.78 48.85 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.264 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -96.65 130.78 43.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.81 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -125.07 138.43 54.19 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.198 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -85.91 -38.02 18.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.731 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -121.36 145.6 47.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.173 0.511 . . . . 1.0 112.039 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.51 -38.41 89.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.615 -0.72 . . . . 1.0 110.802 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -60.72 -39.89 90.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.934 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -63.12 -38.67 92.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.649 0.261 . . . . 1.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.2 mt -60.98 -46.3 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.873 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.7 mt -62.9 -46.14 97.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.581 -0.448 . . . . 1.0 111.669 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.68 -43.7 79.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 112.495 0.554 . . . . 1.0 112.495 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -75.9 -14.12 60.26 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.799 -0.36 . . . . 1.0 111.511 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -94.14 -50.77 5.13 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.638 -0.425 . . . . 1.0 111.825 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 tp -68.85 -39.97 79.62 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.301 0.482 . . . . 1.0 112.301 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -62.94 -48.91 76.85 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 119.971 -0.691 . . . . 1.0 111.379 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -69.57 -42.41 74.54 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.691 -0.403 . . . . 1.0 111.696 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -65.92 -42.55 89.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.218 -0.593 . . . . 1.0 111.191 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.86 -45.13 92.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.495 -0.482 . . . . 1.0 111.296 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -67.1 -44.9 78.79 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.86 -0.336 . . . . 1.0 111.563 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 tp -68.58 -41.77 79.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.501 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.3 tp -63.52 -43.07 98.25 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.193 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.427 ' O ' ' OG ' ' A' ' 103' ' ' SER . 3.2 m-80 -68.63 -37.66 79.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.026 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -70.4 -43.17 70.59 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.686 -0.406 . . . . 1.0 111.562 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.2 tpt -66.28 -55.06 17.93 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.279 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 104' ' ' SER . 9.7 m -58.34 -38.42 77.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.028 0.442 . . . . 1.0 110.349 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 99' ' ' ASN . 86.7 p -72.36 10.57 0.76 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.634 -0.712 . . . . 1.0 111.049 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.441 ' H ' ' C ' ' A' ' 102' ' ' THR . 11.7 t -91.84 134.16 35.01 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.832 0.349 . . . . 1.0 110.248 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.31 -20.81 46.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 1.0 111.196 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.58 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 45.9 mtpt -87.9 40.63 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.943 -0.571 . . . . 1.0 109.761 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -130.68 109.14 10.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.135 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -134.8 124.93 25.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.732 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.2 p -92.61 82.8 4.82 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.879 0.371 . . . . 1.0 110.933 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -103.84 147.89 16.78 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.887 -0.885 . . . . 1.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.6 p -73.53 168.48 19.2 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.007 -0.368 . . . . 1.0 110.007 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -58.89 -40.57 84.85 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.743 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -70.83 -44.0 67.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.183 0.516 . . . . 1.0 110.641 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.54 -22.57 63.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.994 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.7 t -68.11 -44.76 84.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.089 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.5 t -63.91 -45.85 95.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.098 0.475 . . . . 1.0 110.263 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.38 -38.65 90.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.977 0.418 . . . . 1.0 111.034 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -64.44 -49.47 71.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.778 -0.647 . . . . 1.0 111.834 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.0 tp -70.24 -38.4 74.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.485 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.447 ' C ' ' HG ' ' A' ' 123' ' ' SER . 83.0 mt-10 -62.22 -41.28 98.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.547 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.71 -48.46 74.57 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.45 -0.5 . . . . 1.0 110.255 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.552 ' CD2' ' OD1' ' A' ' 126' ' ' ASN . 39.8 t80 -61.55 -42.42 98.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.944 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.447 ' HG ' ' C ' ' A' ' 120' ' ' GLU . 96.4 p -57.77 -39.17 76.8 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.272 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -64.42 -37.52 87.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.248 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.4 t -64.8 -40.38 88.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.554 -0.536 . . . . 1.0 109.554 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.552 ' OD1' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -126.55 75.56 74.36 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.385 179.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.567 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 6.6 Cg_exo -71.52 -25.47 21.1 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.485 2.123 . . . . 1.0 112.584 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -99.35 13.48 33.03 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.188 -0.46 . . . . 1.0 112.05 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -136.24 150.41 48.95 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.931 0.396 . . . . 1.0 110.445 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.9 p -80.12 164.32 23.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.742 -0.663 . . . . 1.0 109.79 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 p -153.09 147.41 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -149.16 142.82 25.5 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.861 0.362 . . . . 1.0 111.125 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -153.15 170.5 20.37 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.313 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -135.95 157.08 47.72 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.9 p -151.02 168.0 25.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.356 -0.383 . . . . 1.0 110.296 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.3 tp -78.38 135.01 37.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.442 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 8.4 t-20 -63.25 -176.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.201 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.469 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 8.3 p-80 -138.52 -23.41 0.97 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.707 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -107.31 -10.22 15.85 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.032 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 29.3 m120 -136.93 80.09 37.02 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.413 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.65 128.61 30.72 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.013 1.809 . . . . 1.0 112.469 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.3 -19.92 41.52 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -98.86 149.33 23.02 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 110.0 -0.371 . . . . 1.0 110.0 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -118.13 153.73 33.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.524 . . . . 1.0 109.747 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.45 ' CE1' ' ND2' ' A' ' 137' ' ' ASN . 33.1 m-85 -126.82 137.49 53.2 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.016 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.6 mt -108.07 128.93 55.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.31 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -120.36 146.41 46.19 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.837 -1.172 . . . . 1.0 107.837 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -160.38 146.56 15.37 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -130.41 126.51 37.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 120.814 -0.354 . . . . 1.0 110.285 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -72.92 -45.99 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.32 0.489 . . . . 1.0 112.32 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.567 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 15.6 t-20 -153.55 168.03 27.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.522 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.561 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -61.67 -30.68 70.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.689 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.417 ' ND2' ' C ' ' A' ' 153' ' ' ASN . 0.2 OUTLIER -85.73 -12.5 50.98 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.336 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.7 t -78.77 157.09 28.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.036 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -87.47 148.18 25.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.193 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.3 tp -73.02 122.94 22.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.987 0.422 . . . . 1.0 109.902 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -113.38 132.92 55.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.917 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.7 m -126.96 131.83 50.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.756 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -116.09 163.67 15.6 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.995 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 161' ' ' VAL . 28.5 t-20 -107.54 147.74 30.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.634 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.414 ' N ' ' OD1' ' A' ' 160' ' ' ASN . 44.8 t -127.71 134.79 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.597 -0.52 . . . . 1.0 109.597 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -100.55 128.44 46.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.953 0.406 . . . . 1.0 110.436 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.7 tp -92.84 131.07 38.2 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 70.4 p -129.53 171.25 12.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.39 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -85.16 15.47 4.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.55 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 58.3 p -123.21 -2.99 8.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.466 -0.334 . . . . 1.0 110.549 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 142.74 -138.2 8.22 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.357 -1.097 . . . . 1.0 110.357 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -118.69 128.58 54.65 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.115 -0.328 . . . . 1.0 110.115 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.491 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 4.7 m-85 -103.16 125.94 50.09 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 171' ' ' VAL . 0.8 OUTLIER -119.05 113.93 21.72 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.6 t 36.64 59.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 111.886 0.328 . . . . 1.0 111.886 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.5 m120 66.96 27.87 8.72 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.913 0.709 . . . . 1.0 112.913 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -132.62 121.7 23.59 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.491 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 28.0 t-20 -94.44 119.3 32.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.253 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -99.33 132.13 23.86 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 109.63 -0.507 . . . . 1.0 109.63 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.05 -22.53 19.36 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.985 1.79 . . . . 1.0 113.5 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.8 p -150.37 153.81 36.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.917 0.389 . . . . 1.0 110.939 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.05 -35.5 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.851 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.97 -47.71 90.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.152 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.35 -31.95 73.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.16 -42.14 99.36 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.401 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.467 ' SG ' ' NZ ' ' A' ' 106' ' ' LYS . 75.9 m -62.97 -46.83 85.86 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.745 -0.382 . . . . 1.0 110.343 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 186' ' ' LYS . 35.8 m-80 -64.92 -49.43 70.43 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 108.712 -0.847 . . . . 1.0 108.712 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.18 -46.19 0.49 Allowed Glycine 0 N--CA 1.466 0.657 0 N-CA-C 109.998 -1.241 . . . . 1.0 109.998 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -45.12 71.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.249 0.547 . . . . 1.0 110.046 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 183' ' ' ASN . 17.6 tptm -57.75 -44.36 86.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.242 -0.89 . . . . 1.0 110.467 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 14.4 m -61.19 -45.57 94.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.77 -42.1 98.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.079 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.1 tp -58.34 -43.6 88.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.526 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -59.03 -42.95 91.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.342 0.592 . . . . 1.0 110.228 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.3 t -66.21 -42.68 88.4 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.19 0.519 . . . . 1.0 110.207 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.88 -46.38 85.2 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.303 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.51 -30.09 69.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.456 -0.338 . . . . 1.0 111.679 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -95.47 -9.45 32.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.902 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 73.1 m80 50.8 54.68 10.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.848 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -86.85 103.82 15.62 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.478 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.404 ' CG ' ' O ' ' A' ' 197' ' ' HIS . 85.8 t60 -106.29 54.48 0.68 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.499 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 34.4 m170 47.01 66.26 1.04 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.853 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.925 -1.036 . . . . 1.0 110.755 179.853 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 70.16 16.09 7.47 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.357 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 171.44 27.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.838 0.711 . . . . 1.0 110.387 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.2 p -64.69 -39.08 84.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.71 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.8 pt -67.49 -29.99 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.793 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -95.73 10.35 37.24 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.362 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -66.36 133.65 94.49 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.295 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.536 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 78.4 Cg_exo -48.65 -34.14 26.2 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.834 1.69 . . . . 1.0 112.398 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CE2' ' CZ ' ' A' ' 30' ' ' PHE . 90.6 m-85 -79.66 4.15 16.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.398 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.599 ' HH ' HE21 ' A' ' 34' ' ' GLN . 55.3 t80 -87.19 128.14 35.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.454 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CZ ' ' O ' ' A' ' 8' ' ' PRO . 67.6 m-85 -150.83 115.29 3.22 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.59 112.28 3.49 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.95 1.767 . . . . 1.0 113.623 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.582 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -159.03 165.33 34.22 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.375 0.607 . . . . 1.0 111.187 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 51.4 t-20 -76.71 163.7 26.57 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.506 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . -59.68 -40.2 96.19 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.876 -0.89 . . . . 1.0 110.876 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -64.83 -45.14 87.4 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.994 -0.283 . . . . 1.0 111.033 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -70.0 -36.98 75.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.506 -0.316 . . . . 1.0 111.464 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -42.9 99.36 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.42 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.69 -42.21 82.4 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.118 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -61.82 -40.1 94.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.178 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -64.31 -40.52 96.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.659 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.42 -13.27 59.92 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.019 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -59.24 -42.54 91.34 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.644 -0.423 . . . . 1.0 110.561 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 m -77.97 -19.41 54.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.681 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -79.06 171.41 15.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.003 0.43 . . . . 1.0 110.858 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -77.01 155.52 32.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.786 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -69.08 145.84 53.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.4 2.54 60.28 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.08 -0.808 . . . . 1.0 111.08 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -79.01 154.17 29.7 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.617 ' CZ ' ' CE2' ' A' ' 9' ' ' TYR . 37.5 p90 -138.71 166.33 24.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.593 0.711 . . . . 1.0 111.054 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 m -149.8 162.41 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.721 -1.127 . . . . 1.0 112.046 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.5 mt -117.01 127.02 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.705 -0.479 . . . . 1.0 109.705 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.475 ' NE ' ' O ' ' A' ' 13' ' ' PHE . 75.2 ttt-85 -136.49 158.49 44.3 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.35 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.599 HE21 ' HH ' ' A' ' 10' ' ' TYR . 49.0 mt-30 -114.31 133.09 55.91 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.824 -0.436 . . . . 1.0 109.824 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.2 m -77.2 139.21 39.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.1 p -68.7 -38.01 79.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.96 -0.563 . . . . 1.0 110.434 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 83.0 mmt-85 -88.08 -13.95 40.13 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.771 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -75.02 -64.06 2.4 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.519 -1.033 . . . . 1.0 110.519 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 t70 69.93 -40.2 0.46 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.647 0.261 . . . . 1.0 110.944 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 38' ' ' GLY . 43.0 p-10 -117.15 11.4 14.15 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.71 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -132.24 152.73 51.19 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.933 0.397 . . . . 1.0 110.371 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.8 mp -118.75 144.99 45.92 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.827 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -126.1 130.88 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.284 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 mt -112.97 139.49 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.7 m -115.99 128.64 55.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.677 ' HE1' HE21 ' A' ' 54' ' ' GLN . 8.0 p-90 -142.38 147.73 36.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.915 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.7 mtmm -90.88 136.88 32.78 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.101 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 7.4 mp -94.33 -67.59 0.85 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.192 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.518 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 26.1 t70 -125.91 -173.31 2.81 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.319 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.518 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 88.4 tttt -65.23 134.23 53.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.644 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 56.44 31.42 18.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.052 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 tp -135.02 130.27 35.4 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.879 0.371 . . . . 1.0 110.604 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -132.29 149.81 52.29 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.551 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.677 HE21 ' HE1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -142.86 153.91 43.63 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 179.203 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.482 ' N ' ' CD ' ' A' ' 54' ' ' GLN . 19.1 p80 -123.24 140.73 52.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.207 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 14.7 tt -123.87 128.43 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.788 -0.449 . . . . 1.0 109.788 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 32.6 p-10 -103.72 126.36 50.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.975 0.417 . . . . 1.0 110.919 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.431 HD12 HG21 ' A' ' 58' ' ' ILE . 79.0 mt -106.42 129.1 60.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.104 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -104.94 140.4 38.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.253 -0.431 . . . . 1.0 109.999 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -102.82 157.26 17.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.358 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.457 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -145.16 167.91 21.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.658 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.457 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 50.4 tt0 71.47 37.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.012 -0.54 . . . . 1.0 109.899 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -87.33 115.07 24.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -98.44 -25.26 14.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.011 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -157.11 151.88 20.92 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.194 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.53 -19.0 60.68 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.22 1.947 . . . . 1.0 111.859 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.9 tp -79.3 -14.12 59.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.049 0.452 . . . . 1.0 110.691 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.59 137.95 38.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.267 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.2 mt -79.54 164.38 23.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.441 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.52 97.64 0.18 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -67.78 -36.08 79.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.997 0.427 . . . . 1.0 110.618 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.4 t -117.05 123.78 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.583 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.4 mt -116.7 135.57 53.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.428 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.7 mt -107.17 126.41 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.887 0.375 . . . . 1.0 110.142 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.1 t -143.86 132.55 19.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.32 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 t70 54.68 43.28 30.39 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.052 -0.259 . . . . 1.0 111.002 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 59.27 24.57 13.06 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.943 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -128.52 154.51 46.07 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.229 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -103.94 134.8 46.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.219 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -126.23 139.39 53.38 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.348 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -84.45 -38.04 20.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.714 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -123.09 150.72 42.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.124 0.488 . . . . 1.0 111.986 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.5 tp -66.8 -36.33 82.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.584 -0.735 . . . . 1.0 111.295 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 50.2 p-10 -58.22 -33.42 69.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.805 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.494 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 27.6 mt-30 -64.88 -39.26 93.26 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.657 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.42 ' O ' ' CB ' ' A' ' 90' ' ' TYR . 31.3 mm -62.67 -48.26 89.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.857 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.47 -43.58 98.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 120.334 -0.546 . . . . 1.0 111.734 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.2 -42.59 58.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 113.148 0.796 . . . . 1.0 113.148 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -82.8 -13.41 56.29 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.636 -0.426 . . . . 1.0 111.557 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.42 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 64.1 t80 -95.52 -48.63 5.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.524 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 tp -69.52 -40.62 76.83 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.264 0.468 . . . . 1.0 112.264 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -63.89 -48.59 76.07 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.042 -0.663 . . . . 1.0 111.762 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -68.43 -43.28 77.47 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.75 -0.38 . . . . 1.0 111.757 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -66.05 -42.13 89.89 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.163 -0.615 . . . . 1.0 111.225 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.37 -46.13 91.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.226 -0.59 . . . . 1.0 111.441 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -69.17 -44.3 72.49 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.789 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.3 tp -69.01 -40.31 78.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.152 -0.476 . . . . 1.0 111.719 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.4 tp -64.43 -43.3 94.78 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.292 -0.563 . . . . 1.0 110.08 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -67.79 -38.52 83.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.129 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.452 ' OE1' ' OH ' ' A' ' 168' ' ' TYR . 2.9 tm-20 -70.91 -42.81 69.46 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.802 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.487 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 2.6 ttt -64.98 -54.42 30.8 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.531 -0.467 . . . . 1.0 111.433 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 104' ' ' SER . 55.5 m -61.23 -30.29 70.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.126 0.489 . . . . 1.0 110.496 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.1 t -73.44 10.31 1.07 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.634 -0.712 . . . . 1.0 110.926 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 102' ' ' THR . 36.4 t -96.41 131.68 42.71 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.773 0.32 . . . . 1.0 110.284 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -57.83 -17.89 18.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.944 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.536 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 37.7 mmtm -90.8 40.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.063 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -133.17 111.28 10.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.468 . . . . 1.0 111.071 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -123.34 126.46 46.89 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -94.68 85.85 4.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.977 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.0 149.35 16.9 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.464 ' HG1' ' H ' ' A' ' 114' ' ' ASP . 28.3 p -71.98 170.86 12.9 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -59.87 -39.17 84.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.859 -0.336 . . . . 1.0 110.831 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -68.15 -42.33 80.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.905 0.383 . . . . 1.0 110.455 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.464 ' H ' ' HG1' ' A' ' 111' ' ' THR . 97.7 m-20 -70.6 -18.52 62.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.094 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.19 -44.39 55.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.767 0.318 . . . . 1.0 110.144 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.8 t -62.89 -46.75 95.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.251 0.548 . . . . 1.0 110.157 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -66.02 -36.66 83.87 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.005 0.431 . . . . 1.0 111.099 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -66.61 -49.63 65.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.599 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.5 tp -69.77 -39.4 77.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.305 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -64.82 -42.03 95.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.947 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -63.33 -48.26 78.74 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.427 -0.509 . . . . 1.0 110.052 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -59.94 -43.28 95.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.95 -0.568 . . . . 1.0 109.898 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.4 t -62.9 -39.52 94.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.295 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.8 -41.6 82.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.097 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.24 -41.6 92.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.92 78.6 65.43 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.043 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.529 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 39.1 Cg_endo -71.19 -13.68 31.2 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.449 2.099 . . . . 1.0 112.46 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -101.45 -14.5 17.51 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.651 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -105.97 148.38 27.74 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.978 0.418 . . . . 1.0 110.477 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 60.2 p -81.81 163.78 22.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.883 -0.599 . . . . 1.0 109.615 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 p -152.72 146.27 15.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.421 ' O ' ' CD2' ' A' ' 133' ' ' TYR . 33.0 p90 -149.91 141.53 23.52 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.671 -0.412 . . . . 1.0 111.083 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.421 ' CD2' ' O ' ' A' ' 132' ' ' TYR . 25.4 m-85 -152.91 165.93 33.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.309 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -130.63 154.37 47.96 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 178.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.1 p -150.44 168.14 25.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.205 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.1 tp -81.24 132.41 35.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.604 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.548 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 22.6 p30 -78.25 151.9 32.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.277 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -106.22 -30.4 9.23 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.651 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 41.4 p30 -64.97 -21.14 66.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.197 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.548 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 19.8 t-20 -163.22 106.76 1.0 Allowed Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.59 143.55 38.32 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.796 1.664 . . . . 1.0 112.411 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.82 -39.19 2.81 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.422 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 19.8 m95 -94.47 149.78 20.91 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.815 0.34 . . . . 1.0 110.199 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.487 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 77.1 m-85 -113.26 154.86 26.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.847 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -126.31 139.23 53.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.115 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.5 mt -111.1 126.66 55.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.568 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.6 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -120.98 146.85 46.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.029 -1.1 . . . . 1.0 108.029 178.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -162.44 153.89 18.07 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.25 -0.58 . . . . 1.0 109.769 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -137.73 128.41 26.85 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.801 0.334 . . . . 1.0 110.604 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 150' ' ' ILE . 2.6 mp -69.76 -45.24 77.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 1.0 111.591 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 19.6 m120 -156.47 171.79 19.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.574 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.79 -28.3 69.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.792 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -90.27 8.61 32.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.983 0.421 . . . . 1.0 110.346 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 15.9 t -102.22 150.43 23.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.442 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -80.17 157.16 26.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.014 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 62.1 tp -75.07 124.11 26.41 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.259 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -108.31 129.89 55.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.518 . . . . 1.0 109.615 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 63.9 m -128.2 130.46 48.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.872 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -120.9 159.81 24.77 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.866 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 160' ' ' ASN . 34.5 p30 -105.69 148.32 27.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.984 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.77 136.12 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -98.33 135.27 40.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.773 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 29.3 tp -102.51 128.83 48.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.905 -0.588 . . . . 1.0 109.543 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 166' ' ' THR . 33.4 p -131.04 168.37 17.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.087 0.47 . . . . 1.0 110.398 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -78.74 17.35 0.72 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.669 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 164' ' ' THR . 12.1 p -121.35 -2.38 9.54 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.704 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 137.48 -126.3 3.58 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.264 -1.135 . . . . 1.0 110.264 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.452 ' OH ' ' OE1' ' A' ' 100' ' ' GLU . 19.9 m-85 -127.28 132.84 50.24 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.671 0.272 . . . . 1.0 110.447 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -110.43 120.81 43.62 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.938 0.399 . . . . 1.0 110.143 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.0 tt -114.96 120.92 41.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.4 t 35.97 52.1 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 111.95 0.352 . . . . 1.0 111.95 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 10.2 m120 69.42 27.41 4.98 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.087 0.773 . . . . 1.0 113.087 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -135.78 120.16 17.99 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -91.27 131.24 36.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.359 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -107.54 101.25 38.65 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 109.438 -0.578 . . . . 1.0 109.438 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -48.82 -23.17 5.44 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.462 2.108 . . . . 1.0 113.376 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 40.0 m -141.66 145.74 35.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.991 0.424 . . . . 1.0 111.097 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.62 -34.97 70.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.731 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.497 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 49.2 mm -60.57 -46.98 94.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.336 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.609 ' N ' ' NE2' ' A' ' 180' ' ' GLN . 0.6 OUTLIER -61.65 -32.9 73.09 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.14 -40.3 95.87 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 1.8 p -61.49 -46.85 88.25 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.769 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.6 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 54.5 t30 -71.21 -49.72 40.55 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 119.727 -0.789 . . . . 1.0 108.954 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.31 -43.87 0.53 Allowed Glycine 0 N--CA 1.462 0.398 0 N-CA-C 109.832 -1.307 . . . . 1.0 109.832 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -69.04 -47.93 64.14 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.071 -0.565 . . . . 1.0 109.596 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 183' ' ' ASN . 49.5 tttp -57.25 -39.9 76.55 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.184 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.5 m -60.5 -44.31 96.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 62.9 mt -63.86 -39.03 93.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.152 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.45 -45.32 91.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.713 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -58.7 -45.39 89.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.104 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.1 t -64.49 -40.29 95.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.714 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.76 -42.0 97.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.47 -0.786 . . . . 1.0 111.95 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -63.11 -25.8 68.53 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -89.67 -8.2 52.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.726 0.298 . . . . 1.0 110.863 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.414 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 74.2 t60 54.89 23.2 4.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.949 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -89.23 140.34 29.58 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.552 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 198' ' ' HIS . 4.5 t-80 -59.27 -48.23 82.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.578 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.712 ' CG ' ' H ' ' A' ' 199' ' ' HIS . 30.5 t60 40.4 -166.45 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.033 0.444 . . . . 1.0 111.05 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.712 ' H ' ' CG ' ' A' ' 198' ' ' HIS . 63.2 m80 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.003 -0.998 . . . . 1.0 110.711 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.403 -0.592 . . . . 1.0 109.403 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -88.43 -6.85 57.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.695 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.481 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 83.8 mtp180 -133.22 1.61 3.51 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.486 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.65 -31.83 53.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.522 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.6 pt -75.39 -19.93 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.447 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -103.59 9.11 37.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.6 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 3' ' ' ARG . 0.4 OUTLIER -67.77 147.87 98.55 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 110.057 -0.349 . . . . 1.0 110.057 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.64 -14.25 38.99 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.102 1.868 . . . . 1.0 112.2 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -94.74 5.52 51.64 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.203 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 40.3 t80 -82.88 128.76 34.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.478 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 58.4 m-85 -149.38 120.92 4.17 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.513 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.521 ' O ' ' CD1' ' A' ' 13' ' ' PHE . 72.7 Cg_endo -74.72 109.64 2.95 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.748 1.632 . . . . 1.0 112.479 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' A' ' 12' ' ' PRO . 70.6 m-85 -155.72 156.8 35.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.379 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -79.4 168.05 20.01 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.449 ' CA ' HH12 ' A' ' 33' ' ' ARG . . . -59.65 -43.58 97.61 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.381 -0.914 . . . . 1.0 111.203 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -66.02 -41.22 91.26 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.055 -0.258 . . . . 1.0 110.784 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.85 -35.9 77.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.543 -0.299 . . . . 1.0 111.229 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.77 -40.9 94.25 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.45 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.11 -42.69 93.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -60.47 -42.76 96.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.275 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -60.98 -41.8 97.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.815 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.8 mp -78.9 -15.22 58.62 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.984 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -61.14 -42.13 97.99 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.806 -0.357 . . . . 1.0 110.516 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.3 t -76.75 -18.71 58.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.975 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -87.09 -178.02 6.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.055 0.455 . . . . 1.0 110.676 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.18 179.45 5.56 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.819 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.6 mtt85 -81.01 146.11 30.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.049 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.56 19.44 29.77 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.83 145.67 26.73 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -132.86 167.45 20.18 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.109 0.481 . . . . 1.0 110.95 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.2 t -147.34 158.44 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.242 -0.89 . . . . 1.0 111.443 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.0 mm -114.83 126.33 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.711 -0.848 . . . . 1.0 108.711 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.449 HH12 ' CA ' ' A' ' 15' ' ' GLY . 57.1 ttp180 -137.86 155.86 48.52 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -119.69 137.91 53.61 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.786 -0.45 . . . . 1.0 109.786 178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.6 m -72.37 151.43 42.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.773 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.8 p -69.55 -20.81 63.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.018 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.28 17.68 9.07 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.023 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.58 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -84.54 -74.95 1.23 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.532 -1.027 . . . . 1.0 110.532 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.3 t70 67.68 -35.71 0.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.635 0.255 . . . . 1.0 110.884 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.58 ' H ' ' C ' ' A' ' 38' ' ' GLY . 97.2 m-20 -118.55 12.06 13.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.466 -0.334 . . . . 1.0 110.594 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -144.06 146.55 32.9 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.322 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mp -119.12 145.48 45.92 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.09 -0.504 . . . . 1.0 109.793 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.86 129.23 74.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.146 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.19 137.71 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 108.762 -0.829 . . . . 1.0 108.762 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.8 m -115.16 134.05 55.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.877 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -148.14 151.6 35.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.384 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -99.61 145.51 27.48 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.69 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.461 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 9.5 mp -102.47 -75.52 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.56 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 36.9 t0 -117.06 -166.74 1.2 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.388 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.56 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 51.7 mtmt -69.6 139.37 53.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.947 0.403 . . . . 1.0 110.814 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 52.28 26.66 4.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.909 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.8 tp -130.89 129.01 41.71 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.787 0.327 . . . . 1.0 110.327 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.46 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 61.5 m-85 -133.87 148.99 51.33 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.502 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 53' ' ' PHE . 98.6 mm-40 -139.84 152.09 46.21 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.581 -0.526 . . . . 1.0 109.581 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -129.37 144.15 51.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.427 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 92.8 mt -125.51 131.75 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.786 -0.449 . . . . 1.0 109.786 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -98.53 121.81 40.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.906 0.384 . . . . 1.0 110.575 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.3 mt -97.98 123.58 50.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.094 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -111.31 131.69 54.96 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -103.08 152.78 20.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.242 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.471 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 1.6 tp -144.45 165.69 27.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.414 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 3.1 tm-20 81.94 63.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.201 0.524 . . . . 1.0 110.063 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.89 113.91 27.74 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.034 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.468 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 57.8 mp0 -65.85 -22.85 66.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.688 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 64' ' ' GLU . 1.1 m120 -151.6 160.03 32.37 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.133 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.34 -32.97 64.06 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.986 1.791 . . . . 1.0 112.332 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.1 mt -95.14 -8.82 35.33 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.688 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.85 144.77 45.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.593 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.7 mt -89.71 147.25 23.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.271 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.98 126.76 7.59 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.7 -0.96 . . . . 1.0 110.7 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -81.96 -9.78 59.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.064 0.459 . . . . 1.0 110.459 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.28 118.68 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.735 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.5 mt -115.01 129.23 56.67 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.551 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.2 mt -101.29 121.87 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.951 0.405 . . . . 1.0 110.228 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.88 131.92 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.121 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.7 t0 55.98 42.88 28.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.178 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 59.69 21.13 9.83 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.922 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -128.06 151.98 48.52 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.059 0.456 . . . . 1.0 110.22 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -101.37 128.38 47.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.224 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -122.94 138.67 54.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.32 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -85.25 -38.38 18.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 1.0 111.606 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -113.13 141.23 47.16 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.034 0.445 . . . . 1.0 111.993 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.2 -40.66 96.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.85 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -59.21 -41.71 89.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.746 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -60.81 -38.52 85.68 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.986 -0.285 . . . . 1.0 110.723 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.37 -47.27 94.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.743 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.1 mt -62.09 -46.41 96.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.329 -0.548 . . . . 1.0 111.684 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.0 t -71.15 -42.46 75.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.844 0.683 . . . . 1.0 112.844 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -77.38 -15.4 59.39 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.662 -0.415 . . . . 1.0 111.9 -177.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.621 ' CZ ' ' NZ ' ' A' ' 94' ' ' LYS . 34.8 t80 -94.09 -49.91 5.54 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.651 -0.42 . . . . 1.0 111.713 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.2 mp -69.75 -40.57 76.08 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 112.096 0.406 . . . . 1.0 112.096 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -62.85 -48.53 78.62 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.774 -0.77 . . . . 1.0 111.544 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -69.21 -43.41 74.18 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.522 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.621 ' NZ ' ' CZ ' ' A' ' 90' ' ' TYR . 24.0 mmtp -66.14 -43.77 86.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.213 -0.595 . . . . 1.0 111.243 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.32 -44.79 90.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.339 -0.544 . . . . 1.0 111.023 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -66.03 -47.54 74.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.248 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.0 tp -69.08 -38.93 79.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.282 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.38 -43.28 98.08 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.574 -0.45 . . . . 1.0 110.118 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -67.51 -39.75 85.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.257 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -71.09 -41.38 70.7 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.007 0.373 . . . . 1.0 112.007 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.456 ' O ' ' OG ' ' A' ' 104' ' ' SER . 3.5 ttt -68.38 -54.82 14.69 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.423 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.1 m -58.7 -42.2 88.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.076 0.465 . . . . 1.0 110.411 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.3 m -72.37 8.27 1.44 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.951 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 101' ' ' MET . 60.2 p -84.29 142.82 29.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.734 0.302 . . . . 1.0 110.512 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.63 -19.5 65.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.885 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.554 ' NZ ' ' SG ' ' A' ' 182' ' ' CYS . 98.7 mttt -93.13 39.44 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.828 -0.624 . . . . 1.0 110.161 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -134.12 118.37 17.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.122 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -126.67 133.13 51.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.0 p -99.4 74.7 1.93 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.8 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.71 146.62 18.58 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.52 171.68 10.94 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.036 -0.357 . . . . 1.0 110.036 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -56.66 -38.89 72.82 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.64 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.94 -44.19 77.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.962 0.411 . . . . 1.0 110.724 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -70.17 -20.27 63.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.056 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.2 t -70.78 -45.23 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.299 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.14 -46.67 92.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 120.494 -0.482 . . . . 1.0 110.278 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.03 -35.37 80.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.053 0.454 . . . . 1.0 110.75 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -67.49 -49.63 62.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.596 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.5 tp -70.18 -39.22 76.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.962 0.41 . . . . 1.0 110.459 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -64.24 -39.94 94.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.685 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -60.32 -48.5 81.49 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.548 -0.461 . . . . 1.0 110.31 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -62.76 -39.88 95.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.293 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.9 t -61.49 -42.39 98.72 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.578 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -59.6 -38.17 80.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.055 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.1 t -66.75 -42.28 89.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.658 -0.417 . . . . 1.0 109.974 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -126.26 76.49 72.69 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.217 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -71.29 -14.25 31.21 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 122.578 2.185 . . . . 1.0 112.441 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -103.54 10.17 37.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.655 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -132.98 148.58 52.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.861 0.362 . . . . 1.0 110.621 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 42.0 t -81.08 161.5 24.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.48 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.0 p -152.65 145.19 15.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -144.17 143.66 31.19 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.949 0.404 . . . . 1.0 111.12 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -151.35 161.98 41.75 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.372 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.481 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -132.65 154.86 49.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 179.146 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.661 ' HG ' ' N ' ' A' ' 136' ' ' LEU . 43.1 t -152.54 168.41 25.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.93 0.395 . . . . 1.0 110.105 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.661 ' N ' ' HG ' ' A' ' 135' ' ' SER . 0.8 OUTLIER -82.71 128.98 34.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.067 -0.515 . . . . 1.0 111.019 179.608 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 12.5 t-20 -87.34 135.68 33.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.902 0.382 . . . . 1.0 110.368 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -73.14 -39.64 65.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.971 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -62.44 -15.11 47.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.036 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.542 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 3.6 p30 -167.66 82.52 0.83 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.269 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.25 -37.14 58.92 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.124 1.883 . . . . 1.0 113.142 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -59.78 -34.74 83.78 Favored Glycine 0 C--N 1.312 -0.798 0 N-CA-C 110.956 -0.858 . . . . 1.0 110.956 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -99.72 144.77 28.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.88 0.372 . . . . 1.0 110.242 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -106.61 153.65 22.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.879 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.587 ' HH ' HD22 ' A' ' 160' ' ' ASN . 4.0 m-85 -112.33 134.33 53.93 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.969 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.636 ' CD1' ' HE1' ' A' ' 159' ' ' TRP . 5.3 mt -112.55 123.34 50.08 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.709 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.561 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -123.55 148.89 45.9 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.469 -0.938 . . . . 1.0 108.469 178.21 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.56 ' CE1' ' CZ3' ' A' ' 159' ' ' TRP . 8.1 p90 -163.9 160.81 22.52 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.27 -0.572 . . . . 1.0 109.649 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -140.83 129.86 23.33 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.564 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.528 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 3.6 mt -77.06 -44.94 31.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.282 -0.417 . . . . 1.0 111.592 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 150' ' ' ILE . 2.9 m-80 -154.35 165.68 35.6 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.372 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.91 -31.52 69.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.712 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -85.69 -4.34 59.14 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.043 0.449 . . . . 1.0 110.611 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 11.8 t -84.28 163.21 19.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.514 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.431 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 14.7 mptt -96.57 148.6 22.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.67 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 52.6 tp -70.23 118.81 13.53 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.36 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.438 ' O ' ' CD1' ' A' ' 148' ' ' PHE . 87.4 m-85 -113.66 119.37 37.22 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 86.0 m -130.39 135.18 47.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.848 -0.615 . . . . 1.0 111.874 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . 0.636 ' HE1' ' CD1' ' A' ' 146' ' ' LEU . 7.7 p90 -128.35 -173.94 3.09 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.462 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.587 HD22 ' HH ' ' A' ' 145' ' ' TYR . 94.4 m-20 -124.82 152.7 43.59 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.445 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.6 t -118.56 139.37 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -93.9 130.65 39.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.207 0.527 . . . . 1.0 110.948 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.8 tp -90.93 129.72 36.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.562 -0.745 . . . . 1.0 109.446 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 165' ' ' ASN . 0.1 OUTLIER -131.65 177.84 7.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.616 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.508 ' N ' ' OG1' ' A' ' 164' ' ' THR . 65.3 t30 -86.13 15.68 4.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.704 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 77.2 p -121.07 -1.7 9.78 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.575 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 132.87 -126.09 4.32 Favored Glycine 0 N--CA 1.464 0.533 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.427 ' HH ' ' HB2' ' A' ' 101' ' ' MET . 22.5 m-85 -122.13 129.27 52.18 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.545 0.212 . . . . 1.0 110.517 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.54 120.77 42.47 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.0 tt -113.32 114.98 27.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.4 t 35.47 59.46 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.253 0.464 . . . . 1.0 112.253 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.8 m120 69.16 27.34 5.26 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.17 0.804 . . . . 1.0 113.17 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -134.89 119.19 17.76 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -99.73 124.9 45.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.84 0.353 . . . . 1.0 111.736 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -102.36 131.85 22.07 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.31 -0.626 . . . . 1.0 109.31 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.36 -18.41 29.95 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.193 1.929 . . . . 1.0 113.443 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 89.7 p -152.08 156.02 39.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.084 0.468 . . . . 1.0 110.908 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.16 -36.05 72.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.716 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.05 -43.32 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 120.909 0.385 . . . . 1.0 110.123 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -61.12 -35.12 76.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.25 -39.93 94.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.211 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.554 ' SG ' ' NZ ' ' A' ' 106' ' ' LYS . 13.8 t -57.04 -48.4 78.62 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.271 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 186' ' ' LYS . 65.7 t30 -66.7 -47.61 71.84 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.21 -44.02 0.76 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.376 -1.49 . . . . 1.0 109.376 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -68.96 -47.58 65.28 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.387 0.613 . . . . 1.0 109.496 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 183' ' ' ASN . 63.1 tttm -55.97 -39.11 71.31 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.251 -0.886 . . . . 1.0 109.866 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 19.0 m -63.33 -47.18 83.29 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 75.6 mt -62.9 -42.71 99.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.108 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 45.0 tp -57.35 -46.53 83.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.719 -0.392 . . . . 1.0 110.29 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -56.19 -41.83 76.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.142 0.496 . . . . 1.0 109.857 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.1 t -66.59 -42.78 86.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.832 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.66 -45.55 86.26 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.595 -0.729 . . . . 1.0 112.177 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -67.81 -35.49 78.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.785 0.326 . . . . 1.0 111.826 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . 0.559 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 10.4 t-80 -80.95 -7.73 59.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.577 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' A' ' 194' ' ' HIS . 50.5 p-80 42.4 52.24 4.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.338 -0.392 . . . . 1.0 111.105 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -54.14 134.33 44.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.69 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -69.58 82.78 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.75 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -82.62 -32.97 28.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.872 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.63 -179.588 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -94.79 9.83 37.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.512 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.3 mmt-85 -128.43 -30.83 2.33 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.627 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.67 -33.43 63.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.617 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.7 pt -81.48 -30.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.547 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -95.11 3.77 54.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.342 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -65.09 140.93 98.18 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.375 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.18 -12.89 35.07 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.92 1.747 . . . . 1.0 112.038 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -102.48 7.65 40.17 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.614 0.245 . . . . 1.0 111.152 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.529 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 30.6 t80 -90.95 127.76 36.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.442 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 65.1 m-85 -151.65 108.97 2.92 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.549 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 41.7 Cg_exo -57.56 108.18 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.712 1.608 . . . . 1.0 112.734 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 66.2 m-85 -160.94 157.97 27.34 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.64 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -79.09 163.87 24.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' OE1' ' A' ' 19' ' ' GLU . . . -55.48 -45.51 83.81 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.248 -0.977 . . . . 1.0 110.853 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -65.2 -39.66 93.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.868 0.366 . . . . 1.0 110.758 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.35 -33.83 76.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.498 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.06 -38.82 87.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.436 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.552 ' OE2' ' NE2' ' A' ' 55' ' ' HIS . 4.3 mp0 -67.09 -43.51 82.36 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.566 -0.454 . . . . 1.0 110.37 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.51 -46.15 91.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.227 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -61.02 -44.82 96.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.423 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 tp -75.36 -15.98 60.43 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.064 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -60.67 -42.13 96.46 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.393 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p -75.32 -18.63 59.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.627 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -82.22 179.83 7.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.621 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -90.1 154.72 19.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.812 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -68.05 143.45 55.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.759 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.0 10.09 43.62 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.223 -0.751 . . . . 1.0 111.223 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -91.68 156.43 17.6 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -125.11 155.72 39.43 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.295 0.569 . . . . 1.0 111.004 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 t -141.4 152.76 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 115.145 -0.934 . . . . 1.0 111.184 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.95 125.8 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -142.16 158.64 43.51 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.077 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.64 HE22 ' CD2' ' A' ' 42' ' ' LEU . 95.2 mm-40 -103.15 131.17 50.36 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.437 ' C ' ' H ' ' A' ' 37' ' ' ARG . 7.2 t -48.82 -12.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.918 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.493 ' H ' ' C ' ' A' ' 34' ' ' GLN . 3.0 m 63.24 2.06 1.05 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.652 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.437 ' H ' ' C ' ' A' ' 35' ' ' SER . 34.4 ttm180 -154.47 58.88 0.7 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.629 -0.26 . . . . 1.0 110.582 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.526 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -157.62 -50.06 0.01 OUTLIER Glycine 0 N--CA 1.463 0.446 0 N-CA-C 110.384 -1.086 . . . . 1.0 110.384 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.9 t0 73.63 -28.3 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.796 0.331 . . . . 1.0 111.026 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.526 ' H ' ' C ' ' A' ' 38' ' ' GLY . 36.3 t70 -121.59 20.26 11.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.984 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -142.19 141.42 32.57 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.826 0.346 . . . . 1.0 110.541 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.64 ' CD2' HE22 ' A' ' 34' ' ' GLN . 5.3 mp -120.57 144.65 47.97 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.095 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.8 t -126.16 130.78 72.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.217 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mt -112.06 139.47 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.5 m -118.25 132.2 56.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.391 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.555 ' CZ3' ' CD2' ' A' ' 48' ' ' LEU . 2.8 p-90 -146.15 143.68 29.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.989 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -92.52 140.72 29.27 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.961 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.555 ' CD2' ' CZ3' ' A' ' 46' ' ' TRP . 8.4 mt -103.67 -75.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.331 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -115.45 -176.88 3.01 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.263 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -66.21 130.23 42.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.932 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.4 t0 61.88 30.33 18.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.033 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.0 tp -137.8 126.04 23.11 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.874 0.369 . . . . 1.0 110.412 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -134.85 149.48 50.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.55 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -138.88 153.98 48.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.853 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.552 ' NE2' ' OE2' ' A' ' 19' ' ' GLU . 44.9 m80 -124.08 141.35 52.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.243 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.7 mt -121.53 124.8 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -98.2 122.07 40.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.662 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 80.8 mt -101.15 126.0 55.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.363 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -103.71 134.58 46.8 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.978 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -104.37 146.59 28.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 1.0 109.995 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.475 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 9.8 mt -142.15 166.47 24.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.764 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 1.5 tm-20 82.32 54.73 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.856 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -106.62 93.86 4.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.878 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.11 -35.12 77.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.898 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -145.71 156.5 52.28 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.973 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.16 -19.53 68.92 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.39 2.06 . . . . 1.0 112.104 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.488 ' H ' ' CG ' ' A' ' 65' ' ' ASN . 4.8 tp -83.26 -9.88 58.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.998 0.427 . . . . 1.0 110.931 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.582 ' N ' ' ND2' ' A' ' 65' ' ' ASN . . . -113.24 143.63 44.08 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.158 0.504 . . . . 1.0 110.17 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.55 168.94 11.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.319 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.34 109.69 2.86 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.417 ' NZ ' ' OE1' ' A' ' 62' ' ' GLU . 34.2 mtmm -72.8 -11.85 60.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.02 0.438 . . . . 1.0 110.727 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.1 t -118.3 120.68 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.816 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.4 mt -115.67 130.88 57.02 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.7 mt -102.47 121.08 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -140.88 132.92 30.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.201 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.422 ' OD2' ' OD1' ' A' ' 165' ' ' ASN . 46.8 t0 53.9 42.98 31.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.774 0.321 . . . . 1.0 110.997 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 59.79 22.87 11.77 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.826 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.444 ' OE1' ' OH ' ' A' ' 80' ' ' TYR . 85.9 mt-30 -128.56 143.75 51.02 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.254 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.43 ' CB ' ' HZ2' ' A' ' 79' ' ' LYS . 8.2 mtmp? -98.12 126.98 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.872 -179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.444 ' OH ' ' OE1' ' A' ' 78' ' ' GLN . 93.8 m-85 -120.32 137.48 54.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.167 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -85.29 -38.09 19.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.777 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -112.02 141.39 45.74 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.047 0.451 . . . . 1.0 112.11 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.97 -41.06 97.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.473 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -61.56 -39.75 92.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.793 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -59.89 -39.66 86.12 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.74 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.68 -50.15 81.42 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 C-N-CA 120.352 -0.539 . . . . 1.0 111.113 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.58 -43.49 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.57 -0.452 . . . . 1.0 111.795 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.435 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 93.9 t -66.4 -22.23 29.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.112 -0.495 . . . . 1.0 112.15 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -100.18 -10.84 20.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.911 0.386 . . . . 1.0 111.011 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.84 -50.33 5.62 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.39 -0.524 . . . . 1.0 112.368 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.6 mp -64.62 -45.38 87.12 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 112.802 0.667 . . . . 1.0 112.802 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 93' ' ' ASN . 14.7 pt20 -64.8 -48.12 75.59 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.706 -0.798 . . . . 1.0 111.842 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.449 ' N ' ' HG3' ' A' ' 92' ' ' GLN . 58.1 t-20 -71.37 -43.08 67.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.649 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.704 ' HZ2' ' ND2' ' A' ' 165' ' ' ASN . 37.0 mmtm -66.56 -44.38 82.46 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.18 -0.608 . . . . 1.0 111.403 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.7 t -66.5 -44.49 90.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.211 -0.596 . . . . 1.0 111.364 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -68.22 -43.11 78.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.489 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 tp -67.05 -41.02 87.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.427 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 mt -63.69 -43.85 95.41 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.272 -0.571 . . . . 1.0 110.5 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -68.78 -38.64 80.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.146 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -70.66 -43.48 69.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.954 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.404 ' HB2' ' HH ' ' A' ' 168' ' ' TYR . 1.3 tpt -66.1 -54.34 26.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.476 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 104' ' ' SER . 9.8 m -59.67 -40.36 87.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.085 0.469 . . . . 1.0 110.438 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.0 m -72.23 10.18 0.83 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.705 -0.68 . . . . 1.0 111.249 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 102' ' ' THR . 6.8 t -92.43 136.62 33.06 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.865 0.364 . . . . 1.0 110.274 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -60.82 -20.71 62.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.068 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.593 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 67.9 mttm -89.43 39.12 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.763 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -131.61 115.59 16.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.379 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -140.2 113.28 8.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.701 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.2 t -98.12 88.07 4.11 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.076 0.465 . . . . 1.0 110.916 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.98 171.13 14.67 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.1 p -74.62 165.38 25.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -60.62 -39.75 89.36 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.805 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -67.43 -42.51 83.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.154 0.502 . . . . 1.0 110.803 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -70.73 -20.11 62.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.72 . . . . 1.0 111.045 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.0 t -70.43 -45.85 73.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.809 -0.356 . . . . 1.0 110.267 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.47 -45.03 98.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.102 0.477 . . . . 1.0 110.073 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.06 -34.4 78.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.993 0.425 . . . . 1.0 110.729 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -66.58 -49.98 64.57 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.915 -0.584 . . . . 1.0 111.85 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.9 tp -69.93 -38.91 76.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.476 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.552 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 66.5 mm-40 -63.89 -39.99 95.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.56 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -64.84 -47.27 78.55 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.601 -0.439 . . . . 1.0 110.345 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -60.25 -45.46 93.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.947 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.3 t -63.87 -38.14 89.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.319 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -58.36 -41.76 85.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.839 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.3 t -66.7 -41.95 88.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -123.6 75.83 54.97 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.505 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.91 -17.21 32.53 Favored 'Trans proline' 0 N--CA 1.488 1.157 0 C-N-CA 122.531 2.154 . . . . 1.0 112.2 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -101.64 22.37 12.88 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.577 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -143.64 151.56 40.27 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.862 0.363 . . . . 1.0 110.664 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 94.4 p -81.19 163.16 23.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.817 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 p -152.41 146.55 15.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.249 -0.648 . . . . 1.0 109.249 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -147.77 142.39 26.58 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.834 0.35 . . . . 1.0 111.208 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -152.93 171.4 18.38 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.374 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.593 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.8 p90 -141.05 158.52 43.81 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.25 -0.648 . . . . 1.0 109.25 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.8 p -151.74 168.28 25.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.824 0.345 . . . . 1.0 110.255 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.9 tp -80.27 129.41 34.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.588 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -72.07 156.86 38.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.272 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.43 ' CG ' ' N ' ' A' ' 139' ' ' ASP . 12.9 p-80 -96.18 -46.95 6.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.889 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.43 ' N ' ' CG ' ' A' ' 138' ' ' HIS . 95.0 m-20 -76.15 -7.52 54.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.21 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 139' ' ' ASP . 63.4 m-80 -160.86 70.11 2.7 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.37 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -49.55 -35.4 37.04 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.258 1.972 . . . . 1.0 112.711 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -60.55 -32.16 77.14 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.793 -0.923 . . . . 1.0 110.793 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -96.36 147.13 24.12 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.726 0.298 . . . . 1.0 110.219 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -113.2 152.32 29.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.704 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -123.18 139.94 53.54 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.972 0.415 . . . . 1.0 110.181 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.5 mt -108.79 121.37 44.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.291 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -112.85 143.23 44.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.944 -1.132 . . . . 1.0 107.944 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -161.73 151.51 16.66 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.552 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 69.4 tttt -134.76 128.89 33.73 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.391 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.544 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 3.4 mp -69.53 -46.47 75.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.303 0.483 . . . . 1.0 112.303 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 150' ' ' ILE . 20.7 m120 -159.48 173.98 15.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.515 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.84 74.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.836 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -86.81 8.15 24.01 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.385 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.416 ' HG ' ' H ' ' A' ' 155' ' ' LYS . 7.8 t -96.3 165.54 12.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.441 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.48 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 61.2 mttp -99.22 149.85 22.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 1.0 109.928 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.7 tp -69.42 122.63 19.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.038 0.447 . . . . 1.0 109.871 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 87.9 m-85 -114.31 128.64 56.45 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.855 -0.611 . . . . 1.0 109.822 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 97.8 m -123.37 128.77 50.35 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.679 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -114.2 160.78 18.62 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.036 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -107.68 146.45 32.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.9 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.82 135.98 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -97.72 133.34 42.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.049 0.452 . . . . 1.0 110.844 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 31.6 tp -95.68 130.3 42.61 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.559 ' HG1' ' H ' ' A' ' 166' ' ' THR . 27.4 p -133.47 178.28 7.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.055 0.455 . . . . 1.0 110.266 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.704 ' ND2' ' HZ2' ' A' ' 94' ' ' LYS . 25.0 m120 -86.17 17.16 3.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.663 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.559 ' H ' ' HG1' ' A' ' 164' ' ' THR . 13.4 p -121.2 -2.18 9.64 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.811 0.339 . . . . 1.0 110.626 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.02 -127.16 4.47 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.373 -1.091 . . . . 1.0 110.373 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.404 ' HH ' ' HB2' ' A' ' 101' ' ' MET . 24.9 m-85 -121.31 130.06 53.44 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 110.219 -0.289 . . . . 1.0 110.219 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -104.08 124.7 49.53 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 109.854 -0.425 . . . . 1.0 109.854 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.9 tt -119.02 115.18 23.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.535 -0.543 . . . . 1.0 109.535 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.425 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 3.5 t 40.73 57.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 111.976 0.361 . . . . 1.0 111.976 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.8 m120 65.2 27.28 12.26 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.906 0.706 . . . . 1.0 112.906 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.425 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 73.6 m-85 -134.72 121.52 20.89 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.62 131.49 37.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.45 -0.341 . . . . 1.0 111.199 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -112.34 96.12 34.14 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.79 -22.53 7.22 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.499 2.133 . . . . 1.0 113.292 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.8 p -133.66 138.24 45.78 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.846 0.355 . . . . 1.0 110.999 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.6 p -61.04 -33.08 54.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.772 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.1 mm -62.0 -45.88 97.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.937 0.399 . . . . 1.0 110.194 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -65.61 -32.36 73.89 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.87 -42.5 99.79 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.424 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 74.0 m -63.36 -46.38 86.8 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.704 -0.399 . . . . 1.0 110.378 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 186' ' ' LYS . 74.6 m-20 -66.94 -49.29 65.96 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 119.682 -0.807 . . . . 1.0 108.926 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.12 -45.13 0.59 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.706 -1.357 . . . . 1.0 109.706 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -69.26 -47.06 65.73 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.218 0.532 . . . . 1.0 109.752 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 183' ' ' ASN . 89.1 tttt -56.52 -41.41 76.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.481 -0.781 . . . . 1.0 109.922 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 86.7 m -60.79 -45.58 93.84 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.57 -41.42 98.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.813 -0.631 . . . . 1.0 110.036 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.16 -43.61 82.69 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.786 -0.366 . . . . 1.0 110.716 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -60.75 -42.96 98.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.15 0.5 . . . . 1.0 110.434 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 48.4 m -61.72 -38.59 88.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.634 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 87.3 mt -65.13 -39.19 92.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.594 -0.73 . . . . 1.0 112.233 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -64.07 -30.51 71.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.651 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -94.34 -8.89 37.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.471 -0.331 . . . . 1.0 111.007 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.519 ' O ' ' CG ' ' A' ' 196' ' ' HIS . 28.2 t60 44.56 22.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.036 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.519 ' CG ' ' O ' ' A' ' 195' ' ' HIS . 47.0 m80 -159.92 125.71 4.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.005 0.431 . . . . 1.0 110.454 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -161.19 172.87 15.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.71 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 77.4 t60 51.11 72.46 0.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.801 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 80.0 m80 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 118.023 -0.989 . . . . 1.0 110.635 179.827 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.5 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 76.1 2.41 3.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.518 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -156.67 6.01 0.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.53 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 p -63.5 -32.91 58.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.341 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.9 pt -79.28 -12.22 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.316 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -105.13 4.91 31.86 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.645 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.16 150.05 94.51 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 41.0 Cg_endo -66.01 -22.66 54.95 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.817 1.678 . . . . 1.0 112.261 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.537 ' CD1' ' CE2' ' A' ' 30' ' ' PHE . 25.4 m-85 -87.26 5.87 36.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.556 -0.293 . . . . 1.0 111.164 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.468 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 42.0 t80 -87.23 127.8 35.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.435 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.468 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 63.4 m-85 -149.19 108.87 3.42 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 109.935 -0.394 . . . . 1.0 109.935 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.526 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 33.3 Cg_exo -59.54 109.82 0.63 Allowed 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 121.548 1.499 . . . . 1.0 112.828 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 66.0 m-85 -159.2 150.46 20.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.405 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -77.9 164.25 25.31 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.452 -0.573 . . . . 1.0 109.452 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' OE2' ' A' ' 19' ' ' GLU . . . -59.07 -41.68 96.63 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -67.0 -42.7 84.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.743 0.306 . . . . 1.0 111.144 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -66.3 -35.95 81.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.136 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.46 88.38 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.741 -0.384 . . . . 1.0 110.33 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -59.47 -46.42 88.83 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.638 -0.425 . . . . 1.0 109.872 179.479 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.85 -44.97 94.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.168 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -61.69 -41.48 97.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.701 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.8 mp -79.69 -12.96 59.78 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.995 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.23 -42.41 99.23 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.76 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.5 m -79.48 -20.24 47.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.847 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -80.48 173.76 12.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 1.0 110.636 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.1 pm0 -85.16 170.11 13.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.492 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -80.22 145.77 32.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.88 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.67 -0.27 57.96 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -85.89 146.87 26.53 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.537 ' CE2' ' CD1' ' A' ' 9' ' ' TYR . 51.7 p90 -131.42 164.64 25.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.295 0.569 . . . . 1.0 111.108 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.415 ' CG1' ' N ' ' A' ' 32' ' ' ILE . 69.1 t -147.3 158.19 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.422 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.415 ' N ' ' CG1' ' A' ' 31' ' ' VAL . 79.1 mt -116.98 123.71 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -143.38 158.44 43.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.36 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.694 ' C ' ' H ' ' A' ' 36' ' ' SER . 27.1 mt-30 -109.65 148.25 31.67 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.927 -0.397 . . . . 1.0 109.927 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 37' ' ' ARG . 7.2 m -61.17 18.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.256 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.694 ' H ' ' C ' ' A' ' 34' ' ' GLN . 1.5 m 69.21 -42.12 0.49 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.769 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 35' ' ' SER . 79.4 mtp85 -121.51 11.39 10.62 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.915 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -71.5 -66.75 2.05 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.489 -1.045 . . . . 1.0 110.489 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 67.08 -45.82 0.47 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.217 0.532 . . . . 1.0 110.914 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 38' ' ' GLY . 52.5 t0 -93.28 -4.79 51.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.802 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -146.24 149.9 34.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.542 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.91 150.85 40.45 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.991 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.9 t -124.73 132.09 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.005 -0.368 . . . . 1.0 110.005 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.8 mt -110.85 138.18 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.5 m -119.21 138.13 53.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.777 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.441 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 3.8 p-90 -147.15 146.75 30.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.743 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -92.48 138.61 31.37 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.209 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.436 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.0 mp -103.54 -82.71 0.49 Allowed 'General case' 0 C--N 1.339 0.129 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.123 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -94.16 -175.27 3.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.557 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -58.33 -41.09 83.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.898 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -127.32 53.63 1.72 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.021 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.5 tp -150.01 131.71 14.98 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.796 0.331 . . . . 1.0 110.413 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -132.7 148.89 52.34 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.297 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -137.17 151.16 48.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.722 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -127.64 141.99 51.47 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.132 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.407 HD13 HG22 ' A' ' 56' ' ' ILE . 95.5 mt -121.56 124.2 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -92.96 121.58 34.45 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.039 0.447 . . . . 1.0 110.544 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.0 mt -99.94 129.58 50.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.453 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -116.15 125.12 51.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 1.0 109.88 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -101.58 143.49 31.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.332 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 84.6 mt -143.78 -179.39 6.43 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.463 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 75.76 50.59 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.034 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.456 ' NZ ' ' OD1' ' A' ' 40' ' ' ASP . 99.4 mttt -95.49 125.88 40.4 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.779 -0.646 . . . . 1.0 109.945 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -69.72 -21.63 63.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.692 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -157.62 165.14 19.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.061 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.54 -33.89 80.18 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.91 1.74 . . . . 1.0 112.451 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.7 mt -93.43 -4.45 51.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.575 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.33 146.88 31.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.649 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.0 mt -89.47 157.41 18.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.213 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.57 126.66 8.64 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -85.67 -11.11 54.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.089 0.471 . . . . 1.0 110.582 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.43 120.18 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.571 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.1 mt -113.77 122.3 46.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.827 -0.624 . . . . 1.0 109.43 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 70.9 mt -101.82 124.39 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.985 -0.376 . . . . 1.0 109.985 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.1 t -142.63 133.31 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.261 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 77' ' ' ASN . 97.0 m-20 51.91 48.17 23.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.978 -0.289 . . . . 1.0 111.031 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 5.4 p30 55.25 21.69 4.23 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.384 0.428 . . . . 1.0 110.981 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -127.4 139.37 52.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.196 0.522 . . . . 1.0 110.155 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -88.53 134.38 33.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.002 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -129.2 138.11 51.52 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.421 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -78.66 -37.14 42.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.772 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 16.3 t0 -136.98 160.65 38.28 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.375 0.607 . . . . 1.0 111.637 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.473 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 3.0 pp -71.93 -36.27 69.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.447 -0.797 . . . . 1.0 111.799 178.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 2.4 p30 -58.58 -41.94 86.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.93 0.715 . . . . 1.0 112.93 -176.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.455 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 6.1 pt20 -63.81 -38.33 90.68 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.632 0.253 . . . . 1.0 110.882 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 86' ' ' ILE . 82.4 mt -61.27 -46.23 97.02 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 C-N-CA 120.485 -0.486 . . . . 1.0 110.882 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -61.62 -38.87 81.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 120.966 0.412 . . . . 1.0 111.49 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.8 t -78.31 -32.73 17.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 112.799 0.666 . . . . 1.0 112.799 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -88.7 -13.8 38.82 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.739 -0.384 . . . . 1.0 111.61 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.651 ' CZ ' ' NZ ' ' A' ' 94' ' ' LYS . 11.0 t80 -96.69 -48.66 5.41 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.786 -0.365 . . . . 1.0 111.525 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 4.3 mm? -71.21 -39.78 71.54 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.023 -0.535 . . . . 1.0 112.001 -177.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -63.81 -49.05 74.41 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.791 -0.764 . . . . 1.0 111.948 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -71.24 -42.72 68.49 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.616 -0.434 . . . . 1.0 111.863 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.651 ' NZ ' ' CZ ' ' A' ' 90' ' ' TYR . 21.1 mmtp -66.34 -42.12 88.6 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.274 -0.57 . . . . 1.0 111.285 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.6 t -65.02 -45.68 93.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.253 -0.579 . . . . 1.0 111.277 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -68.06 -44.78 75.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.483 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 tp -66.7 -40.04 88.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.294 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.1 tp -64.36 -42.53 96.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.401 -0.52 . . . . 1.0 109.935 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -67.84 -38.1 82.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.143 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -71.28 -42.28 68.92 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.845 -0.342 . . . . 1.0 111.617 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.512 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 5.0 ttt -66.46 -54.63 21.89 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.641 -0.424 . . . . 1.0 111.241 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.406 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 20.4 m -57.86 -32.54 67.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.273 0.558 . . . . 1.0 110.531 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -75.03 10.63 1.39 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.342 -0.845 . . . . 1.0 111.612 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 101' ' ' MET . 93.3 p -91.44 133.93 35.06 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.895 0.379 . . . . 1.0 110.489 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -60.61 -20.48 60.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.777 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.56 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 69.2 mttm -87.71 40.28 0.93 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.714 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.416 ' HB2' ' HG ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -132.25 116.87 17.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.387 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.51 ' NZ ' ' CE1' ' A' ' 118' ' ' PHE . 50.5 mtpt -135.99 109.72 8.08 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 178.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.1 t -91.21 88.88 7.1 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.216 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.97 160.86 12.98 Favored Glycine 0 N--CA 1.466 0.641 0 N-CA-C 110.829 -0.909 . . . . 1.0 110.829 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.402 ' CG2' ' N ' ' A' ' 112' ' ' LYS . 56.7 m -71.52 165.38 23.99 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.862 -0.422 . . . . 1.0 109.862 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.402 ' N ' ' CG2' ' A' ' 111' ' ' THR . 49.3 tptt -55.04 -38.54 68.11 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.56 -0.456 . . . . 1.0 110.558 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -67.35 -45.09 77.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.403 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.9 -19.85 62.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.952 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.7 t -68.82 -44.54 81.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.89 -44.62 92.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.211 0.529 . . . . 1.0 110.075 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -64.98 -36.13 83.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.915 0.388 . . . . 1.0 110.63 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.51 ' CE1' ' NZ ' ' A' ' 108' ' ' LYS . 11.1 t80 -64.64 -51.07 64.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.754 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.6 tp -69.9 -38.91 76.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.02 0.438 . . . . 1.0 110.17 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.546 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 65.1 mm-40 -64.1 -42.74 96.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.667 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.89 -48.22 82.8 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.438 -0.505 . . . . 1.0 110.24 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -60.48 -39.34 87.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.716 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.0 t -59.62 -40.99 89.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.228 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -62.17 -38.6 89.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.972 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.3 t -64.12 -43.31 97.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -130.24 74.59 80.24 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.226 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.45 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 7.7 Cg_exo -69.81 -23.6 30.38 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.894 2.396 . . . . 1.0 112.77 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -88.78 -14.38 37.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.981 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -112.59 153.96 26.75 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.144 0.497 . . . . 1.0 110.563 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.7 t -80.65 164.83 22.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.555 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 p -151.86 148.44 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -144.42 142.96 30.68 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.976 0.417 . . . . 1.0 111.213 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -151.65 167.91 26.66 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.294 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.56 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 2.1 p90 -140.53 155.28 46.67 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.2 m -155.66 171.75 19.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.343 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 51.3 tp -80.38 134.61 36.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.651 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.692 HD21 ' H ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -95.8 140.51 30.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.797 0.332 . . . . 1.0 110.348 179.381 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.455 ' ND1' ' N ' ' A' ' 138' ' ' HIS . 2.1 m80 -89.1 -28.75 19.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.712 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.66 -31.01 69.15 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.276 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.512 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -147.53 105.75 3.76 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.74 136.73 26.02 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.76 1.64 . . . . 1.0 112.691 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.11 -25.12 26.12 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.537 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 12.5 m95 -98.13 152.28 19.5 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.908 0.385 . . . . 1.0 110.246 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.512 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 91.5 m-85 -119.57 156.25 30.68 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.465 -0.568 . . . . 1.0 109.465 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -130.53 145.09 51.79 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.034 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.2 mt -111.06 121.74 46.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.893 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 11.7 ptp -110.43 140.93 44.19 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.686 -1.227 . . . . 1.0 107.686 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -161.47 153.35 19.4 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.384 -0.527 . . . . 1.0 109.59 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.546 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 33.8 mtpt -136.67 131.87 34.19 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.764 0.316 . . . . 1.0 110.604 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 23.7 mm -72.31 -45.13 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.355 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 127' ' ' PRO . 26.4 m-80 -157.81 170.58 22.04 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.495 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.37 -26.54 65.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.764 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -87.53 -10.24 52.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.056 0.455 . . . . 1.0 110.35 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 23.8 t -80.58 155.03 27.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.533 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.75 156.93 18.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.894 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.5 tp -69.99 115.98 9.83 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.188 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -107.38 130.32 54.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.628 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.3 m -126.29 130.11 50.2 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.809 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -112.95 156.91 22.19 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.025 -0.534 . . . . 1.0 109.786 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -106.38 146.22 30.73 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.867 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.82 137.7 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -99.1 135.42 40.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.854 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.17 130.71 44.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 81.4 p -129.27 172.35 11.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.332 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -85.64 18.07 3.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.871 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.07 -2.63 8.15 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.594 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 141.63 -129.73 4.1 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -125.25 132.29 52.98 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.815 0.341 . . . . 1.0 110.175 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -106.5 123.51 48.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.14 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.9 tt -119.02 117.89 30.0 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.36 -0.608 . . . . 1.0 109.36 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.2 t 36.02 52.02 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 111.89 0.329 . . . . 1.0 111.89 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.0 m120 71.98 26.66 2.85 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.105 0.78 . . . . 1.0 113.105 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -133.24 118.77 18.99 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.341 -0.614 . . . . 1.0 109.341 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -93.31 121.14 34.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.46 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -100.56 132.47 22.31 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -71.93 -18.96 27.49 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 C-N-CA 122.12 1.88 . . . . 1.0 113.33 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 35.4 m -153.47 157.12 39.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.966 0.412 . . . . 1.0 111.013 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.58 -33.97 62.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.957 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.499 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 50.4 mm -60.05 -46.64 94.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.89 -0.324 . . . . 1.0 110.548 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -68.84 -29.95 68.38 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 48.5 tp -64.81 -42.21 95.18 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.457 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.607 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 8.1 p -62.44 -47.63 83.23 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.768 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.607 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 44.6 t-20 -66.38 -46.9 75.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.974 -0.75 . . . . 1.0 108.974 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.87 -45.54 0.82 Allowed Glycine 0 C--N 1.334 0.437 0 N-CA-C 110.021 -1.232 . . . . 1.0 110.021 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -69.03 -46.83 66.94 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 183' ' ' ASN . 88.4 tttt -55.49 -40.1 71.27 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.841 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.3 m -60.95 -44.76 96.82 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.54 -40.82 98.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.826 -0.625 . . . . 1.0 109.963 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 40.9 tp -57.46 -42.25 82.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.412 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -63.12 -43.07 99.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.132 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.0 t -63.52 -39.37 94.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.394 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.83 -43.31 99.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.463 -0.79 . . . . 1.0 112.064 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -68.2 -29.37 68.21 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.815 0.302 . . . . 1.0 111.815 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -81.45 7.97 10.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.847 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.586 ' O ' ' N ' ' A' ' 197' ' ' HIS . 44.2 t-80 61.05 51.78 4.33 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.221 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.401 ' O ' ' C ' ' A' ' 197' ' ' HIS . 71.8 m-70 56.83 -70.44 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 O-C-N 123.719 0.637 . . . . 1.0 111.009 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.586 ' N ' ' O ' ' A' ' 195' ' ' HIS . 78.2 t60 -38.2 102.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.962 0.411 . . . . 1.0 110.687 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.473 ' O ' ' CD2' ' A' ' 198' ' ' HIS . 38.6 p-80 -112.55 106.24 14.64 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.561 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.957 -1.021 . . . . 1.0 110.561 -179.893 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 29.7 p . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.44 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 53.5 t-80 -154.08 -37.63 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.592 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -109.22 -16.32 14.1 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.565 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.36 -34.85 71.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.573 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.7 pt -79.3 -14.02 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.347 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 2' ' ' HIS . 29.9 m120 -89.84 -4.72 57.45 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.471 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -81.38 138.34 48.32 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.393 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.54 -16.1 46.45 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.898 1.732 . . . . 1.0 112.272 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.502 ' CD1' ' CE2' ' A' ' 30' ' ' PHE . 96.0 m-85 -93.13 8.91 38.18 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.281 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 87.6 t80 -88.45 127.42 35.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.498 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 61.2 m-85 -149.28 126.12 5.39 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.525 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 74.1 Cg_endo -73.36 107.67 2.44 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.433 1.422 . . . . 1.0 112.853 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.525 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 43.8 m-85 -162.76 152.49 15.81 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.522 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.544 ' ND2' HE22 ' A' ' 17' ' ' GLN . 52.6 p-10 -88.33 -176.23 5.28 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.62 -40.63 99.39 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.314 -0.946 . . . . 1.0 111.377 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -61.97 -48.17 81.55 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.894 -0.323 . . . . 1.0 111.189 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.544 HE22 ' ND2' ' A' ' 14' ' ' ASN . 0.9 OUTLIER -69.63 -30.93 68.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.291 -179.501 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.72 -46.04 91.35 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.651 -0.42 . . . . 1.0 110.292 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE2' ' CE1' ' A' ' 53' ' ' PHE . 81.2 tt0 -65.48 -41.07 93.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.67 -0.412 . . . . 1.0 109.996 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -62.24 -43.34 99.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.083 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -62.52 -44.89 95.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.455 -0.339 . . . . 1.0 110.536 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.37 -13.32 61.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.971 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 ttp85 -59.6 -43.21 93.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.956 0.408 . . . . 1.0 110.589 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.5 t -77.46 -19.15 56.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.829 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -86.41 -174.75 5.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.47 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 55.9 mp0 -104.54 -176.67 3.14 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.672 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -81.53 146.6 30.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.804 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.85 -1.02 59.44 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.175 -0.77 . . . . 1.0 111.175 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -85.58 148.62 25.84 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.066 -0.716 . . . . 1.0 109.066 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CE2' ' CD1' ' A' ' 9' ' ' TYR . 51.9 p90 -136.26 163.12 31.13 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.363 0.602 . . . . 1.0 110.965 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.2 m -147.68 158.89 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 114.98 -1.009 . . . . 1.0 111.645 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 79.0 mt -117.79 124.73 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -143.96 157.42 44.35 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.315 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.596 ' C ' ' H ' ' A' ' 36' ' ' SER . 35.3 mt-30 -108.76 142.54 39.16 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.867 -0.419 . . . . 1.0 109.867 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.436 ' C ' ' H ' ' A' ' 37' ' ' ARG . 28.3 m -60.46 5.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.865 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.596 ' H ' ' C ' ' A' ' 34' ' ' GLN . 0.2 OUTLIER 71.72 -47.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.451 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 35' ' ' SER . 35.4 ptt180 -100.02 0.29 40.65 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.891 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.561 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -73.4 -68.42 1.59 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.425 -1.07 . . . . 1.0 110.425 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 t70 69.23 -36.36 0.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.661 0.267 . . . . 1.0 110.799 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 38' ' ' GLY . 95.2 m-20 -106.66 1.64 25.28 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -148.04 148.66 30.92 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.469 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.7 152.84 37.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.916 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.92 132.99 70.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.275 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.07 139.24 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.1 m -118.95 139.38 51.76 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.551 ' CZ2' ' NZ ' ' A' ' 94' ' ' LYS . 5.7 p-90 -148.65 144.93 27.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.415 -0.811 . . . . 1.0 111.027 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -91.58 141.22 28.95 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.807 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.3 mp -97.85 -71.99 0.66 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.42 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 50' ' ' LYS . 62.3 t0 -162.01 146.46 12.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.144 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.543 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 1.1 ttmp? 46.54 -145.93 0.2 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.948 0.404 . . . . 1.0 111.126 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -79.79 68.95 6.02 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.81 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.8 tp -149.3 126.51 11.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.848 0.356 . . . . 1.0 110.426 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.519 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 64.0 m-85 -132.32 149.1 52.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.43 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 53' ' ' PHE . 98.0 mm-40 -135.78 152.7 51.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.031 -0.531 . . . . 1.0 109.666 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -128.07 142.68 51.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.302 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -118.88 122.54 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -92.23 120.58 32.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.053 0.454 . . . . 1.0 110.804 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.1 mm -99.34 131.68 46.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.41 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -114.4 136.57 52.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.024 -0.534 . . . . 1.0 109.833 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -100.54 152.92 19.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.119 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.429 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 3.1 tt -142.97 161.19 38.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.898 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.429 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 18.4 tt0 79.51 60.64 0.02 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.142 0.496 . . . . 1.0 109.781 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -106.55 103.31 12.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.0 -0.546 . . . . 1.0 109.725 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -70.43 -34.45 72.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.75 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 68' ' ' ALA . 15.6 p30 -161.16 157.0 21.66 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.42 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.96 -28.03 22.82 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.212 1.941 . . . . 1.0 112.193 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -83.93 -11.45 56.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.998 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 65' ' ' ASN . . . -92.7 140.15 29.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.318 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.8 mt -90.15 158.25 17.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.284 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.89 108.8 2.64 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.678 -0.969 . . . . 1.0 110.678 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -76.18 -18.29 59.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.834 0.35 . . . . 1.0 110.782 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.1 t -116.56 122.92 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.915 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.4 mt -116.3 133.92 55.48 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.6 mt -103.06 124.98 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.864 0.364 . . . . 1.0 110.076 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.7 133.7 32.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.411 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 t70 52.23 41.92 30.52 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.827 -0.349 . . . . 1.0 111.094 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 61.26 22.84 13.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.965 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.406 ' NE2' ' HH ' ' A' ' 80' ' ' TYR . 32.7 mt-30 -128.48 156.75 42.74 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.177 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -102.67 130.07 49.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.05 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.406 ' HH ' ' NE2' ' A' ' 78' ' ' GLN . 84.7 m-85 -129.24 139.37 51.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.253 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -86.55 -37.26 18.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.816 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -109.3 134.95 51.16 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.127 0.489 . . . . 1.0 112.312 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 46.9 tp -65.49 -38.1 88.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.559 -0.746 . . . . 1.0 110.722 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 4.6 p30 -58.6 -33.65 70.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 1.0 111.875 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.45 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 27.1 mt-30 -64.51 -37.98 89.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.696 0.284 . . . . 1.0 110.658 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.0 mm -59.58 -49.48 83.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.146 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 72.2 mt -62.94 -43.61 99.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.15 -0.62 . . . . 1.0 111.414 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.4 t -70.36 -41.14 78.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -80.23 -15.58 56.69 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.818 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -94.02 -49.88 5.57 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.56 -0.456 . . . . 1.0 111.799 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.6 -40.06 80.62 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.463 0.542 . . . . 1.0 112.463 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -63.38 -49.28 74.44 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.67 -0.812 . . . . 1.0 111.631 -177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -65.96 -43.11 88.88 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.851 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.551 ' NZ ' ' CZ2' ' A' ' 46' ' ' TRP . 25.6 mmtp -65.93 -42.57 89.91 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.458 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.7 t -65.58 -45.88 91.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.32 -0.552 . . . . 1.0 111.407 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -67.32 -46.56 73.14 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.598 -0.441 . . . . 1.0 111.47 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.9 tp -67.92 -40.12 83.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.627 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.39 -43.32 91.05 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.544 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -68.86 -35.63 77.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.404 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -70.61 -42.52 70.86 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.921 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 13.6 ttm -71.22 -53.04 15.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.484 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 104' ' ' SER . 9.0 m -57.11 -39.83 75.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.05 0.453 . . . . 1.0 110.222 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.7 m -71.45 9.72 0.76 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.888 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 102' ' ' THR . 8.3 t -92.74 133.23 36.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.276 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -60.82 -18.42 55.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.086 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.558 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 99.0 mttt -91.85 41.01 1.06 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.055 -0.521 . . . . 1.0 109.718 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -134.69 118.18 16.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.285 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -138.15 114.81 10.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.074 -0.512 . . . . 1.0 109.732 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.5 p -93.44 91.84 7.34 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.062 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.83 166.63 13.02 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.844 -0.903 . . . . 1.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 82.5 p -76.8 163.44 26.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -56.05 -35.55 67.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.826 0.346 . . . . 1.0 110.764 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -68.58 -43.89 75.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.145 0.498 . . . . 1.0 110.768 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -71.26 -19.26 62.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.013 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.74 -44.55 76.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 110.04 -0.355 . . . . 1.0 110.04 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.68 -45.57 91.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.063 0.459 . . . . 1.0 110.416 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.59 -36.9 85.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.845 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -65.1 -50.12 67.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.888 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.8 tp -70.35 -40.01 77.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.447 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -64.47 -45.06 89.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.589 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -60.54 -48.46 81.66 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.007 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.55 ' CD1' ' OD1' ' A' ' 126' ' ' ASN . 23.9 t80 -60.86 -42.06 97.11 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.646 -0.501 . . . . 1.0 109.646 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.5 t -59.93 -42.68 94.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.596 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -60.09 -39.95 87.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.356 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.92 -41.3 91.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.55 ' OD1' ' CD1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -118.95 76.42 14.59 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.31 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.526 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 37.4 Cg_endo -72.44 -21.16 23.05 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 122.398 2.065 . . . . 1.0 112.346 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -106.81 18.24 22.11 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.71 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -138.16 152.01 48.28 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.881 0.372 . . . . 1.0 110.654 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 t -81.74 163.19 22.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.89 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -154.19 145.43 14.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.168 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -148.49 144.34 27.3 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.784 0.326 . . . . 1.0 111.053 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -151.69 167.37 28.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.406 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.558 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -139.71 155.83 47.13 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 179.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.452 ' OG ' ' CZ ' ' A' ' 145' ' ' TYR . 15.0 p -152.07 169.4 22.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.405 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.1 tp -79.43 130.33 35.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.889 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -77.82 114.51 16.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.351 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -73.31 -36.14 66.2 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.591 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -65.91 -26.2 67.5 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.098 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -139.81 84.27 15.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.77 129.72 36.12 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.079 1.853 . . . . 1.0 112.346 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.94 -24.25 23.73 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.121 -0.791 . . . . 1.0 111.121 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -99.26 150.99 21.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.79 0.328 . . . . 1.0 110.263 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -123.76 160.84 26.41 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.954 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 145' ' ' TYR . 4.7 p90 -142.89 148.3 36.75 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.343 0.402 . . . . 1.0 109.929 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.9 mt -110.07 131.47 55.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.161 0.505 . . . . 1.0 110.497 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.45 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -118.85 145.32 45.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 177.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -161.93 154.47 19.86 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.479 -0.488 . . . . 1.0 109.705 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -139.77 127.31 21.62 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.514 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.443 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 3.3 mp -68.88 -44.62 81.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.091 0.404 . . . . 1.0 112.091 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 27.4 m120 -159.22 175.31 13.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.54 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.79 -31.94 73.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -84.31 -12.61 54.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.518 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.7 t -80.03 146.28 32.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.327 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -79.64 151.18 30.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.93 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.53 127.81 34.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.997 0.427 . . . . 1.0 110.178 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -114.63 130.84 56.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.663 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 86.4 m -126.3 129.08 48.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.838 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -116.06 154.53 29.76 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.77 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -105.19 141.67 36.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.796 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.94 132.89 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -95.41 136.17 36.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.704 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.5 tp -98.2 131.09 44.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.06 -0.518 . . . . 1.0 109.712 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.503 ' HG1' ' HG1' ' A' ' 166' ' ' THR . 46.1 p -131.17 163.84 26.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.356 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -76.98 16.3 0.56 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.542 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.503 ' HG1' ' HG1' ' A' ' 164' ' ' THR . 14.8 p -122.1 -1.26 9.31 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.791 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 138.43 -129.42 4.53 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.289 -1.124 . . . . 1.0 110.289 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -126.03 130.83 51.94 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.588 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 5.8 m-85 -107.99 123.04 48.06 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.3 tt -115.32 119.24 35.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.079 -0.51 . . . . 1.0 109.638 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.2 t 34.86 52.91 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 112.132 0.419 . . . . 1.0 112.132 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.2 m120 72.47 27.37 2.42 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.074 0.768 . . . . 1.0 113.074 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -135.54 120.66 18.84 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.588 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 15.6 t-20 -91.23 131.7 36.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.156 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -112.0 95.29 28.76 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 109.545 -0.539 . . . . 1.0 109.545 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.84 -20.34 6.71 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.296 1.998 . . . . 1.0 113.536 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 48.8 m -135.66 139.76 43.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.885 0.374 . . . . 1.0 111.094 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.0 p -62.78 -34.8 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.706 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.08 -44.16 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-O 120.904 0.383 . . . . 1.0 110.124 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.36 -33.83 76.75 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.99 -39.87 94.12 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.539 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 71.8 m -61.59 -48.03 82.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.598 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 186' ' ' LYS . 41.5 t30 -69.6 -48.84 58.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.872 -0.788 . . . . 1.0 108.872 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.56 -45.96 0.54 Allowed Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.788 -1.325 . . . . 1.0 109.788 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -68.01 -47.76 67.58 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.204 0.526 . . . . 1.0 109.657 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 183' ' ' ASN . 19.3 ttpp -56.6 -41.26 76.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.427 -0.806 . . . . 1.0 110.019 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 94.3 m -61.16 -45.63 93.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.84 -41.07 99.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.908 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 57.2 tp -58.25 -43.37 87.82 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.806 -0.357 . . . . 1.0 110.719 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -58.7 -45.74 88.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.153 0.501 . . . . 1.0 110.205 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 58.5 m -62.84 -39.6 94.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.476 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.49 -39.06 93.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.592 -0.731 . . . . 1.0 112.062 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.78 -24.58 61.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.83 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -91.61 6.57 45.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.084 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' A' ' 195' ' ' HIS . 76.6 t60 50.77 22.84 1.22 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.917 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.517 ' CG ' ' O ' ' A' ' 195' ' ' HIS . 20.7 p80 40.42 -165.47 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.785 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -131.64 5.89 4.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.613 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 85.0 t60 42.77 91.82 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.865 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.102 -0.952 . . . . 1.0 110.646 179.972 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.564 ' O ' ' CG ' ' A' ' 2' ' ' HIS . 13.0 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.564 ' CG ' ' O ' ' A' ' 1' ' ' THR . 18.6 p80 44.56 15.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.607 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 1' ' ' THR . 4.1 tpt180 -160.22 11.8 0.11 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.83 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 p -69.12 -33.81 60.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.601 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.432 HG23 HD13 ' A' ' 5' ' ' ILE . 36.6 pt -58.19 -13.95 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.658 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -134.79 24.97 3.67 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.399 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.3 147.43 58.0 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.495 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -50.88 -34.22 44.58 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.626 1.55 . . . . 1.0 112.321 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -88.74 10.14 21.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.391 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.49 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 42.5 t80 -91.17 129.07 37.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.55 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 65.2 m-85 -149.75 132.25 8.01 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.8 113.55 3.79 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.761 1.641 . . . . 1.0 112.701 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 11' ' ' PHE . 12.0 p90 -154.18 162.0 41.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.703 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -90.23 172.76 8.56 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.682 ' N ' HH12 ' A' ' 33' ' ' ARG . . . -58.31 -51.26 59.66 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.734 -0.946 . . . . 1.0 110.734 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -65.82 -39.06 90.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.676 0.274 . . . . 1.0 110.817 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -65.59 -32.48 74.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.388 . . . . 1.0 111.289 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.86 92.93 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.282 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.69 -40.88 92.78 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.662 -0.415 . . . . 1.0 109.99 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -63.06 -45.75 90.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.296 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -60.56 -42.37 96.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.542 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.7 mp -80.54 -13.29 59.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.893 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -61.72 -41.63 97.88 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.542 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.0 p -77.22 -17.17 58.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.903 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -82.85 177.86 8.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.664 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -95.31 178.22 5.59 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.713 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.476 ' NH2' ' OD1' ' A' ' 99' ' ' ASN . 60.5 ttp180 -76.17 144.73 40.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.053 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.12 26.16 17.14 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.312 -0.715 . . . . 1.0 111.312 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -112.13 142.03 45.09 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.121 -0.696 . . . . 1.0 109.121 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -134.08 169.62 16.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.499 0.666 . . . . 1.0 111.052 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.3 m -148.41 160.21 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 114.971 -1.013 . . . . 1.0 111.812 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.0 mm -115.87 130.4 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.682 HH12 ' N ' ' A' ' 15' ' ' GLY . 69.5 ttt180 -143.36 154.22 43.51 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.107 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -115.15 138.02 51.37 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 t -82.93 126.49 32.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.861 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.6 t -62.65 -43.42 98.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.672 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.75 -23.68 59.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.012 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.554 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -123.21 55.45 0.69 Allowed Glycine 0 N--CA 1.466 0.661 0 N-CA-C 110.611 -0.996 . . . . 1.0 110.611 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -59.14 -0.55 0.13 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.84 0.352 . . . . 1.0 110.731 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.554 ' H ' ' C ' ' A' ' 38' ' ' GLY . 73.0 m-20 -96.38 -2.34 45.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.663 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -140.78 164.84 29.13 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.192 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.01 146.95 46.16 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.246 -0.434 . . . . 1.0 109.905 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.97 132.05 71.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.792 0.329 . . . . 1.0 110.271 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.6 mt -112.94 138.95 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.6 m -117.54 138.73 51.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.225 0.536 . . . . 1.0 109.647 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 3.3 p-90 -145.33 156.78 44.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.687 -0.688 . . . . 1.0 110.784 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.544 ' NZ ' ' O ' ' A' ' 49' ' ' ASP . 25.1 ttpp -104.67 136.2 44.64 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.292 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.452 ' O ' ' CD ' ' A' ' 27' ' ' ARG . 10.3 mp -97.1 -68.49 0.8 Allowed 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.048 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.544 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 98.2 m-20 -106.66 -165.19 1.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.156 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.403 ' HD3' ' H ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -78.66 -17.7 55.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.674 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 51' ' ' ASP . 68.0 t0 -139.68 48.11 1.83 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.783 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.7 tp -155.69 133.47 11.21 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.926 0.394 . . . . 1.0 110.425 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -134.1 149.77 51.12 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.59 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -139.26 154.69 48.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.825 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 30.7 p-80 -127.03 142.49 51.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.212 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.51 121.34 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 109.708 -0.478 . . . . 1.0 109.708 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -92.51 121.7 34.22 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.976 0.417 . . . . 1.0 110.615 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 58' ' ' ILE . 84.2 mt -104.04 127.6 58.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.244 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -118.58 133.4 55.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.987 0.422 . . . . 1.0 109.92 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 40' ' ' ASP . 1.4 mp0 -99.97 144.63 28.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.015 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 70' ' ' GLY . 81.4 mt -146.4 167.24 24.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.627 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 17.4 tp10 81.04 17.28 0.52 Allowed 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.47 0.481 . . . . 1.0 109.89 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -54.97 116.72 2.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.194 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -73.27 -23.72 60.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.713 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -157.71 153.95 23.88 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.115 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -58.74 -26.54 80.27 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.29 1.993 . . . . 1.0 112.134 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.6 mt -98.17 -1.87 41.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.464 -0.334 . . . . 1.0 110.607 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.93 160.26 14.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.949 0.404 . . . . 1.0 110.335 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.6 mt -72.75 160.66 31.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.387 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 71' ' ' LYS . . . -60.89 -33.35 83.12 Favored Glycine 0 C--O 1.224 -0.499 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 70' ' ' GLY . 41.1 tttm 84.73 -31.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.061 0.457 . . . . 1.0 110.654 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.44 123.88 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.563 -0.744 . . . . 1.0 110.702 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.2 mt -112.82 122.85 48.88 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.476 -0.565 . . . . 1.0 109.476 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.5 mt -101.24 123.11 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.826 0.346 . . . . 1.0 110.219 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.12 130.48 29.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.233 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 165' ' ' ASN . 42.1 t0 53.66 45.35 28.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 1.0 111.116 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.9 m120 58.1 23.23 9.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.908 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -128.12 139.28 52.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.931 0.396 . . . . 1.0 110.252 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -89.62 133.37 34.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.976 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -123.96 138.57 54.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.333 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -85.4 -36.64 20.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.566 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -127.25 150.34 49.59 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.207 0.527 . . . . 1.0 111.857 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.7 tp -63.52 -39.2 93.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.671 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -58.18 -44.27 87.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.757 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -58.9 -37.87 77.6 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 110.34 -0.245 . . . . 1.0 110.34 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.1 -45.86 97.57 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 C-N-CA 120.428 -0.509 . . . . 1.0 111.008 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.6 mt -68.1 -44.24 84.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 120.526 -0.47 . . . . 1.0 111.585 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.7 t -77.8 -36.21 22.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 113.029 0.752 . . . . 1.0 113.029 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -84.78 -12.89 52.74 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.886 -0.325 . . . . 1.0 111.743 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -98.2 -48.22 5.17 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.564 -0.455 . . . . 1.0 111.727 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.16 -40.15 78.35 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.316 0.487 . . . . 1.0 112.316 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -62.73 -48.81 77.59 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.852 -0.739 . . . . 1.0 111.478 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -66.91 -42.47 85.35 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.599 -0.44 . . . . 1.0 111.814 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -65.51 -43.65 89.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.097 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.31 -44.33 94.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.405 -0.518 . . . . 1.0 111.018 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -68.0 -47.29 68.93 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.594 -0.442 . . . . 1.0 111.621 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 tp -68.05 -39.78 82.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.248 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.07 -43.13 96.37 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.314 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.476 ' OD1' ' NH2' ' A' ' 27' ' ' ARG . 94.3 m-20 -66.94 -37.71 84.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.035 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -71.01 -42.01 70.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.755 -0.378 . . . . 1.0 111.748 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.5 ttt -66.12 -54.98 18.88 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.494 -0.482 . . . . 1.0 111.458 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.409 ' C ' ' H ' ' A' ' 104' ' ' SER . 84.0 m -59.15 -40.64 86.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.043 0.449 . . . . 1.0 110.33 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.1 t -73.1 10.19 1.01 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.056 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 102' ' ' THR . 9.0 t -91.53 138.43 31.58 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.754 0.311 . . . . 1.0 110.256 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.75 -16.92 59.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.169 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.561 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 57.4 mmtt -93.87 38.57 1.07 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.056 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -133.08 116.76 16.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.045 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.497 ' NZ ' ' CE1' ' A' ' 118' ' ' PHE . 48.6 mtpt -133.2 128.83 36.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.951 -0.568 . . . . 1.0 109.901 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.4 p -96.64 77.66 2.9 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.912 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -111.29 151.8 17.72 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.946 -0.861 . . . . 1.0 110.946 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 58.1 p -73.5 168.29 19.58 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -55.46 -36.49 66.64 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.876 -0.33 . . . . 1.0 110.813 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -68.18 -44.18 76.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.625 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.53 -20.83 63.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.878 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.1 t -70.54 -44.95 76.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.746 -0.382 . . . . 1.0 110.186 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.8 t -64.31 -46.71 92.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-O 121.057 0.456 . . . . 1.0 110.334 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -65.86 -34.84 79.06 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.957 0.408 . . . . 1.0 110.821 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.497 ' CE1' ' NZ ' ' A' ' 108' ' ' LYS . 25.0 t80 -66.73 -50.11 63.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.914 -0.584 . . . . 1.0 111.667 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.2 tp -70.31 -39.86 77.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.96 0.41 . . . . 1.0 110.35 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -65.1 -40.06 94.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.646 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -63.61 -47.85 79.73 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.504 -0.478 . . . . 1.0 110.291 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -61.89 -41.77 98.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.012 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 90.6 p -64.53 -34.89 79.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.221 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -63.56 -41.21 98.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.166 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.3 t -67.18 -42.06 87.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.766 -0.457 . . . . 1.0 109.766 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -124.83 75.62 65.51 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.351 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.3 -13.71 30.9 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.676 2.251 . . . . 1.0 112.345 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -103.79 13.7 32.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.622 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -134.88 149.84 50.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.052 0.453 . . . . 1.0 110.576 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.5 p -80.58 161.78 24.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.803 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.2 p -153.32 148.13 13.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -148.05 142.84 26.73 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.887 0.375 . . . . 1.0 111.2 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -152.1 166.48 31.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.438 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.561 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.2 p90 -140.06 157.27 45.91 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 30.9 p -150.6 168.3 24.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.799 0.333 . . . . 1.0 110.237 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.3 tp -81.7 131.25 35.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.118 -0.492 . . . . 1.0 111.015 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.464 HD22 HD21 ' A' ' 140' ' ' ASN . 58.3 t-20 -79.94 111.86 16.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.409 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.46 -45.19 69.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.899 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.84 -20.39 65.04 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.195 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.464 HD21 HD22 ' A' ' 137' ' ' ASN . 68.7 m-80 -141.79 82.65 13.62 Favored Pre-proline 0 N--CA 1.463 0.193 0 N-CA-C 110.018 -0.364 . . . . 1.0 110.018 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.51 137.75 51.92 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.815 1.677 . . . . 1.0 112.5 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.5 -17.34 53.6 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -109.58 145.42 36.4 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.891 0.377 . . . . 1.0 109.989 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -120.51 159.79 24.47 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 115.992 -0.549 . . . . 1.0 109.806 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 145' ' ' TYR . 4.3 p90 -142.63 148.01 36.73 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 123.382 0.426 . . . . 1.0 110.017 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.02 132.52 54.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.129 0.49 . . . . 1.0 110.46 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.507 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -121.65 146.89 46.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 178.109 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -160.89 155.17 23.09 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -140.26 129.06 23.18 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.69 -0.404 . . . . 1.0 110.502 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.455 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 3.5 mp -72.62 -48.71 45.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.217 0.451 . . . . 1.0 112.217 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 150' ' ' ILE . 86.5 m-20 -153.35 170.31 20.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.474 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.49 -31.08 71.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.943 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -84.7 -11.48 55.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.42 . . . . 1.0 110.525 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 29.5 t -80.1 155.45 27.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.351 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -86.86 147.96 25.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.893 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.0 tp -70.7 128.72 37.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.923 0.392 . . . . 1.0 110.223 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -117.62 129.5 55.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.628 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 71.9 m -130.71 129.55 42.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.937 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -116.07 167.24 11.16 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.828 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -109.79 144.08 38.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.958 -0.565 . . . . 1.0 111.051 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 63.6 t -122.24 134.71 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -100.27 132.12 45.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.382 . . . . 1.0 110.792 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 57.0 tp -92.21 130.81 37.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.715 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.497 ' HG1' ' HG1' ' A' ' 166' ' ' THR . 41.5 p -128.04 168.14 15.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.479 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.409 ' OD1' ' OD2' ' A' ' 76' ' ' ASP . 21.9 m120 -82.58 14.24 3.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.598 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.497 ' HG1' ' HG1' ' A' ' 164' ' ' THR . 57.2 p -122.01 -2.55 9.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.707 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 143.14 -133.34 5.43 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.228 -1.149 . . . . 1.0 110.228 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -122.87 128.42 50.31 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.61 0.243 . . . . 1.0 110.448 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -103.13 123.07 45.98 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.4 tt -119.87 115.11 23.15 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.3 t 35.42 56.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.432 0.53 . . . . 1.0 112.432 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.5 m120 71.7 27.68 2.86 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.164 0.801 . . . . 1.0 113.164 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -135.54 120.11 18.19 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -94.56 119.2 32.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.411 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -99.01 133.62 22.05 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.24 -16.36 25.04 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.127 1.885 . . . . 1.0 113.604 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.1 p -154.25 158.22 39.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.946 0.403 . . . . 1.0 110.912 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 p -63.29 -40.18 88.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.739 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.7 mp -59.87 -47.09 92.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.806 0.336 . . . . 1.0 110.42 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -62.61 -35.7 80.38 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.58 -40.61 97.4 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.136 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 96.0 m -60.04 -45.57 92.38 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.54 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 186' ' ' LYS . 32.8 t30 -69.92 -49.4 52.41 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 119.692 -0.803 . . . . 1.0 108.869 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.05 -44.38 0.51 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.815 -1.314 . . . . 1.0 109.815 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -68.72 -47.4 66.46 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.084 -0.558 . . . . 1.0 109.586 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 183' ' ' ASN . 64.1 tttp -56.9 -41.83 78.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.816 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 16.9 m -61.03 -45.5 94.54 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 24.5 mt -62.19 -40.91 97.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.813 -0.631 . . . . 1.0 109.93 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.26 -44.04 92.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.461 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -59.47 -40.57 87.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.229 0.538 . . . . 1.0 110.056 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.4 t -67.18 -39.64 86.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.252 0.548 . . . . 1.0 110.791 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 25.2 mt -63.59 -44.54 93.75 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.603 -0.726 . . . . 1.0 112.261 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.8 -27.37 68.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.422 -0.354 . . . . 1.0 111.647 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 196' ' ' HIS . 0.8 OUTLIER -81.6 7.35 12.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.759 -179.126 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.523 ' CG ' ' O ' ' A' ' 195' ' ' HIS . 82.8 t60 44.32 24.99 0.1 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.979 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.469 ' ND1' ' O ' ' A' ' 195' ' ' HIS . 6.4 m-70 -132.01 158.62 41.02 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.348 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -109.16 149.63 29.07 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.292 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -70.92 99.85 1.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.767 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 14.1 m80 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.946 -1.026 . . . . 1.0 110.65 -179.988 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 38.8 p . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.433 -0.58 . . . . 1.0 109.433 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -90.09 3.27 53.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.615 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 7' ' ' HIS . 36.3 mmt180 -124.4 2.81 8.42 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.556 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 p -64.26 -42.8 96.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.573 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.2 pt -75.54 -25.06 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.365 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -99.44 -0.7 40.29 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.302 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 3' ' ' ARG . 1.3 t60 -54.41 140.17 56.23 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.226 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.61 -15.86 48.89 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.919 1.746 . . . . 1.0 112.152 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -93.77 -5.43 48.3 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.627 -0.261 . . . . 1.0 111.151 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 44.0 t80 -71.12 126.66 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.532 -0.303 . . . . 1.0 110.608 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 52.2 m-85 -146.36 122.21 5.63 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 110.184 -0.302 . . . . 1.0 110.184 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.59 109.76 2.92 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.887 1.725 . . . . 1.0 112.492 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -157.14 156.06 32.06 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.631 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.463 ' ND2' ' H ' ' A' ' 15' ' ' GLY . 13.2 t-20 -77.07 173.49 11.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.463 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -61.42 -46.33 94.6 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.298 -0.954 . . . . 1.0 111.032 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -67.55 -37.79 83.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.899 0.38 . . . . 1.0 110.877 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -67.41 -33.04 74.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.418 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.585 ' CB ' ' NH1' ' A' ' 33' ' ' ARG . . . -61.23 -43.12 99.38 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.482 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -61.55 -41.75 97.82 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.694 -0.402 . . . . 1.0 109.963 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.1 -39.97 91.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.106 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -63.79 -40.6 97.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.525 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.6 -13.55 59.88 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.927 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -58.09 -43.28 86.97 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.367 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 m -78.53 -17.99 55.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.72 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -84.75 -175.89 5.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.354 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.3 pm0 -112.61 -172.86 2.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.59 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -79.15 146.38 33.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.789 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.55 23.57 25.91 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.274 -0.73 . . . . 1.0 111.274 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -112.66 145.17 40.9 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 30' ' ' PHE . 11.9 p90 -133.51 160.38 37.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.214 0.531 . . . . 1.0 110.919 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 88.1 t -146.34 155.39 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.255 -0.884 . . . . 1.0 111.459 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.87 123.39 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.004 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.585 ' NH1' ' CB ' ' A' ' 18' ' ' ALA . 18.6 ptt-85 -140.5 167.11 22.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.343 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 36' ' ' SER . 25.7 mt-30 -112.41 132.17 55.17 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.037 -0.357 . . . . 1.0 110.037 178.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.522 ' C ' ' H ' ' A' ' 37' ' ' ARG . 61.7 m -56.65 80.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.657 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 34' ' ' GLN . 0.2 OUTLIER 69.83 -42.2 0.5 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.319 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.618 ' O ' ' N ' ' A' ' 39' ' ' ASP . 82.1 mtp180 -150.4 -20.9 0.24 Allowed 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.251 -0.431 . . . . 1.0 111.218 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.614 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . 60.41 -53.76 0.02 OUTLIER Glycine 0 C--O 1.221 -0.697 0 N-CA-C 110.45 -1.06 . . . . 1.0 110.45 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.618 ' N ' ' O ' ' A' ' 37' ' ' ARG . 66.7 t0 55.34 -73.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.082 0.467 . . . . 1.0 110.004 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.614 ' N ' ' O ' ' A' ' 38' ' ' GLY . 23.5 p-10 -124.89 19.06 8.53 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.039 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.488 ' ND1' ' OE1' ' A' ' 59' ' ' GLN . 88.6 m-70 -147.61 152.25 37.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.368 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mp -133.28 147.82 51.92 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.273 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.6 t -126.19 132.96 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.242 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.2 mt -113.69 139.66 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.585 ' OG1' ' NH1' ' A' ' 33' ' ' ARG . 29.2 m -122.53 143.31 49.8 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.694 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.547 ' NE1' ' CG ' ' A' ' 54' ' ' GLN . 5.8 p-90 -152.46 151.13 30.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.47 -0.786 . . . . 1.0 111.047 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -91.13 139.15 31.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.99 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.571 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 6.4 mp -95.67 -59.18 1.92 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.287 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -151.5 -174.34 4.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.338 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -54.88 128.36 32.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.815 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 56.04 39.83 30.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.129 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.63 120.38 10.53 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.844 0.354 . . . . 1.0 110.283 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -135.23 149.03 49.79 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.631 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.547 ' CG ' ' NE1' ' A' ' 46' ' ' TRP . 0.5 OUTLIER -141.96 156.09 45.47 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.707 179.353 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.48 ' CA ' ' NE2' ' A' ' 54' ' ' GLN . 33.9 m-70 -129.39 145.34 51.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.956 -0.566 . . . . 1.0 110.63 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.434 HG13 HE22 ' A' ' 54' ' ' GLN . 41.9 mt -125.39 130.96 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 43.8 p-10 -99.61 122.59 42.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.879 0.371 . . . . 1.0 110.489 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.403 HG21 HD12 ' A' ' 58' ' ' ILE . 78.0 mt -102.32 130.67 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.489 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.488 ' OE1' ' ND1' ' A' ' 41' ' ' HIS . 55.5 mm-40 -113.94 126.66 55.4 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -102.1 155.63 18.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.492 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.444 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 2.0 tp -145.19 170.67 15.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.818 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.444 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 20.6 tp10 79.77 53.07 0.02 OUTLIER 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 109.674 -0.491 . . . . 1.0 109.674 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -91.36 90.52 7.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.875 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.499 ' OE1' ' ND2' ' A' ' 65' ' ' ASN . 3.4 tm-20 -67.13 -34.54 77.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.908 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.499 ' ND2' ' OE1' ' A' ' 64' ' ' GLU . 31.2 m120 -145.63 152.81 50.0 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.244 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.64 -33.35 48.51 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.314 2.009 . . . . 1.0 112.061 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.0 mt -86.9 -9.56 55.41 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.863 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.26 134.36 51.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.271 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.8 mt -85.36 152.55 23.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.351 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.59 96.63 0.02 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.721 -0.951 . . . . 1.0 110.721 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -68.43 -43.69 76.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.153 0.501 . . . . 1.0 110.639 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.2 t -111.05 121.83 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.602 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.2 mt -116.04 130.58 56.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.455 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 66.5 mt -108.04 128.39 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 109.869 -0.419 . . . . 1.0 109.869 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.2 t -145.94 134.01 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.36 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.533 ' OD2' ' ND2' ' A' ' 165' ' ' ASN . 32.7 t70 52.96 44.52 30.32 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.208 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 57.06 25.35 10.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.8 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -128.55 147.8 50.72 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.123 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -101.16 130.36 47.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.854 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -124.59 138.84 54.29 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.165 -0.471 . . . . 1.0 109.916 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -85.29 -38.33 18.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.639 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 57.2 t0 -117.11 144.1 45.06 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.076 0.465 . . . . 1.0 111.728 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.496 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 12.3 tp -64.89 -38.44 90.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.619 -0.719 . . . . 1.0 110.551 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.0 -45.06 87.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.96 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -58.39 -38.9 78.29 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.66 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.81 -46.38 96.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.827 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.42 HG23 HD11 ' A' ' 87' ' ' ILE . 41.1 mm -64.27 -43.49 97.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.487 -0.485 . . . . 1.0 111.362 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.05 -43.35 88.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.093 -0.503 . . . . 1.0 112.21 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -71.95 -14.77 62.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.943 0.401 . . . . 1.0 111.267 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -91.94 -50.26 5.81 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.339 -0.544 . . . . 1.0 111.777 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.97 -41.51 86.73 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.329 0.492 . . . . 1.0 112.329 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -63.58 -49.9 71.57 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.65 -0.82 . . . . 1.0 111.524 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -70.39 -43.11 70.74 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.465 -0.494 . . . . 1.0 111.961 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -65.85 -42.03 90.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.184 -0.606 . . . . 1.0 111.407 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.57 -46.08 90.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.185 -0.606 . . . . 1.0 111.395 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -69.42 -44.84 70.55 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.436 -0.506 . . . . 1.0 111.415 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.1 tp -66.02 -42.58 89.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.484 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.6 tp -65.08 -40.27 94.39 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.389 -0.524 . . . . 1.0 110.4 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.424 ' O ' ' OG ' ' A' ' 103' ' ' SER . 7.0 m120 -67.93 -38.82 83.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.839 -0.618 . . . . 1.0 111.261 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -70.4 -39.97 74.16 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 120.628 -0.429 . . . . 1.0 111.71 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.602 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 2.9 ttt -69.33 -56.27 8.0 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.438 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 104' ' ' SER . 17.0 m -58.39 -41.45 84.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.085 0.469 . . . . 1.0 110.599 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 99' ' ' ASN . 35.8 m -71.64 10.82 0.58 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.625 -0.716 . . . . 1.0 111.276 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.486 ' OG ' ' O ' ' A' ' 101' ' ' MET . 65.0 p -94.38 133.76 37.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.788 0.327 . . . . 1.0 110.436 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.3 -20.55 55.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.812 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.556 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -89.29 40.57 0.99 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.136 -0.483 . . . . 1.0 109.881 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -132.2 114.34 14.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.065 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -139.33 113.12 8.54 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 116.088 -0.505 . . . . 1.0 109.868 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 t -97.41 89.89 4.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.993 0.425 . . . . 1.0 110.876 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -112.45 168.98 12.84 Favored Glycine 0 N--CA 1.467 0.731 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.8 m -71.86 162.03 30.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -57.02 -37.88 72.35 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.591 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -69.87 -45.22 68.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.164 0.507 . . . . 1.0 110.801 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -68.1 -21.67 64.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.648 -0.706 . . . . 1.0 110.906 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -69.82 -44.38 79.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.172 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.65 -44.81 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.032 0.444 . . . . 1.0 110.279 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -65.89 -34.26 77.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.902 0.382 . . . . 1.0 110.698 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.4 -50.68 62.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.849 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.6 tt -70.88 -39.97 75.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.445 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.529 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 58.7 mm-40 -59.98 -41.81 92.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.359 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.58 -46.95 83.49 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.24 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -60.73 -45.84 92.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.066 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.3 t -61.58 -38.15 86.47 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.492 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -61.64 -40.05 93.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.034 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.67 -41.93 94.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.473 ' N ' ' ND2' ' A' ' 126' ' ' ASN . 0.0 OUTLIER -126.48 78.83 71.72 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.209 179.24 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.533 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 10.3 Cg_exo -67.9 -20.22 45.46 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.967 2.444 . . . . 1.0 112.339 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -97.19 -6.86 33.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.998 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -113.92 148.04 37.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.871 0.367 . . . . 1.0 110.637 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.6 p -80.16 164.83 23.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.592 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 p -152.71 146.09 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -144.35 142.34 30.31 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.752 0.31 . . . . 1.0 111.14 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -152.54 164.54 37.42 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.51 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.556 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.5 OUTLIER -133.72 157.05 46.82 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.1 t -152.59 167.72 27.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.889 0.376 . . . . 1.0 110.223 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 137' ' ' ASN . 1.0 OUTLIER -84.05 136.19 34.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.827 179.503 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.555 ' ND2' ' H ' ' A' ' 138' ' ' HIS . 47.4 t30 -60.19 -136.18 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.422 -0.353 . . . . 1.0 110.339 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.555 ' H ' ' ND2' ' A' ' 137' ' ' ASN . 32.2 m80 -158.01 -61.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.657 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 139' ' ' ASP . 15.7 p-10 -90.29 1.58 56.38 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.937 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.541 ' OD1' ' ND2' ' A' ' 137' ' ' ASN . 6.6 m120 -116.4 90.53 30.36 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.459 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.42 104.55 1.59 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.081 1.854 . . . . 1.0 112.216 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.48 36.55 2.82 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.409 -1.076 . . . . 1.0 110.409 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -138.21 147.88 44.21 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.525 0.202 . . . . 1.0 110.552 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.602 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 69.5 m-85 -130.86 148.58 52.64 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.719 -0.475 . . . . 1.0 109.719 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.485 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 31.2 m-85 -124.41 136.82 54.36 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.051 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 16.3 mt -107.31 123.69 48.7 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.291 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -116.76 146.35 42.88 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.977 -1.119 . . . . 1.0 107.977 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -161.86 152.03 17.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.529 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 67.2 tttt -136.34 126.73 26.68 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 120.801 -0.359 . . . . 1.0 110.567 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.539 ' CD1' ' HG ' ' A' ' 154' ' ' SER . 3.4 mp -69.59 -47.96 68.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 23.6 m120 -157.48 174.55 15.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.48 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.92 75.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.88 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -85.33 6.88 24.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.039 0.447 . . . . 1.0 110.313 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.539 ' HG ' ' CD1' ' A' ' 150' ' ' ILE . 10.6 t -98.31 152.58 19.28 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.416 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.477 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 99.4 mttt -86.2 153.54 21.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.996 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 22.0 tp -69.95 125.9 28.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.407 . . . . 1.0 110.022 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 95.2 m-85 -115.9 127.29 54.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.703 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 94.3 m -126.45 130.81 51.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.823 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -115.63 160.65 19.75 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.054 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.485 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 84.7 m-20 -108.07 145.35 34.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.834 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.8 t -127.52 135.61 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -99.92 131.85 45.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.033 0.444 . . . . 1.0 110.61 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 54.5 tp -92.03 131.04 37.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 1.0 109.868 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 166' ' ' THR . 56.0 p -133.6 166.8 21.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.344 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.533 ' ND2' ' OD2' ' A' ' 76' ' ' ASP . 19.6 p30 -78.2 16.29 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.722 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.415 ' H ' ' C ' ' A' ' 164' ' ' THR . 62.1 p -119.57 -1.23 10.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.425 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 133.93 -125.8 4.03 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.251 -1.14 . . . . 1.0 110.251 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -122.78 129.66 51.99 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.242 -0.281 . . . . 1.0 110.242 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.98 118.1 35.79 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 tt -115.43 118.05 32.1 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.2 t 37.44 54.0 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.007 0.373 . . . . 1.0 112.007 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.8 m120 69.76 27.26 4.67 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.894 0.701 . . . . 1.0 112.894 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -131.96 120.38 22.41 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -94.84 120.68 35.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.364 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -98.09 135.37 21.41 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.438 -0.578 . . . . 1.0 109.438 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.26 -19.12 29.68 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.279 1.986 . . . . 1.0 113.55 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.448 ' OG ' ' OE1' ' A' ' 180' ' ' GLN . 19.4 p -150.1 153.78 36.98 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.968 0.413 . . . . 1.0 110.85 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.42 -36.27 75.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.696 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.513 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 48.5 mm -62.6 -47.63 92.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.946 0.403 . . . . 1.0 110.357 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.448 ' OE1' ' OG ' ' A' ' 177' ' ' SER . 6.0 mp0 -61.56 -30.75 70.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.8 tp -64.25 -40.46 96.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.272 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.619 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 2.6 p -60.27 -47.54 85.57 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.519 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.619 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 51.3 t30 -69.64 -49.01 57.87 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.2 -45.26 0.44 Allowed Glycine 0 N--CA 1.465 0.581 0 N-CA-C 109.876 -1.29 . . . . 1.0 109.876 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -67.67 -47.88 68.22 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.1 tttm -56.45 -40.33 74.63 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.54 -0.755 . . . . 1.0 110.1 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 97.9 m -61.04 -45.28 95.44 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.33 -39.71 95.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.872 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 59.7 tp -58.73 -44.55 90.47 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.619 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -59.8 -46.17 90.04 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.737 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.5 t -63.08 -39.9 96.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.197 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.49 -43.08 95.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.64 . . . . 1.0 111.963 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.49 -29.94 67.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.465 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -94.92 -7.52 39.78 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.886 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.414 ' O ' ' C ' ' A' ' 196' ' ' HIS . 86.4 m-70 47.2 56.86 6.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.123 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 195' ' ' HIS . 61.5 t-80 -35.91 -51.23 0.7 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.984 0.421 . . . . 1.0 110.718 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -158.28 -178.56 7.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.644 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -43.96 110.83 0.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 70.9 m80 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.055 -0.974 . . . . 1.0 110.728 179.701 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.462 ' CG ' ' O ' ' A' ' 2' ' ' HIS . 52.2 t-80 -84.31 -1.16 54.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.59 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -140.1 12.18 2.41 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.338 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.6 -27.39 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.574 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.4 pt -75.49 -22.06 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.484 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -106.32 5.98 30.13 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.961 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -58.93 150.91 58.01 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 38.2 Cg_endo -65.23 -19.88 62.47 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.171 1.914 . . . . 1.0 112.029 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.4 3.23 54.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.608 -0.269 . . . . 1.0 110.99 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -88.97 125.75 35.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.528 -0.306 . . . . 1.0 110.477 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.421 ' CZ ' ' O ' ' A' ' 8' ' ' PRO . 71.1 m-85 -143.17 128.69 10.07 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 110.186 -0.301 . . . . 1.0 110.186 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.489 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 74.0 Cg_endo -73.3 110.01 2.96 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.758 1.638 . . . . 1.0 112.766 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.489 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 52.4 m-85 -160.98 152.29 19.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.361 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 20.9 t-20 -75.84 165.09 25.52 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.464 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . -57.11 -43.41 93.36 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.461 -0.875 . . . . 1.0 110.937 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 48.6 mmm-85 -67.44 -37.65 83.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.864 0.364 . . . . 1.0 110.596 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -73.57 -32.57 64.22 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.62 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.56 -47.45 85.49 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.417 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -65.89 -36.85 84.56 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.43 ' O ' ' CG ' ' A' ' 23' ' ' ARG . 97.4 m-20 -63.33 -42.76 98.99 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -66.25 -36.55 83.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.715 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.5 tp -82.12 -11.84 58.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.101 -0.499 . . . . 1.0 111.381 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.43 ' CG ' ' O ' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -65.15 -28.57 69.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.826 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.2 t -83.56 -19.94 34.72 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.714 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -84.93 -178.15 6.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.428 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -88.69 167.9 12.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.799 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -74.72 145.15 43.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.808 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.77 4.95 56.8 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.872 -0.891 . . . . 1.0 110.872 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -88.98 148.3 23.85 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -128.31 165.03 21.33 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.219 0.533 . . . . 1.0 111.027 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 t -145.51 155.03 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.309 -0.86 . . . . 1.0 110.894 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -117.5 122.22 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.541 ' NH1' ' OG ' ' A' ' 35' ' ' SER . 32.8 ptt85 -148.66 158.76 44.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.297 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -107.55 137.08 46.23 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.541 ' OG ' ' NH1' ' A' ' 33' ' ' ARG . 2.9 p 169.16 97.74 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.539 0.524 . . . . 1.0 111.073 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.4 p -169.16 30.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.242 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? 53.15 20.26 1.74 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.233 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.702 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -150.1 89.95 0.14 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.677 -0.969 . . . . 1.0 110.677 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -57.18 11.91 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.225 -0.488 . . . . 1.0 111.142 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.702 ' H ' ' C ' ' A' ' 38' ' ' GLY . 32.0 p-10 -107.76 -0.44 21.72 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -129.59 155.47 45.76 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.783 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.41 150.28 40.46 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.006 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.7 t -126.21 133.29 69.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.109 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.5 mt -112.53 138.44 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.749 -0.834 . . . . 1.0 108.749 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 87.6 m -116.5 135.37 53.88 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.04 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.472 ' CZ2' ' OH ' ' A' ' 90' ' ' TYR . 1.8 p-90 -146.0 151.75 38.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.934 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -98.26 138.03 36.12 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.946 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.513 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 9.2 mp -95.82 -73.25 0.6 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.046 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 23.4 t70 -103.07 -170.77 1.84 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.497 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.526 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 7.8 ttpm? -63.17 -38.66 92.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.616 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -127.21 61.25 1.37 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.873 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.8 tp -157.47 130.25 7.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.421 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.3 148.66 50.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.662 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.44 ' C ' ' ND1' ' A' ' 55' ' ' HIS . 26.7 mm100 -143.09 152.37 41.77 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.016 -0.538 . . . . 1.0 109.75 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.44 ' ND1' ' C ' ' A' ' 54' ' ' GLN . 3.7 m-70 -126.36 141.2 51.99 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.288 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.07 123.14 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.291 -0.413 . . . . 1.0 109.931 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -95.67 121.94 37.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.538 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.433 HG21 HD11 ' A' ' 58' ' ' ILE . 79.9 mt -102.47 124.02 56.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.441 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -107.56 136.16 47.8 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -103.34 151.71 22.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.034 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.0 mt -139.81 171.33 14.37 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.493 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 77.66 45.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.246 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.76 77.38 2.84 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.917 -0.583 . . . . 1.0 109.927 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -65.21 -35.84 82.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.585 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -131.09 150.38 76.4 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.01 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.32 -20.39 66.54 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.235 1.957 . . . . 1.0 112.082 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.61 -4.4 50.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.711 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.26 129.79 54.23 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.947 0.403 . . . . 1.0 110.308 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.8 mt -81.21 153.35 27.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.515 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.06 114.0 6.41 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.526 -1.03 . . . . 1.0 110.526 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.98 -10.65 59.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.876 0.37 . . . . 1.0 110.799 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.7 t -117.87 118.83 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.43 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.5 mt -114.76 128.79 56.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.388 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.4 HG22 HD13 ' A' ' 74' ' ' ILE . 96.6 mt -100.28 120.26 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.883 0.373 . . . . 1.0 110.539 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.65 133.08 31.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.393 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 55.43 43.99 27.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.11 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.3 t30 58.47 21.76 8.84 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.02 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -128.86 152.27 48.7 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.336 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -100.09 131.64 45.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 1.0 111.041 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -128.81 136.8 50.99 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.204 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -85.5 -37.44 19.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.591 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -112.29 141.2 46.3 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.971 0.415 . . . . 1.0 111.575 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.9 -40.44 95.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.726 -0.67 . . . . 1.0 111.173 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 42.9 p30 -59.89 -33.66 72.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 1.0 111.64 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.561 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 25.8 mt-30 -65.92 -39.14 90.29 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.799 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.65 -45.72 98.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.716 -0.394 . . . . 1.0 110.778 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.6 mm -65.12 -44.01 95.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.422 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.453 ' O ' ' CG ' ' A' ' 92' ' ' GLN . 98.1 t -69.36 -44.6 80.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 112.433 0.531 . . . . 1.0 112.433 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -76.95 -13.05 60.02 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.288 -0.565 . . . . 1.0 111.692 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.472 ' OH ' ' CZ2' ' A' ' 46' ' ' TRP . 63.0 t80 -93.85 -48.6 6.21 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.977 0.362 . . . . 1.0 111.977 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.89 -42.45 76.92 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.425 0.528 . . . . 1.0 112.425 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.493 ' CD ' ' N ' ' A' ' 93' ' ' ASN . 1.5 pp0? -63.84 -47.46 80.65 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.025 -0.67 . . . . 1.0 111.526 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.493 ' N ' ' CD ' ' A' ' 92' ' ' GLN . 2.7 t30 -69.27 -42.81 75.05 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.685 -0.406 . . . . 1.0 111.509 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -65.68 -42.86 90.75 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.296 -0.562 . . . . 1.0 111.018 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.7 t -66.04 -46.46 87.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.12 -0.632 . . . . 1.0 111.137 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.471 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 82.6 mtp180 -67.08 -45.54 77.01 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.272 -0.571 . . . . 1.0 111.842 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.1 tp -69.57 -41.43 75.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.534 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.47 -45.72 86.18 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.43 -0.508 . . . . 1.0 110.674 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.471 ' ND2' ' HA ' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -69.11 -35.03 76.0 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.439 -0.504 . . . . 1.0 111.161 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -71.72 -42.86 66.8 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.578 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 9.2 tpt -68.78 -52.88 25.56 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.495 -0.482 . . . . 1.0 111.117 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.433 ' C ' ' H ' ' A' ' 104' ' ' SER . 58.9 m -58.48 -40.78 83.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 1.0 110.551 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.5 t -72.61 9.77 1.01 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.877 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 102' ' ' THR . 6.0 t -92.26 136.49 33.14 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 110.178 -0.305 . . . . 1.0 110.178 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -62.71 -16.83 59.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.85 0.357 . . . . 1.0 110.836 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.473 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 99.3 mttt -91.76 39.3 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.999 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -132.95 114.84 14.48 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.989 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -130.03 115.5 17.2 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 64.5 p -97.59 81.52 2.95 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.863 0.363 . . . . 1.0 110.912 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.93 167.43 12.32 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.831 -0.908 . . . . 1.0 110.831 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 80.9 p -77.28 162.81 27.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.971 -0.381 . . . . 1.0 109.971 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -55.99 -35.68 67.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.554 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.74 -43.61 83.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.651 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -70.78 -19.76 62.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.982 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 43.2 t -70.25 -44.69 77.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.336 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.31 -44.89 94.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.293 0.568 . . . . 1.0 110.395 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -65.65 -34.89 79.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.656 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -67.35 -50.13 61.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.539 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.2 tp -69.7 -39.45 78.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.225 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -63.46 -43.57 96.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.661 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.86 -47.45 86.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.29 -0.564 . . . . 1.0 110.219 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.562 ' CE2' ' OD1' ' A' ' 126' ' ' ASN . 50.3 t80 -61.42 -40.05 92.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.015 -0.539 . . . . 1.0 109.844 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.6 t -60.35 -42.41 95.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.572 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -61.14 -40.84 95.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.404 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.35 -41.27 83.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.562 ' OD1' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -123.15 73.95 48.91 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.732 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.53 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 41.2 Cg_endo -72.01 -22.26 23.18 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.131 1.887 . . . . 1.0 112.442 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -104.07 24.45 11.39 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.74 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -140.77 151.52 44.5 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.826 0.346 . . . . 1.0 110.633 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.9 p -80.12 162.22 24.88 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.554 -0.535 . . . . 1.0 109.554 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 p -152.63 144.76 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.446 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 27.2 p90 -153.49 142.76 21.51 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.962 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -151.76 169.47 22.13 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.438 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.473 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -131.02 149.92 52.39 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.435 ' HG ' ' N ' ' A' ' 136' ' ' LEU . 26.9 t -150.55 169.98 20.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.329 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.435 ' N ' ' HG ' ' A' ' 135' ' ' SER . 43.6 tp -67.89 140.55 56.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.422 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.56 ' C ' ' H ' ' A' ' 139' ' ' ASP . 9.8 p30 -55.59 -43.64 76.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.565 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 19.2 t60 70.39 -19.71 0.21 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.707 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.56 ' H ' ' C ' ' A' ' 137' ' ' ASN . 30.3 m-20 -103.0 -24.24 13.65 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.065 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.434 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 4.7 p30 -153.56 91.75 3.25 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.11 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.504 ' HA ' HD22 ' A' ' 137' ' ' ASN . 44.8 Cg_exo -54.25 135.26 64.37 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.203 1.935 . . . . 1.0 112.665 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 117.58 -28.99 6.84 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.001 -0.84 . . . . 1.0 111.001 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -113.96 150.49 33.72 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.931 0.396 . . . . 1.0 110.538 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -115.33 156.24 25.85 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -125.36 134.94 52.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.029 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.4 mt -106.68 126.24 52.03 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.651 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -117.15 146.39 43.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 178.472 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -160.86 150.59 17.31 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.216 -0.593 . . . . 1.0 109.723 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -130.94 127.37 38.31 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.746 0.308 . . . . 1.0 110.281 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 37.6 mm -72.92 -46.08 53.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.204 -0.453 . . . . 1.0 111.803 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 152' ' ' ALA . 11.9 t-20 -157.07 169.61 24.41 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.699 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.537 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -60.51 -30.08 69.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.813 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -90.41 8.79 31.88 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.036 0.446 . . . . 1.0 110.393 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 15.6 t -97.45 159.73 14.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.716 -0.674 . . . . 1.0 110.486 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -92.37 153.2 19.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.039 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 48.5 tp -70.84 118.52 13.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -108.07 129.98 55.11 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 51.8 m -126.41 128.94 47.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.611 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -113.9 160.97 18.2 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.035 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 160' ' ' ASN . 50.9 p30 -104.75 147.99 27.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.906 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 47.4 t -128.31 137.48 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.85 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -104.0 131.53 51.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.367 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.0 tp -95.26 130.53 41.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 1.0 109.789 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 48.8 p -127.89 171.01 12.18 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.252 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -84.97 16.48 3.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.851 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m -122.91 -3.25 8.65 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.935 0.398 . . . . 1.0 110.458 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 143.41 -132.24 4.88 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.422 -1.071 . . . . 1.0 110.422 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -122.91 130.2 52.55 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -106.48 122.52 46.46 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 tt -116.28 118.08 31.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 1.0 109.856 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.466 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 4.7 t 37.48 58.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.176 0.436 . . . . 1.0 112.176 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.5 m120 65.46 27.34 11.76 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.949 0.722 . . . . 1.0 112.949 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.466 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 89.0 m-85 -133.85 120.37 20.35 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -96.49 126.2 41.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.439 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -105.08 131.72 21.52 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -73.31 -20.79 20.75 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.192 1.928 . . . . 1.0 113.31 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 67.9 m -143.86 147.44 34.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.945 0.402 . . . . 1.0 111.218 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.08 -34.51 60.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.67 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 58.8 mt -62.2 -44.95 99.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.886 0.374 . . . . 1.0 110.135 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -67.98 -31.22 70.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.059 -0.519 . . . . 1.0 109.629 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.14 -42.79 99.53 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 110.084 -0.339 . . . . 1.0 110.084 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.425 ' SG ' ' NZ ' ' A' ' 106' ' ' LYS . 73.1 m -63.13 -44.98 94.06 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.26 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.559 ' O ' ' N ' ' A' ' 186' ' ' LYS . 37.3 m-80 -65.73 -48.83 70.59 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.47 -43.43 0.75 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.678 -1.369 . . . . 1.0 109.678 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.432 ' O ' ' HG ' ' A' ' 188' ' ' LEU . 2.6 t80 -69.56 -46.85 65.46 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 122.096 0.951 . . . . 1.0 109.329 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.559 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.7 tttm -59.01 -35.58 73.51 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.118 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.7 m -63.43 -50.5 69.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 1.0 111.177 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 185' ' ' PHE . 0.7 OUTLIER -66.55 -36.05 81.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.66 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 45.7 tp -58.03 -43.84 86.99 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.432 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -61.13 -40.28 93.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.956 -0.566 . . . . 1.0 109.792 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.0 t -61.59 -36.85 81.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.741 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 92.6 mt -69.95 -36.94 75.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.405 -0.816 . . . . 1.0 112.047 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.57 -31.88 69.85 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.051 0.389 . . . . 1.0 112.051 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -81.31 -4.44 55.64 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.881 -0.327 . . . . 1.0 110.725 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.407 ' CG ' ' O ' ' A' ' 195' ' ' HIS . 79.0 t60 54.76 40.73 32.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.382 . . . . 1.0 111.064 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -118.51 124.46 47.6 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.417 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -140.96 132.78 27.47 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.012 0.435 . . . . 1.0 110.447 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.459 ' O ' ' CG ' ' A' ' 199' ' ' HIS . 93.3 m-70 -61.1 -41.87 97.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.867 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.459 ' CG ' ' O ' ' A' ' 198' ' ' HIS . 98.2 m-70 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.984 -1.008 . . . . 1.0 110.533 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 81.7 p . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.276 -0.638 . . . . 1.0 109.276 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -131.18 -31.79 1.64 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.602 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.402 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 69.5 mtp180 -108.34 -22.4 12.34 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.895 0.379 . . . . 1.0 110.375 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 p -64.8 -31.36 53.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.556 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.7 pt -73.79 -17.26 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.46 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -98.03 0.32 46.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.389 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.41 ' O ' ' N ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -62.78 123.22 78.76 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.285 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.477 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 77.5 Cg_exo -43.9 -25.72 1.13 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.848 1.699 . . . . 1.0 112.39 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.598 ' CD1' ' CZ ' ' A' ' 30' ' ' PHE . 78.5 m-85 -87.0 9.16 20.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.506 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 7' ' ' HIS . 44.2 t80 -92.68 125.48 37.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.377 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.477 ' CZ ' ' O ' ' A' ' 8' ' ' PRO . 66.1 m-85 -145.3 128.27 8.29 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 110.12 -0.326 . . . . 1.0 110.12 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.88 110.54 3.1 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.717 1.611 . . . . 1.0 112.712 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -154.52 152.48 30.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.439 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -79.31 174.03 11.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.398 -0.593 . . . . 1.0 109.398 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.44 -46.86 93.56 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.403 -0.903 . . . . 1.0 111.338 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -67.32 -35.29 79.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.539 0.209 . . . . 1.0 111.15 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -67.68 -37.22 82.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.379 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.29 94.94 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.691 -0.404 . . . . 1.0 110.425 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.47 -43.99 92.47 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.019 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.61 -42.63 99.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.432 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -63.05 -41.51 99.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.831 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.9 mp -78.63 -11.31 59.96 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.97 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -56.21 -43.52 78.61 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.519 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.0 m -79.3 -15.84 57.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.739 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -81.44 175.57 10.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.472 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -100.9 -176.38 3.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.515 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -82.3 146.2 29.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.88 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.51 14.01 45.77 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.192 -0.763 . . . . 1.0 111.192 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -100.49 144.07 29.91 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.598 ' CZ ' ' CD1' ' A' ' 9' ' ' TYR . 9.1 p90 -132.9 162.19 32.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.116 0.484 . . . . 1.0 110.832 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -147.29 157.77 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.193 -0.912 . . . . 1.0 111.533 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 80.8 mt -117.75 124.82 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 43' ' ' VAL . 1.5 ptm180 -150.27 156.03 40.8 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.321 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.404 ' C ' ' H ' ' A' ' 36' ' ' SER . 54.4 mt-30 -88.33 169.87 11.46 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 37' ' ' ARG . 16.5 p -81.09 28.13 0.38 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.405 -0.362 . . . . 1.0 110.987 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 34' ' ' GLN . 1.5 m 70.94 -41.4 0.5 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.809 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.508 ' H ' ' C ' ' A' ' 35' ' ' SER . 83.9 mtt85 -140.21 19.01 2.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.01 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -70.66 -65.18 2.57 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.618 -0.993 . . . . 1.0 110.618 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 68.03 -43.72 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.726 0.298 . . . . 1.0 110.647 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 38' ' ' GLY . 38.2 t70 -94.8 -9.63 33.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.652 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -136.98 151.33 48.87 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.898 0.38 . . . . 1.0 110.348 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.96 147.91 44.81 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.097 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 33' ' ' ARG . 62.4 t -126.47 134.24 66.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.437 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.1 mt -112.95 138.86 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.1 m -116.9 135.36 53.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.825 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 4.1 p-90 -144.4 148.02 34.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.521 -0.763 . . . . 1.0 110.787 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -95.29 137.13 34.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.972 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.489 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 9.6 mp -101.87 -82.14 0.48 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.385 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -90.01 174.74 7.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.522 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -58.52 -29.59 66.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.82 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -132.56 52.95 2.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.992 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.0 tp -152.9 136.76 16.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.905 0.384 . . . . 1.0 110.442 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.553 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 87.0 m-85 -131.63 148.22 52.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.385 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 53' ' ' PHE . 98.0 mm-40 -142.73 153.81 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.681 -0.489 . . . . 1.0 109.681 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.502 ' ND1' ' O ' ' A' ' 55' ' ' HIS . 7.7 p80 -129.45 144.65 51.34 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.287 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.3 mt -122.64 125.57 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -96.45 122.67 39.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.952 0.406 . . . . 1.0 110.359 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.429 HG21 HD13 ' A' ' 58' ' ' ILE . 75.3 mt -104.82 129.64 57.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.31 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.795 ' H ' HE21 ' A' ' 59' ' ' GLN . 0.0 OUTLIER -112.23 135.15 53.26 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.096 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -100.53 151.52 21.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.312 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.44 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.7 tp -143.5 176.18 9.38 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.513 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.44 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 64.0 tt0 67.63 44.37 1.68 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.264 0.554 . . . . 1.0 109.633 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -83.01 90.44 7.02 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.806 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.466 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 49.4 tp10 -65.66 -38.38 89.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.819 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 64' ' ' GLU . 6.6 m120 -144.16 153.67 56.74 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.259 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.82 -33.83 62.61 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.079 1.853 . . . . 1.0 112.324 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 pp -85.14 -10.92 56.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.857 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.51 133.86 48.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.367 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.2 mt -79.67 152.45 29.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.364 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.86 92.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.01 -37.11 86.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.867 0.365 . . . . 1.0 110.772 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.2 t -122.93 123.0 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.804 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.7 mt -116.13 134.22 55.17 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.423 HG23 HD11 ' A' ' 74' ' ' ILE . 18.5 mm -99.57 120.09 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.919 0.39 . . . . 1.0 110.128 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.66 131.47 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.229 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.405 ' OD2' ' ND2' ' A' ' 165' ' ' ASN . 42.6 t0 54.14 43.45 30.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.18 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 59.54 24.31 13.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.017 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -129.53 156.96 43.32 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.434 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.14 133.51 41.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.187 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -135.19 136.4 41.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.241 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -87.06 -37.66 17.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.889 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -109.33 136.71 48.34 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.21 0.529 . . . . 1.0 112.324 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.4 tp -66.08 -38.12 87.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.767 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 54.1 t0 -59.7 -36.58 76.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.894 -176.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.415 ' OE1' ' OE2' ' A' ' 89' ' ' GLU . 9.5 tt0 -59.8 -38.96 83.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.627 0.251 . . . . 1.0 110.608 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.1 mm -60.71 -47.76 91.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.708 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.431 HG22 HD11 ' A' ' 87' ' ' ILE . 96.8 mt -62.16 -42.7 96.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 120.512 -0.475 . . . . 1.0 111.786 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.428 ' O ' ' OE1' ' A' ' 92' ' ' GLN . 40.6 t -76.44 -37.57 30.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.152 0.797 . . . . 1.0 113.152 -177.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.415 ' OE2' ' OE1' ' A' ' 85' ' ' GLN . 95.8 mt-10 -84.37 -14.49 49.36 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.912 0.338 . . . . 1.0 111.912 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -95.27 -48.7 5.79 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.629 -0.428 . . . . 1.0 112.129 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.9 mp -69.76 -40.49 76.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.337 0.495 . . . . 1.0 112.337 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.515 ' OE1' ' N ' ' A' ' 92' ' ' GLN . 5.1 mp0 -64.2 -48.95 73.91 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.969 -0.692 . . . . 1.0 111.767 -177.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -69.29 -42.9 74.85 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.622 -0.431 . . . . 1.0 111.866 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -66.35 -43.62 85.52 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.359 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.4 t -61.56 -45.52 98.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.3 -0.56 . . . . 1.0 111.235 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -69.24 -42.7 75.29 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.487 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.8 tp -66.44 -42.24 87.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.616 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.7 mp -65.4 -41.11 94.02 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.504 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.48 -36.24 78.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.18 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -71.66 -42.28 67.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 120.824 -0.351 . . . . 1.0 111.784 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.3 tpt -67.46 -54.96 15.72 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.438 -0.505 . . . . 1.0 111.65 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 55.3 m -59.68 -29.42 68.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.956 0.407 . . . . 1.0 110.559 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.0 p -74.25 9.61 1.58 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.123 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.7 t -98.45 130.1 45.06 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 110.123 -0.325 . . . . 1.0 110.123 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -58.23 -17.49 19.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.127 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.533 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 98.6 mttt -88.56 40.63 0.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.671 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -135.24 113.41 11.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.104 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -133.44 120.43 20.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.052 -0.522 . . . . 1.0 109.977 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.6 p -91.75 94.68 9.48 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.053 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.2 151.8 16.89 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.431 ' OG1' ' OD1' ' A' ' 114' ' ' ASP . 19.1 p -71.34 162.76 28.92 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -58.92 -40.1 83.54 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.539 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.85 -46.16 72.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.872 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.431 ' OD1' ' OG1' ' A' ' 111' ' ' THR . 2.8 m-20 -71.34 -19.37 62.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.744 -0.662 . . . . 1.0 111.084 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.2 t -73.7 -43.92 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.172 -0.307 . . . . 1.0 110.172 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.0 -46.56 96.21 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 CA-C-O 121.118 0.485 . . . . 1.0 110.054 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -65.86 -34.32 77.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.988 0.423 . . . . 1.0 110.696 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -68.94 -49.29 59.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.731 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.1 tp -70.6 -39.59 76.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.518 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -62.52 -41.65 98.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.765 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.96 -47.63 74.01 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.582 -0.447 . . . . 1.0 110.373 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.536 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 42.4 t80 -61.39 -42.09 98.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.99 -0.55 . . . . 1.0 109.914 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.5 p -64.87 -33.56 76.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.419 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -61.81 -42.02 98.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.998 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.76 -40.91 90.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.536 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -113.77 75.27 2.69 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.056 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.531 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 41.4 Cg_endo -71.99 -19.35 26.81 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.24 1.96 . . . . 1.0 112.406 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -104.67 -14.64 15.53 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.041 0.386 . . . . 1.0 112.041 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -103.4 147.1 27.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.082 0.467 . . . . 1.0 110.52 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.9 m -80.81 162.1 24.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.515 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 p -153.03 146.36 14.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -149.73 143.05 25.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.885 0.374 . . . . 1.0 111.041 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -151.24 165.25 34.53 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.317 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.533 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -133.57 151.63 51.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.383 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.9 m -146.31 167.51 23.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.252 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.9 tp -79.82 128.81 33.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.612 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.465 ' CG ' ' CD2' ' A' ' 145' ' ' TYR . 5.5 m-20 -53.11 173.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.109 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -127.58 -38.85 1.88 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.531 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -95.44 -8.04 36.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.177 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -136.62 75.5 50.36 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.255 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.34 132.42 50.79 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.964 1.776 . . . . 1.0 112.442 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 109.43 -33.49 6.06 Favored Glycine 0 N--CA 1.466 0.645 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.432 ' O ' ' CG ' ' A' ' 137' ' ' ASN . 15.6 m0 -92.16 156.49 17.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.723 0.297 . . . . 1.0 110.22 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -119.12 149.77 41.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 1.0 109.834 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.465 ' CD2' ' CG ' ' A' ' 137' ' ' ASN . 35.8 m-85 -120.99 132.99 55.25 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.246 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 15.0 mt -107.32 123.38 48.25 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.236 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -120.64 145.32 47.53 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.979 -1.119 . . . . 1.0 107.979 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -163.48 151.58 13.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.51 -0.476 . . . . 1.0 109.719 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -128.39 130.57 47.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.761 0.315 . . . . 1.0 110.455 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -75.68 -45.92 37.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.217 0.451 . . . . 1.0 112.217 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.666 ' H ' ' HG ' ' A' ' 154' ' ' SER . 17.5 t-20 -152.15 164.08 38.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.477 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.505 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -57.14 -22.89 43.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.776 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -96.87 -4.54 40.04 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.402 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.666 ' HG ' ' H ' ' A' ' 151' ' ' ASN . 5.1 p -82.91 150.76 26.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.488 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.486 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -82.35 154.56 25.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.176 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.2 tp -69.39 113.7 6.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.971 0.415 . . . . 1.0 110.073 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 99.0 m-85 -99.92 131.23 46.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.803 -0.635 . . . . 1.0 109.636 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 58.4 m -127.62 130.94 49.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.774 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -117.1 153.26 33.07 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.111 0.481 . . . . 1.0 109.942 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -105.2 144.95 31.28 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.791 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.5 t -127.61 135.44 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.646 -0.502 . . . . 1.0 109.646 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -98.19 131.23 44.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.378 -0.373 . . . . 1.0 110.474 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.3 tp -99.71 131.35 45.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.078 -0.51 . . . . 1.0 109.698 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.1 p -132.58 174.32 10.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.461 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.405 ' ND2' ' OD2' ' A' ' 76' ' ' ASP . 3.0 p30 -85.67 17.02 3.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.699 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 44.0 p -121.79 -2.63 9.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.566 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.32 -134.48 6.52 Favored Glycine 0 N--CA 1.465 0.591 0 N-CA-C 110.329 -1.108 . . . . 1.0 110.329 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -122.23 130.15 52.91 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 110.316 -0.253 . . . . 1.0 110.316 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -105.67 119.2 38.53 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.8 tt -117.02 119.73 36.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.8 t 38.54 53.66 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.004 0.372 . . . . 1.0 112.004 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.5 m120 67.7 27.19 7.66 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.017 0.747 . . . . 1.0 113.017 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -135.47 120.68 18.94 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -93.2 126.06 38.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.493 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -102.51 139.63 20.39 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -72.71 -18.59 25.02 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.024 1.816 . . . . 1.0 113.613 -177.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.9 p -154.67 158.24 39.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.917 0.389 . . . . 1.0 110.962 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.2 p -64.77 -37.52 80.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.141 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 80.4 mt -59.7 -45.03 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.306 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.468 ' HA ' HE21 ' A' ' 180' ' ' GLN . 0.3 OUTLIER -63.59 -37.6 87.96 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.7 tt -64.86 -39.78 94.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.422 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 83.1 m -59.29 -47.87 83.75 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.432 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' A' ' 186' ' ' LYS . 61.2 t30 -69.74 -49.28 54.64 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.35 -44.96 0.63 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.699 -1.36 . . . . 1.0 109.699 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.78 -47.34 69.44 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.192 -0.669 . . . . 1.0 109.192 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 183' ' ' ASN . 63.9 tttp -56.56 -41.53 77.03 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.522 -0.763 . . . . 1.0 109.827 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 94.5 m -60.02 -46.98 87.71 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.75 -41.23 98.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 1.0 109.815 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.1 tp -60.24 -45.81 91.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.542 -0.299 . . . . 1.0 110.451 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -60.89 -44.17 97.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.291 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.4 t -64.31 -37.38 87.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.258 0.551 . . . . 1.0 110.499 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.19 -42.26 99.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.87 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -63.5 -25.69 68.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 111.878 0.325 . . . . 1.0 111.878 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -100.48 -8.56 23.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.086 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.544 ' C ' ' H ' ' A' ' 197' ' ' HIS . 96.2 m-70 44.17 42.61 5.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.414 -0.357 . . . . 1.0 111.122 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.417 ' CG ' ' O ' ' A' ' 196' ' ' HIS . 79.8 t60 56.13 3.44 0.1 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.696 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.544 ' H ' ' C ' ' A' ' 195' ' ' HIS . 85.3 t60 -166.12 -109.12 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.538 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.476 ' N ' ' CG ' ' A' ' 197' ' ' HIS . 85.7 t60 41.35 96.56 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.999 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.401 ' ND1' ' N ' ' A' ' 199' ' ' HIS . 2.9 m80 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.053 -0.975 . . . . 1.0 110.683 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 3' ' ' ARG . 2.0 t . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.443 ' ND1' ' O ' ' A' ' 2' ' ' HIS . 52.9 t-80 64.88 2.39 1.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.511 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.432 ' H ' ' C ' ' A' ' 1' ' ' THR . 80.0 mtt85 -141.23 7.94 2.01 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.35 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.85 -26.22 34.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.542 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.0 pt -71.63 -26.66 26.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 1.0 110.689 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -106.95 7.9 30.21 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.575 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -46.8 136.14 7.9 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.313 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -49.05 -31.55 21.16 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.648 1.565 . . . . 1.0 112.526 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.612 ' CE2' ' CZ ' ' A' ' 30' ' ' PHE . 52.0 m-85 -88.38 3.74 48.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.728 0.299 . . . . 1.0 111.244 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.528 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 34.3 t80 -75.12 127.74 33.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.178 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 52.1 m-85 -147.49 108.92 3.86 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.606 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.495 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 31.3 Cg_exo -59.67 111.74 1.05 Allowed 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 121.71 1.607 . . . . 1.0 112.624 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.529 ' O ' ' NH1' ' A' ' 33' ' ' ARG . 56.2 m-85 -160.34 159.39 31.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.29 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 15' ' ' GLY . 11.1 t-20 -81.19 164.72 22.11 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.413 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -58.26 -48.53 82.92 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.606 -0.998 . . . . 1.0 110.606 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.7 mmp_? -67.32 -39.56 85.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.723 0.297 . . . . 1.0 111.029 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.16 -37.07 84.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.326 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.59 -44.01 97.8 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.669 -0.412 . . . . 1.0 110.414 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.514 ' OE2' ' CD1' ' A' ' 53' ' ' PHE . 42.6 tt0 -61.34 -45.73 93.22 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.045 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.1 -38.71 89.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.322 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.632 ' CE2' ' NZ ' ' A' ' 25' ' ' LYS . 57.3 t80 -67.2 -36.87 82.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.078 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.8 mp -81.65 -11.88 58.92 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.115 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -63.51 -33.57 75.86 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.248 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -81.18 -20.14 41.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.004 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.632 ' NZ ' ' CE2' ' A' ' 21' ' ' TYR . 48.7 mttp -81.89 176.4 9.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.998 0.428 . . . . 1.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -88.72 165.74 14.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.809 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.538 ' NH2' ' OD1' ' A' ' 99' ' ' ASN . 64.6 ttp85 -65.65 146.18 55.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.949 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.29 22.75 31.19 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.317 -0.713 . . . . 1.0 111.317 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -101.41 142.14 33.24 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.612 ' CZ ' ' CE2' ' A' ' 9' ' ' TYR . 17.3 p90 -133.24 167.19 20.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.489 0.661 . . . . 1.0 110.699 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 m -149.68 163.1 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.715 -1.13 . . . . 1.0 111.827 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.7 mm -115.65 126.71 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 13' ' ' PHE . 26.8 ttt85 -136.76 162.58 32.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.689 -0.687 . . . . 1.0 110.188 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.557 ' C ' ' H ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -117.11 128.58 55.27 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.6 t -52.72 -6.21 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.557 ' H ' ' C ' ' A' ' 34' ' ' GLN . 1.5 t 72.07 -49.12 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.442 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -93.39 -6.09 47.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.653 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -70.96 -53.84 10.34 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.632 -0.987 . . . . 1.0 110.632 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 t70 71.44 -36.89 0.38 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.627 0.251 . . . . 1.0 111.084 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 38' ' ' GLY . 98.4 m-20 -120.08 -7.34 9.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.744 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -120.42 146.89 45.76 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.056 0.455 . . . . 1.0 110.944 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.88 151.79 41.39 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.129 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.8 t -125.82 134.36 66.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.299 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.0 mt -110.71 137.16 44.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.4 m -117.66 134.17 55.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.661 -0.699 . . . . 1.0 109.349 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.696 ' HE1' HE21 ' A' ' 54' ' ' GLN . 2.1 p-90 -151.89 154.21 35.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.349 -0.841 . . . . 1.0 110.768 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.87 143.46 28.45 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.293 0.568 . . . . 1.0 111.793 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.2 mt -97.18 -57.76 2.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.226 -0.897 . . . . 1.0 110.35 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -119.38 -166.85 1.32 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.37 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -65.1 -39.29 92.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.793 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -128.13 53.39 1.8 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.281 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.9 tp -153.87 129.36 9.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.263 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CD1' ' OE2' ' A' ' 19' ' ' GLU . 47.8 m-85 -134.99 150.25 50.31 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.983 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.696 HE21 ' HE1' ' A' ' 46' ' ' TRP . 14.9 pt20 -141.07 157.73 44.9 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.164 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -121.77 139.95 52.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.454 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.8 mt -119.41 123.42 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.806 -0.442 . . . . 1.0 109.806 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -96.29 122.1 38.8 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.889 0.376 . . . . 1.0 110.567 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 86.2 mt -102.64 129.98 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.212 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.533 HE22 ' CD1' ' A' ' 61' ' ' LEU . 1.1 tm0? -119.1 134.62 55.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.131 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 60' ' ' GLU . 0.3 OUTLIER -100.67 157.62 16.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.583 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.533 ' CD1' HE22 ' A' ' 59' ' ' GLN . 1.4 mt -146.18 178.42 8.24 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.106 0.479 . . . . 1.0 110.345 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 58.59 39.59 24.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.385 -0.825 . . . . 1.0 110.5 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -81.19 125.88 30.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.382 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -68.84 -30.78 69.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.106 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -162.39 156.95 18.83 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.556 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.64 -33.04 57.19 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.608 1.539 . . . . 1.0 112.295 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.51 -10.35 58.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.507 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.66 135.47 44.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.342 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.8 mt -78.15 148.35 34.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.51 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.68 132.82 14.65 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -77.74 -15.51 59.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.046 0.451 . . . . 1.0 110.806 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.0 t -111.09 119.64 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.682 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.6 mt -115.59 131.91 56.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.539 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.4 mt -102.53 122.33 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.838 0.351 . . . . 1.0 110.443 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.1 t -142.36 133.82 25.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.29 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 56.32 41.24 29.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.681 0.277 . . . . 1.0 111.124 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.36 13.72 5.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.91 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -120.66 151.85 38.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.983 0.421 . . . . 1.0 109.944 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -101.1 126.07 47.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.982 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.538 ' CE1' ' OE2' ' A' ' 89' ' ' GLU . 95.9 m-85 -120.75 139.13 53.53 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.186 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -85.71 -30.42 23.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.584 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 51.4 t0 -123.86 141.65 51.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.01 0.433 . . . . 1.0 111.842 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.4 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 56.6 tp -65.46 -39.9 92.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.584 -0.735 . . . . 1.0 111.147 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.48 -40.19 90.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.727 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -59.7 -39.64 85.23 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.799 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.44 -46.12 97.17 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 CA-C-O 120.898 0.38 . . . . 1.0 110.955 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 64.8 mt -62.73 -46.07 97.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.976 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.4 t -69.87 -43.58 79.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.81 0.671 . . . . 1.0 112.81 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.538 ' OE2' ' CE1' ' A' ' 80' ' ' TYR . 9.1 pt-20 -80.68 -12.07 59.54 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.523 -0.471 . . . . 1.0 111.666 -177.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.589 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 64.4 t80 -94.19 -49.11 5.89 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.636 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.37 -42.1 72.21 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.348 -0.541 . . . . 1.0 112.118 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -63.9 -49.08 74.08 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.041 -0.664 . . . . 1.0 111.565 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -69.12 -42.77 75.61 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.618 -0.433 . . . . 1.0 111.522 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.589 ' NZ ' ' CE1' ' A' ' 90' ' ' TYR . 15.9 mmtp -65.81 -42.32 90.78 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.39 -0.524 . . . . 1.0 111.228 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.41 -46.5 89.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.527 -0.469 . . . . 1.0 111.183 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -68.09 -44.02 77.21 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.615 -0.434 . . . . 1.0 111.6 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.2 tp -67.71 -41.64 83.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.267 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.7 tp -65.35 -42.92 92.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.193 -0.603 . . . . 1.0 110.217 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.538 ' OD1' ' NH2' ' A' ' 27' ' ' ARG . 99.2 m-20 -68.04 -36.95 80.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.244 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -71.82 -42.89 66.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 111.892 0.33 . . . . 1.0 111.892 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.413 ' HB2' ' HH ' ' A' ' 168' ' ' TYR . 4.5 tpt -66.03 -53.8 33.98 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.213 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.464 ' C ' ' H ' ' A' ' 104' ' ' SER . 53.8 m -60.14 -36.12 76.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.593 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.9 t -71.07 9.49 0.71 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.879 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 102' ' ' THR . 32.0 t -91.52 134.32 34.75 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 110.001 -0.37 . . . . 1.0 110.001 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -58.59 -19.21 36.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.983 0.42 . . . . 1.0 110.823 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.557 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 60.4 mttp -90.14 39.91 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.785 -0.643 . . . . 1.0 109.798 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -132.85 120.42 21.51 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.535 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.59 124.02 15.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.142 -0.481 . . . . 1.0 109.906 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.3 m -100.17 86.66 3.27 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.734 0.302 . . . . 1.0 110.968 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.16 163.63 12.12 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.924 -0.87 . . . . 1.0 110.924 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.458 ' CB ' ' HZ2' ' A' ' 113' ' ' LYS . 61.6 p -77.65 169.52 18.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -58.6 -38.59 78.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.912 0.387 . . . . 1.0 110.561 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.458 ' HZ2' ' CB ' ' A' ' 111' ' ' THR . 25.0 pttm -69.27 -39.53 78.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.654 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -70.08 -24.46 63.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.874 -0.603 . . . . 1.0 111.154 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.65 -45.5 73.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.509 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 82.6 t -63.67 -46.66 94.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.106 0.479 . . . . 1.0 110.445 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -66.04 -37.42 85.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.085 0.469 . . . . 1.0 110.896 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -67.11 -49.24 65.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.751 -0.659 . . . . 1.0 111.763 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.1 tp -69.84 -40.0 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.55 -0.46 . . . . 1.0 110.47 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -65.44 -41.64 93.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.806 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -63.82 -48.17 77.91 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.448 -0.501 . . . . 1.0 110.297 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -60.45 -44.57 95.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.007 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 81.2 p -66.25 -28.6 68.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.038 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -63.96 -43.87 94.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.337 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.7 t -66.82 -41.76 88.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.298 -0.41 . . . . 1.0 109.938 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -122.02 75.43 39.38 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.561 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -71.3 -13.51 30.81 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.662 2.241 . . . . 1.0 112.34 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -106.2 24.87 11.76 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.642 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -141.13 151.72 44.14 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.86 0.362 . . . . 1.0 110.743 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 86.5 p -80.78 160.81 24.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.119 -0.491 . . . . 1.0 109.841 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.6 p -153.97 144.86 14.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.597 -0.52 . . . . 1.0 109.597 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 19.0 p90 -153.33 143.61 22.36 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.691 -0.404 . . . . 1.0 111.104 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -152.57 169.71 21.97 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.355 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.6 p90 -136.77 156.12 48.93 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 28.8 t -148.55 169.5 20.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.322 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.4 tp -74.59 146.46 42.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.483 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 138' ' ' HIS . 28.1 t-20 -42.74 147.96 0.27 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.539 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.43 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 92.5 m-70 -60.05 -50.24 74.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.018 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 139' ' ' ASP . 25.7 p-10 -156.7 44.09 0.39 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.536 -0.302 . . . . 1.0 110.629 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.412 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 73.3 m-20 -160.26 84.32 2.07 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.31 144.86 92.28 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.699 1.599 . . . . 1.0 112.671 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.401 ' C ' ' CD1' ' A' ' 143' ' ' TRP . . . 142.93 -39.25 1.35 Allowed Glycine 0 C--O 1.226 -0.382 0 N-CA-C 110.887 -0.885 . . . . 1.0 110.887 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.534 ' CD1' ' N ' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -134.95 153.89 51.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.812 0.339 . . . . 1.0 110.188 -179.353 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -102.36 156.97 17.24 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -113.37 134.9 54.39 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.093 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.3 mt -110.55 126.17 54.12 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.436 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.62 142.98 51.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.644 -1.243 . . . . 1.0 107.644 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -159.43 160.25 34.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.781 -0.451 . . . . 1.0 109.781 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -138.57 128.63 25.48 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.858 0.361 . . . . 1.0 110.686 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.8 mp -72.43 -44.98 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.787 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -160.83 174.0 14.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.729 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.38 -32.81 73.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.784 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -83.68 -13.15 54.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.143 0.496 . . . . 1.0 110.376 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t -80.09 157.15 26.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.473 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -90.28 157.37 17.7 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.989 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 30.8 tp -76.57 121.66 23.49 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.087 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -108.32 136.39 48.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.743 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 99.8 m -128.98 132.33 47.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.905 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -123.37 161.89 23.82 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.803 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -109.72 151.79 26.47 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.796 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 67.8 t -127.78 134.18 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -97.54 132.35 43.3 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.027 0.442 . . . . 1.0 111.061 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.4 tp -92.23 130.28 37.97 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.727 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.497 ' C ' ' H ' ' A' ' 166' ' ' THR . 65.7 p -129.58 157.35 42.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.339 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -73.45 15.21 0.26 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.645 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.497 ' H ' ' C ' ' A' ' 164' ' ' THR . 19.3 p -121.46 -2.43 9.48 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.775 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.51 -135.49 7.06 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.477 -1.049 . . . . 1.0 110.477 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.413 ' HH ' ' HB2' ' A' ' 101' ' ' MET . 36.8 m-85 -118.9 131.68 56.06 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.551 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 5.9 m-85 -109.33 118.7 37.38 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.8 tt -109.29 121.3 44.87 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.465 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 5.0 t 34.93 59.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.467 0.543 . . . . 1.0 112.467 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 63.26 27.54 15.51 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.981 0.734 . . . . 1.0 112.981 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.465 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 79.3 m-85 -132.75 121.88 23.71 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.303 -0.628 . . . . 1.0 109.303 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.551 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 8.3 t-20 -91.15 133.4 35.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.391 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -115.65 131.88 23.44 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.903 -0.589 . . . . 1.0 109.462 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.66 -21.33 19.26 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.171 1.914 . . . . 1.0 113.443 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 73.4 m -147.99 150.99 35.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.928 0.394 . . . . 1.0 111.25 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.94 -36.3 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.833 -0.622 . . . . 1.0 110.857 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.511 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 46.6 mm -60.95 -45.98 97.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 1.0 110.066 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -65.82 -32.3 73.76 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.1 tp -63.95 -42.31 97.35 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.465 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.611 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 5.1 p -60.99 -47.88 84.39 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.632 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.611 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 36.3 t30 -66.71 -48.51 69.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.744 -0.783 . . . . 1.0 108.983 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.57 -45.01 0.95 Allowed Glycine 0 N--CA 1.462 0.374 0 N-CA-C 109.907 -1.277 . . . . 1.0 109.907 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -68.89 -47.48 65.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 183' ' ' ASN . 36.4 ttpt -56.66 -39.53 73.91 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.544 -0.753 . . . . 1.0 109.982 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 19.9 m -60.58 -45.94 92.09 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.459 ' O ' ' OG ' ' A' ' 191' ' ' SER . 75.8 mt -63.73 -39.42 94.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.865 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.6 tp -58.88 -43.31 90.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.903 0.383 . . . . 1.0 110.458 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -59.09 -45.71 90.17 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.527 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 188' ' ' LEU . 77.6 p -61.79 -36.89 82.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.167 0.508 . . . . 1.0 110.619 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.8 mt -69.47 -39.44 77.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.381 -0.827 . . . . 1.0 111.954 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -62.46 -29.17 70.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.892 0.33 . . . . 1.0 111.892 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -82.44 6.23 17.95 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.907 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 77.7 m80 43.75 41.5 3.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.049 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 56.08 -176.68 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.582 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -154.54 -26.3 0.12 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.575 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -66.18 -39.95 90.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.849 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 80.5 m80 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.022 -0.99 . . . . 1.0 110.453 -179.692 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -87.3 -0.25 56.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.534 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -111.38 -2.57 15.56 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.817 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.1 p -64.46 -30.48 50.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.532 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.1 pt -71.01 -15.23 18.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.515 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -94.21 -0.1 55.38 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.44 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.73 140.67 59.08 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.217 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.13 -21.39 62.74 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.111 1.874 . . . . 1.0 112.116 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.451 ' CE1' ' CZ ' ' A' ' 30' ' ' PHE . 24.5 m-85 -92.24 10.16 30.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.202 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 79.0 t80 -84.47 128.07 34.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.423 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 64.2 m-85 -150.89 114.78 3.18 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 110.154 -0.313 . . . . 1.0 110.154 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.91 110.09 3.01 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.743 1.629 . . . . 1.0 112.919 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -155.53 153.77 30.73 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.539 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.473 ' ND2' ' H ' ' A' ' 15' ' ' GLY . 11.2 t-20 -77.68 164.45 25.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.473 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -57.84 -42.73 94.77 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.207 -0.997 . . . . 1.0 110.948 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -66.31 -42.96 87.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.745 0.307 . . . . 1.0 110.963 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -67.86 -33.82 75.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.277 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.43 -43.01 97.23 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.257 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -58.61 -42.29 87.85 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.582 -0.447 . . . . 1.0 109.992 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -62.21 -46.52 88.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.503 . . . . 1.0 110.287 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -60.18 -40.95 91.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.446 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.34 -13.59 60.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.952 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -58.49 -43.85 89.17 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.403 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.4 t -76.43 -19.44 58.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.718 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -83.28 177.05 8.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.527 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.6 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 52.2 mp0 -105.3 -176.93 3.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.738 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -74.92 144.69 43.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.828 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.51 -0.34 61.4 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.219 -0.753 . . . . 1.0 111.219 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -83.88 144.3 29.31 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CZ ' ' CE1' ' A' ' 9' ' ' TYR . 16.8 p90 -136.73 165.58 25.58 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.177 0.513 . . . . 1.0 110.971 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.3 t -146.98 156.58 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.087 -0.961 . . . . 1.0 111.67 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 91.6 mt -117.3 124.19 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -152.02 153.17 33.48 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.336 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -108.41 152.19 25.01 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.917 -0.401 . . . . 1.0 109.917 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 t -82.36 145.19 30.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.843 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 m -59.02 -39.07 80.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.664 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -95.41 6.95 47.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.792 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.547 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -86.97 -79.75 1.22 Allowed Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.572 -1.011 . . . . 1.0 110.572 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 t70 68.8 -38.89 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 1.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.547 ' H ' ' C ' ' A' ' 38' ' ' GLY . 36.5 t70 -104.11 2.44 31.99 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.828 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -143.82 153.62 42.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.946 0.403 . . . . 1.0 110.283 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.12 148.8 42.66 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.952 -0.567 . . . . 1.0 109.752 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.21 132.46 71.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.221 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.8 mt -111.7 138.36 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 108.949 -0.76 . . . . 1.0 108.949 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 87.9 m -120.73 138.7 53.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.575 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.754 ' HE1' ' NE2' ' A' ' 54' ' ' GLN . 2.9 p-90 -153.91 148.11 25.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.884 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.495 ' HZ2' ' C ' ' A' ' 49' ' ' ASP . 64.1 tttm -88.93 141.19 28.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.128 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.2 mt -98.76 -68.06 0.82 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.072 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.495 ' C ' ' HZ2' ' A' ' 47' ' ' LYS . 38.2 t0 -136.11 171.22 14.79 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.186 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -46.64 130.58 11.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.986 0.422 . . . . 1.0 110.897 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 56.37 39.82 29.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.06 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.8 tp -149.01 122.38 9.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.784 0.326 . . . . 1.0 110.443 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -135.56 149.92 49.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.568 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.754 ' NE2' ' HE1' ' A' ' 46' ' ' TRP . 6.7 pt20 -139.43 156.49 46.93 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.958 -0.564 . . . . 1.0 109.823 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -125.41 142.28 51.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.301 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 83.1 mt -120.48 122.84 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -93.98 120.83 34.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.877 0.37 . . . . 1.0 110.496 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 92.6 mt -100.84 128.96 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.422 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -112.29 141.78 45.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.171 -0.468 . . . . 1.0 109.781 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -98.73 152.79 19.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 1.0 109.988 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.495 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 2.9 tp -141.56 165.49 27.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.696 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.495 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 72.6 tt0 66.04 48.61 1.72 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.41 0.624 . . . . 1.0 109.719 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.418 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 32.5 pttt -102.44 107.81 18.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.988 -0.551 . . . . 1.0 109.945 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -67.26 -25.19 65.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.857 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -159.23 158.22 28.2 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.214 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.96 -34.39 56.22 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.213 1.942 . . . . 1.0 112.074 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.441 ' CD2' ' H ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -85.49 -10.24 56.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.688 -179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.67 145.12 55.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.299 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.7 mt -77.81 151.84 33.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.371 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.22 91.25 1.13 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.673 -0.971 . . . . 1.0 110.673 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -63.78 -32.36 73.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.037 0.446 . . . . 1.0 110.596 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.7 t -125.26 124.18 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.787 -0.642 . . . . 1.0 111.051 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.13 131.07 57.04 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.0 mt -100.22 120.93 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.899 0.381 . . . . 1.0 110.179 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -141.59 132.54 26.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.235 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 56.15 43.11 27.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.717 0.294 . . . . 1.0 111.025 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.4 t30 59.27 15.9 4.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.779 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -121.68 146.52 46.93 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.228 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -99.57 126.26 45.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.644 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -125.06 137.33 54.21 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.028 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -85.75 -38.49 18.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.831 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -105.3 135.33 46.87 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.127 0.489 . . . . 1.0 111.935 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 58.2 tp -63.81 -41.93 97.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.571 -0.74 . . . . 1.0 110.672 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -60.27 -42.44 95.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 1.0 111.92 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -60.98 -37.24 81.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.762 0.315 . . . . 1.0 110.644 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.01 -44.92 99.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.564 -0.454 . . . . 1.0 110.551 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 87' ' ' ILE . 40.4 mm -62.92 -44.78 99.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.449 -0.5 . . . . 1.0 111.35 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.492 ' O ' ' CG ' ' A' ' 92' ' ' GLN . 79.7 t -67.49 -45.67 84.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 112.723 0.638 . . . . 1.0 112.723 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.06 -19.38 61.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.739 0.304 . . . . 1.0 111.76 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -93.59 -50.73 5.27 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.353 -0.539 . . . . 1.0 111.781 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.6 -43.64 84.31 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.382 0.512 . . . . 1.0 112.382 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.492 ' CG ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -65.75 -41.9 91.58 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.098 -0.641 . . . . 1.0 111.455 -177.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.414 ' H ' ' HG3' ' A' ' 92' ' ' GLN . 8.9 t-20 -70.94 -44.12 66.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.304 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -65.9 -41.99 90.77 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.239 -0.585 . . . . 1.0 111.154 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.0 t -65.53 -44.51 94.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.363 -0.535 . . . . 1.0 111.114 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.501 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -66.56 -46.96 74.32 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.569 -0.453 . . . . 1.0 111.706 -178.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 tp -69.78 -41.13 75.54 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.717 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.1 tp -61.61 -44.63 96.63 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.344 -0.542 . . . . 1.0 110.565 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.505 ' OD1' ' C ' ' A' ' 99' ' ' ASN . 1.1 p30 -70.0 -35.97 74.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.154 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.454 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 44.2 tt0 -71.37 -43.81 66.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.564 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 5.5 ttt -66.93 -55.08 16.15 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.575 -0.45 . . . . 1.0 111.63 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 104' ' ' SER . 52.6 m -57.82 -37.99 74.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.071 0.462 . . . . 1.0 110.639 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 41.4 t -72.33 10.36 0.81 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.636 -0.711 . . . . 1.0 110.999 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 101' ' ' MET . 78.1 p -92.91 135.46 34.13 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.565 -0.288 . . . . 1.0 110.454 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.59 -16.72 40.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.567 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 24.2 mmtp -93.82 38.46 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 1.0 109.808 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -132.04 111.83 11.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.284 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -131.06 114.0 14.63 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.7 p -89.67 88.97 7.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.001 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.79 156.32 15.71 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.8 p -75.05 169.58 17.73 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -57.28 -38.32 73.75 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.841 -0.343 . . . . 1.0 110.415 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -68.49 -42.94 77.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.356 0.598 . . . . 1.0 110.933 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 51.6 t0 -68.09 -21.78 64.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.411 -0.813 . . . . 1.0 110.89 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.4 t -71.63 -43.33 71.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.767 0.317 . . . . 1.0 110.198 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.83 -47.13 92.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.09 0.471 . . . . 1.0 110.409 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -65.66 -38.24 88.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.076 0.465 . . . . 1.0 110.851 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -65.02 -49.81 68.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.821 -0.627 . . . . 1.0 111.76 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.6 tp -70.26 -39.49 76.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.866 0.365 . . . . 1.0 110.571 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.513 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 63.7 mm-40 -62.67 -42.75 99.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.553 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -61.14 -47.68 85.12 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.574 -0.45 . . . . 1.0 110.279 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -61.12 -39.7 91.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.77 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 120' ' ' GLU . 59.5 p -60.16 -38.59 83.63 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.404 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -62.46 -40.32 96.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.258 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.03 -42.69 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.657 -0.498 . . . . 1.0 109.657 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.74 75.67 79.4 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.2 178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.31 -23.43 44.73 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.75 2.3 . . . . 1.0 112.53 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -95.89 -9.75 30.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.146 -0.479 . . . . 1.0 112.028 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -107.29 149.83 27.35 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.977 0.418 . . . . 1.0 110.379 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.415 ' H ' ' HG ' ' A' ' 130' ' ' SER . 14.9 p -80.83 162.81 23.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.757 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 p -152.37 147.55 14.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.489 ' O ' ' CD1' ' A' ' 133' ' ' TYR . 28.7 p90 -149.39 142.61 25.08 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.789 0.328 . . . . 1.0 111.118 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 29.7 m-85 -151.75 169.2 22.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.306 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.567 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -133.83 152.62 51.93 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 179.19 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 72.3 m -152.11 170.16 20.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.419 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.0 tp -80.94 145.2 31.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.839 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 4.3 p30 -53.85 -171.89 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.179 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.463 ' CG ' ' O ' ' A' ' 138' ' ' HIS . 35.4 t-80 -135.31 35.2 3.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.531 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -169.63 -53.89 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.67 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.52 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 21.3 t-20 -105.16 86.69 1.67 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.099 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.61 100.76 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.077 1.851 . . . . 1.0 112.316 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.497 ' H ' HD22 ' A' ' 137' ' ' ASN . . . 169.55 -36.3 0.19 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.517 -1.033 . . . . 1.0 110.517 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.407 ' CD1' ' N ' ' A' ' 143' ' ' TRP . 21.5 m95 -98.7 144.7 27.67 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 110.04 -0.356 . . . . 1.0 110.04 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 61.7 m-85 -107.42 149.6 27.71 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.173 -0.467 . . . . 1.0 109.778 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.405 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 32.3 m-85 -120.41 137.68 54.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.394 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt -110.04 121.01 44.26 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.318 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.553 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -116.41 145.89 42.91 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 178.402 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -159.69 155.26 25.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.513 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 64.5 tttt -141.36 129.61 22.27 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.752 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.438 HG23 HD13 ' A' ' 150' ' ' ILE . 41.5 mm -71.15 -46.48 66.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.875 -0.33 . . . . 1.0 111.725 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 151' ' ' ASN . 7.6 p-10 -162.24 177.88 9.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.35 . . . . 1.0 110.589 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.29 -32.89 74.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.067 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -84.45 7.59 19.22 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.018 0.437 . . . . 1.0 110.713 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.5 t -104.99 158.4 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.08 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -88.88 162.46 16.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.91 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.6 tp -80.38 118.94 22.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.982 0.42 . . . . 1.0 110.281 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -105.27 132.86 50.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.738 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 87.0 m -130.6 130.46 44.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.847 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -116.35 161.09 19.58 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.075 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.405 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 78.0 m-20 -107.2 144.68 33.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.739 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.8 t -126.57 136.7 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -99.62 130.41 45.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.912 0.387 . . . . 1.0 110.759 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.8 tp -92.36 130.8 37.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.032 -0.531 . . . . 1.0 109.66 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.3 p -129.73 165.76 21.24 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.0 0.429 . . . . 1.0 110.35 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -79.23 15.72 1.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.628 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 20.0 p -122.27 -2.31 9.08 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.802 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.56 -131.87 5.19 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.419 -1.072 . . . . 1.0 110.419 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.403 ' HH ' ' HB2' ' A' ' 101' ' ' MET . 17.2 m-85 -122.85 130.55 53.02 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.077 -0.342 . . . . 1.0 110.077 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.629 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 5.7 m-85 -107.52 121.71 45.19 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.821 -0.437 . . . . 1.0 109.821 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.8 tt -114.38 119.1 35.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.711 -0.477 . . . . 1.0 109.711 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.5 t 36.16 57.92 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 112.166 0.432 . . . . 1.0 112.166 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 14.5 m120 65.27 27.17 12.16 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.045 0.757 . . . . 1.0 113.045 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -133.95 119.95 19.72 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 8.1 t-20 -93.67 129.03 40.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 1.0 111.226 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -107.77 101.39 40.13 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -45.91 -23.49 1.72 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.489 2.126 . . . . 1.0 113.33 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.96 146.66 37.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 1.0 111.009 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.47 -33.42 56.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.92 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.87 -44.2 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.278 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -69.7 -30.34 67.96 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.5 -0.555 . . . . 1.0 109.5 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.29 -43.08 98.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.281 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 93.5 m -63.7 -46.49 85.24 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.336 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 186' ' ' LYS . 75.9 m-20 -65.19 -48.82 72.07 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.09 -45.68 0.89 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -68.92 -45.91 69.64 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 183' ' ' ASN . 36.6 tptt -57.14 -40.88 78.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.455 -0.793 . . . . 1.0 109.902 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 16.5 m -59.71 -46.7 88.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.1 -40.32 95.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.826 -0.624 . . . . 1.0 109.881 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 59.3 tp -57.87 -45.7 85.94 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.647 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -54.83 -45.65 74.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.167 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.7 t -62.25 -40.75 97.22 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.161 0.505 . . . . 1.0 110.34 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.41 -37.02 86.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.761 -0.654 . . . . 1.0 111.974 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -58.33 -30.14 66.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.622 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -82.2 -7.41 59.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.92 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.467 ' CG ' ' O ' ' A' ' 195' ' ' HIS . 83.9 t60 50.73 49.34 21.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.01 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.511 ' O ' ' N ' ' A' ' 198' ' ' HIS . 50.0 t-80 -91.35 45.87 1.27 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.397 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 86.1 t60 53.89 -83.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.599 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 196' ' ' HIS . 85.7 t60 -151.97 118.6 5.71 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.475 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.427 ' ND1' ' N ' ' A' ' 199' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.087 -0.959 . . . . 1.0 110.65 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.9 mtp85 . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 120.863 0.363 . . . . 1.0 110.558 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.46 -27.47 41.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.565 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 13.3 pt -67.78 -40.77 84.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.435 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -107.2 14.01 26.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.432 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -46.97 145.97 2.99 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.422 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -49.98 -36.22 43.51 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.671 1.581 . . . . 1.0 112.226 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.61 ' CD2' ' CZ ' ' A' ' 30' ' ' PHE . 80.2 m-85 -82.7 -1.56 51.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.385 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.531 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 42.2 t80 -72.32 129.61 38.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.34 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 54.0 m-85 -148.69 115.92 3.85 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 120.9 -0.32 . . . . 1.0 110.43 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.477 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 73.1 Cg_endo -74.76 109.88 3.0 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.754 1.636 . . . . 1.0 112.703 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 76.5 m-85 -155.33 159.4 39.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.525 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -77.16 172.16 13.68 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.449 ' C ' ' HE ' ' A' ' 16' ' ' ARG . . . -61.67 -46.84 93.42 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.446 -0.883 . . . . 1.0 111.108 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.639 ' HE ' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -66.06 -41.52 90.69 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 121.038 -0.265 . . . . 1.0 111.164 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -66.09 -35.66 81.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.279 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.84 -44.98 96.25 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.308 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -65.78 -41.97 91.37 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.034 179.135 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.46 -41.64 97.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.212 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -63.07 -39.47 94.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.54 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.2 mp -79.57 -13.26 59.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.723 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -63.57 -42.95 98.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.731 -0.388 . . . . 1.0 110.47 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.0 t -76.65 -20.33 56.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.79 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -84.17 177.55 8.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.456 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -89.2 176.33 7.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.863 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.448 ' NE ' ' OD1' ' A' ' 49' ' ' ASP . 84.9 mtt85 -76.32 147.57 38.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.974 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.46 19.67 37.49 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -99.73 140.79 33.42 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.61 ' CZ ' ' CD2' ' A' ' 9' ' ' TYR . 7.1 p90 -134.68 168.56 18.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.338 0.589 . . . . 1.0 111.11 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -147.32 158.25 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.251 -0.886 . . . . 1.0 111.498 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -116.87 129.17 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -138.74 157.85 45.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.418 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -115.63 135.51 53.99 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.859 -0.423 . . . . 1.0 109.859 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.1 t -95.27 126.74 40.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.764 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 96.5 p -59.59 -37.68 79.18 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.598 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.3 -24.37 62.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.874 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -75.37 -63.24 2.54 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.689 -0.964 . . . . 1.0 110.689 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 t0 73.66 -40.19 0.46 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.694 0.283 . . . . 1.0 110.803 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 38' ' ' GLY . 92.3 m-20 -118.91 11.08 12.45 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.748 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.436 ' CE1' HE21 ' A' ' 59' ' ' GLN . 10.8 m-70 -138.7 150.73 46.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.929 0.395 . . . . 1.0 110.205 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.04 154.19 33.51 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.064 -0.516 . . . . 1.0 109.727 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.7 t -124.39 130.01 73.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 1.0 110.079 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.7 mt -112.97 139.21 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.7 m -118.68 140.04 50.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.928 -0.578 . . . . 1.0 109.455 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -144.01 159.58 42.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.515 -0.766 . . . . 1.0 111.001 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.582 ' NZ ' ' O ' ' A' ' 50' ' ' LYS . 36.2 tttp -107.28 138.54 43.28 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.89 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.857 ' N ' HD12 ' A' ' 48' ' ' LEU . 3.2 mp -95.85 -74.23 0.56 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.371 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 50' ' ' LYS . 66.9 t0 -159.66 140.08 12.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.336 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.582 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 2.9 ttmm 43.81 -152.92 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.083 0.468 . . . . 1.0 111.183 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.74 63.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.836 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 50' ' ' LYS . 17.2 tp -145.68 120.75 10.09 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.977 0.418 . . . . 1.0 110.278 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -134.18 149.16 51.0 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.36 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -137.97 153.49 49.44 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.76 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.479 ' ND1' ' N ' ' A' ' 55' ' ' HIS . 1.9 p-80 -126.61 142.37 51.56 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.153 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.5 mt -126.06 131.7 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -94.27 120.53 34.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.028 0.442 . . . . 1.0 110.726 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.1 mm -90.47 128.0 42.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.083 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 60' ' ' GLU . 3.4 tm0? -113.71 128.9 56.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.042 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.52 ' O ' ' NE2' ' A' ' 59' ' ' GLN . 1.9 pp20? -101.17 148.6 24.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.276 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 1.9 tt -142.66 173.1 11.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.475 -0.329 . . . . 1.0 110.919 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 2.0 tm-20 82.07 25.2 0.19 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.383 0.611 . . . . 1.0 110.05 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.721 ' H ' ' CD ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -80.49 117.1 20.92 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.794 0.807 . . . . 1.0 110.122 178.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -89.66 -33.43 16.64 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.834 -0.541 . . . . 1.0 110.539 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.524 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -154.05 165.4 18.0 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.073 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.5 -29.7 60.93 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.162 1.908 . . . . 1.0 112.242 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.9 mt -90.02 -1.35 57.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.535 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.524 ' HB3' ' H ' ' A' ' 65' ' ' ASN . . . -92.25 134.45 34.87 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.278 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.4 mt -89.86 147.09 23.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.375 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.2 104.86 1.5 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -75.64 -13.43 60.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.772 0.32 . . . . 1.0 110.781 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.8 t -123.54 124.41 69.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.771 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.6 mt -117.07 133.32 56.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.52 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mp -102.41 124.61 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.825 0.345 . . . . 1.0 110.076 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -143.03 133.17 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.551 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 77' ' ' ASN . 46.7 t0 53.44 46.49 26.13 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.985 -0.286 . . . . 1.0 111.046 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.3 OUTLIER 56.75 18.68 3.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.977 179.464 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -125.12 147.26 49.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 1.0 110.135 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.86 127.92 44.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.224 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -120.46 139.91 52.16 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.18 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -84.51 -36.99 21.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.73 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -119.52 144.2 47.16 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.202 0.525 . . . . 1.0 111.989 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.7 tp -64.77 -39.38 93.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.764 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -60.19 -42.75 95.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 1.0 111.562 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.68 -37.87 83.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.58 0.229 . . . . 1.0 110.67 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.58 -47.41 92.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.901 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.75 -45.22 99.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.525 -0.47 . . . . 1.0 111.658 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.28 -43.29 74.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 112.626 0.602 . . . . 1.0 112.626 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -74.73 -15.81 60.76 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.721 -0.392 . . . . 1.0 111.862 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -94.8 -49.44 5.59 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.651 -0.419 . . . . 1.0 111.953 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.508 ' O ' HG23 ' A' ' 95' ' ' VAL . 9.8 mp -69.15 -40.35 78.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.228 0.455 . . . . 1.0 112.228 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -63.38 -49.2 74.74 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.797 -0.761 . . . . 1.0 111.556 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -72.67 -41.7 65.11 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.694 -0.403 . . . . 1.0 111.673 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -66.3 -41.48 89.69 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.334 -0.546 . . . . 1.0 111.389 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 91' ' ' LEU . 54.7 t -64.99 -46.7 90.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.251 -0.58 . . . . 1.0 111.355 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -66.34 -44.27 83.78 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.495 -0.482 . . . . 1.0 111.744 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.4 tp -66.94 -43.86 82.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.42 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 tt -64.64 -43.23 94.34 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.302 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -68.11 -35.76 78.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.859 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -70.69 -41.86 71.45 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 120.776 -0.37 . . . . 1.0 111.777 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.598 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 5.2 ttt -67.81 -54.56 18.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.538 -0.465 . . . . 1.0 111.462 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.8 m -58.45 -41.32 84.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.992 0.425 . . . . 1.0 110.301 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.9 m -72.37 8.09 1.51 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.863 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -85.6 140.18 30.81 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.823 0.344 . . . . 1.0 110.495 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.63 -22.15 66.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.674 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.55 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 24.8 mtmm -89.22 39.97 0.96 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.983 -0.553 . . . . 1.0 109.778 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -132.14 109.43 9.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.329 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -126.4 129.02 47.95 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.181 -0.463 . . . . 1.0 109.8 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.4 t -93.66 74.99 4.35 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.749 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.45 143.52 15.91 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.027 -0.829 . . . . 1.0 111.027 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.552 ' O ' HG23 ' A' ' 115' ' ' VAL . 81.1 p -75.12 172.04 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.051 -0.351 . . . . 1.0 110.051 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -57.51 -41.2 80.36 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.419 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -68.48 -45.01 73.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.88 0.372 . . . . 1.0 110.754 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.13 -20.51 64.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.865 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 111' ' ' THR . 13.4 t -70.71 -45.52 73.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.808 0.337 . . . . 1.0 110.428 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.5 t -64.45 -45.33 96.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.148 0.499 . . . . 1.0 110.235 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -66.07 -34.3 77.76 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.942 0.401 . . . . 1.0 111.019 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -69.5 -49.2 56.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.999 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.0 tp -69.67 -39.59 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.42 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -65.37 -43.19 91.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.72 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.82 -48.24 77.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.311 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.644 ' CD2' ' ND2' ' A' ' 126' ' ' ASN . 47.1 t80 -62.91 -43.26 99.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.93 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 88.1 p -61.02 -35.38 76.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.226 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -62.36 -42.61 99.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.06 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.9 t -66.67 -30.4 49.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 1.0 109.849 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.644 ' ND2' ' CD2' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -128.21 74.26 79.49 Favored Pre-proline 0 N--CA 1.471 0.59 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.531 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -71.88 -24.53 20.97 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.801 2.334 . . . . 1.0 112.609 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -102.3 14.59 31.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.018 -0.537 . . . . 1.0 112.002 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -137.54 144.93 42.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.117 0.484 . . . . 1.0 110.313 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.1 p -80.89 163.09 23.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.014 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 p -152.21 147.26 15.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -143.39 142.09 31.12 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.895 0.378 . . . . 1.0 111.196 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -152.43 168.46 25.41 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.432 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.55 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.7 OUTLIER -138.1 157.53 46.14 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 179.187 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.8 p -151.61 168.38 25.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.292 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 51.5 tp -80.65 136.86 36.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.821 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 23.8 t-20 -95.12 138.48 32.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.333 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -91.31 -31.66 16.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.714 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.41 -24.55 64.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.235 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 4.5 m120 -141.67 81.0 15.41 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.268 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -58.82 134.55 61.13 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.12 1.88 . . . . 1.0 112.445 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.89 -28.62 14.04 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 110.999 -0.84 . . . . 1.0 110.999 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 10.4 m0 -95.54 147.21 23.8 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.856 0.36 . . . . 1.0 110.284 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.598 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 70.9 m-85 -111.61 149.81 30.97 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.035 -0.53 . . . . 1.0 109.812 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.538 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 14.4 m-85 -120.08 136.13 54.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.22 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 16.5 mt -107.96 124.78 50.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.424 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.517 ' SD ' HG13 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -121.58 146.76 46.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.885 -1.154 . . . . 1.0 107.885 178.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -162.05 152.44 17.12 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.592 -0.522 . . . . 1.0 109.592 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.535 ' NZ ' ' O ' ' A' ' 154' ' ' SER . 37.5 tttp -136.41 129.5 31.29 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.472 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.696 HD12 ' H ' ' A' ' 150' ' ' ILE . 4.8 mp -72.49 -46.22 56.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.266 0.469 . . . . 1.0 112.266 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 150' ' ' ILE . 85.2 m-20 -156.95 170.15 23.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.573 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.08 71.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.947 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -89.01 6.68 38.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.433 . . . . 1.0 110.454 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.535 ' O ' ' NZ ' ' A' ' 149' ' ' LYS . 18.0 t -97.31 154.6 17.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.476 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -84.39 145.95 27.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.104 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.5 tp -70.63 126.28 29.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.958 0.409 . . . . 1.0 109.991 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -113.85 132.64 55.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.944 -0.571 . . . . 1.0 109.927 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 97.2 m -129.86 131.28 46.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.818 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.03 163.93 15.87 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.03 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.538 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 58.8 m-20 -111.9 148.85 32.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.695 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.65 137.58 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -100.17 132.36 45.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.98 0.419 . . . . 1.0 110.623 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.9 tp -92.62 131.26 37.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.662 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.0 p -130.38 171.18 13.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.482 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -84.63 15.66 3.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.759 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 2.1 m -122.66 -3.13 8.79 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.96 0.41 . . . . 1.0 110.685 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 141.01 -136.04 7.3 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -117.47 129.08 55.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.641 0.258 . . . . 1.0 110.35 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -106.38 119.84 40.33 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.0 tt -116.68 117.48 29.93 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.403 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.7 t 35.46 56.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.338 0.495 . . . . 1.0 112.338 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.5 m120 69.57 28.15 4.64 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.247 0.832 . . . . 1.0 113.247 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -134.31 121.01 20.63 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -90.83 127.66 36.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.226 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -115.16 91.59 28.17 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.32 -20.04 14.16 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.553 2.168 . . . . 1.0 113.291 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 72.1 m -133.1 138.49 46.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.044 0.45 . . . . 1.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.38 -34.4 60.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.777 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.16 -43.47 96.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -65.17 -34.62 78.83 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.8 tp -64.56 -41.36 96.36 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.389 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 77.8 m -61.29 -47.37 86.27 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 120.559 -0.456 . . . . 1.0 110.616 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 186' ' ' LYS . 62.8 t-20 -69.03 -48.4 63.02 Favored 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 119.647 -0.821 . . . . 1.0 108.915 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.51 -45.48 0.5 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.914 -1.274 . . . . 1.0 109.914 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -68.86 -47.76 65.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.061 -0.57 . . . . 1.0 109.64 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' A' ' 183' ' ' ASN . 47.0 tttp -56.77 -41.29 77.36 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.014 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 18.1 m -63.81 -44.56 92.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 15.4 mt -62.92 -43.28 99.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.006 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.7 tp -59.82 -43.36 94.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.34 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.39 -43.21 99.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.425 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 18.2 p -65.49 -37.66 87.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.066 0.46 . . . . 1.0 110.803 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 24.4 mt -64.0 -41.01 97.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.692 -0.686 . . . . 1.0 111.818 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.72 -25.33 68.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.464 -0.334 . . . . 1.0 111.817 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 120.656 0.265 . . . . 1.0 110.987 -179.495 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 83.6 mtm-85 . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 120.896 0.379 . . . . 1.0 110.368 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.5 p -64.52 -30.98 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.55 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.6 pt -72.4 -20.96 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.658 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -96.34 7.35 46.68 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.428 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.63 141.23 64.58 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.321 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.76 -21.12 58.7 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.75 1.633 . . . . 1.0 112.181 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.88 3.22 49.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.214 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -83.68 132.4 34.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.569 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -152.41 118.14 3.03 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 120.931 -0.308 . . . . 1.0 110.247 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.49 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 72.5 Cg_endo -74.91 112.04 3.47 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.732 1.621 . . . . 1.0 112.659 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.49 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 70.2 m-85 -159.8 158.21 30.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.399 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -80.09 176.4 9.78 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.45 -50.33 67.74 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.373 -0.917 . . . . 1.0 110.988 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -66.01 -41.36 91.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.764 0.316 . . . . 1.0 110.956 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.412 ' OE1' ' N ' ' A' ' 17' ' ' GLN . 7.4 mp0 -62.8 -37.04 85.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.09 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.436 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -62.87 -44.52 95.9 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.508 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -60.82 -48.18 82.99 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.669 -0.412 . . . . 1.0 109.925 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -61.7 -40.22 94.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.201 -0.454 . . . . 1.0 109.899 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -61.96 -39.31 91.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.243 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 18' ' ' ALA . 7.9 mp -82.15 -13.83 56.59 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.846 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.6 ttp85 -65.11 -41.16 95.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.852 0.358 . . . . 1.0 110.336 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.3 m -78.17 -19.86 53.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.875 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -85.12 -179.84 7.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.823 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -81.78 165.49 20.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.813 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -75.75 145.77 40.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.778 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 17.92 49.46 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.982 -0.847 . . . . 1.0 110.982 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -85.16 147.56 26.55 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.425 ' CD2' ' HB3' ' A' ' 46' ' ' TRP . 27.6 m-85 -129.65 153.38 48.16 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.308 0.575 . . . . 1.0 111.098 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 44' ' ' ILE . 16.0 m -144.55 153.91 14.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.187 -0.915 . . . . 1.0 111.211 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.1 mm -115.49 131.19 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -133.74 151.69 51.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.997 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -109.93 130.66 55.5 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.17 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.8 t -82.72 162.82 21.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.579 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.9 p -111.7 -10.97 14.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.717 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -80.79 -30.18 35.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.165 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.656 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . -115.74 -12.14 9.68 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.01 -64.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.978 0.458 . . . . 1.0 110.405 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.656 ' N ' ' O ' ' A' ' 38' ' ' GLY . 24.8 t0 -78.45 12.47 1.96 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.441 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -117.19 142.4 47.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.83 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.25 148.33 44.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.344 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.9 t -123.49 130.2 74.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.781 -0.452 . . . . 1.0 109.781 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 31' ' ' VAL . 79.3 mt -110.62 136.88 45.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 94.0 m -118.39 140.98 49.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.536 -0.756 . . . . 1.0 109.344 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.56 ' CE2' HD11 ' A' ' 48' ' ' LEU . 5.3 p-90 -147.94 151.37 35.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.968 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.503 ' C ' HD12 ' A' ' 48' ' ' LEU . 18.6 ttmm -96.51 140.62 30.87 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.746 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.5 mp -99.57 -68.74 0.79 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.342 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -137.32 -153.19 0.47 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.226 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -68.64 136.46 53.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.667 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 42.08 43.54 2.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.848 -0.615 . . . . 1.0 111.111 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.432 HD11 ' HB3' ' A' ' 141' ' ' PRO . 11.5 tp -140.44 122.71 15.88 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.942 0.401 . . . . 1.0 109.952 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.473 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 47.8 m-85 -133.22 150.1 51.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.583 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 53' ' ' PHE . 27.9 mm-40 -138.57 150.22 46.09 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.667 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -125.05 138.9 54.19 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.213 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.7 mt -123.84 129.78 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 41.2 p-10 -95.5 121.03 36.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.934 0.397 . . . . 1.0 111.243 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.3 mm -98.42 122.48 50.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.032 -0.531 . . . . 1.0 109.99 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -117.4 132.28 56.6 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.813 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -98.96 153.64 18.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.342 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.498 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.8 tp -145.14 -179.07 6.39 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.567 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.498 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 20.5 tt0 70.66 42.89 0.79 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.991 -0.55 . . . . 1.0 109.705 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -83.75 102.22 12.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.78 -0.645 . . . . 1.0 109.844 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.435 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 80.6 mm-40 -68.45 -28.42 67.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.67 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 64' ' ' GLU . 2.6 m-80 -158.01 163.79 23.44 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.226 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.58 -32.04 52.1 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.12 1.88 . . . . 1.0 112.371 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.498 HD23 ' H ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -89.61 -5.28 57.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.826 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.73 134.28 51.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.327 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.7 mt -83.7 156.19 22.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.379 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.91 86.84 0.05 OUTLIER Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.455 -1.058 . . . . 1.0 110.455 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.27 -39.49 86.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.969 0.414 . . . . 1.0 111.067 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 51.0 t -117.13 123.92 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.768 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.3 mt -116.14 129.3 56.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.243 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.4 mt -101.29 125.67 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -140.91 130.24 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.313 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.426 ' OD1' ' OD1' ' A' ' 165' ' ' ASN . 15.5 t70 53.28 46.4 26.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.231 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 57.63 16.03 3.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.895 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -120.63 136.29 54.87 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.948 0.404 . . . . 1.0 110.045 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -89.84 127.59 36.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.738 -0.665 . . . . 1.0 111.102 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -118.27 142.86 47.05 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.199 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -83.45 -37.52 23.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.817 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 50.7 t0 -129.66 153.69 47.87 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.242 0.544 . . . . 1.0 111.819 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.567 ' HA ' HD12 ' A' ' 86' ' ' ILE . 54.0 tp -63.98 -38.78 92.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.791 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.69 -45.47 89.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.562 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -61.18 -37.31 82.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.687 0.28 . . . . 1.0 110.641 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 83' ' ' LEU . 96.6 mt -58.87 -47.63 88.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.659 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.8 mm -62.99 -44.82 99.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.476 -0.489 . . . . 1.0 111.678 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.85 -43.52 96.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 112.372 0.508 . . . . 1.0 112.372 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -72.96 -21.29 60.89 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.577 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.55 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 2.2 t80 -89.35 -51.29 5.64 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.176 -0.61 . . . . 1.0 111.485 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 95' ' ' VAL . 10.3 mp -62.69 -42.69 99.77 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.629 -0.429 . . . . 1.0 111.832 -178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -63.54 -50.79 68.15 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.691 -0.803 . . . . 1.0 111.446 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -68.94 -42.66 76.41 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.715 -0.394 . . . . 1.0 111.54 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -65.31 -44.32 88.24 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.162 -0.615 . . . . 1.0 111.318 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 91' ' ' LEU . 75.3 t -66.53 -44.22 90.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.406 -0.518 . . . . 1.0 111.205 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -67.25 -45.18 77.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.482 -0.327 . . . . 1.0 111.353 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.21 -44.59 91.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.583 -0.281 . . . . 1.0 111.649 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.2 tp -63.56 -40.55 97.28 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.021 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.4 ' O ' ' CB ' ' A' ' 103' ' ' SER . 92.7 m-20 -67.21 -42.42 84.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.77 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -64.38 -43.18 95.27 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 121.983 -0.448 . . . . 1.0 111.545 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.5 ttm -67.63 -56.23 10.21 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.42 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.2 m -59.54 -44.17 93.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.032 0.444 . . . . 1.0 110.815 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 7.6 t -72.99 11.73 0.64 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.68 -0.691 . . . . 1.0 111.298 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.3 t -92.89 135.48 34.11 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.87 0.367 . . . . 1.0 110.248 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.58 -21.14 66.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.942 0.401 . . . . 1.0 111.17 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.537 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 52.9 mttp -89.87 41.09 1.03 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.919 -0.582 . . . . 1.0 109.903 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -133.34 115.25 14.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.2 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -134.43 120.87 20.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.786 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.0 m -90.25 82.44 6.0 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.914 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.76 150.99 17.12 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.848 -0.901 . . . . 1.0 110.848 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 115' ' ' VAL . 9.0 p -79.41 173.96 12.05 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.033 -0.358 . . . . 1.0 110.033 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.42 ' NZ ' ' CG ' ' A' ' 138' ' ' HIS . 16.0 mtmm -59.39 -37.6 78.4 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.821 -0.352 . . . . 1.0 110.684 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -68.27 -43.25 78.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.052 0.453 . . . . 1.0 110.562 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -70.63 -19.19 62.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.73 -0.668 . . . . 1.0 111.067 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.557 HG13 ' SD ' ' A' ' 147' ' ' MET . 19.2 t -70.74 -45.34 74.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.704 -0.398 . . . . 1.0 110.13 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.99 -45.43 90.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-O 121.333 0.587 . . . . 1.0 110.251 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -65.84 -37.88 87.38 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.931 0.396 . . . . 1.0 111.326 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -69.43 -47.82 62.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.913 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.8 tp -69.64 -39.89 78.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.397 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.472 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 61.1 mm-40 -64.56 -42.76 95.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.728 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.13 -48.16 77.16 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.298 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CD1' ' OD1' ' A' ' 126' ' ' ASN . 30.0 t80 -62.34 -43.76 98.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.137 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.1 t -59.58 -40.4 87.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.096 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -58.48 -42.59 87.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 1.0 109.939 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.0 t -64.03 -37.98 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.445 ' OD1' ' CD1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -124.62 76.83 63.91 Favored Pre-proline 0 N--CA 1.473 0.704 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.351 179.69 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.487 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 7.1 Cg_exo -71.17 -27.29 20.2 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.634 2.223 . . . . 1.0 112.621 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -100.51 11.33 39.69 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.885 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -131.46 146.22 52.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.188 0.518 . . . . 1.0 110.433 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.8 m -80.83 163.52 23.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.537 -0.756 . . . . 1.0 109.913 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 p -151.24 145.65 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -145.89 142.24 28.59 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.912 0.387 . . . . 1.0 111.112 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -152.47 167.8 27.6 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.347 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -132.2 156.31 46.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 179.039 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.5 p -152.93 169.64 22.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.447 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 137' ' ' ASN . 54.0 tp -77.04 136.33 38.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.546 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 138' ' ' HIS . 11.0 t-20 -44.08 170.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.403 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.515 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 71.4 t60 -77.26 -56.45 4.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.038 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 139' ' ' ASP . 66.5 t0 -139.6 45.25 1.93 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.981 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -136.87 102.47 9.29 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 109.905 -0.405 . . . . 1.0 109.905 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.432 ' HB3' HD11 ' A' ' 52' ' ' LEU . 45.8 Cg_endo -75.19 120.59 6.07 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.944 1.762 . . . . 1.0 112.608 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.16 20.68 22.57 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.886 -0.886 . . . . 1.0 110.886 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -134.44 139.86 45.83 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.873 0.368 . . . . 1.0 110.281 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -132.5 160.04 37.65 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.841 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 145' ' ' TYR . 8.1 p90 -142.11 146.94 35.95 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.2 mt -106.36 126.57 52.41 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.136 0.493 . . . . 1.0 110.366 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.557 ' SD ' HG13 ' A' ' 115' ' ' VAL . 5.9 ptt? -116.86 144.83 44.05 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.928 -1.138 . . . . 1.0 107.928 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 148' ' ' PHE . 13.3 p90 -162.8 154.19 17.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.549 -0.538 . . . . 1.0 109.549 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.472 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 69.2 tttt -135.13 131.13 36.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.468 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.486 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 38.6 mm -72.41 -45.61 59.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.994 0.368 . . . . 1.0 111.994 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 27.8 m120 -161.61 173.06 15.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.577 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.52 -34.44 75.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.071 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -83.75 -12.96 55.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.588 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.431 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 8.4 t -79.82 158.71 26.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.32 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -89.77 150.58 22.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 1.0 109.98 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.6 tp -71.07 124.75 25.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.872 0.368 . . . . 1.0 110.211 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -110.91 129.3 55.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.667 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 91.1 m -131.24 131.43 43.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.114 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.75 166.15 13.13 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -107.97 142.45 38.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.114 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.5 t -122.3 138.29 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -106.01 135.15 47.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.034 0.445 . . . . 1.0 110.742 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.6 131.69 45.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.688 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.2 p -134.83 178.01 7.34 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.349 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.55 ' ND2' ' CE1' ' A' ' 90' ' ' TYR . 5.3 m120 -86.78 14.59 6.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.717 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 17.9 p -119.01 -1.12 11.01 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.483 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.74 -131.35 5.84 Favored Glycine 0 N--CA 1.465 0.59 0 N-CA-C 110.25 -1.14 . . . . 1.0 110.25 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -121.8 127.28 50.42 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -102.29 123.83 46.79 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.4 tt -117.96 111.79 19.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.519 -0.549 . . . . 1.0 109.519 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.5 t 35.94 59.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.175 0.435 . . . . 1.0 112.175 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.8 m120 69.4 27.52 4.97 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.98 0.733 . . . . 1.0 112.98 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -134.13 120.59 20.32 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -95.91 126.68 41.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.238 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -108.9 99.29 34.21 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 109.573 -0.528 . . . . 1.0 109.573 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.15 -21.57 9.51 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.382 2.055 . . . . 1.0 113.444 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 38.5 m -132.92 139.07 47.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.041 0.448 . . . . 1.0 111.253 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.96 -35.61 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.617 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.421 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 95.4 mt -63.32 -43.36 98.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 1.0 110.054 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.491 ' N ' ' OE1' ' A' ' 180' ' ' GLN . 6.3 mp0 -63.11 -31.46 72.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.224 -0.658 . . . . 1.0 109.224 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.78 -41.9 97.86 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.327 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' CYS . . . . . 0.63 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 3.0 p -58.96 -47.98 83.15 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.617 -0.433 . . . . 1.0 110.629 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.63 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 48.3 t30 -69.52 -48.91 58.95 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.44 -44.78 0.45 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.756 -1.338 . . . . 1.0 109.756 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -68.83 -47.44 66.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.052 -0.574 . . . . 1.0 109.76 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.574 ' N ' ' O ' ' A' ' 183' ' ' ASN . 88.8 tttt -57.03 -42.27 80.14 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.362 -0.836 . . . . 1.0 110.116 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 96.7 m -61.71 -44.33 97.14 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 53.1 mt -61.73 -41.57 97.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.773 -0.648 . . . . 1.0 109.928 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 59.2 tp -58.95 -44.15 91.4 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.388 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 16.5 tptp -62.01 -43.98 97.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.474 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.0 t -63.33 -38.45 91.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.363 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.4 mt -63.76 -42.08 97.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.829 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.41 -30.09 66.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.56 -0.291 . . . . 1.0 111.67 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.843 -179.123 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.435 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 41.1 mmm-85 . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 120.839 0.352 . . . . 1.0 110.503 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.83 -27.93 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.653 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.2 pt -76.49 -18.76 14.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.536 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 3' ' ' ARG . 56.1 p30 -99.35 7.44 45.55 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.485 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -84.99 138.49 37.12 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 110.091 -0.337 . . . . 1.0 110.091 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.59 -13.32 32.48 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.889 1.726 . . . . 1.0 112.342 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.418 ' CD1' ' CZ ' ' A' ' 30' ' ' PHE . 40.4 m-85 -99.35 10.68 40.95 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.572 -0.286 . . . . 1.0 111.069 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.532 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 91.0 t80 -85.98 123.36 31.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.316 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 49.5 m-85 -146.5 108.92 4.15 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 110.092 -0.336 . . . . 1.0 110.092 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.508 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 45.3 Cg_exo -58.88 109.57 0.54 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 121.697 1.598 . . . . 1.0 112.48 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 23.4 m-85 -159.48 155.69 26.95 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.626 -0.716 . . . . 1.0 110.555 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 18.8 t-20 -84.03 164.04 19.54 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.295 -0.631 . . . . 1.0 109.295 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . -61.14 -40.81 99.06 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.569 -0.824 . . . . 1.0 111.095 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -66.73 -43.97 82.81 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.911 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -69.46 -36.0 76.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.392 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -39.49 90.09 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.304 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -60.43 -44.07 96.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.081 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -61.57 -42.45 98.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.281 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -63.05 -42.16 99.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.59 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mp -77.67 -13.59 59.86 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.295 -0.411 . . . . 1.0 111.081 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -58.49 -42.83 88.46 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.385 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p -79.48 -18.4 52.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -82.54 177.91 8.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.499 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.536 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 56.4 mp0 -90.01 173.23 8.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.77 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 ptt-85 -81.19 145.01 31.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.727 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.94 -1.39 55.2 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -82.1 147.82 28.88 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.418 ' CZ ' ' CD1' ' A' ' 9' ' ' TYR . 13.7 p90 -133.47 163.17 29.97 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.353 0.597 . . . . 1.0 110.961 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.684 ' O ' HG23 ' A' ' 44' ' ' ILE . 31.1 m -146.88 157.95 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.21 -0.904 . . . . 1.0 111.298 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.8 mt -117.53 127.47 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.109 -0.496 . . . . 1.0 109.715 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -146.46 153.29 40.26 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.394 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -104.93 139.6 39.41 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.735 -0.468 . . . . 1.0 109.735 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -67.69 149.58 49.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.796 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 t -63.77 -20.5 65.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.966 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -125.01 10.18 8.17 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.574 -0.285 . . . . 1.0 110.684 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . -68.57 -56.93 8.76 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t0 67.54 -51.33 0.5 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.734 0.302 . . . . 1.0 110.874 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 38' ' ' GLY . 90.5 m-20 -122.05 4.92 9.84 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.008 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -120.16 149.96 41.4 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.042 0.449 . . . . 1.0 110.517 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.423 ' CD1' ' OE2' ' A' ' 60' ' ' GLU . 5.2 mp -121.45 147.5 45.66 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.096 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -126.5 132.13 70.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.684 HG23 ' O ' ' A' ' 31' ' ' VAL . 57.0 mt -113.74 139.83 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 108.837 -0.801 . . . . 1.0 108.837 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.2 m -120.4 142.39 49.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.035 -0.53 . . . . 1.0 109.692 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.67 ' CE2' HD11 ' A' ' 48' ' ' LEU . 2.4 p-90 -147.68 151.6 36.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.977 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.601 ' C ' HD12 ' A' ' 48' ' ' LEU . 87.6 tttt -99.66 140.33 34.01 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.87 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.703 HD21 ' NE2' ' A' ' 54' ' ' GLN . 9.0 mp -105.77 -82.08 0.53 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.605 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -93.81 -178.67 4.75 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.801 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -57.48 -40.48 78.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.667 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -127.51 53.45 1.75 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.092 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tp -151.42 128.22 10.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.898 0.38 . . . . 1.0 110.195 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -132.31 148.72 52.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.535 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.703 ' NE2' HD21 ' A' ' 48' ' ' LEU . 29.8 mt-30 -137.79 152.61 49.32 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.972 -0.558 . . . . 1.0 109.628 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -129.31 144.9 51.41 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.201 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.433 HD11 ' OH ' ' A' ' 90' ' ' TYR . 96.6 mt -126.27 130.82 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.842 -0.429 . . . . 1.0 109.842 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 43.7 p-10 -99.84 124.81 45.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.899 0.38 . . . . 1.0 110.633 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 90.1 mt -102.21 133.05 46.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.48 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -119.96 134.84 55.12 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.853 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.423 ' OE2' ' CD1' ' A' ' 42' ' ' LEU . 3.6 mt-10 -100.09 143.91 29.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.145 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.4 mt -141.22 174.8 10.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.413 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 74.05 35.36 0.78 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.957 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -95.12 103.14 14.99 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.021 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.3 -31.84 72.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.837 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -147.67 155.84 45.01 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.265 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.98 -31.96 46.06 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.199 1.933 . . . . 1.0 112.079 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tp -79.69 -10.82 59.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.881 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.73 136.23 45.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.494 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 71' ' ' LYS . 64.7 mt -81.44 154.23 26.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.312 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.6 86.01 0.01 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.427 -1.069 . . . . 1.0 110.427 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 69' ' ' LEU . 68.3 mttm -61.35 -35.65 78.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.997 0.427 . . . . 1.0 110.823 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.4 t -127.62 124.16 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.798 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.0 mt -114.77 126.44 54.84 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.8 mt -102.18 123.1 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.84 0.353 . . . . 1.0 110.24 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.2 t -143.45 132.72 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.138 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 54.49 43.66 29.99 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.954 -0.299 . . . . 1.0 111.05 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.6 m120 57.98 19.96 6.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.708 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -128.32 139.12 52.57 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.873 0.368 . . . . 1.0 110.33 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -89.15 133.18 34.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.041 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -124.52 138.23 54.35 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.131 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -81.92 -37.32 26.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 1.0 111.62 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -123.22 149.91 44.09 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.124 0.487 . . . . 1.0 111.887 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.2 tp -65.74 -40.76 92.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.825 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -59.44 -43.54 93.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.905 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -56.93 -38.62 73.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.566 0.222 . . . . 1.0 110.633 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.22 -44.65 99.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.619 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.01 -46.16 97.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.52 -0.472 . . . . 1.0 111.647 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.98 -41.42 59.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 112.677 0.621 . . . . 1.0 112.677 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -78.5 -13.35 59.88 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.948 -0.301 . . . . 1.0 111.401 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.433 ' OH ' HD11 ' A' ' 56' ' ' ILE . 63.1 t80 -94.39 -49.3 5.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.113 0.412 . . . . 1.0 112.113 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.581 ' O ' HG23 ' A' ' 95' ' ' VAL . 2.9 mp -71.68 -38.08 70.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.965 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -62.07 -48.26 81.0 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.968 -0.693 . . . . 1.0 111.215 -177.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.04 -42.35 69.61 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.848 -0.341 . . . . 1.0 111.683 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -66.05 -42.33 89.64 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.503 -0.479 . . . . 1.0 111.169 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 91' ' ' LEU . 68.6 t -63.63 -47.86 89.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.347 -0.541 . . . . 1.0 111.214 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -69.93 -42.54 73.14 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.578 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.485 HD11 ' CZ ' ' A' ' 168' ' ' TYR . 13.7 tp -68.63 -41.93 78.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.428 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.2 tp -62.92 -43.41 98.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.031 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -66.14 -39.98 90.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.788 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -70.06 -41.61 73.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.398 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.6 tpt -64.22 -56.36 15.23 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.456 -0.498 . . . . 1.0 111.369 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' ' 104' ' ' SER . 14.0 m -60.69 -39.46 88.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.043 0.449 . . . . 1.0 110.51 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 91.8 p -73.16 11.26 0.76 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.767 -0.651 . . . . 1.0 111.117 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 102' ' ' THR . 13.8 t -90.5 138.02 31.89 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.259 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.67 -20.1 63.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.194 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.582 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 64.3 mttp -87.99 39.12 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.691 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -129.17 110.14 11.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.372 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.56 122.94 37.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.206 -0.452 . . . . 1.0 109.884 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.6 m -95.0 72.83 3.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.118 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.58 151.28 16.93 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.953 -0.859 . . . . 1.0 110.953 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -73.35 175.84 6.55 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.032 -0.359 . . . . 1.0 110.032 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt -56.11 -37.79 69.89 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.95 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -68.47 -42.73 78.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.097 0.475 . . . . 1.0 110.729 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -70.28 -23.0 62.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.112 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 111' ' ' THR . 41.3 t -69.39 -45.74 78.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.158 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.1 t -65.92 -45.75 90.31 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 CA-C-O 121.158 0.504 . . . . 1.0 110.548 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.99 -33.06 74.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.794 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -68.61 -50.01 54.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.618 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.442 HD11 HG13 ' A' ' 131' ' ' VAL . 11.0 tp -70.03 -39.22 77.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.851 0.358 . . . . 1.0 110.253 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -64.97 -40.12 94.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.455 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -59.9 -47.53 85.4 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.686 -0.405 . . . . 1.0 110.286 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -60.98 -40.62 94.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.076 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 7.4 t -62.18 -41.72 98.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.548 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -59.49 -43.52 93.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.297 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.38 -41.96 92.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.71 76.29 77.26 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.488 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.537 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 10.2 Cg_exo -68.03 -21.14 43.57 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.857 2.372 . . . . 1.0 112.641 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -102.45 13.76 33.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.838 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -128.05 152.8 47.52 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.107 0.479 . . . . 1.0 110.379 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.1 p -81.39 161.16 23.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.637 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.442 HG13 HD11 ' A' ' 119' ' ' ILE . 5.1 p -154.89 146.12 13.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 20.7 p90 -151.4 142.06 22.73 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.834 0.35 . . . . 1.0 111.026 178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -152.62 168.14 26.58 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.393 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 5.1 p90 -136.46 157.19 47.38 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.257 -0.645 . . . . 1.0 109.257 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.2 p -149.27 168.58 22.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.815 0.34 . . . . 1.0 110.184 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 46.7 tp -79.26 144.46 34.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.355 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 0.0 OUTLIER -67.56 -172.82 0.27 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.026 -0.534 . . . . 1.0 109.999 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.516 ' ND1' ' N ' ' A' ' 138' ' ' HIS . 0.2 OUTLIER -110.31 -56.59 2.32 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.941 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -114.09 19.88 16.1 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.082 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.529 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 5.9 m120 -125.06 68.36 56.33 Favored Pre-proline 0 N--CA 1.466 0.344 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.236 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -63.13 127.71 20.93 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.989 1.793 . . . . 1.0 112.46 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.36 11.56 41.46 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 110.761 -0.936 . . . . 1.0 110.761 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.524 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 57.7 m95 -132.95 156.54 47.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.818 0.342 . . . . 1.0 110.092 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -129.67 148.65 51.58 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.479 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 18.3 m-85 -116.84 136.13 53.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.063 0.459 . . . . 1.0 110.193 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.2 mt -109.77 124.61 51.57 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.302 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -121.48 147.52 45.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.053 -1.092 . . . . 1.0 108.053 178.221 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -160.18 150.74 18.64 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.608 -0.515 . . . . 1.0 109.608 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -136.23 128.34 29.73 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.851 -0.34 . . . . 1.0 110.521 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.5 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 34.3 mm -69.99 -45.79 75.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.421 -0.354 . . . . 1.0 111.716 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 31.1 m120 -158.94 173.68 16.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.559 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.11 -34.6 76.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.79 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -86.86 9.2 19.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.041 0.448 . . . . 1.0 110.46 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 13.1 t -98.59 165.92 11.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.431 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -96.79 145.58 25.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.929 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.04 121.45 22.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.063 0.459 . . . . 1.0 109.931 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -111.67 128.09 55.96 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.91 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.9 m -123.76 127.61 48.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.778 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.53 171.67 7.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.024 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.479 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 93.6 m-20 -109.51 149.17 30.01 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.836 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 45.8 t -126.35 136.92 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -104.88 125.8 51.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.021 0.439 . . . . 1.0 110.715 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 46.2 tp -88.6 129.8 35.41 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.399 -0.593 . . . . 1.0 109.399 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.3 p -128.34 171.83 11.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.408 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -83.98 16.09 3.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.512 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 67.0 p -122.71 -2.94 8.78 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.555 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 139.93 -128.69 3.99 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.453 -1.059 . . . . 1.0 110.453 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.485 ' CZ ' HD11 ' A' ' 97' ' ' LEU . 46.2 m-85 -123.81 127.35 47.96 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.729 0.299 . . . . 1.0 110.445 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -103.58 123.99 47.97 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 171' ' ' VAL . 0.5 OUTLIER -115.14 112.46 22.57 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.208 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 170' ' ' LEU . 5.2 t 34.74 64.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 65.0 27.39 12.64 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.012 0.745 . . . . 1.0 113.012 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -132.42 121.58 23.65 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.176 -0.675 . . . . 1.0 109.176 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -94.61 123.44 38.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.822 0.344 . . . . 1.0 111.427 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -103.47 134.96 19.47 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.01 -23.21 22.02 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.037 1.825 . . . . 1.0 113.377 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 70.8 m -156.45 161.28 40.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.952 0.406 . . . . 1.0 111.035 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 179' ' ' ILE . 7.5 p -61.12 -42.01 91.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.853 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.479 ' N ' HG13 ' A' ' 178' ' ' VAL . 48.1 mm -60.29 -47.4 92.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.722 -0.391 . . . . 1.0 110.299 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -62.02 -35.92 80.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.8 tt -62.96 -40.1 96.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.271 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 72.8 m -60.77 -47.76 84.84 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.579 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.639 ' O ' ' N ' ' A' ' 186' ' ' LYS . 56.8 t-20 -66.82 -47.37 72.25 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.58 -45.5 0.51 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.954 -1.259 . . . . 1.0 109.954 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.514 ' O ' ' HG ' ' A' ' 188' ' ' LEU . 0.3 OUTLIER -69.84 -41.82 74.4 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-O 121.913 0.863 . . . . 1.0 109.762 178.25 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.639 ' N ' ' O ' ' A' ' 183' ' ' ASN . 87.9 tttt -60.84 -34.24 74.28 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.87 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.1 m -64.09 -51.59 63.3 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.899 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.599 ' C ' HD12 ' A' ' 188' ' ' LEU . 0.9 OUTLIER -65.57 -35.67 81.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.123 179.001 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.441 ' N ' ' HG ' ' A' ' 188' ' ' LEU . 37.1 tp -57.27 -46.47 83.06 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.172 -0.467 . . . . 1.0 109.97 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.51 -39.82 94.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.136 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.7 t -59.9 -36.43 76.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.498 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.5 mt -67.85 -41.6 82.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.785 -0.643 . . . . 1.0 112.208 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.1 -36.98 83.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.771 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' HIS . . . . . 0.469 ' O ' ' ND1' ' A' ' 194' ' ' HIS . 2.4 t-80 . . . . . 0 C--N 1.324 -0.514 0 CA-C-O 120.843 0.354 . . . . 1.0 110.85 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.6 ttp-105 . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 120.85 0.357 . . . . 1.0 110.351 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.2 p -66.38 -32.6 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.669 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 pt -67.26 -24.07 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.672 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -93.59 0.76 56.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.397 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -64.27 130.75 94.77 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.221 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -47.64 -32.36 16.15 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.705 1.603 . . . . 1.0 112.516 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -85.32 9.66 14.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.372 -0.377 . . . . 1.0 111.181 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.505 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 80.6 t80 -89.95 129.83 36.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.467 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 61.7 m-85 -149.24 127.6 5.92 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 110.2 -0.296 . . . . 1.0 110.2 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 73.7 Cg_endo -73.24 109.9 2.94 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.901 1.734 . . . . 1.0 112.724 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 71.4 m-85 -160.89 151.78 18.56 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.489 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -76.26 -170.05 1.34 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.95 -44.53 8.17 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.546 -1.021 . . . . 1.0 110.546 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -67.02 -43.77 81.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.664 0.268 . . . . 1.0 111.025 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.2 -33.89 77.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.057 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.5 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.15 -39.47 90.2 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.741 -0.383 . . . . 1.0 110.326 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.25 -42.08 96.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.043 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.37 -44.39 96.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.439 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -63.32 -42.23 98.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.35 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 18' ' ' ALA . 7.9 mp -73.29 -12.79 60.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.805 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -58.97 -40.73 85.63 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.357 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.6 t -75.82 -18.71 59.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.766 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.482 ' N ' ' CD ' ' A' ' 25' ' ' LYS . 3.1 mptp? -83.5 179.89 7.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.438 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.407 ' OE1' ' O ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -104.37 -176.01 2.96 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.367 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.458 ' CD ' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -75.08 143.26 43.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.458 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.47 7.54 57.98 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.844 -0.902 . . . . 1.0 110.844 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -87.0 140.58 29.41 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -135.85 162.13 33.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.253 0.549 . . . . 1.0 110.92 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.2 m -147.44 158.65 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.155 -0.93 . . . . 1.0 111.612 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.0 mt -117.69 127.21 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -146.98 155.29 42.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.463 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.79 137.27 45.14 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.9 t -74.75 144.85 43.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.974 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.0 p -64.83 -30.21 71.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.723 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -102.35 0.79 34.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.707 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.99 -56.47 5.29 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.428 -1.069 . . . . 1.0 110.428 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 72.64 -54.6 0.69 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.561 0.22 . . . . 1.0 111.024 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -119.52 2.41 11.22 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.756 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -117.9 150.47 39.15 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.869 0.366 . . . . 1.0 110.566 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.03 151.76 38.52 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 116.004 -0.544 . . . . 1.0 109.912 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.1 t -126.05 132.95 70.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.26 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.62 HD12 HD11 ' A' ' 58' ' ' ILE . 40.2 mt -111.86 137.88 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.0 m -117.48 136.82 52.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.841 -0.618 . . . . 1.0 109.846 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.678 ' CH2' HD21 ' A' ' 48' ' ' LEU . 1.3 p-90 -146.22 147.2 31.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.496 -0.774 . . . . 1.0 110.921 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HZ3' ' C ' ' A' ' 49' ' ' ASP . 64.7 tttm -93.84 140.66 29.41 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.075 -0.512 . . . . 1.0 111.255 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.678 HD21 ' CH2' ' A' ' 46' ' ' TRP . 82.0 mt -97.27 -66.25 0.91 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.486 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.452 ' C ' ' HZ3' ' A' ' 47' ' ' LYS . 4.6 p30 -144.56 -166.64 2.44 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.607 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -59.18 131.63 51.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.972 0.415 . . . . 1.0 110.682 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 49.87 52.79 13.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.907 -0.588 . . . . 1.0 111.156 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 141' ' ' PRO . 16.8 tp -158.89 119.12 3.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.338 . . . . 1.0 110.421 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.5 149.46 52.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.592 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.41 ' HG3' HD11 ' A' ' 48' ' ' LEU . 9.8 mm100 -137.05 151.9 49.45 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.136 -0.484 . . . . 1.0 109.751 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -125.8 140.62 52.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.203 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 95.7 mt -120.85 123.7 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -94.95 122.23 37.38 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.58 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.62 HD11 HD12 ' A' ' 44' ' ' ILE . 83.0 mt -102.53 129.68 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.336 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -119.82 134.37 55.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.099 -0.501 . . . . 1.0 109.891 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -102.62 148.78 25.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.109 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.1 mt -141.97 174.72 10.33 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.328 -0.397 . . . . 1.0 110.461 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 67.81 41.62 2.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.016 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.716 ' H ' ' CD ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -111.85 134.55 53.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.242 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.25 -20.3 30.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.538 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.458 ' ND2' ' HB2' ' A' ' 68' ' ' ALA . 1.6 p-10 -157.63 153.41 22.85 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.153 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.83 -20.91 68.53 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.267 1.978 . . . . 1.0 111.884 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.5 tp -85.49 -12.37 51.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.144 0.497 . . . . 1.0 110.639 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.458 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . . . -79.35 151.57 30.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.527 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.8 mt -75.86 147.24 39.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.284 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.79 98.91 0.37 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.551 -1.02 . . . . 1.0 110.551 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -62.55 -38.27 89.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.92 0.39 . . . . 1.0 110.544 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.53 123.65 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.624 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.4 mt -116.47 130.57 56.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.869 -0.605 . . . . 1.0 109.401 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mp -107.49 124.65 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.81 0.338 . . . . 1.0 110.362 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -139.2 132.11 37.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.288 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 39.3 t0 51.92 42.03 29.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.654 0.264 . . . . 1.0 111.035 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.1 t30 61.19 22.92 13.19 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.297 -0.411 . . . . 1.0 111.042 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -127.0 133.36 50.57 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.114 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -86.31 128.24 34.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.735 -0.666 . . . . 1.0 111.089 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -121.49 138.56 54.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.151 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -84.99 -34.55 22.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.542 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -126.31 149.45 49.14 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.062 0.458 . . . . 1.0 112.058 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.0 tp -65.38 -39.7 92.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.945 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.401 ' O ' HG23 ' A' ' 88' ' ' VAL . 89.5 m-20 -60.2 -40.81 91.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 1.0 111.741 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -61.0 -38.45 86.1 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.769 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.83 -45.84 97.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.726 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.9 mm -65.44 -43.45 94.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.506 -0.478 . . . . 1.0 111.47 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 84' ' ' ASP . 60.9 t -71.73 -43.07 70.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 112.642 0.608 . . . . 1.0 112.642 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.03 -13.13 59.55 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.722 -0.391 . . . . 1.0 111.61 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -95.3 -49.01 5.65 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.772 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 95' ' ' VAL . 2.1 tp -70.06 -41.41 74.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.312 -0.404 . . . . 1.0 112.018 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -63.96 -49.14 73.71 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.918 -0.713 . . . . 1.0 111.456 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -70.53 -42.05 71.73 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.62 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -65.88 -41.88 90.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.347 -0.541 . . . . 1.0 111.266 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 91' ' ' LEU . 51.5 t -64.76 -46.43 92.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.39 -0.524 . . . . 1.0 111.181 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -65.94 -44.57 84.66 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.593 -0.443 . . . . 1.0 111.259 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.552 HD11 ' CZ ' ' A' ' 168' ' ' TYR . 10.7 tp -65.57 -41.82 92.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.497 -0.32 . . . . 1.0 111.511 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.25 -42.3 99.17 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.299 -0.561 . . . . 1.0 110.045 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.414 ' O ' ' OG ' ' A' ' 103' ' ' SER . 91.1 m-20 -66.31 -40.41 89.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.262 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -69.37 -40.8 77.23 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.673 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.4 tpt -66.5 -56.11 12.41 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.104 -0.638 . . . . 1.0 111.301 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 65.1 m -60.44 -39.11 86.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.047 0.451 . . . . 1.0 110.852 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 99' ' ' ASN . 99.2 p -71.91 10.42 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.638 -0.71 . . . . 1.0 111.124 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.1 p -93.94 133.7 37.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.711 0.291 . . . . 1.0 110.468 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 37.9 mp0 -57.46 -21.07 34.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.138 0.494 . . . . 1.0 110.594 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.555 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 49.2 mttp -87.61 39.7 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.771 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -128.45 113.22 15.25 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.604 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -125.61 110.47 13.86 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.197 -0.456 . . . . 1.0 109.804 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.7 m -85.03 77.05 10.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.981 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -116.63 157.96 14.74 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 115' ' ' VAL . 72.3 p -78.53 168.05 20.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.843 -0.429 . . . . 1.0 109.843 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -56.68 -36.85 70.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.74 0.305 . . . . 1.0 110.329 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -67.39 -45.22 76.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.913 0.387 . . . . 1.0 110.539 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -70.52 -17.2 62.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.786 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 111' ' ' THR . 22.7 t -72.2 -44.01 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.293 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.5 t -63.45 -46.94 93.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.211 0.529 . . . . 1.0 110.304 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -66.17 -35.71 81.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.901 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -67.69 -49.12 64.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.757 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.9 tp -69.87 -39.65 77.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.856 -0.337 . . . . 1.0 110.424 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.5 -40.24 95.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.706 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.6 -47.51 78.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.514 -0.474 . . . . 1.0 110.255 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.451 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 32.1 t80 -60.61 -43.14 97.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.061 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.1 p -65.88 -33.24 75.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.486 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -60.71 -42.28 96.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.931 -0.577 . . . . 1.0 109.915 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.49 -41.5 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.451 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -125.87 74.58 70.98 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.213 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 151' ' ' ASN . 46.1 Cg_endo -73.17 -17.89 24.17 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.354 2.036 . . . . 1.0 112.557 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 48.0 p30 -90.85 -10.31 43.16 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.157 0.429 . . . . 1.0 112.157 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -118.63 147.03 44.18 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.925 0.393 . . . . 1.0 110.404 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.9 m -80.94 160.9 24.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.782 -0.645 . . . . 1.0 109.693 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.89 146.89 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 133' ' ' TYR . 26.3 p90 -139.32 143.92 38.06 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.85 0.357 . . . . 1.0 111.56 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 18.4 m-85 -151.85 166.23 32.07 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.491 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 4.1 p90 -135.01 152.3 51.6 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.8 m -150.94 172.41 15.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.442 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.696 HD13 ' H ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -77.21 142.36 39.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.616 179.697 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.696 ' H ' HD13 ' A' ' 136' ' ' LEU . 10.7 t-20 -98.98 111.84 24.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.837 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -66.67 -43.23 85.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.676 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.15 -27.53 65.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.373 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.474 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 31.6 m120 -125.14 73.96 66.74 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.267 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.526 ' HB3' HD11 ' A' ' 52' ' ' LEU . 27.2 Cg_endo -62.76 126.11 17.48 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.911 1.741 . . . . 1.0 112.463 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.06 -7.68 48.62 Favored Glycine 0 N--CA 1.467 0.741 0 N-CA-C 111.065 -0.814 . . . . 1.0 111.065 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -116.81 141.18 48.55 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.713 0.292 . . . . 1.0 110.418 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.404 ' CE1' HD22 ' A' ' 136' ' ' LEU . 56.0 m-85 -102.09 142.77 32.83 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.542 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 11.1 m-85 -119.15 131.05 55.84 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.235 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.98 121.49 42.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.357 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -117.34 144.46 44.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.192 -1.04 . . . . 1.0 108.192 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -160.57 153.69 21.62 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.403 -0.591 . . . . 1.0 109.403 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -137.36 131.31 31.94 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.692 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 35.9 mm -70.98 -47.2 63.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.695 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.454 ' H ' ' HB3' ' A' ' 154' ' ' SER . 12.2 p30 -161.92 177.19 10.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.076 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.59 -34.37 78.1 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.09 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -84.88 9.5 14.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.668 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 3.3 t -105.28 163.61 12.47 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.182 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -92.21 156.63 17.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.936 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 50.5 tp -75.79 127.29 32.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.942 0.401 . . . . 1.0 110.26 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -112.26 133.17 54.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.081 -0.509 . . . . 1.0 109.751 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 85.5 m -131.39 131.79 43.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.036 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -121.91 164.73 17.07 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.806 -0.442 . . . . 1.0 109.806 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.542 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 24.2 m-20 -115.57 147.58 40.57 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.992 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 39.1 t -128.91 138.92 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -97.61 126.68 43.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.993 0.425 . . . . 1.0 110.704 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.4 tp -90.23 128.84 36.49 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 35.6 p -129.66 175.11 9.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.394 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -83.96 15.87 3.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.71 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 5.6 p -121.85 -1.83 9.36 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.739 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.88 -134.02 7.1 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.337 -1.105 . . . . 1.0 110.337 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.552 ' CZ ' HD11 ' A' ' 97' ' ' LEU . 7.9 m-85 -117.79 128.6 55.03 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.142 -0.318 . . . . 1.0 110.142 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -107.86 121.55 44.98 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.52 ' C ' HD23 ' A' ' 170' ' ' LEU . 6.7 tt -111.71 115.84 29.76 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 109.009 -0.738 . . . . 1.0 109.009 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.645 ' O ' HG12 ' A' ' 171' ' ' VAL . 99.3 t 33.19 62.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.349 0.5 . . . . 1.0 112.349 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.4 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 1.7 m120 67.32 27.45 8.23 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.635 0.976 . . . . 1.0 113.635 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -131.79 120.1 22.19 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.338 -0.615 . . . . 1.0 109.338 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -91.73 129.42 37.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.883 0.373 . . . . 1.0 111.253 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -109.08 99.22 34.6 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.62 -24.4 12.73 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.636 2.224 . . . . 1.0 113.603 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.436 ' OG ' ' OE1' ' A' ' 180' ' ' GLN . 6.9 p -138.05 142.87 40.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.917 0.389 . . . . 1.0 111.272 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.61 -33.92 59.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.683 -0.69 . . . . 1.0 110.583 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.37 -44.08 98.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 122.038 -0.414 . . . . 1.0 110.363 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.521 ' N ' ' OE1' ' A' ' 180' ' ' GLN . 3.2 mp0 -65.89 -29.34 69.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 52.4 tp -64.0 -40.72 97.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.255 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 74.1 m -62.56 -47.79 82.31 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.364 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 186' ' ' LYS . 43.6 t30 -68.01 -47.41 68.55 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 119.503 -0.879 . . . . 1.0 108.88 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.4 -45.31 0.67 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 109.919 -1.272 . . . . 1.0 109.919 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -68.79 -46.99 67.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.376 0.608 . . . . 1.0 109.502 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 183' ' ' ASN . 1.4 tmtp? -56.81 -42.72 80.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.243 -0.89 . . . . 1.0 110.05 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 23.8 m -61.25 -44.0 97.96 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 188' ' ' LEU . 39.8 mt -62.21 -42.11 98.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.115 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 44.7 tp -58.48 -42.8 88.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.336 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.48 -44.94 92.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.371 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 17.4 m -62.7 -39.34 93.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.895 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.17 -41.13 99.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.609 -0.723 . . . . 1.0 111.735 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.68 -26.68 67.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.793 0.294 . . . . 1.0 111.793 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 . . . . . 0 C--N 1.326 -0.426 0 CA-C-O 120.818 0.342 . . . . 1.0 110.884 -179.619 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 . . . . . 0 CA--C 1.521 -0.162 0 CA-C-O 120.868 0.366 . . . . 1.0 110.599 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.0 p -97.06 -17.4 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.564 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.6 pt -85.51 -25.95 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.658 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -89.57 -0.01 57.22 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.613 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.63 146.87 96.31 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.092 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.98 -20.67 50.67 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.913 1.742 . . . . 1.0 112.353 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.439 ' CE1' ' CZ ' ' A' ' 30' ' ' PHE . 74.7 m-85 -88.97 3.3 52.01 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.326 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -88.16 135.45 33.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.322 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.573 ' O ' ' NH1' ' A' ' 33' ' ' ARG . 74.6 m-85 -151.27 119.64 3.42 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 110.013 -0.365 . . . . 1.0 110.013 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.521 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 73.7 Cg_endo -72.82 109.62 2.84 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.671 1.58 . . . . 1.0 113.129 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.551 ' O ' ' NE ' ' A' ' 33' ' ' ARG . 56.4 m-85 -160.41 159.25 30.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.623 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -78.69 173.47 12.42 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.14 -49.06 82.27 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.27 -0.967 . . . . 1.0 110.858 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -67.95 -40.15 83.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 1.0 110.823 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -66.61 -32.63 74.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 1.0 111.146 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.35 92.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.933 -0.307 . . . . 1.0 110.221 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.479 ' OE2' ' CD1' ' A' ' 53' ' ' PHE . 84.1 tt0 -63.31 -42.74 99.04 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.699 -0.4 . . . . 1.0 109.996 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -60.78 -40.36 92.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.091 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -62.19 -42.49 99.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.826 0.346 . . . . 1.0 110.474 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.16 -13.6 60.19 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.874 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.9 ttm-85 -61.33 -40.15 93.18 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.844 -0.342 . . . . 1.0 110.256 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.4 p -77.58 -19.08 56.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.751 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -84.67 -179.77 7.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.912 0.387 . . . . 1.0 110.566 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -103.15 -177.47 3.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.784 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -75.45 145.0 41.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.772 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.17 11.01 59.08 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -97.09 140.75 31.13 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CZ ' ' CE1' ' A' ' 9' ' ' TYR . 35.1 p90 -135.08 168.57 18.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.444 0.64 . . . . 1.0 111.116 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.8 m -148.54 161.32 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.012 -0.994 . . . . 1.0 111.762 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -116.09 131.19 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.573 ' NH1' ' O ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -137.74 164.13 29.64 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.839 -179.214 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -120.51 126.89 51.51 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 t -62.56 134.16 55.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.128 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.5 t -72.17 -20.77 61.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.885 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -117.8 37.59 3.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.819 0.343 . . . . 1.0 110.767 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -175.1 58.71 0.11 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.939 -0.865 . . . . 1.0 110.939 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -57.57 3.41 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.652 0.263 . . . . 1.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.577 ' H ' ' C ' ' A' ' 38' ' ' GLY . 97.9 m-20 -102.94 -1.74 28.92 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.595 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.429 ' ND1' ' O ' ' A' ' 40' ' ' ASP . 60.6 m-70 -143.59 157.72 44.21 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.375 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 mp -119.74 152.75 36.7 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.15 -0.477 . . . . 1.0 109.988 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.3 t -124.2 130.9 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 110.06 -0.348 . . . . 1.0 110.06 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.686 HD12 HD11 ' A' ' 58' ' ' ILE . 36.4 mt -111.58 138.1 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 96.2 m -116.93 136.13 53.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.537 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.471 ' CZ2' ' NZ ' ' A' ' 94' ' ' LYS . 4.4 p-90 -145.36 160.91 40.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.658 -0.701 . . . . 1.0 110.846 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -107.65 140.9 39.98 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.022 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.429 ' H ' HD12 ' A' ' 48' ' ' LEU . 3.1 mp -98.0 -72.35 0.65 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.652 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -158.29 157.34 32.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.259 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt 41.81 -141.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.798 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -89.71 64.3 6.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.848 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.9 tp -140.57 128.89 22.46 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.877 0.37 . . . . 1.0 110.323 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.479 ' CD1' ' OE2' ' A' ' 19' ' ' GLU . 51.6 m-85 -131.4 150.36 52.18 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.379 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -136.66 153.75 50.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.831 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.421 ' ND1' ' N ' ' A' ' 55' ' ' HIS . 10.8 p-80 -127.67 143.08 51.18 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.066 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 78.2 mt -123.4 129.23 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.228 -0.442 . . . . 1.0 109.966 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -97.23 122.45 40.27 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.03 0.443 . . . . 1.0 110.513 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.686 HD11 HD12 ' A' ' 44' ' ' ILE . 79.9 mt -99.32 129.95 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.4 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -113.56 132.35 55.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.0 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -101.03 156.58 17.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.188 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.7 tp -126.19 172.2 10.25 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.493 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 73.9 mm-40 60.02 39.0 20.44 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.99 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -81.47 78.88 8.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.082 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.64 -36.15 80.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.869 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -142.81 152.56 59.47 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.044 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.68 -25.56 68.58 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.295 1.997 . . . . 1.0 112.142 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.7 mt -97.84 -4.41 36.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.606 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.13 144.05 52.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.581 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.5 mt -78.5 146.31 34.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.366 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.27 101.16 1.22 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.539 -1.025 . . . . 1.0 110.539 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -63.58 -38.33 90.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.04 0.448 . . . . 1.0 111.029 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.17 125.52 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.593 -0.73 . . . . 1.0 111.004 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.6 mt -115.18 129.76 56.74 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 71.5 mt -102.13 126.24 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.884 0.373 . . . . 1.0 110.189 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.9 t -143.9 133.11 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.386 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t0 53.1 45.36 28.88 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.11 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 57.63 25.57 11.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.311 -0.404 . . . . 1.0 111.051 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -130.15 156.81 43.94 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.322 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -108.06 125.98 52.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.022 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -123.89 139.47 53.93 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.134 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -85.05 -38.84 18.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.77 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -110.08 138.22 46.76 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.201 0.524 . . . . 1.0 111.844 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.39 -41.35 96.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.874 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 38.0 p-10 -59.63 -45.97 90.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.982 -177.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.535 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 33.2 tt0 -57.93 -37.86 74.86 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 120.68 0.276 . . . . 1.0 110.778 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.81 -46.44 93.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.451 -0.5 . . . . 1.0 110.714 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.7 mm -64.4 -44.08 97.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.2 -0.6 . . . . 1.0 111.626 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.16 -43.63 74.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 113.067 0.765 . . . . 1.0 113.067 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -78.17 -13.27 59.93 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.641 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.457 ' CE2' ' NZ ' ' A' ' 94' ' ' LYS . 50.0 t80 -94.75 -50.72 5.03 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.95 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.544 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -71.38 -38.21 71.54 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.173 0.434 . . . . 1.0 112.173 -177.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -59.31 -47.25 86.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.027 -0.669 . . . . 1.0 111.527 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -64.43 -45.1 89.01 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.537 -0.465 . . . . 1.0 111.905 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.599 ' O ' HD13 ' A' ' 98' ' ' LEU . 45.9 mtmt -66.67 -42.68 86.17 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.237 -0.585 . . . . 1.0 111.407 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 91' ' ' LEU . 54.3 t -60.06 -45.66 95.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.398 -0.521 . . . . 1.0 111.367 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -66.59 -44.21 82.8 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.562 -0.455 . . . . 1.0 111.965 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.431 HD21 HD11 ' A' ' 163' ' ' LEU . 5.3 tp -67.07 -38.94 86.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.637 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 94' ' ' LYS . 8.2 mp -65.99 -42.16 90.14 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.353 -0.539 . . . . 1.0 110.626 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 95' ' ' VAL . 76.3 m-20 -68.65 -37.27 79.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.205 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -70.98 -41.22 71.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.831 -0.348 . . . . 1.0 111.564 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.576 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 15.9 ttm -70.03 -53.28 18.26 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.53 -0.468 . . . . 1.0 111.594 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.514 HG23 ' CE2' ' A' ' 107' ' ' PHE . 11.5 m -57.04 -38.83 73.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.056 0.455 . . . . 1.0 110.3 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.7 m -70.36 10.96 0.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.958 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 102' ' ' THR . 74.4 p -95.61 132.17 41.05 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.893 0.378 . . . . 1.0 110.385 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -60.38 -17.4 43.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.945 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.529 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 67.8 mttm -94.73 41.1 1.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.999 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.514 ' CE2' HG23 ' A' ' 102' ' ' THR . 64.6 t80 -134.91 118.63 17.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.035 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -140.1 129.6 24.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.12 -0.491 . . . . 1.0 109.717 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.6 m -100.43 93.48 5.66 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.735 0.303 . . . . 1.0 110.953 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -120.17 162.94 14.06 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 115' ' ' VAL . 21.5 p -78.73 163.41 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.925 -0.398 . . . . 1.0 109.925 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -63.35 -37.08 85.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.386 . . . . 1.0 110.54 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -68.08 -45.65 73.19 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.904 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -71.12 -17.26 62.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.59 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.492 HG13 ' SD ' ' A' ' 147' ' ' MET . 2.6 t -70.81 -45.4 73.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.88 -46.47 96.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.192 0.52 . . . . 1.0 110.036 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -66.05 -38.59 88.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.925 0.393 . . . . 1.0 110.663 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -65.77 -48.39 71.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.796 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.4 tp -69.19 -39.69 79.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.418 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -59.72 -43.72 94.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.353 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.02 -47.44 83.04 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.446 -0.501 . . . . 1.0 110.019 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -60.05 -44.91 94.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.972 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.1 p -62.47 -33.9 75.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.414 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -61.82 -42.44 99.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.96 -0.563 . . . . 1.0 110.243 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.32 -41.56 89.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.711 -0.396 . . . . 1.0 109.985 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.8 75.07 56.3 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 121.202 0.525 . . . . 1.0 110.128 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.526 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 42.0 Cg_endo -73.21 -14.87 25.72 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.402 2.068 . . . . 1.0 112.568 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -100.31 -13.19 18.93 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.797 0.295 . . . . 1.0 111.797 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -106.45 150.78 25.73 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.152 0.501 . . . . 1.0 110.429 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 m -80.66 162.06 24.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.629 -0.714 . . . . 1.0 109.659 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.3 p -152.74 144.96 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.538 -0.542 . . . . 1.0 109.538 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 25.3 p90 -151.3 144.19 24.5 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.848 -0.341 . . . . 1.0 111.124 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -151.45 169.75 21.26 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.344 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.529 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -137.9 153.69 49.51 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.082 -0.71 . . . . 1.0 109.082 179.107 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 98.9 p -151.21 169.66 21.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.9 0.381 . . . . 1.0 110.32 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.7 tp -79.49 141.54 36.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.524 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.509 ' ND2' ' CE1' ' A' ' 145' ' ' TYR . 6.6 t-20 -75.06 168.44 19.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.199 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -126.98 -30.11 2.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.356 -0.383 . . . . 1.0 110.66 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -90.53 -20.42 22.67 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.4 -0.364 . . . . 1.0 111.143 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 25.5 t-20 -138.64 76.33 35.84 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.396 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.06 130.76 41.39 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.062 1.841 . . . . 1.0 112.217 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 117.09 -26.34 8.34 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -107.28 147.92 29.63 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.576 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 75.2 m-85 -109.7 155.78 21.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.864 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.539 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 32.6 m-85 -125.77 137.46 53.8 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.048 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.9 mt -108.03 127.23 53.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.51 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.492 ' SD ' HG13 ' A' ' 115' ' ' VAL . 20.7 ptt? -118.6 144.3 46.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -162.5 153.49 17.46 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.374 -0.53 . . . . 1.0 109.707 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -133.99 129.23 35.88 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.26 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.436 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.8 mp -76.48 -47.25 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.424 0.527 . . . . 1.0 112.424 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 152' ' ' ALA . 17.0 t-20 -154.01 166.06 34.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.554 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.532 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -60.78 -27.57 68.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -85.53 -14.3 46.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.984 0.421 . . . . 1.0 110.318 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 12.8 t -81.18 160.76 24.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.335 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -92.29 163.46 13.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.138 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 57.2 tp -79.67 118.71 21.74 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.011 -0.366 . . . . 1.0 110.011 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.39 132.72 52.09 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.968 -0.56 . . . . 1.0 109.986 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 96.4 m -124.38 126.29 45.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.532 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -111.48 155.7 22.82 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.241 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.539 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 82.5 m-20 -104.9 144.16 32.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.591 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.2 t -123.89 136.16 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 109.535 -0.543 . . . . 1.0 109.535 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -95.57 135.26 37.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.627 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.431 HD11 HD21 ' A' ' 97' ' ' LEU . 28.7 tp -99.38 130.14 45.63 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 71.5 p -128.57 159.9 34.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.244 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -76.91 17.46 0.43 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.633 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 60.5 p -123.11 -2.29 8.65 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.669 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 143.12 -132.88 5.22 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.353 -1.099 . . . . 1.0 110.353 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -123.49 134.37 53.9 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 110.167 -0.309 . . . . 1.0 110.167 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.525 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 7.5 m-85 -111.62 122.87 48.96 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 tt -117.84 121.78 41.66 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.492 -0.559 . . . . 1.0 109.492 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.2 t 37.88 51.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.153 0.427 . . . . 1.0 112.153 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.4 m120 68.43 27.52 6.34 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.413 0.894 . . . . 1.0 113.413 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -135.65 123.09 21.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.525 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 19.5 t-20 -92.0 129.5 37.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.566 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -103.71 133.39 20.3 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.86 -20.7 22.12 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.053 1.836 . . . . 1.0 113.594 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.426 ' OG ' ' OE1' ' A' ' 180' ' ' GLN . 14.3 p -153.95 158.37 40.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.961 0.41 . . . . 1.0 111.095 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.31 -36.22 76.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.012 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.6 mm -60.54 -48.49 88.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.811 0.339 . . . . 1.0 110.243 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.426 ' OE1' ' OG ' ' A' ' 177' ' ' SER . 9.0 mp0 -65.96 -33.33 75.57 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.18 -41.9 97.62 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 110.025 -0.361 . . . . 1.0 110.025 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 81.6 m -62.3 -46.23 89.69 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 120.57 -0.452 . . . . 1.0 110.116 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 186' ' ' LYS . 65.9 m-20 -65.07 -49.02 71.68 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.89 -46.07 0.86 Allowed Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.841 -1.304 . . . . 1.0 109.841 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -67.77 -47.17 69.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 183' ' ' ASN . 64.7 tttm -56.72 -40.46 75.72 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.764 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 25.7 m -61.16 -45.11 96.0 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.55 -40.86 98.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.859 -0.609 . . . . 1.0 110.1 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.0 tp -57.81 -41.23 81.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.406 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -64.03 -45.13 90.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.112 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.7 p -62.95 -39.4 94.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.973 0.416 . . . . 1.0 110.637 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 61.2 mt -63.81 -43.5 96.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.606 -0.724 . . . . 1.0 111.965 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -71.15 -30.1 66.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.845 0.313 . . . . 1.0 111.845 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.991 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.866 0.365 . . . . 1.0 110.583 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.805 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 7.2 p -60.41 -47.63 91.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.566 0 CA-C-O 121.756 0.789 . . . . 1.0 110.089 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.554 ' N ' HG13 ' A' ' 4' ' ' VAL . 35.9 pt -59.94 12.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 O-C-N 121.255 -0.903 . . . . 1.0 111.011 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.673 ' H ' ' C ' ' A' ' 4' ' ' VAL . 54.9 t-20 -161.53 32.7 0.13 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.288 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.805 ' ND1' ' O ' ' A' ' 4' ' ' VAL . 3.8 p-80 -75.74 154.35 85.27 Favored Pre-proline 0 N--CA 1.468 0.426 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.02 -28.43 19.01 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.097 1.865 . . . . 1.0 112.7 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -79.94 -9.05 59.64 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.282 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -73.56 134.87 43.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.248 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -150.5 117.17 3.42 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 120.983 -0.287 . . . . 1.0 110.264 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.83 111.59 3.36 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.742 1.628 . . . . 1.0 112.829 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -156.68 155.63 32.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.275 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -78.8 -172.44 3.02 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.49 -48.36 18.5 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.543 -1.023 . . . . 1.0 110.543 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -64.41 -44.14 92.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.76 0.314 . . . . 1.0 110.734 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.17 -35.19 79.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.985 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.07 97.63 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.656 -0.417 . . . . 1.0 110.395 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.57 -43.97 83.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.008 -0.367 . . . . 1.0 110.008 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.06 -43.94 97.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.288 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.503 ' OH ' ' NZ ' ' A' ' 25' ' ' LYS . 94.1 t80 -61.63 -45.39 94.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.875 0.369 . . . . 1.0 110.288 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -72.4 -14.37 61.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.153 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -67.34 -41.84 84.52 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.621 -0.431 . . . . 1.0 110.799 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.6 m -76.37 -23.88 54.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.188 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.503 ' NZ ' ' OH ' ' A' ' 21' ' ' TYR . 32.7 mttp -81.9 176.78 9.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.151 0.5 . . . . 1.0 110.661 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -84.03 161.63 20.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.769 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -76.07 146.31 39.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.033 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.5 12.67 47.21 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.537 ' HB3' HD11 ' A' ' 22' ' ' LEU . 54.5 tp10 -106.54 148.05 28.7 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -127.81 172.49 10.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.473 0.654 . . . . 1.0 111.413 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.57 153.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 114.975 -1.011 . . . . 1.0 111.477 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.484 ' HB ' ' HE2' ' A' ' 7' ' ' HIS . 97.5 mt -116.84 118.48 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.93 151.01 30.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.198 -179.128 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.403 ' NE2' ' O ' ' A' ' 34' ' ' GLN . 3.0 pp0? -98.32 148.1 24.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.422 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 t -69.05 161.38 29.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.82 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.9 p -65.56 -21.83 66.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.833 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -129.53 25.18 5.42 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.413 -0.358 . . . . 1.0 111.167 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . -75.59 -62.32 2.72 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.618 -0.993 . . . . 1.0 110.618 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.3 t0 64.75 -50.62 0.32 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.728 0.299 . . . . 1.0 111.334 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 38' ' ' GLY . 99.5 m-20 -120.66 20.65 11.71 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.977 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.567 ' C ' HD12 ' A' ' 42' ' ' LEU . 79.5 m-70 -147.86 147.73 30.1 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.567 HD12 ' C ' ' A' ' 41' ' ' HIS . 11.2 mp -119.14 151.13 38.85 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.711 -0.478 . . . . 1.0 109.711 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 33' ' ' ARG . 76.4 t -126.96 135.06 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.331 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.644 HD12 HD11 ' A' ' 58' ' ' ILE . 62.8 mt -111.64 137.47 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.076 -0.712 . . . . 1.0 109.076 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.1 m -117.49 135.56 53.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.928 -0.578 . . . . 1.0 109.523 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.575 ' CZ2' HD11 ' A' ' 48' ' ' LEU . 1.5 p-90 -151.99 155.58 38.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.794 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -95.44 141.13 29.35 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.35 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.575 HD11 ' CZ2' ' A' ' 46' ' ' TRP . 9.3 mp -94.82 -35.09 12.23 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.131 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 36.2 t0 -162.89 -138.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.191 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.524 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 70.5 mmtt -53.76 -104.05 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.055 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.476 ' O ' ' CE2' ' A' ' 53' ' ' PHE . 32.3 t70 -85.65 20.91 1.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.232 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.713 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.7 mm? -88.35 131.49 34.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.874 0.369 . . . . 1.0 110.612 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.476 ' CE2' ' O ' ' A' ' 51' ' ' ASP . 25.4 m-85 -136.46 143.82 44.06 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.332 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -146.54 152.67 39.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.024 -0.534 . . . . 1.0 109.677 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -126.88 139.79 52.82 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.207 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.1 mm -115.29 117.61 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -90.53 119.39 30.75 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.904 0.383 . . . . 1.0 110.773 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.644 HD11 HD12 ' A' ' 44' ' ' ILE . 81.5 mt -100.19 131.29 47.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.269 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -118.06 126.52 52.44 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 40' ' ' ASP . 9.6 mp0 -99.68 147.69 25.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.126 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.435 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.8 tt -141.55 170.85 14.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.46 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.435 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 61.8 tt0 72.51 52.24 0.17 Allowed 'General case' 0 C--N 1.334 -0.099 0 O-C-N 123.625 0.578 . . . . 1.0 109.769 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -117.29 84.81 2.22 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.652 -0.703 . . . . 1.0 109.841 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -65.94 -36.76 84.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.056 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -107.66 118.5 53.02 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.051 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -50.11 -30.18 24.4 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.081 1.854 . . . . 1.0 112.105 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 tp -79.51 -11.79 59.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.043 0.449 . . . . 1.0 110.828 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.15 140.57 35.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.188 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.1 mt -81.49 151.15 27.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.498 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.38 122.79 30.97 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.499 -1.041 . . . . 1.0 110.499 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -72.01 -13.01 61.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.87 0.367 . . . . 1.0 110.797 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.1 t -118.12 120.44 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.604 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.2 mt -114.37 126.8 55.41 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.141 -0.688 . . . . 1.0 109.141 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.3 mm -100.18 121.33 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.07 0.462 . . . . 1.0 110.48 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.557 HG21 HD13 ' A' ' 86' ' ' ILE . 5.2 t -138.17 131.28 40.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.283 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 51.8 t0 53.26 47.83 23.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.039 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER 55.52 21.45 4.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.077 179.277 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -128.0 144.23 51.1 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.281 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -88.57 135.01 33.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.957 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -123.74 138.2 54.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.293 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -81.71 -37.97 26.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.692 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -132.7 157.57 44.55 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.225 0.536 . . . . 1.0 111.781 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.2 tp -65.17 -39.27 92.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.501 -0.772 . . . . 1.0 111.215 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.49 -40.91 88.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.734 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -62.2 -38.38 88.89 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 121.004 -0.279 . . . . 1.0 110.757 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.557 HD13 HG21 ' A' ' 75' ' ' VAL . 89.0 mt -62.23 -45.8 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.048 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.5 mt -61.39 -47.27 94.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.483 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.09 -42.38 67.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 112.569 0.581 . . . . 1.0 112.569 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.22 -18.39 60.14 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.748 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -91.89 -50.06 5.92 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.533 -0.467 . . . . 1.0 111.413 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 95' ' ' VAL . 8.0 mp -67.0 -42.21 85.39 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 112.296 0.48 . . . . 1.0 112.296 -178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -63.34 -49.83 72.37 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.739 -0.784 . . . . 1.0 111.64 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -68.69 -43.51 75.92 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.516 -0.474 . . . . 1.0 111.546 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -65.92 -43.88 86.78 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.048 -0.661 . . . . 1.0 111.313 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 91' ' ' LEU . 55.6 t -65.65 -45.45 92.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.237 -0.585 . . . . 1.0 111.203 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -68.24 -46.08 71.45 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.715 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.82 -41.61 87.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.467 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.96 -42.17 94.83 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.314 -0.554 . . . . 1.0 110.134 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -67.74 -38.61 83.73 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.035 -0.529 . . . . 1.0 111.196 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -70.59 -42.46 71.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.877 -0.329 . . . . 1.0 111.78 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.601 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 4.1 ttt -67.24 -55.03 15.71 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.465 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.1 m -59.04 -41.95 89.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.983 0.42 . . . . 1.0 110.669 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.6 p -72.45 8.78 1.25 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.991 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.6 t -88.53 138.49 31.38 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.722 0.296 . . . . 1.0 110.234 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -61.88 -18.24 59.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.869 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.555 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 59.8 mttp -89.34 39.05 0.93 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.023 -0.535 . . . . 1.0 109.694 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -130.99 111.75 12.32 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.357 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -131.34 114.63 15.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.057 -0.519 . . . . 1.0 109.828 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.7 m -88.76 78.97 7.55 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.046 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -105.46 152.87 17.24 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.582 ' O ' HG23 ' A' ' 115' ' ' VAL . 62.1 p -72.56 171.51 12.27 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -57.51 -40.72 79.36 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.575 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -68.08 -42.59 80.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.019 0.438 . . . . 1.0 110.505 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -70.18 -21.86 63.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.117 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 111' ' ' THR . 32.4 t -69.43 -44.33 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.085 -0.339 . . . . 1.0 110.085 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.7 t -65.44 -45.46 92.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.099 0.476 . . . . 1.0 110.342 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -65.91 -34.12 77.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.984 0.421 . . . . 1.0 110.842 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -67.44 -50.23 60.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.628 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.4 tp -70.18 -39.08 76.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.046 0.451 . . . . 1.0 110.312 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.0 -42.43 97.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.624 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -61.3 -46.85 88.6 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.264 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.537 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 34.4 t80 -61.65 -43.08 99.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.107 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.2 p -61.89 -36.64 81.89 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.424 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -62.3 -39.04 91.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.313 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.38 -43.06 84.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.455 -0.498 . . . . 1.0 109.834 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.537 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -128.44 73.88 80.16 Favored Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.227 179.317 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.69 -16.54 26.66 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.475 2.117 . . . . 1.0 112.443 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -89.76 -5.55 56.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.678 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -127.07 149.93 49.7 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.004 0.431 . . . . 1.0 110.432 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.9 p -80.18 162.63 24.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.561 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 p -151.5 145.41 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -140.06 145.48 37.75 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.852 0.358 . . . . 1.0 111.25 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -151.37 171.3 17.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.221 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -137.25 156.91 47.72 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.268 -0.641 . . . . 1.0 109.268 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 29.3 p -155.07 168.7 26.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.371 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.0 tp -79.76 138.49 37.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.51 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 32.7 p-10 -97.5 141.47 30.52 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.238 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -95.01 -16.98 22.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.583 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 18.0 p30 -69.93 -27.01 64.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.274 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 139' ' ' ASP . 22.7 m120 -159.2 92.26 1.89 Allowed Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 109.954 -0.387 . . . . 1.0 109.954 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.01 142.7 94.04 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.013 1.808 . . . . 1.0 112.404 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.53 -25.38 27.0 Favored Glycine 0 N--CA 1.464 0.542 0 N-CA-C 110.779 -0.928 . . . . 1.0 110.779 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -99.47 144.87 28.08 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 120.897 0.38 . . . . 1.0 110.09 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.601 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 70.9 m-85 -109.7 146.47 34.81 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.792 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.523 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 12.0 m-85 -119.28 132.01 55.84 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.036 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.429 HD12 ' CG2' ' A' ' 161' ' ' VAL . 11.5 mt -106.78 128.56 54.34 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.442 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.582 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -126.36 148.17 49.63 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 178.6 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -158.44 155.34 28.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.28 -0.568 . . . . 1.0 109.57 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.524 ' NZ ' ' O ' ' A' ' 154' ' ' SER . 4.1 tttm -134.15 130.41 37.28 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.851 0.357 . . . . 1.0 110.552 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.543 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 23.5 mm -75.76 -48.65 28.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.816 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 150' ' ' ILE . 29.2 m120 -155.51 169.11 25.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.629 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.11 -28.38 66.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.787 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -91.68 4.78 51.92 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.06 0.457 . . . . 1.0 110.417 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.524 ' O ' ' NZ ' ' A' ' 149' ' ' LYS . 12.4 t -90.89 165.85 13.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.316 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -99.09 148.97 23.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.47 . . . . 1.0 109.789 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 44.5 tp -72.28 118.44 15.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.901 0.381 . . . . 1.0 110.285 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -109.07 131.39 55.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.077 -0.51 . . . . 1.0 109.644 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 92.5 m -128.76 130.6 47.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.926 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -116.77 168.33 10.3 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.107 -0.497 . . . . 1.0 109.914 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.523 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 83.9 m-20 -111.7 148.34 33.64 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.648 -0.706 . . . . 1.0 110.84 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.429 ' CG2' HD12 ' A' ' 146' ' ' LEU . 74.5 t -128.36 138.18 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -103.59 128.84 50.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.196 0.522 . . . . 1.0 110.877 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.2 tp -89.16 129.23 35.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.545 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 80.8 p -129.17 174.62 9.41 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.38 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -86.43 14.13 7.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.693 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.593 ' O ' HG22 ' A' ' 166' ' ' THR . 26.9 m -121.91 -2.58 9.23 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.446 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 138.1 -141.66 12.36 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.112 -1.195 . . . . 1.0 110.112 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -109.58 126.51 53.68 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.452 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 4.6 m-85 -104.76 116.48 32.09 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.9 tt -113.08 115.42 28.3 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.4 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 4.4 t 37.89 62.3 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 112.084 0.402 . . . . 1.0 112.084 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.4 m120 63.43 27.9 15.32 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.165 0.802 . . . . 1.0 113.165 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 62.8 m-85 -133.87 122.49 23.27 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.452 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 7.1 t-20 -100.05 120.56 40.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.688 0.28 . . . . 1.0 111.529 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -98.66 136.96 20.58 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.44 -23.11 24.05 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.185 1.923 . . . . 1.0 113.396 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 5.1 t -154.17 158.45 40.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.104 0.478 . . . . 1.0 110.923 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.9 p -59.74 -34.42 55.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.816 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.0 -44.83 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.368 . . . . 1.0 110.246 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -69.08 -31.25 69.86 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 43.8 tp -62.67 -42.18 99.48 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.102 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 75.0 m -63.21 -45.9 89.51 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 120.634 -0.426 . . . . 1.0 110.209 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 186' ' ' LYS . 38.8 m-80 -63.28 -46.47 86.65 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 108.512 -0.921 . . . . 1.0 108.512 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.54 -46.55 0.8 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.818 -1.313 . . . . 1.0 109.818 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.89 -43.9 74.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.11 -0.545 . . . . 1.0 109.935 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.0 tttm -56.92 -43.8 81.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.401 -0.818 . . . . 1.0 110.016 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 13.7 m -61.64 -45.48 93.87 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.83 -43.55 98.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.061 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.9 tp -57.85 -45.4 86.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.855 0.359 . . . . 1.0 110.493 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.406 ' CE ' ' NZ ' ' A' ' 186' ' ' LYS . 46.9 mttm -61.96 -45.02 95.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.397 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.4 m -62.1 -41.78 98.56 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.985 0.421 . . . . 1.0 110.608 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 69.5 mt -63.98 -42.96 97.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.49 -0.777 . . . . 1.0 111.831 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -67.11 -30.71 70.8 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.885 0.328 . . . . 1.0 111.885 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' HIS . . . . . 0.414 ' O ' ' ND1' ' A' ' 194' ' ' HIS . 13.0 t-80 . . . . . 0 C--N 1.326 -0.419 0 C-N-CA 120.874 -0.33 . . . . 1.0 110.696 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.429 ' O ' ' CE1' ' A' ' 7' ' ' HIS . 18.7 mmm180 . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 120.963 0.411 . . . . 1.0 110.353 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.27 -30.62 49.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.425 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.1 pt -69.72 -19.22 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.427 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -91.28 3.28 55.26 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.697 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.429 ' CE1' ' O ' ' A' ' 3' ' ' ARG . 0.6 OUTLIER -88.91 143.67 31.81 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.072 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.7 -15.14 40.63 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.262 1.975 . . . . 1.0 112.132 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.529 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 54.2 m-85 -92.02 8.05 39.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.12 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -104.18 125.72 50.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 1.0 110.291 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -157.73 117.69 1.94 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 109.43 -0.581 . . . . 1.0 109.43 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.9 129.5 34.85 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 121.227 1.285 . . . . 1.0 112.626 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -157.99 149.13 21.14 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.091 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 16' ' ' ARG . 13.8 t-20 -77.91 164.44 25.13 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.22 -49.79 74.75 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.462 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 23.3 mmt85 -65.7 -39.52 91.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.696 0.284 . . . . 1.0 110.797 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.5 ' N ' ' CD ' ' A' ' 17' ' ' GLN . 1.1 mp0 -66.07 -35.4 80.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.069 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.09 -46.02 92.35 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.268 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -60.81 -45.15 95.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.933 -0.395 . . . . 1.0 109.933 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.04 -42.63 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.104 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.484 ' CZ ' ' NZ ' ' A' ' 25' ' ' LYS . 66.4 t80 -62.87 -42.27 99.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.403 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 18' ' ' ALA . 8.5 mp -74.27 -15.31 60.98 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.843 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -61.87 -42.57 99.22 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.393 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.1 p -77.48 -21.04 53.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.784 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.484 ' NZ ' ' CZ ' ' A' ' 21' ' ' TYR . 44.4 mmtm -79.64 176.05 10.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.51 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -100.43 171.58 7.66 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.667 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -61.73 143.58 55.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.822 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.35 10.3 59.55 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.057 -0.817 . . . . 1.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -86.88 137.43 32.4 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -135.52 161.83 34.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.266 0.555 . . . . 1.0 110.836 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.706 ' O ' HG23 ' A' ' 44' ' ' ILE . 11.0 m -147.49 157.28 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.274 -0.875 . . . . 1.0 111.316 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 84.1 mt -118.43 128.41 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.481 ' CZ ' ' OG1' ' A' ' 45' ' ' THR . 23.8 ptt180 -147.34 154.78 41.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.32 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -104.7 144.78 31.26 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.3 t -89.32 136.0 33.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.591 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.2 t -60.62 -40.6 92.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.566 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -79.32 -11.41 59.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.577 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.94 -68.48 1.45 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.542 -1.023 . . . . 1.0 110.542 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 t0 74.85 -39.88 0.42 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.604 0.24 . . . . 1.0 110.942 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -113.58 -11.27 13.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.838 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.613 ' C ' HD12 ' A' ' 42' ' ' LEU . 6.6 m-70 -117.71 151.14 37.86 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.344 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.613 HD12 ' C ' ' A' ' 41' ' ' HIS . 11.2 mp -117.39 153.83 32.37 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.1 t -127.7 134.91 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.343 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 31' ' ' VAL . 69.0 mt -114.24 138.35 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 108.768 -0.827 . . . . 1.0 108.768 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.481 ' OG1' ' CZ ' ' A' ' 33' ' ' ARG . 26.4 m -117.61 138.26 52.07 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.136 0.493 . . . . 1.0 109.805 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.555 ' CZ2' HD11 ' A' ' 48' ' ' LEU . 5.2 p-90 -148.93 156.54 42.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.457 -0.792 . . . . 1.0 111.163 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.453 ' C ' HD12 ' A' ' 48' ' ' LEU . 37.5 ttpt -100.78 140.2 35.41 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.034 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.6 mp -96.53 -68.19 0.81 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.217 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -152.98 147.88 26.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.276 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt 46.73 -127.81 1.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.858 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 16.3 p-10 -93.61 25.99 3.26 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.696 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.619 HD13 ' N ' ' A' ' 53' ' ' PHE . 0.3 OUTLIER -92.69 119.65 32.3 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 -179.634 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.619 ' N ' HD13 ' A' ' 52' ' ' LEU . 94.8 m-85 -123.52 148.38 46.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.3 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -142.3 153.47 43.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.83 -0.623 . . . . 1.0 109.966 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -128.39 142.44 51.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.439 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.3 mt -120.55 125.35 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.001 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -95.29 120.75 36.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.912 0.386 . . . . 1.0 110.378 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.406 HD11 ' CD1' ' A' ' 44' ' ' ILE . 96.2 mt -98.69 132.13 44.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.431 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -114.68 140.88 48.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 1.0 109.696 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -99.39 157.55 16.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.456 . . . . 1.0 109.862 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.494 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.9 tp -141.77 171.71 13.69 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.485 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.494 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 79.1 mm-40 59.06 28.87 18.27 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.284 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -94.26 48.76 1.25 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.049 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.19 -39.17 86.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.291 -0.868 . . . . 1.0 111.411 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 68' ' ' ALA . 8.9 p30 -113.43 114.44 47.8 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.482 -0.327 . . . . 1.0 110.332 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.06 -13.31 0.92 Allowed 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.854 1.702 . . . . 1.0 112.167 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.6 mt -80.73 -7.56 59.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.433 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.435 ' N ' ' OD1' ' A' ' 65' ' ' ASN . . . -118.66 131.89 56.17 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.974 0.416 . . . . 1.0 110.18 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 71' ' ' LYS . 54.1 mt -76.43 156.46 33.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.288 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -43.62 91.84 0.01 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.594 -1.002 . . . . 1.0 110.594 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 69' ' ' LEU . 7.0 ttpm? -63.52 -31.07 72.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.974 0.416 . . . . 1.0 110.706 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.2 t -128.92 125.21 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.945 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.9 mt -115.77 130.13 56.73 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.89 -0.596 . . . . 1.0 109.424 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.6 mt -100.4 121.67 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 120.869 0.366 . . . . 1.0 110.535 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -141.84 133.11 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.452 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' A' ' 77' ' ' ASN . 90.2 m-20 52.7 47.64 24.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.968 -0.293 . . . . 1.0 111.211 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.2 OUTLIER 56.32 15.79 2.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.123 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -124.76 142.32 51.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.367 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -93.14 131.58 38.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.008 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.444 ' HB2' HD11 ' A' ' 86' ' ' ILE . 96.8 m-85 -127.07 138.31 53.18 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.199 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -84.42 -37.05 21.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.496 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -117.46 142.14 47.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.887 0.375 . . . . 1.0 111.95 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.97 -40.69 95.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.882 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.61 -41.74 91.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.796 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -59.15 -38.87 80.74 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.637 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.444 HD11 ' HB2' ' A' ' 80' ' ' TYR . 97.6 mt -62.43 -45.11 99.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.678 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.83 -44.67 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.59 -0.444 . . . . 1.0 111.112 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 61.8 t -68.14 -42.32 84.84 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-N 115.92 -0.582 . . . . 1.0 112.282 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -80.37 -13.16 59.39 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.322 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.516 ' OH ' ' CZ2' ' A' ' 46' ' ' TRP . 77.4 t80 -94.39 -50.21 5.34 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.661 -0.416 . . . . 1.0 111.992 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -66.34 -43.25 86.59 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.539 -0.464 . . . . 1.0 112.197 -177.576 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 13.4 pt20 -64.01 -47.17 81.31 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.943 -0.703 . . . . 1.0 111.668 -178.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 165' ' ' ASN . 53.9 t-20 -69.19 -43.34 74.38 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.544 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -65.93 -42.53 89.97 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.146 -0.621 . . . . 1.0 111.363 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.524 ' O ' ' ND2' ' A' ' 99' ' ' ASN . 56.1 t -63.64 -47.13 92.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.01 -0.676 . . . . 1.0 111.336 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -68.98 -41.28 78.09 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.567 -0.453 . . . . 1.0 111.512 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.524 HD11 ' CZ ' ' A' ' 168' ' ' TYR . 12.3 tp -66.3 -44.37 83.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.806 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 mp -65.37 -43.16 91.67 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.306 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 95' ' ' VAL . 2.7 m-80 -67.17 -37.12 83.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.987 -0.552 . . . . 1.0 111.192 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -71.28 -42.79 68.27 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 121.033 -0.267 . . . . 1.0 111.683 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 tpt -67.63 -54.0 23.32 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.397 -0.521 . . . . 1.0 111.329 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.9 m -58.6 -42.6 88.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.046 0.451 . . . . 1.0 110.335 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.4 t -73.72 8.18 2.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.881 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.8 t -86.24 141.4 29.32 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.64 0.257 . . . . 1.0 110.498 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -65.35 -20.57 66.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.9 0.381 . . . . 1.0 110.773 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.564 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 70.0 mmtt -88.92 38.87 0.9 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.831 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -131.48 111.92 12.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.754 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -118.61 109.66 16.41 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.411 -0.589 . . . . 1.0 109.411 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.2 t -87.56 70.39 9.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.565 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.51 160.85 12.97 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 110.714 -0.954 . . . . 1.0 110.714 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.508 HG22 ' N ' ' A' ' 112' ' ' LYS . 28.5 m -70.36 164.17 25.07 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.508 ' N ' HG22 ' A' ' 111' ' ' THR . 63.5 mttp -54.67 -36.13 64.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.743 0.306 . . . . 1.0 110.493 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -66.52 -42.23 87.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.952 0.406 . . . . 1.0 110.553 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -70.29 -21.15 62.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.993 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.75 -45.44 81.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.242 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.46 -44.7 94.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.147 0.499 . . . . 1.0 110.433 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -65.89 -33.63 76.27 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.962 0.41 . . . . 1.0 110.644 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -68.42 -50.07 55.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.535 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.457 HD11 HG13 ' A' ' 131' ' ' VAL . 9.6 tp -69.92 -39.55 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.415 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -64.72 -40.45 95.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.645 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -59.56 -47.56 85.06 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.365 -0.534 . . . . 1.0 110.151 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -61.48 -40.3 94.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.046 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.5 t -62.39 -42.7 99.63 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.534 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -61.6 -40.04 93.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.68 -42.37 86.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.688 -0.405 . . . . 1.0 109.938 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.65 75.23 74.97 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.174 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.09 -14.08 31.68 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.237 1.958 . . . . 1.0 112.496 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -102.79 11.14 37.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.533 -0.303 . . . . 1.0 111.532 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -132.81 147.57 52.31 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.925 0.393 . . . . 1.0 110.497 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.42 ' HB3' HD12 ' A' ' 150' ' ' ILE . 16.8 p -81.18 162.21 23.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.747 -0.661 . . . . 1.0 109.856 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 119' ' ' ILE . 3.8 p -153.59 146.21 14.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.501 ' O ' ' CD1' ' A' ' 133' ' ' TYR . 10.3 p90 -144.94 142.67 30.04 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.907 0.384 . . . . 1.0 111.312 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 26.0 m-85 -152.75 167.64 28.33 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.555 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.564 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 4.1 p90 -135.64 151.8 50.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.423 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.1 p -154.17 170.51 21.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.518 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 tt -84.79 134.36 34.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.679 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 138' ' ' HIS . 69.3 m-80 -159.51 166.78 30.14 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.918 -0.401 . . . . 1.0 109.918 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.46 ' O ' ' OD1' ' A' ' 139' ' ' ASP . 3.9 t60 76.21 -158.48 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.462 -0.336 . . . . 1.0 110.733 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 138' ' ' HIS . 92.8 m-20 -142.67 64.07 1.38 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.592 ' O ' ' N ' ' A' ' 142' ' ' GLY . 2.7 m120 -129.33 156.01 79.11 Favored Pre-proline 0 CA--C 1.53 0.176 0 N-CA-C 108.897 -0.779 . . . . 1.0 108.897 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -42.81 78.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.753 2.302 . . . . 1.0 113.046 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 140' ' ' ASN . . . 52.07 64.35 4.05 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.247 -0.741 . . . . 1.0 111.247 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -94.94 152.5 18.29 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.674 -0.491 . . . . 1.0 109.674 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -121.05 153.15 37.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.798 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -127.16 127.97 45.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.872 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.1 mt -95.47 123.02 38.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.003 0.43 . . . . 1.0 110.982 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.64 145.61 46.3 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.127 -1.064 . . . . 1.0 108.127 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -159.79 157.59 29.57 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.299 -0.56 . . . . 1.0 109.944 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.554 ' NZ ' ' O ' ' A' ' 151' ' ' ASN . 36.6 tttm -142.87 126.28 16.69 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 120.668 -0.413 . . . . 1.0 110.056 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 151' ' ' ASN . 4.7 tp -78.84 -45.64 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.802 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.561 ' N ' HG23 ' A' ' 150' ' ' ILE . 29.4 m120 -144.86 157.98 43.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.842 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.03 -26.5 68.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.875 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -83.25 -16.43 46.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.177 0.513 . . . . 1.0 110.199 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.1 t -77.94 170.51 16.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.153 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -97.31 155.03 17.06 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.367 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.22 120.03 18.27 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.26 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -106.04 127.17 52.99 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.107 -0.497 . . . . 1.0 109.839 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 95.9 m -128.62 130.87 47.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.994 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -118.88 170.1 9.3 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.863 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -111.83 147.39 35.84 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.8 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.1 t -128.21 135.62 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.504 ' NZ ' ' CG2' ' A' ' 164' ' ' THR . 17.1 ttpp -101.56 130.72 47.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.869 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.2 tp -88.91 130.69 35.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.686 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.504 ' CG2' ' NZ ' ' A' ' 162' ' ' LYS . 66.2 p -129.28 171.46 12.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.582 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.533 ' O ' ' ND2' ' A' ' 93' ' ' ASN . 14.4 p30 -83.84 13.97 4.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.67 -0.696 . . . . 1.0 110.472 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 25.1 p -121.76 -2.22 9.35 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.606 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 139.4 -126.37 3.3 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.303 -1.119 . . . . 1.0 110.303 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.524 ' CZ ' HD11 ' A' ' 97' ' ' LEU . 28.6 m-85 -127.41 127.31 43.93 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.652 0.263 . . . . 1.0 110.635 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.514 ' CE1' ' OD1' ' A' ' 174' ' ' ASN . 4.3 m-85 -100.87 124.47 46.58 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.8 tt -116.83 111.16 19.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.572 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 170' ' ' LEU . 4.7 t 35.49 63.44 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 67.29 26.28 8.6 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -132.87 121.45 22.92 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.514 ' OD1' ' CE1' ' A' ' 169' ' ' PHE . 63.7 t30 -98.24 120.65 39.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.944 0.402 . . . . 1.0 111.635 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -105.13 125.61 33.15 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.2 -20.6 18.72 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.33 2.02 . . . . 1.0 113.504 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.2 m -137.2 141.39 42.13 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.982 0.42 . . . . 1.0 111.07 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.08 -34.67 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.575 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.08 -44.31 98.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.635 -0.426 . . . . 1.0 109.934 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -68.86 -30.26 68.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.1 tp -63.53 -43.24 97.72 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.205 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 7.7 p -62.87 -47.43 83.37 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.52 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.583 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 42.8 m-80 -65.01 -48.03 75.38 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.944 -0.761 . . . . 1.0 108.944 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.84 -44.85 1.0 Allowed Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.818 -1.313 . . . . 1.0 109.818 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -69.13 -47.05 66.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.9 tttm -56.12 -41.23 74.97 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.327 -0.851 . . . . 1.0 110.039 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 94.0 m -61.39 -45.04 96.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 51.7 mt -62.86 -41.08 99.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.001 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.535 HD11 HD13 ' A' ' 150' ' ' ILE . 57.6 tp -59.43 -44.16 92.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.323 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.42 -45.09 95.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.243 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 37.0 t -64.09 -38.87 92.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.804 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.2 mt -63.17 -41.95 99.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.61 -0.723 . . . . 1.0 111.608 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -59.96 -23.53 63.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.609 0.243 . . . . 1.0 111.555 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 194' ' ' HIS . 47.7 t-80 . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.785 0.326 . . . . 1.0 110.906 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 . . . . . 0 N--CA 1.464 0.231 0 CA-C-O 120.806 0.336 . . . . 1.0 110.53 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.36 -37.03 79.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.676 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.3 pt -62.34 -26.45 40.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.363 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -74.9 -13.28 60.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.477 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -79.21 115.67 54.53 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.284 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.458 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 76.6 Cg_exo -48.38 -24.9 6.64 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.869 1.712 . . . . 1.0 112.305 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -81.73 3.95 23.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.184 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 91.9 t80 -85.95 132.8 34.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.594 -0.275 . . . . 1.0 110.436 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 62.1 m-85 -150.77 123.58 4.18 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 120.995 -0.282 . . . . 1.0 110.476 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.474 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 73.7 Cg_endo -73.83 110.21 3.03 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.935 1.757 . . . . 1.0 112.631 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.474 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 74.1 m-85 -159.82 154.64 24.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.338 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -80.86 166.29 21.06 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.632 ' N ' ' NH1' ' A' ' 33' ' ' ARG . . . -57.03 -46.89 90.99 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.756 -0.938 . . . . 1.0 110.756 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -65.51 -39.01 91.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.59 0.233 . . . . 1.0 110.736 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -66.14 -37.14 84.96 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.696 -0.229 . . . . 1.0 111.205 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.415 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.15 -45.22 95.54 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.659 -0.417 . . . . 1.0 110.31 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -61.43 -46.5 89.86 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.669 -0.412 . . . . 1.0 109.948 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -62.28 -43.36 98.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.315 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -63.08 -44.48 95.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.56 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 18' ' ' ALA . 8.8 mp -75.02 -13.6 60.52 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.647 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -60.97 -41.92 97.31 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.39 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.9 t -74.93 -18.54 60.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.503 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -85.46 -175.66 5.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.788 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.46 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 45.4 mp0 -99.72 -179.25 4.13 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.472 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -81.41 145.56 30.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.634 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.39 8.0 53.46 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.143 -0.783 . . . . 1.0 111.143 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -95.77 139.63 31.72 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.387 -0.598 . . . . 1.0 109.387 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -131.05 167.96 18.2 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.284 0.564 . . . . 1.0 111.133 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -148.81 159.54 6.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.19 -0.913 . . . . 1.0 111.414 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.56 127.11 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.338 -0.616 . . . . 1.0 109.338 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.632 ' NH1' ' N ' ' A' ' 15' ' ' GLY . 44.4 ttp180 -134.39 153.58 51.82 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.152 -0.476 . . . . 1.0 109.752 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.419 ' N ' ' HG2' ' A' ' 33' ' ' ARG . 51.7 mt-30 -105.83 131.23 53.42 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.673 -0.492 . . . . 1.0 109.673 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -77.56 124.3 27.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.867 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.8 p -63.76 -38.82 92.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.625 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -79.11 -25.09 43.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.797 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -69.99 -53.85 13.58 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.54 -1.024 . . . . 1.0 110.54 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t0 70.7 -42.45 0.53 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.725 0.298 . . . . 1.0 111.034 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 38' ' ' GLY . 98.2 m-20 -119.45 19.92 12.58 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.65 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -140.27 150.71 44.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.669 0.271 . . . . 1.0 110.475 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.03 151.36 39.11 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.844 -0.428 . . . . 1.0 109.844 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.1 t -126.19 133.81 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.587 0.232 . . . . 1.0 110.727 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.531 HD12 HD11 ' A' ' 58' ' ' ILE . 92.3 mt -110.55 136.31 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.9 m -117.63 139.31 51.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.006 -0.543 . . . . 1.0 109.635 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.562 ' CE2' ' OH ' ' A' ' 90' ' ' TYR . 3.7 p-90 -143.3 153.1 42.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.776 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' A' ' 49' ' ' ASP . 64.7 tttp -101.4 133.3 46.22 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.829 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -96.07 -75.51 0.53 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.503 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.511 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 72.4 m-20 -109.99 -167.81 1.24 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.872 -0.603 . . . . 1.0 110.596 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -60.38 -42.31 95.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.775 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -128.43 56.94 1.6 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.797 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 44.5 tp -153.59 115.48 4.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.913 0.387 . . . . 1.0 110.081 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -124.88 148.19 48.41 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.33 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -136.87 152.69 50.53 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.971 -0.558 . . . . 1.0 110.283 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -129.9 144.39 51.29 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.661 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.521 HD12 ' CZ ' ' A' ' 90' ' ' TYR . 97.0 mt -125.36 131.52 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.228 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -98.27 122.79 41.87 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.978 0.418 . . . . 1.0 110.84 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.531 HD11 HD12 ' A' ' 44' ' ' ILE . 91.2 mt -101.13 133.75 43.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.385 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 59' ' ' GLN . 1.2 pm0 -120.12 132.49 55.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -99.99 144.54 28.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.103 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.728 HD13 ' H ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -135.91 173.48 11.66 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.158 0.504 . . . . 1.0 109.947 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.728 ' H ' HD13 ' A' ' 61' ' ' LEU . 13.1 tp10 87.32 33.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.677 -1.147 . . . . 1.0 109.922 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -92.33 76.26 5.23 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.756 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.4 ' O ' ' OD1' ' A' ' 65' ' ' ASN . 12.5 pt-20 -64.99 -36.48 84.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.813 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.423 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 4.9 m-20 -136.15 153.66 76.82 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.305 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.12 -33.26 53.03 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.769 1.646 . . . . 1.0 112.29 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.7 mt -84.6 -6.72 59.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.373 . . . . 1.0 110.383 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.423 ' HB3' ' H ' ' A' ' 65' ' ' ASN . . . -88.19 127.33 35.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.273 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.0 mt -86.03 153.73 21.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.302 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.9 95.51 0.41 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.313 -1.115 . . . . 1.0 110.313 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -71.92 -15.41 62.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.927 0.394 . . . . 1.0 110.684 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.2 t -118.26 120.35 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.669 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.2 mt -113.82 126.02 54.73 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.9 mt -102.08 123.64 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.882 0.372 . . . . 1.0 110.653 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.435 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 57.8 t -142.88 134.18 23.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.976 -0.557 . . . . 1.0 110.34 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.437 ' OD2' ' O ' ' A' ' 76' ' ' ASP . 3.4 p-10 48.67 44.32 21.23 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.216 0.323 . . . . 1.0 111.263 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 59.69 23.18 11.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.038 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -129.15 138.38 51.74 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.358 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -92.23 132.16 36.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 1.0 111.11 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.481 ' HB2' HD11 ' A' ' 86' ' ' ILE . 90.4 m-85 -126.88 138.07 53.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.263 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -82.76 -37.73 24.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.821 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -109.48 133.34 53.2 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.005 0.431 . . . . 1.0 112.028 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.4 tp -64.41 -40.73 96.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.503 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -62.06 -43.23 99.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.501 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.46 ' O ' ' OE1' ' A' ' 89' ' ' GLU . 32.8 tt0 -58.39 -38.3 77.05 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.345 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 80' ' ' TYR . 96.1 mt -59.66 -45.31 94.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.753 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.843 ' O ' HD12 ' A' ' 91' ' ' LEU . 43.9 mm -62.57 -47.42 93.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.429 -0.508 . . . . 1.0 111.607 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.1 t -69.86 -23.56 25.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 112.967 0.728 . . . . 1.0 112.967 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 85' ' ' GLN . 4.5 mp0 -98.1 -9.59 25.64 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.142 -0.223 . . . . 1.0 111.054 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.562 ' OH ' ' CE2' ' A' ' 46' ' ' TRP . 12.5 t80 -89.38 -54.58 4.03 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.913 0.709 . . . . 1.0 112.913 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.957 HD13 ' H ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -71.59 -33.56 69.14 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.706 -0.679 . . . . 1.0 112.107 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.957 ' H ' HD13 ' A' ' 91' ' ' LEU . 3.5 mm-40 -61.2 -48.68 80.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.07 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -67.72 -40.53 84.21 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.068 -0.653 . . . . 1.0 111.448 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -63.11 -42.6 99.59 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.438 -0.505 . . . . 1.0 111.275 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.93 -45.88 93.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.331 -0.548 . . . . 1.0 111.279 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -66.8 -45.4 78.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.383 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tp -69.04 -41.16 78.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.55 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.44 -42.25 92.61 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.472 -0.491 . . . . 1.0 110.053 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -66.38 -39.92 89.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.382 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -71.18 -42.81 68.56 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 120.781 -0.368 . . . . 1.0 111.783 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.1 tpt -63.96 -54.01 41.24 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.349 -0.54 . . . . 1.0 111.096 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.7 m -61.26 -39.36 90.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.48 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.2 t -73.16 9.77 1.15 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.911 -0.586 . . . . 1.0 111.224 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 87.1 p -88.03 139.22 30.73 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.681 0.277 . . . . 1.0 110.725 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.68 -22.32 66.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.996 0.427 . . . . 1.0 110.626 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.564 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 31.5 mtmm -88.2 39.63 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.804 -0.635 . . . . 1.0 109.828 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -129.84 114.02 15.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.068 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -122.75 124.66 43.86 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -93.65 68.09 3.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.826 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.13 147.51 16.84 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 115' ' ' VAL . 29.2 p -72.42 172.08 11.09 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -55.9 -37.66 69.18 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.364 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -67.47 -45.07 77.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.841 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.73 -20.37 63.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.781 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 111' ' ' THR . 39.4 t -69.71 -44.82 78.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.343 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.58 -46.38 95.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.207 0.527 . . . . 1.0 110.178 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -65.77 -33.99 77.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.829 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -68.31 -50.23 54.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.795 -0.639 . . . . 1.0 111.679 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.429 HD11 HG13 ' A' ' 131' ' ' VAL . 10.4 tp -69.99 -39.4 77.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.682 -0.407 . . . . 1.0 110.457 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.51 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 66.8 mm-40 -63.75 -40.56 97.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.716 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -63.43 -46.85 84.39 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.11 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.687 ' CE1' ' ND2' ' A' ' 126' ' ' ASN . 9.2 t80 -61.92 -41.83 98.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.14 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.5 t -62.28 -40.53 96.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.41 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -57.74 -44.03 85.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.315 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.47 -38.89 83.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.368 -0.605 . . . . 1.0 109.368 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.687 ' ND2' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -124.56 76.25 63.34 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.598 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -70.5 -24.56 26.14 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.799 2.333 . . . . 1.0 112.514 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -100.94 13.54 34.81 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.867 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.33 151.0 51.84 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.846 0.355 . . . . 1.0 110.482 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 m -80.91 160.87 24.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.887 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.429 HG13 HD11 ' A' ' 119' ' ' ILE . 4.2 p -153.05 149.81 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 109.36 -0.607 . . . . 1.0 109.36 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -151.0 143.44 24.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.922 0.392 . . . . 1.0 111.307 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -151.37 165.13 35.03 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.374 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.564 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.6 p90 -136.08 148.55 48.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 1.0 109.481 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 75.1 m -143.92 167.77 21.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.088 0.471 . . . . 1.0 110.214 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.8 tt -83.61 131.72 34.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.252 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -104.31 133.45 49.18 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.221 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -85.81 0.81 51.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.846 0.355 . . . . 1.0 110.585 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 139' ' ' ASP . 66.4 t0 -64.13 -37.9 89.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.127 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -150.81 104.59 3.04 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.085 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -48.65 124.04 10.38 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.597 1.531 . . . . 1.0 112.78 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.99 29.5 9.02 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.839 -0.905 . . . . 1.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -134.9 142.21 46.51 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.676 0.274 . . . . 1.0 110.32 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -122.16 146.49 47.18 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.475 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 13.6 m-85 -117.89 138.68 51.96 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.188 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.436 HD12 ' CG2' ' A' ' 161' ' ' VAL . 7.3 mt -110.44 120.95 44.08 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.617 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.57 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -116.07 145.01 43.37 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.988 -1.115 . . . . 1.0 107.988 178.02 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -161.68 149.74 15.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.39 -0.524 . . . . 1.0 109.679 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.51 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 67.0 tttt -135.4 130.39 34.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 120.934 -0.306 . . . . 1.0 110.257 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.439 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 28.9 mm -71.04 -45.03 74.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 1.0 111.348 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 150' ' ' ILE . 82.7 m-20 -160.31 174.23 14.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.665 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.92 -36.11 80.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.985 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -86.4 8.61 20.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.008 0.432 . . . . 1.0 110.531 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.3 t -96.9 157.53 15.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.516 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.431 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 68.8 mttm -88.16 143.24 27.17 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.216 -0.447 . . . . 1.0 109.891 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 43.6 tp -70.28 130.14 41.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.909 0.385 . . . . 1.0 110.141 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.431 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 93.6 m-85 -119.83 135.09 55.0 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.803 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 91.3 m -129.99 132.69 46.37 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.932 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.77 169.06 11.47 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.124 -0.489 . . . . 1.0 109.961 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.475 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 74.3 m-20 -117.17 150.57 38.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.885 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.436 ' CG2' HD12 ' A' ' 146' ' ' LEU . 78.5 t -128.26 137.96 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.804 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -100.24 125.77 46.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.984 0.421 . . . . 1.0 110.592 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.9 tp -88.39 130.68 35.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.788 -0.642 . . . . 1.0 109.372 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 37.6 p -128.82 176.67 7.65 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.93 0.395 . . . . 1.0 110.445 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -88.98 13.49 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.36 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 12.5 p -121.65 -2.5 9.37 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.814 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.35 -140.56 10.68 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.36 -1.096 . . . . 1.0 110.36 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -116.42 126.99 54.21 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.469 ' CE1' ' OD1' ' A' ' 174' ' ' ASN . 7.7 m-85 -106.43 117.8 34.99 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.0 tt -113.45 117.66 32.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.7 -0.482 . . . . 1.0 109.7 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.4 t 36.25 60.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.088 0.403 . . . . 1.0 112.088 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 65.19 27.91 12.19 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.061 0.763 . . . . 1.0 113.061 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -133.87 120.79 20.85 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.469 ' OD1' ' CE1' ' A' ' 169' ' ' PHE . 44.3 t30 -97.48 121.19 39.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.532 -0.304 . . . . 1.0 111.435 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -101.8 137.21 19.48 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.78 -21.4 33.46 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 122.412 2.075 . . . . 1.0 113.134 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 4.5 t -156.48 160.82 39.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.111 0.481 . . . . 1.0 111.002 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.98 -34.83 61.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.795 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 93.3 mt -61.75 -44.96 99.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.081 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -69.7 -29.81 67.32 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.65 -43.87 95.5 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 110.118 -0.327 . . . . 1.0 110.118 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 86.9 m -63.22 -46.22 87.98 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.386 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.554 ' O ' ' N ' ' A' ' 186' ' ' LYS . 88.8 m-20 -64.33 -48.18 76.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.17 -44.73 0.57 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.05 -47.52 65.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.048 -0.576 . . . . 1.0 109.781 178.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 183' ' ' ASN . 64.9 tttp -56.82 -41.7 78.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.591 -0.731 . . . . 1.0 110.227 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.5 m -61.45 -44.8 96.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.405 ' O ' ' OG ' ' A' ' 191' ' ' SER . 23.1 mt -62.94 -40.47 97.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.857 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.51 -43.94 93.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.23 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -58.7 -45.96 88.36 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.269 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 188' ' ' LEU . 80.0 p -62.1 -37.36 84.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.5 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.47 -42.93 82.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.347 -0.842 . . . . 1.0 111.923 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -69.15 -34.47 75.04 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 111.871 0.323 . . . . 1.0 111.871 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 6.0 t60 . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.011 -179.321 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 120.931 0.396 . . . . 1.0 110.609 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.72 -25.94 38.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.698 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.662 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -78.91 -17.63 13.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.39 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -98.67 3.5 47.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.413 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -77.56 143.1 67.43 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.305 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.419 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 56.3 Cg_endo -70.65 -13.83 32.76 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.855 1.703 . . . . 1.0 112.243 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.472 ' CD1' ' CZ ' ' A' ' 30' ' ' PHE . 88.6 m-85 -94.53 3.94 54.48 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.533 -0.303 . . . . 1.0 111.128 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.545 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 88.1 t80 -87.29 127.72 35.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.488 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 68.4 m-85 -155.04 106.93 2.28 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.974 -0.38 . . . . 1.0 109.974 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.5 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 32.5 Cg_exo -59.15 110.87 0.76 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.716 1.611 . . . . 1.0 112.926 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.5 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 57.0 m-85 -159.64 150.95 19.79 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.425 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -78.51 171.97 14.34 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.11 -41.22 98.54 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.34 -0.933 . . . . 1.0 111.062 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.416 ' O ' ' CG ' ' A' ' 19' ' ' GLU . 84.9 mtt85 -66.41 -42.35 87.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.884 0.373 . . . . 1.0 110.861 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -71.84 -31.97 67.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.17 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.43 -48.51 79.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.825 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 20' ' ' ASP . 14.4 pt-20 -60.32 -39.08 85.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.023 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 9.2 m-20 -63.95 -43.61 95.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.078 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.593 ' CE2' ' NZ ' ' A' ' 25' ' ' LYS . 42.5 t80 -67.4 -41.59 84.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.446 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.24 -11.2 60.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.749 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -59.18 -44.51 92.17 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.867 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 m -78.67 -19.03 53.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.765 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.593 ' NZ ' ' CE2' ' A' ' 21' ' ' TYR . 43.8 mmtm -72.91 159.1 34.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.543 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.62 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.6 pm0 -82.34 156.74 24.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.637 . . . . 1.0 110.657 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.2 mtm-85 -54.05 141.62 27.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.907 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.01 17.63 50.44 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.305 -0.718 . . . . 1.0 111.305 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -94.96 136.51 35.18 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.472 ' CZ ' ' CD1' ' A' ' 9' ' ' TYR . 26.0 p90 -133.78 167.62 20.22 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.355 0.598 . . . . 1.0 110.883 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.2 m -146.77 157.76 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 114.924 -1.034 . . . . 1.0 111.64 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.0 mm -116.32 125.84 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.262 -0.644 . . . . 1.0 109.262 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -140.12 165.16 28.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.064 -0.517 . . . . 1.0 110.461 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -118.53 135.53 54.35 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 m -65.04 146.0 55.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.801 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.5 m -60.49 -26.01 66.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.692 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -123.29 27.19 7.63 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.036 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.507 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -92.49 -77.24 1.36 Allowed Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 t0 70.81 -35.49 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.623 0.249 . . . . 1.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' A' ' 38' ' ' GLY . 21.1 t70 -118.63 10.49 12.52 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.754 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.443 ' ND1' ' O ' ' A' ' 40' ' ' ASP . 25.0 m-70 -142.31 151.99 42.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.381 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mt -121.13 145.58 47.66 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.076 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.9 t -123.62 129.48 74.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.096 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.424 HD12 HD11 ' A' ' 58' ' ' ILE . 61.3 mt -111.51 137.66 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.5 m -121.63 141.71 50.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.437 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.727 ' HE1' ' NE2' ' A' ' 54' ' ' GLN . 3.5 p-90 -154.04 154.79 34.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.215 -0.902 . . . . 1.0 110.972 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -95.7 143.72 26.72 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.148 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.792 ' N ' HD12 ' A' ' 48' ' ' LEU . 3.3 mp -93.02 -73.06 0.57 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.458 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -145.26 119.08 9.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.594 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt 45.0 -129.13 1.05 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.064 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -70.94 73.95 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.068 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.4 tp -167.56 121.38 0.96 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.272 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -135.15 150.37 50.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.628 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.727 ' NE2' ' HE1' ' A' ' 46' ' ' TRP . 20.3 pt20 -135.8 155.05 50.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.714 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -124.04 141.27 52.19 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.067 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.44 132.47 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.743 -0.466 . . . . 1.0 109.743 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -102.23 123.81 46.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.894 0.378 . . . . 1.0 110.534 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.424 HD11 HD12 ' A' ' 44' ' ' ILE . 86.3 mt -103.1 133.87 45.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.343 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -112.95 141.78 46.39 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.869 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.514 ' OE1' ' NZ ' ' A' ' 63' ' ' LYS . 78.8 mt-10 -99.79 148.51 24.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.813 -0.44 . . . . 1.0 109.813 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.436 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.6 tp -122.73 176.22 6.08 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.579 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.436 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 69.9 mm-40 57.66 32.34 21.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.022 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.514 ' NZ ' ' OE1' ' A' ' 60' ' ' GLU . 20.1 mmtm -78.65 74.13 5.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.881 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.7 -29.51 70.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.707 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -150.31 149.11 25.96 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.068 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.62 -25.14 66.14 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.268 1.979 . . . . 1.0 112.13 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.0 mp -91.27 -11.09 39.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.722 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.34 140.07 50.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.371 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.2 mt -77.14 148.89 35.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.377 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.47 92.39 0.27 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -63.17 -35.2 79.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.831 0.348 . . . . 1.0 110.875 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.1 t -127.11 125.06 65.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.073 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.1 mt -115.23 129.63 56.69 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.5 mm -99.41 123.54 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.933 0.397 . . . . 1.0 110.298 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.583 HG21 HD13 ' A' ' 86' ' ' ILE . 10.3 t -139.88 130.47 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.28 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 54.24 40.7 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.954 -0.298 . . . . 1.0 111.096 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.6 t30 62.0 24.05 14.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.729 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -128.21 151.78 48.85 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.264 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -96.65 130.78 43.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.81 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -125.07 138.43 54.19 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.198 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -85.91 -38.02 18.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.731 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -121.36 145.6 47.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.173 0.511 . . . . 1.0 112.039 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.51 -38.41 89.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.615 -0.72 . . . . 1.0 110.802 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -60.72 -39.89 90.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.934 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -63.12 -38.67 92.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.649 0.261 . . . . 1.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.583 HD13 HG21 ' A' ' 75' ' ' VAL . 94.2 mt -60.98 -46.3 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.873 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.7 mt -62.9 -46.14 97.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.581 -0.448 . . . . 1.0 111.669 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.68 -43.7 79.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 112.495 0.554 . . . . 1.0 112.495 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -75.9 -14.12 60.26 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.799 -0.36 . . . . 1.0 111.511 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -94.14 -50.77 5.13 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.638 -0.425 . . . . 1.0 111.825 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 95' ' ' VAL . 1.9 tp -68.85 -39.97 79.62 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.301 0.482 . . . . 1.0 112.301 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -62.94 -48.91 76.85 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 119.971 -0.691 . . . . 1.0 111.379 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -69.57 -42.41 74.54 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.691 -0.403 . . . . 1.0 111.696 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -65.92 -42.55 89.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.218 -0.593 . . . . 1.0 111.191 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 91' ' ' LEU . 53.6 t -65.86 -45.13 92.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.495 -0.482 . . . . 1.0 111.296 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -67.1 -44.9 78.79 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.86 -0.336 . . . . 1.0 111.563 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 tp -68.58 -41.77 79.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.501 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.3 tp -63.52 -43.07 98.25 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.193 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -68.63 -37.66 79.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.026 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -70.4 -43.17 70.59 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.686 -0.406 . . . . 1.0 111.562 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.2 tpt -66.28 -55.06 17.93 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.279 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 104' ' ' SER . 9.7 m -58.34 -38.42 77.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.028 0.442 . . . . 1.0 110.349 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.7 p -72.36 10.57 0.76 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.634 -0.712 . . . . 1.0 111.049 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 102' ' ' THR . 11.7 t -91.84 134.16 35.01 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.832 0.349 . . . . 1.0 110.248 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.31 -20.81 46.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 1.0 111.196 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.58 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 45.9 mtpt -87.9 40.63 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.943 -0.571 . . . . 1.0 109.761 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -130.68 109.14 10.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.135 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -134.8 124.93 25.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.732 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.2 p -92.61 82.8 4.82 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.879 0.371 . . . . 1.0 110.933 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -103.84 147.89 16.78 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.887 -0.885 . . . . 1.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 115' ' ' VAL . 7.6 p -73.53 168.48 19.2 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.007 -0.368 . . . . 1.0 110.007 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -58.89 -40.57 84.85 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.743 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -70.83 -44.0 67.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.183 0.516 . . . . 1.0 110.641 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.54 -22.57 63.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.994 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 111' ' ' THR . 23.7 t -68.11 -44.76 84.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.089 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.5 t -63.91 -45.85 95.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.098 0.475 . . . . 1.0 110.263 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.38 -38.65 90.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.977 0.418 . . . . 1.0 111.034 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -64.44 -49.47 71.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.778 -0.647 . . . . 1.0 111.834 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.0 tp -70.24 -38.4 74.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.485 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -62.22 -41.28 98.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.547 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.71 -48.46 74.57 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.45 -0.5 . . . . 1.0 110.255 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.552 ' CD2' ' OD1' ' A' ' 126' ' ' ASN . 39.8 t80 -61.55 -42.42 98.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.944 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 96.4 p -57.77 -39.17 76.8 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.272 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -64.42 -37.52 87.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.248 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.4 t -64.8 -40.38 88.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.554 -0.536 . . . . 1.0 109.554 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.552 ' OD1' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -126.55 75.56 74.36 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.385 179.547 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.567 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 6.6 Cg_exo -71.52 -25.47 21.1 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.485 2.123 . . . . 1.0 112.584 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -99.35 13.48 33.03 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.188 -0.46 . . . . 1.0 112.05 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -136.24 150.41 48.95 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.931 0.396 . . . . 1.0 110.445 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.9 p -80.12 164.32 23.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.742 -0.663 . . . . 1.0 109.79 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 p -153.09 147.41 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -149.16 142.82 25.5 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.861 0.362 . . . . 1.0 111.125 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -153.15 170.5 20.37 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.313 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -135.95 157.08 47.72 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.9 p -151.02 168.0 25.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.356 -0.383 . . . . 1.0 110.296 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.3 tp -78.38 135.01 37.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.442 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 8.4 t-20 -63.25 -176.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.201 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.451 ' ND1' ' N ' ' A' ' 138' ' ' HIS . 8.3 p-80 -138.52 -23.41 0.97 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.707 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -107.31 -10.22 15.85 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.032 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 80.6 m-20 -136.93 80.09 37.02 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.413 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.65 128.61 30.72 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.013 1.809 . . . . 1.0 112.469 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.3 -19.92 41.52 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -98.86 149.33 23.02 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 110.0 -0.371 . . . . 1.0 110.0 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -118.13 153.73 33.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.524 . . . . 1.0 109.747 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.45 ' CE1' ' ND2' ' A' ' 137' ' ' ASN . 33.1 m-85 -126.82 137.49 53.2 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.016 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.6 mt -108.07 128.93 55.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.31 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.444 ' SD ' HG13 ' A' ' 115' ' ' VAL . 2.5 ptt? -120.36 146.41 46.19 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.837 -1.172 . . . . 1.0 107.837 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -160.38 146.56 15.37 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -130.41 126.51 37.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 120.814 -0.354 . . . . 1.0 110.285 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.667 HD12 ' H ' ' A' ' 150' ' ' ILE . 5.3 mp -72.92 -45.99 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.32 0.489 . . . . 1.0 112.32 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.576 ' OD1' ' N ' ' A' ' 152' ' ' ALA . 15.6 t-20 -153.55 168.03 27.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.522 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.576 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -61.67 -30.68 70.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.689 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.73 -12.5 50.98 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.336 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.7 t -78.77 157.09 28.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.036 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -87.47 148.18 25.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.193 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.3 tp -73.02 122.94 22.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.987 0.422 . . . . 1.0 109.902 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -113.38 132.92 55.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.917 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.7 m -126.96 131.83 50.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.756 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -116.09 163.67 15.6 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.995 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 161' ' ' VAL . 28.5 t-20 -107.54 147.74 30.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.634 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.414 ' N ' ' OD1' ' A' ' 160' ' ' ASN . 44.8 t -127.71 134.79 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.597 -0.52 . . . . 1.0 109.597 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -100.55 128.44 46.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.953 0.406 . . . . 1.0 110.436 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.7 tp -92.84 131.07 38.2 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 70.4 p -129.53 171.25 12.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.39 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -85.16 15.47 4.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.55 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 58.3 p -123.21 -2.99 8.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.466 -0.334 . . . . 1.0 110.549 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 142.74 -138.2 8.22 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.357 -1.097 . . . . 1.0 110.357 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -118.69 128.58 54.65 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.115 -0.328 . . . . 1.0 110.115 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.491 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 4.7 m-85 -103.16 125.94 50.09 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 171' ' ' VAL . 0.8 OUTLIER -119.05 113.93 21.72 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.6 t 36.64 59.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 111.886 0.328 . . . . 1.0 111.886 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.5 m120 66.96 27.87 8.72 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.913 0.709 . . . . 1.0 112.913 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -132.62 121.7 23.59 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.491 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 28.0 t-20 -94.44 119.3 32.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.253 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -99.33 132.13 23.86 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 109.63 -0.507 . . . . 1.0 109.63 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.05 -22.53 19.36 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.985 1.79 . . . . 1.0 113.5 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.8 p -150.37 153.81 36.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.917 0.389 . . . . 1.0 110.939 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.05 -35.5 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.851 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.97 -47.71 90.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.152 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.35 -31.95 73.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.16 -42.14 99.36 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.401 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 75.9 m -62.97 -46.83 85.86 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.745 -0.382 . . . . 1.0 110.343 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 186' ' ' LYS . 35.8 m-80 -64.92 -49.43 70.43 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 108.712 -0.847 . . . . 1.0 108.712 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.18 -46.19 0.49 Allowed Glycine 0 N--CA 1.466 0.657 0 N-CA-C 109.998 -1.241 . . . . 1.0 109.998 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -45.12 71.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.249 0.547 . . . . 1.0 110.046 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 183' ' ' ASN . 17.6 tptm -57.75 -44.36 86.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.242 -0.89 . . . . 1.0 110.467 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 14.4 m -61.19 -45.57 94.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.77 -42.1 98.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.079 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.1 tp -58.34 -43.6 88.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.526 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -59.03 -42.95 91.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.342 0.592 . . . . 1.0 110.228 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.3 t -66.21 -42.68 88.4 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.19 0.519 . . . . 1.0 110.207 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.88 -46.38 85.2 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.303 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.51 -30.09 69.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.456 -0.338 . . . . 1.0 111.679 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 44.1 m80 . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.902 -178.885 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 121.152 0.501 . . . . 1.0 110.387 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 5' ' ' ILE . 14.2 p -64.69 -39.08 84.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.71 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.446 ' N ' HG13 ' A' ' 4' ' ' VAL . 43.8 pt -67.49 -29.99 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.793 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -95.73 10.35 37.24 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.362 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -66.36 133.65 94.49 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.295 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.536 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 78.4 Cg_exo -48.65 -34.14 26.2 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.834 1.69 . . . . 1.0 112.398 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CE2' ' CZ ' ' A' ' 30' ' ' PHE . 90.6 m-85 -79.66 4.15 16.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.398 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.447 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 55.3 t80 -87.19 128.14 35.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.454 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CZ ' ' O ' ' A' ' 8' ' ' PRO . 67.6 m-85 -150.83 115.29 3.22 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.59 112.28 3.49 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.95 1.767 . . . . 1.0 113.623 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.582 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -159.03 165.33 34.22 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.375 0.607 . . . . 1.0 111.187 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 51.4 t-20 -76.71 163.7 26.57 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.506 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . -59.68 -40.2 96.19 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.876 -0.89 . . . . 1.0 110.876 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -64.83 -45.14 87.4 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.994 -0.283 . . . . 1.0 111.033 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -70.0 -36.98 75.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.506 -0.316 . . . . 1.0 111.464 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -42.9 99.36 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.42 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.69 -42.21 82.4 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.118 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -61.82 -40.1 94.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.178 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -64.31 -40.52 96.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.659 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.42 -13.27 59.92 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.019 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -59.24 -42.54 91.34 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.644 -0.423 . . . . 1.0 110.561 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 m -77.97 -19.41 54.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.681 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -79.06 171.41 15.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.003 0.43 . . . . 1.0 110.858 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -77.01 155.52 32.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.786 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -69.08 145.84 53.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.4 2.54 60.28 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.08 -0.808 . . . . 1.0 111.08 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -79.01 154.17 29.7 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.617 ' CZ ' ' CE2' ' A' ' 9' ' ' TYR . 37.5 p90 -138.71 166.33 24.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.593 0.711 . . . . 1.0 111.054 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 45' ' ' THR . 16.1 m -149.8 162.41 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.721 -1.127 . . . . 1.0 112.046 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.5 mt -117.01 127.02 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.705 -0.479 . . . . 1.0 109.705 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.475 ' NE ' ' O ' ' A' ' 13' ' ' PHE . 75.2 ttt-85 -136.49 158.49 44.3 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.35 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -114.31 133.09 55.91 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.824 -0.436 . . . . 1.0 109.824 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.2 m -77.2 139.21 39.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.1 p -68.7 -38.01 79.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.96 -0.563 . . . . 1.0 110.434 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 83.0 mmt-85 -88.08 -13.95 40.13 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.771 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -75.02 -64.06 2.4 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.519 -1.033 . . . . 1.0 110.519 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 t70 69.93 -40.2 0.46 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.647 0.261 . . . . 1.0 110.944 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 38' ' ' GLY . 43.0 p-10 -117.15 11.4 14.15 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.71 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.535 ' C ' HD12 ' A' ' 42' ' ' LEU . 32.7 m-70 -132.24 152.73 51.19 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.933 0.397 . . . . 1.0 110.371 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.535 HD12 ' C ' ' A' ' 41' ' ' HIS . 10.8 mp -118.75 144.99 45.92 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.827 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -126.1 130.88 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.284 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 31' ' ' VAL . 20.3 mt -112.97 139.49 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.484 ' O ' HG22 ' A' ' 31' ' ' VAL . 47.7 m -115.99 128.64 55.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.536 ' CE2' HD11 ' A' ' 48' ' ' LEU . 8.0 p-90 -142.38 147.73 36.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.915 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' C ' HD12 ' A' ' 48' ' ' LEU . 24.7 mtmm -90.88 136.88 32.78 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.101 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 48' ' ' LEU . 7.4 mp -94.33 -67.59 0.85 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.192 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.493 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 26.1 t70 -125.91 -173.31 2.81 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.319 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.493 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 88.4 tttt -65.23 134.23 53.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.644 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 56.44 31.42 18.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.052 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 tp -135.02 130.27 35.4 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.879 0.371 . . . . 1.0 110.604 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -132.29 149.81 52.29 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.551 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.605 ' NE2' ' N ' ' A' ' 55' ' ' HIS . 0.0 OUTLIER -142.86 153.91 43.63 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 179.203 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.605 ' N ' ' NE2' ' A' ' 54' ' ' GLN . 19.1 p80 -123.24 140.73 52.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.207 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 56' ' ' ILE . 14.7 tt -123.87 128.43 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.788 -0.449 . . . . 1.0 109.788 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -103.72 126.36 50.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.975 0.417 . . . . 1.0 110.919 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.0 mt -106.42 129.1 60.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.104 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -104.94 140.4 38.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.253 -0.431 . . . . 1.0 109.999 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -102.82 157.26 17.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.358 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.483 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -145.16 167.91 21.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.658 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.483 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 50.4 tt0 71.47 37.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.012 -0.54 . . . . 1.0 109.899 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -87.33 115.07 24.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -98.44 -25.26 14.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.011 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -157.11 151.88 20.92 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.194 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.53 -19.0 60.68 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.22 1.947 . . . . 1.0 111.859 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.9 tp -79.3 -14.12 59.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.049 0.452 . . . . 1.0 110.691 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.59 137.95 38.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.267 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.2 mt -79.54 164.38 23.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.441 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.52 97.64 0.18 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -67.78 -36.08 79.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.997 0.427 . . . . 1.0 110.618 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.4 t -117.05 123.78 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.583 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.4 mt -116.7 135.57 53.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.428 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.7 mt -107.17 126.41 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.887 0.375 . . . . 1.0 110.142 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.1 t -143.86 132.55 19.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.32 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 t70 54.68 43.28 30.39 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.052 -0.259 . . . . 1.0 111.002 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.4 t30 59.27 24.57 13.06 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.943 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -128.52 154.51 46.07 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.229 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -103.94 134.8 46.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.219 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.737 ' CD1' HD11 ' A' ' 86' ' ' ILE . 96.4 m-85 -126.23 139.39 53.38 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.348 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -84.45 -38.04 20.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.714 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -123.09 150.72 42.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.124 0.488 . . . . 1.0 111.986 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.5 tp -66.8 -36.33 82.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.584 -0.735 . . . . 1.0 111.295 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 50.2 p-10 -58.22 -33.42 69.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.805 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.494 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 82.2 mt-30 -64.88 -39.26 93.26 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.657 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.737 HD11 ' CD1' ' A' ' 80' ' ' TYR . 31.3 mm -62.67 -48.26 89.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.857 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.47 -43.58 98.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 120.334 -0.546 . . . . 1.0 111.734 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 84' ' ' ASP . 59.7 t -73.2 -42.59 58.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 113.148 0.796 . . . . 1.0 113.148 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -82.8 -13.41 56.29 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.636 -0.426 . . . . 1.0 111.557 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.42 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 64.1 t80 -95.52 -48.63 5.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.524 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 95' ' ' VAL . 3.9 tp -69.52 -40.62 76.83 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.264 0.468 . . . . 1.0 112.264 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -63.89 -48.59 76.07 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.042 -0.663 . . . . 1.0 111.762 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -68.43 -43.28 77.47 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.75 -0.38 . . . . 1.0 111.757 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -66.05 -42.13 89.89 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.163 -0.615 . . . . 1.0 111.225 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 91' ' ' LEU . 53.6 t -65.37 -46.13 91.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.226 -0.59 . . . . 1.0 111.441 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -69.17 -44.3 72.49 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.789 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.3 tp -69.01 -40.31 78.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.152 -0.476 . . . . 1.0 111.719 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.4 tp -64.43 -43.3 94.78 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.292 -0.563 . . . . 1.0 110.08 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -67.79 -38.52 83.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.129 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.452 ' OE1' ' OH ' ' A' ' 168' ' ' TYR . 2.9 tm-20 -70.91 -42.81 69.46 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.802 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.487 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 2.6 ttt -64.98 -54.42 30.8 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.531 -0.467 . . . . 1.0 111.433 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.43 HG23 ' CE2' ' A' ' 107' ' ' PHE . 55.5 m -61.23 -30.29 70.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.126 0.489 . . . . 1.0 110.496 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.1 t -73.44 10.31 1.07 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.634 -0.712 . . . . 1.0 110.926 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 36.4 t -96.41 131.68 42.71 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.773 0.32 . . . . 1.0 110.284 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -57.83 -17.89 18.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.944 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.536 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 37.7 mmtm -90.8 40.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.063 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CE2' HG23 ' A' ' 102' ' ' THR . 70.2 t80 -133.17 111.28 10.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.468 . . . . 1.0 111.071 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -123.34 126.46 46.89 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -94.68 85.85 4.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.977 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.0 149.35 16.9 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.673 ' O ' HG23 ' A' ' 115' ' ' VAL . 28.3 p -71.98 170.86 12.9 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -59.87 -39.17 84.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.859 -0.336 . . . . 1.0 110.831 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -68.15 -42.33 80.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.905 0.383 . . . . 1.0 110.455 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -70.6 -18.52 62.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.094 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 111' ' ' THR . 40.9 t -73.19 -44.39 55.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.767 0.318 . . . . 1.0 110.144 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.8 t -62.89 -46.75 95.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.251 0.548 . . . . 1.0 110.157 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -66.02 -36.66 83.87 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.005 0.431 . . . . 1.0 111.099 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -66.61 -49.63 65.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.599 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.5 tp -69.77 -39.4 77.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.305 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -64.82 -42.03 95.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.947 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -63.33 -48.26 78.74 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.427 -0.509 . . . . 1.0 110.052 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -59.94 -43.28 95.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.95 -0.568 . . . . 1.0 109.898 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.4 t -62.9 -39.52 94.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.295 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.8 -41.6 82.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.097 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.24 -41.6 92.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.92 78.6 65.43 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.043 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -71.19 -13.68 31.2 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.449 2.099 . . . . 1.0 112.46 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -101.45 -14.5 17.51 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.651 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -105.97 148.38 27.74 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.978 0.418 . . . . 1.0 110.477 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.401 ' OG ' HD21 ' A' ' 189' ' ' LEU . 60.2 p -81.81 163.78 22.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.883 -0.599 . . . . 1.0 109.615 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 p -152.72 146.27 15.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.421 ' O ' ' CD2' ' A' ' 133' ' ' TYR . 33.0 p90 -149.91 141.53 23.52 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.671 -0.412 . . . . 1.0 111.083 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.421 ' CD2' ' O ' ' A' ' 132' ' ' TYR . 25.4 m-85 -152.91 165.93 33.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.309 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -130.63 154.37 47.96 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 178.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.1 p -150.44 168.14 25.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.205 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.1 tp -81.24 132.41 35.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.604 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.548 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 22.6 p30 -78.25 151.9 32.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.277 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -106.22 -30.4 9.23 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.651 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 41.4 p30 -64.97 -21.14 66.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.197 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.548 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 19.8 t-20 -163.22 106.76 1.0 Allowed Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.59 143.55 38.32 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.796 1.664 . . . . 1.0 112.411 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.82 -39.19 2.81 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.422 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 19.8 m95 -94.47 149.78 20.91 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.815 0.34 . . . . 1.0 110.199 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.487 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 77.1 m-85 -113.26 154.86 26.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.847 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -126.31 139.23 53.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.115 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.5 mt -111.1 126.66 55.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.568 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.6 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -120.98 146.85 46.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.029 -1.1 . . . . 1.0 108.029 178.378 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -162.44 153.89 18.07 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.25 -0.58 . . . . 1.0 109.769 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -137.73 128.41 26.85 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.801 0.334 . . . . 1.0 110.604 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.668 ' N ' HD12 ' A' ' 150' ' ' ILE . 2.6 mp -69.76 -45.24 77.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 1.0 111.591 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.411 ' ND2' HG22 ' A' ' 150' ' ' ILE . 76.6 m-20 -156.47 171.79 19.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.574 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.79 -28.3 69.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.792 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -90.27 8.61 32.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.983 0.421 . . . . 1.0 110.346 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 15.9 t -102.22 150.43 23.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.442 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -80.17 157.16 26.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.014 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 62.1 tp -75.07 124.11 26.41 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.259 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -108.31 129.89 55.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.518 . . . . 1.0 109.615 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 63.9 m -128.2 130.46 48.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.872 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -120.9 159.81 24.77 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.866 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 160' ' ' ASN . 34.5 p30 -105.69 148.32 27.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.984 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.77 136.12 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -98.33 135.27 40.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.773 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 29.3 tp -102.51 128.83 48.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.905 -0.588 . . . . 1.0 109.543 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.4 p -131.04 168.37 17.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.087 0.47 . . . . 1.0 110.398 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -78.74 17.35 0.72 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.669 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 12.1 p -121.35 -2.38 9.54 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.704 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 137.48 -126.3 3.58 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.264 -1.135 . . . . 1.0 110.264 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.452 ' OH ' ' OE1' ' A' ' 100' ' ' GLU . 19.9 m-85 -127.28 132.84 50.24 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.671 0.272 . . . . 1.0 110.447 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -110.43 120.81 43.62 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.938 0.399 . . . . 1.0 110.143 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.0 tt -114.96 120.92 41.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.4 t 35.97 52.1 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 111.95 0.352 . . . . 1.0 111.95 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 10.2 m120 69.42 27.41 4.98 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.087 0.773 . . . . 1.0 113.087 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -135.78 120.16 17.99 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -91.27 131.24 36.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.359 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -107.54 101.25 38.65 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 109.438 -0.578 . . . . 1.0 109.438 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -48.82 -23.17 5.44 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.462 2.108 . . . . 1.0 113.376 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 40.0 m -141.66 145.74 35.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.991 0.424 . . . . 1.0 111.097 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.62 -34.97 70.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.731 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.462 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 49.2 mm -60.57 -46.98 94.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.336 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.458 ' N ' ' OE1' ' A' ' 180' ' ' GLN . 6.6 mp0 -61.65 -32.9 73.09 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.14 -40.3 95.87 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 1.8 p -61.49 -46.85 88.25 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.769 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.6 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 54.5 t30 -71.21 -49.72 40.55 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 119.727 -0.789 . . . . 1.0 108.954 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.31 -43.87 0.53 Allowed Glycine 0 N--CA 1.462 0.398 0 N-CA-C 109.832 -1.307 . . . . 1.0 109.832 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -69.04 -47.93 64.14 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.071 -0.565 . . . . 1.0 109.596 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 183' ' ' ASN . 49.5 tttp -57.25 -39.9 76.55 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.184 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.5 m -60.5 -44.31 96.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 62.9 mt -63.86 -39.03 93.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.152 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.401 HD21 ' OG ' ' A' ' 130' ' ' SER . 62.3 tp -59.45 -45.32 91.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.713 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -58.7 -45.39 89.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.104 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.1 t -64.49 -40.29 95.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.714 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.76 -42.0 97.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.47 -0.786 . . . . 1.0 111.95 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -63.11 -25.8 68.53 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 7.3 m80 . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 120.726 0.298 . . . . 1.0 110.863 -179.691 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.481 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 83.8 mtp180 . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 120.871 0.367 . . . . 1.0 110.486 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.65 -31.83 53.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.522 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.6 pt -75.39 -19.93 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.447 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -103.59 9.11 37.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.6 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 3' ' ' ARG . 0.4 OUTLIER -67.77 147.87 98.55 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 110.057 -0.349 . . . . 1.0 110.057 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.64 -14.25 38.99 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.102 1.868 . . . . 1.0 112.2 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -94.74 5.52 51.64 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.203 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 40.3 t80 -82.88 128.76 34.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.478 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 58.4 m-85 -149.38 120.92 4.17 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.513 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.521 ' O ' ' CD1' ' A' ' 13' ' ' PHE . 72.7 Cg_endo -74.72 109.64 2.95 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.748 1.632 . . . . 1.0 112.479 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' A' ' 12' ' ' PRO . 70.6 m-85 -155.72 156.8 35.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.379 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -79.4 168.05 20.01 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.461 ' CA ' HH12 ' A' ' 33' ' ' ARG . . . -59.65 -43.58 97.61 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.381 -0.914 . . . . 1.0 111.203 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -66.02 -41.22 91.26 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.055 -0.258 . . . . 1.0 110.784 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.85 -35.9 77.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.543 -0.299 . . . . 1.0 111.229 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.77 -40.9 94.25 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.45 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.11 -42.69 93.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -60.47 -42.76 96.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.275 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -60.98 -41.8 97.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.815 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.8 mp -78.9 -15.22 58.62 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.984 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -61.14 -42.13 97.99 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.806 -0.357 . . . . 1.0 110.516 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.3 t -76.75 -18.71 58.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.975 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -87.09 -178.02 6.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.055 0.455 . . . . 1.0 110.676 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.18 179.45 5.56 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.819 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.6 mtt85 -81.01 146.11 30.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.049 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.56 19.44 29.77 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.83 145.67 26.73 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -132.86 167.45 20.18 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.109 0.481 . . . . 1.0 110.95 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 32' ' ' ILE . 45.2 t -147.34 158.44 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.242 -0.89 . . . . 1.0 111.443 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.491 ' N ' HG12 ' A' ' 31' ' ' VAL . 6.0 mm -114.83 126.33 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.711 -0.848 . . . . 1.0 108.711 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.461 HH12 ' CA ' ' A' ' 15' ' ' GLY . 57.1 ttp180 -137.86 155.86 48.52 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.402 ' N ' ' HG2' ' A' ' 33' ' ' ARG . 91.2 mt-30 -119.69 137.91 53.61 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.786 -0.45 . . . . 1.0 109.786 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.6 m -72.37 151.43 42.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.773 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.8 p -69.55 -20.81 63.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.018 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.28 17.68 9.07 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.023 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -84.54 -74.95 1.23 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.532 -1.027 . . . . 1.0 110.532 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.3 t70 67.68 -35.71 0.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.635 0.255 . . . . 1.0 110.884 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' A' ' 38' ' ' GLY . 97.2 m-20 -118.55 12.06 13.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.466 -0.334 . . . . 1.0 110.594 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.565 ' C ' HD12 ' A' ' 42' ' ' LEU . 99.5 m-70 -144.06 146.55 32.9 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.322 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.565 HD12 ' C ' ' A' ' 41' ' ' HIS . 10.9 mp -119.12 145.48 45.92 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.09 -0.504 . . . . 1.0 109.793 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.86 129.23 74.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.146 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.477 HG22 HD13 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -111.19 137.71 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 108.762 -0.829 . . . . 1.0 108.762 -179.409 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.8 m -115.16 134.05 55.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.877 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.535 ' CZ2' HD11 ' A' ' 48' ' ' LEU . 1.8 p-90 -148.14 151.6 35.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.384 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.529 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -99.61 145.51 27.48 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.69 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.535 HD11 ' CZ2' ' A' ' 46' ' ' TRP . 9.5 mp -102.47 -75.52 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 36.9 t0 -117.06 -166.74 1.2 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.388 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.529 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 51.7 mtmt -69.6 139.37 53.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.947 0.403 . . . . 1.0 110.814 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 52.28 26.66 4.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.909 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.8 tp -130.89 129.01 41.71 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.787 0.327 . . . . 1.0 110.327 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -133.87 148.99 51.33 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.502 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 -139.84 152.09 46.21 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.581 -0.526 . . . . 1.0 109.581 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -129.37 144.15 51.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.427 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 92.8 mt -125.51 131.75 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.786 -0.449 . . . . 1.0 109.786 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -98.53 121.81 40.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.906 0.384 . . . . 1.0 110.575 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.3 mt -97.98 123.58 50.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.094 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -111.31 131.69 54.96 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -103.08 152.78 20.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.242 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.471 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 1.6 tp -144.45 165.69 27.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.414 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 3.1 tm-20 81.94 63.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.201 0.524 . . . . 1.0 110.063 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HD3' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -105.89 113.91 27.74 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.034 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.468 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 57.8 mp0 -65.85 -22.85 66.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.688 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.611 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 1.1 m120 -151.6 160.03 32.37 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.133 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.34 -32.97 64.06 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.986 1.791 . . . . 1.0 112.332 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.1 mt -95.14 -8.82 35.33 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.688 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.611 ' HB3' ' H ' ' A' ' 65' ' ' ASN . . . -73.85 144.77 45.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.593 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.7 mt -89.71 147.25 23.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.271 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.98 126.76 7.59 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.7 -0.96 . . . . 1.0 110.7 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -81.96 -9.78 59.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.064 0.459 . . . . 1.0 110.459 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.28 118.68 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.735 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.5 mt -115.01 129.23 56.67 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.551 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.2 mt -101.29 121.87 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.951 0.405 . . . . 1.0 110.228 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.88 131.92 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.121 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.7 t0 55.98 42.88 28.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.178 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 59.69 21.13 9.83 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.922 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -128.06 151.98 48.52 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.059 0.456 . . . . 1.0 110.22 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -101.37 128.38 47.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.224 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -122.94 138.67 54.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.32 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -85.25 -38.38 18.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 1.0 111.606 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -113.13 141.23 47.16 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.034 0.445 . . . . 1.0 111.993 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.2 -40.66 96.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.85 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -59.21 -41.71 89.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.746 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -60.81 -38.52 85.68 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.986 -0.285 . . . . 1.0 110.723 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.37 -47.27 94.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.743 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.1 mt -62.09 -46.41 96.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.329 -0.548 . . . . 1.0 111.684 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.0 t -71.15 -42.46 75.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.844 0.683 . . . . 1.0 112.844 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -77.38 -15.4 59.39 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.662 -0.415 . . . . 1.0 111.9 -177.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.621 ' CZ ' ' NZ ' ' A' ' 94' ' ' LYS . 34.8 t80 -94.09 -49.91 5.54 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.651 -0.42 . . . . 1.0 111.713 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.2 mp -69.75 -40.57 76.08 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 112.096 0.406 . . . . 1.0 112.096 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -62.85 -48.53 78.62 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.774 -0.77 . . . . 1.0 111.544 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -69.21 -43.41 74.18 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.522 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.621 ' NZ ' ' CZ ' ' A' ' 90' ' ' TYR . 24.0 mmtp -66.14 -43.77 86.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.213 -0.595 . . . . 1.0 111.243 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.32 -44.79 90.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.339 -0.544 . . . . 1.0 111.023 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -66.03 -47.54 74.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.248 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.434 HD21 ' CE1' ' A' ' 168' ' ' TYR . 3.0 tp -69.08 -38.93 79.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.282 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.38 -43.28 98.08 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.574 -0.45 . . . . 1.0 110.118 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -67.51 -39.75 85.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.257 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -71.09 -41.38 70.7 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.007 0.373 . . . . 1.0 112.007 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.5 ttt -68.38 -54.82 14.69 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.423 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.1 m -58.7 -42.2 88.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.076 0.465 . . . . 1.0 110.411 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.3 m -72.37 8.27 1.44 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.951 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -84.29 142.82 29.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.734 0.302 . . . . 1.0 110.512 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.63 -19.5 65.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.885 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.552 ' NZ ' ' SG ' ' A' ' 182' ' ' CYS . 98.7 mttt -93.13 39.44 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.828 -0.624 . . . . 1.0 110.161 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -134.12 118.37 17.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.122 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -126.67 133.13 51.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.0 p -99.4 74.7 1.93 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.8 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.71 146.62 18.58 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.635 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -71.52 171.68 10.94 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.036 -0.357 . . . . 1.0 110.036 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -56.66 -38.89 72.82 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.64 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.94 -44.19 77.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.962 0.411 . . . . 1.0 110.724 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -70.17 -20.27 63.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.056 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 111' ' ' THR . 40.2 t -70.78 -45.23 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.299 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.14 -46.67 92.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 120.494 -0.482 . . . . 1.0 110.278 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.03 -35.37 80.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.053 0.454 . . . . 1.0 110.75 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -67.49 -49.63 62.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.596 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 119' ' ' ILE . 10.5 tp -70.18 -39.22 76.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.962 0.41 . . . . 1.0 110.459 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -64.24 -39.94 94.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.685 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -60.32 -48.5 81.49 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.548 -0.461 . . . . 1.0 110.31 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -62.76 -39.88 95.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.293 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.9 t -61.49 -42.39 98.72 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.578 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -59.6 -38.17 80.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.055 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.1 t -66.75 -42.28 89.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.658 -0.417 . . . . 1.0 109.974 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -126.26 76.49 72.69 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.217 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -71.29 -14.25 31.21 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 122.578 2.185 . . . . 1.0 112.441 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -103.54 10.17 37.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.655 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -132.98 148.58 52.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.861 0.362 . . . . 1.0 110.621 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 42.0 t -81.08 161.5 24.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.48 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.0 p -152.65 145.19 15.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -144.17 143.66 31.19 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.949 0.404 . . . . 1.0 111.12 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -151.35 161.98 41.75 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.372 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.481 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -132.65 154.86 49.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 179.146 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.1 t -152.54 168.41 25.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.93 0.395 . . . . 1.0 110.105 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.71 128.98 34.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.067 -0.515 . . . . 1.0 111.019 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 12.5 t-20 -87.34 135.68 33.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.902 0.382 . . . . 1.0 110.368 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -73.14 -39.64 65.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.971 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -62.44 -15.11 47.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.036 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.542 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 3.6 p30 -167.66 82.52 0.83 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.269 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.25 -37.14 58.92 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.124 1.883 . . . . 1.0 113.142 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -59.78 -34.74 83.78 Favored Glycine 0 C--N 1.312 -0.798 0 N-CA-C 110.956 -0.858 . . . . 1.0 110.956 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -99.72 144.77 28.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.88 0.372 . . . . 1.0 110.242 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -106.61 153.65 22.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.879 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.564 ' CZ ' ' ND2' ' A' ' 160' ' ' ASN . 4.0 m-85 -112.33 134.33 53.93 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.969 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.688 ' CD1' ' HE1' ' A' ' 159' ' ' TRP . 5.3 mt -112.55 123.34 50.08 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.709 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.561 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -123.55 148.89 45.9 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.469 -0.938 . . . . 1.0 108.469 178.21 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.56 ' CE1' ' CZ3' ' A' ' 159' ' ' TRP . 8.1 p90 -163.9 160.81 22.52 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.27 -0.572 . . . . 1.0 109.649 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -140.83 129.86 23.33 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.564 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mt -77.06 -44.94 31.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.282 -0.417 . . . . 1.0 111.592 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -154.35 165.68 35.6 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.372 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.91 -31.52 69.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.712 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -85.69 -4.34 59.14 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.043 0.449 . . . . 1.0 110.611 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 11.8 t -84.28 163.21 19.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.514 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.431 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 14.7 mptt -96.57 148.6 22.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.67 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 52.6 tp -70.23 118.81 13.53 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.36 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.438 ' O ' ' CD1' ' A' ' 148' ' ' PHE . 87.4 m-85 -113.66 119.37 37.22 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 146' ' ' LEU . 86.0 m -130.39 135.18 47.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.848 -0.615 . . . . 1.0 111.874 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.688 ' HE1' ' CD1' ' A' ' 146' ' ' LEU . 7.7 p90 -128.35 -173.94 3.09 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.462 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.564 ' ND2' ' CZ ' ' A' ' 145' ' ' TYR . 94.4 m-20 -124.82 152.7 43.59 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.445 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 169' ' ' PHE . 27.6 t -118.56 139.37 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -93.9 130.65 39.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.207 0.527 . . . . 1.0 110.948 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.8 tp -90.93 129.72 36.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.562 -0.745 . . . . 1.0 109.446 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 165' ' ' ASN . 0.1 OUTLIER -131.65 177.84 7.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.616 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.508 ' N ' ' OG1' ' A' ' 164' ' ' THR . 65.3 t30 -86.13 15.68 4.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.704 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 77.2 p -121.07 -1.7 9.78 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.575 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 132.87 -126.09 4.32 Favored Glycine 0 N--CA 1.464 0.533 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.434 ' CE1' HD21 ' A' ' 97' ' ' LEU . 22.5 m-85 -122.13 129.27 52.18 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.545 0.212 . . . . 1.0 110.517 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.437 ' O ' HG13 ' A' ' 161' ' ' VAL . 0.1 OUTLIER -105.54 120.77 42.47 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.0 tt -113.32 114.98 27.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.4 t 35.47 59.46 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.253 0.464 . . . . 1.0 112.253 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.8 m120 69.16 27.34 5.26 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.17 0.804 . . . . 1.0 113.17 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -134.89 119.19 17.76 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -99.73 124.9 45.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.84 0.353 . . . . 1.0 111.736 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -102.36 131.85 22.07 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.31 -0.626 . . . . 1.0 109.31 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.36 -18.41 29.95 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.193 1.929 . . . . 1.0 113.443 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 89.7 p -152.08 156.02 39.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.084 0.468 . . . . 1.0 110.908 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.16 -36.05 72.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.716 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.05 -43.32 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 120.909 0.385 . . . . 1.0 110.123 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -61.12 -35.12 76.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.25 -39.93 94.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.211 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' CYS . . . . . 0.552 ' SG ' ' NZ ' ' A' ' 106' ' ' LYS . 13.8 t -57.04 -48.4 78.62 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.271 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 186' ' ' LYS . 65.7 t30 -66.7 -47.61 71.84 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.21 -44.02 0.76 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.376 -1.49 . . . . 1.0 109.376 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -68.96 -47.58 65.28 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.387 0.613 . . . . 1.0 109.496 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 183' ' ' ASN . 63.1 tttm -55.97 -39.11 71.31 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.251 -0.886 . . . . 1.0 109.866 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 19.0 m -63.33 -47.18 83.29 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 75.6 mt -62.9 -42.71 99.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.108 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 45.0 tp -57.35 -46.53 83.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.719 -0.392 . . . . 1.0 110.29 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -56.19 -41.83 76.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.142 0.496 . . . . 1.0 109.857 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.1 t -66.59 -42.78 86.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.832 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.66 -45.55 86.26 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.595 -0.729 . . . . 1.0 112.177 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -67.81 -35.49 78.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.785 0.326 . . . . 1.0 111.826 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.577 -178.658 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.3 mmt-85 . . . . . 0 N--CA 1.465 0.306 0 CA-C-O 120.695 0.283 . . . . 1.0 110.627 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.67 -33.43 63.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.617 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.7 pt -81.48 -30.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.547 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -95.11 3.77 54.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.342 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -65.09 140.93 98.18 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.375 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.18 -12.89 35.07 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.92 1.747 . . . . 1.0 112.038 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -102.48 7.65 40.17 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.614 0.245 . . . . 1.0 111.152 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.529 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 30.6 t80 -90.95 127.76 36.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.442 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 65.1 m-85 -151.65 108.97 2.92 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.549 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 41.7 Cg_exo -57.56 108.18 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.712 1.608 . . . . 1.0 112.734 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 66.2 m-85 -160.94 157.97 27.34 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.64 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -79.09 163.87 24.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' OE1' ' A' ' 19' ' ' GLU . . . -55.48 -45.51 83.81 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.248 -0.977 . . . . 1.0 110.853 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -65.2 -39.66 93.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.868 0.366 . . . . 1.0 110.758 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.35 -33.83 76.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.498 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.06 -38.82 87.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.436 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.552 ' OE2' ' NE2' ' A' ' 55' ' ' HIS . 4.3 mp0 -67.09 -43.51 82.36 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.566 -0.454 . . . . 1.0 110.37 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.51 -46.15 91.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.227 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -61.02 -44.82 96.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.423 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 tp -75.36 -15.98 60.43 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.064 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -60.67 -42.13 96.46 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.393 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p -75.32 -18.63 59.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.627 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -82.22 179.83 7.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.621 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -90.1 154.72 19.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.812 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -68.05 143.45 55.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.759 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.0 10.09 43.62 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.223 -0.751 . . . . 1.0 111.223 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -91.68 156.43 17.6 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -125.11 155.72 39.43 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.295 0.569 . . . . 1.0 111.004 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 t -141.4 152.76 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 115.145 -0.934 . . . . 1.0 111.184 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.95 125.8 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -142.16 158.64 43.51 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.077 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.487 HE22 ' HG ' ' A' ' 42' ' ' LEU . 27.0 mm100 -103.15 131.17 50.36 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 37' ' ' ARG . 7.2 t -48.82 -12.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.918 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 34' ' ' GLN . 3.0 m 63.24 2.06 1.05 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.652 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.402 ' H ' ' C ' ' A' ' 35' ' ' SER . 34.4 ttm180 -154.47 58.88 0.7 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.629 -0.26 . . . . 1.0 110.582 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -157.62 -50.06 0.01 OUTLIER Glycine 0 N--CA 1.463 0.446 0 N-CA-C 110.384 -1.086 . . . . 1.0 110.384 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.9 t0 73.63 -28.3 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.796 0.331 . . . . 1.0 111.026 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 38' ' ' GLY . 36.3 t70 -121.59 20.26 11.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.984 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -142.19 141.42 32.57 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.826 0.346 . . . . 1.0 110.541 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.487 ' HG ' HE22 ' A' ' 34' ' ' GLN . 5.3 mp -120.57 144.65 47.97 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.095 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.8 t -126.16 130.78 72.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.217 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mt -112.06 139.47 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.5 m -118.25 132.2 56.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.391 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.555 ' CZ3' ' CD2' ' A' ' 48' ' ' LEU . 2.8 p-90 -146.15 143.68 29.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.989 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -92.52 140.72 29.27 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.961 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.555 ' CD2' ' CZ3' ' A' ' 46' ' ' TRP . 8.4 mt -103.67 -75.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.331 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -115.45 -176.88 3.01 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.263 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -66.21 130.23 42.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.932 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.4 t0 61.88 30.33 18.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.033 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.0 tp -137.8 126.04 23.11 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.874 0.369 . . . . 1.0 110.412 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -134.85 149.48 50.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.55 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -138.88 153.98 48.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.853 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.552 ' NE2' ' OE2' ' A' ' 19' ' ' GLU . 44.9 m80 -124.08 141.35 52.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.243 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.7 mt -121.53 124.8 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -98.2 122.07 40.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.662 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 80.8 mt -101.15 126.0 55.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.363 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -103.71 134.58 46.8 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.978 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -104.37 146.59 28.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 1.0 109.995 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.475 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 9.8 mt -142.15 166.47 24.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.764 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 1.5 tm-20 82.32 54.73 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.856 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -106.62 93.86 4.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.878 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.11 -35.12 77.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.898 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -145.71 156.5 52.28 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.973 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.16 -19.53 68.92 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.39 2.06 . . . . 1.0 112.104 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.548 ' H ' ' CG ' ' A' ' 65' ' ' ASN . 4.8 tp -83.26 -9.88 58.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.998 0.427 . . . . 1.0 110.931 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.582 ' N ' ' ND2' ' A' ' 65' ' ' ASN . . . -113.24 143.63 44.08 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.158 0.504 . . . . 1.0 110.17 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.515 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -90.55 168.94 11.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.319 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.34 109.69 2.86 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.417 ' NZ ' ' OE1' ' A' ' 62' ' ' GLU . 34.2 mtmm -72.8 -11.85 60.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.02 0.438 . . . . 1.0 110.727 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.1 t -118.3 120.68 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.816 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.4 mt -115.67 130.88 57.02 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.7 mt -102.47 121.08 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -140.88 132.92 30.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.201 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.572 ' OD2' ' ND2' ' A' ' 165' ' ' ASN . 46.8 t0 53.9 42.98 31.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.774 0.321 . . . . 1.0 110.997 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 59.79 22.87 11.77 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.826 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -128.56 143.75 51.02 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.254 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -98.12 126.98 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.872 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CG ' HG12 ' A' ' 86' ' ' ILE . 93.8 m-85 -120.32 137.48 54.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.167 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -85.29 -38.09 19.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.777 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -112.02 141.39 45.74 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.047 0.451 . . . . 1.0 112.11 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.97 -41.06 97.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.473 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 88' ' ' VAL . 60.9 m-20 -61.56 -39.75 92.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.793 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -59.89 -39.66 86.12 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.74 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.41 HG12 ' CG ' ' A' ' 80' ' ' TYR . 75.5 mt -61.68 -50.15 81.42 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 C-N-CA 120.352 -0.539 . . . . 1.0 111.113 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.58 -43.49 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.57 -0.452 . . . . 1.0 111.795 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.435 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 93.9 t -66.4 -22.23 29.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.112 -0.495 . . . . 1.0 112.15 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -100.18 -10.84 20.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.911 0.386 . . . . 1.0 111.011 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.84 -50.33 5.62 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.39 -0.524 . . . . 1.0 112.368 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 95' ' ' VAL . 7.6 mp -64.62 -45.38 87.12 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 112.802 0.667 . . . . 1.0 112.802 -176.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.474 ' HG3' ' N ' ' A' ' 93' ' ' ASN . 14.7 pt20 -64.8 -48.12 75.59 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.706 -0.798 . . . . 1.0 111.842 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.474 ' N ' ' HG3' ' A' ' 92' ' ' GLN . 58.1 t-20 -71.37 -43.08 67.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.649 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -66.56 -44.38 82.46 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.18 -0.608 . . . . 1.0 111.403 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 91' ' ' LEU . 76.7 t -66.5 -44.49 90.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.211 -0.596 . . . . 1.0 111.364 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -68.22 -43.11 78.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.489 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 tp -67.05 -41.02 87.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.427 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 mt -63.69 -43.85 95.41 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.272 -0.571 . . . . 1.0 110.5 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -68.78 -38.64 80.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.146 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -70.66 -43.48 69.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.954 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.3 tpt -66.1 -54.34 26.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.476 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 104' ' ' SER . 9.8 m -59.67 -40.36 87.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.085 0.469 . . . . 1.0 110.438 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.0 m -72.23 10.18 0.83 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.705 -0.68 . . . . 1.0 111.249 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 102' ' ' THR . 6.8 t -92.43 136.62 33.06 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.865 0.364 . . . . 1.0 110.274 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -60.82 -20.71 62.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.068 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.593 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 67.9 mttm -89.43 39.12 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.763 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -131.61 115.59 16.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.379 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -140.2 113.28 8.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.701 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.2 t -98.12 88.07 4.11 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.076 0.465 . . . . 1.0 110.916 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.98 171.13 14.67 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 115' ' ' VAL . 10.1 p -74.62 165.38 25.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -60.62 -39.75 89.36 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.805 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -67.43 -42.51 83.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.154 0.502 . . . . 1.0 110.803 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -70.73 -20.11 62.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.72 . . . . 1.0 111.045 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 111' ' ' THR . 18.0 t -70.43 -45.85 73.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.809 -0.356 . . . . 1.0 110.267 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.47 -45.03 98.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.102 0.477 . . . . 1.0 110.073 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.06 -34.4 78.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.993 0.425 . . . . 1.0 110.729 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -66.58 -49.98 64.57 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.915 -0.584 . . . . 1.0 111.85 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.9 tp -69.93 -38.91 76.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.476 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.552 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 66.5 mm-40 -63.89 -39.99 95.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.56 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -64.84 -47.27 78.55 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.601 -0.439 . . . . 1.0 110.345 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -60.25 -45.46 93.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.947 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.3 t -63.87 -38.14 89.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.319 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -58.36 -41.76 85.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.839 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.3 t -66.7 -41.95 88.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -123.6 75.83 54.97 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.505 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.91 -17.21 32.53 Favored 'Trans proline' 0 N--CA 1.488 1.157 0 C-N-CA 122.531 2.154 . . . . 1.0 112.2 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -101.64 22.37 12.88 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.577 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -143.64 151.56 40.27 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.862 0.363 . . . . 1.0 110.664 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 94.4 p -81.19 163.16 23.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.817 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 p -152.41 146.55 15.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.249 -0.648 . . . . 1.0 109.249 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -147.77 142.39 26.58 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.834 0.35 . . . . 1.0 111.208 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -152.93 171.4 18.38 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.374 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.593 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.8 p90 -141.05 158.52 43.81 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.25 -0.648 . . . . 1.0 109.25 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.8 p -151.74 168.28 25.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.824 0.345 . . . . 1.0 110.255 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.9 tp -80.27 129.41 34.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.588 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -72.07 156.86 38.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.272 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.43 ' CG ' ' N ' ' A' ' 139' ' ' ASP . 12.9 p-80 -96.18 -46.95 6.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.889 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.43 ' N ' ' CG ' ' A' ' 138' ' ' HIS . 95.0 m-20 -76.15 -7.52 54.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.21 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 139' ' ' ASP . 63.4 m-80 -160.86 70.11 2.7 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.37 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -49.55 -35.4 37.04 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.258 1.972 . . . . 1.0 112.711 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -60.55 -32.16 77.14 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.793 -0.923 . . . . 1.0 110.793 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -96.36 147.13 24.12 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.726 0.298 . . . . 1.0 110.219 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -113.2 152.32 29.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.704 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -123.18 139.94 53.54 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.972 0.415 . . . . 1.0 110.181 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.5 mt -108.79 121.37 44.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.291 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.537 ' SD ' HG13 ' A' ' 115' ' ' VAL . 5.0 ptt? -112.85 143.23 44.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.944 -1.132 . . . . 1.0 107.944 178.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -161.73 151.51 16.66 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.552 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 69.4 tttt -134.76 128.89 33.73 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.391 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.4 mp -69.53 -46.47 75.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.303 0.483 . . . . 1.0 112.303 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -159.48 173.98 15.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.515 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.84 74.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.836 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -86.81 8.15 24.01 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.385 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -96.3 165.54 12.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.441 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.48 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 61.2 mttp -99.22 149.85 22.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 1.0 109.928 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.7 tp -69.42 122.63 19.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.038 0.447 . . . . 1.0 109.871 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 87.9 m-85 -114.31 128.64 56.45 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.855 -0.611 . . . . 1.0 109.822 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 97.8 m -123.37 128.77 50.35 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.679 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -114.2 160.78 18.62 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.036 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -107.68 146.45 32.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.9 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 169' ' ' PHE . 42.4 t -128.82 135.98 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -97.72 133.34 42.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.049 0.452 . . . . 1.0 110.844 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 31.6 tp -95.68 130.3 42.61 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.4 p -133.47 178.28 7.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.055 0.455 . . . . 1.0 110.266 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.572 ' ND2' ' OD2' ' A' ' 76' ' ' ASP . 67.0 m-80 -86.17 17.16 3.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.663 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 13.4 p -121.2 -2.18 9.64 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.811 0.339 . . . . 1.0 110.626 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.02 -127.16 4.47 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.373 -1.091 . . . . 1.0 110.373 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -121.31 130.06 53.44 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 110.219 -0.289 . . . . 1.0 110.219 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.426 ' O ' HG13 ' A' ' 161' ' ' VAL . 2.8 m-85 -104.08 124.7 49.53 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 109.854 -0.425 . . . . 1.0 109.854 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.9 tt -119.02 115.18 23.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.535 -0.543 . . . . 1.0 109.535 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.425 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 3.5 t 40.73 57.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 111.976 0.361 . . . . 1.0 111.976 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.8 m120 65.2 27.28 12.26 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.906 0.706 . . . . 1.0 112.906 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.425 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 73.6 m-85 -134.72 121.52 20.89 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.62 131.49 37.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.45 -0.341 . . . . 1.0 111.199 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -112.34 96.12 34.14 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.79 -22.53 7.22 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.499 2.133 . . . . 1.0 113.292 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.8 p -133.66 138.24 45.78 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.846 0.355 . . . . 1.0 110.999 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.6 p -61.04 -33.08 54.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.772 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.1 mm -62.0 -45.88 97.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.937 0.399 . . . . 1.0 110.194 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -65.61 -32.36 73.89 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.87 -42.5 99.79 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.424 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 74.0 m -63.36 -46.38 86.8 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.704 -0.399 . . . . 1.0 110.378 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 186' ' ' LYS . 74.6 m-20 -66.94 -49.29 65.96 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 119.682 -0.807 . . . . 1.0 108.926 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.12 -45.13 0.59 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.706 -1.357 . . . . 1.0 109.706 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -69.26 -47.06 65.73 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.218 0.532 . . . . 1.0 109.752 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 183' ' ' ASN . 89.1 tttt -56.52 -41.41 76.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.481 -0.781 . . . . 1.0 109.922 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 86.7 m -60.79 -45.58 93.84 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.57 -41.42 98.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.813 -0.631 . . . . 1.0 110.036 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.16 -43.61 82.69 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.786 -0.366 . . . . 1.0 110.716 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -60.75 -42.96 98.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.15 0.5 . . . . 1.0 110.434 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 48.4 m -61.72 -38.59 88.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.634 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 87.3 mt -65.13 -39.19 92.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.594 -0.73 . . . . 1.0 112.233 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -64.07 -30.51 71.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.651 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.471 -0.331 . . . . 1.0 111.007 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.642 0.258 . . . . 1.0 110.53 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 p -63.5 -32.91 58.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.341 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.9 pt -79.28 -12.22 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.316 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -105.13 4.91 31.86 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.645 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.16 150.05 94.51 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.446 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 41.0 Cg_endo -66.01 -22.66 54.95 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.817 1.678 . . . . 1.0 112.261 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.537 ' CD1' ' CE2' ' A' ' 30' ' ' PHE . 25.4 m-85 -87.26 5.87 36.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.556 -0.293 . . . . 1.0 111.164 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.468 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 42.0 t80 -87.23 127.8 35.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.435 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.468 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 63.4 m-85 -149.19 108.87 3.42 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 109.935 -0.394 . . . . 1.0 109.935 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.526 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 33.3 Cg_exo -59.54 109.82 0.63 Allowed 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 121.548 1.499 . . . . 1.0 112.828 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 66.0 m-85 -159.2 150.46 20.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.405 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -77.9 164.25 25.31 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.452 -0.573 . . . . 1.0 109.452 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' OE2' ' A' ' 19' ' ' GLU . . . -59.07 -41.68 96.63 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -67.0 -42.7 84.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.743 0.306 . . . . 1.0 111.144 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -66.3 -35.95 81.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.136 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.46 88.38 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.741 -0.384 . . . . 1.0 110.33 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -59.47 -46.42 88.83 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.638 -0.425 . . . . 1.0 109.872 179.479 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.85 -44.97 94.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.168 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -61.69 -41.48 97.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.701 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.8 mp -79.69 -12.96 59.78 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.995 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.23 -42.41 99.23 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.76 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.5 m -79.48 -20.24 47.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.847 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -80.48 173.76 12.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 1.0 110.636 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.587 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.1 pm0 -85.16 170.11 13.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.492 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -80.22 145.77 32.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.88 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.67 -0.27 57.96 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -85.89 146.87 26.53 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.537 ' CE2' ' CD1' ' A' ' 9' ' ' TYR . 51.7 p90 -131.42 164.64 25.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.295 0.569 . . . . 1.0 111.108 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 32' ' ' ILE . 69.1 t -147.3 158.19 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.422 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.472 ' N ' HG12 ' A' ' 31' ' ' VAL . 79.1 mt -116.98 123.71 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -143.38 158.44 43.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.36 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.666 ' C ' ' H ' ' A' ' 36' ' ' SER . 97.1 mt-30 -109.65 148.25 31.67 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.927 -0.397 . . . . 1.0 109.927 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 37' ' ' ARG . 7.2 m -61.17 18.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.256 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.666 ' H ' ' C ' ' A' ' 34' ' ' GLN . 1.5 m 69.21 -42.12 0.49 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.769 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 35' ' ' SER . 79.4 mtp85 -121.51 11.39 10.62 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.915 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -71.5 -66.75 2.05 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.489 -1.045 . . . . 1.0 110.489 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 67.08 -45.82 0.47 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.217 0.532 . . . . 1.0 110.914 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 38' ' ' GLY . 52.5 t0 -93.28 -4.79 51.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.802 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -146.24 149.9 34.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.542 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.91 150.85 40.45 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.991 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.9 t -124.73 132.09 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.005 -0.368 . . . . 1.0 110.005 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.682 HD12 HD11 ' A' ' 58' ' ' ILE . 56.8 mt -110.85 138.18 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.43 HG23 ' ND1' ' A' ' 55' ' ' HIS . 90.5 m -119.21 138.13 53.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.777 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.441 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 3.8 p-90 -147.15 146.75 30.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.743 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.509 ' C ' HD12 ' A' ' 48' ' ' LEU . 86.1 tttt -92.48 138.61 31.37 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.209 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.509 HD12 ' C ' ' A' ' 47' ' ' LYS . 10.0 mp -103.54 -82.71 0.49 Allowed 'General case' 0 C--N 1.339 0.129 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.123 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -94.16 -175.27 3.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.557 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -58.33 -41.09 83.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.898 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -127.32 53.63 1.72 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.021 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.5 tp -150.01 131.71 14.98 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.796 0.331 . . . . 1.0 110.413 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -132.7 148.89 52.34 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.297 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -137.17 151.16 48.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.722 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.43 ' ND1' HG23 ' A' ' 45' ' ' THR . 10.2 m-70 -127.64 141.99 51.47 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.132 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 95.5 mt -121.56 124.2 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -92.96 121.58 34.45 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.039 0.447 . . . . 1.0 110.544 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.682 HD11 HD12 ' A' ' 44' ' ' ILE . 84.0 mt -99.94 129.58 50.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.453 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -116.15 125.12 51.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 1.0 109.88 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -101.58 143.49 31.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.332 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 84.6 mt -143.78 -179.39 6.43 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.463 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 75.76 50.59 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.034 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -95.49 125.88 40.4 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.779 -0.646 . . . . 1.0 109.945 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -69.72 -21.63 63.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.692 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.624 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 4.1 m-80 -157.62 165.14 19.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.061 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.54 -33.89 80.18 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.91 1.74 . . . . 1.0 112.451 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.7 mt -93.43 -4.45 51.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.575 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.624 ' HB3' ' H ' ' A' ' 65' ' ' ASN . . . -80.33 146.88 31.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.649 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.0 mt -89.47 157.41 18.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.213 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.57 126.66 8.64 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -85.67 -11.11 54.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.089 0.471 . . . . 1.0 110.582 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.43 120.18 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.571 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.1 mt -113.77 122.3 46.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.827 -0.624 . . . . 1.0 109.43 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 70.9 mt -101.82 124.39 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.985 -0.376 . . . . 1.0 109.985 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.1 t -142.63 133.31 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.261 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 77' ' ' ASN . 97.0 m-20 51.91 48.17 23.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.978 -0.289 . . . . 1.0 111.031 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.589 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 0.1 OUTLIER 55.25 21.69 4.23 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.384 0.428 . . . . 1.0 110.981 179.157 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -127.4 139.37 52.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.196 0.522 . . . . 1.0 110.155 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -88.53 134.38 33.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.002 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -129.2 138.11 51.52 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.421 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -78.66 -37.14 42.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.772 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 16.3 t0 -136.98 160.65 38.28 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.375 0.607 . . . . 1.0 111.637 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.511 ' C ' HD12 ' A' ' 83' ' ' LEU . 3.0 pp -71.93 -36.27 69.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.447 -0.797 . . . . 1.0 111.799 178.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 2.4 p30 -58.58 -41.94 86.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.93 0.715 . . . . 1.0 112.93 -176.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.455 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 6.1 pt20 -63.81 -38.33 90.68 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.632 0.253 . . . . 1.0 110.882 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.4 mt -61.27 -46.23 97.02 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 C-N-CA 120.485 -0.486 . . . . 1.0 110.882 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -61.62 -38.87 81.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 120.966 0.412 . . . . 1.0 111.49 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 84' ' ' ASP . 30.8 t -78.31 -32.73 17.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 112.799 0.666 . . . . 1.0 112.799 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -88.7 -13.8 38.82 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.739 -0.384 . . . . 1.0 111.61 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.651 ' CZ ' ' NZ ' ' A' ' 94' ' ' LYS . 11.0 t80 -96.69 -48.66 5.41 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.786 -0.365 . . . . 1.0 111.525 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 95' ' ' VAL . 4.3 mm? -71.21 -39.78 71.54 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.023 -0.535 . . . . 1.0 112.001 -177.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -63.81 -49.05 74.41 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.791 -0.764 . . . . 1.0 111.948 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -71.24 -42.72 68.49 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.616 -0.434 . . . . 1.0 111.863 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.651 ' NZ ' ' CZ ' ' A' ' 90' ' ' TYR . 21.1 mmtp -66.34 -42.12 88.6 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.274 -0.57 . . . . 1.0 111.285 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 91' ' ' LEU . 58.6 t -65.02 -45.68 93.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.253 -0.579 . . . . 1.0 111.277 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -68.06 -44.78 75.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.483 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 tp -66.7 -40.04 88.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.294 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.1 tp -64.36 -42.53 96.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.401 -0.52 . . . . 1.0 109.935 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -67.84 -38.1 82.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.143 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -71.28 -42.28 68.92 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.845 -0.342 . . . . 1.0 111.617 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.512 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 5.0 ttt -66.46 -54.63 21.89 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.641 -0.424 . . . . 1.0 111.241 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.43 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 20.4 m -57.86 -32.54 67.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.273 0.558 . . . . 1.0 110.531 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -75.03 10.63 1.39 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.342 -0.845 . . . . 1.0 111.612 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 93.3 p -91.44 133.93 35.06 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.895 0.379 . . . . 1.0 110.489 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -60.61 -20.48 60.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.777 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.56 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 69.2 mttm -87.71 40.28 0.93 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.714 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 102' ' ' THR . 0.4 OUTLIER -132.25 116.87 17.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.387 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.465 ' NZ ' ' CE1' ' A' ' 118' ' ' PHE . 50.5 mtpt -135.99 109.72 8.08 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 178.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.1 t -91.21 88.88 7.1 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.216 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.97 160.86 12.98 Favored Glycine 0 N--CA 1.466 0.641 0 N-CA-C 110.829 -0.909 . . . . 1.0 110.829 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.586 HG22 ' N ' ' A' ' 112' ' ' LYS . 56.7 m -71.52 165.38 23.99 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.862 -0.422 . . . . 1.0 109.862 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 111' ' ' THR . 49.3 tptt -55.04 -38.54 68.11 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.56 -0.456 . . . . 1.0 110.558 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -67.35 -45.09 77.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.403 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.9 -19.85 62.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.952 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 111' ' ' THR . 23.7 t -68.82 -44.54 81.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.89 -44.62 92.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.211 0.529 . . . . 1.0 110.075 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -64.98 -36.13 83.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.915 0.388 . . . . 1.0 110.63 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.465 ' CE1' ' NZ ' ' A' ' 108' ' ' LYS . 11.1 t80 -64.64 -51.07 64.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.754 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.6 tp -69.9 -38.91 76.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.02 0.438 . . . . 1.0 110.17 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.537 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 65.1 mm-40 -64.1 -42.74 96.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.667 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.89 -48.22 82.8 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.438 -0.505 . . . . 1.0 110.24 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -60.48 -39.34 87.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.716 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.0 t -59.62 -40.99 89.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.228 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -62.17 -38.6 89.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.972 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.3 t -64.12 -43.31 97.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -130.24 74.59 80.24 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.226 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.6 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 7.7 Cg_exo -69.81 -23.6 30.38 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.894 2.396 . . . . 1.0 112.77 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -88.78 -14.38 37.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.981 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -112.59 153.96 26.75 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.144 0.497 . . . . 1.0 110.563 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.7 t -80.65 164.83 22.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.555 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 p -151.86 148.44 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -144.42 142.96 30.68 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.976 0.417 . . . . 1.0 111.213 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -151.65 167.91 26.66 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.294 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.56 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 2.1 p90 -140.53 155.28 46.67 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.2 m -155.66 171.75 19.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.343 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 51.3 tp -80.38 134.61 36.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.651 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.614 HD22 ' HB3' ' A' ' 140' ' ' ASN . 22.7 p-10 -95.8 140.51 30.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.797 0.332 . . . . 1.0 110.348 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.455 ' ND1' ' N ' ' A' ' 138' ' ' HIS . 2.1 m80 -89.1 -28.75 19.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.712 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.66 -31.01 69.15 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.276 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.614 ' HB3' HD22 ' A' ' 137' ' ' ASN . 17.7 t-20 -147.53 105.75 3.76 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.74 136.73 26.02 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.76 1.64 . . . . 1.0 112.691 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.11 -25.12 26.12 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -98.13 152.28 19.5 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.908 0.385 . . . . 1.0 110.246 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.512 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 91.5 m-85 -119.57 156.25 30.68 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.465 -0.568 . . . . 1.0 109.465 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -130.53 145.09 51.79 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.034 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.2 mt -111.06 121.74 46.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.893 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 11.7 ptp -110.43 140.93 44.19 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.686 -1.227 . . . . 1.0 107.686 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -161.47 153.35 19.4 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.384 -0.527 . . . . 1.0 109.59 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.537 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 33.8 mtpt -136.67 131.87 34.19 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.764 0.316 . . . . 1.0 110.604 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 23.7 mm -72.31 -45.13 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.355 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 8.0 m120 -157.81 170.58 22.04 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.495 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.37 -26.54 65.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.764 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -87.53 -10.24 52.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.056 0.455 . . . . 1.0 110.35 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 23.8 t -80.58 155.03 27.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.533 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.75 156.93 18.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.894 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.5 tp -69.99 115.98 9.83 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.188 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -107.38 130.32 54.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.628 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.3 m -126.29 130.11 50.2 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.809 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -112.95 156.91 22.19 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.025 -0.534 . . . . 1.0 109.786 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -106.38 146.22 30.73 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.867 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.82 137.7 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -99.1 135.42 40.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.854 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.17 130.71 44.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 81.4 p -129.27 172.35 11.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.332 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -85.64 18.07 3.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.871 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.07 -2.63 8.15 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.594 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 141.63 -129.73 4.1 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -125.25 132.29 52.98 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.815 0.341 . . . . 1.0 110.175 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -106.5 123.51 48.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.14 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.9 tt -119.02 117.89 30.0 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.36 -0.608 . . . . 1.0 109.36 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.2 t 36.02 52.02 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 111.89 0.329 . . . . 1.0 111.89 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.0 m120 71.98 26.66 2.85 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.105 0.78 . . . . 1.0 113.105 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -133.24 118.77 18.99 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.341 -0.614 . . . . 1.0 109.341 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -93.31 121.14 34.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.46 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -100.56 132.47 22.31 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -71.93 -18.96 27.49 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 C-N-CA 122.12 1.88 . . . . 1.0 113.33 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 35.4 m -153.47 157.12 39.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.966 0.412 . . . . 1.0 111.013 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.58 -33.97 62.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.957 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.4 mm -60.05 -46.64 94.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.89 -0.324 . . . . 1.0 110.548 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -68.84 -29.95 68.38 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 48.5 tp -64.81 -42.21 95.18 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.457 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' CYS . . . . . 0.607 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 8.1 p -62.44 -47.63 83.23 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.768 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.607 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 44.6 t-20 -66.38 -46.9 75.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.974 -0.75 . . . . 1.0 108.974 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.87 -45.54 0.82 Allowed Glycine 0 C--N 1.334 0.437 0 N-CA-C 110.021 -1.232 . . . . 1.0 110.021 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -69.03 -46.83 66.94 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 183' ' ' ASN . 88.4 tttt -55.49 -40.1 71.27 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.841 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.3 m -60.95 -44.76 96.82 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.54 -40.82 98.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.826 -0.625 . . . . 1.0 109.963 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 40.9 tp -57.46 -42.25 82.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.412 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -63.12 -43.07 99.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.132 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.0 t -63.52 -39.37 94.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.394 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.83 -43.31 99.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.463 -0.79 . . . . 1.0 112.064 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -68.2 -29.37 68.21 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.815 0.302 . . . . 1.0 111.815 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 1.6 t60 . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.847 -179.332 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 . . . . . 0 N--CA 1.466 0.337 0 CA-C-O 120.83 0.347 . . . . 1.0 110.565 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.36 -34.85 71.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.573 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.7 pt -79.3 -14.02 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.347 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -89.84 -4.72 57.45 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.471 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -81.38 138.34 48.32 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.393 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.54 -16.1 46.45 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.898 1.732 . . . . 1.0 112.272 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.502 ' CD1' ' CE2' ' A' ' 30' ' ' PHE . 96.0 m-85 -93.13 8.91 38.18 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.281 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 87.6 t80 -88.45 127.42 35.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.498 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 61.2 m-85 -149.28 126.12 5.39 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.525 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 74.1 Cg_endo -73.36 107.67 2.44 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.433 1.422 . . . . 1.0 112.853 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.525 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 43.8 m-85 -162.76 152.49 15.81 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.522 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -88.33 -176.23 5.28 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.62 -40.63 99.39 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.314 -0.946 . . . . 1.0 111.377 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.512 ' HB2' HE22 ' A' ' 17' ' ' GLN . 83.5 mtp180 -61.97 -48.17 81.55 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.894 -0.323 . . . . 1.0 111.189 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.685 ' NE2' ' N ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -69.63 -30.93 68.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.291 -179.501 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.441 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.72 -46.04 91.35 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.651 -0.42 . . . . 1.0 110.292 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE2' ' CE1' ' A' ' 53' ' ' PHE . 81.2 tt0 -65.48 -41.07 93.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.67 -0.412 . . . . 1.0 109.996 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -62.24 -43.34 99.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.083 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -62.52 -44.89 95.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.455 -0.339 . . . . 1.0 110.536 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 18' ' ' ALA . 6.8 mp -73.37 -13.32 61.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.971 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 ttp85 -59.6 -43.21 93.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.956 0.408 . . . . 1.0 110.589 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.5 t -77.46 -19.15 56.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.829 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -86.41 -174.75 5.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.47 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 55.9 mp0 -104.54 -176.67 3.14 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.672 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -81.53 146.6 30.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.804 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.85 -1.02 59.44 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.175 -0.77 . . . . 1.0 111.175 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -85.58 148.62 25.84 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.066 -0.716 . . . . 1.0 109.066 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CE2' ' CD1' ' A' ' 9' ' ' TYR . 51.9 p90 -136.26 163.12 31.13 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.363 0.602 . . . . 1.0 110.965 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.2 m -147.68 158.89 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 114.98 -1.009 . . . . 1.0 111.645 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 79.0 mt -117.79 124.73 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -143.96 157.42 44.35 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.315 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.551 ' C ' ' H ' ' A' ' 36' ' ' SER . 35.3 mt-30 -108.76 142.54 39.16 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.867 -0.419 . . . . 1.0 109.867 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 37' ' ' ARG . 28.3 m -60.46 5.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.865 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.551 ' H ' ' C ' ' A' ' 34' ' ' GLN . 0.2 OUTLIER 71.72 -47.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.451 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.401 ' H ' ' C ' ' A' ' 35' ' ' SER . 35.4 ptt180 -100.02 0.29 40.65 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.891 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -73.4 -68.42 1.59 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.425 -1.07 . . . . 1.0 110.425 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 t70 69.23 -36.36 0.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.661 0.267 . . . . 1.0 110.799 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.528 ' H ' ' C ' ' A' ' 38' ' ' GLY . 95.2 m-20 -106.66 1.64 25.28 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -148.04 148.66 30.92 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.469 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.7 152.84 37.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.916 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.92 132.99 70.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.275 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.07 139.24 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.503 HG23 ' ND1' ' A' ' 55' ' ' HIS . 85.1 m -118.95 139.38 51.76 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.551 ' CZ2' ' NZ ' ' A' ' 94' ' ' LYS . 5.7 p-90 -148.65 144.93 27.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.415 -0.811 . . . . 1.0 111.027 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' C ' HD12 ' A' ' 48' ' ' LEU . 87.3 tttt -91.58 141.22 28.95 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.807 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.3 mp -97.85 -71.99 0.66 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.42 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 50' ' ' LYS . 62.3 t0 -162.01 146.46 12.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.144 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.543 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 1.1 ttmp? 46.54 -145.93 0.2 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.948 0.404 . . . . 1.0 111.126 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -79.79 68.95 6.02 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.81 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.8 tp -149.3 126.51 11.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.848 0.356 . . . . 1.0 110.426 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CE1' ' OE2' ' A' ' 19' ' ' GLU . 64.0 m-85 -132.32 149.1 52.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.43 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -135.78 152.7 51.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.031 -0.531 . . . . 1.0 109.666 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.513 ' O ' HD12 ' A' ' 56' ' ' ILE . 25.6 m-70 -128.07 142.68 51.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.302 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.513 HD12 ' O ' ' A' ' 55' ' ' HIS . 1.4 mp -118.88 122.54 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -92.23 120.58 32.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.053 0.454 . . . . 1.0 110.804 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.1 mm -99.34 131.68 46.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.41 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -114.4 136.57 52.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.024 -0.534 . . . . 1.0 109.833 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -100.54 152.92 19.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.119 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.429 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 3.1 tt -142.97 161.19 38.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.898 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.429 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 18.4 tt0 79.51 60.64 0.02 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.142 0.496 . . . . 1.0 109.781 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -106.55 103.31 12.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.0 -0.546 . . . . 1.0 109.725 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -70.43 -34.45 72.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.75 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 68' ' ' ALA . 15.6 p30 -161.16 157.0 21.66 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.42 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.96 -28.03 22.82 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.212 1.941 . . . . 1.0 112.193 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 67' ' ' LEU . 10.9 mp -83.93 -11.45 56.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.998 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 65' ' ' ASN . . . -92.7 140.15 29.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.318 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.8 mt -90.15 158.25 17.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.284 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.89 108.8 2.64 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.678 -0.969 . . . . 1.0 110.678 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -76.18 -18.29 59.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.834 0.35 . . . . 1.0 110.782 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.1 t -116.56 122.92 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.915 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.4 mt -116.3 133.92 55.48 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.6 mt -103.06 124.98 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.864 0.364 . . . . 1.0 110.076 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.7 133.7 32.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.411 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 t70 52.23 41.92 30.52 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.827 -0.349 . . . . 1.0 111.094 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 61.26 22.84 13.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.965 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -128.48 156.75 42.74 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.177 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -102.67 130.07 49.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.05 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.493 ' CD2' HD11 ' A' ' 86' ' ' ILE . 84.7 m-85 -129.24 139.37 51.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.253 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -86.55 -37.26 18.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.816 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -109.3 134.95 51.16 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.127 0.489 . . . . 1.0 112.312 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 46.9 tp -65.49 -38.1 88.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.559 -0.746 . . . . 1.0 110.722 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 4.6 p30 -58.6 -33.65 70.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 1.0 111.875 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.45 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 89.4 mt-30 -64.51 -37.98 89.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.696 0.284 . . . . 1.0 110.658 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.493 HD11 ' CD2' ' A' ' 80' ' ' TYR . 49.0 mm -59.58 -49.48 83.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.146 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 72.2 mt -62.94 -43.61 99.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.15 -0.62 . . . . 1.0 111.414 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 84' ' ' ASP . 61.4 t -70.36 -41.14 78.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 -178.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -80.23 -15.58 56.69 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.818 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -94.02 -49.88 5.57 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.56 -0.456 . . . . 1.0 111.799 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.495 ' HA ' HD13 ' A' ' 91' ' ' LEU . 4.3 mm? -68.6 -40.06 80.62 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.463 0.542 . . . . 1.0 112.463 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -63.38 -49.28 74.44 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.67 -0.812 . . . . 1.0 111.631 -177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -65.96 -43.11 88.88 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.851 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.551 ' NZ ' ' CZ2' ' A' ' 46' ' ' TRP . 25.6 mmtp -65.93 -42.57 89.91 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.458 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 91' ' ' LEU . 56.7 t -65.58 -45.88 91.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.32 -0.552 . . . . 1.0 111.407 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -67.32 -46.56 73.14 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.598 -0.441 . . . . 1.0 111.47 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.9 tp -67.92 -40.12 83.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.627 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.39 -43.32 91.05 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.544 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -68.86 -35.63 77.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.404 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -70.61 -42.52 70.86 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.921 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 13.6 ttm -71.22 -53.04 15.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.484 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.442 HG23 ' CE2' ' A' ' 107' ' ' PHE . 9.0 m -57.11 -39.83 75.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.05 0.453 . . . . 1.0 110.222 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.7 m -71.45 9.72 0.76 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.888 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 102' ' ' THR . 8.3 t -92.74 133.23 36.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.276 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -60.82 -18.42 55.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.086 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.558 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 99.0 mttt -91.85 41.01 1.06 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.055 -0.521 . . . . 1.0 109.718 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.442 ' CE2' HG23 ' A' ' 102' ' ' THR . 82.7 t80 -134.69 118.18 16.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.285 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -138.15 114.81 10.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.074 -0.512 . . . . 1.0 109.732 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.5 p -93.44 91.84 7.34 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.062 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.83 166.63 13.02 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.844 -0.903 . . . . 1.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 115' ' ' VAL . 82.5 p -76.8 163.44 26.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -56.05 -35.55 67.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.826 0.346 . . . . 1.0 110.764 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -68.58 -43.89 75.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.145 0.498 . . . . 1.0 110.768 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -71.26 -19.26 62.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.013 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 111' ' ' THR . 38.7 t -70.74 -44.55 76.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 110.04 -0.355 . . . . 1.0 110.04 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.68 -45.57 91.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.063 0.459 . . . . 1.0 110.416 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.59 -36.9 85.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.845 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -65.1 -50.12 67.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.888 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 120' ' ' GLU . 10.8 tp -70.35 -40.01 77.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.447 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.409 ' N ' HG23 ' A' ' 119' ' ' ILE . 93.1 mt-10 -64.47 -45.06 89.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.589 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -60.54 -48.46 81.66 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.007 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.55 ' CD1' ' OD1' ' A' ' 126' ' ' ASN . 23.9 t80 -60.86 -42.06 97.11 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.646 -0.501 . . . . 1.0 109.646 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.5 t -59.93 -42.68 94.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.596 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -60.09 -39.95 87.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.356 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.92 -41.3 91.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.55 ' OD1' ' CD1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -118.95 76.42 14.59 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.31 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.526 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 37.4 Cg_endo -72.44 -21.16 23.05 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 122.398 2.065 . . . . 1.0 112.346 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -106.81 18.24 22.11 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.71 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -138.16 152.01 48.28 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.881 0.372 . . . . 1.0 110.654 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.412 ' OG ' HD21 ' A' ' 189' ' ' LEU . 4.0 t -81.74 163.19 22.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.89 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -154.19 145.43 14.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.168 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -148.49 144.34 27.3 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.784 0.326 . . . . 1.0 111.053 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -151.69 167.37 28.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.406 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.558 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -139.71 155.83 47.13 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 179.13 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.436 ' OG ' ' CZ ' ' A' ' 145' ' ' TYR . 15.0 p -152.07 169.4 22.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.405 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.1 tp -79.43 130.33 35.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.889 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -77.82 114.51 16.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.351 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -73.31 -36.14 66.2 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.591 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -65.91 -26.2 67.5 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.098 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -139.81 84.27 15.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.77 129.72 36.12 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.079 1.853 . . . . 1.0 112.346 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.94 -24.25 23.73 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.121 -0.791 . . . . 1.0 111.121 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -99.26 150.99 21.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.79 0.328 . . . . 1.0 110.263 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -123.76 160.84 26.41 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.954 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.47 ' N ' ' CD1' ' A' ' 145' ' ' TYR . 4.7 p90 -142.89 148.3 36.75 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.343 0.402 . . . . 1.0 109.929 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.9 mt -110.07 131.47 55.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.161 0.505 . . . . 1.0 110.497 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.45 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -118.85 145.32 45.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 177.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -161.93 154.47 19.86 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.479 -0.488 . . . . 1.0 109.705 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -139.77 127.31 21.62 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.514 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.443 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 3.3 mp -68.88 -44.62 81.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.091 0.404 . . . . 1.0 112.091 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 27.4 m120 -159.22 175.31 13.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.54 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.79 -31.94 73.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -84.31 -12.61 54.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.518 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.447 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 16.7 t -80.03 146.28 32.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.327 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -79.64 151.18 30.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.93 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.53 127.81 34.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.997 0.427 . . . . 1.0 110.178 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -114.63 130.84 56.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.663 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 86.4 m -126.3 129.08 48.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.838 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -116.06 154.53 29.76 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.77 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -105.19 141.67 36.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.796 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.94 132.89 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -95.41 136.17 36.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.704 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.5 tp -98.2 131.09 44.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.06 -0.518 . . . . 1.0 109.712 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 46.1 p -131.17 163.84 26.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.356 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -76.98 16.3 0.56 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.542 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 14.8 p -122.1 -1.26 9.31 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.791 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 138.43 -129.42 4.53 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.289 -1.124 . . . . 1.0 110.289 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -126.03 130.83 51.94 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.588 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 5.8 m-85 -107.99 123.04 48.06 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.3 tt -115.32 119.24 35.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.079 -0.51 . . . . 1.0 109.638 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.2 t 34.86 52.91 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 112.132 0.419 . . . . 1.0 112.132 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.2 m120 72.47 27.37 2.42 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.074 0.768 . . . . 1.0 113.074 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -135.54 120.66 18.84 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.588 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 15.6 t-20 -91.23 131.7 36.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.156 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -112.0 95.29 28.76 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 109.545 -0.539 . . . . 1.0 109.545 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.84 -20.34 6.71 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.296 1.998 . . . . 1.0 113.536 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 48.8 m -135.66 139.76 43.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.885 0.374 . . . . 1.0 111.094 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.0 p -62.78 -34.8 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.706 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.08 -44.16 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-O 120.904 0.383 . . . . 1.0 110.124 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.36 -33.83 76.75 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.99 -39.87 94.12 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.539 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 71.8 m -61.59 -48.03 82.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.598 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 186' ' ' LYS . 41.5 t30 -69.6 -48.84 58.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.872 -0.788 . . . . 1.0 108.872 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.56 -45.96 0.54 Allowed Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.788 -1.325 . . . . 1.0 109.788 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -68.01 -47.76 67.58 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.204 0.526 . . . . 1.0 109.657 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 183' ' ' ASN . 19.3 ttpp -56.6 -41.26 76.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.427 -0.806 . . . . 1.0 110.019 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 94.3 m -61.16 -45.63 93.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.84 -41.07 99.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.908 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.412 HD21 ' OG ' ' A' ' 130' ' ' SER . 57.2 tp -58.25 -43.37 87.82 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.806 -0.357 . . . . 1.0 110.719 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -58.7 -45.74 88.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.153 0.501 . . . . 1.0 110.205 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 58.5 m -62.84 -39.6 94.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.476 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.49 -39.06 93.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.592 -0.731 . . . . 1.0 112.062 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.78 -24.58 61.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.83 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.084 -179.349 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.816 0.341 . . . . 1.0 110.83 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 p -69.12 -33.81 60.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.601 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.6 pt -58.19 -13.95 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.658 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -134.79 24.97 3.67 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.399 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.3 147.43 58.0 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.495 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -50.88 -34.22 44.58 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.626 1.55 . . . . 1.0 112.321 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -88.74 10.14 21.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.391 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.49 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 42.5 t80 -91.17 129.07 37.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.55 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 65.2 m-85 -149.75 132.25 8.01 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.8 113.55 3.79 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.761 1.641 . . . . 1.0 112.701 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 18' ' ' ALA . 12.0 p90 -154.18 162.0 41.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.703 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.44 ' H ' ' HB2' ' A' ' 17' ' ' GLN . 66.7 t30 -90.23 172.76 8.56 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.699 ' N ' HH12 ' A' ' 33' ' ' ARG . . . -58.31 -51.26 59.66 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.734 -0.946 . . . . 1.0 110.734 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -65.82 -39.06 90.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.676 0.274 . . . . 1.0 110.817 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.44 ' HB2' ' H ' ' A' ' 14' ' ' ASN . 88.1 mm-40 -65.59 -32.48 74.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.388 . . . . 1.0 111.289 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.558 ' HB2' ' CD1' ' A' ' 13' ' ' PHE . . . -61.15 -45.86 92.93 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.282 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.69 -40.88 92.78 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.662 -0.415 . . . . 1.0 109.99 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -63.06 -45.75 90.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.296 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -60.56 -42.37 96.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.542 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.7 mp -80.54 -13.29 59.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.893 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -61.72 -41.63 97.88 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.542 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.0 p -77.22 -17.17 58.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.903 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -82.85 177.86 8.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.664 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -95.31 178.22 5.59 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.713 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.476 ' NH2' ' OD1' ' A' ' 99' ' ' ASN . 60.5 ttp180 -76.17 144.73 40.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.053 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.12 26.16 17.14 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.312 -0.715 . . . . 1.0 111.312 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -112.13 142.03 45.09 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.121 -0.696 . . . . 1.0 109.121 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -134.08 169.62 16.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.499 0.666 . . . . 1.0 111.052 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.69 ' O ' HG23 ' A' ' 44' ' ' ILE . 15.3 m -148.41 160.21 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 114.971 -1.013 . . . . 1.0 111.812 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.0 mm -115.87 130.4 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.699 HH12 ' N ' ' A' ' 15' ' ' GLY . 69.5 ttt180 -143.36 154.22 43.51 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.107 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -115.15 138.02 51.37 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 t -82.93 126.49 32.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.861 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.6 t -62.65 -43.42 98.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.672 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.415 ' HD3' ' H ' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -73.75 -23.68 59.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.012 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -123.21 55.45 0.69 Allowed Glycine 0 N--CA 1.466 0.661 0 N-CA-C 110.611 -0.996 . . . . 1.0 110.611 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -59.14 -0.55 0.13 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.84 0.352 . . . . 1.0 110.731 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 38' ' ' GLY . 73.0 m-20 -96.38 -2.34 45.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.663 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -140.78 164.84 29.13 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.192 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.01 146.95 46.16 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.246 -0.434 . . . . 1.0 109.905 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.421 HG22 ' OD1' ' A' ' 57' ' ' ASP . 58.1 t -125.97 132.05 71.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.792 0.329 . . . . 1.0 110.271 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 31' ' ' VAL . 59.6 mt -112.94 138.95 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.6 m -117.54 138.73 51.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.225 0.536 . . . . 1.0 109.647 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.491 ' CZ2' HD11 ' A' ' 48' ' ' LEU . 3.3 p-90 -145.33 156.78 44.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.687 -0.688 . . . . 1.0 110.784 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' C ' HD12 ' A' ' 48' ' ' LEU . 25.1 ttpp -104.67 136.2 44.64 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.292 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.3 mp -97.1 -68.49 0.8 Allowed 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.048 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -106.66 -165.19 1.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.156 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.467 ' HD3' ' H ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -78.66 -17.7 55.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.674 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 68.0 t0 -139.68 48.11 1.83 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.783 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.7 tp -155.69 133.47 11.21 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.926 0.394 . . . . 1.0 110.425 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -134.1 149.77 51.12 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.59 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.507 ' OE1' HD21 ' A' ' 48' ' ' LEU . 65.1 mt-30 -139.26 154.69 48.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.825 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -127.03 142.49 51.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.212 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.51 121.34 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 109.708 -0.478 . . . . 1.0 109.708 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD1' HG22 ' A' ' 43' ' ' VAL . 95.8 m-20 -92.51 121.7 34.22 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.976 0.417 . . . . 1.0 110.615 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.2 mt -104.04 127.6 58.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.244 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -118.58 133.4 55.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.987 0.422 . . . . 1.0 109.92 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 40' ' ' ASP . 1.4 mp0 -99.97 144.63 28.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.015 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 70' ' ' GLY . 81.4 mt -146.4 167.24 24.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.627 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 17.4 tp10 81.04 17.28 0.52 Allowed 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.47 0.481 . . . . 1.0 109.89 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -54.97 116.72 2.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.194 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -73.27 -23.72 60.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.713 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -157.71 153.95 23.88 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.115 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -58.74 -26.54 80.27 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.29 1.993 . . . . 1.0 112.134 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.6 mt -98.17 -1.87 41.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.464 -0.334 . . . . 1.0 110.607 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.93 160.26 14.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.949 0.404 . . . . 1.0 110.335 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.6 mt -72.75 160.66 31.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.387 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 71' ' ' LYS . . . -60.89 -33.35 83.12 Favored Glycine 0 C--O 1.224 -0.499 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 70' ' ' GLY . 41.1 tttm 84.73 -31.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.061 0.457 . . . . 1.0 110.654 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.44 123.88 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.563 -0.744 . . . . 1.0 110.702 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.2 mt -112.82 122.85 48.88 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.476 -0.565 . . . . 1.0 109.476 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.5 mt -101.24 123.11 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.826 0.346 . . . . 1.0 110.219 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.12 130.48 29.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.233 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 165' ' ' ASN . 42.1 t0 53.66 45.35 28.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 1.0 111.116 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.9 m120 58.1 23.23 9.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.908 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -128.12 139.28 52.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.931 0.396 . . . . 1.0 110.252 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -89.62 133.37 34.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.976 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -123.96 138.57 54.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.333 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -85.4 -36.64 20.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.566 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -127.25 150.34 49.59 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.207 0.527 . . . . 1.0 111.857 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.7 tp -63.52 -39.2 93.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.671 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -58.18 -44.27 87.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.757 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -58.9 -37.87 77.6 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 110.34 -0.245 . . . . 1.0 110.34 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.408 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 96.9 mt -63.1 -45.86 97.57 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 C-N-CA 120.428 -0.509 . . . . 1.0 111.008 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.6 mt -68.1 -44.24 84.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 120.526 -0.47 . . . . 1.0 111.585 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.7 t -77.8 -36.21 22.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 113.029 0.752 . . . . 1.0 113.029 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -84.78 -12.89 52.74 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.886 -0.325 . . . . 1.0 111.743 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 23.1 t80 -98.2 -48.22 5.17 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.564 -0.455 . . . . 1.0 111.727 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.443 ' HA ' HD13 ' A' ' 91' ' ' LEU . 4.5 mm? -69.16 -40.15 78.35 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.316 0.487 . . . . 1.0 112.316 -177.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -62.73 -48.81 77.59 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.852 -0.739 . . . . 1.0 111.478 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -66.91 -42.47 85.35 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.599 -0.44 . . . . 1.0 111.814 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -65.51 -43.65 89.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.097 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 91' ' ' LEU . 76.1 t -65.31 -44.33 94.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.405 -0.518 . . . . 1.0 111.018 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -68.0 -47.29 68.93 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.594 -0.442 . . . . 1.0 111.621 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.551 HD21 ' CZ ' ' A' ' 168' ' ' TYR . 3.7 tp -68.05 -39.78 82.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.248 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.07 -43.13 96.37 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.314 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.476 ' OD1' ' NH2' ' A' ' 27' ' ' ARG . 94.3 m-20 -66.94 -37.71 84.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.035 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -71.01 -42.01 70.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.755 -0.378 . . . . 1.0 111.748 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.5 ttt -66.12 -54.98 18.88 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.494 -0.482 . . . . 1.0 111.458 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 84.0 m -59.15 -40.64 86.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.043 0.449 . . . . 1.0 110.33 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.1 t -73.1 10.19 1.01 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.056 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.0 t -91.53 138.43 31.58 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.754 0.311 . . . . 1.0 110.256 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.75 -16.92 59.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.169 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.561 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 57.4 mmtt -93.87 38.57 1.07 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.056 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -133.08 116.76 16.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.045 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.497 ' NZ ' ' CE1' ' A' ' 118' ' ' PHE . 48.6 mtpt -133.2 128.83 36.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.951 -0.568 . . . . 1.0 109.901 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.4 p -96.64 77.66 2.9 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.912 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -111.29 151.8 17.72 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.946 -0.861 . . . . 1.0 110.946 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 115' ' ' VAL . 58.1 p -73.5 168.29 19.58 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -55.46 -36.49 66.64 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.876 -0.33 . . . . 1.0 110.813 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -68.18 -44.18 76.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.625 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.53 -20.83 63.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.878 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 111' ' ' THR . 53.1 t -70.54 -44.95 76.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.746 -0.382 . . . . 1.0 110.186 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.8 t -64.31 -46.71 92.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-O 121.057 0.456 . . . . 1.0 110.334 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -65.86 -34.84 79.06 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.957 0.408 . . . . 1.0 110.821 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.497 ' CE1' ' NZ ' ' A' ' 108' ' ' LYS . 25.0 t80 -66.73 -50.11 63.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.914 -0.584 . . . . 1.0 111.667 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.434 HD11 HG13 ' A' ' 131' ' ' VAL . 11.2 tp -70.31 -39.86 77.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.96 0.41 . . . . 1.0 110.35 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -65.1 -40.06 94.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.646 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -63.61 -47.85 79.73 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.504 -0.478 . . . . 1.0 110.291 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -61.89 -41.77 98.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.012 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 90.6 p -64.53 -34.89 79.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.221 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -63.56 -41.21 98.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.166 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.3 t -67.18 -42.06 87.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.766 -0.457 . . . . 1.0 109.766 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -124.83 75.62 65.51 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.351 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.3 -13.71 30.9 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.676 2.251 . . . . 1.0 112.345 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -103.79 13.7 32.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.622 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -134.88 149.84 50.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.052 0.453 . . . . 1.0 110.576 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.5 p -80.58 161.78 24.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.803 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.434 HG13 HD11 ' A' ' 119' ' ' ILE . 3.2 p -153.32 148.13 13.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -148.05 142.84 26.73 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.887 0.375 . . . . 1.0 111.2 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -152.1 166.48 31.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.438 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.561 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.2 p90 -140.06 157.27 45.91 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 30.9 p -150.6 168.3 24.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.799 0.333 . . . . 1.0 110.237 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.3 tp -81.7 131.25 35.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.118 -0.492 . . . . 1.0 111.015 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -79.94 111.86 16.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.409 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.46 -45.19 69.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.899 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.84 -20.39 65.04 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.195 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -141.79 82.65 13.62 Favored Pre-proline 0 N--CA 1.463 0.193 0 N-CA-C 110.018 -0.364 . . . . 1.0 110.018 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.51 137.75 51.92 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.815 1.677 . . . . 1.0 112.5 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.5 -17.34 53.6 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -109.58 145.42 36.4 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.891 0.377 . . . . 1.0 109.989 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -120.51 159.79 24.47 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 115.992 -0.549 . . . . 1.0 109.806 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 145' ' ' TYR . 4.3 p90 -142.63 148.01 36.73 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 123.382 0.426 . . . . 1.0 110.017 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.02 132.52 54.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.129 0.49 . . . . 1.0 110.46 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.507 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -121.65 146.89 46.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 178.109 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -160.89 155.17 23.09 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -140.26 129.06 23.18 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.69 -0.404 . . . . 1.0 110.502 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.484 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.5 mp -72.62 -48.71 45.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.217 0.451 . . . . 1.0 112.217 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 150' ' ' ILE . 86.5 m-20 -153.35 170.31 20.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.474 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.49 -31.08 71.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.943 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -84.7 -11.48 55.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.42 . . . . 1.0 110.525 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.43 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 29.5 t -80.1 155.45 27.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.351 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -86.86 147.96 25.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.893 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.0 tp -70.7 128.72 37.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.923 0.392 . . . . 1.0 110.223 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -117.62 129.5 55.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.628 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 71.9 m -130.71 129.55 42.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.937 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -116.07 167.24 11.16 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.828 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -109.79 144.08 38.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.958 -0.565 . . . . 1.0 111.051 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 63.6 t -122.24 134.71 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -100.27 132.12 45.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.382 . . . . 1.0 110.792 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 57.0 tp -92.21 130.81 37.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.715 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 41.5 p -128.04 168.14 15.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.479 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.409 ' OD1' ' OD2' ' A' ' 76' ' ' ASP . 21.9 m120 -82.58 14.24 3.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.598 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 57.2 p -122.01 -2.55 9.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.707 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 143.14 -133.34 5.43 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.228 -1.149 . . . . 1.0 110.228 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.551 ' CZ ' HD21 ' A' ' 97' ' ' LEU . 91.1 m-85 -122.87 128.42 50.31 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.61 0.243 . . . . 1.0 110.448 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -103.13 123.07 45.98 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.4 tt -119.87 115.11 23.15 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.3 t 35.42 56.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.432 0.53 . . . . 1.0 112.432 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.5 m120 71.7 27.68 2.86 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.164 0.801 . . . . 1.0 113.164 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -135.54 120.11 18.19 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -94.56 119.2 32.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.411 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -99.01 133.62 22.05 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.24 -16.36 25.04 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.127 1.885 . . . . 1.0 113.604 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.1 p -154.25 158.22 39.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.946 0.403 . . . . 1.0 110.912 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 179' ' ' ILE . 12.5 p -63.29 -40.18 88.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.739 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.499 ' H ' HD12 ' A' ' 179' ' ' ILE . 3.7 mp -59.87 -47.09 92.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.806 0.336 . . . . 1.0 110.42 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -62.61 -35.7 80.38 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.58 -40.61 97.4 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.136 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 96.0 m -60.04 -45.57 92.38 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.54 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 186' ' ' LYS . 32.8 t30 -69.92 -49.4 52.41 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 119.692 -0.803 . . . . 1.0 108.869 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.05 -44.38 0.51 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.815 -1.314 . . . . 1.0 109.815 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -68.72 -47.4 66.46 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.084 -0.558 . . . . 1.0 109.586 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 183' ' ' ASN . 64.1 tttp -56.9 -41.83 78.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.816 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 16.9 m -61.03 -45.5 94.54 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 24.5 mt -62.19 -40.91 97.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.813 -0.631 . . . . 1.0 109.93 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.26 -44.04 92.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.461 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -59.47 -40.57 87.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.229 0.538 . . . . 1.0 110.056 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.4 t -67.18 -39.64 86.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.252 0.548 . . . . 1.0 110.791 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 25.2 mt -63.59 -44.54 93.75 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.603 -0.726 . . . . 1.0 112.261 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.8 -27.37 68.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.422 -0.354 . . . . 1.0 111.647 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.759 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 7' ' ' HIS . 36.3 mmt180 . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 120.86 0.362 . . . . 1.0 110.556 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 5' ' ' ILE . 14.7 p -64.26 -42.8 96.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.573 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.508 ' N ' HG13 ' A' ' 4' ' ' VAL . 38.2 pt -75.54 -25.06 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.365 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -99.44 -0.7 40.29 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.302 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 3' ' ' ARG . 1.3 t60 -54.41 140.17 56.23 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.226 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.61 -15.86 48.89 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.919 1.746 . . . . 1.0 112.152 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -93.77 -5.43 48.3 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.627 -0.261 . . . . 1.0 111.151 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 44.0 t80 -71.12 126.66 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.532 -0.303 . . . . 1.0 110.608 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 52.2 m-85 -146.36 122.21 5.63 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 110.184 -0.302 . . . . 1.0 110.184 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.59 109.76 2.92 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.887 1.725 . . . . 1.0 112.492 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -157.14 156.06 32.06 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.631 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.428 ' CG ' ' N ' ' A' ' 15' ' ' GLY . 45.2 t30 -77.07 173.49 11.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.428 ' N ' ' CG ' ' A' ' 14' ' ' ASN . . . -61.42 -46.33 94.6 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.298 -0.954 . . . . 1.0 111.032 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -67.55 -37.79 83.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.899 0.38 . . . . 1.0 110.877 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -67.41 -33.04 74.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.418 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.585 ' CB ' ' NH1' ' A' ' 33' ' ' ARG . . . -61.23 -43.12 99.38 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.482 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -61.55 -41.75 97.82 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.694 -0.402 . . . . 1.0 109.963 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.1 -39.97 91.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.106 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -63.79 -40.6 97.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.525 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.6 -13.55 59.88 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.927 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -58.09 -43.28 86.97 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.367 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 m -78.53 -17.99 55.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.72 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -84.75 -175.89 5.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.354 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.562 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.3 pm0 -112.61 -172.86 2.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.59 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -79.15 146.38 33.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.789 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.55 23.57 25.91 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.274 -0.73 . . . . 1.0 111.274 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -112.66 145.17 40.9 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.445 ' CD1' HD21 ' A' ' 91' ' ' LEU . 11.9 p90 -133.51 160.38 37.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.214 0.531 . . . . 1.0 110.919 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 44' ' ' ILE . 88.1 t -146.34 155.39 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.255 -0.884 . . . . 1.0 111.459 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.431 ' N ' HG12 ' A' ' 31' ' ' VAL . 4.0 mp -118.87 123.39 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.004 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.585 ' NH1' ' CB ' ' A' ' 18' ' ' ALA . 18.6 ptt-85 -140.5 167.11 22.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.343 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 36' ' ' SER . 94.2 mt-30 -112.41 132.17 55.17 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.037 -0.357 . . . . 1.0 110.037 178.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.491 ' C ' ' H ' ' A' ' 37' ' ' ARG . 61.7 m -56.65 80.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.657 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 34' ' ' GLN . 0.2 OUTLIER 69.83 -42.2 0.5 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.319 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.674 ' O ' ' N ' ' A' ' 39' ' ' ASP . 82.1 mtp180 -150.4 -20.9 0.24 Allowed 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.251 -0.431 . . . . 1.0 111.218 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.614 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . 60.41 -53.76 0.02 OUTLIER Glycine 0 C--O 1.221 -0.697 0 N-CA-C 110.45 -1.06 . . . . 1.0 110.45 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.674 ' N ' ' O ' ' A' ' 37' ' ' ARG . 66.7 t0 55.34 -73.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.082 0.467 . . . . 1.0 110.004 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.614 ' N ' ' O ' ' A' ' 38' ' ' GLY . 23.5 p-10 -124.89 19.06 8.53 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.039 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.488 ' ND1' ' OE1' ' A' ' 59' ' ' GLN . 88.6 m-70 -147.61 152.25 37.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.368 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mp -133.28 147.82 51.92 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.273 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.6 t -126.19 132.96 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.242 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 31' ' ' VAL . 60.2 mt -113.69 139.66 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.585 ' OG1' ' NH1' ' A' ' 33' ' ' ARG . 29.2 m -122.53 143.31 49.8 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.694 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.547 ' NE1' ' CG ' ' A' ' 54' ' ' GLN . 5.8 p-90 -152.46 151.13 30.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.47 -0.786 . . . . 1.0 111.047 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.506 ' C ' HD12 ' A' ' 48' ' ' LEU . 88.8 tttt -91.13 139.15 31.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.99 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.75 ' N ' HD12 ' A' ' 48' ' ' LEU . 6.4 mp -95.67 -59.18 1.92 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.287 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -151.5 -174.34 4.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.338 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -54.88 128.36 32.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.815 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 56.04 39.83 30.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.129 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -144.63 120.38 10.53 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.844 0.354 . . . . 1.0 110.283 179.414 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.607 ' N ' HD13 ' A' ' 52' ' ' LEU . 60.7 m-85 -135.23 149.03 49.79 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.631 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.684 HE22 HG13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -141.96 156.09 45.47 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.707 179.353 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -129.39 145.34 51.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.956 -0.566 . . . . 1.0 110.63 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.684 HG13 HE22 ' A' ' 54' ' ' GLN . 41.9 mt -125.39 130.96 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 43.8 p-10 -99.61 122.59 42.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.879 0.371 . . . . 1.0 110.489 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.417 HD11 HD12 ' A' ' 44' ' ' ILE . 78.0 mt -102.32 130.67 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.489 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.488 ' OE1' ' ND1' ' A' ' 41' ' ' HIS . 55.5 mm-40 -113.94 126.66 55.4 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -102.1 155.63 18.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.492 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.462 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 2.0 tp -145.19 170.67 15.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.818 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.462 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 20.6 tp10 79.77 53.07 0.02 OUTLIER 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 109.674 -0.491 . . . . 1.0 109.674 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -91.36 90.52 7.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.875 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.565 ' OE1' ' ND2' ' A' ' 65' ' ' ASN . 3.4 tm-20 -67.13 -34.54 77.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.908 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.565 ' ND2' ' OE1' ' A' ' 64' ' ' GLU . 56.9 m-80 -145.63 152.81 50.0 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.244 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.64 -33.35 48.51 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.314 2.009 . . . . 1.0 112.061 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.0 mt -86.9 -9.56 55.41 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.863 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.26 134.36 51.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.271 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.8 mt -85.36 152.55 23.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.351 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.59 96.63 0.02 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.721 -0.951 . . . . 1.0 110.721 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -68.43 -43.69 76.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.153 0.501 . . . . 1.0 110.639 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.2 t -111.05 121.83 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.602 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.2 mt -116.04 130.58 56.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.455 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 66.5 mt -108.04 128.39 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 109.869 -0.419 . . . . 1.0 109.869 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.2 t -145.94 134.01 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.36 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.533 ' OD2' ' ND2' ' A' ' 165' ' ' ASN . 32.7 t70 52.96 44.52 30.32 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.208 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 57.06 25.35 10.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.8 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -128.55 147.8 50.72 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.123 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -101.16 130.36 47.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.854 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -124.59 138.84 54.29 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.165 -0.471 . . . . 1.0 109.916 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -85.29 -38.33 18.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.639 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 57.2 t0 -117.11 144.1 45.06 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.076 0.465 . . . . 1.0 111.728 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.496 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 12.3 tp -64.89 -38.44 90.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.619 -0.719 . . . . 1.0 110.551 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.0 -45.06 87.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.96 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -58.39 -38.9 78.29 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.66 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.81 -46.38 96.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.827 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.1 mm -64.27 -43.49 97.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.487 -0.485 . . . . 1.0 111.362 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.05 -43.35 88.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.093 -0.503 . . . . 1.0 112.21 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -71.95 -14.77 62.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.943 0.401 . . . . 1.0 111.267 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -91.94 -50.26 5.81 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.339 -0.544 . . . . 1.0 111.777 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.52 ' O ' HG23 ' A' ' 95' ' ' VAL . 11.0 mp -66.97 -41.51 86.73 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.329 0.492 . . . . 1.0 112.329 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -63.58 -49.9 71.57 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.65 -0.82 . . . . 1.0 111.524 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -70.39 -43.11 70.74 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.465 -0.494 . . . . 1.0 111.961 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -65.85 -42.03 90.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.184 -0.606 . . . . 1.0 111.407 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 91' ' ' LEU . 75.5 t -65.57 -46.08 90.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.185 -0.606 . . . . 1.0 111.395 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -69.42 -44.84 70.55 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.436 -0.506 . . . . 1.0 111.415 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.1 tp -66.02 -42.58 89.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.484 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.6 tp -65.08 -40.27 94.39 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.389 -0.524 . . . . 1.0 110.4 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -67.93 -38.82 83.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.839 -0.618 . . . . 1.0 111.261 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -70.4 -39.97 74.16 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 120.628 -0.429 . . . . 1.0 111.71 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.602 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 2.9 ttt -69.33 -56.27 8.0 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.438 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.417 ' C ' ' H ' ' A' ' 104' ' ' SER . 17.0 m -58.39 -41.45 84.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.085 0.469 . . . . 1.0 110.599 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.8 m -71.64 10.82 0.58 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.625 -0.716 . . . . 1.0 111.276 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 101' ' ' MET . 65.0 p -94.38 133.76 37.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.788 0.327 . . . . 1.0 110.436 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.3 -20.55 55.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.812 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.556 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -89.29 40.57 0.99 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.136 -0.483 . . . . 1.0 109.881 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -132.2 114.34 14.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.065 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -139.33 113.12 8.54 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 116.088 -0.505 . . . . 1.0 109.868 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 t -97.41 89.89 4.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.993 0.425 . . . . 1.0 110.876 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -112.45 168.98 12.84 Favored Glycine 0 N--CA 1.467 0.731 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.662 ' O ' HG23 ' A' ' 115' ' ' VAL . 12.8 m -71.86 162.03 30.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.464 ' N ' HG22 ' A' ' 111' ' ' THR . 64.5 tttp -57.02 -37.88 72.35 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.591 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -69.87 -45.22 68.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.164 0.507 . . . . 1.0 110.801 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -68.1 -21.67 64.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.648 -0.706 . . . . 1.0 110.906 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 111' ' ' THR . 41.6 t -69.82 -44.38 79.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.172 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.65 -44.81 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.032 0.444 . . . . 1.0 110.279 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -65.89 -34.26 77.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.902 0.382 . . . . 1.0 110.698 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.4 -50.68 62.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.849 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 120' ' ' GLU . 1.6 tt -70.88 -39.97 75.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.445 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.519 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 58.7 mm-40 -59.98 -41.81 92.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.359 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.58 -46.95 83.49 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.24 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -60.73 -45.84 92.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.066 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.3 t -61.58 -38.15 86.47 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.492 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -61.64 -40.05 93.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.034 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.67 -41.93 94.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.48 78.83 71.72 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.209 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -67.9 -20.22 45.46 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.967 2.444 . . . . 1.0 112.339 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -97.19 -6.86 33.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.998 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -113.92 148.04 37.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.871 0.367 . . . . 1.0 110.637 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.6 p -80.16 164.83 23.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.592 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 p -152.71 146.09 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -144.35 142.34 30.31 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.752 0.31 . . . . 1.0 111.14 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -152.54 164.54 37.42 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.51 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.556 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.5 OUTLIER -133.72 157.05 46.82 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.1 t -152.59 167.72 27.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.889 0.376 . . . . 1.0 110.223 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.677 HD23 ' N ' ' A' ' 137' ' ' ASN . 1.0 OUTLIER -84.05 136.19 34.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.827 179.503 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.677 ' N ' HD23 ' A' ' 136' ' ' LEU . 9.3 t-20 -60.19 -136.18 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.422 -0.353 . . . . 1.0 110.339 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.504 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 32.2 m80 -158.01 -61.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.657 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 139' ' ' ASP . 15.7 p-10 -90.29 1.58 56.38 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.937 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -116.4 90.53 30.36 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.459 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.42 104.55 1.59 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.081 1.854 . . . . 1.0 112.216 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.48 36.55 2.82 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.409 -1.076 . . . . 1.0 110.409 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -138.21 147.88 44.21 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.525 0.202 . . . . 1.0 110.552 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.602 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 69.5 m-85 -130.86 148.58 52.64 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.719 -0.475 . . . . 1.0 109.719 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.485 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 31.2 m-85 -124.41 136.82 54.36 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.051 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 16.3 mt -107.31 123.69 48.7 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.291 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -116.76 146.35 42.88 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.977 -1.119 . . . . 1.0 107.977 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -161.86 152.03 17.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.519 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 67.2 tttt -136.34 126.73 26.68 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 120.801 -0.359 . . . . 1.0 110.567 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.44 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.4 mp -69.59 -47.96 68.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -157.48 174.55 15.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.48 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.92 75.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.88 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -85.33 6.88 24.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.039 0.447 . . . . 1.0 110.313 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.6 t -98.31 152.58 19.28 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.416 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.477 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 99.4 mttt -86.2 153.54 21.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.996 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 22.0 tp -69.95 125.9 28.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.407 . . . . 1.0 110.022 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 95.2 m-85 -115.9 127.29 54.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.703 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 94.3 m -126.45 130.81 51.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.823 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -115.63 160.65 19.75 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.054 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.485 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 84.7 m-20 -108.07 145.35 34.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.834 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.8 t -127.52 135.61 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -99.92 131.85 45.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.033 0.444 . . . . 1.0 110.61 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 54.5 tp -92.03 131.04 37.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 1.0 109.868 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 56.0 p -133.6 166.8 21.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.344 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.533 ' ND2' ' OD2' ' A' ' 76' ' ' ASP . 19.6 p30 -78.2 16.29 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.722 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 62.1 p -119.57 -1.23 10.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.425 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 133.93 -125.8 4.03 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.251 -1.14 . . . . 1.0 110.251 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -122.78 129.66 51.99 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.242 -0.281 . . . . 1.0 110.242 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.98 118.1 35.79 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 tt -115.43 118.05 32.1 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.2 t 37.44 54.0 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.007 0.373 . . . . 1.0 112.007 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.8 m120 69.76 27.26 4.67 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.894 0.701 . . . . 1.0 112.894 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -131.96 120.38 22.41 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -94.84 120.68 35.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.364 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -98.09 135.37 21.41 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.438 -0.578 . . . . 1.0 109.438 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.26 -19.12 29.68 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.279 1.986 . . . . 1.0 113.55 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.427 ' OG ' ' OE1' ' A' ' 180' ' ' GLN . 19.4 p -150.1 153.78 36.98 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.968 0.413 . . . . 1.0 110.85 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.42 -36.27 75.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.696 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.475 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 48.5 mm -62.6 -47.63 92.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.946 0.403 . . . . 1.0 110.357 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.427 ' OE1' ' OG ' ' A' ' 177' ' ' SER . 6.0 mp0 -61.56 -30.75 70.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.8 tp -64.25 -40.46 96.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.272 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' CYS . . . . . 0.619 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 2.6 p -60.27 -47.54 85.57 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.519 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.619 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 51.3 t30 -69.64 -49.01 57.87 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.2 -45.26 0.44 Allowed Glycine 0 N--CA 1.465 0.581 0 N-CA-C 109.876 -1.29 . . . . 1.0 109.876 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -67.67 -47.88 68.22 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.1 tttm -56.45 -40.33 74.63 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.54 -0.755 . . . . 1.0 110.1 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 97.9 m -61.04 -45.28 95.44 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.33 -39.71 95.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.872 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 59.7 tp -58.73 -44.55 90.47 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.619 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -59.8 -46.17 90.04 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.737 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.5 t -63.08 -39.9 96.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.197 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.49 -43.08 95.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.64 . . . . 1.0 111.963 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.49 -29.94 67.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.465 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 . . . . . 0 N--CA 1.465 0.31 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.886 -179.015 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.846 0.355 . . . . 1.0 110.338 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.6 -27.39 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.574 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.4 pt -75.49 -22.06 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.484 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -106.32 5.98 30.13 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.961 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -58.93 150.91 58.01 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.421 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 38.2 Cg_endo -65.23 -19.88 62.47 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.171 1.914 . . . . 1.0 112.029 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.4 3.23 54.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.608 -0.269 . . . . 1.0 110.99 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -88.97 125.75 35.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.528 -0.306 . . . . 1.0 110.477 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.421 ' CZ ' ' O ' ' A' ' 8' ' ' PRO . 71.1 m-85 -143.17 128.69 10.07 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 110.186 -0.301 . . . . 1.0 110.186 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.489 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 74.0 Cg_endo -73.3 110.01 2.96 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.758 1.638 . . . . 1.0 112.766 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.489 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 52.4 m-85 -160.98 152.29 19.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.361 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 20.9 t-20 -75.84 165.09 25.52 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.464 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . -57.11 -43.41 93.36 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.461 -0.875 . . . . 1.0 110.937 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 48.6 mmm-85 -67.44 -37.65 83.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.864 0.364 . . . . 1.0 110.596 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -73.57 -32.57 64.22 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.62 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.56 -47.45 85.49 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.417 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -65.89 -36.85 84.56 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.43 ' O ' ' CG ' ' A' ' 23' ' ' ARG . 97.4 m-20 -63.33 -42.76 98.99 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -66.25 -36.55 83.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.715 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 22' ' ' LEU . 10.5 tp -82.12 -11.84 58.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.101 -0.499 . . . . 1.0 111.381 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.43 ' CG ' ' O ' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -65.15 -28.57 69.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.826 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.2 t -83.56 -19.94 34.72 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.714 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -84.93 -178.15 6.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.428 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -88.69 167.9 12.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.799 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -74.72 145.15 43.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.808 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.77 4.95 56.8 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.872 -0.891 . . . . 1.0 110.872 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -88.98 148.3 23.85 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -128.31 165.03 21.33 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.219 0.533 . . . . 1.0 111.027 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.757 ' O ' HG23 ' A' ' 44' ' ' ILE . 3.6 t -145.51 155.03 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.309 -0.86 . . . . 1.0 110.894 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -117.5 122.22 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.541 ' NH1' ' OG ' ' A' ' 35' ' ' SER . 32.8 ptt85 -148.66 158.76 44.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.297 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -107.55 137.08 46.23 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.541 ' OG ' ' NH1' ' A' ' 33' ' ' ARG . 2.9 p 169.16 97.74 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.539 0.524 . . . . 1.0 111.073 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.4 p -169.16 30.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.242 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? 53.15 20.26 1.74 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.233 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.676 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -150.1 89.95 0.14 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.677 -0.969 . . . . 1.0 110.677 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -57.18 11.91 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.225 -0.488 . . . . 1.0 111.142 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.676 ' H ' ' C ' ' A' ' 38' ' ' GLY . 32.0 p-10 -107.76 -0.44 21.72 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -129.59 155.47 45.76 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.783 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.41 150.28 40.46 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.006 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.7 t -126.21 133.29 69.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.109 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 31' ' ' VAL . 61.5 mt -112.53 138.44 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.749 -0.834 . . . . 1.0 108.749 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 87.6 m -116.5 135.37 53.88 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.04 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.598 ' CE2' HD11 ' A' ' 48' ' ' LEU . 1.8 p-90 -146.0 151.75 38.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.934 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.458 ' C ' HD12 ' A' ' 48' ' ' LEU . 35.2 ttmt -98.26 138.03 36.12 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.946 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.598 HD11 ' CE2' ' A' ' 46' ' ' TRP . 9.2 mp -95.82 -73.25 0.6 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.046 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 23.4 t70 -103.07 -170.77 1.84 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.497 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.5 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 7.8 ttpm? -63.17 -38.66 92.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.616 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -127.21 61.25 1.37 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.873 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.8 tp -157.47 130.25 7.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.421 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.545 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 96.0 m-85 -128.3 148.66 50.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.662 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 53' ' ' PHE . 75.6 mm-40 -143.09 152.37 41.77 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.016 -0.538 . . . . 1.0 109.75 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.51 ' HD1' ' C ' ' A' ' 54' ' ' GLN . 3.7 m-70 -126.36 141.2 51.99 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.288 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.07 123.14 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.291 -0.413 . . . . 1.0 109.931 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -95.67 121.94 37.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.538 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.9 mt -102.47 124.02 56.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.441 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -107.56 136.16 47.8 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -103.34 151.71 22.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.034 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.0 mt -139.81 171.33 14.37 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.493 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 77.66 45.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.246 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.76 77.38 2.84 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.917 -0.583 . . . . 1.0 109.927 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -65.21 -35.84 82.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.585 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -131.09 150.38 76.4 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.01 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.32 -20.39 66.54 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.235 1.957 . . . . 1.0 112.082 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.61 -4.4 50.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.711 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.26 129.79 54.23 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.947 0.403 . . . . 1.0 110.308 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.8 mt -81.21 153.35 27.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.515 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.06 114.0 6.41 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.526 -1.03 . . . . 1.0 110.526 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.98 -10.65 59.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.876 0.37 . . . . 1.0 110.799 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.7 t -117.87 118.83 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.43 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.5 mt -114.76 128.79 56.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.388 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -100.28 120.26 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.883 0.373 . . . . 1.0 110.539 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.555 HG21 HD13 ' A' ' 86' ' ' ILE . 40.9 t -140.65 133.08 31.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.393 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 55.43 43.99 27.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.11 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.3 t30 58.47 21.76 8.84 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.02 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -128.86 152.27 48.7 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.336 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -100.09 131.64 45.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 1.0 111.041 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -128.81 136.8 50.99 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.204 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -85.5 -37.44 19.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.591 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -112.29 141.2 46.3 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.971 0.415 . . . . 1.0 111.575 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.9 -40.44 95.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.726 -0.67 . . . . 1.0 111.173 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 42.9 p30 -59.89 -33.66 72.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 1.0 111.64 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.561 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 87.5 mt-30 -65.92 -39.14 90.29 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.799 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.555 HD13 HG21 ' A' ' 75' ' ' VAL . 97.1 mt -62.65 -45.72 98.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.716 -0.394 . . . . 1.0 110.778 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.6 mm -65.12 -44.01 95.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.422 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.453 ' O ' ' CG ' ' A' ' 92' ' ' GLN . 98.1 t -69.36 -44.6 80.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 112.433 0.531 . . . . 1.0 112.433 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -76.95 -13.05 60.02 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.288 -0.565 . . . . 1.0 111.692 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.472 ' OH ' ' CZ2' ' A' ' 46' ' ' TRP . 63.0 t80 -93.85 -48.6 6.21 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.977 0.362 . . . . 1.0 111.977 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.89 -42.45 76.92 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.425 0.528 . . . . 1.0 112.425 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.493 ' CD ' ' N ' ' A' ' 93' ' ' ASN . 1.5 pp0? -63.84 -47.46 80.65 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.025 -0.67 . . . . 1.0 111.526 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.493 ' N ' ' CD ' ' A' ' 92' ' ' GLN . 2.7 t30 -69.27 -42.81 75.05 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.685 -0.406 . . . . 1.0 111.509 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -65.68 -42.86 90.75 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.296 -0.562 . . . . 1.0 111.018 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.7 t -66.04 -46.46 87.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.12 -0.632 . . . . 1.0 111.137 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.497 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 82.6 mtp180 -67.08 -45.54 77.01 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.272 -0.571 . . . . 1.0 111.842 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.456 HD11 ' CZ ' ' A' ' 168' ' ' TYR . 7.1 tp -69.57 -41.43 75.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.534 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.47 -45.72 86.18 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.43 -0.508 . . . . 1.0 110.674 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -69.11 -35.03 76.0 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.439 -0.504 . . . . 1.0 111.161 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -71.72 -42.86 66.8 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.578 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 9.2 tpt -68.78 -52.88 25.56 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.495 -0.482 . . . . 1.0 111.117 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.9 m -58.48 -40.78 83.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 1.0 110.551 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.5 t -72.61 9.77 1.01 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.877 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.0 t -92.26 136.49 33.14 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 110.178 -0.305 . . . . 1.0 110.178 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -62.71 -16.83 59.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.85 0.357 . . . . 1.0 110.836 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.473 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 99.3 mttt -91.76 39.3 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.999 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -132.95 114.84 14.48 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.989 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -130.03 115.5 17.2 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 64.5 p -97.59 81.52 2.95 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.863 0.363 . . . . 1.0 110.912 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.93 167.43 12.32 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.831 -0.908 . . . . 1.0 110.831 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 115' ' ' VAL . 80.9 p -77.28 162.81 27.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.971 -0.381 . . . . 1.0 109.971 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -55.99 -35.68 67.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.554 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.74 -43.61 83.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.651 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -70.78 -19.76 62.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.982 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 111' ' ' THR . 43.2 t -70.25 -44.69 77.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.336 178.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.31 -44.89 94.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.293 0.568 . . . . 1.0 110.395 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -65.65 -34.89 79.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.656 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -67.35 -50.13 61.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.539 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.414 HD11 HG13 ' A' ' 131' ' ' VAL . 8.2 tp -69.7 -39.45 78.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.225 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -63.46 -43.57 96.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.661 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.44 ' HA ' ' HE ' ' A' ' 124' ' ' ARG . 90.5 m-20 -60.86 -47.45 86.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.29 -0.564 . . . . 1.0 110.219 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.562 ' CE2' ' OD1' ' A' ' 126' ' ' ASN . 50.3 t80 -61.42 -40.05 92.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.015 -0.539 . . . . 1.0 109.844 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.6 t -60.35 -42.41 95.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.572 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.44 ' HE ' ' HA ' ' A' ' 121' ' ' ASP . 77.7 mtm180 -61.14 -40.84 95.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.404 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.35 -41.27 83.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.562 ' OD1' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -123.15 73.95 48.91 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.732 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.53 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 41.2 Cg_endo -72.01 -22.26 23.18 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.131 1.887 . . . . 1.0 112.442 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -104.07 24.45 11.39 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.74 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -140.77 151.52 44.5 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.826 0.346 . . . . 1.0 110.633 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.9 p -80.12 162.22 24.88 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.554 -0.535 . . . . 1.0 109.554 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.414 HG13 HD11 ' A' ' 119' ' ' ILE . 3.5 p -152.63 144.76 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 178.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.446 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 27.2 p90 -153.49 142.76 21.51 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.962 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -151.76 169.47 22.13 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.438 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.473 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -131.02 149.92 52.39 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.9 t -150.55 169.98 20.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.329 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.6 tp -67.89 140.55 56.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.422 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.607 HD21 ' HA ' ' A' ' 141' ' ' PRO . 9.8 p30 -55.59 -43.64 76.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.565 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 19.2 t60 70.39 -19.71 0.21 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.707 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.533 ' H ' ' C ' ' A' ' 137' ' ' ASN . 30.3 m-20 -103.0 -24.24 13.65 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.065 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.434 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 4.7 p30 -153.56 91.75 3.25 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.11 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.607 ' HA ' HD21 ' A' ' 137' ' ' ASN . 44.8 Cg_exo -54.25 135.26 64.37 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.203 1.935 . . . . 1.0 112.665 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 117.58 -28.99 6.84 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.001 -0.84 . . . . 1.0 111.001 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -113.96 150.49 33.72 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.931 0.396 . . . . 1.0 110.538 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -115.33 156.24 25.85 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -125.36 134.94 52.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.029 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.4 mt -106.68 126.24 52.03 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.651 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -117.15 146.39 43.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 178.472 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -160.86 150.59 17.31 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.216 -0.593 . . . . 1.0 109.723 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -130.94 127.37 38.31 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.746 0.308 . . . . 1.0 110.281 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 37.6 mm -72.92 -46.08 53.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.204 -0.453 . . . . 1.0 111.803 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 152' ' ' ALA . 11.9 t-20 -157.07 169.61 24.41 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.699 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.537 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -60.51 -30.08 69.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.813 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -90.41 8.79 31.88 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.036 0.446 . . . . 1.0 110.393 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 15.6 t -97.45 159.73 14.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.716 -0.674 . . . . 1.0 110.486 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -92.37 153.2 19.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.039 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 48.5 tp -70.84 118.52 13.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -108.07 129.98 55.11 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 51.8 m -126.41 128.94 47.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.611 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -113.9 160.97 18.2 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.035 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 160' ' ' ASN . 50.9 p30 -104.75 147.99 27.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.906 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 47.4 t -128.31 137.48 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.85 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -104.0 131.53 51.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.367 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.0 tp -95.26 130.53 41.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 1.0 109.789 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 48.8 p -127.89 171.01 12.18 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.252 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -84.97 16.48 3.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.851 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m -122.91 -3.25 8.65 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.935 0.398 . . . . 1.0 110.458 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 143.41 -132.24 4.88 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.422 -1.071 . . . . 1.0 110.422 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.456 ' CZ ' HD11 ' A' ' 97' ' ' LEU . 17.5 m-85 -122.91 130.2 52.55 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -106.48 122.52 46.46 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 tt -116.28 118.08 31.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 1.0 109.856 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.466 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 4.7 t 37.48 58.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.176 0.436 . . . . 1.0 112.176 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.5 m120 65.46 27.34 11.76 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.949 0.722 . . . . 1.0 112.949 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.466 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 89.0 m-85 -133.85 120.37 20.35 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -96.49 126.2 41.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.439 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -105.08 131.72 21.52 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -73.31 -20.79 20.75 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.192 1.928 . . . . 1.0 113.31 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 67.9 m -143.86 147.44 34.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.945 0.402 . . . . 1.0 111.218 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.08 -34.51 60.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.67 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 58.8 mt -62.2 -44.95 99.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.886 0.374 . . . . 1.0 110.135 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -67.98 -31.22 70.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.059 -0.519 . . . . 1.0 109.629 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.14 -42.79 99.53 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 110.084 -0.339 . . . . 1.0 110.084 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 73.1 m -63.13 -44.98 94.06 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.26 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.559 ' O ' ' N ' ' A' ' 186' ' ' LYS . 37.3 m-80 -65.73 -48.83 70.59 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.47 -43.43 0.75 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.678 -1.369 . . . . 1.0 109.678 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.461 ' O ' ' HG ' ' A' ' 188' ' ' LEU . 2.6 t80 -69.56 -46.85 65.46 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 122.096 0.951 . . . . 1.0 109.329 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.559 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.7 tttm -59.01 -35.58 73.51 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.118 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.7 m -63.43 -50.5 69.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 1.0 111.177 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.586 ' C ' HD12 ' A' ' 188' ' ' LEU . 0.7 OUTLIER -66.55 -36.05 81.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.66 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.424 ' N ' ' HG ' ' A' ' 188' ' ' LEU . 45.7 tp -58.03 -43.84 86.99 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.432 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -61.13 -40.28 93.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.956 -0.566 . . . . 1.0 109.792 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.0 t -61.59 -36.85 81.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.741 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 92.6 mt -69.95 -36.94 75.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.405 -0.816 . . . . 1.0 112.047 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.57 -31.88 69.85 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.051 0.389 . . . . 1.0 112.051 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 . . . . . 0 C--N 1.325 -0.464 0 C-N-CA 120.881 -0.327 . . . . 1.0 110.725 -179.595 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.402 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 69.5 mtp180 . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 120.895 0.379 . . . . 1.0 110.375 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 p -64.8 -31.36 53.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.556 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.7 pt -73.79 -17.26 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.46 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -98.03 0.32 46.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.389 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.41 ' O ' ' N ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -62.78 123.22 78.76 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.285 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.477 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 77.5 Cg_exo -43.9 -25.72 1.13 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.848 1.699 . . . . 1.0 112.39 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.598 ' CD1' ' CZ ' ' A' ' 30' ' ' PHE . 78.5 m-85 -87.0 9.16 20.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.506 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 7' ' ' HIS . 44.2 t80 -92.68 125.48 37.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.377 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.477 ' CZ ' ' O ' ' A' ' 8' ' ' PRO . 66.1 m-85 -145.3 128.27 8.29 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 110.12 -0.326 . . . . 1.0 110.12 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.88 110.54 3.1 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.717 1.611 . . . . 1.0 112.712 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -154.52 152.48 30.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.439 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -79.31 174.03 11.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.398 -0.593 . . . . 1.0 109.398 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.44 -46.86 93.56 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.403 -0.903 . . . . 1.0 111.338 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -67.32 -35.29 79.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.539 0.209 . . . . 1.0 111.15 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -67.68 -37.22 82.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.379 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.29 94.94 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.691 -0.404 . . . . 1.0 110.425 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.47 -43.99 92.47 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.019 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.61 -42.63 99.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.432 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -63.05 -41.51 99.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.831 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.9 mp -78.63 -11.31 59.96 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.97 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -56.21 -43.52 78.61 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.519 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.0 m -79.3 -15.84 57.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.739 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -81.44 175.57 10.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.472 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -100.9 -176.38 3.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.515 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -82.3 146.2 29.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.88 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.51 14.01 45.77 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.192 -0.763 . . . . 1.0 111.192 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -100.49 144.07 29.91 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.598 ' CZ ' ' CD1' ' A' ' 9' ' ' TYR . 9.1 p90 -132.9 162.19 32.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.116 0.484 . . . . 1.0 110.832 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.739 ' O ' HG23 ' A' ' 44' ' ' ILE . 45.7 t -147.29 157.77 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.193 -0.912 . . . . 1.0 111.533 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.476 ' N ' HG12 ' A' ' 31' ' ' VAL . 80.8 mt -117.75 124.82 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 43' ' ' VAL . 1.5 ptm180 -150.27 156.03 40.8 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.321 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -88.33 169.87 11.46 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 38' ' ' GLY . 16.5 p -81.09 28.13 0.38 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.405 -0.362 . . . . 1.0 110.987 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m 70.94 -41.4 0.5 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.809 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.464 ' H ' ' C ' ' A' ' 35' ' ' SER . 83.9 mtt85 -140.21 19.01 2.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.01 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.486 ' N ' ' OG ' ' A' ' 35' ' ' SER . . . -70.66 -65.18 2.57 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.618 -0.993 . . . . 1.0 110.618 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 68.03 -43.72 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.726 0.298 . . . . 1.0 110.647 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 38' ' ' GLY . 38.2 t70 -94.8 -9.63 33.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.652 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -136.98 151.33 48.87 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.898 0.38 . . . . 1.0 110.348 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.96 147.91 44.81 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.097 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 33' ' ' ARG . 62.4 t -126.47 134.24 66.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.437 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 31' ' ' VAL . 48.1 mt -112.95 138.86 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.1 m -116.9 135.36 53.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.825 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.565 ' CE2' HD11 ' A' ' 48' ' ' LEU . 4.1 p-90 -144.4 148.02 34.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.521 -0.763 . . . . 1.0 110.787 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.543 ' C ' HD12 ' A' ' 48' ' ' LEU . 85.3 tttt -95.29 137.13 34.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.972 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.6 mp -101.87 -82.14 0.48 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.385 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -90.01 174.74 7.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.522 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -58.52 -29.59 66.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.82 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -132.56 52.95 2.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.992 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.0 tp -152.9 136.76 16.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.905 0.384 . . . . 1.0 110.442 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.403 ' O ' ' OE1' ' A' ' 54' ' ' GLN . 87.0 m-85 -131.63 148.22 52.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.385 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.403 ' OE1' ' O ' ' A' ' 53' ' ' PHE . 28.3 mm100 -142.73 153.81 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.681 -0.489 . . . . 1.0 109.681 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.502 ' O ' ' ND1' ' A' ' 55' ' ' HIS . 7.7 p80 -129.45 144.65 51.34 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.287 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.3 mt -122.64 125.57 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -96.45 122.67 39.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.952 0.406 . . . . 1.0 110.359 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.3 mt -104.82 129.64 57.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.31 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -112.23 135.15 53.26 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.096 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.4 ' H ' ' HG3' ' A' ' 60' ' ' GLU . 2.8 pp20? -100.53 151.52 21.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.312 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.7 tp -143.5 176.18 9.38 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.513 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.445 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 64.0 tt0 67.63 44.37 1.68 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.264 0.554 . . . . 1.0 109.633 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -83.01 90.44 7.02 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.806 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -65.66 -38.38 89.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.819 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -144.16 153.67 56.74 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.259 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.82 -33.83 62.61 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.079 1.853 . . . . 1.0 112.324 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 pp -85.14 -10.92 56.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.857 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.51 133.86 48.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.367 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.2 mt -79.67 152.45 29.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.364 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.86 92.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.01 -37.11 86.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.867 0.365 . . . . 1.0 110.772 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.2 t -122.93 123.0 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.804 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.7 mt -116.13 134.22 55.17 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.5 mm -99.57 120.09 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.919 0.39 . . . . 1.0 110.128 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.66 131.47 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.229 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.6 t0 54.14 43.45 30.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.18 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 59.54 24.31 13.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.017 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -129.53 156.96 43.32 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.434 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.14 133.51 41.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.187 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.566 ' CG ' HD11 ' A' ' 86' ' ' ILE . 66.1 m-85 -135.19 136.4 41.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.241 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -87.06 -37.66 17.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.889 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -109.33 136.71 48.34 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.21 0.529 . . . . 1.0 112.324 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.4 tp -66.08 -38.12 87.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.767 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 54.1 t0 -59.7 -36.58 76.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.894 -176.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.518 ' NE2' ' OE2' ' A' ' 89' ' ' GLU . 66.2 tt0 -59.8 -38.96 83.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.627 0.251 . . . . 1.0 110.608 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.566 HD11 ' CG ' ' A' ' 80' ' ' TYR . 50.1 mm -60.71 -47.76 91.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.708 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.16 -42.7 96.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 120.512 -0.475 . . . . 1.0 111.786 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.428 ' O ' ' OE1' ' A' ' 92' ' ' GLN . 40.6 t -76.44 -37.57 30.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.152 0.797 . . . . 1.0 113.152 -177.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.518 ' OE2' ' NE2' ' A' ' 85' ' ' GLN . 95.8 mt-10 -84.37 -14.49 49.36 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.912 0.338 . . . . 1.0 111.912 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 12.0 t80 -95.27 -48.7 5.79 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.629 -0.428 . . . . 1.0 112.129 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 95' ' ' VAL . 10.9 mp -69.76 -40.49 76.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.337 0.495 . . . . 1.0 112.337 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.515 ' OE1' ' N ' ' A' ' 92' ' ' GLN . 5.1 mp0 -64.2 -48.95 73.91 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.969 -0.692 . . . . 1.0 111.767 -177.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -69.29 -42.9 74.85 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.622 -0.431 . . . . 1.0 111.866 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.553 ' O ' HD13 ' A' ' 98' ' ' LEU . 42.1 mmtm -66.35 -43.62 85.52 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.359 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 91' ' ' LEU . 47.4 t -61.56 -45.52 98.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.3 -0.56 . . . . 1.0 111.235 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -69.24 -42.7 75.29 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.487 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.8 tp -66.44 -42.24 87.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.616 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 94' ' ' LYS . 8.7 mp -65.4 -41.11 94.02 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.504 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -68.48 -36.24 78.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.18 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -71.66 -42.28 67.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 120.824 -0.351 . . . . 1.0 111.784 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.3 tpt -67.46 -54.96 15.72 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.438 -0.505 . . . . 1.0 111.65 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.402 HG23 ' CE2' ' A' ' 107' ' ' PHE . 55.3 m -59.68 -29.42 68.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.956 0.407 . . . . 1.0 110.559 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.0 p -74.25 9.61 1.58 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.123 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.7 t -98.45 130.1 45.06 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 110.123 -0.325 . . . . 1.0 110.123 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -58.23 -17.49 19.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.127 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.533 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 98.6 mttt -88.56 40.63 0.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.671 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.402 ' CE2' HG23 ' A' ' 102' ' ' THR . 48.6 t80 -135.24 113.41 11.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.104 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -133.44 120.43 20.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.052 -0.522 . . . . 1.0 109.977 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.6 p -91.75 94.68 9.48 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.053 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.2 151.8 16.89 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.595 ' O ' HG23 ' A' ' 115' ' ' VAL . 19.1 p -71.34 162.76 28.92 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -58.92 -40.1 83.54 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.539 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.85 -46.16 72.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.872 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.431 ' OD1' ' OG1' ' A' ' 111' ' ' THR . 2.8 m-20 -71.34 -19.37 62.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.744 -0.662 . . . . 1.0 111.084 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 111' ' ' THR . 10.2 t -73.7 -43.92 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.172 -0.307 . . . . 1.0 110.172 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.0 -46.56 96.21 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 CA-C-O 121.118 0.485 . . . . 1.0 110.054 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -65.86 -34.32 77.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.988 0.423 . . . . 1.0 110.696 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -68.94 -49.29 59.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.731 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.1 tp -70.6 -39.59 76.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.518 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -62.52 -41.65 98.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.765 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.96 -47.63 74.01 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.582 -0.447 . . . . 1.0 110.373 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.686 ' CE1' ' ND2' ' A' ' 126' ' ' ASN . 42.4 t80 -61.39 -42.09 98.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.99 -0.55 . . . . 1.0 109.914 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.5 p -64.87 -33.56 76.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.419 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -61.81 -42.02 98.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.998 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.76 -40.91 90.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.686 ' ND2' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -113.77 75.27 2.69 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.056 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.531 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 41.4 Cg_endo -71.99 -19.35 26.81 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.24 1.96 . . . . 1.0 112.406 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -104.67 -14.64 15.53 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.041 0.386 . . . . 1.0 112.041 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -103.4 147.1 27.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.082 0.467 . . . . 1.0 110.52 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.9 m -80.81 162.1 24.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.515 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 p -153.03 146.36 14.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -149.73 143.05 25.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.885 0.374 . . . . 1.0 111.041 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -151.24 165.25 34.53 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.317 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.533 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -133.57 151.63 51.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.383 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.9 m -146.31 167.51 23.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.252 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.9 tp -79.82 128.81 33.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.612 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.465 ' CG ' ' CD2' ' A' ' 145' ' ' TYR . 5.5 m-20 -53.11 173.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.109 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -127.58 -38.85 1.88 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.531 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -95.44 -8.04 36.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.177 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -136.62 75.5 50.36 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.255 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.34 132.42 50.79 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.964 1.776 . . . . 1.0 112.442 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 109.43 -33.49 6.06 Favored Glycine 0 N--CA 1.466 0.645 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.432 ' O ' ' CG ' ' A' ' 137' ' ' ASN . 15.6 m0 -92.16 156.49 17.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.723 0.297 . . . . 1.0 110.22 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -119.12 149.77 41.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 1.0 109.834 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.465 ' CD2' ' CG ' ' A' ' 137' ' ' ASN . 35.8 m-85 -120.99 132.99 55.25 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.246 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 15.0 mt -107.32 123.38 48.25 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.236 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.457 ' SD ' HG13 ' A' ' 115' ' ' VAL . 0.9 OUTLIER -120.64 145.32 47.53 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.979 -1.119 . . . . 1.0 107.979 178.948 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -163.48 151.58 13.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.51 -0.476 . . . . 1.0 109.719 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -128.39 130.57 47.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.761 0.315 . . . . 1.0 110.455 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.424 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.9 mp -75.68 -45.92 37.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.217 0.451 . . . . 1.0 112.217 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 17.5 t-20 -152.15 164.08 38.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.477 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.505 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -57.14 -22.89 43.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.776 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -96.87 -4.54 40.04 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.402 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.1 p -82.91 150.76 26.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.488 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.486 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -82.35 154.56 25.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.176 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.2 tp -69.39 113.7 6.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.971 0.415 . . . . 1.0 110.073 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 99.0 m-85 -99.92 131.23 46.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.803 -0.635 . . . . 1.0 109.636 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 58.4 m -127.62 130.94 49.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.774 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -117.1 153.26 33.07 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.111 0.481 . . . . 1.0 109.942 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -105.2 144.95 31.28 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.791 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.5 t -127.61 135.44 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.646 -0.502 . . . . 1.0 109.646 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -98.19 131.23 44.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.378 -0.373 . . . . 1.0 110.474 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.3 tp -99.71 131.35 45.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.078 -0.51 . . . . 1.0 109.698 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.1 p -132.58 174.32 10.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.461 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -85.67 17.02 3.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.699 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 44.0 p -121.79 -2.63 9.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.566 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.32 -134.48 6.52 Favored Glycine 0 N--CA 1.465 0.591 0 N-CA-C 110.329 -1.108 . . . . 1.0 110.329 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -122.23 130.15 52.91 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 110.316 -0.253 . . . . 1.0 110.316 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -105.67 119.2 38.53 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.8 tt -117.02 119.73 36.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.8 t 38.54 53.66 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.004 0.372 . . . . 1.0 112.004 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.5 m120 67.7 27.19 7.66 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.017 0.747 . . . . 1.0 113.017 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -135.47 120.68 18.94 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -93.2 126.06 38.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.493 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -102.51 139.63 20.39 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -72.71 -18.59 25.02 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.024 1.816 . . . . 1.0 113.613 -177.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.9 p -154.67 158.24 39.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.917 0.389 . . . . 1.0 110.962 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 179' ' ' ILE . 14.2 p -64.77 -37.52 80.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.141 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.425 ' N ' HG13 ' A' ' 178' ' ' VAL . 80.4 mt -59.7 -45.03 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.306 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -63.59 -37.6 87.96 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.7 tt -64.86 -39.78 94.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.422 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 83.1 m -59.29 -47.87 83.75 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.432 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' A' ' 186' ' ' LYS . 61.2 t30 -69.74 -49.28 54.64 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.35 -44.96 0.63 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.699 -1.36 . . . . 1.0 109.699 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.78 -47.34 69.44 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.192 -0.669 . . . . 1.0 109.192 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 183' ' ' ASN . 63.9 tttp -56.56 -41.53 77.03 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.522 -0.763 . . . . 1.0 109.827 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 94.5 m -60.02 -46.98 87.71 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.75 -41.23 98.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 1.0 109.815 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.1 tp -60.24 -45.81 91.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.542 -0.299 . . . . 1.0 110.451 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -60.89 -44.17 97.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.291 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.4 t -64.31 -37.38 87.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.258 0.551 . . . . 1.0 110.499 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.19 -42.26 99.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.87 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -63.5 -25.69 68.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 111.878 0.325 . . . . 1.0 111.878 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.086 -179.596 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.757 0.313 . . . . 1.0 110.35 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.85 -26.22 34.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.542 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.0 pt -71.63 -26.66 26.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 1.0 110.689 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -106.95 7.9 30.21 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.575 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -46.8 136.14 7.9 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.313 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -49.05 -31.55 21.16 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.648 1.565 . . . . 1.0 112.526 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.612 ' CE2' ' CZ ' ' A' ' 30' ' ' PHE . 52.0 m-85 -88.38 3.74 48.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.728 0.299 . . . . 1.0 111.244 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.528 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 34.3 t80 -75.12 127.74 33.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.178 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 52.1 m-85 -147.49 108.92 3.86 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.606 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.495 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 31.3 Cg_exo -59.67 111.74 1.05 Allowed 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 121.71 1.607 . . . . 1.0 112.624 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.529 ' O ' ' NH1' ' A' ' 33' ' ' ARG . 56.2 m-85 -160.34 159.39 31.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.29 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.409 ' CG ' ' N ' ' A' ' 15' ' ' GLY . 11.1 t-20 -81.19 164.72 22.11 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.409 ' N ' ' CG ' ' A' ' 14' ' ' ASN . . . -58.26 -48.53 82.92 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.606 -0.998 . . . . 1.0 110.606 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.7 mmp_? -67.32 -39.56 85.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.723 0.297 . . . . 1.0 111.029 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.16 -37.07 84.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.326 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.471 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.59 -44.01 97.8 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.669 -0.412 . . . . 1.0 110.414 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.514 ' OE2' ' CD1' ' A' ' 53' ' ' PHE . 42.6 tt0 -61.34 -45.73 93.22 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.045 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.1 -38.71 89.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.322 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.607 ' CE2' ' NZ ' ' A' ' 25' ' ' LYS . 57.3 t80 -67.2 -36.87 82.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.078 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 18' ' ' ALA . 7.8 mp -81.65 -11.88 58.92 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.115 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -63.51 -33.57 75.86 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.248 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -81.18 -20.14 41.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.004 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.607 ' NZ ' ' CE2' ' A' ' 21' ' ' TYR . 48.7 mttp -81.89 176.4 9.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.998 0.428 . . . . 1.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -88.72 165.74 14.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.809 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.538 ' NH2' ' OD1' ' A' ' 99' ' ' ASN . 64.6 ttp85 -65.65 146.18 55.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.949 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.29 22.75 31.19 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.317 -0.713 . . . . 1.0 111.317 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -101.41 142.14 33.24 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.612 ' CZ ' ' CE2' ' A' ' 9' ' ' TYR . 17.3 p90 -133.24 167.19 20.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.489 0.661 . . . . 1.0 110.699 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 45' ' ' THR . 11.0 m -149.68 163.1 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.715 -1.13 . . . . 1.0 111.827 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.518 HD13 ' CG1' ' A' ' 44' ' ' ILE . 3.7 mm -115.65 126.71 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 13' ' ' PHE . 26.8 ttt85 -136.76 162.58 32.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.689 -0.687 . . . . 1.0 110.188 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.523 ' H ' ' CD ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -117.11 128.58 55.27 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.6 t -52.72 -6.21 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.521 ' H ' ' C ' ' A' ' 34' ' ' GLN . 1.5 t 72.07 -49.12 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.442 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -93.39 -6.09 47.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.653 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -70.96 -53.84 10.34 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.632 -0.987 . . . . 1.0 110.632 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 t70 71.44 -36.89 0.38 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.627 0.251 . . . . 1.0 111.084 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 38' ' ' GLY . 98.4 m-20 -120.08 -7.34 9.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.744 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -120.42 146.89 45.76 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.056 0.455 . . . . 1.0 110.944 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.88 151.79 41.39 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.129 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.8 t -125.82 134.36 66.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.299 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.685 HD12 HD11 ' A' ' 58' ' ' ILE . 16.0 mt -110.71 137.16 44.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.571 ' O ' HG22 ' A' ' 31' ' ' VAL . 75.4 m -117.66 134.17 55.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.661 -0.699 . . . . 1.0 109.349 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.742 ' HE1' HE21 ' A' ' 54' ' ' GLN . 2.1 p-90 -151.89 154.21 35.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.349 -0.841 . . . . 1.0 110.768 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -97.87 143.46 28.45 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.293 0.568 . . . . 1.0 111.793 -179.041 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.2 mt -97.18 -57.76 2.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.226 -0.897 . . . . 1.0 110.35 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -119.38 -166.85 1.32 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.37 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -65.1 -39.29 92.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.793 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -128.13 53.39 1.8 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.281 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.9 tp -153.87 129.36 9.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.263 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CD1' ' OE2' ' A' ' 19' ' ' GLU . 47.8 m-85 -134.99 150.25 50.31 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.983 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.742 HE21 ' HE1' ' A' ' 46' ' ' TRP . 14.9 pt20 -141.07 157.73 44.9 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.164 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -121.77 139.95 52.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.454 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.8 mt -119.41 123.42 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.806 -0.442 . . . . 1.0 109.806 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -96.29 122.1 38.8 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.889 0.376 . . . . 1.0 110.567 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.685 HD11 HD12 ' A' ' 44' ' ' ILE . 86.2 mt -102.64 129.98 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.212 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.759 HE21 ' C ' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -119.1 134.62 55.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.131 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 60' ' ' GLU . 0.3 OUTLIER -100.67 157.62 16.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.583 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 mt -146.18 178.42 8.24 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.106 0.479 . . . . 1.0 110.345 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 58.59 39.59 24.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.385 -0.825 . . . . 1.0 110.5 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.417 ' H ' ' HG2' ' A' ' 63' ' ' LYS . 58.2 pttt -81.19 125.88 30.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.382 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -68.84 -30.78 69.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.106 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -162.39 156.95 18.83 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.556 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.64 -33.04 57.19 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.608 1.539 . . . . 1.0 112.295 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.51 -10.35 58.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.507 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.66 135.47 44.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.342 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.8 mt -78.15 148.35 34.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.51 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.68 132.82 14.65 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -77.74 -15.51 59.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.046 0.451 . . . . 1.0 110.806 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.0 t -111.09 119.64 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.682 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.6 mt -115.59 131.91 56.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.539 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.4 mt -102.53 122.33 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.838 0.351 . . . . 1.0 110.443 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.469 HG21 HD13 ' A' ' 86' ' ' ILE . 46.1 t -142.36 133.82 25.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.29 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 56.32 41.24 29.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.681 0.277 . . . . 1.0 111.124 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.36 13.72 5.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.91 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -120.66 151.85 38.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.983 0.421 . . . . 1.0 109.944 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -101.1 126.07 47.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.982 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.538 ' CE1' ' OE2' ' A' ' 89' ' ' GLU . 95.9 m-85 -120.75 139.13 53.53 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.186 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -85.71 -30.42 23.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.584 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 51.4 t0 -123.86 141.65 51.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.01 0.433 . . . . 1.0 111.842 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.4 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 56.6 tp -65.46 -39.9 92.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.584 -0.735 . . . . 1.0 111.147 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.48 -40.19 90.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.727 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -59.7 -39.64 85.23 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.799 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.469 HD13 HG21 ' A' ' 75' ' ' VAL . 96.9 mt -62.44 -46.12 97.17 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 CA-C-O 120.898 0.38 . . . . 1.0 110.955 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 64.8 mt -62.73 -46.07 97.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.976 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.4 t -69.87 -43.58 79.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.81 0.671 . . . . 1.0 112.81 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.538 ' OE2' ' CE1' ' A' ' 80' ' ' TYR . 9.1 pt-20 -80.68 -12.07 59.54 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.523 -0.471 . . . . 1.0 111.666 -177.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.589 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 64.4 t80 -94.19 -49.11 5.89 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.636 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.497 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -70.37 -42.1 72.21 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.348 -0.541 . . . . 1.0 112.118 -177.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -63.9 -49.08 74.08 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.041 -0.664 . . . . 1.0 111.565 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -69.12 -42.77 75.61 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.618 -0.433 . . . . 1.0 111.522 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.589 ' NZ ' ' CE1' ' A' ' 90' ' ' TYR . 15.9 mmtp -65.81 -42.32 90.78 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.39 -0.524 . . . . 1.0 111.228 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 91' ' ' LEU . 53.4 t -65.41 -46.5 89.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.527 -0.469 . . . . 1.0 111.183 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -68.09 -44.02 77.21 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.615 -0.434 . . . . 1.0 111.6 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.2 tp -67.71 -41.64 83.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.267 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.7 tp -65.35 -42.92 92.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.193 -0.603 . . . . 1.0 110.217 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.538 ' OD1' ' NH2' ' A' ' 27' ' ' ARG . 99.2 m-20 -68.04 -36.95 80.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.244 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -71.82 -42.89 66.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 111.892 0.33 . . . . 1.0 111.892 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.5 tpt -66.03 -53.8 33.98 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.213 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.432 HG23 ' CE2' ' A' ' 107' ' ' PHE . 53.8 m -60.14 -36.12 76.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.593 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.9 t -71.07 9.49 0.71 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.879 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 102' ' ' THR . 32.0 t -91.52 134.32 34.75 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 110.001 -0.37 . . . . 1.0 110.001 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -58.59 -19.21 36.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.983 0.42 . . . . 1.0 110.823 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.557 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 60.4 mttp -90.14 39.91 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.785 -0.643 . . . . 1.0 109.798 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.432 ' CE2' HG23 ' A' ' 102' ' ' THR . 87.9 t80 -132.85 120.42 21.51 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.535 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.59 124.02 15.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.142 -0.481 . . . . 1.0 109.906 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.3 m -100.17 86.66 3.27 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.734 0.302 . . . . 1.0 110.968 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.16 163.63 12.12 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.924 -0.87 . . . . 1.0 110.924 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' HZ3' ' A' ' 113' ' ' LYS . 61.6 p -77.65 169.52 18.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -58.6 -38.59 78.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.912 0.387 . . . . 1.0 110.561 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.578 ' HZ3' ' CB ' ' A' ' 111' ' ' THR . 25.0 pttm -69.27 -39.53 78.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.654 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -70.08 -24.46 63.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.874 -0.603 . . . . 1.0 111.154 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 111' ' ' THR . 48.8 t -70.65 -45.5 73.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.509 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 82.6 t -63.67 -46.66 94.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.106 0.479 . . . . 1.0 110.445 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -66.04 -37.42 85.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.085 0.469 . . . . 1.0 110.896 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -67.11 -49.24 65.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.751 -0.659 . . . . 1.0 111.763 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.415 HG23 ' N ' ' A' ' 120' ' ' GLU . 11.1 tp -69.84 -40.0 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.55 -0.46 . . . . 1.0 110.47 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 119' ' ' ILE . 96.3 mt-10 -65.44 -41.64 93.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.806 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -63.82 -48.17 77.91 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.448 -0.501 . . . . 1.0 110.297 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -60.45 -44.57 95.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.007 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 81.2 p -66.25 -28.6 68.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.038 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -63.96 -43.87 94.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.337 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.7 t -66.82 -41.76 88.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.298 -0.41 . . . . 1.0 109.938 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -122.02 75.43 39.38 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.561 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -71.3 -13.51 30.81 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.662 2.241 . . . . 1.0 112.34 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -106.2 24.87 11.76 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.642 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -141.13 151.72 44.14 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.86 0.362 . . . . 1.0 110.743 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 86.5 p -80.78 160.81 24.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.119 -0.491 . . . . 1.0 109.841 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.6 p -153.97 144.86 14.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.597 -0.52 . . . . 1.0 109.597 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 19.0 p90 -153.33 143.61 22.36 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.691 -0.404 . . . . 1.0 111.104 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -152.57 169.71 21.97 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.355 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.6 p90 -136.77 156.12 48.93 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 28.8 t -148.55 169.5 20.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.322 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.4 tp -74.59 146.46 42.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.483 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 138' ' ' HIS . 28.1 t-20 -42.74 147.96 0.27 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.539 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.43 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 92.5 m-70 -60.05 -50.24 74.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.018 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 139' ' ' ASP . 25.7 p-10 -156.7 44.09 0.39 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.536 -0.302 . . . . 1.0 110.629 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.412 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 73.3 m-20 -160.26 84.32 2.07 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.31 144.86 92.28 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.699 1.599 . . . . 1.0 112.671 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.401 ' C ' ' CD1' ' A' ' 143' ' ' TRP . . . 142.93 -39.25 1.35 Allowed Glycine 0 C--O 1.226 -0.382 0 N-CA-C 110.887 -0.885 . . . . 1.0 110.887 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.534 ' CD1' ' N ' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -134.95 153.89 51.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.812 0.339 . . . . 1.0 110.188 -179.353 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -102.36 156.97 17.24 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -113.37 134.9 54.39 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.093 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.466 HD12 ' CG2' ' A' ' 161' ' ' VAL . 12.3 mt -110.55 126.17 54.12 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.436 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.62 142.98 51.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.644 -1.243 . . . . 1.0 107.644 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -159.43 160.25 34.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.781 -0.451 . . . . 1.0 109.781 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -138.57 128.63 25.48 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.858 0.361 . . . . 1.0 110.686 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.442 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.8 mp -72.43 -44.98 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.787 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.411 ' H ' ' HB3' ' A' ' 154' ' ' SER . 77.9 m-20 -160.83 174.0 14.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.729 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.38 -32.81 73.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.784 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -83.68 -13.15 54.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.143 0.496 . . . . 1.0 110.376 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.411 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 8.8 t -80.09 157.15 26.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.473 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -90.28 157.37 17.7 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.989 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 30.8 tp -76.57 121.66 23.49 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.087 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -108.32 136.39 48.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.743 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 99.8 m -128.98 132.33 47.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.905 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -123.37 161.89 23.82 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.803 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -109.72 151.79 26.47 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.796 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.466 ' CG2' HD12 ' A' ' 146' ' ' LEU . 67.8 t -127.78 134.18 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -97.54 132.35 43.3 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.027 0.442 . . . . 1.0 111.061 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.4 tp -92.23 130.28 37.97 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.727 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.454 ' C ' ' H ' ' A' ' 166' ' ' THR . 65.7 p -129.58 157.35 42.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.339 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -73.45 15.21 0.26 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.645 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 164' ' ' THR . 19.3 p -121.46 -2.43 9.48 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.775 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.51 -135.49 7.06 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.477 -1.049 . . . . 1.0 110.477 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -118.9 131.68 56.06 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.401 ' CE1' ' OD1' ' A' ' 174' ' ' ASN . 5.9 m-85 -109.33 118.7 37.38 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.8 tt -109.29 121.3 44.87 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.465 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 5.0 t 34.93 59.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.467 0.543 . . . . 1.0 112.467 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.2 m120 63.26 27.54 15.51 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.981 0.734 . . . . 1.0 112.981 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.465 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 79.3 m-85 -132.75 121.88 23.71 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.303 -0.628 . . . . 1.0 109.303 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.401 ' OD1' ' CE1' ' A' ' 169' ' ' PHE . 46.4 t30 -91.15 133.4 35.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.391 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -115.65 131.88 23.44 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.903 -0.589 . . . . 1.0 109.462 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.66 -21.33 19.26 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.171 1.914 . . . . 1.0 113.443 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 73.4 m -147.99 150.99 35.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.928 0.394 . . . . 1.0 111.25 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.94 -36.3 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.833 -0.622 . . . . 1.0 110.857 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.431 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 46.6 mm -60.95 -45.98 97.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 1.0 110.066 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -65.82 -32.3 73.76 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.1 tp -63.95 -42.31 97.35 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.465 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' CYS . . . . . 0.611 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 5.1 p -60.99 -47.88 84.39 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.632 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.611 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 36.3 t30 -66.71 -48.51 69.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.744 -0.783 . . . . 1.0 108.983 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.57 -45.01 0.95 Allowed Glycine 0 N--CA 1.462 0.374 0 N-CA-C 109.907 -1.277 . . . . 1.0 109.907 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -68.89 -47.48 65.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 183' ' ' ASN . 36.4 ttpt -56.66 -39.53 73.91 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.544 -0.753 . . . . 1.0 109.982 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 19.9 m -60.58 -45.94 92.09 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.416 ' O ' ' OG ' ' A' ' 191' ' ' SER . 75.8 mt -63.73 -39.42 94.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.865 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.6 tp -58.88 -43.31 90.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.903 0.383 . . . . 1.0 110.458 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -59.09 -45.71 90.17 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.527 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 188' ' ' LEU . 77.6 p -61.79 -36.89 82.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.167 0.508 . . . . 1.0 110.619 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.8 mt -69.47 -39.44 77.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.381 -0.827 . . . . 1.0 111.954 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -62.46 -29.17 70.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.892 0.33 . . . . 1.0 111.892 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 . . . . . 0 C--N 1.325 -0.492 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.907 -179.592 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 . . . . . 0 N--CA 1.464 0.258 0 CA-C-O 120.928 0.394 . . . . 1.0 110.817 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.1 p -64.46 -30.48 50.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.532 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.1 pt -71.01 -15.23 18.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.515 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -94.21 -0.1 55.38 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.44 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.73 140.67 59.08 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.217 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.13 -21.39 62.74 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.111 1.874 . . . . 1.0 112.116 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.451 ' CE1' ' CZ ' ' A' ' 30' ' ' PHE . 24.5 m-85 -92.24 10.16 30.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.202 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 79.0 t80 -84.47 128.07 34.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.423 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 64.2 m-85 -150.89 114.78 3.18 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 110.154 -0.313 . . . . 1.0 110.154 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.91 110.09 3.01 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.743 1.629 . . . . 1.0 112.919 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -155.53 153.77 30.73 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.539 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.463 ' ND2' ' H ' ' A' ' 15' ' ' GLY . 11.2 t-20 -77.68 164.45 25.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.463 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -57.84 -42.73 94.77 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.207 -0.997 . . . . 1.0 110.948 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -66.31 -42.96 87.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.745 0.307 . . . . 1.0 110.963 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -67.86 -33.82 75.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.277 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.43 -43.01 97.23 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.257 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -58.61 -42.29 87.85 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.582 -0.447 . . . . 1.0 109.992 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -62.21 -46.52 88.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.503 . . . . 1.0 110.287 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -60.18 -40.95 91.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.446 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.34 -13.59 60.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.952 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -58.49 -43.85 89.17 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.403 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.4 t -76.43 -19.44 58.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.718 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -83.28 177.05 8.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.527 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.6 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 52.2 mp0 -105.3 -176.93 3.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.738 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -74.92 144.69 43.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.828 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.51 -0.34 61.4 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.219 -0.753 . . . . 1.0 111.219 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -83.88 144.3 29.31 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.659 ' CD1' HD21 ' A' ' 91' ' ' LEU . 16.8 p90 -136.73 165.58 25.58 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.177 0.513 . . . . 1.0 110.971 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 32' ' ' ILE . 60.3 t -146.98 156.58 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.087 -0.961 . . . . 1.0 111.67 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.463 ' N ' HG12 ' A' ' 31' ' ' VAL . 91.6 mt -117.3 124.19 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -152.02 153.17 33.48 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.336 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -108.41 152.19 25.01 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.917 -0.401 . . . . 1.0 109.917 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 t -82.36 145.19 30.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.843 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 m -59.02 -39.07 80.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.664 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -95.41 6.95 47.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.792 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -86.97 -79.75 1.22 Allowed Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.572 -1.011 . . . . 1.0 110.572 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 t70 68.8 -38.89 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 1.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 38' ' ' GLY . 36.5 t70 -104.11 2.44 31.99 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.828 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -143.82 153.62 42.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.946 0.403 . . . . 1.0 110.283 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.12 148.8 42.66 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.952 -0.567 . . . . 1.0 109.752 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.21 132.46 71.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.221 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.694 HD12 HD11 ' A' ' 58' ' ' ILE . 56.8 mt -111.7 138.36 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 108.949 -0.76 . . . . 1.0 108.949 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 87.9 m -120.73 138.7 53.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.575 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.456 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 2.9 p-90 -153.91 148.11 25.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.884 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.476 ' HZ3' ' C ' ' A' ' 49' ' ' ASP . 64.1 tttm -88.93 141.19 28.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.128 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.665 HD11 HE21 ' A' ' 54' ' ' GLN . 26.2 mt -98.76 -68.06 0.82 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.072 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.476 ' C ' ' HZ3' ' A' ' 47' ' ' LYS . 38.2 t0 -136.11 171.22 14.79 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.186 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -46.64 130.58 11.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.986 0.422 . . . . 1.0 110.897 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 56.37 39.82 29.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.06 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.8 tp -149.01 122.38 9.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.784 0.326 . . . . 1.0 110.443 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -135.56 149.92 49.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.568 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.665 HE21 HD11 ' A' ' 48' ' ' LEU . 3.0 pt20 -139.43 156.49 46.93 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.958 -0.564 . . . . 1.0 109.823 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -125.41 142.28 51.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.301 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 83.1 mt -120.48 122.84 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -93.98 120.83 34.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.877 0.37 . . . . 1.0 110.496 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.694 HD11 HD12 ' A' ' 44' ' ' ILE . 92.6 mt -100.84 128.96 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.422 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -112.29 141.78 45.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.171 -0.468 . . . . 1.0 109.781 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -98.73 152.79 19.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 1.0 109.988 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 2.9 tp -141.56 165.49 27.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.696 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.493 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 72.6 tt0 66.04 48.61 1.72 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.41 0.624 . . . . 1.0 109.719 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.4 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 32.5 pttt -102.44 107.81 18.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.988 -0.551 . . . . 1.0 109.945 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -67.26 -25.19 65.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.857 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -159.23 158.22 28.2 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.214 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.96 -34.39 56.22 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.213 1.942 . . . . 1.0 112.074 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.494 ' CD2' ' H ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -85.49 -10.24 56.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.688 -179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.67 145.12 55.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.299 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.7 mt -77.81 151.84 33.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.371 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.22 91.25 1.13 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.673 -0.971 . . . . 1.0 110.673 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -63.78 -32.36 73.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.037 0.446 . . . . 1.0 110.596 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.7 t -125.26 124.18 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.787 -0.642 . . . . 1.0 111.051 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.13 131.07 57.04 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.0 mt -100.22 120.93 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.899 0.381 . . . . 1.0 110.179 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -141.59 132.54 26.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.235 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 56.15 43.11 27.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.717 0.294 . . . . 1.0 111.025 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.4 t30 59.27 15.9 4.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.779 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -121.68 146.52 46.93 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.228 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -99.57 126.26 45.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.644 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -125.06 137.33 54.21 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.028 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -85.75 -38.49 18.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.831 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -105.3 135.33 46.87 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.127 0.489 . . . . 1.0 111.935 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 58.2 tp -63.81 -41.93 97.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.571 -0.74 . . . . 1.0 110.672 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -60.27 -42.44 95.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 1.0 111.92 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -60.98 -37.24 81.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.762 0.315 . . . . 1.0 110.644 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.01 -44.92 99.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.564 -0.454 . . . . 1.0 110.551 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.4 mm -62.92 -44.78 99.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.449 -0.5 . . . . 1.0 111.35 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.492 ' O ' ' CG ' ' A' ' 92' ' ' GLN . 79.7 t -67.49 -45.67 84.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 112.723 0.638 . . . . 1.0 112.723 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.06 -19.38 61.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.739 0.304 . . . . 1.0 111.76 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -93.59 -50.73 5.27 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.353 -0.539 . . . . 1.0 111.781 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.659 HD21 ' CD1' ' A' ' 30' ' ' PHE . 11.1 mp -66.6 -43.64 84.31 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.382 0.512 . . . . 1.0 112.382 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.492 ' CG ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -65.75 -41.9 91.58 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.098 -0.641 . . . . 1.0 111.455 -177.753 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -70.94 -44.12 66.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.304 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -65.9 -41.99 90.77 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.239 -0.585 . . . . 1.0 111.154 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.0 t -65.53 -44.51 94.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.363 -0.535 . . . . 1.0 111.114 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.529 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -66.56 -46.96 74.32 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.569 -0.453 . . . . 1.0 111.706 -178.871 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 tp -69.78 -41.13 75.54 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.717 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.1 tp -61.61 -44.63 96.63 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.344 -0.542 . . . . 1.0 110.565 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.529 ' ND2' ' HA ' ' A' ' 96' ' ' ARG . 1.1 p30 -70.0 -35.97 74.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.154 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.454 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 44.2 tt0 -71.37 -43.81 66.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.564 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 5.5 ttt -66.93 -55.08 16.15 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.575 -0.45 . . . . 1.0 111.63 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.42 HG23 ' CE2' ' A' ' 107' ' ' PHE . 52.6 m -57.82 -37.99 74.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.071 0.462 . . . . 1.0 110.639 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 41.4 t -72.33 10.36 0.81 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.636 -0.711 . . . . 1.0 110.999 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 101' ' ' MET . 78.1 p -92.91 135.46 34.13 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.565 -0.288 . . . . 1.0 110.454 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.59 -16.72 40.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.567 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 24.2 mmtp -93.82 38.46 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 1.0 109.808 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.42 ' CE2' HG23 ' A' ' 102' ' ' THR . 86.8 t80 -132.04 111.83 11.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.284 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -131.06 114.0 14.63 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.7 p -89.67 88.97 7.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.001 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.79 156.32 15.71 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.538 ' O ' HG23 ' A' ' 115' ' ' VAL . 67.8 p -75.05 169.58 17.73 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -57.28 -38.32 73.75 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.841 -0.343 . . . . 1.0 110.415 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -68.49 -42.94 77.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.356 0.598 . . . . 1.0 110.933 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 51.6 t0 -68.09 -21.78 64.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.411 -0.813 . . . . 1.0 110.89 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 111' ' ' THR . 44.4 t -71.63 -43.33 71.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.767 0.317 . . . . 1.0 110.198 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.83 -47.13 92.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.09 0.471 . . . . 1.0 110.409 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -65.66 -38.24 88.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.076 0.465 . . . . 1.0 110.851 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -65.02 -49.81 68.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.821 -0.627 . . . . 1.0 111.76 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.401 HD11 HG13 ' A' ' 131' ' ' VAL . 10.6 tp -70.26 -39.49 76.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.866 0.365 . . . . 1.0 110.571 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.513 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 63.7 mm-40 -62.67 -42.75 99.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.553 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -61.14 -47.68 85.12 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.574 -0.45 . . . . 1.0 110.279 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -61.12 -39.7 91.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.77 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.5 p -60.16 -38.59 83.63 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.404 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -62.46 -40.32 96.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.258 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.03 -42.69 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.657 -0.498 . . . . 1.0 109.657 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.74 75.67 79.4 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.2 178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.31 -23.43 44.73 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.75 2.3 . . . . 1.0 112.53 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -95.89 -9.75 30.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.146 -0.479 . . . . 1.0 112.028 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -107.29 149.83 27.35 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.977 0.418 . . . . 1.0 110.379 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.9 p -80.83 162.81 23.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.757 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.401 HG13 HD11 ' A' ' 119' ' ' ILE . 3.9 p -152.37 147.55 14.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.489 ' O ' ' CD1' ' A' ' 133' ' ' TYR . 28.7 p90 -149.39 142.61 25.08 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.789 0.328 . . . . 1.0 111.118 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 29.7 m-85 -151.75 169.2 22.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.306 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.567 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -133.83 152.62 51.93 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 179.19 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 72.3 m -152.11 170.16 20.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.419 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.0 tp -80.94 145.2 31.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.839 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 4.3 p30 -53.85 -171.89 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.179 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.463 ' CG ' ' O ' ' A' ' 138' ' ' HIS . 35.4 t-80 -135.31 35.2 3.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.531 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -169.63 -53.89 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.67 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.52 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 21.3 t-20 -105.16 86.69 1.67 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.099 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.473 ' HA ' HD21 ' A' ' 137' ' ' ASN . 29.9 Cg_endo -64.61 100.76 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.077 1.851 . . . . 1.0 112.316 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.506 ' H ' HD21 ' A' ' 137' ' ' ASN . . . 169.55 -36.3 0.19 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.517 -1.033 . . . . 1.0 110.517 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.407 ' CD1' ' N ' ' A' ' 143' ' ' TRP . 21.5 m95 -98.7 144.7 27.67 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 110.04 -0.356 . . . . 1.0 110.04 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 61.7 m-85 -107.42 149.6 27.71 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.173 -0.467 . . . . 1.0 109.778 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.405 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 32.3 m-85 -120.41 137.68 54.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.394 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.426 HD12 ' CG2' ' A' ' 161' ' ' VAL . 11.8 mt -110.04 121.01 44.26 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.318 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.553 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -116.41 145.89 42.91 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 178.402 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -159.69 155.26 25.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.513 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 64.5 tttt -141.36 129.61 22.27 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.752 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.5 mm -71.15 -46.48 66.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.875 -0.33 . . . . 1.0 111.725 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 151' ' ' ASN . 7.6 p-10 -162.24 177.88 9.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.35 . . . . 1.0 110.589 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.29 -32.89 74.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.067 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -84.45 7.59 19.22 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.018 0.437 . . . . 1.0 110.713 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.462 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 1.5 t -104.99 158.4 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.08 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -88.88 162.46 16.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.91 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.6 tp -80.38 118.94 22.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.982 0.42 . . . . 1.0 110.281 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -105.27 132.86 50.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.738 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 87.0 m -130.6 130.46 44.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.847 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -116.35 161.09 19.58 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.075 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.405 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 78.0 m-20 -107.2 144.68 33.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.739 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.426 ' CG2' HD12 ' A' ' 146' ' ' LEU . 58.8 t -126.57 136.7 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -99.62 130.41 45.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.912 0.387 . . . . 1.0 110.759 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.8 tp -92.36 130.8 37.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.032 -0.531 . . . . 1.0 109.66 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.3 p -129.73 165.76 21.24 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.0 0.429 . . . . 1.0 110.35 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 165' ' ' ASN . 9.1 t30 -79.23 15.72 1.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.628 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 20.0 p -122.27 -2.31 9.08 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.802 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.56 -131.87 5.19 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.419 -1.072 . . . . 1.0 110.419 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.85 130.55 53.02 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.077 -0.342 . . . . 1.0 110.077 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.477 ' CE1' ' OD1' ' A' ' 174' ' ' ASN . 5.7 m-85 -107.52 121.71 45.19 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.821 -0.437 . . . . 1.0 109.821 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.8 tt -114.38 119.1 35.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.711 -0.477 . . . . 1.0 109.711 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.5 t 36.16 57.92 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 112.166 0.432 . . . . 1.0 112.166 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 14.5 m120 65.27 27.17 12.16 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.045 0.757 . . . . 1.0 113.045 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -133.95 119.95 19.72 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.477 ' OD1' ' CE1' ' A' ' 169' ' ' PHE . 62.4 t30 -93.67 129.03 40.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 1.0 111.226 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -107.77 101.39 40.13 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -45.91 -23.49 1.72 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.489 2.126 . . . . 1.0 113.33 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.96 146.66 37.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 1.0 111.009 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.47 -33.42 56.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.92 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 179' ' ' ILE . 33.9 mm -60.87 -44.2 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.278 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -69.7 -30.34 67.96 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.5 -0.555 . . . . 1.0 109.5 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.29 -43.08 98.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.281 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 93.5 m -63.7 -46.49 85.24 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.336 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 186' ' ' LYS . 75.9 m-20 -65.19 -48.82 72.07 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.09 -45.68 0.89 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -68.92 -45.91 69.64 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 183' ' ' ASN . 36.6 tptt -57.14 -40.88 78.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.455 -0.793 . . . . 1.0 109.902 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 16.5 m -59.71 -46.7 88.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.1 -40.32 95.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.826 -0.624 . . . . 1.0 109.881 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 59.3 tp -57.87 -45.7 85.94 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.647 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -54.83 -45.65 74.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.167 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.7 t -62.25 -40.75 97.22 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.161 0.505 . . . . 1.0 110.34 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.41 -37.02 86.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.761 -0.654 . . . . 1.0 111.974 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -58.33 -30.14 66.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.622 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 24.8 m80 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.92 -179.296 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.507 ' OG1' ' N ' ' A' ' 2' ' ' HIS . 2.7 t . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.507 ' N ' ' OG1' ' A' ' 1' ' ' THR . 51.6 t-80 58.87 5.27 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.538 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.431 ' H ' ' C ' ' A' ' 1' ' ' THR . 80.9 mtp85 -135.82 1.8 2.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.558 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.46 -27.47 41.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.565 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 13.3 pt -67.78 -40.77 84.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.435 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -107.2 14.01 26.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.432 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -46.97 145.97 2.99 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.422 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -49.98 -36.22 43.51 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.671 1.581 . . . . 1.0 112.226 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.61 ' CD2' ' CZ ' ' A' ' 30' ' ' PHE . 80.2 m-85 -82.7 -1.56 51.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.385 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.531 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 42.2 t80 -72.32 129.61 38.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.34 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 54.0 m-85 -148.69 115.92 3.85 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 120.9 -0.32 . . . . 1.0 110.43 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.477 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 73.1 Cg_endo -74.76 109.88 3.0 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.754 1.636 . . . . 1.0 112.703 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 76.5 m-85 -155.33 159.4 39.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.525 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -77.16 172.16 13.68 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.449 ' C ' ' HE ' ' A' ' 16' ' ' ARG . . . -61.67 -46.84 93.42 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.446 -0.883 . . . . 1.0 111.108 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.639 ' HE ' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -66.06 -41.52 90.69 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 121.038 -0.265 . . . . 1.0 111.164 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -66.09 -35.66 81.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.279 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.84 -44.98 96.25 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.308 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -65.78 -41.97 91.37 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.034 179.135 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.46 -41.64 97.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.212 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -63.07 -39.47 94.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.54 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.2 mp -79.57 -13.26 59.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.723 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -63.57 -42.95 98.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.731 -0.388 . . . . 1.0 110.47 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.0 t -76.65 -20.33 56.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.79 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -84.17 177.55 8.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.456 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -89.2 176.33 7.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.863 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.448 ' NE ' ' OD1' ' A' ' 49' ' ' ASP . 84.9 mtt85 -76.32 147.57 38.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.974 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.46 19.67 37.49 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -99.73 140.79 33.42 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.61 ' CZ ' ' CD2' ' A' ' 9' ' ' TYR . 7.1 p90 -134.68 168.56 18.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.338 0.589 . . . . 1.0 111.11 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -147.32 158.25 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.251 -0.886 . . . . 1.0 111.498 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -116.87 129.17 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -138.74 157.85 45.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.418 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -115.63 135.51 53.99 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.859 -0.423 . . . . 1.0 109.859 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.1 t -95.27 126.74 40.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.764 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 96.5 p -59.59 -37.68 79.18 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.598 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.3 -24.37 62.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.874 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -75.37 -63.24 2.54 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.689 -0.964 . . . . 1.0 110.689 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 t0 73.66 -40.19 0.46 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.694 0.283 . . . . 1.0 110.803 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 38' ' ' GLY . 92.3 m-20 -118.91 11.08 12.45 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.748 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.436 ' CE1' HE21 ' A' ' 59' ' ' GLN . 10.8 m-70 -138.7 150.73 46.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.929 0.395 . . . . 1.0 110.205 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.04 154.19 33.51 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.064 -0.516 . . . . 1.0 109.727 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.7 t -124.39 130.01 73.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 1.0 110.079 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.7 mt -112.97 139.21 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.7 m -118.68 140.04 50.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.928 -0.578 . . . . 1.0 109.455 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -144.01 159.58 42.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.515 -0.766 . . . . 1.0 111.001 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.582 ' NZ ' ' O ' ' A' ' 50' ' ' LYS . 36.2 tttp -107.28 138.54 43.28 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.89 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.857 ' N ' HD12 ' A' ' 48' ' ' LEU . 3.2 mp -95.85 -74.23 0.56 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.371 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 50' ' ' LYS . 66.9 t0 -159.66 140.08 12.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.336 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.582 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 2.9 ttmm 43.81 -152.92 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.083 0.468 . . . . 1.0 111.183 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.74 63.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.836 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 50' ' ' LYS . 17.2 tp -145.68 120.75 10.09 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.977 0.418 . . . . 1.0 110.278 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -134.18 149.16 51.0 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.36 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -137.97 153.49 49.44 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.76 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.479 ' ND1' ' N ' ' A' ' 55' ' ' HIS . 1.9 p-80 -126.61 142.37 51.56 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.153 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.5 mt -126.06 131.7 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -94.27 120.53 34.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.028 0.442 . . . . 1.0 110.726 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.1 mm -90.47 128.0 42.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.083 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 60' ' ' GLU . 3.4 tm0? -113.71 128.9 56.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.042 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.52 ' O ' ' NE2' ' A' ' 59' ' ' GLN . 1.9 pp20? -101.17 148.6 24.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.276 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 1.9 tt -142.66 173.1 11.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.475 -0.329 . . . . 1.0 110.919 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 2.0 tm-20 82.07 25.2 0.19 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.383 0.611 . . . . 1.0 110.05 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.721 ' H ' ' CD ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -80.49 117.1 20.92 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.794 0.807 . . . . 1.0 110.122 178.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -89.66 -33.43 16.64 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.834 -0.541 . . . . 1.0 110.539 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.524 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -154.05 165.4 18.0 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.073 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.5 -29.7 60.93 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.162 1.908 . . . . 1.0 112.242 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.9 mt -90.02 -1.35 57.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.535 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.524 ' HB3' ' H ' ' A' ' 65' ' ' ASN . . . -92.25 134.45 34.87 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.278 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.4 mt -89.86 147.09 23.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.375 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.2 104.86 1.5 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -75.64 -13.43 60.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.772 0.32 . . . . 1.0 110.781 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.8 t -123.54 124.41 69.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.771 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.6 mt -117.07 133.32 56.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.52 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mp -102.41 124.61 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.825 0.345 . . . . 1.0 110.076 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -143.03 133.17 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.551 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 77' ' ' ASN . 46.7 t0 53.44 46.49 26.13 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.985 -0.286 . . . . 1.0 111.046 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.3 OUTLIER 56.75 18.68 3.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.977 179.464 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -125.12 147.26 49.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 1.0 110.135 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.86 127.92 44.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.224 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -120.46 139.91 52.16 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.18 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -84.51 -36.99 21.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.73 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -119.52 144.2 47.16 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.202 0.525 . . . . 1.0 111.989 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.7 tp -64.77 -39.38 93.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.764 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -60.19 -42.75 95.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 1.0 111.562 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.68 -37.87 83.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.58 0.229 . . . . 1.0 110.67 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.58 -47.41 92.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.901 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.75 -45.22 99.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.525 -0.47 . . . . 1.0 111.658 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.28 -43.29 74.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 112.626 0.602 . . . . 1.0 112.626 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -74.73 -15.81 60.76 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.721 -0.392 . . . . 1.0 111.862 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -94.8 -49.44 5.59 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.651 -0.419 . . . . 1.0 111.953 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.508 ' O ' HG23 ' A' ' 95' ' ' VAL . 9.8 mp -69.15 -40.35 78.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.228 0.455 . . . . 1.0 112.228 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -63.38 -49.2 74.74 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.797 -0.761 . . . . 1.0 111.556 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -72.67 -41.7 65.11 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.694 -0.403 . . . . 1.0 111.673 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -66.3 -41.48 89.69 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.334 -0.546 . . . . 1.0 111.389 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 91' ' ' LEU . 54.7 t -64.99 -46.7 90.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.251 -0.58 . . . . 1.0 111.355 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -66.34 -44.27 83.78 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.495 -0.482 . . . . 1.0 111.744 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.4 tp -66.94 -43.86 82.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.42 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 tt -64.64 -43.23 94.34 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.302 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -68.11 -35.76 78.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.859 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -70.69 -41.86 71.45 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 120.776 -0.37 . . . . 1.0 111.777 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.598 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 5.2 ttt -67.81 -54.56 18.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.538 -0.465 . . . . 1.0 111.462 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.8 m -58.45 -41.32 84.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.992 0.425 . . . . 1.0 110.301 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.9 m -72.37 8.09 1.51 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.863 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -85.6 140.18 30.81 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.823 0.344 . . . . 1.0 110.495 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.63 -22.15 66.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.674 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.55 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 24.8 mtmm -89.22 39.97 0.96 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.983 -0.553 . . . . 1.0 109.778 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -132.14 109.43 9.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.329 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -126.4 129.02 47.95 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.181 -0.463 . . . . 1.0 109.8 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.4 t -93.66 74.99 4.35 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.749 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.45 143.52 15.91 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.027 -0.829 . . . . 1.0 111.027 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.552 ' O ' HG23 ' A' ' 115' ' ' VAL . 81.1 p -75.12 172.04 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.051 -0.351 . . . . 1.0 110.051 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -57.51 -41.2 80.36 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.419 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -68.48 -45.01 73.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.88 0.372 . . . . 1.0 110.754 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.13 -20.51 64.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.865 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 111' ' ' THR . 13.4 t -70.71 -45.52 73.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.808 0.337 . . . . 1.0 110.428 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.5 t -64.45 -45.33 96.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.148 0.499 . . . . 1.0 110.235 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -66.07 -34.3 77.76 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.942 0.401 . . . . 1.0 111.019 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -69.5 -49.2 56.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.999 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.0 tp -69.67 -39.59 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.42 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -65.37 -43.19 91.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.72 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.82 -48.24 77.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.311 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.644 ' CD2' ' ND2' ' A' ' 126' ' ' ASN . 47.1 t80 -62.91 -43.26 99.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.93 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 88.1 p -61.02 -35.38 76.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.226 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -62.36 -42.61 99.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.06 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.9 t -66.67 -30.4 49.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 1.0 109.849 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.644 ' ND2' ' CD2' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -128.21 74.26 79.49 Favored Pre-proline 0 N--CA 1.471 0.59 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.531 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -71.88 -24.53 20.97 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.801 2.334 . . . . 1.0 112.609 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -102.3 14.59 31.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.018 -0.537 . . . . 1.0 112.002 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -137.54 144.93 42.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.117 0.484 . . . . 1.0 110.313 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.1 p -80.89 163.09 23.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.014 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 p -152.21 147.26 15.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -143.39 142.09 31.12 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.895 0.378 . . . . 1.0 111.196 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -152.43 168.46 25.41 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.432 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.55 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.7 OUTLIER -138.1 157.53 46.14 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 179.187 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.8 p -151.61 168.38 25.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.292 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 51.5 tp -80.65 136.86 36.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.821 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 23.8 t-20 -95.12 138.48 32.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.333 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -91.31 -31.66 16.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.714 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.41 -24.55 64.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.235 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 4.5 m120 -141.67 81.0 15.41 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.268 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -58.82 134.55 61.13 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.12 1.88 . . . . 1.0 112.445 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.89 -28.62 14.04 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 110.999 -0.84 . . . . 1.0 110.999 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 10.4 m0 -95.54 147.21 23.8 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.856 0.36 . . . . 1.0 110.284 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.598 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 70.9 m-85 -111.61 149.81 30.97 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.035 -0.53 . . . . 1.0 109.812 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.538 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 14.4 m-85 -120.08 136.13 54.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.22 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 16.5 mt -107.96 124.78 50.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.424 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.517 ' SD ' HG13 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -121.58 146.76 46.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.885 -1.154 . . . . 1.0 107.885 178.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -162.05 152.44 17.12 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.592 -0.522 . . . . 1.0 109.592 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.535 ' NZ ' ' O ' ' A' ' 154' ' ' SER . 37.5 tttp -136.41 129.5 31.29 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.472 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.696 HD12 ' H ' ' A' ' 150' ' ' ILE . 4.8 mp -72.49 -46.22 56.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.266 0.469 . . . . 1.0 112.266 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 150' ' ' ILE . 85.2 m-20 -156.95 170.15 23.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.573 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.08 71.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.947 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -89.01 6.68 38.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.433 . . . . 1.0 110.454 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.535 ' O ' ' NZ ' ' A' ' 149' ' ' LYS . 18.0 t -97.31 154.6 17.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.476 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -84.39 145.95 27.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.104 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.5 tp -70.63 126.28 29.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.958 0.409 . . . . 1.0 109.991 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -113.85 132.64 55.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.944 -0.571 . . . . 1.0 109.927 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 97.2 m -129.86 131.28 46.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.818 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.03 163.93 15.87 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.03 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.538 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 58.8 m-20 -111.9 148.85 32.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.695 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.65 137.58 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -100.17 132.36 45.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.98 0.419 . . . . 1.0 110.623 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.9 tp -92.62 131.26 37.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.662 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.0 p -130.38 171.18 13.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.482 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -84.63 15.66 3.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.759 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 2.1 m -122.66 -3.13 8.79 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.96 0.41 . . . . 1.0 110.685 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 141.01 -136.04 7.3 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -117.47 129.08 55.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.641 0.258 . . . . 1.0 110.35 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -106.38 119.84 40.33 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.0 tt -116.68 117.48 29.93 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.403 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.7 t 35.46 56.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.338 0.495 . . . . 1.0 112.338 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.5 m120 69.57 28.15 4.64 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.247 0.832 . . . . 1.0 113.247 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -134.31 121.01 20.63 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -90.83 127.66 36.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.226 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -115.16 91.59 28.17 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.32 -20.04 14.16 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.553 2.168 . . . . 1.0 113.291 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 72.1 m -133.1 138.49 46.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.044 0.45 . . . . 1.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.38 -34.4 60.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.777 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.16 -43.47 96.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -65.17 -34.62 78.83 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.8 tp -64.56 -41.36 96.36 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.389 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 77.8 m -61.29 -47.37 86.27 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 120.559 -0.456 . . . . 1.0 110.616 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 186' ' ' LYS . 62.8 t-20 -69.03 -48.4 63.02 Favored 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 119.647 -0.821 . . . . 1.0 108.915 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.51 -45.48 0.5 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.914 -1.274 . . . . 1.0 109.914 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -68.86 -47.76 65.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.061 -0.57 . . . . 1.0 109.64 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' A' ' 183' ' ' ASN . 47.0 tttp -56.77 -41.29 77.36 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.014 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 18.1 m -63.81 -44.56 92.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 15.4 mt -62.92 -43.28 99.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.006 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.7 tp -59.82 -43.36 94.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.34 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.39 -43.21 99.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.425 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 18.2 p -65.49 -37.66 87.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.066 0.46 . . . . 1.0 110.803 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 24.4 mt -64.0 -41.01 97.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.692 -0.686 . . . . 1.0 111.818 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.72 -25.33 68.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.464 -0.334 . . . . 1.0 111.817 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -94.73 -9.58 34.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.656 0.265 . . . . 1.0 110.987 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 46.35 25.84 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.445 -0.343 . . . . 1.0 111.082 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.412 ' O ' ' N ' ' A' ' 198' ' ' HIS . 0.3 OUTLIER -88.15 -6.99 57.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.617 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 51.24 -92.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.558 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.536 ' O ' ' CG ' ' A' ' 199' ' ' HIS . 99.8 m-70 -110.94 -43.51 3.76 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.751 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 198' ' ' HIS . 60.9 m-70 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 118.123 -0.941 . . . . 1.0 110.658 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -93.25 -7.15 45.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.516 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 83.6 mtm-85 -122.79 -5.47 8.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.896 0.379 . . . . 1.0 110.368 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.5 p -64.52 -30.98 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.55 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.6 pt -72.4 -20.96 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.658 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -96.34 7.35 46.68 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.428 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.63 141.23 64.58 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.321 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.76 -21.12 58.7 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.75 1.633 . . . . 1.0 112.181 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.88 3.22 49.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.214 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -83.68 132.4 34.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.569 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -152.41 118.14 3.03 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 120.931 -0.308 . . . . 1.0 110.247 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.49 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 72.5 Cg_endo -74.91 112.04 3.47 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.732 1.621 . . . . 1.0 112.659 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.49 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 70.2 m-85 -159.8 158.21 30.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.399 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -80.09 176.4 9.78 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.45 -50.33 67.74 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.373 -0.917 . . . . 1.0 110.988 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -66.01 -41.36 91.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.764 0.316 . . . . 1.0 110.956 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.412 ' OE1' ' N ' ' A' ' 17' ' ' GLN . 7.4 mp0 -62.8 -37.04 85.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.09 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.436 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -62.87 -44.52 95.9 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.508 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -60.82 -48.18 82.99 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.669 -0.412 . . . . 1.0 109.925 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -61.7 -40.22 94.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.201 -0.454 . . . . 1.0 109.899 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -61.96 -39.31 91.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.243 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 18' ' ' ALA . 7.9 mp -82.15 -13.83 56.59 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.846 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.6 ttp85 -65.11 -41.16 95.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.852 0.358 . . . . 1.0 110.336 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.3 m -78.17 -19.86 53.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.875 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -85.12 -179.84 7.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.823 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -81.78 165.49 20.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.813 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -75.75 145.77 40.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.778 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 17.92 49.46 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.982 -0.847 . . . . 1.0 110.982 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -85.16 147.56 26.55 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.425 ' CD2' ' HB3' ' A' ' 46' ' ' TRP . 27.6 m-85 -129.65 153.38 48.16 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.308 0.575 . . . . 1.0 111.098 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 44' ' ' ILE . 16.0 m -144.55 153.91 14.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.187 -0.915 . . . . 1.0 111.211 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.1 mm -115.49 131.19 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -133.74 151.69 51.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.997 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -109.93 130.66 55.5 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.17 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.8 t -82.72 162.82 21.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.579 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.9 p -111.7 -10.97 14.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.717 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -80.79 -30.18 35.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.165 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.656 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . -115.74 -12.14 9.68 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.01 -64.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.978 0.458 . . . . 1.0 110.405 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.656 ' N ' ' O ' ' A' ' 38' ' ' GLY . 24.8 t0 -78.45 12.47 1.96 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.441 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -117.19 142.4 47.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.83 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.25 148.33 44.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.344 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.9 t -123.49 130.2 74.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.781 -0.452 . . . . 1.0 109.781 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 31' ' ' VAL . 79.3 mt -110.62 136.88 45.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 94.0 m -118.39 140.98 49.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.536 -0.756 . . . . 1.0 109.344 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.56 ' CE2' HD11 ' A' ' 48' ' ' LEU . 5.3 p-90 -147.94 151.37 35.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.968 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.503 ' C ' HD12 ' A' ' 48' ' ' LEU . 18.6 ttmm -96.51 140.62 30.87 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.746 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.5 mp -99.57 -68.74 0.79 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.342 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -137.32 -153.19 0.47 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.226 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -68.64 136.46 53.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.667 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 42.08 43.54 2.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.848 -0.615 . . . . 1.0 111.111 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.432 HD11 ' HB3' ' A' ' 141' ' ' PRO . 11.5 tp -140.44 122.71 15.88 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.942 0.401 . . . . 1.0 109.952 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.473 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 47.8 m-85 -133.22 150.1 51.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.583 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 53' ' ' PHE . 27.9 mm-40 -138.57 150.22 46.09 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.667 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -125.05 138.9 54.19 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.213 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.7 mt -123.84 129.78 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 41.2 p-10 -95.5 121.03 36.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.934 0.397 . . . . 1.0 111.243 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.3 mm -98.42 122.48 50.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.032 -0.531 . . . . 1.0 109.99 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -117.4 132.28 56.6 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.813 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -98.96 153.64 18.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.342 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.498 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.8 tp -145.14 -179.07 6.39 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.567 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.498 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 20.5 tt0 70.66 42.89 0.79 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.991 -0.55 . . . . 1.0 109.705 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -83.75 102.22 12.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.78 -0.645 . . . . 1.0 109.844 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.435 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 80.6 mm-40 -68.45 -28.42 67.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.67 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 64' ' ' GLU . 2.6 m-80 -158.01 163.79 23.44 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.226 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.58 -32.04 52.1 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.12 1.88 . . . . 1.0 112.371 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.498 HD23 ' H ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -89.61 -5.28 57.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.826 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.73 134.28 51.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.327 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.7 mt -83.7 156.19 22.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.379 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.91 86.84 0.05 OUTLIER Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.455 -1.058 . . . . 1.0 110.455 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.27 -39.49 86.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.969 0.414 . . . . 1.0 111.067 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 51.0 t -117.13 123.92 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.768 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.3 mt -116.14 129.3 56.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.243 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.4 mt -101.29 125.67 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -140.91 130.24 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.313 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.426 ' OD1' ' OD1' ' A' ' 165' ' ' ASN . 15.5 t70 53.28 46.4 26.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.231 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 57.63 16.03 3.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.895 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -120.63 136.29 54.87 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.948 0.404 . . . . 1.0 110.045 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -89.84 127.59 36.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.738 -0.665 . . . . 1.0 111.102 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -118.27 142.86 47.05 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.199 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -83.45 -37.52 23.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.817 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 50.7 t0 -129.66 153.69 47.87 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.242 0.544 . . . . 1.0 111.819 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.567 ' HA ' HD12 ' A' ' 86' ' ' ILE . 54.0 tp -63.98 -38.78 92.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.791 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.69 -45.47 89.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.562 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -61.18 -37.31 82.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.687 0.28 . . . . 1.0 110.641 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 83' ' ' LEU . 96.6 mt -58.87 -47.63 88.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.659 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.8 mm -62.99 -44.82 99.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.476 -0.489 . . . . 1.0 111.678 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.85 -43.52 96.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 112.372 0.508 . . . . 1.0 112.372 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -72.96 -21.29 60.89 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.577 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.55 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 2.2 t80 -89.35 -51.29 5.64 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.176 -0.61 . . . . 1.0 111.485 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 95' ' ' VAL . 10.3 mp -62.69 -42.69 99.77 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.629 -0.429 . . . . 1.0 111.832 -178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -63.54 -50.79 68.15 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.691 -0.803 . . . . 1.0 111.446 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -68.94 -42.66 76.41 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.715 -0.394 . . . . 1.0 111.54 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -65.31 -44.32 88.24 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.162 -0.615 . . . . 1.0 111.318 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 91' ' ' LEU . 75.3 t -66.53 -44.22 90.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.406 -0.518 . . . . 1.0 111.205 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -67.25 -45.18 77.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.482 -0.327 . . . . 1.0 111.353 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.21 -44.59 91.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.583 -0.281 . . . . 1.0 111.649 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.2 tp -63.56 -40.55 97.28 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.021 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.4 ' O ' ' CB ' ' A' ' 103' ' ' SER . 92.7 m-20 -67.21 -42.42 84.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.77 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -64.38 -43.18 95.27 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 121.983 -0.448 . . . . 1.0 111.545 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.5 ttm -67.63 -56.23 10.21 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.42 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.2 m -59.54 -44.17 93.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.032 0.444 . . . . 1.0 110.815 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 7.6 t -72.99 11.73 0.64 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.68 -0.691 . . . . 1.0 111.298 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.3 t -92.89 135.48 34.11 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.87 0.367 . . . . 1.0 110.248 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.58 -21.14 66.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.942 0.401 . . . . 1.0 111.17 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.537 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 52.9 mttp -89.87 41.09 1.03 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.919 -0.582 . . . . 1.0 109.903 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -133.34 115.25 14.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.2 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -134.43 120.87 20.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.786 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.0 m -90.25 82.44 6.0 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.914 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.76 150.99 17.12 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.848 -0.901 . . . . 1.0 110.848 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 115' ' ' VAL . 9.0 p -79.41 173.96 12.05 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.033 -0.358 . . . . 1.0 110.033 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.42 ' NZ ' ' CG ' ' A' ' 138' ' ' HIS . 16.0 mtmm -59.39 -37.6 78.4 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.821 -0.352 . . . . 1.0 110.684 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -68.27 -43.25 78.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.052 0.453 . . . . 1.0 110.562 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -70.63 -19.19 62.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.73 -0.668 . . . . 1.0 111.067 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.557 HG13 ' SD ' ' A' ' 147' ' ' MET . 19.2 t -70.74 -45.34 74.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.704 -0.398 . . . . 1.0 110.13 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.99 -45.43 90.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-O 121.333 0.587 . . . . 1.0 110.251 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -65.84 -37.88 87.38 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.931 0.396 . . . . 1.0 111.326 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -69.43 -47.82 62.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.913 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.8 tp -69.64 -39.89 78.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.397 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.472 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 61.1 mm-40 -64.56 -42.76 95.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.728 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.13 -48.16 77.16 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.298 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CD1' ' OD1' ' A' ' 126' ' ' ASN . 30.0 t80 -62.34 -43.76 98.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.137 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.1 t -59.58 -40.4 87.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.096 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -58.48 -42.59 87.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 1.0 109.939 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.0 t -64.03 -37.98 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.445 ' OD1' ' CD1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -124.62 76.83 63.91 Favored Pre-proline 0 N--CA 1.473 0.704 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.351 179.69 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.487 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 7.1 Cg_exo -71.17 -27.29 20.2 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.634 2.223 . . . . 1.0 112.621 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -100.51 11.33 39.69 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.885 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -131.46 146.22 52.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.188 0.518 . . . . 1.0 110.433 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.8 m -80.83 163.52 23.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.537 -0.756 . . . . 1.0 109.913 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 p -151.24 145.65 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -145.89 142.24 28.59 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.912 0.387 . . . . 1.0 111.112 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -152.47 167.8 27.6 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.347 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -132.2 156.31 46.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 179.039 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.5 p -152.93 169.64 22.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.447 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 137' ' ' ASN . 54.0 tp -77.04 136.33 38.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.546 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 138' ' ' HIS . 11.0 t-20 -44.08 170.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.403 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.515 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 71.4 t60 -77.26 -56.45 4.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.038 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 139' ' ' ASP . 66.5 t0 -139.6 45.25 1.93 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.981 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -136.87 102.47 9.29 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 109.905 -0.405 . . . . 1.0 109.905 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.432 ' HB3' HD11 ' A' ' 52' ' ' LEU . 45.8 Cg_endo -75.19 120.59 6.07 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.944 1.762 . . . . 1.0 112.608 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.16 20.68 22.57 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.886 -0.886 . . . . 1.0 110.886 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -134.44 139.86 45.83 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.873 0.368 . . . . 1.0 110.281 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -132.5 160.04 37.65 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.841 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 145' ' ' TYR . 8.1 p90 -142.11 146.94 35.95 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.2 mt -106.36 126.57 52.41 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.136 0.493 . . . . 1.0 110.366 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.557 ' SD ' HG13 ' A' ' 115' ' ' VAL . 5.9 ptt? -116.86 144.83 44.05 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.928 -1.138 . . . . 1.0 107.928 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 148' ' ' PHE . 13.3 p90 -162.8 154.19 17.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.549 -0.538 . . . . 1.0 109.549 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.472 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 69.2 tttt -135.13 131.13 36.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.468 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.486 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 38.6 mm -72.41 -45.61 59.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.994 0.368 . . . . 1.0 111.994 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 27.8 m120 -161.61 173.06 15.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.577 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.52 -34.44 75.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.071 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -83.75 -12.96 55.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.588 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.431 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 8.4 t -79.82 158.71 26.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.32 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -89.77 150.58 22.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 1.0 109.98 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.6 tp -71.07 124.75 25.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.872 0.368 . . . . 1.0 110.211 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -110.91 129.3 55.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.667 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 91.1 m -131.24 131.43 43.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.114 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.75 166.15 13.13 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -107.97 142.45 38.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.114 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.5 t -122.3 138.29 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -106.01 135.15 47.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.034 0.445 . . . . 1.0 110.742 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.6 131.69 45.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.688 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.2 p -134.83 178.01 7.34 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.349 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.55 ' ND2' ' CE1' ' A' ' 90' ' ' TYR . 5.3 m120 -86.78 14.59 6.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.717 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 17.9 p -119.01 -1.12 11.01 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.483 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.74 -131.35 5.84 Favored Glycine 0 N--CA 1.465 0.59 0 N-CA-C 110.25 -1.14 . . . . 1.0 110.25 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -121.8 127.28 50.42 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -102.29 123.83 46.79 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.4 tt -117.96 111.79 19.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.519 -0.549 . . . . 1.0 109.519 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.5 t 35.94 59.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.175 0.435 . . . . 1.0 112.175 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.8 m120 69.4 27.52 4.97 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.98 0.733 . . . . 1.0 112.98 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -134.13 120.59 20.32 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -95.91 126.68 41.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.238 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -108.9 99.29 34.21 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 109.573 -0.528 . . . . 1.0 109.573 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.15 -21.57 9.51 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.382 2.055 . . . . 1.0 113.444 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 38.5 m -132.92 139.07 47.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.041 0.448 . . . . 1.0 111.253 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.96 -35.61 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.617 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.421 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 95.4 mt -63.32 -43.36 98.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 1.0 110.054 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.491 ' N ' ' OE1' ' A' ' 180' ' ' GLN . 6.3 mp0 -63.11 -31.46 72.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.224 -0.658 . . . . 1.0 109.224 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.78 -41.9 97.86 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.327 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.63 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 3.0 p -58.96 -47.98 83.15 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.617 -0.433 . . . . 1.0 110.629 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.63 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 48.3 t30 -69.52 -48.91 58.95 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.44 -44.78 0.45 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.756 -1.338 . . . . 1.0 109.756 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -68.83 -47.44 66.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.052 -0.574 . . . . 1.0 109.76 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.574 ' N ' ' O ' ' A' ' 183' ' ' ASN . 88.8 tttt -57.03 -42.27 80.14 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.362 -0.836 . . . . 1.0 110.116 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 96.7 m -61.71 -44.33 97.14 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 53.1 mt -61.73 -41.57 97.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.773 -0.648 . . . . 1.0 109.928 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 59.2 tp -58.95 -44.15 91.4 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.388 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 16.5 tptp -62.01 -43.98 97.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.474 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.0 t -63.33 -38.45 91.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.363 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.4 mt -63.76 -42.08 97.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.829 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.41 -30.09 66.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.56 -0.291 . . . . 1.0 111.67 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -81.02 -3.46 51.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.843 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 79.4 t60 55.53 56.11 6.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.321 -0.399 . . . . 1.0 111.04 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -43.2 135.76 3.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.881 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -80.07 135.34 36.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.56 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.568 ' CG ' ' H ' ' A' ' 199' ' ' HIS . 26.7 t-80 -159.09 -128.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.528 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.568 ' H ' ' CG ' ' A' ' 198' ' ' HIS . 13.1 p80 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.933 -1.032 . . . . 1.0 110.853 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 74.3 p . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.57 ' CG ' ' N ' ' A' ' 3' ' ' ARG . 13.6 p-80 -149.61 -49.98 0.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.524 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.57 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 41.1 mmm-85 -125.64 3.82 7.52 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.839 0.352 . . . . 1.0 110.503 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.83 -27.93 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.653 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.2 pt -76.49 -18.76 14.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.536 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 3' ' ' ARG . 56.1 p30 -99.35 7.44 45.55 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.485 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -84.99 138.49 37.12 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 110.091 -0.337 . . . . 1.0 110.091 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.59 -13.32 32.48 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.889 1.726 . . . . 1.0 112.342 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.418 ' CD1' ' CZ ' ' A' ' 30' ' ' PHE . 40.4 m-85 -99.35 10.68 40.95 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.572 -0.286 . . . . 1.0 111.069 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.532 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 91.0 t80 -85.98 123.36 31.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.316 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 49.5 m-85 -146.5 108.92 4.15 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 110.092 -0.336 . . . . 1.0 110.092 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.508 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 45.3 Cg_exo -58.88 109.57 0.54 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 121.697 1.598 . . . . 1.0 112.48 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 23.4 m-85 -159.48 155.69 26.95 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.626 -0.716 . . . . 1.0 110.555 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 18.8 t-20 -84.03 164.04 19.54 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.295 -0.631 . . . . 1.0 109.295 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . -61.14 -40.81 99.06 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.569 -0.824 . . . . 1.0 111.095 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -66.73 -43.97 82.81 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.911 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -69.46 -36.0 76.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.392 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -39.49 90.09 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.304 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -60.43 -44.07 96.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.081 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -61.57 -42.45 98.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.281 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -63.05 -42.16 99.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.59 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mp -77.67 -13.59 59.86 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.295 -0.411 . . . . 1.0 111.081 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -58.49 -42.83 88.46 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.385 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p -79.48 -18.4 52.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -82.54 177.91 8.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.499 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.536 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 56.4 mp0 -90.01 173.23 8.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.77 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 ptt-85 -81.19 145.01 31.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.727 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.94 -1.39 55.2 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -82.1 147.82 28.88 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.418 ' CZ ' ' CD1' ' A' ' 9' ' ' TYR . 13.7 p90 -133.47 163.17 29.97 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.353 0.597 . . . . 1.0 110.961 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.684 ' O ' HG23 ' A' ' 44' ' ' ILE . 31.1 m -146.88 157.95 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.21 -0.904 . . . . 1.0 111.298 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.8 mt -117.53 127.47 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.109 -0.496 . . . . 1.0 109.715 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -146.46 153.29 40.26 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.394 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -104.93 139.6 39.41 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.735 -0.468 . . . . 1.0 109.735 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -67.69 149.58 49.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.796 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 t -63.77 -20.5 65.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.966 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -125.01 10.18 8.17 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.574 -0.285 . . . . 1.0 110.684 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . -68.57 -56.93 8.76 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t0 67.54 -51.33 0.5 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.734 0.302 . . . . 1.0 110.874 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 38' ' ' GLY . 90.5 m-20 -122.05 4.92 9.84 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.008 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -120.16 149.96 41.4 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.042 0.449 . . . . 1.0 110.517 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.423 ' CD1' ' OE2' ' A' ' 60' ' ' GLU . 5.2 mp -121.45 147.5 45.66 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.096 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -126.5 132.13 70.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.684 HG23 ' O ' ' A' ' 31' ' ' VAL . 57.0 mt -113.74 139.83 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 108.837 -0.801 . . . . 1.0 108.837 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.2 m -120.4 142.39 49.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.035 -0.53 . . . . 1.0 109.692 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.67 ' CE2' HD11 ' A' ' 48' ' ' LEU . 2.4 p-90 -147.68 151.6 36.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.977 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.601 ' C ' HD12 ' A' ' 48' ' ' LEU . 87.6 tttt -99.66 140.33 34.01 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.87 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.703 HD21 ' NE2' ' A' ' 54' ' ' GLN . 9.0 mp -105.77 -82.08 0.53 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.605 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -93.81 -178.67 4.75 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.801 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -57.48 -40.48 78.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.667 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -127.51 53.45 1.75 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.092 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tp -151.42 128.22 10.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.898 0.38 . . . . 1.0 110.195 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -132.31 148.72 52.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.535 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.703 ' NE2' HD21 ' A' ' 48' ' ' LEU . 29.8 mt-30 -137.79 152.61 49.32 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.972 -0.558 . . . . 1.0 109.628 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -129.31 144.9 51.41 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.201 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.433 HD11 ' OH ' ' A' ' 90' ' ' TYR . 96.6 mt -126.27 130.82 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.842 -0.429 . . . . 1.0 109.842 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 43.7 p-10 -99.84 124.81 45.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.899 0.38 . . . . 1.0 110.633 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 90.1 mt -102.21 133.05 46.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.48 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -119.96 134.84 55.12 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.853 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.423 ' OE2' ' CD1' ' A' ' 42' ' ' LEU . 3.6 mt-10 -100.09 143.91 29.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.145 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.4 mt -141.22 174.8 10.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.413 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 74.05 35.36 0.78 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.957 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -95.12 103.14 14.99 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.021 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.3 -31.84 72.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.837 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -147.67 155.84 45.01 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.265 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.98 -31.96 46.06 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.199 1.933 . . . . 1.0 112.079 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tp -79.69 -10.82 59.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.881 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.73 136.23 45.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.494 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 71' ' ' LYS . 64.7 mt -81.44 154.23 26.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.312 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.6 86.01 0.01 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.427 -1.069 . . . . 1.0 110.427 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 69' ' ' LEU . 68.3 mttm -61.35 -35.65 78.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.997 0.427 . . . . 1.0 110.823 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.4 t -127.62 124.16 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.798 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.0 mt -114.77 126.44 54.84 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.8 mt -102.18 123.1 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.84 0.353 . . . . 1.0 110.24 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.2 t -143.45 132.72 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.138 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 54.49 43.66 29.99 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.954 -0.299 . . . . 1.0 111.05 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.6 m120 57.98 19.96 6.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.708 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -128.32 139.12 52.57 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.873 0.368 . . . . 1.0 110.33 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -89.15 133.18 34.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.041 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -124.52 138.23 54.35 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.131 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -81.92 -37.32 26.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 1.0 111.62 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -123.22 149.91 44.09 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.124 0.487 . . . . 1.0 111.887 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.2 tp -65.74 -40.76 92.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.825 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -59.44 -43.54 93.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.905 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -56.93 -38.62 73.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.566 0.222 . . . . 1.0 110.633 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.22 -44.65 99.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.619 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.01 -46.16 97.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.52 -0.472 . . . . 1.0 111.647 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.98 -41.42 59.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 112.677 0.621 . . . . 1.0 112.677 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -78.5 -13.35 59.88 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.948 -0.301 . . . . 1.0 111.401 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.433 ' OH ' HD11 ' A' ' 56' ' ' ILE . 63.1 t80 -94.39 -49.3 5.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.113 0.412 . . . . 1.0 112.113 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.581 ' O ' HG23 ' A' ' 95' ' ' VAL . 2.9 mp -71.68 -38.08 70.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.965 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -62.07 -48.26 81.0 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.968 -0.693 . . . . 1.0 111.215 -177.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.04 -42.35 69.61 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.848 -0.341 . . . . 1.0 111.683 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -66.05 -42.33 89.64 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.503 -0.479 . . . . 1.0 111.169 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 91' ' ' LEU . 68.6 t -63.63 -47.86 89.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.347 -0.541 . . . . 1.0 111.214 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -69.93 -42.54 73.14 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.578 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.485 HD11 ' CZ ' ' A' ' 168' ' ' TYR . 13.7 tp -68.63 -41.93 78.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.428 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.2 tp -62.92 -43.41 98.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.031 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -66.14 -39.98 90.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.788 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -70.06 -41.61 73.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.398 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.6 tpt -64.22 -56.36 15.23 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.456 -0.498 . . . . 1.0 111.369 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' ' 104' ' ' SER . 14.0 m -60.69 -39.46 88.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.043 0.449 . . . . 1.0 110.51 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 91.8 p -73.16 11.26 0.76 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.767 -0.651 . . . . 1.0 111.117 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 102' ' ' THR . 13.8 t -90.5 138.02 31.89 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.259 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.67 -20.1 63.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.194 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.582 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 64.3 mttp -87.99 39.12 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.691 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -129.17 110.14 11.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.372 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.56 122.94 37.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.206 -0.452 . . . . 1.0 109.884 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.6 m -95.0 72.83 3.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.118 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.58 151.28 16.93 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.953 -0.859 . . . . 1.0 110.953 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -73.35 175.84 6.55 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.032 -0.359 . . . . 1.0 110.032 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt -56.11 -37.79 69.89 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.95 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -68.47 -42.73 78.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.097 0.475 . . . . 1.0 110.729 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -70.28 -23.0 62.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.112 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 111' ' ' THR . 41.3 t -69.39 -45.74 78.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.158 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.1 t -65.92 -45.75 90.31 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 CA-C-O 121.158 0.504 . . . . 1.0 110.548 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.99 -33.06 74.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.794 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -68.61 -50.01 54.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.618 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.442 HD11 HG13 ' A' ' 131' ' ' VAL . 11.0 tp -70.03 -39.22 77.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.851 0.358 . . . . 1.0 110.253 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -64.97 -40.12 94.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.455 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -59.9 -47.53 85.4 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.686 -0.405 . . . . 1.0 110.286 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -60.98 -40.62 94.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.076 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 7.4 t -62.18 -41.72 98.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.548 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -59.49 -43.52 93.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.297 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.38 -41.96 92.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.71 76.29 77.26 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.488 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.537 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 10.2 Cg_exo -68.03 -21.14 43.57 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.857 2.372 . . . . 1.0 112.641 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -102.45 13.76 33.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.838 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -128.05 152.8 47.52 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.107 0.479 . . . . 1.0 110.379 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.1 p -81.39 161.16 23.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.637 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.442 HG13 HD11 ' A' ' 119' ' ' ILE . 5.1 p -154.89 146.12 13.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 20.7 p90 -151.4 142.06 22.73 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.834 0.35 . . . . 1.0 111.026 178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -152.62 168.14 26.58 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.393 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 5.1 p90 -136.46 157.19 47.38 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.257 -0.645 . . . . 1.0 109.257 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.2 p -149.27 168.58 22.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.815 0.34 . . . . 1.0 110.184 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 46.7 tp -79.26 144.46 34.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.355 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 0.0 OUTLIER -67.56 -172.82 0.27 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.026 -0.534 . . . . 1.0 109.999 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.516 ' ND1' ' N ' ' A' ' 138' ' ' HIS . 0.2 OUTLIER -110.31 -56.59 2.32 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.941 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -114.09 19.88 16.1 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.082 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.529 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 5.9 m120 -125.06 68.36 56.33 Favored Pre-proline 0 N--CA 1.466 0.344 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.236 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -63.13 127.71 20.93 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.989 1.793 . . . . 1.0 112.46 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.36 11.56 41.46 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 110.761 -0.936 . . . . 1.0 110.761 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.524 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 57.7 m95 -132.95 156.54 47.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.818 0.342 . . . . 1.0 110.092 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -129.67 148.65 51.58 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.479 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 18.3 m-85 -116.84 136.13 53.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.063 0.459 . . . . 1.0 110.193 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.2 mt -109.77 124.61 51.57 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.302 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -121.48 147.52 45.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.053 -1.092 . . . . 1.0 108.053 178.221 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -160.18 150.74 18.64 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.608 -0.515 . . . . 1.0 109.608 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -136.23 128.34 29.73 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.851 -0.34 . . . . 1.0 110.521 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.5 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 34.3 mm -69.99 -45.79 75.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.421 -0.354 . . . . 1.0 111.716 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 31.1 m120 -158.94 173.68 16.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.559 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.11 -34.6 76.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.79 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -86.86 9.2 19.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.041 0.448 . . . . 1.0 110.46 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 13.1 t -98.59 165.92 11.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.431 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -96.79 145.58 25.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.929 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.04 121.45 22.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.063 0.459 . . . . 1.0 109.931 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -111.67 128.09 55.96 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.91 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.9 m -123.76 127.61 48.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.778 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.53 171.67 7.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.024 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.479 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 93.6 m-20 -109.51 149.17 30.01 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.836 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 45.8 t -126.35 136.92 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -104.88 125.8 51.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.021 0.439 . . . . 1.0 110.715 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 46.2 tp -88.6 129.8 35.41 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.399 -0.593 . . . . 1.0 109.399 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.3 p -128.34 171.83 11.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.408 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -83.98 16.09 3.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.512 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 67.0 p -122.71 -2.94 8.78 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.555 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 139.93 -128.69 3.99 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.453 -1.059 . . . . 1.0 110.453 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.485 ' CZ ' HD11 ' A' ' 97' ' ' LEU . 46.2 m-85 -123.81 127.35 47.96 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.729 0.299 . . . . 1.0 110.445 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -103.58 123.99 47.97 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 171' ' ' VAL . 0.5 OUTLIER -115.14 112.46 22.57 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.208 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 170' ' ' LEU . 5.2 t 34.74 64.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 65.0 27.39 12.64 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.012 0.745 . . . . 1.0 113.012 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -132.42 121.58 23.65 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.176 -0.675 . . . . 1.0 109.176 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -94.61 123.44 38.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.822 0.344 . . . . 1.0 111.427 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -103.47 134.96 19.47 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.01 -23.21 22.02 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.037 1.825 . . . . 1.0 113.377 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 70.8 m -156.45 161.28 40.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.952 0.406 . . . . 1.0 111.035 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 179' ' ' ILE . 7.5 p -61.12 -42.01 91.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.853 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.479 ' N ' HG13 ' A' ' 178' ' ' VAL . 48.1 mm -60.29 -47.4 92.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.722 -0.391 . . . . 1.0 110.299 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -62.02 -35.92 80.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.8 tt -62.96 -40.1 96.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.271 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 72.8 m -60.77 -47.76 84.84 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.579 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.639 ' O ' ' N ' ' A' ' 186' ' ' LYS . 56.8 t-20 -66.82 -47.37 72.25 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.58 -45.5 0.51 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.954 -1.259 . . . . 1.0 109.954 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.514 ' O ' ' HG ' ' A' ' 188' ' ' LEU . 0.3 OUTLIER -69.84 -41.82 74.4 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-O 121.913 0.863 . . . . 1.0 109.762 178.25 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.639 ' N ' ' O ' ' A' ' 183' ' ' ASN . 87.9 tttt -60.84 -34.24 74.28 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.87 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.1 m -64.09 -51.59 63.3 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.899 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.599 ' C ' HD12 ' A' ' 188' ' ' LEU . 0.9 OUTLIER -65.57 -35.67 81.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.123 179.001 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.441 ' N ' ' HG ' ' A' ' 188' ' ' LEU . 37.1 tp -57.27 -46.47 83.06 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.172 -0.467 . . . . 1.0 109.97 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.51 -39.82 94.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.136 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.7 t -59.9 -36.43 76.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.498 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.5 mt -67.85 -41.6 82.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.785 -0.643 . . . . 1.0 112.208 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.1 -36.98 83.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.771 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' HIS . . . . . 0.469 ' O ' ' ND1' ' A' ' 194' ' ' HIS . 2.4 t-80 -80.58 -8.5 59.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.843 0.354 . . . . 1.0 110.85 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.474 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 35.1 t-80 50.09 49.56 20.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.426 . . . . 1.0 111.069 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -136.59 94.51 3.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.369 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -157.15 146.5 20.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.626 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.459 ' C ' ' ND1' ' A' ' 198' ' ' HIS . 5.8 p80 -77.35 167.18 22.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.703 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.977 -1.011 . . . . 1.0 110.681 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.477 ' N ' HD23 ' A' ' 69' ' ' LEU . 50.0 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -149.32 10.71 0.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.534 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.6 ttp-105 -130.52 -26.76 2.23 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.351 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.2 p -66.38 -32.6 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.669 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 pt -67.26 -24.07 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.672 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -93.59 0.76 56.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.397 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -64.27 130.75 94.77 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.221 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -47.64 -32.36 16.15 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.705 1.603 . . . . 1.0 112.516 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -85.32 9.66 14.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.372 -0.377 . . . . 1.0 111.181 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.505 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 80.6 t80 -89.95 129.83 36.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.467 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 61.7 m-85 -149.24 127.6 5.92 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 110.2 -0.296 . . . . 1.0 110.2 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 73.7 Cg_endo -73.24 109.9 2.94 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.901 1.734 . . . . 1.0 112.724 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 71.4 m-85 -160.89 151.78 18.56 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.489 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -76.26 -170.05 1.34 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.95 -44.53 8.17 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.546 -1.021 . . . . 1.0 110.546 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -67.02 -43.77 81.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.664 0.268 . . . . 1.0 111.025 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.2 -33.89 77.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.057 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.5 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.15 -39.47 90.2 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.741 -0.383 . . . . 1.0 110.326 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.25 -42.08 96.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.043 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.37 -44.39 96.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.439 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -63.32 -42.23 98.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.35 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 18' ' ' ALA . 7.9 mp -73.29 -12.79 60.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.805 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -58.97 -40.73 85.63 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.357 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.6 t -75.82 -18.71 59.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.766 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.482 ' N ' ' CD ' ' A' ' 25' ' ' LYS . 3.1 mptp? -83.5 179.89 7.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.438 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.407 ' OE1' ' O ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -104.37 -176.01 2.96 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.367 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.458 ' CD ' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -75.08 143.26 43.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.458 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.47 7.54 57.98 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.844 -0.902 . . . . 1.0 110.844 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -87.0 140.58 29.41 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -135.85 162.13 33.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.253 0.549 . . . . 1.0 110.92 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.2 m -147.44 158.65 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.155 -0.93 . . . . 1.0 111.612 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.0 mt -117.69 127.21 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -146.98 155.29 42.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.463 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.79 137.27 45.14 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.9 t -74.75 144.85 43.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.974 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.0 p -64.83 -30.21 71.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.723 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -102.35 0.79 34.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.707 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.99 -56.47 5.29 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.428 -1.069 . . . . 1.0 110.428 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 72.64 -54.6 0.69 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.561 0.22 . . . . 1.0 111.024 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -119.52 2.41 11.22 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.756 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -117.9 150.47 39.15 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.869 0.366 . . . . 1.0 110.566 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.03 151.76 38.52 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 116.004 -0.544 . . . . 1.0 109.912 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.1 t -126.05 132.95 70.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.26 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.62 HD12 HD11 ' A' ' 58' ' ' ILE . 40.2 mt -111.86 137.88 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.0 m -117.48 136.82 52.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.841 -0.618 . . . . 1.0 109.846 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.678 ' CH2' HD21 ' A' ' 48' ' ' LEU . 1.3 p-90 -146.22 147.2 31.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.496 -0.774 . . . . 1.0 110.921 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HZ3' ' C ' ' A' ' 49' ' ' ASP . 64.7 tttm -93.84 140.66 29.41 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.075 -0.512 . . . . 1.0 111.255 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.678 HD21 ' CH2' ' A' ' 46' ' ' TRP . 82.0 mt -97.27 -66.25 0.91 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.486 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.452 ' C ' ' HZ3' ' A' ' 47' ' ' LYS . 4.6 p30 -144.56 -166.64 2.44 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.607 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -59.18 131.63 51.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.972 0.415 . . . . 1.0 110.682 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 49.87 52.79 13.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.907 -0.588 . . . . 1.0 111.156 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 141' ' ' PRO . 16.8 tp -158.89 119.12 3.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.338 . . . . 1.0 110.421 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.5 149.46 52.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.592 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.41 ' HG3' HD11 ' A' ' 48' ' ' LEU . 9.8 mm100 -137.05 151.9 49.45 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.136 -0.484 . . . . 1.0 109.751 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -125.8 140.62 52.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.203 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 95.7 mt -120.85 123.7 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -94.95 122.23 37.38 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.58 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.62 HD11 HD12 ' A' ' 44' ' ' ILE . 83.0 mt -102.53 129.68 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.336 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -119.82 134.37 55.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.099 -0.501 . . . . 1.0 109.891 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -102.62 148.78 25.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.109 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.1 mt -141.97 174.72 10.33 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.328 -0.397 . . . . 1.0 110.461 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 67.81 41.62 2.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.016 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.716 ' H ' ' CD ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -111.85 134.55 53.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.242 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.25 -20.3 30.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.538 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.458 ' ND2' ' HB2' ' A' ' 68' ' ' ALA . 1.6 p-10 -157.63 153.41 22.85 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.153 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.83 -20.91 68.53 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.267 1.978 . . . . 1.0 111.884 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.5 tp -85.49 -12.37 51.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.144 0.497 . . . . 1.0 110.639 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.458 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . . . -79.35 151.57 30.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.527 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 1' ' ' THR . 53.8 mt -75.86 147.24 39.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.284 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.79 98.91 0.37 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.551 -1.02 . . . . 1.0 110.551 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -62.55 -38.27 89.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.92 0.39 . . . . 1.0 110.544 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.53 123.65 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.624 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.4 mt -116.47 130.57 56.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.869 -0.605 . . . . 1.0 109.401 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mp -107.49 124.65 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.81 0.338 . . . . 1.0 110.362 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -139.2 132.11 37.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.288 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 39.3 t0 51.92 42.03 29.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.654 0.264 . . . . 1.0 111.035 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.1 t30 61.19 22.92 13.19 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.297 -0.411 . . . . 1.0 111.042 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -127.0 133.36 50.57 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.114 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -86.31 128.24 34.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.735 -0.666 . . . . 1.0 111.089 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -121.49 138.56 54.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.151 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -84.99 -34.55 22.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.542 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -126.31 149.45 49.14 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.062 0.458 . . . . 1.0 112.058 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.0 tp -65.38 -39.7 92.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.945 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.401 ' O ' HG23 ' A' ' 88' ' ' VAL . 89.5 m-20 -60.2 -40.81 91.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 1.0 111.741 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -61.0 -38.45 86.1 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.769 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.83 -45.84 97.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.726 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.9 mm -65.44 -43.45 94.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.506 -0.478 . . . . 1.0 111.47 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 84' ' ' ASP . 60.9 t -71.73 -43.07 70.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 112.642 0.608 . . . . 1.0 112.642 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.03 -13.13 59.55 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.722 -0.391 . . . . 1.0 111.61 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -95.3 -49.01 5.65 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.772 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 95' ' ' VAL . 2.1 tp -70.06 -41.41 74.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.312 -0.404 . . . . 1.0 112.018 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -63.96 -49.14 73.71 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.918 -0.713 . . . . 1.0 111.456 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -70.53 -42.05 71.73 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.62 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -65.88 -41.88 90.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.347 -0.541 . . . . 1.0 111.266 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 91' ' ' LEU . 51.5 t -64.76 -46.43 92.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.39 -0.524 . . . . 1.0 111.181 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -65.94 -44.57 84.66 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.593 -0.443 . . . . 1.0 111.259 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.552 HD11 ' CZ ' ' A' ' 168' ' ' TYR . 10.7 tp -65.57 -41.82 92.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.497 -0.32 . . . . 1.0 111.511 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.25 -42.3 99.17 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.299 -0.561 . . . . 1.0 110.045 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.414 ' O ' ' OG ' ' A' ' 103' ' ' SER . 91.1 m-20 -66.31 -40.41 89.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.262 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -69.37 -40.8 77.23 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.673 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.4 tpt -66.5 -56.11 12.41 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.104 -0.638 . . . . 1.0 111.301 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 65.1 m -60.44 -39.11 86.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.047 0.451 . . . . 1.0 110.852 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 99' ' ' ASN . 99.2 p -71.91 10.42 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.638 -0.71 . . . . 1.0 111.124 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.1 p -93.94 133.7 37.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.711 0.291 . . . . 1.0 110.468 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 37.9 mp0 -57.46 -21.07 34.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.138 0.494 . . . . 1.0 110.594 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.555 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 49.2 mttp -87.61 39.7 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.771 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -128.45 113.22 15.25 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.604 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -125.61 110.47 13.86 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.197 -0.456 . . . . 1.0 109.804 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.7 m -85.03 77.05 10.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.981 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -116.63 157.96 14.74 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 115' ' ' VAL . 72.3 p -78.53 168.05 20.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.843 -0.429 . . . . 1.0 109.843 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -56.68 -36.85 70.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.74 0.305 . . . . 1.0 110.329 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -67.39 -45.22 76.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.913 0.387 . . . . 1.0 110.539 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -70.52 -17.2 62.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.786 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 111' ' ' THR . 22.7 t -72.2 -44.01 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.293 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.5 t -63.45 -46.94 93.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.211 0.529 . . . . 1.0 110.304 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -66.17 -35.71 81.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.901 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -67.69 -49.12 64.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.757 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.9 tp -69.87 -39.65 77.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.856 -0.337 . . . . 1.0 110.424 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.5 -40.24 95.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.706 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.6 -47.51 78.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.514 -0.474 . . . . 1.0 110.255 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.451 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 32.1 t80 -60.61 -43.14 97.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.061 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.1 p -65.88 -33.24 75.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.486 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -60.71 -42.28 96.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.931 -0.577 . . . . 1.0 109.915 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.49 -41.5 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.451 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -125.87 74.58 70.98 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.213 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 151' ' ' ASN . 46.1 Cg_endo -73.17 -17.89 24.17 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.354 2.036 . . . . 1.0 112.557 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 48.0 p30 -90.85 -10.31 43.16 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.157 0.429 . . . . 1.0 112.157 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -118.63 147.03 44.18 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.925 0.393 . . . . 1.0 110.404 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.9 m -80.94 160.9 24.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.782 -0.645 . . . . 1.0 109.693 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.89 146.89 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 133' ' ' TYR . 26.3 p90 -139.32 143.92 38.06 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.85 0.357 . . . . 1.0 111.56 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 18.4 m-85 -151.85 166.23 32.07 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.491 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 4.1 p90 -135.01 152.3 51.6 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.8 m -150.94 172.41 15.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.442 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.696 HD13 ' H ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -77.21 142.36 39.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.616 179.697 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.696 ' H ' HD13 ' A' ' 136' ' ' LEU . 10.7 t-20 -98.98 111.84 24.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.837 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -66.67 -43.23 85.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.676 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.15 -27.53 65.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.373 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.474 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 31.6 m120 -125.14 73.96 66.74 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.267 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.526 ' HB3' HD11 ' A' ' 52' ' ' LEU . 27.2 Cg_endo -62.76 126.11 17.48 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.911 1.741 . . . . 1.0 112.463 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.06 -7.68 48.62 Favored Glycine 0 N--CA 1.467 0.741 0 N-CA-C 111.065 -0.814 . . . . 1.0 111.065 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -116.81 141.18 48.55 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.713 0.292 . . . . 1.0 110.418 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.404 ' CE1' HD22 ' A' ' 136' ' ' LEU . 56.0 m-85 -102.09 142.77 32.83 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.542 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 11.1 m-85 -119.15 131.05 55.84 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.235 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.98 121.49 42.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.357 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -117.34 144.46 44.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.192 -1.04 . . . . 1.0 108.192 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -160.57 153.69 21.62 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.403 -0.591 . . . . 1.0 109.403 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -137.36 131.31 31.94 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.692 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 35.9 mm -70.98 -47.2 63.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.695 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.454 ' H ' ' HB3' ' A' ' 154' ' ' SER . 12.2 p30 -161.92 177.19 10.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.076 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.59 -34.37 78.1 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.09 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -84.88 9.5 14.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.668 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 3.3 t -105.28 163.61 12.47 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.182 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -92.21 156.63 17.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.936 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 50.5 tp -75.79 127.29 32.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.942 0.401 . . . . 1.0 110.26 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -112.26 133.17 54.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.081 -0.509 . . . . 1.0 109.751 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 85.5 m -131.39 131.79 43.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.036 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -121.91 164.73 17.07 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.806 -0.442 . . . . 1.0 109.806 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.542 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 24.2 m-20 -115.57 147.58 40.57 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.992 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 39.1 t -128.91 138.92 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -97.61 126.68 43.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.993 0.425 . . . . 1.0 110.704 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.4 tp -90.23 128.84 36.49 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 35.6 p -129.66 175.11 9.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.394 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -83.96 15.87 3.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.71 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 5.6 p -121.85 -1.83 9.36 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.739 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.88 -134.02 7.1 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.337 -1.105 . . . . 1.0 110.337 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.552 ' CZ ' HD11 ' A' ' 97' ' ' LEU . 7.9 m-85 -117.79 128.6 55.03 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.142 -0.318 . . . . 1.0 110.142 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -107.86 121.55 44.98 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.52 ' C ' HD23 ' A' ' 170' ' ' LEU . 6.7 tt -111.71 115.84 29.76 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 109.009 -0.738 . . . . 1.0 109.009 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.645 ' O ' HG12 ' A' ' 171' ' ' VAL . 99.3 t 33.19 62.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.349 0.5 . . . . 1.0 112.349 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.4 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 1.7 m120 67.32 27.45 8.23 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.635 0.976 . . . . 1.0 113.635 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -131.79 120.1 22.19 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.338 -0.615 . . . . 1.0 109.338 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -91.73 129.42 37.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.883 0.373 . . . . 1.0 111.253 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -109.08 99.22 34.6 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.62 -24.4 12.73 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.636 2.224 . . . . 1.0 113.603 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.436 ' OG ' ' OE1' ' A' ' 180' ' ' GLN . 6.9 p -138.05 142.87 40.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.917 0.389 . . . . 1.0 111.272 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.61 -33.92 59.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.683 -0.69 . . . . 1.0 110.583 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.37 -44.08 98.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 122.038 -0.414 . . . . 1.0 110.363 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.521 ' N ' ' OE1' ' A' ' 180' ' ' GLN . 3.2 mp0 -65.89 -29.34 69.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 52.4 tp -64.0 -40.72 97.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.255 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 74.1 m -62.56 -47.79 82.31 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.364 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 186' ' ' LYS . 43.6 t30 -68.01 -47.41 68.55 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 119.503 -0.879 . . . . 1.0 108.88 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.4 -45.31 0.67 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 109.919 -1.272 . . . . 1.0 109.919 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -68.79 -46.99 67.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.376 0.608 . . . . 1.0 109.502 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 183' ' ' ASN . 1.4 tmtp? -56.81 -42.72 80.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.243 -0.89 . . . . 1.0 110.05 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 23.8 m -61.25 -44.0 97.96 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 188' ' ' LEU . 39.8 mt -62.21 -42.11 98.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.115 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 44.7 tp -58.48 -42.8 88.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.336 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.48 -44.94 92.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.371 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 17.4 m -62.7 -39.34 93.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.895 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.17 -41.13 99.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.609 -0.723 . . . . 1.0 111.735 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.68 -26.68 67.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.793 0.294 . . . . 1.0 111.793 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -82.76 6.14 19.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.818 0.342 . . . . 1.0 110.884 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 196' ' ' HIS . 73.0 t60 59.19 43.88 16.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.089 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 195' ' ' HIS . 84.7 t60 57.31 149.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.695 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -88.85 131.7 34.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.476 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.47 ' ND1' ' N ' ' A' ' 198' ' ' HIS . 0.0 OUTLIER -127.11 2.82 6.47 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.574 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.056 -0.973 . . . . 1.0 110.692 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.518 ' C ' ' H ' ' A' ' 3' ' ' ARG . 24.3 p . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.481 ' O ' ' CG ' ' A' ' 2' ' ' HIS . 86.6 t60 50.94 8.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.486 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.518 ' H ' ' C ' ' A' ' 1' ' ' THR . 80.0 mtp85 -135.51 -23.91 1.4 Allowed 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.599 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.0 p -97.06 -17.4 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.564 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.6 pt -85.51 -25.95 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.658 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -89.57 -0.01 57.22 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.613 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.63 146.87 96.31 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.092 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.98 -20.67 50.67 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.913 1.742 . . . . 1.0 112.353 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.439 ' CE1' ' CZ ' ' A' ' 30' ' ' PHE . 74.7 m-85 -88.97 3.3 52.01 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.326 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -88.16 135.45 33.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.322 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.573 ' O ' ' NH1' ' A' ' 33' ' ' ARG . 74.6 m-85 -151.27 119.64 3.42 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 110.013 -0.365 . . . . 1.0 110.013 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.521 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 73.7 Cg_endo -72.82 109.62 2.84 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.671 1.58 . . . . 1.0 113.129 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.551 ' O ' ' NE ' ' A' ' 33' ' ' ARG . 56.4 m-85 -160.41 159.25 30.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.623 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -78.69 173.47 12.42 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.14 -49.06 82.27 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.27 -0.967 . . . . 1.0 110.858 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -67.95 -40.15 83.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 1.0 110.823 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -66.61 -32.63 74.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 1.0 111.146 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.35 92.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.933 -0.307 . . . . 1.0 110.221 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.479 ' OE2' ' CD1' ' A' ' 53' ' ' PHE . 84.1 tt0 -63.31 -42.74 99.04 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.699 -0.4 . . . . 1.0 109.996 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -60.78 -40.36 92.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.091 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -62.19 -42.49 99.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.826 0.346 . . . . 1.0 110.474 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.16 -13.6 60.19 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.874 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.9 ttm-85 -61.33 -40.15 93.18 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.844 -0.342 . . . . 1.0 110.256 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.4 p -77.58 -19.08 56.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.751 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -84.67 -179.77 7.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.912 0.387 . . . . 1.0 110.566 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -103.15 -177.47 3.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.784 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -75.45 145.0 41.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.772 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.17 11.01 59.08 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -97.09 140.75 31.13 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CZ ' ' CE1' ' A' ' 9' ' ' TYR . 35.1 p90 -135.08 168.57 18.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.444 0.64 . . . . 1.0 111.116 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.8 m -148.54 161.32 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.012 -0.994 . . . . 1.0 111.762 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -116.09 131.19 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.573 ' NH1' ' O ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -137.74 164.13 29.64 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.839 -179.214 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -120.51 126.89 51.51 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 t -62.56 134.16 55.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.128 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.5 t -72.17 -20.77 61.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.885 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -117.8 37.59 3.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.819 0.343 . . . . 1.0 110.767 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -175.1 58.71 0.11 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.939 -0.865 . . . . 1.0 110.939 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -57.57 3.41 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.652 0.263 . . . . 1.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.577 ' H ' ' C ' ' A' ' 38' ' ' GLY . 97.9 m-20 -102.94 -1.74 28.92 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.595 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.429 ' ND1' ' O ' ' A' ' 40' ' ' ASP . 60.6 m-70 -143.59 157.72 44.21 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.375 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 mp -119.74 152.75 36.7 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.15 -0.477 . . . . 1.0 109.988 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.3 t -124.2 130.9 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 110.06 -0.348 . . . . 1.0 110.06 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.686 HD12 HD11 ' A' ' 58' ' ' ILE . 36.4 mt -111.58 138.1 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 96.2 m -116.93 136.13 53.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.537 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.471 ' CZ2' ' NZ ' ' A' ' 94' ' ' LYS . 4.4 p-90 -145.36 160.91 40.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.658 -0.701 . . . . 1.0 110.846 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -107.65 140.9 39.98 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.022 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' H ' HD12 ' A' ' 48' ' ' LEU . 3.1 mp -98.0 -72.35 0.65 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.652 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -158.29 157.34 32.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.259 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt 41.81 -141.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.798 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -89.71 64.3 6.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.848 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.9 tp -140.57 128.89 22.46 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.877 0.37 . . . . 1.0 110.323 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.479 ' CD1' ' OE2' ' A' ' 19' ' ' GLU . 51.6 m-85 -131.4 150.36 52.18 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.379 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -136.66 153.75 50.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.831 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.421 ' ND1' ' N ' ' A' ' 55' ' ' HIS . 10.8 p-80 -127.67 143.08 51.18 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.066 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 78.2 mt -123.4 129.23 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.228 -0.442 . . . . 1.0 109.966 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -97.23 122.45 40.27 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.03 0.443 . . . . 1.0 110.513 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.686 HD11 HD12 ' A' ' 44' ' ' ILE . 79.9 mt -99.32 129.95 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.4 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -113.56 132.35 55.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.0 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -101.03 156.58 17.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.188 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.7 tp -126.19 172.2 10.25 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.493 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 73.9 mm-40 60.02 39.0 20.44 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.99 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -81.47 78.88 8.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.082 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.64 -36.15 80.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.869 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -142.81 152.56 59.47 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.044 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.68 -25.56 68.58 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.295 1.997 . . . . 1.0 112.142 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.7 mt -97.84 -4.41 36.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.606 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.13 144.05 52.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.581 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.5 mt -78.5 146.31 34.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.366 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.27 101.16 1.22 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.539 -1.025 . . . . 1.0 110.539 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -63.58 -38.33 90.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.04 0.448 . . . . 1.0 111.029 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.17 125.52 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.593 -0.73 . . . . 1.0 111.004 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.6 mt -115.18 129.76 56.74 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 71.5 mt -102.13 126.24 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.884 0.373 . . . . 1.0 110.189 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.9 t -143.9 133.11 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.386 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t0 53.1 45.36 28.88 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.11 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 57.63 25.57 11.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.311 -0.404 . . . . 1.0 111.051 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -130.15 156.81 43.94 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.322 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -108.06 125.98 52.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.022 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -123.89 139.47 53.93 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.134 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -85.05 -38.84 18.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.77 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -110.08 138.22 46.76 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.201 0.524 . . . . 1.0 111.844 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.39 -41.35 96.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.874 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 38.0 p-10 -59.63 -45.97 90.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.982 -177.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.535 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 33.2 tt0 -57.93 -37.86 74.86 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 120.68 0.276 . . . . 1.0 110.778 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.81 -46.44 93.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.451 -0.5 . . . . 1.0 110.714 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.7 mm -64.4 -44.08 97.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.2 -0.6 . . . . 1.0 111.626 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.16 -43.63 74.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 113.067 0.765 . . . . 1.0 113.067 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -78.17 -13.27 59.93 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.641 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.457 ' CE2' ' NZ ' ' A' ' 94' ' ' LYS . 50.0 t80 -94.75 -50.72 5.03 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.95 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.544 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -71.38 -38.21 71.54 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.173 0.434 . . . . 1.0 112.173 -177.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -59.31 -47.25 86.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.027 -0.669 . . . . 1.0 111.527 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -64.43 -45.1 89.01 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.537 -0.465 . . . . 1.0 111.905 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.599 ' O ' HD13 ' A' ' 98' ' ' LEU . 45.9 mtmt -66.67 -42.68 86.17 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.237 -0.585 . . . . 1.0 111.407 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 91' ' ' LEU . 54.3 t -60.06 -45.66 95.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.398 -0.521 . . . . 1.0 111.367 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -66.59 -44.21 82.8 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.562 -0.455 . . . . 1.0 111.965 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.431 HD21 HD11 ' A' ' 163' ' ' LEU . 5.3 tp -67.07 -38.94 86.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.637 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 94' ' ' LYS . 8.2 mp -65.99 -42.16 90.14 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.353 -0.539 . . . . 1.0 110.626 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 95' ' ' VAL . 76.3 m-20 -68.65 -37.27 79.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.205 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -70.98 -41.22 71.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.831 -0.348 . . . . 1.0 111.564 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.576 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 15.9 ttm -70.03 -53.28 18.26 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.53 -0.468 . . . . 1.0 111.594 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.514 HG23 ' CE2' ' A' ' 107' ' ' PHE . 11.5 m -57.04 -38.83 73.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.056 0.455 . . . . 1.0 110.3 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.7 m -70.36 10.96 0.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.958 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 102' ' ' THR . 74.4 p -95.61 132.17 41.05 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.893 0.378 . . . . 1.0 110.385 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -60.38 -17.4 43.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.945 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.529 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 67.8 mttm -94.73 41.1 1.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.999 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.514 ' CE2' HG23 ' A' ' 102' ' ' THR . 64.6 t80 -134.91 118.63 17.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.035 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -140.1 129.6 24.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.12 -0.491 . . . . 1.0 109.717 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.6 m -100.43 93.48 5.66 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.735 0.303 . . . . 1.0 110.953 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -120.17 162.94 14.06 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 115' ' ' VAL . 21.5 p -78.73 163.41 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.925 -0.398 . . . . 1.0 109.925 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -63.35 -37.08 85.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.386 . . . . 1.0 110.54 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -68.08 -45.65 73.19 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.904 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -71.12 -17.26 62.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.59 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.492 HG13 ' SD ' ' A' ' 147' ' ' MET . 2.6 t -70.81 -45.4 73.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.88 -46.47 96.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.192 0.52 . . . . 1.0 110.036 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -66.05 -38.59 88.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.925 0.393 . . . . 1.0 110.663 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -65.77 -48.39 71.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.796 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.4 tp -69.19 -39.69 79.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.418 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -59.72 -43.72 94.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.353 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.02 -47.44 83.04 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.446 -0.501 . . . . 1.0 110.019 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -60.05 -44.91 94.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.972 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.1 p -62.47 -33.9 75.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.414 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -61.82 -42.44 99.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.96 -0.563 . . . . 1.0 110.243 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.32 -41.56 89.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.711 -0.396 . . . . 1.0 109.985 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.8 75.07 56.3 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 121.202 0.525 . . . . 1.0 110.128 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.526 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 42.0 Cg_endo -73.21 -14.87 25.72 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.402 2.068 . . . . 1.0 112.568 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -100.31 -13.19 18.93 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.797 0.295 . . . . 1.0 111.797 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -106.45 150.78 25.73 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.152 0.501 . . . . 1.0 110.429 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 m -80.66 162.06 24.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.629 -0.714 . . . . 1.0 109.659 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.3 p -152.74 144.96 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.538 -0.542 . . . . 1.0 109.538 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 25.3 p90 -151.3 144.19 24.5 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.848 -0.341 . . . . 1.0 111.124 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -151.45 169.75 21.26 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.344 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.529 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -137.9 153.69 49.51 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.082 -0.71 . . . . 1.0 109.082 179.107 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 98.9 p -151.21 169.66 21.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.9 0.381 . . . . 1.0 110.32 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.7 tp -79.49 141.54 36.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.524 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.509 ' ND2' ' CE1' ' A' ' 145' ' ' TYR . 6.6 t-20 -75.06 168.44 19.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.199 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -126.98 -30.11 2.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.356 -0.383 . . . . 1.0 110.66 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -90.53 -20.42 22.67 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.4 -0.364 . . . . 1.0 111.143 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 25.5 t-20 -138.64 76.33 35.84 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.396 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.06 130.76 41.39 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.062 1.841 . . . . 1.0 112.217 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 117.09 -26.34 8.34 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -107.28 147.92 29.63 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.576 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 75.2 m-85 -109.7 155.78 21.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.864 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.539 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 32.6 m-85 -125.77 137.46 53.8 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.048 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.9 mt -108.03 127.23 53.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.51 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.492 ' SD ' HG13 ' A' ' 115' ' ' VAL . 20.7 ptt? -118.6 144.3 46.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -162.5 153.49 17.46 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.374 -0.53 . . . . 1.0 109.707 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -133.99 129.23 35.88 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.26 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.436 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.8 mp -76.48 -47.25 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.424 0.527 . . . . 1.0 112.424 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 152' ' ' ALA . 17.0 t-20 -154.01 166.06 34.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.554 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.532 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -60.78 -27.57 68.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -85.53 -14.3 46.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.984 0.421 . . . . 1.0 110.318 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 12.8 t -81.18 160.76 24.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.335 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -92.29 163.46 13.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.138 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 57.2 tp -79.67 118.71 21.74 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.011 -0.366 . . . . 1.0 110.011 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.39 132.72 52.09 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.968 -0.56 . . . . 1.0 109.986 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 96.4 m -124.38 126.29 45.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.532 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -111.48 155.7 22.82 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.241 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.539 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 82.5 m-20 -104.9 144.16 32.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.591 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.2 t -123.89 136.16 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 109.535 -0.543 . . . . 1.0 109.535 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -95.57 135.26 37.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.627 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.431 HD11 HD21 ' A' ' 97' ' ' LEU . 28.7 tp -99.38 130.14 45.63 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 71.5 p -128.57 159.9 34.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.244 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -76.91 17.46 0.43 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.633 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 60.5 p -123.11 -2.29 8.65 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.669 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 143.12 -132.88 5.22 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.353 -1.099 . . . . 1.0 110.353 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -123.49 134.37 53.9 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 110.167 -0.309 . . . . 1.0 110.167 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.525 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 7.5 m-85 -111.62 122.87 48.96 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 tt -117.84 121.78 41.66 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.492 -0.559 . . . . 1.0 109.492 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.2 t 37.88 51.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.153 0.427 . . . . 1.0 112.153 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.4 m120 68.43 27.52 6.34 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.413 0.894 . . . . 1.0 113.413 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -135.65 123.09 21.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.525 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 19.5 t-20 -92.0 129.5 37.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.566 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -103.71 133.39 20.3 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.86 -20.7 22.12 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.053 1.836 . . . . 1.0 113.594 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.426 ' OG ' ' OE1' ' A' ' 180' ' ' GLN . 14.3 p -153.95 158.37 40.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.961 0.41 . . . . 1.0 111.095 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.31 -36.22 76.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.012 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.6 mm -60.54 -48.49 88.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.811 0.339 . . . . 1.0 110.243 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.426 ' OE1' ' OG ' ' A' ' 177' ' ' SER . 9.0 mp0 -65.96 -33.33 75.57 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.18 -41.9 97.62 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 110.025 -0.361 . . . . 1.0 110.025 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 81.6 m -62.3 -46.23 89.69 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 120.57 -0.452 . . . . 1.0 110.116 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 186' ' ' LYS . 65.9 m-20 -65.07 -49.02 71.68 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.89 -46.07 0.86 Allowed Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.841 -1.304 . . . . 1.0 109.841 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -67.77 -47.17 69.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 183' ' ' ASN . 64.7 tttm -56.72 -40.46 75.72 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.764 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 25.7 m -61.16 -45.11 96.0 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.55 -40.86 98.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.859 -0.609 . . . . 1.0 110.1 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.0 tp -57.81 -41.23 81.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.406 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -64.03 -45.13 90.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.112 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.7 p -62.95 -39.4 94.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.973 0.416 . . . . 1.0 110.637 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 61.2 mt -63.81 -43.5 96.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.606 -0.724 . . . . 1.0 111.965 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -71.15 -30.1 66.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.845 0.313 . . . . 1.0 111.845 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' HIS . . . . . 0.558 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 0.9 OUTLIER -91.24 -2.75 57.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.991 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' A' ' 194' ' ' HIS . 55.0 p-80 43.23 51.68 5.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.177 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 57.02 160.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.791 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.435 ' N ' ' ND1' ' A' ' 197' ' ' HIS . 0.0 OUTLIER -154.41 154.3 33.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.676 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 74.5 t60 40.36 81.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.055 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 37.0 m80 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 117.949 -1.025 . . . . 1.0 110.733 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.469 ' C ' ' H ' ' A' ' 3' ' ' ARG . 20.2 p . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.492 ' CD2' ' HG3' ' A' ' 3' ' ' ARG . 37.6 p-80 -70.66 10.23 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.464 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.492 ' HG3' ' CD2' ' A' ' 2' ' ' HIS . 90.4 mtt180 -148.78 23.6 0.98 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.583 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.805 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 7.2 p -60.41 -47.63 91.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.566 0 CA-C-O 121.756 0.789 . . . . 1.0 110.089 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.554 ' N ' HG13 ' A' ' 4' ' ' VAL . 35.9 pt -59.94 12.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 O-C-N 121.255 -0.903 . . . . 1.0 111.011 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.673 ' H ' ' C ' ' A' ' 4' ' ' VAL . 54.9 t-20 -161.53 32.7 0.13 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.288 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.805 ' ND1' ' O ' ' A' ' 4' ' ' VAL . 3.8 p-80 -75.74 154.35 85.27 Favored Pre-proline 0 N--CA 1.468 0.426 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.02 -28.43 19.01 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.097 1.865 . . . . 1.0 112.7 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -79.94 -9.05 59.64 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.282 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -73.56 134.87 43.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.248 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -150.5 117.17 3.42 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 120.983 -0.287 . . . . 1.0 110.264 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.83 111.59 3.36 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.742 1.628 . . . . 1.0 112.829 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -156.68 155.63 32.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.275 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -78.8 -172.44 3.02 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.49 -48.36 18.5 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.543 -1.023 . . . . 1.0 110.543 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -64.41 -44.14 92.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.76 0.314 . . . . 1.0 110.734 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.17 -35.19 79.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.985 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.07 97.63 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.656 -0.417 . . . . 1.0 110.395 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.57 -43.97 83.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.008 -0.367 . . . . 1.0 110.008 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.06 -43.94 97.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.288 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.503 ' OH ' ' NZ ' ' A' ' 25' ' ' LYS . 94.1 t80 -61.63 -45.39 94.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.875 0.369 . . . . 1.0 110.288 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -72.4 -14.37 61.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.153 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -67.34 -41.84 84.52 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.621 -0.431 . . . . 1.0 110.799 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.6 m -76.37 -23.88 54.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.188 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.503 ' NZ ' ' OH ' ' A' ' 21' ' ' TYR . 32.7 mttp -81.9 176.78 9.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.151 0.5 . . . . 1.0 110.661 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -84.03 161.63 20.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.769 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -76.07 146.31 39.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.033 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.5 12.67 47.21 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.537 ' HB3' HD11 ' A' ' 22' ' ' LEU . 54.5 tp10 -106.54 148.05 28.7 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -127.81 172.49 10.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.473 0.654 . . . . 1.0 111.413 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.57 153.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 114.975 -1.011 . . . . 1.0 111.477 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.484 ' HB ' ' HE2' ' A' ' 7' ' ' HIS . 97.5 mt -116.84 118.48 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.93 151.01 30.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.198 -179.128 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.403 ' NE2' ' O ' ' A' ' 34' ' ' GLN . 3.0 pp0? -98.32 148.1 24.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.422 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 t -69.05 161.38 29.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.82 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.9 p -65.56 -21.83 66.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.833 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -129.53 25.18 5.42 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.413 -0.358 . . . . 1.0 111.167 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . -75.59 -62.32 2.72 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.618 -0.993 . . . . 1.0 110.618 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.3 t0 64.75 -50.62 0.32 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.728 0.299 . . . . 1.0 111.334 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 38' ' ' GLY . 99.5 m-20 -120.66 20.65 11.71 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.977 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.567 ' C ' HD12 ' A' ' 42' ' ' LEU . 79.5 m-70 -147.86 147.73 30.1 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.567 HD12 ' C ' ' A' ' 41' ' ' HIS . 11.2 mp -119.14 151.13 38.85 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.711 -0.478 . . . . 1.0 109.711 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 33' ' ' ARG . 76.4 t -126.96 135.06 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.331 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.644 HD12 HD11 ' A' ' 58' ' ' ILE . 62.8 mt -111.64 137.47 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.076 -0.712 . . . . 1.0 109.076 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.1 m -117.49 135.56 53.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.928 -0.578 . . . . 1.0 109.523 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.575 ' CZ2' HD11 ' A' ' 48' ' ' LEU . 1.5 p-90 -151.99 155.58 38.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.794 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -95.44 141.13 29.35 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.35 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.575 HD11 ' CZ2' ' A' ' 46' ' ' TRP . 9.3 mp -94.82 -35.09 12.23 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.131 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 36.2 t0 -162.89 -138.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.191 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.524 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 70.5 mmtt -53.76 -104.05 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.055 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.476 ' O ' ' CE2' ' A' ' 53' ' ' PHE . 32.3 t70 -85.65 20.91 1.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.232 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.713 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.7 mm? -88.35 131.49 34.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.874 0.369 . . . . 1.0 110.612 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.476 ' CE2' ' O ' ' A' ' 51' ' ' ASP . 25.4 m-85 -136.46 143.82 44.06 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.332 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -146.54 152.67 39.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.024 -0.534 . . . . 1.0 109.677 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -126.88 139.79 52.82 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.207 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.1 mm -115.29 117.61 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -90.53 119.39 30.75 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.904 0.383 . . . . 1.0 110.773 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.644 HD11 HD12 ' A' ' 44' ' ' ILE . 81.5 mt -100.19 131.29 47.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.269 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -118.06 126.52 52.44 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 40' ' ' ASP . 9.6 mp0 -99.68 147.69 25.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.126 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.435 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.8 tt -141.55 170.85 14.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.46 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.435 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 61.8 tt0 72.51 52.24 0.17 Allowed 'General case' 0 C--N 1.334 -0.099 0 O-C-N 123.625 0.578 . . . . 1.0 109.769 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -117.29 84.81 2.22 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.652 -0.703 . . . . 1.0 109.841 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -65.94 -36.76 84.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.056 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -107.66 118.5 53.02 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.051 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -50.11 -30.18 24.4 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.081 1.854 . . . . 1.0 112.105 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 tp -79.51 -11.79 59.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.043 0.449 . . . . 1.0 110.828 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.15 140.57 35.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.188 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.1 mt -81.49 151.15 27.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.498 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.38 122.79 30.97 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.499 -1.041 . . . . 1.0 110.499 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -72.01 -13.01 61.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.87 0.367 . . . . 1.0 110.797 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.1 t -118.12 120.44 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.604 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.2 mt -114.37 126.8 55.41 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.141 -0.688 . . . . 1.0 109.141 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.3 mm -100.18 121.33 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.07 0.462 . . . . 1.0 110.48 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.557 HG21 HD13 ' A' ' 86' ' ' ILE . 5.2 t -138.17 131.28 40.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.283 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 51.8 t0 53.26 47.83 23.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.039 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER 55.52 21.45 4.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.077 179.277 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -128.0 144.23 51.1 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.281 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -88.57 135.01 33.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.957 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -123.74 138.2 54.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.293 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -81.71 -37.97 26.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.692 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -132.7 157.57 44.55 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.225 0.536 . . . . 1.0 111.781 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.2 tp -65.17 -39.27 92.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.501 -0.772 . . . . 1.0 111.215 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.49 -40.91 88.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.734 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -62.2 -38.38 88.89 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 121.004 -0.279 . . . . 1.0 110.757 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.557 HD13 HG21 ' A' ' 75' ' ' VAL . 89.0 mt -62.23 -45.8 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.048 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.5 mt -61.39 -47.27 94.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.483 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.09 -42.38 67.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 112.569 0.581 . . . . 1.0 112.569 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.22 -18.39 60.14 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.748 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -91.89 -50.06 5.92 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.533 -0.467 . . . . 1.0 111.413 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 95' ' ' VAL . 8.0 mp -67.0 -42.21 85.39 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 112.296 0.48 . . . . 1.0 112.296 -178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -63.34 -49.83 72.37 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.739 -0.784 . . . . 1.0 111.64 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -68.69 -43.51 75.92 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.516 -0.474 . . . . 1.0 111.546 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -65.92 -43.88 86.78 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.048 -0.661 . . . . 1.0 111.313 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 91' ' ' LEU . 55.6 t -65.65 -45.45 92.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.237 -0.585 . . . . 1.0 111.203 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -68.24 -46.08 71.45 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.715 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.82 -41.61 87.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.467 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.96 -42.17 94.83 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.314 -0.554 . . . . 1.0 110.134 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -67.74 -38.61 83.73 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.035 -0.529 . . . . 1.0 111.196 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -70.59 -42.46 71.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.877 -0.329 . . . . 1.0 111.78 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.601 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 4.1 ttt -67.24 -55.03 15.71 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.465 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.1 m -59.04 -41.95 89.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.983 0.42 . . . . 1.0 110.669 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.6 p -72.45 8.78 1.25 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.991 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.6 t -88.53 138.49 31.38 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.722 0.296 . . . . 1.0 110.234 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -61.88 -18.24 59.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.869 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.555 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 59.8 mttp -89.34 39.05 0.93 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.023 -0.535 . . . . 1.0 109.694 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -130.99 111.75 12.32 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.357 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -131.34 114.63 15.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.057 -0.519 . . . . 1.0 109.828 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.7 m -88.76 78.97 7.55 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.046 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -105.46 152.87 17.24 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.582 ' O ' HG23 ' A' ' 115' ' ' VAL . 62.1 p -72.56 171.51 12.27 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -57.51 -40.72 79.36 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.575 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -68.08 -42.59 80.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.019 0.438 . . . . 1.0 110.505 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -70.18 -21.86 63.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.117 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 111' ' ' THR . 32.4 t -69.43 -44.33 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.085 -0.339 . . . . 1.0 110.085 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.7 t -65.44 -45.46 92.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.099 0.476 . . . . 1.0 110.342 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -65.91 -34.12 77.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.984 0.421 . . . . 1.0 110.842 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -67.44 -50.23 60.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.628 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.4 tp -70.18 -39.08 76.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.046 0.451 . . . . 1.0 110.312 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.0 -42.43 97.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.624 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -61.3 -46.85 88.6 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.264 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.537 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 34.4 t80 -61.65 -43.08 99.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.107 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.2 p -61.89 -36.64 81.89 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.424 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -62.3 -39.04 91.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.313 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.38 -43.06 84.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.455 -0.498 . . . . 1.0 109.834 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.537 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -128.44 73.88 80.16 Favored Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.227 179.317 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.69 -16.54 26.66 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.475 2.117 . . . . 1.0 112.443 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -89.76 -5.55 56.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.678 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -127.07 149.93 49.7 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.004 0.431 . . . . 1.0 110.432 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.9 p -80.18 162.63 24.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.561 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 p -151.5 145.41 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -140.06 145.48 37.75 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.852 0.358 . . . . 1.0 111.25 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -151.37 171.3 17.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.221 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -137.25 156.91 47.72 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.268 -0.641 . . . . 1.0 109.268 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 29.3 p -155.07 168.7 26.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.371 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.0 tp -79.76 138.49 37.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.51 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 32.7 p-10 -97.5 141.47 30.52 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.238 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -95.01 -16.98 22.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.583 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 18.0 p30 -69.93 -27.01 64.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.274 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 139' ' ' ASP . 22.7 m120 -159.2 92.26 1.89 Allowed Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 109.954 -0.387 . . . . 1.0 109.954 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.01 142.7 94.04 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.013 1.808 . . . . 1.0 112.404 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.53 -25.38 27.0 Favored Glycine 0 N--CA 1.464 0.542 0 N-CA-C 110.779 -0.928 . . . . 1.0 110.779 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -99.47 144.87 28.08 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 120.897 0.38 . . . . 1.0 110.09 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.601 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 70.9 m-85 -109.7 146.47 34.81 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.792 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.523 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 12.0 m-85 -119.28 132.01 55.84 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.036 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.429 HD12 ' CG2' ' A' ' 161' ' ' VAL . 11.5 mt -106.78 128.56 54.34 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.442 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.582 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -126.36 148.17 49.63 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 178.6 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -158.44 155.34 28.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.28 -0.568 . . . . 1.0 109.57 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.524 ' NZ ' ' O ' ' A' ' 154' ' ' SER . 4.1 tttm -134.15 130.41 37.28 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.851 0.357 . . . . 1.0 110.552 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.543 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 23.5 mm -75.76 -48.65 28.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.816 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 150' ' ' ILE . 29.2 m120 -155.51 169.11 25.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.629 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.11 -28.38 66.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.787 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -91.68 4.78 51.92 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.06 0.457 . . . . 1.0 110.417 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.524 ' O ' ' NZ ' ' A' ' 149' ' ' LYS . 12.4 t -90.89 165.85 13.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.316 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -99.09 148.97 23.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.47 . . . . 1.0 109.789 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 44.5 tp -72.28 118.44 15.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.901 0.381 . . . . 1.0 110.285 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -109.07 131.39 55.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.077 -0.51 . . . . 1.0 109.644 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 92.5 m -128.76 130.6 47.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.926 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -116.77 168.33 10.3 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.107 -0.497 . . . . 1.0 109.914 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.523 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 83.9 m-20 -111.7 148.34 33.64 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.648 -0.706 . . . . 1.0 110.84 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.429 ' CG2' HD12 ' A' ' 146' ' ' LEU . 74.5 t -128.36 138.18 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -103.59 128.84 50.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.196 0.522 . . . . 1.0 110.877 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.2 tp -89.16 129.23 35.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.545 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 80.8 p -129.17 174.62 9.41 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.38 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -86.43 14.13 7.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.693 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.593 ' O ' HG22 ' A' ' 166' ' ' THR . 26.9 m -121.91 -2.58 9.23 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.446 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 138.1 -141.66 12.36 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.112 -1.195 . . . . 1.0 110.112 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -109.58 126.51 53.68 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.452 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 4.6 m-85 -104.76 116.48 32.09 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.9 tt -113.08 115.42 28.3 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.4 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 4.4 t 37.89 62.3 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 112.084 0.402 . . . . 1.0 112.084 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.4 m120 63.43 27.9 15.32 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.165 0.802 . . . . 1.0 113.165 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 62.8 m-85 -133.87 122.49 23.27 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.452 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 7.1 t-20 -100.05 120.56 40.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.688 0.28 . . . . 1.0 111.529 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -98.66 136.96 20.58 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.44 -23.11 24.05 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.185 1.923 . . . . 1.0 113.396 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 5.1 t -154.17 158.45 40.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.104 0.478 . . . . 1.0 110.923 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.9 p -59.74 -34.42 55.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.816 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.0 -44.83 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.368 . . . . 1.0 110.246 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -69.08 -31.25 69.86 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 43.8 tp -62.67 -42.18 99.48 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.102 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 75.0 m -63.21 -45.9 89.51 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 120.634 -0.426 . . . . 1.0 110.209 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 186' ' ' LYS . 38.8 m-80 -63.28 -46.47 86.65 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 108.512 -0.921 . . . . 1.0 108.512 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.54 -46.55 0.8 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.818 -1.313 . . . . 1.0 109.818 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.89 -43.9 74.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.11 -0.545 . . . . 1.0 109.935 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.0 tttm -56.92 -43.8 81.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.401 -0.818 . . . . 1.0 110.016 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 13.7 m -61.64 -45.48 93.87 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.83 -43.55 98.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.061 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.9 tp -57.85 -45.4 86.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.855 0.359 . . . . 1.0 110.493 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.406 ' CE ' ' NZ ' ' A' ' 186' ' ' LYS . 46.9 mttm -61.96 -45.02 95.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.397 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.4 m -62.1 -41.78 98.56 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.985 0.421 . . . . 1.0 110.608 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 69.5 mt -63.98 -42.96 97.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.49 -0.777 . . . . 1.0 111.831 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -67.11 -30.71 70.8 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.885 0.328 . . . . 1.0 111.885 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' HIS . . . . . 0.414 ' O ' ' ND1' ' A' ' 194' ' ' HIS . 13.0 t-80 -79.98 -6.22 57.14 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.874 -0.33 . . . . 1.0 110.696 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 1.7 m80 49.29 50.85 17.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.026 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.501 ' O ' ' ND1' ' A' ' 197' ' ' HIS . 83.0 t60 -70.17 -85.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.675 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 196' ' ' HIS . 68.0 m-70 -156.76 166.8 32.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.669 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -65.86 148.45 51.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.801 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 69.0 m80 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.008 -0.996 . . . . 1.0 110.67 179.741 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -107.81 -2.02 20.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.433 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.429 ' O ' ' CE1' ' A' ' 7' ' ' HIS . 18.7 mmm180 -119.31 -28.19 5.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.963 0.411 . . . . 1.0 110.353 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.27 -30.62 49.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.425 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.1 pt -69.72 -19.22 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.427 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -91.28 3.28 55.26 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.697 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.429 ' CE1' ' O ' ' A' ' 3' ' ' ARG . 0.6 OUTLIER -88.91 143.67 31.81 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.072 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.7 -15.14 40.63 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.262 1.975 . . . . 1.0 112.132 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.529 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 54.2 m-85 -92.02 8.05 39.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.12 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -104.18 125.72 50.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 1.0 110.291 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -157.73 117.69 1.94 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 109.43 -0.581 . . . . 1.0 109.43 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.9 129.5 34.85 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 121.227 1.285 . . . . 1.0 112.626 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -157.99 149.13 21.14 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.091 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 16' ' ' ARG . 13.8 t-20 -77.91 164.44 25.13 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.22 -49.79 74.75 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.462 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 23.3 mmt85 -65.7 -39.52 91.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.696 0.284 . . . . 1.0 110.797 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.5 ' N ' ' CD ' ' A' ' 17' ' ' GLN . 1.1 mp0 -66.07 -35.4 80.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.069 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.09 -46.02 92.35 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.268 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -60.81 -45.15 95.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.933 -0.395 . . . . 1.0 109.933 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.04 -42.63 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.104 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.484 ' CZ ' ' NZ ' ' A' ' 25' ' ' LYS . 66.4 t80 -62.87 -42.27 99.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.403 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 18' ' ' ALA . 8.5 mp -74.27 -15.31 60.98 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.843 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -61.87 -42.57 99.22 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.393 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.1 p -77.48 -21.04 53.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.784 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.484 ' NZ ' ' CZ ' ' A' ' 21' ' ' TYR . 44.4 mmtm -79.64 176.05 10.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.51 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -100.43 171.58 7.66 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.667 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -61.73 143.58 55.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.822 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.35 10.3 59.55 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.057 -0.817 . . . . 1.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -86.88 137.43 32.4 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -135.52 161.83 34.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.266 0.555 . . . . 1.0 110.836 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.706 ' O ' HG23 ' A' ' 44' ' ' ILE . 11.0 m -147.49 157.28 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.274 -0.875 . . . . 1.0 111.316 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 84.1 mt -118.43 128.41 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.481 ' CZ ' ' OG1' ' A' ' 45' ' ' THR . 23.8 ptt180 -147.34 154.78 41.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.32 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -104.7 144.78 31.26 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.3 t -89.32 136.0 33.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.591 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.2 t -60.62 -40.6 92.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.566 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -79.32 -11.41 59.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.577 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.94 -68.48 1.45 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.542 -1.023 . . . . 1.0 110.542 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 t0 74.85 -39.88 0.42 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.604 0.24 . . . . 1.0 110.942 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -113.58 -11.27 13.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.838 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.613 ' C ' HD12 ' A' ' 42' ' ' LEU . 6.6 m-70 -117.71 151.14 37.86 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.344 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.613 HD12 ' C ' ' A' ' 41' ' ' HIS . 11.2 mp -117.39 153.83 32.37 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.1 t -127.7 134.91 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.343 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 31' ' ' VAL . 69.0 mt -114.24 138.35 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 108.768 -0.827 . . . . 1.0 108.768 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.481 ' OG1' ' CZ ' ' A' ' 33' ' ' ARG . 26.4 m -117.61 138.26 52.07 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.136 0.493 . . . . 1.0 109.805 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.555 ' CZ2' HD11 ' A' ' 48' ' ' LEU . 5.2 p-90 -148.93 156.54 42.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.457 -0.792 . . . . 1.0 111.163 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.453 ' C ' HD12 ' A' ' 48' ' ' LEU . 37.5 ttpt -100.78 140.2 35.41 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.034 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.6 mp -96.53 -68.19 0.81 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.217 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -152.98 147.88 26.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.276 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt 46.73 -127.81 1.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.858 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 16.3 p-10 -93.61 25.99 3.26 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.696 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.619 HD13 ' N ' ' A' ' 53' ' ' PHE . 0.3 OUTLIER -92.69 119.65 32.3 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 -179.634 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.619 ' N ' HD13 ' A' ' 52' ' ' LEU . 94.8 m-85 -123.52 148.38 46.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.3 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -142.3 153.47 43.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.83 -0.623 . . . . 1.0 109.966 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -128.39 142.44 51.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.439 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.3 mt -120.55 125.35 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.001 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -95.29 120.75 36.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.912 0.386 . . . . 1.0 110.378 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.406 HD11 ' CD1' ' A' ' 44' ' ' ILE . 96.2 mt -98.69 132.13 44.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.431 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -114.68 140.88 48.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 1.0 109.696 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -99.39 157.55 16.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.456 . . . . 1.0 109.862 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.494 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.9 tp -141.77 171.71 13.69 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.485 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.494 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 79.1 mm-40 59.06 28.87 18.27 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.284 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -94.26 48.76 1.25 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.049 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.19 -39.17 86.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.291 -0.868 . . . . 1.0 111.411 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 68' ' ' ALA . 8.9 p30 -113.43 114.44 47.8 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.482 -0.327 . . . . 1.0 110.332 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.06 -13.31 0.92 Allowed 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.854 1.702 . . . . 1.0 112.167 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.6 mt -80.73 -7.56 59.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.433 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.435 ' N ' ' OD1' ' A' ' 65' ' ' ASN . . . -118.66 131.89 56.17 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.974 0.416 . . . . 1.0 110.18 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 71' ' ' LYS . 54.1 mt -76.43 156.46 33.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.288 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -43.62 91.84 0.01 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.594 -1.002 . . . . 1.0 110.594 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 69' ' ' LEU . 7.0 ttpm? -63.52 -31.07 72.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.974 0.416 . . . . 1.0 110.706 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.2 t -128.92 125.21 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.945 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.9 mt -115.77 130.13 56.73 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.89 -0.596 . . . . 1.0 109.424 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.6 mt -100.4 121.67 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 120.869 0.366 . . . . 1.0 110.535 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -141.84 133.11 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.452 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' A' ' 77' ' ' ASN . 90.2 m-20 52.7 47.64 24.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.968 -0.293 . . . . 1.0 111.211 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.2 OUTLIER 56.32 15.79 2.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.123 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -124.76 142.32 51.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.367 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -93.14 131.58 38.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.008 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.444 ' HB2' HD11 ' A' ' 86' ' ' ILE . 96.8 m-85 -127.07 138.31 53.18 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.199 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -84.42 -37.05 21.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.496 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -117.46 142.14 47.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.887 0.375 . . . . 1.0 111.95 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.97 -40.69 95.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.882 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.61 -41.74 91.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.796 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -59.15 -38.87 80.74 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.637 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.444 HD11 ' HB2' ' A' ' 80' ' ' TYR . 97.6 mt -62.43 -45.11 99.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.678 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.83 -44.67 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.59 -0.444 . . . . 1.0 111.112 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 92' ' ' GLN . 61.8 t -68.14 -42.32 84.84 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-N 115.92 -0.582 . . . . 1.0 112.282 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -80.37 -13.16 59.39 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.322 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.516 ' OH ' ' CZ2' ' A' ' 46' ' ' TRP . 77.4 t80 -94.39 -50.21 5.34 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.661 -0.416 . . . . 1.0 111.992 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -66.34 -43.25 86.59 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.539 -0.464 . . . . 1.0 112.197 -177.576 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 13.4 pt20 -64.01 -47.17 81.31 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.943 -0.703 . . . . 1.0 111.668 -178.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 165' ' ' ASN . 53.9 t-20 -69.19 -43.34 74.38 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.544 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -65.93 -42.53 89.97 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.146 -0.621 . . . . 1.0 111.363 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.524 ' O ' ' ND2' ' A' ' 99' ' ' ASN . 56.1 t -63.64 -47.13 92.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.01 -0.676 . . . . 1.0 111.336 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -68.98 -41.28 78.09 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.567 -0.453 . . . . 1.0 111.512 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.524 HD11 ' CZ ' ' A' ' 168' ' ' TYR . 12.3 tp -66.3 -44.37 83.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.806 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 mp -65.37 -43.16 91.67 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.306 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 95' ' ' VAL . 2.7 m-80 -67.17 -37.12 83.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.987 -0.552 . . . . 1.0 111.192 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -71.28 -42.79 68.27 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 121.033 -0.267 . . . . 1.0 111.683 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 tpt -67.63 -54.0 23.32 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.397 -0.521 . . . . 1.0 111.329 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.9 m -58.6 -42.6 88.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.046 0.451 . . . . 1.0 110.335 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.4 t -73.72 8.18 2.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.881 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.8 t -86.24 141.4 29.32 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.64 0.257 . . . . 1.0 110.498 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -65.35 -20.57 66.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.9 0.381 . . . . 1.0 110.773 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.564 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 70.0 mmtt -88.92 38.87 0.9 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.831 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -131.48 111.92 12.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.754 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -118.61 109.66 16.41 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.411 -0.589 . . . . 1.0 109.411 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.2 t -87.56 70.39 9.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.565 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.51 160.85 12.97 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 110.714 -0.954 . . . . 1.0 110.714 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.508 HG22 ' N ' ' A' ' 112' ' ' LYS . 28.5 m -70.36 164.17 25.07 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.508 ' N ' HG22 ' A' ' 111' ' ' THR . 63.5 mttp -54.67 -36.13 64.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.743 0.306 . . . . 1.0 110.493 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -66.52 -42.23 87.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.952 0.406 . . . . 1.0 110.553 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -70.29 -21.15 62.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.993 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.75 -45.44 81.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.242 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.46 -44.7 94.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.147 0.499 . . . . 1.0 110.433 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -65.89 -33.63 76.27 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.962 0.41 . . . . 1.0 110.644 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -68.42 -50.07 55.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.535 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.457 HD11 HG13 ' A' ' 131' ' ' VAL . 9.6 tp -69.92 -39.55 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.415 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -64.72 -40.45 95.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.645 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -59.56 -47.56 85.06 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.365 -0.534 . . . . 1.0 110.151 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -61.48 -40.3 94.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.046 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.5 t -62.39 -42.7 99.63 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.534 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -61.6 -40.04 93.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.68 -42.37 86.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.688 -0.405 . . . . 1.0 109.938 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.65 75.23 74.97 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.174 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.09 -14.08 31.68 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.237 1.958 . . . . 1.0 112.496 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -102.79 11.14 37.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.533 -0.303 . . . . 1.0 111.532 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -132.81 147.57 52.31 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.925 0.393 . . . . 1.0 110.497 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.42 ' HB3' HD12 ' A' ' 150' ' ' ILE . 16.8 p -81.18 162.21 23.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.747 -0.661 . . . . 1.0 109.856 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 119' ' ' ILE . 3.8 p -153.59 146.21 14.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.501 ' O ' ' CD1' ' A' ' 133' ' ' TYR . 10.3 p90 -144.94 142.67 30.04 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.907 0.384 . . . . 1.0 111.312 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 26.0 m-85 -152.75 167.64 28.33 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.555 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.564 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 4.1 p90 -135.64 151.8 50.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.423 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.1 p -154.17 170.51 21.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.518 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 tt -84.79 134.36 34.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.679 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 138' ' ' HIS . 69.3 m-80 -159.51 166.78 30.14 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.918 -0.401 . . . . 1.0 109.918 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.46 ' O ' ' OD1' ' A' ' 139' ' ' ASP . 3.9 t60 76.21 -158.48 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.462 -0.336 . . . . 1.0 110.733 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 138' ' ' HIS . 92.8 m-20 -142.67 64.07 1.38 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.592 ' O ' ' N ' ' A' ' 142' ' ' GLY . 2.7 m120 -129.33 156.01 79.11 Favored Pre-proline 0 CA--C 1.53 0.176 0 N-CA-C 108.897 -0.779 . . . . 1.0 108.897 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -42.81 78.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.753 2.302 . . . . 1.0 113.046 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 140' ' ' ASN . . . 52.07 64.35 4.05 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.247 -0.741 . . . . 1.0 111.247 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -94.94 152.5 18.29 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.674 -0.491 . . . . 1.0 109.674 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -121.05 153.15 37.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.798 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -127.16 127.97 45.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.872 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.1 mt -95.47 123.02 38.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.003 0.43 . . . . 1.0 110.982 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.64 145.61 46.3 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.127 -1.064 . . . . 1.0 108.127 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -159.79 157.59 29.57 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.299 -0.56 . . . . 1.0 109.944 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.554 ' NZ ' ' O ' ' A' ' 151' ' ' ASN . 36.6 tttm -142.87 126.28 16.69 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 120.668 -0.413 . . . . 1.0 110.056 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 151' ' ' ASN . 4.7 tp -78.84 -45.64 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.802 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.561 ' N ' HG23 ' A' ' 150' ' ' ILE . 29.4 m120 -144.86 157.98 43.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.842 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.03 -26.5 68.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.875 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -83.25 -16.43 46.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.177 0.513 . . . . 1.0 110.199 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.1 t -77.94 170.51 16.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.153 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -97.31 155.03 17.06 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.367 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.22 120.03 18.27 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.26 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -106.04 127.17 52.99 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.107 -0.497 . . . . 1.0 109.839 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 95.9 m -128.62 130.87 47.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.994 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -118.88 170.1 9.3 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.863 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -111.83 147.39 35.84 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.8 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.1 t -128.21 135.62 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.504 ' NZ ' ' CG2' ' A' ' 164' ' ' THR . 17.1 ttpp -101.56 130.72 47.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.869 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.2 tp -88.91 130.69 35.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.686 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.504 ' CG2' ' NZ ' ' A' ' 162' ' ' LYS . 66.2 p -129.28 171.46 12.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.582 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.533 ' O ' ' ND2' ' A' ' 93' ' ' ASN . 14.4 p30 -83.84 13.97 4.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.67 -0.696 . . . . 1.0 110.472 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 25.1 p -121.76 -2.22 9.35 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.606 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 139.4 -126.37 3.3 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.303 -1.119 . . . . 1.0 110.303 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.524 ' CZ ' HD11 ' A' ' 97' ' ' LEU . 28.6 m-85 -127.41 127.31 43.93 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.652 0.263 . . . . 1.0 110.635 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.514 ' CE1' ' OD1' ' A' ' 174' ' ' ASN . 4.3 m-85 -100.87 124.47 46.58 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.8 tt -116.83 111.16 19.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.572 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 170' ' ' LEU . 4.7 t 35.49 63.44 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 67.29 26.28 8.6 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -132.87 121.45 22.92 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.514 ' OD1' ' CE1' ' A' ' 169' ' ' PHE . 63.7 t30 -98.24 120.65 39.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.944 0.402 . . . . 1.0 111.635 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -105.13 125.61 33.15 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.2 -20.6 18.72 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.33 2.02 . . . . 1.0 113.504 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.2 m -137.2 141.39 42.13 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.982 0.42 . . . . 1.0 111.07 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.08 -34.67 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.575 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.08 -44.31 98.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.635 -0.426 . . . . 1.0 109.934 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -68.86 -30.26 68.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.1 tp -63.53 -43.24 97.72 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.205 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 7.7 p -62.87 -47.43 83.37 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.52 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.583 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 42.8 m-80 -65.01 -48.03 75.38 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.944 -0.761 . . . . 1.0 108.944 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.84 -44.85 1.0 Allowed Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.818 -1.313 . . . . 1.0 109.818 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -69.13 -47.05 66.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.9 tttm -56.12 -41.23 74.97 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.327 -0.851 . . . . 1.0 110.039 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 94.0 m -61.39 -45.04 96.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 51.7 mt -62.86 -41.08 99.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.001 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.535 HD11 HD13 ' A' ' 150' ' ' ILE . 57.6 tp -59.43 -44.16 92.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.323 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.42 -45.09 95.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.243 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 37.0 t -64.09 -38.87 92.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.804 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.2 mt -63.17 -41.95 99.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.61 -0.723 . . . . 1.0 111.608 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -59.96 -23.53 63.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.609 0.243 . . . . 1.0 111.555 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 194' ' ' HIS . 47.7 t-80 -81.07 9.98 5.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.785 0.326 . . . . 1.0 110.906 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.41 ' O ' ' N ' ' A' ' 197' ' ' HIS . 16.5 t60 71.67 23.58 3.7 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.969 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.425 ' CG ' ' N ' ' A' ' 197' ' ' HIS . 33.6 t-80 37.44 -96.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.372 -0.377 . . . . 1.0 111.083 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.521 ' ND1' ' N ' ' A' ' 198' ' ' HIS . 56.9 t-80 48.9 -111.3 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.687 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.521 ' N ' ' ND1' ' A' ' 197' ' ' HIS . 51.5 t-80 -81.94 136.65 35.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.738 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.001 -1.0 . . . . 1.0 110.506 179.96 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -107.64 -22.69 12.41 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.682 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -143.02 8.55 1.66 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.806 0.336 . . . . 1.0 110.53 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.36 -37.03 79.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.676 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.3 pt -62.34 -26.45 40.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.363 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -74.9 -13.28 60.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.477 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -79.21 115.67 54.53 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.284 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 76.6 Cg_exo -48.38 -24.9 6.64 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.869 1.712 . . . . 1.0 112.305 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -81.73 3.95 23.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.184 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 91.9 t80 -85.95 132.8 34.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.594 -0.275 . . . . 1.0 110.436 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 62.1 m-85 -150.77 123.58 4.18 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 120.995 -0.282 . . . . 1.0 110.476 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.474 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 73.7 Cg_endo -73.83 110.21 3.03 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.935 1.757 . . . . 1.0 112.631 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.474 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 74.1 m-85 -159.82 154.64 24.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.338 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -80.86 166.29 21.06 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.632 ' N ' ' NH1' ' A' ' 33' ' ' ARG . . . -57.03 -46.89 90.99 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.756 -0.938 . . . . 1.0 110.756 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -65.51 -39.01 91.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.59 0.233 . . . . 1.0 110.736 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -66.14 -37.14 84.96 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.696 -0.229 . . . . 1.0 111.205 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.415 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.15 -45.22 95.54 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.659 -0.417 . . . . 1.0 110.31 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -61.43 -46.5 89.86 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.669 -0.412 . . . . 1.0 109.948 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -62.28 -43.36 98.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.315 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -63.08 -44.48 95.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.56 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 18' ' ' ALA . 8.8 mp -75.02 -13.6 60.52 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.647 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -60.97 -41.92 97.31 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.39 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.9 t -74.93 -18.54 60.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.503 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -85.46 -175.66 5.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.788 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.46 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 45.4 mp0 -99.72 -179.25 4.13 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.472 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -81.41 145.56 30.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.634 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.39 8.0 53.46 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.143 -0.783 . . . . 1.0 111.143 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -95.77 139.63 31.72 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.387 -0.598 . . . . 1.0 109.387 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -131.05 167.96 18.2 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.284 0.564 . . . . 1.0 111.133 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -148.81 159.54 6.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.19 -0.913 . . . . 1.0 111.414 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.56 127.11 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.338 -0.616 . . . . 1.0 109.338 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.632 ' NH1' ' N ' ' A' ' 15' ' ' GLY . 44.4 ttp180 -134.39 153.58 51.82 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.152 -0.476 . . . . 1.0 109.752 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.419 ' N ' ' HG2' ' A' ' 33' ' ' ARG . 51.7 mt-30 -105.83 131.23 53.42 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.673 -0.492 . . . . 1.0 109.673 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -77.56 124.3 27.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.867 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.8 p -63.76 -38.82 92.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.625 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -79.11 -25.09 43.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.797 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -69.99 -53.85 13.58 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.54 -1.024 . . . . 1.0 110.54 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t0 70.7 -42.45 0.53 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.725 0.298 . . . . 1.0 111.034 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 38' ' ' GLY . 98.2 m-20 -119.45 19.92 12.58 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.65 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -140.27 150.71 44.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.669 0.271 . . . . 1.0 110.475 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.03 151.36 39.11 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.844 -0.428 . . . . 1.0 109.844 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.1 t -126.19 133.81 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.587 0.232 . . . . 1.0 110.727 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.531 HD12 HD11 ' A' ' 58' ' ' ILE . 92.3 mt -110.55 136.31 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.9 m -117.63 139.31 51.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.006 -0.543 . . . . 1.0 109.635 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.562 ' CE2' ' OH ' ' A' ' 90' ' ' TYR . 3.7 p-90 -143.3 153.1 42.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.776 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' A' ' 49' ' ' ASP . 64.7 tttp -101.4 133.3 46.22 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.829 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -96.07 -75.51 0.53 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.503 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.511 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 72.4 m-20 -109.99 -167.81 1.24 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.872 -0.603 . . . . 1.0 110.596 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -60.38 -42.31 95.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.775 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -128.43 56.94 1.6 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.797 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 44.5 tp -153.59 115.48 4.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.913 0.387 . . . . 1.0 110.081 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -124.88 148.19 48.41 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.33 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -136.87 152.69 50.53 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.971 -0.558 . . . . 1.0 110.283 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -129.9 144.39 51.29 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.661 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.521 HD12 ' CZ ' ' A' ' 90' ' ' TYR . 97.0 mt -125.36 131.52 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.228 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -98.27 122.79 41.87 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.978 0.418 . . . . 1.0 110.84 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.531 HD11 HD12 ' A' ' 44' ' ' ILE . 91.2 mt -101.13 133.75 43.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.385 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 59' ' ' GLN . 1.2 pm0 -120.12 132.49 55.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -99.99 144.54 28.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.103 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.728 HD13 ' H ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -135.91 173.48 11.66 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.158 0.504 . . . . 1.0 109.947 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.728 ' H ' HD13 ' A' ' 61' ' ' LEU . 13.1 tp10 87.32 33.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.677 -1.147 . . . . 1.0 109.922 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -92.33 76.26 5.23 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.756 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.4 ' O ' ' OD1' ' A' ' 65' ' ' ASN . 12.5 pt-20 -64.99 -36.48 84.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.813 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.423 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 4.9 m-20 -136.15 153.66 76.82 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.305 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.12 -33.26 53.03 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.769 1.646 . . . . 1.0 112.29 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.7 mt -84.6 -6.72 59.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.373 . . . . 1.0 110.383 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.423 ' HB3' ' H ' ' A' ' 65' ' ' ASN . . . -88.19 127.33 35.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.273 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.0 mt -86.03 153.73 21.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.302 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.9 95.51 0.41 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.313 -1.115 . . . . 1.0 110.313 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -71.92 -15.41 62.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.927 0.394 . . . . 1.0 110.684 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.2 t -118.26 120.35 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.669 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.2 mt -113.82 126.02 54.73 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.9 mt -102.08 123.64 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.882 0.372 . . . . 1.0 110.653 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.435 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 57.8 t -142.88 134.18 23.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.976 -0.557 . . . . 1.0 110.34 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.437 ' OD2' ' O ' ' A' ' 76' ' ' ASP . 3.4 p-10 48.67 44.32 21.23 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.216 0.323 . . . . 1.0 111.263 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 59.69 23.18 11.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.038 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -129.15 138.38 51.74 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.358 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -92.23 132.16 36.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 1.0 111.11 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.481 ' HB2' HD11 ' A' ' 86' ' ' ILE . 90.4 m-85 -126.88 138.07 53.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.263 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -82.76 -37.73 24.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.821 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -109.48 133.34 53.2 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.005 0.431 . . . . 1.0 112.028 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.4 tp -64.41 -40.73 96.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.503 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -62.06 -43.23 99.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.501 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.46 ' O ' ' OE1' ' A' ' 89' ' ' GLU . 32.8 tt0 -58.39 -38.3 77.05 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.345 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 80' ' ' TYR . 96.1 mt -59.66 -45.31 94.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.753 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.843 ' O ' HD12 ' A' ' 91' ' ' LEU . 43.9 mm -62.57 -47.42 93.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.429 -0.508 . . . . 1.0 111.607 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.1 t -69.86 -23.56 25.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 112.967 0.728 . . . . 1.0 112.967 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 85' ' ' GLN . 4.5 mp0 -98.1 -9.59 25.64 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.142 -0.223 . . . . 1.0 111.054 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.562 ' OH ' ' CE2' ' A' ' 46' ' ' TRP . 12.5 t80 -89.38 -54.58 4.03 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.913 0.709 . . . . 1.0 112.913 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.957 HD13 ' H ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -71.59 -33.56 69.14 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.706 -0.679 . . . . 1.0 112.107 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.957 ' H ' HD13 ' A' ' 91' ' ' LEU . 3.5 mm-40 -61.2 -48.68 80.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.07 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -67.72 -40.53 84.21 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.068 -0.653 . . . . 1.0 111.448 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -63.11 -42.6 99.59 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.438 -0.505 . . . . 1.0 111.275 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.93 -45.88 93.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.331 -0.548 . . . . 1.0 111.279 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -66.8 -45.4 78.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.383 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tp -69.04 -41.16 78.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.55 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.44 -42.25 92.61 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.472 -0.491 . . . . 1.0 110.053 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -66.38 -39.92 89.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.382 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -71.18 -42.81 68.56 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 120.781 -0.368 . . . . 1.0 111.783 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.1 tpt -63.96 -54.01 41.24 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.349 -0.54 . . . . 1.0 111.096 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.7 m -61.26 -39.36 90.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.48 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.2 t -73.16 9.77 1.15 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.911 -0.586 . . . . 1.0 111.224 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 87.1 p -88.03 139.22 30.73 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.681 0.277 . . . . 1.0 110.725 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.68 -22.32 66.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.996 0.427 . . . . 1.0 110.626 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.564 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 31.5 mtmm -88.2 39.63 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.804 -0.635 . . . . 1.0 109.828 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -129.84 114.02 15.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.068 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -122.75 124.66 43.86 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -93.65 68.09 3.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.826 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.13 147.51 16.84 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 115' ' ' VAL . 29.2 p -72.42 172.08 11.09 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -55.9 -37.66 69.18 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.364 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -67.47 -45.07 77.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.841 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.73 -20.37 63.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.781 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 111' ' ' THR . 39.4 t -69.71 -44.82 78.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.343 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.58 -46.38 95.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.207 0.527 . . . . 1.0 110.178 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -65.77 -33.99 77.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.829 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -68.31 -50.23 54.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.795 -0.639 . . . . 1.0 111.679 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.429 HD11 HG13 ' A' ' 131' ' ' VAL . 10.4 tp -69.99 -39.4 77.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.682 -0.407 . . . . 1.0 110.457 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.51 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 66.8 mm-40 -63.75 -40.56 97.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.716 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -63.43 -46.85 84.39 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.11 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.687 ' CE1' ' ND2' ' A' ' 126' ' ' ASN . 9.2 t80 -61.92 -41.83 98.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.14 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.5 t -62.28 -40.53 96.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.41 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -57.74 -44.03 85.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.315 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.47 -38.89 83.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.368 -0.605 . . . . 1.0 109.368 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.687 ' ND2' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -124.56 76.25 63.34 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.598 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -70.5 -24.56 26.14 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.799 2.333 . . . . 1.0 112.514 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -100.94 13.54 34.81 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.867 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.33 151.0 51.84 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.846 0.355 . . . . 1.0 110.482 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 m -80.91 160.87 24.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.887 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.429 HG13 HD11 ' A' ' 119' ' ' ILE . 4.2 p -153.05 149.81 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 109.36 -0.607 . . . . 1.0 109.36 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -151.0 143.44 24.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.922 0.392 . . . . 1.0 111.307 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -151.37 165.13 35.03 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.374 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.564 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.6 p90 -136.08 148.55 48.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 1.0 109.481 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 75.1 m -143.92 167.77 21.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.088 0.471 . . . . 1.0 110.214 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.8 tt -83.61 131.72 34.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.252 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -104.31 133.45 49.18 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.221 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -85.81 0.81 51.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.846 0.355 . . . . 1.0 110.585 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 139' ' ' ASP . 66.4 t0 -64.13 -37.9 89.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.127 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -150.81 104.59 3.04 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.085 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -48.65 124.04 10.38 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.597 1.531 . . . . 1.0 112.78 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.99 29.5 9.02 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.839 -0.905 . . . . 1.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -134.9 142.21 46.51 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.676 0.274 . . . . 1.0 110.32 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -122.16 146.49 47.18 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.475 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 13.6 m-85 -117.89 138.68 51.96 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.188 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.436 HD12 ' CG2' ' A' ' 161' ' ' VAL . 7.3 mt -110.44 120.95 44.08 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.617 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.57 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -116.07 145.01 43.37 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.988 -1.115 . . . . 1.0 107.988 178.02 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -161.68 149.74 15.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.39 -0.524 . . . . 1.0 109.679 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.51 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 67.0 tttt -135.4 130.39 34.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 120.934 -0.306 . . . . 1.0 110.257 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.439 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 28.9 mm -71.04 -45.03 74.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 1.0 111.348 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 150' ' ' ILE . 82.7 m-20 -160.31 174.23 14.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.665 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.92 -36.11 80.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.985 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -86.4 8.61 20.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.008 0.432 . . . . 1.0 110.531 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.3 t -96.9 157.53 15.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.516 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.431 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 68.8 mttm -88.16 143.24 27.17 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.216 -0.447 . . . . 1.0 109.891 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 43.6 tp -70.28 130.14 41.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.909 0.385 . . . . 1.0 110.141 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.431 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 93.6 m-85 -119.83 135.09 55.0 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.803 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 91.3 m -129.99 132.69 46.37 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.932 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.77 169.06 11.47 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.124 -0.489 . . . . 1.0 109.961 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.475 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 74.3 m-20 -117.17 150.57 38.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.885 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.436 ' CG2' HD12 ' A' ' 146' ' ' LEU . 78.5 t -128.26 137.96 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.804 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -100.24 125.77 46.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.984 0.421 . . . . 1.0 110.592 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.9 tp -88.39 130.68 35.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.788 -0.642 . . . . 1.0 109.372 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 37.6 p -128.82 176.67 7.65 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.93 0.395 . . . . 1.0 110.445 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -88.98 13.49 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.36 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 12.5 p -121.65 -2.5 9.37 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.814 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.35 -140.56 10.68 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.36 -1.096 . . . . 1.0 110.36 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -116.42 126.99 54.21 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.469 ' CE1' ' OD1' ' A' ' 174' ' ' ASN . 7.7 m-85 -106.43 117.8 34.99 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.0 tt -113.45 117.66 32.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.7 -0.482 . . . . 1.0 109.7 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.4 t 36.25 60.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.088 0.403 . . . . 1.0 112.088 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 65.19 27.91 12.19 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.061 0.763 . . . . 1.0 113.061 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -133.87 120.79 20.85 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.469 ' OD1' ' CE1' ' A' ' 169' ' ' PHE . 44.3 t30 -97.48 121.19 39.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.532 -0.304 . . . . 1.0 111.435 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -101.8 137.21 19.48 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.78 -21.4 33.46 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 122.412 2.075 . . . . 1.0 113.134 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 4.5 t -156.48 160.82 39.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.111 0.481 . . . . 1.0 111.002 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.98 -34.83 61.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.795 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 93.3 mt -61.75 -44.96 99.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.081 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -69.7 -29.81 67.32 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.65 -43.87 95.5 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 110.118 -0.327 . . . . 1.0 110.118 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 86.9 m -63.22 -46.22 87.98 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.386 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.554 ' O ' ' N ' ' A' ' 186' ' ' LYS . 88.8 m-20 -64.33 -48.18 76.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.17 -44.73 0.57 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.05 -47.52 65.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.048 -0.576 . . . . 1.0 109.781 178.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 183' ' ' ASN . 64.9 tttp -56.82 -41.7 78.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.591 -0.731 . . . . 1.0 110.227 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.5 m -61.45 -44.8 96.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.405 ' O ' ' OG ' ' A' ' 191' ' ' SER . 23.1 mt -62.94 -40.47 97.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.857 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.51 -43.94 93.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.23 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -58.7 -45.96 88.36 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.269 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 188' ' ' LEU . 80.0 p -62.1 -37.36 84.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.5 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.47 -42.93 82.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.347 -0.842 . . . . 1.0 111.923 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -69.15 -34.47 75.04 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 111.871 0.323 . . . . 1.0 111.871 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' HIS . . . . . 0.544 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 6.0 t60 -82.03 1.47 35.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.011 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.544 ' CG ' ' O ' ' A' ' 194' ' ' HIS . 32.8 p80 42.67 24.29 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.965 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.411 ' N ' ' C ' ' A' ' 194' ' ' HIS . 24.0 t-80 -86.31 130.9 34.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.68 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -45.66 107.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.295 -0.412 . . . . 1.0 110.632 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -77.04 93.82 3.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.695 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 77.4 m80 . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.66 179.789 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 27.6 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -127.7 -6.71 5.68 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.527 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -129.45 -1.93 4.95 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.609 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.72 -25.94 38.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.698 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.662 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -78.91 -17.63 13.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.39 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -98.67 3.5 47.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.413 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -77.56 143.1 67.43 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.305 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.419 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 56.3 Cg_endo -70.65 -13.83 32.76 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.855 1.703 . . . . 1.0 112.243 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.472 ' CD1' ' CZ ' ' A' ' 30' ' ' PHE . 88.6 m-85 -94.53 3.94 54.48 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.533 -0.303 . . . . 1.0 111.128 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.545 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 88.1 t80 -87.29 127.72 35.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.488 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 68.4 m-85 -155.04 106.93 2.28 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.974 -0.38 . . . . 1.0 109.974 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.5 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 32.5 Cg_exo -59.15 110.87 0.76 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.716 1.611 . . . . 1.0 112.926 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.5 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 57.0 m-85 -159.64 150.95 19.79 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.425 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -78.51 171.97 14.34 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.11 -41.22 98.54 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.34 -0.933 . . . . 1.0 111.062 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.416 ' O ' ' CG ' ' A' ' 19' ' ' GLU . 84.9 mtt85 -66.41 -42.35 87.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.884 0.373 . . . . 1.0 110.861 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -71.84 -31.97 67.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.17 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.43 -48.51 79.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.825 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 20' ' ' ASP . 14.4 pt-20 -60.32 -39.08 85.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.023 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 9.2 m-20 -63.95 -43.61 95.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.078 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.593 ' CE2' ' NZ ' ' A' ' 25' ' ' LYS . 42.5 t80 -67.4 -41.59 84.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.446 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.24 -11.2 60.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.749 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -59.18 -44.51 92.17 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.867 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 m -78.67 -19.03 53.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.765 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.593 ' NZ ' ' CE2' ' A' ' 21' ' ' TYR . 43.8 mmtm -72.91 159.1 34.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.543 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.62 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.6 pm0 -82.34 156.74 24.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.637 . . . . 1.0 110.657 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.2 mtm-85 -54.05 141.62 27.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.907 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.01 17.63 50.44 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.305 -0.718 . . . . 1.0 111.305 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -94.96 136.51 35.18 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.472 ' CZ ' ' CD1' ' A' ' 9' ' ' TYR . 26.0 p90 -133.78 167.62 20.22 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.355 0.598 . . . . 1.0 110.883 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.2 m -146.77 157.76 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 114.924 -1.034 . . . . 1.0 111.64 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.0 mm -116.32 125.84 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.262 -0.644 . . . . 1.0 109.262 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -140.12 165.16 28.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.064 -0.517 . . . . 1.0 110.461 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -118.53 135.53 54.35 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 m -65.04 146.0 55.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.801 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.5 m -60.49 -26.01 66.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.692 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -123.29 27.19 7.63 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.036 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.507 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -92.49 -77.24 1.36 Allowed Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 t0 70.81 -35.49 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.623 0.249 . . . . 1.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' A' ' 38' ' ' GLY . 21.1 t70 -118.63 10.49 12.52 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.754 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.443 ' ND1' ' O ' ' A' ' 40' ' ' ASP . 25.0 m-70 -142.31 151.99 42.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.381 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mt -121.13 145.58 47.66 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.076 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.9 t -123.62 129.48 74.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.096 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.424 HD12 HD11 ' A' ' 58' ' ' ILE . 61.3 mt -111.51 137.66 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.5 m -121.63 141.71 50.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.437 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.727 ' HE1' ' NE2' ' A' ' 54' ' ' GLN . 3.5 p-90 -154.04 154.79 34.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.215 -0.902 . . . . 1.0 110.972 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -95.7 143.72 26.72 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.148 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.792 ' N ' HD12 ' A' ' 48' ' ' LEU . 3.3 mp -93.02 -73.06 0.57 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.458 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -145.26 119.08 9.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.594 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt 45.0 -129.13 1.05 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.064 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -70.94 73.95 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.068 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.4 tp -167.56 121.38 0.96 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.272 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -135.15 150.37 50.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.628 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.727 ' NE2' ' HE1' ' A' ' 46' ' ' TRP . 20.3 pt20 -135.8 155.05 50.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.714 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -124.04 141.27 52.19 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.067 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.44 132.47 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.743 -0.466 . . . . 1.0 109.743 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -102.23 123.81 46.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.894 0.378 . . . . 1.0 110.534 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.424 HD11 HD12 ' A' ' 44' ' ' ILE . 86.3 mt -103.1 133.87 45.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.343 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -112.95 141.78 46.39 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.869 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.514 ' OE1' ' NZ ' ' A' ' 63' ' ' LYS . 78.8 mt-10 -99.79 148.51 24.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.813 -0.44 . . . . 1.0 109.813 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.436 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.6 tp -122.73 176.22 6.08 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.579 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.436 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 69.9 mm-40 57.66 32.34 21.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.022 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.514 ' NZ ' ' OE1' ' A' ' 60' ' ' GLU . 20.1 mmtm -78.65 74.13 5.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.881 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.7 -29.51 70.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.707 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -150.31 149.11 25.96 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.068 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.62 -25.14 66.14 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.268 1.979 . . . . 1.0 112.13 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.0 mp -91.27 -11.09 39.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.722 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.34 140.07 50.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.371 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.2 mt -77.14 148.89 35.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.377 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.47 92.39 0.27 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -63.17 -35.2 79.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.831 0.348 . . . . 1.0 110.875 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.1 t -127.11 125.06 65.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.073 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.1 mt -115.23 129.63 56.69 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.5 mm -99.41 123.54 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.933 0.397 . . . . 1.0 110.298 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.583 HG21 HD13 ' A' ' 86' ' ' ILE . 10.3 t -139.88 130.47 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.28 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 54.24 40.7 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.954 -0.298 . . . . 1.0 111.096 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.6 t30 62.0 24.05 14.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.729 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -128.21 151.78 48.85 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.264 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -96.65 130.78 43.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.81 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -125.07 138.43 54.19 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.198 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -85.91 -38.02 18.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.731 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -121.36 145.6 47.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.173 0.511 . . . . 1.0 112.039 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.51 -38.41 89.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.615 -0.72 . . . . 1.0 110.802 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -60.72 -39.89 90.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.934 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -63.12 -38.67 92.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.649 0.261 . . . . 1.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.583 HD13 HG21 ' A' ' 75' ' ' VAL . 94.2 mt -60.98 -46.3 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.873 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.7 mt -62.9 -46.14 97.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.581 -0.448 . . . . 1.0 111.669 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.68 -43.7 79.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 112.495 0.554 . . . . 1.0 112.495 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -75.9 -14.12 60.26 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.799 -0.36 . . . . 1.0 111.511 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -94.14 -50.77 5.13 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.638 -0.425 . . . . 1.0 111.825 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 95' ' ' VAL . 1.9 tp -68.85 -39.97 79.62 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.301 0.482 . . . . 1.0 112.301 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -62.94 -48.91 76.85 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 119.971 -0.691 . . . . 1.0 111.379 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -69.57 -42.41 74.54 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.691 -0.403 . . . . 1.0 111.696 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -65.92 -42.55 89.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.218 -0.593 . . . . 1.0 111.191 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 91' ' ' LEU . 53.6 t -65.86 -45.13 92.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.495 -0.482 . . . . 1.0 111.296 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -67.1 -44.9 78.79 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.86 -0.336 . . . . 1.0 111.563 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 tp -68.58 -41.77 79.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.501 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.3 tp -63.52 -43.07 98.25 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.193 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -68.63 -37.66 79.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.026 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -70.4 -43.17 70.59 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.686 -0.406 . . . . 1.0 111.562 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.2 tpt -66.28 -55.06 17.93 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.279 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 104' ' ' SER . 9.7 m -58.34 -38.42 77.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.028 0.442 . . . . 1.0 110.349 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.7 p -72.36 10.57 0.76 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.634 -0.712 . . . . 1.0 111.049 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 102' ' ' THR . 11.7 t -91.84 134.16 35.01 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.832 0.349 . . . . 1.0 110.248 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.31 -20.81 46.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 1.0 111.196 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.58 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 45.9 mtpt -87.9 40.63 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.943 -0.571 . . . . 1.0 109.761 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -130.68 109.14 10.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.135 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -134.8 124.93 25.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.732 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.2 p -92.61 82.8 4.82 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.879 0.371 . . . . 1.0 110.933 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -103.84 147.89 16.78 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.887 -0.885 . . . . 1.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 115' ' ' VAL . 7.6 p -73.53 168.48 19.2 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.007 -0.368 . . . . 1.0 110.007 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -58.89 -40.57 84.85 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.743 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -70.83 -44.0 67.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.183 0.516 . . . . 1.0 110.641 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.54 -22.57 63.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.994 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 111' ' ' THR . 23.7 t -68.11 -44.76 84.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.089 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.5 t -63.91 -45.85 95.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.098 0.475 . . . . 1.0 110.263 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.38 -38.65 90.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.977 0.418 . . . . 1.0 111.034 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -64.44 -49.47 71.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.778 -0.647 . . . . 1.0 111.834 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.0 tp -70.24 -38.4 74.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.485 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -62.22 -41.28 98.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.547 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.71 -48.46 74.57 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.45 -0.5 . . . . 1.0 110.255 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.552 ' CD2' ' OD1' ' A' ' 126' ' ' ASN . 39.8 t80 -61.55 -42.42 98.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.944 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 96.4 p -57.77 -39.17 76.8 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.272 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -64.42 -37.52 87.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.248 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.4 t -64.8 -40.38 88.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.554 -0.536 . . . . 1.0 109.554 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.552 ' OD1' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -126.55 75.56 74.36 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.385 179.547 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.567 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 6.6 Cg_exo -71.52 -25.47 21.1 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.485 2.123 . . . . 1.0 112.584 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -99.35 13.48 33.03 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.188 -0.46 . . . . 1.0 112.05 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -136.24 150.41 48.95 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.931 0.396 . . . . 1.0 110.445 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.9 p -80.12 164.32 23.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.742 -0.663 . . . . 1.0 109.79 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 p -153.09 147.41 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -149.16 142.82 25.5 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.861 0.362 . . . . 1.0 111.125 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -153.15 170.5 20.37 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.313 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -135.95 157.08 47.72 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.9 p -151.02 168.0 25.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.356 -0.383 . . . . 1.0 110.296 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.3 tp -78.38 135.01 37.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.442 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 8.4 t-20 -63.25 -176.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.201 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.451 ' ND1' ' N ' ' A' ' 138' ' ' HIS . 8.3 p-80 -138.52 -23.41 0.97 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.707 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -107.31 -10.22 15.85 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.032 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 80.6 m-20 -136.93 80.09 37.02 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.413 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.65 128.61 30.72 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.013 1.809 . . . . 1.0 112.469 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.3 -19.92 41.52 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -98.86 149.33 23.02 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 110.0 -0.371 . . . . 1.0 110.0 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -118.13 153.73 33.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.524 . . . . 1.0 109.747 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.45 ' CE1' ' ND2' ' A' ' 137' ' ' ASN . 33.1 m-85 -126.82 137.49 53.2 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.016 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.6 mt -108.07 128.93 55.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.31 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.444 ' SD ' HG13 ' A' ' 115' ' ' VAL . 2.5 ptt? -120.36 146.41 46.19 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.837 -1.172 . . . . 1.0 107.837 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -160.38 146.56 15.37 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -130.41 126.51 37.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 120.814 -0.354 . . . . 1.0 110.285 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.667 HD12 ' H ' ' A' ' 150' ' ' ILE . 5.3 mp -72.92 -45.99 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.32 0.489 . . . . 1.0 112.32 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.576 ' OD1' ' N ' ' A' ' 152' ' ' ALA . 15.6 t-20 -153.55 168.03 27.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.522 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.576 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -61.67 -30.68 70.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.689 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.73 -12.5 50.98 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.336 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.7 t -78.77 157.09 28.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.036 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -87.47 148.18 25.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.193 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.3 tp -73.02 122.94 22.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.987 0.422 . . . . 1.0 109.902 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -113.38 132.92 55.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.917 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.7 m -126.96 131.83 50.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.756 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -116.09 163.67 15.6 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.995 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 161' ' ' VAL . 28.5 t-20 -107.54 147.74 30.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.634 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.414 ' N ' ' OD1' ' A' ' 160' ' ' ASN . 44.8 t -127.71 134.79 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.597 -0.52 . . . . 1.0 109.597 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -100.55 128.44 46.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.953 0.406 . . . . 1.0 110.436 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.7 tp -92.84 131.07 38.2 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 70.4 p -129.53 171.25 12.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.39 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -85.16 15.47 4.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.55 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 58.3 p -123.21 -2.99 8.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.466 -0.334 . . . . 1.0 110.549 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 142.74 -138.2 8.22 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.357 -1.097 . . . . 1.0 110.357 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -118.69 128.58 54.65 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.115 -0.328 . . . . 1.0 110.115 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.491 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 4.7 m-85 -103.16 125.94 50.09 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 171' ' ' VAL . 0.8 OUTLIER -119.05 113.93 21.72 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.6 t 36.64 59.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 111.886 0.328 . . . . 1.0 111.886 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.5 m120 66.96 27.87 8.72 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.913 0.709 . . . . 1.0 112.913 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -132.62 121.7 23.59 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.491 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 28.0 t-20 -94.44 119.3 32.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.253 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -99.33 132.13 23.86 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 109.63 -0.507 . . . . 1.0 109.63 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.05 -22.53 19.36 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.985 1.79 . . . . 1.0 113.5 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.8 p -150.37 153.81 36.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.917 0.389 . . . . 1.0 110.939 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.05 -35.5 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.851 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.97 -47.71 90.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.152 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.35 -31.95 73.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.16 -42.14 99.36 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.401 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 75.9 m -62.97 -46.83 85.86 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.745 -0.382 . . . . 1.0 110.343 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 186' ' ' LYS . 35.8 m-80 -64.92 -49.43 70.43 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 108.712 -0.847 . . . . 1.0 108.712 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.18 -46.19 0.49 Allowed Glycine 0 N--CA 1.466 0.657 0 N-CA-C 109.998 -1.241 . . . . 1.0 109.998 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -45.12 71.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.249 0.547 . . . . 1.0 110.046 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 183' ' ' ASN . 17.6 tptm -57.75 -44.36 86.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.242 -0.89 . . . . 1.0 110.467 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 14.4 m -61.19 -45.57 94.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.77 -42.1 98.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.079 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.1 tp -58.34 -43.6 88.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.526 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -59.03 -42.95 91.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.342 0.592 . . . . 1.0 110.228 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.3 t -66.21 -42.68 88.4 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.19 0.519 . . . . 1.0 110.207 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.88 -46.38 85.2 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.303 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.51 -30.09 69.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.456 -0.338 . . . . 1.0 111.679 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -95.47 -9.45 32.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.902 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 73.1 m80 50.8 54.68 10.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.848 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -86.85 103.82 15.62 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.478 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.404 ' CG ' ' O ' ' A' ' 197' ' ' HIS . 85.8 t60 -106.29 54.48 0.68 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.499 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 34.4 m170 47.01 66.26 1.04 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.853 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.925 -1.036 . . . . 1.0 110.755 179.853 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 70.16 16.09 7.47 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.357 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 171.44 27.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.838 0.711 . . . . 1.0 110.387 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 5' ' ' ILE . 14.2 p -64.69 -39.08 84.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.71 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.446 ' N ' HG13 ' A' ' 4' ' ' VAL . 43.8 pt -67.49 -29.99 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.793 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -95.73 10.35 37.24 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.362 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -66.36 133.65 94.49 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.295 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.536 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 78.4 Cg_exo -48.65 -34.14 26.2 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.834 1.69 . . . . 1.0 112.398 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CE2' ' CZ ' ' A' ' 30' ' ' PHE . 90.6 m-85 -79.66 4.15 16.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.398 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.447 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 55.3 t80 -87.19 128.14 35.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.454 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CZ ' ' O ' ' A' ' 8' ' ' PRO . 67.6 m-85 -150.83 115.29 3.22 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.59 112.28 3.49 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.95 1.767 . . . . 1.0 113.623 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.582 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -159.03 165.33 34.22 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.375 0.607 . . . . 1.0 111.187 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 51.4 t-20 -76.71 163.7 26.57 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.506 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . -59.68 -40.2 96.19 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.876 -0.89 . . . . 1.0 110.876 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -64.83 -45.14 87.4 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.994 -0.283 . . . . 1.0 111.033 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -70.0 -36.98 75.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.506 -0.316 . . . . 1.0 111.464 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -42.9 99.36 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.42 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.69 -42.21 82.4 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.118 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -61.82 -40.1 94.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.178 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -64.31 -40.52 96.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.659 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.42 -13.27 59.92 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.019 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -59.24 -42.54 91.34 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.644 -0.423 . . . . 1.0 110.561 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 m -77.97 -19.41 54.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.681 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -79.06 171.41 15.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.003 0.43 . . . . 1.0 110.858 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -77.01 155.52 32.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.786 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -69.08 145.84 53.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.4 2.54 60.28 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.08 -0.808 . . . . 1.0 111.08 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -79.01 154.17 29.7 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.617 ' CZ ' ' CE2' ' A' ' 9' ' ' TYR . 37.5 p90 -138.71 166.33 24.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.593 0.711 . . . . 1.0 111.054 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 45' ' ' THR . 16.1 m -149.8 162.41 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.721 -1.127 . . . . 1.0 112.046 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.5 mt -117.01 127.02 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.705 -0.479 . . . . 1.0 109.705 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.475 ' NE ' ' O ' ' A' ' 13' ' ' PHE . 75.2 ttt-85 -136.49 158.49 44.3 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.35 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -114.31 133.09 55.91 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.824 -0.436 . . . . 1.0 109.824 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.2 m -77.2 139.21 39.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.1 p -68.7 -38.01 79.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.96 -0.563 . . . . 1.0 110.434 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 83.0 mmt-85 -88.08 -13.95 40.13 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.771 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -75.02 -64.06 2.4 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.519 -1.033 . . . . 1.0 110.519 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 t70 69.93 -40.2 0.46 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.647 0.261 . . . . 1.0 110.944 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 38' ' ' GLY . 43.0 p-10 -117.15 11.4 14.15 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.71 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.535 ' C ' HD12 ' A' ' 42' ' ' LEU . 32.7 m-70 -132.24 152.73 51.19 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.933 0.397 . . . . 1.0 110.371 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.535 HD12 ' C ' ' A' ' 41' ' ' HIS . 10.8 mp -118.75 144.99 45.92 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.827 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -126.1 130.88 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.284 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 31' ' ' VAL . 20.3 mt -112.97 139.49 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.484 ' O ' HG22 ' A' ' 31' ' ' VAL . 47.7 m -115.99 128.64 55.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.536 ' CE2' HD11 ' A' ' 48' ' ' LEU . 8.0 p-90 -142.38 147.73 36.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.915 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' C ' HD12 ' A' ' 48' ' ' LEU . 24.7 mtmm -90.88 136.88 32.78 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.101 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 48' ' ' LEU . 7.4 mp -94.33 -67.59 0.85 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.192 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.493 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 26.1 t70 -125.91 -173.31 2.81 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.319 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.493 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 88.4 tttt -65.23 134.23 53.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.644 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 56.44 31.42 18.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.052 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 tp -135.02 130.27 35.4 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.879 0.371 . . . . 1.0 110.604 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -132.29 149.81 52.29 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.551 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.605 ' NE2' ' N ' ' A' ' 55' ' ' HIS . 0.0 OUTLIER -142.86 153.91 43.63 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 179.203 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.605 ' N ' ' NE2' ' A' ' 54' ' ' GLN . 19.1 p80 -123.24 140.73 52.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.207 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 56' ' ' ILE . 14.7 tt -123.87 128.43 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.788 -0.449 . . . . 1.0 109.788 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -103.72 126.36 50.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.975 0.417 . . . . 1.0 110.919 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.0 mt -106.42 129.1 60.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.104 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -104.94 140.4 38.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.253 -0.431 . . . . 1.0 109.999 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -102.82 157.26 17.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.358 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.483 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -145.16 167.91 21.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.658 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.483 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 50.4 tt0 71.47 37.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.012 -0.54 . . . . 1.0 109.899 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -87.33 115.07 24.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -98.44 -25.26 14.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.011 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -157.11 151.88 20.92 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.194 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.53 -19.0 60.68 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.22 1.947 . . . . 1.0 111.859 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.9 tp -79.3 -14.12 59.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.049 0.452 . . . . 1.0 110.691 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.59 137.95 38.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.267 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.2 mt -79.54 164.38 23.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.441 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.52 97.64 0.18 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -67.78 -36.08 79.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.997 0.427 . . . . 1.0 110.618 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.4 t -117.05 123.78 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.583 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.4 mt -116.7 135.57 53.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.428 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.7 mt -107.17 126.41 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.887 0.375 . . . . 1.0 110.142 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.1 t -143.86 132.55 19.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.32 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 t70 54.68 43.28 30.39 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.052 -0.259 . . . . 1.0 111.002 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.4 t30 59.27 24.57 13.06 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.943 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -128.52 154.51 46.07 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.229 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -103.94 134.8 46.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.219 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.737 ' CD1' HD11 ' A' ' 86' ' ' ILE . 96.4 m-85 -126.23 139.39 53.38 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.348 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -84.45 -38.04 20.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.714 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -123.09 150.72 42.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.124 0.488 . . . . 1.0 111.986 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.5 tp -66.8 -36.33 82.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.584 -0.735 . . . . 1.0 111.295 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 50.2 p-10 -58.22 -33.42 69.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.805 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.494 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 82.2 mt-30 -64.88 -39.26 93.26 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.657 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.737 HD11 ' CD1' ' A' ' 80' ' ' TYR . 31.3 mm -62.67 -48.26 89.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.857 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.47 -43.58 98.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 120.334 -0.546 . . . . 1.0 111.734 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 84' ' ' ASP . 59.7 t -73.2 -42.59 58.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 113.148 0.796 . . . . 1.0 113.148 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -82.8 -13.41 56.29 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.636 -0.426 . . . . 1.0 111.557 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.42 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 64.1 t80 -95.52 -48.63 5.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.524 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 95' ' ' VAL . 3.9 tp -69.52 -40.62 76.83 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.264 0.468 . . . . 1.0 112.264 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -63.89 -48.59 76.07 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.042 -0.663 . . . . 1.0 111.762 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -68.43 -43.28 77.47 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.75 -0.38 . . . . 1.0 111.757 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -66.05 -42.13 89.89 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.163 -0.615 . . . . 1.0 111.225 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 91' ' ' LEU . 53.6 t -65.37 -46.13 91.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.226 -0.59 . . . . 1.0 111.441 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -69.17 -44.3 72.49 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.789 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.3 tp -69.01 -40.31 78.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.152 -0.476 . . . . 1.0 111.719 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.4 tp -64.43 -43.3 94.78 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.292 -0.563 . . . . 1.0 110.08 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -67.79 -38.52 83.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.129 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.452 ' OE1' ' OH ' ' A' ' 168' ' ' TYR . 2.9 tm-20 -70.91 -42.81 69.46 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.802 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.487 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 2.6 ttt -64.98 -54.42 30.8 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.531 -0.467 . . . . 1.0 111.433 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.43 HG23 ' CE2' ' A' ' 107' ' ' PHE . 55.5 m -61.23 -30.29 70.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.126 0.489 . . . . 1.0 110.496 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.1 t -73.44 10.31 1.07 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.634 -0.712 . . . . 1.0 110.926 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 36.4 t -96.41 131.68 42.71 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.773 0.32 . . . . 1.0 110.284 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -57.83 -17.89 18.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.944 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.536 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 37.7 mmtm -90.8 40.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.063 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CE2' HG23 ' A' ' 102' ' ' THR . 70.2 t80 -133.17 111.28 10.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.468 . . . . 1.0 111.071 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -123.34 126.46 46.89 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -94.68 85.85 4.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.977 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.0 149.35 16.9 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.673 ' O ' HG23 ' A' ' 115' ' ' VAL . 28.3 p -71.98 170.86 12.9 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -59.87 -39.17 84.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.859 -0.336 . . . . 1.0 110.831 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -68.15 -42.33 80.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.905 0.383 . . . . 1.0 110.455 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -70.6 -18.52 62.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.094 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 111' ' ' THR . 40.9 t -73.19 -44.39 55.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.767 0.318 . . . . 1.0 110.144 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.8 t -62.89 -46.75 95.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.251 0.548 . . . . 1.0 110.157 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -66.02 -36.66 83.87 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.005 0.431 . . . . 1.0 111.099 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -66.61 -49.63 65.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.599 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.5 tp -69.77 -39.4 77.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.305 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -64.82 -42.03 95.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.947 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -63.33 -48.26 78.74 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.427 -0.509 . . . . 1.0 110.052 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -59.94 -43.28 95.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.95 -0.568 . . . . 1.0 109.898 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.4 t -62.9 -39.52 94.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.295 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.8 -41.6 82.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.097 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.24 -41.6 92.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.92 78.6 65.43 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.043 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -71.19 -13.68 31.2 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.449 2.099 . . . . 1.0 112.46 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -101.45 -14.5 17.51 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.651 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -105.97 148.38 27.74 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.978 0.418 . . . . 1.0 110.477 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.401 ' OG ' HD21 ' A' ' 189' ' ' LEU . 60.2 p -81.81 163.78 22.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.883 -0.599 . . . . 1.0 109.615 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 p -152.72 146.27 15.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.421 ' O ' ' CD2' ' A' ' 133' ' ' TYR . 33.0 p90 -149.91 141.53 23.52 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.671 -0.412 . . . . 1.0 111.083 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.421 ' CD2' ' O ' ' A' ' 132' ' ' TYR . 25.4 m-85 -152.91 165.93 33.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.309 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -130.63 154.37 47.96 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 178.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.1 p -150.44 168.14 25.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.205 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.1 tp -81.24 132.41 35.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.604 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.548 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 22.6 p30 -78.25 151.9 32.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.277 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -106.22 -30.4 9.23 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.651 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 41.4 p30 -64.97 -21.14 66.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.197 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.548 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 19.8 t-20 -163.22 106.76 1.0 Allowed Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.59 143.55 38.32 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.796 1.664 . . . . 1.0 112.411 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.82 -39.19 2.81 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.422 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 19.8 m95 -94.47 149.78 20.91 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.815 0.34 . . . . 1.0 110.199 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.487 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 77.1 m-85 -113.26 154.86 26.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.847 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -126.31 139.23 53.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.115 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.5 mt -111.1 126.66 55.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.568 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.6 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -120.98 146.85 46.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.029 -1.1 . . . . 1.0 108.029 178.378 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -162.44 153.89 18.07 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.25 -0.58 . . . . 1.0 109.769 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -137.73 128.41 26.85 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.801 0.334 . . . . 1.0 110.604 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.668 ' N ' HD12 ' A' ' 150' ' ' ILE . 2.6 mp -69.76 -45.24 77.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 1.0 111.591 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.411 ' ND2' HG22 ' A' ' 150' ' ' ILE . 76.6 m-20 -156.47 171.79 19.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.574 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.79 -28.3 69.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.792 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -90.27 8.61 32.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.983 0.421 . . . . 1.0 110.346 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 15.9 t -102.22 150.43 23.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.442 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -80.17 157.16 26.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.014 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 62.1 tp -75.07 124.11 26.41 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.259 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -108.31 129.89 55.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.518 . . . . 1.0 109.615 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 63.9 m -128.2 130.46 48.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.872 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -120.9 159.81 24.77 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.866 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 160' ' ' ASN . 34.5 p30 -105.69 148.32 27.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.984 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.77 136.12 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -98.33 135.27 40.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.773 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 29.3 tp -102.51 128.83 48.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.905 -0.588 . . . . 1.0 109.543 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.4 p -131.04 168.37 17.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.087 0.47 . . . . 1.0 110.398 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -78.74 17.35 0.72 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.669 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 12.1 p -121.35 -2.38 9.54 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.704 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 137.48 -126.3 3.58 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.264 -1.135 . . . . 1.0 110.264 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.452 ' OH ' ' OE1' ' A' ' 100' ' ' GLU . 19.9 m-85 -127.28 132.84 50.24 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.671 0.272 . . . . 1.0 110.447 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -110.43 120.81 43.62 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.938 0.399 . . . . 1.0 110.143 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.0 tt -114.96 120.92 41.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.4 t 35.97 52.1 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 111.95 0.352 . . . . 1.0 111.95 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 10.2 m120 69.42 27.41 4.98 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.087 0.773 . . . . 1.0 113.087 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -135.78 120.16 17.99 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -91.27 131.24 36.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.359 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -107.54 101.25 38.65 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 109.438 -0.578 . . . . 1.0 109.438 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -48.82 -23.17 5.44 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.462 2.108 . . . . 1.0 113.376 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 40.0 m -141.66 145.74 35.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.991 0.424 . . . . 1.0 111.097 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.62 -34.97 70.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.731 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.462 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 49.2 mm -60.57 -46.98 94.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.336 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.458 ' N ' ' OE1' ' A' ' 180' ' ' GLN . 6.6 mp0 -61.65 -32.9 73.09 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.14 -40.3 95.87 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 1.8 p -61.49 -46.85 88.25 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.769 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.6 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 54.5 t30 -71.21 -49.72 40.55 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 119.727 -0.789 . . . . 1.0 108.954 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.31 -43.87 0.53 Allowed Glycine 0 N--CA 1.462 0.398 0 N-CA-C 109.832 -1.307 . . . . 1.0 109.832 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -69.04 -47.93 64.14 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.071 -0.565 . . . . 1.0 109.596 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 183' ' ' ASN . 49.5 tttp -57.25 -39.9 76.55 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.184 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.5 m -60.5 -44.31 96.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 62.9 mt -63.86 -39.03 93.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.152 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.401 HD21 ' OG ' ' A' ' 130' ' ' SER . 62.3 tp -59.45 -45.32 91.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.713 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -58.7 -45.39 89.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.104 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.1 t -64.49 -40.29 95.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.714 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.76 -42.0 97.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.47 -0.786 . . . . 1.0 111.95 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -63.11 -25.8 68.53 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -89.67 -8.2 52.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.726 0.298 . . . . 1.0 110.863 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.414 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 74.2 t60 54.89 23.2 4.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.949 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -89.23 140.34 29.58 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.552 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 198' ' ' HIS . 4.5 t-80 -59.27 -48.23 82.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.578 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.675 ' CG ' ' H ' ' A' ' 199' ' ' HIS . 30.5 t60 40.4 -166.45 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.033 0.444 . . . . 1.0 111.05 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.675 ' H ' ' CG ' ' A' ' 198' ' ' HIS . 63.2 m80 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.003 -0.998 . . . . 1.0 110.711 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.403 -0.592 . . . . 1.0 109.403 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -88.43 -6.85 57.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.695 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.481 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 83.8 mtp180 -133.22 1.61 3.51 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.486 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.65 -31.83 53.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.522 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.6 pt -75.39 -19.93 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.447 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -103.59 9.11 37.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.6 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 3' ' ' ARG . 0.4 OUTLIER -67.77 147.87 98.55 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 110.057 -0.349 . . . . 1.0 110.057 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.64 -14.25 38.99 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.102 1.868 . . . . 1.0 112.2 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -94.74 5.52 51.64 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.203 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 40.3 t80 -82.88 128.76 34.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.478 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 58.4 m-85 -149.38 120.92 4.17 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.513 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.521 ' O ' ' CD1' ' A' ' 13' ' ' PHE . 72.7 Cg_endo -74.72 109.64 2.95 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.748 1.632 . . . . 1.0 112.479 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' A' ' 12' ' ' PRO . 70.6 m-85 -155.72 156.8 35.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.379 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -79.4 168.05 20.01 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.461 ' CA ' HH12 ' A' ' 33' ' ' ARG . . . -59.65 -43.58 97.61 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.381 -0.914 . . . . 1.0 111.203 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -66.02 -41.22 91.26 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.055 -0.258 . . . . 1.0 110.784 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.85 -35.9 77.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.543 -0.299 . . . . 1.0 111.229 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.77 -40.9 94.25 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.45 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.11 -42.69 93.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -60.47 -42.76 96.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.275 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -60.98 -41.8 97.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.815 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.8 mp -78.9 -15.22 58.62 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.984 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -61.14 -42.13 97.99 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.806 -0.357 . . . . 1.0 110.516 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.3 t -76.75 -18.71 58.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.975 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -87.09 -178.02 6.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.055 0.455 . . . . 1.0 110.676 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.18 179.45 5.56 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.819 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.6 mtt85 -81.01 146.11 30.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.049 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.56 19.44 29.77 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.83 145.67 26.73 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -132.86 167.45 20.18 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.109 0.481 . . . . 1.0 110.95 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 32' ' ' ILE . 45.2 t -147.34 158.44 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.242 -0.89 . . . . 1.0 111.443 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.491 ' N ' HG12 ' A' ' 31' ' ' VAL . 6.0 mm -114.83 126.33 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.711 -0.848 . . . . 1.0 108.711 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.461 HH12 ' CA ' ' A' ' 15' ' ' GLY . 57.1 ttp180 -137.86 155.86 48.52 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.402 ' N ' ' HG2' ' A' ' 33' ' ' ARG . 91.2 mt-30 -119.69 137.91 53.61 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.786 -0.45 . . . . 1.0 109.786 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.6 m -72.37 151.43 42.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.773 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.8 p -69.55 -20.81 63.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.018 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.28 17.68 9.07 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.023 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -84.54 -74.95 1.23 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.532 -1.027 . . . . 1.0 110.532 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.3 t70 67.68 -35.71 0.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.635 0.255 . . . . 1.0 110.884 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' A' ' 38' ' ' GLY . 97.2 m-20 -118.55 12.06 13.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.466 -0.334 . . . . 1.0 110.594 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.565 ' C ' HD12 ' A' ' 42' ' ' LEU . 99.5 m-70 -144.06 146.55 32.9 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.322 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.565 HD12 ' C ' ' A' ' 41' ' ' HIS . 10.9 mp -119.12 145.48 45.92 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.09 -0.504 . . . . 1.0 109.793 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.86 129.23 74.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.146 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.477 HG22 HD13 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -111.19 137.71 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 108.762 -0.829 . . . . 1.0 108.762 -179.409 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.8 m -115.16 134.05 55.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.877 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.535 ' CZ2' HD11 ' A' ' 48' ' ' LEU . 1.8 p-90 -148.14 151.6 35.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.384 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.529 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -99.61 145.51 27.48 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.69 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.535 HD11 ' CZ2' ' A' ' 46' ' ' TRP . 9.5 mp -102.47 -75.52 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 36.9 t0 -117.06 -166.74 1.2 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.388 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.529 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 51.7 mtmt -69.6 139.37 53.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.947 0.403 . . . . 1.0 110.814 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 52.28 26.66 4.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.909 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.8 tp -130.89 129.01 41.71 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.787 0.327 . . . . 1.0 110.327 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -133.87 148.99 51.33 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.502 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 -139.84 152.09 46.21 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.581 -0.526 . . . . 1.0 109.581 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -129.37 144.15 51.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.427 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 92.8 mt -125.51 131.75 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.786 -0.449 . . . . 1.0 109.786 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -98.53 121.81 40.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.906 0.384 . . . . 1.0 110.575 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.3 mt -97.98 123.58 50.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.094 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -111.31 131.69 54.96 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -103.08 152.78 20.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.242 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.471 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 1.6 tp -144.45 165.69 27.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.414 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 3.1 tm-20 81.94 63.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.201 0.524 . . . . 1.0 110.063 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HD3' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -105.89 113.91 27.74 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.034 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.468 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 57.8 mp0 -65.85 -22.85 66.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.688 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.611 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 1.1 m120 -151.6 160.03 32.37 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.133 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.34 -32.97 64.06 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.986 1.791 . . . . 1.0 112.332 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.1 mt -95.14 -8.82 35.33 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.688 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.611 ' HB3' ' H ' ' A' ' 65' ' ' ASN . . . -73.85 144.77 45.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.593 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.7 mt -89.71 147.25 23.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.271 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.98 126.76 7.59 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.7 -0.96 . . . . 1.0 110.7 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -81.96 -9.78 59.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.064 0.459 . . . . 1.0 110.459 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.28 118.68 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.735 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.5 mt -115.01 129.23 56.67 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.551 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.2 mt -101.29 121.87 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.951 0.405 . . . . 1.0 110.228 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.88 131.92 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.121 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.7 t0 55.98 42.88 28.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.178 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 59.69 21.13 9.83 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.922 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -128.06 151.98 48.52 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.059 0.456 . . . . 1.0 110.22 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -101.37 128.38 47.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.224 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -122.94 138.67 54.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.32 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -85.25 -38.38 18.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 1.0 111.606 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -113.13 141.23 47.16 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.034 0.445 . . . . 1.0 111.993 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.2 -40.66 96.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.85 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -59.21 -41.71 89.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.746 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -60.81 -38.52 85.68 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.986 -0.285 . . . . 1.0 110.723 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.37 -47.27 94.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.743 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.1 mt -62.09 -46.41 96.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.329 -0.548 . . . . 1.0 111.684 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.0 t -71.15 -42.46 75.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.844 0.683 . . . . 1.0 112.844 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -77.38 -15.4 59.39 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.662 -0.415 . . . . 1.0 111.9 -177.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.621 ' CZ ' ' NZ ' ' A' ' 94' ' ' LYS . 34.8 t80 -94.09 -49.91 5.54 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.651 -0.42 . . . . 1.0 111.713 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.2 mp -69.75 -40.57 76.08 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 112.096 0.406 . . . . 1.0 112.096 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -62.85 -48.53 78.62 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.774 -0.77 . . . . 1.0 111.544 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -69.21 -43.41 74.18 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.522 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.621 ' NZ ' ' CZ ' ' A' ' 90' ' ' TYR . 24.0 mmtp -66.14 -43.77 86.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.213 -0.595 . . . . 1.0 111.243 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.32 -44.79 90.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.339 -0.544 . . . . 1.0 111.023 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -66.03 -47.54 74.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.248 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.434 HD21 ' CE1' ' A' ' 168' ' ' TYR . 3.0 tp -69.08 -38.93 79.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.282 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.38 -43.28 98.08 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.574 -0.45 . . . . 1.0 110.118 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -67.51 -39.75 85.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.257 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -71.09 -41.38 70.7 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.007 0.373 . . . . 1.0 112.007 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.5 ttt -68.38 -54.82 14.69 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.423 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.1 m -58.7 -42.2 88.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.076 0.465 . . . . 1.0 110.411 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.3 m -72.37 8.27 1.44 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.951 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -84.29 142.82 29.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.734 0.302 . . . . 1.0 110.512 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.63 -19.5 65.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.885 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.552 ' NZ ' ' SG ' ' A' ' 182' ' ' CYS . 98.7 mttt -93.13 39.44 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.828 -0.624 . . . . 1.0 110.161 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -134.12 118.37 17.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.122 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -126.67 133.13 51.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.0 p -99.4 74.7 1.93 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.8 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.71 146.62 18.58 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.635 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -71.52 171.68 10.94 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.036 -0.357 . . . . 1.0 110.036 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -56.66 -38.89 72.82 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.64 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.94 -44.19 77.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.962 0.411 . . . . 1.0 110.724 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -70.17 -20.27 63.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.056 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 111' ' ' THR . 40.2 t -70.78 -45.23 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.299 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.14 -46.67 92.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 120.494 -0.482 . . . . 1.0 110.278 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.03 -35.37 80.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.053 0.454 . . . . 1.0 110.75 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -67.49 -49.63 62.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.596 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 119' ' ' ILE . 10.5 tp -70.18 -39.22 76.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.962 0.41 . . . . 1.0 110.459 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -64.24 -39.94 94.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.685 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -60.32 -48.5 81.49 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.548 -0.461 . . . . 1.0 110.31 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -62.76 -39.88 95.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.293 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.9 t -61.49 -42.39 98.72 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.578 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -59.6 -38.17 80.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.055 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.1 t -66.75 -42.28 89.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.658 -0.417 . . . . 1.0 109.974 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -126.26 76.49 72.69 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.217 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -71.29 -14.25 31.21 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 122.578 2.185 . . . . 1.0 112.441 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -103.54 10.17 37.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.655 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -132.98 148.58 52.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.861 0.362 . . . . 1.0 110.621 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 42.0 t -81.08 161.5 24.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.48 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.0 p -152.65 145.19 15.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -144.17 143.66 31.19 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.949 0.404 . . . . 1.0 111.12 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -151.35 161.98 41.75 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.372 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.481 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -132.65 154.86 49.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 179.146 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.1 t -152.54 168.41 25.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.93 0.395 . . . . 1.0 110.105 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.71 128.98 34.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.067 -0.515 . . . . 1.0 111.019 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 12.5 t-20 -87.34 135.68 33.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.902 0.382 . . . . 1.0 110.368 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -73.14 -39.64 65.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.971 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -62.44 -15.11 47.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.036 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.542 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 3.6 p30 -167.66 82.52 0.83 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.269 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.25 -37.14 58.92 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.124 1.883 . . . . 1.0 113.142 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -59.78 -34.74 83.78 Favored Glycine 0 C--N 1.312 -0.798 0 N-CA-C 110.956 -0.858 . . . . 1.0 110.956 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -99.72 144.77 28.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.88 0.372 . . . . 1.0 110.242 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -106.61 153.65 22.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.879 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.564 ' CZ ' ' ND2' ' A' ' 160' ' ' ASN . 4.0 m-85 -112.33 134.33 53.93 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.969 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.688 ' CD1' ' HE1' ' A' ' 159' ' ' TRP . 5.3 mt -112.55 123.34 50.08 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.709 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.561 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -123.55 148.89 45.9 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.469 -0.938 . . . . 1.0 108.469 178.21 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.56 ' CE1' ' CZ3' ' A' ' 159' ' ' TRP . 8.1 p90 -163.9 160.81 22.52 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.27 -0.572 . . . . 1.0 109.649 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -140.83 129.86 23.33 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.564 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mt -77.06 -44.94 31.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.282 -0.417 . . . . 1.0 111.592 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -154.35 165.68 35.6 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.372 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.91 -31.52 69.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.712 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -85.69 -4.34 59.14 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.043 0.449 . . . . 1.0 110.611 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 11.8 t -84.28 163.21 19.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.514 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.431 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 14.7 mptt -96.57 148.6 22.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.67 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 52.6 tp -70.23 118.81 13.53 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.36 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.438 ' O ' ' CD1' ' A' ' 148' ' ' PHE . 87.4 m-85 -113.66 119.37 37.22 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 146' ' ' LEU . 86.0 m -130.39 135.18 47.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.848 -0.615 . . . . 1.0 111.874 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.688 ' HE1' ' CD1' ' A' ' 146' ' ' LEU . 7.7 p90 -128.35 -173.94 3.09 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.462 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.564 ' ND2' ' CZ ' ' A' ' 145' ' ' TYR . 94.4 m-20 -124.82 152.7 43.59 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.445 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 169' ' ' PHE . 27.6 t -118.56 139.37 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -93.9 130.65 39.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.207 0.527 . . . . 1.0 110.948 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.8 tp -90.93 129.72 36.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.562 -0.745 . . . . 1.0 109.446 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 165' ' ' ASN . 0.1 OUTLIER -131.65 177.84 7.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.616 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.508 ' N ' ' OG1' ' A' ' 164' ' ' THR . 65.3 t30 -86.13 15.68 4.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.704 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 77.2 p -121.07 -1.7 9.78 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.575 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 132.87 -126.09 4.32 Favored Glycine 0 N--CA 1.464 0.533 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.434 ' CE1' HD21 ' A' ' 97' ' ' LEU . 22.5 m-85 -122.13 129.27 52.18 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.545 0.212 . . . . 1.0 110.517 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.437 ' O ' HG13 ' A' ' 161' ' ' VAL . 0.1 OUTLIER -105.54 120.77 42.47 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.0 tt -113.32 114.98 27.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.4 t 35.47 59.46 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.253 0.464 . . . . 1.0 112.253 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.8 m120 69.16 27.34 5.26 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.17 0.804 . . . . 1.0 113.17 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -134.89 119.19 17.76 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -99.73 124.9 45.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.84 0.353 . . . . 1.0 111.736 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -102.36 131.85 22.07 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.31 -0.626 . . . . 1.0 109.31 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.36 -18.41 29.95 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.193 1.929 . . . . 1.0 113.443 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 89.7 p -152.08 156.02 39.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.084 0.468 . . . . 1.0 110.908 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.16 -36.05 72.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.716 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.05 -43.32 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 120.909 0.385 . . . . 1.0 110.123 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -61.12 -35.12 76.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.25 -39.93 94.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.211 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.552 ' SG ' ' NZ ' ' A' ' 106' ' ' LYS . 13.8 t -57.04 -48.4 78.62 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.271 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 186' ' ' LYS . 65.7 t30 -66.7 -47.61 71.84 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.21 -44.02 0.76 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.376 -1.49 . . . . 1.0 109.376 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -68.96 -47.58 65.28 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.387 0.613 . . . . 1.0 109.496 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 183' ' ' ASN . 63.1 tttm -55.97 -39.11 71.31 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.251 -0.886 . . . . 1.0 109.866 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 19.0 m -63.33 -47.18 83.29 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 75.6 mt -62.9 -42.71 99.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.108 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 45.0 tp -57.35 -46.53 83.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.719 -0.392 . . . . 1.0 110.29 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -56.19 -41.83 76.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.142 0.496 . . . . 1.0 109.857 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.1 t -66.59 -42.78 86.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.832 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.66 -45.55 86.26 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.595 -0.729 . . . . 1.0 112.177 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -67.81 -35.49 78.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.785 0.326 . . . . 1.0 111.826 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' HIS . . . . . 0.559 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 10.4 t-80 -80.95 -7.73 59.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.577 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' A' ' 194' ' ' HIS . 50.5 p-80 42.4 52.24 4.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.338 -0.392 . . . . 1.0 111.105 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -54.14 134.33 44.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.69 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -69.58 82.78 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.75 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -82.62 -32.97 28.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.872 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.63 -179.588 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -94.79 9.83 37.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.512 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.3 mmt-85 -128.43 -30.83 2.33 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.627 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.67 -33.43 63.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.617 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.7 pt -81.48 -30.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.547 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -95.11 3.77 54.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.342 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -65.09 140.93 98.18 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.375 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.18 -12.89 35.07 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.92 1.747 . . . . 1.0 112.038 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -102.48 7.65 40.17 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.614 0.245 . . . . 1.0 111.152 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.529 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 30.6 t80 -90.95 127.76 36.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.442 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 65.1 m-85 -151.65 108.97 2.92 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.549 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 41.7 Cg_exo -57.56 108.18 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.712 1.608 . . . . 1.0 112.734 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 66.2 m-85 -160.94 157.97 27.34 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.64 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -79.09 163.87 24.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' OE1' ' A' ' 19' ' ' GLU . . . -55.48 -45.51 83.81 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.248 -0.977 . . . . 1.0 110.853 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -65.2 -39.66 93.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.868 0.366 . . . . 1.0 110.758 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.35 -33.83 76.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.498 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.06 -38.82 87.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.436 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.552 ' OE2' ' NE2' ' A' ' 55' ' ' HIS . 4.3 mp0 -67.09 -43.51 82.36 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.566 -0.454 . . . . 1.0 110.37 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.51 -46.15 91.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.227 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -61.02 -44.82 96.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.423 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 tp -75.36 -15.98 60.43 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.064 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -60.67 -42.13 96.46 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.393 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p -75.32 -18.63 59.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.627 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -82.22 179.83 7.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.621 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -90.1 154.72 19.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.812 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -68.05 143.45 55.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.759 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.0 10.09 43.62 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.223 -0.751 . . . . 1.0 111.223 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -91.68 156.43 17.6 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -125.11 155.72 39.43 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.295 0.569 . . . . 1.0 111.004 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 t -141.4 152.76 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 115.145 -0.934 . . . . 1.0 111.184 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.95 125.8 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -142.16 158.64 43.51 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.077 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.487 HE22 ' HG ' ' A' ' 42' ' ' LEU . 27.0 mm100 -103.15 131.17 50.36 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 37' ' ' ARG . 7.2 t -48.82 -12.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.918 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 34' ' ' GLN . 3.0 m 63.24 2.06 1.05 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.652 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.402 ' H ' ' C ' ' A' ' 35' ' ' SER . 34.4 ttm180 -154.47 58.88 0.7 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.629 -0.26 . . . . 1.0 110.582 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -157.62 -50.06 0.01 OUTLIER Glycine 0 N--CA 1.463 0.446 0 N-CA-C 110.384 -1.086 . . . . 1.0 110.384 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.9 t0 73.63 -28.3 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.796 0.331 . . . . 1.0 111.026 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 38' ' ' GLY . 36.3 t70 -121.59 20.26 11.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.984 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -142.19 141.42 32.57 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.826 0.346 . . . . 1.0 110.541 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.487 ' HG ' HE22 ' A' ' 34' ' ' GLN . 5.3 mp -120.57 144.65 47.97 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.095 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.8 t -126.16 130.78 72.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.217 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mt -112.06 139.47 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.5 m -118.25 132.2 56.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.391 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.555 ' CZ3' ' CD2' ' A' ' 48' ' ' LEU . 2.8 p-90 -146.15 143.68 29.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.989 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -92.52 140.72 29.27 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.961 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.555 ' CD2' ' CZ3' ' A' ' 46' ' ' TRP . 8.4 mt -103.67 -75.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.331 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -115.45 -176.88 3.01 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.263 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -66.21 130.23 42.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.932 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.4 t0 61.88 30.33 18.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.033 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.0 tp -137.8 126.04 23.11 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.874 0.369 . . . . 1.0 110.412 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -134.85 149.48 50.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.55 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -138.88 153.98 48.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.853 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.552 ' NE2' ' OE2' ' A' ' 19' ' ' GLU . 44.9 m80 -124.08 141.35 52.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.243 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.7 mt -121.53 124.8 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -98.2 122.07 40.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.662 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 80.8 mt -101.15 126.0 55.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.363 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -103.71 134.58 46.8 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.978 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -104.37 146.59 28.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 1.0 109.995 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.475 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 9.8 mt -142.15 166.47 24.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.764 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 1.5 tm-20 82.32 54.73 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.856 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -106.62 93.86 4.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.878 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.11 -35.12 77.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.898 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -145.71 156.5 52.28 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.973 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.16 -19.53 68.92 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.39 2.06 . . . . 1.0 112.104 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.548 ' H ' ' CG ' ' A' ' 65' ' ' ASN . 4.8 tp -83.26 -9.88 58.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.998 0.427 . . . . 1.0 110.931 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.582 ' N ' ' ND2' ' A' ' 65' ' ' ASN . . . -113.24 143.63 44.08 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.158 0.504 . . . . 1.0 110.17 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.515 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -90.55 168.94 11.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.319 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.34 109.69 2.86 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.417 ' NZ ' ' OE1' ' A' ' 62' ' ' GLU . 34.2 mtmm -72.8 -11.85 60.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.02 0.438 . . . . 1.0 110.727 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.1 t -118.3 120.68 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.816 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.4 mt -115.67 130.88 57.02 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.7 mt -102.47 121.08 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -140.88 132.92 30.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.201 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.572 ' OD2' ' ND2' ' A' ' 165' ' ' ASN . 46.8 t0 53.9 42.98 31.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.774 0.321 . . . . 1.0 110.997 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 59.79 22.87 11.77 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.826 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -128.56 143.75 51.02 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.254 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -98.12 126.98 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.872 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CG ' HG12 ' A' ' 86' ' ' ILE . 93.8 m-85 -120.32 137.48 54.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.167 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -85.29 -38.09 19.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.777 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -112.02 141.39 45.74 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.047 0.451 . . . . 1.0 112.11 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.97 -41.06 97.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.473 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 88' ' ' VAL . 60.9 m-20 -61.56 -39.75 92.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.793 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -59.89 -39.66 86.12 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.74 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.41 HG12 ' CG ' ' A' ' 80' ' ' TYR . 75.5 mt -61.68 -50.15 81.42 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 C-N-CA 120.352 -0.539 . . . . 1.0 111.113 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.58 -43.49 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.57 -0.452 . . . . 1.0 111.795 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.435 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 93.9 t -66.4 -22.23 29.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.112 -0.495 . . . . 1.0 112.15 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -100.18 -10.84 20.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.911 0.386 . . . . 1.0 111.011 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.84 -50.33 5.62 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.39 -0.524 . . . . 1.0 112.368 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 95' ' ' VAL . 7.6 mp -64.62 -45.38 87.12 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 112.802 0.667 . . . . 1.0 112.802 -176.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.474 ' HG3' ' N ' ' A' ' 93' ' ' ASN . 14.7 pt20 -64.8 -48.12 75.59 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.706 -0.798 . . . . 1.0 111.842 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.474 ' N ' ' HG3' ' A' ' 92' ' ' GLN . 58.1 t-20 -71.37 -43.08 67.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.649 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -66.56 -44.38 82.46 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.18 -0.608 . . . . 1.0 111.403 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 91' ' ' LEU . 76.7 t -66.5 -44.49 90.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.211 -0.596 . . . . 1.0 111.364 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -68.22 -43.11 78.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.489 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 tp -67.05 -41.02 87.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.427 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 mt -63.69 -43.85 95.41 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.272 -0.571 . . . . 1.0 110.5 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -68.78 -38.64 80.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.146 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -70.66 -43.48 69.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.954 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.3 tpt -66.1 -54.34 26.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.476 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 104' ' ' SER . 9.8 m -59.67 -40.36 87.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.085 0.469 . . . . 1.0 110.438 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.0 m -72.23 10.18 0.83 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.705 -0.68 . . . . 1.0 111.249 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 102' ' ' THR . 6.8 t -92.43 136.62 33.06 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.865 0.364 . . . . 1.0 110.274 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -60.82 -20.71 62.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.068 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.593 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 67.9 mttm -89.43 39.12 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.763 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -131.61 115.59 16.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.379 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -140.2 113.28 8.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.701 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.2 t -98.12 88.07 4.11 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.076 0.465 . . . . 1.0 110.916 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.98 171.13 14.67 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 115' ' ' VAL . 10.1 p -74.62 165.38 25.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -60.62 -39.75 89.36 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.805 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -67.43 -42.51 83.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.154 0.502 . . . . 1.0 110.803 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -70.73 -20.11 62.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.72 . . . . 1.0 111.045 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 111' ' ' THR . 18.0 t -70.43 -45.85 73.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.809 -0.356 . . . . 1.0 110.267 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.47 -45.03 98.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.102 0.477 . . . . 1.0 110.073 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.06 -34.4 78.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.993 0.425 . . . . 1.0 110.729 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -66.58 -49.98 64.57 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.915 -0.584 . . . . 1.0 111.85 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.9 tp -69.93 -38.91 76.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.476 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.552 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 66.5 mm-40 -63.89 -39.99 95.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.56 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -64.84 -47.27 78.55 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.601 -0.439 . . . . 1.0 110.345 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -60.25 -45.46 93.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.947 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.3 t -63.87 -38.14 89.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.319 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -58.36 -41.76 85.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.839 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.3 t -66.7 -41.95 88.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -123.6 75.83 54.97 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.505 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.91 -17.21 32.53 Favored 'Trans proline' 0 N--CA 1.488 1.157 0 C-N-CA 122.531 2.154 . . . . 1.0 112.2 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -101.64 22.37 12.88 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.577 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -143.64 151.56 40.27 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.862 0.363 . . . . 1.0 110.664 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 94.4 p -81.19 163.16 23.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.817 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 p -152.41 146.55 15.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.249 -0.648 . . . . 1.0 109.249 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -147.77 142.39 26.58 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.834 0.35 . . . . 1.0 111.208 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -152.93 171.4 18.38 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.374 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.593 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.8 p90 -141.05 158.52 43.81 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.25 -0.648 . . . . 1.0 109.25 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.8 p -151.74 168.28 25.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.824 0.345 . . . . 1.0 110.255 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.9 tp -80.27 129.41 34.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.588 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -72.07 156.86 38.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.272 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.43 ' CG ' ' N ' ' A' ' 139' ' ' ASP . 12.9 p-80 -96.18 -46.95 6.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.889 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.43 ' N ' ' CG ' ' A' ' 138' ' ' HIS . 95.0 m-20 -76.15 -7.52 54.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.21 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 139' ' ' ASP . 63.4 m-80 -160.86 70.11 2.7 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.37 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -49.55 -35.4 37.04 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.258 1.972 . . . . 1.0 112.711 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -60.55 -32.16 77.14 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.793 -0.923 . . . . 1.0 110.793 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -96.36 147.13 24.12 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.726 0.298 . . . . 1.0 110.219 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -113.2 152.32 29.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.704 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -123.18 139.94 53.54 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.972 0.415 . . . . 1.0 110.181 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.5 mt -108.79 121.37 44.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.291 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.537 ' SD ' HG13 ' A' ' 115' ' ' VAL . 5.0 ptt? -112.85 143.23 44.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.944 -1.132 . . . . 1.0 107.944 178.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -161.73 151.51 16.66 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.552 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 69.4 tttt -134.76 128.89 33.73 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.391 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.4 mp -69.53 -46.47 75.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.303 0.483 . . . . 1.0 112.303 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -159.48 173.98 15.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.515 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.84 74.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.836 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -86.81 8.15 24.01 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.385 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -96.3 165.54 12.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.441 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.48 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 61.2 mttp -99.22 149.85 22.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 1.0 109.928 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.7 tp -69.42 122.63 19.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.038 0.447 . . . . 1.0 109.871 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 87.9 m-85 -114.31 128.64 56.45 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.855 -0.611 . . . . 1.0 109.822 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 97.8 m -123.37 128.77 50.35 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.679 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -114.2 160.78 18.62 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.036 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -107.68 146.45 32.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.9 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 169' ' ' PHE . 42.4 t -128.82 135.98 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -97.72 133.34 42.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.049 0.452 . . . . 1.0 110.844 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 31.6 tp -95.68 130.3 42.61 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.4 p -133.47 178.28 7.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.055 0.455 . . . . 1.0 110.266 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.572 ' ND2' ' OD2' ' A' ' 76' ' ' ASP . 67.0 m-80 -86.17 17.16 3.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.663 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 13.4 p -121.2 -2.18 9.64 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.811 0.339 . . . . 1.0 110.626 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.02 -127.16 4.47 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.373 -1.091 . . . . 1.0 110.373 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -121.31 130.06 53.44 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 110.219 -0.289 . . . . 1.0 110.219 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.426 ' O ' HG13 ' A' ' 161' ' ' VAL . 2.8 m-85 -104.08 124.7 49.53 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 109.854 -0.425 . . . . 1.0 109.854 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.9 tt -119.02 115.18 23.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.535 -0.543 . . . . 1.0 109.535 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.425 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 3.5 t 40.73 57.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 111.976 0.361 . . . . 1.0 111.976 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.8 m120 65.2 27.28 12.26 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.906 0.706 . . . . 1.0 112.906 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.425 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 73.6 m-85 -134.72 121.52 20.89 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.62 131.49 37.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.45 -0.341 . . . . 1.0 111.199 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -112.34 96.12 34.14 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.79 -22.53 7.22 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.499 2.133 . . . . 1.0 113.292 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.8 p -133.66 138.24 45.78 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.846 0.355 . . . . 1.0 110.999 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.6 p -61.04 -33.08 54.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.772 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.1 mm -62.0 -45.88 97.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.937 0.399 . . . . 1.0 110.194 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -65.61 -32.36 73.89 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.87 -42.5 99.79 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.424 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 74.0 m -63.36 -46.38 86.8 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.704 -0.399 . . . . 1.0 110.378 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 186' ' ' LYS . 74.6 m-20 -66.94 -49.29 65.96 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 119.682 -0.807 . . . . 1.0 108.926 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.12 -45.13 0.59 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.706 -1.357 . . . . 1.0 109.706 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -69.26 -47.06 65.73 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.218 0.532 . . . . 1.0 109.752 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 183' ' ' ASN . 89.1 tttt -56.52 -41.41 76.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.481 -0.781 . . . . 1.0 109.922 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 86.7 m -60.79 -45.58 93.84 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.57 -41.42 98.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.813 -0.631 . . . . 1.0 110.036 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.16 -43.61 82.69 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.786 -0.366 . . . . 1.0 110.716 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -60.75 -42.96 98.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.15 0.5 . . . . 1.0 110.434 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 48.4 m -61.72 -38.59 88.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.634 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 87.3 mt -65.13 -39.19 92.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.594 -0.73 . . . . 1.0 112.233 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -64.07 -30.51 71.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.651 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -94.34 -8.89 37.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.471 -0.331 . . . . 1.0 111.007 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.519 ' O ' ' CG ' ' A' ' 196' ' ' HIS . 28.2 t60 44.56 22.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.036 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.519 ' CG ' ' O ' ' A' ' 195' ' ' HIS . 47.0 m80 -159.92 125.71 4.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.005 0.431 . . . . 1.0 110.454 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -161.19 172.87 15.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.71 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 77.4 t60 51.11 72.46 0.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.801 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 80.0 m80 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 118.023 -0.989 . . . . 1.0 110.635 179.827 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.5 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 76.1 2.41 3.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.518 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -156.67 6.01 0.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.53 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 p -63.5 -32.91 58.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.341 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.9 pt -79.28 -12.22 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.316 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -105.13 4.91 31.86 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.645 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.16 150.05 94.51 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 41.0 Cg_endo -66.01 -22.66 54.95 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.817 1.678 . . . . 1.0 112.261 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.537 ' CD1' ' CE2' ' A' ' 30' ' ' PHE . 25.4 m-85 -87.26 5.87 36.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.556 -0.293 . . . . 1.0 111.164 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.468 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 42.0 t80 -87.23 127.8 35.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.435 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.468 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 63.4 m-85 -149.19 108.87 3.42 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 109.935 -0.394 . . . . 1.0 109.935 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.526 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 33.3 Cg_exo -59.54 109.82 0.63 Allowed 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 121.548 1.499 . . . . 1.0 112.828 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 66.0 m-85 -159.2 150.46 20.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.405 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -77.9 164.25 25.31 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.452 -0.573 . . . . 1.0 109.452 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' OE2' ' A' ' 19' ' ' GLU . . . -59.07 -41.68 96.63 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -67.0 -42.7 84.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.743 0.306 . . . . 1.0 111.144 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -66.3 -35.95 81.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.136 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.46 88.38 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.741 -0.384 . . . . 1.0 110.33 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -59.47 -46.42 88.83 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.638 -0.425 . . . . 1.0 109.872 179.479 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.85 -44.97 94.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.168 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -61.69 -41.48 97.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.701 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.8 mp -79.69 -12.96 59.78 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.995 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.23 -42.41 99.23 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.76 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.5 m -79.48 -20.24 47.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.847 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -80.48 173.76 12.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 1.0 110.636 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.587 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.1 pm0 -85.16 170.11 13.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.492 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -80.22 145.77 32.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.88 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.67 -0.27 57.96 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -85.89 146.87 26.53 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.537 ' CE2' ' CD1' ' A' ' 9' ' ' TYR . 51.7 p90 -131.42 164.64 25.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.295 0.569 . . . . 1.0 111.108 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 32' ' ' ILE . 69.1 t -147.3 158.19 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.422 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.472 ' N ' HG12 ' A' ' 31' ' ' VAL . 79.1 mt -116.98 123.71 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -143.38 158.44 43.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.36 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.666 ' C ' ' H ' ' A' ' 36' ' ' SER . 97.1 mt-30 -109.65 148.25 31.67 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.927 -0.397 . . . . 1.0 109.927 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 37' ' ' ARG . 7.2 m -61.17 18.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.256 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.666 ' H ' ' C ' ' A' ' 34' ' ' GLN . 1.5 m 69.21 -42.12 0.49 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.769 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 35' ' ' SER . 79.4 mtp85 -121.51 11.39 10.62 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.915 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -71.5 -66.75 2.05 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.489 -1.045 . . . . 1.0 110.489 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 67.08 -45.82 0.47 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.217 0.532 . . . . 1.0 110.914 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 38' ' ' GLY . 52.5 t0 -93.28 -4.79 51.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.802 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -146.24 149.9 34.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.542 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.91 150.85 40.45 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.991 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.9 t -124.73 132.09 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.005 -0.368 . . . . 1.0 110.005 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.682 HD12 HD11 ' A' ' 58' ' ' ILE . 56.8 mt -110.85 138.18 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.43 HG23 ' ND1' ' A' ' 55' ' ' HIS . 90.5 m -119.21 138.13 53.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.777 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.441 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 3.8 p-90 -147.15 146.75 30.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.743 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.509 ' C ' HD12 ' A' ' 48' ' ' LEU . 86.1 tttt -92.48 138.61 31.37 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.209 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.509 HD12 ' C ' ' A' ' 47' ' ' LYS . 10.0 mp -103.54 -82.71 0.49 Allowed 'General case' 0 C--N 1.339 0.129 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.123 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -94.16 -175.27 3.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.557 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -58.33 -41.09 83.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.898 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -127.32 53.63 1.72 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.021 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.5 tp -150.01 131.71 14.98 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.796 0.331 . . . . 1.0 110.413 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -132.7 148.89 52.34 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.297 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -137.17 151.16 48.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.722 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.43 ' ND1' HG23 ' A' ' 45' ' ' THR . 10.2 m-70 -127.64 141.99 51.47 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.132 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 95.5 mt -121.56 124.2 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -92.96 121.58 34.45 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.039 0.447 . . . . 1.0 110.544 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.682 HD11 HD12 ' A' ' 44' ' ' ILE . 84.0 mt -99.94 129.58 50.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.453 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -116.15 125.12 51.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 1.0 109.88 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -101.58 143.49 31.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.332 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 84.6 mt -143.78 -179.39 6.43 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.463 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 75.76 50.59 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.034 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -95.49 125.88 40.4 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.779 -0.646 . . . . 1.0 109.945 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -69.72 -21.63 63.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.692 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.624 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 4.1 m-80 -157.62 165.14 19.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.061 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.54 -33.89 80.18 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.91 1.74 . . . . 1.0 112.451 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.7 mt -93.43 -4.45 51.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.575 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.624 ' HB3' ' H ' ' A' ' 65' ' ' ASN . . . -80.33 146.88 31.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.649 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.0 mt -89.47 157.41 18.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.213 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.57 126.66 8.64 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -85.67 -11.11 54.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.089 0.471 . . . . 1.0 110.582 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.43 120.18 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.571 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.1 mt -113.77 122.3 46.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.827 -0.624 . . . . 1.0 109.43 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 70.9 mt -101.82 124.39 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.985 -0.376 . . . . 1.0 109.985 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.1 t -142.63 133.31 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.261 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 77' ' ' ASN . 97.0 m-20 51.91 48.17 23.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.978 -0.289 . . . . 1.0 111.031 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.589 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 0.1 OUTLIER 55.25 21.69 4.23 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.384 0.428 . . . . 1.0 110.981 179.157 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -127.4 139.37 52.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.196 0.522 . . . . 1.0 110.155 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -88.53 134.38 33.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.002 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -129.2 138.11 51.52 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.421 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -78.66 -37.14 42.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.772 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 16.3 t0 -136.98 160.65 38.28 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.375 0.607 . . . . 1.0 111.637 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.511 ' C ' HD12 ' A' ' 83' ' ' LEU . 3.0 pp -71.93 -36.27 69.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.447 -0.797 . . . . 1.0 111.799 178.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 2.4 p30 -58.58 -41.94 86.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.93 0.715 . . . . 1.0 112.93 -176.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.455 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 6.1 pt20 -63.81 -38.33 90.68 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.632 0.253 . . . . 1.0 110.882 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.4 mt -61.27 -46.23 97.02 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 C-N-CA 120.485 -0.486 . . . . 1.0 110.882 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -61.62 -38.87 81.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 120.966 0.412 . . . . 1.0 111.49 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 84' ' ' ASP . 30.8 t -78.31 -32.73 17.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 112.799 0.666 . . . . 1.0 112.799 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -88.7 -13.8 38.82 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.739 -0.384 . . . . 1.0 111.61 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.651 ' CZ ' ' NZ ' ' A' ' 94' ' ' LYS . 11.0 t80 -96.69 -48.66 5.41 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.786 -0.365 . . . . 1.0 111.525 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 95' ' ' VAL . 4.3 mm? -71.21 -39.78 71.54 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.023 -0.535 . . . . 1.0 112.001 -177.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -63.81 -49.05 74.41 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.791 -0.764 . . . . 1.0 111.948 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -71.24 -42.72 68.49 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.616 -0.434 . . . . 1.0 111.863 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.651 ' NZ ' ' CZ ' ' A' ' 90' ' ' TYR . 21.1 mmtp -66.34 -42.12 88.6 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.274 -0.57 . . . . 1.0 111.285 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 91' ' ' LEU . 58.6 t -65.02 -45.68 93.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.253 -0.579 . . . . 1.0 111.277 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -68.06 -44.78 75.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.483 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 tp -66.7 -40.04 88.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.294 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.1 tp -64.36 -42.53 96.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.401 -0.52 . . . . 1.0 109.935 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -67.84 -38.1 82.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.143 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -71.28 -42.28 68.92 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.845 -0.342 . . . . 1.0 111.617 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.512 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 5.0 ttt -66.46 -54.63 21.89 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.641 -0.424 . . . . 1.0 111.241 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.43 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 20.4 m -57.86 -32.54 67.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.273 0.558 . . . . 1.0 110.531 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -75.03 10.63 1.39 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.342 -0.845 . . . . 1.0 111.612 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 93.3 p -91.44 133.93 35.06 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.895 0.379 . . . . 1.0 110.489 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -60.61 -20.48 60.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.777 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.56 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 69.2 mttm -87.71 40.28 0.93 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.714 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 102' ' ' THR . 0.4 OUTLIER -132.25 116.87 17.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.387 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.465 ' NZ ' ' CE1' ' A' ' 118' ' ' PHE . 50.5 mtpt -135.99 109.72 8.08 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 178.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.1 t -91.21 88.88 7.1 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.216 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.97 160.86 12.98 Favored Glycine 0 N--CA 1.466 0.641 0 N-CA-C 110.829 -0.909 . . . . 1.0 110.829 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.586 HG22 ' N ' ' A' ' 112' ' ' LYS . 56.7 m -71.52 165.38 23.99 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.862 -0.422 . . . . 1.0 109.862 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 111' ' ' THR . 49.3 tptt -55.04 -38.54 68.11 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.56 -0.456 . . . . 1.0 110.558 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -67.35 -45.09 77.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.403 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.9 -19.85 62.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.952 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 111' ' ' THR . 23.7 t -68.82 -44.54 81.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.89 -44.62 92.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.211 0.529 . . . . 1.0 110.075 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -64.98 -36.13 83.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.915 0.388 . . . . 1.0 110.63 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.465 ' CE1' ' NZ ' ' A' ' 108' ' ' LYS . 11.1 t80 -64.64 -51.07 64.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.754 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.6 tp -69.9 -38.91 76.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.02 0.438 . . . . 1.0 110.17 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.537 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 65.1 mm-40 -64.1 -42.74 96.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.667 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.89 -48.22 82.8 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.438 -0.505 . . . . 1.0 110.24 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -60.48 -39.34 87.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.716 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.0 t -59.62 -40.99 89.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.228 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -62.17 -38.6 89.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.972 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.3 t -64.12 -43.31 97.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -130.24 74.59 80.24 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.226 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.6 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 7.7 Cg_exo -69.81 -23.6 30.38 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.894 2.396 . . . . 1.0 112.77 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -88.78 -14.38 37.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.981 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -112.59 153.96 26.75 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.144 0.497 . . . . 1.0 110.563 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.7 t -80.65 164.83 22.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.555 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 p -151.86 148.44 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -144.42 142.96 30.68 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.976 0.417 . . . . 1.0 111.213 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -151.65 167.91 26.66 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.294 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.56 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 2.1 p90 -140.53 155.28 46.67 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.2 m -155.66 171.75 19.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.343 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 51.3 tp -80.38 134.61 36.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.651 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.614 HD22 ' HB3' ' A' ' 140' ' ' ASN . 22.7 p-10 -95.8 140.51 30.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.797 0.332 . . . . 1.0 110.348 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.455 ' ND1' ' N ' ' A' ' 138' ' ' HIS . 2.1 m80 -89.1 -28.75 19.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.712 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.66 -31.01 69.15 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.276 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.614 ' HB3' HD22 ' A' ' 137' ' ' ASN . 17.7 t-20 -147.53 105.75 3.76 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.74 136.73 26.02 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.76 1.64 . . . . 1.0 112.691 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.11 -25.12 26.12 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -98.13 152.28 19.5 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.908 0.385 . . . . 1.0 110.246 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.512 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 91.5 m-85 -119.57 156.25 30.68 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.465 -0.568 . . . . 1.0 109.465 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -130.53 145.09 51.79 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.034 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.2 mt -111.06 121.74 46.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.893 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 11.7 ptp -110.43 140.93 44.19 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.686 -1.227 . . . . 1.0 107.686 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -161.47 153.35 19.4 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.384 -0.527 . . . . 1.0 109.59 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.537 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 33.8 mtpt -136.67 131.87 34.19 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.764 0.316 . . . . 1.0 110.604 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 23.7 mm -72.31 -45.13 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.355 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 8.0 m120 -157.81 170.58 22.04 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.495 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.37 -26.54 65.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.764 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -87.53 -10.24 52.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.056 0.455 . . . . 1.0 110.35 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 23.8 t -80.58 155.03 27.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.533 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.75 156.93 18.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.894 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.5 tp -69.99 115.98 9.83 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.188 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -107.38 130.32 54.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.628 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.3 m -126.29 130.11 50.2 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.809 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -112.95 156.91 22.19 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.025 -0.534 . . . . 1.0 109.786 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -106.38 146.22 30.73 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.867 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.82 137.7 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -99.1 135.42 40.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.854 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.17 130.71 44.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 81.4 p -129.27 172.35 11.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.332 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -85.64 18.07 3.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.871 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.07 -2.63 8.15 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.594 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 141.63 -129.73 4.1 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -125.25 132.29 52.98 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.815 0.341 . . . . 1.0 110.175 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -106.5 123.51 48.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.14 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.9 tt -119.02 117.89 30.0 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.36 -0.608 . . . . 1.0 109.36 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.2 t 36.02 52.02 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 111.89 0.329 . . . . 1.0 111.89 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.0 m120 71.98 26.66 2.85 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.105 0.78 . . . . 1.0 113.105 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -133.24 118.77 18.99 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.341 -0.614 . . . . 1.0 109.341 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -93.31 121.14 34.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.46 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -100.56 132.47 22.31 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -71.93 -18.96 27.49 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 C-N-CA 122.12 1.88 . . . . 1.0 113.33 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 35.4 m -153.47 157.12 39.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.966 0.412 . . . . 1.0 111.013 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.58 -33.97 62.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.957 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.4 mm -60.05 -46.64 94.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.89 -0.324 . . . . 1.0 110.548 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -68.84 -29.95 68.38 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 48.5 tp -64.81 -42.21 95.18 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.457 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.607 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 8.1 p -62.44 -47.63 83.23 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.768 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.607 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 44.6 t-20 -66.38 -46.9 75.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.974 -0.75 . . . . 1.0 108.974 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.87 -45.54 0.82 Allowed Glycine 0 C--N 1.334 0.437 0 N-CA-C 110.021 -1.232 . . . . 1.0 110.021 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -69.03 -46.83 66.94 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 183' ' ' ASN . 88.4 tttt -55.49 -40.1 71.27 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.841 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.3 m -60.95 -44.76 96.82 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.54 -40.82 98.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.826 -0.625 . . . . 1.0 109.963 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 40.9 tp -57.46 -42.25 82.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.412 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -63.12 -43.07 99.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.132 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.0 t -63.52 -39.37 94.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.394 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.83 -43.31 99.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.463 -0.79 . . . . 1.0 112.064 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -68.2 -29.37 68.21 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.815 0.302 . . . . 1.0 111.815 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -81.45 7.97 10.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.847 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.589 ' O ' ' N ' ' A' ' 197' ' ' HIS . 44.2 t-80 61.05 51.78 4.33 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.221 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.401 ' O ' ' C ' ' A' ' 197' ' ' HIS . 71.8 m-70 56.83 -70.44 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 O-C-N 123.719 0.637 . . . . 1.0 111.009 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 195' ' ' HIS . 78.2 t60 -38.2 102.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.962 0.411 . . . . 1.0 110.687 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.473 ' CD2' ' O ' ' A' ' 198' ' ' HIS . 38.6 p-80 -112.55 106.24 14.64 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.561 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.957 -1.021 . . . . 1.0 110.561 -179.893 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 29.7 p . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.44 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 53.5 t-80 -154.08 -37.63 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.592 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -109.22 -16.32 14.1 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.565 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.36 -34.85 71.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.573 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.7 pt -79.3 -14.02 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.347 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 2' ' ' HIS . 29.9 m120 -89.84 -4.72 57.45 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.471 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -81.38 138.34 48.32 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.393 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.54 -16.1 46.45 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.898 1.732 . . . . 1.0 112.272 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.502 ' CD1' ' CE2' ' A' ' 30' ' ' PHE . 96.0 m-85 -93.13 8.91 38.18 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.281 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 87.6 t80 -88.45 127.42 35.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.498 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 61.2 m-85 -149.28 126.12 5.39 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.525 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 74.1 Cg_endo -73.36 107.67 2.44 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.433 1.422 . . . . 1.0 112.853 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.525 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 43.8 m-85 -162.76 152.49 15.81 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.522 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -88.33 -176.23 5.28 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.62 -40.63 99.39 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.314 -0.946 . . . . 1.0 111.377 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.512 ' HB2' HE22 ' A' ' 17' ' ' GLN . 83.5 mtp180 -61.97 -48.17 81.55 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.894 -0.323 . . . . 1.0 111.189 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.685 ' NE2' ' N ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -69.63 -30.93 68.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.291 -179.501 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.441 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.72 -46.04 91.35 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.651 -0.42 . . . . 1.0 110.292 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE2' ' CE1' ' A' ' 53' ' ' PHE . 81.2 tt0 -65.48 -41.07 93.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.67 -0.412 . . . . 1.0 109.996 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -62.24 -43.34 99.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.083 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -62.52 -44.89 95.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.455 -0.339 . . . . 1.0 110.536 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 18' ' ' ALA . 6.8 mp -73.37 -13.32 61.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.971 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 ttp85 -59.6 -43.21 93.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.956 0.408 . . . . 1.0 110.589 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.5 t -77.46 -19.15 56.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.829 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -86.41 -174.75 5.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.47 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 55.9 mp0 -104.54 -176.67 3.14 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.672 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -81.53 146.6 30.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.804 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.85 -1.02 59.44 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.175 -0.77 . . . . 1.0 111.175 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -85.58 148.62 25.84 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.066 -0.716 . . . . 1.0 109.066 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CE2' ' CD1' ' A' ' 9' ' ' TYR . 51.9 p90 -136.26 163.12 31.13 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.363 0.602 . . . . 1.0 110.965 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.2 m -147.68 158.89 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 114.98 -1.009 . . . . 1.0 111.645 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 79.0 mt -117.79 124.73 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -143.96 157.42 44.35 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.315 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.551 ' C ' ' H ' ' A' ' 36' ' ' SER . 35.3 mt-30 -108.76 142.54 39.16 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.867 -0.419 . . . . 1.0 109.867 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 37' ' ' ARG . 28.3 m -60.46 5.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.865 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.551 ' H ' ' C ' ' A' ' 34' ' ' GLN . 0.2 OUTLIER 71.72 -47.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.451 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.401 ' H ' ' C ' ' A' ' 35' ' ' SER . 35.4 ptt180 -100.02 0.29 40.65 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.891 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -73.4 -68.42 1.59 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.425 -1.07 . . . . 1.0 110.425 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 t70 69.23 -36.36 0.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.661 0.267 . . . . 1.0 110.799 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.528 ' H ' ' C ' ' A' ' 38' ' ' GLY . 95.2 m-20 -106.66 1.64 25.28 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -148.04 148.66 30.92 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.469 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.7 152.84 37.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.916 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.92 132.99 70.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.275 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.07 139.24 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.503 HG23 ' ND1' ' A' ' 55' ' ' HIS . 85.1 m -118.95 139.38 51.76 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.551 ' CZ2' ' NZ ' ' A' ' 94' ' ' LYS . 5.7 p-90 -148.65 144.93 27.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.415 -0.811 . . . . 1.0 111.027 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' C ' HD12 ' A' ' 48' ' ' LEU . 87.3 tttt -91.58 141.22 28.95 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.807 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.3 mp -97.85 -71.99 0.66 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.42 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 50' ' ' LYS . 62.3 t0 -162.01 146.46 12.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.144 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.543 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 1.1 ttmp? 46.54 -145.93 0.2 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.948 0.404 . . . . 1.0 111.126 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -79.79 68.95 6.02 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.81 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.8 tp -149.3 126.51 11.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.848 0.356 . . . . 1.0 110.426 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CE1' ' OE2' ' A' ' 19' ' ' GLU . 64.0 m-85 -132.32 149.1 52.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.43 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -135.78 152.7 51.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.031 -0.531 . . . . 1.0 109.666 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.513 ' O ' HD12 ' A' ' 56' ' ' ILE . 25.6 m-70 -128.07 142.68 51.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.302 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.513 HD12 ' O ' ' A' ' 55' ' ' HIS . 1.4 mp -118.88 122.54 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -92.23 120.58 32.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.053 0.454 . . . . 1.0 110.804 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.1 mm -99.34 131.68 46.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.41 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -114.4 136.57 52.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.024 -0.534 . . . . 1.0 109.833 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -100.54 152.92 19.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.119 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.429 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 3.1 tt -142.97 161.19 38.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.898 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.429 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 18.4 tt0 79.51 60.64 0.02 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.142 0.496 . . . . 1.0 109.781 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -106.55 103.31 12.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.0 -0.546 . . . . 1.0 109.725 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -70.43 -34.45 72.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.75 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 68' ' ' ALA . 15.6 p30 -161.16 157.0 21.66 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.42 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.96 -28.03 22.82 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.212 1.941 . . . . 1.0 112.193 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 67' ' ' LEU . 10.9 mp -83.93 -11.45 56.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.998 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 65' ' ' ASN . . . -92.7 140.15 29.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.318 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.8 mt -90.15 158.25 17.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.284 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.89 108.8 2.64 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.678 -0.969 . . . . 1.0 110.678 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -76.18 -18.29 59.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.834 0.35 . . . . 1.0 110.782 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.1 t -116.56 122.92 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.915 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.4 mt -116.3 133.92 55.48 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.6 mt -103.06 124.98 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.864 0.364 . . . . 1.0 110.076 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.7 133.7 32.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.411 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 t70 52.23 41.92 30.52 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.827 -0.349 . . . . 1.0 111.094 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 61.26 22.84 13.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.965 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -128.48 156.75 42.74 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.177 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -102.67 130.07 49.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.05 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.493 ' CD2' HD11 ' A' ' 86' ' ' ILE . 84.7 m-85 -129.24 139.37 51.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.253 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -86.55 -37.26 18.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.816 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -109.3 134.95 51.16 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.127 0.489 . . . . 1.0 112.312 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 46.9 tp -65.49 -38.1 88.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.559 -0.746 . . . . 1.0 110.722 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 4.6 p30 -58.6 -33.65 70.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 1.0 111.875 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.45 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 89.4 mt-30 -64.51 -37.98 89.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.696 0.284 . . . . 1.0 110.658 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.493 HD11 ' CD2' ' A' ' 80' ' ' TYR . 49.0 mm -59.58 -49.48 83.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.146 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 72.2 mt -62.94 -43.61 99.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.15 -0.62 . . . . 1.0 111.414 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 84' ' ' ASP . 61.4 t -70.36 -41.14 78.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 -178.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -80.23 -15.58 56.69 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.818 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -94.02 -49.88 5.57 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.56 -0.456 . . . . 1.0 111.799 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.495 ' HA ' HD13 ' A' ' 91' ' ' LEU . 4.3 mm? -68.6 -40.06 80.62 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.463 0.542 . . . . 1.0 112.463 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -63.38 -49.28 74.44 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.67 -0.812 . . . . 1.0 111.631 -177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -65.96 -43.11 88.88 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.851 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.551 ' NZ ' ' CZ2' ' A' ' 46' ' ' TRP . 25.6 mmtp -65.93 -42.57 89.91 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.458 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 91' ' ' LEU . 56.7 t -65.58 -45.88 91.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.32 -0.552 . . . . 1.0 111.407 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -67.32 -46.56 73.14 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.598 -0.441 . . . . 1.0 111.47 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.9 tp -67.92 -40.12 83.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.627 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.39 -43.32 91.05 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.544 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -68.86 -35.63 77.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.404 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -70.61 -42.52 70.86 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.921 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 13.6 ttm -71.22 -53.04 15.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.484 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.442 HG23 ' CE2' ' A' ' 107' ' ' PHE . 9.0 m -57.11 -39.83 75.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.05 0.453 . . . . 1.0 110.222 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.7 m -71.45 9.72 0.76 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.888 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 102' ' ' THR . 8.3 t -92.74 133.23 36.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.276 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -60.82 -18.42 55.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.086 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.558 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 99.0 mttt -91.85 41.01 1.06 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.055 -0.521 . . . . 1.0 109.718 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.442 ' CE2' HG23 ' A' ' 102' ' ' THR . 82.7 t80 -134.69 118.18 16.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.285 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -138.15 114.81 10.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.074 -0.512 . . . . 1.0 109.732 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.5 p -93.44 91.84 7.34 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.062 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.83 166.63 13.02 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.844 -0.903 . . . . 1.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 115' ' ' VAL . 82.5 p -76.8 163.44 26.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -56.05 -35.55 67.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.826 0.346 . . . . 1.0 110.764 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -68.58 -43.89 75.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.145 0.498 . . . . 1.0 110.768 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -71.26 -19.26 62.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.013 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 111' ' ' THR . 38.7 t -70.74 -44.55 76.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 110.04 -0.355 . . . . 1.0 110.04 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.68 -45.57 91.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.063 0.459 . . . . 1.0 110.416 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.59 -36.9 85.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.845 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -65.1 -50.12 67.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.888 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 120' ' ' GLU . 10.8 tp -70.35 -40.01 77.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.447 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.409 ' N ' HG23 ' A' ' 119' ' ' ILE . 93.1 mt-10 -64.47 -45.06 89.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.589 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -60.54 -48.46 81.66 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.007 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.55 ' CD1' ' OD1' ' A' ' 126' ' ' ASN . 23.9 t80 -60.86 -42.06 97.11 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.646 -0.501 . . . . 1.0 109.646 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.5 t -59.93 -42.68 94.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.596 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -60.09 -39.95 87.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.356 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.92 -41.3 91.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.55 ' OD1' ' CD1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -118.95 76.42 14.59 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.31 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.526 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 37.4 Cg_endo -72.44 -21.16 23.05 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 122.398 2.065 . . . . 1.0 112.346 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -106.81 18.24 22.11 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.71 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -138.16 152.01 48.28 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.881 0.372 . . . . 1.0 110.654 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.412 ' OG ' HD21 ' A' ' 189' ' ' LEU . 4.0 t -81.74 163.19 22.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.89 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -154.19 145.43 14.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.168 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -148.49 144.34 27.3 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.784 0.326 . . . . 1.0 111.053 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -151.69 167.37 28.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.406 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.558 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -139.71 155.83 47.13 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 179.13 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.436 ' OG ' ' CZ ' ' A' ' 145' ' ' TYR . 15.0 p -152.07 169.4 22.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.405 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.1 tp -79.43 130.33 35.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.889 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -77.82 114.51 16.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.351 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -73.31 -36.14 66.2 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.591 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -65.91 -26.2 67.5 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.098 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -139.81 84.27 15.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.77 129.72 36.12 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.079 1.853 . . . . 1.0 112.346 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.94 -24.25 23.73 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.121 -0.791 . . . . 1.0 111.121 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -99.26 150.99 21.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.79 0.328 . . . . 1.0 110.263 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -123.76 160.84 26.41 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.954 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.47 ' N ' ' CD1' ' A' ' 145' ' ' TYR . 4.7 p90 -142.89 148.3 36.75 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.343 0.402 . . . . 1.0 109.929 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.9 mt -110.07 131.47 55.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.161 0.505 . . . . 1.0 110.497 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.45 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -118.85 145.32 45.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 177.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -161.93 154.47 19.86 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.479 -0.488 . . . . 1.0 109.705 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -139.77 127.31 21.62 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.514 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.443 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 3.3 mp -68.88 -44.62 81.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.091 0.404 . . . . 1.0 112.091 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 27.4 m120 -159.22 175.31 13.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.54 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.79 -31.94 73.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -84.31 -12.61 54.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.518 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.447 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 16.7 t -80.03 146.28 32.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.327 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -79.64 151.18 30.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.93 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.53 127.81 34.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.997 0.427 . . . . 1.0 110.178 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -114.63 130.84 56.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.663 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 86.4 m -126.3 129.08 48.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.838 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -116.06 154.53 29.76 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.77 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -105.19 141.67 36.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.796 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.94 132.89 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -95.41 136.17 36.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.704 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.5 tp -98.2 131.09 44.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.06 -0.518 . . . . 1.0 109.712 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 46.1 p -131.17 163.84 26.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.356 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -76.98 16.3 0.56 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.542 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 14.8 p -122.1 -1.26 9.31 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.791 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 138.43 -129.42 4.53 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.289 -1.124 . . . . 1.0 110.289 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -126.03 130.83 51.94 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.588 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 5.8 m-85 -107.99 123.04 48.06 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.3 tt -115.32 119.24 35.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.079 -0.51 . . . . 1.0 109.638 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.2 t 34.86 52.91 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 112.132 0.419 . . . . 1.0 112.132 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.2 m120 72.47 27.37 2.42 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.074 0.768 . . . . 1.0 113.074 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -135.54 120.66 18.84 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.588 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 15.6 t-20 -91.23 131.7 36.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.156 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -112.0 95.29 28.76 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 109.545 -0.539 . . . . 1.0 109.545 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.84 -20.34 6.71 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.296 1.998 . . . . 1.0 113.536 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 48.8 m -135.66 139.76 43.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.885 0.374 . . . . 1.0 111.094 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.0 p -62.78 -34.8 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.706 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.08 -44.16 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-O 120.904 0.383 . . . . 1.0 110.124 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.36 -33.83 76.75 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.99 -39.87 94.12 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.539 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 71.8 m -61.59 -48.03 82.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.598 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 186' ' ' LYS . 41.5 t30 -69.6 -48.84 58.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.872 -0.788 . . . . 1.0 108.872 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.56 -45.96 0.54 Allowed Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.788 -1.325 . . . . 1.0 109.788 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -68.01 -47.76 67.58 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.204 0.526 . . . . 1.0 109.657 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 183' ' ' ASN . 19.3 ttpp -56.6 -41.26 76.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.427 -0.806 . . . . 1.0 110.019 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 94.3 m -61.16 -45.63 93.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.84 -41.07 99.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.908 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.412 HD21 ' OG ' ' A' ' 130' ' ' SER . 57.2 tp -58.25 -43.37 87.82 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.806 -0.357 . . . . 1.0 110.719 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -58.7 -45.74 88.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.153 0.501 . . . . 1.0 110.205 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 58.5 m -62.84 -39.6 94.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.476 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.49 -39.06 93.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.592 -0.731 . . . . 1.0 112.062 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.78 -24.58 61.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.83 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -91.61 6.57 45.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.084 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.528 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 76.6 t60 50.77 22.84 1.22 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.917 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.517 ' CG ' ' O ' ' A' ' 195' ' ' HIS . 20.7 p80 40.42 -165.47 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.785 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -131.64 5.89 4.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.613 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 85.0 t60 42.77 91.82 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.865 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.102 -0.952 . . . . 1.0 110.646 179.972 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.564 ' O ' ' CG ' ' A' ' 2' ' ' HIS . 13.0 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.564 ' CG ' ' O ' ' A' ' 1' ' ' THR . 18.6 p80 44.56 15.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.607 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 1' ' ' THR . 4.1 tpt180 -160.22 11.8 0.11 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.83 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 p -69.12 -33.81 60.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.601 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.6 pt -58.19 -13.95 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.658 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -134.79 24.97 3.67 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.399 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.3 147.43 58.0 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.495 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -50.88 -34.22 44.58 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.626 1.55 . . . . 1.0 112.321 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -88.74 10.14 21.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.391 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.49 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 42.5 t80 -91.17 129.07 37.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.55 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 65.2 m-85 -149.75 132.25 8.01 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.8 113.55 3.79 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.761 1.641 . . . . 1.0 112.701 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 18' ' ' ALA . 12.0 p90 -154.18 162.0 41.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.703 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.44 ' H ' ' HB2' ' A' ' 17' ' ' GLN . 66.7 t30 -90.23 172.76 8.56 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.699 ' N ' HH12 ' A' ' 33' ' ' ARG . . . -58.31 -51.26 59.66 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.734 -0.946 . . . . 1.0 110.734 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -65.82 -39.06 90.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.676 0.274 . . . . 1.0 110.817 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.44 ' HB2' ' H ' ' A' ' 14' ' ' ASN . 88.1 mm-40 -65.59 -32.48 74.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.388 . . . . 1.0 111.289 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.558 ' HB2' ' CD1' ' A' ' 13' ' ' PHE . . . -61.15 -45.86 92.93 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.282 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.69 -40.88 92.78 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.662 -0.415 . . . . 1.0 109.99 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -63.06 -45.75 90.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.296 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -60.56 -42.37 96.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.542 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.7 mp -80.54 -13.29 59.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.893 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -61.72 -41.63 97.88 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.542 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.0 p -77.22 -17.17 58.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.903 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -82.85 177.86 8.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.664 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -95.31 178.22 5.59 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.713 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.476 ' NH2' ' OD1' ' A' ' 99' ' ' ASN . 60.5 ttp180 -76.17 144.73 40.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.053 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.12 26.16 17.14 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.312 -0.715 . . . . 1.0 111.312 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -112.13 142.03 45.09 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.121 -0.696 . . . . 1.0 109.121 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -134.08 169.62 16.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.499 0.666 . . . . 1.0 111.052 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.69 ' O ' HG23 ' A' ' 44' ' ' ILE . 15.3 m -148.41 160.21 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 114.971 -1.013 . . . . 1.0 111.812 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.0 mm -115.87 130.4 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.699 HH12 ' N ' ' A' ' 15' ' ' GLY . 69.5 ttt180 -143.36 154.22 43.51 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.107 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -115.15 138.02 51.37 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 t -82.93 126.49 32.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.861 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.6 t -62.65 -43.42 98.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.672 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.415 ' HD3' ' H ' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -73.75 -23.68 59.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.012 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -123.21 55.45 0.69 Allowed Glycine 0 N--CA 1.466 0.661 0 N-CA-C 110.611 -0.996 . . . . 1.0 110.611 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -59.14 -0.55 0.13 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.84 0.352 . . . . 1.0 110.731 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 38' ' ' GLY . 73.0 m-20 -96.38 -2.34 45.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.663 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -140.78 164.84 29.13 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.192 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.01 146.95 46.16 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.246 -0.434 . . . . 1.0 109.905 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.421 HG22 ' OD1' ' A' ' 57' ' ' ASP . 58.1 t -125.97 132.05 71.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.792 0.329 . . . . 1.0 110.271 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 31' ' ' VAL . 59.6 mt -112.94 138.95 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.6 m -117.54 138.73 51.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.225 0.536 . . . . 1.0 109.647 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.491 ' CZ2' HD11 ' A' ' 48' ' ' LEU . 3.3 p-90 -145.33 156.78 44.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.687 -0.688 . . . . 1.0 110.784 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' C ' HD12 ' A' ' 48' ' ' LEU . 25.1 ttpp -104.67 136.2 44.64 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.292 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.3 mp -97.1 -68.49 0.8 Allowed 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.048 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -106.66 -165.19 1.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.156 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.467 ' HD3' ' H ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -78.66 -17.7 55.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.674 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 68.0 t0 -139.68 48.11 1.83 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.783 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.7 tp -155.69 133.47 11.21 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.926 0.394 . . . . 1.0 110.425 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -134.1 149.77 51.12 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.59 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.507 ' OE1' HD21 ' A' ' 48' ' ' LEU . 65.1 mt-30 -139.26 154.69 48.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.825 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -127.03 142.49 51.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.212 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.51 121.34 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 109.708 -0.478 . . . . 1.0 109.708 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD1' HG22 ' A' ' 43' ' ' VAL . 95.8 m-20 -92.51 121.7 34.22 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.976 0.417 . . . . 1.0 110.615 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.2 mt -104.04 127.6 58.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.244 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -118.58 133.4 55.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.987 0.422 . . . . 1.0 109.92 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 40' ' ' ASP . 1.4 mp0 -99.97 144.63 28.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.015 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 70' ' ' GLY . 81.4 mt -146.4 167.24 24.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.627 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 17.4 tp10 81.04 17.28 0.52 Allowed 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.47 0.481 . . . . 1.0 109.89 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -54.97 116.72 2.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.194 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -73.27 -23.72 60.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.713 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -157.71 153.95 23.88 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.115 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -58.74 -26.54 80.27 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.29 1.993 . . . . 1.0 112.134 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.6 mt -98.17 -1.87 41.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.464 -0.334 . . . . 1.0 110.607 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.93 160.26 14.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.949 0.404 . . . . 1.0 110.335 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.6 mt -72.75 160.66 31.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.387 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 71' ' ' LYS . . . -60.89 -33.35 83.12 Favored Glycine 0 C--O 1.224 -0.499 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 70' ' ' GLY . 41.1 tttm 84.73 -31.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.061 0.457 . . . . 1.0 110.654 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.44 123.88 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.563 -0.744 . . . . 1.0 110.702 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.2 mt -112.82 122.85 48.88 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.476 -0.565 . . . . 1.0 109.476 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.5 mt -101.24 123.11 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.826 0.346 . . . . 1.0 110.219 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.12 130.48 29.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.233 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 165' ' ' ASN . 42.1 t0 53.66 45.35 28.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 1.0 111.116 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.9 m120 58.1 23.23 9.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.908 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -128.12 139.28 52.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.931 0.396 . . . . 1.0 110.252 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -89.62 133.37 34.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.976 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -123.96 138.57 54.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.333 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -85.4 -36.64 20.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.566 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -127.25 150.34 49.59 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.207 0.527 . . . . 1.0 111.857 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.7 tp -63.52 -39.2 93.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.671 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -58.18 -44.27 87.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.757 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -58.9 -37.87 77.6 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 110.34 -0.245 . . . . 1.0 110.34 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.408 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 96.9 mt -63.1 -45.86 97.57 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 C-N-CA 120.428 -0.509 . . . . 1.0 111.008 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.6 mt -68.1 -44.24 84.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 120.526 -0.47 . . . . 1.0 111.585 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.7 t -77.8 -36.21 22.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 113.029 0.752 . . . . 1.0 113.029 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -84.78 -12.89 52.74 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.886 -0.325 . . . . 1.0 111.743 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 23.1 t80 -98.2 -48.22 5.17 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.564 -0.455 . . . . 1.0 111.727 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.443 ' HA ' HD13 ' A' ' 91' ' ' LEU . 4.5 mm? -69.16 -40.15 78.35 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.316 0.487 . . . . 1.0 112.316 -177.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -62.73 -48.81 77.59 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.852 -0.739 . . . . 1.0 111.478 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -66.91 -42.47 85.35 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.599 -0.44 . . . . 1.0 111.814 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -65.51 -43.65 89.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.097 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 91' ' ' LEU . 76.1 t -65.31 -44.33 94.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.405 -0.518 . . . . 1.0 111.018 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -68.0 -47.29 68.93 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.594 -0.442 . . . . 1.0 111.621 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.551 HD21 ' CZ ' ' A' ' 168' ' ' TYR . 3.7 tp -68.05 -39.78 82.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.248 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.07 -43.13 96.37 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.314 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.476 ' OD1' ' NH2' ' A' ' 27' ' ' ARG . 94.3 m-20 -66.94 -37.71 84.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.035 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -71.01 -42.01 70.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.755 -0.378 . . . . 1.0 111.748 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.5 ttt -66.12 -54.98 18.88 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.494 -0.482 . . . . 1.0 111.458 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 84.0 m -59.15 -40.64 86.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.043 0.449 . . . . 1.0 110.33 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.1 t -73.1 10.19 1.01 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.056 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.0 t -91.53 138.43 31.58 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.754 0.311 . . . . 1.0 110.256 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.75 -16.92 59.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.169 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.561 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 57.4 mmtt -93.87 38.57 1.07 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.056 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -133.08 116.76 16.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.045 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.497 ' NZ ' ' CE1' ' A' ' 118' ' ' PHE . 48.6 mtpt -133.2 128.83 36.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.951 -0.568 . . . . 1.0 109.901 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.4 p -96.64 77.66 2.9 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.912 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -111.29 151.8 17.72 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.946 -0.861 . . . . 1.0 110.946 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 115' ' ' VAL . 58.1 p -73.5 168.29 19.58 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -55.46 -36.49 66.64 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.876 -0.33 . . . . 1.0 110.813 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -68.18 -44.18 76.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.625 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.53 -20.83 63.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.878 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 111' ' ' THR . 53.1 t -70.54 -44.95 76.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.746 -0.382 . . . . 1.0 110.186 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.8 t -64.31 -46.71 92.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-O 121.057 0.456 . . . . 1.0 110.334 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -65.86 -34.84 79.06 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.957 0.408 . . . . 1.0 110.821 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.497 ' CE1' ' NZ ' ' A' ' 108' ' ' LYS . 25.0 t80 -66.73 -50.11 63.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.914 -0.584 . . . . 1.0 111.667 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.434 HD11 HG13 ' A' ' 131' ' ' VAL . 11.2 tp -70.31 -39.86 77.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.96 0.41 . . . . 1.0 110.35 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -65.1 -40.06 94.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.646 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -63.61 -47.85 79.73 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.504 -0.478 . . . . 1.0 110.291 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -61.89 -41.77 98.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.012 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 90.6 p -64.53 -34.89 79.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.221 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -63.56 -41.21 98.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.166 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.3 t -67.18 -42.06 87.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.766 -0.457 . . . . 1.0 109.766 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -124.83 75.62 65.51 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.351 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.3 -13.71 30.9 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.676 2.251 . . . . 1.0 112.345 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -103.79 13.7 32.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.622 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -134.88 149.84 50.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.052 0.453 . . . . 1.0 110.576 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.5 p -80.58 161.78 24.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.803 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.434 HG13 HD11 ' A' ' 119' ' ' ILE . 3.2 p -153.32 148.13 13.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -148.05 142.84 26.73 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.887 0.375 . . . . 1.0 111.2 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -152.1 166.48 31.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.438 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.561 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.2 p90 -140.06 157.27 45.91 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 30.9 p -150.6 168.3 24.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.799 0.333 . . . . 1.0 110.237 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.3 tp -81.7 131.25 35.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.118 -0.492 . . . . 1.0 111.015 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -79.94 111.86 16.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.409 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.46 -45.19 69.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.899 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.84 -20.39 65.04 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.195 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -141.79 82.65 13.62 Favored Pre-proline 0 N--CA 1.463 0.193 0 N-CA-C 110.018 -0.364 . . . . 1.0 110.018 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.51 137.75 51.92 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.815 1.677 . . . . 1.0 112.5 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.5 -17.34 53.6 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -109.58 145.42 36.4 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.891 0.377 . . . . 1.0 109.989 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -120.51 159.79 24.47 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 115.992 -0.549 . . . . 1.0 109.806 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 145' ' ' TYR . 4.3 p90 -142.63 148.01 36.73 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 123.382 0.426 . . . . 1.0 110.017 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.02 132.52 54.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.129 0.49 . . . . 1.0 110.46 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.507 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -121.65 146.89 46.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 178.109 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -160.89 155.17 23.09 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -140.26 129.06 23.18 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.69 -0.404 . . . . 1.0 110.502 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.484 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.5 mp -72.62 -48.71 45.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.217 0.451 . . . . 1.0 112.217 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 150' ' ' ILE . 86.5 m-20 -153.35 170.31 20.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.474 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.49 -31.08 71.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.943 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -84.7 -11.48 55.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.42 . . . . 1.0 110.525 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.43 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 29.5 t -80.1 155.45 27.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.351 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -86.86 147.96 25.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.893 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.0 tp -70.7 128.72 37.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.923 0.392 . . . . 1.0 110.223 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -117.62 129.5 55.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.628 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 71.9 m -130.71 129.55 42.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.937 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -116.07 167.24 11.16 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.828 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -109.79 144.08 38.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.958 -0.565 . . . . 1.0 111.051 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 63.6 t -122.24 134.71 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -100.27 132.12 45.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.382 . . . . 1.0 110.792 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 57.0 tp -92.21 130.81 37.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.715 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 41.5 p -128.04 168.14 15.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.479 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.409 ' OD1' ' OD2' ' A' ' 76' ' ' ASP . 21.9 m120 -82.58 14.24 3.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.598 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 57.2 p -122.01 -2.55 9.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.707 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 143.14 -133.34 5.43 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.228 -1.149 . . . . 1.0 110.228 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.551 ' CZ ' HD21 ' A' ' 97' ' ' LEU . 91.1 m-85 -122.87 128.42 50.31 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.61 0.243 . . . . 1.0 110.448 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -103.13 123.07 45.98 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.4 tt -119.87 115.11 23.15 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.3 t 35.42 56.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.432 0.53 . . . . 1.0 112.432 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.5 m120 71.7 27.68 2.86 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.164 0.801 . . . . 1.0 113.164 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -135.54 120.11 18.19 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -94.56 119.2 32.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.411 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -99.01 133.62 22.05 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.24 -16.36 25.04 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.127 1.885 . . . . 1.0 113.604 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.1 p -154.25 158.22 39.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.946 0.403 . . . . 1.0 110.912 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 179' ' ' ILE . 12.5 p -63.29 -40.18 88.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.739 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.499 ' H ' HD12 ' A' ' 179' ' ' ILE . 3.7 mp -59.87 -47.09 92.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.806 0.336 . . . . 1.0 110.42 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -62.61 -35.7 80.38 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.58 -40.61 97.4 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.136 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 96.0 m -60.04 -45.57 92.38 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.54 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 186' ' ' LYS . 32.8 t30 -69.92 -49.4 52.41 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 119.692 -0.803 . . . . 1.0 108.869 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.05 -44.38 0.51 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.815 -1.314 . . . . 1.0 109.815 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -68.72 -47.4 66.46 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.084 -0.558 . . . . 1.0 109.586 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 183' ' ' ASN . 64.1 tttp -56.9 -41.83 78.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.816 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 16.9 m -61.03 -45.5 94.54 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 24.5 mt -62.19 -40.91 97.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.813 -0.631 . . . . 1.0 109.93 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.26 -44.04 92.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.461 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -59.47 -40.57 87.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.229 0.538 . . . . 1.0 110.056 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.4 t -67.18 -39.64 86.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.252 0.548 . . . . 1.0 110.791 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 25.2 mt -63.59 -44.54 93.75 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.603 -0.726 . . . . 1.0 112.261 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.8 -27.37 68.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.422 -0.354 . . . . 1.0 111.647 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 196' ' ' HIS . 0.8 OUTLIER -81.6 7.35 12.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.759 -179.126 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.523 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 53.4 t-80 44.32 24.99 0.1 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.979 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.459 ' ND1' ' O ' ' A' ' 195' ' ' HIS . 6.4 m-70 -132.01 158.62 41.02 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.348 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -109.16 149.63 29.07 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.292 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -70.92 99.85 1.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.767 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 14.1 m80 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.946 -1.026 . . . . 1.0 110.65 -179.988 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 38.8 p . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.433 -0.58 . . . . 1.0 109.433 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -90.09 3.27 53.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.615 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 7' ' ' HIS . 36.3 mmt180 -124.4 2.81 8.42 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.556 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 5' ' ' ILE . 14.7 p -64.26 -42.8 96.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.573 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.508 ' N ' HG13 ' A' ' 4' ' ' VAL . 38.2 pt -75.54 -25.06 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.365 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -99.44 -0.7 40.29 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.302 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 3' ' ' ARG . 1.3 t60 -54.41 140.17 56.23 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.226 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.61 -15.86 48.89 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.919 1.746 . . . . 1.0 112.152 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -93.77 -5.43 48.3 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.627 -0.261 . . . . 1.0 111.151 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 44.0 t80 -71.12 126.66 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.532 -0.303 . . . . 1.0 110.608 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 52.2 m-85 -146.36 122.21 5.63 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 110.184 -0.302 . . . . 1.0 110.184 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.59 109.76 2.92 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.887 1.725 . . . . 1.0 112.492 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -157.14 156.06 32.06 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.631 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.428 ' CG ' ' N ' ' A' ' 15' ' ' GLY . 45.2 t30 -77.07 173.49 11.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.428 ' N ' ' CG ' ' A' ' 14' ' ' ASN . . . -61.42 -46.33 94.6 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.298 -0.954 . . . . 1.0 111.032 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -67.55 -37.79 83.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.899 0.38 . . . . 1.0 110.877 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -67.41 -33.04 74.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.418 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.585 ' CB ' ' NH1' ' A' ' 33' ' ' ARG . . . -61.23 -43.12 99.38 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.482 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -61.55 -41.75 97.82 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.694 -0.402 . . . . 1.0 109.963 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.1 -39.97 91.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.106 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -63.79 -40.6 97.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.525 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.6 -13.55 59.88 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.927 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -58.09 -43.28 86.97 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.367 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 m -78.53 -17.99 55.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.72 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -84.75 -175.89 5.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.354 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.562 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.3 pm0 -112.61 -172.86 2.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.59 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -79.15 146.38 33.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.789 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.55 23.57 25.91 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.274 -0.73 . . . . 1.0 111.274 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -112.66 145.17 40.9 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.445 ' CD1' HD21 ' A' ' 91' ' ' LEU . 11.9 p90 -133.51 160.38 37.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.214 0.531 . . . . 1.0 110.919 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 44' ' ' ILE . 88.1 t -146.34 155.39 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.255 -0.884 . . . . 1.0 111.459 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.431 ' N ' HG12 ' A' ' 31' ' ' VAL . 4.0 mp -118.87 123.39 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.004 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.585 ' NH1' ' CB ' ' A' ' 18' ' ' ALA . 18.6 ptt-85 -140.5 167.11 22.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.343 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 36' ' ' SER . 94.2 mt-30 -112.41 132.17 55.17 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.037 -0.357 . . . . 1.0 110.037 178.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.491 ' C ' ' H ' ' A' ' 37' ' ' ARG . 61.7 m -56.65 80.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.657 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 34' ' ' GLN . 0.2 OUTLIER 69.83 -42.2 0.5 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.319 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.674 ' O ' ' N ' ' A' ' 39' ' ' ASP . 82.1 mtp180 -150.4 -20.9 0.24 Allowed 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.251 -0.431 . . . . 1.0 111.218 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.614 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . 60.41 -53.76 0.02 OUTLIER Glycine 0 C--O 1.221 -0.697 0 N-CA-C 110.45 -1.06 . . . . 1.0 110.45 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.674 ' N ' ' O ' ' A' ' 37' ' ' ARG . 66.7 t0 55.34 -73.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.082 0.467 . . . . 1.0 110.004 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.614 ' N ' ' O ' ' A' ' 38' ' ' GLY . 23.5 p-10 -124.89 19.06 8.53 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.039 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.488 ' ND1' ' OE1' ' A' ' 59' ' ' GLN . 88.6 m-70 -147.61 152.25 37.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.368 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mp -133.28 147.82 51.92 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.273 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.6 t -126.19 132.96 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.242 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 31' ' ' VAL . 60.2 mt -113.69 139.66 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.585 ' OG1' ' NH1' ' A' ' 33' ' ' ARG . 29.2 m -122.53 143.31 49.8 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.694 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.547 ' NE1' ' CG ' ' A' ' 54' ' ' GLN . 5.8 p-90 -152.46 151.13 30.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.47 -0.786 . . . . 1.0 111.047 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.506 ' C ' HD12 ' A' ' 48' ' ' LEU . 88.8 tttt -91.13 139.15 31.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.99 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.75 ' N ' HD12 ' A' ' 48' ' ' LEU . 6.4 mp -95.67 -59.18 1.92 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.287 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -151.5 -174.34 4.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.338 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -54.88 128.36 32.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.815 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 56.04 39.83 30.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.129 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -144.63 120.38 10.53 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.844 0.354 . . . . 1.0 110.283 179.414 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.607 ' N ' HD13 ' A' ' 52' ' ' LEU . 60.7 m-85 -135.23 149.03 49.79 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.631 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.684 HE22 HG13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -141.96 156.09 45.47 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.707 179.353 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -129.39 145.34 51.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.956 -0.566 . . . . 1.0 110.63 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.684 HG13 HE22 ' A' ' 54' ' ' GLN . 41.9 mt -125.39 130.96 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 43.8 p-10 -99.61 122.59 42.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.879 0.371 . . . . 1.0 110.489 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.417 HD11 HD12 ' A' ' 44' ' ' ILE . 78.0 mt -102.32 130.67 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.489 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.488 ' OE1' ' ND1' ' A' ' 41' ' ' HIS . 55.5 mm-40 -113.94 126.66 55.4 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -102.1 155.63 18.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.492 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.462 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 2.0 tp -145.19 170.67 15.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.818 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.462 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 20.6 tp10 79.77 53.07 0.02 OUTLIER 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 109.674 -0.491 . . . . 1.0 109.674 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -91.36 90.52 7.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.875 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.565 ' OE1' ' ND2' ' A' ' 65' ' ' ASN . 3.4 tm-20 -67.13 -34.54 77.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.908 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.565 ' ND2' ' OE1' ' A' ' 64' ' ' GLU . 56.9 m-80 -145.63 152.81 50.0 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.244 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.64 -33.35 48.51 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.314 2.009 . . . . 1.0 112.061 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.0 mt -86.9 -9.56 55.41 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.863 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.26 134.36 51.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.271 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.8 mt -85.36 152.55 23.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.351 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.59 96.63 0.02 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.721 -0.951 . . . . 1.0 110.721 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -68.43 -43.69 76.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.153 0.501 . . . . 1.0 110.639 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.2 t -111.05 121.83 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.602 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.2 mt -116.04 130.58 56.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.455 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 66.5 mt -108.04 128.39 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 109.869 -0.419 . . . . 1.0 109.869 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.2 t -145.94 134.01 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.36 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.533 ' OD2' ' ND2' ' A' ' 165' ' ' ASN . 32.7 t70 52.96 44.52 30.32 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.208 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 57.06 25.35 10.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.8 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -128.55 147.8 50.72 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.123 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -101.16 130.36 47.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.854 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -124.59 138.84 54.29 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.165 -0.471 . . . . 1.0 109.916 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -85.29 -38.33 18.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.639 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 57.2 t0 -117.11 144.1 45.06 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.076 0.465 . . . . 1.0 111.728 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.496 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 12.3 tp -64.89 -38.44 90.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.619 -0.719 . . . . 1.0 110.551 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.0 -45.06 87.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.96 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -58.39 -38.9 78.29 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.66 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.81 -46.38 96.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.827 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.1 mm -64.27 -43.49 97.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.487 -0.485 . . . . 1.0 111.362 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.05 -43.35 88.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.093 -0.503 . . . . 1.0 112.21 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -71.95 -14.77 62.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.943 0.401 . . . . 1.0 111.267 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -91.94 -50.26 5.81 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.339 -0.544 . . . . 1.0 111.777 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.52 ' O ' HG23 ' A' ' 95' ' ' VAL . 11.0 mp -66.97 -41.51 86.73 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.329 0.492 . . . . 1.0 112.329 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -63.58 -49.9 71.57 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.65 -0.82 . . . . 1.0 111.524 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -70.39 -43.11 70.74 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.465 -0.494 . . . . 1.0 111.961 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -65.85 -42.03 90.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.184 -0.606 . . . . 1.0 111.407 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 91' ' ' LEU . 75.5 t -65.57 -46.08 90.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.185 -0.606 . . . . 1.0 111.395 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -69.42 -44.84 70.55 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.436 -0.506 . . . . 1.0 111.415 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.1 tp -66.02 -42.58 89.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.484 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.6 tp -65.08 -40.27 94.39 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.389 -0.524 . . . . 1.0 110.4 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -67.93 -38.82 83.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.839 -0.618 . . . . 1.0 111.261 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -70.4 -39.97 74.16 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 120.628 -0.429 . . . . 1.0 111.71 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.602 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 2.9 ttt -69.33 -56.27 8.0 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.438 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.417 ' C ' ' H ' ' A' ' 104' ' ' SER . 17.0 m -58.39 -41.45 84.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.085 0.469 . . . . 1.0 110.599 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.8 m -71.64 10.82 0.58 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.625 -0.716 . . . . 1.0 111.276 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 101' ' ' MET . 65.0 p -94.38 133.76 37.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.788 0.327 . . . . 1.0 110.436 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.3 -20.55 55.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.812 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.556 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -89.29 40.57 0.99 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.136 -0.483 . . . . 1.0 109.881 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -132.2 114.34 14.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.065 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -139.33 113.12 8.54 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 116.088 -0.505 . . . . 1.0 109.868 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 t -97.41 89.89 4.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.993 0.425 . . . . 1.0 110.876 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -112.45 168.98 12.84 Favored Glycine 0 N--CA 1.467 0.731 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.662 ' O ' HG23 ' A' ' 115' ' ' VAL . 12.8 m -71.86 162.03 30.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.464 ' N ' HG22 ' A' ' 111' ' ' THR . 64.5 tttp -57.02 -37.88 72.35 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.591 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -69.87 -45.22 68.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.164 0.507 . . . . 1.0 110.801 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -68.1 -21.67 64.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.648 -0.706 . . . . 1.0 110.906 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 111' ' ' THR . 41.6 t -69.82 -44.38 79.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.172 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.65 -44.81 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.032 0.444 . . . . 1.0 110.279 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -65.89 -34.26 77.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.902 0.382 . . . . 1.0 110.698 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.4 -50.68 62.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.849 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 120' ' ' GLU . 1.6 tt -70.88 -39.97 75.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.445 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.519 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 58.7 mm-40 -59.98 -41.81 92.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.359 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.58 -46.95 83.49 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.24 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -60.73 -45.84 92.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.066 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.3 t -61.58 -38.15 86.47 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.492 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -61.64 -40.05 93.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.034 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.67 -41.93 94.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.48 78.83 71.72 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.209 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -67.9 -20.22 45.46 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.967 2.444 . . . . 1.0 112.339 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -97.19 -6.86 33.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.998 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -113.92 148.04 37.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.871 0.367 . . . . 1.0 110.637 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.6 p -80.16 164.83 23.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.592 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 p -152.71 146.09 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -144.35 142.34 30.31 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.752 0.31 . . . . 1.0 111.14 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -152.54 164.54 37.42 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.51 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.556 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.5 OUTLIER -133.72 157.05 46.82 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.1 t -152.59 167.72 27.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.889 0.376 . . . . 1.0 110.223 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.677 HD23 ' N ' ' A' ' 137' ' ' ASN . 1.0 OUTLIER -84.05 136.19 34.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.827 179.503 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.677 ' N ' HD23 ' A' ' 136' ' ' LEU . 9.3 t-20 -60.19 -136.18 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.422 -0.353 . . . . 1.0 110.339 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.504 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 32.2 m80 -158.01 -61.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.657 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 139' ' ' ASP . 15.7 p-10 -90.29 1.58 56.38 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.937 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -116.4 90.53 30.36 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.459 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.42 104.55 1.59 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.081 1.854 . . . . 1.0 112.216 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.48 36.55 2.82 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.409 -1.076 . . . . 1.0 110.409 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -138.21 147.88 44.21 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.525 0.202 . . . . 1.0 110.552 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.602 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 69.5 m-85 -130.86 148.58 52.64 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.719 -0.475 . . . . 1.0 109.719 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.485 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 31.2 m-85 -124.41 136.82 54.36 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.051 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 16.3 mt -107.31 123.69 48.7 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.291 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -116.76 146.35 42.88 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.977 -1.119 . . . . 1.0 107.977 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -161.86 152.03 17.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.519 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 67.2 tttt -136.34 126.73 26.68 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 120.801 -0.359 . . . . 1.0 110.567 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.44 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.4 mp -69.59 -47.96 68.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -157.48 174.55 15.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.48 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.92 75.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.88 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -85.33 6.88 24.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.039 0.447 . . . . 1.0 110.313 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.6 t -98.31 152.58 19.28 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.416 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.477 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 99.4 mttt -86.2 153.54 21.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.996 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 22.0 tp -69.95 125.9 28.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.407 . . . . 1.0 110.022 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 95.2 m-85 -115.9 127.29 54.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.703 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 94.3 m -126.45 130.81 51.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.823 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -115.63 160.65 19.75 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.054 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.485 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 84.7 m-20 -108.07 145.35 34.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.834 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.8 t -127.52 135.61 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -99.92 131.85 45.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.033 0.444 . . . . 1.0 110.61 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 54.5 tp -92.03 131.04 37.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 1.0 109.868 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 56.0 p -133.6 166.8 21.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.344 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.533 ' ND2' ' OD2' ' A' ' 76' ' ' ASP . 19.6 p30 -78.2 16.29 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.722 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 62.1 p -119.57 -1.23 10.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.425 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 133.93 -125.8 4.03 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.251 -1.14 . . . . 1.0 110.251 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -122.78 129.66 51.99 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.242 -0.281 . . . . 1.0 110.242 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.98 118.1 35.79 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 tt -115.43 118.05 32.1 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.2 t 37.44 54.0 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.007 0.373 . . . . 1.0 112.007 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.8 m120 69.76 27.26 4.67 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.894 0.701 . . . . 1.0 112.894 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -131.96 120.38 22.41 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -94.84 120.68 35.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.364 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -98.09 135.37 21.41 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.438 -0.578 . . . . 1.0 109.438 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.26 -19.12 29.68 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.279 1.986 . . . . 1.0 113.55 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.427 ' OG ' ' OE1' ' A' ' 180' ' ' GLN . 19.4 p -150.1 153.78 36.98 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.968 0.413 . . . . 1.0 110.85 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.42 -36.27 75.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.696 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.475 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 48.5 mm -62.6 -47.63 92.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.946 0.403 . . . . 1.0 110.357 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.427 ' OE1' ' OG ' ' A' ' 177' ' ' SER . 6.0 mp0 -61.56 -30.75 70.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.8 tp -64.25 -40.46 96.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.272 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.619 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 2.6 p -60.27 -47.54 85.57 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.519 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.619 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 51.3 t30 -69.64 -49.01 57.87 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.2 -45.26 0.44 Allowed Glycine 0 N--CA 1.465 0.581 0 N-CA-C 109.876 -1.29 . . . . 1.0 109.876 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -67.67 -47.88 68.22 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.1 tttm -56.45 -40.33 74.63 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.54 -0.755 . . . . 1.0 110.1 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 97.9 m -61.04 -45.28 95.44 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.33 -39.71 95.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.872 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 59.7 tp -58.73 -44.55 90.47 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.619 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -59.8 -46.17 90.04 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.737 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.5 t -63.08 -39.9 96.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.197 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.49 -43.08 95.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.64 . . . . 1.0 111.963 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.49 -29.94 67.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.465 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -94.92 -7.52 39.78 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.886 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.414 ' O ' ' C ' ' A' ' 196' ' ' HIS . 86.4 m-70 47.2 56.86 6.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.123 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 195' ' ' HIS . 61.5 t-80 -35.91 -51.23 0.7 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.984 0.421 . . . . 1.0 110.718 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -158.28 -178.56 7.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.644 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -43.96 110.83 0.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 70.9 m80 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.055 -0.974 . . . . 1.0 110.728 179.701 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.462 ' O ' ' CG ' ' A' ' 2' ' ' HIS . 52.2 t-80 -84.31 -1.16 54.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.59 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -140.1 12.18 2.41 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.338 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.6 -27.39 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.574 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.4 pt -75.49 -22.06 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.484 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -106.32 5.98 30.13 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.961 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -58.93 150.91 58.01 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 38.2 Cg_endo -65.23 -19.88 62.47 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.171 1.914 . . . . 1.0 112.029 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.4 3.23 54.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.608 -0.269 . . . . 1.0 110.99 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -88.97 125.75 35.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.528 -0.306 . . . . 1.0 110.477 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.421 ' CZ ' ' O ' ' A' ' 8' ' ' PRO . 71.1 m-85 -143.17 128.69 10.07 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 110.186 -0.301 . . . . 1.0 110.186 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.489 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 74.0 Cg_endo -73.3 110.01 2.96 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.758 1.638 . . . . 1.0 112.766 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.489 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 52.4 m-85 -160.98 152.29 19.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.361 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 20.9 t-20 -75.84 165.09 25.52 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.464 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . -57.11 -43.41 93.36 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.461 -0.875 . . . . 1.0 110.937 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 48.6 mmm-85 -67.44 -37.65 83.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.864 0.364 . . . . 1.0 110.596 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -73.57 -32.57 64.22 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.62 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.56 -47.45 85.49 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.417 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -65.89 -36.85 84.56 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.43 ' O ' ' CG ' ' A' ' 23' ' ' ARG . 97.4 m-20 -63.33 -42.76 98.99 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -66.25 -36.55 83.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.715 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 22' ' ' LEU . 10.5 tp -82.12 -11.84 58.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.101 -0.499 . . . . 1.0 111.381 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.43 ' CG ' ' O ' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -65.15 -28.57 69.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.826 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.2 t -83.56 -19.94 34.72 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.714 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -84.93 -178.15 6.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.428 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -88.69 167.9 12.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.799 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -74.72 145.15 43.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.808 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.77 4.95 56.8 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.872 -0.891 . . . . 1.0 110.872 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -88.98 148.3 23.85 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -128.31 165.03 21.33 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.219 0.533 . . . . 1.0 111.027 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.757 ' O ' HG23 ' A' ' 44' ' ' ILE . 3.6 t -145.51 155.03 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.309 -0.86 . . . . 1.0 110.894 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -117.5 122.22 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.541 ' NH1' ' OG ' ' A' ' 35' ' ' SER . 32.8 ptt85 -148.66 158.76 44.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.297 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -107.55 137.08 46.23 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.541 ' OG ' ' NH1' ' A' ' 33' ' ' ARG . 2.9 p 169.16 97.74 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.539 0.524 . . . . 1.0 111.073 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.4 p -169.16 30.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.242 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? 53.15 20.26 1.74 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.233 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.676 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -150.1 89.95 0.14 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.677 -0.969 . . . . 1.0 110.677 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -57.18 11.91 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.225 -0.488 . . . . 1.0 111.142 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.676 ' H ' ' C ' ' A' ' 38' ' ' GLY . 32.0 p-10 -107.76 -0.44 21.72 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -129.59 155.47 45.76 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.783 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.41 150.28 40.46 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.006 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.7 t -126.21 133.29 69.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.109 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 31' ' ' VAL . 61.5 mt -112.53 138.44 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.749 -0.834 . . . . 1.0 108.749 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 87.6 m -116.5 135.37 53.88 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.04 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.598 ' CE2' HD11 ' A' ' 48' ' ' LEU . 1.8 p-90 -146.0 151.75 38.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.934 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.458 ' C ' HD12 ' A' ' 48' ' ' LEU . 35.2 ttmt -98.26 138.03 36.12 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.946 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.598 HD11 ' CE2' ' A' ' 46' ' ' TRP . 9.2 mp -95.82 -73.25 0.6 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.046 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 23.4 t70 -103.07 -170.77 1.84 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.497 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.5 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 7.8 ttpm? -63.17 -38.66 92.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.616 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -127.21 61.25 1.37 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.873 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.8 tp -157.47 130.25 7.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.421 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.545 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 96.0 m-85 -128.3 148.66 50.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.662 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 53' ' ' PHE . 75.6 mm-40 -143.09 152.37 41.77 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.016 -0.538 . . . . 1.0 109.75 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.51 ' HD1' ' C ' ' A' ' 54' ' ' GLN . 3.7 m-70 -126.36 141.2 51.99 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.288 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.07 123.14 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.291 -0.413 . . . . 1.0 109.931 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -95.67 121.94 37.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.538 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.9 mt -102.47 124.02 56.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.441 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -107.56 136.16 47.8 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -103.34 151.71 22.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.034 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.0 mt -139.81 171.33 14.37 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.493 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 77.66 45.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.246 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.76 77.38 2.84 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.917 -0.583 . . . . 1.0 109.927 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -65.21 -35.84 82.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.585 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -131.09 150.38 76.4 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.01 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.32 -20.39 66.54 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.235 1.957 . . . . 1.0 112.082 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.61 -4.4 50.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.711 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.26 129.79 54.23 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.947 0.403 . . . . 1.0 110.308 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.8 mt -81.21 153.35 27.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.515 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.06 114.0 6.41 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.526 -1.03 . . . . 1.0 110.526 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.98 -10.65 59.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.876 0.37 . . . . 1.0 110.799 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.7 t -117.87 118.83 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.43 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.5 mt -114.76 128.79 56.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.388 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -100.28 120.26 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.883 0.373 . . . . 1.0 110.539 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.555 HG21 HD13 ' A' ' 86' ' ' ILE . 40.9 t -140.65 133.08 31.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.393 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 55.43 43.99 27.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.11 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.3 t30 58.47 21.76 8.84 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.02 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -128.86 152.27 48.7 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.336 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -100.09 131.64 45.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 1.0 111.041 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -128.81 136.8 50.99 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.204 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -85.5 -37.44 19.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.591 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -112.29 141.2 46.3 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.971 0.415 . . . . 1.0 111.575 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.9 -40.44 95.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.726 -0.67 . . . . 1.0 111.173 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 42.9 p30 -59.89 -33.66 72.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 1.0 111.64 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.561 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 87.5 mt-30 -65.92 -39.14 90.29 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.799 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.555 HD13 HG21 ' A' ' 75' ' ' VAL . 97.1 mt -62.65 -45.72 98.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.716 -0.394 . . . . 1.0 110.778 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.6 mm -65.12 -44.01 95.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.422 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.453 ' O ' ' CG ' ' A' ' 92' ' ' GLN . 98.1 t -69.36 -44.6 80.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 112.433 0.531 . . . . 1.0 112.433 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -76.95 -13.05 60.02 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.288 -0.565 . . . . 1.0 111.692 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.472 ' OH ' ' CZ2' ' A' ' 46' ' ' TRP . 63.0 t80 -93.85 -48.6 6.21 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.977 0.362 . . . . 1.0 111.977 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.89 -42.45 76.92 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.425 0.528 . . . . 1.0 112.425 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.493 ' CD ' ' N ' ' A' ' 93' ' ' ASN . 1.5 pp0? -63.84 -47.46 80.65 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.025 -0.67 . . . . 1.0 111.526 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.493 ' N ' ' CD ' ' A' ' 92' ' ' GLN . 2.7 t30 -69.27 -42.81 75.05 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.685 -0.406 . . . . 1.0 111.509 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -65.68 -42.86 90.75 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.296 -0.562 . . . . 1.0 111.018 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.7 t -66.04 -46.46 87.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.12 -0.632 . . . . 1.0 111.137 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.497 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 82.6 mtp180 -67.08 -45.54 77.01 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.272 -0.571 . . . . 1.0 111.842 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.456 HD11 ' CZ ' ' A' ' 168' ' ' TYR . 7.1 tp -69.57 -41.43 75.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.534 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.47 -45.72 86.18 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.43 -0.508 . . . . 1.0 110.674 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -69.11 -35.03 76.0 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.439 -0.504 . . . . 1.0 111.161 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -71.72 -42.86 66.8 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.578 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 9.2 tpt -68.78 -52.88 25.56 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.495 -0.482 . . . . 1.0 111.117 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.9 m -58.48 -40.78 83.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 1.0 110.551 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.5 t -72.61 9.77 1.01 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.877 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.0 t -92.26 136.49 33.14 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 110.178 -0.305 . . . . 1.0 110.178 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -62.71 -16.83 59.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.85 0.357 . . . . 1.0 110.836 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.473 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 99.3 mttt -91.76 39.3 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.999 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -132.95 114.84 14.48 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.989 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -130.03 115.5 17.2 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 64.5 p -97.59 81.52 2.95 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.863 0.363 . . . . 1.0 110.912 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.93 167.43 12.32 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.831 -0.908 . . . . 1.0 110.831 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 115' ' ' VAL . 80.9 p -77.28 162.81 27.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.971 -0.381 . . . . 1.0 109.971 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -55.99 -35.68 67.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.554 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.74 -43.61 83.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.651 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -70.78 -19.76 62.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.982 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 111' ' ' THR . 43.2 t -70.25 -44.69 77.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.336 178.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.31 -44.89 94.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.293 0.568 . . . . 1.0 110.395 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -65.65 -34.89 79.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.656 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -67.35 -50.13 61.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.539 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.414 HD11 HG13 ' A' ' 131' ' ' VAL . 8.2 tp -69.7 -39.45 78.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.225 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -63.46 -43.57 96.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.661 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.44 ' HA ' ' HE ' ' A' ' 124' ' ' ARG . 90.5 m-20 -60.86 -47.45 86.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.29 -0.564 . . . . 1.0 110.219 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.562 ' CE2' ' OD1' ' A' ' 126' ' ' ASN . 50.3 t80 -61.42 -40.05 92.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.015 -0.539 . . . . 1.0 109.844 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.6 t -60.35 -42.41 95.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.572 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.44 ' HE ' ' HA ' ' A' ' 121' ' ' ASP . 77.7 mtm180 -61.14 -40.84 95.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.404 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.35 -41.27 83.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.562 ' OD1' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -123.15 73.95 48.91 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.732 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.53 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 41.2 Cg_endo -72.01 -22.26 23.18 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.131 1.887 . . . . 1.0 112.442 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -104.07 24.45 11.39 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.74 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -140.77 151.52 44.5 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.826 0.346 . . . . 1.0 110.633 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.9 p -80.12 162.22 24.88 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.554 -0.535 . . . . 1.0 109.554 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.414 HG13 HD11 ' A' ' 119' ' ' ILE . 3.5 p -152.63 144.76 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 178.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.446 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 27.2 p90 -153.49 142.76 21.51 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.962 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -151.76 169.47 22.13 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.438 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.473 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -131.02 149.92 52.39 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.9 t -150.55 169.98 20.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.329 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.6 tp -67.89 140.55 56.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.422 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.607 HD21 ' HA ' ' A' ' 141' ' ' PRO . 9.8 p30 -55.59 -43.64 76.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.565 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 19.2 t60 70.39 -19.71 0.21 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.707 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.533 ' H ' ' C ' ' A' ' 137' ' ' ASN . 30.3 m-20 -103.0 -24.24 13.65 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.065 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.434 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 4.7 p30 -153.56 91.75 3.25 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.11 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.607 ' HA ' HD21 ' A' ' 137' ' ' ASN . 44.8 Cg_exo -54.25 135.26 64.37 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.203 1.935 . . . . 1.0 112.665 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 117.58 -28.99 6.84 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.001 -0.84 . . . . 1.0 111.001 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -113.96 150.49 33.72 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.931 0.396 . . . . 1.0 110.538 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -115.33 156.24 25.85 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -125.36 134.94 52.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.029 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.4 mt -106.68 126.24 52.03 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.651 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -117.15 146.39 43.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 178.472 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -160.86 150.59 17.31 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.216 -0.593 . . . . 1.0 109.723 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -130.94 127.37 38.31 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.746 0.308 . . . . 1.0 110.281 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 37.6 mm -72.92 -46.08 53.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.204 -0.453 . . . . 1.0 111.803 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 152' ' ' ALA . 11.9 t-20 -157.07 169.61 24.41 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.699 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.537 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -60.51 -30.08 69.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.813 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -90.41 8.79 31.88 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.036 0.446 . . . . 1.0 110.393 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 15.6 t -97.45 159.73 14.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.716 -0.674 . . . . 1.0 110.486 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -92.37 153.2 19.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.039 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 48.5 tp -70.84 118.52 13.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -108.07 129.98 55.11 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 51.8 m -126.41 128.94 47.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.611 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -113.9 160.97 18.2 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.035 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 160' ' ' ASN . 50.9 p30 -104.75 147.99 27.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.906 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 47.4 t -128.31 137.48 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.85 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -104.0 131.53 51.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.367 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.0 tp -95.26 130.53 41.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 1.0 109.789 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 48.8 p -127.89 171.01 12.18 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.252 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -84.97 16.48 3.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.851 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m -122.91 -3.25 8.65 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.935 0.398 . . . . 1.0 110.458 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 143.41 -132.24 4.88 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.422 -1.071 . . . . 1.0 110.422 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.456 ' CZ ' HD11 ' A' ' 97' ' ' LEU . 17.5 m-85 -122.91 130.2 52.55 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -106.48 122.52 46.46 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 tt -116.28 118.08 31.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 1.0 109.856 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.466 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 4.7 t 37.48 58.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.176 0.436 . . . . 1.0 112.176 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.5 m120 65.46 27.34 11.76 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.949 0.722 . . . . 1.0 112.949 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.466 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 89.0 m-85 -133.85 120.37 20.35 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -96.49 126.2 41.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.439 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -105.08 131.72 21.52 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -73.31 -20.79 20.75 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.192 1.928 . . . . 1.0 113.31 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 67.9 m -143.86 147.44 34.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.945 0.402 . . . . 1.0 111.218 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.08 -34.51 60.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.67 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 58.8 mt -62.2 -44.95 99.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.886 0.374 . . . . 1.0 110.135 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -67.98 -31.22 70.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.059 -0.519 . . . . 1.0 109.629 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.14 -42.79 99.53 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 110.084 -0.339 . . . . 1.0 110.084 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 73.1 m -63.13 -44.98 94.06 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.26 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.559 ' O ' ' N ' ' A' ' 186' ' ' LYS . 37.3 m-80 -65.73 -48.83 70.59 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.47 -43.43 0.75 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.678 -1.369 . . . . 1.0 109.678 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.461 ' O ' ' HG ' ' A' ' 188' ' ' LEU . 2.6 t80 -69.56 -46.85 65.46 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 122.096 0.951 . . . . 1.0 109.329 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.559 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.7 tttm -59.01 -35.58 73.51 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.118 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.7 m -63.43 -50.5 69.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 1.0 111.177 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.586 ' C ' HD12 ' A' ' 188' ' ' LEU . 0.7 OUTLIER -66.55 -36.05 81.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.66 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.424 ' N ' ' HG ' ' A' ' 188' ' ' LEU . 45.7 tp -58.03 -43.84 86.99 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.432 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -61.13 -40.28 93.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.956 -0.566 . . . . 1.0 109.792 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.0 t -61.59 -36.85 81.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.741 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 92.6 mt -69.95 -36.94 75.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.405 -0.816 . . . . 1.0 112.047 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.57 -31.88 69.85 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.051 0.389 . . . . 1.0 112.051 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -81.31 -4.44 55.64 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.881 -0.327 . . . . 1.0 110.725 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.407 ' CG ' ' O ' ' A' ' 195' ' ' HIS . 79.0 t60 54.76 40.73 32.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.382 . . . . 1.0 111.064 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -118.51 124.46 47.6 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.417 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -140.96 132.78 27.47 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.012 0.435 . . . . 1.0 110.447 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.459 ' O ' ' CG ' ' A' ' 199' ' ' HIS . 93.3 m-70 -61.1 -41.87 97.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.867 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.459 ' CG ' ' O ' ' A' ' 198' ' ' HIS . 98.2 m-70 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.984 -1.008 . . . . 1.0 110.533 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 81.7 p . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.276 -0.638 . . . . 1.0 109.276 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -131.18 -31.79 1.64 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.602 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.402 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 69.5 mtp180 -108.34 -22.4 12.34 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.895 0.379 . . . . 1.0 110.375 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 p -64.8 -31.36 53.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.556 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.7 pt -73.79 -17.26 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.46 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -98.03 0.32 46.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.389 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.41 ' O ' ' N ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -62.78 123.22 78.76 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.285 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.477 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 77.5 Cg_exo -43.9 -25.72 1.13 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.848 1.699 . . . . 1.0 112.39 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.598 ' CD1' ' CZ ' ' A' ' 30' ' ' PHE . 78.5 m-85 -87.0 9.16 20.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.506 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 7' ' ' HIS . 44.2 t80 -92.68 125.48 37.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.377 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.477 ' CZ ' ' O ' ' A' ' 8' ' ' PRO . 66.1 m-85 -145.3 128.27 8.29 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 110.12 -0.326 . . . . 1.0 110.12 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.88 110.54 3.1 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.717 1.611 . . . . 1.0 112.712 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -154.52 152.48 30.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.439 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -79.31 174.03 11.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.398 -0.593 . . . . 1.0 109.398 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.44 -46.86 93.56 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.403 -0.903 . . . . 1.0 111.338 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -67.32 -35.29 79.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.539 0.209 . . . . 1.0 111.15 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -67.68 -37.22 82.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.379 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.29 94.94 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.691 -0.404 . . . . 1.0 110.425 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.47 -43.99 92.47 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.019 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.61 -42.63 99.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.432 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -63.05 -41.51 99.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.831 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.9 mp -78.63 -11.31 59.96 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.97 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -56.21 -43.52 78.61 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.519 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.0 m -79.3 -15.84 57.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.739 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -81.44 175.57 10.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.472 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -100.9 -176.38 3.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.515 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -82.3 146.2 29.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.88 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.51 14.01 45.77 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.192 -0.763 . . . . 1.0 111.192 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -100.49 144.07 29.91 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.598 ' CZ ' ' CD1' ' A' ' 9' ' ' TYR . 9.1 p90 -132.9 162.19 32.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.116 0.484 . . . . 1.0 110.832 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.739 ' O ' HG23 ' A' ' 44' ' ' ILE . 45.7 t -147.29 157.77 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.193 -0.912 . . . . 1.0 111.533 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.476 ' N ' HG12 ' A' ' 31' ' ' VAL . 80.8 mt -117.75 124.82 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 43' ' ' VAL . 1.5 ptm180 -150.27 156.03 40.8 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.321 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -88.33 169.87 11.46 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 38' ' ' GLY . 16.5 p -81.09 28.13 0.38 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.405 -0.362 . . . . 1.0 110.987 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m 70.94 -41.4 0.5 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.809 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.464 ' H ' ' C ' ' A' ' 35' ' ' SER . 83.9 mtt85 -140.21 19.01 2.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.01 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.486 ' N ' ' OG ' ' A' ' 35' ' ' SER . . . -70.66 -65.18 2.57 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.618 -0.993 . . . . 1.0 110.618 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 68.03 -43.72 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.726 0.298 . . . . 1.0 110.647 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 38' ' ' GLY . 38.2 t70 -94.8 -9.63 33.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.652 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -136.98 151.33 48.87 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.898 0.38 . . . . 1.0 110.348 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.96 147.91 44.81 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.097 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 33' ' ' ARG . 62.4 t -126.47 134.24 66.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.437 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 31' ' ' VAL . 48.1 mt -112.95 138.86 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.1 m -116.9 135.36 53.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.825 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.565 ' CE2' HD11 ' A' ' 48' ' ' LEU . 4.1 p-90 -144.4 148.02 34.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.521 -0.763 . . . . 1.0 110.787 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.543 ' C ' HD12 ' A' ' 48' ' ' LEU . 85.3 tttt -95.29 137.13 34.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.972 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.6 mp -101.87 -82.14 0.48 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.385 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -90.01 174.74 7.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.522 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -58.52 -29.59 66.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.82 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -132.56 52.95 2.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.992 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.0 tp -152.9 136.76 16.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.905 0.384 . . . . 1.0 110.442 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.403 ' O ' ' OE1' ' A' ' 54' ' ' GLN . 87.0 m-85 -131.63 148.22 52.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.385 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.403 ' OE1' ' O ' ' A' ' 53' ' ' PHE . 28.3 mm100 -142.73 153.81 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.681 -0.489 . . . . 1.0 109.681 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.502 ' O ' ' ND1' ' A' ' 55' ' ' HIS . 7.7 p80 -129.45 144.65 51.34 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.287 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.3 mt -122.64 125.57 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -96.45 122.67 39.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.952 0.406 . . . . 1.0 110.359 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.3 mt -104.82 129.64 57.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.31 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -112.23 135.15 53.26 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.096 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.4 ' H ' ' HG3' ' A' ' 60' ' ' GLU . 2.8 pp20? -100.53 151.52 21.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.312 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.7 tp -143.5 176.18 9.38 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.513 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.445 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 64.0 tt0 67.63 44.37 1.68 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.264 0.554 . . . . 1.0 109.633 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -83.01 90.44 7.02 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.806 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -65.66 -38.38 89.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.819 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -144.16 153.67 56.74 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.259 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.82 -33.83 62.61 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.079 1.853 . . . . 1.0 112.324 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 pp -85.14 -10.92 56.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.857 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.51 133.86 48.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.367 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.2 mt -79.67 152.45 29.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.364 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.86 92.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.01 -37.11 86.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.867 0.365 . . . . 1.0 110.772 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.2 t -122.93 123.0 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.804 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.7 mt -116.13 134.22 55.17 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.5 mm -99.57 120.09 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.919 0.39 . . . . 1.0 110.128 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.66 131.47 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.229 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.6 t0 54.14 43.45 30.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.18 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 59.54 24.31 13.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.017 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -129.53 156.96 43.32 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.434 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.14 133.51 41.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.187 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.566 ' CG ' HD11 ' A' ' 86' ' ' ILE . 66.1 m-85 -135.19 136.4 41.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.241 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -87.06 -37.66 17.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.889 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -109.33 136.71 48.34 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.21 0.529 . . . . 1.0 112.324 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.4 tp -66.08 -38.12 87.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.767 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 54.1 t0 -59.7 -36.58 76.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.894 -176.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.518 ' NE2' ' OE2' ' A' ' 89' ' ' GLU . 66.2 tt0 -59.8 -38.96 83.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.627 0.251 . . . . 1.0 110.608 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.566 HD11 ' CG ' ' A' ' 80' ' ' TYR . 50.1 mm -60.71 -47.76 91.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.708 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.16 -42.7 96.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 120.512 -0.475 . . . . 1.0 111.786 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.428 ' O ' ' OE1' ' A' ' 92' ' ' GLN . 40.6 t -76.44 -37.57 30.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.152 0.797 . . . . 1.0 113.152 -177.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.518 ' OE2' ' NE2' ' A' ' 85' ' ' GLN . 95.8 mt-10 -84.37 -14.49 49.36 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.912 0.338 . . . . 1.0 111.912 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 12.0 t80 -95.27 -48.7 5.79 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.629 -0.428 . . . . 1.0 112.129 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 95' ' ' VAL . 10.9 mp -69.76 -40.49 76.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.337 0.495 . . . . 1.0 112.337 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.515 ' OE1' ' N ' ' A' ' 92' ' ' GLN . 5.1 mp0 -64.2 -48.95 73.91 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.969 -0.692 . . . . 1.0 111.767 -177.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -69.29 -42.9 74.85 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.622 -0.431 . . . . 1.0 111.866 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.553 ' O ' HD13 ' A' ' 98' ' ' LEU . 42.1 mmtm -66.35 -43.62 85.52 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.359 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 91' ' ' LEU . 47.4 t -61.56 -45.52 98.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.3 -0.56 . . . . 1.0 111.235 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -69.24 -42.7 75.29 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.487 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.8 tp -66.44 -42.24 87.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.616 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 94' ' ' LYS . 8.7 mp -65.4 -41.11 94.02 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.504 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -68.48 -36.24 78.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.18 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -71.66 -42.28 67.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 120.824 -0.351 . . . . 1.0 111.784 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.3 tpt -67.46 -54.96 15.72 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.438 -0.505 . . . . 1.0 111.65 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.402 HG23 ' CE2' ' A' ' 107' ' ' PHE . 55.3 m -59.68 -29.42 68.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.956 0.407 . . . . 1.0 110.559 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.0 p -74.25 9.61 1.58 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.123 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.7 t -98.45 130.1 45.06 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 110.123 -0.325 . . . . 1.0 110.123 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -58.23 -17.49 19.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.127 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.533 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 98.6 mttt -88.56 40.63 0.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.671 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.402 ' CE2' HG23 ' A' ' 102' ' ' THR . 48.6 t80 -135.24 113.41 11.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.104 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -133.44 120.43 20.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.052 -0.522 . . . . 1.0 109.977 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.6 p -91.75 94.68 9.48 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.053 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.2 151.8 16.89 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.595 ' O ' HG23 ' A' ' 115' ' ' VAL . 19.1 p -71.34 162.76 28.92 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -58.92 -40.1 83.54 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.539 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.85 -46.16 72.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.872 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.431 ' OD1' ' OG1' ' A' ' 111' ' ' THR . 2.8 m-20 -71.34 -19.37 62.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.744 -0.662 . . . . 1.0 111.084 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 111' ' ' THR . 10.2 t -73.7 -43.92 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.172 -0.307 . . . . 1.0 110.172 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.0 -46.56 96.21 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 CA-C-O 121.118 0.485 . . . . 1.0 110.054 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -65.86 -34.32 77.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.988 0.423 . . . . 1.0 110.696 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -68.94 -49.29 59.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.731 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.1 tp -70.6 -39.59 76.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.518 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -62.52 -41.65 98.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.765 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.96 -47.63 74.01 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.582 -0.447 . . . . 1.0 110.373 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.686 ' CE1' ' ND2' ' A' ' 126' ' ' ASN . 42.4 t80 -61.39 -42.09 98.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.99 -0.55 . . . . 1.0 109.914 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.5 p -64.87 -33.56 76.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.419 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -61.81 -42.02 98.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.998 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.76 -40.91 90.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.686 ' ND2' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -113.77 75.27 2.69 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.056 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.531 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 41.4 Cg_endo -71.99 -19.35 26.81 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.24 1.96 . . . . 1.0 112.406 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -104.67 -14.64 15.53 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.041 0.386 . . . . 1.0 112.041 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -103.4 147.1 27.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.082 0.467 . . . . 1.0 110.52 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.9 m -80.81 162.1 24.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.515 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 p -153.03 146.36 14.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -149.73 143.05 25.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.885 0.374 . . . . 1.0 111.041 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -151.24 165.25 34.53 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.317 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.533 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -133.57 151.63 51.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.383 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.9 m -146.31 167.51 23.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.252 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.9 tp -79.82 128.81 33.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.612 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.465 ' CG ' ' CD2' ' A' ' 145' ' ' TYR . 5.5 m-20 -53.11 173.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.109 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -127.58 -38.85 1.88 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.531 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -95.44 -8.04 36.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.177 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -136.62 75.5 50.36 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.255 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.34 132.42 50.79 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.964 1.776 . . . . 1.0 112.442 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 109.43 -33.49 6.06 Favored Glycine 0 N--CA 1.466 0.645 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.432 ' O ' ' CG ' ' A' ' 137' ' ' ASN . 15.6 m0 -92.16 156.49 17.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.723 0.297 . . . . 1.0 110.22 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -119.12 149.77 41.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 1.0 109.834 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.465 ' CD2' ' CG ' ' A' ' 137' ' ' ASN . 35.8 m-85 -120.99 132.99 55.25 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.246 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 15.0 mt -107.32 123.38 48.25 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.236 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.457 ' SD ' HG13 ' A' ' 115' ' ' VAL . 0.9 OUTLIER -120.64 145.32 47.53 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.979 -1.119 . . . . 1.0 107.979 178.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -163.48 151.58 13.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.51 -0.476 . . . . 1.0 109.719 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -128.39 130.57 47.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.761 0.315 . . . . 1.0 110.455 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.424 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.9 mp -75.68 -45.92 37.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.217 0.451 . . . . 1.0 112.217 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 17.5 t-20 -152.15 164.08 38.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.477 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.505 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -57.14 -22.89 43.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.776 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -96.87 -4.54 40.04 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.402 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.1 p -82.91 150.76 26.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.488 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.486 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -82.35 154.56 25.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.176 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.2 tp -69.39 113.7 6.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.971 0.415 . . . . 1.0 110.073 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 99.0 m-85 -99.92 131.23 46.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.803 -0.635 . . . . 1.0 109.636 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 58.4 m -127.62 130.94 49.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.774 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -117.1 153.26 33.07 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.111 0.481 . . . . 1.0 109.942 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -105.2 144.95 31.28 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.791 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.5 t -127.61 135.44 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.646 -0.502 . . . . 1.0 109.646 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -98.19 131.23 44.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.378 -0.373 . . . . 1.0 110.474 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.3 tp -99.71 131.35 45.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.078 -0.51 . . . . 1.0 109.698 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.1 p -132.58 174.32 10.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.461 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -85.67 17.02 3.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.699 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 44.0 p -121.79 -2.63 9.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.566 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.32 -134.48 6.52 Favored Glycine 0 N--CA 1.465 0.591 0 N-CA-C 110.329 -1.108 . . . . 1.0 110.329 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -122.23 130.15 52.91 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 110.316 -0.253 . . . . 1.0 110.316 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -105.67 119.2 38.53 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.8 tt -117.02 119.73 36.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.8 t 38.54 53.66 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.004 0.372 . . . . 1.0 112.004 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.5 m120 67.7 27.19 7.66 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.017 0.747 . . . . 1.0 113.017 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -135.47 120.68 18.94 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -93.2 126.06 38.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.493 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -102.51 139.63 20.39 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -72.71 -18.59 25.02 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.024 1.816 . . . . 1.0 113.613 -177.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.9 p -154.67 158.24 39.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.917 0.389 . . . . 1.0 110.962 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 179' ' ' ILE . 14.2 p -64.77 -37.52 80.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.141 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.425 ' N ' HG13 ' A' ' 178' ' ' VAL . 80.4 mt -59.7 -45.03 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.306 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -63.59 -37.6 87.96 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.7 tt -64.86 -39.78 94.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.422 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 83.1 m -59.29 -47.87 83.75 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.432 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' A' ' 186' ' ' LYS . 61.2 t30 -69.74 -49.28 54.64 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.35 -44.96 0.63 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.699 -1.36 . . . . 1.0 109.699 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.78 -47.34 69.44 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.192 -0.669 . . . . 1.0 109.192 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 183' ' ' ASN . 63.9 tttp -56.56 -41.53 77.03 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.522 -0.763 . . . . 1.0 109.827 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 94.5 m -60.02 -46.98 87.71 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.75 -41.23 98.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 1.0 109.815 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.1 tp -60.24 -45.81 91.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.542 -0.299 . . . . 1.0 110.451 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -60.89 -44.17 97.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.291 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.4 t -64.31 -37.38 87.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.258 0.551 . . . . 1.0 110.499 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.19 -42.26 99.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.87 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -63.5 -25.69 68.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 111.878 0.325 . . . . 1.0 111.878 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -100.48 -8.56 23.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.086 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.514 ' C ' ' H ' ' A' ' 197' ' ' HIS . 96.2 m-70 44.17 42.61 5.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.414 -0.357 . . . . 1.0 111.122 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 196' ' ' HIS . 55.5 t-80 56.13 3.44 0.1 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.696 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.514 ' H ' ' C ' ' A' ' 195' ' ' HIS . 38.4 t-80 -166.12 -109.12 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.538 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.476 ' N ' ' CG ' ' A' ' 197' ' ' HIS . 85.7 t60 41.35 96.56 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.999 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.401 ' N ' ' ND1' ' A' ' 199' ' ' HIS . 2.9 m80 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.053 -0.975 . . . . 1.0 110.683 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.443 ' O ' ' ND1' ' A' ' 2' ' ' HIS . 52.9 t-80 64.88 2.39 1.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.511 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -141.23 7.94 2.01 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.35 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.85 -26.22 34.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.542 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.0 pt -71.63 -26.66 26.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 1.0 110.689 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -106.95 7.9 30.21 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.575 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -46.8 136.14 7.9 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.313 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -49.05 -31.55 21.16 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.648 1.565 . . . . 1.0 112.526 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.612 ' CE2' ' CZ ' ' A' ' 30' ' ' PHE . 52.0 m-85 -88.38 3.74 48.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.728 0.299 . . . . 1.0 111.244 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.528 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 34.3 t80 -75.12 127.74 33.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.178 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 52.1 m-85 -147.49 108.92 3.86 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.606 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.495 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 31.3 Cg_exo -59.67 111.74 1.05 Allowed 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 121.71 1.607 . . . . 1.0 112.624 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.529 ' O ' ' NH1' ' A' ' 33' ' ' ARG . 56.2 m-85 -160.34 159.39 31.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.29 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.409 ' CG ' ' N ' ' A' ' 15' ' ' GLY . 11.1 t-20 -81.19 164.72 22.11 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.409 ' N ' ' CG ' ' A' ' 14' ' ' ASN . . . -58.26 -48.53 82.92 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.606 -0.998 . . . . 1.0 110.606 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.7 mmp_? -67.32 -39.56 85.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.723 0.297 . . . . 1.0 111.029 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.16 -37.07 84.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.326 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.471 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.59 -44.01 97.8 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.669 -0.412 . . . . 1.0 110.414 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.514 ' OE2' ' CD1' ' A' ' 53' ' ' PHE . 42.6 tt0 -61.34 -45.73 93.22 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.045 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.1 -38.71 89.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.322 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.607 ' CE2' ' NZ ' ' A' ' 25' ' ' LYS . 57.3 t80 -67.2 -36.87 82.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.078 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 18' ' ' ALA . 7.8 mp -81.65 -11.88 58.92 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.115 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -63.51 -33.57 75.86 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.248 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -81.18 -20.14 41.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.004 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.607 ' NZ ' ' CE2' ' A' ' 21' ' ' TYR . 48.7 mttp -81.89 176.4 9.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.998 0.428 . . . . 1.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -88.72 165.74 14.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.809 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.538 ' NH2' ' OD1' ' A' ' 99' ' ' ASN . 64.6 ttp85 -65.65 146.18 55.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.949 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.29 22.75 31.19 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.317 -0.713 . . . . 1.0 111.317 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -101.41 142.14 33.24 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.612 ' CZ ' ' CE2' ' A' ' 9' ' ' TYR . 17.3 p90 -133.24 167.19 20.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.489 0.661 . . . . 1.0 110.699 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 45' ' ' THR . 11.0 m -149.68 163.1 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.715 -1.13 . . . . 1.0 111.827 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.518 HD13 ' CG1' ' A' ' 44' ' ' ILE . 3.7 mm -115.65 126.71 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 13' ' ' PHE . 26.8 ttt85 -136.76 162.58 32.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.689 -0.687 . . . . 1.0 110.188 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.523 ' H ' ' CD ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -117.11 128.58 55.27 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.6 t -52.72 -6.21 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.521 ' H ' ' C ' ' A' ' 34' ' ' GLN . 1.5 t 72.07 -49.12 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.442 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -93.39 -6.09 47.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.653 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -70.96 -53.84 10.34 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.632 -0.987 . . . . 1.0 110.632 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 t70 71.44 -36.89 0.38 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.627 0.251 . . . . 1.0 111.084 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 38' ' ' GLY . 98.4 m-20 -120.08 -7.34 9.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.744 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -120.42 146.89 45.76 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.056 0.455 . . . . 1.0 110.944 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.88 151.79 41.39 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.129 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.8 t -125.82 134.36 66.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.299 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.685 HD12 HD11 ' A' ' 58' ' ' ILE . 16.0 mt -110.71 137.16 44.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.571 ' O ' HG22 ' A' ' 31' ' ' VAL . 75.4 m -117.66 134.17 55.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.661 -0.699 . . . . 1.0 109.349 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.742 ' HE1' HE21 ' A' ' 54' ' ' GLN . 2.1 p-90 -151.89 154.21 35.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.349 -0.841 . . . . 1.0 110.768 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -97.87 143.46 28.45 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.293 0.568 . . . . 1.0 111.793 -179.041 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.2 mt -97.18 -57.76 2.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.226 -0.897 . . . . 1.0 110.35 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -119.38 -166.85 1.32 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.37 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -65.1 -39.29 92.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.793 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -128.13 53.39 1.8 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.281 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.9 tp -153.87 129.36 9.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.263 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CD1' ' OE2' ' A' ' 19' ' ' GLU . 47.8 m-85 -134.99 150.25 50.31 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.983 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.742 HE21 ' HE1' ' A' ' 46' ' ' TRP . 14.9 pt20 -141.07 157.73 44.9 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.164 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -121.77 139.95 52.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.454 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.8 mt -119.41 123.42 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.806 -0.442 . . . . 1.0 109.806 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -96.29 122.1 38.8 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.889 0.376 . . . . 1.0 110.567 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.685 HD11 HD12 ' A' ' 44' ' ' ILE . 86.2 mt -102.64 129.98 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.212 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.759 HE21 ' C ' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -119.1 134.62 55.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.131 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 60' ' ' GLU . 0.3 OUTLIER -100.67 157.62 16.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.583 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 mt -146.18 178.42 8.24 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.106 0.479 . . . . 1.0 110.345 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 58.59 39.59 24.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.385 -0.825 . . . . 1.0 110.5 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' H ' ' HG2' ' A' ' 63' ' ' LYS . 58.2 pttt -81.19 125.88 30.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.382 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -68.84 -30.78 69.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.106 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -162.39 156.95 18.83 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.556 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.64 -33.04 57.19 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.608 1.539 . . . . 1.0 112.295 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.51 -10.35 58.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.507 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.66 135.47 44.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.342 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.8 mt -78.15 148.35 34.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.51 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.68 132.82 14.65 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -77.74 -15.51 59.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.046 0.451 . . . . 1.0 110.806 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.0 t -111.09 119.64 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.682 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.6 mt -115.59 131.91 56.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.539 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.4 mt -102.53 122.33 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.838 0.351 . . . . 1.0 110.443 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.469 HG21 HD13 ' A' ' 86' ' ' ILE . 46.1 t -142.36 133.82 25.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.29 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 56.32 41.24 29.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.681 0.277 . . . . 1.0 111.124 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.36 13.72 5.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.91 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -120.66 151.85 38.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.983 0.421 . . . . 1.0 109.944 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -101.1 126.07 47.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.982 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.538 ' CE1' ' OE2' ' A' ' 89' ' ' GLU . 95.9 m-85 -120.75 139.13 53.53 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.186 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -85.71 -30.42 23.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.584 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 51.4 t0 -123.86 141.65 51.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.01 0.433 . . . . 1.0 111.842 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.4 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 56.6 tp -65.46 -39.9 92.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.584 -0.735 . . . . 1.0 111.147 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.48 -40.19 90.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.727 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -59.7 -39.64 85.23 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.799 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.469 HD13 HG21 ' A' ' 75' ' ' VAL . 96.9 mt -62.44 -46.12 97.17 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 CA-C-O 120.898 0.38 . . . . 1.0 110.955 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 64.8 mt -62.73 -46.07 97.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.976 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.4 t -69.87 -43.58 79.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.81 0.671 . . . . 1.0 112.81 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.538 ' OE2' ' CE1' ' A' ' 80' ' ' TYR . 9.1 pt-20 -80.68 -12.07 59.54 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.523 -0.471 . . . . 1.0 111.666 -177.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.589 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 64.4 t80 -94.19 -49.11 5.89 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.636 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.497 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -70.37 -42.1 72.21 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.348 -0.541 . . . . 1.0 112.118 -177.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -63.9 -49.08 74.08 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.041 -0.664 . . . . 1.0 111.565 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -69.12 -42.77 75.61 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.618 -0.433 . . . . 1.0 111.522 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.589 ' NZ ' ' CE1' ' A' ' 90' ' ' TYR . 15.9 mmtp -65.81 -42.32 90.78 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.39 -0.524 . . . . 1.0 111.228 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 91' ' ' LEU . 53.4 t -65.41 -46.5 89.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.527 -0.469 . . . . 1.0 111.183 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -68.09 -44.02 77.21 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.615 -0.434 . . . . 1.0 111.6 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.2 tp -67.71 -41.64 83.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.267 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.7 tp -65.35 -42.92 92.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.193 -0.603 . . . . 1.0 110.217 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.538 ' OD1' ' NH2' ' A' ' 27' ' ' ARG . 99.2 m-20 -68.04 -36.95 80.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.244 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -71.82 -42.89 66.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 111.892 0.33 . . . . 1.0 111.892 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.5 tpt -66.03 -53.8 33.98 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.213 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.432 HG23 ' CE2' ' A' ' 107' ' ' PHE . 53.8 m -60.14 -36.12 76.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.593 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.9 t -71.07 9.49 0.71 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.879 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 102' ' ' THR . 32.0 t -91.52 134.32 34.75 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 110.001 -0.37 . . . . 1.0 110.001 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -58.59 -19.21 36.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.983 0.42 . . . . 1.0 110.823 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.557 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 60.4 mttp -90.14 39.91 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.785 -0.643 . . . . 1.0 109.798 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.432 ' CE2' HG23 ' A' ' 102' ' ' THR . 87.9 t80 -132.85 120.42 21.51 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.535 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.59 124.02 15.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.142 -0.481 . . . . 1.0 109.906 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.3 m -100.17 86.66 3.27 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.734 0.302 . . . . 1.0 110.968 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.16 163.63 12.12 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.924 -0.87 . . . . 1.0 110.924 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' HZ3' ' A' ' 113' ' ' LYS . 61.6 p -77.65 169.52 18.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -58.6 -38.59 78.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.912 0.387 . . . . 1.0 110.561 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.578 ' HZ3' ' CB ' ' A' ' 111' ' ' THR . 25.0 pttm -69.27 -39.53 78.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.654 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -70.08 -24.46 63.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.874 -0.603 . . . . 1.0 111.154 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 111' ' ' THR . 48.8 t -70.65 -45.5 73.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.509 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 82.6 t -63.67 -46.66 94.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.106 0.479 . . . . 1.0 110.445 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -66.04 -37.42 85.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.085 0.469 . . . . 1.0 110.896 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -67.11 -49.24 65.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.751 -0.659 . . . . 1.0 111.763 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.415 HG23 ' N ' ' A' ' 120' ' ' GLU . 11.1 tp -69.84 -40.0 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.55 -0.46 . . . . 1.0 110.47 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 119' ' ' ILE . 96.3 mt-10 -65.44 -41.64 93.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.806 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -63.82 -48.17 77.91 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.448 -0.501 . . . . 1.0 110.297 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -60.45 -44.57 95.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.007 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 81.2 p -66.25 -28.6 68.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.038 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -63.96 -43.87 94.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.337 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.7 t -66.82 -41.76 88.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.298 -0.41 . . . . 1.0 109.938 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -122.02 75.43 39.38 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.561 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -71.3 -13.51 30.81 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.662 2.241 . . . . 1.0 112.34 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -106.2 24.87 11.76 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.642 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -141.13 151.72 44.14 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.86 0.362 . . . . 1.0 110.743 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 86.5 p -80.78 160.81 24.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.119 -0.491 . . . . 1.0 109.841 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.6 p -153.97 144.86 14.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.597 -0.52 . . . . 1.0 109.597 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 19.0 p90 -153.33 143.61 22.36 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.691 -0.404 . . . . 1.0 111.104 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -152.57 169.71 21.97 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.355 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.6 p90 -136.77 156.12 48.93 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 28.8 t -148.55 169.5 20.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.322 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.4 tp -74.59 146.46 42.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.483 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 138' ' ' HIS . 28.1 t-20 -42.74 147.96 0.27 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.539 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.43 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 92.5 m-70 -60.05 -50.24 74.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.018 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 139' ' ' ASP . 25.7 p-10 -156.7 44.09 0.39 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.536 -0.302 . . . . 1.0 110.629 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.412 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 73.3 m-20 -160.26 84.32 2.07 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.31 144.86 92.28 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.699 1.599 . . . . 1.0 112.671 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.401 ' C ' ' CD1' ' A' ' 143' ' ' TRP . . . 142.93 -39.25 1.35 Allowed Glycine 0 C--O 1.226 -0.382 0 N-CA-C 110.887 -0.885 . . . . 1.0 110.887 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.534 ' CD1' ' N ' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -134.95 153.89 51.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.812 0.339 . . . . 1.0 110.188 -179.353 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -102.36 156.97 17.24 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -113.37 134.9 54.39 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.093 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.466 HD12 ' CG2' ' A' ' 161' ' ' VAL . 12.3 mt -110.55 126.17 54.12 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.436 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.62 142.98 51.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.644 -1.243 . . . . 1.0 107.644 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -159.43 160.25 34.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.781 -0.451 . . . . 1.0 109.781 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -138.57 128.63 25.48 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.858 0.361 . . . . 1.0 110.686 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.442 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.8 mp -72.43 -44.98 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.787 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.411 ' H ' ' HB3' ' A' ' 154' ' ' SER . 77.9 m-20 -160.83 174.0 14.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.729 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.38 -32.81 73.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.784 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -83.68 -13.15 54.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.143 0.496 . . . . 1.0 110.376 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.411 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 8.8 t -80.09 157.15 26.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.473 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -90.28 157.37 17.7 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.989 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 30.8 tp -76.57 121.66 23.49 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.087 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -108.32 136.39 48.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.743 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 99.8 m -128.98 132.33 47.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.905 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -123.37 161.89 23.82 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.803 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -109.72 151.79 26.47 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.796 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.466 ' CG2' HD12 ' A' ' 146' ' ' LEU . 67.8 t -127.78 134.18 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -97.54 132.35 43.3 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.027 0.442 . . . . 1.0 111.061 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.4 tp -92.23 130.28 37.97 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.727 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.454 ' C ' ' H ' ' A' ' 166' ' ' THR . 65.7 p -129.58 157.35 42.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.339 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -73.45 15.21 0.26 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.645 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 164' ' ' THR . 19.3 p -121.46 -2.43 9.48 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.775 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.51 -135.49 7.06 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.477 -1.049 . . . . 1.0 110.477 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -118.9 131.68 56.06 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.401 ' CE1' ' OD1' ' A' ' 174' ' ' ASN . 5.9 m-85 -109.33 118.7 37.38 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.8 tt -109.29 121.3 44.87 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.465 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 5.0 t 34.93 59.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.467 0.543 . . . . 1.0 112.467 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.2 m120 63.26 27.54 15.51 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.981 0.734 . . . . 1.0 112.981 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.465 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 79.3 m-85 -132.75 121.88 23.71 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.303 -0.628 . . . . 1.0 109.303 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.401 ' OD1' ' CE1' ' A' ' 169' ' ' PHE . 46.4 t30 -91.15 133.4 35.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.391 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -115.65 131.88 23.44 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.903 -0.589 . . . . 1.0 109.462 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.66 -21.33 19.26 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.171 1.914 . . . . 1.0 113.443 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 73.4 m -147.99 150.99 35.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.928 0.394 . . . . 1.0 111.25 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.94 -36.3 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.833 -0.622 . . . . 1.0 110.857 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.431 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 46.6 mm -60.95 -45.98 97.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 1.0 110.066 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -65.82 -32.3 73.76 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.1 tp -63.95 -42.31 97.35 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.465 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.611 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 5.1 p -60.99 -47.88 84.39 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.632 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.611 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 36.3 t30 -66.71 -48.51 69.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.744 -0.783 . . . . 1.0 108.983 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.57 -45.01 0.95 Allowed Glycine 0 N--CA 1.462 0.374 0 N-CA-C 109.907 -1.277 . . . . 1.0 109.907 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -68.89 -47.48 65.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 183' ' ' ASN . 36.4 ttpt -56.66 -39.53 73.91 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.544 -0.753 . . . . 1.0 109.982 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 19.9 m -60.58 -45.94 92.09 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.416 ' O ' ' OG ' ' A' ' 191' ' ' SER . 75.8 mt -63.73 -39.42 94.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.865 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.6 tp -58.88 -43.31 90.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.903 0.383 . . . . 1.0 110.458 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -59.09 -45.71 90.17 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.527 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 188' ' ' LEU . 77.6 p -61.79 -36.89 82.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.167 0.508 . . . . 1.0 110.619 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.8 mt -69.47 -39.44 77.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.381 -0.827 . . . . 1.0 111.954 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -62.46 -29.17 70.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.892 0.33 . . . . 1.0 111.892 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -82.44 6.23 17.95 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.907 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 77.7 m80 43.75 41.5 3.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.049 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 56.08 -176.68 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.582 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -154.54 -26.3 0.12 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.575 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -66.18 -39.95 90.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.849 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 80.5 m80 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.022 -0.99 . . . . 1.0 110.453 -179.692 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.493 ' O ' HG12 ' A' ' 4' ' ' VAL . 81.9 p . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -87.3 -0.25 56.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.534 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -111.38 -2.57 15.56 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.817 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 1' ' ' THR . 14.1 p -64.46 -30.48 50.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.532 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.1 pt -71.01 -15.23 18.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.515 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -94.21 -0.1 55.38 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.44 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.73 140.67 59.08 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.217 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.13 -21.39 62.74 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.111 1.874 . . . . 1.0 112.116 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.451 ' CE1' ' CZ ' ' A' ' 30' ' ' PHE . 24.5 m-85 -92.24 10.16 30.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.202 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 79.0 t80 -84.47 128.07 34.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.423 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 64.2 m-85 -150.89 114.78 3.18 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 110.154 -0.313 . . . . 1.0 110.154 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.91 110.09 3.01 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.743 1.629 . . . . 1.0 112.919 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -155.53 153.77 30.73 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.539 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.463 ' ND2' ' H ' ' A' ' 15' ' ' GLY . 11.2 t-20 -77.68 164.45 25.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.463 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -57.84 -42.73 94.77 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.207 -0.997 . . . . 1.0 110.948 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -66.31 -42.96 87.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.745 0.307 . . . . 1.0 110.963 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -67.86 -33.82 75.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.277 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.43 -43.01 97.23 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.257 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -58.61 -42.29 87.85 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.582 -0.447 . . . . 1.0 109.992 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -62.21 -46.52 88.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.503 . . . . 1.0 110.287 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -60.18 -40.95 91.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.446 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.34 -13.59 60.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.952 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -58.49 -43.85 89.17 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.403 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.4 t -76.43 -19.44 58.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.718 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -83.28 177.05 8.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.527 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.6 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 52.2 mp0 -105.3 -176.93 3.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.738 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -74.92 144.69 43.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.828 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.51 -0.34 61.4 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.219 -0.753 . . . . 1.0 111.219 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -83.88 144.3 29.31 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.659 ' CD1' HD21 ' A' ' 91' ' ' LEU . 16.8 p90 -136.73 165.58 25.58 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.177 0.513 . . . . 1.0 110.971 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 32' ' ' ILE . 60.3 t -146.98 156.58 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.087 -0.961 . . . . 1.0 111.67 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.463 ' N ' HG12 ' A' ' 31' ' ' VAL . 91.6 mt -117.3 124.19 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -152.02 153.17 33.48 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.336 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -108.41 152.19 25.01 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.917 -0.401 . . . . 1.0 109.917 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 t -82.36 145.19 30.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.843 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 m -59.02 -39.07 80.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.664 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -95.41 6.95 47.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.792 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -86.97 -79.75 1.22 Allowed Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.572 -1.011 . . . . 1.0 110.572 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 t70 68.8 -38.89 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 1.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 38' ' ' GLY . 36.5 t70 -104.11 2.44 31.99 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.828 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -143.82 153.62 42.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.946 0.403 . . . . 1.0 110.283 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.12 148.8 42.66 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.952 -0.567 . . . . 1.0 109.752 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.21 132.46 71.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.221 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.694 HD12 HD11 ' A' ' 58' ' ' ILE . 56.8 mt -111.7 138.36 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 108.949 -0.76 . . . . 1.0 108.949 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 87.9 m -120.73 138.7 53.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.575 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.456 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 2.9 p-90 -153.91 148.11 25.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.884 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.476 ' HZ3' ' C ' ' A' ' 49' ' ' ASP . 64.1 tttm -88.93 141.19 28.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.128 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.665 HD11 HE21 ' A' ' 54' ' ' GLN . 26.2 mt -98.76 -68.06 0.82 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.072 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.476 ' C ' ' HZ3' ' A' ' 47' ' ' LYS . 38.2 t0 -136.11 171.22 14.79 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.186 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -46.64 130.58 11.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.986 0.422 . . . . 1.0 110.897 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 56.37 39.82 29.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.06 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.8 tp -149.01 122.38 9.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.784 0.326 . . . . 1.0 110.443 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -135.56 149.92 49.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.568 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.665 HE21 HD11 ' A' ' 48' ' ' LEU . 3.0 pt20 -139.43 156.49 46.93 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.958 -0.564 . . . . 1.0 109.823 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -125.41 142.28 51.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.301 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 83.1 mt -120.48 122.84 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -93.98 120.83 34.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.877 0.37 . . . . 1.0 110.496 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.694 HD11 HD12 ' A' ' 44' ' ' ILE . 92.6 mt -100.84 128.96 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.422 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -112.29 141.78 45.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.171 -0.468 . . . . 1.0 109.781 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -98.73 152.79 19.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 1.0 109.988 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 2.9 tp -141.56 165.49 27.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.696 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.493 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 72.6 tt0 66.04 48.61 1.72 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.41 0.624 . . . . 1.0 109.719 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 32.5 pttt -102.44 107.81 18.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.988 -0.551 . . . . 1.0 109.945 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -67.26 -25.19 65.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.857 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -159.23 158.22 28.2 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.214 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.96 -34.39 56.22 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.213 1.942 . . . . 1.0 112.074 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.494 ' CD2' ' H ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -85.49 -10.24 56.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.688 -179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.67 145.12 55.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.299 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.7 mt -77.81 151.84 33.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.371 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.22 91.25 1.13 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.673 -0.971 . . . . 1.0 110.673 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -63.78 -32.36 73.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.037 0.446 . . . . 1.0 110.596 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.7 t -125.26 124.18 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.787 -0.642 . . . . 1.0 111.051 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.13 131.07 57.04 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.0 mt -100.22 120.93 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.899 0.381 . . . . 1.0 110.179 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -141.59 132.54 26.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.235 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 56.15 43.11 27.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.717 0.294 . . . . 1.0 111.025 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.4 t30 59.27 15.9 4.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.779 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -121.68 146.52 46.93 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.228 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -99.57 126.26 45.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.644 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -125.06 137.33 54.21 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.028 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -85.75 -38.49 18.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.831 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -105.3 135.33 46.87 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.127 0.489 . . . . 1.0 111.935 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 58.2 tp -63.81 -41.93 97.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.571 -0.74 . . . . 1.0 110.672 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -60.27 -42.44 95.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 1.0 111.92 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -60.98 -37.24 81.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.762 0.315 . . . . 1.0 110.644 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.01 -44.92 99.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.564 -0.454 . . . . 1.0 110.551 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.4 mm -62.92 -44.78 99.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.449 -0.5 . . . . 1.0 111.35 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.492 ' O ' ' CG ' ' A' ' 92' ' ' GLN . 79.7 t -67.49 -45.67 84.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 112.723 0.638 . . . . 1.0 112.723 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.06 -19.38 61.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.739 0.304 . . . . 1.0 111.76 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -93.59 -50.73 5.27 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.353 -0.539 . . . . 1.0 111.781 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.659 HD21 ' CD1' ' A' ' 30' ' ' PHE . 11.1 mp -66.6 -43.64 84.31 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.382 0.512 . . . . 1.0 112.382 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.492 ' CG ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -65.75 -41.9 91.58 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.098 -0.641 . . . . 1.0 111.455 -177.753 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -70.94 -44.12 66.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.304 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -65.9 -41.99 90.77 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.239 -0.585 . . . . 1.0 111.154 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.0 t -65.53 -44.51 94.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.363 -0.535 . . . . 1.0 111.114 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.529 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -66.56 -46.96 74.32 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.569 -0.453 . . . . 1.0 111.706 -178.871 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 tp -69.78 -41.13 75.54 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.717 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.1 tp -61.61 -44.63 96.63 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.344 -0.542 . . . . 1.0 110.565 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.529 ' ND2' ' HA ' ' A' ' 96' ' ' ARG . 1.1 p30 -70.0 -35.97 74.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.154 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.454 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 44.2 tt0 -71.37 -43.81 66.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.564 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 5.5 ttt -66.93 -55.08 16.15 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.575 -0.45 . . . . 1.0 111.63 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.42 HG23 ' CE2' ' A' ' 107' ' ' PHE . 52.6 m -57.82 -37.99 74.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.071 0.462 . . . . 1.0 110.639 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 41.4 t -72.33 10.36 0.81 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.636 -0.711 . . . . 1.0 110.999 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 101' ' ' MET . 78.1 p -92.91 135.46 34.13 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.565 -0.288 . . . . 1.0 110.454 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.59 -16.72 40.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.567 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 24.2 mmtp -93.82 38.46 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 1.0 109.808 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.42 ' CE2' HG23 ' A' ' 102' ' ' THR . 86.8 t80 -132.04 111.83 11.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.284 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -131.06 114.0 14.63 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.7 p -89.67 88.97 7.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.001 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.79 156.32 15.71 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.538 ' O ' HG23 ' A' ' 115' ' ' VAL . 67.8 p -75.05 169.58 17.73 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -57.28 -38.32 73.75 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.841 -0.343 . . . . 1.0 110.415 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -68.49 -42.94 77.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.356 0.598 . . . . 1.0 110.933 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 51.6 t0 -68.09 -21.78 64.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.411 -0.813 . . . . 1.0 110.89 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 111' ' ' THR . 44.4 t -71.63 -43.33 71.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.767 0.317 . . . . 1.0 110.198 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.83 -47.13 92.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.09 0.471 . . . . 1.0 110.409 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -65.66 -38.24 88.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.076 0.465 . . . . 1.0 110.851 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -65.02 -49.81 68.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.821 -0.627 . . . . 1.0 111.76 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.401 HD11 HG13 ' A' ' 131' ' ' VAL . 10.6 tp -70.26 -39.49 76.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.866 0.365 . . . . 1.0 110.571 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.513 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 63.7 mm-40 -62.67 -42.75 99.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.553 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -61.14 -47.68 85.12 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.574 -0.45 . . . . 1.0 110.279 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -61.12 -39.7 91.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.77 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.5 p -60.16 -38.59 83.63 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.404 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -62.46 -40.32 96.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.258 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.03 -42.69 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.657 -0.498 . . . . 1.0 109.657 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.74 75.67 79.4 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.2 178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.31 -23.43 44.73 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.75 2.3 . . . . 1.0 112.53 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -95.89 -9.75 30.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.146 -0.479 . . . . 1.0 112.028 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -107.29 149.83 27.35 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.977 0.418 . . . . 1.0 110.379 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.9 p -80.83 162.81 23.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.757 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.401 HG13 HD11 ' A' ' 119' ' ' ILE . 3.9 p -152.37 147.55 14.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.489 ' O ' ' CD1' ' A' ' 133' ' ' TYR . 28.7 p90 -149.39 142.61 25.08 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.789 0.328 . . . . 1.0 111.118 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 29.7 m-85 -151.75 169.2 22.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.306 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.567 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -133.83 152.62 51.93 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 179.19 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 72.3 m -152.11 170.16 20.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.419 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.0 tp -80.94 145.2 31.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.839 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 4.3 p30 -53.85 -171.89 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.179 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.463 ' CG ' ' O ' ' A' ' 138' ' ' HIS . 35.4 t-80 -135.31 35.2 3.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.531 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -169.63 -53.89 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.67 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.52 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 21.3 t-20 -105.16 86.69 1.67 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.099 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.473 ' HA ' HD21 ' A' ' 137' ' ' ASN . 29.9 Cg_endo -64.61 100.76 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.077 1.851 . . . . 1.0 112.316 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.506 ' H ' HD21 ' A' ' 137' ' ' ASN . . . 169.55 -36.3 0.19 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.517 -1.033 . . . . 1.0 110.517 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.407 ' CD1' ' N ' ' A' ' 143' ' ' TRP . 21.5 m95 -98.7 144.7 27.67 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 110.04 -0.356 . . . . 1.0 110.04 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 61.7 m-85 -107.42 149.6 27.71 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.173 -0.467 . . . . 1.0 109.778 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.405 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 32.3 m-85 -120.41 137.68 54.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.394 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.426 HD12 ' CG2' ' A' ' 161' ' ' VAL . 11.8 mt -110.04 121.01 44.26 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.318 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.553 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -116.41 145.89 42.91 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 178.402 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -159.69 155.26 25.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.513 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 64.5 tttt -141.36 129.61 22.27 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.752 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.5 mm -71.15 -46.48 66.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.875 -0.33 . . . . 1.0 111.725 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 151' ' ' ASN . 7.6 p-10 -162.24 177.88 9.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.35 . . . . 1.0 110.589 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.29 -32.89 74.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.067 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -84.45 7.59 19.22 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.018 0.437 . . . . 1.0 110.713 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.462 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 1.5 t -104.99 158.4 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.08 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -88.88 162.46 16.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.91 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.6 tp -80.38 118.94 22.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.982 0.42 . . . . 1.0 110.281 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -105.27 132.86 50.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.738 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 87.0 m -130.6 130.46 44.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.847 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -116.35 161.09 19.58 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.075 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.405 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 78.0 m-20 -107.2 144.68 33.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.739 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.426 ' CG2' HD12 ' A' ' 146' ' ' LEU . 58.8 t -126.57 136.7 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -99.62 130.41 45.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.912 0.387 . . . . 1.0 110.759 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.8 tp -92.36 130.8 37.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.032 -0.531 . . . . 1.0 109.66 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.3 p -129.73 165.76 21.24 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.0 0.429 . . . . 1.0 110.35 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 165' ' ' ASN . 9.1 t30 -79.23 15.72 1.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.628 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 20.0 p -122.27 -2.31 9.08 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.802 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.56 -131.87 5.19 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.419 -1.072 . . . . 1.0 110.419 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.85 130.55 53.02 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.077 -0.342 . . . . 1.0 110.077 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.477 ' CE1' ' OD1' ' A' ' 174' ' ' ASN . 5.7 m-85 -107.52 121.71 45.19 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.821 -0.437 . . . . 1.0 109.821 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.8 tt -114.38 119.1 35.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.711 -0.477 . . . . 1.0 109.711 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.5 t 36.16 57.92 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 112.166 0.432 . . . . 1.0 112.166 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 14.5 m120 65.27 27.17 12.16 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.045 0.757 . . . . 1.0 113.045 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -133.95 119.95 19.72 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.477 ' OD1' ' CE1' ' A' ' 169' ' ' PHE . 62.4 t30 -93.67 129.03 40.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 1.0 111.226 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -107.77 101.39 40.13 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -45.91 -23.49 1.72 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.489 2.126 . . . . 1.0 113.33 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.96 146.66 37.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 1.0 111.009 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.47 -33.42 56.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.92 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 179' ' ' ILE . 33.9 mm -60.87 -44.2 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.278 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -69.7 -30.34 67.96 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.5 -0.555 . . . . 1.0 109.5 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.29 -43.08 98.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.281 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 93.5 m -63.7 -46.49 85.24 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.336 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 186' ' ' LYS . 75.9 m-20 -65.19 -48.82 72.07 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.09 -45.68 0.89 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -68.92 -45.91 69.64 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 183' ' ' ASN . 36.6 tptt -57.14 -40.88 78.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.455 -0.793 . . . . 1.0 109.902 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 16.5 m -59.71 -46.7 88.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.1 -40.32 95.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.826 -0.624 . . . . 1.0 109.881 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 59.3 tp -57.87 -45.7 85.94 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.647 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -54.83 -45.65 74.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.167 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.7 t -62.25 -40.75 97.22 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.161 0.505 . . . . 1.0 110.34 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.41 -37.02 86.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.761 -0.654 . . . . 1.0 111.974 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -58.33 -30.14 66.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.622 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -82.2 -7.41 59.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.92 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 83.9 t60 50.73 49.34 21.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.01 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.511 ' O ' ' N ' ' A' ' 198' ' ' HIS . 50.0 t-80 -91.35 45.87 1.27 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.397 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 86.1 t60 53.89 -83.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.599 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 196' ' ' HIS . 85.7 t60 -151.97 118.6 5.71 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.475 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.427 ' ND1' ' N ' ' A' ' 199' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.087 -0.959 . . . . 1.0 110.65 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.9 mtp85 . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 120.863 0.363 . . . . 1.0 110.558 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.46 -27.47 41.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.565 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 13.3 pt -67.78 -40.77 84.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.435 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -107.2 14.01 26.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.432 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -46.97 145.97 2.99 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.422 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -49.98 -36.22 43.51 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.671 1.581 . . . . 1.0 112.226 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.61 ' CD2' ' CZ ' ' A' ' 30' ' ' PHE . 80.2 m-85 -82.7 -1.56 51.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.385 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.531 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 42.2 t80 -72.32 129.61 38.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.34 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 54.0 m-85 -148.69 115.92 3.85 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 120.9 -0.32 . . . . 1.0 110.43 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.477 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 73.1 Cg_endo -74.76 109.88 3.0 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.754 1.636 . . . . 1.0 112.703 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 76.5 m-85 -155.33 159.4 39.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.525 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -77.16 172.16 13.68 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.449 ' C ' ' HE ' ' A' ' 16' ' ' ARG . . . -61.67 -46.84 93.42 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.446 -0.883 . . . . 1.0 111.108 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.639 ' HE ' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -66.06 -41.52 90.69 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 121.038 -0.265 . . . . 1.0 111.164 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -66.09 -35.66 81.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.279 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.84 -44.98 96.25 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.308 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -65.78 -41.97 91.37 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.034 179.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.46 -41.64 97.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.212 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -63.07 -39.47 94.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.54 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.2 mp -79.57 -13.26 59.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.723 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -63.57 -42.95 98.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.731 -0.388 . . . . 1.0 110.47 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.0 t -76.65 -20.33 56.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.79 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -84.17 177.55 8.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.456 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -89.2 176.33 7.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.863 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.448 ' NE ' ' OD1' ' A' ' 49' ' ' ASP . 84.9 mtt85 -76.32 147.57 38.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.974 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.46 19.67 37.49 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -99.73 140.79 33.42 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.61 ' CZ ' ' CD2' ' A' ' 9' ' ' TYR . 7.1 p90 -134.68 168.56 18.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.338 0.589 . . . . 1.0 111.11 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -147.32 158.25 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.251 -0.886 . . . . 1.0 111.498 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -116.87 129.17 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -138.74 157.85 45.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.418 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -115.63 135.51 53.99 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.859 -0.423 . . . . 1.0 109.859 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.1 t -95.27 126.74 40.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.764 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 96.5 p -59.59 -37.68 79.18 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.598 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.3 -24.37 62.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.874 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -75.37 -63.24 2.54 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.689 -0.964 . . . . 1.0 110.689 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 t0 73.66 -40.19 0.46 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.694 0.283 . . . . 1.0 110.803 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 38' ' ' GLY . 92.3 m-20 -118.91 11.08 12.45 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.748 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.436 ' CE1' HE21 ' A' ' 59' ' ' GLN . 10.8 m-70 -138.7 150.73 46.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.929 0.395 . . . . 1.0 110.205 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.04 154.19 33.51 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.064 -0.516 . . . . 1.0 109.727 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.7 t -124.39 130.01 73.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 1.0 110.079 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.7 mt -112.97 139.21 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.7 m -118.68 140.04 50.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.928 -0.578 . . . . 1.0 109.455 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -144.01 159.58 42.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.515 -0.766 . . . . 1.0 111.001 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.582 ' NZ ' ' O ' ' A' ' 50' ' ' LYS . 36.2 tttp -107.28 138.54 43.28 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.89 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.857 ' N ' HD12 ' A' ' 48' ' ' LEU . 3.2 mp -95.85 -74.23 0.56 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.371 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 50' ' ' LYS . 66.9 t0 -159.66 140.08 12.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.336 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.582 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 2.9 ttmm 43.81 -152.92 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.083 0.468 . . . . 1.0 111.183 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.74 63.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.836 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 50' ' ' LYS . 17.2 tp -145.68 120.75 10.09 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.977 0.418 . . . . 1.0 110.278 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -134.18 149.16 51.0 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.36 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -137.97 153.49 49.44 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.76 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.479 ' ND1' ' N ' ' A' ' 55' ' ' HIS . 1.9 p-80 -126.61 142.37 51.56 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.153 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.5 mt -126.06 131.7 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -94.27 120.53 34.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.028 0.442 . . . . 1.0 110.726 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.1 mm -90.47 128.0 42.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.083 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 60' ' ' GLU . 3.4 tm0? -113.71 128.9 56.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.042 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.52 ' O ' ' NE2' ' A' ' 59' ' ' GLN . 1.9 pp20? -101.17 148.6 24.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.276 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 1.9 tt -142.66 173.1 11.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.475 -0.329 . . . . 1.0 110.919 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 2.0 tm-20 82.07 25.2 0.19 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.383 0.611 . . . . 1.0 110.05 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.721 ' H ' ' CD ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -80.49 117.1 20.92 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.794 0.807 . . . . 1.0 110.122 178.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -89.66 -33.43 16.64 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.834 -0.541 . . . . 1.0 110.539 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.524 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -154.05 165.4 18.0 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.073 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.5 -29.7 60.93 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.162 1.908 . . . . 1.0 112.242 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.9 mt -90.02 -1.35 57.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.535 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.524 ' HB3' ' H ' ' A' ' 65' ' ' ASN . . . -92.25 134.45 34.87 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.278 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.4 mt -89.86 147.09 23.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.375 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.2 104.86 1.5 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -75.64 -13.43 60.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.772 0.32 . . . . 1.0 110.781 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.8 t -123.54 124.41 69.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.771 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.6 mt -117.07 133.32 56.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.52 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mp -102.41 124.61 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.825 0.345 . . . . 1.0 110.076 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -143.03 133.17 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.551 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.498 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 46.7 t0 53.44 46.49 26.13 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.985 -0.286 . . . . 1.0 111.046 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 76' ' ' ASP . 4.1 p30 56.75 18.68 3.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.977 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -125.12 147.26 49.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 1.0 110.135 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.86 127.92 44.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.224 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -120.46 139.91 52.16 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.18 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -84.51 -36.99 21.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.73 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -119.52 144.2 47.16 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.202 0.525 . . . . 1.0 111.989 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.7 tp -64.77 -39.38 93.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.764 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -60.19 -42.75 95.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 1.0 111.562 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -60.68 -37.87 83.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.58 0.229 . . . . 1.0 110.67 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.58 -47.41 92.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.901 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.75 -45.22 99.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.525 -0.47 . . . . 1.0 111.658 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.28 -43.29 74.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 112.626 0.602 . . . . 1.0 112.626 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -74.73 -15.81 60.76 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.721 -0.392 . . . . 1.0 111.862 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -94.8 -49.44 5.59 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.651 -0.419 . . . . 1.0 111.953 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.508 ' O ' HG23 ' A' ' 95' ' ' VAL . 9.8 mp -69.15 -40.35 78.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.228 0.455 . . . . 1.0 112.228 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -63.38 -49.2 74.74 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.797 -0.761 . . . . 1.0 111.556 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -72.67 -41.7 65.11 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.694 -0.403 . . . . 1.0 111.673 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -66.3 -41.48 89.69 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.334 -0.546 . . . . 1.0 111.389 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 91' ' ' LEU . 54.7 t -64.99 -46.7 90.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.251 -0.58 . . . . 1.0 111.355 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -66.34 -44.27 83.78 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.495 -0.482 . . . . 1.0 111.744 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.4 tp -66.94 -43.86 82.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.42 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 tt -64.64 -43.23 94.34 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.302 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -68.11 -35.76 78.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.859 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -70.69 -41.86 71.45 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 120.776 -0.37 . . . . 1.0 111.777 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.598 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 5.2 ttt -67.81 -54.56 18.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.538 -0.465 . . . . 1.0 111.462 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.8 m -58.45 -41.32 84.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.992 0.425 . . . . 1.0 110.301 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.9 m -72.37 8.09 1.51 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.863 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -85.6 140.18 30.81 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.823 0.344 . . . . 1.0 110.495 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.63 -22.15 66.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.674 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.55 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 24.8 mtmm -89.22 39.97 0.96 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.983 -0.553 . . . . 1.0 109.778 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -132.14 109.43 9.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.329 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -126.4 129.02 47.95 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.181 -0.463 . . . . 1.0 109.8 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.4 t -93.66 74.99 4.35 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.749 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.45 143.52 15.91 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.027 -0.829 . . . . 1.0 111.027 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.552 ' O ' HG23 ' A' ' 115' ' ' VAL . 81.1 p -75.12 172.04 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.051 -0.351 . . . . 1.0 110.051 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -57.51 -41.2 80.36 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.419 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -68.48 -45.01 73.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.88 0.372 . . . . 1.0 110.754 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.13 -20.51 64.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.865 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 111' ' ' THR . 13.4 t -70.71 -45.52 73.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.808 0.337 . . . . 1.0 110.428 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.5 t -64.45 -45.33 96.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.148 0.499 . . . . 1.0 110.235 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -66.07 -34.3 77.76 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.942 0.401 . . . . 1.0 111.019 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -69.5 -49.2 56.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.999 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.0 tp -69.67 -39.59 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.42 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -65.37 -43.19 91.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.72 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.82 -48.24 77.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.311 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.501 ' CD2' ' OD1' ' A' ' 126' ' ' ASN . 47.1 t80 -62.91 -43.26 99.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.93 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 88.1 p -61.02 -35.38 76.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.226 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -62.36 -42.61 99.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.06 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.9 t -66.67 -30.4 49.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 1.0 109.849 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.501 ' OD1' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -128.21 74.26 79.49 Favored Pre-proline 0 N--CA 1.471 0.59 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.531 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -71.88 -24.53 20.97 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.801 2.334 . . . . 1.0 112.609 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -102.3 14.59 31.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.018 -0.537 . . . . 1.0 112.002 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -137.54 144.93 42.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.117 0.484 . . . . 1.0 110.313 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.1 p -80.89 163.09 23.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.014 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 p -152.21 147.26 15.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -143.39 142.09 31.12 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.895 0.378 . . . . 1.0 111.196 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -152.43 168.46 25.41 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.432 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.55 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.7 OUTLIER -138.1 157.53 46.14 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 179.187 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.8 p -151.61 168.38 25.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.292 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 51.5 tp -80.65 136.86 36.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.821 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 23.8 t-20 -95.12 138.48 32.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.333 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -91.31 -31.66 16.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.714 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.41 -24.55 64.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.235 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 4.5 m120 -141.67 81.0 15.41 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.268 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -58.82 134.55 61.13 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.12 1.88 . . . . 1.0 112.445 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.89 -28.62 14.04 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 110.999 -0.84 . . . . 1.0 110.999 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 10.4 m0 -95.54 147.21 23.8 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.856 0.36 . . . . 1.0 110.284 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.598 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 70.9 m-85 -111.61 149.81 30.97 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.035 -0.53 . . . . 1.0 109.812 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.538 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 14.4 m-85 -120.08 136.13 54.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.22 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 16.5 mt -107.96 124.78 50.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.424 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.517 ' SD ' HG13 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -121.58 146.76 46.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.885 -1.154 . . . . 1.0 107.885 178.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -162.05 152.44 17.12 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.592 -0.522 . . . . 1.0 109.592 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.535 ' NZ ' ' O ' ' A' ' 154' ' ' SER . 37.5 tttp -136.41 129.5 31.29 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.472 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.696 HD12 ' H ' ' A' ' 150' ' ' ILE . 4.8 mp -72.49 -46.22 56.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.266 0.469 . . . . 1.0 112.266 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 150' ' ' ILE . 85.2 m-20 -156.95 170.15 23.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.573 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.08 71.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.947 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -89.01 6.68 38.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.433 . . . . 1.0 110.454 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.535 ' O ' ' NZ ' ' A' ' 149' ' ' LYS . 18.0 t -97.31 154.6 17.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.476 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -84.39 145.95 27.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.104 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.5 tp -70.63 126.28 29.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.958 0.409 . . . . 1.0 109.991 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -113.85 132.64 55.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.944 -0.571 . . . . 1.0 109.927 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 97.2 m -129.86 131.28 46.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.818 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.03 163.93 15.87 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.03 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.538 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 58.8 m-20 -111.9 148.85 32.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.695 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.65 137.58 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -100.17 132.36 45.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.98 0.419 . . . . 1.0 110.623 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.9 tp -92.62 131.26 37.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.662 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.0 p -130.38 171.18 13.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.482 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -84.63 15.66 3.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.759 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 2.1 m -122.66 -3.13 8.79 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.96 0.41 . . . . 1.0 110.685 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 141.01 -136.04 7.3 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -117.47 129.08 55.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.641 0.258 . . . . 1.0 110.35 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -106.38 119.84 40.33 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.0 tt -116.68 117.48 29.93 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.403 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.7 t 35.46 56.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.338 0.495 . . . . 1.0 112.338 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.5 m120 69.57 28.15 4.64 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.247 0.832 . . . . 1.0 113.247 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -134.31 121.01 20.63 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -90.83 127.66 36.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.226 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -115.16 91.59 28.17 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.32 -20.04 14.16 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.553 2.168 . . . . 1.0 113.291 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 72.1 m -133.1 138.49 46.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.044 0.45 . . . . 1.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.38 -34.4 60.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.777 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.16 -43.47 96.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -65.17 -34.62 78.83 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.8 tp -64.56 -41.36 96.36 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.389 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 77.8 m -61.29 -47.37 86.27 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 120.559 -0.456 . . . . 1.0 110.616 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 186' ' ' LYS . 62.8 t-20 -69.03 -48.4 63.02 Favored 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 119.647 -0.821 . . . . 1.0 108.915 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.51 -45.48 0.5 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.914 -1.274 . . . . 1.0 109.914 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -68.86 -47.76 65.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.061 -0.57 . . . . 1.0 109.64 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' A' ' 183' ' ' ASN . 47.0 tttp -56.77 -41.29 77.36 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.014 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 18.1 m -63.81 -44.56 92.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 15.4 mt -62.92 -43.28 99.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.006 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.7 tp -59.82 -43.36 94.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.34 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.39 -43.21 99.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.425 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 18.2 p -65.49 -37.66 87.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.066 0.46 . . . . 1.0 110.803 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 24.4 mt -64.0 -41.01 97.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.692 -0.686 . . . . 1.0 111.818 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.72 -25.33 68.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.464 -0.334 . . . . 1.0 111.817 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 120.656 0.265 . . . . 1.0 110.987 -179.495 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 83.6 mtm-85 . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 120.896 0.379 . . . . 1.0 110.368 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.5 p -64.52 -30.98 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.55 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.6 pt -72.4 -20.96 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.658 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -96.34 7.35 46.68 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.428 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.63 141.23 64.58 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.321 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.76 -21.12 58.7 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.75 1.633 . . . . 1.0 112.181 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.88 3.22 49.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.214 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -83.68 132.4 34.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.569 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -152.41 118.14 3.03 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 120.931 -0.308 . . . . 1.0 110.247 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.49 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 72.5 Cg_endo -74.91 112.04 3.47 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.732 1.621 . . . . 1.0 112.659 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.49 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 70.2 m-85 -159.8 158.21 30.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.399 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -80.09 176.4 9.78 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.45 -50.33 67.74 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.373 -0.917 . . . . 1.0 110.988 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -66.01 -41.36 91.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.764 0.316 . . . . 1.0 110.956 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.412 ' OE1' ' N ' ' A' ' 17' ' ' GLN . 7.4 mp0 -62.8 -37.04 85.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.09 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.436 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -62.87 -44.52 95.9 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.508 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -60.82 -48.18 82.99 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.669 -0.412 . . . . 1.0 109.925 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -61.7 -40.22 94.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.201 -0.454 . . . . 1.0 109.899 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -61.96 -39.31 91.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.243 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 18' ' ' ALA . 7.9 mp -82.15 -13.83 56.59 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.846 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.6 ttp85 -65.11 -41.16 95.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.852 0.358 . . . . 1.0 110.336 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.3 m -78.17 -19.86 53.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.875 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -85.12 -179.84 7.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.823 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -81.78 165.49 20.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.813 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -75.75 145.77 40.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.778 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 17.92 49.46 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.982 -0.847 . . . . 1.0 110.982 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -85.16 147.56 26.55 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.425 ' CD2' ' HB3' ' A' ' 46' ' ' TRP . 27.6 m-85 -129.65 153.38 48.16 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.308 0.575 . . . . 1.0 111.098 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 44' ' ' ILE . 16.0 m -144.55 153.91 14.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.187 -0.915 . . . . 1.0 111.211 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.1 mm -115.49 131.19 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -133.74 151.69 51.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.997 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -109.93 130.66 55.5 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.17 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.8 t -82.72 162.82 21.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.579 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.9 p -111.7 -10.97 14.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.717 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -80.79 -30.18 35.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.165 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.656 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . -115.74 -12.14 9.68 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.01 -64.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.978 0.458 . . . . 1.0 110.405 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.656 ' N ' ' O ' ' A' ' 38' ' ' GLY . 24.8 t0 -78.45 12.47 1.96 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.441 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -117.19 142.4 47.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.83 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.25 148.33 44.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.344 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.9 t -123.49 130.2 74.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.781 -0.452 . . . . 1.0 109.781 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 31' ' ' VAL . 79.3 mt -110.62 136.88 45.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 94.0 m -118.39 140.98 49.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.536 -0.756 . . . . 1.0 109.344 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.56 ' CE2' HD11 ' A' ' 48' ' ' LEU . 5.3 p-90 -147.94 151.37 35.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.968 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.503 ' C ' HD12 ' A' ' 48' ' ' LEU . 18.6 ttmm -96.51 140.62 30.87 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.746 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.5 mp -99.57 -68.74 0.79 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.342 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -137.32 -153.19 0.47 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.226 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -68.64 136.46 53.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.667 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 42.08 43.54 2.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.848 -0.615 . . . . 1.0 111.111 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.432 HD11 ' HB3' ' A' ' 141' ' ' PRO . 11.5 tp -140.44 122.71 15.88 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.942 0.401 . . . . 1.0 109.952 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.432 ' O ' ' OE1' ' A' ' 54' ' ' GLN . 47.8 m-85 -133.22 150.1 51.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.583 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.432 ' OE1' ' O ' ' A' ' 53' ' ' PHE . 16.0 mm100 -138.57 150.22 46.09 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.667 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -125.05 138.9 54.19 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.213 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.7 mt -123.84 129.78 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 41.2 p-10 -95.5 121.03 36.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.934 0.397 . . . . 1.0 111.243 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.3 mm -98.42 122.48 50.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.032 -0.531 . . . . 1.0 109.99 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -117.4 132.28 56.6 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.813 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -98.96 153.64 18.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.342 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.498 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.8 tp -145.14 -179.07 6.39 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.567 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.498 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 20.5 tt0 70.66 42.89 0.79 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.991 -0.55 . . . . 1.0 109.705 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -83.75 102.22 12.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.78 -0.645 . . . . 1.0 109.844 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.435 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 80.6 mm-40 -68.45 -28.42 67.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.67 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 64' ' ' GLU . 2.6 m-80 -158.01 163.79 23.44 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.226 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.58 -32.04 52.1 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.12 1.88 . . . . 1.0 112.371 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.498 HD23 ' H ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -89.61 -5.28 57.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.826 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.73 134.28 51.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.327 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.7 mt -83.7 156.19 22.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.379 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.91 86.84 0.05 OUTLIER Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.455 -1.058 . . . . 1.0 110.455 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.27 -39.49 86.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.969 0.414 . . . . 1.0 111.067 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 51.0 t -117.13 123.92 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.768 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.3 mt -116.14 129.3 56.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.243 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.4 mt -101.29 125.67 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -140.91 130.24 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.313 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.426 ' OD1' ' OD1' ' A' ' 165' ' ' ASN . 15.5 t70 53.28 46.4 26.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.231 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.8 m120 57.63 16.03 3.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.895 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -120.63 136.29 54.87 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.948 0.404 . . . . 1.0 110.045 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -89.84 127.59 36.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.738 -0.665 . . . . 1.0 111.102 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -118.27 142.86 47.05 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.199 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -83.45 -37.52 23.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.817 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 50.7 t0 -129.66 153.69 47.87 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.242 0.544 . . . . 1.0 111.819 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.567 ' HA ' HD12 ' A' ' 86' ' ' ILE . 54.0 tp -63.98 -38.78 92.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.791 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.69 -45.47 89.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.562 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -61.18 -37.31 82.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.687 0.28 . . . . 1.0 110.641 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 83' ' ' LEU . 96.6 mt -58.87 -47.63 88.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.659 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.8 mm -62.99 -44.82 99.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.476 -0.489 . . . . 1.0 111.678 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.85 -43.52 96.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 112.372 0.508 . . . . 1.0 112.372 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -72.96 -21.29 60.89 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.577 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.55 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 2.2 t80 -89.35 -51.29 5.64 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.176 -0.61 . . . . 1.0 111.485 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 95' ' ' VAL . 10.3 mp -62.69 -42.69 99.77 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.629 -0.429 . . . . 1.0 111.832 -178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -63.54 -50.79 68.15 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.691 -0.803 . . . . 1.0 111.446 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -68.94 -42.66 76.41 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.715 -0.394 . . . . 1.0 111.54 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -65.31 -44.32 88.24 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.162 -0.615 . . . . 1.0 111.318 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 91' ' ' LEU . 75.3 t -66.53 -44.22 90.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.406 -0.518 . . . . 1.0 111.205 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -67.25 -45.18 77.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.482 -0.327 . . . . 1.0 111.353 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.21 -44.59 91.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.583 -0.281 . . . . 1.0 111.649 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.2 tp -63.56 -40.55 97.28 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.021 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.4 ' O ' ' CB ' ' A' ' 103' ' ' SER . 92.7 m-20 -67.21 -42.42 84.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.77 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -64.38 -43.18 95.27 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 121.983 -0.448 . . . . 1.0 111.545 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.5 ttm -67.63 -56.23 10.21 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.42 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.2 m -59.54 -44.17 93.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.032 0.444 . . . . 1.0 110.815 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 7.6 t -72.99 11.73 0.64 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.68 -0.691 . . . . 1.0 111.298 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.3 t -92.89 135.48 34.11 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.87 0.367 . . . . 1.0 110.248 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.58 -21.14 66.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.942 0.401 . . . . 1.0 111.17 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.537 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 52.9 mttp -89.87 41.09 1.03 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.919 -0.582 . . . . 1.0 109.903 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -133.34 115.25 14.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.2 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -134.43 120.87 20.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.786 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.0 m -90.25 82.44 6.0 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.914 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.76 150.99 17.12 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.848 -0.901 . . . . 1.0 110.848 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 115' ' ' VAL . 9.0 p -79.41 173.96 12.05 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.033 -0.358 . . . . 1.0 110.033 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.42 ' NZ ' ' CG ' ' A' ' 138' ' ' HIS . 16.0 mtmm -59.39 -37.6 78.4 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.821 -0.352 . . . . 1.0 110.684 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -68.27 -43.25 78.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.052 0.453 . . . . 1.0 110.562 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -70.63 -19.19 62.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.73 -0.668 . . . . 1.0 111.067 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.557 HG13 ' SD ' ' A' ' 147' ' ' MET . 19.2 t -70.74 -45.34 74.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.704 -0.398 . . . . 1.0 110.13 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.99 -45.43 90.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-O 121.333 0.587 . . . . 1.0 110.251 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -65.84 -37.88 87.38 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.931 0.396 . . . . 1.0 111.326 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -69.43 -47.82 62.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.913 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.8 tp -69.64 -39.89 78.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.397 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.472 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 61.1 mm-40 -64.56 -42.76 95.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.728 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.13 -48.16 77.16 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.298 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CD1' ' OD1' ' A' ' 126' ' ' ASN . 30.0 t80 -62.34 -43.76 98.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.137 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.1 t -59.58 -40.4 87.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.096 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -58.48 -42.59 87.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 1.0 109.939 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.0 t -64.03 -37.98 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.445 ' OD1' ' CD1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -124.62 76.83 63.91 Favored Pre-proline 0 N--CA 1.473 0.704 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.351 179.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.487 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 7.1 Cg_exo -71.17 -27.29 20.2 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.634 2.223 . . . . 1.0 112.621 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -100.51 11.33 39.69 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.885 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -131.46 146.22 52.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.188 0.518 . . . . 1.0 110.433 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.8 m -80.83 163.52 23.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.537 -0.756 . . . . 1.0 109.913 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 p -151.24 145.65 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -145.89 142.24 28.59 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.912 0.387 . . . . 1.0 111.112 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -152.47 167.8 27.6 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.347 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -132.2 156.31 46.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 179.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.5 p -152.93 169.64 22.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.447 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 137' ' ' ASN . 54.0 tp -77.04 136.33 38.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.546 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.536 ' OD1' ' ND2' ' A' ' 140' ' ' ASN . 11.0 t-20 -44.08 170.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.403 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.515 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 57.1 t-80 -77.26 -56.45 4.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.038 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 139' ' ' ASP . 66.5 t0 -139.6 45.25 1.93 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.981 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.536 ' ND2' ' OD1' ' A' ' 137' ' ' ASN . 1.3 m-80 -136.87 102.47 9.29 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 109.905 -0.405 . . . . 1.0 109.905 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.432 ' HB3' HD11 ' A' ' 52' ' ' LEU . 45.8 Cg_endo -75.19 120.59 6.07 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.944 1.762 . . . . 1.0 112.608 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.16 20.68 22.57 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.886 -0.886 . . . . 1.0 110.886 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -134.44 139.86 45.83 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.873 0.368 . . . . 1.0 110.281 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -132.5 160.04 37.65 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.841 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 145' ' ' TYR . 8.1 p90 -142.11 146.94 35.95 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.2 mt -106.36 126.57 52.41 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.136 0.493 . . . . 1.0 110.366 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.557 ' SD ' HG13 ' A' ' 115' ' ' VAL . 5.9 ptt? -116.86 144.83 44.05 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.928 -1.138 . . . . 1.0 107.928 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 148' ' ' PHE . 13.3 p90 -162.8 154.19 17.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.549 -0.538 . . . . 1.0 109.549 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.472 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 69.2 tttt -135.13 131.13 36.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.468 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.486 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 38.6 mm -72.41 -45.61 59.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.994 0.368 . . . . 1.0 111.994 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 27.8 m120 -161.61 173.06 15.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.577 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.52 -34.44 75.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.071 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.75 -12.96 55.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.588 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.431 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 8.4 t -79.82 158.71 26.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.32 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -89.77 150.58 22.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 1.0 109.98 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.6 tp -71.07 124.75 25.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.872 0.368 . . . . 1.0 110.211 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -110.91 129.3 55.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.667 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 91.1 m -131.24 131.43 43.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.114 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.75 166.15 13.13 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -107.97 142.45 38.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.114 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.5 t -122.3 138.29 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -106.01 135.15 47.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.034 0.445 . . . . 1.0 110.742 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.6 131.69 45.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.688 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.2 p -134.83 178.01 7.34 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.349 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.55 ' ND2' ' CE1' ' A' ' 90' ' ' TYR . 5.3 m120 -86.78 14.59 6.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.717 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 17.9 p -119.01 -1.12 11.01 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.483 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.74 -131.35 5.84 Favored Glycine 0 N--CA 1.465 0.59 0 N-CA-C 110.25 -1.14 . . . . 1.0 110.25 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -121.8 127.28 50.42 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -102.29 123.83 46.79 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.4 tt -117.96 111.79 19.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.519 -0.549 . . . . 1.0 109.519 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.5 t 35.94 59.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.175 0.435 . . . . 1.0 112.175 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.8 m120 69.4 27.52 4.97 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.98 0.733 . . . . 1.0 112.98 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -134.13 120.59 20.32 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -95.91 126.68 41.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.238 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -108.9 99.29 34.21 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 109.573 -0.528 . . . . 1.0 109.573 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.15 -21.57 9.51 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.382 2.055 . . . . 1.0 113.444 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.424 ' HB2' HE21 ' A' ' 180' ' ' GLN . 38.5 m -132.92 139.07 47.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.041 0.448 . . . . 1.0 111.253 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.96 -35.61 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.617 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.421 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 95.4 mt -63.32 -43.36 98.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 1.0 110.054 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.693 ' H ' HE21 ' A' ' 180' ' ' GLN . 0.6 OUTLIER -63.11 -31.46 72.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.224 -0.658 . . . . 1.0 109.224 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.78 -41.9 97.86 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.327 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . 0.63 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 3.0 p -58.96 -47.98 83.15 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.617 -0.433 . . . . 1.0 110.629 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.63 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 48.3 t30 -69.52 -48.91 58.95 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.44 -44.78 0.45 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.756 -1.338 . . . . 1.0 109.756 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -68.83 -47.44 66.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.052 -0.574 . . . . 1.0 109.76 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.574 ' N ' ' O ' ' A' ' 183' ' ' ASN . 88.8 tttt -57.03 -42.27 80.14 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.362 -0.836 . . . . 1.0 110.116 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 96.7 m -61.71 -44.33 97.14 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 53.1 mt -61.73 -41.57 97.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.773 -0.648 . . . . 1.0 109.928 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 59.2 tp -58.95 -44.15 91.4 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.388 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 16.5 tptp -62.01 -43.98 97.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.474 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.0 t -63.33 -38.45 91.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.363 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.4 mt -63.76 -42.08 97.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.829 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.41 -30.09 66.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.56 -0.291 . . . . 1.0 111.67 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.843 -179.123 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.435 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 41.1 mmm-85 . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 120.839 0.352 . . . . 1.0 110.503 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.83 -27.93 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.653 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.2 pt -76.49 -18.76 14.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.536 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 3' ' ' ARG . 56.1 p30 -99.35 7.44 45.55 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.485 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -84.99 138.49 37.12 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 110.091 -0.337 . . . . 1.0 110.091 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.59 -13.32 32.48 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.889 1.726 . . . . 1.0 112.342 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.418 ' CD1' ' CZ ' ' A' ' 30' ' ' PHE . 40.4 m-85 -99.35 10.68 40.95 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.572 -0.286 . . . . 1.0 111.069 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.532 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 91.0 t80 -85.98 123.36 31.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.316 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 49.5 m-85 -146.5 108.92 4.15 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 110.092 -0.336 . . . . 1.0 110.092 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.508 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 45.3 Cg_exo -58.88 109.57 0.54 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 121.697 1.598 . . . . 1.0 112.48 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 23.4 m-85 -159.48 155.69 26.95 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.626 -0.716 . . . . 1.0 110.555 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 18.8 t-20 -84.03 164.04 19.54 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.295 -0.631 . . . . 1.0 109.295 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . -61.14 -40.81 99.06 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.569 -0.824 . . . . 1.0 111.095 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -66.73 -43.97 82.81 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.911 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -69.46 -36.0 76.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.392 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -39.49 90.09 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.304 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -60.43 -44.07 96.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.081 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -61.57 -42.45 98.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.281 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -63.05 -42.16 99.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.59 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mp -77.67 -13.59 59.86 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.295 -0.411 . . . . 1.0 111.081 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -58.49 -42.83 88.46 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.385 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p -79.48 -18.4 52.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -82.54 177.91 8.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.499 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.536 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 56.4 mp0 -90.01 173.23 8.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.77 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 ptt-85 -81.19 145.01 31.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.727 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.94 -1.39 55.2 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -82.1 147.82 28.88 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.418 ' CZ ' ' CD1' ' A' ' 9' ' ' TYR . 13.7 p90 -133.47 163.17 29.97 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.353 0.597 . . . . 1.0 110.961 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.684 ' O ' HG23 ' A' ' 44' ' ' ILE . 31.1 m -146.88 157.95 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.21 -0.904 . . . . 1.0 111.298 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.8 mt -117.53 127.47 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.109 -0.496 . . . . 1.0 109.715 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -146.46 153.29 40.26 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.394 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -104.93 139.6 39.41 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.735 -0.468 . . . . 1.0 109.735 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -67.69 149.58 49.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.796 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 t -63.77 -20.5 65.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.966 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -125.01 10.18 8.17 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.574 -0.285 . . . . 1.0 110.684 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . -68.57 -56.93 8.76 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t0 67.54 -51.33 0.5 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.734 0.302 . . . . 1.0 110.874 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 38' ' ' GLY . 90.5 m-20 -122.05 4.92 9.84 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.008 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -120.16 149.96 41.4 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.042 0.449 . . . . 1.0 110.517 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.423 ' CD1' ' OE2' ' A' ' 60' ' ' GLU . 5.2 mp -121.45 147.5 45.66 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.096 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -126.5 132.13 70.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.684 HG23 ' O ' ' A' ' 31' ' ' VAL . 57.0 mt -113.74 139.83 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 108.837 -0.801 . . . . 1.0 108.837 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.2 m -120.4 142.39 49.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.035 -0.53 . . . . 1.0 109.692 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.67 ' CE2' HD11 ' A' ' 48' ' ' LEU . 2.4 p-90 -147.68 151.6 36.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.977 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.601 ' C ' HD12 ' A' ' 48' ' ' LEU . 87.6 tttt -99.66 140.33 34.01 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.87 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.67 HD11 ' CE2' ' A' ' 46' ' ' TRP . 9.0 mp -105.77 -82.08 0.53 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.605 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -93.81 -178.67 4.75 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.801 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -57.48 -40.48 78.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.667 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -127.51 53.45 1.75 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.092 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tp -151.42 128.22 10.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.898 0.38 . . . . 1.0 110.195 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -132.31 148.72 52.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.535 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.55 ' OE1' HD21 ' A' ' 48' ' ' LEU . 94.2 mt-30 -137.79 152.61 49.32 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.972 -0.558 . . . . 1.0 109.628 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -129.31 144.9 51.41 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.201 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.433 HD11 ' OH ' ' A' ' 90' ' ' TYR . 96.6 mt -126.27 130.82 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.842 -0.429 . . . . 1.0 109.842 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 43.7 p-10 -99.84 124.81 45.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.899 0.38 . . . . 1.0 110.633 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 90.1 mt -102.21 133.05 46.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.48 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -119.96 134.84 55.12 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.853 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.423 ' OE2' ' CD1' ' A' ' 42' ' ' LEU . 3.6 mt-10 -100.09 143.91 29.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.145 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.4 mt -141.22 174.8 10.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.413 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 74.05 35.36 0.78 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.957 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -95.12 103.14 14.99 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.021 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.3 -31.84 72.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.837 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -147.67 155.84 45.01 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.265 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.98 -31.96 46.06 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.199 1.933 . . . . 1.0 112.079 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tp -79.69 -10.82 59.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.881 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.73 136.23 45.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.494 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 71' ' ' LYS . 64.7 mt -81.44 154.23 26.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.312 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.6 86.01 0.01 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.427 -1.069 . . . . 1.0 110.427 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 69' ' ' LEU . 68.3 mttm -61.35 -35.65 78.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.997 0.427 . . . . 1.0 110.823 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.4 t -127.62 124.16 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.798 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.0 mt -114.77 126.44 54.84 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.8 mt -102.18 123.1 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.84 0.353 . . . . 1.0 110.24 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.2 t -143.45 132.72 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.138 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 54.49 43.66 29.99 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.954 -0.299 . . . . 1.0 111.05 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.6 m120 57.98 19.96 6.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.708 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -128.32 139.12 52.57 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.873 0.368 . . . . 1.0 110.33 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -89.15 133.18 34.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.041 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -124.52 138.23 54.35 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.131 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -81.92 -37.32 26.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 1.0 111.62 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -123.22 149.91 44.09 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.124 0.487 . . . . 1.0 111.887 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.2 tp -65.74 -40.76 92.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.825 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -59.44 -43.54 93.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.905 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -56.93 -38.62 73.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.566 0.222 . . . . 1.0 110.633 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.22 -44.65 99.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.619 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.01 -46.16 97.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.52 -0.472 . . . . 1.0 111.647 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.98 -41.42 59.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 112.677 0.621 . . . . 1.0 112.677 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -78.5 -13.35 59.88 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.948 -0.301 . . . . 1.0 111.401 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.433 ' OH ' HD11 ' A' ' 56' ' ' ILE . 63.1 t80 -94.39 -49.3 5.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.113 0.412 . . . . 1.0 112.113 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.581 ' O ' HG23 ' A' ' 95' ' ' VAL . 2.9 mp -71.68 -38.08 70.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.965 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -62.07 -48.26 81.0 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.968 -0.693 . . . . 1.0 111.215 -177.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.04 -42.35 69.61 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.848 -0.341 . . . . 1.0 111.683 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -66.05 -42.33 89.64 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.503 -0.479 . . . . 1.0 111.169 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 91' ' ' LEU . 68.6 t -63.63 -47.86 89.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.347 -0.541 . . . . 1.0 111.214 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -69.93 -42.54 73.14 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.578 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.485 HD11 ' CZ ' ' A' ' 168' ' ' TYR . 13.7 tp -68.63 -41.93 78.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.428 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.2 tp -62.92 -43.41 98.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.031 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -66.14 -39.98 90.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.788 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -70.06 -41.61 73.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.398 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.6 tpt -64.22 -56.36 15.23 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.456 -0.498 . . . . 1.0 111.369 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' ' 104' ' ' SER . 14.0 m -60.69 -39.46 88.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.043 0.449 . . . . 1.0 110.51 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 91.8 p -73.16 11.26 0.76 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.767 -0.651 . . . . 1.0 111.117 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 102' ' ' THR . 13.8 t -90.5 138.02 31.89 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.259 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.67 -20.1 63.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.194 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.582 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 64.3 mttp -87.99 39.12 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.691 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -129.17 110.14 11.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.372 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.56 122.94 37.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.206 -0.452 . . . . 1.0 109.884 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.6 m -95.0 72.83 3.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.118 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.58 151.28 16.93 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.953 -0.859 . . . . 1.0 110.953 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -73.35 175.84 6.55 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.032 -0.359 . . . . 1.0 110.032 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt -56.11 -37.79 69.89 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.95 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -68.47 -42.73 78.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.097 0.475 . . . . 1.0 110.729 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -70.28 -23.0 62.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.112 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 111' ' ' THR . 41.3 t -69.39 -45.74 78.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.158 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.1 t -65.92 -45.75 90.31 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 CA-C-O 121.158 0.504 . . . . 1.0 110.548 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.99 -33.06 74.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.794 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -68.61 -50.01 54.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.618 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.442 HD11 HG13 ' A' ' 131' ' ' VAL . 11.0 tp -70.03 -39.22 77.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.851 0.358 . . . . 1.0 110.253 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -64.97 -40.12 94.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.455 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -59.9 -47.53 85.4 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.686 -0.405 . . . . 1.0 110.286 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -60.98 -40.62 94.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.076 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 7.4 t -62.18 -41.72 98.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.548 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -59.49 -43.52 93.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.297 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.38 -41.96 92.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.71 76.29 77.26 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.488 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.537 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 10.2 Cg_exo -68.03 -21.14 43.57 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.857 2.372 . . . . 1.0 112.641 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -102.45 13.76 33.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.838 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -128.05 152.8 47.52 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.107 0.479 . . . . 1.0 110.379 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.1 p -81.39 161.16 23.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.637 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.442 HG13 HD11 ' A' ' 119' ' ' ILE . 5.1 p -154.89 146.12 13.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 20.7 p90 -151.4 142.06 22.73 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.834 0.35 . . . . 1.0 111.026 178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -152.62 168.14 26.58 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.393 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 5.1 p90 -136.46 157.19 47.38 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.257 -0.645 . . . . 1.0 109.257 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.2 p -149.27 168.58 22.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.815 0.34 . . . . 1.0 110.184 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 46.7 tp -79.26 144.46 34.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.355 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 0.0 OUTLIER -67.56 -172.82 0.27 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.026 -0.534 . . . . 1.0 109.999 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.516 ' ND1' ' N ' ' A' ' 138' ' ' HIS . 0.2 OUTLIER -110.31 -56.59 2.32 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.941 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.441 ' OD1' ' ND2' ' A' ' 140' ' ' ASN . 41.8 p-10 -114.09 19.88 16.1 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.082 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.529 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 7.5 m-80 -125.06 68.36 56.33 Favored Pre-proline 0 N--CA 1.466 0.344 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.236 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.476 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 26.1 Cg_endo -63.13 127.71 20.93 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.989 1.793 . . . . 1.0 112.46 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.426 ' HA3' HE22 ' A' ' 54' ' ' GLN . . . 100.36 11.56 41.46 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 110.761 -0.936 . . . . 1.0 110.761 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.524 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 57.7 m95 -132.95 156.54 47.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.818 0.342 . . . . 1.0 110.092 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -129.67 148.65 51.58 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.479 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 18.3 m-85 -116.84 136.13 53.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.063 0.459 . . . . 1.0 110.193 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.2 mt -109.77 124.61 51.57 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.302 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -121.48 147.52 45.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.053 -1.092 . . . . 1.0 108.053 178.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -160.18 150.74 18.64 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.608 -0.515 . . . . 1.0 109.608 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -136.23 128.34 29.73 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.851 -0.34 . . . . 1.0 110.521 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.5 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 34.3 mm -69.99 -45.79 75.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.421 -0.354 . . . . 1.0 111.716 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 31.1 m120 -158.94 173.68 16.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.559 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.11 -34.6 76.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.79 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -86.86 9.2 19.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.041 0.448 . . . . 1.0 110.46 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 13.1 t -98.59 165.92 11.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.431 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -96.79 145.58 25.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.929 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.04 121.45 22.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.063 0.459 . . . . 1.0 109.931 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -111.67 128.09 55.96 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.91 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.9 m -123.76 127.61 48.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.778 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.53 171.67 7.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.024 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.479 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 93.6 m-20 -109.51 149.17 30.01 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.836 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 45.8 t -126.35 136.92 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -104.88 125.8 51.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.021 0.439 . . . . 1.0 110.715 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 46.2 tp -88.6 129.8 35.41 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.399 -0.593 . . . . 1.0 109.399 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.3 p -128.34 171.83 11.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.408 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.776 ' H ' HD22 ' A' ' 165' ' ' ASN . 0.1 OUTLIER -83.98 16.09 3.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.512 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 67.0 p -122.71 -2.94 8.78 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.555 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 139.93 -128.69 3.99 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.453 -1.059 . . . . 1.0 110.453 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.485 ' CZ ' HD11 ' A' ' 97' ' ' LEU . 46.2 m-85 -123.81 127.35 47.96 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.729 0.299 . . . . 1.0 110.445 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -103.58 123.99 47.97 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 171' ' ' VAL . 0.5 OUTLIER -115.14 112.46 22.57 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.208 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 170' ' ' LEU . 5.2 t 34.74 64.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 7.7 m120 65.0 27.39 12.64 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.012 0.745 . . . . 1.0 113.012 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -132.42 121.58 23.65 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.176 -0.675 . . . . 1.0 109.176 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -94.61 123.44 38.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.822 0.344 . . . . 1.0 111.427 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -103.47 134.96 19.47 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.01 -23.21 22.02 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.037 1.825 . . . . 1.0 113.377 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 70.8 m -156.45 161.28 40.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.952 0.406 . . . . 1.0 111.035 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 179' ' ' ILE . 7.5 p -61.12 -42.01 91.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.853 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.479 ' N ' HG13 ' A' ' 178' ' ' VAL . 48.1 mm -60.29 -47.4 92.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.722 -0.391 . . . . 1.0 110.299 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -62.02 -35.92 80.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.8 tt -62.96 -40.1 96.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.271 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 72.8 m -60.77 -47.76 84.84 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.579 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.639 ' O ' ' N ' ' A' ' 186' ' ' LYS . 56.8 t-20 -66.82 -47.37 72.25 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.58 -45.5 0.51 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.954 -1.259 . . . . 1.0 109.954 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.514 ' O ' ' HG ' ' A' ' 188' ' ' LEU . 0.3 OUTLIER -69.84 -41.82 74.4 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-O 121.913 0.863 . . . . 1.0 109.762 178.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.639 ' N ' ' O ' ' A' ' 183' ' ' ASN . 87.9 tttt -60.84 -34.24 74.28 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.87 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.1 m -64.09 -51.59 63.3 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.899 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.599 ' C ' HD12 ' A' ' 188' ' ' LEU . 0.9 OUTLIER -65.57 -35.67 81.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.123 179.001 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.441 ' N ' ' HG ' ' A' ' 188' ' ' LEU . 37.1 tp -57.27 -46.47 83.06 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.172 -0.467 . . . . 1.0 109.97 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.51 -39.82 94.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.136 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.7 t -59.9 -36.43 76.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.498 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.5 mt -67.85 -41.6 82.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.785 -0.643 . . . . 1.0 112.208 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.1 -36.98 83.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.771 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . 0.469 ' O ' ' ND1' ' A' ' 194' ' ' HIS . 2.4 t-80 . . . . . 0 C--N 1.324 -0.514 0 CA-C-O 120.843 0.354 . . . . 1.0 110.85 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.6 ttp-105 . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 120.85 0.357 . . . . 1.0 110.351 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.2 p -66.38 -32.6 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.669 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 pt -67.26 -24.07 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.672 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -93.59 0.76 56.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.397 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -64.27 130.75 94.77 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.221 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -47.64 -32.36 16.15 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.705 1.603 . . . . 1.0 112.516 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -85.32 9.66 14.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.372 -0.377 . . . . 1.0 111.181 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.505 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 80.6 t80 -89.95 129.83 36.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.467 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 61.7 m-85 -149.24 127.6 5.92 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 110.2 -0.296 . . . . 1.0 110.2 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 73.7 Cg_endo -73.24 109.9 2.94 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.901 1.734 . . . . 1.0 112.724 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 71.4 m-85 -160.89 151.78 18.56 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.489 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -76.26 -170.05 1.34 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.95 -44.53 8.17 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.546 -1.021 . . . . 1.0 110.546 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -67.02 -43.77 81.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.664 0.268 . . . . 1.0 111.025 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -65.2 -33.89 77.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.057 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.5 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.15 -39.47 90.2 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.741 -0.383 . . . . 1.0 110.326 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.25 -42.08 96.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.043 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.37 -44.39 96.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.439 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -63.32 -42.23 98.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.35 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 18' ' ' ALA . 7.9 mp -73.29 -12.79 60.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.805 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -58.97 -40.73 85.63 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.357 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.6 t -75.82 -18.71 59.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.766 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.482 ' N ' ' CD ' ' A' ' 25' ' ' LYS . 3.1 mptp? -83.5 179.89 7.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.438 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.407 ' OE1' ' O ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -104.37 -176.01 2.96 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.367 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.458 ' CD ' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -75.08 143.26 43.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.458 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.47 7.54 57.98 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.844 -0.902 . . . . 1.0 110.844 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -87.0 140.58 29.41 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -135.85 162.13 33.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.253 0.549 . . . . 1.0 110.92 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.2 m -147.44 158.65 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.155 -0.93 . . . . 1.0 111.612 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.0 mt -117.69 127.21 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -146.98 155.29 42.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.463 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.79 137.27 45.14 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.9 t -74.75 144.85 43.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.974 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.0 p -64.83 -30.21 71.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.723 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -102.35 0.79 34.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.707 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.99 -56.47 5.29 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.428 -1.069 . . . . 1.0 110.428 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 72.64 -54.6 0.69 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.561 0.22 . . . . 1.0 111.024 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.515 ' OD1' ' CD2' ' A' ' 41' ' ' HIS . 55.2 p-10 -119.52 2.41 11.22 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.756 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.515 ' CD2' ' OD1' ' A' ' 40' ' ' ASP . 38.3 m170 -117.9 150.47 39.15 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.869 0.366 . . . . 1.0 110.566 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.03 151.76 38.52 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 116.004 -0.544 . . . . 1.0 109.912 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.1 t -126.05 132.95 70.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.26 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.62 HD12 HD11 ' A' ' 58' ' ' ILE . 40.2 mt -111.86 137.88 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.0 m -117.48 136.82 52.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.841 -0.618 . . . . 1.0 109.846 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.678 ' CH2' HD21 ' A' ' 48' ' ' LEU . 1.3 p-90 -146.22 147.2 31.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.496 -0.774 . . . . 1.0 110.921 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HZ3' ' C ' ' A' ' 49' ' ' ASP . 64.7 tttm -93.84 140.66 29.41 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.075 -0.512 . . . . 1.0 111.255 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.678 HD21 ' CH2' ' A' ' 46' ' ' TRP . 82.0 mt -97.27 -66.25 0.91 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.486 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.452 ' C ' ' HZ3' ' A' ' 47' ' ' LYS . 4.6 p30 -144.56 -166.64 2.44 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.607 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -59.18 131.63 51.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.972 0.415 . . . . 1.0 110.682 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 49.87 52.79 13.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.907 -0.588 . . . . 1.0 111.156 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 141' ' ' PRO . 16.8 tp -158.89 119.12 3.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.338 . . . . 1.0 110.421 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.5 149.46 52.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.592 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.41 ' HG3' HD11 ' A' ' 48' ' ' LEU . 9.8 mm100 -137.05 151.9 49.45 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.136 -0.484 . . . . 1.0 109.751 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -125.8 140.62 52.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.203 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 95.7 mt -120.85 123.7 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -94.95 122.23 37.38 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.58 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.62 HD11 HD12 ' A' ' 44' ' ' ILE . 83.0 mt -102.53 129.68 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.336 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -119.82 134.37 55.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.099 -0.501 . . . . 1.0 109.891 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -102.62 148.78 25.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.109 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.1 mt -141.97 174.72 10.33 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.328 -0.397 . . . . 1.0 110.461 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 67.81 41.62 2.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.016 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.716 ' H ' ' CD ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -111.85 134.55 53.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.242 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.25 -20.3 30.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.538 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.63 153.41 22.85 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.153 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.83 -20.91 68.53 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.267 1.978 . . . . 1.0 111.884 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.5 tp -85.49 -12.37 51.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.144 0.497 . . . . 1.0 110.639 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.35 151.57 30.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.527 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.8 mt -75.86 147.24 39.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.284 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.79 98.91 0.37 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.551 -1.02 . . . . 1.0 110.551 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -62.55 -38.27 89.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.92 0.39 . . . . 1.0 110.544 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.53 123.65 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.624 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.4 mt -116.47 130.57 56.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.869 -0.605 . . . . 1.0 109.401 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mp -107.49 124.65 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.81 0.338 . . . . 1.0 110.362 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -139.2 132.11 37.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.288 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 39.3 t0 51.92 42.03 29.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.654 0.264 . . . . 1.0 111.035 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.1 t30 61.19 22.92 13.19 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.297 -0.411 . . . . 1.0 111.042 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -127.0 133.36 50.57 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.114 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -86.31 128.24 34.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.735 -0.666 . . . . 1.0 111.089 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -121.49 138.56 54.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.151 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -84.99 -34.55 22.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.542 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -126.31 149.45 49.14 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.062 0.458 . . . . 1.0 112.058 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.0 tp -65.38 -39.7 92.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.945 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.401 ' O ' HG23 ' A' ' 88' ' ' VAL . 89.5 m-20 -60.2 -40.81 91.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 1.0 111.741 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -61.0 -38.45 86.1 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.769 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.83 -45.84 97.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.726 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.9 mm -65.44 -43.45 94.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.506 -0.478 . . . . 1.0 111.47 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 84' ' ' ASP . 60.9 t -71.73 -43.07 70.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 112.642 0.608 . . . . 1.0 112.642 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.03 -13.13 59.55 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.722 -0.391 . . . . 1.0 111.61 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -95.3 -49.01 5.65 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.772 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 95' ' ' VAL . 2.1 tp -70.06 -41.41 74.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.312 -0.404 . . . . 1.0 112.018 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -63.96 -49.14 73.71 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.918 -0.713 . . . . 1.0 111.456 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -70.53 -42.05 71.73 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.62 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -65.88 -41.88 90.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.347 -0.541 . . . . 1.0 111.266 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 91' ' ' LEU . 51.5 t -64.76 -46.43 92.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.39 -0.524 . . . . 1.0 111.181 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -65.94 -44.57 84.66 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.593 -0.443 . . . . 1.0 111.259 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.552 HD11 ' CZ ' ' A' ' 168' ' ' TYR . 10.7 tp -65.57 -41.82 92.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.497 -0.32 . . . . 1.0 111.511 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.25 -42.3 99.17 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.299 -0.561 . . . . 1.0 110.045 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.414 ' O ' ' OG ' ' A' ' 103' ' ' SER . 91.1 m-20 -66.31 -40.41 89.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.262 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -69.37 -40.8 77.23 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.673 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.4 tpt -66.5 -56.11 12.41 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.104 -0.638 . . . . 1.0 111.301 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 65.1 m -60.44 -39.11 86.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.047 0.451 . . . . 1.0 110.852 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 99' ' ' ASN . 99.2 p -71.91 10.42 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.638 -0.71 . . . . 1.0 111.124 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.1 p -93.94 133.7 37.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.711 0.291 . . . . 1.0 110.468 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 37.9 mp0 -57.46 -21.07 34.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.138 0.494 . . . . 1.0 110.594 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.555 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 49.2 mttp -87.61 39.7 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.771 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -128.45 113.22 15.25 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.604 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -125.61 110.47 13.86 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.197 -0.456 . . . . 1.0 109.804 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.7 m -85.03 77.05 10.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.981 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -116.63 157.96 14.74 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 115' ' ' VAL . 72.3 p -78.53 168.05 20.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.843 -0.429 . . . . 1.0 109.843 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -56.68 -36.85 70.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.74 0.305 . . . . 1.0 110.329 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -67.39 -45.22 76.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.913 0.387 . . . . 1.0 110.539 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -70.52 -17.2 62.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.786 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 111' ' ' THR . 22.7 t -72.2 -44.01 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.293 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.5 t -63.45 -46.94 93.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.211 0.529 . . . . 1.0 110.304 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -66.17 -35.71 81.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.901 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -67.69 -49.12 64.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.757 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.9 tp -69.87 -39.65 77.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.856 -0.337 . . . . 1.0 110.424 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.5 -40.24 95.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.706 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.6 -47.51 78.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.514 -0.474 . . . . 1.0 110.255 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.451 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 32.1 t80 -60.61 -43.14 97.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.061 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.1 p -65.88 -33.24 75.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.486 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -60.71 -42.28 96.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.931 -0.577 . . . . 1.0 109.915 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.49 -41.5 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.451 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -125.87 74.58 70.98 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.213 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 151' ' ' ASN . 46.1 Cg_endo -73.17 -17.89 24.17 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.354 2.036 . . . . 1.0 112.557 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 48.0 p30 -90.85 -10.31 43.16 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.157 0.429 . . . . 1.0 112.157 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -118.63 147.03 44.18 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.925 0.393 . . . . 1.0 110.404 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.9 m -80.94 160.9 24.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.782 -0.645 . . . . 1.0 109.693 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.89 146.89 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 133' ' ' TYR . 26.3 p90 -139.32 143.92 38.06 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.85 0.357 . . . . 1.0 111.56 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 18.4 m-85 -151.85 166.23 32.07 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.491 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 4.1 p90 -135.01 152.3 51.6 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.8 m -150.94 172.41 15.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.442 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.696 HD13 ' H ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -77.21 142.36 39.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.616 179.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.696 ' H ' HD13 ' A' ' 136' ' ' LEU . 10.7 t-20 -98.98 111.84 24.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.837 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -66.67 -43.23 85.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.676 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.15 -27.53 65.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.373 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.474 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 31.6 m120 -125.14 73.96 66.74 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.267 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.526 ' HB3' HD11 ' A' ' 52' ' ' LEU . 27.2 Cg_endo -62.76 126.11 17.48 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.911 1.741 . . . . 1.0 112.463 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.06 -7.68 48.62 Favored Glycine 0 N--CA 1.467 0.741 0 N-CA-C 111.065 -0.814 . . . . 1.0 111.065 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -116.81 141.18 48.55 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.713 0.292 . . . . 1.0 110.418 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.404 ' CE1' HD22 ' A' ' 136' ' ' LEU . 56.0 m-85 -102.09 142.77 32.83 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.542 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 11.1 m-85 -119.15 131.05 55.84 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.235 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.98 121.49 42.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.357 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -117.34 144.46 44.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.192 -1.04 . . . . 1.0 108.192 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -160.57 153.69 21.62 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.403 -0.591 . . . . 1.0 109.403 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -137.36 131.31 31.94 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.692 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 35.9 mm -70.98 -47.2 63.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.695 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.454 ' H ' ' HB3' ' A' ' 154' ' ' SER . 12.2 p30 -161.92 177.19 10.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.076 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.59 -34.37 78.1 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.09 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -84.88 9.5 14.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.668 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 3.3 t -105.28 163.61 12.47 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.182 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -92.21 156.63 17.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.936 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 50.5 tp -75.79 127.29 32.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.942 0.401 . . . . 1.0 110.26 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -112.26 133.17 54.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.081 -0.509 . . . . 1.0 109.751 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 85.5 m -131.39 131.79 43.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.036 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -121.91 164.73 17.07 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.806 -0.442 . . . . 1.0 109.806 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.542 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 24.2 m-20 -115.57 147.58 40.57 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.992 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 39.1 t -128.91 138.92 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -97.61 126.68 43.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.993 0.425 . . . . 1.0 110.704 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.4 tp -90.23 128.84 36.49 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 35.6 p -129.66 175.11 9.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.394 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -83.96 15.87 3.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.71 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 5.6 p -121.85 -1.83 9.36 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.739 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.88 -134.02 7.1 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.337 -1.105 . . . . 1.0 110.337 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.552 ' CZ ' HD11 ' A' ' 97' ' ' LEU . 7.9 m-85 -117.79 128.6 55.03 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.142 -0.318 . . . . 1.0 110.142 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -107.86 121.55 44.98 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.52 ' C ' HD23 ' A' ' 170' ' ' LEU . 6.7 tt -111.71 115.84 29.76 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 109.009 -0.738 . . . . 1.0 109.009 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.645 ' O ' HG12 ' A' ' 171' ' ' VAL . 99.3 t 33.19 62.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.349 0.5 . . . . 1.0 112.349 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.723 ' N ' HD22 ' A' ' 172' ' ' ASN . 0.5 OUTLIER 67.32 27.45 8.23 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.635 0.976 . . . . 1.0 113.635 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -131.79 120.1 22.19 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.338 -0.615 . . . . 1.0 109.338 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -91.73 129.42 37.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.883 0.373 . . . . 1.0 111.253 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -109.08 99.22 34.6 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.62 -24.4 12.73 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.636 2.224 . . . . 1.0 113.603 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.436 ' OG ' ' OE1' ' A' ' 180' ' ' GLN . 6.9 p -138.05 142.87 40.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.917 0.389 . . . . 1.0 111.272 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.61 -33.92 59.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.683 -0.69 . . . . 1.0 110.583 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.37 -44.08 98.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 122.038 -0.414 . . . . 1.0 110.363 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.521 ' N ' ' OE1' ' A' ' 180' ' ' GLN . 3.2 mp0 -65.89 -29.34 69.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 52.4 tp -64.0 -40.72 97.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.255 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 74.1 m -62.56 -47.79 82.31 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.364 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 186' ' ' LYS . 43.6 t30 -68.01 -47.41 68.55 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 119.503 -0.879 . . . . 1.0 108.88 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.4 -45.31 0.67 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 109.919 -1.272 . . . . 1.0 109.919 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -68.79 -46.99 67.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.376 0.608 . . . . 1.0 109.502 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 183' ' ' ASN . 1.4 tmtp? -56.81 -42.72 80.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.243 -0.89 . . . . 1.0 110.05 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 23.8 m -61.25 -44.0 97.96 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 188' ' ' LEU . 39.8 mt -62.21 -42.11 98.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.115 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 44.7 tp -58.48 -42.8 88.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.336 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.48 -44.94 92.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.371 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 17.4 m -62.7 -39.34 93.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.895 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.17 -41.13 99.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.609 -0.723 . . . . 1.0 111.735 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.68 -26.68 67.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.793 0.294 . . . . 1.0 111.793 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 . . . . . 0 C--N 1.326 -0.426 0 CA-C-O 120.818 0.342 . . . . 1.0 110.884 -179.619 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.537 ' O ' ' ND2' ' A' ' 6' ' ' ASN . 80.0 mtp85 . . . . . 0 CA--C 1.521 -0.162 0 CA-C-O 120.868 0.366 . . . . 1.0 110.599 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.0 p -97.06 -17.4 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.564 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.6 pt -85.51 -25.95 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.658 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.646 HD22 ' N ' ' A' ' 7' ' ' HIS . 0.0 OUTLIER -89.57 -0.01 57.22 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.613 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.646 ' N ' HD22 ' A' ' 6' ' ' ASN . 0.1 OUTLIER -69.63 146.87 96.31 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.092 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.98 -20.67 50.67 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.913 1.742 . . . . 1.0 112.353 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.439 ' CE1' ' CZ ' ' A' ' 30' ' ' PHE . 74.7 m-85 -88.97 3.3 52.01 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.326 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -88.16 135.45 33.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.322 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.573 ' O ' ' NH1' ' A' ' 33' ' ' ARG . 74.6 m-85 -151.27 119.64 3.42 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 110.013 -0.365 . . . . 1.0 110.013 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.521 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 73.7 Cg_endo -72.82 109.62 2.84 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.671 1.58 . . . . 1.0 113.129 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.551 ' O ' ' NE ' ' A' ' 33' ' ' ARG . 56.4 m-85 -160.41 159.25 30.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.623 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -78.69 173.47 12.42 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.14 -49.06 82.27 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.27 -0.967 . . . . 1.0 110.858 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -67.95 -40.15 83.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 1.0 110.823 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -66.61 -32.63 74.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 1.0 111.146 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.35 92.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.933 -0.307 . . . . 1.0 110.221 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.479 ' OE2' ' CD1' ' A' ' 53' ' ' PHE . 84.1 tt0 -63.31 -42.74 99.04 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.699 -0.4 . . . . 1.0 109.996 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -60.78 -40.36 92.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.091 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -62.19 -42.49 99.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.826 0.346 . . . . 1.0 110.474 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.16 -13.6 60.19 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.874 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.9 ttm-85 -61.33 -40.15 93.18 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.844 -0.342 . . . . 1.0 110.256 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.4 p -77.58 -19.08 56.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.751 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -84.67 -179.77 7.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.912 0.387 . . . . 1.0 110.566 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -103.15 -177.47 3.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.784 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -75.45 145.0 41.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.772 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.17 11.01 59.08 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -97.09 140.75 31.13 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CZ ' ' CE1' ' A' ' 9' ' ' TYR . 35.1 p90 -135.08 168.57 18.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.444 0.64 . . . . 1.0 111.116 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.8 m -148.54 161.32 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.012 -0.994 . . . . 1.0 111.762 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -116.09 131.19 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.573 ' NH1' ' O ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -137.74 164.13 29.64 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.839 -179.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -120.51 126.89 51.51 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 t -62.56 134.16 55.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.128 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.5 t -72.17 -20.77 61.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.885 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -117.8 37.59 3.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.819 0.343 . . . . 1.0 110.767 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -175.1 58.71 0.11 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.939 -0.865 . . . . 1.0 110.939 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -57.57 3.41 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.652 0.263 . . . . 1.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.577 ' H ' ' C ' ' A' ' 38' ' ' GLY . 97.9 m-20 -102.94 -1.74 28.92 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.595 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.429 ' ND1' ' O ' ' A' ' 40' ' ' ASP . 60.6 m-70 -143.59 157.72 44.21 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.375 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 mp -119.74 152.75 36.7 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.15 -0.477 . . . . 1.0 109.988 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.3 t -124.2 130.9 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 110.06 -0.348 . . . . 1.0 110.06 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.686 HD12 HD11 ' A' ' 58' ' ' ILE . 36.4 mt -111.58 138.1 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 96.2 m -116.93 136.13 53.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.537 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.471 ' CZ2' ' NZ ' ' A' ' 94' ' ' LYS . 4.4 p-90 -145.36 160.91 40.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.658 -0.701 . . . . 1.0 110.846 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -107.65 140.9 39.98 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.022 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.429 ' H ' HD12 ' A' ' 48' ' ' LEU . 3.1 mp -98.0 -72.35 0.65 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.652 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -158.29 157.34 32.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.259 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt 41.81 -141.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.798 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -89.71 64.3 6.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.848 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.9 tp -140.57 128.89 22.46 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.877 0.37 . . . . 1.0 110.323 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.479 ' CD1' ' OE2' ' A' ' 19' ' ' GLU . 51.6 m-85 -131.4 150.36 52.18 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.379 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -136.66 153.75 50.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.831 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.421 ' ND1' ' N ' ' A' ' 55' ' ' HIS . 10.8 p-80 -127.67 143.08 51.18 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.066 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 78.2 mt -123.4 129.23 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.228 -0.442 . . . . 1.0 109.966 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -97.23 122.45 40.27 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.03 0.443 . . . . 1.0 110.513 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.686 HD11 HD12 ' A' ' 44' ' ' ILE . 79.9 mt -99.32 129.95 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.4 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -113.56 132.35 55.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.0 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -101.03 156.58 17.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.188 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.7 tp -126.19 172.2 10.25 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.493 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 73.9 mm-40 60.02 39.0 20.44 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.99 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -81.47 78.88 8.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.082 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.64 -36.15 80.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.869 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -142.81 152.56 59.47 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.044 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.68 -25.56 68.58 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.295 1.997 . . . . 1.0 112.142 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.7 mt -97.84 -4.41 36.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.606 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.13 144.05 52.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.581 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.5 mt -78.5 146.31 34.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.366 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.27 101.16 1.22 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.539 -1.025 . . . . 1.0 110.539 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -63.58 -38.33 90.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.04 0.448 . . . . 1.0 111.029 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.17 125.52 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.593 -0.73 . . . . 1.0 111.004 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.6 mt -115.18 129.76 56.74 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 71.5 mt -102.13 126.24 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.884 0.373 . . . . 1.0 110.189 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.9 t -143.9 133.11 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.386 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t0 53.1 45.36 28.88 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.11 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 57.63 25.57 11.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.311 -0.404 . . . . 1.0 111.051 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -130.15 156.81 43.94 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.322 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -108.06 125.98 52.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.022 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -123.89 139.47 53.93 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.134 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -85.05 -38.84 18.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.77 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -110.08 138.22 46.76 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.201 0.524 . . . . 1.0 111.844 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.39 -41.35 96.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.874 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 38.0 p-10 -59.63 -45.97 90.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.982 -177.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.535 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 33.2 tt0 -57.93 -37.86 74.86 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 120.68 0.276 . . . . 1.0 110.778 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.81 -46.44 93.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.451 -0.5 . . . . 1.0 110.714 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.7 mm -64.4 -44.08 97.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.2 -0.6 . . . . 1.0 111.626 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.16 -43.63 74.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 113.067 0.765 . . . . 1.0 113.067 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -78.17 -13.27 59.93 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.641 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.457 ' CE2' ' NZ ' ' A' ' 94' ' ' LYS . 50.0 t80 -94.75 -50.72 5.03 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.95 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.544 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -71.38 -38.21 71.54 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.173 0.434 . . . . 1.0 112.173 -177.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -59.31 -47.25 86.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.027 -0.669 . . . . 1.0 111.527 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -64.43 -45.1 89.01 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.537 -0.465 . . . . 1.0 111.905 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.599 ' O ' HD13 ' A' ' 98' ' ' LEU . 45.9 mtmt -66.67 -42.68 86.17 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.237 -0.585 . . . . 1.0 111.407 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 91' ' ' LEU . 54.3 t -60.06 -45.66 95.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.398 -0.521 . . . . 1.0 111.367 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -66.59 -44.21 82.8 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.562 -0.455 . . . . 1.0 111.965 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.431 HD21 HD11 ' A' ' 163' ' ' LEU . 5.3 tp -67.07 -38.94 86.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.637 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 94' ' ' LYS . 8.2 mp -65.99 -42.16 90.14 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.353 -0.539 . . . . 1.0 110.626 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 95' ' ' VAL . 76.3 m-20 -68.65 -37.27 79.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.205 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -70.98 -41.22 71.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.831 -0.348 . . . . 1.0 111.564 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.576 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 15.9 ttm -70.03 -53.28 18.26 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.53 -0.468 . . . . 1.0 111.594 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.514 HG23 ' CE2' ' A' ' 107' ' ' PHE . 11.5 m -57.04 -38.83 73.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.056 0.455 . . . . 1.0 110.3 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.7 m -70.36 10.96 0.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.958 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 102' ' ' THR . 74.4 p -95.61 132.17 41.05 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.893 0.378 . . . . 1.0 110.385 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -60.38 -17.4 43.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.945 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.529 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 67.8 mttm -94.73 41.1 1.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.999 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.514 ' CE2' HG23 ' A' ' 102' ' ' THR . 64.6 t80 -134.91 118.63 17.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.035 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -140.1 129.6 24.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.12 -0.491 . . . . 1.0 109.717 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.6 m -100.43 93.48 5.66 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.735 0.303 . . . . 1.0 110.953 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -120.17 162.94 14.06 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 115' ' ' VAL . 21.5 p -78.73 163.41 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.925 -0.398 . . . . 1.0 109.925 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -63.35 -37.08 85.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.386 . . . . 1.0 110.54 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -68.08 -45.65 73.19 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.904 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -71.12 -17.26 62.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.59 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.492 HG13 ' SD ' ' A' ' 147' ' ' MET . 2.6 t -70.81 -45.4 73.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.88 -46.47 96.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.192 0.52 . . . . 1.0 110.036 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -66.05 -38.59 88.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.925 0.393 . . . . 1.0 110.663 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -65.77 -48.39 71.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.796 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.4 tp -69.19 -39.69 79.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.418 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -59.72 -43.72 94.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.353 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.02 -47.44 83.04 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.446 -0.501 . . . . 1.0 110.019 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -60.05 -44.91 94.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.972 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.1 p -62.47 -33.9 75.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.414 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -61.82 -42.44 99.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.96 -0.563 . . . . 1.0 110.243 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.32 -41.56 89.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.711 -0.396 . . . . 1.0 109.985 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.8 75.07 56.3 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 121.202 0.525 . . . . 1.0 110.128 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.526 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 42.0 Cg_endo -73.21 -14.87 25.72 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.402 2.068 . . . . 1.0 112.568 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -100.31 -13.19 18.93 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.797 0.295 . . . . 1.0 111.797 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -106.45 150.78 25.73 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.152 0.501 . . . . 1.0 110.429 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 m -80.66 162.06 24.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.629 -0.714 . . . . 1.0 109.659 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.3 p -152.74 144.96 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.538 -0.542 . . . . 1.0 109.538 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 25.3 p90 -151.3 144.19 24.5 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.848 -0.341 . . . . 1.0 111.124 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -151.45 169.75 21.26 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.344 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.529 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -137.9 153.69 49.51 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.082 -0.71 . . . . 1.0 109.082 179.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 98.9 p -151.21 169.66 21.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.9 0.381 . . . . 1.0 110.32 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.7 tp -79.49 141.54 36.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.524 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.509 ' ND2' ' CE1' ' A' ' 145' ' ' TYR . 6.6 t-20 -75.06 168.44 19.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.199 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -126.98 -30.11 2.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.356 -0.383 . . . . 1.0 110.66 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -90.53 -20.42 22.67 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.4 -0.364 . . . . 1.0 111.143 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 25.5 t-20 -138.64 76.33 35.84 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.396 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.06 130.76 41.39 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.062 1.841 . . . . 1.0 112.217 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 117.09 -26.34 8.34 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -107.28 147.92 29.63 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.576 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 75.2 m-85 -109.7 155.78 21.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.864 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.539 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 32.6 m-85 -125.77 137.46 53.8 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.048 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.9 mt -108.03 127.23 53.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.51 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.492 ' SD ' HG13 ' A' ' 115' ' ' VAL . 20.7 ptt? -118.6 144.3 46.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -162.5 153.49 17.46 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.374 -0.53 . . . . 1.0 109.707 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -133.99 129.23 35.88 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.26 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.436 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.8 mp -76.48 -47.25 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.424 0.527 . . . . 1.0 112.424 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 152' ' ' ALA . 17.0 t-20 -154.01 166.06 34.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.554 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.532 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -60.78 -27.57 68.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -85.53 -14.3 46.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.984 0.421 . . . . 1.0 110.318 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 12.8 t -81.18 160.76 24.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.335 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -92.29 163.46 13.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.138 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 57.2 tp -79.67 118.71 21.74 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.011 -0.366 . . . . 1.0 110.011 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.39 132.72 52.09 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.968 -0.56 . . . . 1.0 109.986 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 96.4 m -124.38 126.29 45.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.532 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -111.48 155.7 22.82 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.241 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.539 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 82.5 m-20 -104.9 144.16 32.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.591 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.2 t -123.89 136.16 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 109.535 -0.543 . . . . 1.0 109.535 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -95.57 135.26 37.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.627 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.431 HD11 HD21 ' A' ' 97' ' ' LEU . 28.7 tp -99.38 130.14 45.63 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 71.5 p -128.57 159.9 34.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.244 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -76.91 17.46 0.43 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.633 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 60.5 p -123.11 -2.29 8.65 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.669 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 143.12 -132.88 5.22 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.353 -1.099 . . . . 1.0 110.353 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -123.49 134.37 53.9 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 110.167 -0.309 . . . . 1.0 110.167 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.525 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 7.5 m-85 -111.62 122.87 48.96 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 tt -117.84 121.78 41.66 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.492 -0.559 . . . . 1.0 109.492 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.603 ' C ' HD22 ' A' ' 172' ' ' ASN . 4.2 t 37.88 51.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.153 0.427 . . . . 1.0 112.153 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.65 ' N ' HD22 ' A' ' 172' ' ' ASN . 0.6 OUTLIER 68.43 27.52 6.34 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.413 0.894 . . . . 1.0 113.413 179.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -135.65 123.09 21.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.525 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 19.5 t-20 -92.0 129.5 37.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.566 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -103.71 133.39 20.3 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.86 -20.7 22.12 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.053 1.836 . . . . 1.0 113.594 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.426 ' OG ' ' OE1' ' A' ' 180' ' ' GLN . 14.3 p -153.95 158.37 40.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.961 0.41 . . . . 1.0 111.095 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.31 -36.22 76.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.012 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.6 mm -60.54 -48.49 88.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.811 0.339 . . . . 1.0 110.243 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.426 ' OE1' ' OG ' ' A' ' 177' ' ' SER . 9.0 mp0 -65.96 -33.33 75.57 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.18 -41.9 97.62 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 110.025 -0.361 . . . . 1.0 110.025 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 81.6 m -62.3 -46.23 89.69 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 120.57 -0.452 . . . . 1.0 110.116 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 186' ' ' LYS . 65.9 m-20 -65.07 -49.02 71.68 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.89 -46.07 0.86 Allowed Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.841 -1.304 . . . . 1.0 109.841 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -67.77 -47.17 69.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 183' ' ' ASN . 64.7 tttm -56.72 -40.46 75.72 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.764 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 25.7 m -61.16 -45.11 96.0 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.55 -40.86 98.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.859 -0.609 . . . . 1.0 110.1 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.0 tp -57.81 -41.23 81.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.406 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -64.03 -45.13 90.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.112 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.7 p -62.95 -39.4 94.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.973 0.416 . . . . 1.0 110.637 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 61.2 mt -63.81 -43.5 96.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.606 -0.724 . . . . 1.0 111.965 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -71.15 -30.1 66.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.845 0.313 . . . . 1.0 111.845 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.991 -179.117 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.866 0.365 . . . . 1.0 110.583 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.805 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 7.2 p -60.41 -47.63 91.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.566 0 CA-C-O 121.756 0.789 . . . . 1.0 110.089 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.554 ' N ' HG13 ' A' ' 4' ' ' VAL . 35.9 pt -59.94 12.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 O-C-N 121.255 -0.903 . . . . 1.0 111.011 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.673 ' H ' ' C ' ' A' ' 4' ' ' VAL . 54.9 t-20 -161.53 32.7 0.13 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.288 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.805 ' ND1' ' O ' ' A' ' 4' ' ' VAL . 3.8 p-80 -75.74 154.35 85.27 Favored Pre-proline 0 N--CA 1.468 0.426 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.02 -28.43 19.01 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.097 1.865 . . . . 1.0 112.7 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -79.94 -9.05 59.64 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.282 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -73.56 134.87 43.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.248 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -150.5 117.17 3.42 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 120.983 -0.287 . . . . 1.0 110.264 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.83 111.59 3.36 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.742 1.628 . . . . 1.0 112.829 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -156.68 155.63 32.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.275 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -78.8 -172.44 3.02 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.49 -48.36 18.5 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.543 -1.023 . . . . 1.0 110.543 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -64.41 -44.14 92.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.76 0.314 . . . . 1.0 110.734 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.17 -35.19 79.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.985 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.07 97.63 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.656 -0.417 . . . . 1.0 110.395 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.57 -43.97 83.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.008 -0.367 . . . . 1.0 110.008 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.06 -43.94 97.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.288 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.503 ' OH ' ' NZ ' ' A' ' 25' ' ' LYS . 94.1 t80 -61.63 -45.39 94.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.875 0.369 . . . . 1.0 110.288 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -72.4 -14.37 61.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.153 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -67.34 -41.84 84.52 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.621 -0.431 . . . . 1.0 110.799 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.6 m -76.37 -23.88 54.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.188 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.503 ' NZ ' ' OH ' ' A' ' 21' ' ' TYR . 32.7 mttp -81.9 176.78 9.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.151 0.5 . . . . 1.0 110.661 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -84.03 161.63 20.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.769 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -76.07 146.31 39.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.033 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.5 12.67 47.21 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.537 ' HB3' HD11 ' A' ' 22' ' ' LEU . 54.5 tp10 -106.54 148.05 28.7 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -127.81 172.49 10.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.473 0.654 . . . . 1.0 111.413 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.57 153.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 114.975 -1.011 . . . . 1.0 111.477 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.484 ' HB ' ' HE2' ' A' ' 7' ' ' HIS . 97.5 mt -116.84 118.48 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.93 151.01 30.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.198 -179.128 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.403 ' NE2' ' O ' ' A' ' 34' ' ' GLN . 3.0 pp0? -98.32 148.1 24.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.422 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 t -69.05 161.38 29.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.82 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.9 p -65.56 -21.83 66.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.833 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -129.53 25.18 5.42 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.413 -0.358 . . . . 1.0 111.167 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . -75.59 -62.32 2.72 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.618 -0.993 . . . . 1.0 110.618 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.3 t0 64.75 -50.62 0.32 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.728 0.299 . . . . 1.0 111.334 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 38' ' ' GLY . 99.5 m-20 -120.66 20.65 11.71 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.977 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.567 ' C ' HD12 ' A' ' 42' ' ' LEU . 79.5 m-70 -147.86 147.73 30.1 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.567 HD12 ' C ' ' A' ' 41' ' ' HIS . 11.2 mp -119.14 151.13 38.85 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.711 -0.478 . . . . 1.0 109.711 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 33' ' ' ARG . 76.4 t -126.96 135.06 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.331 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.644 HD12 HD11 ' A' ' 58' ' ' ILE . 62.8 mt -111.64 137.47 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.076 -0.712 . . . . 1.0 109.076 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.1 m -117.49 135.56 53.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.928 -0.578 . . . . 1.0 109.523 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.575 ' CZ2' HD11 ' A' ' 48' ' ' LEU . 1.5 p-90 -151.99 155.58 38.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.794 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -95.44 141.13 29.35 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.35 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.575 HD11 ' CZ2' ' A' ' 46' ' ' TRP . 9.3 mp -94.82 -35.09 12.23 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.131 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 36.2 t0 -162.89 -138.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.191 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.524 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 70.5 mmtt -53.76 -104.05 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.055 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.476 ' O ' ' CE2' ' A' ' 53' ' ' PHE . 32.3 t70 -85.65 20.91 1.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.232 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.713 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.7 mm? -88.35 131.49 34.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.874 0.369 . . . . 1.0 110.612 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.476 ' CE2' ' O ' ' A' ' 51' ' ' ASP . 25.4 m-85 -136.46 143.82 44.06 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.332 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -146.54 152.67 39.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.024 -0.534 . . . . 1.0 109.677 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -126.88 139.79 52.82 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.207 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.1 mm -115.29 117.61 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -90.53 119.39 30.75 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.904 0.383 . . . . 1.0 110.773 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.644 HD11 HD12 ' A' ' 44' ' ' ILE . 81.5 mt -100.19 131.29 47.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.269 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -118.06 126.52 52.44 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 40' ' ' ASP . 9.6 mp0 -99.68 147.69 25.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.126 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.435 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.8 tt -141.55 170.85 14.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.46 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.435 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 61.8 tt0 72.51 52.24 0.17 Allowed 'General case' 0 C--N 1.334 -0.099 0 O-C-N 123.625 0.578 . . . . 1.0 109.769 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -117.29 84.81 2.22 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.652 -0.703 . . . . 1.0 109.841 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -65.94 -36.76 84.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.056 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -107.66 118.5 53.02 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.051 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -50.11 -30.18 24.4 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.081 1.854 . . . . 1.0 112.105 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 tp -79.51 -11.79 59.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.043 0.449 . . . . 1.0 110.828 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.15 140.57 35.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.188 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.1 mt -81.49 151.15 27.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.498 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.38 122.79 30.97 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.499 -1.041 . . . . 1.0 110.499 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -72.01 -13.01 61.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.87 0.367 . . . . 1.0 110.797 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.1 t -118.12 120.44 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.604 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.2 mt -114.37 126.8 55.41 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.141 -0.688 . . . . 1.0 109.141 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.3 mm -100.18 121.33 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.07 0.462 . . . . 1.0 110.48 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.557 HG21 HD13 ' A' ' 86' ' ' ILE . 5.2 t -138.17 131.28 40.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.283 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 51.8 t0 53.26 47.83 23.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.039 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER 55.52 21.45 4.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.077 179.277 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -128.0 144.23 51.1 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.281 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -88.57 135.01 33.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.957 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -123.74 138.2 54.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.293 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -81.71 -37.97 26.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.692 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -132.7 157.57 44.55 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.225 0.536 . . . . 1.0 111.781 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.2 tp -65.17 -39.27 92.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.501 -0.772 . . . . 1.0 111.215 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.49 -40.91 88.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.734 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -62.2 -38.38 88.89 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 121.004 -0.279 . . . . 1.0 110.757 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.557 HD13 HG21 ' A' ' 75' ' ' VAL . 89.0 mt -62.23 -45.8 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.048 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.5 mt -61.39 -47.27 94.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.483 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.09 -42.38 67.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 112.569 0.581 . . . . 1.0 112.569 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.22 -18.39 60.14 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.748 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -91.89 -50.06 5.92 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.533 -0.467 . . . . 1.0 111.413 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 95' ' ' VAL . 8.0 mp -67.0 -42.21 85.39 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 112.296 0.48 . . . . 1.0 112.296 -178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -63.34 -49.83 72.37 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.739 -0.784 . . . . 1.0 111.64 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -68.69 -43.51 75.92 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.516 -0.474 . . . . 1.0 111.546 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -65.92 -43.88 86.78 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.048 -0.661 . . . . 1.0 111.313 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 91' ' ' LEU . 55.6 t -65.65 -45.45 92.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.237 -0.585 . . . . 1.0 111.203 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -68.24 -46.08 71.45 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.715 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.82 -41.61 87.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.467 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.96 -42.17 94.83 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.314 -0.554 . . . . 1.0 110.134 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -67.74 -38.61 83.73 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.035 -0.529 . . . . 1.0 111.196 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -70.59 -42.46 71.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.877 -0.329 . . . . 1.0 111.78 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.601 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 4.1 ttt -67.24 -55.03 15.71 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.465 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.1 m -59.04 -41.95 89.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.983 0.42 . . . . 1.0 110.669 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.6 p -72.45 8.78 1.25 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.991 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.6 t -88.53 138.49 31.38 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.722 0.296 . . . . 1.0 110.234 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -61.88 -18.24 59.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.869 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.555 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 59.8 mttp -89.34 39.05 0.93 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.023 -0.535 . . . . 1.0 109.694 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -130.99 111.75 12.32 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.357 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -131.34 114.63 15.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.057 -0.519 . . . . 1.0 109.828 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.7 m -88.76 78.97 7.55 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.046 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -105.46 152.87 17.24 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.582 ' O ' HG23 ' A' ' 115' ' ' VAL . 62.1 p -72.56 171.51 12.27 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -57.51 -40.72 79.36 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.575 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -68.08 -42.59 80.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.019 0.438 . . . . 1.0 110.505 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -70.18 -21.86 63.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.117 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 111' ' ' THR . 32.4 t -69.43 -44.33 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.085 -0.339 . . . . 1.0 110.085 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.7 t -65.44 -45.46 92.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.099 0.476 . . . . 1.0 110.342 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -65.91 -34.12 77.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.984 0.421 . . . . 1.0 110.842 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -67.44 -50.23 60.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.628 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.4 tp -70.18 -39.08 76.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.046 0.451 . . . . 1.0 110.312 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.0 -42.43 97.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.624 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -61.3 -46.85 88.6 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.264 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.537 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 34.4 t80 -61.65 -43.08 99.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.107 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.2 p -61.89 -36.64 81.89 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.424 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -62.3 -39.04 91.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.313 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.38 -43.06 84.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.455 -0.498 . . . . 1.0 109.834 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.537 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -128.44 73.88 80.16 Favored Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.227 179.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.69 -16.54 26.66 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.475 2.117 . . . . 1.0 112.443 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -89.76 -5.55 56.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.678 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -127.07 149.93 49.7 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.004 0.431 . . . . 1.0 110.432 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.9 p -80.18 162.63 24.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.561 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 p -151.5 145.41 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -140.06 145.48 37.75 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.852 0.358 . . . . 1.0 111.25 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -151.37 171.3 17.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.221 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -137.25 156.91 47.72 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.268 -0.641 . . . . 1.0 109.268 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 29.3 p -155.07 168.7 26.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.371 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.0 tp -79.76 138.49 37.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.51 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.822 ' H ' HD22 ' A' ' 137' ' ' ASN . 0.1 OUTLIER -97.5 141.47 30.52 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.238 179.31 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -95.01 -16.98 22.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.583 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 18.0 p30 -69.93 -27.01 64.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.274 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 139' ' ' ASP . 22.7 m120 -159.2 92.26 1.89 Allowed Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 109.954 -0.387 . . . . 1.0 109.954 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.01 142.7 94.04 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.013 1.808 . . . . 1.0 112.404 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.53 -25.38 27.0 Favored Glycine 0 N--CA 1.464 0.542 0 N-CA-C 110.779 -0.928 . . . . 1.0 110.779 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.521 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 7.6 m0 -99.47 144.87 28.08 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 120.897 0.38 . . . . 1.0 110.09 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.601 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 70.9 m-85 -109.7 146.47 34.81 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.792 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.523 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 12.0 m-85 -119.28 132.01 55.84 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.036 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.429 HD12 ' CG2' ' A' ' 161' ' ' VAL . 11.5 mt -106.78 128.56 54.34 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.442 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.582 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -126.36 148.17 49.63 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 178.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -158.44 155.34 28.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.28 -0.568 . . . . 1.0 109.57 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.524 ' NZ ' ' O ' ' A' ' 154' ' ' SER . 4.1 tttm -134.15 130.41 37.28 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.851 0.357 . . . . 1.0 110.552 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.543 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 23.5 mm -75.76 -48.65 28.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.816 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 150' ' ' ILE . 29.2 m120 -155.51 169.11 25.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.629 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.11 -28.38 66.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.787 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.68 4.78 51.92 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.06 0.457 . . . . 1.0 110.417 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.524 ' O ' ' NZ ' ' A' ' 149' ' ' LYS . 12.4 t -90.89 165.85 13.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.316 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -99.09 148.97 23.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.47 . . . . 1.0 109.789 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 44.5 tp -72.28 118.44 15.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.901 0.381 . . . . 1.0 110.285 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -109.07 131.39 55.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.077 -0.51 . . . . 1.0 109.644 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 92.5 m -128.76 130.6 47.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.926 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -116.77 168.33 10.3 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.107 -0.497 . . . . 1.0 109.914 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.523 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 83.9 m-20 -111.7 148.34 33.64 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.648 -0.706 . . . . 1.0 110.84 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.429 ' CG2' HD12 ' A' ' 146' ' ' LEU . 74.5 t -128.36 138.18 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -103.59 128.84 50.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.196 0.522 . . . . 1.0 110.877 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.2 tp -89.16 129.23 35.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.545 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 80.8 p -129.17 174.62 9.41 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.38 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -86.43 14.13 7.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.693 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.593 ' O ' HG22 ' A' ' 166' ' ' THR . 26.9 m -121.91 -2.58 9.23 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.446 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 138.1 -141.66 12.36 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.112 -1.195 . . . . 1.0 110.112 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -109.58 126.51 53.68 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.452 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 4.6 m-85 -104.76 116.48 32.09 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.9 tt -113.08 115.42 28.3 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.583 ' C ' HD22 ' A' ' 172' ' ' ASN . 4.4 t 37.89 62.3 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 112.084 0.402 . . . . 1.0 112.084 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.646 ' N ' HD22 ' A' ' 172' ' ' ASN . 0.6 OUTLIER 63.43 27.9 15.32 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.165 0.802 . . . . 1.0 113.165 178.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 62.8 m-85 -133.87 122.49 23.27 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.452 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 7.1 t-20 -100.05 120.56 40.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.688 0.28 . . . . 1.0 111.529 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -98.66 136.96 20.58 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.44 -23.11 24.05 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.185 1.923 . . . . 1.0 113.396 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 5.1 t -154.17 158.45 40.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.104 0.478 . . . . 1.0 110.923 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.9 p -59.74 -34.42 55.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.816 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.0 -44.83 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.368 . . . . 1.0 110.246 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -69.08 -31.25 69.86 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 43.8 tp -62.67 -42.18 99.48 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.102 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 75.0 m -63.21 -45.9 89.51 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 120.634 -0.426 . . . . 1.0 110.209 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 186' ' ' LYS . 38.8 m-80 -63.28 -46.47 86.65 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 108.512 -0.921 . . . . 1.0 108.512 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.54 -46.55 0.8 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.818 -1.313 . . . . 1.0 109.818 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.89 -43.9 74.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.11 -0.545 . . . . 1.0 109.935 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.0 tttm -56.92 -43.8 81.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.401 -0.818 . . . . 1.0 110.016 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 13.7 m -61.64 -45.48 93.87 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.83 -43.55 98.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.061 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.9 tp -57.85 -45.4 86.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.855 0.359 . . . . 1.0 110.493 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.406 ' CE ' ' NZ ' ' A' ' 186' ' ' LYS . 46.9 mttm -61.96 -45.02 95.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.397 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.4 m -62.1 -41.78 98.56 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.985 0.421 . . . . 1.0 110.608 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 69.5 mt -63.98 -42.96 97.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.49 -0.777 . . . . 1.0 111.831 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -67.11 -30.71 70.8 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.885 0.328 . . . . 1.0 111.885 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . 0.414 ' O ' ' ND1' ' A' ' 194' ' ' HIS . 13.0 t-80 . . . . . 0 C--N 1.326 -0.419 0 C-N-CA 120.874 -0.33 . . . . 1.0 110.696 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.429 ' O ' ' CE1' ' A' ' 7' ' ' HIS . 18.7 mmm180 . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 120.963 0.411 . . . . 1.0 110.353 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.27 -30.62 49.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.425 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.1 pt -69.72 -19.22 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.427 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -91.28 3.28 55.26 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.697 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.429 ' CE1' ' O ' ' A' ' 3' ' ' ARG . 0.6 OUTLIER -88.91 143.67 31.81 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.072 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.7 -15.14 40.63 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.262 1.975 . . . . 1.0 112.132 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.529 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 54.2 m-85 -92.02 8.05 39.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.12 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.497 ' OH ' ' NE2' ' A' ' 34' ' ' GLN . 85.6 t80 -104.18 125.72 50.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 1.0 110.291 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -157.73 117.69 1.94 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 109.43 -0.581 . . . . 1.0 109.43 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.9 129.5 34.85 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 121.227 1.285 . . . . 1.0 112.626 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -157.99 149.13 21.14 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.091 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 16' ' ' ARG . 13.8 t-20 -77.91 164.44 25.13 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.22 -49.79 74.75 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.462 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 23.3 mmt85 -65.7 -39.52 91.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.696 0.284 . . . . 1.0 110.797 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.5 ' N ' ' CD ' ' A' ' 17' ' ' GLN . 1.1 mp0 -66.07 -35.4 80.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.069 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.09 -46.02 92.35 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.268 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -60.81 -45.15 95.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.933 -0.395 . . . . 1.0 109.933 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.04 -42.63 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.104 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.484 ' CZ ' ' NZ ' ' A' ' 25' ' ' LYS . 66.4 t80 -62.87 -42.27 99.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.403 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 18' ' ' ALA . 8.5 mp -74.27 -15.31 60.98 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.843 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -61.87 -42.57 99.22 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.393 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.1 p -77.48 -21.04 53.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.784 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.484 ' NZ ' ' CZ ' ' A' ' 21' ' ' TYR . 44.4 mmtm -79.64 176.05 10.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.51 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -100.43 171.58 7.66 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.667 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -61.73 143.58 55.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.822 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.35 10.3 59.55 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.057 -0.817 . . . . 1.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -86.88 137.43 32.4 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -135.52 161.83 34.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.266 0.555 . . . . 1.0 110.836 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.706 ' O ' HG23 ' A' ' 44' ' ' ILE . 11.0 m -147.49 157.28 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.274 -0.875 . . . . 1.0 111.316 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 84.1 mt -118.43 128.41 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.481 ' CZ ' ' OG1' ' A' ' 45' ' ' THR . 23.8 ptt180 -147.34 154.78 41.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.32 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.497 ' NE2' ' OH ' ' A' ' 10' ' ' TYR . 4.2 pt20 -104.7 144.78 31.26 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.3 t -89.32 136.0 33.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.591 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.2 t -60.62 -40.6 92.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.566 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -79.32 -11.41 59.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.577 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.94 -68.48 1.45 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.542 -1.023 . . . . 1.0 110.542 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 t0 74.85 -39.88 0.42 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.604 0.24 . . . . 1.0 110.942 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -113.58 -11.27 13.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.838 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.613 ' C ' HD12 ' A' ' 42' ' ' LEU . 14.3 m170 -117.71 151.14 37.86 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.344 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.613 HD12 ' C ' ' A' ' 41' ' ' HIS . 11.2 mp -117.39 153.83 32.37 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.1 t -127.7 134.91 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.343 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 31' ' ' VAL . 69.0 mt -114.24 138.35 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 108.768 -0.827 . . . . 1.0 108.768 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.481 ' OG1' ' CZ ' ' A' ' 33' ' ' ARG . 26.4 m -117.61 138.26 52.07 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.136 0.493 . . . . 1.0 109.805 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.555 ' CZ2' HD11 ' A' ' 48' ' ' LEU . 5.2 p-90 -148.93 156.54 42.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.457 -0.792 . . . . 1.0 111.163 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.453 ' C ' HD12 ' A' ' 48' ' ' LEU . 37.5 ttpt -100.78 140.2 35.41 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.034 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.6 mp -96.53 -68.19 0.81 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.217 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -152.98 147.88 26.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.276 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt 46.73 -127.81 1.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.858 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 16.3 p-10 -93.61 25.99 3.26 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.696 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.619 HD13 ' N ' ' A' ' 53' ' ' PHE . 0.3 OUTLIER -92.69 119.65 32.3 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 -179.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.619 ' N ' HD13 ' A' ' 52' ' ' LEU . 94.8 m-85 -123.52 148.38 46.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.3 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -142.3 153.47 43.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.83 -0.623 . . . . 1.0 109.966 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -128.39 142.44 51.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.439 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.3 mt -120.55 125.35 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.001 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -95.29 120.75 36.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.912 0.386 . . . . 1.0 110.378 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.406 HD11 ' CD1' ' A' ' 44' ' ' ILE . 96.2 mt -98.69 132.13 44.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.431 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -114.68 140.88 48.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 1.0 109.696 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -99.39 157.55 16.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.456 . . . . 1.0 109.862 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.494 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.9 tp -141.77 171.71 13.69 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.485 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.494 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 79.1 mm-40 59.06 28.87 18.27 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.284 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -94.26 48.76 1.25 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.049 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.19 -39.17 86.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.291 -0.868 . . . . 1.0 111.411 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 68' ' ' ALA . 8.9 p30 -113.43 114.44 47.8 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.482 -0.327 . . . . 1.0 110.332 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.06 -13.31 0.92 Allowed 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.854 1.702 . . . . 1.0 112.167 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.6 mt -80.73 -7.56 59.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.433 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.435 ' N ' ' OD1' ' A' ' 65' ' ' ASN . . . -118.66 131.89 56.17 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.974 0.416 . . . . 1.0 110.18 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 71' ' ' LYS . 54.1 mt -76.43 156.46 33.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.288 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -43.62 91.84 0.01 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.594 -1.002 . . . . 1.0 110.594 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 69' ' ' LEU . 7.0 ttpm? -63.52 -31.07 72.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.974 0.416 . . . . 1.0 110.706 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.2 t -128.92 125.21 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.945 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.9 mt -115.77 130.13 56.73 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.89 -0.596 . . . . 1.0 109.424 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.6 mt -100.4 121.67 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 120.869 0.366 . . . . 1.0 110.535 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -141.84 133.11 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.452 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' A' ' 77' ' ' ASN . 90.2 m-20 52.7 47.64 24.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.968 -0.293 . . . . 1.0 111.211 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 3.6 p30 56.32 15.79 2.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.123 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -124.76 142.32 51.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.367 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -93.14 131.58 38.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.008 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.444 ' HB2' HD11 ' A' ' 86' ' ' ILE . 96.8 m-85 -127.07 138.31 53.18 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.199 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -84.42 -37.05 21.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.496 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -117.46 142.14 47.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.887 0.375 . . . . 1.0 111.95 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.97 -40.69 95.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.882 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.61 -41.74 91.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.796 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -59.15 -38.87 80.74 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.637 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.444 HD11 ' HB2' ' A' ' 80' ' ' TYR . 97.6 mt -62.43 -45.11 99.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.678 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.83 -44.67 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.59 -0.444 . . . . 1.0 111.112 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.492 HG12 ' NE2' ' A' ' 92' ' ' GLN . 61.8 t -68.14 -42.32 84.84 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-N 115.92 -0.582 . . . . 1.0 112.282 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -80.37 -13.16 59.39 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.322 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.516 ' OH ' ' CZ2' ' A' ' 46' ' ' TRP . 77.4 t80 -94.39 -50.21 5.34 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.661 -0.416 . . . . 1.0 111.992 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -66.34 -43.25 86.59 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.539 -0.464 . . . . 1.0 112.197 -177.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.492 ' NE2' HG12 ' A' ' 88' ' ' VAL . 2.9 pt20 -64.01 -47.17 81.31 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.943 -0.703 . . . . 1.0 111.668 -178.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 165' ' ' ASN . 53.9 t-20 -69.19 -43.34 74.38 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.544 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -65.93 -42.53 89.97 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.146 -0.621 . . . . 1.0 111.363 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.524 ' O ' ' ND2' ' A' ' 99' ' ' ASN . 56.1 t -63.64 -47.13 92.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.01 -0.676 . . . . 1.0 111.336 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -68.98 -41.28 78.09 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.567 -0.453 . . . . 1.0 111.512 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.524 HD11 ' CZ ' ' A' ' 168' ' ' TYR . 12.3 tp -66.3 -44.37 83.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.806 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 mp -65.37 -43.16 91.67 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.306 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 95' ' ' VAL . 2.7 m-80 -67.17 -37.12 83.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.987 -0.552 . . . . 1.0 111.192 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -71.28 -42.79 68.27 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 121.033 -0.267 . . . . 1.0 111.683 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 tpt -67.63 -54.0 23.32 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.397 -0.521 . . . . 1.0 111.329 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.9 m -58.6 -42.6 88.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.046 0.451 . . . . 1.0 110.335 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.4 t -73.72 8.18 2.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.881 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.8 t -86.24 141.4 29.32 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.64 0.257 . . . . 1.0 110.498 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -65.35 -20.57 66.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.9 0.381 . . . . 1.0 110.773 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.564 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 70.0 mmtt -88.92 38.87 0.9 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.831 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -131.48 111.92 12.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.754 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -118.61 109.66 16.41 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.411 -0.589 . . . . 1.0 109.411 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.2 t -87.56 70.39 9.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.565 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.51 160.85 12.97 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 110.714 -0.954 . . . . 1.0 110.714 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.508 HG22 ' N ' ' A' ' 112' ' ' LYS . 28.5 m -70.36 164.17 25.07 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.508 ' N ' HG22 ' A' ' 111' ' ' THR . 63.5 mttp -54.67 -36.13 64.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.743 0.306 . . . . 1.0 110.493 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -66.52 -42.23 87.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.952 0.406 . . . . 1.0 110.553 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -70.29 -21.15 62.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.993 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.75 -45.44 81.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.242 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.46 -44.7 94.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.147 0.499 . . . . 1.0 110.433 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -65.89 -33.63 76.27 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.962 0.41 . . . . 1.0 110.644 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -68.42 -50.07 55.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.535 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.457 HD11 HG13 ' A' ' 131' ' ' VAL . 9.6 tp -69.92 -39.55 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.415 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -64.72 -40.45 95.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.645 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -59.56 -47.56 85.06 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.365 -0.534 . . . . 1.0 110.151 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -61.48 -40.3 94.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.046 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.5 t -62.39 -42.7 99.63 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.534 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -61.6 -40.04 93.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.68 -42.37 86.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.688 -0.405 . . . . 1.0 109.938 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.65 75.23 74.97 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.174 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.09 -14.08 31.68 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.237 1.958 . . . . 1.0 112.496 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.507 HD22 ' C ' ' A' ' 128' ' ' ASN . 0.1 OUTLIER -102.79 11.14 37.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.533 -0.303 . . . . 1.0 111.532 -179.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.475 ' N ' HD22 ' A' ' 128' ' ' ASN . 52.2 mtpt -132.81 147.57 52.31 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.925 0.393 . . . . 1.0 110.497 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.42 ' HB3' HD12 ' A' ' 150' ' ' ILE . 16.8 p -81.18 162.21 23.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.747 -0.661 . . . . 1.0 109.856 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 119' ' ' ILE . 3.8 p -153.59 146.21 14.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.501 ' O ' ' CD1' ' A' ' 133' ' ' TYR . 10.3 p90 -144.94 142.67 30.04 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.907 0.384 . . . . 1.0 111.312 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 26.0 m-85 -152.75 167.64 28.33 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.555 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.564 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 4.1 p90 -135.64 151.8 50.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.423 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.1 p -154.17 170.51 21.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.518 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 tt -84.79 134.36 34.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.679 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 138' ' ' HIS . 69.3 m-80 -159.51 166.78 30.14 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.918 -0.401 . . . . 1.0 109.918 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.46 ' O ' ' OD1' ' A' ' 139' ' ' ASP . 3.9 t60 76.21 -158.48 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.462 -0.336 . . . . 1.0 110.733 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 138' ' ' HIS . 92.8 m-20 -142.67 64.07 1.38 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.592 ' O ' ' N ' ' A' ' 142' ' ' GLY . 2.7 m120 -129.33 156.01 79.11 Favored Pre-proline 0 CA--C 1.53 0.176 0 N-CA-C 108.897 -0.779 . . . . 1.0 108.897 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -42.81 78.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.753 2.302 . . . . 1.0 113.046 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 140' ' ' ASN . . . 52.07 64.35 4.05 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.247 -0.741 . . . . 1.0 111.247 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -94.94 152.5 18.29 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.674 -0.491 . . . . 1.0 109.674 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -121.05 153.15 37.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.798 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -127.16 127.97 45.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.872 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.1 mt -95.47 123.02 38.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.003 0.43 . . . . 1.0 110.982 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.64 145.61 46.3 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.127 -1.064 . . . . 1.0 108.127 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -159.79 157.59 29.57 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.299 -0.56 . . . . 1.0 109.944 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.554 ' NZ ' ' O ' ' A' ' 151' ' ' ASN . 36.6 tttm -142.87 126.28 16.69 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 120.668 -0.413 . . . . 1.0 110.056 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 151' ' ' ASN . 4.7 tp -78.84 -45.64 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.802 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.561 ' N ' HG23 ' A' ' 150' ' ' ILE . 29.4 m120 -144.86 157.98 43.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.842 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.03 -26.5 68.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.875 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -83.25 -16.43 46.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.177 0.513 . . . . 1.0 110.199 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.1 t -77.94 170.51 16.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.153 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -97.31 155.03 17.06 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.367 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.22 120.03 18.27 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.26 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -106.04 127.17 52.99 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.107 -0.497 . . . . 1.0 109.839 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 95.9 m -128.62 130.87 47.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.994 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -118.88 170.1 9.3 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.863 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -111.83 147.39 35.84 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.8 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.1 t -128.21 135.62 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.504 ' NZ ' ' CG2' ' A' ' 164' ' ' THR . 17.1 ttpp -101.56 130.72 47.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.869 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.2 tp -88.91 130.69 35.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.686 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.504 ' CG2' ' NZ ' ' A' ' 162' ' ' LYS . 66.2 p -129.28 171.46 12.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.582 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.533 ' O ' ' ND2' ' A' ' 93' ' ' ASN . 14.4 p30 -83.84 13.97 4.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.67 -0.696 . . . . 1.0 110.472 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 25.1 p -121.76 -2.22 9.35 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.606 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 139.4 -126.37 3.3 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.303 -1.119 . . . . 1.0 110.303 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.524 ' CZ ' HD11 ' A' ' 97' ' ' LEU . 28.6 m-85 -127.41 127.31 43.93 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.652 0.263 . . . . 1.0 110.635 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.514 ' CE1' ' OD1' ' A' ' 174' ' ' ASN . 4.3 m-85 -100.87 124.47 46.58 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.8 tt -116.83 111.16 19.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.572 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 170' ' ' LEU . 4.7 t 35.49 63.44 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.6 m120 67.29 26.28 8.6 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -132.87 121.45 22.92 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.514 ' OD1' ' CE1' ' A' ' 169' ' ' PHE . 63.7 t30 -98.24 120.65 39.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.944 0.402 . . . . 1.0 111.635 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -105.13 125.61 33.15 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.2 -20.6 18.72 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.33 2.02 . . . . 1.0 113.504 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.2 m -137.2 141.39 42.13 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.982 0.42 . . . . 1.0 111.07 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.08 -34.67 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.575 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.08 -44.31 98.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.635 -0.426 . . . . 1.0 109.934 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -68.86 -30.26 68.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.1 tp -63.53 -43.24 97.72 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.205 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 7.7 p -62.87 -47.43 83.37 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.52 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.583 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 42.8 m-80 -65.01 -48.03 75.38 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.944 -0.761 . . . . 1.0 108.944 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.84 -44.85 1.0 Allowed Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.818 -1.313 . . . . 1.0 109.818 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -69.13 -47.05 66.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.9 tttm -56.12 -41.23 74.97 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.327 -0.851 . . . . 1.0 110.039 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 94.0 m -61.39 -45.04 96.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 51.7 mt -62.86 -41.08 99.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.001 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.535 HD11 HD13 ' A' ' 150' ' ' ILE . 57.6 tp -59.43 -44.16 92.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.323 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.42 -45.09 95.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.243 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 37.0 t -64.09 -38.87 92.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.804 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.2 mt -63.17 -41.95 99.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.61 -0.723 . . . . 1.0 111.608 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -59.96 -23.53 63.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.609 0.243 . . . . 1.0 111.555 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 194' ' ' HIS . 47.7 t-80 . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.785 0.326 . . . . 1.0 110.906 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 . . . . . 0 N--CA 1.464 0.231 0 CA-C-O 120.806 0.336 . . . . 1.0 110.53 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.36 -37.03 79.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.676 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.3 pt -62.34 -26.45 40.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.363 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -74.9 -13.28 60.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.477 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -79.21 115.67 54.53 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.284 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.458 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 76.6 Cg_exo -48.38 -24.9 6.64 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.869 1.712 . . . . 1.0 112.305 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -81.73 3.95 23.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.184 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 91.9 t80 -85.95 132.8 34.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.594 -0.275 . . . . 1.0 110.436 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 62.1 m-85 -150.77 123.58 4.18 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 120.995 -0.282 . . . . 1.0 110.476 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.474 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 73.7 Cg_endo -73.83 110.21 3.03 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.935 1.757 . . . . 1.0 112.631 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.474 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 74.1 m-85 -159.82 154.64 24.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.338 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -80.86 166.29 21.06 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.632 ' N ' ' NH1' ' A' ' 33' ' ' ARG . . . -57.03 -46.89 90.99 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.756 -0.938 . . . . 1.0 110.756 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -65.51 -39.01 91.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.59 0.233 . . . . 1.0 110.736 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -66.14 -37.14 84.96 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.696 -0.229 . . . . 1.0 111.205 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.415 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.15 -45.22 95.54 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.659 -0.417 . . . . 1.0 110.31 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -61.43 -46.5 89.86 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.669 -0.412 . . . . 1.0 109.948 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -62.28 -43.36 98.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.315 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -63.08 -44.48 95.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.56 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 18' ' ' ALA . 8.8 mp -75.02 -13.6 60.52 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.647 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -60.97 -41.92 97.31 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.39 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.9 t -74.93 -18.54 60.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.503 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -85.46 -175.66 5.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.788 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.46 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 45.4 mp0 -99.72 -179.25 4.13 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.472 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -81.41 145.56 30.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.634 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.39 8.0 53.46 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.143 -0.783 . . . . 1.0 111.143 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -95.77 139.63 31.72 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.387 -0.598 . . . . 1.0 109.387 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -131.05 167.96 18.2 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.284 0.564 . . . . 1.0 111.133 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -148.81 159.54 6.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.19 -0.913 . . . . 1.0 111.414 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.56 127.11 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.338 -0.616 . . . . 1.0 109.338 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.632 ' NH1' ' N ' ' A' ' 15' ' ' GLY . 44.4 ttp180 -134.39 153.58 51.82 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.152 -0.476 . . . . 1.0 109.752 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.419 ' N ' ' HG2' ' A' ' 33' ' ' ARG . 51.7 mt-30 -105.83 131.23 53.42 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.673 -0.492 . . . . 1.0 109.673 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -77.56 124.3 27.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.867 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.8 p -63.76 -38.82 92.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.625 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -79.11 -25.09 43.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.797 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -69.99 -53.85 13.58 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.54 -1.024 . . . . 1.0 110.54 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t0 70.7 -42.45 0.53 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.725 0.298 . . . . 1.0 111.034 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 38' ' ' GLY . 98.2 m-20 -119.45 19.92 12.58 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.65 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -140.27 150.71 44.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.669 0.271 . . . . 1.0 110.475 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.03 151.36 39.11 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.844 -0.428 . . . . 1.0 109.844 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.1 t -126.19 133.81 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.587 0.232 . . . . 1.0 110.727 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.531 HD12 HD11 ' A' ' 58' ' ' ILE . 92.3 mt -110.55 136.31 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.9 m -117.63 139.31 51.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.006 -0.543 . . . . 1.0 109.635 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.562 ' CE2' ' OH ' ' A' ' 90' ' ' TYR . 3.7 p-90 -143.3 153.1 42.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.776 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' A' ' 49' ' ' ASP . 64.7 tttp -101.4 133.3 46.22 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.829 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -96.07 -75.51 0.53 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.503 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.511 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 72.4 m-20 -109.99 -167.81 1.24 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.872 -0.603 . . . . 1.0 110.596 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -60.38 -42.31 95.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.775 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -128.43 56.94 1.6 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.797 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 44.5 tp -153.59 115.48 4.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.913 0.387 . . . . 1.0 110.081 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -124.88 148.19 48.41 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.33 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -136.87 152.69 50.53 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.971 -0.558 . . . . 1.0 110.283 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -129.9 144.39 51.29 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.661 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.521 HD12 ' CZ ' ' A' ' 90' ' ' TYR . 97.0 mt -125.36 131.52 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.228 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -98.27 122.79 41.87 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.978 0.418 . . . . 1.0 110.84 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.531 HD11 HD12 ' A' ' 44' ' ' ILE . 91.2 mt -101.13 133.75 43.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.385 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 59' ' ' GLN . 1.2 pm0 -120.12 132.49 55.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -99.99 144.54 28.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.103 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.728 HD13 ' H ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -135.91 173.48 11.66 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.158 0.504 . . . . 1.0 109.947 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.728 ' H ' HD13 ' A' ' 61' ' ' LEU . 13.1 tp10 87.32 33.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.677 -1.147 . . . . 1.0 109.922 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -92.33 76.26 5.23 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.756 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.4 ' O ' ' OD1' ' A' ' 65' ' ' ASN . 12.5 pt-20 -64.99 -36.48 84.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.813 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.423 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 4.9 m-20 -136.15 153.66 76.82 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.305 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.12 -33.26 53.03 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.769 1.646 . . . . 1.0 112.29 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.7 mt -84.6 -6.72 59.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.373 . . . . 1.0 110.383 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.423 ' HB3' ' H ' ' A' ' 65' ' ' ASN . . . -88.19 127.33 35.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.273 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.0 mt -86.03 153.73 21.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.302 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.9 95.51 0.41 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.313 -1.115 . . . . 1.0 110.313 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -71.92 -15.41 62.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.927 0.394 . . . . 1.0 110.684 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.2 t -118.26 120.35 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.669 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.2 mt -113.82 126.02 54.73 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.9 mt -102.08 123.64 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.882 0.372 . . . . 1.0 110.653 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.435 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 57.8 t -142.88 134.18 23.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.976 -0.557 . . . . 1.0 110.34 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.437 ' OD2' ' O ' ' A' ' 76' ' ' ASP . 3.4 p-10 48.67 44.32 21.23 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.216 0.323 . . . . 1.0 111.263 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 59.69 23.18 11.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.038 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -129.15 138.38 51.74 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.358 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -92.23 132.16 36.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 1.0 111.11 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.481 ' HB2' HD11 ' A' ' 86' ' ' ILE . 90.4 m-85 -126.88 138.07 53.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.263 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -82.76 -37.73 24.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.821 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -109.48 133.34 53.2 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.005 0.431 . . . . 1.0 112.028 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.4 tp -64.41 -40.73 96.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.503 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -62.06 -43.23 99.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.501 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.46 ' O ' ' OE1' ' A' ' 89' ' ' GLU . 32.8 tt0 -58.39 -38.3 77.05 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.345 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 80' ' ' TYR . 96.1 mt -59.66 -45.31 94.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.753 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.843 ' O ' HD12 ' A' ' 91' ' ' LEU . 43.9 mm -62.57 -47.42 93.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.429 -0.508 . . . . 1.0 111.607 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.1 t -69.86 -23.56 25.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 112.967 0.728 . . . . 1.0 112.967 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 85' ' ' GLN . 4.5 mp0 -98.1 -9.59 25.64 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.142 -0.223 . . . . 1.0 111.054 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.562 ' OH ' ' CE2' ' A' ' 46' ' ' TRP . 12.5 t80 -89.38 -54.58 4.03 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.913 0.709 . . . . 1.0 112.913 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.957 HD13 ' H ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -71.59 -33.56 69.14 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.706 -0.679 . . . . 1.0 112.107 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.957 ' H ' HD13 ' A' ' 91' ' ' LEU . 3.5 mm-40 -61.2 -48.68 80.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.07 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -67.72 -40.53 84.21 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.068 -0.653 . . . . 1.0 111.448 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -63.11 -42.6 99.59 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.438 -0.505 . . . . 1.0 111.275 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.93 -45.88 93.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.331 -0.548 . . . . 1.0 111.279 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -66.8 -45.4 78.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.383 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tp -69.04 -41.16 78.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.55 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.44 -42.25 92.61 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.472 -0.491 . . . . 1.0 110.053 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -66.38 -39.92 89.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.382 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -71.18 -42.81 68.56 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 120.781 -0.368 . . . . 1.0 111.783 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.1 tpt -63.96 -54.01 41.24 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.349 -0.54 . . . . 1.0 111.096 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.7 m -61.26 -39.36 90.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.48 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.2 t -73.16 9.77 1.15 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.911 -0.586 . . . . 1.0 111.224 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 87.1 p -88.03 139.22 30.73 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.681 0.277 . . . . 1.0 110.725 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.68 -22.32 66.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.996 0.427 . . . . 1.0 110.626 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.564 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 31.5 mtmm -88.2 39.63 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.804 -0.635 . . . . 1.0 109.828 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -129.84 114.02 15.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.068 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -122.75 124.66 43.86 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -93.65 68.09 3.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.826 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.13 147.51 16.84 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 115' ' ' VAL . 29.2 p -72.42 172.08 11.09 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -55.9 -37.66 69.18 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.364 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -67.47 -45.07 77.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.841 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.73 -20.37 63.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.781 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 111' ' ' THR . 39.4 t -69.71 -44.82 78.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.343 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.58 -46.38 95.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.207 0.527 . . . . 1.0 110.178 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -65.77 -33.99 77.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.829 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -68.31 -50.23 54.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.795 -0.639 . . . . 1.0 111.679 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.429 HD11 HG13 ' A' ' 131' ' ' VAL . 10.4 tp -69.99 -39.4 77.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.682 -0.407 . . . . 1.0 110.457 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.51 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 66.8 mm-40 -63.75 -40.56 97.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.716 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -63.43 -46.85 84.39 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.11 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.537 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 9.2 t80 -61.92 -41.83 98.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.14 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.5 t -62.28 -40.53 96.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.41 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -57.74 -44.03 85.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.315 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.47 -38.89 83.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.368 -0.605 . . . . 1.0 109.368 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.537 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -124.56 76.25 63.34 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.598 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -70.5 -24.56 26.14 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.799 2.333 . . . . 1.0 112.514 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -100.94 13.54 34.81 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.867 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.33 151.0 51.84 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.846 0.355 . . . . 1.0 110.482 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 m -80.91 160.87 24.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.887 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.429 HG13 HD11 ' A' ' 119' ' ' ILE . 4.2 p -153.05 149.81 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 109.36 -0.607 . . . . 1.0 109.36 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -151.0 143.44 24.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.922 0.392 . . . . 1.0 111.307 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -151.37 165.13 35.03 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.374 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.564 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.6 p90 -136.08 148.55 48.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 1.0 109.481 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 75.1 m -143.92 167.77 21.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.088 0.471 . . . . 1.0 110.214 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.8 tt -83.61 131.72 34.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.252 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -104.31 133.45 49.18 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.221 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -85.81 0.81 51.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.846 0.355 . . . . 1.0 110.585 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 139' ' ' ASP . 66.4 t0 -64.13 -37.9 89.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.127 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -150.81 104.59 3.04 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.085 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -48.65 124.04 10.38 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.597 1.531 . . . . 1.0 112.78 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.99 29.5 9.02 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.839 -0.905 . . . . 1.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -134.9 142.21 46.51 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.676 0.274 . . . . 1.0 110.32 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -122.16 146.49 47.18 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.625 ' CE2' ' ND2' ' A' ' 160' ' ' ASN . 13.6 m-85 -117.89 138.68 51.96 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.188 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.436 HD12 ' CG2' ' A' ' 161' ' ' VAL . 7.3 mt -110.44 120.95 44.08 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.617 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.57 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -116.07 145.01 43.37 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.988 -1.115 . . . . 1.0 107.988 178.02 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -161.68 149.74 15.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.39 -0.524 . . . . 1.0 109.679 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.51 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 67.0 tttt -135.4 130.39 34.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 120.934 -0.306 . . . . 1.0 110.257 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.439 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 28.9 mm -71.04 -45.03 74.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 1.0 111.348 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 150' ' ' ILE . 82.7 m-20 -160.31 174.23 14.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.665 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.92 -36.11 80.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.985 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -86.4 8.61 20.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.008 0.432 . . . . 1.0 110.531 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.3 t -96.9 157.53 15.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.516 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.431 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 68.8 mttm -88.16 143.24 27.17 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.216 -0.447 . . . . 1.0 109.891 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 43.6 tp -70.28 130.14 41.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.909 0.385 . . . . 1.0 110.141 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.431 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 93.6 m-85 -119.83 135.09 55.0 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.803 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 91.3 m -129.99 132.69 46.37 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.932 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.77 169.06 11.47 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.124 -0.489 . . . . 1.0 109.961 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.625 ' ND2' ' CE2' ' A' ' 145' ' ' TYR . 5.8 m120 -117.17 150.57 38.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.885 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.436 ' CG2' HD12 ' A' ' 146' ' ' LEU . 78.5 t -128.26 137.96 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.804 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -100.24 125.77 46.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.984 0.421 . . . . 1.0 110.592 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.9 tp -88.39 130.68 35.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.788 -0.642 . . . . 1.0 109.372 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 37.6 p -128.82 176.67 7.65 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.93 0.395 . . . . 1.0 110.445 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -88.98 13.49 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.36 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 12.5 p -121.65 -2.5 9.37 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.814 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.35 -140.56 10.68 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.36 -1.096 . . . . 1.0 110.36 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -116.42 126.99 54.21 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.616 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 7.7 m-85 -106.43 117.8 34.99 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.0 tt -113.45 117.66 32.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.7 -0.482 . . . . 1.0 109.7 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.4 t 36.25 60.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.088 0.403 . . . . 1.0 112.088 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.7 m120 65.19 27.91 12.19 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.061 0.763 . . . . 1.0 113.061 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -133.87 120.79 20.85 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.616 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 16.4 t-20 -97.48 121.19 39.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.532 -0.304 . . . . 1.0 111.435 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -101.8 137.21 19.48 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.78 -21.4 33.46 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 122.412 2.075 . . . . 1.0 113.134 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 4.5 t -156.48 160.82 39.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.111 0.481 . . . . 1.0 111.002 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.98 -34.83 61.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.795 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 93.3 mt -61.75 -44.96 99.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.081 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -69.7 -29.81 67.32 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.65 -43.87 95.5 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 110.118 -0.327 . . . . 1.0 110.118 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 86.9 m -63.22 -46.22 87.98 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.386 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.554 ' O ' ' N ' ' A' ' 186' ' ' LYS . 88.8 m-20 -64.33 -48.18 76.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.17 -44.73 0.57 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.05 -47.52 65.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.048 -0.576 . . . . 1.0 109.781 178.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 183' ' ' ASN . 64.9 tttp -56.82 -41.7 78.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.591 -0.731 . . . . 1.0 110.227 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.5 m -61.45 -44.8 96.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.405 ' O ' ' OG ' ' A' ' 191' ' ' SER . 23.1 mt -62.94 -40.47 97.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.857 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.51 -43.94 93.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.23 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -58.7 -45.96 88.36 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.269 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 188' ' ' LEU . 80.0 p -62.1 -37.36 84.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.5 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.47 -42.93 82.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.347 -0.842 . . . . 1.0 111.923 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -69.15 -34.47 75.04 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 111.871 0.323 . . . . 1.0 111.871 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 6.0 t60 . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.011 -179.321 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 120.931 0.396 . . . . 1.0 110.609 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.72 -25.94 38.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.698 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.662 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -78.91 -17.63 13.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.39 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.519 HD22 ' N ' ' A' ' 6' ' ' ASN . 2.0 m120 -98.67 3.5 47.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.413 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -77.56 143.1 67.43 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.305 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.419 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 56.3 Cg_endo -70.65 -13.83 32.76 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.855 1.703 . . . . 1.0 112.243 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.472 ' CD1' ' CZ ' ' A' ' 30' ' ' PHE . 88.6 m-85 -94.53 3.94 54.48 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.533 -0.303 . . . . 1.0 111.128 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.545 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 88.1 t80 -87.29 127.72 35.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.488 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 68.4 m-85 -155.04 106.93 2.28 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.974 -0.38 . . . . 1.0 109.974 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.5 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 32.5 Cg_exo -59.15 110.87 0.76 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.716 1.611 . . . . 1.0 112.926 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.5 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 57.0 m-85 -159.64 150.95 19.79 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.425 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -78.51 171.97 14.34 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.11 -41.22 98.54 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.34 -0.933 . . . . 1.0 111.062 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.416 ' O ' ' CG ' ' A' ' 19' ' ' GLU . 84.9 mtt85 -66.41 -42.35 87.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.884 0.373 . . . . 1.0 110.861 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -71.84 -31.97 67.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.17 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.43 -48.51 79.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.825 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 20' ' ' ASP . 14.4 pt-20 -60.32 -39.08 85.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.023 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 9.2 m-20 -63.95 -43.61 95.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.078 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.593 ' CE2' ' NZ ' ' A' ' 25' ' ' LYS . 42.5 t80 -67.4 -41.59 84.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.446 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.24 -11.2 60.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.749 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -59.18 -44.51 92.17 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.867 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 m -78.67 -19.03 53.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.765 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.593 ' NZ ' ' CE2' ' A' ' 21' ' ' TYR . 43.8 mmtm -72.91 159.1 34.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.543 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.62 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.6 pm0 -82.34 156.74 24.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.637 . . . . 1.0 110.657 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.2 mtm-85 -54.05 141.62 27.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.907 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.01 17.63 50.44 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.305 -0.718 . . . . 1.0 111.305 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -94.96 136.51 35.18 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.472 ' CZ ' ' CD1' ' A' ' 9' ' ' TYR . 26.0 p90 -133.78 167.62 20.22 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.355 0.598 . . . . 1.0 110.883 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.2 m -146.77 157.76 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 114.924 -1.034 . . . . 1.0 111.64 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.0 mm -116.32 125.84 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.262 -0.644 . . . . 1.0 109.262 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -140.12 165.16 28.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.064 -0.517 . . . . 1.0 110.461 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -118.53 135.53 54.35 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 m -65.04 146.0 55.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.801 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.5 m -60.49 -26.01 66.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.692 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -123.29 27.19 7.63 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.036 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.507 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -92.49 -77.24 1.36 Allowed Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 t0 70.81 -35.49 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.623 0.249 . . . . 1.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' A' ' 38' ' ' GLY . 21.1 t70 -118.63 10.49 12.52 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.754 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.443 ' ND1' ' O ' ' A' ' 40' ' ' ASP . 25.0 m-70 -142.31 151.99 42.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.381 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mt -121.13 145.58 47.66 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.076 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.9 t -123.62 129.48 74.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.096 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.424 HD12 HD11 ' A' ' 58' ' ' ILE . 61.3 mt -111.51 137.66 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.5 m -121.63 141.71 50.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.437 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.727 ' HE1' ' NE2' ' A' ' 54' ' ' GLN . 3.5 p-90 -154.04 154.79 34.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.215 -0.902 . . . . 1.0 110.972 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -95.7 143.72 26.72 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.148 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.792 ' N ' HD12 ' A' ' 48' ' ' LEU . 3.3 mp -93.02 -73.06 0.57 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.458 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -145.26 119.08 9.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.594 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt 45.0 -129.13 1.05 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.064 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -70.94 73.95 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.068 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.4 tp -167.56 121.38 0.96 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.272 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -135.15 150.37 50.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.628 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.727 ' NE2' ' HE1' ' A' ' 46' ' ' TRP . 20.3 pt20 -135.8 155.05 50.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.714 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.47 ' CD2' ' H ' ' A' ' 55' ' ' HIS . 6.8 p80 -124.04 141.27 52.19 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.067 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.44 132.47 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.743 -0.466 . . . . 1.0 109.743 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -102.23 123.81 46.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.894 0.378 . . . . 1.0 110.534 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.424 HD11 HD12 ' A' ' 44' ' ' ILE . 86.3 mt -103.1 133.87 45.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.343 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -112.95 141.78 46.39 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.869 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.514 ' OE1' ' NZ ' ' A' ' 63' ' ' LYS . 78.8 mt-10 -99.79 148.51 24.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.813 -0.44 . . . . 1.0 109.813 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.436 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.6 tp -122.73 176.22 6.08 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.579 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.436 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 69.9 mm-40 57.66 32.34 21.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.022 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.514 ' NZ ' ' OE1' ' A' ' 60' ' ' GLU . 20.1 mmtm -78.65 74.13 5.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.881 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.7 -29.51 70.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.707 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -150.31 149.11 25.96 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.068 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.62 -25.14 66.14 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.268 1.979 . . . . 1.0 112.13 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.0 mp -91.27 -11.09 39.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.722 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.34 140.07 50.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.371 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.2 mt -77.14 148.89 35.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.377 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.47 92.39 0.27 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -63.17 -35.2 79.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.831 0.348 . . . . 1.0 110.875 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.1 t -127.11 125.06 65.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.073 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.1 mt -115.23 129.63 56.69 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.5 mm -99.41 123.54 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.933 0.397 . . . . 1.0 110.298 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.583 HG21 HD13 ' A' ' 86' ' ' ILE . 10.3 t -139.88 130.47 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.28 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 54.24 40.7 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.954 -0.298 . . . . 1.0 111.096 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.6 t30 62.0 24.05 14.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.729 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -128.21 151.78 48.85 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.264 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -96.65 130.78 43.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.81 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -125.07 138.43 54.19 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.198 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -85.91 -38.02 18.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.731 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -121.36 145.6 47.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.173 0.511 . . . . 1.0 112.039 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.51 -38.41 89.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.615 -0.72 . . . . 1.0 110.802 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -60.72 -39.89 90.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.934 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -63.12 -38.67 92.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.649 0.261 . . . . 1.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.583 HD13 HG21 ' A' ' 75' ' ' VAL . 94.2 mt -60.98 -46.3 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.873 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.7 mt -62.9 -46.14 97.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.581 -0.448 . . . . 1.0 111.669 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.68 -43.7 79.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 112.495 0.554 . . . . 1.0 112.495 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -75.9 -14.12 60.26 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.799 -0.36 . . . . 1.0 111.511 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -94.14 -50.77 5.13 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.638 -0.425 . . . . 1.0 111.825 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 95' ' ' VAL . 1.9 tp -68.85 -39.97 79.62 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.301 0.482 . . . . 1.0 112.301 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -62.94 -48.91 76.85 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 119.971 -0.691 . . . . 1.0 111.379 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -69.57 -42.41 74.54 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.691 -0.403 . . . . 1.0 111.696 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -65.92 -42.55 89.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.218 -0.593 . . . . 1.0 111.191 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 91' ' ' LEU . 53.6 t -65.86 -45.13 92.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.495 -0.482 . . . . 1.0 111.296 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -67.1 -44.9 78.79 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.86 -0.336 . . . . 1.0 111.563 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 tp -68.58 -41.77 79.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.501 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.3 tp -63.52 -43.07 98.25 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.193 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -68.63 -37.66 79.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.026 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -70.4 -43.17 70.59 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.686 -0.406 . . . . 1.0 111.562 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.2 tpt -66.28 -55.06 17.93 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.279 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 104' ' ' SER . 9.7 m -58.34 -38.42 77.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.028 0.442 . . . . 1.0 110.349 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.7 p -72.36 10.57 0.76 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.634 -0.712 . . . . 1.0 111.049 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 102' ' ' THR . 11.7 t -91.84 134.16 35.01 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.832 0.349 . . . . 1.0 110.248 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.31 -20.81 46.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 1.0 111.196 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.58 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 45.9 mtpt -87.9 40.63 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.943 -0.571 . . . . 1.0 109.761 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -130.68 109.14 10.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.135 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -134.8 124.93 25.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.732 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.2 p -92.61 82.8 4.82 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.879 0.371 . . . . 1.0 110.933 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -103.84 147.89 16.78 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.887 -0.885 . . . . 1.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 115' ' ' VAL . 7.6 p -73.53 168.48 19.2 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.007 -0.368 . . . . 1.0 110.007 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -58.89 -40.57 84.85 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.743 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -70.83 -44.0 67.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.183 0.516 . . . . 1.0 110.641 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.54 -22.57 63.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.994 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 111' ' ' THR . 23.7 t -68.11 -44.76 84.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.089 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.5 t -63.91 -45.85 95.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.098 0.475 . . . . 1.0 110.263 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.38 -38.65 90.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.977 0.418 . . . . 1.0 111.034 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -64.44 -49.47 71.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.778 -0.647 . . . . 1.0 111.834 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.0 tp -70.24 -38.4 74.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.485 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -62.22 -41.28 98.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.547 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.71 -48.46 74.57 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.45 -0.5 . . . . 1.0 110.255 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.552 ' CD2' ' OD1' ' A' ' 126' ' ' ASN . 39.8 t80 -61.55 -42.42 98.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.944 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 96.4 p -57.77 -39.17 76.8 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.272 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -64.42 -37.52 87.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.248 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.4 t -64.8 -40.38 88.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.554 -0.536 . . . . 1.0 109.554 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.552 ' OD1' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -126.55 75.56 74.36 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.385 179.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.567 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 6.6 Cg_exo -71.52 -25.47 21.1 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.485 2.123 . . . . 1.0 112.584 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -99.35 13.48 33.03 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.188 -0.46 . . . . 1.0 112.05 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -136.24 150.41 48.95 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.931 0.396 . . . . 1.0 110.445 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.9 p -80.12 164.32 23.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.742 -0.663 . . . . 1.0 109.79 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 p -153.09 147.41 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -149.16 142.82 25.5 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.861 0.362 . . . . 1.0 111.125 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -153.15 170.5 20.37 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.313 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -135.95 157.08 47.72 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.9 p -151.02 168.0 25.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.356 -0.383 . . . . 1.0 110.296 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.3 tp -78.38 135.01 37.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.442 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 8.4 t-20 -63.25 -176.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.201 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.451 ' ND1' ' N ' ' A' ' 138' ' ' HIS . 8.3 p-80 -138.52 -23.41 0.97 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.707 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -107.31 -10.22 15.85 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.032 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 29.3 m120 -136.93 80.09 37.02 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.413 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.65 128.61 30.72 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.013 1.809 . . . . 1.0 112.469 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.3 -19.92 41.52 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -98.86 149.33 23.02 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 110.0 -0.371 . . . . 1.0 110.0 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -118.13 153.73 33.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.524 . . . . 1.0 109.747 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.45 ' CE1' ' ND2' ' A' ' 137' ' ' ASN . 33.1 m-85 -126.82 137.49 53.2 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.016 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.6 mt -108.07 128.93 55.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.31 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.444 ' SD ' HG13 ' A' ' 115' ' ' VAL . 2.5 ptt? -120.36 146.41 46.19 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.837 -1.172 . . . . 1.0 107.837 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -160.38 146.56 15.37 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -130.41 126.51 37.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 120.814 -0.354 . . . . 1.0 110.285 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.667 HD12 ' H ' ' A' ' 150' ' ' ILE . 5.3 mp -72.92 -45.99 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.32 0.489 . . . . 1.0 112.32 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.576 ' OD1' ' N ' ' A' ' 152' ' ' ALA . 15.6 t-20 -153.55 168.03 27.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.522 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.576 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -61.67 -30.68 70.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.689 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.417 ' ND2' ' C ' ' A' ' 153' ' ' ASN . 0.2 OUTLIER -85.73 -12.5 50.98 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.336 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.7 t -78.77 157.09 28.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.036 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -87.47 148.18 25.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.193 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.3 tp -73.02 122.94 22.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.987 0.422 . . . . 1.0 109.902 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -113.38 132.92 55.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.917 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.7 m -126.96 131.83 50.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.756 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -116.09 163.67 15.6 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.995 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 161' ' ' VAL . 28.5 t-20 -107.54 147.74 30.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.634 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.414 ' N ' ' OD1' ' A' ' 160' ' ' ASN . 44.8 t -127.71 134.79 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.597 -0.52 . . . . 1.0 109.597 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -100.55 128.44 46.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.953 0.406 . . . . 1.0 110.436 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.7 tp -92.84 131.07 38.2 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 70.4 p -129.53 171.25 12.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.39 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -85.16 15.47 4.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.55 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 58.3 p -123.21 -2.99 8.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.466 -0.334 . . . . 1.0 110.549 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 142.74 -138.2 8.22 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.357 -1.097 . . . . 1.0 110.357 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -118.69 128.58 54.65 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.115 -0.328 . . . . 1.0 110.115 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.491 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 4.7 m-85 -103.16 125.94 50.09 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 171' ' ' VAL . 0.8 OUTLIER -119.05 113.93 21.72 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.6 t 36.64 59.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 111.886 0.328 . . . . 1.0 111.886 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.5 m120 66.96 27.87 8.72 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.913 0.709 . . . . 1.0 112.913 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -132.62 121.7 23.59 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.491 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 28.0 t-20 -94.44 119.3 32.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.253 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -99.33 132.13 23.86 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 109.63 -0.507 . . . . 1.0 109.63 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.05 -22.53 19.36 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.985 1.79 . . . . 1.0 113.5 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.8 p -150.37 153.81 36.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.917 0.389 . . . . 1.0 110.939 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.05 -35.5 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.851 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.97 -47.71 90.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.152 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.35 -31.95 73.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.16 -42.14 99.36 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.401 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 75.9 m -62.97 -46.83 85.86 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.745 -0.382 . . . . 1.0 110.343 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 186' ' ' LYS . 35.8 m-80 -64.92 -49.43 70.43 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 108.712 -0.847 . . . . 1.0 108.712 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.18 -46.19 0.49 Allowed Glycine 0 N--CA 1.466 0.657 0 N-CA-C 109.998 -1.241 . . . . 1.0 109.998 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -45.12 71.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.249 0.547 . . . . 1.0 110.046 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 183' ' ' ASN . 17.6 tptm -57.75 -44.36 86.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.242 -0.89 . . . . 1.0 110.467 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 14.4 m -61.19 -45.57 94.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.77 -42.1 98.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.079 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.1 tp -58.34 -43.6 88.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.526 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -59.03 -42.95 91.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.342 0.592 . . . . 1.0 110.228 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.3 t -66.21 -42.68 88.4 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.19 0.519 . . . . 1.0 110.207 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.88 -46.38 85.2 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.303 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.51 -30.09 69.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.456 -0.338 . . . . 1.0 111.679 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 44.1 m80 . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.902 -178.885 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 121.152 0.501 . . . . 1.0 110.387 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 5' ' ' ILE . 14.2 p -64.69 -39.08 84.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.71 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.446 ' N ' HG13 ' A' ' 4' ' ' VAL . 43.8 pt -67.49 -29.99 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.793 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -95.73 10.35 37.24 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.362 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -66.36 133.65 94.49 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.295 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.536 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 78.4 Cg_exo -48.65 -34.14 26.2 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.834 1.69 . . . . 1.0 112.398 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CE2' ' CZ ' ' A' ' 30' ' ' PHE . 90.6 m-85 -79.66 4.15 16.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.398 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.447 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 55.3 t80 -87.19 128.14 35.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.454 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CZ ' ' O ' ' A' ' 8' ' ' PRO . 67.6 m-85 -150.83 115.29 3.22 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.59 112.28 3.49 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.95 1.767 . . . . 1.0 113.623 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.582 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -159.03 165.33 34.22 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.375 0.607 . . . . 1.0 111.187 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 51.4 t-20 -76.71 163.7 26.57 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.506 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . -59.68 -40.2 96.19 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.876 -0.89 . . . . 1.0 110.876 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -64.83 -45.14 87.4 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.994 -0.283 . . . . 1.0 111.033 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -70.0 -36.98 75.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.506 -0.316 . . . . 1.0 111.464 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -42.9 99.36 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.42 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.69 -42.21 82.4 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.118 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -61.82 -40.1 94.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.178 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -64.31 -40.52 96.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.659 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.42 -13.27 59.92 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.019 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -59.24 -42.54 91.34 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.644 -0.423 . . . . 1.0 110.561 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 m -77.97 -19.41 54.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.681 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -79.06 171.41 15.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.003 0.43 . . . . 1.0 110.858 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -77.01 155.52 32.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.786 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -69.08 145.84 53.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.4 2.54 60.28 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.08 -0.808 . . . . 1.0 111.08 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -79.01 154.17 29.7 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.617 ' CZ ' ' CE2' ' A' ' 9' ' ' TYR . 37.5 p90 -138.71 166.33 24.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.593 0.711 . . . . 1.0 111.054 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 45' ' ' THR . 16.1 m -149.8 162.41 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.721 -1.127 . . . . 1.0 112.046 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.5 mt -117.01 127.02 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.705 -0.479 . . . . 1.0 109.705 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.475 ' NE ' ' O ' ' A' ' 13' ' ' PHE . 75.2 ttt-85 -136.49 158.49 44.3 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.35 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -114.31 133.09 55.91 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.824 -0.436 . . . . 1.0 109.824 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.2 m -77.2 139.21 39.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.1 p -68.7 -38.01 79.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.96 -0.563 . . . . 1.0 110.434 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 83.0 mmt-85 -88.08 -13.95 40.13 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.771 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -75.02 -64.06 2.4 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.519 -1.033 . . . . 1.0 110.519 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 t70 69.93 -40.2 0.46 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.647 0.261 . . . . 1.0 110.944 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 38' ' ' GLY . 43.0 p-10 -117.15 11.4 14.15 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.71 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.535 ' C ' HD12 ' A' ' 42' ' ' LEU . 32.7 m-70 -132.24 152.73 51.19 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.933 0.397 . . . . 1.0 110.371 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.535 HD12 ' C ' ' A' ' 41' ' ' HIS . 10.8 mp -118.75 144.99 45.92 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.827 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -126.1 130.88 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.284 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 31' ' ' VAL . 20.3 mt -112.97 139.49 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.484 ' O ' HG22 ' A' ' 31' ' ' VAL . 47.7 m -115.99 128.64 55.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.732 ' HE1' HE21 ' A' ' 54' ' ' GLN . 8.0 p-90 -142.38 147.73 36.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.915 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' C ' HD12 ' A' ' 48' ' ' LEU . 24.7 mtmm -90.88 136.88 32.78 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.101 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 48' ' ' LEU . 7.4 mp -94.33 -67.59 0.85 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.192 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.493 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 26.1 t70 -125.91 -173.31 2.81 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.319 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.493 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 88.4 tttt -65.23 134.23 53.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.644 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 56.44 31.42 18.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.052 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 tp -135.02 130.27 35.4 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.879 0.371 . . . . 1.0 110.604 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -132.29 149.81 52.29 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.551 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.732 HE21 ' HE1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -142.86 153.91 43.63 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 179.203 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.482 ' N ' ' CD ' ' A' ' 54' ' ' GLN . 19.1 p80 -123.24 140.73 52.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.207 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 56' ' ' ILE . 14.7 tt -123.87 128.43 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.788 -0.449 . . . . 1.0 109.788 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -103.72 126.36 50.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.975 0.417 . . . . 1.0 110.919 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.0 mt -106.42 129.1 60.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.104 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -104.94 140.4 38.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.253 -0.431 . . . . 1.0 109.999 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -102.82 157.26 17.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.358 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.483 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -145.16 167.91 21.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.658 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.483 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 50.4 tt0 71.47 37.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.012 -0.54 . . . . 1.0 109.899 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -87.33 115.07 24.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -98.44 -25.26 14.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.011 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -157.11 151.88 20.92 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.194 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.53 -19.0 60.68 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.22 1.947 . . . . 1.0 111.859 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.9 tp -79.3 -14.12 59.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.049 0.452 . . . . 1.0 110.691 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.59 137.95 38.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.267 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.2 mt -79.54 164.38 23.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.441 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.52 97.64 0.18 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -67.78 -36.08 79.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.997 0.427 . . . . 1.0 110.618 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.4 t -117.05 123.78 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.583 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.4 mt -116.7 135.57 53.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.428 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.7 mt -107.17 126.41 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.887 0.375 . . . . 1.0 110.142 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.1 t -143.86 132.55 19.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.32 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 t70 54.68 43.28 30.39 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.052 -0.259 . . . . 1.0 111.002 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 59.27 24.57 13.06 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.943 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -128.52 154.51 46.07 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.229 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -103.94 134.8 46.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.219 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.737 ' CD1' HD11 ' A' ' 86' ' ' ILE . 96.4 m-85 -126.23 139.39 53.38 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.348 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -84.45 -38.04 20.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.714 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -123.09 150.72 42.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.124 0.488 . . . . 1.0 111.986 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.5 tp -66.8 -36.33 82.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.584 -0.735 . . . . 1.0 111.295 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 50.2 p-10 -58.22 -33.42 69.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.805 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.494 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 27.6 mt-30 -64.88 -39.26 93.26 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.657 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.737 HD11 ' CD1' ' A' ' 80' ' ' TYR . 31.3 mm -62.67 -48.26 89.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.857 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.47 -43.58 98.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 120.334 -0.546 . . . . 1.0 111.734 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 84' ' ' ASP . 59.7 t -73.2 -42.59 58.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 113.148 0.796 . . . . 1.0 113.148 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -82.8 -13.41 56.29 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.636 -0.426 . . . . 1.0 111.557 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.42 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 64.1 t80 -95.52 -48.63 5.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.524 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 95' ' ' VAL . 3.9 tp -69.52 -40.62 76.83 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.264 0.468 . . . . 1.0 112.264 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -63.89 -48.59 76.07 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.042 -0.663 . . . . 1.0 111.762 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -68.43 -43.28 77.47 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.75 -0.38 . . . . 1.0 111.757 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -66.05 -42.13 89.89 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.163 -0.615 . . . . 1.0 111.225 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 91' ' ' LEU . 53.6 t -65.37 -46.13 91.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.226 -0.59 . . . . 1.0 111.441 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -69.17 -44.3 72.49 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.789 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.3 tp -69.01 -40.31 78.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.152 -0.476 . . . . 1.0 111.719 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.4 tp -64.43 -43.3 94.78 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.292 -0.563 . . . . 1.0 110.08 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -67.79 -38.52 83.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.129 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.452 ' OE1' ' OH ' ' A' ' 168' ' ' TYR . 2.9 tm-20 -70.91 -42.81 69.46 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.802 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.487 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 2.6 ttt -64.98 -54.42 30.8 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.531 -0.467 . . . . 1.0 111.433 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.43 HG23 ' CE2' ' A' ' 107' ' ' PHE . 55.5 m -61.23 -30.29 70.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.126 0.489 . . . . 1.0 110.496 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.1 t -73.44 10.31 1.07 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.634 -0.712 . . . . 1.0 110.926 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 36.4 t -96.41 131.68 42.71 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.773 0.32 . . . . 1.0 110.284 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -57.83 -17.89 18.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.944 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.536 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 37.7 mmtm -90.8 40.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.063 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CE2' HG23 ' A' ' 102' ' ' THR . 70.2 t80 -133.17 111.28 10.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.468 . . . . 1.0 111.071 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -123.34 126.46 46.89 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -94.68 85.85 4.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.977 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.0 149.35 16.9 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.673 ' O ' HG23 ' A' ' 115' ' ' VAL . 28.3 p -71.98 170.86 12.9 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -59.87 -39.17 84.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.859 -0.336 . . . . 1.0 110.831 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -68.15 -42.33 80.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.905 0.383 . . . . 1.0 110.455 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -70.6 -18.52 62.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.094 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 111' ' ' THR . 40.9 t -73.19 -44.39 55.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.767 0.318 . . . . 1.0 110.144 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.8 t -62.89 -46.75 95.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.251 0.548 . . . . 1.0 110.157 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -66.02 -36.66 83.87 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.005 0.431 . . . . 1.0 111.099 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -66.61 -49.63 65.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.599 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.5 tp -69.77 -39.4 77.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.305 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -64.82 -42.03 95.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.947 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -63.33 -48.26 78.74 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.427 -0.509 . . . . 1.0 110.052 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -59.94 -43.28 95.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.95 -0.568 . . . . 1.0 109.898 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.4 t -62.9 -39.52 94.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.295 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.8 -41.6 82.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.097 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.24 -41.6 92.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.92 78.6 65.43 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.043 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.529 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 39.1 Cg_endo -71.19 -13.68 31.2 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.449 2.099 . . . . 1.0 112.46 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -101.45 -14.5 17.51 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.651 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -105.97 148.38 27.74 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.978 0.418 . . . . 1.0 110.477 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.401 ' OG ' HD21 ' A' ' 189' ' ' LEU . 60.2 p -81.81 163.78 22.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.883 -0.599 . . . . 1.0 109.615 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 p -152.72 146.27 15.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.421 ' O ' ' CD2' ' A' ' 133' ' ' TYR . 33.0 p90 -149.91 141.53 23.52 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.671 -0.412 . . . . 1.0 111.083 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.421 ' CD2' ' O ' ' A' ' 132' ' ' TYR . 25.4 m-85 -152.91 165.93 33.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.309 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -130.63 154.37 47.96 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 178.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.1 p -150.44 168.14 25.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.205 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.1 tp -81.24 132.41 35.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.604 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.548 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 22.6 p30 -78.25 151.9 32.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.277 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -106.22 -30.4 9.23 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.651 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 41.4 p30 -64.97 -21.14 66.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.197 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.548 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 19.8 t-20 -163.22 106.76 1.0 Allowed Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.59 143.55 38.32 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.796 1.664 . . . . 1.0 112.411 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.82 -39.19 2.81 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.422 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 19.8 m95 -94.47 149.78 20.91 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.815 0.34 . . . . 1.0 110.199 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.487 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 77.1 m-85 -113.26 154.86 26.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.847 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -126.31 139.23 53.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.115 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.5 mt -111.1 126.66 55.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.568 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.6 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -120.98 146.85 46.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.029 -1.1 . . . . 1.0 108.029 178.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -162.44 153.89 18.07 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.25 -0.58 . . . . 1.0 109.769 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -137.73 128.41 26.85 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.801 0.334 . . . . 1.0 110.604 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.668 ' N ' HD12 ' A' ' 150' ' ' ILE . 2.6 mp -69.76 -45.24 77.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 1.0 111.591 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 19.6 m120 -156.47 171.79 19.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.574 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.79 -28.3 69.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.792 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -90.27 8.61 32.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.983 0.421 . . . . 1.0 110.346 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 15.9 t -102.22 150.43 23.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.442 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -80.17 157.16 26.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.014 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 62.1 tp -75.07 124.11 26.41 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.259 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -108.31 129.89 55.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.518 . . . . 1.0 109.615 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 63.9 m -128.2 130.46 48.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.872 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -120.9 159.81 24.77 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.866 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 160' ' ' ASN . 34.5 p30 -105.69 148.32 27.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.984 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.77 136.12 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -98.33 135.27 40.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.773 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 29.3 tp -102.51 128.83 48.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.905 -0.588 . . . . 1.0 109.543 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.4 p -131.04 168.37 17.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.087 0.47 . . . . 1.0 110.398 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -78.74 17.35 0.72 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.669 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 12.1 p -121.35 -2.38 9.54 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.704 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 137.48 -126.3 3.58 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.264 -1.135 . . . . 1.0 110.264 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.452 ' OH ' ' OE1' ' A' ' 100' ' ' GLU . 19.9 m-85 -127.28 132.84 50.24 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.671 0.272 . . . . 1.0 110.447 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -110.43 120.81 43.62 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.938 0.399 . . . . 1.0 110.143 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.0 tt -114.96 120.92 41.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.4 t 35.97 52.1 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 111.95 0.352 . . . . 1.0 111.95 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 10.2 m120 69.42 27.41 4.98 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.087 0.773 . . . . 1.0 113.087 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -135.78 120.16 17.99 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -91.27 131.24 36.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.359 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -107.54 101.25 38.65 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 109.438 -0.578 . . . . 1.0 109.438 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -48.82 -23.17 5.44 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.462 2.108 . . . . 1.0 113.376 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 40.0 m -141.66 145.74 35.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.991 0.424 . . . . 1.0 111.097 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.62 -34.97 70.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.731 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.462 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 49.2 mm -60.57 -46.98 94.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.336 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.689 ' H ' HE21 ' A' ' 180' ' ' GLN . 0.6 OUTLIER -61.65 -32.9 73.09 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.14 -40.3 95.87 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 1.8 p -61.49 -46.85 88.25 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.769 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.6 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 54.5 t30 -71.21 -49.72 40.55 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 119.727 -0.789 . . . . 1.0 108.954 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.31 -43.87 0.53 Allowed Glycine 0 N--CA 1.462 0.398 0 N-CA-C 109.832 -1.307 . . . . 1.0 109.832 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -69.04 -47.93 64.14 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.071 -0.565 . . . . 1.0 109.596 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 183' ' ' ASN . 49.5 tttp -57.25 -39.9 76.55 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.184 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.5 m -60.5 -44.31 96.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 62.9 mt -63.86 -39.03 93.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.152 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.401 HD21 ' OG ' ' A' ' 130' ' ' SER . 62.3 tp -59.45 -45.32 91.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.713 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -58.7 -45.39 89.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.104 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.1 t -64.49 -40.29 95.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.714 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.76 -42.0 97.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.47 -0.786 . . . . 1.0 111.95 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -63.11 -25.8 68.53 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 7.3 m80 . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 120.726 0.298 . . . . 1.0 110.863 -179.691 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.481 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 83.8 mtp180 . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 120.871 0.367 . . . . 1.0 110.486 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.65 -31.83 53.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.522 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.6 pt -75.39 -19.93 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.447 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -103.59 9.11 37.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.6 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 3' ' ' ARG . 0.4 OUTLIER -67.77 147.87 98.55 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 110.057 -0.349 . . . . 1.0 110.057 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.64 -14.25 38.99 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.102 1.868 . . . . 1.0 112.2 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -94.74 5.52 51.64 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.203 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 40.3 t80 -82.88 128.76 34.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.478 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 58.4 m-85 -149.38 120.92 4.17 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.513 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.521 ' O ' ' CD1' ' A' ' 13' ' ' PHE . 72.7 Cg_endo -74.72 109.64 2.95 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.748 1.632 . . . . 1.0 112.479 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' A' ' 12' ' ' PRO . 70.6 m-85 -155.72 156.8 35.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.379 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -79.4 168.05 20.01 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.461 ' CA ' HH12 ' A' ' 33' ' ' ARG . . . -59.65 -43.58 97.61 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.381 -0.914 . . . . 1.0 111.203 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -66.02 -41.22 91.26 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.055 -0.258 . . . . 1.0 110.784 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.85 -35.9 77.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.543 -0.299 . . . . 1.0 111.229 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.77 -40.9 94.25 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.45 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.11 -42.69 93.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -60.47 -42.76 96.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.275 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -60.98 -41.8 97.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.815 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.8 mp -78.9 -15.22 58.62 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.984 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -61.14 -42.13 97.99 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.806 -0.357 . . . . 1.0 110.516 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.3 t -76.75 -18.71 58.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.975 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -87.09 -178.02 6.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.055 0.455 . . . . 1.0 110.676 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.18 179.45 5.56 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.819 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.6 mtt85 -81.01 146.11 30.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.049 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.56 19.44 29.77 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.83 145.67 26.73 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -132.86 167.45 20.18 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.109 0.481 . . . . 1.0 110.95 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 32' ' ' ILE . 45.2 t -147.34 158.44 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.242 -0.89 . . . . 1.0 111.443 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.491 ' N ' HG12 ' A' ' 31' ' ' VAL . 6.0 mm -114.83 126.33 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.711 -0.848 . . . . 1.0 108.711 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.461 HH12 ' CA ' ' A' ' 15' ' ' GLY . 57.1 ttp180 -137.86 155.86 48.52 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.402 ' N ' ' HG2' ' A' ' 33' ' ' ARG . 21.9 mt-30 -119.69 137.91 53.61 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.786 -0.45 . . . . 1.0 109.786 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.6 m -72.37 151.43 42.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.773 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.8 p -69.55 -20.81 63.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.018 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.28 17.68 9.07 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.023 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -84.54 -74.95 1.23 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.532 -1.027 . . . . 1.0 110.532 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.3 t70 67.68 -35.71 0.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.635 0.255 . . . . 1.0 110.884 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' A' ' 38' ' ' GLY . 97.2 m-20 -118.55 12.06 13.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.466 -0.334 . . . . 1.0 110.594 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.565 ' C ' HD12 ' A' ' 42' ' ' LEU . 99.5 m-70 -144.06 146.55 32.9 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.322 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.565 HD12 ' C ' ' A' ' 41' ' ' HIS . 10.9 mp -119.12 145.48 45.92 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.09 -0.504 . . . . 1.0 109.793 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.86 129.23 74.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.146 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.477 HG22 HD13 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -111.19 137.71 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 108.762 -0.829 . . . . 1.0 108.762 -179.409 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.8 m -115.16 134.05 55.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.877 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.535 ' CZ2' HD11 ' A' ' 48' ' ' LEU . 1.8 p-90 -148.14 151.6 35.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.384 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.529 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -99.61 145.51 27.48 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.69 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.535 HD11 ' CZ2' ' A' ' 46' ' ' TRP . 9.5 mp -102.47 -75.52 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 36.9 t0 -117.06 -166.74 1.2 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.388 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.529 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 51.7 mtmt -69.6 139.37 53.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.947 0.403 . . . . 1.0 110.814 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 52.28 26.66 4.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.909 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.8 tp -130.89 129.01 41.71 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.787 0.327 . . . . 1.0 110.327 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.46 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 61.5 m-85 -133.87 148.99 51.33 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.502 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 53' ' ' PHE . 98.6 mm-40 -139.84 152.09 46.21 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.581 -0.526 . . . . 1.0 109.581 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -129.37 144.15 51.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.427 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 92.8 mt -125.51 131.75 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.786 -0.449 . . . . 1.0 109.786 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -98.53 121.81 40.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.906 0.384 . . . . 1.0 110.575 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.3 mt -97.98 123.58 50.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.094 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -111.31 131.69 54.96 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -103.08 152.78 20.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.242 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.471 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 1.6 tp -144.45 165.69 27.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.414 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 3.1 tm-20 81.94 63.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.201 0.524 . . . . 1.0 110.063 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HD3' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -105.89 113.91 27.74 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.034 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.468 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 57.8 mp0 -65.85 -22.85 66.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.688 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.611 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 1.1 m120 -151.6 160.03 32.37 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.133 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.34 -32.97 64.06 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.986 1.791 . . . . 1.0 112.332 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.1 mt -95.14 -8.82 35.33 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.688 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.611 ' HB3' ' H ' ' A' ' 65' ' ' ASN . . . -73.85 144.77 45.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.593 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.7 mt -89.71 147.25 23.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.271 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.98 126.76 7.59 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.7 -0.96 . . . . 1.0 110.7 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -81.96 -9.78 59.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.064 0.459 . . . . 1.0 110.459 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.28 118.68 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.735 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.5 mt -115.01 129.23 56.67 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.551 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.2 mt -101.29 121.87 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.951 0.405 . . . . 1.0 110.228 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.88 131.92 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.121 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.7 t0 55.98 42.88 28.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.178 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 59.69 21.13 9.83 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.922 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -128.06 151.98 48.52 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.059 0.456 . . . . 1.0 110.22 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -101.37 128.38 47.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.224 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -122.94 138.67 54.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.32 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -85.25 -38.38 18.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 1.0 111.606 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -113.13 141.23 47.16 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.034 0.445 . . . . 1.0 111.993 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.2 -40.66 96.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.85 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -59.21 -41.71 89.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.746 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -60.81 -38.52 85.68 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.986 -0.285 . . . . 1.0 110.723 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.37 -47.27 94.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.743 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.1 mt -62.09 -46.41 96.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.329 -0.548 . . . . 1.0 111.684 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.0 t -71.15 -42.46 75.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.844 0.683 . . . . 1.0 112.844 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -77.38 -15.4 59.39 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.662 -0.415 . . . . 1.0 111.9 -177.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.621 ' CZ ' ' NZ ' ' A' ' 94' ' ' LYS . 34.8 t80 -94.09 -49.91 5.54 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.651 -0.42 . . . . 1.0 111.713 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.2 mp -69.75 -40.57 76.08 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 112.096 0.406 . . . . 1.0 112.096 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -62.85 -48.53 78.62 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.774 -0.77 . . . . 1.0 111.544 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -69.21 -43.41 74.18 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.522 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.621 ' NZ ' ' CZ ' ' A' ' 90' ' ' TYR . 24.0 mmtp -66.14 -43.77 86.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.213 -0.595 . . . . 1.0 111.243 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.32 -44.79 90.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.339 -0.544 . . . . 1.0 111.023 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -66.03 -47.54 74.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.248 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.434 HD21 ' CE1' ' A' ' 168' ' ' TYR . 3.0 tp -69.08 -38.93 79.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.282 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.38 -43.28 98.08 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.574 -0.45 . . . . 1.0 110.118 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -67.51 -39.75 85.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.257 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -71.09 -41.38 70.7 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.007 0.373 . . . . 1.0 112.007 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.5 ttt -68.38 -54.82 14.69 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.423 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.1 m -58.7 -42.2 88.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.076 0.465 . . . . 1.0 110.411 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.3 m -72.37 8.27 1.44 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.951 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -84.29 142.82 29.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.734 0.302 . . . . 1.0 110.512 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.63 -19.5 65.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.885 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.552 ' NZ ' ' SG ' ' A' ' 182' ' ' CYS . 98.7 mttt -93.13 39.44 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.828 -0.624 . . . . 1.0 110.161 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -134.12 118.37 17.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.122 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -126.67 133.13 51.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.0 p -99.4 74.7 1.93 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.8 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.71 146.62 18.58 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.635 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -71.52 171.68 10.94 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.036 -0.357 . . . . 1.0 110.036 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -56.66 -38.89 72.82 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.64 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.94 -44.19 77.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.962 0.411 . . . . 1.0 110.724 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -70.17 -20.27 63.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.056 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 111' ' ' THR . 40.2 t -70.78 -45.23 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.299 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.14 -46.67 92.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 120.494 -0.482 . . . . 1.0 110.278 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.03 -35.37 80.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.053 0.454 . . . . 1.0 110.75 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -67.49 -49.63 62.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.596 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 119' ' ' ILE . 10.5 tp -70.18 -39.22 76.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.962 0.41 . . . . 1.0 110.459 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -64.24 -39.94 94.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.685 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -60.32 -48.5 81.49 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.548 -0.461 . . . . 1.0 110.31 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -62.76 -39.88 95.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.293 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.9 t -61.49 -42.39 98.72 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.578 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -59.6 -38.17 80.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.055 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.1 t -66.75 -42.28 89.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.658 -0.417 . . . . 1.0 109.974 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -126.26 76.49 72.69 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.217 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -71.29 -14.25 31.21 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 122.578 2.185 . . . . 1.0 112.441 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -103.54 10.17 37.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.655 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -132.98 148.58 52.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.861 0.362 . . . . 1.0 110.621 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 42.0 t -81.08 161.5 24.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.48 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.0 p -152.65 145.19 15.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -144.17 143.66 31.19 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.949 0.404 . . . . 1.0 111.12 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -151.35 161.98 41.75 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.372 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.481 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -132.65 154.86 49.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 179.146 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.1 t -152.54 168.41 25.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.93 0.395 . . . . 1.0 110.105 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.71 128.98 34.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.067 -0.515 . . . . 1.0 111.019 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 12.5 t-20 -87.34 135.68 33.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.902 0.382 . . . . 1.0 110.368 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -73.14 -39.64 65.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.971 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -62.44 -15.11 47.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.036 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.542 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 3.6 p30 -167.66 82.52 0.83 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.269 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.25 -37.14 58.92 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.124 1.883 . . . . 1.0 113.142 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -59.78 -34.74 83.78 Favored Glycine 0 C--N 1.312 -0.798 0 N-CA-C 110.956 -0.858 . . . . 1.0 110.956 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -99.72 144.77 28.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.88 0.372 . . . . 1.0 110.242 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -106.61 153.65 22.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.879 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.564 ' CZ ' ' ND2' ' A' ' 160' ' ' ASN . 4.0 m-85 -112.33 134.33 53.93 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.969 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.688 ' CD1' ' HE1' ' A' ' 159' ' ' TRP . 5.3 mt -112.55 123.34 50.08 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.709 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.561 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -123.55 148.89 45.9 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.469 -0.938 . . . . 1.0 108.469 178.21 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.56 ' CE1' ' CZ3' ' A' ' 159' ' ' TRP . 8.1 p90 -163.9 160.81 22.52 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.27 -0.572 . . . . 1.0 109.649 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -140.83 129.86 23.33 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.564 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.669 HG22 HD22 ' A' ' 151' ' ' ASN . 3.6 mt -77.06 -44.94 31.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.282 -0.417 . . . . 1.0 111.592 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.669 HD22 HG22 ' A' ' 150' ' ' ILE . 2.9 m-80 -154.35 165.68 35.6 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.372 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.91 -31.52 69.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.712 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -85.69 -4.34 59.14 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.043 0.449 . . . . 1.0 110.611 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 11.8 t -84.28 163.21 19.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.514 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.431 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 14.7 mptt -96.57 148.6 22.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.67 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 52.6 tp -70.23 118.81 13.53 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.36 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.438 ' O ' ' CD1' ' A' ' 148' ' ' PHE . 87.4 m-85 -113.66 119.37 37.22 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 146' ' ' LEU . 86.0 m -130.39 135.18 47.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.848 -0.615 . . . . 1.0 111.874 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.688 ' HE1' ' CD1' ' A' ' 146' ' ' LEU . 7.7 p90 -128.35 -173.94 3.09 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.462 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.564 ' ND2' ' CZ ' ' A' ' 145' ' ' TYR . 94.4 m-20 -124.82 152.7 43.59 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.445 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 169' ' ' PHE . 27.6 t -118.56 139.37 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -93.9 130.65 39.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.207 0.527 . . . . 1.0 110.948 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.8 tp -90.93 129.72 36.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.562 -0.745 . . . . 1.0 109.446 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 165' ' ' ASN . 0.1 OUTLIER -131.65 177.84 7.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.616 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.508 ' N ' ' OG1' ' A' ' 164' ' ' THR . 65.3 t30 -86.13 15.68 4.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.704 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 77.2 p -121.07 -1.7 9.78 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.575 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 132.87 -126.09 4.32 Favored Glycine 0 N--CA 1.464 0.533 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.434 ' CE1' HD21 ' A' ' 97' ' ' LEU . 22.5 m-85 -122.13 129.27 52.18 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.545 0.212 . . . . 1.0 110.517 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.437 ' O ' HG13 ' A' ' 161' ' ' VAL . 0.1 OUTLIER -105.54 120.77 42.47 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.0 tt -113.32 114.98 27.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.4 t 35.47 59.46 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.253 0.464 . . . . 1.0 112.253 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.8 m120 69.16 27.34 5.26 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.17 0.804 . . . . 1.0 113.17 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -134.89 119.19 17.76 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -99.73 124.9 45.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.84 0.353 . . . . 1.0 111.736 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -102.36 131.85 22.07 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.31 -0.626 . . . . 1.0 109.31 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.36 -18.41 29.95 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.193 1.929 . . . . 1.0 113.443 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 89.7 p -152.08 156.02 39.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.084 0.468 . . . . 1.0 110.908 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.16 -36.05 72.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.716 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.05 -43.32 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 120.909 0.385 . . . . 1.0 110.123 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -61.12 -35.12 76.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.25 -39.93 94.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.211 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . 0.552 ' SG ' ' NZ ' ' A' ' 106' ' ' LYS . 13.8 t -57.04 -48.4 78.62 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.271 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 186' ' ' LYS . 65.7 t30 -66.7 -47.61 71.84 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.21 -44.02 0.76 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.376 -1.49 . . . . 1.0 109.376 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -68.96 -47.58 65.28 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.387 0.613 . . . . 1.0 109.496 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 183' ' ' ASN . 63.1 tttm -55.97 -39.11 71.31 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.251 -0.886 . . . . 1.0 109.866 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 19.0 m -63.33 -47.18 83.29 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 75.6 mt -62.9 -42.71 99.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.108 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 45.0 tp -57.35 -46.53 83.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.719 -0.392 . . . . 1.0 110.29 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -56.19 -41.83 76.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.142 0.496 . . . . 1.0 109.857 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.1 t -66.59 -42.78 86.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.832 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.66 -45.55 86.26 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.595 -0.729 . . . . 1.0 112.177 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -67.81 -35.49 78.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.785 0.326 . . . . 1.0 111.826 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.577 -178.658 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.3 mmt-85 . . . . . 0 N--CA 1.465 0.306 0 CA-C-O 120.695 0.283 . . . . 1.0 110.627 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.67 -33.43 63.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.617 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.7 pt -81.48 -30.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.547 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -95.11 3.77 54.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.342 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -65.09 140.93 98.18 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.375 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.18 -12.89 35.07 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.92 1.747 . . . . 1.0 112.038 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -102.48 7.65 40.17 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.614 0.245 . . . . 1.0 111.152 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.529 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 30.6 t80 -90.95 127.76 36.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.442 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 65.1 m-85 -151.65 108.97 2.92 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.549 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 41.7 Cg_exo -57.56 108.18 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.712 1.608 . . . . 1.0 112.734 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 66.2 m-85 -160.94 157.97 27.34 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.64 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -79.09 163.87 24.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' OE1' ' A' ' 19' ' ' GLU . . . -55.48 -45.51 83.81 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.248 -0.977 . . . . 1.0 110.853 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -65.2 -39.66 93.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.868 0.366 . . . . 1.0 110.758 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.35 -33.83 76.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.498 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.06 -38.82 87.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.436 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.552 ' OE2' ' NE2' ' A' ' 55' ' ' HIS . 4.3 mp0 -67.09 -43.51 82.36 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.566 -0.454 . . . . 1.0 110.37 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.51 -46.15 91.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.227 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -61.02 -44.82 96.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.423 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 tp -75.36 -15.98 60.43 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.064 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -60.67 -42.13 96.46 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.393 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p -75.32 -18.63 59.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.627 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -82.22 179.83 7.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.621 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -90.1 154.72 19.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.812 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -68.05 143.45 55.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.759 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.0 10.09 43.62 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.223 -0.751 . . . . 1.0 111.223 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -91.68 156.43 17.6 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -125.11 155.72 39.43 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.295 0.569 . . . . 1.0 111.004 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 t -141.4 152.76 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 115.145 -0.934 . . . . 1.0 111.184 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.95 125.8 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -142.16 158.64 43.51 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.077 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.682 HE22 ' CD2' ' A' ' 42' ' ' LEU . 95.2 mm-40 -103.15 131.17 50.36 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 37' ' ' ARG . 7.2 t -48.82 -12.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.918 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 34' ' ' GLN . 3.0 m 63.24 2.06 1.05 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.652 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.402 ' H ' ' C ' ' A' ' 35' ' ' SER . 34.4 ttm180 -154.47 58.88 0.7 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.629 -0.26 . . . . 1.0 110.582 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -157.62 -50.06 0.01 OUTLIER Glycine 0 N--CA 1.463 0.446 0 N-CA-C 110.384 -1.086 . . . . 1.0 110.384 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.9 t0 73.63 -28.3 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.796 0.331 . . . . 1.0 111.026 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 38' ' ' GLY . 36.3 t70 -121.59 20.26 11.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.984 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -142.19 141.42 32.57 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.826 0.346 . . . . 1.0 110.541 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.682 ' CD2' HE22 ' A' ' 34' ' ' GLN . 5.3 mp -120.57 144.65 47.97 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.095 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.8 t -126.16 130.78 72.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.217 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mt -112.06 139.47 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.5 m -118.25 132.2 56.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.391 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.555 ' CZ3' ' CD2' ' A' ' 48' ' ' LEU . 2.8 p-90 -146.15 143.68 29.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.989 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -92.52 140.72 29.27 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.961 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.555 ' CD2' ' CZ3' ' A' ' 46' ' ' TRP . 8.4 mt -103.67 -75.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.331 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -115.45 -176.88 3.01 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.263 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -66.21 130.23 42.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.932 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.4 t0 61.88 30.33 18.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.033 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.0 tp -137.8 126.04 23.11 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.874 0.369 . . . . 1.0 110.412 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -134.85 149.48 50.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.55 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -138.88 153.98 48.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.853 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.552 ' NE2' ' OE2' ' A' ' 19' ' ' GLU . 44.9 m80 -124.08 141.35 52.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.243 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.7 mt -121.53 124.8 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -98.2 122.07 40.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.662 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 80.8 mt -101.15 126.0 55.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.363 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -103.71 134.58 46.8 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.978 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -104.37 146.59 28.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 1.0 109.995 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.475 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 9.8 mt -142.15 166.47 24.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.764 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 1.5 tm-20 82.32 54.73 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.856 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -106.62 93.86 4.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.878 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.11 -35.12 77.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.898 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -145.71 156.5 52.28 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.973 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.16 -19.53 68.92 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.39 2.06 . . . . 1.0 112.104 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.548 ' H ' ' CG ' ' A' ' 65' ' ' ASN . 4.8 tp -83.26 -9.88 58.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.998 0.427 . . . . 1.0 110.931 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.582 ' N ' ' ND2' ' A' ' 65' ' ' ASN . . . -113.24 143.63 44.08 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.158 0.504 . . . . 1.0 110.17 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.515 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -90.55 168.94 11.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.319 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.34 109.69 2.86 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.417 ' NZ ' ' OE1' ' A' ' 62' ' ' GLU . 34.2 mtmm -72.8 -11.85 60.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.02 0.438 . . . . 1.0 110.727 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.1 t -118.3 120.68 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.816 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.4 mt -115.67 130.88 57.02 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.7 mt -102.47 121.08 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -140.88 132.92 30.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.201 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.422 ' OD2' ' OD1' ' A' ' 165' ' ' ASN . 46.8 t0 53.9 42.98 31.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.774 0.321 . . . . 1.0 110.997 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 59.79 22.87 11.77 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.826 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -128.56 143.75 51.02 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.254 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -98.12 126.98 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.872 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CG ' HG12 ' A' ' 86' ' ' ILE . 93.8 m-85 -120.32 137.48 54.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.167 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -85.29 -38.09 19.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.777 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -112.02 141.39 45.74 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.047 0.451 . . . . 1.0 112.11 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.97 -41.06 97.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.473 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 88' ' ' VAL . 60.9 m-20 -61.56 -39.75 92.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.793 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -59.89 -39.66 86.12 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.74 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.41 HG12 ' CG ' ' A' ' 80' ' ' TYR . 75.5 mt -61.68 -50.15 81.42 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 C-N-CA 120.352 -0.539 . . . . 1.0 111.113 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.58 -43.49 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.57 -0.452 . . . . 1.0 111.795 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.435 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 93.9 t -66.4 -22.23 29.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.112 -0.495 . . . . 1.0 112.15 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -100.18 -10.84 20.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.911 0.386 . . . . 1.0 111.011 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.84 -50.33 5.62 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.39 -0.524 . . . . 1.0 112.368 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 95' ' ' VAL . 7.6 mp -64.62 -45.38 87.12 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 112.802 0.667 . . . . 1.0 112.802 -176.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.474 ' HG3' ' N ' ' A' ' 93' ' ' ASN . 14.7 pt20 -64.8 -48.12 75.59 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.706 -0.798 . . . . 1.0 111.842 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.474 ' N ' ' HG3' ' A' ' 92' ' ' GLN . 58.1 t-20 -71.37 -43.08 67.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.649 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.577 ' NZ ' ' ND2' ' A' ' 165' ' ' ASN . 37.0 mmtm -66.56 -44.38 82.46 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.18 -0.608 . . . . 1.0 111.403 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 91' ' ' LEU . 76.7 t -66.5 -44.49 90.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.211 -0.596 . . . . 1.0 111.364 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -68.22 -43.11 78.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.489 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 tp -67.05 -41.02 87.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.427 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 mt -63.69 -43.85 95.41 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.272 -0.571 . . . . 1.0 110.5 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -68.78 -38.64 80.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.146 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -70.66 -43.48 69.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.954 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.3 tpt -66.1 -54.34 26.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.476 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 104' ' ' SER . 9.8 m -59.67 -40.36 87.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.085 0.469 . . . . 1.0 110.438 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.0 m -72.23 10.18 0.83 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.705 -0.68 . . . . 1.0 111.249 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 102' ' ' THR . 6.8 t -92.43 136.62 33.06 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.865 0.364 . . . . 1.0 110.274 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -60.82 -20.71 62.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.068 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.593 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 67.9 mttm -89.43 39.12 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.763 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -131.61 115.59 16.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.379 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -140.2 113.28 8.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.701 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.2 t -98.12 88.07 4.11 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.076 0.465 . . . . 1.0 110.916 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.98 171.13 14.67 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 115' ' ' VAL . 10.1 p -74.62 165.38 25.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -60.62 -39.75 89.36 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.805 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -67.43 -42.51 83.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.154 0.502 . . . . 1.0 110.803 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -70.73 -20.11 62.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.72 . . . . 1.0 111.045 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 111' ' ' THR . 18.0 t -70.43 -45.85 73.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.809 -0.356 . . . . 1.0 110.267 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.47 -45.03 98.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.102 0.477 . . . . 1.0 110.073 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.06 -34.4 78.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.993 0.425 . . . . 1.0 110.729 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -66.58 -49.98 64.57 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.915 -0.584 . . . . 1.0 111.85 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.9 tp -69.93 -38.91 76.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.476 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.552 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 66.5 mm-40 -63.89 -39.99 95.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.56 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -64.84 -47.27 78.55 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.601 -0.439 . . . . 1.0 110.345 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -60.25 -45.46 93.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.947 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.3 t -63.87 -38.14 89.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.319 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -58.36 -41.76 85.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.839 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.3 t -66.7 -41.95 88.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -123.6 75.83 54.97 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.505 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.91 -17.21 32.53 Favored 'Trans proline' 0 N--CA 1.488 1.157 0 C-N-CA 122.531 2.154 . . . . 1.0 112.2 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -101.64 22.37 12.88 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.577 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -143.64 151.56 40.27 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.862 0.363 . . . . 1.0 110.664 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 94.4 p -81.19 163.16 23.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.817 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 p -152.41 146.55 15.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.249 -0.648 . . . . 1.0 109.249 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -147.77 142.39 26.58 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.834 0.35 . . . . 1.0 111.208 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -152.93 171.4 18.38 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.374 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.593 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.8 p90 -141.05 158.52 43.81 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.25 -0.648 . . . . 1.0 109.25 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.8 p -151.74 168.28 25.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.824 0.345 . . . . 1.0 110.255 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.9 tp -80.27 129.41 34.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.588 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.408 HD22 ' HB2' ' A' ' 140' ' ' ASN . 43.8 t30 -72.07 156.86 38.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.272 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.43 ' CG ' ' N ' ' A' ' 139' ' ' ASP . 12.9 p-80 -96.18 -46.95 6.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.889 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.43 ' N ' ' CG ' ' A' ' 138' ' ' HIS . 95.0 m-20 -76.15 -7.52 54.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.21 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 139' ' ' ASP . 63.4 m-80 -160.86 70.11 2.7 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.37 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -49.55 -35.4 37.04 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.258 1.972 . . . . 1.0 112.711 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -60.55 -32.16 77.14 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.793 -0.923 . . . . 1.0 110.793 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -96.36 147.13 24.12 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.726 0.298 . . . . 1.0 110.219 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -113.2 152.32 29.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.704 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -123.18 139.94 53.54 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.972 0.415 . . . . 1.0 110.181 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.5 mt -108.79 121.37 44.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.291 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.537 ' SD ' HG13 ' A' ' 115' ' ' VAL . 5.0 ptt? -112.85 143.23 44.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.944 -1.132 . . . . 1.0 107.944 178.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -161.73 151.51 16.66 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.552 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 69.4 tttt -134.76 128.89 33.73 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.391 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.544 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 3.4 mp -69.53 -46.47 75.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.303 0.483 . . . . 1.0 112.303 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 150' ' ' ILE . 20.7 m120 -159.48 173.98 15.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.515 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.84 74.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.836 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -86.81 8.15 24.01 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.385 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -96.3 165.54 12.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.441 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.48 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 61.2 mttp -99.22 149.85 22.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 1.0 109.928 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.7 tp -69.42 122.63 19.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.038 0.447 . . . . 1.0 109.871 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 87.9 m-85 -114.31 128.64 56.45 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.855 -0.611 . . . . 1.0 109.822 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 97.8 m -123.37 128.77 50.35 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.679 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -114.2 160.78 18.62 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.036 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -107.68 146.45 32.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.9 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 169' ' ' PHE . 42.4 t -128.82 135.98 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -97.72 133.34 42.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.049 0.452 . . . . 1.0 110.844 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 31.6 tp -95.68 130.3 42.61 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.4 p -133.47 178.28 7.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.055 0.455 . . . . 1.0 110.266 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.577 ' ND2' ' NZ ' ' A' ' 94' ' ' LYS . 25.0 m120 -86.17 17.16 3.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.663 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 13.4 p -121.2 -2.18 9.64 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.811 0.339 . . . . 1.0 110.626 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.02 -127.16 4.47 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.373 -1.091 . . . . 1.0 110.373 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -121.31 130.06 53.44 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 110.219 -0.289 . . . . 1.0 110.219 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.426 ' O ' HG13 ' A' ' 161' ' ' VAL . 2.8 m-85 -104.08 124.7 49.53 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 109.854 -0.425 . . . . 1.0 109.854 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.9 tt -119.02 115.18 23.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.535 -0.543 . . . . 1.0 109.535 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.425 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 3.5 t 40.73 57.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 111.976 0.361 . . . . 1.0 111.976 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.8 m120 65.2 27.28 12.26 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.906 0.706 . . . . 1.0 112.906 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.425 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 73.6 m-85 -134.72 121.52 20.89 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.62 131.49 37.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.45 -0.341 . . . . 1.0 111.199 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -112.34 96.12 34.14 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.79 -22.53 7.22 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.499 2.133 . . . . 1.0 113.292 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.8 p -133.66 138.24 45.78 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.846 0.355 . . . . 1.0 110.999 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.6 p -61.04 -33.08 54.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.772 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.1 mm -62.0 -45.88 97.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.937 0.399 . . . . 1.0 110.194 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -65.61 -32.36 73.89 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.87 -42.5 99.79 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.424 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 74.0 m -63.36 -46.38 86.8 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.704 -0.399 . . . . 1.0 110.378 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 186' ' ' LYS . 74.6 m-20 -66.94 -49.29 65.96 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 119.682 -0.807 . . . . 1.0 108.926 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.12 -45.13 0.59 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.706 -1.357 . . . . 1.0 109.706 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -69.26 -47.06 65.73 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.218 0.532 . . . . 1.0 109.752 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 183' ' ' ASN . 89.1 tttt -56.52 -41.41 76.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.481 -0.781 . . . . 1.0 109.922 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 86.7 m -60.79 -45.58 93.84 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.57 -41.42 98.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.813 -0.631 . . . . 1.0 110.036 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.16 -43.61 82.69 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.786 -0.366 . . . . 1.0 110.716 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -60.75 -42.96 98.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.15 0.5 . . . . 1.0 110.434 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 48.4 m -61.72 -38.59 88.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.634 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 87.3 mt -65.13 -39.19 92.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.594 -0.73 . . . . 1.0 112.233 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -64.07 -30.51 71.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.651 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.471 -0.331 . . . . 1.0 111.007 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.642 0.258 . . . . 1.0 110.53 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 p -63.5 -32.91 58.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.341 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.9 pt -79.28 -12.22 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.316 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -105.13 4.91 31.86 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.645 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.16 150.05 94.51 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.446 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 41.0 Cg_endo -66.01 -22.66 54.95 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.817 1.678 . . . . 1.0 112.261 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.537 ' CD1' ' CE2' ' A' ' 30' ' ' PHE . 25.4 m-85 -87.26 5.87 36.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.556 -0.293 . . . . 1.0 111.164 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.468 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 42.0 t80 -87.23 127.8 35.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.435 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.468 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 63.4 m-85 -149.19 108.87 3.42 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 109.935 -0.394 . . . . 1.0 109.935 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.526 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 33.3 Cg_exo -59.54 109.82 0.63 Allowed 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 121.548 1.499 . . . . 1.0 112.828 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 66.0 m-85 -159.2 150.46 20.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.405 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -77.9 164.25 25.31 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.452 -0.573 . . . . 1.0 109.452 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' OE2' ' A' ' 19' ' ' GLU . . . -59.07 -41.68 96.63 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -67.0 -42.7 84.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.743 0.306 . . . . 1.0 111.144 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -66.3 -35.95 81.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.136 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.46 88.38 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.741 -0.384 . . . . 1.0 110.33 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -59.47 -46.42 88.83 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.638 -0.425 . . . . 1.0 109.872 179.479 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.85 -44.97 94.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.168 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -61.69 -41.48 97.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.701 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.8 mp -79.69 -12.96 59.78 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.995 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.23 -42.41 99.23 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.76 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.5 m -79.48 -20.24 47.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.847 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -80.48 173.76 12.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 1.0 110.636 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.587 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.1 pm0 -85.16 170.11 13.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.492 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -80.22 145.77 32.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.88 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.67 -0.27 57.96 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -85.89 146.87 26.53 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.537 ' CE2' ' CD1' ' A' ' 9' ' ' TYR . 51.7 p90 -131.42 164.64 25.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.295 0.569 . . . . 1.0 111.108 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 32' ' ' ILE . 69.1 t -147.3 158.19 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.422 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.472 ' N ' HG12 ' A' ' 31' ' ' VAL . 79.1 mt -116.98 123.71 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -143.38 158.44 43.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.36 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.666 ' C ' ' H ' ' A' ' 36' ' ' SER . 27.1 mt-30 -109.65 148.25 31.67 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.927 -0.397 . . . . 1.0 109.927 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 37' ' ' ARG . 7.2 m -61.17 18.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.256 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.666 ' H ' ' C ' ' A' ' 34' ' ' GLN . 1.5 m 69.21 -42.12 0.49 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.769 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 35' ' ' SER . 79.4 mtp85 -121.51 11.39 10.62 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.915 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -71.5 -66.75 2.05 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.489 -1.045 . . . . 1.0 110.489 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 67.08 -45.82 0.47 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.217 0.532 . . . . 1.0 110.914 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 38' ' ' GLY . 52.5 t0 -93.28 -4.79 51.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.802 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -146.24 149.9 34.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.542 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.91 150.85 40.45 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.991 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.9 t -124.73 132.09 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.005 -0.368 . . . . 1.0 110.005 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.682 HD12 HD11 ' A' ' 58' ' ' ILE . 56.8 mt -110.85 138.18 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.43 HG23 ' ND1' ' A' ' 55' ' ' HIS . 90.5 m -119.21 138.13 53.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.777 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.441 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 3.8 p-90 -147.15 146.75 30.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.743 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.509 ' C ' HD12 ' A' ' 48' ' ' LEU . 86.1 tttt -92.48 138.61 31.37 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.209 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.509 HD12 ' C ' ' A' ' 47' ' ' LYS . 10.0 mp -103.54 -82.71 0.49 Allowed 'General case' 0 C--N 1.339 0.129 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.123 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -94.16 -175.27 3.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.557 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -58.33 -41.09 83.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.898 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -127.32 53.63 1.72 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.021 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.5 tp -150.01 131.71 14.98 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.796 0.331 . . . . 1.0 110.413 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -132.7 148.89 52.34 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.297 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -137.17 151.16 48.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.722 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.43 ' ND1' HG23 ' A' ' 45' ' ' THR . 10.2 m-70 -127.64 141.99 51.47 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.132 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 95.5 mt -121.56 124.2 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -92.96 121.58 34.45 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.039 0.447 . . . . 1.0 110.544 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.682 HD11 HD12 ' A' ' 44' ' ' ILE . 84.0 mt -99.94 129.58 50.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.453 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -116.15 125.12 51.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 1.0 109.88 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -101.58 143.49 31.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.332 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 84.6 mt -143.78 -179.39 6.43 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.463 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 75.76 50.59 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.034 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -95.49 125.88 40.4 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.779 -0.646 . . . . 1.0 109.945 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -69.72 -21.63 63.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.692 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.624 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 4.1 m-80 -157.62 165.14 19.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.061 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.54 -33.89 80.18 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.91 1.74 . . . . 1.0 112.451 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.7 mt -93.43 -4.45 51.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.575 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.624 ' HB3' ' H ' ' A' ' 65' ' ' ASN . . . -80.33 146.88 31.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.649 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.0 mt -89.47 157.41 18.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.213 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.57 126.66 8.64 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -85.67 -11.11 54.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.089 0.471 . . . . 1.0 110.582 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.43 120.18 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.571 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.1 mt -113.77 122.3 46.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.827 -0.624 . . . . 1.0 109.43 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 70.9 mt -101.82 124.39 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.985 -0.376 . . . . 1.0 109.985 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.1 t -142.63 133.31 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.261 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 77' ' ' ASN . 97.0 m-20 51.91 48.17 23.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.978 -0.289 . . . . 1.0 111.031 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 5.4 p30 55.25 21.69 4.23 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.384 0.428 . . . . 1.0 110.981 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -127.4 139.37 52.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.196 0.522 . . . . 1.0 110.155 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -88.53 134.38 33.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.002 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -129.2 138.11 51.52 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.421 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -78.66 -37.14 42.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.772 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 16.3 t0 -136.98 160.65 38.28 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.375 0.607 . . . . 1.0 111.637 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.511 ' C ' HD12 ' A' ' 83' ' ' LEU . 3.0 pp -71.93 -36.27 69.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.447 -0.797 . . . . 1.0 111.799 178.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 2.4 p30 -58.58 -41.94 86.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.93 0.715 . . . . 1.0 112.93 -176.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.455 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 6.1 pt20 -63.81 -38.33 90.68 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.632 0.253 . . . . 1.0 110.882 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.4 mt -61.27 -46.23 97.02 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 C-N-CA 120.485 -0.486 . . . . 1.0 110.882 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -61.62 -38.87 81.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 120.966 0.412 . . . . 1.0 111.49 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 84' ' ' ASP . 30.8 t -78.31 -32.73 17.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 112.799 0.666 . . . . 1.0 112.799 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -88.7 -13.8 38.82 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.739 -0.384 . . . . 1.0 111.61 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.651 ' CZ ' ' NZ ' ' A' ' 94' ' ' LYS . 11.0 t80 -96.69 -48.66 5.41 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.786 -0.365 . . . . 1.0 111.525 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 95' ' ' VAL . 4.3 mm? -71.21 -39.78 71.54 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.023 -0.535 . . . . 1.0 112.001 -177.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -63.81 -49.05 74.41 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.791 -0.764 . . . . 1.0 111.948 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -71.24 -42.72 68.49 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.616 -0.434 . . . . 1.0 111.863 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.651 ' NZ ' ' CZ ' ' A' ' 90' ' ' TYR . 21.1 mmtp -66.34 -42.12 88.6 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.274 -0.57 . . . . 1.0 111.285 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 91' ' ' LEU . 58.6 t -65.02 -45.68 93.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.253 -0.579 . . . . 1.0 111.277 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -68.06 -44.78 75.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.483 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 tp -66.7 -40.04 88.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.294 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.1 tp -64.36 -42.53 96.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.401 -0.52 . . . . 1.0 109.935 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -67.84 -38.1 82.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.143 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -71.28 -42.28 68.92 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.845 -0.342 . . . . 1.0 111.617 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.512 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 5.0 ttt -66.46 -54.63 21.89 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.641 -0.424 . . . . 1.0 111.241 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.43 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 20.4 m -57.86 -32.54 67.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.273 0.558 . . . . 1.0 110.531 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -75.03 10.63 1.39 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.342 -0.845 . . . . 1.0 111.612 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 93.3 p -91.44 133.93 35.06 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.895 0.379 . . . . 1.0 110.489 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -60.61 -20.48 60.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.777 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.56 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 69.2 mttm -87.71 40.28 0.93 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.714 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 102' ' ' THR . 0.4 OUTLIER -132.25 116.87 17.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.387 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.465 ' NZ ' ' CE1' ' A' ' 118' ' ' PHE . 50.5 mtpt -135.99 109.72 8.08 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 178.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.1 t -91.21 88.88 7.1 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.216 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.97 160.86 12.98 Favored Glycine 0 N--CA 1.466 0.641 0 N-CA-C 110.829 -0.909 . . . . 1.0 110.829 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.586 HG22 ' N ' ' A' ' 112' ' ' LYS . 56.7 m -71.52 165.38 23.99 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.862 -0.422 . . . . 1.0 109.862 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 111' ' ' THR . 49.3 tptt -55.04 -38.54 68.11 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.56 -0.456 . . . . 1.0 110.558 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -67.35 -45.09 77.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.403 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.9 -19.85 62.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.952 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 111' ' ' THR . 23.7 t -68.82 -44.54 81.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.89 -44.62 92.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.211 0.529 . . . . 1.0 110.075 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -64.98 -36.13 83.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.915 0.388 . . . . 1.0 110.63 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.465 ' CE1' ' NZ ' ' A' ' 108' ' ' LYS . 11.1 t80 -64.64 -51.07 64.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.754 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.6 tp -69.9 -38.91 76.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.02 0.438 . . . . 1.0 110.17 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.537 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 65.1 mm-40 -64.1 -42.74 96.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.667 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.89 -48.22 82.8 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.438 -0.505 . . . . 1.0 110.24 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -60.48 -39.34 87.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.716 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.0 t -59.62 -40.99 89.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.228 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -62.17 -38.6 89.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.972 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.3 t -64.12 -43.31 97.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -130.24 74.59 80.24 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.226 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.45 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 7.7 Cg_exo -69.81 -23.6 30.38 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.894 2.396 . . . . 1.0 112.77 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -88.78 -14.38 37.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.981 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -112.59 153.96 26.75 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.144 0.497 . . . . 1.0 110.563 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.7 t -80.65 164.83 22.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.555 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 p -151.86 148.44 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -144.42 142.96 30.68 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.976 0.417 . . . . 1.0 111.213 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -151.65 167.91 26.66 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.294 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.56 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 2.1 p90 -140.53 155.28 46.67 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.2 m -155.66 171.75 19.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.343 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 51.3 tp -80.38 134.61 36.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.651 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.781 ' H ' HD22 ' A' ' 137' ' ' ASN . 0.1 OUTLIER -95.8 140.51 30.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.797 0.332 . . . . 1.0 110.348 179.381 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.455 ' ND1' ' N ' ' A' ' 138' ' ' HIS . 2.1 m80 -89.1 -28.75 19.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.712 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.66 -31.01 69.15 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.276 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.512 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -147.53 105.75 3.76 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.74 136.73 26.02 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.76 1.64 . . . . 1.0 112.691 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.11 -25.12 26.12 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.537 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 12.5 m95 -98.13 152.28 19.5 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.908 0.385 . . . . 1.0 110.246 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.512 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 91.5 m-85 -119.57 156.25 30.68 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.465 -0.568 . . . . 1.0 109.465 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -130.53 145.09 51.79 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.034 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.2 mt -111.06 121.74 46.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.893 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 11.7 ptp -110.43 140.93 44.19 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.686 -1.227 . . . . 1.0 107.686 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -161.47 153.35 19.4 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.384 -0.527 . . . . 1.0 109.59 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.537 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 33.8 mtpt -136.67 131.87 34.19 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.764 0.316 . . . . 1.0 110.604 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.532 HG22 HD22 ' A' ' 151' ' ' ASN . 23.7 mm -72.31 -45.13 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.355 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.532 HD22 HG22 ' A' ' 150' ' ' ILE . 26.4 m-80 -157.81 170.58 22.04 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.495 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.37 -26.54 65.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.764 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -87.53 -10.24 52.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.056 0.455 . . . . 1.0 110.35 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 23.8 t -80.58 155.03 27.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.533 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.75 156.93 18.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.894 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.5 tp -69.99 115.98 9.83 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.188 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -107.38 130.32 54.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.628 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.3 m -126.29 130.11 50.2 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.809 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -112.95 156.91 22.19 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.025 -0.534 . . . . 1.0 109.786 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -106.38 146.22 30.73 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.867 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.82 137.7 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -99.1 135.42 40.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.854 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.17 130.71 44.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 81.4 p -129.27 172.35 11.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.332 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -85.64 18.07 3.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.871 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.07 -2.63 8.15 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.594 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 141.63 -129.73 4.1 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -125.25 132.29 52.98 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.815 0.341 . . . . 1.0 110.175 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -106.5 123.51 48.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.14 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.9 tt -119.02 117.89 30.0 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.36 -0.608 . . . . 1.0 109.36 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.2 t 36.02 52.02 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 111.89 0.329 . . . . 1.0 111.89 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.0 m120 71.98 26.66 2.85 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.105 0.78 . . . . 1.0 113.105 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -133.24 118.77 18.99 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.341 -0.614 . . . . 1.0 109.341 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -93.31 121.14 34.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.46 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -100.56 132.47 22.31 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -71.93 -18.96 27.49 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 C-N-CA 122.12 1.88 . . . . 1.0 113.33 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 35.4 m -153.47 157.12 39.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.966 0.412 . . . . 1.0 111.013 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.58 -33.97 62.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.957 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.4 mm -60.05 -46.64 94.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.89 -0.324 . . . . 1.0 110.548 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -68.84 -29.95 68.38 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 48.5 tp -64.81 -42.21 95.18 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.457 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . 0.607 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 8.1 p -62.44 -47.63 83.23 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.768 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.607 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 44.6 t-20 -66.38 -46.9 75.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.974 -0.75 . . . . 1.0 108.974 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.87 -45.54 0.82 Allowed Glycine 0 C--N 1.334 0.437 0 N-CA-C 110.021 -1.232 . . . . 1.0 110.021 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -69.03 -46.83 66.94 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 183' ' ' ASN . 88.4 tttt -55.49 -40.1 71.27 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.841 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.3 m -60.95 -44.76 96.82 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.54 -40.82 98.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.826 -0.625 . . . . 1.0 109.963 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 40.9 tp -57.46 -42.25 82.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.412 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -63.12 -43.07 99.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.132 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.0 t -63.52 -39.37 94.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.394 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.83 -43.31 99.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.463 -0.79 . . . . 1.0 112.064 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -68.2 -29.37 68.21 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.815 0.302 . . . . 1.0 111.815 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 1.6 t60 . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.847 -179.332 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 . . . . . 0 N--CA 1.466 0.337 0 CA-C-O 120.83 0.347 . . . . 1.0 110.565 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.36 -34.85 71.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.573 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.7 pt -79.3 -14.02 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.347 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -89.84 -4.72 57.45 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.471 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -81.38 138.34 48.32 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.393 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.54 -16.1 46.45 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.898 1.732 . . . . 1.0 112.272 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.502 ' CD1' ' CE2' ' A' ' 30' ' ' PHE . 96.0 m-85 -93.13 8.91 38.18 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.281 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 87.6 t80 -88.45 127.42 35.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.498 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 61.2 m-85 -149.28 126.12 5.39 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.525 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 74.1 Cg_endo -73.36 107.67 2.44 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.433 1.422 . . . . 1.0 112.853 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.525 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 43.8 m-85 -162.76 152.49 15.81 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.522 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.559 ' ND2' HE22 ' A' ' 17' ' ' GLN . 52.6 p-10 -88.33 -176.23 5.28 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.62 -40.63 99.39 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.314 -0.946 . . . . 1.0 111.377 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -61.97 -48.17 81.55 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.894 -0.323 . . . . 1.0 111.189 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.559 HE22 ' ND2' ' A' ' 14' ' ' ASN . 0.9 OUTLIER -69.63 -30.93 68.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.291 -179.501 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.441 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.72 -46.04 91.35 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.651 -0.42 . . . . 1.0 110.292 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE2' ' CE1' ' A' ' 53' ' ' PHE . 81.2 tt0 -65.48 -41.07 93.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.67 -0.412 . . . . 1.0 109.996 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -62.24 -43.34 99.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.083 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -62.52 -44.89 95.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.455 -0.339 . . . . 1.0 110.536 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 18' ' ' ALA . 6.8 mp -73.37 -13.32 61.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.971 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 ttp85 -59.6 -43.21 93.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.956 0.408 . . . . 1.0 110.589 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.5 t -77.46 -19.15 56.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.829 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -86.41 -174.75 5.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.47 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 55.9 mp0 -104.54 -176.67 3.14 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.672 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -81.53 146.6 30.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.804 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.85 -1.02 59.44 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.175 -0.77 . . . . 1.0 111.175 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -85.58 148.62 25.84 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.066 -0.716 . . . . 1.0 109.066 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CE2' ' CD1' ' A' ' 9' ' ' TYR . 51.9 p90 -136.26 163.12 31.13 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.363 0.602 . . . . 1.0 110.965 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.2 m -147.68 158.89 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 114.98 -1.009 . . . . 1.0 111.645 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 79.0 mt -117.79 124.73 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -143.96 157.42 44.35 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.315 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.551 ' C ' ' H ' ' A' ' 36' ' ' SER . 35.3 mt-30 -108.76 142.54 39.16 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.867 -0.419 . . . . 1.0 109.867 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 37' ' ' ARG . 28.3 m -60.46 5.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.865 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.551 ' H ' ' C ' ' A' ' 34' ' ' GLN . 0.2 OUTLIER 71.72 -47.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.451 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.401 ' H ' ' C ' ' A' ' 35' ' ' SER . 35.4 ptt180 -100.02 0.29 40.65 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.891 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -73.4 -68.42 1.59 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.425 -1.07 . . . . 1.0 110.425 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 t70 69.23 -36.36 0.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.661 0.267 . . . . 1.0 110.799 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.528 ' H ' ' C ' ' A' ' 38' ' ' GLY . 95.2 m-20 -106.66 1.64 25.28 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -148.04 148.66 30.92 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.469 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.7 152.84 37.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.916 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.92 132.99 70.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.275 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.07 139.24 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.503 HG23 ' ND1' ' A' ' 55' ' ' HIS . 85.1 m -118.95 139.38 51.76 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.551 ' CZ2' ' NZ ' ' A' ' 94' ' ' LYS . 5.7 p-90 -148.65 144.93 27.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.415 -0.811 . . . . 1.0 111.027 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' C ' HD12 ' A' ' 48' ' ' LEU . 87.3 tttt -91.58 141.22 28.95 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.807 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.3 mp -97.85 -71.99 0.66 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.42 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 50' ' ' LYS . 62.3 t0 -162.01 146.46 12.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.144 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.543 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 1.1 ttmp? 46.54 -145.93 0.2 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.948 0.404 . . . . 1.0 111.126 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -79.79 68.95 6.02 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.81 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.8 tp -149.3 126.51 11.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.848 0.356 . . . . 1.0 110.426 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.519 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 64.0 m-85 -132.32 149.1 52.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.43 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 53' ' ' PHE . 98.0 mm-40 -135.78 152.7 51.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.031 -0.531 . . . . 1.0 109.666 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.513 ' O ' HD12 ' A' ' 56' ' ' ILE . 25.6 m-70 -128.07 142.68 51.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.302 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.513 HD12 ' O ' ' A' ' 55' ' ' HIS . 1.4 mp -118.88 122.54 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -92.23 120.58 32.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.053 0.454 . . . . 1.0 110.804 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.1 mm -99.34 131.68 46.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.41 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -114.4 136.57 52.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.024 -0.534 . . . . 1.0 109.833 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -100.54 152.92 19.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.119 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.429 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 3.1 tt -142.97 161.19 38.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.898 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.429 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 18.4 tt0 79.51 60.64 0.02 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.142 0.496 . . . . 1.0 109.781 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -106.55 103.31 12.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.0 -0.546 . . . . 1.0 109.725 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -70.43 -34.45 72.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.75 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 68' ' ' ALA . 15.6 p30 -161.16 157.0 21.66 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.42 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.96 -28.03 22.82 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.212 1.941 . . . . 1.0 112.193 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 67' ' ' LEU . 10.9 mp -83.93 -11.45 56.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.998 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 65' ' ' ASN . . . -92.7 140.15 29.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.318 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.8 mt -90.15 158.25 17.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.284 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.89 108.8 2.64 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.678 -0.969 . . . . 1.0 110.678 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -76.18 -18.29 59.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.834 0.35 . . . . 1.0 110.782 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.1 t -116.56 122.92 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.915 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.4 mt -116.3 133.92 55.48 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.6 mt -103.06 124.98 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.864 0.364 . . . . 1.0 110.076 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.7 133.7 32.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.411 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 t70 52.23 41.92 30.52 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.827 -0.349 . . . . 1.0 111.094 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 61.26 22.84 13.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.965 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -128.48 156.75 42.74 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.177 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -102.67 130.07 49.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.05 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.493 ' CD2' HD11 ' A' ' 86' ' ' ILE . 84.7 m-85 -129.24 139.37 51.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.253 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -86.55 -37.26 18.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.816 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -109.3 134.95 51.16 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.127 0.489 . . . . 1.0 112.312 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 46.9 tp -65.49 -38.1 88.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.559 -0.746 . . . . 1.0 110.722 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 4.6 p30 -58.6 -33.65 70.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 1.0 111.875 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.45 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 27.1 mt-30 -64.51 -37.98 89.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.696 0.284 . . . . 1.0 110.658 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.493 HD11 ' CD2' ' A' ' 80' ' ' TYR . 49.0 mm -59.58 -49.48 83.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.146 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 72.2 mt -62.94 -43.61 99.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.15 -0.62 . . . . 1.0 111.414 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 84' ' ' ASP . 61.4 t -70.36 -41.14 78.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 -178.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -80.23 -15.58 56.69 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.818 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -94.02 -49.88 5.57 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.56 -0.456 . . . . 1.0 111.799 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.495 ' HA ' HD13 ' A' ' 91' ' ' LEU . 4.3 mm? -68.6 -40.06 80.62 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.463 0.542 . . . . 1.0 112.463 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -63.38 -49.28 74.44 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.67 -0.812 . . . . 1.0 111.631 -177.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -65.96 -43.11 88.88 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.851 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.551 ' NZ ' ' CZ2' ' A' ' 46' ' ' TRP . 25.6 mmtp -65.93 -42.57 89.91 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.458 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 91' ' ' LEU . 56.7 t -65.58 -45.88 91.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.32 -0.552 . . . . 1.0 111.407 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -67.32 -46.56 73.14 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.598 -0.441 . . . . 1.0 111.47 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.9 tp -67.92 -40.12 83.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.627 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.39 -43.32 91.05 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.544 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -68.86 -35.63 77.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.404 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -70.61 -42.52 70.86 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.921 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 13.6 ttm -71.22 -53.04 15.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.484 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.442 HG23 ' CE2' ' A' ' 107' ' ' PHE . 9.0 m -57.11 -39.83 75.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.05 0.453 . . . . 1.0 110.222 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.7 m -71.45 9.72 0.76 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.888 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 102' ' ' THR . 8.3 t -92.74 133.23 36.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.276 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -60.82 -18.42 55.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.086 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.558 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 99.0 mttt -91.85 41.01 1.06 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.055 -0.521 . . . . 1.0 109.718 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.442 ' CE2' HG23 ' A' ' 102' ' ' THR . 82.7 t80 -134.69 118.18 16.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.285 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -138.15 114.81 10.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.074 -0.512 . . . . 1.0 109.732 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.5 p -93.44 91.84 7.34 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.062 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.83 166.63 13.02 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.844 -0.903 . . . . 1.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 115' ' ' VAL . 82.5 p -76.8 163.44 26.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -56.05 -35.55 67.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.826 0.346 . . . . 1.0 110.764 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -68.58 -43.89 75.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.145 0.498 . . . . 1.0 110.768 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -71.26 -19.26 62.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.013 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 111' ' ' THR . 38.7 t -70.74 -44.55 76.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 110.04 -0.355 . . . . 1.0 110.04 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.68 -45.57 91.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.063 0.459 . . . . 1.0 110.416 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.59 -36.9 85.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.845 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -65.1 -50.12 67.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.888 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 120' ' ' GLU . 10.8 tp -70.35 -40.01 77.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.447 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.409 ' N ' HG23 ' A' ' 119' ' ' ILE . 93.1 mt-10 -64.47 -45.06 89.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.589 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -60.54 -48.46 81.66 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.007 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.55 ' CD1' ' OD1' ' A' ' 126' ' ' ASN . 23.9 t80 -60.86 -42.06 97.11 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.646 -0.501 . . . . 1.0 109.646 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.5 t -59.93 -42.68 94.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.596 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -60.09 -39.95 87.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.356 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.92 -41.3 91.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.55 ' OD1' ' CD1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -118.95 76.42 14.59 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.31 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.526 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 37.4 Cg_endo -72.44 -21.16 23.05 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 122.398 2.065 . . . . 1.0 112.346 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.415 ' N ' HD22 ' A' ' 128' ' ' ASN . 1.8 m-80 -106.81 18.24 22.11 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.71 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -138.16 152.01 48.28 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.881 0.372 . . . . 1.0 110.654 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.412 ' OG ' HD21 ' A' ' 189' ' ' LEU . 4.0 t -81.74 163.19 22.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.89 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -154.19 145.43 14.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.168 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -148.49 144.34 27.3 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.784 0.326 . . . . 1.0 111.053 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -151.69 167.37 28.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.406 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.558 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -139.71 155.83 47.13 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 179.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.436 ' OG ' ' CZ ' ' A' ' 145' ' ' TYR . 15.0 p -152.07 169.4 22.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.405 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.1 tp -79.43 130.33 35.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.889 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -77.82 114.51 16.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.351 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -73.31 -36.14 66.2 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.591 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -65.91 -26.2 67.5 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.098 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -139.81 84.27 15.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.404 ' HG2' HE22 ' A' ' 54' ' ' GLN . 31.9 Cg_exo -56.77 129.72 36.12 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.079 1.853 . . . . 1.0 112.346 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.94 -24.25 23.73 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.121 -0.791 . . . . 1.0 111.121 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -99.26 150.99 21.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.79 0.328 . . . . 1.0 110.263 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -123.76 160.84 26.41 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.954 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.47 ' N ' ' CD1' ' A' ' 145' ' ' TYR . 4.7 p90 -142.89 148.3 36.75 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.343 0.402 . . . . 1.0 109.929 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.9 mt -110.07 131.47 55.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.161 0.505 . . . . 1.0 110.497 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.45 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -118.85 145.32 45.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 177.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -161.93 154.47 19.86 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.479 -0.488 . . . . 1.0 109.705 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -139.77 127.31 21.62 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.514 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.443 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 3.3 mp -68.88 -44.62 81.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.091 0.404 . . . . 1.0 112.091 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 27.4 m120 -159.22 175.31 13.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.54 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.79 -31.94 73.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -84.31 -12.61 54.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.518 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.447 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 16.7 t -80.03 146.28 32.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.327 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -79.64 151.18 30.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.93 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.53 127.81 34.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.997 0.427 . . . . 1.0 110.178 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -114.63 130.84 56.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.663 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 86.4 m -126.3 129.08 48.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.838 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -116.06 154.53 29.76 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.77 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -105.19 141.67 36.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.796 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.94 132.89 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -95.41 136.17 36.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.704 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.5 tp -98.2 131.09 44.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.06 -0.518 . . . . 1.0 109.712 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 46.1 p -131.17 163.84 26.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.356 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -76.98 16.3 0.56 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.542 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 14.8 p -122.1 -1.26 9.31 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.791 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 138.43 -129.42 4.53 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.289 -1.124 . . . . 1.0 110.289 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -126.03 130.83 51.94 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.588 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 5.8 m-85 -107.99 123.04 48.06 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.3 tt -115.32 119.24 35.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.079 -0.51 . . . . 1.0 109.638 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.2 t 34.86 52.91 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 112.132 0.419 . . . . 1.0 112.132 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.2 m120 72.47 27.37 2.42 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.074 0.768 . . . . 1.0 113.074 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -135.54 120.66 18.84 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.588 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 15.6 t-20 -91.23 131.7 36.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.156 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -112.0 95.29 28.76 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 109.545 -0.539 . . . . 1.0 109.545 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.84 -20.34 6.71 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.296 1.998 . . . . 1.0 113.536 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 48.8 m -135.66 139.76 43.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.885 0.374 . . . . 1.0 111.094 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.0 p -62.78 -34.8 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.706 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.08 -44.16 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-O 120.904 0.383 . . . . 1.0 110.124 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.36 -33.83 76.75 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.99 -39.87 94.12 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.539 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 71.8 m -61.59 -48.03 82.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.598 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 186' ' ' LYS . 41.5 t30 -69.6 -48.84 58.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.872 -0.788 . . . . 1.0 108.872 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.56 -45.96 0.54 Allowed Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.788 -1.325 . . . . 1.0 109.788 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -68.01 -47.76 67.58 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.204 0.526 . . . . 1.0 109.657 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 183' ' ' ASN . 19.3 ttpp -56.6 -41.26 76.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.427 -0.806 . . . . 1.0 110.019 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 94.3 m -61.16 -45.63 93.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.84 -41.07 99.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.908 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.412 HD21 ' OG ' ' A' ' 130' ' ' SER . 57.2 tp -58.25 -43.37 87.82 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.806 -0.357 . . . . 1.0 110.719 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -58.7 -45.74 88.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.153 0.501 . . . . 1.0 110.205 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 58.5 m -62.84 -39.6 94.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.476 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.49 -39.06 93.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.592 -0.731 . . . . 1.0 112.062 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.78 -24.58 61.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.83 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.084 -179.349 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.816 0.341 . . . . 1.0 110.83 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 p -69.12 -33.81 60.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.601 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.6 pt -58.19 -13.95 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.658 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -134.79 24.97 3.67 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.399 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.3 147.43 58.0 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.495 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -50.88 -34.22 44.58 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.626 1.55 . . . . 1.0 112.321 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -88.74 10.14 21.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.391 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.49 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 42.5 t80 -91.17 129.07 37.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.55 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 65.2 m-85 -149.75 132.25 8.01 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.8 113.55 3.79 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.761 1.641 . . . . 1.0 112.701 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 18' ' ' ALA . 12.0 p90 -154.18 162.0 41.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.703 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.44 ' H ' ' HB2' ' A' ' 17' ' ' GLN . 66.7 t30 -90.23 172.76 8.56 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.699 ' N ' HH12 ' A' ' 33' ' ' ARG . . . -58.31 -51.26 59.66 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.734 -0.946 . . . . 1.0 110.734 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -65.82 -39.06 90.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.676 0.274 . . . . 1.0 110.817 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.44 ' HB2' ' H ' ' A' ' 14' ' ' ASN . 88.1 mm-40 -65.59 -32.48 74.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.388 . . . . 1.0 111.289 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.558 ' HB2' ' CD1' ' A' ' 13' ' ' PHE . . . -61.15 -45.86 92.93 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.282 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.69 -40.88 92.78 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.662 -0.415 . . . . 1.0 109.99 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -63.06 -45.75 90.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.296 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -60.56 -42.37 96.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.542 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.7 mp -80.54 -13.29 59.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.893 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -61.72 -41.63 97.88 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.542 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.0 p -77.22 -17.17 58.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.903 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -82.85 177.86 8.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.664 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -95.31 178.22 5.59 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.713 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.476 ' NH2' ' OD1' ' A' ' 99' ' ' ASN . 60.5 ttp180 -76.17 144.73 40.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.053 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.12 26.16 17.14 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.312 -0.715 . . . . 1.0 111.312 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -112.13 142.03 45.09 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.121 -0.696 . . . . 1.0 109.121 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -134.08 169.62 16.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.499 0.666 . . . . 1.0 111.052 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.69 ' O ' HG23 ' A' ' 44' ' ' ILE . 15.3 m -148.41 160.21 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 114.971 -1.013 . . . . 1.0 111.812 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.0 mm -115.87 130.4 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.699 HH12 ' N ' ' A' ' 15' ' ' GLY . 69.5 ttt180 -143.36 154.22 43.51 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.107 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -115.15 138.02 51.37 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 t -82.93 126.49 32.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.861 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.6 t -62.65 -43.42 98.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.672 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.415 ' HD3' ' H ' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -73.75 -23.68 59.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.012 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -123.21 55.45 0.69 Allowed Glycine 0 N--CA 1.466 0.661 0 N-CA-C 110.611 -0.996 . . . . 1.0 110.611 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -59.14 -0.55 0.13 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.84 0.352 . . . . 1.0 110.731 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 38' ' ' GLY . 73.0 m-20 -96.38 -2.34 45.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.663 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -140.78 164.84 29.13 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.192 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.01 146.95 46.16 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.246 -0.434 . . . . 1.0 109.905 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.421 HG22 ' OD1' ' A' ' 57' ' ' ASP . 58.1 t -125.97 132.05 71.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.792 0.329 . . . . 1.0 110.271 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 31' ' ' VAL . 59.6 mt -112.94 138.95 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.6 m -117.54 138.73 51.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.225 0.536 . . . . 1.0 109.647 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.491 ' CZ2' HD11 ' A' ' 48' ' ' LEU . 3.3 p-90 -145.33 156.78 44.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.687 -0.688 . . . . 1.0 110.784 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' C ' HD12 ' A' ' 48' ' ' LEU . 25.1 ttpp -104.67 136.2 44.64 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.292 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.3 mp -97.1 -68.49 0.8 Allowed 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.048 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -106.66 -165.19 1.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.156 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.467 ' HD3' ' H ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -78.66 -17.7 55.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.674 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 68.0 t0 -139.68 48.11 1.83 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.783 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.7 tp -155.69 133.47 11.21 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.926 0.394 . . . . 1.0 110.425 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -134.1 149.77 51.12 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.59 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.507 ' OE1' HD21 ' A' ' 48' ' ' LEU . 65.1 mt-30 -139.26 154.69 48.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.825 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 30.7 p-80 -127.03 142.49 51.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.212 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.51 121.34 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 109.708 -0.478 . . . . 1.0 109.708 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD1' HG22 ' A' ' 43' ' ' VAL . 95.8 m-20 -92.51 121.7 34.22 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.976 0.417 . . . . 1.0 110.615 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.2 mt -104.04 127.6 58.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.244 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -118.58 133.4 55.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.987 0.422 . . . . 1.0 109.92 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 40' ' ' ASP . 1.4 mp0 -99.97 144.63 28.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.015 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 70' ' ' GLY . 81.4 mt -146.4 167.24 24.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.627 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 17.4 tp10 81.04 17.28 0.52 Allowed 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.47 0.481 . . . . 1.0 109.89 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -54.97 116.72 2.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.194 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -73.27 -23.72 60.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.713 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -157.71 153.95 23.88 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.115 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -58.74 -26.54 80.27 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.29 1.993 . . . . 1.0 112.134 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.6 mt -98.17 -1.87 41.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.464 -0.334 . . . . 1.0 110.607 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.93 160.26 14.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.949 0.404 . . . . 1.0 110.335 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.6 mt -72.75 160.66 31.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.387 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 71' ' ' LYS . . . -60.89 -33.35 83.12 Favored Glycine 0 C--O 1.224 -0.499 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 70' ' ' GLY . 41.1 tttm 84.73 -31.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.061 0.457 . . . . 1.0 110.654 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.44 123.88 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.563 -0.744 . . . . 1.0 110.702 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.2 mt -112.82 122.85 48.88 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.476 -0.565 . . . . 1.0 109.476 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.5 mt -101.24 123.11 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.826 0.346 . . . . 1.0 110.219 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.12 130.48 29.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.233 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 165' ' ' ASN . 42.1 t0 53.66 45.35 28.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 1.0 111.116 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.9 m120 58.1 23.23 9.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.908 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -128.12 139.28 52.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.931 0.396 . . . . 1.0 110.252 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -89.62 133.37 34.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.976 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -123.96 138.57 54.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.333 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -85.4 -36.64 20.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.566 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -127.25 150.34 49.59 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.207 0.527 . . . . 1.0 111.857 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.7 tp -63.52 -39.2 93.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.671 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -58.18 -44.27 87.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.757 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -58.9 -37.87 77.6 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 110.34 -0.245 . . . . 1.0 110.34 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.408 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 96.9 mt -63.1 -45.86 97.57 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 C-N-CA 120.428 -0.509 . . . . 1.0 111.008 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.6 mt -68.1 -44.24 84.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 120.526 -0.47 . . . . 1.0 111.585 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.7 t -77.8 -36.21 22.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 113.029 0.752 . . . . 1.0 113.029 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -84.78 -12.89 52.74 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.886 -0.325 . . . . 1.0 111.743 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 23.1 t80 -98.2 -48.22 5.17 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.564 -0.455 . . . . 1.0 111.727 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.443 ' HA ' HD13 ' A' ' 91' ' ' LEU . 4.5 mm? -69.16 -40.15 78.35 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.316 0.487 . . . . 1.0 112.316 -177.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -62.73 -48.81 77.59 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.852 -0.739 . . . . 1.0 111.478 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -66.91 -42.47 85.35 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.599 -0.44 . . . . 1.0 111.814 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -65.51 -43.65 89.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.097 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 91' ' ' LEU . 76.1 t -65.31 -44.33 94.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.405 -0.518 . . . . 1.0 111.018 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -68.0 -47.29 68.93 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.594 -0.442 . . . . 1.0 111.621 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.551 HD21 ' CZ ' ' A' ' 168' ' ' TYR . 3.7 tp -68.05 -39.78 82.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.248 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.07 -43.13 96.37 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.314 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.476 ' OD1' ' NH2' ' A' ' 27' ' ' ARG . 94.3 m-20 -66.94 -37.71 84.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.035 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -71.01 -42.01 70.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.755 -0.378 . . . . 1.0 111.748 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.5 ttt -66.12 -54.98 18.88 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.494 -0.482 . . . . 1.0 111.458 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 84.0 m -59.15 -40.64 86.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.043 0.449 . . . . 1.0 110.33 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.1 t -73.1 10.19 1.01 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.056 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.0 t -91.53 138.43 31.58 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.754 0.311 . . . . 1.0 110.256 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.75 -16.92 59.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.169 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.561 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 57.4 mmtt -93.87 38.57 1.07 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.056 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -133.08 116.76 16.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.045 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.497 ' NZ ' ' CE1' ' A' ' 118' ' ' PHE . 48.6 mtpt -133.2 128.83 36.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.951 -0.568 . . . . 1.0 109.901 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.4 p -96.64 77.66 2.9 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.912 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -111.29 151.8 17.72 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.946 -0.861 . . . . 1.0 110.946 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 115' ' ' VAL . 58.1 p -73.5 168.29 19.58 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -55.46 -36.49 66.64 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.876 -0.33 . . . . 1.0 110.813 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -68.18 -44.18 76.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.625 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.53 -20.83 63.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.878 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 111' ' ' THR . 53.1 t -70.54 -44.95 76.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.746 -0.382 . . . . 1.0 110.186 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.8 t -64.31 -46.71 92.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-O 121.057 0.456 . . . . 1.0 110.334 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -65.86 -34.84 79.06 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.957 0.408 . . . . 1.0 110.821 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.497 ' CE1' ' NZ ' ' A' ' 108' ' ' LYS . 25.0 t80 -66.73 -50.11 63.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.914 -0.584 . . . . 1.0 111.667 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.434 HD11 HG13 ' A' ' 131' ' ' VAL . 11.2 tp -70.31 -39.86 77.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.96 0.41 . . . . 1.0 110.35 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -65.1 -40.06 94.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.646 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -63.61 -47.85 79.73 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.504 -0.478 . . . . 1.0 110.291 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -61.89 -41.77 98.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.012 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 90.6 p -64.53 -34.89 79.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.221 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -63.56 -41.21 98.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.166 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.3 t -67.18 -42.06 87.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.766 -0.457 . . . . 1.0 109.766 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -124.83 75.62 65.51 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.351 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.3 -13.71 30.9 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.676 2.251 . . . . 1.0 112.345 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -103.79 13.7 32.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.622 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -134.88 149.84 50.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.052 0.453 . . . . 1.0 110.576 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.5 p -80.58 161.78 24.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.803 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.434 HG13 HD11 ' A' ' 119' ' ' ILE . 3.2 p -153.32 148.13 13.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -148.05 142.84 26.73 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.887 0.375 . . . . 1.0 111.2 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -152.1 166.48 31.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.438 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.561 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.2 p90 -140.06 157.27 45.91 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 30.9 p -150.6 168.3 24.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.799 0.333 . . . . 1.0 110.237 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.3 tp -81.7 131.25 35.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.118 -0.492 . . . . 1.0 111.015 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.513 HD21 HD22 ' A' ' 140' ' ' ASN . 58.3 t-20 -79.94 111.86 16.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.409 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.46 -45.19 69.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.899 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.84 -20.39 65.04 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.195 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.513 HD22 HD21 ' A' ' 137' ' ' ASN . 68.7 m-80 -141.79 82.65 13.62 Favored Pre-proline 0 N--CA 1.463 0.193 0 N-CA-C 110.018 -0.364 . . . . 1.0 110.018 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.51 137.75 51.92 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.815 1.677 . . . . 1.0 112.5 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.5 -17.34 53.6 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -109.58 145.42 36.4 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.891 0.377 . . . . 1.0 109.989 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -120.51 159.79 24.47 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 115.992 -0.549 . . . . 1.0 109.806 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 145' ' ' TYR . 4.3 p90 -142.63 148.01 36.73 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 123.382 0.426 . . . . 1.0 110.017 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.02 132.52 54.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.129 0.49 . . . . 1.0 110.46 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.507 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -121.65 146.89 46.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 178.109 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -160.89 155.17 23.09 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -140.26 129.06 23.18 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.69 -0.404 . . . . 1.0 110.502 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.484 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.5 mp -72.62 -48.71 45.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.217 0.451 . . . . 1.0 112.217 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 150' ' ' ILE . 86.5 m-20 -153.35 170.31 20.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.474 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.49 -31.08 71.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.943 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -84.7 -11.48 55.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.42 . . . . 1.0 110.525 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.43 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 29.5 t -80.1 155.45 27.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.351 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -86.86 147.96 25.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.893 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.0 tp -70.7 128.72 37.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.923 0.392 . . . . 1.0 110.223 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -117.62 129.5 55.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.628 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 71.9 m -130.71 129.55 42.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.937 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -116.07 167.24 11.16 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.828 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -109.79 144.08 38.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.958 -0.565 . . . . 1.0 111.051 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 63.6 t -122.24 134.71 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -100.27 132.12 45.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.382 . . . . 1.0 110.792 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 57.0 tp -92.21 130.81 37.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.715 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 41.5 p -128.04 168.14 15.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.479 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.409 ' OD1' ' OD2' ' A' ' 76' ' ' ASP . 21.9 m120 -82.58 14.24 3.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.598 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 57.2 p -122.01 -2.55 9.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.707 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 143.14 -133.34 5.43 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.228 -1.149 . . . . 1.0 110.228 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.551 ' CZ ' HD21 ' A' ' 97' ' ' LEU . 91.1 m-85 -122.87 128.42 50.31 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.61 0.243 . . . . 1.0 110.448 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -103.13 123.07 45.98 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.4 tt -119.87 115.11 23.15 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.3 t 35.42 56.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.432 0.53 . . . . 1.0 112.432 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.5 m120 71.7 27.68 2.86 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.164 0.801 . . . . 1.0 113.164 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -135.54 120.11 18.19 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -94.56 119.2 32.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.411 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -99.01 133.62 22.05 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.24 -16.36 25.04 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.127 1.885 . . . . 1.0 113.604 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.1 p -154.25 158.22 39.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.946 0.403 . . . . 1.0 110.912 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 179' ' ' ILE . 12.5 p -63.29 -40.18 88.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.739 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.499 ' H ' HD12 ' A' ' 179' ' ' ILE . 3.7 mp -59.87 -47.09 92.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.806 0.336 . . . . 1.0 110.42 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -62.61 -35.7 80.38 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.58 -40.61 97.4 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.136 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 96.0 m -60.04 -45.57 92.38 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.54 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 186' ' ' LYS . 32.8 t30 -69.92 -49.4 52.41 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 119.692 -0.803 . . . . 1.0 108.869 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.05 -44.38 0.51 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.815 -1.314 . . . . 1.0 109.815 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -68.72 -47.4 66.46 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.084 -0.558 . . . . 1.0 109.586 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 183' ' ' ASN . 64.1 tttp -56.9 -41.83 78.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.816 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 16.9 m -61.03 -45.5 94.54 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 24.5 mt -62.19 -40.91 97.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.813 -0.631 . . . . 1.0 109.93 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.26 -44.04 92.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.461 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -59.47 -40.57 87.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.229 0.538 . . . . 1.0 110.056 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.4 t -67.18 -39.64 86.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.252 0.548 . . . . 1.0 110.791 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 25.2 mt -63.59 -44.54 93.75 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.603 -0.726 . . . . 1.0 112.261 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.8 -27.37 68.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.422 -0.354 . . . . 1.0 111.647 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.759 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 7' ' ' HIS . 36.3 mmt180 . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 120.86 0.362 . . . . 1.0 110.556 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 5' ' ' ILE . 14.7 p -64.26 -42.8 96.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.573 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.508 ' N ' HG13 ' A' ' 4' ' ' VAL . 38.2 pt -75.54 -25.06 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.365 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -99.44 -0.7 40.29 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.302 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 3' ' ' ARG . 1.3 t60 -54.41 140.17 56.23 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.226 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.61 -15.86 48.89 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.919 1.746 . . . . 1.0 112.152 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -93.77 -5.43 48.3 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.627 -0.261 . . . . 1.0 111.151 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 44.0 t80 -71.12 126.66 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.532 -0.303 . . . . 1.0 110.608 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 52.2 m-85 -146.36 122.21 5.63 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 110.184 -0.302 . . . . 1.0 110.184 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.59 109.76 2.92 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.887 1.725 . . . . 1.0 112.492 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -157.14 156.06 32.06 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.631 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' ND2' ' H ' ' A' ' 15' ' ' GLY . 13.2 t-20 -77.07 173.49 11.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.458 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -61.42 -46.33 94.6 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.298 -0.954 . . . . 1.0 111.032 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -67.55 -37.79 83.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.899 0.38 . . . . 1.0 110.877 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -67.41 -33.04 74.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.418 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.585 ' CB ' ' NH1' ' A' ' 33' ' ' ARG . . . -61.23 -43.12 99.38 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.482 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -61.55 -41.75 97.82 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.694 -0.402 . . . . 1.0 109.963 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.1 -39.97 91.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.106 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -63.79 -40.6 97.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.525 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.6 -13.55 59.88 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.927 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -58.09 -43.28 86.97 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.367 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 m -78.53 -17.99 55.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.72 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -84.75 -175.89 5.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.354 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.562 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.3 pm0 -112.61 -172.86 2.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.59 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -79.15 146.38 33.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.789 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.55 23.57 25.91 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.274 -0.73 . . . . 1.0 111.274 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -112.66 145.17 40.9 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.445 ' CD1' HD21 ' A' ' 91' ' ' LEU . 11.9 p90 -133.51 160.38 37.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.214 0.531 . . . . 1.0 110.919 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 44' ' ' ILE . 88.1 t -146.34 155.39 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.255 -0.884 . . . . 1.0 111.459 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.431 ' N ' HG12 ' A' ' 31' ' ' VAL . 4.0 mp -118.87 123.39 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.004 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.585 ' NH1' ' CB ' ' A' ' 18' ' ' ALA . 18.6 ptt-85 -140.5 167.11 22.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.343 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 36' ' ' SER . 25.7 mt-30 -112.41 132.17 55.17 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.037 -0.357 . . . . 1.0 110.037 178.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.491 ' C ' ' H ' ' A' ' 37' ' ' ARG . 61.7 m -56.65 80.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.657 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 34' ' ' GLN . 0.2 OUTLIER 69.83 -42.2 0.5 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.319 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.674 ' O ' ' N ' ' A' ' 39' ' ' ASP . 82.1 mtp180 -150.4 -20.9 0.24 Allowed 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.251 -0.431 . . . . 1.0 111.218 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.614 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . 60.41 -53.76 0.02 OUTLIER Glycine 0 C--O 1.221 -0.697 0 N-CA-C 110.45 -1.06 . . . . 1.0 110.45 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.674 ' N ' ' O ' ' A' ' 37' ' ' ARG . 66.7 t0 55.34 -73.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.082 0.467 . . . . 1.0 110.004 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.614 ' N ' ' O ' ' A' ' 38' ' ' GLY . 23.5 p-10 -124.89 19.06 8.53 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.039 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.488 ' ND1' ' OE1' ' A' ' 59' ' ' GLN . 88.6 m-70 -147.61 152.25 37.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.368 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mp -133.28 147.82 51.92 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.273 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.6 t -126.19 132.96 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.242 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 31' ' ' VAL . 60.2 mt -113.69 139.66 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.585 ' OG1' ' NH1' ' A' ' 33' ' ' ARG . 29.2 m -122.53 143.31 49.8 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.694 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.547 ' NE1' ' CG ' ' A' ' 54' ' ' GLN . 5.8 p-90 -152.46 151.13 30.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.47 -0.786 . . . . 1.0 111.047 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.506 ' C ' HD12 ' A' ' 48' ' ' LEU . 88.8 tttt -91.13 139.15 31.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.99 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.75 ' N ' HD12 ' A' ' 48' ' ' LEU . 6.4 mp -95.67 -59.18 1.92 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.287 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -151.5 -174.34 4.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.338 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -54.88 128.36 32.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.815 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 56.04 39.83 30.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.129 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -144.63 120.38 10.53 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.844 0.354 . . . . 1.0 110.283 179.414 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.607 ' N ' HD13 ' A' ' 52' ' ' LEU . 60.7 m-85 -135.23 149.03 49.79 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.631 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.547 ' CG ' ' NE1' ' A' ' 46' ' ' TRP . 0.5 OUTLIER -141.96 156.09 45.47 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.707 179.353 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.48 ' CA ' ' NE2' ' A' ' 54' ' ' GLN . 33.9 m-70 -129.39 145.34 51.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.956 -0.566 . . . . 1.0 110.63 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.455 HG13 HE22 ' A' ' 54' ' ' GLN . 41.9 mt -125.39 130.96 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 43.8 p-10 -99.61 122.59 42.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.879 0.371 . . . . 1.0 110.489 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.417 HD11 HD12 ' A' ' 44' ' ' ILE . 78.0 mt -102.32 130.67 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.489 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.488 ' OE1' ' ND1' ' A' ' 41' ' ' HIS . 55.5 mm-40 -113.94 126.66 55.4 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -102.1 155.63 18.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.492 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.462 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 2.0 tp -145.19 170.67 15.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.818 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.462 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 20.6 tp10 79.77 53.07 0.02 OUTLIER 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 109.674 -0.491 . . . . 1.0 109.674 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -91.36 90.52 7.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.875 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.499 ' OE1' ' ND2' ' A' ' 65' ' ' ASN . 3.4 tm-20 -67.13 -34.54 77.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.908 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.499 ' ND2' ' OE1' ' A' ' 64' ' ' GLU . 31.2 m120 -145.63 152.81 50.0 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.244 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.64 -33.35 48.51 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.314 2.009 . . . . 1.0 112.061 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.0 mt -86.9 -9.56 55.41 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.863 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.26 134.36 51.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.271 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.8 mt -85.36 152.55 23.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.351 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.59 96.63 0.02 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.721 -0.951 . . . . 1.0 110.721 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -68.43 -43.69 76.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.153 0.501 . . . . 1.0 110.639 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.2 t -111.05 121.83 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.602 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.2 mt -116.04 130.58 56.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.455 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 66.5 mt -108.04 128.39 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 109.869 -0.419 . . . . 1.0 109.869 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.2 t -145.94 134.01 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.36 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.533 ' OD2' ' ND2' ' A' ' 165' ' ' ASN . 32.7 t70 52.96 44.52 30.32 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.208 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 57.06 25.35 10.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.8 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -128.55 147.8 50.72 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.123 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -101.16 130.36 47.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.854 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -124.59 138.84 54.29 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.165 -0.471 . . . . 1.0 109.916 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -85.29 -38.33 18.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.639 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 57.2 t0 -117.11 144.1 45.06 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.076 0.465 . . . . 1.0 111.728 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.496 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 12.3 tp -64.89 -38.44 90.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.619 -0.719 . . . . 1.0 110.551 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.0 -45.06 87.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.96 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -58.39 -38.9 78.29 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.66 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.81 -46.38 96.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.827 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.1 mm -64.27 -43.49 97.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.487 -0.485 . . . . 1.0 111.362 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.05 -43.35 88.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.093 -0.503 . . . . 1.0 112.21 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -71.95 -14.77 62.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.943 0.401 . . . . 1.0 111.267 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -91.94 -50.26 5.81 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.339 -0.544 . . . . 1.0 111.777 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.52 ' O ' HG23 ' A' ' 95' ' ' VAL . 11.0 mp -66.97 -41.51 86.73 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.329 0.492 . . . . 1.0 112.329 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -63.58 -49.9 71.57 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.65 -0.82 . . . . 1.0 111.524 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -70.39 -43.11 70.74 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.465 -0.494 . . . . 1.0 111.961 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -65.85 -42.03 90.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.184 -0.606 . . . . 1.0 111.407 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 91' ' ' LEU . 75.5 t -65.57 -46.08 90.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.185 -0.606 . . . . 1.0 111.395 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -69.42 -44.84 70.55 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.436 -0.506 . . . . 1.0 111.415 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.1 tp -66.02 -42.58 89.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.484 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.6 tp -65.08 -40.27 94.39 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.389 -0.524 . . . . 1.0 110.4 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -67.93 -38.82 83.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.839 -0.618 . . . . 1.0 111.261 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -70.4 -39.97 74.16 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 120.628 -0.429 . . . . 1.0 111.71 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.602 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 2.9 ttt -69.33 -56.27 8.0 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.438 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.417 ' C ' ' H ' ' A' ' 104' ' ' SER . 17.0 m -58.39 -41.45 84.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.085 0.469 . . . . 1.0 110.599 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.8 m -71.64 10.82 0.58 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.625 -0.716 . . . . 1.0 111.276 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 101' ' ' MET . 65.0 p -94.38 133.76 37.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.788 0.327 . . . . 1.0 110.436 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.3 -20.55 55.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.812 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.556 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -89.29 40.57 0.99 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.136 -0.483 . . . . 1.0 109.881 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -132.2 114.34 14.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.065 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -139.33 113.12 8.54 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 116.088 -0.505 . . . . 1.0 109.868 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 t -97.41 89.89 4.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.993 0.425 . . . . 1.0 110.876 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -112.45 168.98 12.84 Favored Glycine 0 N--CA 1.467 0.731 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.662 ' O ' HG23 ' A' ' 115' ' ' VAL . 12.8 m -71.86 162.03 30.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.464 ' N ' HG22 ' A' ' 111' ' ' THR . 64.5 tttp -57.02 -37.88 72.35 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.591 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -69.87 -45.22 68.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.164 0.507 . . . . 1.0 110.801 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -68.1 -21.67 64.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.648 -0.706 . . . . 1.0 110.906 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 111' ' ' THR . 41.6 t -69.82 -44.38 79.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.172 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.65 -44.81 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.032 0.444 . . . . 1.0 110.279 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -65.89 -34.26 77.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.902 0.382 . . . . 1.0 110.698 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.4 -50.68 62.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.849 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 120' ' ' GLU . 1.6 tt -70.88 -39.97 75.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.445 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.519 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 58.7 mm-40 -59.98 -41.81 92.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.359 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.58 -46.95 83.49 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.24 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -60.73 -45.84 92.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.066 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.3 t -61.58 -38.15 86.47 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.492 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -61.64 -40.05 93.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.034 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.67 -41.93 94.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 0.0 OUTLIER -126.48 78.83 71.72 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.209 179.24 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.533 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 10.3 Cg_exo -67.9 -20.22 45.46 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.967 2.444 . . . . 1.0 112.339 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -97.19 -6.86 33.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.998 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -113.92 148.04 37.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.871 0.367 . . . . 1.0 110.637 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.6 p -80.16 164.83 23.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.592 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 p -152.71 146.09 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -144.35 142.34 30.31 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.752 0.31 . . . . 1.0 111.14 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -152.54 164.54 37.42 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.51 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.556 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.5 OUTLIER -133.72 157.05 46.82 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.1 t -152.59 167.72 27.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.889 0.376 . . . . 1.0 110.223 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.677 HD23 ' N ' ' A' ' 137' ' ' ASN . 1.0 OUTLIER -84.05 136.19 34.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.827 179.503 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.677 ' N ' HD23 ' A' ' 136' ' ' LEU . 47.4 t30 -60.19 -136.18 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.422 -0.353 . . . . 1.0 110.339 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.577 ' H ' ' ND2' ' A' ' 137' ' ' ASN . 32.2 m80 -158.01 -61.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.657 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 139' ' ' ASP . 15.7 p-10 -90.29 1.58 56.38 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.937 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.603 ' H ' HD22 ' A' ' 137' ' ' ASN . 6.6 m120 -116.4 90.53 30.36 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.459 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.42 104.55 1.59 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.081 1.854 . . . . 1.0 112.216 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.48 36.55 2.82 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.409 -1.076 . . . . 1.0 110.409 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -138.21 147.88 44.21 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.525 0.202 . . . . 1.0 110.552 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.602 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 69.5 m-85 -130.86 148.58 52.64 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.719 -0.475 . . . . 1.0 109.719 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.485 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 31.2 m-85 -124.41 136.82 54.36 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.051 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 16.3 mt -107.31 123.69 48.7 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.291 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -116.76 146.35 42.88 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.977 -1.119 . . . . 1.0 107.977 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -161.86 152.03 17.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.519 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 67.2 tttt -136.34 126.73 26.68 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 120.801 -0.359 . . . . 1.0 110.567 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.481 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 3.4 mp -69.59 -47.96 68.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 23.6 m120 -157.48 174.55 15.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.48 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.92 75.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.88 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -85.33 6.88 24.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.039 0.447 . . . . 1.0 110.313 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.6 t -98.31 152.58 19.28 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.416 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.477 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 99.4 mttt -86.2 153.54 21.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.996 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 22.0 tp -69.95 125.9 28.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.407 . . . . 1.0 110.022 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 95.2 m-85 -115.9 127.29 54.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.703 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 94.3 m -126.45 130.81 51.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.823 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -115.63 160.65 19.75 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.054 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.485 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 84.7 m-20 -108.07 145.35 34.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.834 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.8 t -127.52 135.61 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -99.92 131.85 45.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.033 0.444 . . . . 1.0 110.61 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 54.5 tp -92.03 131.04 37.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 1.0 109.868 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 56.0 p -133.6 166.8 21.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.344 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.533 ' ND2' ' OD2' ' A' ' 76' ' ' ASP . 19.6 p30 -78.2 16.29 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.722 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 62.1 p -119.57 -1.23 10.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.425 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 133.93 -125.8 4.03 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.251 -1.14 . . . . 1.0 110.251 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -122.78 129.66 51.99 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.242 -0.281 . . . . 1.0 110.242 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.98 118.1 35.79 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 tt -115.43 118.05 32.1 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.2 t 37.44 54.0 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.007 0.373 . . . . 1.0 112.007 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.8 m120 69.76 27.26 4.67 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.894 0.701 . . . . 1.0 112.894 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -131.96 120.38 22.41 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -94.84 120.68 35.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.364 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -98.09 135.37 21.41 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.438 -0.578 . . . . 1.0 109.438 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.26 -19.12 29.68 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.279 1.986 . . . . 1.0 113.55 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.427 ' OG ' ' OE1' ' A' ' 180' ' ' GLN . 19.4 p -150.1 153.78 36.98 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.968 0.413 . . . . 1.0 110.85 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.42 -36.27 75.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.696 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.475 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 48.5 mm -62.6 -47.63 92.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.946 0.403 . . . . 1.0 110.357 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.427 ' OE1' ' OG ' ' A' ' 177' ' ' SER . 6.0 mp0 -61.56 -30.75 70.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.8 tp -64.25 -40.46 96.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.272 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . 0.619 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 2.6 p -60.27 -47.54 85.57 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.519 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.619 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 51.3 t30 -69.64 -49.01 57.87 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.2 -45.26 0.44 Allowed Glycine 0 N--CA 1.465 0.581 0 N-CA-C 109.876 -1.29 . . . . 1.0 109.876 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -67.67 -47.88 68.22 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.1 tttm -56.45 -40.33 74.63 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.54 -0.755 . . . . 1.0 110.1 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 97.9 m -61.04 -45.28 95.44 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.33 -39.71 95.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.872 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 59.7 tp -58.73 -44.55 90.47 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.619 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -59.8 -46.17 90.04 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.737 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.5 t -63.08 -39.9 96.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.197 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.49 -43.08 95.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.64 . . . . 1.0 111.963 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.49 -29.94 67.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.465 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 . . . . . 0 N--CA 1.465 0.31 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.886 -179.015 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.846 0.355 . . . . 1.0 110.338 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.6 -27.39 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.574 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.4 pt -75.49 -22.06 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.484 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -106.32 5.98 30.13 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.961 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -58.93 150.91 58.01 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.421 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 38.2 Cg_endo -65.23 -19.88 62.47 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.171 1.914 . . . . 1.0 112.029 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.4 3.23 54.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.608 -0.269 . . . . 1.0 110.99 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -88.97 125.75 35.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.528 -0.306 . . . . 1.0 110.477 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.421 ' CZ ' ' O ' ' A' ' 8' ' ' PRO . 71.1 m-85 -143.17 128.69 10.07 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 110.186 -0.301 . . . . 1.0 110.186 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.489 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 74.0 Cg_endo -73.3 110.01 2.96 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.758 1.638 . . . . 1.0 112.766 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.489 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 52.4 m-85 -160.98 152.29 19.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.361 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 20.9 t-20 -75.84 165.09 25.52 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.464 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . -57.11 -43.41 93.36 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.461 -0.875 . . . . 1.0 110.937 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 48.6 mmm-85 -67.44 -37.65 83.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.864 0.364 . . . . 1.0 110.596 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -73.57 -32.57 64.22 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.62 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.56 -47.45 85.49 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.417 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -65.89 -36.85 84.56 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.43 ' O ' ' CG ' ' A' ' 23' ' ' ARG . 97.4 m-20 -63.33 -42.76 98.99 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -66.25 -36.55 83.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.715 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 22' ' ' LEU . 10.5 tp -82.12 -11.84 58.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.101 -0.499 . . . . 1.0 111.381 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.43 ' CG ' ' O ' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -65.15 -28.57 69.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.826 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.2 t -83.56 -19.94 34.72 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.714 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -84.93 -178.15 6.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.428 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -88.69 167.9 12.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.799 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -74.72 145.15 43.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.808 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.77 4.95 56.8 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.872 -0.891 . . . . 1.0 110.872 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -88.98 148.3 23.85 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -128.31 165.03 21.33 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.219 0.533 . . . . 1.0 111.027 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.757 ' O ' HG23 ' A' ' 44' ' ' ILE . 3.6 t -145.51 155.03 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.309 -0.86 . . . . 1.0 110.894 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -117.5 122.22 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.541 ' NH1' ' OG ' ' A' ' 35' ' ' SER . 32.8 ptt85 -148.66 158.76 44.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.297 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -107.55 137.08 46.23 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.541 ' OG ' ' NH1' ' A' ' 33' ' ' ARG . 2.9 p 169.16 97.74 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.539 0.524 . . . . 1.0 111.073 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.4 p -169.16 30.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.242 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? 53.15 20.26 1.74 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.233 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.676 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -150.1 89.95 0.14 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.677 -0.969 . . . . 1.0 110.677 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -57.18 11.91 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.225 -0.488 . . . . 1.0 111.142 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.676 ' H ' ' C ' ' A' ' 38' ' ' GLY . 32.0 p-10 -107.76 -0.44 21.72 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -129.59 155.47 45.76 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.783 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.41 150.28 40.46 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.006 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.7 t -126.21 133.29 69.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.109 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 31' ' ' VAL . 61.5 mt -112.53 138.44 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.749 -0.834 . . . . 1.0 108.749 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 87.6 m -116.5 135.37 53.88 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.04 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.598 ' CE2' HD11 ' A' ' 48' ' ' LEU . 1.8 p-90 -146.0 151.75 38.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.934 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.458 ' C ' HD12 ' A' ' 48' ' ' LEU . 35.2 ttmt -98.26 138.03 36.12 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.946 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.598 HD11 ' CE2' ' A' ' 46' ' ' TRP . 9.2 mp -95.82 -73.25 0.6 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.046 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 23.4 t70 -103.07 -170.77 1.84 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.497 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.5 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 7.8 ttpm? -63.17 -38.66 92.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.616 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -127.21 61.25 1.37 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.873 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.8 tp -157.47 130.25 7.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.421 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.3 148.66 50.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.662 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.51 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 26.7 mm100 -143.09 152.37 41.77 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.016 -0.538 . . . . 1.0 109.75 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.51 ' HD1' ' C ' ' A' ' 54' ' ' GLN . 3.7 m-70 -126.36 141.2 51.99 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.288 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.07 123.14 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.291 -0.413 . . . . 1.0 109.931 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -95.67 121.94 37.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.538 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.9 mt -102.47 124.02 56.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.441 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -107.56 136.16 47.8 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -103.34 151.71 22.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.034 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.0 mt -139.81 171.33 14.37 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.493 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 77.66 45.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.246 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.76 77.38 2.84 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.917 -0.583 . . . . 1.0 109.927 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -65.21 -35.84 82.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.585 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -131.09 150.38 76.4 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.01 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.32 -20.39 66.54 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.235 1.957 . . . . 1.0 112.082 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.61 -4.4 50.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.711 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.26 129.79 54.23 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.947 0.403 . . . . 1.0 110.308 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.8 mt -81.21 153.35 27.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.515 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.06 114.0 6.41 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.526 -1.03 . . . . 1.0 110.526 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.98 -10.65 59.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.876 0.37 . . . . 1.0 110.799 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.7 t -117.87 118.83 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.43 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.5 mt -114.76 128.79 56.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.388 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -100.28 120.26 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.883 0.373 . . . . 1.0 110.539 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.555 HG21 HD13 ' A' ' 86' ' ' ILE . 40.9 t -140.65 133.08 31.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.393 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 55.43 43.99 27.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.11 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.3 t30 58.47 21.76 8.84 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.02 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -128.86 152.27 48.7 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.336 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -100.09 131.64 45.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 1.0 111.041 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -128.81 136.8 50.99 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.204 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -85.5 -37.44 19.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.591 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -112.29 141.2 46.3 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.971 0.415 . . . . 1.0 111.575 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.9 -40.44 95.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.726 -0.67 . . . . 1.0 111.173 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 42.9 p30 -59.89 -33.66 72.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 1.0 111.64 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.561 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 25.8 mt-30 -65.92 -39.14 90.29 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.799 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.555 HD13 HG21 ' A' ' 75' ' ' VAL . 97.1 mt -62.65 -45.72 98.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.716 -0.394 . . . . 1.0 110.778 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.6 mm -65.12 -44.01 95.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.422 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.453 ' O ' ' CG ' ' A' ' 92' ' ' GLN . 98.1 t -69.36 -44.6 80.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 112.433 0.531 . . . . 1.0 112.433 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -76.95 -13.05 60.02 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.288 -0.565 . . . . 1.0 111.692 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.472 ' OH ' ' CZ2' ' A' ' 46' ' ' TRP . 63.0 t80 -93.85 -48.6 6.21 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.977 0.362 . . . . 1.0 111.977 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.89 -42.45 76.92 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.425 0.528 . . . . 1.0 112.425 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.493 ' CD ' ' N ' ' A' ' 93' ' ' ASN . 1.5 pp0? -63.84 -47.46 80.65 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.025 -0.67 . . . . 1.0 111.526 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.493 ' N ' ' CD ' ' A' ' 92' ' ' GLN . 2.7 t30 -69.27 -42.81 75.05 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.685 -0.406 . . . . 1.0 111.509 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -65.68 -42.86 90.75 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.296 -0.562 . . . . 1.0 111.018 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.7 t -66.04 -46.46 87.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.12 -0.632 . . . . 1.0 111.137 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.497 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 82.6 mtp180 -67.08 -45.54 77.01 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.272 -0.571 . . . . 1.0 111.842 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.456 HD11 ' CZ ' ' A' ' 168' ' ' TYR . 7.1 tp -69.57 -41.43 75.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.534 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.47 -45.72 86.18 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.43 -0.508 . . . . 1.0 110.674 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -69.11 -35.03 76.0 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.439 -0.504 . . . . 1.0 111.161 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -71.72 -42.86 66.8 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.578 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 9.2 tpt -68.78 -52.88 25.56 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.495 -0.482 . . . . 1.0 111.117 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.9 m -58.48 -40.78 83.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 1.0 110.551 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.5 t -72.61 9.77 1.01 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.877 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.0 t -92.26 136.49 33.14 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 110.178 -0.305 . . . . 1.0 110.178 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -62.71 -16.83 59.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.85 0.357 . . . . 1.0 110.836 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.473 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 99.3 mttt -91.76 39.3 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.999 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -132.95 114.84 14.48 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.989 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -130.03 115.5 17.2 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 64.5 p -97.59 81.52 2.95 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.863 0.363 . . . . 1.0 110.912 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.93 167.43 12.32 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.831 -0.908 . . . . 1.0 110.831 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 115' ' ' VAL . 80.9 p -77.28 162.81 27.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.971 -0.381 . . . . 1.0 109.971 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -55.99 -35.68 67.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.554 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.74 -43.61 83.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.651 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -70.78 -19.76 62.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.982 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 111' ' ' THR . 43.2 t -70.25 -44.69 77.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.336 178.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.31 -44.89 94.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.293 0.568 . . . . 1.0 110.395 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -65.65 -34.89 79.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.656 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -67.35 -50.13 61.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.539 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.414 HD11 HG13 ' A' ' 131' ' ' VAL . 8.2 tp -69.7 -39.45 78.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.225 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -63.46 -43.57 96.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.661 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.44 ' HA ' ' HE ' ' A' ' 124' ' ' ARG . 90.5 m-20 -60.86 -47.45 86.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.29 -0.564 . . . . 1.0 110.219 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.562 ' CE2' ' OD1' ' A' ' 126' ' ' ASN . 50.3 t80 -61.42 -40.05 92.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.015 -0.539 . . . . 1.0 109.844 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.6 t -60.35 -42.41 95.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.572 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.44 ' HE ' ' HA ' ' A' ' 121' ' ' ASP . 77.7 mtm180 -61.14 -40.84 95.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.404 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.35 -41.27 83.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.562 ' OD1' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -123.15 73.95 48.91 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.732 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.53 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 41.2 Cg_endo -72.01 -22.26 23.18 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.131 1.887 . . . . 1.0 112.442 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -104.07 24.45 11.39 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.74 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -140.77 151.52 44.5 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.826 0.346 . . . . 1.0 110.633 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.9 p -80.12 162.22 24.88 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.554 -0.535 . . . . 1.0 109.554 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.414 HG13 HD11 ' A' ' 119' ' ' ILE . 3.5 p -152.63 144.76 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 178.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.446 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 27.2 p90 -153.49 142.76 21.51 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.962 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -151.76 169.47 22.13 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.438 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.473 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -131.02 149.92 52.39 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.9 t -150.55 169.98 20.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.329 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.6 tp -67.89 140.55 56.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.422 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.607 HD21 ' HA ' ' A' ' 141' ' ' PRO . 9.8 p30 -55.59 -43.64 76.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.565 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 19.2 t60 70.39 -19.71 0.21 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.707 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.533 ' H ' ' C ' ' A' ' 137' ' ' ASN . 30.3 m-20 -103.0 -24.24 13.65 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.065 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.434 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 4.7 p30 -153.56 91.75 3.25 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.11 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.607 ' HA ' HD21 ' A' ' 137' ' ' ASN . 44.8 Cg_exo -54.25 135.26 64.37 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.203 1.935 . . . . 1.0 112.665 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 117.58 -28.99 6.84 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.001 -0.84 . . . . 1.0 111.001 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -113.96 150.49 33.72 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.931 0.396 . . . . 1.0 110.538 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -115.33 156.24 25.85 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -125.36 134.94 52.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.029 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.4 mt -106.68 126.24 52.03 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.651 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -117.15 146.39 43.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 178.472 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -160.86 150.59 17.31 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.216 -0.593 . . . . 1.0 109.723 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -130.94 127.37 38.31 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.746 0.308 . . . . 1.0 110.281 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 37.6 mm -72.92 -46.08 53.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.204 -0.453 . . . . 1.0 111.803 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 152' ' ' ALA . 11.9 t-20 -157.07 169.61 24.41 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.699 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.537 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -60.51 -30.08 69.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.813 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -90.41 8.79 31.88 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.036 0.446 . . . . 1.0 110.393 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 15.6 t -97.45 159.73 14.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.716 -0.674 . . . . 1.0 110.486 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -92.37 153.2 19.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.039 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 48.5 tp -70.84 118.52 13.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -108.07 129.98 55.11 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 51.8 m -126.41 128.94 47.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.611 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -113.9 160.97 18.2 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.035 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 160' ' ' ASN . 50.9 p30 -104.75 147.99 27.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.906 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 47.4 t -128.31 137.48 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.85 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -104.0 131.53 51.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.367 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.0 tp -95.26 130.53 41.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 1.0 109.789 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 48.8 p -127.89 171.01 12.18 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.252 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -84.97 16.48 3.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.851 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m -122.91 -3.25 8.65 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.935 0.398 . . . . 1.0 110.458 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 143.41 -132.24 4.88 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.422 -1.071 . . . . 1.0 110.422 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.456 ' CZ ' HD11 ' A' ' 97' ' ' LEU . 17.5 m-85 -122.91 130.2 52.55 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -106.48 122.52 46.46 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 tt -116.28 118.08 31.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 1.0 109.856 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.466 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 4.7 t 37.48 58.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.176 0.436 . . . . 1.0 112.176 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.5 m120 65.46 27.34 11.76 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.949 0.722 . . . . 1.0 112.949 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.466 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 89.0 m-85 -133.85 120.37 20.35 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -96.49 126.2 41.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.439 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -105.08 131.72 21.52 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -73.31 -20.79 20.75 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.192 1.928 . . . . 1.0 113.31 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 67.9 m -143.86 147.44 34.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.945 0.402 . . . . 1.0 111.218 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.08 -34.51 60.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.67 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 58.8 mt -62.2 -44.95 99.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.886 0.374 . . . . 1.0 110.135 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -67.98 -31.22 70.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.059 -0.519 . . . . 1.0 109.629 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.14 -42.79 99.53 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 110.084 -0.339 . . . . 1.0 110.084 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 73.1 m -63.13 -44.98 94.06 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.26 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.559 ' O ' ' N ' ' A' ' 186' ' ' LYS . 37.3 m-80 -65.73 -48.83 70.59 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.47 -43.43 0.75 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.678 -1.369 . . . . 1.0 109.678 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.461 ' O ' ' HG ' ' A' ' 188' ' ' LEU . 2.6 t80 -69.56 -46.85 65.46 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 122.096 0.951 . . . . 1.0 109.329 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.559 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.7 tttm -59.01 -35.58 73.51 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.118 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.7 m -63.43 -50.5 69.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 1.0 111.177 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.586 ' C ' HD12 ' A' ' 188' ' ' LEU . 0.7 OUTLIER -66.55 -36.05 81.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.66 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.424 ' N ' ' HG ' ' A' ' 188' ' ' LEU . 45.7 tp -58.03 -43.84 86.99 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.432 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -61.13 -40.28 93.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.956 -0.566 . . . . 1.0 109.792 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.0 t -61.59 -36.85 81.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.741 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 92.6 mt -69.95 -36.94 75.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.405 -0.816 . . . . 1.0 112.047 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.57 -31.88 69.85 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.051 0.389 . . . . 1.0 112.051 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 27.2 m170 . . . . . 0 C--N 1.325 -0.464 0 C-N-CA 120.881 -0.327 . . . . 1.0 110.725 -179.595 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.402 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 69.5 mtp180 . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 120.895 0.379 . . . . 1.0 110.375 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 p -64.8 -31.36 53.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.556 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.7 pt -73.79 -17.26 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.46 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -98.03 0.32 46.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.389 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.41 ' O ' ' N ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -62.78 123.22 78.76 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.285 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.477 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 77.5 Cg_exo -43.9 -25.72 1.13 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.848 1.699 . . . . 1.0 112.39 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.598 ' CD1' ' CZ ' ' A' ' 30' ' ' PHE . 78.5 m-85 -87.0 9.16 20.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.506 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 7' ' ' HIS . 44.2 t80 -92.68 125.48 37.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.377 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.477 ' CZ ' ' O ' ' A' ' 8' ' ' PRO . 66.1 m-85 -145.3 128.27 8.29 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 110.12 -0.326 . . . . 1.0 110.12 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.88 110.54 3.1 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.717 1.611 . . . . 1.0 112.712 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -154.52 152.48 30.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.439 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -79.31 174.03 11.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.398 -0.593 . . . . 1.0 109.398 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.44 -46.86 93.56 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.403 -0.903 . . . . 1.0 111.338 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -67.32 -35.29 79.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.539 0.209 . . . . 1.0 111.15 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -67.68 -37.22 82.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.379 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.29 94.94 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.691 -0.404 . . . . 1.0 110.425 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.47 -43.99 92.47 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.019 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.61 -42.63 99.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.432 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -63.05 -41.51 99.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.831 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.9 mp -78.63 -11.31 59.96 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.97 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -56.21 -43.52 78.61 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.519 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.0 m -79.3 -15.84 57.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.739 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -81.44 175.57 10.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.472 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -100.9 -176.38 3.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.515 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -82.3 146.2 29.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.88 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.51 14.01 45.77 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.192 -0.763 . . . . 1.0 111.192 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -100.49 144.07 29.91 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.598 ' CZ ' ' CD1' ' A' ' 9' ' ' TYR . 9.1 p90 -132.9 162.19 32.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.116 0.484 . . . . 1.0 110.832 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.739 ' O ' HG23 ' A' ' 44' ' ' ILE . 45.7 t -147.29 157.77 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.193 -0.912 . . . . 1.0 111.533 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.476 ' N ' HG12 ' A' ' 31' ' ' VAL . 80.8 mt -117.75 124.82 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 43' ' ' VAL . 1.5 ptm180 -150.27 156.03 40.8 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.321 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -88.33 169.87 11.46 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 38' ' ' GLY . 16.5 p -81.09 28.13 0.38 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.405 -0.362 . . . . 1.0 110.987 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m 70.94 -41.4 0.5 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.809 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.464 ' H ' ' C ' ' A' ' 35' ' ' SER . 83.9 mtt85 -140.21 19.01 2.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.01 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.486 ' N ' ' OG ' ' A' ' 35' ' ' SER . . . -70.66 -65.18 2.57 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.618 -0.993 . . . . 1.0 110.618 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 68.03 -43.72 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.726 0.298 . . . . 1.0 110.647 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 38' ' ' GLY . 38.2 t70 -94.8 -9.63 33.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.652 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -136.98 151.33 48.87 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.898 0.38 . . . . 1.0 110.348 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.96 147.91 44.81 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.097 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 33' ' ' ARG . 62.4 t -126.47 134.24 66.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.437 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 31' ' ' VAL . 48.1 mt -112.95 138.86 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.1 m -116.9 135.36 53.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.825 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.565 ' CE2' HD11 ' A' ' 48' ' ' LEU . 4.1 p-90 -144.4 148.02 34.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.521 -0.763 . . . . 1.0 110.787 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.543 ' C ' HD12 ' A' ' 48' ' ' LEU . 85.3 tttt -95.29 137.13 34.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.972 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.6 mp -101.87 -82.14 0.48 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.385 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -90.01 174.74 7.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.522 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -58.52 -29.59 66.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.82 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -132.56 52.95 2.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.992 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.0 tp -152.9 136.76 16.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.905 0.384 . . . . 1.0 110.442 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.553 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 87.0 m-85 -131.63 148.22 52.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.385 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 53' ' ' PHE . 98.0 mm-40 -142.73 153.81 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.681 -0.489 . . . . 1.0 109.681 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.502 ' O ' ' ND1' ' A' ' 55' ' ' HIS . 7.7 p80 -129.45 144.65 51.34 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.287 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.3 mt -122.64 125.57 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -96.45 122.67 39.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.952 0.406 . . . . 1.0 110.359 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.3 mt -104.82 129.64 57.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.31 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.862 ' H ' HE21 ' A' ' 59' ' ' GLN . 0.0 OUTLIER -112.23 135.15 53.26 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.096 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.4 ' H ' ' HG3' ' A' ' 60' ' ' GLU . 2.8 pp20? -100.53 151.52 21.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.312 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.7 tp -143.5 176.18 9.38 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.513 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.445 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 64.0 tt0 67.63 44.37 1.68 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.264 0.554 . . . . 1.0 109.633 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -83.01 90.44 7.02 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.806 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.466 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 49.4 tp10 -65.66 -38.38 89.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.819 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 64' ' ' GLU . 6.6 m120 -144.16 153.67 56.74 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.259 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.82 -33.83 62.61 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.079 1.853 . . . . 1.0 112.324 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 pp -85.14 -10.92 56.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.857 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.51 133.86 48.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.367 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.2 mt -79.67 152.45 29.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.364 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.86 92.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.01 -37.11 86.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.867 0.365 . . . . 1.0 110.772 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.2 t -122.93 123.0 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.804 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.7 mt -116.13 134.22 55.17 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.5 mm -99.57 120.09 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.919 0.39 . . . . 1.0 110.128 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.66 131.47 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.229 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.405 ' OD2' ' ND2' ' A' ' 165' ' ' ASN . 42.6 t0 54.14 43.45 30.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.18 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 59.54 24.31 13.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.017 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -129.53 156.96 43.32 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.434 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.14 133.51 41.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.187 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.566 ' CG ' HD11 ' A' ' 86' ' ' ILE . 66.1 m-85 -135.19 136.4 41.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.241 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -87.06 -37.66 17.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.889 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -109.33 136.71 48.34 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.21 0.529 . . . . 1.0 112.324 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.4 tp -66.08 -38.12 87.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.767 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 54.1 t0 -59.7 -36.58 76.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.894 -176.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.415 ' OE1' ' OE2' ' A' ' 89' ' ' GLU . 9.5 tt0 -59.8 -38.96 83.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.627 0.251 . . . . 1.0 110.608 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.566 HD11 ' CG ' ' A' ' 80' ' ' TYR . 50.1 mm -60.71 -47.76 91.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.708 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.16 -42.7 96.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 120.512 -0.475 . . . . 1.0 111.786 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.428 ' O ' ' OE1' ' A' ' 92' ' ' GLN . 40.6 t -76.44 -37.57 30.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.152 0.797 . . . . 1.0 113.152 -177.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.415 ' OE2' ' OE1' ' A' ' 85' ' ' GLN . 95.8 mt-10 -84.37 -14.49 49.36 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.912 0.338 . . . . 1.0 111.912 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 12.0 t80 -95.27 -48.7 5.79 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.629 -0.428 . . . . 1.0 112.129 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 95' ' ' VAL . 10.9 mp -69.76 -40.49 76.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.337 0.495 . . . . 1.0 112.337 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.515 ' OE1' ' N ' ' A' ' 92' ' ' GLN . 5.1 mp0 -64.2 -48.95 73.91 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.969 -0.692 . . . . 1.0 111.767 -177.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -69.29 -42.9 74.85 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.622 -0.431 . . . . 1.0 111.866 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.553 ' O ' HD13 ' A' ' 98' ' ' LEU . 42.1 mmtm -66.35 -43.62 85.52 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.359 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 91' ' ' LEU . 47.4 t -61.56 -45.52 98.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.3 -0.56 . . . . 1.0 111.235 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -69.24 -42.7 75.29 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.487 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.8 tp -66.44 -42.24 87.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.616 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 94' ' ' LYS . 8.7 mp -65.4 -41.11 94.02 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.504 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.48 -36.24 78.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.18 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -71.66 -42.28 67.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 120.824 -0.351 . . . . 1.0 111.784 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.3 tpt -67.46 -54.96 15.72 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.438 -0.505 . . . . 1.0 111.65 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.402 HG23 ' CE2' ' A' ' 107' ' ' PHE . 55.3 m -59.68 -29.42 68.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.956 0.407 . . . . 1.0 110.559 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.0 p -74.25 9.61 1.58 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.123 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.7 t -98.45 130.1 45.06 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 110.123 -0.325 . . . . 1.0 110.123 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -58.23 -17.49 19.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.127 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.533 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 98.6 mttt -88.56 40.63 0.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.671 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.402 ' CE2' HG23 ' A' ' 102' ' ' THR . 48.6 t80 -135.24 113.41 11.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.104 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -133.44 120.43 20.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.052 -0.522 . . . . 1.0 109.977 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.6 p -91.75 94.68 9.48 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.053 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.2 151.8 16.89 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.595 ' O ' HG23 ' A' ' 115' ' ' VAL . 19.1 p -71.34 162.76 28.92 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -58.92 -40.1 83.54 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.539 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.85 -46.16 72.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.872 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.431 ' OD1' ' OG1' ' A' ' 111' ' ' THR . 2.8 m-20 -71.34 -19.37 62.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.744 -0.662 . . . . 1.0 111.084 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 111' ' ' THR . 10.2 t -73.7 -43.92 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.172 -0.307 . . . . 1.0 110.172 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.0 -46.56 96.21 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 CA-C-O 121.118 0.485 . . . . 1.0 110.054 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -65.86 -34.32 77.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.988 0.423 . . . . 1.0 110.696 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -68.94 -49.29 59.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.731 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.1 tp -70.6 -39.59 76.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.518 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -62.52 -41.65 98.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.765 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.96 -47.63 74.01 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.582 -0.447 . . . . 1.0 110.373 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.536 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 42.4 t80 -61.39 -42.09 98.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.99 -0.55 . . . . 1.0 109.914 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.5 p -64.87 -33.56 76.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.419 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -61.81 -42.02 98.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.998 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.76 -40.91 90.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.536 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -113.77 75.27 2.69 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.056 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.531 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 41.4 Cg_endo -71.99 -19.35 26.81 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.24 1.96 . . . . 1.0 112.406 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -104.67 -14.64 15.53 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.041 0.386 . . . . 1.0 112.041 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -103.4 147.1 27.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.082 0.467 . . . . 1.0 110.52 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.9 m -80.81 162.1 24.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.515 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 p -153.03 146.36 14.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -149.73 143.05 25.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.885 0.374 . . . . 1.0 111.041 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -151.24 165.25 34.53 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.317 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.533 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -133.57 151.63 51.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.383 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.9 m -146.31 167.51 23.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.252 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.9 tp -79.82 128.81 33.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.612 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.465 ' CG ' ' CD2' ' A' ' 145' ' ' TYR . 5.5 m-20 -53.11 173.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.109 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -127.58 -38.85 1.88 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.531 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -95.44 -8.04 36.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.177 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -136.62 75.5 50.36 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.255 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.406 ' HG2' HE22 ' A' ' 54' ' ' GLN . 32.1 Cg_exo -57.34 132.42 50.79 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.964 1.776 . . . . 1.0 112.442 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 109.43 -33.49 6.06 Favored Glycine 0 N--CA 1.466 0.645 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.432 ' O ' ' CG ' ' A' ' 137' ' ' ASN . 15.6 m0 -92.16 156.49 17.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.723 0.297 . . . . 1.0 110.22 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -119.12 149.77 41.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 1.0 109.834 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.465 ' CD2' ' CG ' ' A' ' 137' ' ' ASN . 35.8 m-85 -120.99 132.99 55.25 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.246 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 15.0 mt -107.32 123.38 48.25 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.236 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.457 ' SD ' HG13 ' A' ' 115' ' ' VAL . 0.9 OUTLIER -120.64 145.32 47.53 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.979 -1.119 . . . . 1.0 107.979 178.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -163.48 151.58 13.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.51 -0.476 . . . . 1.0 109.719 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -128.39 130.57 47.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.761 0.315 . . . . 1.0 110.455 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.424 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.9 mp -75.68 -45.92 37.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.217 0.451 . . . . 1.0 112.217 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 17.5 t-20 -152.15 164.08 38.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.477 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.505 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -57.14 -22.89 43.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.776 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -96.87 -4.54 40.04 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.402 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.1 p -82.91 150.76 26.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.488 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.486 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -82.35 154.56 25.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.176 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.2 tp -69.39 113.7 6.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.971 0.415 . . . . 1.0 110.073 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 99.0 m-85 -99.92 131.23 46.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.803 -0.635 . . . . 1.0 109.636 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 58.4 m -127.62 130.94 49.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.774 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -117.1 153.26 33.07 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.111 0.481 . . . . 1.0 109.942 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -105.2 144.95 31.28 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.791 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.5 t -127.61 135.44 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.646 -0.502 . . . . 1.0 109.646 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -98.19 131.23 44.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.378 -0.373 . . . . 1.0 110.474 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.3 tp -99.71 131.35 45.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.078 -0.51 . . . . 1.0 109.698 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.1 p -132.58 174.32 10.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.461 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.479 ' ND2' ' H ' ' A' ' 165' ' ' ASN . 3.0 p30 -85.67 17.02 3.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.699 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 44.0 p -121.79 -2.63 9.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.566 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.32 -134.48 6.52 Favored Glycine 0 N--CA 1.465 0.591 0 N-CA-C 110.329 -1.108 . . . . 1.0 110.329 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -122.23 130.15 52.91 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 110.316 -0.253 . . . . 1.0 110.316 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -105.67 119.2 38.53 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.8 tt -117.02 119.73 36.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.8 t 38.54 53.66 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.004 0.372 . . . . 1.0 112.004 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.5 m120 67.7 27.19 7.66 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.017 0.747 . . . . 1.0 113.017 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -135.47 120.68 18.94 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -93.2 126.06 38.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.493 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -102.51 139.63 20.39 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -72.71 -18.59 25.02 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.024 1.816 . . . . 1.0 113.613 -177.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.9 p -154.67 158.24 39.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.917 0.389 . . . . 1.0 110.962 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 179' ' ' ILE . 14.2 p -64.77 -37.52 80.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.141 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.425 ' N ' HG13 ' A' ' 178' ' ' VAL . 80.4 mt -59.7 -45.03 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.306 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.534 ' HA ' HE21 ' A' ' 180' ' ' GLN . 0.3 OUTLIER -63.59 -37.6 87.96 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.7 tt -64.86 -39.78 94.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.422 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 83.1 m -59.29 -47.87 83.75 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.432 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' A' ' 186' ' ' LYS . 61.2 t30 -69.74 -49.28 54.64 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.35 -44.96 0.63 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.699 -1.36 . . . . 1.0 109.699 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.78 -47.34 69.44 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.192 -0.669 . . . . 1.0 109.192 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 183' ' ' ASN . 63.9 tttp -56.56 -41.53 77.03 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.522 -0.763 . . . . 1.0 109.827 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 94.5 m -60.02 -46.98 87.71 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.75 -41.23 98.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 1.0 109.815 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.1 tp -60.24 -45.81 91.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.542 -0.299 . . . . 1.0 110.451 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -60.89 -44.17 97.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.291 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.4 t -64.31 -37.38 87.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.258 0.551 . . . . 1.0 110.499 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.19 -42.26 99.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.87 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -63.5 -25.69 68.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 111.878 0.325 . . . . 1.0 111.878 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.086 -179.596 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.757 0.313 . . . . 1.0 110.35 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.85 -26.22 34.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.542 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.0 pt -71.63 -26.66 26.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 1.0 110.689 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -106.95 7.9 30.21 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.575 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -46.8 136.14 7.9 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.313 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -49.05 -31.55 21.16 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.648 1.565 . . . . 1.0 112.526 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.612 ' CE2' ' CZ ' ' A' ' 30' ' ' PHE . 52.0 m-85 -88.38 3.74 48.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.728 0.299 . . . . 1.0 111.244 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.528 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 34.3 t80 -75.12 127.74 33.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.178 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 52.1 m-85 -147.49 108.92 3.86 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.606 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.495 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 31.3 Cg_exo -59.67 111.74 1.05 Allowed 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 121.71 1.607 . . . . 1.0 112.624 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.529 ' O ' ' NH1' ' A' ' 33' ' ' ARG . 56.2 m-85 -160.34 159.39 31.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.29 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.409 ' CG ' ' N ' ' A' ' 15' ' ' GLY . 11.1 t-20 -81.19 164.72 22.11 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.409 ' N ' ' CG ' ' A' ' 14' ' ' ASN . . . -58.26 -48.53 82.92 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.606 -0.998 . . . . 1.0 110.606 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.7 mmp_? -67.32 -39.56 85.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.723 0.297 . . . . 1.0 111.029 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.16 -37.07 84.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.326 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.471 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.59 -44.01 97.8 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.669 -0.412 . . . . 1.0 110.414 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.514 ' OE2' ' CD1' ' A' ' 53' ' ' PHE . 42.6 tt0 -61.34 -45.73 93.22 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.045 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.1 -38.71 89.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.322 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.607 ' CE2' ' NZ ' ' A' ' 25' ' ' LYS . 57.3 t80 -67.2 -36.87 82.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.078 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 18' ' ' ALA . 7.8 mp -81.65 -11.88 58.92 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.115 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -63.51 -33.57 75.86 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.248 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -81.18 -20.14 41.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.004 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.607 ' NZ ' ' CE2' ' A' ' 21' ' ' TYR . 48.7 mttp -81.89 176.4 9.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.998 0.428 . . . . 1.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -88.72 165.74 14.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.809 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.538 ' NH2' ' OD1' ' A' ' 99' ' ' ASN . 64.6 ttp85 -65.65 146.18 55.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.949 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.29 22.75 31.19 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.317 -0.713 . . . . 1.0 111.317 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -101.41 142.14 33.24 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.612 ' CZ ' ' CE2' ' A' ' 9' ' ' TYR . 17.3 p90 -133.24 167.19 20.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.489 0.661 . . . . 1.0 110.699 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 45' ' ' THR . 11.0 m -149.68 163.1 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.715 -1.13 . . . . 1.0 111.827 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.518 HD13 ' CG1' ' A' ' 44' ' ' ILE . 3.7 mm -115.65 126.71 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 13' ' ' PHE . 26.8 ttt85 -136.76 162.58 32.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.689 -0.687 . . . . 1.0 110.188 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.523 ' H ' ' CD ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -117.11 128.58 55.27 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.6 t -52.72 -6.21 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.521 ' H ' ' C ' ' A' ' 34' ' ' GLN . 1.5 t 72.07 -49.12 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.442 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -93.39 -6.09 47.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.653 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -70.96 -53.84 10.34 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.632 -0.987 . . . . 1.0 110.632 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 t70 71.44 -36.89 0.38 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.627 0.251 . . . . 1.0 111.084 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 38' ' ' GLY . 98.4 m-20 -120.08 -7.34 9.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.744 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -120.42 146.89 45.76 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.056 0.455 . . . . 1.0 110.944 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.88 151.79 41.39 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.129 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.8 t -125.82 134.36 66.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.299 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.685 HD12 HD11 ' A' ' 58' ' ' ILE . 16.0 mt -110.71 137.16 44.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.571 ' O ' HG22 ' A' ' 31' ' ' VAL . 75.4 m -117.66 134.17 55.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.661 -0.699 . . . . 1.0 109.349 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.742 ' HE1' HE21 ' A' ' 54' ' ' GLN . 2.1 p-90 -151.89 154.21 35.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.349 -0.841 . . . . 1.0 110.768 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -97.87 143.46 28.45 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.293 0.568 . . . . 1.0 111.793 -179.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.2 mt -97.18 -57.76 2.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.226 -0.897 . . . . 1.0 110.35 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -119.38 -166.85 1.32 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.37 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -65.1 -39.29 92.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.793 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -128.13 53.39 1.8 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.281 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.9 tp -153.87 129.36 9.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.263 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CD1' ' OE2' ' A' ' 19' ' ' GLU . 47.8 m-85 -134.99 150.25 50.31 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.983 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.742 HE21 ' HE1' ' A' ' 46' ' ' TRP . 14.9 pt20 -141.07 157.73 44.9 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.164 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -121.77 139.95 52.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.454 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.8 mt -119.41 123.42 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.806 -0.442 . . . . 1.0 109.806 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -96.29 122.1 38.8 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.889 0.376 . . . . 1.0 110.567 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.685 HD11 HD12 ' A' ' 44' ' ' ILE . 86.2 mt -102.64 129.98 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.212 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.574 HE22 ' CD1' ' A' ' 61' ' ' LEU . 1.1 tm0? -119.1 134.62 55.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.131 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 60' ' ' GLU . 0.3 OUTLIER -100.67 157.62 16.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.583 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.574 ' CD1' HE22 ' A' ' 59' ' ' GLN . 1.4 mt -146.18 178.42 8.24 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.106 0.479 . . . . 1.0 110.345 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 58.59 39.59 24.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.385 -0.825 . . . . 1.0 110.5 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.417 ' H ' ' HG2' ' A' ' 63' ' ' LYS . 58.2 pttt -81.19 125.88 30.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.382 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -68.84 -30.78 69.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.106 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -162.39 156.95 18.83 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.556 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.64 -33.04 57.19 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.608 1.539 . . . . 1.0 112.295 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.51 -10.35 58.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.507 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.66 135.47 44.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.342 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.8 mt -78.15 148.35 34.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.51 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.68 132.82 14.65 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -77.74 -15.51 59.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.046 0.451 . . . . 1.0 110.806 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.0 t -111.09 119.64 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.682 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.6 mt -115.59 131.91 56.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.539 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.4 mt -102.53 122.33 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.838 0.351 . . . . 1.0 110.443 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.469 HG21 HD13 ' A' ' 86' ' ' ILE . 46.1 t -142.36 133.82 25.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.29 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 56.32 41.24 29.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.681 0.277 . . . . 1.0 111.124 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.36 13.72 5.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.91 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -120.66 151.85 38.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.983 0.421 . . . . 1.0 109.944 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -101.1 126.07 47.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.982 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.538 ' CE1' ' OE2' ' A' ' 89' ' ' GLU . 95.9 m-85 -120.75 139.13 53.53 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.186 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -85.71 -30.42 23.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.584 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 51.4 t0 -123.86 141.65 51.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.01 0.433 . . . . 1.0 111.842 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.4 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 56.6 tp -65.46 -39.9 92.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.584 -0.735 . . . . 1.0 111.147 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.48 -40.19 90.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.727 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -59.7 -39.64 85.23 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.799 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.469 HD13 HG21 ' A' ' 75' ' ' VAL . 96.9 mt -62.44 -46.12 97.17 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 CA-C-O 120.898 0.38 . . . . 1.0 110.955 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 64.8 mt -62.73 -46.07 97.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.976 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.4 t -69.87 -43.58 79.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.81 0.671 . . . . 1.0 112.81 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.538 ' OE2' ' CE1' ' A' ' 80' ' ' TYR . 9.1 pt-20 -80.68 -12.07 59.54 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.523 -0.471 . . . . 1.0 111.666 -177.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.589 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 64.4 t80 -94.19 -49.11 5.89 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.636 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.497 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -70.37 -42.1 72.21 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.348 -0.541 . . . . 1.0 112.118 -177.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -63.9 -49.08 74.08 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.041 -0.664 . . . . 1.0 111.565 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -69.12 -42.77 75.61 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.618 -0.433 . . . . 1.0 111.522 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.589 ' NZ ' ' CE1' ' A' ' 90' ' ' TYR . 15.9 mmtp -65.81 -42.32 90.78 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.39 -0.524 . . . . 1.0 111.228 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 91' ' ' LEU . 53.4 t -65.41 -46.5 89.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.527 -0.469 . . . . 1.0 111.183 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -68.09 -44.02 77.21 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.615 -0.434 . . . . 1.0 111.6 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.2 tp -67.71 -41.64 83.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.267 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.7 tp -65.35 -42.92 92.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.193 -0.603 . . . . 1.0 110.217 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.538 ' OD1' ' NH2' ' A' ' 27' ' ' ARG . 99.2 m-20 -68.04 -36.95 80.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.244 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -71.82 -42.89 66.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 111.892 0.33 . . . . 1.0 111.892 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.5 tpt -66.03 -53.8 33.98 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.213 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.432 HG23 ' CE2' ' A' ' 107' ' ' PHE . 53.8 m -60.14 -36.12 76.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.593 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.9 t -71.07 9.49 0.71 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.879 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 102' ' ' THR . 32.0 t -91.52 134.32 34.75 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 110.001 -0.37 . . . . 1.0 110.001 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -58.59 -19.21 36.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.983 0.42 . . . . 1.0 110.823 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.557 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 60.4 mttp -90.14 39.91 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.785 -0.643 . . . . 1.0 109.798 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.432 ' CE2' HG23 ' A' ' 102' ' ' THR . 87.9 t80 -132.85 120.42 21.51 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.535 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.59 124.02 15.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.142 -0.481 . . . . 1.0 109.906 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.3 m -100.17 86.66 3.27 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.734 0.302 . . . . 1.0 110.968 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.16 163.63 12.12 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.924 -0.87 . . . . 1.0 110.924 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' HZ3' ' A' ' 113' ' ' LYS . 61.6 p -77.65 169.52 18.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -58.6 -38.59 78.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.912 0.387 . . . . 1.0 110.561 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.578 ' HZ3' ' CB ' ' A' ' 111' ' ' THR . 25.0 pttm -69.27 -39.53 78.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.654 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -70.08 -24.46 63.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.874 -0.603 . . . . 1.0 111.154 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 111' ' ' THR . 48.8 t -70.65 -45.5 73.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.509 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 82.6 t -63.67 -46.66 94.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.106 0.479 . . . . 1.0 110.445 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -66.04 -37.42 85.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.085 0.469 . . . . 1.0 110.896 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -67.11 -49.24 65.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.751 -0.659 . . . . 1.0 111.763 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.415 HG23 ' N ' ' A' ' 120' ' ' GLU . 11.1 tp -69.84 -40.0 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.55 -0.46 . . . . 1.0 110.47 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 119' ' ' ILE . 96.3 mt-10 -65.44 -41.64 93.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.806 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -63.82 -48.17 77.91 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.448 -0.501 . . . . 1.0 110.297 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -60.45 -44.57 95.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.007 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 81.2 p -66.25 -28.6 68.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.038 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -63.96 -43.87 94.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.337 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.7 t -66.82 -41.76 88.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.298 -0.41 . . . . 1.0 109.938 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -122.02 75.43 39.38 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.561 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -71.3 -13.51 30.81 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.662 2.241 . . . . 1.0 112.34 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -106.2 24.87 11.76 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.642 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -141.13 151.72 44.14 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.86 0.362 . . . . 1.0 110.743 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 86.5 p -80.78 160.81 24.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.119 -0.491 . . . . 1.0 109.841 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.6 p -153.97 144.86 14.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.597 -0.52 . . . . 1.0 109.597 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 19.0 p90 -153.33 143.61 22.36 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.691 -0.404 . . . . 1.0 111.104 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -152.57 169.71 21.97 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.355 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.6 p90 -136.77 156.12 48.93 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 28.8 t -148.55 169.5 20.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.322 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.4 tp -74.59 146.46 42.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.483 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 138' ' ' HIS . 28.1 t-20 -42.74 147.96 0.27 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.539 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.43 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 92.5 m-70 -60.05 -50.24 74.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.018 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 139' ' ' ASP . 25.7 p-10 -156.7 44.09 0.39 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.536 -0.302 . . . . 1.0 110.629 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.412 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 73.3 m-20 -160.26 84.32 2.07 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.31 144.86 92.28 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.699 1.599 . . . . 1.0 112.671 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.401 ' C ' ' CD1' ' A' ' 143' ' ' TRP . . . 142.93 -39.25 1.35 Allowed Glycine 0 C--O 1.226 -0.382 0 N-CA-C 110.887 -0.885 . . . . 1.0 110.887 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.534 ' CD1' ' N ' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -134.95 153.89 51.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.812 0.339 . . . . 1.0 110.188 -179.353 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -102.36 156.97 17.24 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -113.37 134.9 54.39 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.093 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.466 HD12 ' CG2' ' A' ' 161' ' ' VAL . 12.3 mt -110.55 126.17 54.12 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.436 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.62 142.98 51.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.644 -1.243 . . . . 1.0 107.644 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -159.43 160.25 34.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.781 -0.451 . . . . 1.0 109.781 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -138.57 128.63 25.48 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.858 0.361 . . . . 1.0 110.686 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.442 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.8 mp -72.43 -44.98 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.787 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.411 ' H ' ' HB3' ' A' ' 154' ' ' SER . 77.9 m-20 -160.83 174.0 14.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.729 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.38 -32.81 73.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.784 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -83.68 -13.15 54.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.143 0.496 . . . . 1.0 110.376 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.411 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 8.8 t -80.09 157.15 26.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.473 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -90.28 157.37 17.7 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.989 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 30.8 tp -76.57 121.66 23.49 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.087 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -108.32 136.39 48.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.743 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 99.8 m -128.98 132.33 47.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.905 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -123.37 161.89 23.82 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.803 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -109.72 151.79 26.47 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.796 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.466 ' CG2' HD12 ' A' ' 146' ' ' LEU . 67.8 t -127.78 134.18 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -97.54 132.35 43.3 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.027 0.442 . . . . 1.0 111.061 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.4 tp -92.23 130.28 37.97 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.727 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.454 ' C ' ' H ' ' A' ' 166' ' ' THR . 65.7 p -129.58 157.35 42.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.339 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -73.45 15.21 0.26 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.645 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 164' ' ' THR . 19.3 p -121.46 -2.43 9.48 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.775 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.51 -135.49 7.06 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.477 -1.049 . . . . 1.0 110.477 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -118.9 131.68 56.06 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.551 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 5.9 m-85 -109.33 118.7 37.38 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.8 tt -109.29 121.3 44.87 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.465 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 5.0 t 34.93 59.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.467 0.543 . . . . 1.0 112.467 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 63.26 27.54 15.51 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.981 0.734 . . . . 1.0 112.981 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.465 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 79.3 m-85 -132.75 121.88 23.71 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.303 -0.628 . . . . 1.0 109.303 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.551 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 8.3 t-20 -91.15 133.4 35.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.391 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -115.65 131.88 23.44 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.903 -0.589 . . . . 1.0 109.462 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.66 -21.33 19.26 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.171 1.914 . . . . 1.0 113.443 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 73.4 m -147.99 150.99 35.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.928 0.394 . . . . 1.0 111.25 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.94 -36.3 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.833 -0.622 . . . . 1.0 110.857 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.431 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 46.6 mm -60.95 -45.98 97.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 1.0 110.066 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -65.82 -32.3 73.76 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.1 tp -63.95 -42.31 97.35 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.465 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . 0.611 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 5.1 p -60.99 -47.88 84.39 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.632 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.611 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 36.3 t30 -66.71 -48.51 69.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.744 -0.783 . . . . 1.0 108.983 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.57 -45.01 0.95 Allowed Glycine 0 N--CA 1.462 0.374 0 N-CA-C 109.907 -1.277 . . . . 1.0 109.907 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -68.89 -47.48 65.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 183' ' ' ASN . 36.4 ttpt -56.66 -39.53 73.91 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.544 -0.753 . . . . 1.0 109.982 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 19.9 m -60.58 -45.94 92.09 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.416 ' O ' ' OG ' ' A' ' 191' ' ' SER . 75.8 mt -63.73 -39.42 94.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.865 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.6 tp -58.88 -43.31 90.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.903 0.383 . . . . 1.0 110.458 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -59.09 -45.71 90.17 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.527 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 188' ' ' LEU . 77.6 p -61.79 -36.89 82.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.167 0.508 . . . . 1.0 110.619 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.8 mt -69.47 -39.44 77.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.381 -0.827 . . . . 1.0 111.954 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -62.46 -29.17 70.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.892 0.33 . . . . 1.0 111.892 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 . . . . . 0 C--N 1.325 -0.492 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.907 -179.592 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 . . . . . 0 N--CA 1.464 0.258 0 CA-C-O 120.928 0.394 . . . . 1.0 110.817 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.1 p -64.46 -30.48 50.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.532 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.1 pt -71.01 -15.23 18.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.515 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -94.21 -0.1 55.38 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.44 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.73 140.67 59.08 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.217 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.13 -21.39 62.74 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.111 1.874 . . . . 1.0 112.116 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.451 ' CE1' ' CZ ' ' A' ' 30' ' ' PHE . 24.5 m-85 -92.24 10.16 30.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.202 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 79.0 t80 -84.47 128.07 34.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.423 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 64.2 m-85 -150.89 114.78 3.18 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 110.154 -0.313 . . . . 1.0 110.154 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.91 110.09 3.01 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.743 1.629 . . . . 1.0 112.919 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -155.53 153.77 30.73 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.539 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.463 ' ND2' ' H ' ' A' ' 15' ' ' GLY . 11.2 t-20 -77.68 164.45 25.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.463 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -57.84 -42.73 94.77 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.207 -0.997 . . . . 1.0 110.948 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -66.31 -42.96 87.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.745 0.307 . . . . 1.0 110.963 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -67.86 -33.82 75.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.277 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.43 -43.01 97.23 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.257 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -58.61 -42.29 87.85 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.582 -0.447 . . . . 1.0 109.992 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -62.21 -46.52 88.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.503 . . . . 1.0 110.287 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -60.18 -40.95 91.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.446 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.34 -13.59 60.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.952 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -58.49 -43.85 89.17 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.403 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.4 t -76.43 -19.44 58.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.718 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -83.28 177.05 8.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.527 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.6 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 52.2 mp0 -105.3 -176.93 3.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.738 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -74.92 144.69 43.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.828 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.51 -0.34 61.4 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.219 -0.753 . . . . 1.0 111.219 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -83.88 144.3 29.31 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.659 ' CD1' HD21 ' A' ' 91' ' ' LEU . 16.8 p90 -136.73 165.58 25.58 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.177 0.513 . . . . 1.0 110.971 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 32' ' ' ILE . 60.3 t -146.98 156.58 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.087 -0.961 . . . . 1.0 111.67 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.463 ' N ' HG12 ' A' ' 31' ' ' VAL . 91.6 mt -117.3 124.19 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -152.02 153.17 33.48 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.336 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -108.41 152.19 25.01 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.917 -0.401 . . . . 1.0 109.917 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 t -82.36 145.19 30.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.843 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 m -59.02 -39.07 80.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.664 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -95.41 6.95 47.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.792 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -86.97 -79.75 1.22 Allowed Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.572 -1.011 . . . . 1.0 110.572 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 t70 68.8 -38.89 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 1.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 38' ' ' GLY . 36.5 t70 -104.11 2.44 31.99 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.828 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -143.82 153.62 42.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.946 0.403 . . . . 1.0 110.283 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.12 148.8 42.66 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.952 -0.567 . . . . 1.0 109.752 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.21 132.46 71.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.221 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.694 HD12 HD11 ' A' ' 58' ' ' ILE . 56.8 mt -111.7 138.36 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 108.949 -0.76 . . . . 1.0 108.949 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 87.9 m -120.73 138.7 53.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.575 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.767 ' HE1' ' NE2' ' A' ' 54' ' ' GLN . 2.9 p-90 -153.91 148.11 25.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.884 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.476 ' HZ3' ' C ' ' A' ' 49' ' ' ASP . 64.1 tttm -88.93 141.19 28.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.128 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.425 HD21 ' CZ2' ' A' ' 46' ' ' TRP . 26.2 mt -98.76 -68.06 0.82 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.072 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.476 ' C ' ' HZ3' ' A' ' 47' ' ' LYS . 38.2 t0 -136.11 171.22 14.79 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.186 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -46.64 130.58 11.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.986 0.422 . . . . 1.0 110.897 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 56.37 39.82 29.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.06 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.8 tp -149.01 122.38 9.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.784 0.326 . . . . 1.0 110.443 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -135.56 149.92 49.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.568 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.767 ' NE2' ' HE1' ' A' ' 46' ' ' TRP . 6.7 pt20 -139.43 156.49 46.93 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.958 -0.564 . . . . 1.0 109.823 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -125.41 142.28 51.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.301 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 83.1 mt -120.48 122.84 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -93.98 120.83 34.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.877 0.37 . . . . 1.0 110.496 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.694 HD11 HD12 ' A' ' 44' ' ' ILE . 92.6 mt -100.84 128.96 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.422 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -112.29 141.78 45.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.171 -0.468 . . . . 1.0 109.781 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -98.73 152.79 19.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 1.0 109.988 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 2.9 tp -141.56 165.49 27.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.696 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.493 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 72.6 tt0 66.04 48.61 1.72 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.41 0.624 . . . . 1.0 109.719 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.4 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 32.5 pttt -102.44 107.81 18.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.988 -0.551 . . . . 1.0 109.945 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -67.26 -25.19 65.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.857 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -159.23 158.22 28.2 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.214 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.96 -34.39 56.22 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.213 1.942 . . . . 1.0 112.074 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.494 ' CD2' ' H ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -85.49 -10.24 56.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.688 -179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.67 145.12 55.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.299 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.7 mt -77.81 151.84 33.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.371 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.22 91.25 1.13 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.673 -0.971 . . . . 1.0 110.673 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -63.78 -32.36 73.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.037 0.446 . . . . 1.0 110.596 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.7 t -125.26 124.18 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.787 -0.642 . . . . 1.0 111.051 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.13 131.07 57.04 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.0 mt -100.22 120.93 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.899 0.381 . . . . 1.0 110.179 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -141.59 132.54 26.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.235 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 56.15 43.11 27.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.717 0.294 . . . . 1.0 111.025 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.4 t30 59.27 15.9 4.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.779 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -121.68 146.52 46.93 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.228 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -99.57 126.26 45.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.644 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -125.06 137.33 54.21 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.028 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -85.75 -38.49 18.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.831 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -105.3 135.33 46.87 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.127 0.489 . . . . 1.0 111.935 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 58.2 tp -63.81 -41.93 97.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.571 -0.74 . . . . 1.0 110.672 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -60.27 -42.44 95.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 1.0 111.92 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -60.98 -37.24 81.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.762 0.315 . . . . 1.0 110.644 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.01 -44.92 99.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.564 -0.454 . . . . 1.0 110.551 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.4 mm -62.92 -44.78 99.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.449 -0.5 . . . . 1.0 111.35 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.492 ' O ' ' CG ' ' A' ' 92' ' ' GLN . 79.7 t -67.49 -45.67 84.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 112.723 0.638 . . . . 1.0 112.723 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.06 -19.38 61.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.739 0.304 . . . . 1.0 111.76 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -93.59 -50.73 5.27 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.353 -0.539 . . . . 1.0 111.781 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.659 HD21 ' CD1' ' A' ' 30' ' ' PHE . 11.1 mp -66.6 -43.64 84.31 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.382 0.512 . . . . 1.0 112.382 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.492 ' CG ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -65.75 -41.9 91.58 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.098 -0.641 . . . . 1.0 111.455 -177.753 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -70.94 -44.12 66.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.304 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -65.9 -41.99 90.77 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.239 -0.585 . . . . 1.0 111.154 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.0 t -65.53 -44.51 94.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.363 -0.535 . . . . 1.0 111.114 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.529 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -66.56 -46.96 74.32 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.569 -0.453 . . . . 1.0 111.706 -178.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 tp -69.78 -41.13 75.54 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.717 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.1 tp -61.61 -44.63 96.63 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.344 -0.542 . . . . 1.0 110.565 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.529 ' ND2' ' HA ' ' A' ' 96' ' ' ARG . 1.1 p30 -70.0 -35.97 74.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.154 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.454 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 44.2 tt0 -71.37 -43.81 66.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.564 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 5.5 ttt -66.93 -55.08 16.15 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.575 -0.45 . . . . 1.0 111.63 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.42 HG23 ' CE2' ' A' ' 107' ' ' PHE . 52.6 m -57.82 -37.99 74.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.071 0.462 . . . . 1.0 110.639 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 41.4 t -72.33 10.36 0.81 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.636 -0.711 . . . . 1.0 110.999 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 101' ' ' MET . 78.1 p -92.91 135.46 34.13 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.565 -0.288 . . . . 1.0 110.454 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.59 -16.72 40.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.567 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 24.2 mmtp -93.82 38.46 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 1.0 109.808 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.42 ' CE2' HG23 ' A' ' 102' ' ' THR . 86.8 t80 -132.04 111.83 11.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.284 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -131.06 114.0 14.63 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.7 p -89.67 88.97 7.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.001 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.79 156.32 15.71 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.538 ' O ' HG23 ' A' ' 115' ' ' VAL . 67.8 p -75.05 169.58 17.73 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -57.28 -38.32 73.75 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.841 -0.343 . . . . 1.0 110.415 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -68.49 -42.94 77.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.356 0.598 . . . . 1.0 110.933 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 51.6 t0 -68.09 -21.78 64.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.411 -0.813 . . . . 1.0 110.89 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 111' ' ' THR . 44.4 t -71.63 -43.33 71.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.767 0.317 . . . . 1.0 110.198 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.83 -47.13 92.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.09 0.471 . . . . 1.0 110.409 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -65.66 -38.24 88.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.076 0.465 . . . . 1.0 110.851 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -65.02 -49.81 68.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.821 -0.627 . . . . 1.0 111.76 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.401 HD11 HG13 ' A' ' 131' ' ' VAL . 10.6 tp -70.26 -39.49 76.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.866 0.365 . . . . 1.0 110.571 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.513 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 63.7 mm-40 -62.67 -42.75 99.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.553 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -61.14 -47.68 85.12 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.574 -0.45 . . . . 1.0 110.279 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -61.12 -39.7 91.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.77 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.5 p -60.16 -38.59 83.63 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.404 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -62.46 -40.32 96.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.258 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.03 -42.69 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.657 -0.498 . . . . 1.0 109.657 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.74 75.67 79.4 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.2 178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.31 -23.43 44.73 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.75 2.3 . . . . 1.0 112.53 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -95.89 -9.75 30.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.146 -0.479 . . . . 1.0 112.028 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -107.29 149.83 27.35 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.977 0.418 . . . . 1.0 110.379 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.9 p -80.83 162.81 23.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.757 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.401 HG13 HD11 ' A' ' 119' ' ' ILE . 3.9 p -152.37 147.55 14.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.489 ' O ' ' CD1' ' A' ' 133' ' ' TYR . 28.7 p90 -149.39 142.61 25.08 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.789 0.328 . . . . 1.0 111.118 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 29.7 m-85 -151.75 169.2 22.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.306 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.567 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -133.83 152.62 51.93 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 179.19 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 72.3 m -152.11 170.16 20.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.419 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.0 tp -80.94 145.2 31.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.839 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 4.3 p30 -53.85 -171.89 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.179 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.463 ' CG ' ' O ' ' A' ' 138' ' ' HIS . 35.4 t-80 -135.31 35.2 3.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.531 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -169.63 -53.89 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.67 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.52 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 21.3 t-20 -105.16 86.69 1.67 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.099 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.473 ' HA ' HD21 ' A' ' 137' ' ' ASN . 29.9 Cg_endo -64.61 100.76 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.077 1.851 . . . . 1.0 112.316 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.506 ' H ' HD21 ' A' ' 137' ' ' ASN . . . 169.55 -36.3 0.19 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.517 -1.033 . . . . 1.0 110.517 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.407 ' CD1' ' N ' ' A' ' 143' ' ' TRP . 21.5 m95 -98.7 144.7 27.67 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 110.04 -0.356 . . . . 1.0 110.04 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 61.7 m-85 -107.42 149.6 27.71 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.173 -0.467 . . . . 1.0 109.778 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.405 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 32.3 m-85 -120.41 137.68 54.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.394 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.426 HD12 ' CG2' ' A' ' 161' ' ' VAL . 11.8 mt -110.04 121.01 44.26 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.318 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.553 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -116.41 145.89 42.91 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 178.402 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -159.69 155.26 25.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.513 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 64.5 tttt -141.36 129.61 22.27 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.752 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.5 mm -71.15 -46.48 66.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.875 -0.33 . . . . 1.0 111.725 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 151' ' ' ASN . 7.6 p-10 -162.24 177.88 9.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.35 . . . . 1.0 110.589 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.29 -32.89 74.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.067 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -84.45 7.59 19.22 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.018 0.437 . . . . 1.0 110.713 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.462 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 1.5 t -104.99 158.4 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.08 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -88.88 162.46 16.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.91 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.6 tp -80.38 118.94 22.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.982 0.42 . . . . 1.0 110.281 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -105.27 132.86 50.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.738 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 87.0 m -130.6 130.46 44.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.847 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -116.35 161.09 19.58 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.075 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.405 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 78.0 m-20 -107.2 144.68 33.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.739 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.426 ' CG2' HD12 ' A' ' 146' ' ' LEU . 58.8 t -126.57 136.7 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -99.62 130.41 45.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.912 0.387 . . . . 1.0 110.759 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.8 tp -92.36 130.8 37.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.032 -0.531 . . . . 1.0 109.66 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.3 p -129.73 165.76 21.24 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.0 0.429 . . . . 1.0 110.35 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -79.23 15.72 1.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.628 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 20.0 p -122.27 -2.31 9.08 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.802 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.56 -131.87 5.19 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.419 -1.072 . . . . 1.0 110.419 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.85 130.55 53.02 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.077 -0.342 . . . . 1.0 110.077 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.629 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 5.7 m-85 -107.52 121.71 45.19 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.821 -0.437 . . . . 1.0 109.821 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.8 tt -114.38 119.1 35.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.711 -0.477 . . . . 1.0 109.711 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.5 t 36.16 57.92 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 112.166 0.432 . . . . 1.0 112.166 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 14.5 m120 65.27 27.17 12.16 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.045 0.757 . . . . 1.0 113.045 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -133.95 119.95 19.72 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 8.1 t-20 -93.67 129.03 40.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 1.0 111.226 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -107.77 101.39 40.13 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -45.91 -23.49 1.72 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.489 2.126 . . . . 1.0 113.33 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.96 146.66 37.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 1.0 111.009 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.47 -33.42 56.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.92 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 179' ' ' ILE . 33.9 mm -60.87 -44.2 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.278 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -69.7 -30.34 67.96 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.5 -0.555 . . . . 1.0 109.5 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.29 -43.08 98.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.281 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 93.5 m -63.7 -46.49 85.24 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.336 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 186' ' ' LYS . 75.9 m-20 -65.19 -48.82 72.07 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.09 -45.68 0.89 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -68.92 -45.91 69.64 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 183' ' ' ASN . 36.6 tptt -57.14 -40.88 78.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.455 -0.793 . . . . 1.0 109.902 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 16.5 m -59.71 -46.7 88.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.1 -40.32 95.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.826 -0.624 . . . . 1.0 109.881 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 59.3 tp -57.87 -45.7 85.94 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.647 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -54.83 -45.65 74.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.167 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.7 t -62.25 -40.75 97.22 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.161 0.505 . . . . 1.0 110.34 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.41 -37.02 86.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.761 -0.654 . . . . 1.0 111.974 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -58.33 -30.14 66.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.622 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 24.8 m80 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.92 -179.296 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.507 ' OG1' ' N ' ' A' ' 2' ' ' HIS . 2.7 t . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.507 ' N ' ' OG1' ' A' ' 1' ' ' THR . 51.6 t-80 58.87 5.27 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.538 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.431 ' H ' ' C ' ' A' ' 1' ' ' THR . 80.9 mtp85 -135.82 1.8 2.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.558 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.46 -27.47 41.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.565 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 13.3 pt -67.78 -40.77 84.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.435 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -107.2 14.01 26.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.432 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -46.97 145.97 2.99 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.422 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -49.98 -36.22 43.51 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.671 1.581 . . . . 1.0 112.226 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.61 ' CD2' ' CZ ' ' A' ' 30' ' ' PHE . 80.2 m-85 -82.7 -1.56 51.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.385 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.531 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 42.2 t80 -72.32 129.61 38.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.34 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 54.0 m-85 -148.69 115.92 3.85 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 120.9 -0.32 . . . . 1.0 110.43 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.477 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 73.1 Cg_endo -74.76 109.88 3.0 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.754 1.636 . . . . 1.0 112.703 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 76.5 m-85 -155.33 159.4 39.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.525 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -77.16 172.16 13.68 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.449 ' C ' ' HE ' ' A' ' 16' ' ' ARG . . . -61.67 -46.84 93.42 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.446 -0.883 . . . . 1.0 111.108 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.639 ' HE ' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -66.06 -41.52 90.69 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 121.038 -0.265 . . . . 1.0 111.164 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -66.09 -35.66 81.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.279 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.84 -44.98 96.25 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.308 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -65.78 -41.97 91.37 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.034 179.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.46 -41.64 97.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.212 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -63.07 -39.47 94.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.54 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.2 mp -79.57 -13.26 59.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.723 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -63.57 -42.95 98.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.731 -0.388 . . . . 1.0 110.47 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.0 t -76.65 -20.33 56.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.79 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -84.17 177.55 8.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.456 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -89.2 176.33 7.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.863 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.448 ' NE ' ' OD1' ' A' ' 49' ' ' ASP . 84.9 mtt85 -76.32 147.57 38.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.974 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.46 19.67 37.49 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -99.73 140.79 33.42 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.61 ' CZ ' ' CD2' ' A' ' 9' ' ' TYR . 7.1 p90 -134.68 168.56 18.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.338 0.589 . . . . 1.0 111.11 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -147.32 158.25 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.251 -0.886 . . . . 1.0 111.498 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -116.87 129.17 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -138.74 157.85 45.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.418 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -115.63 135.51 53.99 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.859 -0.423 . . . . 1.0 109.859 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.1 t -95.27 126.74 40.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.764 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 96.5 p -59.59 -37.68 79.18 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.598 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.3 -24.37 62.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.874 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -75.37 -63.24 2.54 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.689 -0.964 . . . . 1.0 110.689 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 t0 73.66 -40.19 0.46 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.694 0.283 . . . . 1.0 110.803 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 38' ' ' GLY . 92.3 m-20 -118.91 11.08 12.45 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.748 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.436 ' CE1' HE21 ' A' ' 59' ' ' GLN . 10.8 m-70 -138.7 150.73 46.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.929 0.395 . . . . 1.0 110.205 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.04 154.19 33.51 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.064 -0.516 . . . . 1.0 109.727 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.7 t -124.39 130.01 73.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 1.0 110.079 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.7 mt -112.97 139.21 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.7 m -118.68 140.04 50.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.928 -0.578 . . . . 1.0 109.455 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -144.01 159.58 42.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.515 -0.766 . . . . 1.0 111.001 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.582 ' NZ ' ' O ' ' A' ' 50' ' ' LYS . 36.2 tttp -107.28 138.54 43.28 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.89 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.857 ' N ' HD12 ' A' ' 48' ' ' LEU . 3.2 mp -95.85 -74.23 0.56 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.371 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 50' ' ' LYS . 66.9 t0 -159.66 140.08 12.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.336 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.582 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 2.9 ttmm 43.81 -152.92 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.083 0.468 . . . . 1.0 111.183 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.74 63.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.836 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 50' ' ' LYS . 17.2 tp -145.68 120.75 10.09 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.977 0.418 . . . . 1.0 110.278 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -134.18 149.16 51.0 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.36 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -137.97 153.49 49.44 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.76 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.479 ' ND1' ' N ' ' A' ' 55' ' ' HIS . 1.9 p-80 -126.61 142.37 51.56 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.153 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.5 mt -126.06 131.7 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -94.27 120.53 34.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.028 0.442 . . . . 1.0 110.726 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.1 mm -90.47 128.0 42.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.083 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 60' ' ' GLU . 3.4 tm0? -113.71 128.9 56.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.042 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.52 ' O ' ' NE2' ' A' ' 59' ' ' GLN . 1.9 pp20? -101.17 148.6 24.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.276 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 1.9 tt -142.66 173.1 11.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.475 -0.329 . . . . 1.0 110.919 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 2.0 tm-20 82.07 25.2 0.19 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.383 0.611 . . . . 1.0 110.05 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.721 ' H ' ' CD ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -80.49 117.1 20.92 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.794 0.807 . . . . 1.0 110.122 178.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -89.66 -33.43 16.64 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.834 -0.541 . . . . 1.0 110.539 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.524 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -154.05 165.4 18.0 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.073 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.5 -29.7 60.93 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.162 1.908 . . . . 1.0 112.242 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.9 mt -90.02 -1.35 57.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.535 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.524 ' HB3' ' H ' ' A' ' 65' ' ' ASN . . . -92.25 134.45 34.87 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.278 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.4 mt -89.86 147.09 23.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.375 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.2 104.86 1.5 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -75.64 -13.43 60.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.772 0.32 . . . . 1.0 110.781 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.8 t -123.54 124.41 69.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.771 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.6 mt -117.07 133.32 56.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.52 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mp -102.41 124.61 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.825 0.345 . . . . 1.0 110.076 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -143.03 133.17 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.551 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.498 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 46.7 t0 53.44 46.49 26.13 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.985 -0.286 . . . . 1.0 111.046 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 76' ' ' ASP . 4.1 p30 56.75 18.68 3.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.977 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -125.12 147.26 49.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 1.0 110.135 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.86 127.92 44.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.224 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -120.46 139.91 52.16 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.18 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -84.51 -36.99 21.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.73 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -119.52 144.2 47.16 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.202 0.525 . . . . 1.0 111.989 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.7 tp -64.77 -39.38 93.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.764 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -60.19 -42.75 95.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 1.0 111.562 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -60.68 -37.87 83.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.58 0.229 . . . . 1.0 110.67 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.58 -47.41 92.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.901 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.75 -45.22 99.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.525 -0.47 . . . . 1.0 111.658 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.28 -43.29 74.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 112.626 0.602 . . . . 1.0 112.626 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -74.73 -15.81 60.76 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.721 -0.392 . . . . 1.0 111.862 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -94.8 -49.44 5.59 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.651 -0.419 . . . . 1.0 111.953 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.508 ' O ' HG23 ' A' ' 95' ' ' VAL . 9.8 mp -69.15 -40.35 78.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.228 0.455 . . . . 1.0 112.228 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -63.38 -49.2 74.74 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.797 -0.761 . . . . 1.0 111.556 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -72.67 -41.7 65.11 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.694 -0.403 . . . . 1.0 111.673 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -66.3 -41.48 89.69 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.334 -0.546 . . . . 1.0 111.389 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 91' ' ' LEU . 54.7 t -64.99 -46.7 90.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.251 -0.58 . . . . 1.0 111.355 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -66.34 -44.27 83.78 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.495 -0.482 . . . . 1.0 111.744 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.4 tp -66.94 -43.86 82.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.42 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 tt -64.64 -43.23 94.34 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.302 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -68.11 -35.76 78.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.859 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -70.69 -41.86 71.45 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 120.776 -0.37 . . . . 1.0 111.777 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.598 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 5.2 ttt -67.81 -54.56 18.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.538 -0.465 . . . . 1.0 111.462 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.8 m -58.45 -41.32 84.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.992 0.425 . . . . 1.0 110.301 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.9 m -72.37 8.09 1.51 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.863 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -85.6 140.18 30.81 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.823 0.344 . . . . 1.0 110.495 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.63 -22.15 66.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.674 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.55 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 24.8 mtmm -89.22 39.97 0.96 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.983 -0.553 . . . . 1.0 109.778 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -132.14 109.43 9.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.329 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -126.4 129.02 47.95 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.181 -0.463 . . . . 1.0 109.8 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.4 t -93.66 74.99 4.35 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.749 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.45 143.52 15.91 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.027 -0.829 . . . . 1.0 111.027 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.552 ' O ' HG23 ' A' ' 115' ' ' VAL . 81.1 p -75.12 172.04 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.051 -0.351 . . . . 1.0 110.051 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -57.51 -41.2 80.36 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.419 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -68.48 -45.01 73.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.88 0.372 . . . . 1.0 110.754 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.13 -20.51 64.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.865 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 111' ' ' THR . 13.4 t -70.71 -45.52 73.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.808 0.337 . . . . 1.0 110.428 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.5 t -64.45 -45.33 96.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.148 0.499 . . . . 1.0 110.235 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -66.07 -34.3 77.76 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.942 0.401 . . . . 1.0 111.019 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -69.5 -49.2 56.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.999 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.0 tp -69.67 -39.59 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.42 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -65.37 -43.19 91.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.72 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.82 -48.24 77.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.311 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.501 ' CD2' ' OD1' ' A' ' 126' ' ' ASN . 47.1 t80 -62.91 -43.26 99.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.93 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 88.1 p -61.02 -35.38 76.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.226 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -62.36 -42.61 99.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.06 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.9 t -66.67 -30.4 49.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 1.0 109.849 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.501 ' OD1' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -128.21 74.26 79.49 Favored Pre-proline 0 N--CA 1.471 0.59 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.531 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -71.88 -24.53 20.97 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.801 2.334 . . . . 1.0 112.609 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -102.3 14.59 31.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.018 -0.537 . . . . 1.0 112.002 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -137.54 144.93 42.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.117 0.484 . . . . 1.0 110.313 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.1 p -80.89 163.09 23.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.014 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 p -152.21 147.26 15.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -143.39 142.09 31.12 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.895 0.378 . . . . 1.0 111.196 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -152.43 168.46 25.41 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.432 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.55 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.7 OUTLIER -138.1 157.53 46.14 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 179.187 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.8 p -151.61 168.38 25.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.292 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 51.5 tp -80.65 136.86 36.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.821 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 23.8 t-20 -95.12 138.48 32.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.333 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -91.31 -31.66 16.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.714 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.41 -24.55 64.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.235 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 4.5 m120 -141.67 81.0 15.41 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.268 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -58.82 134.55 61.13 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.12 1.88 . . . . 1.0 112.445 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.89 -28.62 14.04 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 110.999 -0.84 . . . . 1.0 110.999 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 10.4 m0 -95.54 147.21 23.8 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.856 0.36 . . . . 1.0 110.284 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.598 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 70.9 m-85 -111.61 149.81 30.97 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.035 -0.53 . . . . 1.0 109.812 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.538 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 14.4 m-85 -120.08 136.13 54.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.22 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 16.5 mt -107.96 124.78 50.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.424 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.517 ' SD ' HG13 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -121.58 146.76 46.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.885 -1.154 . . . . 1.0 107.885 178.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -162.05 152.44 17.12 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.592 -0.522 . . . . 1.0 109.592 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.535 ' NZ ' ' O ' ' A' ' 154' ' ' SER . 37.5 tttp -136.41 129.5 31.29 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.472 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.696 HD12 ' H ' ' A' ' 150' ' ' ILE . 4.8 mp -72.49 -46.22 56.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.266 0.469 . . . . 1.0 112.266 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 150' ' ' ILE . 85.2 m-20 -156.95 170.15 23.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.573 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.08 71.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.947 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -89.01 6.68 38.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.433 . . . . 1.0 110.454 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.535 ' O ' ' NZ ' ' A' ' 149' ' ' LYS . 18.0 t -97.31 154.6 17.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.476 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -84.39 145.95 27.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.104 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.5 tp -70.63 126.28 29.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.958 0.409 . . . . 1.0 109.991 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -113.85 132.64 55.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.944 -0.571 . . . . 1.0 109.927 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 97.2 m -129.86 131.28 46.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.818 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.03 163.93 15.87 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.03 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.538 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 58.8 m-20 -111.9 148.85 32.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.695 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.65 137.58 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -100.17 132.36 45.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.98 0.419 . . . . 1.0 110.623 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.9 tp -92.62 131.26 37.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.662 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.0 p -130.38 171.18 13.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.482 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -84.63 15.66 3.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.759 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 2.1 m -122.66 -3.13 8.79 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.96 0.41 . . . . 1.0 110.685 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 141.01 -136.04 7.3 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -117.47 129.08 55.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.641 0.258 . . . . 1.0 110.35 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -106.38 119.84 40.33 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.0 tt -116.68 117.48 29.93 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.403 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.7 t 35.46 56.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.338 0.495 . . . . 1.0 112.338 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.5 m120 69.57 28.15 4.64 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.247 0.832 . . . . 1.0 113.247 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -134.31 121.01 20.63 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -90.83 127.66 36.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.226 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -115.16 91.59 28.17 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.32 -20.04 14.16 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.553 2.168 . . . . 1.0 113.291 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 72.1 m -133.1 138.49 46.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.044 0.45 . . . . 1.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.38 -34.4 60.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.777 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.16 -43.47 96.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.789 -0.448 . . . . 1.0 109.789 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -65.17 -34.62 78.83 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.8 tp -64.56 -41.36 96.36 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.389 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 77.8 m -61.29 -47.37 86.27 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 120.559 -0.456 . . . . 1.0 110.616 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 186' ' ' LYS . 62.8 t-20 -69.03 -48.4 63.02 Favored 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 119.647 -0.821 . . . . 1.0 108.915 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.51 -45.48 0.5 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.914 -1.274 . . . . 1.0 109.914 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -68.86 -47.76 65.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.061 -0.57 . . . . 1.0 109.64 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' A' ' 183' ' ' ASN . 47.0 tttp -56.77 -41.29 77.36 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.014 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 18.1 m -63.81 -44.56 92.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 15.4 mt -62.92 -43.28 99.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.006 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.7 tp -59.82 -43.36 94.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.34 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.39 -43.21 99.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.425 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 18.2 p -65.49 -37.66 87.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.066 0.46 . . . . 1.0 110.803 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 24.4 mt -64.0 -41.01 97.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.692 -0.686 . . . . 1.0 111.818 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.72 -25.33 68.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.464 -0.334 . . . . 1.0 111.817 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -94.73 -9.58 34.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.656 0.265 . . . . 1.0 110.987 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 46.35 25.84 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.445 -0.343 . . . . 1.0 111.082 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.412 ' O ' ' N ' ' A' ' 198' ' ' HIS . 0.3 OUTLIER -88.15 -6.99 57.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.617 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 51.24 -92.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.558 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.536 ' O ' ' CG ' ' A' ' 199' ' ' HIS . 99.8 m-70 -110.94 -43.51 3.76 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.751 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 198' ' ' HIS . 60.9 m-70 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 118.123 -0.941 . . . . 1.0 110.658 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -93.25 -7.15 45.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.516 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 83.6 mtm-85 -122.79 -5.47 8.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.896 0.379 . . . . 1.0 110.368 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.5 p -64.52 -30.98 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.55 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.6 pt -72.4 -20.96 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.658 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -96.34 7.35 46.68 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.428 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.63 141.23 64.58 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.321 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.76 -21.12 58.7 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.75 1.633 . . . . 1.0 112.181 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.88 3.22 49.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.214 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -83.68 132.4 34.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.569 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -152.41 118.14 3.03 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 120.931 -0.308 . . . . 1.0 110.247 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.49 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 72.5 Cg_endo -74.91 112.04 3.47 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.732 1.621 . . . . 1.0 112.659 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.49 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 70.2 m-85 -159.8 158.21 30.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.399 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -80.09 176.4 9.78 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.512 -0.551 . . . . 1.0 109.512 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.45 -50.33 67.74 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.373 -0.917 . . . . 1.0 110.988 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -66.01 -41.36 91.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.764 0.316 . . . . 1.0 110.956 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.412 ' OE1' ' N ' ' A' ' 17' ' ' GLN . 7.4 mp0 -62.8 -37.04 85.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.09 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.436 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -62.87 -44.52 95.9 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.508 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -60.82 -48.18 82.99 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.669 -0.412 . . . . 1.0 109.925 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -61.7 -40.22 94.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.201 -0.454 . . . . 1.0 109.899 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -61.96 -39.31 91.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.243 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 18' ' ' ALA . 7.9 mp -82.15 -13.83 56.59 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.846 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.6 ttp85 -65.11 -41.16 95.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.852 0.358 . . . . 1.0 110.336 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.3 m -78.17 -19.86 53.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.875 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -85.12 -179.84 7.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.823 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -81.78 165.49 20.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.813 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -75.75 145.77 40.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.778 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 17.92 49.46 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.982 -0.847 . . . . 1.0 110.982 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -85.16 147.56 26.55 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.425 ' CD2' ' HB3' ' A' ' 46' ' ' TRP . 27.6 m-85 -129.65 153.38 48.16 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.308 0.575 . . . . 1.0 111.098 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 44' ' ' ILE . 16.0 m -144.55 153.91 14.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.187 -0.915 . . . . 1.0 111.211 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.1 mm -115.49 131.19 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -133.74 151.69 51.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.997 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -109.93 130.66 55.5 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.17 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.8 t -82.72 162.82 21.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.579 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.9 p -111.7 -10.97 14.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.717 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -80.79 -30.18 35.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.165 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.656 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . -115.74 -12.14 9.68 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.01 -64.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.978 0.458 . . . . 1.0 110.405 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.656 ' N ' ' O ' ' A' ' 38' ' ' GLY . 24.8 t0 -78.45 12.47 1.96 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.441 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -117.19 142.4 47.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.83 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.25 148.33 44.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.344 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.9 t -123.49 130.2 74.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.781 -0.452 . . . . 1.0 109.781 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 31' ' ' VAL . 79.3 mt -110.62 136.88 45.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 94.0 m -118.39 140.98 49.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.536 -0.756 . . . . 1.0 109.344 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.56 ' CE2' HD11 ' A' ' 48' ' ' LEU . 5.3 p-90 -147.94 151.37 35.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.968 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.503 ' C ' HD12 ' A' ' 48' ' ' LEU . 18.6 ttmm -96.51 140.62 30.87 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.746 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.5 mp -99.57 -68.74 0.79 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.342 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -137.32 -153.19 0.47 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.226 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -68.64 136.46 53.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.667 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 42.08 43.54 2.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.848 -0.615 . . . . 1.0 111.111 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.432 HD11 ' HB3' ' A' ' 141' ' ' PRO . 11.5 tp -140.44 122.71 15.88 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.942 0.401 . . . . 1.0 109.952 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.432 ' O ' ' OE1' ' A' ' 54' ' ' GLN . 47.8 m-85 -133.22 150.1 51.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.583 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.432 ' OE1' ' O ' ' A' ' 53' ' ' PHE . 16.0 mm100 -138.57 150.22 46.09 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.667 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -125.05 138.9 54.19 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.213 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.7 mt -123.84 129.78 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 41.2 p-10 -95.5 121.03 36.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.934 0.397 . . . . 1.0 111.243 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.3 mm -98.42 122.48 50.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.032 -0.531 . . . . 1.0 109.99 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -117.4 132.28 56.6 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.813 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -98.96 153.64 18.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.342 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.498 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.8 tp -145.14 -179.07 6.39 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.567 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.498 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 20.5 tt0 70.66 42.89 0.79 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.991 -0.55 . . . . 1.0 109.705 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -83.75 102.22 12.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.78 -0.645 . . . . 1.0 109.844 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.435 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 80.6 mm-40 -68.45 -28.42 67.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.67 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 64' ' ' GLU . 2.6 m-80 -158.01 163.79 23.44 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.226 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.58 -32.04 52.1 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.12 1.88 . . . . 1.0 112.371 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.498 HD23 ' H ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -89.61 -5.28 57.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.826 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.73 134.28 51.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.327 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.7 mt -83.7 156.19 22.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.379 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.91 86.84 0.05 OUTLIER Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.455 -1.058 . . . . 1.0 110.455 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.27 -39.49 86.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.969 0.414 . . . . 1.0 111.067 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 51.0 t -117.13 123.92 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.768 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.3 mt -116.14 129.3 56.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.243 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.4 mt -101.29 125.67 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -140.91 130.24 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.313 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.426 ' OD1' ' OD1' ' A' ' 165' ' ' ASN . 15.5 t70 53.28 46.4 26.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.231 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.8 m120 57.63 16.03 3.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.895 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -120.63 136.29 54.87 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.948 0.404 . . . . 1.0 110.045 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -89.84 127.59 36.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.738 -0.665 . . . . 1.0 111.102 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -118.27 142.86 47.05 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.199 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -83.45 -37.52 23.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.817 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 50.7 t0 -129.66 153.69 47.87 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.242 0.544 . . . . 1.0 111.819 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.567 ' HA ' HD12 ' A' ' 86' ' ' ILE . 54.0 tp -63.98 -38.78 92.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.791 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.69 -45.47 89.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.562 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -61.18 -37.31 82.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.687 0.28 . . . . 1.0 110.641 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 83' ' ' LEU . 96.6 mt -58.87 -47.63 88.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.659 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.8 mm -62.99 -44.82 99.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.476 -0.489 . . . . 1.0 111.678 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.85 -43.52 96.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 112.372 0.508 . . . . 1.0 112.372 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -72.96 -21.29 60.89 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.577 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.55 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 2.2 t80 -89.35 -51.29 5.64 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.176 -0.61 . . . . 1.0 111.485 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 95' ' ' VAL . 10.3 mp -62.69 -42.69 99.77 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.629 -0.429 . . . . 1.0 111.832 -178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -63.54 -50.79 68.15 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.691 -0.803 . . . . 1.0 111.446 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -68.94 -42.66 76.41 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.715 -0.394 . . . . 1.0 111.54 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -65.31 -44.32 88.24 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.162 -0.615 . . . . 1.0 111.318 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 91' ' ' LEU . 75.3 t -66.53 -44.22 90.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.406 -0.518 . . . . 1.0 111.205 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -67.25 -45.18 77.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.482 -0.327 . . . . 1.0 111.353 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.21 -44.59 91.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.583 -0.281 . . . . 1.0 111.649 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.2 tp -63.56 -40.55 97.28 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.021 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.4 ' O ' ' CB ' ' A' ' 103' ' ' SER . 92.7 m-20 -67.21 -42.42 84.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.77 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -64.38 -43.18 95.27 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 121.983 -0.448 . . . . 1.0 111.545 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.5 ttm -67.63 -56.23 10.21 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.42 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.2 m -59.54 -44.17 93.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.032 0.444 . . . . 1.0 110.815 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 7.6 t -72.99 11.73 0.64 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.68 -0.691 . . . . 1.0 111.298 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.3 t -92.89 135.48 34.11 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.87 0.367 . . . . 1.0 110.248 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.58 -21.14 66.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.942 0.401 . . . . 1.0 111.17 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.537 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 52.9 mttp -89.87 41.09 1.03 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.919 -0.582 . . . . 1.0 109.903 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -133.34 115.25 14.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.2 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -134.43 120.87 20.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.786 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.0 m -90.25 82.44 6.0 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.914 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.76 150.99 17.12 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.848 -0.901 . . . . 1.0 110.848 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 115' ' ' VAL . 9.0 p -79.41 173.96 12.05 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.033 -0.358 . . . . 1.0 110.033 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.42 ' NZ ' ' CG ' ' A' ' 138' ' ' HIS . 16.0 mtmm -59.39 -37.6 78.4 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.821 -0.352 . . . . 1.0 110.684 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -68.27 -43.25 78.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.052 0.453 . . . . 1.0 110.562 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -70.63 -19.19 62.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.73 -0.668 . . . . 1.0 111.067 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.557 HG13 ' SD ' ' A' ' 147' ' ' MET . 19.2 t -70.74 -45.34 74.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.704 -0.398 . . . . 1.0 110.13 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.99 -45.43 90.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-O 121.333 0.587 . . . . 1.0 110.251 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -65.84 -37.88 87.38 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.931 0.396 . . . . 1.0 111.326 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -69.43 -47.82 62.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.913 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.8 tp -69.64 -39.89 78.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.397 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.472 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 61.1 mm-40 -64.56 -42.76 95.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.728 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.13 -48.16 77.16 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.298 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CD1' ' OD1' ' A' ' 126' ' ' ASN . 30.0 t80 -62.34 -43.76 98.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.137 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.1 t -59.58 -40.4 87.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.096 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -58.48 -42.59 87.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 1.0 109.939 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.0 t -64.03 -37.98 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.445 ' OD1' ' CD1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -124.62 76.83 63.91 Favored Pre-proline 0 N--CA 1.473 0.704 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.351 179.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.487 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 7.1 Cg_exo -71.17 -27.29 20.2 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.634 2.223 . . . . 1.0 112.621 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -100.51 11.33 39.69 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.885 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -131.46 146.22 52.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.188 0.518 . . . . 1.0 110.433 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.8 m -80.83 163.52 23.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.537 -0.756 . . . . 1.0 109.913 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 p -151.24 145.65 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -145.89 142.24 28.59 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.912 0.387 . . . . 1.0 111.112 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -152.47 167.8 27.6 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.347 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -132.2 156.31 46.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 179.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.5 p -152.93 169.64 22.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.447 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 137' ' ' ASN . 54.0 tp -77.04 136.33 38.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.546 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.536 ' OD1' ' ND2' ' A' ' 140' ' ' ASN . 11.0 t-20 -44.08 170.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.403 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.515 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 57.1 t-80 -77.26 -56.45 4.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.038 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 139' ' ' ASP . 66.5 t0 -139.6 45.25 1.93 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.981 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.536 ' ND2' ' OD1' ' A' ' 137' ' ' ASN . 1.3 m-80 -136.87 102.47 9.29 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 109.905 -0.405 . . . . 1.0 109.905 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.432 ' HB3' HD11 ' A' ' 52' ' ' LEU . 45.8 Cg_endo -75.19 120.59 6.07 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.944 1.762 . . . . 1.0 112.608 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.16 20.68 22.57 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.886 -0.886 . . . . 1.0 110.886 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -134.44 139.86 45.83 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.873 0.368 . . . . 1.0 110.281 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -132.5 160.04 37.65 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.841 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 145' ' ' TYR . 8.1 p90 -142.11 146.94 35.95 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.2 mt -106.36 126.57 52.41 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.136 0.493 . . . . 1.0 110.366 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.557 ' SD ' HG13 ' A' ' 115' ' ' VAL . 5.9 ptt? -116.86 144.83 44.05 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.928 -1.138 . . . . 1.0 107.928 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 148' ' ' PHE . 13.3 p90 -162.8 154.19 17.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.549 -0.538 . . . . 1.0 109.549 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.472 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 69.2 tttt -135.13 131.13 36.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.468 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.486 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 38.6 mm -72.41 -45.61 59.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.994 0.368 . . . . 1.0 111.994 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 27.8 m120 -161.61 173.06 15.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.577 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.52 -34.44 75.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.071 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.75 -12.96 55.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.588 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.431 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 8.4 t -79.82 158.71 26.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.32 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -89.77 150.58 22.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 1.0 109.98 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.6 tp -71.07 124.75 25.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.872 0.368 . . . . 1.0 110.211 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -110.91 129.3 55.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.667 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 91.1 m -131.24 131.43 43.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.114 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.75 166.15 13.13 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -107.97 142.45 38.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.114 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.5 t -122.3 138.29 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -106.01 135.15 47.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.034 0.445 . . . . 1.0 110.742 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.6 131.69 45.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.688 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.2 p -134.83 178.01 7.34 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.349 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.55 ' ND2' ' CE1' ' A' ' 90' ' ' TYR . 5.3 m120 -86.78 14.59 6.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.717 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 17.9 p -119.01 -1.12 11.01 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.483 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.74 -131.35 5.84 Favored Glycine 0 N--CA 1.465 0.59 0 N-CA-C 110.25 -1.14 . . . . 1.0 110.25 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -121.8 127.28 50.42 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -102.29 123.83 46.79 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.4 tt -117.96 111.79 19.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.519 -0.549 . . . . 1.0 109.519 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.5 t 35.94 59.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.175 0.435 . . . . 1.0 112.175 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.8 m120 69.4 27.52 4.97 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.98 0.733 . . . . 1.0 112.98 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -134.13 120.59 20.32 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -95.91 126.68 41.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.238 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -108.9 99.29 34.21 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 109.573 -0.528 . . . . 1.0 109.573 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.15 -21.57 9.51 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.382 2.055 . . . . 1.0 113.444 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.424 ' HB2' HE21 ' A' ' 180' ' ' GLN . 38.5 m -132.92 139.07 47.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.041 0.448 . . . . 1.0 111.253 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.96 -35.61 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.617 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.421 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 95.4 mt -63.32 -43.36 98.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 1.0 110.054 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.693 ' H ' HE21 ' A' ' 180' ' ' GLN . 0.6 OUTLIER -63.11 -31.46 72.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.224 -0.658 . . . . 1.0 109.224 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.78 -41.9 97.86 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.327 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.63 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 3.0 p -58.96 -47.98 83.15 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.617 -0.433 . . . . 1.0 110.629 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.63 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 48.3 t30 -69.52 -48.91 58.95 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.44 -44.78 0.45 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.756 -1.338 . . . . 1.0 109.756 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -68.83 -47.44 66.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.052 -0.574 . . . . 1.0 109.76 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.574 ' N ' ' O ' ' A' ' 183' ' ' ASN . 88.8 tttt -57.03 -42.27 80.14 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.362 -0.836 . . . . 1.0 110.116 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 96.7 m -61.71 -44.33 97.14 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 53.1 mt -61.73 -41.57 97.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.773 -0.648 . . . . 1.0 109.928 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 59.2 tp -58.95 -44.15 91.4 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.388 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 16.5 tptp -62.01 -43.98 97.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.474 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.0 t -63.33 -38.45 91.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.363 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.4 mt -63.76 -42.08 97.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.829 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.41 -30.09 66.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.56 -0.291 . . . . 1.0 111.67 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -81.02 -3.46 51.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.843 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 79.4 t60 55.53 56.11 6.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.321 -0.399 . . . . 1.0 111.04 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -43.2 135.76 3.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.881 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -80.07 135.34 36.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.56 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.568 ' CG ' ' H ' ' A' ' 199' ' ' HIS . 26.7 t-80 -159.09 -128.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.528 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.568 ' H ' ' CG ' ' A' ' 198' ' ' HIS . 13.1 p80 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.933 -1.032 . . . . 1.0 110.853 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 74.3 p . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.67 ' CD2' ' H ' ' A' ' 3' ' ' ARG . 2.9 p80 -149.61 -49.98 0.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.524 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.67 ' H ' ' CD2' ' A' ' 2' ' ' HIS . 41.1 mmm-85 -125.64 3.82 7.52 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.839 0.352 . . . . 1.0 110.503 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.83 -27.93 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.653 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.2 pt -76.49 -18.76 14.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.536 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 3' ' ' ARG . 56.1 p30 -99.35 7.44 45.55 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.485 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -84.99 138.49 37.12 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 110.091 -0.337 . . . . 1.0 110.091 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.59 -13.32 32.48 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.889 1.726 . . . . 1.0 112.342 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.418 ' CD1' ' CZ ' ' A' ' 30' ' ' PHE . 40.4 m-85 -99.35 10.68 40.95 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.572 -0.286 . . . . 1.0 111.069 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.532 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 91.0 t80 -85.98 123.36 31.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.316 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 49.5 m-85 -146.5 108.92 4.15 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 110.092 -0.336 . . . . 1.0 110.092 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.508 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 45.3 Cg_exo -58.88 109.57 0.54 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 121.697 1.598 . . . . 1.0 112.48 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 23.4 m-85 -159.48 155.69 26.95 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.626 -0.716 . . . . 1.0 110.555 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 18.8 t-20 -84.03 164.04 19.54 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.295 -0.631 . . . . 1.0 109.295 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . -61.14 -40.81 99.06 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.569 -0.824 . . . . 1.0 111.095 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -66.73 -43.97 82.81 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.911 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -69.46 -36.0 76.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.392 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -39.49 90.09 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.304 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -60.43 -44.07 96.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.081 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -61.57 -42.45 98.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.281 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -63.05 -42.16 99.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.59 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mp -77.67 -13.59 59.86 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.295 -0.411 . . . . 1.0 111.081 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -58.49 -42.83 88.46 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.385 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p -79.48 -18.4 52.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -82.54 177.91 8.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.499 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.536 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 56.4 mp0 -90.01 173.23 8.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.77 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 ptt-85 -81.19 145.01 31.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.727 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.94 -1.39 55.2 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -82.1 147.82 28.88 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.418 ' CZ ' ' CD1' ' A' ' 9' ' ' TYR . 13.7 p90 -133.47 163.17 29.97 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.353 0.597 . . . . 1.0 110.961 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.684 ' O ' HG23 ' A' ' 44' ' ' ILE . 31.1 m -146.88 157.95 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.21 -0.904 . . . . 1.0 111.298 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.8 mt -117.53 127.47 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.109 -0.496 . . . . 1.0 109.715 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -146.46 153.29 40.26 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.394 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -104.93 139.6 39.41 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.735 -0.468 . . . . 1.0 109.735 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -67.69 149.58 49.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.796 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 t -63.77 -20.5 65.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.966 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -125.01 10.18 8.17 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.574 -0.285 . . . . 1.0 110.684 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . -68.57 -56.93 8.76 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t0 67.54 -51.33 0.5 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.734 0.302 . . . . 1.0 110.874 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 38' ' ' GLY . 90.5 m-20 -122.05 4.92 9.84 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.008 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -120.16 149.96 41.4 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.042 0.449 . . . . 1.0 110.517 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.423 ' CD1' ' OE2' ' A' ' 60' ' ' GLU . 5.2 mp -121.45 147.5 45.66 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.096 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -126.5 132.13 70.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.684 HG23 ' O ' ' A' ' 31' ' ' VAL . 57.0 mt -113.74 139.83 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 108.837 -0.801 . . . . 1.0 108.837 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.2 m -120.4 142.39 49.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.035 -0.53 . . . . 1.0 109.692 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.67 ' CE2' HD11 ' A' ' 48' ' ' LEU . 2.4 p-90 -147.68 151.6 36.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.977 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.601 ' C ' HD12 ' A' ' 48' ' ' LEU . 87.6 tttt -99.66 140.33 34.01 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.87 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.67 HD11 ' CE2' ' A' ' 46' ' ' TRP . 9.0 mp -105.77 -82.08 0.53 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.605 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -93.81 -178.67 4.75 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.801 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -57.48 -40.48 78.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.667 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -127.51 53.45 1.75 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.092 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tp -151.42 128.22 10.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.898 0.38 . . . . 1.0 110.195 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -132.31 148.72 52.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.535 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.55 ' OE1' HD21 ' A' ' 48' ' ' LEU . 94.2 mt-30 -137.79 152.61 49.32 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.972 -0.558 . . . . 1.0 109.628 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -129.31 144.9 51.41 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.201 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.433 HD11 ' OH ' ' A' ' 90' ' ' TYR . 96.6 mt -126.27 130.82 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.842 -0.429 . . . . 1.0 109.842 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 43.7 p-10 -99.84 124.81 45.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.899 0.38 . . . . 1.0 110.633 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 90.1 mt -102.21 133.05 46.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.48 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -119.96 134.84 55.12 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.853 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.423 ' OE2' ' CD1' ' A' ' 42' ' ' LEU . 3.6 mt-10 -100.09 143.91 29.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.145 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.4 mt -141.22 174.8 10.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.413 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 74.05 35.36 0.78 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.957 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -95.12 103.14 14.99 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.021 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.3 -31.84 72.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.837 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -147.67 155.84 45.01 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.265 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.98 -31.96 46.06 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.199 1.933 . . . . 1.0 112.079 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tp -79.69 -10.82 59.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.881 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.73 136.23 45.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.494 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 71' ' ' LYS . 64.7 mt -81.44 154.23 26.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.312 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.6 86.01 0.01 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.427 -1.069 . . . . 1.0 110.427 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 69' ' ' LEU . 68.3 mttm -61.35 -35.65 78.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.997 0.427 . . . . 1.0 110.823 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.4 t -127.62 124.16 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.798 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.0 mt -114.77 126.44 54.84 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.8 mt -102.18 123.1 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.84 0.353 . . . . 1.0 110.24 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.2 t -143.45 132.72 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.138 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 54.49 43.66 29.99 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.954 -0.299 . . . . 1.0 111.05 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.6 m120 57.98 19.96 6.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.708 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -128.32 139.12 52.57 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.873 0.368 . . . . 1.0 110.33 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -89.15 133.18 34.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.041 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -124.52 138.23 54.35 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.131 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -81.92 -37.32 26.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 1.0 111.62 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -123.22 149.91 44.09 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.124 0.487 . . . . 1.0 111.887 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.2 tp -65.74 -40.76 92.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.825 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -59.44 -43.54 93.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.905 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -56.93 -38.62 73.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.566 0.222 . . . . 1.0 110.633 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.22 -44.65 99.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.619 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.01 -46.16 97.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.52 -0.472 . . . . 1.0 111.647 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.98 -41.42 59.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 112.677 0.621 . . . . 1.0 112.677 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -78.5 -13.35 59.88 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.948 -0.301 . . . . 1.0 111.401 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.433 ' OH ' HD11 ' A' ' 56' ' ' ILE . 63.1 t80 -94.39 -49.3 5.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.113 0.412 . . . . 1.0 112.113 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.581 ' O ' HG23 ' A' ' 95' ' ' VAL . 2.9 mp -71.68 -38.08 70.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.965 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -62.07 -48.26 81.0 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.968 -0.693 . . . . 1.0 111.215 -177.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.04 -42.35 69.61 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.848 -0.341 . . . . 1.0 111.683 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -66.05 -42.33 89.64 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.503 -0.479 . . . . 1.0 111.169 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 91' ' ' LEU . 68.6 t -63.63 -47.86 89.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.347 -0.541 . . . . 1.0 111.214 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -69.93 -42.54 73.14 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.578 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.485 HD11 ' CZ ' ' A' ' 168' ' ' TYR . 13.7 tp -68.63 -41.93 78.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.428 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.2 tp -62.92 -43.41 98.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.031 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -66.14 -39.98 90.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.788 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -70.06 -41.61 73.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.398 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.6 tpt -64.22 -56.36 15.23 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.456 -0.498 . . . . 1.0 111.369 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' ' 104' ' ' SER . 14.0 m -60.69 -39.46 88.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.043 0.449 . . . . 1.0 110.51 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 91.8 p -73.16 11.26 0.76 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.767 -0.651 . . . . 1.0 111.117 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 102' ' ' THR . 13.8 t -90.5 138.02 31.89 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.259 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.67 -20.1 63.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.194 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.582 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 64.3 mttp -87.99 39.12 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 1.0 109.691 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -129.17 110.14 11.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.372 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.56 122.94 37.97 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.206 -0.452 . . . . 1.0 109.884 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.6 m -95.0 72.83 3.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.118 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.58 151.28 16.93 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.953 -0.859 . . . . 1.0 110.953 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -73.35 175.84 6.55 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.032 -0.359 . . . . 1.0 110.032 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt -56.11 -37.79 69.89 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.95 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -68.47 -42.73 78.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.097 0.475 . . . . 1.0 110.729 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -70.28 -23.0 62.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.112 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 111' ' ' THR . 41.3 t -69.39 -45.74 78.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.158 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.1 t -65.92 -45.75 90.31 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 CA-C-O 121.158 0.504 . . . . 1.0 110.548 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.99 -33.06 74.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.794 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -68.61 -50.01 54.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.618 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.442 HD11 HG13 ' A' ' 131' ' ' VAL . 11.0 tp -70.03 -39.22 77.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.851 0.358 . . . . 1.0 110.253 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -64.97 -40.12 94.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.455 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -59.9 -47.53 85.4 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.686 -0.405 . . . . 1.0 110.286 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -60.98 -40.62 94.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.076 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 7.4 t -62.18 -41.72 98.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.548 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -59.49 -43.52 93.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.297 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.38 -41.96 92.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.71 76.29 77.26 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.488 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.537 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 10.2 Cg_exo -68.03 -21.14 43.57 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.857 2.372 . . . . 1.0 112.641 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -102.45 13.76 33.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.838 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -128.05 152.8 47.52 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.107 0.479 . . . . 1.0 110.379 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.1 p -81.39 161.16 23.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.637 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.442 HG13 HD11 ' A' ' 119' ' ' ILE . 5.1 p -154.89 146.12 13.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 20.7 p90 -151.4 142.06 22.73 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.834 0.35 . . . . 1.0 111.026 178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -152.62 168.14 26.58 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.393 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 5.1 p90 -136.46 157.19 47.38 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.257 -0.645 . . . . 1.0 109.257 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.2 p -149.27 168.58 22.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.815 0.34 . . . . 1.0 110.184 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 46.7 tp -79.26 144.46 34.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.355 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 0.0 OUTLIER -67.56 -172.82 0.27 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.026 -0.534 . . . . 1.0 109.999 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.516 ' ND1' ' N ' ' A' ' 138' ' ' HIS . 0.2 OUTLIER -110.31 -56.59 2.32 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.941 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.441 ' OD1' ' ND2' ' A' ' 140' ' ' ASN . 41.8 p-10 -114.09 19.88 16.1 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.082 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.529 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 7.5 m-80 -125.06 68.36 56.33 Favored Pre-proline 0 N--CA 1.466 0.344 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.236 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.476 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 26.1 Cg_endo -63.13 127.71 20.93 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.989 1.793 . . . . 1.0 112.46 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.426 ' HA3' HE22 ' A' ' 54' ' ' GLN . . . 100.36 11.56 41.46 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 110.761 -0.936 . . . . 1.0 110.761 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.524 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 57.7 m95 -132.95 156.54 47.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.818 0.342 . . . . 1.0 110.092 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -129.67 148.65 51.58 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.479 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 18.3 m-85 -116.84 136.13 53.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.063 0.459 . . . . 1.0 110.193 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.2 mt -109.77 124.61 51.57 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.302 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -121.48 147.52 45.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.053 -1.092 . . . . 1.0 108.053 178.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -160.18 150.74 18.64 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.608 -0.515 . . . . 1.0 109.608 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -136.23 128.34 29.73 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.851 -0.34 . . . . 1.0 110.521 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.5 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 34.3 mm -69.99 -45.79 75.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.421 -0.354 . . . . 1.0 111.716 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 31.1 m120 -158.94 173.68 16.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.559 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.11 -34.6 76.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.79 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -86.86 9.2 19.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.041 0.448 . . . . 1.0 110.46 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 13.1 t -98.59 165.92 11.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.431 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -96.79 145.58 25.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.929 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.04 121.45 22.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.063 0.459 . . . . 1.0 109.931 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -111.67 128.09 55.96 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.91 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.9 m -123.76 127.61 48.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.778 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.53 171.67 7.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.024 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.479 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 93.6 m-20 -109.51 149.17 30.01 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.836 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 45.8 t -126.35 136.92 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -104.88 125.8 51.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.021 0.439 . . . . 1.0 110.715 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 46.2 tp -88.6 129.8 35.41 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.399 -0.593 . . . . 1.0 109.399 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.3 p -128.34 171.83 11.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.408 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.776 ' H ' HD22 ' A' ' 165' ' ' ASN . 0.1 OUTLIER -83.98 16.09 3.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.512 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 67.0 p -122.71 -2.94 8.78 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.555 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 139.93 -128.69 3.99 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.453 -1.059 . . . . 1.0 110.453 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.485 ' CZ ' HD11 ' A' ' 97' ' ' LEU . 46.2 m-85 -123.81 127.35 47.96 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.729 0.299 . . . . 1.0 110.445 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -103.58 123.99 47.97 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 171' ' ' VAL . 0.5 OUTLIER -115.14 112.46 22.57 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.208 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 170' ' ' LEU . 5.2 t 34.74 64.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 7.7 m120 65.0 27.39 12.64 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.012 0.745 . . . . 1.0 113.012 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -132.42 121.58 23.65 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.176 -0.675 . . . . 1.0 109.176 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -94.61 123.44 38.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.822 0.344 . . . . 1.0 111.427 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -103.47 134.96 19.47 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.01 -23.21 22.02 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.037 1.825 . . . . 1.0 113.377 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 70.8 m -156.45 161.28 40.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.952 0.406 . . . . 1.0 111.035 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 179' ' ' ILE . 7.5 p -61.12 -42.01 91.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.853 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.479 ' N ' HG13 ' A' ' 178' ' ' VAL . 48.1 mm -60.29 -47.4 92.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.722 -0.391 . . . . 1.0 110.299 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -62.02 -35.92 80.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.8 tt -62.96 -40.1 96.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.271 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 72.8 m -60.77 -47.76 84.84 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.579 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.639 ' O ' ' N ' ' A' ' 186' ' ' LYS . 56.8 t-20 -66.82 -47.37 72.25 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.58 -45.5 0.51 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.954 -1.259 . . . . 1.0 109.954 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.514 ' O ' ' HG ' ' A' ' 188' ' ' LEU . 0.3 OUTLIER -69.84 -41.82 74.4 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-O 121.913 0.863 . . . . 1.0 109.762 178.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.639 ' N ' ' O ' ' A' ' 183' ' ' ASN . 87.9 tttt -60.84 -34.24 74.28 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.87 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.1 m -64.09 -51.59 63.3 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.899 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.599 ' C ' HD12 ' A' ' 188' ' ' LEU . 0.9 OUTLIER -65.57 -35.67 81.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.123 179.001 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.441 ' N ' ' HG ' ' A' ' 188' ' ' LEU . 37.1 tp -57.27 -46.47 83.06 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.172 -0.467 . . . . 1.0 109.97 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.51 -39.82 94.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.136 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.7 t -59.9 -36.43 76.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.498 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.5 mt -67.85 -41.6 82.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.785 -0.643 . . . . 1.0 112.208 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.1 -36.98 83.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.771 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . 0.469 ' O ' ' ND1' ' A' ' 194' ' ' HIS . 2.4 t-80 -80.58 -8.5 59.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.843 0.354 . . . . 1.0 110.85 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.474 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 35.1 t-80 50.09 49.56 20.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.426 . . . . 1.0 111.069 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -136.59 94.51 3.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.369 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -157.15 146.5 20.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.626 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.459 ' C ' ' ND1' ' A' ' 198' ' ' HIS . 5.8 p80 -77.35 167.18 22.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.703 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.403 ' CD2' ' N ' ' A' ' 199' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.977 -1.011 . . . . 1.0 110.681 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.477 ' N ' HD23 ' A' ' 69' ' ' LEU . 50.0 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -149.32 10.71 0.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.534 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.6 ttp-105 -130.52 -26.76 2.23 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.351 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.2 p -66.38 -32.6 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.669 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 pt -67.26 -24.07 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.672 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -93.59 0.76 56.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.397 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -64.27 130.75 94.77 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.221 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -47.64 -32.36 16.15 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.705 1.603 . . . . 1.0 112.516 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -85.32 9.66 14.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.372 -0.377 . . . . 1.0 111.181 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.505 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 80.6 t80 -89.95 129.83 36.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.467 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 61.7 m-85 -149.24 127.6 5.92 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 110.2 -0.296 . . . . 1.0 110.2 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 73.7 Cg_endo -73.24 109.9 2.94 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.901 1.734 . . . . 1.0 112.724 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 71.4 m-85 -160.89 151.78 18.56 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.489 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -76.26 -170.05 1.34 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.95 -44.53 8.17 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.546 -1.021 . . . . 1.0 110.546 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -67.02 -43.77 81.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.664 0.268 . . . . 1.0 111.025 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -65.2 -33.89 77.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.057 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.5 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.15 -39.47 90.2 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.741 -0.383 . . . . 1.0 110.326 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.25 -42.08 96.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.043 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.37 -44.39 96.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.439 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -63.32 -42.23 98.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.35 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 18' ' ' ALA . 7.9 mp -73.29 -12.79 60.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.805 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -58.97 -40.73 85.63 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.357 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.6 t -75.82 -18.71 59.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.766 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.482 ' N ' ' CD ' ' A' ' 25' ' ' LYS . 3.1 mptp? -83.5 179.89 7.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.438 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.407 ' OE1' ' O ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -104.37 -176.01 2.96 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.367 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.458 ' CD ' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -75.08 143.26 43.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.458 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.47 7.54 57.98 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.844 -0.902 . . . . 1.0 110.844 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -87.0 140.58 29.41 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -135.85 162.13 33.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.253 0.549 . . . . 1.0 110.92 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.2 m -147.44 158.65 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.155 -0.93 . . . . 1.0 111.612 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.0 mt -117.69 127.21 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -146.98 155.29 42.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.463 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.79 137.27 45.14 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.9 t -74.75 144.85 43.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.974 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.0 p -64.83 -30.21 71.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.723 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -102.35 0.79 34.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.707 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.99 -56.47 5.29 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.428 -1.069 . . . . 1.0 110.428 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 72.64 -54.6 0.69 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.561 0.22 . . . . 1.0 111.024 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.515 ' OD1' ' CD2' ' A' ' 41' ' ' HIS . 55.2 p-10 -119.52 2.41 11.22 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.756 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.515 ' CD2' ' OD1' ' A' ' 40' ' ' ASP . 38.3 m170 -117.9 150.47 39.15 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.869 0.366 . . . . 1.0 110.566 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.03 151.76 38.52 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 116.004 -0.544 . . . . 1.0 109.912 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.1 t -126.05 132.95 70.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.26 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.62 HD12 HD11 ' A' ' 58' ' ' ILE . 40.2 mt -111.86 137.88 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.0 m -117.48 136.82 52.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.841 -0.618 . . . . 1.0 109.846 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.678 ' CH2' HD21 ' A' ' 48' ' ' LEU . 1.3 p-90 -146.22 147.2 31.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.496 -0.774 . . . . 1.0 110.921 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HZ3' ' C ' ' A' ' 49' ' ' ASP . 64.7 tttm -93.84 140.66 29.41 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.075 -0.512 . . . . 1.0 111.255 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.678 HD21 ' CH2' ' A' ' 46' ' ' TRP . 82.0 mt -97.27 -66.25 0.91 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.486 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.452 ' C ' ' HZ3' ' A' ' 47' ' ' LYS . 4.6 p30 -144.56 -166.64 2.44 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.607 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -59.18 131.63 51.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.972 0.415 . . . . 1.0 110.682 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 49.87 52.79 13.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.907 -0.588 . . . . 1.0 111.156 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 141' ' ' PRO . 16.8 tp -158.89 119.12 3.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.338 . . . . 1.0 110.421 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.5 149.46 52.32 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.592 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.41 ' HG3' HD11 ' A' ' 48' ' ' LEU . 9.8 mm100 -137.05 151.9 49.45 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.136 -0.484 . . . . 1.0 109.751 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -125.8 140.62 52.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.203 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 95.7 mt -120.85 123.7 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -94.95 122.23 37.38 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.58 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.62 HD11 HD12 ' A' ' 44' ' ' ILE . 83.0 mt -102.53 129.68 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.336 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -119.82 134.37 55.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.099 -0.501 . . . . 1.0 109.891 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -102.62 148.78 25.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.109 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.1 mt -141.97 174.72 10.33 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.328 -0.397 . . . . 1.0 110.461 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 67.81 41.62 2.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.016 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.716 ' H ' ' CD ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -111.85 134.55 53.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.242 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.25 -20.3 30.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.538 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.63 153.41 22.85 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.153 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.83 -20.91 68.53 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.267 1.978 . . . . 1.0 111.884 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.5 tp -85.49 -12.37 51.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.144 0.497 . . . . 1.0 110.639 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.35 151.57 30.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.527 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 1' ' ' THR . 53.8 mt -75.86 147.24 39.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.284 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.79 98.91 0.37 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.551 -1.02 . . . . 1.0 110.551 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -62.55 -38.27 89.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.92 0.39 . . . . 1.0 110.544 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.53 123.65 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.624 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.4 mt -116.47 130.57 56.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.869 -0.605 . . . . 1.0 109.401 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mp -107.49 124.65 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.81 0.338 . . . . 1.0 110.362 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -139.2 132.11 37.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.288 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 39.3 t0 51.92 42.03 29.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.654 0.264 . . . . 1.0 111.035 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.1 t30 61.19 22.92 13.19 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.297 -0.411 . . . . 1.0 111.042 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -127.0 133.36 50.57 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.114 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -86.31 128.24 34.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.735 -0.666 . . . . 1.0 111.089 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -121.49 138.56 54.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.151 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -84.99 -34.55 22.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.542 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -126.31 149.45 49.14 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.062 0.458 . . . . 1.0 112.058 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.0 tp -65.38 -39.7 92.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.945 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.401 ' O ' HG23 ' A' ' 88' ' ' VAL . 89.5 m-20 -60.2 -40.81 91.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 1.0 111.741 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -61.0 -38.45 86.1 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.769 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.83 -45.84 97.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.726 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.9 mm -65.44 -43.45 94.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.506 -0.478 . . . . 1.0 111.47 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 84' ' ' ASP . 60.9 t -71.73 -43.07 70.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 112.642 0.608 . . . . 1.0 112.642 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.03 -13.13 59.55 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.722 -0.391 . . . . 1.0 111.61 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -95.3 -49.01 5.65 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.772 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 95' ' ' VAL . 2.1 tp -70.06 -41.41 74.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.312 -0.404 . . . . 1.0 112.018 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -63.96 -49.14 73.71 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.918 -0.713 . . . . 1.0 111.456 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -70.53 -42.05 71.73 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.62 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -65.88 -41.88 90.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.347 -0.541 . . . . 1.0 111.266 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 91' ' ' LEU . 51.5 t -64.76 -46.43 92.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.39 -0.524 . . . . 1.0 111.181 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -65.94 -44.57 84.66 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.593 -0.443 . . . . 1.0 111.259 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.552 HD11 ' CZ ' ' A' ' 168' ' ' TYR . 10.7 tp -65.57 -41.82 92.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.497 -0.32 . . . . 1.0 111.511 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.25 -42.3 99.17 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.299 -0.561 . . . . 1.0 110.045 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.414 ' O ' ' OG ' ' A' ' 103' ' ' SER . 91.1 m-20 -66.31 -40.41 89.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.262 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -69.37 -40.8 77.23 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.673 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.4 tpt -66.5 -56.11 12.41 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.104 -0.638 . . . . 1.0 111.301 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 65.1 m -60.44 -39.11 86.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.047 0.451 . . . . 1.0 110.852 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 99' ' ' ASN . 99.2 p -71.91 10.42 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.638 -0.71 . . . . 1.0 111.124 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.1 p -93.94 133.7 37.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.711 0.291 . . . . 1.0 110.468 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 37.9 mp0 -57.46 -21.07 34.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.138 0.494 . . . . 1.0 110.594 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.555 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 49.2 mttp -87.61 39.7 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.771 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -128.45 113.22 15.25 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.604 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -125.61 110.47 13.86 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.197 -0.456 . . . . 1.0 109.804 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.7 m -85.03 77.05 10.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.981 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -116.63 157.96 14.74 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 115' ' ' VAL . 72.3 p -78.53 168.05 20.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.843 -0.429 . . . . 1.0 109.843 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -56.68 -36.85 70.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.74 0.305 . . . . 1.0 110.329 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -67.39 -45.22 76.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.913 0.387 . . . . 1.0 110.539 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -70.52 -17.2 62.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.786 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 111' ' ' THR . 22.7 t -72.2 -44.01 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.293 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.5 t -63.45 -46.94 93.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.211 0.529 . . . . 1.0 110.304 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -66.17 -35.71 81.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.901 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -67.69 -49.12 64.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.757 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.9 tp -69.87 -39.65 77.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.856 -0.337 . . . . 1.0 110.424 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.5 -40.24 95.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.706 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.6 -47.51 78.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.514 -0.474 . . . . 1.0 110.255 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.451 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 32.1 t80 -60.61 -43.14 97.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.061 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.1 p -65.88 -33.24 75.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.486 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -60.71 -42.28 96.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.931 -0.577 . . . . 1.0 109.915 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.49 -41.5 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.451 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -125.87 74.58 70.98 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.213 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 151' ' ' ASN . 46.1 Cg_endo -73.17 -17.89 24.17 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.354 2.036 . . . . 1.0 112.557 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 48.0 p30 -90.85 -10.31 43.16 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.157 0.429 . . . . 1.0 112.157 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -118.63 147.03 44.18 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.925 0.393 . . . . 1.0 110.404 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.9 m -80.94 160.9 24.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.782 -0.645 . . . . 1.0 109.693 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.89 146.89 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 133' ' ' TYR . 26.3 p90 -139.32 143.92 38.06 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.85 0.357 . . . . 1.0 111.56 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 18.4 m-85 -151.85 166.23 32.07 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.491 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 4.1 p90 -135.01 152.3 51.6 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.8 m -150.94 172.41 15.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.442 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.696 HD13 ' H ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -77.21 142.36 39.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.616 179.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.696 ' H ' HD13 ' A' ' 136' ' ' LEU . 10.7 t-20 -98.98 111.84 24.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.837 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -66.67 -43.23 85.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.676 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -69.15 -27.53 65.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.373 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.474 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 31.6 m120 -125.14 73.96 66.74 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.267 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.526 ' HB3' HD11 ' A' ' 52' ' ' LEU . 27.2 Cg_endo -62.76 126.11 17.48 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.911 1.741 . . . . 1.0 112.463 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.06 -7.68 48.62 Favored Glycine 0 N--CA 1.467 0.741 0 N-CA-C 111.065 -0.814 . . . . 1.0 111.065 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -116.81 141.18 48.55 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.713 0.292 . . . . 1.0 110.418 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.404 ' CE1' HD22 ' A' ' 136' ' ' LEU . 56.0 m-85 -102.09 142.77 32.83 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.542 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 11.1 m-85 -119.15 131.05 55.84 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.235 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.98 121.49 42.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.357 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -117.34 144.46 44.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.192 -1.04 . . . . 1.0 108.192 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -160.57 153.69 21.62 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.403 -0.591 . . . . 1.0 109.403 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -137.36 131.31 31.94 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.692 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 35.9 mm -70.98 -47.2 63.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.695 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.454 ' H ' ' HB3' ' A' ' 154' ' ' SER . 12.2 p30 -161.92 177.19 10.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.076 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.59 -34.37 78.1 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.09 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -84.88 9.5 14.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.668 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 3.3 t -105.28 163.61 12.47 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.182 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -92.21 156.63 17.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.936 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 50.5 tp -75.79 127.29 32.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.942 0.401 . . . . 1.0 110.26 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -112.26 133.17 54.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.081 -0.509 . . . . 1.0 109.751 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 85.5 m -131.39 131.79 43.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.036 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -121.91 164.73 17.07 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.806 -0.442 . . . . 1.0 109.806 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.542 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 24.2 m-20 -115.57 147.58 40.57 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.992 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 39.1 t -128.91 138.92 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -97.61 126.68 43.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.993 0.425 . . . . 1.0 110.704 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.4 tp -90.23 128.84 36.49 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 35.6 p -129.66 175.11 9.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.394 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -83.96 15.87 3.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.71 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 5.6 p -121.85 -1.83 9.36 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.739 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.88 -134.02 7.1 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.337 -1.105 . . . . 1.0 110.337 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.552 ' CZ ' HD11 ' A' ' 97' ' ' LEU . 7.9 m-85 -117.79 128.6 55.03 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.142 -0.318 . . . . 1.0 110.142 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -107.86 121.55 44.98 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.52 ' C ' HD23 ' A' ' 170' ' ' LEU . 6.7 tt -111.71 115.84 29.76 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 109.009 -0.738 . . . . 1.0 109.009 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.645 ' O ' HG12 ' A' ' 171' ' ' VAL . 99.3 t 33.19 62.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.349 0.5 . . . . 1.0 112.349 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.723 ' N ' HD22 ' A' ' 172' ' ' ASN . 0.5 OUTLIER 67.32 27.45 8.23 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.635 0.976 . . . . 1.0 113.635 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -131.79 120.1 22.19 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.338 -0.615 . . . . 1.0 109.338 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -91.73 129.42 37.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.883 0.373 . . . . 1.0 111.253 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -109.08 99.22 34.6 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.62 -24.4 12.73 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.636 2.224 . . . . 1.0 113.603 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.436 ' OG ' ' OE1' ' A' ' 180' ' ' GLN . 6.9 p -138.05 142.87 40.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.917 0.389 . . . . 1.0 111.272 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.61 -33.92 59.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.683 -0.69 . . . . 1.0 110.583 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.37 -44.08 98.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 122.038 -0.414 . . . . 1.0 110.363 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.521 ' N ' ' OE1' ' A' ' 180' ' ' GLN . 3.2 mp0 -65.89 -29.34 69.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 52.4 tp -64.0 -40.72 97.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.255 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 74.1 m -62.56 -47.79 82.31 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.364 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 186' ' ' LYS . 43.6 t30 -68.01 -47.41 68.55 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 119.503 -0.879 . . . . 1.0 108.88 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.4 -45.31 0.67 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 109.919 -1.272 . . . . 1.0 109.919 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -68.79 -46.99 67.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.376 0.608 . . . . 1.0 109.502 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 183' ' ' ASN . 1.4 tmtp? -56.81 -42.72 80.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.243 -0.89 . . . . 1.0 110.05 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 23.8 m -61.25 -44.0 97.96 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 188' ' ' LEU . 39.8 mt -62.21 -42.11 98.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.115 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 44.7 tp -58.48 -42.8 88.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.336 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.48 -44.94 92.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.371 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 17.4 m -62.7 -39.34 93.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.895 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.17 -41.13 99.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.609 -0.723 . . . . 1.0 111.735 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.68 -26.68 67.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.793 0.294 . . . . 1.0 111.793 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -82.76 6.14 19.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.818 0.342 . . . . 1.0 110.884 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 196' ' ' HIS . 73.0 t60 59.19 43.88 16.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.089 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 195' ' ' HIS . 84.7 t60 57.31 149.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.695 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -88.85 131.7 34.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.476 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.47 ' ND1' ' N ' ' A' ' 198' ' ' HIS . 0.0 OUTLIER -127.11 2.82 6.47 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.574 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.056 -0.973 . . . . 1.0 110.692 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.518 ' C ' ' H ' ' A' ' 3' ' ' ARG . 24.3 p . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.481 ' O ' ' CG ' ' A' ' 2' ' ' HIS . 86.6 t60 50.94 8.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.486 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.537 ' O ' ' ND2' ' A' ' 6' ' ' ASN . 80.0 mtp85 -135.51 -23.91 1.4 Allowed 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.599 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.0 p -97.06 -17.4 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.564 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.6 pt -85.51 -25.95 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.658 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.646 HD22 ' N ' ' A' ' 7' ' ' HIS . 0.0 OUTLIER -89.57 -0.01 57.22 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.613 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.646 ' N ' HD22 ' A' ' 6' ' ' ASN . 0.1 OUTLIER -69.63 146.87 96.31 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.092 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.98 -20.67 50.67 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.913 1.742 . . . . 1.0 112.353 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.439 ' CE1' ' CZ ' ' A' ' 30' ' ' PHE . 74.7 m-85 -88.97 3.3 52.01 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.326 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -88.16 135.45 33.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.322 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.573 ' O ' ' NH1' ' A' ' 33' ' ' ARG . 74.6 m-85 -151.27 119.64 3.42 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 110.013 -0.365 . . . . 1.0 110.013 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.521 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 73.7 Cg_endo -72.82 109.62 2.84 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.671 1.58 . . . . 1.0 113.129 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.551 ' O ' ' NE ' ' A' ' 33' ' ' ARG . 56.4 m-85 -160.41 159.25 30.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.623 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -78.69 173.47 12.42 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.14 -49.06 82.27 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.27 -0.967 . . . . 1.0 110.858 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -67.95 -40.15 83.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 1.0 110.823 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -66.61 -32.63 74.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 1.0 111.146 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.35 92.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.933 -0.307 . . . . 1.0 110.221 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.479 ' OE2' ' CD1' ' A' ' 53' ' ' PHE . 84.1 tt0 -63.31 -42.74 99.04 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.699 -0.4 . . . . 1.0 109.996 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -60.78 -40.36 92.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.091 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -62.19 -42.49 99.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.826 0.346 . . . . 1.0 110.474 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.16 -13.6 60.19 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.874 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.9 ttm-85 -61.33 -40.15 93.18 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.844 -0.342 . . . . 1.0 110.256 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.4 p -77.58 -19.08 56.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.751 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -84.67 -179.77 7.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.912 0.387 . . . . 1.0 110.566 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -103.15 -177.47 3.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.784 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -75.45 145.0 41.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.772 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.17 11.01 59.08 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -97.09 140.75 31.13 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CZ ' ' CE1' ' A' ' 9' ' ' TYR . 35.1 p90 -135.08 168.57 18.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.444 0.64 . . . . 1.0 111.116 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.8 m -148.54 161.32 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.012 -0.994 . . . . 1.0 111.762 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -116.09 131.19 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.573 ' NH1' ' O ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -137.74 164.13 29.64 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.839 -179.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -120.51 126.89 51.51 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 t -62.56 134.16 55.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.128 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.5 t -72.17 -20.77 61.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.885 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -117.8 37.59 3.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.819 0.343 . . . . 1.0 110.767 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -175.1 58.71 0.11 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.939 -0.865 . . . . 1.0 110.939 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -57.57 3.41 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.652 0.263 . . . . 1.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.577 ' H ' ' C ' ' A' ' 38' ' ' GLY . 97.9 m-20 -102.94 -1.74 28.92 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.595 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.429 ' ND1' ' O ' ' A' ' 40' ' ' ASP . 60.6 m-70 -143.59 157.72 44.21 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.375 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 mp -119.74 152.75 36.7 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.15 -0.477 . . . . 1.0 109.988 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.3 t -124.2 130.9 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 110.06 -0.348 . . . . 1.0 110.06 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.686 HD12 HD11 ' A' ' 58' ' ' ILE . 36.4 mt -111.58 138.1 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 96.2 m -116.93 136.13 53.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.537 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.471 ' CZ2' ' NZ ' ' A' ' 94' ' ' LYS . 4.4 p-90 -145.36 160.91 40.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.658 -0.701 . . . . 1.0 110.846 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -107.65 140.9 39.98 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.022 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' H ' HD12 ' A' ' 48' ' ' LEU . 3.1 mp -98.0 -72.35 0.65 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.652 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -158.29 157.34 32.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.259 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt 41.81 -141.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.798 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -89.71 64.3 6.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.848 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.9 tp -140.57 128.89 22.46 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.877 0.37 . . . . 1.0 110.323 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.479 ' CD1' ' OE2' ' A' ' 19' ' ' GLU . 51.6 m-85 -131.4 150.36 52.18 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.379 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -136.66 153.75 50.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.831 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.421 ' ND1' ' N ' ' A' ' 55' ' ' HIS . 10.8 p-80 -127.67 143.08 51.18 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.066 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 78.2 mt -123.4 129.23 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.228 -0.442 . . . . 1.0 109.966 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -97.23 122.45 40.27 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.03 0.443 . . . . 1.0 110.513 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.686 HD11 HD12 ' A' ' 44' ' ' ILE . 79.9 mt -99.32 129.95 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.4 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -113.56 132.35 55.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.0 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -101.03 156.58 17.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.188 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.7 tp -126.19 172.2 10.25 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.493 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 73.9 mm-40 60.02 39.0 20.44 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.99 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -81.47 78.88 8.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.082 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.64 -36.15 80.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.869 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -142.81 152.56 59.47 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.044 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.68 -25.56 68.58 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.295 1.997 . . . . 1.0 112.142 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.7 mt -97.84 -4.41 36.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.606 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.13 144.05 52.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.581 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.5 mt -78.5 146.31 34.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.366 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.27 101.16 1.22 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.539 -1.025 . . . . 1.0 110.539 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -63.58 -38.33 90.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.04 0.448 . . . . 1.0 111.029 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.17 125.52 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.593 -0.73 . . . . 1.0 111.004 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.6 mt -115.18 129.76 56.74 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 71.5 mt -102.13 126.24 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.884 0.373 . . . . 1.0 110.189 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.9 t -143.9 133.11 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.386 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t0 53.1 45.36 28.88 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.11 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 57.63 25.57 11.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.311 -0.404 . . . . 1.0 111.051 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -130.15 156.81 43.94 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.322 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -108.06 125.98 52.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.022 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -123.89 139.47 53.93 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.134 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -85.05 -38.84 18.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.77 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -110.08 138.22 46.76 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.201 0.524 . . . . 1.0 111.844 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.39 -41.35 96.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.874 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 38.0 p-10 -59.63 -45.97 90.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.982 -177.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.535 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 33.2 tt0 -57.93 -37.86 74.86 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 120.68 0.276 . . . . 1.0 110.778 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.81 -46.44 93.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.451 -0.5 . . . . 1.0 110.714 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.7 mm -64.4 -44.08 97.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.2 -0.6 . . . . 1.0 111.626 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.16 -43.63 74.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 113.067 0.765 . . . . 1.0 113.067 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -78.17 -13.27 59.93 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.641 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.457 ' CE2' ' NZ ' ' A' ' 94' ' ' LYS . 50.0 t80 -94.75 -50.72 5.03 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.95 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.544 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -71.38 -38.21 71.54 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.173 0.434 . . . . 1.0 112.173 -177.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -59.31 -47.25 86.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.027 -0.669 . . . . 1.0 111.527 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -64.43 -45.1 89.01 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.537 -0.465 . . . . 1.0 111.905 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.599 ' O ' HD13 ' A' ' 98' ' ' LEU . 45.9 mtmt -66.67 -42.68 86.17 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.237 -0.585 . . . . 1.0 111.407 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 91' ' ' LEU . 54.3 t -60.06 -45.66 95.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.398 -0.521 . . . . 1.0 111.367 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -66.59 -44.21 82.8 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.562 -0.455 . . . . 1.0 111.965 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.431 HD21 HD11 ' A' ' 163' ' ' LEU . 5.3 tp -67.07 -38.94 86.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.637 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 94' ' ' LYS . 8.2 mp -65.99 -42.16 90.14 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.353 -0.539 . . . . 1.0 110.626 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 95' ' ' VAL . 76.3 m-20 -68.65 -37.27 79.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.205 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -70.98 -41.22 71.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.831 -0.348 . . . . 1.0 111.564 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.576 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 15.9 ttm -70.03 -53.28 18.26 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.53 -0.468 . . . . 1.0 111.594 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.514 HG23 ' CE2' ' A' ' 107' ' ' PHE . 11.5 m -57.04 -38.83 73.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.056 0.455 . . . . 1.0 110.3 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.7 m -70.36 10.96 0.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.958 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 102' ' ' THR . 74.4 p -95.61 132.17 41.05 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.893 0.378 . . . . 1.0 110.385 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -60.38 -17.4 43.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.945 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.529 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 67.8 mttm -94.73 41.1 1.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.999 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.514 ' CE2' HG23 ' A' ' 102' ' ' THR . 64.6 t80 -134.91 118.63 17.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.035 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -140.1 129.6 24.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.12 -0.491 . . . . 1.0 109.717 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.6 m -100.43 93.48 5.66 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.735 0.303 . . . . 1.0 110.953 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -120.17 162.94 14.06 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 115' ' ' VAL . 21.5 p -78.73 163.41 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.925 -0.398 . . . . 1.0 109.925 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -63.35 -37.08 85.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.386 . . . . 1.0 110.54 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -68.08 -45.65 73.19 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.904 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -71.12 -17.26 62.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.59 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.492 HG13 ' SD ' ' A' ' 147' ' ' MET . 2.6 t -70.81 -45.4 73.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.88 -46.47 96.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.192 0.52 . . . . 1.0 110.036 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -66.05 -38.59 88.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.925 0.393 . . . . 1.0 110.663 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -65.77 -48.39 71.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.796 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.4 tp -69.19 -39.69 79.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.418 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -59.72 -43.72 94.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.353 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.02 -47.44 83.04 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.446 -0.501 . . . . 1.0 110.019 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -60.05 -44.91 94.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.215 -0.448 . . . . 1.0 109.972 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.1 p -62.47 -33.9 75.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.414 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -61.82 -42.44 99.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.96 -0.563 . . . . 1.0 110.243 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.32 -41.56 89.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.711 -0.396 . . . . 1.0 109.985 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.8 75.07 56.3 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 121.202 0.525 . . . . 1.0 110.128 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.526 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 42.0 Cg_endo -73.21 -14.87 25.72 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.402 2.068 . . . . 1.0 112.568 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -100.31 -13.19 18.93 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.797 0.295 . . . . 1.0 111.797 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -106.45 150.78 25.73 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.152 0.501 . . . . 1.0 110.429 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 m -80.66 162.06 24.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.629 -0.714 . . . . 1.0 109.659 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.3 p -152.74 144.96 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.538 -0.542 . . . . 1.0 109.538 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 25.3 p90 -151.3 144.19 24.5 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.848 -0.341 . . . . 1.0 111.124 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -151.45 169.75 21.26 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.344 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.529 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -137.9 153.69 49.51 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.082 -0.71 . . . . 1.0 109.082 179.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 98.9 p -151.21 169.66 21.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.9 0.381 . . . . 1.0 110.32 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.7 tp -79.49 141.54 36.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.524 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.509 ' ND2' ' CE1' ' A' ' 145' ' ' TYR . 6.6 t-20 -75.06 168.44 19.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.199 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -126.98 -30.11 2.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.356 -0.383 . . . . 1.0 110.66 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -90.53 -20.42 22.67 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.4 -0.364 . . . . 1.0 111.143 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 25.5 t-20 -138.64 76.33 35.84 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.396 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.06 130.76 41.39 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.062 1.841 . . . . 1.0 112.217 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 117.09 -26.34 8.34 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -107.28 147.92 29.63 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.576 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 75.2 m-85 -109.7 155.78 21.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.864 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.539 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 32.6 m-85 -125.77 137.46 53.8 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.048 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.9 mt -108.03 127.23 53.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.51 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.492 ' SD ' HG13 ' A' ' 115' ' ' VAL . 20.7 ptt? -118.6 144.3 46.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -162.5 153.49 17.46 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.374 -0.53 . . . . 1.0 109.707 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -133.99 129.23 35.88 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.26 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.436 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.8 mp -76.48 -47.25 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.424 0.527 . . . . 1.0 112.424 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 152' ' ' ALA . 17.0 t-20 -154.01 166.06 34.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.554 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.532 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -60.78 -27.57 68.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -85.53 -14.3 46.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.984 0.421 . . . . 1.0 110.318 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 12.8 t -81.18 160.76 24.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.335 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -92.29 163.46 13.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.138 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 57.2 tp -79.67 118.71 21.74 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.011 -0.366 . . . . 1.0 110.011 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.39 132.72 52.09 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.968 -0.56 . . . . 1.0 109.986 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 96.4 m -124.38 126.29 45.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.532 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -111.48 155.7 22.82 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.241 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.539 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 82.5 m-20 -104.9 144.16 32.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.591 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.2 t -123.89 136.16 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 109.535 -0.543 . . . . 1.0 109.535 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -95.57 135.26 37.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.627 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.431 HD11 HD21 ' A' ' 97' ' ' LEU . 28.7 tp -99.38 130.14 45.63 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 71.5 p -128.57 159.9 34.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.244 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -76.91 17.46 0.43 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.633 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 60.5 p -123.11 -2.29 8.65 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.669 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 143.12 -132.88 5.22 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.353 -1.099 . . . . 1.0 110.353 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -123.49 134.37 53.9 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 110.167 -0.309 . . . . 1.0 110.167 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.525 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 7.5 m-85 -111.62 122.87 48.96 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 tt -117.84 121.78 41.66 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.492 -0.559 . . . . 1.0 109.492 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.603 ' C ' HD22 ' A' ' 172' ' ' ASN . 4.2 t 37.88 51.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.153 0.427 . . . . 1.0 112.153 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.65 ' N ' HD22 ' A' ' 172' ' ' ASN . 0.6 OUTLIER 68.43 27.52 6.34 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.413 0.894 . . . . 1.0 113.413 179.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -135.65 123.09 21.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.525 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 19.5 t-20 -92.0 129.5 37.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.566 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -103.71 133.39 20.3 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.86 -20.7 22.12 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.053 1.836 . . . . 1.0 113.594 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.426 ' OG ' ' OE1' ' A' ' 180' ' ' GLN . 14.3 p -153.95 158.37 40.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.961 0.41 . . . . 1.0 111.095 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.31 -36.22 76.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.012 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.6 mm -60.54 -48.49 88.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.811 0.339 . . . . 1.0 110.243 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.426 ' OE1' ' OG ' ' A' ' 177' ' ' SER . 9.0 mp0 -65.96 -33.33 75.57 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.18 -41.9 97.62 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 110.025 -0.361 . . . . 1.0 110.025 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 81.6 m -62.3 -46.23 89.69 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 120.57 -0.452 . . . . 1.0 110.116 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 186' ' ' LYS . 65.9 m-20 -65.07 -49.02 71.68 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.89 -46.07 0.86 Allowed Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.841 -1.304 . . . . 1.0 109.841 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -67.77 -47.17 69.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 183' ' ' ASN . 64.7 tttm -56.72 -40.46 75.72 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.764 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 25.7 m -61.16 -45.11 96.0 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.55 -40.86 98.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.859 -0.609 . . . . 1.0 110.1 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.0 tp -57.81 -41.23 81.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.406 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -64.03 -45.13 90.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.112 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.7 p -62.95 -39.4 94.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.973 0.416 . . . . 1.0 110.637 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 61.2 mt -63.81 -43.5 96.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.606 -0.724 . . . . 1.0 111.965 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -71.15 -30.1 66.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.845 0.313 . . . . 1.0 111.845 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . 0.558 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 5.6 t-160 -91.24 -2.75 57.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.991 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' A' ' 194' ' ' HIS . 55.0 p-80 43.23 51.68 5.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.177 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 57.02 160.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.791 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.435 ' N ' ' ND1' ' A' ' 197' ' ' HIS . 0.0 OUTLIER -154.41 154.3 33.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.676 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 74.5 t60 40.36 81.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.055 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 37.0 m80 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 117.949 -1.025 . . . . 1.0 110.733 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.469 ' C ' ' H ' ' A' ' 3' ' ' ARG . 20.2 p . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.485 -0.561 . . . . 1.0 109.485 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.517 ' H ' ' CD2' ' A' ' 2' ' ' HIS . 8.8 p80 -70.66 10.23 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.464 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.469 ' H ' ' C ' ' A' ' 1' ' ' THR . 90.4 mtt180 -148.78 23.6 0.98 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.583 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.805 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 7.2 p -60.41 -47.63 91.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.566 0 CA-C-O 121.756 0.789 . . . . 1.0 110.089 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.554 ' N ' HG13 ' A' ' 4' ' ' VAL . 35.9 pt -59.94 12.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 O-C-N 121.255 -0.903 . . . . 1.0 111.011 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.673 ' H ' ' C ' ' A' ' 4' ' ' VAL . 54.9 t-20 -161.53 32.7 0.13 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.288 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.805 ' ND1' ' O ' ' A' ' 4' ' ' VAL . 3.8 p-80 -75.74 154.35 85.27 Favored Pre-proline 0 N--CA 1.468 0.426 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.02 -28.43 19.01 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.097 1.865 . . . . 1.0 112.7 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -79.94 -9.05 59.64 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.282 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -73.56 134.87 43.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.248 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -150.5 117.17 3.42 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 120.983 -0.287 . . . . 1.0 110.264 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.83 111.59 3.36 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.742 1.628 . . . . 1.0 112.829 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -156.68 155.63 32.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.275 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -78.8 -172.44 3.02 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.49 -48.36 18.5 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.543 -1.023 . . . . 1.0 110.543 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -64.41 -44.14 92.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.76 0.314 . . . . 1.0 110.734 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.17 -35.19 79.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.985 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.07 97.63 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.656 -0.417 . . . . 1.0 110.395 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.57 -43.97 83.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.008 -0.367 . . . . 1.0 110.008 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.06 -43.94 97.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.288 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.503 ' OH ' ' NZ ' ' A' ' 25' ' ' LYS . 94.1 t80 -61.63 -45.39 94.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.875 0.369 . . . . 1.0 110.288 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -72.4 -14.37 61.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.153 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -67.34 -41.84 84.52 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.621 -0.431 . . . . 1.0 110.799 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.6 m -76.37 -23.88 54.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.188 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.503 ' NZ ' ' OH ' ' A' ' 21' ' ' TYR . 32.7 mttp -81.9 176.78 9.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.151 0.5 . . . . 1.0 110.661 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -84.03 161.63 20.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.769 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -76.07 146.31 39.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.033 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.5 12.67 47.21 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.537 ' HB3' HD11 ' A' ' 22' ' ' LEU . 54.5 tp10 -106.54 148.05 28.7 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -127.81 172.49 10.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.473 0.654 . . . . 1.0 111.413 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.57 153.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 114.975 -1.011 . . . . 1.0 111.477 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.484 ' HB ' ' HE2' ' A' ' 7' ' ' HIS . 97.5 mt -116.84 118.48 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.93 151.01 30.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.198 -179.128 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.403 ' NE2' ' O ' ' A' ' 34' ' ' GLN . 3.0 pp0? -98.32 148.1 24.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.422 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 t -69.05 161.38 29.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.82 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.9 p -65.56 -21.83 66.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.833 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -129.53 25.18 5.42 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.413 -0.358 . . . . 1.0 111.167 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . -75.59 -62.32 2.72 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.618 -0.993 . . . . 1.0 110.618 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.3 t0 64.75 -50.62 0.32 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.728 0.299 . . . . 1.0 111.334 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 38' ' ' GLY . 99.5 m-20 -120.66 20.65 11.71 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.977 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.567 ' C ' HD12 ' A' ' 42' ' ' LEU . 79.5 m-70 -147.86 147.73 30.1 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.567 HD12 ' C ' ' A' ' 41' ' ' HIS . 11.2 mp -119.14 151.13 38.85 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.711 -0.478 . . . . 1.0 109.711 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 33' ' ' ARG . 76.4 t -126.96 135.06 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.331 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.644 HD12 HD11 ' A' ' 58' ' ' ILE . 62.8 mt -111.64 137.47 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.076 -0.712 . . . . 1.0 109.076 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.1 m -117.49 135.56 53.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.928 -0.578 . . . . 1.0 109.523 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.575 ' CZ2' HD11 ' A' ' 48' ' ' LEU . 1.5 p-90 -151.99 155.58 38.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.794 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -95.44 141.13 29.35 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.35 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.575 HD11 ' CZ2' ' A' ' 46' ' ' TRP . 9.3 mp -94.82 -35.09 12.23 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.131 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 36.2 t0 -162.89 -138.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.191 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.524 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 70.5 mmtt -53.76 -104.05 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.055 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.476 ' O ' ' CE2' ' A' ' 53' ' ' PHE . 32.3 t70 -85.65 20.91 1.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.232 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.713 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.7 mm? -88.35 131.49 34.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.874 0.369 . . . . 1.0 110.612 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.476 ' CE2' ' O ' ' A' ' 51' ' ' ASP . 25.4 m-85 -136.46 143.82 44.06 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.332 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -146.54 152.67 39.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.024 -0.534 . . . . 1.0 109.677 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -126.88 139.79 52.82 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.207 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.1 mm -115.29 117.61 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -90.53 119.39 30.75 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.904 0.383 . . . . 1.0 110.773 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.644 HD11 HD12 ' A' ' 44' ' ' ILE . 81.5 mt -100.19 131.29 47.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.269 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -118.06 126.52 52.44 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 40' ' ' ASP . 9.6 mp0 -99.68 147.69 25.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.126 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.435 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.8 tt -141.55 170.85 14.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.46 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.435 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 61.8 tt0 72.51 52.24 0.17 Allowed 'General case' 0 C--N 1.334 -0.099 0 O-C-N 123.625 0.578 . . . . 1.0 109.769 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -117.29 84.81 2.22 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.652 -0.703 . . . . 1.0 109.841 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -65.94 -36.76 84.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.056 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -107.66 118.5 53.02 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.051 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -50.11 -30.18 24.4 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.081 1.854 . . . . 1.0 112.105 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 tp -79.51 -11.79 59.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.043 0.449 . . . . 1.0 110.828 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.15 140.57 35.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.188 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.1 mt -81.49 151.15 27.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.498 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.38 122.79 30.97 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.499 -1.041 . . . . 1.0 110.499 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -72.01 -13.01 61.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.87 0.367 . . . . 1.0 110.797 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.1 t -118.12 120.44 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.604 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.2 mt -114.37 126.8 55.41 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.141 -0.688 . . . . 1.0 109.141 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.3 mm -100.18 121.33 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.07 0.462 . . . . 1.0 110.48 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.557 HG21 HD13 ' A' ' 86' ' ' ILE . 5.2 t -138.17 131.28 40.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.283 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 51.8 t0 53.26 47.83 23.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.039 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER 55.52 21.45 4.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.077 179.277 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -128.0 144.23 51.1 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.281 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -88.57 135.01 33.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.957 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -123.74 138.2 54.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.293 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -81.71 -37.97 26.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.692 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -132.7 157.57 44.55 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.225 0.536 . . . . 1.0 111.781 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.2 tp -65.17 -39.27 92.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.501 -0.772 . . . . 1.0 111.215 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.49 -40.91 88.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.734 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -62.2 -38.38 88.89 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 121.004 -0.279 . . . . 1.0 110.757 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.557 HD13 HG21 ' A' ' 75' ' ' VAL . 89.0 mt -62.23 -45.8 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.048 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.5 mt -61.39 -47.27 94.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.483 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.09 -42.38 67.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 112.569 0.581 . . . . 1.0 112.569 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.22 -18.39 60.14 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.748 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -91.89 -50.06 5.92 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.533 -0.467 . . . . 1.0 111.413 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 95' ' ' VAL . 8.0 mp -67.0 -42.21 85.39 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 112.296 0.48 . . . . 1.0 112.296 -178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -63.34 -49.83 72.37 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.739 -0.784 . . . . 1.0 111.64 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -68.69 -43.51 75.92 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.516 -0.474 . . . . 1.0 111.546 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -65.92 -43.88 86.78 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.048 -0.661 . . . . 1.0 111.313 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 91' ' ' LEU . 55.6 t -65.65 -45.45 92.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.237 -0.585 . . . . 1.0 111.203 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -68.24 -46.08 71.45 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.715 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.82 -41.61 87.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.467 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.96 -42.17 94.83 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.314 -0.554 . . . . 1.0 110.134 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -67.74 -38.61 83.73 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.035 -0.529 . . . . 1.0 111.196 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -70.59 -42.46 71.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.877 -0.329 . . . . 1.0 111.78 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.601 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 4.1 ttt -67.24 -55.03 15.71 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.465 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.1 m -59.04 -41.95 89.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.983 0.42 . . . . 1.0 110.669 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.6 p -72.45 8.78 1.25 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.991 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.6 t -88.53 138.49 31.38 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.722 0.296 . . . . 1.0 110.234 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -61.88 -18.24 59.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.869 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.555 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 59.8 mttp -89.34 39.05 0.93 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.023 -0.535 . . . . 1.0 109.694 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -130.99 111.75 12.32 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.357 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -131.34 114.63 15.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.057 -0.519 . . . . 1.0 109.828 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.7 m -88.76 78.97 7.55 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.046 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -105.46 152.87 17.24 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.582 ' O ' HG23 ' A' ' 115' ' ' VAL . 62.1 p -72.56 171.51 12.27 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -57.51 -40.72 79.36 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.575 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -68.08 -42.59 80.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.019 0.438 . . . . 1.0 110.505 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -70.18 -21.86 63.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.117 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 111' ' ' THR . 32.4 t -69.43 -44.33 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.085 -0.339 . . . . 1.0 110.085 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.7 t -65.44 -45.46 92.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.099 0.476 . . . . 1.0 110.342 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -65.91 -34.12 77.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.984 0.421 . . . . 1.0 110.842 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -67.44 -50.23 60.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.628 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.4 tp -70.18 -39.08 76.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.046 0.451 . . . . 1.0 110.312 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.0 -42.43 97.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.624 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -61.3 -46.85 88.6 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.264 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.537 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 34.4 t80 -61.65 -43.08 99.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.107 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.2 p -61.89 -36.64 81.89 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.424 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -62.3 -39.04 91.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.313 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.38 -43.06 84.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.455 -0.498 . . . . 1.0 109.834 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.537 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -128.44 73.88 80.16 Favored Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.227 179.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.69 -16.54 26.66 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.475 2.117 . . . . 1.0 112.443 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -89.76 -5.55 56.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.678 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -127.07 149.93 49.7 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.004 0.431 . . . . 1.0 110.432 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.9 p -80.18 162.63 24.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.561 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 p -151.5 145.41 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -140.06 145.48 37.75 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.852 0.358 . . . . 1.0 111.25 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -151.37 171.3 17.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.048 -0.523 . . . . 1.0 110.221 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -137.25 156.91 47.72 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.268 -0.641 . . . . 1.0 109.268 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 29.3 p -155.07 168.7 26.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.371 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.0 tp -79.76 138.49 37.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.51 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.822 ' H ' HD22 ' A' ' 137' ' ' ASN . 0.1 OUTLIER -97.5 141.47 30.52 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.238 179.31 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -95.01 -16.98 22.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.583 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 18.0 p30 -69.93 -27.01 64.41 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.274 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 139' ' ' ASP . 22.7 m120 -159.2 92.26 1.89 Allowed Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 109.954 -0.387 . . . . 1.0 109.954 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.01 142.7 94.04 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.013 1.808 . . . . 1.0 112.404 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.53 -25.38 27.0 Favored Glycine 0 N--CA 1.464 0.542 0 N-CA-C 110.779 -0.928 . . . . 1.0 110.779 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.521 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 7.6 m0 -99.47 144.87 28.08 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 120.897 0.38 . . . . 1.0 110.09 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.601 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 70.9 m-85 -109.7 146.47 34.81 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.792 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.523 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 12.0 m-85 -119.28 132.01 55.84 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.036 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.429 HD12 ' CG2' ' A' ' 161' ' ' VAL . 11.5 mt -106.78 128.56 54.34 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.442 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.582 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -126.36 148.17 49.63 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 178.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -158.44 155.34 28.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.28 -0.568 . . . . 1.0 109.57 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.524 ' NZ ' ' O ' ' A' ' 154' ' ' SER . 4.1 tttm -134.15 130.41 37.28 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.851 0.357 . . . . 1.0 110.552 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.543 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 23.5 mm -75.76 -48.65 28.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.816 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 150' ' ' ILE . 29.2 m120 -155.51 169.11 25.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.629 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.11 -28.38 66.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.787 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.68 4.78 51.92 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.06 0.457 . . . . 1.0 110.417 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.524 ' O ' ' NZ ' ' A' ' 149' ' ' LYS . 12.4 t -90.89 165.85 13.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.316 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -99.09 148.97 23.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.47 . . . . 1.0 109.789 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 44.5 tp -72.28 118.44 15.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.901 0.381 . . . . 1.0 110.285 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -109.07 131.39 55.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.077 -0.51 . . . . 1.0 109.644 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 92.5 m -128.76 130.6 47.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.926 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -116.77 168.33 10.3 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.107 -0.497 . . . . 1.0 109.914 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.523 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 83.9 m-20 -111.7 148.34 33.64 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.648 -0.706 . . . . 1.0 110.84 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.429 ' CG2' HD12 ' A' ' 146' ' ' LEU . 74.5 t -128.36 138.18 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -103.59 128.84 50.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.196 0.522 . . . . 1.0 110.877 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.2 tp -89.16 129.23 35.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.545 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 80.8 p -129.17 174.62 9.41 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.38 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -86.43 14.13 7.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.693 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.593 ' O ' HG22 ' A' ' 166' ' ' THR . 26.9 m -121.91 -2.58 9.23 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.446 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 138.1 -141.66 12.36 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.112 -1.195 . . . . 1.0 110.112 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -109.58 126.51 53.68 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.452 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 4.6 m-85 -104.76 116.48 32.09 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.9 tt -113.08 115.42 28.3 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.583 ' C ' HD22 ' A' ' 172' ' ' ASN . 4.4 t 37.89 62.3 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 112.084 0.402 . . . . 1.0 112.084 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.646 ' N ' HD22 ' A' ' 172' ' ' ASN . 0.6 OUTLIER 63.43 27.9 15.32 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.165 0.802 . . . . 1.0 113.165 178.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 62.8 m-85 -133.87 122.49 23.27 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.452 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 7.1 t-20 -100.05 120.56 40.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.688 0.28 . . . . 1.0 111.529 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -98.66 136.96 20.58 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.44 -23.11 24.05 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.185 1.923 . . . . 1.0 113.396 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 5.1 t -154.17 158.45 40.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.104 0.478 . . . . 1.0 110.923 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.9 p -59.74 -34.42 55.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.816 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.0 -44.83 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.368 . . . . 1.0 110.246 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -69.08 -31.25 69.86 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 43.8 tp -62.67 -42.18 99.48 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.102 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 75.0 m -63.21 -45.9 89.51 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 120.634 -0.426 . . . . 1.0 110.209 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 186' ' ' LYS . 38.8 m-80 -63.28 -46.47 86.65 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 108.512 -0.921 . . . . 1.0 108.512 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.54 -46.55 0.8 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.818 -1.313 . . . . 1.0 109.818 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.89 -43.9 74.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.11 -0.545 . . . . 1.0 109.935 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.0 tttm -56.92 -43.8 81.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.401 -0.818 . . . . 1.0 110.016 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 13.7 m -61.64 -45.48 93.87 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.83 -43.55 98.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.061 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.9 tp -57.85 -45.4 86.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.855 0.359 . . . . 1.0 110.493 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.406 ' CE ' ' NZ ' ' A' ' 186' ' ' LYS . 46.9 mttm -61.96 -45.02 95.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.397 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.4 m -62.1 -41.78 98.56 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.985 0.421 . . . . 1.0 110.608 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 69.5 mt -63.98 -42.96 97.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.49 -0.777 . . . . 1.0 111.831 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -67.11 -30.71 70.8 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.885 0.328 . . . . 1.0 111.885 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . 0.414 ' O ' ' ND1' ' A' ' 194' ' ' HIS . 13.0 t-80 -79.98 -6.22 57.14 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.874 -0.33 . . . . 1.0 110.696 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 1.7 m80 49.29 50.85 17.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.026 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.501 ' O ' ' ND1' ' A' ' 197' ' ' HIS . 83.0 t60 -70.17 -85.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.675 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 196' ' ' HIS . 68.0 m-70 -156.76 166.8 32.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.669 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -65.86 148.45 51.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.801 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 69.0 m80 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.008 -0.996 . . . . 1.0 110.67 179.741 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -107.81 -2.02 20.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.433 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.429 ' O ' ' CE1' ' A' ' 7' ' ' HIS . 18.7 mmm180 -119.31 -28.19 5.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.963 0.411 . . . . 1.0 110.353 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.27 -30.62 49.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.425 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.1 pt -69.72 -19.22 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.427 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -91.28 3.28 55.26 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.697 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.429 ' CE1' ' O ' ' A' ' 3' ' ' ARG . 0.6 OUTLIER -88.91 143.67 31.81 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.072 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.7 -15.14 40.63 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.262 1.975 . . . . 1.0 112.132 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.529 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 54.2 m-85 -92.02 8.05 39.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.12 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.497 ' OH ' ' NE2' ' A' ' 34' ' ' GLN . 85.6 t80 -104.18 125.72 50.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 1.0 110.291 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -157.73 117.69 1.94 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 109.43 -0.581 . . . . 1.0 109.43 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.9 129.5 34.85 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 121.227 1.285 . . . . 1.0 112.626 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -157.99 149.13 21.14 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.091 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 16' ' ' ARG . 13.8 t-20 -77.91 164.44 25.13 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.22 -49.79 74.75 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.462 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 23.3 mmt85 -65.7 -39.52 91.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.696 0.284 . . . . 1.0 110.797 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.5 ' N ' ' CD ' ' A' ' 17' ' ' GLN . 1.1 mp0 -66.07 -35.4 80.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.069 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.09 -46.02 92.35 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.268 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -60.81 -45.15 95.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.933 -0.395 . . . . 1.0 109.933 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.04 -42.63 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.104 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.484 ' CZ ' ' NZ ' ' A' ' 25' ' ' LYS . 66.4 t80 -62.87 -42.27 99.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.403 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 18' ' ' ALA . 8.5 mp -74.27 -15.31 60.98 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.843 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -61.87 -42.57 99.22 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.393 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.1 p -77.48 -21.04 53.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.784 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.484 ' NZ ' ' CZ ' ' A' ' 21' ' ' TYR . 44.4 mmtm -79.64 176.05 10.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.51 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -100.43 171.58 7.66 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.667 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -61.73 143.58 55.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.822 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.35 10.3 59.55 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.057 -0.817 . . . . 1.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -86.88 137.43 32.4 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -135.52 161.83 34.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.266 0.555 . . . . 1.0 110.836 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.706 ' O ' HG23 ' A' ' 44' ' ' ILE . 11.0 m -147.49 157.28 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.274 -0.875 . . . . 1.0 111.316 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 84.1 mt -118.43 128.41 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.481 ' CZ ' ' OG1' ' A' ' 45' ' ' THR . 23.8 ptt180 -147.34 154.78 41.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.32 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.497 ' NE2' ' OH ' ' A' ' 10' ' ' TYR . 4.2 pt20 -104.7 144.78 31.26 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.3 t -89.32 136.0 33.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.591 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.2 t -60.62 -40.6 92.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.566 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -79.32 -11.41 59.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.577 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.94 -68.48 1.45 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.542 -1.023 . . . . 1.0 110.542 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 t0 74.85 -39.88 0.42 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.604 0.24 . . . . 1.0 110.942 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -113.58 -11.27 13.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.838 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.613 ' C ' HD12 ' A' ' 42' ' ' LEU . 14.3 m170 -117.71 151.14 37.86 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.344 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.613 HD12 ' C ' ' A' ' 41' ' ' HIS . 11.2 mp -117.39 153.83 32.37 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.661 -0.496 . . . . 1.0 109.661 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.1 t -127.7 134.91 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.343 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 31' ' ' VAL . 69.0 mt -114.24 138.35 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 108.768 -0.827 . . . . 1.0 108.768 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.481 ' OG1' ' CZ ' ' A' ' 33' ' ' ARG . 26.4 m -117.61 138.26 52.07 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.136 0.493 . . . . 1.0 109.805 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.555 ' CZ2' HD11 ' A' ' 48' ' ' LEU . 5.2 p-90 -148.93 156.54 42.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.457 -0.792 . . . . 1.0 111.163 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.453 ' C ' HD12 ' A' ' 48' ' ' LEU . 37.5 ttpt -100.78 140.2 35.41 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.034 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.6 mp -96.53 -68.19 0.81 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.217 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -152.98 147.88 26.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.276 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt 46.73 -127.81 1.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.858 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 16.3 p-10 -93.61 25.99 3.26 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.696 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.619 HD13 ' N ' ' A' ' 53' ' ' PHE . 0.3 OUTLIER -92.69 119.65 32.3 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 -179.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.619 ' N ' HD13 ' A' ' 52' ' ' LEU . 94.8 m-85 -123.52 148.38 46.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.3 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -142.3 153.47 43.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.83 -0.623 . . . . 1.0 109.966 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -128.39 142.44 51.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.439 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.3 mt -120.55 125.35 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.001 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -95.29 120.75 36.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.912 0.386 . . . . 1.0 110.378 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.406 HD11 ' CD1' ' A' ' 44' ' ' ILE . 96.2 mt -98.69 132.13 44.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.431 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -114.68 140.88 48.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 1.0 109.696 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -99.39 157.55 16.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.456 . . . . 1.0 109.862 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.494 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.9 tp -141.77 171.71 13.69 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.485 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.494 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 79.1 mm-40 59.06 28.87 18.27 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.284 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -94.26 48.76 1.25 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.049 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.19 -39.17 86.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.291 -0.868 . . . . 1.0 111.411 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 68' ' ' ALA . 8.9 p30 -113.43 114.44 47.8 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.482 -0.327 . . . . 1.0 110.332 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.06 -13.31 0.92 Allowed 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.854 1.702 . . . . 1.0 112.167 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.6 mt -80.73 -7.56 59.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.433 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.435 ' N ' ' OD1' ' A' ' 65' ' ' ASN . . . -118.66 131.89 56.17 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.974 0.416 . . . . 1.0 110.18 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 71' ' ' LYS . 54.1 mt -76.43 156.46 33.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.288 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -43.62 91.84 0.01 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.594 -1.002 . . . . 1.0 110.594 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 69' ' ' LEU . 7.0 ttpm? -63.52 -31.07 72.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.974 0.416 . . . . 1.0 110.706 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.2 t -128.92 125.21 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.945 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.9 mt -115.77 130.13 56.73 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.89 -0.596 . . . . 1.0 109.424 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.6 mt -100.4 121.67 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 120.869 0.366 . . . . 1.0 110.535 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -141.84 133.11 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.452 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' A' ' 77' ' ' ASN . 90.2 m-20 52.7 47.64 24.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.968 -0.293 . . . . 1.0 111.211 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 3.6 p30 56.32 15.79 2.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.123 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -124.76 142.32 51.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.367 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -93.14 131.58 38.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.008 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.444 ' HB2' HD11 ' A' ' 86' ' ' ILE . 96.8 m-85 -127.07 138.31 53.18 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.199 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -84.42 -37.05 21.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.496 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -117.46 142.14 47.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.887 0.375 . . . . 1.0 111.95 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.97 -40.69 95.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.882 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.61 -41.74 91.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.796 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -59.15 -38.87 80.74 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.637 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.444 HD11 ' HB2' ' A' ' 80' ' ' TYR . 97.6 mt -62.43 -45.11 99.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.678 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.83 -44.67 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.59 -0.444 . . . . 1.0 111.112 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.492 HG12 ' NE2' ' A' ' 92' ' ' GLN . 61.8 t -68.14 -42.32 84.84 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-N 115.92 -0.582 . . . . 1.0 112.282 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -80.37 -13.16 59.39 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.322 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.516 ' OH ' ' CZ2' ' A' ' 46' ' ' TRP . 77.4 t80 -94.39 -50.21 5.34 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.661 -0.416 . . . . 1.0 111.992 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -66.34 -43.25 86.59 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.539 -0.464 . . . . 1.0 112.197 -177.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.492 ' NE2' HG12 ' A' ' 88' ' ' VAL . 2.9 pt20 -64.01 -47.17 81.31 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.943 -0.703 . . . . 1.0 111.668 -178.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 165' ' ' ASN . 53.9 t-20 -69.19 -43.34 74.38 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.544 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -65.93 -42.53 89.97 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.146 -0.621 . . . . 1.0 111.363 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.524 ' O ' ' ND2' ' A' ' 99' ' ' ASN . 56.1 t -63.64 -47.13 92.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.01 -0.676 . . . . 1.0 111.336 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -68.98 -41.28 78.09 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.567 -0.453 . . . . 1.0 111.512 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.524 HD11 ' CZ ' ' A' ' 168' ' ' TYR . 12.3 tp -66.3 -44.37 83.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.806 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 mp -65.37 -43.16 91.67 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.306 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 95' ' ' VAL . 2.7 m-80 -67.17 -37.12 83.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.987 -0.552 . . . . 1.0 111.192 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -71.28 -42.79 68.27 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 121.033 -0.267 . . . . 1.0 111.683 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 tpt -67.63 -54.0 23.32 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.397 -0.521 . . . . 1.0 111.329 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.9 m -58.6 -42.6 88.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.046 0.451 . . . . 1.0 110.335 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.4 t -73.72 8.18 2.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.881 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.8 t -86.24 141.4 29.32 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.64 0.257 . . . . 1.0 110.498 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -65.35 -20.57 66.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.9 0.381 . . . . 1.0 110.773 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.564 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 70.0 mmtt -88.92 38.87 0.9 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.831 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -131.48 111.92 12.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.754 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -118.61 109.66 16.41 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.411 -0.589 . . . . 1.0 109.411 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.2 t -87.56 70.39 9.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.565 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.51 160.85 12.97 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 110.714 -0.954 . . . . 1.0 110.714 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.508 HG22 ' N ' ' A' ' 112' ' ' LYS . 28.5 m -70.36 164.17 25.07 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.508 ' N ' HG22 ' A' ' 111' ' ' THR . 63.5 mttp -54.67 -36.13 64.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.743 0.306 . . . . 1.0 110.493 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -66.52 -42.23 87.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.952 0.406 . . . . 1.0 110.553 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -70.29 -21.15 62.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.993 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.75 -45.44 81.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.242 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.46 -44.7 94.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.147 0.499 . . . . 1.0 110.433 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -65.89 -33.63 76.27 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.962 0.41 . . . . 1.0 110.644 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -68.42 -50.07 55.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.535 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.457 HD11 HG13 ' A' ' 131' ' ' VAL . 9.6 tp -69.92 -39.55 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.415 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -64.72 -40.45 95.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.645 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -59.56 -47.56 85.06 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.365 -0.534 . . . . 1.0 110.151 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -61.48 -40.3 94.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.046 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.5 t -62.39 -42.7 99.63 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.534 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -61.6 -40.04 93.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.68 -42.37 86.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.688 -0.405 . . . . 1.0 109.938 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.65 75.23 74.97 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.174 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.09 -14.08 31.68 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.237 1.958 . . . . 1.0 112.496 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.507 HD22 ' C ' ' A' ' 128' ' ' ASN . 0.1 OUTLIER -102.79 11.14 37.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.533 -0.303 . . . . 1.0 111.532 -179.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.475 ' N ' HD22 ' A' ' 128' ' ' ASN . 52.2 mtpt -132.81 147.57 52.31 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.925 0.393 . . . . 1.0 110.497 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.42 ' HB3' HD12 ' A' ' 150' ' ' ILE . 16.8 p -81.18 162.21 23.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.747 -0.661 . . . . 1.0 109.856 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 119' ' ' ILE . 3.8 p -153.59 146.21 14.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.501 ' O ' ' CD1' ' A' ' 133' ' ' TYR . 10.3 p90 -144.94 142.67 30.04 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.907 0.384 . . . . 1.0 111.312 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 26.0 m-85 -152.75 167.64 28.33 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.555 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.564 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 4.1 p90 -135.64 151.8 50.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.423 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.1 p -154.17 170.51 21.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.518 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 tt -84.79 134.36 34.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.679 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 138' ' ' HIS . 69.3 m-80 -159.51 166.78 30.14 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.918 -0.401 . . . . 1.0 109.918 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.46 ' O ' ' OD1' ' A' ' 139' ' ' ASP . 3.9 t60 76.21 -158.48 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.462 -0.336 . . . . 1.0 110.733 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 138' ' ' HIS . 92.8 m-20 -142.67 64.07 1.38 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.592 ' O ' ' N ' ' A' ' 142' ' ' GLY . 2.7 m120 -129.33 156.01 79.11 Favored Pre-proline 0 CA--C 1.53 0.176 0 N-CA-C 108.897 -0.779 . . . . 1.0 108.897 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -42.81 78.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.753 2.302 . . . . 1.0 113.046 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 140' ' ' ASN . . . 52.07 64.35 4.05 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.247 -0.741 . . . . 1.0 111.247 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -94.94 152.5 18.29 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.674 -0.491 . . . . 1.0 109.674 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -121.05 153.15 37.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.798 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -127.16 127.97 45.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.872 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.1 mt -95.47 123.02 38.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.003 0.43 . . . . 1.0 110.982 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.64 145.61 46.3 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.127 -1.064 . . . . 1.0 108.127 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -159.79 157.59 29.57 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.299 -0.56 . . . . 1.0 109.944 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.554 ' NZ ' ' O ' ' A' ' 151' ' ' ASN . 36.6 tttm -142.87 126.28 16.69 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 120.668 -0.413 . . . . 1.0 110.056 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 151' ' ' ASN . 4.7 tp -78.84 -45.64 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.802 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.561 ' N ' HG23 ' A' ' 150' ' ' ILE . 29.4 m120 -144.86 157.98 43.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.842 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.03 -26.5 68.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.875 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -83.25 -16.43 46.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.177 0.513 . . . . 1.0 110.199 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.1 t -77.94 170.51 16.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.153 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -97.31 155.03 17.06 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.367 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.22 120.03 18.27 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.26 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -106.04 127.17 52.99 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.107 -0.497 . . . . 1.0 109.839 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 95.9 m -128.62 130.87 47.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.994 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -118.88 170.1 9.3 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.863 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -111.83 147.39 35.84 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.8 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.1 t -128.21 135.62 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.504 ' NZ ' ' CG2' ' A' ' 164' ' ' THR . 17.1 ttpp -101.56 130.72 47.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.869 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.2 tp -88.91 130.69 35.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.686 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.504 ' CG2' ' NZ ' ' A' ' 162' ' ' LYS . 66.2 p -129.28 171.46 12.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.582 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.533 ' O ' ' ND2' ' A' ' 93' ' ' ASN . 14.4 p30 -83.84 13.97 4.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.67 -0.696 . . . . 1.0 110.472 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 25.1 p -121.76 -2.22 9.35 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.606 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 139.4 -126.37 3.3 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.303 -1.119 . . . . 1.0 110.303 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.524 ' CZ ' HD11 ' A' ' 97' ' ' LEU . 28.6 m-85 -127.41 127.31 43.93 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.652 0.263 . . . . 1.0 110.635 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.514 ' CE1' ' OD1' ' A' ' 174' ' ' ASN . 4.3 m-85 -100.87 124.47 46.58 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.8 tt -116.83 111.16 19.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.572 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 170' ' ' LEU . 4.7 t 35.49 63.44 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.6 m120 67.29 26.28 8.6 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -132.87 121.45 22.92 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.514 ' OD1' ' CE1' ' A' ' 169' ' ' PHE . 63.7 t30 -98.24 120.65 39.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.944 0.402 . . . . 1.0 111.635 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -105.13 125.61 33.15 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.2 -20.6 18.72 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.33 2.02 . . . . 1.0 113.504 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.2 m -137.2 141.39 42.13 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.982 0.42 . . . . 1.0 111.07 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.08 -34.67 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.575 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.08 -44.31 98.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.635 -0.426 . . . . 1.0 109.934 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -68.86 -30.26 68.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.1 tp -63.53 -43.24 97.72 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.205 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 7.7 p -62.87 -47.43 83.37 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.52 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.583 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 42.8 m-80 -65.01 -48.03 75.38 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.944 -0.761 . . . . 1.0 108.944 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.84 -44.85 1.0 Allowed Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.818 -1.313 . . . . 1.0 109.818 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -69.13 -47.05 66.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.9 tttm -56.12 -41.23 74.97 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.327 -0.851 . . . . 1.0 110.039 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 94.0 m -61.39 -45.04 96.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 51.7 mt -62.86 -41.08 99.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.001 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.535 HD11 HD13 ' A' ' 150' ' ' ILE . 57.6 tp -59.43 -44.16 92.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.323 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.42 -45.09 95.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.243 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 37.0 t -64.09 -38.87 92.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.804 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.2 mt -63.17 -41.95 99.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.61 -0.723 . . . . 1.0 111.608 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -59.96 -23.53 63.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.609 0.243 . . . . 1.0 111.555 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 194' ' ' HIS . 47.7 t-80 -81.07 9.98 5.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.785 0.326 . . . . 1.0 110.906 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.41 ' O ' ' N ' ' A' ' 197' ' ' HIS . 16.5 t60 71.67 23.58 3.7 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.969 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.425 ' CG ' ' N ' ' A' ' 197' ' ' HIS . 33.6 t-80 37.44 -96.72 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.372 -0.377 . . . . 1.0 111.083 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.521 ' ND1' ' N ' ' A' ' 198' ' ' HIS . 56.9 t-80 48.9 -111.3 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.687 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.521 ' N ' ' ND1' ' A' ' 197' ' ' HIS . 51.5 t-80 -81.94 136.65 35.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.738 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.001 -1.0 . . . . 1.0 110.506 179.96 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -107.64 -22.69 12.41 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.682 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -143.02 8.55 1.66 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.806 0.336 . . . . 1.0 110.53 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.36 -37.03 79.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.676 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.3 pt -62.34 -26.45 40.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.363 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -74.9 -13.28 60.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.477 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -79.21 115.67 54.53 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.284 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 76.6 Cg_exo -48.38 -24.9 6.64 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.869 1.712 . . . . 1.0 112.305 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -81.73 3.95 23.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.184 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 91.9 t80 -85.95 132.8 34.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.594 -0.275 . . . . 1.0 110.436 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 62.1 m-85 -150.77 123.58 4.18 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 120.995 -0.282 . . . . 1.0 110.476 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.474 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 73.7 Cg_endo -73.83 110.21 3.03 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.935 1.757 . . . . 1.0 112.631 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.474 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 74.1 m-85 -159.82 154.64 24.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.338 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -80.86 166.29 21.06 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.632 ' N ' ' NH1' ' A' ' 33' ' ' ARG . . . -57.03 -46.89 90.99 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.756 -0.938 . . . . 1.0 110.756 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -65.51 -39.01 91.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.59 0.233 . . . . 1.0 110.736 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -66.14 -37.14 84.96 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.696 -0.229 . . . . 1.0 111.205 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.415 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.15 -45.22 95.54 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.659 -0.417 . . . . 1.0 110.31 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -61.43 -46.5 89.86 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.669 -0.412 . . . . 1.0 109.948 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -62.28 -43.36 98.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.315 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -63.08 -44.48 95.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.56 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 18' ' ' ALA . 8.8 mp -75.02 -13.6 60.52 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.647 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -60.97 -41.92 97.31 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.39 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.9 t -74.93 -18.54 60.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.503 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -85.46 -175.66 5.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.788 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.46 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 45.4 mp0 -99.72 -179.25 4.13 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.472 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -81.41 145.56 30.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.634 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.39 8.0 53.46 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.143 -0.783 . . . . 1.0 111.143 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -95.77 139.63 31.72 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.387 -0.598 . . . . 1.0 109.387 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -131.05 167.96 18.2 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.284 0.564 . . . . 1.0 111.133 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -148.81 159.54 6.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.19 -0.913 . . . . 1.0 111.414 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.56 127.11 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.338 -0.616 . . . . 1.0 109.338 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.632 ' NH1' ' N ' ' A' ' 15' ' ' GLY . 44.4 ttp180 -134.39 153.58 51.82 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.152 -0.476 . . . . 1.0 109.752 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.419 ' N ' ' HG2' ' A' ' 33' ' ' ARG . 51.7 mt-30 -105.83 131.23 53.42 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.673 -0.492 . . . . 1.0 109.673 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -77.56 124.3 27.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.867 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.8 p -63.76 -38.82 92.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.625 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -79.11 -25.09 43.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.797 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -69.99 -53.85 13.58 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.54 -1.024 . . . . 1.0 110.54 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t0 70.7 -42.45 0.53 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.725 0.298 . . . . 1.0 111.034 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 38' ' ' GLY . 98.2 m-20 -119.45 19.92 12.58 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.65 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -140.27 150.71 44.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.669 0.271 . . . . 1.0 110.475 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.03 151.36 39.11 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.844 -0.428 . . . . 1.0 109.844 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.1 t -126.19 133.81 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.587 0.232 . . . . 1.0 110.727 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.531 HD12 HD11 ' A' ' 58' ' ' ILE . 92.3 mt -110.55 136.31 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.9 m -117.63 139.31 51.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.006 -0.543 . . . . 1.0 109.635 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.562 ' CE2' ' OH ' ' A' ' 90' ' ' TYR . 3.7 p-90 -143.3 153.1 42.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.776 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' A' ' 49' ' ' ASP . 64.7 tttp -101.4 133.3 46.22 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.829 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -96.07 -75.51 0.53 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.503 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.511 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 72.4 m-20 -109.99 -167.81 1.24 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.872 -0.603 . . . . 1.0 110.596 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -60.38 -42.31 95.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.775 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -128.43 56.94 1.6 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.797 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 44.5 tp -153.59 115.48 4.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.913 0.387 . . . . 1.0 110.081 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -124.88 148.19 48.41 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.33 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -136.87 152.69 50.53 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.971 -0.558 . . . . 1.0 110.283 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -129.9 144.39 51.29 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.661 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.521 HD12 ' CZ ' ' A' ' 90' ' ' TYR . 97.0 mt -125.36 131.52 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.228 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -98.27 122.79 41.87 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.978 0.418 . . . . 1.0 110.84 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.531 HD11 HD12 ' A' ' 44' ' ' ILE . 91.2 mt -101.13 133.75 43.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.385 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 59' ' ' GLN . 1.2 pm0 -120.12 132.49 55.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -99.99 144.54 28.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.103 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.728 HD13 ' H ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -135.91 173.48 11.66 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.158 0.504 . . . . 1.0 109.947 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.728 ' H ' HD13 ' A' ' 61' ' ' LEU . 13.1 tp10 87.32 33.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.677 -1.147 . . . . 1.0 109.922 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -92.33 76.26 5.23 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.756 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.4 ' O ' ' OD1' ' A' ' 65' ' ' ASN . 12.5 pt-20 -64.99 -36.48 84.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.813 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.423 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 4.9 m-20 -136.15 153.66 76.82 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.305 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.12 -33.26 53.03 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.769 1.646 . . . . 1.0 112.29 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.7 mt -84.6 -6.72 59.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.373 . . . . 1.0 110.383 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.423 ' HB3' ' H ' ' A' ' 65' ' ' ASN . . . -88.19 127.33 35.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.273 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.0 mt -86.03 153.73 21.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.302 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.9 95.51 0.41 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.313 -1.115 . . . . 1.0 110.313 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -71.92 -15.41 62.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.927 0.394 . . . . 1.0 110.684 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.2 t -118.26 120.35 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.669 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.2 mt -113.82 126.02 54.73 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.9 mt -102.08 123.64 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.882 0.372 . . . . 1.0 110.653 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.435 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 57.8 t -142.88 134.18 23.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.976 -0.557 . . . . 1.0 110.34 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.437 ' OD2' ' O ' ' A' ' 76' ' ' ASP . 3.4 p-10 48.67 44.32 21.23 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.216 0.323 . . . . 1.0 111.263 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 59.69 23.18 11.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.038 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -129.15 138.38 51.74 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.358 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -92.23 132.16 36.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 1.0 111.11 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.481 ' HB2' HD11 ' A' ' 86' ' ' ILE . 90.4 m-85 -126.88 138.07 53.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.263 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -82.76 -37.73 24.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.821 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -109.48 133.34 53.2 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.005 0.431 . . . . 1.0 112.028 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.4 tp -64.41 -40.73 96.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.503 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -62.06 -43.23 99.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.501 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.46 ' O ' ' OE1' ' A' ' 89' ' ' GLU . 32.8 tt0 -58.39 -38.3 77.05 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.345 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 80' ' ' TYR . 96.1 mt -59.66 -45.31 94.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.753 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.843 ' O ' HD12 ' A' ' 91' ' ' LEU . 43.9 mm -62.57 -47.42 93.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.429 -0.508 . . . . 1.0 111.607 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.1 t -69.86 -23.56 25.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 112.967 0.728 . . . . 1.0 112.967 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 85' ' ' GLN . 4.5 mp0 -98.1 -9.59 25.64 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.142 -0.223 . . . . 1.0 111.054 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.562 ' OH ' ' CE2' ' A' ' 46' ' ' TRP . 12.5 t80 -89.38 -54.58 4.03 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.913 0.709 . . . . 1.0 112.913 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.957 HD13 ' H ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -71.59 -33.56 69.14 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.706 -0.679 . . . . 1.0 112.107 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.957 ' H ' HD13 ' A' ' 91' ' ' LEU . 3.5 mm-40 -61.2 -48.68 80.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.07 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -67.72 -40.53 84.21 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.068 -0.653 . . . . 1.0 111.448 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -63.11 -42.6 99.59 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.438 -0.505 . . . . 1.0 111.275 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.93 -45.88 93.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.331 -0.548 . . . . 1.0 111.279 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -66.8 -45.4 78.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.383 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tp -69.04 -41.16 78.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.55 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.44 -42.25 92.61 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.472 -0.491 . . . . 1.0 110.053 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -66.38 -39.92 89.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.382 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -71.18 -42.81 68.56 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 120.781 -0.368 . . . . 1.0 111.783 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.1 tpt -63.96 -54.01 41.24 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.349 -0.54 . . . . 1.0 111.096 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.7 m -61.26 -39.36 90.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.48 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.2 t -73.16 9.77 1.15 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.911 -0.586 . . . . 1.0 111.224 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 87.1 p -88.03 139.22 30.73 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.681 0.277 . . . . 1.0 110.725 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.68 -22.32 66.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.996 0.427 . . . . 1.0 110.626 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.564 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 31.5 mtmm -88.2 39.63 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.804 -0.635 . . . . 1.0 109.828 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -129.84 114.02 15.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.515 . . . . 1.0 111.068 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -122.75 124.66 43.86 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -93.65 68.09 3.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.826 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.13 147.51 16.84 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 115' ' ' VAL . 29.2 p -72.42 172.08 11.09 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -55.9 -37.66 69.18 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.364 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -67.47 -45.07 77.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.841 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.73 -20.37 63.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.781 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 111' ' ' THR . 39.4 t -69.71 -44.82 78.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.343 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.58 -46.38 95.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.207 0.527 . . . . 1.0 110.178 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -65.77 -33.99 77.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.829 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -68.31 -50.23 54.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.795 -0.639 . . . . 1.0 111.679 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.429 HD11 HG13 ' A' ' 131' ' ' VAL . 10.4 tp -69.99 -39.4 77.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.682 -0.407 . . . . 1.0 110.457 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.51 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 66.8 mm-40 -63.75 -40.56 97.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.716 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -63.43 -46.85 84.39 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.11 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.537 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 9.2 t80 -61.92 -41.83 98.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.14 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.5 t -62.28 -40.53 96.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.41 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -57.74 -44.03 85.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.315 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.47 -38.89 83.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.368 -0.605 . . . . 1.0 109.368 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.537 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -124.56 76.25 63.34 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.598 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -70.5 -24.56 26.14 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.799 2.333 . . . . 1.0 112.514 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -100.94 13.54 34.81 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.867 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.33 151.0 51.84 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.846 0.355 . . . . 1.0 110.482 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 m -80.91 160.87 24.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.887 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.429 HG13 HD11 ' A' ' 119' ' ' ILE . 4.2 p -153.05 149.81 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 109.36 -0.607 . . . . 1.0 109.36 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -151.0 143.44 24.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.922 0.392 . . . . 1.0 111.307 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -151.37 165.13 35.03 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.374 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.564 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.6 p90 -136.08 148.55 48.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 1.0 109.481 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 75.1 m -143.92 167.77 21.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.088 0.471 . . . . 1.0 110.214 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.8 tt -83.61 131.72 34.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.252 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -104.31 133.45 49.18 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.221 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -85.81 0.81 51.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.846 0.355 . . . . 1.0 110.585 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 139' ' ' ASP . 66.4 t0 -64.13 -37.9 89.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.127 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -150.81 104.59 3.04 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.085 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -48.65 124.04 10.38 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.597 1.531 . . . . 1.0 112.78 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.99 29.5 9.02 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.839 -0.905 . . . . 1.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -134.9 142.21 46.51 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.676 0.274 . . . . 1.0 110.32 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -122.16 146.49 47.18 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.625 ' CE2' ' ND2' ' A' ' 160' ' ' ASN . 13.6 m-85 -117.89 138.68 51.96 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.188 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.436 HD12 ' CG2' ' A' ' 161' ' ' VAL . 7.3 mt -110.44 120.95 44.08 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.617 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.57 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -116.07 145.01 43.37 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.988 -1.115 . . . . 1.0 107.988 178.02 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -161.68 149.74 15.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.39 -0.524 . . . . 1.0 109.679 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.51 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 67.0 tttt -135.4 130.39 34.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 120.934 -0.306 . . . . 1.0 110.257 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.439 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 28.9 mm -71.04 -45.03 74.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 1.0 111.348 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 150' ' ' ILE . 82.7 m-20 -160.31 174.23 14.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.665 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.92 -36.11 80.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.985 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -86.4 8.61 20.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.008 0.432 . . . . 1.0 110.531 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.3 t -96.9 157.53 15.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.516 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.431 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 68.8 mttm -88.16 143.24 27.17 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.216 -0.447 . . . . 1.0 109.891 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 43.6 tp -70.28 130.14 41.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.909 0.385 . . . . 1.0 110.141 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.431 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 93.6 m-85 -119.83 135.09 55.0 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.803 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 91.3 m -129.99 132.69 46.37 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.932 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.77 169.06 11.47 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.124 -0.489 . . . . 1.0 109.961 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.625 ' ND2' ' CE2' ' A' ' 145' ' ' TYR . 5.8 m120 -117.17 150.57 38.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.885 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.436 ' CG2' HD12 ' A' ' 146' ' ' LEU . 78.5 t -128.26 137.96 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.804 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -100.24 125.77 46.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.984 0.421 . . . . 1.0 110.592 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.9 tp -88.39 130.68 35.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.788 -0.642 . . . . 1.0 109.372 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 37.6 p -128.82 176.67 7.65 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.93 0.395 . . . . 1.0 110.445 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -88.98 13.49 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.36 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 12.5 p -121.65 -2.5 9.37 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.814 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.35 -140.56 10.68 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.36 -1.096 . . . . 1.0 110.36 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -116.42 126.99 54.21 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.616 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 7.7 m-85 -106.43 117.8 34.99 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.0 tt -113.45 117.66 32.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.7 -0.482 . . . . 1.0 109.7 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.4 t 36.25 60.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.088 0.403 . . . . 1.0 112.088 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.7 m120 65.19 27.91 12.19 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.061 0.763 . . . . 1.0 113.061 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -133.87 120.79 20.85 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.616 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 16.4 t-20 -97.48 121.19 39.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.532 -0.304 . . . . 1.0 111.435 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -101.8 137.21 19.48 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.78 -21.4 33.46 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 122.412 2.075 . . . . 1.0 113.134 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 4.5 t -156.48 160.82 39.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.111 0.481 . . . . 1.0 111.002 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.98 -34.83 61.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.795 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 93.3 mt -61.75 -44.96 99.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.081 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -69.7 -29.81 67.32 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.65 -43.87 95.5 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 110.118 -0.327 . . . . 1.0 110.118 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 86.9 m -63.22 -46.22 87.98 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.386 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.554 ' O ' ' N ' ' A' ' 186' ' ' LYS . 88.8 m-20 -64.33 -48.18 76.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.17 -44.73 0.57 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.05 -47.52 65.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.048 -0.576 . . . . 1.0 109.781 178.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 183' ' ' ASN . 64.9 tttp -56.82 -41.7 78.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.591 -0.731 . . . . 1.0 110.227 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.5 m -61.45 -44.8 96.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.405 ' O ' ' OG ' ' A' ' 191' ' ' SER . 23.1 mt -62.94 -40.47 97.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.857 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.51 -43.94 93.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.23 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -58.7 -45.96 88.36 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.269 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 188' ' ' LEU . 80.0 p -62.1 -37.36 84.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.5 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.47 -42.93 82.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.347 -0.842 . . . . 1.0 111.923 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -69.15 -34.47 75.04 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 111.871 0.323 . . . . 1.0 111.871 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . 0.544 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 6.0 t60 -82.03 1.47 35.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.011 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.544 ' CG ' ' O ' ' A' ' 194' ' ' HIS . 32.8 p80 42.67 24.29 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.965 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.411 ' N ' ' C ' ' A' ' 194' ' ' HIS . 24.0 t-80 -86.31 130.9 34.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.68 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -45.66 107.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.295 -0.412 . . . . 1.0 110.632 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -77.04 93.82 3.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.695 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 77.4 m80 . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.66 179.789 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 27.6 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -127.7 -6.71 5.68 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.527 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -129.45 -1.93 4.95 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.609 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.72 -25.94 38.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.698 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.662 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -78.91 -17.63 13.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.39 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.519 HD22 ' N ' ' A' ' 6' ' ' ASN . 2.0 m120 -98.67 3.5 47.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.413 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -77.56 143.1 67.43 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.305 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.419 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 56.3 Cg_endo -70.65 -13.83 32.76 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.855 1.703 . . . . 1.0 112.243 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.472 ' CD1' ' CZ ' ' A' ' 30' ' ' PHE . 88.6 m-85 -94.53 3.94 54.48 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.533 -0.303 . . . . 1.0 111.128 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.545 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 88.1 t80 -87.29 127.72 35.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.488 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 68.4 m-85 -155.04 106.93 2.28 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.974 -0.38 . . . . 1.0 109.974 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.5 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 32.5 Cg_exo -59.15 110.87 0.76 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.716 1.611 . . . . 1.0 112.926 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.5 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 57.0 m-85 -159.64 150.95 19.79 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.425 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -78.51 171.97 14.34 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.11 -41.22 98.54 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.34 -0.933 . . . . 1.0 111.062 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.416 ' O ' ' CG ' ' A' ' 19' ' ' GLU . 84.9 mtt85 -66.41 -42.35 87.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.884 0.373 . . . . 1.0 110.861 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -71.84 -31.97 67.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.17 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.43 -48.51 79.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.825 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 20' ' ' ASP . 14.4 pt-20 -60.32 -39.08 85.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.023 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 9.2 m-20 -63.95 -43.61 95.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.078 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.593 ' CE2' ' NZ ' ' A' ' 25' ' ' LYS . 42.5 t80 -67.4 -41.59 84.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.446 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.24 -11.2 60.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.749 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -59.18 -44.51 92.17 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.867 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 m -78.67 -19.03 53.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.765 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.593 ' NZ ' ' CE2' ' A' ' 21' ' ' TYR . 43.8 mmtm -72.91 159.1 34.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.543 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.62 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.6 pm0 -82.34 156.74 24.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.637 . . . . 1.0 110.657 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.2 mtm-85 -54.05 141.62 27.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.907 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.01 17.63 50.44 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.305 -0.718 . . . . 1.0 111.305 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -94.96 136.51 35.18 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.472 ' CZ ' ' CD1' ' A' ' 9' ' ' TYR . 26.0 p90 -133.78 167.62 20.22 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.355 0.598 . . . . 1.0 110.883 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.2 m -146.77 157.76 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 114.924 -1.034 . . . . 1.0 111.64 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.0 mm -116.32 125.84 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.262 -0.644 . . . . 1.0 109.262 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -140.12 165.16 28.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.064 -0.517 . . . . 1.0 110.461 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -118.53 135.53 54.35 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 m -65.04 146.0 55.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.801 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.5 m -60.49 -26.01 66.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.692 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -123.29 27.19 7.63 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.036 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.507 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -92.49 -77.24 1.36 Allowed Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 t0 70.81 -35.49 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.623 0.249 . . . . 1.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' A' ' 38' ' ' GLY . 21.1 t70 -118.63 10.49 12.52 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.754 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.443 ' ND1' ' O ' ' A' ' 40' ' ' ASP . 25.0 m-70 -142.31 151.99 42.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.381 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mt -121.13 145.58 47.66 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.076 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.9 t -123.62 129.48 74.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.096 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.424 HD12 HD11 ' A' ' 58' ' ' ILE . 61.3 mt -111.51 137.66 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.5 m -121.63 141.71 50.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.437 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.727 ' HE1' ' NE2' ' A' ' 54' ' ' GLN . 3.5 p-90 -154.04 154.79 34.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.215 -0.902 . . . . 1.0 110.972 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -95.7 143.72 26.72 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.148 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.792 ' N ' HD12 ' A' ' 48' ' ' LEU . 3.3 mp -93.02 -73.06 0.57 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.458 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -145.26 119.08 9.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.594 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt 45.0 -129.13 1.05 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.064 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -70.94 73.95 0.61 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.068 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.4 tp -167.56 121.38 0.96 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.272 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -135.15 150.37 50.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.628 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.727 ' NE2' ' HE1' ' A' ' 46' ' ' TRP . 20.3 pt20 -135.8 155.05 50.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.714 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.47 ' CD2' ' H ' ' A' ' 55' ' ' HIS . 6.8 p80 -124.04 141.27 52.19 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.067 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.44 132.47 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.743 -0.466 . . . . 1.0 109.743 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -102.23 123.81 46.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.894 0.378 . . . . 1.0 110.534 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.424 HD11 HD12 ' A' ' 44' ' ' ILE . 86.3 mt -103.1 133.87 45.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.343 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -112.95 141.78 46.39 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.869 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.514 ' OE1' ' NZ ' ' A' ' 63' ' ' LYS . 78.8 mt-10 -99.79 148.51 24.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.813 -0.44 . . . . 1.0 109.813 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.436 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.6 tp -122.73 176.22 6.08 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.579 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.436 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 69.9 mm-40 57.66 32.34 21.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.022 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.514 ' NZ ' ' OE1' ' A' ' 60' ' ' GLU . 20.1 mmtm -78.65 74.13 5.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.881 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.7 -29.51 70.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.707 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -150.31 149.11 25.96 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.068 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.62 -25.14 66.14 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.268 1.979 . . . . 1.0 112.13 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.0 mp -91.27 -11.09 39.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.722 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.34 140.07 50.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.371 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.2 mt -77.14 148.89 35.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.377 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.47 92.39 0.27 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -63.17 -35.2 79.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.831 0.348 . . . . 1.0 110.875 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.1 t -127.11 125.06 65.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.073 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.1 mt -115.23 129.63 56.69 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.5 mm -99.41 123.54 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.933 0.397 . . . . 1.0 110.298 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.583 HG21 HD13 ' A' ' 86' ' ' ILE . 10.3 t -139.88 130.47 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.28 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 54.24 40.7 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.954 -0.298 . . . . 1.0 111.096 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.6 t30 62.0 24.05 14.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.729 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -128.21 151.78 48.85 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.264 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -96.65 130.78 43.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.81 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -125.07 138.43 54.19 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.198 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -85.91 -38.02 18.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.731 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -121.36 145.6 47.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.173 0.511 . . . . 1.0 112.039 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.51 -38.41 89.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.615 -0.72 . . . . 1.0 110.802 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -60.72 -39.89 90.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.934 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -63.12 -38.67 92.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.649 0.261 . . . . 1.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.583 HD13 HG21 ' A' ' 75' ' ' VAL . 94.2 mt -60.98 -46.3 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.873 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.7 mt -62.9 -46.14 97.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.581 -0.448 . . . . 1.0 111.669 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.68 -43.7 79.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 112.495 0.554 . . . . 1.0 112.495 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -75.9 -14.12 60.26 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.799 -0.36 . . . . 1.0 111.511 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -94.14 -50.77 5.13 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.638 -0.425 . . . . 1.0 111.825 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 95' ' ' VAL . 1.9 tp -68.85 -39.97 79.62 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.301 0.482 . . . . 1.0 112.301 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -62.94 -48.91 76.85 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 119.971 -0.691 . . . . 1.0 111.379 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -69.57 -42.41 74.54 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.691 -0.403 . . . . 1.0 111.696 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -65.92 -42.55 89.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.218 -0.593 . . . . 1.0 111.191 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 91' ' ' LEU . 53.6 t -65.86 -45.13 92.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.495 -0.482 . . . . 1.0 111.296 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -67.1 -44.9 78.79 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.86 -0.336 . . . . 1.0 111.563 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 tp -68.58 -41.77 79.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.501 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.3 tp -63.52 -43.07 98.25 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.193 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -68.63 -37.66 79.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.026 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -70.4 -43.17 70.59 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.686 -0.406 . . . . 1.0 111.562 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.2 tpt -66.28 -55.06 17.93 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.279 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 104' ' ' SER . 9.7 m -58.34 -38.42 77.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.028 0.442 . . . . 1.0 110.349 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.7 p -72.36 10.57 0.76 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.634 -0.712 . . . . 1.0 111.049 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 102' ' ' THR . 11.7 t -91.84 134.16 35.01 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.832 0.349 . . . . 1.0 110.248 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.31 -20.81 46.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 1.0 111.196 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.58 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 45.9 mtpt -87.9 40.63 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.943 -0.571 . . . . 1.0 109.761 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -130.68 109.14 10.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.135 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -134.8 124.93 25.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.732 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.2 p -92.61 82.8 4.82 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.879 0.371 . . . . 1.0 110.933 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -103.84 147.89 16.78 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.887 -0.885 . . . . 1.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 115' ' ' VAL . 7.6 p -73.53 168.48 19.2 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.007 -0.368 . . . . 1.0 110.007 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -58.89 -40.57 84.85 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.743 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -70.83 -44.0 67.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.183 0.516 . . . . 1.0 110.641 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.54 -22.57 63.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.994 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 111' ' ' THR . 23.7 t -68.11 -44.76 84.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.089 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.5 t -63.91 -45.85 95.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.098 0.475 . . . . 1.0 110.263 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.38 -38.65 90.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.977 0.418 . . . . 1.0 111.034 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -64.44 -49.47 71.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.778 -0.647 . . . . 1.0 111.834 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.0 tp -70.24 -38.4 74.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.485 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -62.22 -41.28 98.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.547 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.71 -48.46 74.57 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.45 -0.5 . . . . 1.0 110.255 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.552 ' CD2' ' OD1' ' A' ' 126' ' ' ASN . 39.8 t80 -61.55 -42.42 98.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.944 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 96.4 p -57.77 -39.17 76.8 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.272 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -64.42 -37.52 87.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.248 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.4 t -64.8 -40.38 88.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.554 -0.536 . . . . 1.0 109.554 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.552 ' OD1' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -126.55 75.56 74.36 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.385 179.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.567 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 6.6 Cg_exo -71.52 -25.47 21.1 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.485 2.123 . . . . 1.0 112.584 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -99.35 13.48 33.03 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.188 -0.46 . . . . 1.0 112.05 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -136.24 150.41 48.95 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.931 0.396 . . . . 1.0 110.445 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.9 p -80.12 164.32 23.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.742 -0.663 . . . . 1.0 109.79 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 p -153.09 147.41 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -149.16 142.82 25.5 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.861 0.362 . . . . 1.0 111.125 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -153.15 170.5 20.37 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.313 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -135.95 157.08 47.72 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.9 p -151.02 168.0 25.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.356 -0.383 . . . . 1.0 110.296 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.3 tp -78.38 135.01 37.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.442 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 8.4 t-20 -63.25 -176.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.201 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.451 ' ND1' ' N ' ' A' ' 138' ' ' HIS . 8.3 p-80 -138.52 -23.41 0.97 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.707 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -107.31 -10.22 15.85 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.032 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 29.3 m120 -136.93 80.09 37.02 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.413 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.65 128.61 30.72 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.013 1.809 . . . . 1.0 112.469 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.3 -19.92 41.52 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -98.86 149.33 23.02 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 110.0 -0.371 . . . . 1.0 110.0 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -118.13 153.73 33.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.524 . . . . 1.0 109.747 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.45 ' CE1' ' ND2' ' A' ' 137' ' ' ASN . 33.1 m-85 -126.82 137.49 53.2 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.016 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.6 mt -108.07 128.93 55.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.31 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.444 ' SD ' HG13 ' A' ' 115' ' ' VAL . 2.5 ptt? -120.36 146.41 46.19 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.837 -1.172 . . . . 1.0 107.837 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -160.38 146.56 15.37 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -130.41 126.51 37.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 120.814 -0.354 . . . . 1.0 110.285 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.667 HD12 ' H ' ' A' ' 150' ' ' ILE . 5.3 mp -72.92 -45.99 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.32 0.489 . . . . 1.0 112.32 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.576 ' OD1' ' N ' ' A' ' 152' ' ' ALA . 15.6 t-20 -153.55 168.03 27.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.522 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.576 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -61.67 -30.68 70.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.689 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.417 ' ND2' ' C ' ' A' ' 153' ' ' ASN . 0.2 OUTLIER -85.73 -12.5 50.98 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.336 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.7 t -78.77 157.09 28.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.036 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -87.47 148.18 25.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.193 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.3 tp -73.02 122.94 22.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.987 0.422 . . . . 1.0 109.902 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -113.38 132.92 55.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.917 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.7 m -126.96 131.83 50.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.756 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -116.09 163.67 15.6 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.995 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 161' ' ' VAL . 28.5 t-20 -107.54 147.74 30.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.634 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.414 ' N ' ' OD1' ' A' ' 160' ' ' ASN . 44.8 t -127.71 134.79 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.597 -0.52 . . . . 1.0 109.597 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -100.55 128.44 46.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.953 0.406 . . . . 1.0 110.436 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.7 tp -92.84 131.07 38.2 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.706 -0.479 . . . . 1.0 109.706 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 70.4 p -129.53 171.25 12.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.39 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -85.16 15.47 4.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.55 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 58.3 p -123.21 -2.99 8.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.466 -0.334 . . . . 1.0 110.549 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 142.74 -138.2 8.22 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.357 -1.097 . . . . 1.0 110.357 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -118.69 128.58 54.65 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.115 -0.328 . . . . 1.0 110.115 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.491 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 4.7 m-85 -103.16 125.94 50.09 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 171' ' ' VAL . 0.8 OUTLIER -119.05 113.93 21.72 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.6 t 36.64 59.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 111.886 0.328 . . . . 1.0 111.886 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.5 m120 66.96 27.87 8.72 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.913 0.709 . . . . 1.0 112.913 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -132.62 121.7 23.59 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.491 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 28.0 t-20 -94.44 119.3 32.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.253 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -99.33 132.13 23.86 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 109.63 -0.507 . . . . 1.0 109.63 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.05 -22.53 19.36 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.985 1.79 . . . . 1.0 113.5 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.8 p -150.37 153.81 36.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.917 0.389 . . . . 1.0 110.939 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.05 -35.5 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.851 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.97 -47.71 90.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.152 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.35 -31.95 73.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.16 -42.14 99.36 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.401 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 75.9 m -62.97 -46.83 85.86 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.745 -0.382 . . . . 1.0 110.343 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 186' ' ' LYS . 35.8 m-80 -64.92 -49.43 70.43 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 108.712 -0.847 . . . . 1.0 108.712 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.18 -46.19 0.49 Allowed Glycine 0 N--CA 1.466 0.657 0 N-CA-C 109.998 -1.241 . . . . 1.0 109.998 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -45.12 71.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.249 0.547 . . . . 1.0 110.046 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 183' ' ' ASN . 17.6 tptm -57.75 -44.36 86.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.242 -0.89 . . . . 1.0 110.467 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 14.4 m -61.19 -45.57 94.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.77 -42.1 98.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.079 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.1 tp -58.34 -43.6 88.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.526 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -59.03 -42.95 91.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.342 0.592 . . . . 1.0 110.228 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.3 t -66.21 -42.68 88.4 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.19 0.519 . . . . 1.0 110.207 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.88 -46.38 85.2 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.303 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.51 -30.09 69.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.456 -0.338 . . . . 1.0 111.679 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -95.47 -9.45 32.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.902 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 73.1 m80 50.8 54.68 10.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.848 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -86.85 103.82 15.62 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.478 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.404 ' CG ' ' O ' ' A' ' 197' ' ' HIS . 85.8 t60 -106.29 54.48 0.68 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.499 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 34.4 m170 47.01 66.26 1.04 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.853 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.925 -1.036 . . . . 1.0 110.755 179.853 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 70.16 16.09 7.47 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.357 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 171.44 27.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.838 0.711 . . . . 1.0 110.387 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 5' ' ' ILE . 14.2 p -64.69 -39.08 84.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.71 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.446 ' N ' HG13 ' A' ' 4' ' ' VAL . 43.8 pt -67.49 -29.99 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.793 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -95.73 10.35 37.24 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.362 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -66.36 133.65 94.49 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.295 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.536 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 78.4 Cg_exo -48.65 -34.14 26.2 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.834 1.69 . . . . 1.0 112.398 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CE2' ' CZ ' ' A' ' 30' ' ' PHE . 90.6 m-85 -79.66 4.15 16.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.398 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.447 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 55.3 t80 -87.19 128.14 35.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.454 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CZ ' ' O ' ' A' ' 8' ' ' PRO . 67.6 m-85 -150.83 115.29 3.22 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.59 112.28 3.49 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.95 1.767 . . . . 1.0 113.623 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.582 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -159.03 165.33 34.22 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.375 0.607 . . . . 1.0 111.187 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 51.4 t-20 -76.71 163.7 26.57 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.506 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . -59.68 -40.2 96.19 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.876 -0.89 . . . . 1.0 110.876 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -64.83 -45.14 87.4 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.994 -0.283 . . . . 1.0 111.033 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -70.0 -36.98 75.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.506 -0.316 . . . . 1.0 111.464 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -42.9 99.36 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.42 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.69 -42.21 82.4 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.118 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -61.82 -40.1 94.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.178 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -64.31 -40.52 96.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.659 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.42 -13.27 59.92 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.019 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -59.24 -42.54 91.34 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.644 -0.423 . . . . 1.0 110.561 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 m -77.97 -19.41 54.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.681 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -79.06 171.41 15.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.003 0.43 . . . . 1.0 110.858 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -77.01 155.52 32.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.786 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -69.08 145.84 53.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.4 2.54 60.28 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.08 -0.808 . . . . 1.0 111.08 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -79.01 154.17 29.7 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.617 ' CZ ' ' CE2' ' A' ' 9' ' ' TYR . 37.5 p90 -138.71 166.33 24.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.593 0.711 . . . . 1.0 111.054 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 45' ' ' THR . 16.1 m -149.8 162.41 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.721 -1.127 . . . . 1.0 112.046 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.5 mt -117.01 127.02 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.705 -0.479 . . . . 1.0 109.705 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.475 ' NE ' ' O ' ' A' ' 13' ' ' PHE . 75.2 ttt-85 -136.49 158.49 44.3 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.35 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -114.31 133.09 55.91 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.824 -0.436 . . . . 1.0 109.824 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.2 m -77.2 139.21 39.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.1 p -68.7 -38.01 79.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.96 -0.563 . . . . 1.0 110.434 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 83.0 mmt-85 -88.08 -13.95 40.13 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.771 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -75.02 -64.06 2.4 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.519 -1.033 . . . . 1.0 110.519 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 t70 69.93 -40.2 0.46 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.647 0.261 . . . . 1.0 110.944 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 38' ' ' GLY . 43.0 p-10 -117.15 11.4 14.15 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.71 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.535 ' C ' HD12 ' A' ' 42' ' ' LEU . 32.7 m-70 -132.24 152.73 51.19 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.933 0.397 . . . . 1.0 110.371 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.535 HD12 ' C ' ' A' ' 41' ' ' HIS . 10.8 mp -118.75 144.99 45.92 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.827 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -126.1 130.88 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.284 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 31' ' ' VAL . 20.3 mt -112.97 139.49 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.484 ' O ' HG22 ' A' ' 31' ' ' VAL . 47.7 m -115.99 128.64 55.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.732 ' HE1' HE21 ' A' ' 54' ' ' GLN . 8.0 p-90 -142.38 147.73 36.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.915 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' C ' HD12 ' A' ' 48' ' ' LEU . 24.7 mtmm -90.88 136.88 32.78 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.101 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 48' ' ' LEU . 7.4 mp -94.33 -67.59 0.85 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.192 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.493 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 26.1 t70 -125.91 -173.31 2.81 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.319 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.493 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 88.4 tttt -65.23 134.23 53.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.644 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 56.44 31.42 18.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.052 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 tp -135.02 130.27 35.4 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.879 0.371 . . . . 1.0 110.604 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -132.29 149.81 52.29 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.551 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.732 HE21 ' HE1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -142.86 153.91 43.63 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.504 -0.554 . . . . 1.0 109.504 179.203 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.482 ' N ' ' CD ' ' A' ' 54' ' ' GLN . 19.1 p80 -123.24 140.73 52.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.207 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 56' ' ' ILE . 14.7 tt -123.87 128.43 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.788 -0.449 . . . . 1.0 109.788 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -103.72 126.36 50.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.975 0.417 . . . . 1.0 110.919 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.0 mt -106.42 129.1 60.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.104 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -104.94 140.4 38.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.253 -0.431 . . . . 1.0 109.999 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -102.82 157.26 17.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.358 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.483 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -145.16 167.91 21.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.658 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.483 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 50.4 tt0 71.47 37.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.012 -0.54 . . . . 1.0 109.899 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -87.33 115.07 24.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -98.44 -25.26 14.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.011 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -157.11 151.88 20.92 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.194 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.53 -19.0 60.68 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.22 1.947 . . . . 1.0 111.859 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.9 tp -79.3 -14.12 59.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.049 0.452 . . . . 1.0 110.691 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.59 137.95 38.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.267 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.2 mt -79.54 164.38 23.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.441 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.52 97.64 0.18 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -67.78 -36.08 79.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.997 0.427 . . . . 1.0 110.618 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.4 t -117.05 123.78 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.583 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.4 mt -116.7 135.57 53.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.428 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.7 mt -107.17 126.41 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.887 0.375 . . . . 1.0 110.142 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.1 t -143.86 132.55 19.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.32 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 t70 54.68 43.28 30.39 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.052 -0.259 . . . . 1.0 111.002 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 59.27 24.57 13.06 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.943 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -128.52 154.51 46.07 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.229 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -103.94 134.8 46.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.219 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.737 ' CD1' HD11 ' A' ' 86' ' ' ILE . 96.4 m-85 -126.23 139.39 53.38 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.348 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -84.45 -38.04 20.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.714 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -123.09 150.72 42.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.124 0.488 . . . . 1.0 111.986 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.5 tp -66.8 -36.33 82.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.584 -0.735 . . . . 1.0 111.295 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 50.2 p-10 -58.22 -33.42 69.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.805 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.494 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 27.6 mt-30 -64.88 -39.26 93.26 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.657 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.737 HD11 ' CD1' ' A' ' 80' ' ' TYR . 31.3 mm -62.67 -48.26 89.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.857 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.47 -43.58 98.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 120.334 -0.546 . . . . 1.0 111.734 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 84' ' ' ASP . 59.7 t -73.2 -42.59 58.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 113.148 0.796 . . . . 1.0 113.148 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -82.8 -13.41 56.29 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.636 -0.426 . . . . 1.0 111.557 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.42 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 64.1 t80 -95.52 -48.63 5.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.524 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 95' ' ' VAL . 3.9 tp -69.52 -40.62 76.83 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.264 0.468 . . . . 1.0 112.264 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -63.89 -48.59 76.07 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.042 -0.663 . . . . 1.0 111.762 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -68.43 -43.28 77.47 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.75 -0.38 . . . . 1.0 111.757 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -66.05 -42.13 89.89 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.163 -0.615 . . . . 1.0 111.225 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 91' ' ' LEU . 53.6 t -65.37 -46.13 91.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.226 -0.59 . . . . 1.0 111.441 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -69.17 -44.3 72.49 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.789 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.3 tp -69.01 -40.31 78.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.152 -0.476 . . . . 1.0 111.719 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.4 tp -64.43 -43.3 94.78 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.292 -0.563 . . . . 1.0 110.08 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -67.79 -38.52 83.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.129 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.452 ' OE1' ' OH ' ' A' ' 168' ' ' TYR . 2.9 tm-20 -70.91 -42.81 69.46 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.802 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.487 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 2.6 ttt -64.98 -54.42 30.8 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.531 -0.467 . . . . 1.0 111.433 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.43 HG23 ' CE2' ' A' ' 107' ' ' PHE . 55.5 m -61.23 -30.29 70.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.126 0.489 . . . . 1.0 110.496 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.1 t -73.44 10.31 1.07 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.634 -0.712 . . . . 1.0 110.926 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 36.4 t -96.41 131.68 42.71 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.773 0.32 . . . . 1.0 110.284 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -57.83 -17.89 18.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.944 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.536 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 37.7 mmtm -90.8 40.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.063 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CE2' HG23 ' A' ' 102' ' ' THR . 70.2 t80 -133.17 111.28 10.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.468 . . . . 1.0 111.071 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -123.34 126.46 46.89 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -94.68 85.85 4.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.977 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.0 149.35 16.9 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.673 ' O ' HG23 ' A' ' 115' ' ' VAL . 28.3 p -71.98 170.86 12.9 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -59.87 -39.17 84.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.859 -0.336 . . . . 1.0 110.831 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -68.15 -42.33 80.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.905 0.383 . . . . 1.0 110.455 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -70.6 -18.52 62.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.094 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 111' ' ' THR . 40.9 t -73.19 -44.39 55.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.767 0.318 . . . . 1.0 110.144 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.8 t -62.89 -46.75 95.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.251 0.548 . . . . 1.0 110.157 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -66.02 -36.66 83.87 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.005 0.431 . . . . 1.0 111.099 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -66.61 -49.63 65.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.599 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.5 tp -69.77 -39.4 77.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.305 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -64.82 -42.03 95.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.947 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -63.33 -48.26 78.74 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.427 -0.509 . . . . 1.0 110.052 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -59.94 -43.28 95.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.95 -0.568 . . . . 1.0 109.898 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.4 t -62.9 -39.52 94.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.295 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.8 -41.6 82.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.097 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.24 -41.6 92.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.92 78.6 65.43 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.043 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.529 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 39.1 Cg_endo -71.19 -13.68 31.2 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.449 2.099 . . . . 1.0 112.46 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -101.45 -14.5 17.51 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.651 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -105.97 148.38 27.74 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.978 0.418 . . . . 1.0 110.477 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.401 ' OG ' HD21 ' A' ' 189' ' ' LEU . 60.2 p -81.81 163.78 22.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.883 -0.599 . . . . 1.0 109.615 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 p -152.72 146.27 15.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.421 ' O ' ' CD2' ' A' ' 133' ' ' TYR . 33.0 p90 -149.91 141.53 23.52 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.671 -0.412 . . . . 1.0 111.083 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.421 ' CD2' ' O ' ' A' ' 132' ' ' TYR . 25.4 m-85 -152.91 165.93 33.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.309 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -130.63 154.37 47.96 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 178.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.1 p -150.44 168.14 25.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.205 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.1 tp -81.24 132.41 35.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.604 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.548 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 22.6 p30 -78.25 151.9 32.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.277 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -106.22 -30.4 9.23 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.651 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 41.4 p30 -64.97 -21.14 66.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.197 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.548 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 19.8 t-20 -163.22 106.76 1.0 Allowed Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.59 143.55 38.32 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.796 1.664 . . . . 1.0 112.411 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.82 -39.19 2.81 Favored Glycine 0 N--CA 1.468 0.782 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.422 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 19.8 m95 -94.47 149.78 20.91 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.815 0.34 . . . . 1.0 110.199 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.487 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 77.1 m-85 -113.26 154.86 26.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.847 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -126.31 139.23 53.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.115 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.5 mt -111.1 126.66 55.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.568 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.6 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -120.98 146.85 46.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.029 -1.1 . . . . 1.0 108.029 178.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -162.44 153.89 18.07 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.25 -0.58 . . . . 1.0 109.769 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -137.73 128.41 26.85 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.801 0.334 . . . . 1.0 110.604 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.668 ' N ' HD12 ' A' ' 150' ' ' ILE . 2.6 mp -69.76 -45.24 77.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 1.0 111.591 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 19.6 m120 -156.47 171.79 19.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.574 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.79 -28.3 69.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.792 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -90.27 8.61 32.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.983 0.421 . . . . 1.0 110.346 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 15.9 t -102.22 150.43 23.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.442 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -80.17 157.16 26.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.014 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 62.1 tp -75.07 124.11 26.41 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.259 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -108.31 129.89 55.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.518 . . . . 1.0 109.615 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 63.9 m -128.2 130.46 48.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.872 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -120.9 159.81 24.77 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.866 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 160' ' ' ASN . 34.5 p30 -105.69 148.32 27.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.984 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.77 136.12 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -98.33 135.27 40.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.773 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 29.3 tp -102.51 128.83 48.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.905 -0.588 . . . . 1.0 109.543 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.4 p -131.04 168.37 17.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.087 0.47 . . . . 1.0 110.398 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -78.74 17.35 0.72 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.669 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 12.1 p -121.35 -2.38 9.54 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.704 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 137.48 -126.3 3.58 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.264 -1.135 . . . . 1.0 110.264 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.452 ' OH ' ' OE1' ' A' ' 100' ' ' GLU . 19.9 m-85 -127.28 132.84 50.24 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.671 0.272 . . . . 1.0 110.447 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -110.43 120.81 43.62 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.938 0.399 . . . . 1.0 110.143 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.0 tt -114.96 120.92 41.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.4 t 35.97 52.1 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 111.95 0.352 . . . . 1.0 111.95 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 10.2 m120 69.42 27.41 4.98 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.087 0.773 . . . . 1.0 113.087 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -135.78 120.16 17.99 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -91.27 131.24 36.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.359 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -107.54 101.25 38.65 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 109.438 -0.578 . . . . 1.0 109.438 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -48.82 -23.17 5.44 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.462 2.108 . . . . 1.0 113.376 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 40.0 m -141.66 145.74 35.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.991 0.424 . . . . 1.0 111.097 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.62 -34.97 70.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.731 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.462 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 49.2 mm -60.57 -46.98 94.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.336 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.689 ' H ' HE21 ' A' ' 180' ' ' GLN . 0.6 OUTLIER -61.65 -32.9 73.09 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.14 -40.3 95.87 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 1.8 p -61.49 -46.85 88.25 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.769 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.6 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 54.5 t30 -71.21 -49.72 40.55 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 119.727 -0.789 . . . . 1.0 108.954 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.31 -43.87 0.53 Allowed Glycine 0 N--CA 1.462 0.398 0 N-CA-C 109.832 -1.307 . . . . 1.0 109.832 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -69.04 -47.93 64.14 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.071 -0.565 . . . . 1.0 109.596 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 183' ' ' ASN . 49.5 tttp -57.25 -39.9 76.55 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.184 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.5 m -60.5 -44.31 96.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 62.9 mt -63.86 -39.03 93.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.152 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.401 HD21 ' OG ' ' A' ' 130' ' ' SER . 62.3 tp -59.45 -45.32 91.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.713 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -58.7 -45.39 89.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.104 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.1 t -64.49 -40.29 95.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.714 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.76 -42.0 97.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.47 -0.786 . . . . 1.0 111.95 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -63.11 -25.8 68.53 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -89.67 -8.2 52.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.726 0.298 . . . . 1.0 110.863 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.414 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 74.2 t60 54.89 23.2 4.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.949 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -89.23 140.34 29.58 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.552 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 198' ' ' HIS . 4.5 t-80 -59.27 -48.23 82.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.578 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.675 ' CG ' ' H ' ' A' ' 199' ' ' HIS . 30.5 t60 40.4 -166.45 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.033 0.444 . . . . 1.0 111.05 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.675 ' H ' ' CG ' ' A' ' 198' ' ' HIS . 63.2 m80 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.003 -0.998 . . . . 1.0 110.711 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.403 -0.592 . . . . 1.0 109.403 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -88.43 -6.85 57.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.695 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.481 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 83.8 mtp180 -133.22 1.61 3.51 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.486 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.65 -31.83 53.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.522 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.6 pt -75.39 -19.93 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.447 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -103.59 9.11 37.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.6 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 3' ' ' ARG . 0.4 OUTLIER -67.77 147.87 98.55 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 110.057 -0.349 . . . . 1.0 110.057 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.64 -14.25 38.99 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.102 1.868 . . . . 1.0 112.2 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -94.74 5.52 51.64 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.203 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 40.3 t80 -82.88 128.76 34.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.478 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 58.4 m-85 -149.38 120.92 4.17 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.513 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.521 ' O ' ' CD1' ' A' ' 13' ' ' PHE . 72.7 Cg_endo -74.72 109.64 2.95 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.748 1.632 . . . . 1.0 112.479 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' A' ' 12' ' ' PRO . 70.6 m-85 -155.72 156.8 35.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.379 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -79.4 168.05 20.01 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.461 ' CA ' HH12 ' A' ' 33' ' ' ARG . . . -59.65 -43.58 97.61 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.381 -0.914 . . . . 1.0 111.203 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -66.02 -41.22 91.26 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.055 -0.258 . . . . 1.0 110.784 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.85 -35.9 77.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.543 -0.299 . . . . 1.0 111.229 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.77 -40.9 94.25 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.45 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.11 -42.69 93.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -60.47 -42.76 96.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.275 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -60.98 -41.8 97.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.815 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.8 mp -78.9 -15.22 58.62 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.984 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -61.14 -42.13 97.99 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.806 -0.357 . . . . 1.0 110.516 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.3 t -76.75 -18.71 58.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.975 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -87.09 -178.02 6.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.055 0.455 . . . . 1.0 110.676 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.18 179.45 5.56 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.819 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.6 mtt85 -81.01 146.11 30.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.049 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.56 19.44 29.77 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -98.83 145.67 26.73 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -132.86 167.45 20.18 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.109 0.481 . . . . 1.0 110.95 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 32' ' ' ILE . 45.2 t -147.34 158.44 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.242 -0.89 . . . . 1.0 111.443 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.491 ' N ' HG12 ' A' ' 31' ' ' VAL . 6.0 mm -114.83 126.33 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.711 -0.848 . . . . 1.0 108.711 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.461 HH12 ' CA ' ' A' ' 15' ' ' GLY . 57.1 ttp180 -137.86 155.86 48.52 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.402 ' N ' ' HG2' ' A' ' 33' ' ' ARG . 21.9 mt-30 -119.69 137.91 53.61 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.786 -0.45 . . . . 1.0 109.786 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.6 m -72.37 151.43 42.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.773 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.8 p -69.55 -20.81 63.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.018 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.28 17.68 9.07 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.023 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -84.54 -74.95 1.23 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.532 -1.027 . . . . 1.0 110.532 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.3 t70 67.68 -35.71 0.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.635 0.255 . . . . 1.0 110.884 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' A' ' 38' ' ' GLY . 97.2 m-20 -118.55 12.06 13.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.466 -0.334 . . . . 1.0 110.594 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.565 ' C ' HD12 ' A' ' 42' ' ' LEU . 99.5 m-70 -144.06 146.55 32.9 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.322 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.565 HD12 ' C ' ' A' ' 41' ' ' HIS . 10.9 mp -119.12 145.48 45.92 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.09 -0.504 . . . . 1.0 109.793 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.86 129.23 74.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.146 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.477 HG22 HD13 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -111.19 137.71 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 108.762 -0.829 . . . . 1.0 108.762 -179.409 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.8 m -115.16 134.05 55.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.877 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.535 ' CZ2' HD11 ' A' ' 48' ' ' LEU . 1.8 p-90 -148.14 151.6 35.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.384 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.529 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -99.61 145.51 27.48 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.69 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.535 HD11 ' CZ2' ' A' ' 46' ' ' TRP . 9.5 mp -102.47 -75.52 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 36.9 t0 -117.06 -166.74 1.2 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.388 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.529 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 51.7 mtmt -69.6 139.37 53.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.947 0.403 . . . . 1.0 110.814 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 52.28 26.66 4.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.909 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.8 tp -130.89 129.01 41.71 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.787 0.327 . . . . 1.0 110.327 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.46 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 61.5 m-85 -133.87 148.99 51.33 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.502 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 53' ' ' PHE . 98.6 mm-40 -139.84 152.09 46.21 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.581 -0.526 . . . . 1.0 109.581 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -129.37 144.15 51.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.427 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 92.8 mt -125.51 131.75 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.786 -0.449 . . . . 1.0 109.786 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -98.53 121.81 40.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.906 0.384 . . . . 1.0 110.575 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.3 mt -97.98 123.58 50.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.094 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -111.31 131.69 54.96 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -103.08 152.78 20.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.242 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.471 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 1.6 tp -144.45 165.69 27.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.414 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 3.1 tm-20 81.94 63.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.201 0.524 . . . . 1.0 110.063 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HD3' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -105.89 113.91 27.74 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.034 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.468 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 57.8 mp0 -65.85 -22.85 66.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.688 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.611 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 1.1 m120 -151.6 160.03 32.37 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.133 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.34 -32.97 64.06 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.986 1.791 . . . . 1.0 112.332 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.1 mt -95.14 -8.82 35.33 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.688 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.611 ' HB3' ' H ' ' A' ' 65' ' ' ASN . . . -73.85 144.77 45.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.593 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.7 mt -89.71 147.25 23.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.271 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.98 126.76 7.59 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.7 -0.96 . . . . 1.0 110.7 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -81.96 -9.78 59.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.064 0.459 . . . . 1.0 110.459 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.28 118.68 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.735 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.5 mt -115.01 129.23 56.67 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.551 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.2 mt -101.29 121.87 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.951 0.405 . . . . 1.0 110.228 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.88 131.92 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.121 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.7 t0 55.98 42.88 28.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.178 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 59.69 21.13 9.83 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.922 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -128.06 151.98 48.52 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.059 0.456 . . . . 1.0 110.22 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -101.37 128.38 47.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.224 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -122.94 138.67 54.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.32 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -85.25 -38.38 18.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 1.0 111.606 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -113.13 141.23 47.16 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.034 0.445 . . . . 1.0 111.993 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.2 -40.66 96.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.85 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -59.21 -41.71 89.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.746 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -60.81 -38.52 85.68 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.986 -0.285 . . . . 1.0 110.723 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.37 -47.27 94.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.743 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.1 mt -62.09 -46.41 96.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.329 -0.548 . . . . 1.0 111.684 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.0 t -71.15 -42.46 75.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.844 0.683 . . . . 1.0 112.844 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -77.38 -15.4 59.39 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.662 -0.415 . . . . 1.0 111.9 -177.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.621 ' CZ ' ' NZ ' ' A' ' 94' ' ' LYS . 34.8 t80 -94.09 -49.91 5.54 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.651 -0.42 . . . . 1.0 111.713 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.2 mp -69.75 -40.57 76.08 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 112.096 0.406 . . . . 1.0 112.096 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -62.85 -48.53 78.62 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.774 -0.77 . . . . 1.0 111.544 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -69.21 -43.41 74.18 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.522 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.621 ' NZ ' ' CZ ' ' A' ' 90' ' ' TYR . 24.0 mmtp -66.14 -43.77 86.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.213 -0.595 . . . . 1.0 111.243 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.32 -44.79 90.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.339 -0.544 . . . . 1.0 111.023 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -66.03 -47.54 74.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.248 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.434 HD21 ' CE1' ' A' ' 168' ' ' TYR . 3.0 tp -69.08 -38.93 79.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.282 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.38 -43.28 98.08 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.574 -0.45 . . . . 1.0 110.118 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -67.51 -39.75 85.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.257 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -71.09 -41.38 70.7 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.007 0.373 . . . . 1.0 112.007 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.5 ttt -68.38 -54.82 14.69 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.423 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.1 m -58.7 -42.2 88.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.076 0.465 . . . . 1.0 110.411 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.3 m -72.37 8.27 1.44 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.951 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -84.29 142.82 29.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.734 0.302 . . . . 1.0 110.512 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.63 -19.5 65.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.885 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.552 ' NZ ' ' SG ' ' A' ' 182' ' ' CYS . 98.7 mttt -93.13 39.44 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.828 -0.624 . . . . 1.0 110.161 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -134.12 118.37 17.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.122 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -126.67 133.13 51.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.0 p -99.4 74.7 1.93 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.8 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.71 146.62 18.58 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.635 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -71.52 171.68 10.94 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.036 -0.357 . . . . 1.0 110.036 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -56.66 -38.89 72.82 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.64 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.94 -44.19 77.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.962 0.411 . . . . 1.0 110.724 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -70.17 -20.27 63.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.056 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 111' ' ' THR . 40.2 t -70.78 -45.23 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.299 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.14 -46.67 92.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 120.494 -0.482 . . . . 1.0 110.278 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.03 -35.37 80.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.053 0.454 . . . . 1.0 110.75 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -67.49 -49.63 62.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.596 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 119' ' ' ILE . 10.5 tp -70.18 -39.22 76.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.962 0.41 . . . . 1.0 110.459 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -64.24 -39.94 94.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.685 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -60.32 -48.5 81.49 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.548 -0.461 . . . . 1.0 110.31 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -62.76 -39.88 95.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.293 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.9 t -61.49 -42.39 98.72 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.578 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -59.6 -38.17 80.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.055 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.1 t -66.75 -42.28 89.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.658 -0.417 . . . . 1.0 109.974 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -126.26 76.49 72.69 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.217 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -71.29 -14.25 31.21 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 122.578 2.185 . . . . 1.0 112.441 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -103.54 10.17 37.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.655 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -132.98 148.58 52.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.861 0.362 . . . . 1.0 110.621 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 42.0 t -81.08 161.5 24.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.48 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.0 p -152.65 145.19 15.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -144.17 143.66 31.19 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.949 0.404 . . . . 1.0 111.12 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -151.35 161.98 41.75 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.372 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.481 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -132.65 154.86 49.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 179.146 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 43.1 t -152.54 168.41 25.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.93 0.395 . . . . 1.0 110.105 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.71 128.98 34.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.067 -0.515 . . . . 1.0 111.019 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 12.5 t-20 -87.34 135.68 33.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.902 0.382 . . . . 1.0 110.368 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -73.14 -39.64 65.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.971 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -62.44 -15.11 47.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.036 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.542 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 3.6 p30 -167.66 82.52 0.83 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.269 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.25 -37.14 58.92 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.124 1.883 . . . . 1.0 113.142 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -59.78 -34.74 83.78 Favored Glycine 0 C--N 1.312 -0.798 0 N-CA-C 110.956 -0.858 . . . . 1.0 110.956 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -99.72 144.77 28.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.88 0.372 . . . . 1.0 110.242 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -106.61 153.65 22.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.879 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.564 ' CZ ' ' ND2' ' A' ' 160' ' ' ASN . 4.0 m-85 -112.33 134.33 53.93 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.969 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.688 ' CD1' ' HE1' ' A' ' 159' ' ' TRP . 5.3 mt -112.55 123.34 50.08 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.709 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.561 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -123.55 148.89 45.9 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.469 -0.938 . . . . 1.0 108.469 178.21 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.56 ' CE1' ' CZ3' ' A' ' 159' ' ' TRP . 8.1 p90 -163.9 160.81 22.52 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.27 -0.572 . . . . 1.0 109.649 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -140.83 129.86 23.33 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.564 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.669 HG22 HD22 ' A' ' 151' ' ' ASN . 3.6 mt -77.06 -44.94 31.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.282 -0.417 . . . . 1.0 111.592 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.669 HD22 HG22 ' A' ' 150' ' ' ILE . 2.9 m-80 -154.35 165.68 35.6 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.372 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.91 -31.52 69.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.712 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -85.69 -4.34 59.14 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.043 0.449 . . . . 1.0 110.611 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 11.8 t -84.28 163.21 19.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.514 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.431 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 14.7 mptt -96.57 148.6 22.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.67 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 52.6 tp -70.23 118.81 13.53 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.36 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.438 ' O ' ' CD1' ' A' ' 148' ' ' PHE . 87.4 m-85 -113.66 119.37 37.22 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 146' ' ' LEU . 86.0 m -130.39 135.18 47.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.848 -0.615 . . . . 1.0 111.874 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.688 ' HE1' ' CD1' ' A' ' 146' ' ' LEU . 7.7 p90 -128.35 -173.94 3.09 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.462 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.564 ' ND2' ' CZ ' ' A' ' 145' ' ' TYR . 94.4 m-20 -124.82 152.7 43.59 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.445 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 169' ' ' PHE . 27.6 t -118.56 139.37 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -93.9 130.65 39.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.207 0.527 . . . . 1.0 110.948 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.8 tp -90.93 129.72 36.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.562 -0.745 . . . . 1.0 109.446 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 165' ' ' ASN . 0.1 OUTLIER -131.65 177.84 7.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.616 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.508 ' N ' ' OG1' ' A' ' 164' ' ' THR . 65.3 t30 -86.13 15.68 4.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.704 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 77.2 p -121.07 -1.7 9.78 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.575 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 132.87 -126.09 4.32 Favored Glycine 0 N--CA 1.464 0.533 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.434 ' CE1' HD21 ' A' ' 97' ' ' LEU . 22.5 m-85 -122.13 129.27 52.18 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.545 0.212 . . . . 1.0 110.517 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.437 ' O ' HG13 ' A' ' 161' ' ' VAL . 0.1 OUTLIER -105.54 120.77 42.47 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.0 tt -113.32 114.98 27.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.4 t 35.47 59.46 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.253 0.464 . . . . 1.0 112.253 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.8 m120 69.16 27.34 5.26 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.17 0.804 . . . . 1.0 113.17 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -134.89 119.19 17.76 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -99.73 124.9 45.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.84 0.353 . . . . 1.0 111.736 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -102.36 131.85 22.07 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.31 -0.626 . . . . 1.0 109.31 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.36 -18.41 29.95 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.193 1.929 . . . . 1.0 113.443 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 89.7 p -152.08 156.02 39.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.084 0.468 . . . . 1.0 110.908 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.16 -36.05 72.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.716 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.05 -43.32 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 120.909 0.385 . . . . 1.0 110.123 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -61.12 -35.12 76.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.25 -39.93 94.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.211 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.552 ' SG ' ' NZ ' ' A' ' 106' ' ' LYS . 13.8 t -57.04 -48.4 78.62 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.271 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 186' ' ' LYS . 65.7 t30 -66.7 -47.61 71.84 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.21 -44.02 0.76 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.376 -1.49 . . . . 1.0 109.376 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -68.96 -47.58 65.28 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.387 0.613 . . . . 1.0 109.496 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 183' ' ' ASN . 63.1 tttm -55.97 -39.11 71.31 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.251 -0.886 . . . . 1.0 109.866 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 19.0 m -63.33 -47.18 83.29 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 75.6 mt -62.9 -42.71 99.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.108 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 45.0 tp -57.35 -46.53 83.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.719 -0.392 . . . . 1.0 110.29 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -56.19 -41.83 76.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.142 0.496 . . . . 1.0 109.857 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.1 t -66.59 -42.78 86.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.832 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.66 -45.55 86.26 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.595 -0.729 . . . . 1.0 112.177 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -67.81 -35.49 78.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.785 0.326 . . . . 1.0 111.826 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . 0.559 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 10.4 t-80 -80.95 -7.73 59.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.577 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' A' ' 194' ' ' HIS . 50.5 p-80 42.4 52.24 4.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.338 -0.392 . . . . 1.0 111.105 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -54.14 134.33 44.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.69 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -69.58 82.78 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.75 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -82.62 -32.97 28.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.872 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.63 -179.588 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -94.79 9.83 37.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.512 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.3 mmt-85 -128.43 -30.83 2.33 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.627 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.67 -33.43 63.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.617 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.7 pt -81.48 -30.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.547 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -95.11 3.77 54.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.342 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -65.09 140.93 98.18 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.375 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.18 -12.89 35.07 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.92 1.747 . . . . 1.0 112.038 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -102.48 7.65 40.17 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.614 0.245 . . . . 1.0 111.152 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.529 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 30.6 t80 -90.95 127.76 36.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.442 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 65.1 m-85 -151.65 108.97 2.92 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.549 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 41.7 Cg_exo -57.56 108.18 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.712 1.608 . . . . 1.0 112.734 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 66.2 m-85 -160.94 157.97 27.34 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.64 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -79.09 163.87 24.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' OE1' ' A' ' 19' ' ' GLU . . . -55.48 -45.51 83.81 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.248 -0.977 . . . . 1.0 110.853 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -65.2 -39.66 93.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.868 0.366 . . . . 1.0 110.758 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.35 -33.83 76.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.498 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.06 -38.82 87.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.436 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.552 ' OE2' ' NE2' ' A' ' 55' ' ' HIS . 4.3 mp0 -67.09 -43.51 82.36 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.566 -0.454 . . . . 1.0 110.37 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.51 -46.15 91.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.227 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -61.02 -44.82 96.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.423 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 tp -75.36 -15.98 60.43 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.064 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -60.67 -42.13 96.46 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.393 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p -75.32 -18.63 59.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.627 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -82.22 179.83 7.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.621 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -90.1 154.72 19.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.812 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -68.05 143.45 55.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.759 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.0 10.09 43.62 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.223 -0.751 . . . . 1.0 111.223 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -91.68 156.43 17.6 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -125.11 155.72 39.43 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.295 0.569 . . . . 1.0 111.004 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 t -141.4 152.76 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 115.145 -0.934 . . . . 1.0 111.184 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.95 125.8 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -142.16 158.64 43.51 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.077 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.682 HE22 ' CD2' ' A' ' 42' ' ' LEU . 95.2 mm-40 -103.15 131.17 50.36 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 37' ' ' ARG . 7.2 t -48.82 -12.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.918 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 34' ' ' GLN . 3.0 m 63.24 2.06 1.05 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.652 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.402 ' H ' ' C ' ' A' ' 35' ' ' SER . 34.4 ttm180 -154.47 58.88 0.7 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.629 -0.26 . . . . 1.0 110.582 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -157.62 -50.06 0.01 OUTLIER Glycine 0 N--CA 1.463 0.446 0 N-CA-C 110.384 -1.086 . . . . 1.0 110.384 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.9 t0 73.63 -28.3 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.796 0.331 . . . . 1.0 111.026 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 38' ' ' GLY . 36.3 t70 -121.59 20.26 11.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.984 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -142.19 141.42 32.57 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.826 0.346 . . . . 1.0 110.541 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.682 ' CD2' HE22 ' A' ' 34' ' ' GLN . 5.3 mp -120.57 144.65 47.97 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.095 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.8 t -126.16 130.78 72.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.217 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mt -112.06 139.47 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.5 m -118.25 132.2 56.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.391 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.555 ' CZ3' ' CD2' ' A' ' 48' ' ' LEU . 2.8 p-90 -146.15 143.68 29.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.989 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -92.52 140.72 29.27 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.961 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.555 ' CD2' ' CZ3' ' A' ' 46' ' ' TRP . 8.4 mt -103.67 -75.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.331 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -115.45 -176.88 3.01 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.263 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -66.21 130.23 42.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.932 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.4 t0 61.88 30.33 18.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.033 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.0 tp -137.8 126.04 23.11 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.874 0.369 . . . . 1.0 110.412 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -134.85 149.48 50.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.55 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -138.88 153.98 48.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.853 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.552 ' NE2' ' OE2' ' A' ' 19' ' ' GLU . 44.9 m80 -124.08 141.35 52.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.243 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.7 mt -121.53 124.8 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -98.2 122.07 40.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.662 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 80.8 mt -101.15 126.0 55.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.363 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -103.71 134.58 46.8 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.978 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -104.37 146.59 28.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 1.0 109.995 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.475 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 9.8 mt -142.15 166.47 24.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.764 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 1.5 tm-20 82.32 54.73 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.856 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -106.62 93.86 4.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.878 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.11 -35.12 77.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.898 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -145.71 156.5 52.28 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.973 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.16 -19.53 68.92 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.39 2.06 . . . . 1.0 112.104 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.548 ' H ' ' CG ' ' A' ' 65' ' ' ASN . 4.8 tp -83.26 -9.88 58.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.998 0.427 . . . . 1.0 110.931 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.582 ' N ' ' ND2' ' A' ' 65' ' ' ASN . . . -113.24 143.63 44.08 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.158 0.504 . . . . 1.0 110.17 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.515 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -90.55 168.94 11.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.319 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.34 109.69 2.86 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.417 ' NZ ' ' OE1' ' A' ' 62' ' ' GLU . 34.2 mtmm -72.8 -11.85 60.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.02 0.438 . . . . 1.0 110.727 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.1 t -118.3 120.68 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.816 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.4 mt -115.67 130.88 57.02 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.7 mt -102.47 121.08 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -140.88 132.92 30.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.201 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.422 ' OD2' ' OD1' ' A' ' 165' ' ' ASN . 46.8 t0 53.9 42.98 31.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.774 0.321 . . . . 1.0 110.997 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 59.79 22.87 11.77 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.826 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -128.56 143.75 51.02 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.254 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -98.12 126.98 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.872 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CG ' HG12 ' A' ' 86' ' ' ILE . 93.8 m-85 -120.32 137.48 54.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.167 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -85.29 -38.09 19.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.777 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -112.02 141.39 45.74 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.047 0.451 . . . . 1.0 112.11 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.97 -41.06 97.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.473 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 88' ' ' VAL . 60.9 m-20 -61.56 -39.75 92.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.793 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -59.89 -39.66 86.12 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.74 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.41 HG12 ' CG ' ' A' ' 80' ' ' TYR . 75.5 mt -61.68 -50.15 81.42 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 C-N-CA 120.352 -0.539 . . . . 1.0 111.113 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.58 -43.49 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.57 -0.452 . . . . 1.0 111.795 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.435 ' O ' ' CD ' ' A' ' 92' ' ' GLN . 93.9 t -66.4 -22.23 29.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.112 -0.495 . . . . 1.0 112.15 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -100.18 -10.84 20.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.911 0.386 . . . . 1.0 111.011 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.84 -50.33 5.62 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.39 -0.524 . . . . 1.0 112.368 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 95' ' ' VAL . 7.6 mp -64.62 -45.38 87.12 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 112.802 0.667 . . . . 1.0 112.802 -176.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.474 ' HG3' ' N ' ' A' ' 93' ' ' ASN . 14.7 pt20 -64.8 -48.12 75.59 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.706 -0.798 . . . . 1.0 111.842 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.474 ' N ' ' HG3' ' A' ' 92' ' ' GLN . 58.1 t-20 -71.37 -43.08 67.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.649 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.577 ' NZ ' ' ND2' ' A' ' 165' ' ' ASN . 37.0 mmtm -66.56 -44.38 82.46 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.18 -0.608 . . . . 1.0 111.403 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 91' ' ' LEU . 76.7 t -66.5 -44.49 90.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.211 -0.596 . . . . 1.0 111.364 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -68.22 -43.11 78.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.489 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 tp -67.05 -41.02 87.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.427 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 mt -63.69 -43.85 95.41 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.272 -0.571 . . . . 1.0 110.5 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -68.78 -38.64 80.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.146 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -70.66 -43.48 69.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.954 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.3 tpt -66.1 -54.34 26.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.476 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 104' ' ' SER . 9.8 m -59.67 -40.36 87.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.085 0.469 . . . . 1.0 110.438 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.0 m -72.23 10.18 0.83 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.705 -0.68 . . . . 1.0 111.249 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 102' ' ' THR . 6.8 t -92.43 136.62 33.06 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.865 0.364 . . . . 1.0 110.274 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -60.82 -20.71 62.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.068 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.593 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 67.9 mttm -89.43 39.12 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.763 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -131.61 115.59 16.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.379 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -140.2 113.28 8.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.701 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.2 t -98.12 88.07 4.11 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.076 0.465 . . . . 1.0 110.916 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.98 171.13 14.67 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 115' ' ' VAL . 10.1 p -74.62 165.38 25.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -60.62 -39.75 89.36 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.805 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -67.43 -42.51 83.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.154 0.502 . . . . 1.0 110.803 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -70.73 -20.11 62.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.72 . . . . 1.0 111.045 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 111' ' ' THR . 18.0 t -70.43 -45.85 73.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.809 -0.356 . . . . 1.0 110.267 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.47 -45.03 98.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.102 0.477 . . . . 1.0 110.073 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.06 -34.4 78.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.993 0.425 . . . . 1.0 110.729 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -66.58 -49.98 64.57 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.915 -0.584 . . . . 1.0 111.85 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.9 tp -69.93 -38.91 76.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.476 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.552 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 66.5 mm-40 -63.89 -39.99 95.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.56 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -64.84 -47.27 78.55 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.601 -0.439 . . . . 1.0 110.345 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -60.25 -45.46 93.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.947 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.3 t -63.87 -38.14 89.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.319 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -58.36 -41.76 85.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.839 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.3 t -66.7 -41.95 88.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -123.6 75.83 54.97 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.505 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.91 -17.21 32.53 Favored 'Trans proline' 0 N--CA 1.488 1.157 0 C-N-CA 122.531 2.154 . . . . 1.0 112.2 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -101.64 22.37 12.88 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.577 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -143.64 151.56 40.27 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.862 0.363 . . . . 1.0 110.664 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 94.4 p -81.19 163.16 23.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.817 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 p -152.41 146.55 15.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.249 -0.648 . . . . 1.0 109.249 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -147.77 142.39 26.58 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.834 0.35 . . . . 1.0 111.208 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -152.93 171.4 18.38 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.374 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.593 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.8 p90 -141.05 158.52 43.81 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.25 -0.648 . . . . 1.0 109.25 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.8 p -151.74 168.28 25.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.824 0.345 . . . . 1.0 110.255 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.9 tp -80.27 129.41 34.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.588 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.408 HD22 ' HB2' ' A' ' 140' ' ' ASN . 43.8 t30 -72.07 156.86 38.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.272 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.43 ' CG ' ' N ' ' A' ' 139' ' ' ASP . 12.9 p-80 -96.18 -46.95 6.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.889 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.43 ' N ' ' CG ' ' A' ' 138' ' ' HIS . 95.0 m-20 -76.15 -7.52 54.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.21 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 139' ' ' ASP . 63.4 m-80 -160.86 70.11 2.7 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.37 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -49.55 -35.4 37.04 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.258 1.972 . . . . 1.0 112.711 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -60.55 -32.16 77.14 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.793 -0.923 . . . . 1.0 110.793 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -96.36 147.13 24.12 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.726 0.298 . . . . 1.0 110.219 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -113.2 152.32 29.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.704 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -123.18 139.94 53.54 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.972 0.415 . . . . 1.0 110.181 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.5 mt -108.79 121.37 44.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.291 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.537 ' SD ' HG13 ' A' ' 115' ' ' VAL . 5.0 ptt? -112.85 143.23 44.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.944 -1.132 . . . . 1.0 107.944 178.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -161.73 151.51 16.66 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.696 -0.483 . . . . 1.0 109.696 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.552 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 69.4 tttt -134.76 128.89 33.73 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.391 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.544 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 3.4 mp -69.53 -46.47 75.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.303 0.483 . . . . 1.0 112.303 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 150' ' ' ILE . 20.7 m120 -159.48 173.98 15.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.515 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.84 74.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.836 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -86.81 8.15 24.01 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.385 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -96.3 165.54 12.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.441 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.48 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 61.2 mttp -99.22 149.85 22.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 1.0 109.928 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.7 tp -69.42 122.63 19.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.038 0.447 . . . . 1.0 109.871 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 87.9 m-85 -114.31 128.64 56.45 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.855 -0.611 . . . . 1.0 109.822 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 97.8 m -123.37 128.77 50.35 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.679 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -114.2 160.78 18.62 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.036 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -107.68 146.45 32.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.9 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 169' ' ' PHE . 42.4 t -128.82 135.98 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -97.72 133.34 42.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.049 0.452 . . . . 1.0 110.844 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 31.6 tp -95.68 130.3 42.61 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.4 p -133.47 178.28 7.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.055 0.455 . . . . 1.0 110.266 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.577 ' ND2' ' NZ ' ' A' ' 94' ' ' LYS . 25.0 m120 -86.17 17.16 3.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.663 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 13.4 p -121.2 -2.18 9.64 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.811 0.339 . . . . 1.0 110.626 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.02 -127.16 4.47 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.373 -1.091 . . . . 1.0 110.373 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -121.31 130.06 53.44 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 110.219 -0.289 . . . . 1.0 110.219 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.426 ' O ' HG13 ' A' ' 161' ' ' VAL . 2.8 m-85 -104.08 124.7 49.53 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 109.854 -0.425 . . . . 1.0 109.854 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.9 tt -119.02 115.18 23.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.535 -0.543 . . . . 1.0 109.535 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.425 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 3.5 t 40.73 57.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 111.976 0.361 . . . . 1.0 111.976 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.8 m120 65.2 27.28 12.26 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.906 0.706 . . . . 1.0 112.906 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.425 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 73.6 m-85 -134.72 121.52 20.89 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.62 131.49 37.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.45 -0.341 . . . . 1.0 111.199 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -112.34 96.12 34.14 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.79 -22.53 7.22 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.499 2.133 . . . . 1.0 113.292 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.8 p -133.66 138.24 45.78 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.846 0.355 . . . . 1.0 110.999 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.6 p -61.04 -33.08 54.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.772 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.1 mm -62.0 -45.88 97.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.937 0.399 . . . . 1.0 110.194 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -65.61 -32.36 73.89 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.87 -42.5 99.79 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.424 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 74.0 m -63.36 -46.38 86.8 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.704 -0.399 . . . . 1.0 110.378 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 186' ' ' LYS . 74.6 m-20 -66.94 -49.29 65.96 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 119.682 -0.807 . . . . 1.0 108.926 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.12 -45.13 0.59 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.706 -1.357 . . . . 1.0 109.706 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -69.26 -47.06 65.73 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.218 0.532 . . . . 1.0 109.752 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 183' ' ' ASN . 89.1 tttt -56.52 -41.41 76.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.481 -0.781 . . . . 1.0 109.922 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 86.7 m -60.79 -45.58 93.84 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.57 -41.42 98.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.813 -0.631 . . . . 1.0 110.036 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.16 -43.61 82.69 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.786 -0.366 . . . . 1.0 110.716 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -60.75 -42.96 98.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.15 0.5 . . . . 1.0 110.434 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 48.4 m -61.72 -38.59 88.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.634 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 87.3 mt -65.13 -39.19 92.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.594 -0.73 . . . . 1.0 112.233 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -64.07 -30.51 71.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.651 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -94.34 -8.89 37.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.471 -0.331 . . . . 1.0 111.007 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.519 ' O ' ' CG ' ' A' ' 196' ' ' HIS . 28.2 t60 44.56 22.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.036 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.519 ' CG ' ' O ' ' A' ' 195' ' ' HIS . 47.0 m80 -159.92 125.71 4.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.005 0.431 . . . . 1.0 110.454 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -161.19 172.87 15.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.71 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 77.4 t60 51.11 72.46 0.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.801 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 80.0 m80 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 118.023 -0.989 . . . . 1.0 110.635 179.827 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.5 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 76.1 2.41 3.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.518 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -156.67 6.01 0.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.53 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 p -63.5 -32.91 58.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.341 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.9 pt -79.28 -12.22 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.316 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -105.13 4.91 31.86 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.645 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.16 150.05 94.51 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.127 -0.323 . . . . 1.0 110.127 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 41.0 Cg_endo -66.01 -22.66 54.95 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.817 1.678 . . . . 1.0 112.261 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.537 ' CD1' ' CE2' ' A' ' 30' ' ' PHE . 25.4 m-85 -87.26 5.87 36.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.556 -0.293 . . . . 1.0 111.164 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.468 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 42.0 t80 -87.23 127.8 35.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.435 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.468 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 63.4 m-85 -149.19 108.87 3.42 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 109.935 -0.394 . . . . 1.0 109.935 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.526 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 33.3 Cg_exo -59.54 109.82 0.63 Allowed 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 121.548 1.499 . . . . 1.0 112.828 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 12' ' ' PRO . 66.0 m-85 -159.2 150.46 20.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.405 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -77.9 164.25 25.31 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.452 -0.573 . . . . 1.0 109.452 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' OE2' ' A' ' 19' ' ' GLU . . . -59.07 -41.68 96.63 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -67.0 -42.7 84.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.743 0.306 . . . . 1.0 111.144 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -66.3 -35.95 81.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.136 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.46 88.38 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.741 -0.384 . . . . 1.0 110.33 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -59.47 -46.42 88.83 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.638 -0.425 . . . . 1.0 109.872 179.479 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.85 -44.97 94.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.168 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -61.69 -41.48 97.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.701 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.8 mp -79.69 -12.96 59.78 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.995 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.23 -42.41 99.23 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.76 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.5 m -79.48 -20.24 47.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.847 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -80.48 173.76 12.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 1.0 110.636 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.587 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.1 pm0 -85.16 170.11 13.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.492 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -80.22 145.77 32.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.88 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.67 -0.27 57.96 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -85.89 146.87 26.53 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.537 ' CE2' ' CD1' ' A' ' 9' ' ' TYR . 51.7 p90 -131.42 164.64 25.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.295 0.569 . . . . 1.0 111.108 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 32' ' ' ILE . 69.1 t -147.3 158.19 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.422 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.472 ' N ' HG12 ' A' ' 31' ' ' VAL . 79.1 mt -116.98 123.71 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -143.38 158.44 43.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.36 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.666 ' C ' ' H ' ' A' ' 36' ' ' SER . 27.1 mt-30 -109.65 148.25 31.67 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.927 -0.397 . . . . 1.0 109.927 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 37' ' ' ARG . 7.2 m -61.17 18.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.256 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.666 ' H ' ' C ' ' A' ' 34' ' ' GLN . 1.5 m 69.21 -42.12 0.49 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.769 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 35' ' ' SER . 79.4 mtp85 -121.51 11.39 10.62 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.915 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -71.5 -66.75 2.05 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.489 -1.045 . . . . 1.0 110.489 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 67.08 -45.82 0.47 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.217 0.532 . . . . 1.0 110.914 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 38' ' ' GLY . 52.5 t0 -93.28 -4.79 51.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.802 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -146.24 149.9 34.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.542 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.91 150.85 40.45 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.991 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.9 t -124.73 132.09 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.005 -0.368 . . . . 1.0 110.005 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.682 HD12 HD11 ' A' ' 58' ' ' ILE . 56.8 mt -110.85 138.18 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.43 HG23 ' ND1' ' A' ' 55' ' ' HIS . 90.5 m -119.21 138.13 53.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.777 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.441 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 3.8 p-90 -147.15 146.75 30.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.743 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.509 ' C ' HD12 ' A' ' 48' ' ' LEU . 86.1 tttt -92.48 138.61 31.37 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.209 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.509 HD12 ' C ' ' A' ' 47' ' ' LYS . 10.0 mp -103.54 -82.71 0.49 Allowed 'General case' 0 C--N 1.339 0.129 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.123 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -94.16 -175.27 3.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.557 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -58.33 -41.09 83.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.898 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -127.32 53.63 1.72 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.021 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.5 tp -150.01 131.71 14.98 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.796 0.331 . . . . 1.0 110.413 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -132.7 148.89 52.34 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.297 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -137.17 151.16 48.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.722 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.43 ' ND1' HG23 ' A' ' 45' ' ' THR . 10.2 m-70 -127.64 141.99 51.47 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.132 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 95.5 mt -121.56 124.2 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -92.96 121.58 34.45 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.039 0.447 . . . . 1.0 110.544 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.682 HD11 HD12 ' A' ' 44' ' ' ILE . 84.0 mt -99.94 129.58 50.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.453 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -116.15 125.12 51.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 1.0 109.88 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -101.58 143.49 31.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.332 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 84.6 mt -143.78 -179.39 6.43 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.463 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 75.76 50.59 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.034 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -95.49 125.88 40.4 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.779 -0.646 . . . . 1.0 109.945 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -69.72 -21.63 63.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.692 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.624 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 4.1 m-80 -157.62 165.14 19.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.061 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.54 -33.89 80.18 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.91 1.74 . . . . 1.0 112.451 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.7 mt -93.43 -4.45 51.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.575 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.624 ' HB3' ' H ' ' A' ' 65' ' ' ASN . . . -80.33 146.88 31.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.649 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.0 mt -89.47 157.41 18.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.213 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.57 126.66 8.64 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -85.67 -11.11 54.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.089 0.471 . . . . 1.0 110.582 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.43 120.18 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.571 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.1 mt -113.77 122.3 46.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.827 -0.624 . . . . 1.0 109.43 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 70.9 mt -101.82 124.39 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.985 -0.376 . . . . 1.0 109.985 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.1 t -142.63 133.31 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.261 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 77' ' ' ASN . 97.0 m-20 51.91 48.17 23.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.978 -0.289 . . . . 1.0 111.031 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 5.4 p30 55.25 21.69 4.23 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.384 0.428 . . . . 1.0 110.981 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -127.4 139.37 52.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.196 0.522 . . . . 1.0 110.155 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -88.53 134.38 33.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.002 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -129.2 138.11 51.52 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.421 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -78.66 -37.14 42.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.077 -0.51 . . . . 1.0 111.772 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 16.3 t0 -136.98 160.65 38.28 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.375 0.607 . . . . 1.0 111.637 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.511 ' C ' HD12 ' A' ' 83' ' ' LEU . 3.0 pp -71.93 -36.27 69.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.447 -0.797 . . . . 1.0 111.799 178.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 2.4 p30 -58.58 -41.94 86.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.93 0.715 . . . . 1.0 112.93 -176.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.455 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 6.1 pt20 -63.81 -38.33 90.68 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.632 0.253 . . . . 1.0 110.882 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.4 mt -61.27 -46.23 97.02 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 C-N-CA 120.485 -0.486 . . . . 1.0 110.882 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -61.62 -38.87 81.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 120.966 0.412 . . . . 1.0 111.49 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 84' ' ' ASP . 30.8 t -78.31 -32.73 17.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 112.799 0.666 . . . . 1.0 112.799 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -88.7 -13.8 38.82 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.739 -0.384 . . . . 1.0 111.61 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.651 ' CZ ' ' NZ ' ' A' ' 94' ' ' LYS . 11.0 t80 -96.69 -48.66 5.41 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.786 -0.365 . . . . 1.0 111.525 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 95' ' ' VAL . 4.3 mm? -71.21 -39.78 71.54 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.023 -0.535 . . . . 1.0 112.001 -177.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -63.81 -49.05 74.41 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.791 -0.764 . . . . 1.0 111.948 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -71.24 -42.72 68.49 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.616 -0.434 . . . . 1.0 111.863 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.651 ' NZ ' ' CZ ' ' A' ' 90' ' ' TYR . 21.1 mmtp -66.34 -42.12 88.6 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.274 -0.57 . . . . 1.0 111.285 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 91' ' ' LEU . 58.6 t -65.02 -45.68 93.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.253 -0.579 . . . . 1.0 111.277 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -68.06 -44.78 75.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.483 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 tp -66.7 -40.04 88.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.294 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.1 tp -64.36 -42.53 96.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.401 -0.52 . . . . 1.0 109.935 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -67.84 -38.1 82.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.143 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -71.28 -42.28 68.92 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.845 -0.342 . . . . 1.0 111.617 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.512 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 5.0 ttt -66.46 -54.63 21.89 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.641 -0.424 . . . . 1.0 111.241 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.43 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 20.4 m -57.86 -32.54 67.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.273 0.558 . . . . 1.0 110.531 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -75.03 10.63 1.39 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.342 -0.845 . . . . 1.0 111.612 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 93.3 p -91.44 133.93 35.06 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.895 0.379 . . . . 1.0 110.489 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -60.61 -20.48 60.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.777 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.56 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 69.2 mttm -87.71 40.28 0.93 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.714 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 102' ' ' THR . 0.4 OUTLIER -132.25 116.87 17.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.387 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.465 ' NZ ' ' CE1' ' A' ' 118' ' ' PHE . 50.5 mtpt -135.99 109.72 8.08 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.611 -0.514 . . . . 1.0 109.611 178.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.1 t -91.21 88.88 7.1 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.216 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.97 160.86 12.98 Favored Glycine 0 N--CA 1.466 0.641 0 N-CA-C 110.829 -0.909 . . . . 1.0 110.829 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.586 HG22 ' N ' ' A' ' 112' ' ' LYS . 56.7 m -71.52 165.38 23.99 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.862 -0.422 . . . . 1.0 109.862 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 111' ' ' THR . 49.3 tptt -55.04 -38.54 68.11 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.56 -0.456 . . . . 1.0 110.558 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -67.35 -45.09 77.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.403 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.9 -19.85 62.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.952 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 111' ' ' THR . 23.7 t -68.82 -44.54 81.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.89 -44.62 92.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.211 0.529 . . . . 1.0 110.075 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -64.98 -36.13 83.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.915 0.388 . . . . 1.0 110.63 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.465 ' CE1' ' NZ ' ' A' ' 108' ' ' LYS . 11.1 t80 -64.64 -51.07 64.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.754 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.6 tp -69.9 -38.91 76.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.02 0.438 . . . . 1.0 110.17 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.537 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 65.1 mm-40 -64.1 -42.74 96.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.667 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.89 -48.22 82.8 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.438 -0.505 . . . . 1.0 110.24 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -60.48 -39.34 87.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.716 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.0 t -59.62 -40.99 89.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.228 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -62.17 -38.6 89.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.972 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.3 t -64.12 -43.31 97.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -130.24 74.59 80.24 Favored Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.226 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.45 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 7.7 Cg_exo -69.81 -23.6 30.38 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.894 2.396 . . . . 1.0 112.77 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -88.78 -14.38 37.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.981 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -112.59 153.96 26.75 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.144 0.497 . . . . 1.0 110.563 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.7 t -80.65 164.83 22.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.555 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 p -151.86 148.44 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -144.42 142.96 30.68 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.976 0.417 . . . . 1.0 111.213 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -151.65 167.91 26.66 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.294 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.56 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 2.1 p90 -140.53 155.28 46.67 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 53.2 m -155.66 171.75 19.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.343 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 51.3 tp -80.38 134.61 36.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.651 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.781 ' H ' HD22 ' A' ' 137' ' ' ASN . 0.1 OUTLIER -95.8 140.51 30.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.797 0.332 . . . . 1.0 110.348 179.381 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.455 ' ND1' ' N ' ' A' ' 138' ' ' HIS . 2.1 m80 -89.1 -28.75 19.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.712 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.66 -31.01 69.15 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.276 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.512 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -147.53 105.75 3.76 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.74 136.73 26.02 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.76 1.64 . . . . 1.0 112.691 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.11 -25.12 26.12 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.537 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 12.5 m95 -98.13 152.28 19.5 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.908 0.385 . . . . 1.0 110.246 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.512 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 91.5 m-85 -119.57 156.25 30.68 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.465 -0.568 . . . . 1.0 109.465 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -130.53 145.09 51.79 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.034 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.2 mt -111.06 121.74 46.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.893 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 11.7 ptp -110.43 140.93 44.19 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.686 -1.227 . . . . 1.0 107.686 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -161.47 153.35 19.4 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.384 -0.527 . . . . 1.0 109.59 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.537 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 33.8 mtpt -136.67 131.87 34.19 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.764 0.316 . . . . 1.0 110.604 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.532 HG22 HD22 ' A' ' 151' ' ' ASN . 23.7 mm -72.31 -45.13 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.355 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.532 HD22 HG22 ' A' ' 150' ' ' ILE . 26.4 m-80 -157.81 170.58 22.04 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.495 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.37 -26.54 65.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.764 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -87.53 -10.24 52.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.056 0.455 . . . . 1.0 110.35 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 23.8 t -80.58 155.03 27.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.533 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.75 156.93 18.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.894 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.5 tp -69.99 115.98 9.83 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.188 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -107.38 130.32 54.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.628 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 89.3 m -126.29 130.11 50.2 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.809 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -112.95 156.91 22.19 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.025 -0.534 . . . . 1.0 109.786 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -106.38 146.22 30.73 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.867 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.82 137.7 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -99.1 135.42 40.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.854 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.17 130.71 44.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 81.4 p -129.27 172.35 11.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.332 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -85.64 18.07 3.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.871 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.07 -2.63 8.15 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.594 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 141.63 -129.73 4.1 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -125.25 132.29 52.98 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.815 0.341 . . . . 1.0 110.175 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -106.5 123.51 48.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.14 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.9 tt -119.02 117.89 30.0 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.36 -0.608 . . . . 1.0 109.36 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.2 t 36.02 52.02 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 111.89 0.329 . . . . 1.0 111.89 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.0 m120 71.98 26.66 2.85 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.105 0.78 . . . . 1.0 113.105 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -133.24 118.77 18.99 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.341 -0.614 . . . . 1.0 109.341 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -93.31 121.14 34.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.46 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -100.56 132.47 22.31 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -71.93 -18.96 27.49 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 C-N-CA 122.12 1.88 . . . . 1.0 113.33 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 35.4 m -153.47 157.12 39.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.966 0.412 . . . . 1.0 111.013 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.58 -33.97 62.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.957 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.4 mm -60.05 -46.64 94.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.89 -0.324 . . . . 1.0 110.548 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -68.84 -29.95 68.38 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 48.5 tp -64.81 -42.21 95.18 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.457 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.607 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 8.1 p -62.44 -47.63 83.23 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.768 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.607 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 44.6 t-20 -66.38 -46.9 75.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.974 -0.75 . . . . 1.0 108.974 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.87 -45.54 0.82 Allowed Glycine 0 C--N 1.334 0.437 0 N-CA-C 110.021 -1.232 . . . . 1.0 110.021 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -69.03 -46.83 66.94 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 183' ' ' ASN . 88.4 tttt -55.49 -40.1 71.27 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.841 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 9.3 m -60.95 -44.76 96.82 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.54 -40.82 98.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.826 -0.625 . . . . 1.0 109.963 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 40.9 tp -57.46 -42.25 82.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.412 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -63.12 -43.07 99.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.132 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.0 t -63.52 -39.37 94.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.394 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.83 -43.31 99.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.463 -0.79 . . . . 1.0 112.064 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -68.2 -29.37 68.21 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.815 0.302 . . . . 1.0 111.815 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -81.45 7.97 10.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.847 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.589 ' O ' ' N ' ' A' ' 197' ' ' HIS . 44.2 t-80 61.05 51.78 4.33 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.221 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.401 ' O ' ' C ' ' A' ' 197' ' ' HIS . 71.8 m-70 56.83 -70.44 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 O-C-N 123.719 0.637 . . . . 1.0 111.009 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 195' ' ' HIS . 78.2 t60 -38.2 102.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.962 0.411 . . . . 1.0 110.687 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.473 ' CD2' ' O ' ' A' ' 198' ' ' HIS . 38.6 p-80 -112.55 106.24 14.64 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.561 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.957 -1.021 . . . . 1.0 110.561 -179.893 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 29.7 p . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.44 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 53.5 t-80 -154.08 -37.63 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.592 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -109.22 -16.32 14.1 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.565 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.36 -34.85 71.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.573 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.7 pt -79.3 -14.02 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.347 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 2' ' ' HIS . 29.9 m120 -89.84 -4.72 57.45 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.471 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -81.38 138.34 48.32 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.393 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.54 -16.1 46.45 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.898 1.732 . . . . 1.0 112.272 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.502 ' CD1' ' CE2' ' A' ' 30' ' ' PHE . 96.0 m-85 -93.13 8.91 38.18 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.281 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 87.6 t80 -88.45 127.42 35.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.498 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 61.2 m-85 -149.28 126.12 5.39 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.525 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 74.1 Cg_endo -73.36 107.67 2.44 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.433 1.422 . . . . 1.0 112.853 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.525 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 43.8 m-85 -162.76 152.49 15.81 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.522 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.559 ' ND2' HE22 ' A' ' 17' ' ' GLN . 52.6 p-10 -88.33 -176.23 5.28 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.62 -40.63 99.39 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.314 -0.946 . . . . 1.0 111.377 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -61.97 -48.17 81.55 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.894 -0.323 . . . . 1.0 111.189 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.559 HE22 ' ND2' ' A' ' 14' ' ' ASN . 0.9 OUTLIER -69.63 -30.93 68.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.291 -179.501 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.441 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.72 -46.04 91.35 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.651 -0.42 . . . . 1.0 110.292 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' OE2' ' CE1' ' A' ' 53' ' ' PHE . 81.2 tt0 -65.48 -41.07 93.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.67 -0.412 . . . . 1.0 109.996 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -62.24 -43.34 99.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.083 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -62.52 -44.89 95.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.455 -0.339 . . . . 1.0 110.536 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 18' ' ' ALA . 6.8 mp -73.37 -13.32 61.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.971 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 ttp85 -59.6 -43.21 93.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.956 0.408 . . . . 1.0 110.589 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.5 t -77.46 -19.15 56.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.829 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -86.41 -174.75 5.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.47 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 55.9 mp0 -104.54 -176.67 3.14 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.672 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -81.53 146.6 30.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.804 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.85 -1.02 59.44 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.175 -0.77 . . . . 1.0 111.175 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -85.58 148.62 25.84 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.066 -0.716 . . . . 1.0 109.066 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CE2' ' CD1' ' A' ' 9' ' ' TYR . 51.9 p90 -136.26 163.12 31.13 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.363 0.602 . . . . 1.0 110.965 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.2 m -147.68 158.89 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 114.98 -1.009 . . . . 1.0 111.645 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 79.0 mt -117.79 124.73 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -143.96 157.42 44.35 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.315 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.551 ' C ' ' H ' ' A' ' 36' ' ' SER . 35.3 mt-30 -108.76 142.54 39.16 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.867 -0.419 . . . . 1.0 109.867 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 37' ' ' ARG . 28.3 m -60.46 5.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.865 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.551 ' H ' ' C ' ' A' ' 34' ' ' GLN . 0.2 OUTLIER 71.72 -47.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.451 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.401 ' H ' ' C ' ' A' ' 35' ' ' SER . 35.4 ptt180 -100.02 0.29 40.65 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.891 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -73.4 -68.42 1.59 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.425 -1.07 . . . . 1.0 110.425 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 t70 69.23 -36.36 0.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.661 0.267 . . . . 1.0 110.799 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.528 ' H ' ' C ' ' A' ' 38' ' ' GLY . 95.2 m-20 -106.66 1.64 25.28 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -148.04 148.66 30.92 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.469 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.7 152.84 37.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.916 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.92 132.99 70.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.275 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.07 139.24 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.503 HG23 ' ND1' ' A' ' 55' ' ' HIS . 85.1 m -118.95 139.38 51.76 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.551 ' CZ2' ' NZ ' ' A' ' 94' ' ' LYS . 5.7 p-90 -148.65 144.93 27.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.415 -0.811 . . . . 1.0 111.027 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' C ' HD12 ' A' ' 48' ' ' LEU . 87.3 tttt -91.58 141.22 28.95 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.807 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.3 mp -97.85 -71.99 0.66 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.42 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 50' ' ' LYS . 62.3 t0 -162.01 146.46 12.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.144 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.543 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 1.1 ttmp? 46.54 -145.93 0.2 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.948 0.404 . . . . 1.0 111.126 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -79.79 68.95 6.02 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.81 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.8 tp -149.3 126.51 11.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.848 0.356 . . . . 1.0 110.426 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.519 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 64.0 m-85 -132.32 149.1 52.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.43 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 53' ' ' PHE . 98.0 mm-40 -135.78 152.7 51.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.031 -0.531 . . . . 1.0 109.666 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.513 ' O ' HD12 ' A' ' 56' ' ' ILE . 25.6 m-70 -128.07 142.68 51.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.302 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.513 HD12 ' O ' ' A' ' 55' ' ' HIS . 1.4 mp -118.88 122.54 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -92.23 120.58 32.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.053 0.454 . . . . 1.0 110.804 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.1 mm -99.34 131.68 46.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.41 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -114.4 136.57 52.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.024 -0.534 . . . . 1.0 109.833 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -100.54 152.92 19.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.119 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.429 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 3.1 tt -142.97 161.19 38.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.898 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.429 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 18.4 tt0 79.51 60.64 0.02 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.142 0.496 . . . . 1.0 109.781 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -106.55 103.31 12.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.0 -0.546 . . . . 1.0 109.725 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -70.43 -34.45 72.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.75 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 68' ' ' ALA . 15.6 p30 -161.16 157.0 21.66 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.42 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.96 -28.03 22.82 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.212 1.941 . . . . 1.0 112.193 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 67' ' ' LEU . 10.9 mp -83.93 -11.45 56.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.998 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 65' ' ' ASN . . . -92.7 140.15 29.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.318 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.8 mt -90.15 158.25 17.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.284 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.89 108.8 2.64 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.678 -0.969 . . . . 1.0 110.678 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -76.18 -18.29 59.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.834 0.35 . . . . 1.0 110.782 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.1 t -116.56 122.92 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.915 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.4 mt -116.3 133.92 55.48 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.6 mt -103.06 124.98 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.864 0.364 . . . . 1.0 110.076 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.7 133.7 32.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.411 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 t70 52.23 41.92 30.52 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.827 -0.349 . . . . 1.0 111.094 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 61.26 22.84 13.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.965 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -128.48 156.75 42.74 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.177 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -102.67 130.07 49.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.05 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.493 ' CD2' HD11 ' A' ' 86' ' ' ILE . 84.7 m-85 -129.24 139.37 51.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.253 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -86.55 -37.26 18.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.816 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -109.3 134.95 51.16 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.127 0.489 . . . . 1.0 112.312 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 46.9 tp -65.49 -38.1 88.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.559 -0.746 . . . . 1.0 110.722 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 4.6 p30 -58.6 -33.65 70.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 1.0 111.875 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.45 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 27.1 mt-30 -64.51 -37.98 89.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.696 0.284 . . . . 1.0 110.658 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.493 HD11 ' CD2' ' A' ' 80' ' ' TYR . 49.0 mm -59.58 -49.48 83.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.146 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 72.2 mt -62.94 -43.61 99.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.15 -0.62 . . . . 1.0 111.414 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 84' ' ' ASP . 61.4 t -70.36 -41.14 78.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 -178.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -80.23 -15.58 56.69 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.818 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -94.02 -49.88 5.57 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.56 -0.456 . . . . 1.0 111.799 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.495 ' HA ' HD13 ' A' ' 91' ' ' LEU . 4.3 mm? -68.6 -40.06 80.62 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.463 0.542 . . . . 1.0 112.463 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -63.38 -49.28 74.44 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.67 -0.812 . . . . 1.0 111.631 -177.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -65.96 -43.11 88.88 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.851 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.551 ' NZ ' ' CZ2' ' A' ' 46' ' ' TRP . 25.6 mmtp -65.93 -42.57 89.91 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.458 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 91' ' ' LEU . 56.7 t -65.58 -45.88 91.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.32 -0.552 . . . . 1.0 111.407 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -67.32 -46.56 73.14 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.598 -0.441 . . . . 1.0 111.47 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.9 tp -67.92 -40.12 83.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.627 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.39 -43.32 91.05 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.544 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -68.86 -35.63 77.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.404 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -70.61 -42.52 70.86 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.921 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 13.6 ttm -71.22 -53.04 15.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.484 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.442 HG23 ' CE2' ' A' ' 107' ' ' PHE . 9.0 m -57.11 -39.83 75.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.05 0.453 . . . . 1.0 110.222 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.7 m -71.45 9.72 0.76 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.888 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 102' ' ' THR . 8.3 t -92.74 133.23 36.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.276 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -60.82 -18.42 55.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.086 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.558 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 99.0 mttt -91.85 41.01 1.06 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.055 -0.521 . . . . 1.0 109.718 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.442 ' CE2' HG23 ' A' ' 102' ' ' THR . 82.7 t80 -134.69 118.18 16.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.285 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -138.15 114.81 10.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.074 -0.512 . . . . 1.0 109.732 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.5 p -93.44 91.84 7.34 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.062 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.83 166.63 13.02 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.844 -0.903 . . . . 1.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 115' ' ' VAL . 82.5 p -76.8 163.44 26.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -56.05 -35.55 67.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.826 0.346 . . . . 1.0 110.764 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -68.58 -43.89 75.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.145 0.498 . . . . 1.0 110.768 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -71.26 -19.26 62.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.013 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 111' ' ' THR . 38.7 t -70.74 -44.55 76.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 110.04 -0.355 . . . . 1.0 110.04 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.68 -45.57 91.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.063 0.459 . . . . 1.0 110.416 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.59 -36.9 85.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.845 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -65.1 -50.12 67.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.888 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 120' ' ' GLU . 10.8 tp -70.35 -40.01 77.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.447 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.409 ' N ' HG23 ' A' ' 119' ' ' ILE . 93.1 mt-10 -64.47 -45.06 89.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.589 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -60.54 -48.46 81.66 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.007 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.55 ' CD1' ' OD1' ' A' ' 126' ' ' ASN . 23.9 t80 -60.86 -42.06 97.11 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.646 -0.501 . . . . 1.0 109.646 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.5 t -59.93 -42.68 94.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.596 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -60.09 -39.95 87.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.356 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.92 -41.3 91.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.55 ' OD1' ' CD1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -118.95 76.42 14.59 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.31 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.526 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 37.4 Cg_endo -72.44 -21.16 23.05 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 122.398 2.065 . . . . 1.0 112.346 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.415 ' N ' HD22 ' A' ' 128' ' ' ASN . 1.8 m-80 -106.81 18.24 22.11 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.71 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -138.16 152.01 48.28 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.881 0.372 . . . . 1.0 110.654 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.412 ' OG ' HD21 ' A' ' 189' ' ' LEU . 4.0 t -81.74 163.19 22.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.89 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -154.19 145.43 14.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.168 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -148.49 144.34 27.3 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.784 0.326 . . . . 1.0 111.053 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -151.69 167.37 28.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.406 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.558 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -139.71 155.83 47.13 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 179.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.436 ' OG ' ' CZ ' ' A' ' 145' ' ' TYR . 15.0 p -152.07 169.4 22.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.405 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.1 tp -79.43 130.33 35.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.889 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -77.82 114.51 16.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.351 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -73.31 -36.14 66.2 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.591 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -65.91 -26.2 67.5 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.098 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -139.81 84.27 15.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.404 ' HG2' HE22 ' A' ' 54' ' ' GLN . 31.9 Cg_exo -56.77 129.72 36.12 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.079 1.853 . . . . 1.0 112.346 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.94 -24.25 23.73 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.121 -0.791 . . . . 1.0 111.121 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -99.26 150.99 21.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.79 0.328 . . . . 1.0 110.263 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -123.76 160.84 26.41 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.954 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.47 ' N ' ' CD1' ' A' ' 145' ' ' TYR . 4.7 p90 -142.89 148.3 36.75 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.343 0.402 . . . . 1.0 109.929 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.9 mt -110.07 131.47 55.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.161 0.505 . . . . 1.0 110.497 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.45 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -118.85 145.32 45.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 177.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -161.93 154.47 19.86 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.479 -0.488 . . . . 1.0 109.705 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -139.77 127.31 21.62 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.514 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.443 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 3.3 mp -68.88 -44.62 81.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.091 0.404 . . . . 1.0 112.091 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 27.4 m120 -159.22 175.31 13.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.54 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.79 -31.94 73.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -84.31 -12.61 54.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.518 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.447 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 16.7 t -80.03 146.28 32.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.327 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -79.64 151.18 30.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.93 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.53 127.81 34.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.997 0.427 . . . . 1.0 110.178 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -114.63 130.84 56.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.663 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 86.4 m -126.3 129.08 48.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.838 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -116.06 154.53 29.76 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.77 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -105.19 141.67 36.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.796 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.94 132.89 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -95.41 136.17 36.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.704 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.5 tp -98.2 131.09 44.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.06 -0.518 . . . . 1.0 109.712 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 46.1 p -131.17 163.84 26.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.356 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -76.98 16.3 0.56 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.542 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 14.8 p -122.1 -1.26 9.31 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.791 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 138.43 -129.42 4.53 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.289 -1.124 . . . . 1.0 110.289 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -126.03 130.83 51.94 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.588 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 5.8 m-85 -107.99 123.04 48.06 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.698 -0.482 . . . . 1.0 109.698 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.3 tt -115.32 119.24 35.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.079 -0.51 . . . . 1.0 109.638 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.2 t 34.86 52.91 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 112.132 0.419 . . . . 1.0 112.132 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.2 m120 72.47 27.37 2.42 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.074 0.768 . . . . 1.0 113.074 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -135.54 120.66 18.84 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.588 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 15.6 t-20 -91.23 131.7 36.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.156 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -112.0 95.29 28.76 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 109.545 -0.539 . . . . 1.0 109.545 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.84 -20.34 6.71 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.296 1.998 . . . . 1.0 113.536 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 48.8 m -135.66 139.76 43.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.885 0.374 . . . . 1.0 111.094 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.0 p -62.78 -34.8 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.706 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.08 -44.16 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-O 120.904 0.383 . . . . 1.0 110.124 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.36 -33.83 76.75 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.99 -39.87 94.12 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.539 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 71.8 m -61.59 -48.03 82.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.598 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 186' ' ' LYS . 41.5 t30 -69.6 -48.84 58.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.872 -0.788 . . . . 1.0 108.872 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.56 -45.96 0.54 Allowed Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.788 -1.325 . . . . 1.0 109.788 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -68.01 -47.76 67.58 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.204 0.526 . . . . 1.0 109.657 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 183' ' ' ASN . 19.3 ttpp -56.6 -41.26 76.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.427 -0.806 . . . . 1.0 110.019 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 94.3 m -61.16 -45.63 93.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.84 -41.07 99.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.908 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.412 HD21 ' OG ' ' A' ' 130' ' ' SER . 57.2 tp -58.25 -43.37 87.82 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.806 -0.357 . . . . 1.0 110.719 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -58.7 -45.74 88.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.153 0.501 . . . . 1.0 110.205 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 58.5 m -62.84 -39.6 94.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.476 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.49 -39.06 93.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.592 -0.731 . . . . 1.0 112.062 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.78 -24.58 61.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.83 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -91.61 6.57 45.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.084 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.528 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 76.6 t60 50.77 22.84 1.22 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.917 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.517 ' CG ' ' O ' ' A' ' 195' ' ' HIS . 20.7 p80 40.42 -165.47 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.785 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -131.64 5.89 4.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.613 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 85.0 t60 42.77 91.82 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.865 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.102 -0.952 . . . . 1.0 110.646 179.972 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.564 ' O ' ' CG ' ' A' ' 2' ' ' HIS . 13.0 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.564 ' CG ' ' O ' ' A' ' 1' ' ' THR . 18.6 p80 44.56 15.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.607 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 1' ' ' THR . 4.1 tpt180 -160.22 11.8 0.11 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.83 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 p -69.12 -33.81 60.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.601 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.6 pt -58.19 -13.95 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.658 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -134.79 24.97 3.67 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.399 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.3 147.43 58.0 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.495 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -50.88 -34.22 44.58 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.626 1.55 . . . . 1.0 112.321 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -88.74 10.14 21.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.391 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.49 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 42.5 t80 -91.17 129.07 37.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.55 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 65.2 m-85 -149.75 132.25 8.01 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.8 113.55 3.79 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.761 1.641 . . . . 1.0 112.701 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 18' ' ' ALA . 12.0 p90 -154.18 162.0 41.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.703 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.44 ' H ' ' HB2' ' A' ' 17' ' ' GLN . 66.7 t30 -90.23 172.76 8.56 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.699 ' N ' HH12 ' A' ' 33' ' ' ARG . . . -58.31 -51.26 59.66 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.734 -0.946 . . . . 1.0 110.734 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -65.82 -39.06 90.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.676 0.274 . . . . 1.0 110.817 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.44 ' HB2' ' H ' ' A' ' 14' ' ' ASN . 88.1 mm-40 -65.59 -32.48 74.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.388 . . . . 1.0 111.289 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.558 ' HB2' ' CD1' ' A' ' 13' ' ' PHE . . . -61.15 -45.86 92.93 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.282 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.69 -40.88 92.78 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.662 -0.415 . . . . 1.0 109.99 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -63.06 -45.75 90.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.296 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -60.56 -42.37 96.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.542 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.7 mp -80.54 -13.29 59.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.893 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -61.72 -41.63 97.88 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.542 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.0 p -77.22 -17.17 58.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.903 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -82.85 177.86 8.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.664 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -95.31 178.22 5.59 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.713 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.476 ' NH2' ' OD1' ' A' ' 99' ' ' ASN . 60.5 ttp180 -76.17 144.73 40.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.053 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.12 26.16 17.14 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.312 -0.715 . . . . 1.0 111.312 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -112.13 142.03 45.09 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.121 -0.696 . . . . 1.0 109.121 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -134.08 169.62 16.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.499 0.666 . . . . 1.0 111.052 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.69 ' O ' HG23 ' A' ' 44' ' ' ILE . 15.3 m -148.41 160.21 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 114.971 -1.013 . . . . 1.0 111.812 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.0 mm -115.87 130.4 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.699 HH12 ' N ' ' A' ' 15' ' ' GLY . 69.5 ttt180 -143.36 154.22 43.51 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.107 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -115.15 138.02 51.37 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 t -82.93 126.49 32.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.861 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.6 t -62.65 -43.42 98.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.672 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.415 ' HD3' ' H ' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -73.75 -23.68 59.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.012 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -123.21 55.45 0.69 Allowed Glycine 0 N--CA 1.466 0.661 0 N-CA-C 110.611 -0.996 . . . . 1.0 110.611 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -59.14 -0.55 0.13 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.84 0.352 . . . . 1.0 110.731 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 38' ' ' GLY . 73.0 m-20 -96.38 -2.34 45.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.663 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -140.78 164.84 29.13 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.192 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.01 146.95 46.16 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.246 -0.434 . . . . 1.0 109.905 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.421 HG22 ' OD1' ' A' ' 57' ' ' ASP . 58.1 t -125.97 132.05 71.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.792 0.329 . . . . 1.0 110.271 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 31' ' ' VAL . 59.6 mt -112.94 138.95 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.6 m -117.54 138.73 51.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.225 0.536 . . . . 1.0 109.647 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.491 ' CZ2' HD11 ' A' ' 48' ' ' LEU . 3.3 p-90 -145.33 156.78 44.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.687 -0.688 . . . . 1.0 110.784 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' C ' HD12 ' A' ' 48' ' ' LEU . 25.1 ttpp -104.67 136.2 44.64 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.292 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.3 mp -97.1 -68.49 0.8 Allowed 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.048 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -106.66 -165.19 1.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.156 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.467 ' HD3' ' H ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -78.66 -17.7 55.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.674 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 68.0 t0 -139.68 48.11 1.83 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.783 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.7 tp -155.69 133.47 11.21 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.926 0.394 . . . . 1.0 110.425 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -134.1 149.77 51.12 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.59 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.507 ' OE1' HD21 ' A' ' 48' ' ' LEU . 65.1 mt-30 -139.26 154.69 48.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.825 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 30.7 p-80 -127.03 142.49 51.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.212 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.51 121.34 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 109.708 -0.478 . . . . 1.0 109.708 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD1' HG22 ' A' ' 43' ' ' VAL . 95.8 m-20 -92.51 121.7 34.22 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.976 0.417 . . . . 1.0 110.615 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.2 mt -104.04 127.6 58.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.244 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -118.58 133.4 55.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.987 0.422 . . . . 1.0 109.92 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 40' ' ' ASP . 1.4 mp0 -99.97 144.63 28.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.015 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 70' ' ' GLY . 81.4 mt -146.4 167.24 24.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.627 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 61' ' ' LEU . 17.4 tp10 81.04 17.28 0.52 Allowed 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.47 0.481 . . . . 1.0 109.89 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -54.97 116.72 2.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.194 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -73.27 -23.72 60.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.713 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -157.71 153.95 23.88 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.115 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -58.74 -26.54 80.27 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.29 1.993 . . . . 1.0 112.134 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.6 mt -98.17 -1.87 41.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.464 -0.334 . . . . 1.0 110.607 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.93 160.26 14.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.949 0.404 . . . . 1.0 110.335 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.6 mt -72.75 160.66 31.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.387 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 71' ' ' LYS . . . -60.89 -33.35 83.12 Favored Glycine 0 C--O 1.224 -0.499 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 70' ' ' GLY . 41.1 tttm 84.73 -31.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.061 0.457 . . . . 1.0 110.654 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.44 123.88 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.563 -0.744 . . . . 1.0 110.702 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.2 mt -112.82 122.85 48.88 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.476 -0.565 . . . . 1.0 109.476 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.5 mt -101.24 123.11 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.826 0.346 . . . . 1.0 110.219 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.12 130.48 29.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.233 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 165' ' ' ASN . 42.1 t0 53.66 45.35 28.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 1.0 111.116 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.9 m120 58.1 23.23 9.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.908 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -128.12 139.28 52.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.931 0.396 . . . . 1.0 110.252 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -89.62 133.37 34.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.976 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -123.96 138.57 54.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.333 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -85.4 -36.64 20.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.566 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -127.25 150.34 49.59 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.207 0.527 . . . . 1.0 111.857 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.7 tp -63.52 -39.2 93.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.671 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -58.18 -44.27 87.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.757 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -58.9 -37.87 77.6 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 110.34 -0.245 . . . . 1.0 110.34 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.408 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 96.9 mt -63.1 -45.86 97.57 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 C-N-CA 120.428 -0.509 . . . . 1.0 111.008 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.6 mt -68.1 -44.24 84.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 120.526 -0.47 . . . . 1.0 111.585 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.7 t -77.8 -36.21 22.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 113.029 0.752 . . . . 1.0 113.029 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -84.78 -12.89 52.74 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.886 -0.325 . . . . 1.0 111.743 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 23.1 t80 -98.2 -48.22 5.17 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.564 -0.455 . . . . 1.0 111.727 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.443 ' HA ' HD13 ' A' ' 91' ' ' LEU . 4.5 mm? -69.16 -40.15 78.35 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.316 0.487 . . . . 1.0 112.316 -177.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -62.73 -48.81 77.59 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.852 -0.739 . . . . 1.0 111.478 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -66.91 -42.47 85.35 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.599 -0.44 . . . . 1.0 111.814 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -65.51 -43.65 89.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.097 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 91' ' ' LEU . 76.1 t -65.31 -44.33 94.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.405 -0.518 . . . . 1.0 111.018 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -68.0 -47.29 68.93 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.594 -0.442 . . . . 1.0 111.621 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.551 HD21 ' CZ ' ' A' ' 168' ' ' TYR . 3.7 tp -68.05 -39.78 82.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.248 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.07 -43.13 96.37 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.314 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.476 ' OD1' ' NH2' ' A' ' 27' ' ' ARG . 94.3 m-20 -66.94 -37.71 84.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.035 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -71.01 -42.01 70.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.755 -0.378 . . . . 1.0 111.748 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.5 ttt -66.12 -54.98 18.88 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.494 -0.482 . . . . 1.0 111.458 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 84.0 m -59.15 -40.64 86.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.043 0.449 . . . . 1.0 110.33 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.1 t -73.1 10.19 1.01 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.056 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.0 t -91.53 138.43 31.58 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.754 0.311 . . . . 1.0 110.256 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.75 -16.92 59.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.169 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.561 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 57.4 mmtt -93.87 38.57 1.07 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.056 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -133.08 116.76 16.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.045 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.497 ' NZ ' ' CE1' ' A' ' 118' ' ' PHE . 48.6 mtpt -133.2 128.83 36.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.951 -0.568 . . . . 1.0 109.901 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.4 p -96.64 77.66 2.9 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.912 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -111.29 151.8 17.72 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.946 -0.861 . . . . 1.0 110.946 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 115' ' ' VAL . 58.1 p -73.5 168.29 19.58 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -55.46 -36.49 66.64 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.876 -0.33 . . . . 1.0 110.813 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -68.18 -44.18 76.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.625 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.53 -20.83 63.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.878 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 111' ' ' THR . 53.1 t -70.54 -44.95 76.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.746 -0.382 . . . . 1.0 110.186 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.8 t -64.31 -46.71 92.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-O 121.057 0.456 . . . . 1.0 110.334 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -65.86 -34.84 79.06 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.957 0.408 . . . . 1.0 110.821 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.497 ' CE1' ' NZ ' ' A' ' 108' ' ' LYS . 25.0 t80 -66.73 -50.11 63.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.914 -0.584 . . . . 1.0 111.667 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.434 HD11 HG13 ' A' ' 131' ' ' VAL . 11.2 tp -70.31 -39.86 77.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.96 0.41 . . . . 1.0 110.35 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -65.1 -40.06 94.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.646 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -63.61 -47.85 79.73 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.504 -0.478 . . . . 1.0 110.291 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -61.89 -41.77 98.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.012 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 90.6 p -64.53 -34.89 79.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.221 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -63.56 -41.21 98.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.166 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.3 t -67.18 -42.06 87.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.766 -0.457 . . . . 1.0 109.766 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -124.83 75.62 65.51 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.351 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.3 -13.71 30.9 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.676 2.251 . . . . 1.0 112.345 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -103.79 13.7 32.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.622 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -134.88 149.84 50.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.052 0.453 . . . . 1.0 110.576 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.5 p -80.58 161.78 24.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.803 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.434 HG13 HD11 ' A' ' 119' ' ' ILE . 3.2 p -153.32 148.13 13.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -148.05 142.84 26.73 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.887 0.375 . . . . 1.0 111.2 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -152.1 166.48 31.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.438 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.561 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.2 p90 -140.06 157.27 45.91 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 30.9 p -150.6 168.3 24.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.799 0.333 . . . . 1.0 110.237 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.3 tp -81.7 131.25 35.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.118 -0.492 . . . . 1.0 111.015 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.513 HD21 HD22 ' A' ' 140' ' ' ASN . 58.3 t-20 -79.94 111.86 16.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.409 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.46 -45.19 69.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.899 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.84 -20.39 65.04 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.195 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.513 HD22 HD21 ' A' ' 137' ' ' ASN . 68.7 m-80 -141.79 82.65 13.62 Favored Pre-proline 0 N--CA 1.463 0.193 0 N-CA-C 110.018 -0.364 . . . . 1.0 110.018 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.51 137.75 51.92 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.815 1.677 . . . . 1.0 112.5 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.5 -17.34 53.6 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -109.58 145.42 36.4 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.891 0.377 . . . . 1.0 109.989 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -120.51 159.79 24.47 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 115.992 -0.549 . . . . 1.0 109.806 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 145' ' ' TYR . 4.3 p90 -142.63 148.01 36.73 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 123.382 0.426 . . . . 1.0 110.017 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.02 132.52 54.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.129 0.49 . . . . 1.0 110.46 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.507 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -121.65 146.89 46.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 178.109 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -160.89 155.17 23.09 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -140.26 129.06 23.18 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.69 -0.404 . . . . 1.0 110.502 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.484 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.5 mp -72.62 -48.71 45.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.217 0.451 . . . . 1.0 112.217 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 150' ' ' ILE . 86.5 m-20 -153.35 170.31 20.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.474 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.49 -31.08 71.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.943 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -84.7 -11.48 55.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.42 . . . . 1.0 110.525 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.43 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 29.5 t -80.1 155.45 27.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.351 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -86.86 147.96 25.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.893 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.0 tp -70.7 128.72 37.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.923 0.392 . . . . 1.0 110.223 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -117.62 129.5 55.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.628 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 71.9 m -130.71 129.55 42.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.937 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -116.07 167.24 11.16 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.207 -0.451 . . . . 1.0 109.828 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -109.79 144.08 38.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.958 -0.565 . . . . 1.0 111.051 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 63.6 t -122.24 134.71 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -100.27 132.12 45.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.382 . . . . 1.0 110.792 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 57.0 tp -92.21 130.81 37.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.715 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 41.5 p -128.04 168.14 15.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.479 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.409 ' OD1' ' OD2' ' A' ' 76' ' ' ASP . 21.9 m120 -82.58 14.24 3.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.598 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 57.2 p -122.01 -2.55 9.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.707 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 143.14 -133.34 5.43 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.228 -1.149 . . . . 1.0 110.228 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.551 ' CZ ' HD21 ' A' ' 97' ' ' LEU . 91.1 m-85 -122.87 128.42 50.31 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.61 0.243 . . . . 1.0 110.448 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -103.13 123.07 45.98 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 171' ' ' VAL . 8.4 tt -119.87 115.11 23.15 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.3 t 35.42 56.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.432 0.53 . . . . 1.0 112.432 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.5 m120 71.7 27.68 2.86 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.164 0.801 . . . . 1.0 113.164 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -135.54 120.11 18.19 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -94.56 119.2 32.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.411 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -99.01 133.62 22.05 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.24 -16.36 25.04 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.127 1.885 . . . . 1.0 113.604 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.1 p -154.25 158.22 39.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.946 0.403 . . . . 1.0 110.912 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 179' ' ' ILE . 12.5 p -63.29 -40.18 88.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.739 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.499 ' H ' HD12 ' A' ' 179' ' ' ILE . 3.7 mp -59.87 -47.09 92.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.806 0.336 . . . . 1.0 110.42 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -62.61 -35.7 80.38 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.58 -40.61 97.4 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.136 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 96.0 m -60.04 -45.57 92.38 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.54 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 186' ' ' LYS . 32.8 t30 -69.92 -49.4 52.41 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 119.692 -0.803 . . . . 1.0 108.869 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.05 -44.38 0.51 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.815 -1.314 . . . . 1.0 109.815 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -68.72 -47.4 66.46 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.084 -0.558 . . . . 1.0 109.586 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 183' ' ' ASN . 64.1 tttp -56.9 -41.83 78.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.816 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 16.9 m -61.03 -45.5 94.54 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 24.5 mt -62.19 -40.91 97.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.813 -0.631 . . . . 1.0 109.93 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.26 -44.04 92.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.461 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -59.47 -40.57 87.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.229 0.538 . . . . 1.0 110.056 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.4 t -67.18 -39.64 86.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.252 0.548 . . . . 1.0 110.791 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 25.2 mt -63.59 -44.54 93.75 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.603 -0.726 . . . . 1.0 112.261 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.8 -27.37 68.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.422 -0.354 . . . . 1.0 111.647 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 196' ' ' HIS . 0.8 OUTLIER -81.6 7.35 12.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.759 -179.126 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.523 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 82.8 t60 44.32 24.99 0.1 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.979 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.459 ' ND1' ' O ' ' A' ' 195' ' ' HIS . 6.4 m-70 -132.01 158.62 41.02 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.348 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -109.16 149.63 29.07 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.292 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -70.92 99.85 1.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.767 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 14.1 m80 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.946 -1.026 . . . . 1.0 110.65 -179.988 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 38.8 p . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.433 -0.58 . . . . 1.0 109.433 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -90.09 3.27 53.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.615 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 7' ' ' HIS . 36.3 mmt180 -124.4 2.81 8.42 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.556 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 5' ' ' ILE . 14.7 p -64.26 -42.8 96.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.573 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.508 ' N ' HG13 ' A' ' 4' ' ' VAL . 38.2 pt -75.54 -25.06 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.365 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -99.44 -0.7 40.29 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.302 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 3' ' ' ARG . 1.3 t60 -54.41 140.17 56.23 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.226 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.61 -15.86 48.89 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.919 1.746 . . . . 1.0 112.152 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -93.77 -5.43 48.3 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.627 -0.261 . . . . 1.0 111.151 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 44.0 t80 -71.12 126.66 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.532 -0.303 . . . . 1.0 110.608 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 52.2 m-85 -146.36 122.21 5.63 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 110.184 -0.302 . . . . 1.0 110.184 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.59 109.76 2.92 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.887 1.725 . . . . 1.0 112.492 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -157.14 156.06 32.06 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.631 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' ND2' ' H ' ' A' ' 15' ' ' GLY . 13.2 t-20 -77.07 173.49 11.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.458 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -61.42 -46.33 94.6 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.298 -0.954 . . . . 1.0 111.032 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -67.55 -37.79 83.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.899 0.38 . . . . 1.0 110.877 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -67.41 -33.04 74.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.418 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.585 ' CB ' ' NH1' ' A' ' 33' ' ' ARG . . . -61.23 -43.12 99.38 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.482 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -61.55 -41.75 97.82 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.694 -0.402 . . . . 1.0 109.963 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.1 -39.97 91.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.106 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -63.79 -40.6 97.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.525 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.6 -13.55 59.88 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.927 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -58.09 -43.28 86.97 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.367 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 m -78.53 -17.99 55.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.72 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -84.75 -175.89 5.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.354 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.562 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.3 pm0 -112.61 -172.86 2.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.59 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -79.15 146.38 33.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.789 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.55 23.57 25.91 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.274 -0.73 . . . . 1.0 111.274 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -112.66 145.17 40.9 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.445 ' CD1' HD21 ' A' ' 91' ' ' LEU . 11.9 p90 -133.51 160.38 37.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.214 0.531 . . . . 1.0 110.919 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 44' ' ' ILE . 88.1 t -146.34 155.39 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.255 -0.884 . . . . 1.0 111.459 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.431 ' N ' HG12 ' A' ' 31' ' ' VAL . 4.0 mp -118.87 123.39 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.004 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.585 ' NH1' ' CB ' ' A' ' 18' ' ' ALA . 18.6 ptt-85 -140.5 167.11 22.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.343 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 36' ' ' SER . 25.7 mt-30 -112.41 132.17 55.17 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.037 -0.357 . . . . 1.0 110.037 178.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.491 ' C ' ' H ' ' A' ' 37' ' ' ARG . 61.7 m -56.65 80.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.657 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 34' ' ' GLN . 0.2 OUTLIER 69.83 -42.2 0.5 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.319 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.674 ' O ' ' N ' ' A' ' 39' ' ' ASP . 82.1 mtp180 -150.4 -20.9 0.24 Allowed 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.251 -0.431 . . . . 1.0 111.218 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.614 ' O ' ' N ' ' A' ' 40' ' ' ASP . . . 60.41 -53.76 0.02 OUTLIER Glycine 0 C--O 1.221 -0.697 0 N-CA-C 110.45 -1.06 . . . . 1.0 110.45 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.674 ' N ' ' O ' ' A' ' 37' ' ' ARG . 66.7 t0 55.34 -73.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.082 0.467 . . . . 1.0 110.004 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.614 ' N ' ' O ' ' A' ' 38' ' ' GLY . 23.5 p-10 -124.89 19.06 8.53 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.039 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.488 ' ND1' ' OE1' ' A' ' 59' ' ' GLN . 88.6 m-70 -147.61 152.25 37.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.368 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mp -133.28 147.82 51.92 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.273 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.6 t -126.19 132.96 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.242 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 31' ' ' VAL . 60.2 mt -113.69 139.66 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.585 ' OG1' ' NH1' ' A' ' 33' ' ' ARG . 29.2 m -122.53 143.31 49.8 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.694 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.547 ' NE1' ' CG ' ' A' ' 54' ' ' GLN . 5.8 p-90 -152.46 151.13 30.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.47 -0.786 . . . . 1.0 111.047 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.506 ' C ' HD12 ' A' ' 48' ' ' LEU . 88.8 tttt -91.13 139.15 31.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.99 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.75 ' N ' HD12 ' A' ' 48' ' ' LEU . 6.4 mp -95.67 -59.18 1.92 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.287 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -151.5 -174.34 4.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.338 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -54.88 128.36 32.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.815 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 56.04 39.83 30.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.129 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -144.63 120.38 10.53 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.844 0.354 . . . . 1.0 110.283 179.414 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.607 ' N ' HD13 ' A' ' 52' ' ' LEU . 60.7 m-85 -135.23 149.03 49.79 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.631 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.547 ' CG ' ' NE1' ' A' ' 46' ' ' TRP . 0.5 OUTLIER -141.96 156.09 45.47 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.707 179.353 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.48 ' CA ' ' NE2' ' A' ' 54' ' ' GLN . 33.9 m-70 -129.39 145.34 51.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.956 -0.566 . . . . 1.0 110.63 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.455 HG13 HE22 ' A' ' 54' ' ' GLN . 41.9 mt -125.39 130.96 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 43.8 p-10 -99.61 122.59 42.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.879 0.371 . . . . 1.0 110.489 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.417 HD11 HD12 ' A' ' 44' ' ' ILE . 78.0 mt -102.32 130.67 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.489 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.488 ' OE1' ' ND1' ' A' ' 41' ' ' HIS . 55.5 mm-40 -113.94 126.66 55.4 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -102.1 155.63 18.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.492 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.462 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 2.0 tp -145.19 170.67 15.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.818 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.462 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 20.6 tp10 79.77 53.07 0.02 OUTLIER 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 109.674 -0.491 . . . . 1.0 109.674 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -91.36 90.52 7.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.875 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.499 ' OE1' ' ND2' ' A' ' 65' ' ' ASN . 3.4 tm-20 -67.13 -34.54 77.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.908 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.499 ' ND2' ' OE1' ' A' ' 64' ' ' GLU . 31.2 m120 -145.63 152.81 50.0 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.244 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.64 -33.35 48.51 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.314 2.009 . . . . 1.0 112.061 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.0 mt -86.9 -9.56 55.41 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.863 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.26 134.36 51.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.271 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.8 mt -85.36 152.55 23.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.351 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.59 96.63 0.02 OUTLIER Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.721 -0.951 . . . . 1.0 110.721 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -68.43 -43.69 76.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.153 0.501 . . . . 1.0 110.639 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.2 t -111.05 121.83 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.602 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.2 mt -116.04 130.58 56.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.455 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 66.5 mt -108.04 128.39 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 109.869 -0.419 . . . . 1.0 109.869 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.2 t -145.94 134.01 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.36 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.533 ' OD2' ' ND2' ' A' ' 165' ' ' ASN . 32.7 t70 52.96 44.52 30.32 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.208 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 57.06 25.35 10.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.8 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -128.55 147.8 50.72 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.123 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -101.16 130.36 47.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.854 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -124.59 138.84 54.29 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.165 -0.471 . . . . 1.0 109.916 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -85.29 -38.33 18.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.639 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 57.2 t0 -117.11 144.1 45.06 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.076 0.465 . . . . 1.0 111.728 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.496 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 12.3 tp -64.89 -38.44 90.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.619 -0.719 . . . . 1.0 110.551 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -58.0 -45.06 87.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.96 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -58.39 -38.9 78.29 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.66 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.81 -46.38 96.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.827 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.1 mm -64.27 -43.49 97.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.487 -0.485 . . . . 1.0 111.362 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.05 -43.35 88.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.093 -0.503 . . . . 1.0 112.21 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -71.95 -14.77 62.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.943 0.401 . . . . 1.0 111.267 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -91.94 -50.26 5.81 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.339 -0.544 . . . . 1.0 111.777 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.52 ' O ' HG23 ' A' ' 95' ' ' VAL . 11.0 mp -66.97 -41.51 86.73 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.329 0.492 . . . . 1.0 112.329 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -63.58 -49.9 71.57 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.65 -0.82 . . . . 1.0 111.524 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -70.39 -43.11 70.74 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.465 -0.494 . . . . 1.0 111.961 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -65.85 -42.03 90.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.184 -0.606 . . . . 1.0 111.407 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 91' ' ' LEU . 75.5 t -65.57 -46.08 90.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.185 -0.606 . . . . 1.0 111.395 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -69.42 -44.84 70.55 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.436 -0.506 . . . . 1.0 111.415 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.1 tp -66.02 -42.58 89.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.484 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.6 tp -65.08 -40.27 94.39 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.389 -0.524 . . . . 1.0 110.4 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -67.93 -38.82 83.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.839 -0.618 . . . . 1.0 111.261 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -70.4 -39.97 74.16 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 120.628 -0.429 . . . . 1.0 111.71 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.602 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 2.9 ttt -69.33 -56.27 8.0 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.438 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.417 ' C ' ' H ' ' A' ' 104' ' ' SER . 17.0 m -58.39 -41.45 84.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.085 0.469 . . . . 1.0 110.599 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.8 m -71.64 10.82 0.58 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.625 -0.716 . . . . 1.0 111.276 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 101' ' ' MET . 65.0 p -94.38 133.76 37.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.788 0.327 . . . . 1.0 110.436 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -59.3 -20.55 55.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.812 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.556 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -89.29 40.57 0.99 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.136 -0.483 . . . . 1.0 109.881 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -132.2 114.34 14.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.065 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -139.33 113.12 8.54 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 116.088 -0.505 . . . . 1.0 109.868 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 t -97.41 89.89 4.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.993 0.425 . . . . 1.0 110.876 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -112.45 168.98 12.84 Favored Glycine 0 N--CA 1.467 0.731 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.662 ' O ' HG23 ' A' ' 115' ' ' VAL . 12.8 m -71.86 162.03 30.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.464 ' N ' HG22 ' A' ' 111' ' ' THR . 64.5 tttp -57.02 -37.88 72.35 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.591 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -69.87 -45.22 68.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.164 0.507 . . . . 1.0 110.801 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -68.1 -21.67 64.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.648 -0.706 . . . . 1.0 110.906 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 111' ' ' THR . 41.6 t -69.82 -44.38 79.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.172 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.65 -44.81 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.032 0.444 . . . . 1.0 110.279 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -65.89 -34.26 77.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.902 0.382 . . . . 1.0 110.698 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.4 -50.68 62.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.849 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 120' ' ' GLU . 1.6 tt -70.88 -39.97 75.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.445 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.519 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 58.7 mm-40 -59.98 -41.81 92.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.359 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.58 -46.95 83.49 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.24 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -60.73 -45.84 92.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.066 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.3 t -61.58 -38.15 86.47 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.492 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -61.64 -40.05 93.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.034 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.67 -41.93 94.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 0.0 OUTLIER -126.48 78.83 71.72 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.209 179.24 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.533 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 10.3 Cg_exo -67.9 -20.22 45.46 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.967 2.444 . . . . 1.0 112.339 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -97.19 -6.86 33.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.998 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -113.92 148.04 37.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.871 0.367 . . . . 1.0 110.637 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.6 p -80.16 164.83 23.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.592 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 p -152.71 146.09 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -144.35 142.34 30.31 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.752 0.31 . . . . 1.0 111.14 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -152.54 164.54 37.42 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.51 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.556 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.5 OUTLIER -133.72 157.05 46.82 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 42.1 t -152.59 167.72 27.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.889 0.376 . . . . 1.0 110.223 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.677 HD23 ' N ' ' A' ' 137' ' ' ASN . 1.0 OUTLIER -84.05 136.19 34.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.827 179.503 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.677 ' N ' HD23 ' A' ' 136' ' ' LEU . 47.4 t30 -60.19 -136.18 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.422 -0.353 . . . . 1.0 110.339 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.577 ' H ' ' ND2' ' A' ' 137' ' ' ASN . 32.2 m80 -158.01 -61.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.657 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 139' ' ' ASP . 15.7 p-10 -90.29 1.58 56.38 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.937 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.603 ' H ' HD22 ' A' ' 137' ' ' ASN . 6.6 m120 -116.4 90.53 30.36 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.459 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.42 104.55 1.59 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.081 1.854 . . . . 1.0 112.216 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.48 36.55 2.82 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.409 -1.076 . . . . 1.0 110.409 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -138.21 147.88 44.21 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.525 0.202 . . . . 1.0 110.552 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.602 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 69.5 m-85 -130.86 148.58 52.64 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.719 -0.475 . . . . 1.0 109.719 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.485 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 31.2 m-85 -124.41 136.82 54.36 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.051 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 16.3 mt -107.31 123.69 48.7 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.291 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -116.76 146.35 42.88 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.977 -1.119 . . . . 1.0 107.977 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -161.86 152.03 17.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.519 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 67.2 tttt -136.34 126.73 26.68 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 120.801 -0.359 . . . . 1.0 110.567 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.481 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 3.4 mp -69.59 -47.96 68.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 23.6 m120 -157.48 174.55 15.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.48 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.92 75.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.88 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -85.33 6.88 24.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.039 0.447 . . . . 1.0 110.313 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.6 t -98.31 152.58 19.28 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.416 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.477 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 99.4 mttt -86.2 153.54 21.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.996 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 22.0 tp -69.95 125.9 28.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.407 . . . . 1.0 110.022 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 95.2 m-85 -115.9 127.29 54.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.946 -0.57 . . . . 1.0 109.703 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 94.3 m -126.45 130.81 51.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.823 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -115.63 160.65 19.75 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.054 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.485 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 84.7 m-20 -108.07 145.35 34.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.834 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.8 t -127.52 135.61 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -99.92 131.85 45.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.033 0.444 . . . . 1.0 110.61 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 54.5 tp -92.03 131.04 37.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 1.0 109.868 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 56.0 p -133.6 166.8 21.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.344 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.533 ' ND2' ' OD2' ' A' ' 76' ' ' ASP . 19.6 p30 -78.2 16.29 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.722 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 62.1 p -119.57 -1.23 10.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.425 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 133.93 -125.8 4.03 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.251 -1.14 . . . . 1.0 110.251 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -122.78 129.66 51.99 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.242 -0.281 . . . . 1.0 110.242 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.98 118.1 35.79 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 tt -115.43 118.05 32.1 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.2 t 37.44 54.0 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.007 0.373 . . . . 1.0 112.007 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.8 m120 69.76 27.26 4.67 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.894 0.701 . . . . 1.0 112.894 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -131.96 120.38 22.41 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -94.84 120.68 35.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.364 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -98.09 135.37 21.41 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.438 -0.578 . . . . 1.0 109.438 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.26 -19.12 29.68 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.279 1.986 . . . . 1.0 113.55 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.427 ' OG ' ' OE1' ' A' ' 180' ' ' GLN . 19.4 p -150.1 153.78 36.98 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.968 0.413 . . . . 1.0 110.85 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.42 -36.27 75.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.696 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.475 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 48.5 mm -62.6 -47.63 92.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.946 0.403 . . . . 1.0 110.357 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.427 ' OE1' ' OG ' ' A' ' 177' ' ' SER . 6.0 mp0 -61.56 -30.75 70.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.8 tp -64.25 -40.46 96.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.272 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.619 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 2.6 p -60.27 -47.54 85.57 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.519 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.619 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 51.3 t30 -69.64 -49.01 57.87 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -34.2 -45.26 0.44 Allowed Glycine 0 N--CA 1.465 0.581 0 N-CA-C 109.876 -1.29 . . . . 1.0 109.876 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -67.67 -47.88 68.22 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.1 tttm -56.45 -40.33 74.63 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.54 -0.755 . . . . 1.0 110.1 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 97.9 m -61.04 -45.28 95.44 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.33 -39.71 95.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.872 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 59.7 tp -58.73 -44.55 90.47 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.619 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -59.8 -46.17 90.04 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.737 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.5 t -63.08 -39.9 96.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.197 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.49 -43.08 95.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.64 . . . . 1.0 111.963 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.49 -29.94 67.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.465 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -94.92 -7.52 39.78 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.886 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.414 ' O ' ' C ' ' A' ' 196' ' ' HIS . 86.4 m-70 47.2 56.86 6.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.123 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 195' ' ' HIS . 61.5 t-80 -35.91 -51.23 0.7 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.984 0.421 . . . . 1.0 110.718 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -158.28 -178.56 7.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.644 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -43.96 110.83 0.23 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 70.9 m80 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.055 -0.974 . . . . 1.0 110.728 179.701 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.462 ' O ' ' CG ' ' A' ' 2' ' ' HIS . 52.2 t-80 -84.31 -1.16 54.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.59 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -140.1 12.18 2.41 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.338 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.6 -27.39 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.574 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.4 pt -75.49 -22.06 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.484 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -106.32 5.98 30.13 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.961 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -58.93 150.91 58.01 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 38.2 Cg_endo -65.23 -19.88 62.47 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.171 1.914 . . . . 1.0 112.029 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.4 3.23 54.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.608 -0.269 . . . . 1.0 110.99 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -88.97 125.75 35.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.528 -0.306 . . . . 1.0 110.477 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.421 ' CZ ' ' O ' ' A' ' 8' ' ' PRO . 71.1 m-85 -143.17 128.69 10.07 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 110.186 -0.301 . . . . 1.0 110.186 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.489 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 74.0 Cg_endo -73.3 110.01 2.96 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.758 1.638 . . . . 1.0 112.766 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.489 ' CG ' ' O ' ' A' ' 12' ' ' PRO . 52.4 m-85 -160.98 152.29 19.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.361 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 20.9 t-20 -75.84 165.09 25.52 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.464 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . -57.11 -43.41 93.36 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.461 -0.875 . . . . 1.0 110.937 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 48.6 mmm-85 -67.44 -37.65 83.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.864 0.364 . . . . 1.0 110.596 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -73.57 -32.57 64.22 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.62 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.56 -47.45 85.49 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.417 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -65.89 -36.85 84.56 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.43 ' O ' ' CG ' ' A' ' 23' ' ' ARG . 97.4 m-20 -63.33 -42.76 98.99 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -66.25 -36.55 83.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.715 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 22' ' ' LEU . 10.5 tp -82.12 -11.84 58.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.101 -0.499 . . . . 1.0 111.381 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.43 ' CG ' ' O ' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -65.15 -28.57 69.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.826 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.2 t -83.56 -19.94 34.72 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.714 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -84.93 -178.15 6.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.428 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -88.69 167.9 12.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.799 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -74.72 145.15 43.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.808 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.77 4.95 56.8 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.872 -0.891 . . . . 1.0 110.872 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -88.98 148.3 23.85 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -128.31 165.03 21.33 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.219 0.533 . . . . 1.0 111.027 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.757 ' O ' HG23 ' A' ' 44' ' ' ILE . 3.6 t -145.51 155.03 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.309 -0.86 . . . . 1.0 110.894 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -117.5 122.22 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.541 ' NH1' ' OG ' ' A' ' 35' ' ' SER . 32.8 ptt85 -148.66 158.76 44.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.297 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -107.55 137.08 46.23 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.541 ' OG ' ' NH1' ' A' ' 33' ' ' ARG . 2.9 p 169.16 97.74 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.539 0.524 . . . . 1.0 111.073 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.4 p -169.16 30.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.242 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? 53.15 20.26 1.74 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.233 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.676 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -150.1 89.95 0.14 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.677 -0.969 . . . . 1.0 110.677 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -57.18 11.91 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.225 -0.488 . . . . 1.0 111.142 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.676 ' H ' ' C ' ' A' ' 38' ' ' GLY . 32.0 p-10 -107.76 -0.44 21.72 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -129.59 155.47 45.76 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.783 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.41 150.28 40.46 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.006 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.7 t -126.21 133.29 69.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.109 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 31' ' ' VAL . 61.5 mt -112.53 138.44 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.749 -0.834 . . . . 1.0 108.749 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 87.6 m -116.5 135.37 53.88 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.04 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.598 ' CE2' HD11 ' A' ' 48' ' ' LEU . 1.8 p-90 -146.0 151.75 38.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.934 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.458 ' C ' HD12 ' A' ' 48' ' ' LEU . 35.2 ttmt -98.26 138.03 36.12 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.946 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.598 HD11 ' CE2' ' A' ' 46' ' ' TRP . 9.2 mp -95.82 -73.25 0.6 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.046 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 23.4 t70 -103.07 -170.77 1.84 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.497 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.5 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 7.8 ttpm? -63.17 -38.66 92.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.616 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -127.21 61.25 1.37 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.873 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.8 tp -157.47 130.25 7.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.421 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.3 148.66 50.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.662 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.51 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 26.7 mm100 -143.09 152.37 41.77 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.016 -0.538 . . . . 1.0 109.75 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.51 ' HD1' ' C ' ' A' ' 54' ' ' GLN . 3.7 m-70 -126.36 141.2 51.99 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.288 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.07 123.14 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.291 -0.413 . . . . 1.0 109.931 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -95.67 121.94 37.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.538 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.9 mt -102.47 124.02 56.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.441 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -107.56 136.16 47.8 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -103.34 151.71 22.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.034 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.0 mt -139.81 171.33 14.37 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.493 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 77.66 45.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.246 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.76 77.38 2.84 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.917 -0.583 . . . . 1.0 109.927 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -65.21 -35.84 82.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.585 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -131.09 150.38 76.4 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.01 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.32 -20.39 66.54 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.235 1.957 . . . . 1.0 112.082 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.61 -4.4 50.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.711 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.26 129.79 54.23 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.947 0.403 . . . . 1.0 110.308 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.8 mt -81.21 153.35 27.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.515 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.06 114.0 6.41 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.526 -1.03 . . . . 1.0 110.526 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.98 -10.65 59.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.876 0.37 . . . . 1.0 110.799 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.7 t -117.87 118.83 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.43 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.5 mt -114.76 128.79 56.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.388 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -100.28 120.26 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.883 0.373 . . . . 1.0 110.539 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.555 HG21 HD13 ' A' ' 86' ' ' ILE . 40.9 t -140.65 133.08 31.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.393 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 55.43 43.99 27.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.11 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.3 t30 58.47 21.76 8.84 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.02 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -128.86 152.27 48.7 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.336 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -100.09 131.64 45.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 1.0 111.041 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -128.81 136.8 50.99 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.204 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -85.5 -37.44 19.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.591 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -112.29 141.2 46.3 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.971 0.415 . . . . 1.0 111.575 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.9 -40.44 95.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.726 -0.67 . . . . 1.0 111.173 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 85' ' ' GLN . 42.9 p30 -59.89 -33.66 72.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 1.0 111.64 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.561 ' N ' ' OD1' ' A' ' 84' ' ' ASP . 25.8 mt-30 -65.92 -39.14 90.29 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.799 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.555 HD13 HG21 ' A' ' 75' ' ' VAL . 97.1 mt -62.65 -45.72 98.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.716 -0.394 . . . . 1.0 110.778 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.6 mm -65.12 -44.01 95.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.422 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.453 ' O ' ' CG ' ' A' ' 92' ' ' GLN . 98.1 t -69.36 -44.6 80.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 112.433 0.531 . . . . 1.0 112.433 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -76.95 -13.05 60.02 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.288 -0.565 . . . . 1.0 111.692 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.472 ' OH ' ' CZ2' ' A' ' 46' ' ' TRP . 63.0 t80 -93.85 -48.6 6.21 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.977 0.362 . . . . 1.0 111.977 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.89 -42.45 76.92 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.425 0.528 . . . . 1.0 112.425 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.493 ' CD ' ' N ' ' A' ' 93' ' ' ASN . 1.5 pp0? -63.84 -47.46 80.65 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.025 -0.67 . . . . 1.0 111.526 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.493 ' N ' ' CD ' ' A' ' 92' ' ' GLN . 2.7 t30 -69.27 -42.81 75.05 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.685 -0.406 . . . . 1.0 111.509 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -65.68 -42.86 90.75 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.296 -0.562 . . . . 1.0 111.018 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.7 t -66.04 -46.46 87.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.12 -0.632 . . . . 1.0 111.137 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.497 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 82.6 mtp180 -67.08 -45.54 77.01 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.272 -0.571 . . . . 1.0 111.842 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.456 HD11 ' CZ ' ' A' ' 168' ' ' TYR . 7.1 tp -69.57 -41.43 75.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.534 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.47 -45.72 86.18 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.43 -0.508 . . . . 1.0 110.674 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -69.11 -35.03 76.0 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.439 -0.504 . . . . 1.0 111.161 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -71.72 -42.86 66.8 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.578 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 9.2 tpt -68.78 -52.88 25.56 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.495 -0.482 . . . . 1.0 111.117 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.9 m -58.48 -40.78 83.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 1.0 110.551 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.5 t -72.61 9.77 1.01 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.877 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.0 t -92.26 136.49 33.14 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 110.178 -0.305 . . . . 1.0 110.178 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -62.71 -16.83 59.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.85 0.357 . . . . 1.0 110.836 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.473 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 99.3 mttt -91.76 39.3 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 1.0 109.999 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -132.95 114.84 14.48 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.989 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -130.03 115.5 17.2 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 64.5 p -97.59 81.52 2.95 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.863 0.363 . . . . 1.0 110.912 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.93 167.43 12.32 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.831 -0.908 . . . . 1.0 110.831 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 115' ' ' VAL . 80.9 p -77.28 162.81 27.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.971 -0.381 . . . . 1.0 109.971 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -55.99 -35.68 67.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.554 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.74 -43.61 83.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.651 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -70.78 -19.76 62.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.982 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 111' ' ' THR . 43.2 t -70.25 -44.69 77.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.903 -0.319 . . . . 1.0 110.336 178.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.31 -44.89 94.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.293 0.568 . . . . 1.0 110.395 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -65.65 -34.89 79.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.656 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -67.35 -50.13 61.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.539 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.414 HD11 HG13 ' A' ' 131' ' ' VAL . 8.2 tp -69.7 -39.45 78.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.225 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -63.46 -43.57 96.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.661 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.44 ' HA ' ' HE ' ' A' ' 124' ' ' ARG . 90.5 m-20 -60.86 -47.45 86.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.29 -0.564 . . . . 1.0 110.219 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.562 ' CE2' ' OD1' ' A' ' 126' ' ' ASN . 50.3 t80 -61.42 -40.05 92.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.015 -0.539 . . . . 1.0 109.844 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.6 t -60.35 -42.41 95.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.572 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.44 ' HE ' ' HA ' ' A' ' 121' ' ' ASP . 77.7 mtm180 -61.14 -40.84 95.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.404 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.35 -41.27 83.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.562 ' OD1' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -123.15 73.95 48.91 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.732 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.53 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 41.2 Cg_endo -72.01 -22.26 23.18 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.131 1.887 . . . . 1.0 112.442 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -104.07 24.45 11.39 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.74 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -140.77 151.52 44.5 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.826 0.346 . . . . 1.0 110.633 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.9 p -80.12 162.22 24.88 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.554 -0.535 . . . . 1.0 109.554 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.414 HG13 HD11 ' A' ' 119' ' ' ILE . 3.5 p -152.63 144.76 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.774 -0.454 . . . . 1.0 109.774 178.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.446 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 27.2 p90 -153.49 142.76 21.51 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.962 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -151.76 169.47 22.13 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.438 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.473 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -131.02 149.92 52.39 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.9 t -150.55 169.98 20.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.329 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.6 tp -67.89 140.55 56.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.422 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.607 HD21 ' HA ' ' A' ' 141' ' ' PRO . 9.8 p30 -55.59 -43.64 76.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.565 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 19.2 t60 70.39 -19.71 0.21 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.707 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.533 ' H ' ' C ' ' A' ' 137' ' ' ASN . 30.3 m-20 -103.0 -24.24 13.65 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.065 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.434 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 4.7 p30 -153.56 91.75 3.25 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.11 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.607 ' HA ' HD21 ' A' ' 137' ' ' ASN . 44.8 Cg_exo -54.25 135.26 64.37 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.203 1.935 . . . . 1.0 112.665 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 117.58 -28.99 6.84 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.001 -0.84 . . . . 1.0 111.001 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -113.96 150.49 33.72 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.931 0.396 . . . . 1.0 110.538 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -115.33 156.24 25.85 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -125.36 134.94 52.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.029 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.4 mt -106.68 126.24 52.03 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.651 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -117.15 146.39 43.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 178.472 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -160.86 150.59 17.31 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.216 -0.593 . . . . 1.0 109.723 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -130.94 127.37 38.31 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.746 0.308 . . . . 1.0 110.281 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 37.6 mm -72.92 -46.08 53.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.204 -0.453 . . . . 1.0 111.803 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 152' ' ' ALA . 11.9 t-20 -157.07 169.61 24.41 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.699 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.537 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -60.51 -30.08 69.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.813 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -90.41 8.79 31.88 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.036 0.446 . . . . 1.0 110.393 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 15.6 t -97.45 159.73 14.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.716 -0.674 . . . . 1.0 110.486 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -92.37 153.2 19.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.039 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 48.5 tp -70.84 118.52 13.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -108.07 129.98 55.11 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 51.8 m -126.41 128.94 47.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.611 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -113.9 160.97 18.2 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.035 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 160' ' ' ASN . 50.9 p30 -104.75 147.99 27.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.906 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 47.4 t -128.31 137.48 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.85 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -104.0 131.53 51.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.367 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.0 tp -95.26 130.53 41.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 1.0 109.789 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 48.8 p -127.89 171.01 12.18 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.252 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -84.97 16.48 3.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.851 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m -122.91 -3.25 8.65 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.935 0.398 . . . . 1.0 110.458 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 143.41 -132.24 4.88 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.422 -1.071 . . . . 1.0 110.422 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.456 ' CZ ' HD11 ' A' ' 97' ' ' LEU . 17.5 m-85 -122.91 130.2 52.55 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -106.48 122.52 46.46 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 tt -116.28 118.08 31.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 1.0 109.856 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.466 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 4.7 t 37.48 58.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.176 0.436 . . . . 1.0 112.176 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.5 m120 65.46 27.34 11.76 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.949 0.722 . . . . 1.0 112.949 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.466 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 89.0 m-85 -133.85 120.37 20.35 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -96.49 126.2 41.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.439 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -105.08 131.72 21.52 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -73.31 -20.79 20.75 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.192 1.928 . . . . 1.0 113.31 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 67.9 m -143.86 147.44 34.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.945 0.402 . . . . 1.0 111.218 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.08 -34.51 60.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.67 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 58.8 mt -62.2 -44.95 99.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.886 0.374 . . . . 1.0 110.135 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -67.98 -31.22 70.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.059 -0.519 . . . . 1.0 109.629 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.14 -42.79 99.53 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 110.084 -0.339 . . . . 1.0 110.084 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 73.1 m -63.13 -44.98 94.06 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.26 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.559 ' O ' ' N ' ' A' ' 186' ' ' LYS . 37.3 m-80 -65.73 -48.83 70.59 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.47 -43.43 0.75 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.678 -1.369 . . . . 1.0 109.678 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.461 ' O ' ' HG ' ' A' ' 188' ' ' LEU . 2.6 t80 -69.56 -46.85 65.46 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 122.096 0.951 . . . . 1.0 109.329 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.559 ' N ' ' O ' ' A' ' 183' ' ' ASN . 65.7 tttm -59.01 -35.58 73.51 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.118 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.7 m -63.43 -50.5 69.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 1.0 111.177 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.586 ' C ' HD12 ' A' ' 188' ' ' LEU . 0.7 OUTLIER -66.55 -36.05 81.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.66 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.424 ' N ' ' HG ' ' A' ' 188' ' ' LEU . 45.7 tp -58.03 -43.84 86.99 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.432 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -61.13 -40.28 93.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.956 -0.566 . . . . 1.0 109.792 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.0 t -61.59 -36.85 81.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.741 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 92.6 mt -69.95 -36.94 75.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.405 -0.816 . . . . 1.0 112.047 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.57 -31.88 69.85 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.051 0.389 . . . . 1.0 112.051 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -81.31 -4.44 55.64 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.881 -0.327 . . . . 1.0 110.725 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.407 ' CG ' ' O ' ' A' ' 195' ' ' HIS . 79.0 t60 54.76 40.73 32.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.382 . . . . 1.0 111.064 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -118.51 124.46 47.6 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.417 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -140.96 132.78 27.47 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.012 0.435 . . . . 1.0 110.447 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.459 ' O ' ' CG ' ' A' ' 199' ' ' HIS . 93.3 m-70 -61.1 -41.87 97.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.867 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.459 ' CG ' ' O ' ' A' ' 198' ' ' HIS . 98.2 m-70 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.984 -1.008 . . . . 1.0 110.533 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 81.7 p . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.276 -0.638 . . . . 1.0 109.276 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -131.18 -31.79 1.64 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.602 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.402 ' O ' ' ND1' ' A' ' 7' ' ' HIS . 69.5 mtp180 -108.34 -22.4 12.34 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.895 0.379 . . . . 1.0 110.375 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 p -64.8 -31.36 53.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.556 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.7 pt -73.79 -17.26 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.46 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -98.03 0.32 46.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.389 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.41 ' O ' ' N ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -62.78 123.22 78.76 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.285 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.477 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 77.5 Cg_exo -43.9 -25.72 1.13 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.848 1.699 . . . . 1.0 112.39 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.598 ' CD1' ' CZ ' ' A' ' 30' ' ' PHE . 78.5 m-85 -87.0 9.16 20.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.506 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 7' ' ' HIS . 44.2 t80 -92.68 125.48 37.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.377 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.477 ' CZ ' ' O ' ' A' ' 8' ' ' PRO . 66.1 m-85 -145.3 128.27 8.29 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 110.12 -0.326 . . . . 1.0 110.12 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.88 110.54 3.1 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.717 1.611 . . . . 1.0 112.712 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -154.52 152.48 30.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.439 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -79.31 174.03 11.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.398 -0.593 . . . . 1.0 109.398 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.44 -46.86 93.56 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.403 -0.903 . . . . 1.0 111.338 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -67.32 -35.29 79.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.539 0.209 . . . . 1.0 111.15 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -67.68 -37.22 82.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.379 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.29 94.94 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.691 -0.404 . . . . 1.0 110.425 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.47 -43.99 92.47 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.019 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.61 -42.63 99.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.432 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -63.05 -41.51 99.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.831 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.9 mp -78.63 -11.31 59.96 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.97 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -56.21 -43.52 78.61 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.519 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.0 m -79.3 -15.84 57.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.739 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -81.44 175.57 10.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.472 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -100.9 -176.38 3.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.515 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -82.3 146.2 29.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.88 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.51 14.01 45.77 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.192 -0.763 . . . . 1.0 111.192 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -100.49 144.07 29.91 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.598 ' CZ ' ' CD1' ' A' ' 9' ' ' TYR . 9.1 p90 -132.9 162.19 32.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.116 0.484 . . . . 1.0 110.832 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.739 ' O ' HG23 ' A' ' 44' ' ' ILE . 45.7 t -147.29 157.77 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.193 -0.912 . . . . 1.0 111.533 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.476 ' N ' HG12 ' A' ' 31' ' ' VAL . 80.8 mt -117.75 124.82 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 43' ' ' VAL . 1.5 ptm180 -150.27 156.03 40.8 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.321 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -88.33 169.87 11.46 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 38' ' ' GLY . 16.5 p -81.09 28.13 0.38 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.405 -0.362 . . . . 1.0 110.987 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m 70.94 -41.4 0.5 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.809 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.464 ' H ' ' C ' ' A' ' 35' ' ' SER . 83.9 mtt85 -140.21 19.01 2.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.01 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.486 ' N ' ' OG ' ' A' ' 35' ' ' SER . . . -70.66 -65.18 2.57 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.618 -0.993 . . . . 1.0 110.618 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 68.03 -43.72 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.726 0.298 . . . . 1.0 110.647 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 38' ' ' GLY . 38.2 t70 -94.8 -9.63 33.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.652 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -136.98 151.33 48.87 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.898 0.38 . . . . 1.0 110.348 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.96 147.91 44.81 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.097 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 33' ' ' ARG . 62.4 t -126.47 134.24 66.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.437 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 31' ' ' VAL . 48.1 mt -112.95 138.86 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.1 m -116.9 135.36 53.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.957 -0.565 . . . . 1.0 109.825 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.565 ' CE2' HD11 ' A' ' 48' ' ' LEU . 4.1 p-90 -144.4 148.02 34.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.521 -0.763 . . . . 1.0 110.787 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.543 ' C ' HD12 ' A' ' 48' ' ' LEU . 85.3 tttt -95.29 137.13 34.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.972 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.6 mp -101.87 -82.14 0.48 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.385 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -90.01 174.74 7.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.522 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -58.52 -29.59 66.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.82 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -132.56 52.95 2.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.992 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.0 tp -152.9 136.76 16.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.905 0.384 . . . . 1.0 110.442 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.553 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 87.0 m-85 -131.63 148.22 52.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.385 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 53' ' ' PHE . 98.0 mm-40 -142.73 153.81 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.681 -0.489 . . . . 1.0 109.681 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.502 ' O ' ' ND1' ' A' ' 55' ' ' HIS . 7.7 p80 -129.45 144.65 51.34 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.287 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.3 mt -122.64 125.57 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -96.45 122.67 39.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.952 0.406 . . . . 1.0 110.359 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.3 mt -104.82 129.64 57.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.31 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.862 ' H ' HE21 ' A' ' 59' ' ' GLN . 0.0 OUTLIER -112.23 135.15 53.26 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.096 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.4 ' H ' ' HG3' ' A' ' 60' ' ' GLU . 2.8 pp20? -100.53 151.52 21.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.312 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 1.7 tp -143.5 176.18 9.38 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.513 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.445 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 64.0 tt0 67.63 44.37 1.68 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.264 0.554 . . . . 1.0 109.633 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -83.01 90.44 7.02 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.791 -0.64 . . . . 1.0 109.806 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.466 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 49.4 tp10 -65.66 -38.38 89.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.819 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 64' ' ' GLU . 6.6 m120 -144.16 153.67 56.74 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.259 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.82 -33.83 62.61 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.079 1.853 . . . . 1.0 112.324 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 pp -85.14 -10.92 56.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.857 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.51 133.86 48.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.367 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.2 mt -79.67 152.45 29.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.364 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.86 92.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.01 -37.11 86.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.867 0.365 . . . . 1.0 110.772 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.2 t -122.93 123.0 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.804 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.7 mt -116.13 134.22 55.17 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.5 mm -99.57 120.09 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.919 0.39 . . . . 1.0 110.128 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.66 131.47 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.229 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.405 ' OD2' ' ND2' ' A' ' 165' ' ' ASN . 42.6 t0 54.14 43.45 30.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.18 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 59.54 24.31 13.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.017 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -129.53 156.96 43.32 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.434 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.14 133.51 41.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.187 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.566 ' CG ' HD11 ' A' ' 86' ' ' ILE . 66.1 m-85 -135.19 136.4 41.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.241 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -87.06 -37.66 17.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.889 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -109.33 136.71 48.34 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.21 0.529 . . . . 1.0 112.324 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.4 tp -66.08 -38.12 87.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.767 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 54.1 t0 -59.7 -36.58 76.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.894 -176.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.415 ' OE1' ' OE2' ' A' ' 89' ' ' GLU . 9.5 tt0 -59.8 -38.96 83.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.627 0.251 . . . . 1.0 110.608 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.566 HD11 ' CG ' ' A' ' 80' ' ' TYR . 50.1 mm -60.71 -47.76 91.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.708 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.16 -42.7 96.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 120.512 -0.475 . . . . 1.0 111.786 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.428 ' O ' ' OE1' ' A' ' 92' ' ' GLN . 40.6 t -76.44 -37.57 30.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.152 0.797 . . . . 1.0 113.152 -177.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.415 ' OE2' ' OE1' ' A' ' 85' ' ' GLN . 95.8 mt-10 -84.37 -14.49 49.36 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.912 0.338 . . . . 1.0 111.912 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 12.0 t80 -95.27 -48.7 5.79 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.629 -0.428 . . . . 1.0 112.129 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 95' ' ' VAL . 10.9 mp -69.76 -40.49 76.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.337 0.495 . . . . 1.0 112.337 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.515 ' OE1' ' N ' ' A' ' 92' ' ' GLN . 5.1 mp0 -64.2 -48.95 73.91 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.969 -0.692 . . . . 1.0 111.767 -177.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -69.29 -42.9 74.85 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.622 -0.431 . . . . 1.0 111.866 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.553 ' O ' HD13 ' A' ' 98' ' ' LEU . 42.1 mmtm -66.35 -43.62 85.52 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.359 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 91' ' ' LEU . 47.4 t -61.56 -45.52 98.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.3 -0.56 . . . . 1.0 111.235 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -69.24 -42.7 75.29 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.487 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.8 tp -66.44 -42.24 87.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.616 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 94' ' ' LYS . 8.7 mp -65.4 -41.11 94.02 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.504 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.48 -36.24 78.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.18 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -71.66 -42.28 67.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 120.824 -0.351 . . . . 1.0 111.784 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.3 tpt -67.46 -54.96 15.72 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.438 -0.505 . . . . 1.0 111.65 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.402 HG23 ' CE2' ' A' ' 107' ' ' PHE . 55.3 m -59.68 -29.42 68.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.956 0.407 . . . . 1.0 110.559 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.0 p -74.25 9.61 1.58 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.123 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.7 t -98.45 130.1 45.06 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 110.123 -0.325 . . . . 1.0 110.123 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -58.23 -17.49 19.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.127 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.533 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 98.6 mttt -88.56 40.63 0.97 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.999 -0.546 . . . . 1.0 109.671 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.402 ' CE2' HG23 ' A' ' 102' ' ' THR . 48.6 t80 -135.24 113.41 11.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.104 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -133.44 120.43 20.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.052 -0.522 . . . . 1.0 109.977 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.6 p -91.75 94.68 9.48 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.053 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.2 151.8 16.89 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.595 ' O ' HG23 ' A' ' 115' ' ' VAL . 19.1 p -71.34 162.76 28.92 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -58.92 -40.1 83.54 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.539 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.85 -46.16 72.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.872 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.431 ' OD1' ' OG1' ' A' ' 111' ' ' THR . 2.8 m-20 -71.34 -19.37 62.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.744 -0.662 . . . . 1.0 111.084 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 111' ' ' THR . 10.2 t -73.7 -43.92 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.172 -0.307 . . . . 1.0 110.172 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.0 -46.56 96.21 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 CA-C-O 121.118 0.485 . . . . 1.0 110.054 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -65.86 -34.32 77.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.988 0.423 . . . . 1.0 110.696 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -68.94 -49.29 59.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.731 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.1 tp -70.6 -39.59 76.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.518 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -62.52 -41.65 98.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.765 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.96 -47.63 74.01 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.582 -0.447 . . . . 1.0 110.373 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.536 ' CE1' ' OD1' ' A' ' 126' ' ' ASN . 42.4 t80 -61.39 -42.09 98.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.99 -0.55 . . . . 1.0 109.914 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.5 p -64.87 -33.56 76.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.419 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -61.81 -42.02 98.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.998 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.76 -40.91 90.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.536 ' OD1' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -113.77 75.27 2.69 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.056 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.531 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 41.4 Cg_endo -71.99 -19.35 26.81 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.24 1.96 . . . . 1.0 112.406 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -104.67 -14.64 15.53 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.041 0.386 . . . . 1.0 112.041 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -103.4 147.1 27.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.082 0.467 . . . . 1.0 110.52 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.9 m -80.81 162.1 24.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.515 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 p -153.03 146.36 14.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -149.73 143.05 25.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.885 0.374 . . . . 1.0 111.041 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -151.24 165.25 34.53 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.317 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.533 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -133.57 151.63 51.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.383 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.9 m -146.31 167.51 23.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.252 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.9 tp -79.82 128.81 33.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.612 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.465 ' CG ' ' CD2' ' A' ' 145' ' ' TYR . 5.5 m-20 -53.11 173.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.109 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -127.58 -38.85 1.88 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.531 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -95.44 -8.04 36.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.177 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -136.62 75.5 50.36 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.255 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.406 ' HG2' HE22 ' A' ' 54' ' ' GLN . 32.1 Cg_exo -57.34 132.42 50.79 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.964 1.776 . . . . 1.0 112.442 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 109.43 -33.49 6.06 Favored Glycine 0 N--CA 1.466 0.645 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.432 ' O ' ' CG ' ' A' ' 137' ' ' ASN . 15.6 m0 -92.16 156.49 17.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.723 0.297 . . . . 1.0 110.22 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -119.12 149.77 41.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 1.0 109.834 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.465 ' CD2' ' CG ' ' A' ' 137' ' ' ASN . 35.8 m-85 -120.99 132.99 55.25 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.246 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 15.0 mt -107.32 123.38 48.25 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.236 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.457 ' SD ' HG13 ' A' ' 115' ' ' VAL . 0.9 OUTLIER -120.64 145.32 47.53 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.979 -1.119 . . . . 1.0 107.979 178.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -163.48 151.58 13.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.51 -0.476 . . . . 1.0 109.719 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -128.39 130.57 47.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.761 0.315 . . . . 1.0 110.455 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.424 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.9 mp -75.68 -45.92 37.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.217 0.451 . . . . 1.0 112.217 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 17.5 t-20 -152.15 164.08 38.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.477 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.505 ' N ' ' OD1' ' A' ' 151' ' ' ASN . . . -57.14 -22.89 43.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.776 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -96.87 -4.54 40.04 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.402 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.1 p -82.91 150.76 26.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.488 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.486 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -82.35 154.56 25.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.176 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.2 tp -69.39 113.7 6.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.971 0.415 . . . . 1.0 110.073 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 155' ' ' LYS . 99.0 m-85 -99.92 131.23 46.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.803 -0.635 . . . . 1.0 109.636 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 58.4 m -127.62 130.94 49.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.774 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -117.1 153.26 33.07 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.111 0.481 . . . . 1.0 109.942 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -105.2 144.95 31.28 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.791 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.5 t -127.61 135.44 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.646 -0.502 . . . . 1.0 109.646 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -98.19 131.23 44.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.378 -0.373 . . . . 1.0 110.474 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.3 tp -99.71 131.35 45.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.078 -0.51 . . . . 1.0 109.698 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.1 p -132.58 174.32 10.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.461 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.479 ' ND2' ' H ' ' A' ' 165' ' ' ASN . 3.0 p30 -85.67 17.02 3.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.699 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 44.0 p -121.79 -2.63 9.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.566 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.32 -134.48 6.52 Favored Glycine 0 N--CA 1.465 0.591 0 N-CA-C 110.329 -1.108 . . . . 1.0 110.329 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -122.23 130.15 52.91 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 110.316 -0.253 . . . . 1.0 110.316 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -105.67 119.2 38.53 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.8 tt -117.02 119.73 36.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.8 t 38.54 53.66 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.004 0.372 . . . . 1.0 112.004 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.5 m120 67.7 27.19 7.66 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.017 0.747 . . . . 1.0 113.017 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -135.47 120.68 18.94 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -93.2 126.06 38.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.493 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -102.51 139.63 20.39 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -72.71 -18.59 25.02 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.024 1.816 . . . . 1.0 113.613 -177.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.9 p -154.67 158.24 39.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.917 0.389 . . . . 1.0 110.962 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 179' ' ' ILE . 14.2 p -64.77 -37.52 80.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.141 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.425 ' N ' HG13 ' A' ' 178' ' ' VAL . 80.4 mt -59.7 -45.03 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.306 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.534 ' HA ' HE21 ' A' ' 180' ' ' GLN . 0.3 OUTLIER -63.59 -37.6 87.96 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.594 -0.521 . . . . 1.0 109.594 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.7 tt -64.86 -39.78 94.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.422 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 83.1 m -59.29 -47.87 83.75 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.432 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' A' ' 186' ' ' LYS . 61.2 t30 -69.74 -49.28 54.64 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -35.35 -44.96 0.63 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.699 -1.36 . . . . 1.0 109.699 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.78 -47.34 69.44 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.192 -0.669 . . . . 1.0 109.192 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 183' ' ' ASN . 63.9 tttp -56.56 -41.53 77.03 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.522 -0.763 . . . . 1.0 109.827 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 94.5 m -60.02 -46.98 87.71 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.75 -41.23 98.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 1.0 109.815 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.1 tp -60.24 -45.81 91.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.542 -0.299 . . . . 1.0 110.451 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -60.89 -44.17 97.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.291 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.4 t -64.31 -37.38 87.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.258 0.551 . . . . 1.0 110.499 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.19 -42.26 99.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.87 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -63.5 -25.69 68.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 111.878 0.325 . . . . 1.0 111.878 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -100.48 -8.56 23.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.086 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.514 ' C ' ' H ' ' A' ' 197' ' ' HIS . 96.2 m-70 44.17 42.61 5.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.414 -0.357 . . . . 1.0 111.122 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 196' ' ' HIS . 79.8 t60 56.13 3.44 0.1 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.696 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.514 ' H ' ' C ' ' A' ' 195' ' ' HIS . 85.3 t60 -166.12 -109.12 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.538 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.476 ' N ' ' CG ' ' A' ' 197' ' ' HIS . 85.7 t60 41.35 96.56 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.999 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.401 ' N ' ' ND1' ' A' ' 199' ' ' HIS . 2.9 m80 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.053 -0.975 . . . . 1.0 110.683 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.443 ' O ' ' ND1' ' A' ' 2' ' ' HIS . 52.9 t-80 64.88 2.39 1.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.511 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -141.23 7.94 2.01 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.35 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.85 -26.22 34.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.542 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.0 pt -71.63 -26.66 26.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 1.0 110.689 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -106.95 7.9 30.21 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.575 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -46.8 136.14 7.9 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.313 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -49.05 -31.55 21.16 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.648 1.565 . . . . 1.0 112.526 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.612 ' CE2' ' CZ ' ' A' ' 30' ' ' PHE . 52.0 m-85 -88.38 3.74 48.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.728 0.299 . . . . 1.0 111.244 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.528 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 34.3 t80 -75.12 127.74 33.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.178 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 52.1 m-85 -147.49 108.92 3.86 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.606 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.495 ' O ' ' CD2' ' A' ' 13' ' ' PHE . 31.3 Cg_exo -59.67 111.74 1.05 Allowed 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 121.71 1.607 . . . . 1.0 112.624 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.529 ' O ' ' NH1' ' A' ' 33' ' ' ARG . 56.2 m-85 -160.34 159.39 31.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.29 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.409 ' CG ' ' N ' ' A' ' 15' ' ' GLY . 11.1 t-20 -81.19 164.72 22.11 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.409 ' N ' ' CG ' ' A' ' 14' ' ' ASN . . . -58.26 -48.53 82.92 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.606 -0.998 . . . . 1.0 110.606 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.7 mmp_? -67.32 -39.56 85.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.723 0.297 . . . . 1.0 111.029 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.16 -37.07 84.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.326 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.471 ' O ' HD13 ' A' ' 22' ' ' LEU . . . -61.59 -44.01 97.8 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.669 -0.412 . . . . 1.0 110.414 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.514 ' OE2' ' CD1' ' A' ' 53' ' ' PHE . 42.6 tt0 -61.34 -45.73 93.22 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.045 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.1 -38.71 89.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.322 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.607 ' CE2' ' NZ ' ' A' ' 25' ' ' LYS . 57.3 t80 -67.2 -36.87 82.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.078 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 18' ' ' ALA . 7.8 mp -81.65 -11.88 58.92 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.115 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -63.51 -33.57 75.86 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.248 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -81.18 -20.14 41.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.004 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.607 ' NZ ' ' CE2' ' A' ' 21' ' ' TYR . 48.7 mttp -81.89 176.4 9.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.998 0.428 . . . . 1.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -88.72 165.74 14.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.809 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.538 ' NH2' ' OD1' ' A' ' 99' ' ' ASN . 64.6 ttp85 -65.65 146.18 55.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.949 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.29 22.75 31.19 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.317 -0.713 . . . . 1.0 111.317 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -101.41 142.14 33.24 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.612 ' CZ ' ' CE2' ' A' ' 9' ' ' TYR . 17.3 p90 -133.24 167.19 20.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.489 0.661 . . . . 1.0 110.699 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 45' ' ' THR . 11.0 m -149.68 163.1 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.715 -1.13 . . . . 1.0 111.827 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.518 HD13 ' CG1' ' A' ' 44' ' ' ILE . 3.7 mm -115.65 126.71 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 13' ' ' PHE . 26.8 ttt85 -136.76 162.58 32.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.689 -0.687 . . . . 1.0 110.188 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.523 ' H ' ' CD ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -117.11 128.58 55.27 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.6 t -52.72 -6.21 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.521 ' H ' ' C ' ' A' ' 34' ' ' GLN . 1.5 t 72.07 -49.12 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.442 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -93.39 -6.09 47.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.653 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -70.96 -53.84 10.34 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.632 -0.987 . . . . 1.0 110.632 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 t70 71.44 -36.89 0.38 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.627 0.251 . . . . 1.0 111.084 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 38' ' ' GLY . 98.4 m-20 -120.08 -7.34 9.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.744 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -120.42 146.89 45.76 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.056 0.455 . . . . 1.0 110.944 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.88 151.79 41.39 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.129 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.8 t -125.82 134.36 66.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.299 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.685 HD12 HD11 ' A' ' 58' ' ' ILE . 16.0 mt -110.71 137.16 44.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.571 ' O ' HG22 ' A' ' 31' ' ' VAL . 75.4 m -117.66 134.17 55.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.661 -0.699 . . . . 1.0 109.349 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.742 ' HE1' HE21 ' A' ' 54' ' ' GLN . 2.1 p-90 -151.89 154.21 35.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.349 -0.841 . . . . 1.0 110.768 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -97.87 143.46 28.45 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.293 0.568 . . . . 1.0 111.793 -179.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.2 mt -97.18 -57.76 2.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.226 -0.897 . . . . 1.0 110.35 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -119.38 -166.85 1.32 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.37 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -65.1 -39.29 92.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.793 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -128.13 53.39 1.8 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.281 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.9 tp -153.87 129.36 9.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.263 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CD1' ' OE2' ' A' ' 19' ' ' GLU . 47.8 m-85 -134.99 150.25 50.31 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.983 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.742 HE21 ' HE1' ' A' ' 46' ' ' TRP . 14.9 pt20 -141.07 157.73 44.9 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.164 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -121.77 139.95 52.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.454 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.8 mt -119.41 123.42 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.806 -0.442 . . . . 1.0 109.806 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -96.29 122.1 38.8 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.889 0.376 . . . . 1.0 110.567 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.685 HD11 HD12 ' A' ' 44' ' ' ILE . 86.2 mt -102.64 129.98 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.212 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.574 HE22 ' CD1' ' A' ' 61' ' ' LEU . 1.1 tm0? -119.1 134.62 55.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.131 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 60' ' ' GLU . 0.3 OUTLIER -100.67 157.62 16.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.583 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.574 ' CD1' HE22 ' A' ' 59' ' ' GLN . 1.4 mt -146.18 178.42 8.24 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.106 0.479 . . . . 1.0 110.345 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 58.59 39.59 24.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.385 -0.825 . . . . 1.0 110.5 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' H ' ' HG2' ' A' ' 63' ' ' LYS . 58.2 pttt -81.19 125.88 30.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.382 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -68.84 -30.78 69.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.106 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -162.39 156.95 18.83 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.556 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.64 -33.04 57.19 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.608 1.539 . . . . 1.0 112.295 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.51 -10.35 58.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.507 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.66 135.47 44.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.342 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.8 mt -78.15 148.35 34.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.51 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.68 132.82 14.65 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -77.74 -15.51 59.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.046 0.451 . . . . 1.0 110.806 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.0 t -111.09 119.64 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.682 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.6 mt -115.59 131.91 56.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.539 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.4 mt -102.53 122.33 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.838 0.351 . . . . 1.0 110.443 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.469 HG21 HD13 ' A' ' 86' ' ' ILE . 46.1 t -142.36 133.82 25.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.29 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 56.32 41.24 29.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.681 0.277 . . . . 1.0 111.124 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.36 13.72 5.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.91 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -120.66 151.85 38.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.983 0.421 . . . . 1.0 109.944 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -101.1 126.07 47.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.982 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.538 ' CE1' ' OE2' ' A' ' 89' ' ' GLU . 95.9 m-85 -120.75 139.13 53.53 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.186 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -85.71 -30.42 23.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.584 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 51.4 t0 -123.86 141.65 51.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.01 0.433 . . . . 1.0 111.842 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.4 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 56.6 tp -65.46 -39.9 92.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.584 -0.735 . . . . 1.0 111.147 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.48 -40.19 90.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.727 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -59.7 -39.64 85.23 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.799 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.469 HD13 HG21 ' A' ' 75' ' ' VAL . 96.9 mt -62.44 -46.12 97.17 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 CA-C-O 120.898 0.38 . . . . 1.0 110.955 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 64.8 mt -62.73 -46.07 97.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.976 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.4 t -69.87 -43.58 79.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.81 0.671 . . . . 1.0 112.81 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.538 ' OE2' ' CE1' ' A' ' 80' ' ' TYR . 9.1 pt-20 -80.68 -12.07 59.54 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.523 -0.471 . . . . 1.0 111.666 -177.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.589 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 64.4 t80 -94.19 -49.11 5.89 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.636 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.497 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -70.37 -42.1 72.21 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.348 -0.541 . . . . 1.0 112.118 -177.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -63.9 -49.08 74.08 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.041 -0.664 . . . . 1.0 111.565 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -69.12 -42.77 75.61 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.618 -0.433 . . . . 1.0 111.522 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.589 ' NZ ' ' CE1' ' A' ' 90' ' ' TYR . 15.9 mmtp -65.81 -42.32 90.78 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.39 -0.524 . . . . 1.0 111.228 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 91' ' ' LEU . 53.4 t -65.41 -46.5 89.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.527 -0.469 . . . . 1.0 111.183 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -68.09 -44.02 77.21 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.615 -0.434 . . . . 1.0 111.6 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.2 tp -67.71 -41.64 83.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.267 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.7 tp -65.35 -42.92 92.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.193 -0.603 . . . . 1.0 110.217 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.538 ' OD1' ' NH2' ' A' ' 27' ' ' ARG . 99.2 m-20 -68.04 -36.95 80.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.244 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -71.82 -42.89 66.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 111.892 0.33 . . . . 1.0 111.892 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.5 tpt -66.03 -53.8 33.98 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.213 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.432 HG23 ' CE2' ' A' ' 107' ' ' PHE . 53.8 m -60.14 -36.12 76.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.593 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.9 t -71.07 9.49 0.71 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.879 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 102' ' ' THR . 32.0 t -91.52 134.32 34.75 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 110.001 -0.37 . . . . 1.0 110.001 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -58.59 -19.21 36.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.983 0.42 . . . . 1.0 110.823 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.557 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 60.4 mttp -90.14 39.91 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.785 -0.643 . . . . 1.0 109.798 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.432 ' CE2' HG23 ' A' ' 102' ' ' THR . 87.9 t80 -132.85 120.42 21.51 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.535 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.59 124.02 15.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.142 -0.481 . . . . 1.0 109.906 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.3 m -100.17 86.66 3.27 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.734 0.302 . . . . 1.0 110.968 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.16 163.63 12.12 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.924 -0.87 . . . . 1.0 110.924 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.578 ' CB ' ' HZ3' ' A' ' 113' ' ' LYS . 61.6 p -77.65 169.52 18.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.945 -0.391 . . . . 1.0 109.945 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -58.6 -38.59 78.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.912 0.387 . . . . 1.0 110.561 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.578 ' HZ3' ' CB ' ' A' ' 111' ' ' THR . 25.0 pttm -69.27 -39.53 78.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.654 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -70.08 -24.46 63.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.874 -0.603 . . . . 1.0 111.154 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 111' ' ' THR . 48.8 t -70.65 -45.5 73.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.509 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 82.6 t -63.67 -46.66 94.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.106 0.479 . . . . 1.0 110.445 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -66.04 -37.42 85.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.085 0.469 . . . . 1.0 110.896 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -67.11 -49.24 65.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.751 -0.659 . . . . 1.0 111.763 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.415 HG23 ' N ' ' A' ' 120' ' ' GLU . 11.1 tp -69.84 -40.0 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.55 -0.46 . . . . 1.0 110.47 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 119' ' ' ILE . 96.3 mt-10 -65.44 -41.64 93.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.806 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -63.82 -48.17 77.91 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.448 -0.501 . . . . 1.0 110.297 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -60.45 -44.57 95.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.007 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 81.2 p -66.25 -28.6 68.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.038 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -63.96 -43.87 94.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.337 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.7 t -66.82 -41.76 88.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.298 -0.41 . . . . 1.0 109.938 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -122.02 75.43 39.38 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.561 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -71.3 -13.51 30.81 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.662 2.241 . . . . 1.0 112.34 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -106.2 24.87 11.76 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.642 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -141.13 151.72 44.14 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.86 0.362 . . . . 1.0 110.743 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 86.5 p -80.78 160.81 24.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.119 -0.491 . . . . 1.0 109.841 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.6 p -153.97 144.86 14.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.597 -0.52 . . . . 1.0 109.597 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 19.0 p90 -153.33 143.61 22.36 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.691 -0.404 . . . . 1.0 111.104 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -152.57 169.71 21.97 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.355 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 1.6 p90 -136.77 156.12 48.93 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 28.8 t -148.55 169.5 20.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.322 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.4 tp -74.59 146.46 42.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.483 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 138' ' ' HIS . 28.1 t-20 -42.74 147.96 0.27 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.539 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.43 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 92.5 m-70 -60.05 -50.24 74.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.018 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 139' ' ' ASP . 25.7 p-10 -156.7 44.09 0.39 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.536 -0.302 . . . . 1.0 110.629 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.412 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 73.3 m-20 -160.26 84.32 2.07 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.31 144.86 92.28 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.699 1.599 . . . . 1.0 112.671 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.401 ' C ' ' CD1' ' A' ' 143' ' ' TRP . . . 142.93 -39.25 1.35 Allowed Glycine 0 C--O 1.226 -0.382 0 N-CA-C 110.887 -0.885 . . . . 1.0 110.887 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.534 ' CD1' ' N ' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -134.95 153.89 51.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.812 0.339 . . . . 1.0 110.188 -179.353 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -102.36 156.97 17.24 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -113.37 134.9 54.39 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.093 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.466 HD12 ' CG2' ' A' ' 161' ' ' VAL . 12.3 mt -110.55 126.17 54.12 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.436 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.62 142.98 51.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.644 -1.243 . . . . 1.0 107.644 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -159.43 160.25 34.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.781 -0.451 . . . . 1.0 109.781 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -138.57 128.63 25.48 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.858 0.361 . . . . 1.0 110.686 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.442 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.8 mp -72.43 -44.98 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.787 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.411 ' H ' ' HB3' ' A' ' 154' ' ' SER . 77.9 m-20 -160.83 174.0 14.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.729 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.38 -32.81 73.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.784 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -83.68 -13.15 54.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.143 0.496 . . . . 1.0 110.376 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.411 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 8.8 t -80.09 157.15 26.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.473 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -90.28 157.37 17.7 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.989 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 30.8 tp -76.57 121.66 23.49 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.087 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -108.32 136.39 48.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.743 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 99.8 m -128.98 132.33 47.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.905 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -123.37 161.89 23.82 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.803 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -109.72 151.79 26.47 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.796 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.466 ' CG2' HD12 ' A' ' 146' ' ' LEU . 67.8 t -127.78 134.18 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -97.54 132.35 43.3 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.027 0.442 . . . . 1.0 111.061 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.4 tp -92.23 130.28 37.97 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.727 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.454 ' C ' ' H ' ' A' ' 166' ' ' THR . 65.7 p -129.58 157.35 42.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.339 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -73.45 15.21 0.26 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.645 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 164' ' ' THR . 19.3 p -121.46 -2.43 9.48 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.775 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.51 -135.49 7.06 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.477 -1.049 . . . . 1.0 110.477 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -118.9 131.68 56.06 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.551 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 5.9 m-85 -109.33 118.7 37.38 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.8 tt -109.29 121.3 44.87 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.465 ' O ' ' CD2' ' A' ' 173' ' ' TYR . 5.0 t 34.93 59.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.467 0.543 . . . . 1.0 112.467 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 63.26 27.54 15.51 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.981 0.734 . . . . 1.0 112.981 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.465 ' CD2' ' O ' ' A' ' 171' ' ' VAL . 79.3 m-85 -132.75 121.88 23.71 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.303 -0.628 . . . . 1.0 109.303 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.551 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 8.3 t-20 -91.15 133.4 35.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.391 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -115.65 131.88 23.44 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.903 -0.589 . . . . 1.0 109.462 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.66 -21.33 19.26 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.171 1.914 . . . . 1.0 113.443 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 73.4 m -147.99 150.99 35.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.928 0.394 . . . . 1.0 111.25 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.94 -36.3 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.833 -0.622 . . . . 1.0 110.857 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.431 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 46.6 mm -60.95 -45.98 97.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 1.0 110.066 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -65.82 -32.3 73.76 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.1 tp -63.95 -42.31 97.35 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.465 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.611 ' SG ' ' N ' ' A' ' 183' ' ' ASN . 5.1 p -60.99 -47.88 84.39 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.632 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.611 ' N ' ' SG ' ' A' ' 182' ' ' CYS . 36.3 t30 -66.71 -48.51 69.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.744 -0.783 . . . . 1.0 108.983 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.57 -45.01 0.95 Allowed Glycine 0 N--CA 1.462 0.374 0 N-CA-C 109.907 -1.277 . . . . 1.0 109.907 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -68.89 -47.48 65.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.516 -0.55 . . . . 1.0 109.516 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 183' ' ' ASN . 36.4 ttpt -56.66 -39.53 73.91 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.544 -0.753 . . . . 1.0 109.982 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 19.9 m -60.58 -45.94 92.09 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.416 ' O ' ' OG ' ' A' ' 191' ' ' SER . 75.8 mt -63.73 -39.42 94.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.865 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.6 tp -58.88 -43.31 90.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.903 0.383 . . . . 1.0 110.458 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -59.09 -45.71 90.17 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.527 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 188' ' ' LEU . 77.6 p -61.79 -36.89 82.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.167 0.508 . . . . 1.0 110.619 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.8 mt -69.47 -39.44 77.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.381 -0.827 . . . . 1.0 111.954 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -62.46 -29.17 70.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.892 0.33 . . . . 1.0 111.892 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -82.44 6.23 17.95 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.907 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 77.7 m80 43.75 41.5 3.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.049 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 56.08 -176.68 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.582 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -154.54 -26.3 0.12 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.575 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -66.18 -39.95 90.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.849 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 80.5 m80 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.022 -0.99 . . . . 1.0 110.453 -179.692 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.493 ' O ' HG12 ' A' ' 4' ' ' VAL . 81.9 p . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -87.3 -0.25 56.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.534 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -111.38 -2.57 15.56 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.817 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 1' ' ' THR . 14.1 p -64.46 -30.48 50.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.532 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.1 pt -71.01 -15.23 18.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.515 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -94.21 -0.1 55.38 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.44 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.73 140.67 59.08 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.217 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.13 -21.39 62.74 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.111 1.874 . . . . 1.0 112.116 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.451 ' CE1' ' CZ ' ' A' ' 30' ' ' PHE . 24.5 m-85 -92.24 10.16 30.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.202 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' A' ' 11' ' ' PHE . 79.0 t80 -84.47 128.07 34.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.423 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 64.2 m-85 -150.89 114.78 3.18 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 110.154 -0.313 . . . . 1.0 110.154 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.91 110.09 3.01 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.743 1.629 . . . . 1.0 112.919 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -155.53 153.77 30.73 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.539 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.463 ' ND2' ' H ' ' A' ' 15' ' ' GLY . 11.2 t-20 -77.68 164.45 25.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.463 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -57.84 -42.73 94.77 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.207 -0.997 . . . . 1.0 110.948 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -66.31 -42.96 87.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.745 0.307 . . . . 1.0 110.963 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -67.86 -33.82 75.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.277 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.43 -43.01 97.23 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.257 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -58.61 -42.29 87.85 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.582 -0.447 . . . . 1.0 109.992 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -62.21 -46.52 88.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.503 . . . . 1.0 110.287 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -60.18 -40.95 91.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.446 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.34 -13.59 60.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.952 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -58.49 -43.85 89.17 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.403 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.4 t -76.43 -19.44 58.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.718 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -83.28 177.05 8.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.527 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.6 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 52.2 mp0 -105.3 -176.93 3.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.738 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -74.92 144.69 43.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.828 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.51 -0.34 61.4 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.219 -0.753 . . . . 1.0 111.219 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -83.88 144.3 29.31 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.659 ' CD1' HD21 ' A' ' 91' ' ' LEU . 16.8 p90 -136.73 165.58 25.58 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.177 0.513 . . . . 1.0 110.971 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 32' ' ' ILE . 60.3 t -146.98 156.58 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.087 -0.961 . . . . 1.0 111.67 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.463 ' N ' HG12 ' A' ' 31' ' ' VAL . 91.6 mt -117.3 124.19 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -152.02 153.17 33.48 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.336 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -108.41 152.19 25.01 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.917 -0.401 . . . . 1.0 109.917 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 t -82.36 145.19 30.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.843 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 m -59.02 -39.07 80.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.664 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -95.41 6.95 47.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.792 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' A' ' 40' ' ' ASP . . . -86.97 -79.75 1.22 Allowed Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.572 -1.011 . . . . 1.0 110.572 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 t70 68.8 -38.89 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 1.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 38' ' ' GLY . 36.5 t70 -104.11 2.44 31.99 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.828 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -143.82 153.62 42.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.946 0.403 . . . . 1.0 110.283 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.12 148.8 42.66 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.952 -0.567 . . . . 1.0 109.752 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.21 132.46 71.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.221 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.694 HD12 HD11 ' A' ' 58' ' ' ILE . 56.8 mt -111.7 138.36 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 108.949 -0.76 . . . . 1.0 108.949 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 87.9 m -120.73 138.7 53.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.575 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.767 ' HE1' ' NE2' ' A' ' 54' ' ' GLN . 2.9 p-90 -153.91 148.11 25.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.884 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.476 ' HZ3' ' C ' ' A' ' 49' ' ' ASP . 64.1 tttm -88.93 141.19 28.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.128 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.425 HD21 ' CZ2' ' A' ' 46' ' ' TRP . 26.2 mt -98.76 -68.06 0.82 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.072 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.476 ' C ' ' HZ3' ' A' ' 47' ' ' LYS . 38.2 t0 -136.11 171.22 14.79 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.186 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -46.64 130.58 11.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.986 0.422 . . . . 1.0 110.897 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 56.37 39.82 29.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.06 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.8 tp -149.01 122.38 9.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.784 0.326 . . . . 1.0 110.443 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -135.56 149.92 49.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.568 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.767 ' NE2' ' HE1' ' A' ' 46' ' ' TRP . 6.7 pt20 -139.43 156.49 46.93 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.958 -0.564 . . . . 1.0 109.823 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -125.41 142.28 51.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.301 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 83.1 mt -120.48 122.84 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -93.98 120.83 34.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.877 0.37 . . . . 1.0 110.496 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.694 HD11 HD12 ' A' ' 44' ' ' ILE . 92.6 mt -100.84 128.96 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.422 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -112.29 141.78 45.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.171 -0.468 . . . . 1.0 109.781 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -98.73 152.79 19.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 1.0 109.988 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 2.9 tp -141.56 165.49 27.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.696 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.493 ' H ' ' HG ' ' A' ' 61' ' ' LEU . 72.6 tt0 66.04 48.61 1.72 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.41 0.624 . . . . 1.0 109.719 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 32.5 pttt -102.44 107.81 18.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.988 -0.551 . . . . 1.0 109.945 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -67.26 -25.19 65.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.857 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -159.23 158.22 28.2 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.214 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.96 -34.39 56.22 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.213 1.942 . . . . 1.0 112.074 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.494 ' CD2' ' H ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -85.49 -10.24 56.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.688 -179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.67 145.12 55.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.299 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.7 mt -77.81 151.84 33.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.371 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.22 91.25 1.13 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.673 -0.971 . . . . 1.0 110.673 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -63.78 -32.36 73.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.037 0.446 . . . . 1.0 110.596 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.7 t -125.26 124.18 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.787 -0.642 . . . . 1.0 111.051 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.13 131.07 57.04 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.0 mt -100.22 120.93 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.899 0.381 . . . . 1.0 110.179 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -141.59 132.54 26.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.235 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 56.15 43.11 27.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.717 0.294 . . . . 1.0 111.025 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.4 t30 59.27 15.9 4.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.779 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -121.68 146.52 46.93 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.228 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -99.57 126.26 45.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.644 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -125.06 137.33 54.21 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.028 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -85.75 -38.49 18.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.831 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -105.3 135.33 46.87 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.127 0.489 . . . . 1.0 111.935 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 58.2 tp -63.81 -41.93 97.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.571 -0.74 . . . . 1.0 110.672 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -60.27 -42.44 95.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 1.0 111.92 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -60.98 -37.24 81.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.762 0.315 . . . . 1.0 110.644 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.01 -44.92 99.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.564 -0.454 . . . . 1.0 110.551 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.4 mm -62.92 -44.78 99.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.449 -0.5 . . . . 1.0 111.35 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.492 ' O ' ' CG ' ' A' ' 92' ' ' GLN . 79.7 t -67.49 -45.67 84.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 112.723 0.638 . . . . 1.0 112.723 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.06 -19.38 61.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.739 0.304 . . . . 1.0 111.76 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -93.59 -50.73 5.27 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.353 -0.539 . . . . 1.0 111.781 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.659 HD21 ' CD1' ' A' ' 30' ' ' PHE . 11.1 mp -66.6 -43.64 84.31 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.382 0.512 . . . . 1.0 112.382 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.492 ' CG ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -65.75 -41.9 91.58 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.098 -0.641 . . . . 1.0 111.455 -177.753 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -70.94 -44.12 66.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.304 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -65.9 -41.99 90.77 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.239 -0.585 . . . . 1.0 111.154 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.0 t -65.53 -44.51 94.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.363 -0.535 . . . . 1.0 111.114 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.529 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -66.56 -46.96 74.32 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.569 -0.453 . . . . 1.0 111.706 -178.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 tp -69.78 -41.13 75.54 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.717 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.1 tp -61.61 -44.63 96.63 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.344 -0.542 . . . . 1.0 110.565 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.529 ' ND2' ' HA ' ' A' ' 96' ' ' ARG . 1.1 p30 -70.0 -35.97 74.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.154 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.454 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 44.2 tt0 -71.37 -43.81 66.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.564 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 144' ' ' PHE . 5.5 ttt -66.93 -55.08 16.15 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.575 -0.45 . . . . 1.0 111.63 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.42 HG23 ' CE2' ' A' ' 107' ' ' PHE . 52.6 m -57.82 -37.99 74.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.071 0.462 . . . . 1.0 110.639 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 41.4 t -72.33 10.36 0.81 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.636 -0.711 . . . . 1.0 110.999 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 101' ' ' MET . 78.1 p -92.91 135.46 34.13 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.565 -0.288 . . . . 1.0 110.454 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.59 -16.72 40.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.567 ' O ' ' CE2' ' A' ' 134' ' ' PHE . 24.2 mmtp -93.82 38.46 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 1.0 109.808 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.42 ' CE2' HG23 ' A' ' 102' ' ' THR . 86.8 t80 -132.04 111.83 11.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.284 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -131.06 114.0 14.63 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.7 p -89.67 88.97 7.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.001 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.79 156.32 15.71 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.538 ' O ' HG23 ' A' ' 115' ' ' VAL . 67.8 p -75.05 169.58 17.73 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -57.28 -38.32 73.75 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.841 -0.343 . . . . 1.0 110.415 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -68.49 -42.94 77.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.356 0.598 . . . . 1.0 110.933 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 51.6 t0 -68.09 -21.78 64.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.411 -0.813 . . . . 1.0 110.89 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 111' ' ' THR . 44.4 t -71.63 -43.33 71.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.767 0.317 . . . . 1.0 110.198 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.83 -47.13 92.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.09 0.471 . . . . 1.0 110.409 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -65.66 -38.24 88.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.076 0.465 . . . . 1.0 110.851 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -65.02 -49.81 68.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.821 -0.627 . . . . 1.0 111.76 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.401 HD11 HG13 ' A' ' 131' ' ' VAL . 10.6 tp -70.26 -39.49 76.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.866 0.365 . . . . 1.0 110.571 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.513 ' OE2' ' NZ ' ' A' ' 149' ' ' LYS . 63.7 mm-40 -62.67 -42.75 99.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.553 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -61.14 -47.68 85.12 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.574 -0.45 . . . . 1.0 110.279 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -61.12 -39.7 91.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.104 -0.498 . . . . 1.0 109.77 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.5 p -60.16 -38.59 83.63 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.404 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -62.46 -40.32 96.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.258 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.03 -42.69 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.657 -0.498 . . . . 1.0 109.657 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.74 75.67 79.4 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.2 178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.31 -23.43 44.73 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.75 2.3 . . . . 1.0 112.53 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -95.89 -9.75 30.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.146 -0.479 . . . . 1.0 112.028 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -107.29 149.83 27.35 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.977 0.418 . . . . 1.0 110.379 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.9 p -80.83 162.81 23.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.757 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.401 HG13 HD11 ' A' ' 119' ' ' ILE . 3.9 p -152.37 147.55 14.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.489 ' O ' ' CD1' ' A' ' 133' ' ' TYR . 28.7 p90 -149.39 142.61 25.08 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.789 0.328 . . . . 1.0 111.118 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 29.7 m-85 -151.75 169.2 22.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.306 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.567 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -133.83 152.62 51.93 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 179.19 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 72.3 m -152.11 170.16 20.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.419 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.0 tp -80.94 145.2 31.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.839 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 140' ' ' ASN . 4.3 p30 -53.85 -171.89 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.179 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.463 ' CG ' ' O ' ' A' ' 138' ' ' HIS . 35.4 t-80 -135.31 35.2 3.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.531 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -169.63 -53.89 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.67 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.52 ' O ' ' ND2' ' A' ' 137' ' ' ASN . 21.3 t-20 -105.16 86.69 1.67 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.099 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.473 ' HA ' HD21 ' A' ' 137' ' ' ASN . 29.9 Cg_endo -64.61 100.76 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.077 1.851 . . . . 1.0 112.316 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.506 ' H ' HD21 ' A' ' 137' ' ' ASN . . . 169.55 -36.3 0.19 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.517 -1.033 . . . . 1.0 110.517 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.407 ' CD1' ' N ' ' A' ' 143' ' ' TRP . 21.5 m95 -98.7 144.7 27.67 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 110.04 -0.356 . . . . 1.0 110.04 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 101' ' ' MET . 61.7 m-85 -107.42 149.6 27.71 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.173 -0.467 . . . . 1.0 109.778 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.405 ' CE2' ' OD1' ' A' ' 160' ' ' ASN . 32.3 m-85 -120.41 137.68 54.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.394 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.426 HD12 ' CG2' ' A' ' 161' ' ' VAL . 11.8 mt -110.04 121.01 44.26 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.318 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.553 ' N ' ' SD ' ' A' ' 147' ' ' MET . 0.0 OUTLIER -116.41 145.89 42.91 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 178.402 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -159.69 155.26 25.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.513 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 64.5 tttt -141.36 129.61 22.27 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.752 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.5 mm -71.15 -46.48 66.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.875 -0.33 . . . . 1.0 111.725 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 151' ' ' ASN . 7.6 p-10 -162.24 177.88 9.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.35 . . . . 1.0 110.589 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.29 -32.89 74.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.067 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -84.45 7.59 19.22 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.018 0.437 . . . . 1.0 110.713 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.462 ' HB3' ' H ' ' A' ' 151' ' ' ASN . 1.5 t -104.99 158.4 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.08 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -88.88 162.46 16.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.969 -0.56 . . . . 1.0 109.91 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.6 tp -80.38 118.94 22.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.982 0.42 . . . . 1.0 110.281 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -105.27 132.86 50.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.738 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 87.0 m -130.6 130.46 44.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.847 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -116.35 161.09 19.58 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.075 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.405 ' OD1' ' CE2' ' A' ' 145' ' ' TYR . 78.0 m-20 -107.2 144.68 33.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.739 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.426 ' CG2' HD12 ' A' ' 146' ' ' LEU . 58.8 t -126.57 136.7 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -99.62 130.41 45.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.912 0.387 . . . . 1.0 110.759 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.8 tp -92.36 130.8 37.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.032 -0.531 . . . . 1.0 109.66 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.3 p -129.73 165.76 21.24 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.0 0.429 . . . . 1.0 110.35 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -79.23 15.72 1.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.628 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 20.0 p -122.27 -2.31 9.08 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.802 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 140.56 -131.87 5.19 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.419 -1.072 . . . . 1.0 110.419 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.85 130.55 53.02 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.077 -0.342 . . . . 1.0 110.077 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.629 ' CE1' ' ND2' ' A' ' 174' ' ' ASN . 5.7 m-85 -107.52 121.71 45.19 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.821 -0.437 . . . . 1.0 109.821 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 171' ' ' VAL . 7.8 tt -114.38 119.1 35.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.711 -0.477 . . . . 1.0 109.711 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 170' ' ' LEU . 3.5 t 36.16 57.92 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 112.166 0.432 . . . . 1.0 112.166 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 14.5 m120 65.27 27.17 12.16 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.045 0.757 . . . . 1.0 113.045 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -133.95 119.95 19.72 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' A' ' 169' ' ' PHE . 8.1 t-20 -93.67 129.03 40.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 1.0 111.226 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -107.77 101.39 40.13 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -45.91 -23.49 1.72 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.489 2.126 . . . . 1.0 113.33 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.96 146.66 37.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 1.0 111.009 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.47 -33.42 56.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.92 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 179' ' ' ILE . 33.9 mm -60.87 -44.2 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.278 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -69.7 -30.34 67.96 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.5 -0.555 . . . . 1.0 109.5 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.29 -43.08 98.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.281 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 93.5 m -63.7 -46.49 85.24 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.336 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 186' ' ' LYS . 75.9 m-20 -65.19 -48.82 72.07 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 183' ' ' ASN . . . -36.09 -45.68 0.89 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -68.92 -45.91 69.64 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 183' ' ' ASN . 36.6 tptt -57.14 -40.88 78.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.455 -0.793 . . . . 1.0 109.902 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 16.5 m -59.71 -46.7 88.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.1 -40.32 95.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.826 -0.624 . . . . 1.0 109.881 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 59.3 tp -57.87 -45.7 85.94 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.647 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -54.83 -45.65 74.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.167 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.7 t -62.25 -40.75 97.22 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.161 0.505 . . . . 1.0 110.34 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.41 -37.02 86.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.761 -0.654 . . . . 1.0 111.974 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -58.33 -30.14 66.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.622 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -82.2 -7.41 59.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.92 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 195' ' ' HIS . 83.9 t60 50.73 49.34 21.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.01 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.511 ' O ' ' N ' ' A' ' 198' ' ' HIS . 50.0 t-80 -91.35 45.87 1.27 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.397 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 86.1 t60 53.89 -83.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.599 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 196' ' ' HIS . 85.7 t60 -151.97 118.6 5.71 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.475 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.427 ' ND1' ' N ' ' A' ' 199' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.087 -0.959 . . . . 1.0 110.65 179.928 . . . . . . . . 2 2 . 1 stop_ save_